fusionGenePair	tumorAnnotations
A1BG::ITIH4	Adenocarcinoma
A2M::ALK	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma | Soft tissue tumor, special type
A2M::ARFGEF2	Adenocarcinoma
A2M::CCT5	Adenocarcinoma
A2M::CLEC2A	Adenocarcinoma
A2M::FAR1	Adenocarcinoma
A2M::SERPINA1	Adenocarcinoma
A2M::TMEM52B	Adenocarcinoma
AAAS::ATP5MC2	Transitional cell carcinoma
AAAS::ITGB7	Squamous cell carcinoma
AACS::DNAH10	Adenocarcinoma
AACS::MAL	Adenocarcinoma
AACS::TMEM132B	Astrocytoma, grade I-II
AAGAB::SMAD3	Mesenchymal tumor, NOS
AAK1::C2ORF42	Adenocarcinoma
AAK1::C2orf42	Adenocarcinoma
AAK1::GALNT14	Squamous cell carcinoma
AAK1::KCMF1	Adenocarcinoma
AAK1::LHX2	Malignant epithelial tumor, special type
AAK1::RPIA	Adenocarcinoma
AAK1::WFDC13	Squamous cell carcinoma
AAMDC::RSF1	Adenocarcinoma
AAMDC::SCGB1D1	Squamous cell carcinoma
AAMDC::SPCS2	Adenocarcinoma
AAMDC::TMEM135	Adenocarcinoma
AAMP::MARCHF4	Squamous cell carcinoma
AARS1::COG4	Adenocarcinoma
AARS1::PPP1R13B	Adenocarcinoma
AARS1::ST3GAL2	Adenocarcinoma
AARS2::SPATS1	Adenocarcinoma
AARSD1::CCR7	Adenocarcinoma
AARSD1::CHRNB1	Malignant epithelial tumor, special type
AARSD1::FBXL20	Transitional cell carcinoma
AARSD1::RGS9	Squamous cell carcinoma
AASDH::CC2D2A	Adenocarcinoma
AASDH::LRRC66	Astrocytoma, grade III-IV/Glioblastoma
AASDHPPT::ABTB2	Adenocarcinoma
AASDHPPT::CARD16	Transitional cell carcinoma
AASS::CADPS2	Squamous cell carcinoma
AASS::DNM3	Mesenchymal tumor, NOS
AATF::ACACA	Adenocarcinoma
AATF::AP2B1	Mesenchymal tumor, NOS
AATF::FTL	Squamous cell carcinoma
AATF::GOSR2	Adenocarcinoma
AATF::KRT15	Adenocarcinoma
AATF::LIG3	Adenocarcinoma
AATF::PCDH11X	Squamous cell carcinoma
AATF::TADA2A	Adenocarcinoma
AATF::UBE2G1	Adenocarcinoma
AATK::FOXP1	Adenocarcinoma
AATK::LAMA5	Adenocarcinoma
AATK::USP32	Adenocarcinoma
ABAT::MARF1	Astrocytoma, grade I-II
ABAT::USP7	Adenocarcinoma
ABAT::VPS35L	Adenocarcinoma
ABCA12::MICU1	Squamous cell carcinoma
ABCA12::SGPP2	Adenocarcinoma
ABCA13::BLVRA	Squamous cell carcinoma
ABCA13::CAP1	Squamous cell carcinoma
ABCA1::HDHD3	Adenocarcinoma
ABCA1::PTGR1	Squamous cell carcinoma
ABCA1::RAB5C	Transitional cell carcinoma
ABCA1::ZBTB26	Squamous cell carcinoma
ABCA1::ZBTB6	Squamous cell carcinoma
ABCA1::ZNF483	Malignant melanoma
ABCA2::TRIM14	Astrocytoma, grade I-II
ABCA3::ATP23	Astrocytoma, grade I-II
ABCA3::RPS16	Multiple myeloma
ABCA5::BCAS3	Adenocarcinoma
ABCA5::C17ORF67	Squamous cell carcinoma
ABCA5::C17orf67	Squamous cell carcinoma
ABCA5::DSCAM	Acute myeloid leukemia, NOS | Skin
ABCA5::MBTD1	Squamous cell carcinoma
ABCA6::LIG3	Adenocarcinoma
ABCA7::CIRBP	Transitional cell carcinoma
ABCA7::COL5A3	Adenocarcinoma
ABCA7::STK11	Transitional cell carcinoma
ABCA9::CEP112	Mesenchymal tumor, NOS
ABCA9::TANC2	Mesenchymal tumor, NOS
ABCB1::GIPC1	Adenocarcinoma
ABCB4::TMEM169	Adenocarcinoma
ABCB7::ACSS2	Adenocarcinoma
ABCB8::IQCA1L	Adenocarcinoma
ABCB8::NOS3	Adenocarcinoma
ABCB9::EIF2B1	Adenocarcinoma
ABCB9::MPHOSPH9	Squamous cell carcinoma
ABCC10::PPP2R5D	Adenocarcinoma
ABCC1::DLGAP1	Adenocarcinoma
ABCC1::NDE1	Squamous cell carcinoma
ABCC1::PRKCB	Adenocarcinoma
ABCC2::CTNNA3	Adenocarcinoma
ABCC2::TSPAN14	Adenocarcinoma
ABCC2::UQCC5	Adenocarcinoma
ABCC3::ACSF2	Adenocarcinoma
ABCC3::BCAN	Adenocarcinoma
ABCC3::DHDH	Adenocarcinoma
ABCC3::KAT7	Adenocarcinoma
ABCC3::TMEM104	Adenocarcinoma
ABCC3::XYLT2	Adenocarcinoma
ABCC4::ABCB4	Squamous cell carcinoma
ABCC4::CCDC169	Adenocarcinoma
ABCC4::COL4A2	Adenocarcinoma
ABCC4::ETV4	Adenocarcinoma
ABCC4::PTPN4	Malignant melanoma
ABCC4::UGGT2	Malignant epithelial tumor, special type
ABCC5::ATP11B	Squamous cell carcinoma
ABCC5::DCUN1D1	Squamous cell carcinoma
ABCC5::NAALADL2	Adenocarcinoma
ABCC5::SPRR4	Malignant melanoma
ABCC6::LTA4H	Adenocarcinoma
ABCC6::PHAF1	Acute myeloid leukemia, NOS | Skin
ABCC9::DMKN	Adenocarcinoma
ABCC9::RASSF8	Adenocarcinoma
ABCD3::ABCA4	Adenocarcinoma
ABCD3::AK5	Squamous cell carcinoma
ABCD3::ARHGAP29	Transitional cell carcinoma
ABCD3::DPYD	Adenocarcinoma
ABCD3::GAP43	Mature B-cell neoplasm, NOS
ABCD3::KMT2E	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ABCD4::MIDEAS	Adenocarcinoma
ABCF1::POLR1H	Mature B-cell neoplasm, NOS
ABCF1::PRR3	Adenocarcinoma
ABCF1::SHC2	Astrocytoma, grade I-II
ABCF2::WDR86	Mesenchymal tumor, NOS
ABCF3::PLEKHB2	Adenocarcinoma
ABCG1::BACE2	Adenocarcinoma
ABCG1::BTG3	Adenocarcinoma
ABCG1::CCDC134	Squamous cell carcinoma
ABCG1::DSCAM	Acute myeloid leukemia, NOS | Skin
ABCG1::MEI1	Squamous cell carcinoma
ABHD12::ENTPD6	Squamous cell carcinoma
ABHD12::ERVFRD-1	Adenocarcinoma
ABHD12::GINS1	Adenocarcinoma
ABHD12::KIF16B	Squamous cell carcinoma
ABHD12::PPP2R2A	Adenocarcinoma
ABHD12::TTI1	Squamous cell carcinoma
ABHD12::UQCC1	Squamous cell carcinoma
ABHD12B::RNASE1	Squamous cell carcinoma
ABHD13::IRS2	Squamous cell carcinoma
ABHD14B::POC1A	Adenocarcinoma | Malignant epithelial tumor, special type
ABHD16A::CLIC1	Adenocarcinoma
ABHD16A::LY6G6F	Squamous cell carcinoma
ABHD16A::VARS1	Transitional cell carcinoma
ABHD17A::AP3D1	Adenocarcinoma
ABHD17A::TCF3	Adenocarcinoma
ABHD17B::CCL25	Adenocarcinoma
ABHD17C::BHLHE41	Adenocarcinoma
ABHD17C::HMG20A	Astrocytoma, grade I-II
ABHD17C::PRAMEF6	Transitional cell carcinoma
ABHD17C::RET	Adenocarcinoma
ABHD17C::SCAPER	Malignant melanoma
ABHD18::SLC25A31	Adenocarcinoma
ABHD2::ACAN	Adenocarcinoma
ABHD2::BIRC6	Transitional cell carcinoma
ABHD3::ANKRD29	Adenocarcinoma
ABHD4::PSMB11	Adenocarcinoma
ABHD6::FLNB	Adenocarcinoma
ABHD8::ILKAP	Transitional cell carcinoma
ABI1::CCDC7	Adenocarcinoma
ABI1::CUBN	Malignant melanoma
ABI1::PTP4A3	Astrocytoma, grade I-II
ABI2::ALK	Squamous cell carcinoma
ABI2::CARF	Adenocarcinoma
ABI2::CHMP1A	Embryonal nervous system tumor, special type
ABI2::CLK1	Skin | Acute myeloid leukemia, NOS
ABI2::CYP20A1	Adenocarcinoma
ABI2::FAM117B	Adenocarcinoma
ABI2::HEXIM2	Astrocytoma, grade I-II
ABI2::MAIP1	Squamous cell carcinoma
ABI2::MTA3	Adenocarcinoma
ABI2::PPP1R1C	Adenocarcinoma
ABI2::SPATS2L	Adenocarcinoma
ABI3::STARD3	Adenocarcinoma
ABI3::TSPOAP1	Mature B-cell neoplasm, NOS
ABI3BP::EXT2	Undifferentiated carcinoma, small cell
ABI3BP::IMPG2	Adenocarcinoma
ABI3BP::NBPF9	Adenocarcinoma
ABI3BP::RET	Adenocarcinoma
ABL1::ADAMTSL2	Adenocarcinoma
ABL1::AIF1L	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ABL1::ANXA4	Adenocarcinoma
ABL1::APBA1	Adenocarcinoma
ABL1::BCR	Acute myeloid leukemia, NOS | Skin
ABL1::BRD3	Adenocarcinoma
ABL1::CBFB	Astrocytoma, grade III-IV/Glioblastoma
ABL1::DDX27	Transitional cell carcinoma
ABL1::EXOSC2	Squamous cell carcinoma
ABL1::FUBP3	Adenocarcinoma
ABL1::KYAT1	Squamous cell carcinoma
ABL1::NHERF1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ABL1::NUP214	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Adenocarcinoma
ABL1::PRDM12	Adenocarcinoma
ABL1::PRRC2B	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ABL1::PTPRN2	Mesenchymal tumor, NOS
ABL1::SLC38A10	Adenocarcinoma
ABL1::SZRD1	Astrocytoma, grade III-IV/Glioblastoma
ABL2::GPR161	Squamous cell carcinoma
ABL2::KCNH1	Adenocarcinoma
ABL2::XRRA1	Transitional cell carcinoma
ABLIM1::PDE6B	Adenocarcinoma
ABLIM1::PTCD2	Adenocarcinoma
ABLIM2::PPP2R2C	Transitional cell carcinoma
ABLIM3::TRPM8	Squamous cell carcinoma
ABO::HTR3B	Mesothelioma
ABR::ACAD10	Transitional cell carcinoma
ABR::ADGRB1	Adenocarcinoma
ABR::ASPA	Adenocarcinoma
ABR::CLUH	Adenocarcinoma
ABR::CRK	Adenocarcinoma
ABR::DNAH2	Osteosarcoma, NOS
ABR::GAS7	Squamous cell carcinoma
ABR::GEMIN4	Adenocarcinoma
ABR::MAN2B1	Astrocytoma, grade I-II
ABR::PITPNA	Germ cell tumor, NOS | Adenocarcinoma
ABR::RTN4RL1	Transitional cell carcinoma
ABR::STAP2	Adenocarcinoma
ABR::YWHAE	Skin | Malignant melanoma | Astrocytoma, grade III-IV/Glioblastoma | Adenocarcinoma | Acute myeloid leukemia, NOS | Astrocytoma, grade I-II
ABRACL::MAP3K5	Squamous cell carcinoma
ABRACL::PERP	Adenocarcinoma
ABRAXAS1::HELQ	Nonneoplastic hematologic disorder/lesion | Nonneoplastic epithelial disorder/lesion
ABTB2::APIP	Adenocarcinoma
ABTB2::ATXN3	Adenocarcinoma
ABTB2::KDM2A	Adenocarcinoma
ABTB2::LMO2	Adenocarcinoma
ABTB2::NDUFB1	Adenocarcinoma
ABTB2::TYR	Adenocarcinoma
ABTB3::CMKLR1	Mesenchymal tumor, NOS
ACAA2::MYO5B	Adenocarcinoma
ACACA::ADAM9	Transitional cell carcinoma
ACACA::ASIC2	Adenocarcinoma
ACACA::CCDC192	Squamous cell carcinoma
ACACA::DDX52	Adenocarcinoma
ACACA::GLIPR1L2	Mesenchymal tumor, NOS
ACACA::GSDMB	Adenocarcinoma
ACACA::HTRA4	Transitional cell carcinoma
ACACA::LASP1	Adenocarcinoma
ACACA::LGALS9	Adenocarcinoma
ACACA::MED1	Adenocarcinoma
ACACA::MED24	Adenocarcinoma
ACACA::METTL25	Mesenchymal tumor, NOS
ACACA::MGME1	Adenocarcinoma
ACACA::MMP28	Adenocarcinoma
ACACA::PRKCA	Adenocarcinoma
ACACA::RARA	Adenocarcinoma
ACACA::SGTB	Adenocarcinoma
ACACA::SRCIN1	Adenocarcinoma
ACACA::SSH2	Adenocarcinoma
ACACA::STAC2	Adenocarcinoma
ACACA::SYNRG	Adenocarcinoma
ACACA::TADA2A	Transitional cell carcinoma
ACACA::TANC2	Adenocarcinoma
ACACA::VCF1	Adenocarcinoma
ACACB::UNG	Malignant melanoma
ACAD10::MAPKAPK5	Acute promyelocytic leukemia (FAB type M3)
ACAD11::ABCE1	Mesenchymal tumor, NOS
ACAD11::TRAPPC13	Adenocarcinoma
ACAD9::CFAP92	Astrocytoma, grade I-II
ACAD9::RAB7A	Adenocarcinoma
ACADM::FOXJ3	Squamous cell carcinoma
ACADS::GTPBP10	Adenocarcinoma
ACADS::PRKAB1	Adenocarcinoma
ACADVL::CD74	Squamous cell carcinoma
ACAP2::APOD	Adenocarcinoma
ACAP2::ATP13A3	Squamous cell carcinoma
ACAP2::ATP5MF	Adenocarcinoma
ACAP2::DLG1	Adenocarcinoma | Mature B-cell neoplasm, NOS
ACAP2::DOCK8	Adenocarcinoma
ACAP2::IQCG	Squamous cell carcinoma
ACAP2::PIK3CA	Astrocytoma, grade III-IV/Glioblastoma
ACAP2::UBE2J2	Adenocarcinoma
ACAP2::XXYLT1	Squamous cell carcinoma | Transitional cell carcinoma | Adenocarcinoma
ACAP3::DVL1	Squamous cell carcinoma | Astrocytoma, grade III-IV/Glioblastoma
ACAP3::INTS11	Adenocarcinoma
ACAP3::SCNN1D	Adenocarcinoma
ACAP3::TMEM240	Adenocarcinoma
ACBD3::RAB5B	Malignant epithelial tumor, special type
ACBD4::LRRC37A	Squamous cell carcinoma
ACBD5::ANKRD26	Adenocarcinoma
ACBD5::RET	Adenocarcinoma
ACBD5::ZEB1	Adenocarcinoma
ACBD6::CCDC122	Mesenchymal tumor, NOS
ACBD6::CHIT1	Adenocarcinoma
ACBD6::GON4L	Adenocarcinoma
ACBD6::IVNS1ABP	Adenocarcinoma
ACBD6::PGBD2	Adenocarcinoma
ACBD6::RRP15	Adenocarcinoma
ACCS::EXT2	Chronic myeloid leukemia, t(9;22) | Heart
ACE2::GPR143	Adenocarcinoma
ACE::CCDC47	Adenocarcinoma
ACE::MAP3K3	Adenocarcinoma
ACER2::CFAP418	Adenocarcinoma
ACER2::DENND4C	Adenocarcinoma
ACER3::EMSY	Adenocarcinoma
ACER3::NARS2	Adenocarcinoma
ACER3::NRL	Adenocarcinoma
ACER3::PC	Adenocarcinoma
ACER3::PPME1	Adenocarcinoma
ACER3::THRSP	Adenocarcinoma
ACER3::UVRAG	Adenocarcinoma
ACER3::ZNF451	Malignant melanoma
ACHE::VPS50	Astrocytoma, grade III-IV/Glioblastoma
ACIN1::HAUS4	Squamous cell carcinoma
ACIN1::NUTM1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ACIN1::SHTN1	Squamous cell carcinoma
ACKR2::POMGNT2	Transitional cell carcinoma
ACKR3::GOLM2	Adenocarcinoma
ACLY::DNAJC7	Adenocarcinoma
ACLY::NEUROD2	Adenocarcinoma
ACLY::NF1	Malignant epithelial tumor, special type
ACLY::TAF15	Mesenchymal tumor, NOS
ACLY::WEE1	Adenocarcinoma
ACO1::TYRP1	Adenocarcinoma
ACO2::ACTB	Adenocarcinoma
ACO2::AHRR	Malignant melanoma
ACO2::ARHGAP8	Adenocarcinoma
ACO2::C1QTNF7	Malignant melanoma
ACO2::CACNG2	Adenocarcinoma
ACO2::CRADD	Adenocarcinoma
ACO2::ISX	Miscellaneous hematopoietic/lymphoid neoplasm, special type
ACO2::PRR5	Adenocarcinoma
ACO2::RASGEF1C	Malignant melanoma
ACO2::TANGO2	Malignant melanoma
ACO2::TBCD	Adenocarcinoma
ACO2::TEF	Adenocarcinoma
ACO2::UBE2A	Adenocarcinoma
ACO2::ZC3H7B	Adenocarcinoma
ACOT11::C8B	Adenocarcinoma
ACOT11::GIP	Malignant epithelial tumor, special type
ACOT12::SSBP2	Adenocarcinoma
ACOT2::ZNF320	Mesenchymal tumor, NOS
ACOT7::DNAJC11	Transitional cell carcinoma | Malignant epithelial tumor, special type
ACOT7::FUCA1	Adenocarcinoma
ACOT7::KLHL21	Adenocarcinoma
ACOT7::MIB2	Squamous cell carcinoma
ACOT7::NPHP4	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Malignant melanoma
ACOT7::NSMCE2	Adenocarcinoma
ACOT7::PLEKHG5	Adenocarcinoma
ACOT7::TTC34	Adenocarcinoma
ACOT7::ZFP69	Russia | Primitive neuroectodermal tumor/Medulloblastoma
ACOT9::APOO	Adenocarcinoma
ACOX1::EXOC7	Adenocarcinoma
ACOX1::PPP2R3B	Transitional cell carcinoma
ACOX1::SRP68	Adenocarcinoma | Transitional cell carcinoma
ACOX3::CD96	Transitional cell carcinoma
ACOX3::STAT1	Mesothelioma
ACOX3::VAMP7	Transitional cell carcinoma
ACOXL::KLHL23	Transitional cell carcinoma
ACOXL::SSB	Transitional cell carcinoma
ACOXL::UNC5D	Transitional cell carcinoma
ACP2::CD74	Squamous cell carcinoma
ACP2::MRPL48	Adenocarcinoma
ACP3::ARFIP1	Adenocarcinoma
ACP3::ATP2C1	Adenocarcinoma
ACP3::AXL	Adenocarcinoma
ACP3::BCR	Adenocarcinoma
ACP3::MYC	Adenocarcinoma
ACP3::NEDD4L	Adenocarcinoma
ACP3::NPY	Adenocarcinoma
ACP3::OGT	Adenocarcinoma
ACP3::PIK3CB	Adenocarcinoma
ACP3::RDH11	Adenocarcinoma
ACP3::SAFB2	Adenocarcinoma
ACP3::SKIL	Adenocarcinoma
ACP3::STAT6	Adenocarcinoma
ACP3::ZNF462	Adenocarcinoma
ACP5::GTF2F1	Malignant melanoma
ACP6::INTS7	Adenocarcinoma
ACP6::PIAS3	Mesenchymal tumor, NOS
ACP7::ACTN4	Adenocarcinoma
ACSBG1::IDH3A	Adenocarcinoma
ACSF2::ABCA9	Malignant melanoma
ACSF2::SPAG9	Adenocarcinoma
ACSF3::MYH7B	Adenocarcinoma
ACSF3::ZC3H18	Mycosis fungoides/Sézary syndrome
ACSF3::ZNF483	Mesenchymal tumor, NOS
ACSL3::ETV1	Adenocarcinoma
ACSL3::KCNE4	Adenocarcinoma
ACSL3::MOGAT1	Adenocarcinoma
ACSL3::PHGDH	Adenocarcinoma
ACSL3::SGPP2	Adenocarcinoma
ACSL3::SMARCAL1	Adenocarcinoma
ACSL4::DCAF6	Adenocarcinoma
ACSL4::USP6	Aneurysmal bone cyst
ACSL5::ATE1	Adenocarcinoma
ACSL5::TCF7L2	Adenocarcinoma
ACSL6::CDS2	Adenocarcinoma
ACSM1::DNAH3	Adenocarcinoma
ACSM2A::ABCC6	Adenocarcinoma
ACSM2B::NOTCH2	Adenocarcinoma
ACSS1::APMAP	Adenocarcinoma
ACSS1::CDH4	Adenocarcinoma
ACSS1::DBNDD2	Squamous cell carcinoma
ACSS1::PHACTR3	Adenocarcinoma
ACSS1::ZFAND3	Adenocarcinoma
ACSS2::GSS	Adenocarcinoma
ACSS3::AVIL	Mesenchymal tumor, NOS
ACSS3::CYP39A1	Mesenchymal tumor, NOS
ACSS3::INSR	Mesenchymal tumor, NOS
ACSS3::STAU2	Mesenchymal tumor, NOS
ACTA2::COL6A1	Mesenchymal tumor, NOS
ACTA2::PLAG1	Adenoma
ACTB::AHSG	Adenocarcinoma
ACTB::ALB	Adenocarcinoma
ACTB::CDC5L	Transitional cell carcinoma
ACTB::CELA3A	Adenocarcinoma
ACTB::COL17A1	Adenocarcinoma | Squamous cell carcinoma
ACTB::CSE1L	Squamous cell carcinoma
ACTB::EML2	Adenocarcinoma
ACTB::FOSB	Pseudomyogenic hemangioendothelioma
ACTB::GLI1	Epithelioid sarcoma | Soft tissue tumor, special type | Vascular and perivascular tumor, special type | Undifferentiated round cell sarcoma | Mesenchymal tumor, NOS | Soft tissue tumor, NOS | Mesenchymal tumor, special type | Pericytoma
ACTB::GNAS	Adenocarcinoma
ACTB::GSE1	Adenocarcinoma
ACTB::HLA-DQB1	Adenocarcinoma
ACTB::KLF2	Multiple myeloma
ACTB::MAML2	Vascular and perivascular tumor, special type
ACTB::MITF	Melanocytic neoplasm, special type
ACTB::NOL4L	Adenocarcinoma
ACTB::NOP53	Squamous cell carcinoma
ACTB::NR4A3	Leiomyosarcoma
ACTB::PMP2	Astrocytoma, grade I-II
ACTB::POTEE	Squamous cell carcinoma
ACTB::RACK1	Adenocarcinoma
ACTB::RNF216	Adenocarcinoma
ACTB::SAFB	Adenocarcinoma
ACTB::SELENOP	Adenocarcinoma
ACTB::TFEB	Adenocarcinoma
ACTB::TM4SF4	Adenocarcinoma
ACTB::YWHAE	Squamous cell carcinoma
ACTG1::ANKS1A	Malignant epithelial tumor, special type
ACTG1::CCNC	Squamous cell carcinoma
ACTG1::CCT5	Adenocarcinoma
ACTG1::CLCN3	Adenocarcinoma
ACTG1::CXCR5	Diffuse large B-cell lymphoma
ACTG1::DDX21	Adenocarcinoma
ACTG1::IGK	Multiple myeloma
ACTG1::MITF	Adenocarcinoma | Melanocytic neoplasm, special type
ACTG1::PLEKHA5	Adenocarcinoma
ACTG1::PPP1R12C	Adenocarcinoma
ACTG1::SPRR1B	Squamous cell carcinoma
ACTG1::STAT6	Adenocarcinoma
ACTG1::THSD4	Adenocarcinoma
ACTG1::USP7	Squamous cell carcinoma
ACTG1::ZNF827	Adenocarcinoma
ACTG2::ALK	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma | Leiomyosarcoma | Mesenchymal tumor, NOS
ACTG2::PLAG1	Leiomyoma
ACTL6A::ALG3	Squamous cell carcinoma
ACTL6A::BGN	Multiple myeloma
ACTL6A::PIK3CA	Adenocarcinoma
ACTL8::ACOX1	Adenocarcinoma
ACTN1::DCAF5	Adenocarcinoma
ACTN1::PRKD1	Adenocarcinoma
ACTN1::RNF41	Adenocarcinoma
ACTN1::SCGN	Adenocarcinoma
ACTN2::CHRM3	Adenocarcinoma
ACTN4::APLP1	Squamous cell carcinoma
ACTN4::CAPZB	Adenocarcinoma
ACTN4::CATSPERG	Squamous cell carcinoma
ACTN4::CIB3	Adenocarcinoma
ACTN4::EIF3K	Transitional cell carcinoma | Adenocarcinoma
ACTN4::FTO	Adenocarcinoma
ACTN4::IGF2BP2	Squamous cell carcinoma
ACTN4::KIRREL2	Squamous cell carcinoma
ACTN4::MGST2	Adenocarcinoma
ACTN4::NOVA2	Adenocarcinoma
ACTN4::RPS16	Adenocarcinoma
ACTN4::RYR1	Adenocarcinoma
ACTN4::SPINT2	Malignant epithelial tumor, special type
ACTN4::SUPT5H	Adenocarcinoma
ACTN4::TXNDC12	Astrocytoma, grade III-IV/Glioblastoma
ACTN4::YIF1B	Adenocarcinoma
ACTR10::GALC	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ACTR10::MKX	Mesenchymal tumor, NOS
ACTR1A::ARL3	Adenocarcinoma
ACTR1A::EFCAB13	Malignant epithelial tumor, special type
ACTR1A::ODAD2	Adenocarcinoma
ACTR1A::STN1	Adenocarcinoma
ACTR2::GGACT	Adenocarcinoma
ACTR2::SORBS2	Adenocarcinoma
ACTR2::TSGA10	Squamous cell carcinoma
ACTR3::POLR1B	Adenocarcinoma
ACTR3::SLC4A10	Squamous cell carcinoma
ACTR3::VPS13B	Squamous cell carcinoma
ACTR3::ZRANB3	Adenocarcinoma
ACTR3B::PTPRN2	Adenocarcinoma
ACTR3B::TAB2	Adenocarcinoma
ACTR3C::GIMAP2	Adenocarcinoma
ACTR3C::SORCS1	Squamous cell carcinoma
ACTR5::RPRD1B	Adenocarcinoma
ACTR5::ZNF217	Adenocarcinoma
ACTR5::ZNF682	Transitional cell carcinoma
ACTR8::GOLM2	Multiple myeloma
ACVR1::CCDC148	Adenocarcinoma
ACVR1::CDK4	Malignant melanoma
ACVR1::GNLY	Adenocarcinoma
ACVR1::NFATC1	Adenocarcinoma
ACVR1B::ACVRL1	Adenocarcinoma
ACVR1B::ANKRD33	Adenocarcinoma
ACVR1B::CS	Adenocarcinoma
ACVR1B::PCBP2	Adenocarcinoma
ACVR1B::SCAF11	Astrocytoma, grade III-IV/Glioblastoma
ACVR1B::SUPT16H	Adenocarcinoma
ACVR1B::TAMALIN	Adenocarcinoma
ACVR1C::MGAT5	Squamous cell carcinoma
ACVR2A::AKT3	Adenocarcinoma
ACVR2A::CASP8	Squamous cell carcinoma
ACVR2A::EPC2	Adenocarcinoma
ACVR2A::KANK1	Adenocarcinoma
ACVR2A::PIGF	Adenocarcinoma
ACVR2A::RAF1	Soft tissue tumor, special type
ACVR2A::SUMO1	Mesenchymal tumor, NOS
ACVR2B::KRTAP5-2	Undifferentiated carcinoma, small cell
ACY1::BAP1	Mesothelioma
ACYP2::ALK	Adenocarcinoma
ACYP2::CFAP36	Adenocarcinoma
ACYP2::EML6	Adenocarcinoma
ACYP2::PPP1CB	Squamous cell carcinoma
ADAL::TERB2	Mesenchymal tumor, NOS
ADAM10::ALDH1A2	Adenocarcinoma
ADAM10::BLVRB	Adenocarcinoma
ADAM10::FIZ1	Adenocarcinoma
ADAM10::MYO1E	Adenocarcinoma
ADAM10::PLAC9	Adenocarcinoma
ADAM10::TERB2	Transitional cell carcinoma
ADAM10::ZNF770	Astrocytoma, grade I-II
ADAM15::CHD1L	Adenocarcinoma
ADAM15::DCST1	Adenocarcinoma
ADAM17::ITGB1BP1	Squamous cell carcinoma
ADAM17::LTO1	Transitional cell carcinoma
ADAM17::NHEJ1	Astrocytoma, grade III-IV/Glioblastoma
ADAM17::YWHAQ	Astrocytoma, grade III-IV/Glioblastoma
ADAM18::LSM1	Adenocarcinoma
ADAM19::FNDC9	Malignant melanoma
ADAM22::ASB4	Adenocarcinoma
ADAM22::RUNDC3B	Adenocarcinoma
ADAM23::CERKL	Squamous cell carcinoma
ADAM23::PLPP1	Squamous cell carcinoma
ADAM23::SGO2	Adenocarcinoma
ADAM2::MTMR2	Adenocarcinoma
ADAM32::ZNF251	Adenocarcinoma
ADAM9::CLYBL	Adenocarcinoma
ADAM9::CRB1	Adenocarcinoma
ADAM9::ERCC8	Squamous cell carcinoma
ADAM9::HTRA4	Squamous cell carcinoma
ADAM9::KCNU1	Adenocarcinoma
ADAM9::LETM2	Adenocarcinoma
ADAM9::PLPBP	Adenocarcinoma
ADAM9::RGS20	Adenocarcinoma
ADAM9::RNF170	Squamous cell carcinoma
ADAM9::TACC1	Adenocarcinoma
ADAM9::TESMIN	Transitional cell carcinoma
ADAM9::UNC5D	Transitional cell carcinoma
ADAMTS10::MLLT1	Adenocarcinoma
ADAMTS12::C1QTNF3	Adenocarcinoma
ADAMTS12::FBXO38	Squamous cell carcinoma
ADAMTS12::RAI14	Malignant melanoma
ADAMTS12::ZFR	Adenocarcinoma
ADAMTS13::LHX2	Adenocarcinoma
ADAMTS16::ETV6	Adenocarcinoma
ADAMTS16::TERT	Adenocarcinoma
ADAMTS17::AKAP13	Malignant melanoma
ADAMTS17::CERS3	Squamous cell carcinoma
ADAMTS17::LPAR1	Astrocytoma, grade III-IV/Glioblastoma
ADAMTS17::LRRC28	Adenocarcinoma
ADAMTS17::NCF4	Malignant melanoma
ADAMTS17::PCDHA13	Adenocarcinoma
ADAMTS17::PCDHA8	Adenocarcinoma
ADAMTS17::PCDHAC1	Adenocarcinoma
ADAMTS17::PCDHAC2	Adenocarcinoma
ADAMTS17::RTKN2	Adenocarcinoma
ADAMTS17::SLC12A1	Mesenchymal tumor, NOS
ADAMTS19::SLC27A6	Adenocarcinoma
ADAMTS20::C12ORF43	Astrocytoma, grade I-II
ADAMTS20::CBFA2T2	Adenoid cystic carcinoma
ADAMTS20::MYRFL	Mesenchymal tumor, NOS
ADAMTS2::OXCT1	Adenocarcinoma
ADAMTS2::ZNF354C	Adenocarcinoma
ADAMTS3::GUCY1B1	Adenocarcinoma
ADAMTS3::SNX30	Squamous cell carcinoma
ADAMTS6::CLPTM1L	Adenocarcinoma
ADAMTS7::TMEM135	Malignant melanoma
ADAMTS9::CHL1	Adenocarcinoma
ADAMTS9::PRICKLE2	Malignant epithelial tumor, special type
ADAMTS9::SYNPR	Adenocarcinoma
ADAMTS9::ULK4	Adenocarcinoma
ADAMTSL1::ERV3-1	Squamous cell carcinoma
ADAMTSL1::UHRF2	Adenocarcinoma
ADAMTSL1::WNT5B	Malignant melanoma
ADAMTSL2::MAPKAP1	Squamous cell carcinoma
ADAP1::COX19	Adenocarcinoma
ADAP1::GET4	Adenocarcinoma
ADAP1::MAD1L1	Transitional cell carcinoma
ADAP1::METTL2B	Adenocarcinoma
ADAP1::NDUFAF6	Adenocarcinoma
ADAP1::NOC4L	Adenocarcinoma
ADAP1::SUN1	Squamous cell carcinoma
ADAP2::USP36	Adenocarcinoma
ADAR::CCT5	Adenocarcinoma
ADAR::GPATCH4	Adenocarcinoma
ADAR::KRTCAP2	Adenocarcinoma
ADAR::LYPD8	Adenocarcinoma
ADAR::UBE2J2	Adenocarcinoma
ADAT1::KARS1	Squamous cell carcinoma
ADAT2::VTA1	Malignant melanoma
ADAT3::DAZAP1	Transitional cell carcinoma
ADCK1::SLIRP	Adenocarcinoma
ADCK2::DPP6	Adenocarcinoma
ADCK2::SLC26A4	Adenocarcinoma
ADCK2::TBXAS1	Adenocarcinoma
ADCK5::CPSF1	Malignant epithelial tumor, special type
ADCK5::HSF1	Malignant melanoma
ADCK5::INPP5B	Adenocarcinoma
ADCK5::MROH1	Squamous cell carcinoma
ADCY10::MPC2	Adenocarcinoma
ADCY1::EYA4	Adenocarcinoma
ADCY1::HNRNPA2B1	Adenocarcinoma
ADCY2::CASC3	Squamous cell carcinoma
ADCY2::CLPTM1L	Malignant melanoma
ADCY2::PARP8	Malignant melanoma
ADCY2::RPAP2	Transitional cell carcinoma
ADCY2::SAMM50	Malignant melanoma
ADCY2::TERT	Malignant melanoma
ADCY3::HADHA	Squamous cell carcinoma
ADCY3::TP53I3	Adenocarcinoma
ADCY5::HACD2	Adenocarcinoma
ADCY7::NUTM1	Skin | Acute myeloid leukemia, NOS
ADCY9::CDIP1	Adenocarcinoma
ADCY9::CLUAP1	Adenocarcinoma
ADCY9::FAHD1	Adenocarcinoma
ADCY9::GLYR1	Adenocarcinoma
ADCY9::JADE3	Adenocarcinoma
ADCY9::NLRC3	Malignant epithelial tumor, special type
ADCY9::NMRAL1	Astrocytoma, grade I-II
ADCY9::PAM16	Adenocarcinoma
ADCY9::PRKCB	Squamous cell carcinoma
ADCY9::PRSS27	Adenocarcinoma
ADCY9::RASSF8	Astrocytoma, grade I-II
ADCY9::RIPOR3	Adenocarcinoma
ADCY9::RMI2	Adenocarcinoma
ADCY9::SPART	Mesenchymal tumor, NOS
ADCY9::SRL	Adenocarcinoma
ADCY9::TEAD4	Astrocytoma, grade I-II
ADCY9::TFAP4	Transitional cell carcinoma
ADCY9::VASN	Astrocytoma, grade I-II
ADCYAP1R1::AQP1	Astrocytoma, grade I-II
ADCYAP1R1::GHRHR	Malignant epithelial tumor, special type
ADCYAP1R1::GSDME	Astrocytoma, grade I-II
ADCYAP1R1::TYK2	Astrocytoma, grade I-II
ADD1::ADK	Squamous cell carcinoma
ADD1::ATP2B4	Astrocytoma, grade I-II
ADD1::FAM193A	Squamous cell carcinoma | Adenocarcinoma
ADD1::PCGF3	Adenocarcinoma
ADD1::SH3BP2	Adenocarcinoma
ADD2::ANTXR1	Adenocarcinoma
ADD2::C2ORF42	Astrocytoma, grade III-IV/Glioblastoma
ADD3::AFAP1L2	Adenocarcinoma
ADD3::OGT	Astrocytoma, grade I-II
ADD3::SIRT1	Adenocarcinoma
ADD3::XPNPEP1	Adenocarcinoma
ADGRA2::GSR	Transitional cell carcinoma
ADGRA3::ERBB2	Adenocarcinoma
ADGRA3::KCNIP4	Adenocarcinoma
ADGRB1::EXT1	Astrocytoma, grade I-II
ADGRB2::HS3ST4	Astrocytoma, grade III-IV/Glioblastoma
ADGRB2::PTP4A2	Adenocarcinoma
ADGRB2::SPOCD1	Adenocarcinoma
ADGRB3::CFHR1	Malignant melanoma
ADGRE5::EPS15L1	Adenocarcinoma
ADGRE5::IGL	Multiple myeloma
ADGRF1::MEP1A	Transitional cell carcinoma
ADGRF1::TNFRSF21	Transitional cell carcinoma
ADGRF1::TRERF1	Adenocarcinoma
ADGRF3::IFT172	Transitional cell carcinoma
ADGRF4::CALR	Adenocarcinoma
ADGRF5::ADGRF1	Adenocarcinoma
ADGRF5::MEP1A	Adenocarcinoma
ADGRG1::GINS3	Transitional cell carcinoma
ADGRG1::MT1F	Adenocarcinoma
ADGRG2::MAP3K15	Adenocarcinoma
ADGRG6::CLSTN2	Adenocarcinoma
ADGRG6::GJE1	Adenocarcinoma
ADGRG6::VTA1	Adenocarcinoma
ADGRG7::LNP1	Adenocarcinoma
ADGRG7::TFG	Acute myeloblastic leukemia without maturation (FAB type M1) | Acute myeloid leukemia, NOS | Diffuse large B-cell lymphoma | Skin
ADGRL1::LGALS4	Adenocarcinoma
ADGRL1::PODNL1	Adenocarcinoma
ADGRL1::TRIR	Adenocarcinoma
ADGRL2::AK5	Adenocarcinoma
ADGRL3::AMTN	Adenocarcinoma
ADGRL3::BBS9	Squamous cell carcinoma
ADGRL3::DBX2	Astrocytoma, grade I-II
ADGRL3::GPM6A	Astrocytoma, grade I-II
ADGRL3::PGLYRP2	Transitional cell carcinoma
ADGRL3::PPP3CA	Adenocarcinoma
ADGRL3::ST3GAL5	Astrocytoma, grade I-II
ADGRV1::ALK	Adenocarcinoma
ADGRV1::ATR	Adenocarcinoma
ADGRV1::CLPTM1L	Adenocarcinoma
ADGRV1::POLR3G	Adenocarcinoma
ADH1B::CES1	Adenocarcinoma
ADH7::CXCR5	Squamous cell carcinoma
ADI1::DPY30	Adenocarcinoma
ADI1::KHDRBS3	Adenocarcinoma
ADI1::ZFP91	Adenocarcinoma
ADIPOR1::CYB5R1	Adenocarcinoma
ADIPOR1::RGS8	Adenocarcinoma
ADIPOR2::CACNA2D4	Adenocarcinoma
ADIPOR2::CASK	Adenocarcinoma
ADIPOR2::DCP1B	Transitional cell carcinoma
ADIPOR2::ERC1	Adenocarcinoma
ADIPOR2::FAM72B	Adenocarcinoma
ADIPOR2::FOXJ2	Adenocarcinoma
ADIPOR2::NINJ2	Adenocarcinoma
ADIPOR2::SLC2A13	Mesenchymal tumor, NOS
ADIPOR2::ST8SIA1	Adenocarcinoma
ADIPOR2::WNT5B	Adenocarcinoma
ADIRF::SNW1	Adenocarcinoma
ADK::FAM149B1	Adenocarcinoma
ADK::KAT6B	Adenocarcinoma
ADK::KCNMA1	Adenocarcinoma
ADK::LRMDA	Adenocarcinoma
ADK::LRRTM3	Adenocarcinoma
ADK::PI4K2A	Adenocarcinoma
ADK::RPP38	Adenocarcinoma
ADK::SIRT1	Adenocarcinoma
ADK::SPTAN1	Adenocarcinoma
ADK::TAF1D	Squamous cell carcinoma
ADK::TTC23	Adenocarcinoma
ADM2::PPP6R2	Adenocarcinoma
ADNP2::L3MBTL4	Adenocarcinoma
ADNP2::PARD6G	Astrocytoma, grade I-II
ADNP2::SLC66A2	Adenocarcinoma
ADNP::BMP7	Malignant melanoma
ADNP::DDX27	Adenocarcinoma
ADNP::DLGAP4	Squamous cell carcinoma
ADNP::DPM1	Adenocarcinoma
ADNP::GHRH	Adenocarcinoma
ADNP::KCNG1	Adenocarcinoma
ADNP::MMP24	Adenocarcinoma
ADNP::MROH8	Adenocarcinoma
ADNP::NFATC2	Adenocarcinoma
ADNP::PCIF1	Squamous cell carcinoma
ADNP::SCCPDH	Adenocarcinoma
ADNP::SLPI	Adenocarcinoma
ADNP::SYCP2	Adenocarcinoma
ADNP::ZNF841	Adenocarcinoma
ADORA2A::NTRK2	Glioma, NOS
ADORA2B::PIGL	Transitional cell carcinoma
ADORA2B::SYN3	Transitional cell carcinoma
ADORA2B::TIMP3	Transitional cell carcinoma
ADPGK::BBS4	Squamous cell carcinoma
ADPRHL1::TFDP1	Adenocarcinoma
ADPRS::SHPK	Adenocarcinoma
ADRA1A::YIPF7	Adenocarcinoma
ADRM1::ANKRD28	Malignant epithelial tumor, special type
ADRM1::CCT5	Adenocarcinoma
ADSL::CDH18	Adenocarcinoma
ADSL::MRTFA	Adenocarcinoma
ADSL::PVALB	Adenocarcinoma
ADSL::SGSM3	Nonneoplastic epithelial disorder/lesion | Nonneoplastic hematologic disorder/lesion
ADSL::TNRC6B	Adenocarcinoma
ADSS2::AZIN1	Astrocytoma, grade I-II
ADSS2::BPNT1	Malignant melanoma
ADSS2::CAPRIN2	Mesenchymal tumor, NOS
ADSS2::SERTAD4	Adenocarcinoma
AEBP1::ANKS1A	Adenocarcinoma
AEBP1::CSRP1	Malignant melanoma
AEBP1::NDUFV1	Adenocarcinoma
AEBP1::SLC38A5	Mesenchymal tumor, NOS
AEBP1::THRA	Adenocarcinoma
AEBP2::FLYWCH2	Astrocytoma, grade I-II
AEBP2::GYS2	Squamous cell carcinoma
AEBP2::LMO3	Mesenchymal tumor, NOS
AEBP2::PIK3C2G	Squamous cell carcinoma
AEBP2::PLEKHA5	Adenocarcinoma
AEBP2::PRLR	Malignant melanoma
AEBP2::ST8SIA1	Malignant melanoma
AFAP1::ABLIM2	Adenocarcinoma
AFAP1::AKR1C1	Astrocytoma, grade I-II
AFAP1::EVC2	Adenocarcinoma
AFAP1::KAT6B	Astrocytoma, grade III-IV/Glioblastoma
AFAP1::KCNIP4	Adenocarcinoma
AFAP1::NTRK1	Astrocytoma, grade III-IV/Glioblastoma | Glioma, NOS
AFAP1::NTRK2	Astrocytoma, grade I-II
AFAP1::SLC45A1	Squamous cell carcinoma
AFAP1L2::ABLIM1	Adenocarcinoma
AFAP1L2::RET	Adenocarcinoma
AFDN::EXOC6B	Adenocarcinoma
AFDN::GMDS	Squamous cell carcinoma
AFDN::HMGCLL1	Adenocarcinoma
AFDN::KCNAB1	Adenocarcinoma
AFDN::KMT2A	Skin | Acute myeloid leukemia, NOS
AFDN::SASH1	Astrocytoma, grade I-II
AFDN::SYK	Adenocarcinoma
AFDN::TTLL2	Adenocarcinoma
AFDN::UNC93A	Adenocarcinoma
AFF1::C4orf36	Mesenchymal tumor, NOS
AFF1::CENATAC	Acute lymphoblastic leukemia/lymphoblastic lymphoma
AFF1::DSCAML1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
AFF1::ELF2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
AFF1::FXYD6	Acute lymphoblastic leukemia/lymphoblastic lymphoma
AFF1::GAST	Adenocarcinoma
AFF1::GPRIN3	Mesenchymal tumor, NOS
AFF1::HSPA8	Acute lymphoblastic leukemia/lymphoblastic lymphoma
AFF1::KLHL8	Mesenchymal tumor, NOS
AFF1::KMT2A	Skin | Acute myeloid leukemia, NOS | Acute lymphoblastic leukemia/lymphoblastic lymphoma
AFF1::NUTM1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
AFF1::PAQR3	Adenocarcinoma
AFF1::PBX1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
AFF1::PTPN13	Squamous cell carcinoma
AFF1::RABGAP1L	Acute lymphoblastic leukemia/lymphoblastic lymphoma
AFF1::RAD51B	Acute lymphoblastic leukemia/lymphoblastic lymphoma
AFF1::RBFOX1	Adenocarcinoma
AFF1::SPATA13	Acute lymphoblastic leukemia/lymphoblastic lymphoma
AFF1::WWOX	Mesenchymal tumor, NOS
AFF3::ASZ1	Adenocarcinoma
AFF3::BCL2	Follicular lymphoma
AFF3::HDAC5	Adenocarcinoma
AFF3::IL1B	Adenocarcinoma
AFF3::ITSN2	Astrocytoma, grade III-IV/Glioblastoma
AFF3::NPAS2	Adenocarcinoma
AFF3::PHF1	Myxofibrosarcoma
AFF3::TMEM182	Adenocarcinoma
AFF3::TMPRSS2	Adenocarcinoma
AFF3::ZNF658	Adenocarcinoma
AFF4::DTWD2	Adenocarcinoma
AFF4::FSTL4	Adenocarcinoma
AFF4::IRF1	Dendritic cell neoplasm
AFF4::KDM2B	Chronic lymphocytic leukemia
AFF4::LAMC3	Adenocarcinoma
AFF4::RPL34	Adenocarcinoma
AFF4::SNTG2	Adenocarcinoma
AFF4::SPATA21	Adenocarcinoma
AFG1L::ARMC2	Astrocytoma, grade I-II
AFG1L::MET	Adenocarcinoma
AFG1L::SNX3	Adenocarcinoma
AFG1L::ZUP1	Adenocarcinoma
AFG2A::CENPE	Adenocarcinoma
AFG2A::MMRN1	Adenocarcinoma
AFG2B::RUNX1	Refractory anemia with excess blasts-2
AFG3L2::ETV4	Adenocarcinoma
AFG3L2::LYZ	Transitional cell carcinoma
AFG3L2::TIAM1	Adenocarcinoma
AFM::AFP	Adenocarcinoma
AFM::ALB	Adenocarcinoma
AFMID::TMC8	Adenocarcinoma
AFMID::TNRC6C	Adenocarcinoma
AFP::ALB	Adenocarcinoma
AFP::SMC1A	Adenocarcinoma
AFTPH::C1D	Adenocarcinoma
AFTPH::ELF1	Adenocarcinoma
AFTPH::GLYATL3	Squamous cell carcinoma
AFTPH::SANBR	Astrocytoma, grade I-II
AFTPH::THRB	Adenocarcinoma
AGAP1::AANAT	Squamous cell carcinoma
AGAP1::ADAMTS2	Adenocarcinoma
AGAP1::ATG4B	Mesenchymal tumor, NOS
AGAP1::C1ORF115	Adenocarcinoma
AGAP1::C1orf115	Adenocarcinoma
AGAP1::CIR1	Adenocarcinoma
AGAP1::ERBB4	Adenocarcinoma
AGAP1::FGFR1	Mesenchymal tumor, special type
AGAP1::IFIH1	Adenocarcinoma
AGAP1::IGSF21	Astrocytoma, grade I-II
AGAP1::MATN2	Adenocarcinoma
AGAP1::NAA35	Adenocarcinoma
AGAP1::NTRK2	Glioma, NOS
AGAP1::PACRG	Adenocarcinoma
AGAP1::PINX1	Adenocarcinoma
AGAP1::RHOU	Adenocarcinoma
AGAP1::RINT1	Adenocarcinoma
AGAP1::SNX1	Mesenchymal tumor, NOS
AGAP1::SOX7	Adenocarcinoma
AGAP1::SP140L	Adenocarcinoma
AGAP1::SPATA6	Squamous cell carcinoma
AGAP1::TRHDE	Mesenchymal tumor, NOS
AGAP1::UBE2F	Squamous cell carcinoma
AGAP1::USP40	Squamous cell carcinoma
AGAP1::WDR11	Adenocarcinoma
AGAP1::ZC2HC1A	Adenocarcinoma
AGAP2::CNOT2	Mesenchymal tumor, NOS
AGAP2::CYP27B1	Astrocytoma, grade III-IV/Glioblastoma
AGAP2::KIF5A	Astrocytoma, grade III-IV/Glioblastoma
AGAP2::PGC	Mesenchymal tumor, NOS
AGAP2::RAB21	Mesenchymal tumor, NOS
AGAP2::TMEM67	Astrocytoma, grade III-IV/Glioblastoma
AGAP3::BRAF	Acinic cell carcinoma | Benign nevus | Malignant melanoma | Gastrointestinal stromal tumor | Undifferentiated carcinoma | Adenocarcinoma | Soft tissue tumor, special type
AGAP3::CREB5	Astrocytoma, grade III-IV/Glioblastoma
AGAP3::EXOSC9	Mesenchymal tumor, NOS
AGAP3::GIMAP1	Adenocarcinoma
AGAP3::GIMAP2	Adenocarcinoma
AGAP3::GRM3	Squamous cell carcinoma
AGAP3::MKLN1	Adenocarcinoma
AGAP3::RELN	Squamous cell carcinoma
AGAP3::SPP2	Adenocarcinoma
AGAP3::TG	Adenocarcinoma
AGBL1::NTRK3	Astrocytoma, grade III-IV/Glioblastoma
AGBL4::DTL	Adenocarcinoma
AGBL4::FAF1	Adenocarcinoma
AGBL4::NTRK2	Astrocytoma, grade III-IV/Glioblastoma
AGBL4::RET	Adenocarcinoma
AGFG1::CCDC169	Adenocarcinoma
AGFG1::FBXL14	Adenocarcinoma
AGFG1::MFF	Adenocarcinoma
AGFG1::TET3	Adenocarcinoma
AGFG2::ARPC1A	Adenocarcinoma
AGFG2::COPS6	Adenocarcinoma
AGFG2::GJC3	Adenocarcinoma
AGGF1::PDGFRB	Acute lymphoblastic leukemia/lymphoblastic lymphoma
AGGF1::RAF1	Adenocarcinoma
AGK::BRAF	Astrocytoma, grade III-IV/Glioblastoma | Oligodendroglioma | Malignant melanoma | Adenocarcinoma | Soft tissue tumor, special type
AGK::DYNC2I1	Astrocytoma, grade III-IV/Glioblastoma
AGL::ARHGDIB	Adenocarcinoma
AGL::UBE4B	Adenocarcinoma
AGMO::MEOX2	Squamous cell carcinoma
AGMO::POU6F2	Adenocarcinoma
AGO2::CHRAC1	Adenocarcinoma
AGO2::CNBD1	Adenocarcinoma
AGO2::DNAH10	Astrocytoma, grade I-II
AGO2::DOCK5	Adenocarcinoma
AGO2::PCMTD1	Adenocarcinoma
AGO2::PTK2	Squamous cell carcinoma | Adenocarcinoma
AGO2::SAMD12	Adenocarcinoma
AGO2::TRAPPC9	Angiosarcoma
AGO3::PIK3CD	Adenocarcinoma
AGPAT1::HECA	Astrocytoma, grade I-II
AGPAT2::CDC42SE1	Adenocarcinoma
AGPAT3::AGO3	Adenocarcinoma
AGPAT3::APP	Adenocarcinoma
AGPAT3::ELK4	Adenocarcinoma
AGPAT3::KSR1	Adenocarcinoma
AGPAT3::NAALADL2	Adenocarcinoma
AGPAT3::PDE9A	Adenocarcinoma
AGPAT3::PDXK	Adenocarcinoma
AGPAT3::PFKL	Adenocarcinoma
AGPAT3::PRY	Astrocytoma, grade I-II
AGPAT3::RPS19	Adenocarcinoma
AGPAT3::RRP1	Adenocarcinoma
AGPAT3::SOAT2	Adenocarcinoma
AGPAT5::FDFT1	Adenocarcinoma
AGPAT5::KCNU1	Squamous cell carcinoma
AGPAT5::PRSS55	Adenocarcinoma
AGPAT5::TXNDC16	Undifferentiated carcinoma, small cell
AGPS::MOB4	Squamous cell carcinoma
AGPS::PDE11A	Adenocarcinoma
AGPS::ZNF385B	Adenocarcinoma
AGR2::ANKS1A	Adenocarcinoma
AGR2::ANXA1	Squamous cell carcinoma
AGR2::EIF2AK2	Adenocarcinoma
AGRN::BAD	Squamous cell carcinoma
AGRN::ISG15	Adenocarcinoma
AGRN::NDUFS5	Adenocarcinoma
AGRN::NOC4L	Squamous cell carcinoma
AGRN::NRG1	Malignant epithelial tumor, special type
AGRN::PLCH2	Astrocytoma, grade III-IV/Glioblastoma
AGRN::SIAE	Adenocarcinoma
AGRN::ZC3H18	Adenocarcinoma
AGRP::ATP6V0D1	Nonneoplastic epithelial disorder/lesion
AGTPBP1::BOLL	Adenocarcinoma
AGTPBP1::DAPK1	Mesenchymal tumor, NOS
AGTPBP1::NAA35	Acute erythroleukemia (FAB type M6)
AGTRAP::BRAF	Adenocarcinoma
AGTRAP::DHRS7	Adenocarcinoma
AHCTF1::ATP2B4	Adenocarcinoma
AHCTF1::NAAA	Adenocarcinoma
AHCTF1::SMYD3	Malignant melanoma | Squamous cell carcinoma
AHCTF1::TFB2M	Squamous cell carcinoma
AHCY::ACTR5	Squamous cell carcinoma
AHCY::RPLP1	Adenocarcinoma
AHCYL1::DENND2D	Adenocarcinoma
AHCYL1::GNAI3	Adenocarcinoma
AHCYL1::GSTM5	Adenocarcinoma
AHCYL1::LRRIQ3	Adenocarcinoma
AHCYL1::MAN1A2	Adenocarcinoma
AHCYL1::RAD51C	Adenocarcinoma
AHCYL2::IP6K2	Adenocarcinoma
AHCYL2::SND1	Adenocarcinoma
AHDC1::ALCAM	Adenocarcinoma
AHDC1::CACHD1	Malignant melanoma
AHDC1::DNAJC8	Malignant melanoma
AHDC1::IFI6	Adenocarcinoma
AHDC1::MORN1	Adenocarcinoma
AHDC1::NUP214	Adenocarcinoma
AHDC1::ST3GAL3	Malignant epithelial tumor, special type
AHDC1::TAF12	Adenocarcinoma
AHDC1::TMPO	Astrocytoma, grade III-IV/Glioblastoma
AHI1::C12ORF50	Malignant melanoma
AHI1::C12orf50	Malignant melanoma
AHI1::CHEK2	Adenocarcinoma
AHI1::HBS1L	Adenocarcinoma
AHI1::MYB	Adenocarcinoma
AHI1::TRB	Acute lymphoblastic leukemia/lymphoblastic lymphoma
AHNAK2::CD244	Squamous cell carcinoma
AHNAK::BIRC6	Malignant melanoma
AHNAK::DPF2	Squamous cell carcinoma
AHNAK::EEF1G	Squamous cell carcinoma | Adenocarcinoma
AHNAK::EIF2AK2	Adenocarcinoma
AHNAK::INTS5	Adenocarcinoma
AHNAK::KLF2	Multiple myeloma
AHNAK::KMT2A	Leiomyosarcoma
AHNAK::MACROD1	Adenocarcinoma
AHNAK::NXF1	Squamous cell carcinoma
AHNAK::RPS6KA4	Adenocarcinoma
AHNAK::SF1	Multiple myeloma
AHNAK::STIP1	Adenocarcinoma
AHNAK::SUPT16H	Squamous cell carcinoma
AHNAK::TYK2	Acute myeloid leukemia, NOS | Skin
AHNAK::UBC	Multiple myeloma
AHNAK::USP6	Aneurysmal bone cyst
AHNAK::ZNF827	Adenocarcinoma
AHNAK::ZNFX1	Adenocarcinoma
AHR::CDK14	Adenocarcinoma
AHR::CUL4B	Malignant melanoma
AHR::LRRC72	Adenocarcinoma
AHR::TSPAN13	Transitional cell carcinoma | Squamous cell carcinoma
AHRR::AVIL	Mesenchymal tumor, NOS
AHRR::CSNK1E	Malignant melanoma
AHRR::NCOA2	Angiofibroma
AHRR::NCOA3	Angiofibroma
AHRR::PLEKHG4B	Malignant melanoma
AHSA1::TMEM67	Adenocarcinoma
AHSG::STAT6	Adenocarcinoma
AHSG::TF	Adenocarcinoma
AICDA::MYC	Diffuse large B-cell lymphoma
AICDA::SLC9A7	Diffuse large B-cell lymphoma
AIF1L::ETV6	Acute lymphoblastic leukemia/lymphoblastic lymphoma
AIF1L::NRSN2	Malignant melanoma
AIF1L::SYN2	Malignant melanoma
AIFM1::ARL3	Adenocarcinoma
AIG1::ADGRG6	Adenocarcinoma
AIG1::COL8A1	Adenocarcinoma
AIG1::IL20RA	Squamous cell carcinoma
AIG1::TIAM2	Transitional cell carcinoma
AIP::KMT2A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
AIP::LYZL6	Astrocytoma, grade I-II
AIP::POLD4	Adenocarcinoma
AIP::PRSS53	Malignant epithelial tumor, special type
AJAP1::CYTH3	Adenocarcinoma
AJM1::PHPT1	Squamous cell carcinoma
AJUBA::CEP192	Adenocarcinoma
AJUBA::SLC7A8	Adenocarcinoma
AK1::ST6GALNAC4	Squamous cell carcinoma
AK2::MRTFA	Adenocarcinoma
AK3::DOCK8	Adenocarcinoma
AK3::IL33	Squamous cell carcinoma
AK3::RCL1	Squamous cell carcinoma
AK4::NDC1	Adenocarcinoma
AK5::ALK	Soft tissue tumor, special type
AK5::USP33	Squamous cell carcinoma
AK6::ADAMTS6	Adenocarcinoma
AK9::FAM184A	Adenocarcinoma
AK9::PDSS2	Adenocarcinoma
AKAP10::CCL3	Mesenchymal tumor, NOS
AKAP10::GID4	Adenocarcinoma
AKAP10::HELZ	Adenocarcinoma
AKAP10::PSMD11	Squamous cell carcinoma
AKAP11::DGKH	Squamous cell carcinoma
AKAP11::MRPS31	Astrocytoma, grade III-IV/Glioblastoma
AKAP11::PACS1	Adenocarcinoma
AKAP12::ASCC3	Mesenchymal tumor, NOS
AKAP13::ADAMTSL3	Transitional cell carcinoma
AKAP13::CHD2	Squamous cell carcinoma
AKAP13::CHSY3	Adenocarcinoma
AKAP13::DMXL2	Adenocarcinoma
AKAP13::GOLM2	Mesothelioma
AKAP13::IGF1R	Squamous cell carcinoma | Adenocarcinoma
AKAP13::INTS14	Adenocarcinoma
AKAP13::MUSK	Adenocarcinoma
AKAP13::MYL5	Adenocarcinoma
AKAP13::NOX5	Adenocarcinoma
AKAP13::NRG1	Adenocarcinoma
AKAP13::NTRK3	Malignant melanoma | Astrocytoma, grade I-II
AKAP13::PDE8A	Adenocarcinoma
AKAP13::RET	Adenocarcinoma
AKAP13::RFX7	Squamous cell carcinoma
AKAP13::SYNE1	Adenocarcinoma
AKAP1::ANKFN1	Adenocarcinoma
AKAP1::C17ORF67	Adenocarcinoma
AKAP1::C17orf67	Adenocarcinoma
AKAP1::GGA3	Adenocarcinoma
AKAP1::PITPNC1	Adenocarcinoma
AKAP1::WIPF2	Adenocarcinoma
AKAP6::EGLN3	Astrocytoma, grade III-IV/Glioblastoma
AKAP6::PRKD1	Malignant melanoma
AKAP6::SPTSSA	Adenocarcinoma
AKAP7::ADGB	Malignant melanoma
AKAP7::ESR1	Adenocarcinoma
AKAP8::BRD4	Chondrosarcoma, NOS
AKAP8::CALR3	Mesenchymal tumor, NOS
AKAP8::KLF2	Multiple myeloma
AKAP8::MYO9B	Adenocarcinoma
AKAP8::RPL28	Adenocarcinoma
AKAP8::VMP1	Adenocarcinoma
AKAP8L::EFCAB3	Adenocarcinoma
AKAP8L::WIZ	Malignant melanoma
AKAP9::ANKIB1	Squamous cell carcinoma
AKAP9::BRAF	Astrocytoma, pilocytic/juvenile | Melanocytic neoplasm, special type | Malignant melanoma | Adenocarcinoma | Benign nevus
AKAP9::CDK14	Adenocarcinoma | Squamous cell carcinoma
AKAP9::PDGFRA	Acute myeloid leukemia, NOS | Skin
AKAP9::PON2	Astrocytoma, grade III-IV/Glioblastoma
AKAP9::PPP2R3B	Squamous cell carcinoma
AKAP9::RUNX1	Adenocarcinoma
AKAP9::SEC61G	Astrocytoma, grade III-IV/Glioblastoma
AKAP9::ZNF3	Adenocarcinoma
AKIRIN1::MEAF6	Adenocarcinoma
AKIRIN2::ANKRD55	Adenocarcinoma
AKIRIN2::CUL7	Astrocytoma, grade I-II
AKIRIN2::GAREM1	Mesenchymal tumor, NOS
AKNA::ENOX1	Mesenchymal tumor, NOS
AKNA::WHRN	Adenocarcinoma
AKR1A1::AGO3	Squamous cell carcinoma
AKR1C3::AKR1E2	Squamous cell carcinoma
AKR1E2::WAC	Adenocarcinoma
AKT1::ANKS1A	Transitional cell carcinoma
AKT1::MTA1	Multiple myeloma
AKT1::PHRF1	Adenocarcinoma
AKT2::BTBD2	Astrocytoma, grade III-IV/Glioblastoma
AKT2::CXCL11	Adenocarcinoma
AKT2::DPY19L3	Adenocarcinoma
AKT2::ELK3	Malignant melanoma
AKT2::NSMAF	Adenocarcinoma
AKT2::SRRM5	Astrocytoma, grade I-II
AKT2::UPF1	Astrocytoma, grade I-II
AKT2::YIF1B	Adenocarcinoma
AKT2::ZNF576	Astrocytoma, grade I-II
AKT3::ADSS2	Adenocarcinoma
AKT3::CDC14A	Malignant melanoma
AKT3::GCSAML	Astrocytoma, grade III-IV/Glioblastoma
AKT3::HEATR1	Mesothelioma
AKT3::PPP2R2A	Adenocarcinoma
AKT3::PTPRR	Malignant melanoma
AKT3::RGS7	Astrocytoma, grade III-IV/Glioblastoma
AKTIP::COTL1	Astrocytoma, grade I-II
ALAS1::HHEX	Adenocarcinoma
ALAS1::PARP3	Squamous cell carcinoma
ALAS1::RBM6	Adenocarcinoma
ALB::ARFGEF2	Adenocarcinoma
ALB::DDX21	Adenocarcinoma
ALB::EXOSC9	Adenocarcinoma
ALB::FOXP1	Adenocarcinoma
ALB::PLEKHA5	Adenocarcinoma
ALB::SEC63	Adenocarcinoma
ALB::SIAE	Adenocarcinoma
ALB::SQSTM1	Adenocarcinoma
ALB::TLN1	Adenocarcinoma
ALB::UBAC1	Adenocarcinoma
ALCAM::EIF2A	Adenocarcinoma
ALCAM::EPHA6	Squamous cell carcinoma
ALCAM::NRROS	Adenocarcinoma
ALCAM::RAF1	Malignant epithelial tumor, special type
ALCAM::SH3KBP1	Transitional cell carcinoma
ALCAM::YIF1B	Adenocarcinoma
ALDH18A1::PDLIM1	Squamous cell carcinoma
ALDH1A1::FXYD1	Adenocarcinoma
ALDH1A1::TYK2	Adenocarcinoma
ALDH1A3::IGF1R	Squamous cell carcinoma
ALDH1A3::USP25	Adenocarcinoma
ALDH1A3::VPS53	Adenocarcinoma
ALDH1L1::SLC41A3	Adenocarcinoma
ALDH2::ACTB	Adenocarcinoma
ALDH2::ATXN2	Adenocarcinoma
ALDH2::LIN7A	Mesenchymal tumor, NOS
ALDH2::LRBA	Squamous cell carcinoma
ALDH3A1::MYH9	Squamous cell carcinoma
ALDH3A1::NF1	Miscellaneous hematopoietic/lymphoid neoplasm, special type | Benign epithelial tumor, special type
ALDH3A1::ULK2	Squamous cell carcinoma
ALDH3A2::EIF5A	Adenocarcinoma
ALDH3A2::IFNK	Adenocarcinoma
ALDH3A2::PITPNM2	Adenocarcinoma
ALDH3A2::SLC47A1	Squamous cell carcinoma
ALDH3B1::PC	Squamous cell carcinoma
ALDH3B2::PLAAT3	Squamous cell carcinoma
ALDH3B2::TENM4	Adenocarcinoma
ALDH5A1::MAP3K5	Adenocarcinoma
ALDH7A1::PIP	Adenocarcinoma
ALDH8A1::PPM1H	Adenocarcinoma
ALDH9A1::MGST3	Mesenchymal tumor, NOS
ALDH9A1::NME7	Adenocarcinoma
ALDH9A1::TMCO1	Adenocarcinoma
ALDOA::ANKS1A	Transitional cell carcinoma
ALDOA::ARFGEF2	Adenocarcinoma
ALDOA::ASPHD1	Adenocarcinoma
ALDOA::CCT5	Malignant epithelial tumor, special type
ALDOA::COL1A1	Adenocarcinoma
ALDOA::DDX27	Adenocarcinoma
ALDOA::DDX54	Adenocarcinoma
ALDOA::FADS2	Adenocarcinoma
ALDOA::INTS9	Transitional cell carcinoma
ALDOA::MPHOSPH8	Adenocarcinoma
ALDOA::NDUFV1	Adenocarcinoma
ALDOA::PANK2	Adenocarcinoma
ALDOA::RPL7A	Transitional cell carcinoma
ALDOA::SCN2A	Astrocytoma, grade I-II
ALDOA::SIAE	Adenocarcinoma
ALDOA::SLC1A3	Astrocytoma, grade I-II
ALDOB::C3	Adenocarcinoma
ALDOC::KIF3A	Astrocytoma, grade I-II
ALDOC::MAN1A2	Squamous cell carcinoma
ALG10::IGFBP6	Squamous cell carcinoma
ALG10B::IGFBP6	Squamous cell carcinoma
ALG11::JPH3	Adenocarcinoma
ALG11::ZFYVE28	Adenocarcinoma
ALG12::CDT1	Adenocarcinoma
ALG12::DENND6B	Malignant epithelial tumor, special type
ALG12::IL17REL	Adenocarcinoma
ALG12::ZBED4	Squamous cell carcinoma
ALG14::CFAP276	Adenocarcinoma
ALG14::HACD1	Malignant melanoma
ALG14::JAK1	Transitional cell carcinoma
ALG14::NRDC	Adenocarcinoma
ALG1::SEC14L5	Squamous cell carcinoma
ALG5::GALNT17	Transitional cell carcinoma
ALG5::PIGU	Adenocarcinoma
ALG6::BMPR1B	Squamous cell carcinoma
ALG6::DUT	Squamous cell carcinoma
ALG6::SLC22A15	Malignant melanoma
ALG6::UBE2U	Adenocarcinoma
ALG8::FGF19	Squamous cell carcinoma
ALG8::KHDC1	Adenocarcinoma
ALG8::NARS2	Adenocarcinoma
ALG8::OXA1L	Adenocarcinoma
ALG8::SNX29	Adenocarcinoma
ALG8::TENM4	Adenocarcinoma
ALG8::USP32	Adenocarcinoma
ALG9::PDGFD	Mesothelioma
ALK::ATIC	Anaplastic large cell lymphoma, cutaneous type
ALK::CACNA1D	Adenocarcinoma
ALK::CARS1	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma
ALK::DHX8	Adenocarcinoma
ALK::EML4	Astrocytoma, grade III-IV/Glioblastoma
ALK::EML4::FBXO11	Adenocarcinoma
ALK::GALNT14	Adenocarcinoma
ALK::IGFBP5	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma
ALK::LIMS1	Adenocarcinoma
ALK::LRRN2	Adenocarcinoma
ALK::PPP1CB	Embryonal nervous system tumor, NOS
ALK::PTPN3	Adenocarcinoma
ALK::R3HDM1	Adenocarcinoma
ALK::RAB10	Adenocarcinoma
ALK::RNF144A	Adenocarcinoma
ALK::ROS1	Acute myeloid leukemia, NOS | Skin
ALK::RRBP1	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma
ALK::SAP130	Adenocarcinoma
ALK::SCEL	Adenocarcinoma
ALK::SFPQ	Neuroglial neoplasm, special type
ALK::SPDYA	Embryonal nervous system tumor, NOS
ALK::SSH2	Adenocarcinoma
ALK::STK39	Malignant melanoma
ALK::THBS1	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma
ALKBH3::ANO3	Squamous cell carcinoma
ALKBH3::TCIRG1	Undifferentiated carcinoma, small cell
ALKBH5::GID4	Squamous cell carcinoma
ALKBH5::MYO15A	Adenocarcinoma
ALKBH5::NUF2	Mesenchymal tumor, NOS
ALKBH8::C11orf65	Adenocarcinoma
ALMS1::ALK	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma
ALMS1::TNC	Adenocarcinoma
ALPK1::GALNTL6	Mesothelioma
ALPK1::NAA15	Malignant melanoma
ALPL::EIF4G3	Mesenchymal tumor, NOS
ALPL::FILIP1L	Adenocarcinoma
ALX4::LMX1A	Mesenchymal tumor, NOS
ALX4::NCOA2	Soft tissue tumor, special type
ALX4::STK33	Adenocarcinoma
ALYREF::CCDC57	Adenocarcinoma
AMACR::AMACR	Adenocarcinoma
AMACR::NDUFAF2	Adenocarcinoma
AMBP::ORM1	Adenocarcinoma
AMBP::RAE1	Adenocarcinoma
AMBP::RBP4	Adenocarcinoma
AMBP::SEC63	Adenocarcinoma
AMBP::TYK2	Adenocarcinoma
AMBRA1::ARHGAP1	Adenocarcinoma
AMBRA1::CAT	Adenocarcinoma
AMBRA1::CCDC61	Astrocytoma, grade I-II
AMBRA1::CKAP5	Transitional cell carcinoma
AMBRA1::HARBI1	Malignant melanoma | Adenocarcinoma
AMBRA1::LRP4	Adenocarcinoma
AMBRA1::TAGLN	Adenocarcinoma
AMBRA1::TRPC6	Adenocarcinoma
AMD1::EPG5	Adenocarcinoma
AMD1::FIG4	Malignant epithelial tumor, special type
AMD1::MBOAT2	Adenocarcinoma
AMDHD1::ACSS3	Mesenchymal tumor, NOS
AMDHD2::COG7	Adenocarcinoma
AMFR::BBS2	Adenocarcinoma
AMFR::ITGAM	Adenocarcinoma
AMFR::PLLP	Mesenchymal tumor, NOS
AMMECR1::PLA2G12B	Adenocarcinoma
AMMECR1L::SAP130	Adenocarcinoma
AMMECR1L::TNFRSF10C	Adenocarcinoma
AMN1::FAR2	Adenocarcinoma
AMN::TNFAIP2	Adenocarcinoma
AMOTL1::CCDC88B	Astrocytoma, grade I-II
AMOTL1::CEP295	Squamous cell carcinoma
AMOTL1::PIWIL4	Mesenchymal tumor, NOS
AMOTL1::SLCO2B1	Transitional cell carcinoma
AMOTL2::TOPBP1	Adenocarcinoma
AMPD2::ALB	Adenocarcinoma
AMPD2::STXBP3	Adenocarcinoma
AMPD3::ANKH	Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
AMPH::TAX1BP1	Adenocarcinoma
AMZ2::KDM1B	Adenocarcinoma
ANAPC15::RAI14	Adenocarcinoma
ANAPC16::MICU1	Adenocarcinoma
ANAPC1::LIMS1	Squamous cell carcinoma
ANAPC1::RGPD3	Adenocarcinoma
ANAPC2::CEBPA	Acute myeloid leukemia, NOS | Skin
ANAPC2::EXD3	Adenocarcinoma
ANAPC2::EYS	Transitional cell carcinoma
ANAPC4::RBPJ	Adenocarcinoma
ANAPC5::ADAM15	Malignant melanoma
ANAPC5::KDM2B	Adenocarcinoma
ANAPC7::CORO1C	Astrocytoma, grade I-II
ANAPC7::PAH	Adenocarcinoma
ANAPC7::PDE11A	Adenocarcinoma
ANGPT1::CXCL12	Squamous cell carcinoma
ANGPT1::EIF3H	Fibroma
ANGPT1::TNFRSF11B	Mesenchymal tumor, NOS
ANGPTL2::USP6	Superficial fibromatosis
ANGPTL4::CLCN3	Adenocarcinoma
ANK1::ADAM7	Adenocarcinoma
ANK1::FGFR1	Adenocarcinoma
ANK1::FUT10	Adenocarcinoma
ANK1::ZMAT4	Adenocarcinoma
ANK2::ALPK1	Astrocytoma, grade I-II | Adenocarcinoma
ANK2::ARHGAP10	Astrocytoma, grade III-IV/Glioblastoma
ANK2::ARHGAP31	Astrocytoma, grade I-II
ANK3::ACTA2	Adenocarcinoma
ANK3::ATAD1	Adenocarcinoma
ANK3::BRAF	Adenocarcinoma
ANK3::CCDC6	Adenocarcinoma
ANK3::CDK1	Adenocarcinoma
ANK3::CHN2	Adenocarcinoma
ANK3::IFIT5	Adenocarcinoma
ANK3::MCU	Malignant epithelial tumor, special type
ANK3::RET	Carcinoma, NOS
ANK3::RHOBTB1	Adenocarcinoma | Transitional cell carcinoma
ANK3::SP2	Adenocarcinoma
ANK3::TMPRSS15	Adenocarcinoma
ANK3::UBE2I	Adenocarcinoma
ANK3::USP9Y	Adenocarcinoma
ANK3::WDFY4	Adenocarcinoma
ANKAR::ASNSD1	Adenocarcinoma
ANKAR::MFSD6	Adenocarcinoma
ANKAR::PMS1	Adenocarcinoma
ANKDD1A::PLEKHO2	Astrocytoma, grade III-IV/Glioblastoma
ANKFY1::CCDC88C	Adenocarcinoma
ANKFY1::NLRP1	Adenocarcinoma
ANKFY1::SPINT2	Adenocarcinoma
ANKH::ANO6	Malignant melanoma
ANKH::ARHGEF38	Adenocarcinoma
ANKH::DNAH5	Mesenchymal tumor, NOS
ANKH::MXD3	Adenocarcinoma
ANKH::R3HDM1	Mesenchymal tumor, NOS
ANKH::STEAP3	Mesenchymal tumor, NOS
ANKH::TENM2	Neuroblastoma
ANKHD1::CYSTM1	Malignant melanoma | Adenocarcinoma
ANKHD1::PAIP2	Adenocarcinoma
ANKHD1::PCDH1	Adenocarcinoma
ANKHD1::PCDHGA10	Adenocarcinoma
ANKHD1::PCDHGA11	Adenocarcinoma
ANKHD1::PCDHGA12	Adenocarcinoma
ANKHD1::PCDHGA8	Adenocarcinoma
ANKHD1::PCDHGA9	Adenocarcinoma
ANKHD1::PCDHGB5	Adenocarcinoma
ANKHD1::PCDHGB6	Adenocarcinoma
ANKHD1::PCDHGB7	Adenocarcinoma
ANKHD1::PCDHGC3	Adenocarcinoma
ANKHD1::PCDHGC4	Adenocarcinoma
ANKHD1::PCDHGC5	Adenocarcinoma
ANKHD1::SLC4A9	Malignant epithelial tumor, special type
ANKHD1::TIAM2	Adenocarcinoma
ANKHD1::USO1	Adenocarcinoma
ANKIB1::AKAP9	Adenocarcinoma
ANKIB1::CDK14	Adenocarcinoma
ANKIB1::CYP3A4	Adenocarcinoma
ANKIB1::GNAI1	Squamous cell carcinoma
ANKIB1::LMTK2	Squamous cell carcinoma
ANKIB1::PEX1	Adenocarcinoma
ANKIB1::TNFRSF17	Adenocarcinoma
ANKLE2::CHFR	Adenocarcinoma
ANKLE2::MGAT1	Mesenchymal tumor, NOS
ANKLE2::NCOR2	Astrocytoma, grade I-II
ANKLE2::POLE	Squamous cell carcinoma
ANKLE2::RNF180	Adenocarcinoma
ANKLE2::SNU13	Adenocarcinoma
ANKLE2::ZNF605	Transitional cell carcinoma
ANKMY1::GPR35	Adenocarcinoma
ANKMY1::PDE11A	Adenocarcinoma
ANKMY2::CRPPA	Undifferentiated carcinoma, small cell
ANKRD10::MYO16	Adenocarcinoma
ANKRD11::BRMS1	Malignant melanoma
ANKRD11::CDH15	Adenocarcinoma
ANKRD11::CES5A	Adenocarcinoma
ANKRD11::CHMP1A	Adenocarcinoma
ANKRD11::CNOT1	Adenocarcinoma
ANKRD11::CPNE7	Malignant melanoma
ANKRD11::DPEP1	Adenocarcinoma
ANKRD11::DYNLRB2	Adenocarcinoma
ANKRD11::E4F1	Squamous cell carcinoma
ANKRD11::ERGIC2	Adenocarcinoma
ANKRD11::ETS1	Multiple myeloma
ANKRD11::FANCA	Adenocarcinoma
ANKRD11::KLHL32	Adenocarcinoma
ANKRD11::LINGO1	Adenocarcinoma
ANKRD11::NAALADL2	Mesenchymal tumor, NOS
ANKRD11::PARVA	Adenocarcinoma
ANKRD11::PKD1L3	Refractory anemia with ringed sideroblasts
ANKRD11::PSMB1	Adenocarcinoma
ANKRD11::RAB11FIP3	Adenocarcinoma
ANKRD11::SPG7	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ANKRD11::SPIRE2	Adenocarcinoma
ANKRD11::STARD10	Transitional cell carcinoma
ANKRD11::TBCD	Adenocarcinoma
ANKRD11::TGIF1	Adenocarcinoma
ANKRD11::VPS9D1	Adenocarcinoma | Mature B-cell neoplasm, NOS
ANKRD12::CCDC178	Adenocarcinoma
ANKRD12::DLGAP1	Adenocarcinoma
ANKRD12::EPB41L3	Squamous cell carcinoma
ANKRD12::LRMDA	Adenocarcinoma
ANKRD12::MTHFD2L	Adenocarcinoma
ANKRD12::PTPRM	Adenocarcinoma
ANKRD12::RIOK3	Squamous cell carcinoma
ANKRD12::TXNDC2	Adenocarcinoma
ANKRD13C::FZR1	Adenocarcinoma
ANKRD13C::OR5V1	Adenocarcinoma
ANKRD13C::PTGER3	Mesenchymal tumor, NOS
ANKRD13C::RALYL	Adenocarcinoma
ANKRD13D::FCRL4	Transitional cell carcinoma
ANKRD17::AK2	Adenocarcinoma
ANKRD17::GC	Adenocarcinoma
ANKRD17::HS3ST1	Adenocarcinoma
ANKRD17::KCNIP4	Adenocarcinoma
ANKRD17::RPRD1B	Adenocarcinoma
ANKRD17::SQOR	Adenocarcinoma
ANKRD17::WDFY3	Adenocarcinoma
ANKRD18A::B4GALT1	Adenocarcinoma
ANKRD18A::ZNF521	Mesenchymal tumor, NOS
ANKRD18B::SNX30	Adenocarcinoma
ANKRD22::LRRTM3	Adenocarcinoma
ANKRD22::MSMB	Adenocarcinoma
ANKRD23::FAM178B	Squamous cell carcinoma
ANKRD26::MCM10	Transitional cell carcinoma
ANKRD26::RET	Adenocarcinoma
ANKRD27::DPY19L3	Squamous cell carcinoma
ANKRD27::PEPD	Adenocarcinoma
ANKRD27::RNF38	Malignant melanoma
ANKRD27::SLC7A9	Adenocarcinoma
ANKRD27::TDRD12	Squamous cell carcinoma
ANKRD27::ZFP14	Squamous cell carcinoma
ANKRD27::ZNF536	Squamous cell carcinoma
ANKRD27::ZNF790	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
ANKRD28::COLQ	Adenocarcinoma
ANKRD28::EYS	Adenocarcinoma
ANKRD28::FLT3	Skin | Acute myeloid leukemia, NOS
ANKRD28::GRM7	Transitional cell carcinoma
ANKRD28::HACL1	Germ cell tumor, NOS
ANKRD28::NUP98	Skin | Acute myeloid leukemia, NOS
ANKRD28::RFTN1	Squamous cell carcinoma
ANKRD28::TBC1D5	Adenocarcinoma
ANKRD28::TM9SF4	Malignant melanoma
ANKRD29::NPC1	Adenocarcinoma
ANKRD30A::FAM227B	Adenocarcinoma
ANKRD33B::ADAMTS16	Adenocarcinoma
ANKRD33B::ANKH	Mesenchymal tumor, NOS
ANKRD33B::MAML1	Adenocarcinoma
ANKRD33B::NIPBL	Adenocarcinoma
ANKRD36::UGGT1	Mesenchymal tumor, NOS
ANKRD37::MTERF4	Adenocarcinoma
ANKRD39::FAM178B	Squamous cell carcinoma
ANKRD40::DNAAF11	Adenocarcinoma
ANKRD40::NFIX	Squamous cell carcinoma
ANKRD42::PICALM	Squamous cell carcinoma
ANKRD42::RHOD	Adenocarcinoma
ANKRD44::ABCB10	Mature B-cell neoplasm, NOS
ANKRD44::ANKAR	Mesothelioma
ANKRD44::FASTKD1	Adenocarcinoma
ANKRD44::RFTN2	Astrocytoma, grade I-II
ANKRD45::HOOK3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ANKRD46::LRRC4C	Transitional cell carcinoma
ANKRD46::NCALD	Transitional cell carcinoma
ANKRD46::ODF1	Transitional cell carcinoma
ANKRD46::TMEM222	Adenocarcinoma
ANKRD50::ATP2B1	Adenocarcinoma
ANKRD52::ASPHD1	Adenocarcinoma
ANKRD52::DYRK2	Adenocarcinoma
ANKRD52::PGS1	Adenocarcinoma
ANKRD52::RASSF3	Adenocarcinoma
ANKRD54::C22ORF23	Adenocarcinoma
ANKRD6::CASP8AP2	Squamous cell carcinoma
ANKRD6::ZDHHC14	Astrocytoma, grade I-II
ANKRD7::DUS4L	Squamous cell carcinoma
ANKS1A::DCDC2	Squamous cell carcinoma
ANKS1A::MYO1F	Malignant melanoma
ANKS1A::PIGN	Adenocarcinoma
ANKS1A::UQCC2	Adenocarcinoma
ANKS1B::BLTP3B	Adenocarcinoma
ANKS1B::CCER1	Adenocarcinoma
ANKS1B::ERP29	Malignant melanoma
ANKS1B::NDUFA12	Adenocarcinoma
ANKS1B::PTPRQ	Mesothelioma
ANKS3::DNAAF8	Adenocarcinoma
ANKS3::GLYR1	Adenocarcinoma
ANKS3::SEPTIN12	Adenocarcinoma
ANKS3::ZNF500	Adenocarcinoma
ANKS6::STX17	Squamous cell carcinoma
ANLN::DGKB	Mesenchymal tumor, NOS
ANLN::EEPD1	Adenocarcinoma
ANLN::POU6F2	Transitional cell carcinoma | Astrocytoma, grade III-IV/Glioblastoma
ANLN::TMEM135	Mesenchymal tumor, NOS
ANO10::NUP98	Acute myeloid leukemia, NOS | Skin
ANO10::SCN5A	Adenocarcinoma
ANO1::ABCC11	Adenocarcinoma
ANO1::ABHD15	Adenocarcinoma
ANO1::CDC42BPG	Germ cell tumor, NOS
ANO1::CWF19L2	Transitional cell carcinoma
ANO1::CYP2R1	Adenocarcinoma
ANO1::EMSY	Adenocarcinoma
ANO1::FGF19	Squamous cell carcinoma
ANO1::FGF3	Squamous cell carcinoma
ANO1::FOLR3	Squamous cell carcinoma
ANO1::KIF21A	Malignant melanoma
ANO1::OR4D10	Adenocarcinoma
ANO1::SLC7A8	Squamous cell carcinoma
ANO1::UNC5D	Adenocarcinoma
ANO2::BICD1	Transitional cell carcinoma
ANO2::DCP1B	Adenocarcinoma
ANO2::FBXL14	Undifferentiated carcinoma, small cell
ANO2::GALNT8	Adenocarcinoma
ANO2::NUDT3	Mesenchymal tumor, NOS
ANO3::FGFR4	Carcinoma, NOS
ANO4::KICS2	Mesenchymal tumor, NOS
ANO4::NTS	Mesenchymal tumor, NOS
ANO5::CARS1	Mesenchymal tumor, NOS
ANO5::CPM	Mesenchymal tumor, NOS
ANO6::EDA	Mesenchymal tumor, NOS
ANO6::HNRNPUL1	Astrocytoma, grade I-II
ANO6::IAPP	Adenocarcinoma
ANO6::LRIG3	Soft tissue tumor, NOS
ANO6::PEBP4	Adenocarcinoma
ANO6::PKP2	Adenocarcinoma
ANO7::PHC2	Adenocarcinoma
ANO7::PKNOX1	Adenocarcinoma
ANO7::RALBP1	Adenocarcinoma
ANO9::DEAF1	Adenocarcinoma
ANOS1::ARHGEF26	Adenocarcinoma
ANP32A::DNAAF11	Adenocarcinoma
ANP32A::IGF1R	Myelodysplastic syndrome, NOS
ANP32E::CTSK	Adenocarcinoma
ANP32E::KAT6B	Adenocarcinoma
ANPEP::MMP14	Malignant melanoma
ANTXR1::APLF	Adenocarcinoma
ANTXR2::CHMP1A	Adenocarcinoma
ANXA10::GASK1B	Adenocarcinoma
ANXA11::MAT1A	Adenocarcinoma
ANXA13::DCAF13	Adenocarcinoma
ANXA1::TLN1	Squamous cell carcinoma
ANXA2::NTRK3	Leiomyosarcoma
ANXA2::RNF114	Adenocarcinoma
ANXA2::RORA	Adenocarcinoma
ANXA2::SLC51A	Adenocarcinoma
ANXA2::SMG1	Adenocarcinoma
ANXA3::BMP2K	Adenocarcinoma
ANXA4::GKN1	Transitional cell carcinoma
ANXA4::MEIG1	Adenocarcinoma
ANXA4::PKN1	Adenocarcinoma
ANXA4::TMEM67	Adenocarcinoma
ANXA5::CCNA2	Adenocarcinoma
ANXA5::TRMT44	Adenocarcinoma
ANXA6::CCDC69	Adenocarcinoma
ANXA6::UTRN	Adenocarcinoma
ANXA7::LGALS12	Adenocarcinoma
ANXA7::PRKD1	Adenocarcinoma
ANXA8::SPATA17	Transitional cell carcinoma
ANXA9::MRPL9	Transitional cell carcinoma
AOAH::ELMO1	Squamous cell carcinoma
AOPEP::CUEDC1	Squamous cell carcinoma
AOPEP::MFSD14B	Adenocarcinoma
AOPEP::PTPDC1	Adenocarcinoma
AOPEP::TBC1D9	Malignant melanoma
AOPEP::UBAP2	Adenocarcinoma
AOPEP::VCAN	Malignant melanoma
AOPEP::WDR53	Squamous cell carcinoma
AOPEP::ZNF169	Adenocarcinoma
AOPEP::ZNF462	Mesenchymal tumor, NOS
AP1AR::NDST4	Adenocarcinoma
AP1B1::CHEK2	Alveolar rhabdomyosarcoma
AP1B1::CLCN3	Transitional cell carcinoma
AP1B1::CLTCL1	Adenocarcinoma
AP1B1::DUSP18	Adenocarcinoma
AP1B1::ESR1	Liposarcoma, myxoid/round cell
AP1B1::GRK3	Transitional cell carcinoma
AP1B1::IGL	Astrocytoma, grade III-IV/Glioblastoma
AP1B1::NIPSNAP1	Transitional cell carcinoma
AP1B1::SGSM3	Astrocytoma, grade III-IV/Glioblastoma
AP1B1::TTC28	Adenocarcinoma
AP1G1::IST1	Adenocarcinoma
AP1G1::MTSS2	Mesenchymal tumor, NOS
AP1G1::NT5DC1	Adenocarcinoma
AP1G1::PMFBP1	Adenocarcinoma
AP1M1::CYP4F11	Adenocarcinoma
AP1M1::PYCR1	Mesenchymal tumor, NOS
AP1M1::RAB8A	Adenocarcinoma
AP1M1::ZNF93	Adenocarcinoma
AP1M2::CACNA1A	Adenocarcinoma
AP1M2::CELF5	Adenocarcinoma
AP1M2::FBXL12	Adenocarcinoma
AP1M2::HIP1	Adenocarcinoma
AP1M2::TMED1	Adenocarcinoma
AP1S1::PTOV1	Malignant epithelial tumor, special type
AP1S3::MAPK4	Mature B-cell neoplasm, NOS
AP2A1::DHDH	Adenocarcinoma
AP2A1::FCGRT	Adenocarcinoma
AP2A1::SCAF1	Adenocarcinoma
AP2A1::VRK3	Malignant melanoma | Squamous cell carcinoma
AP2A2::DRD4	Adenocarcinoma
AP2A2::EPS8L2	Squamous cell carcinoma
AP2A2::NLRC5	Adenocarcinoma
AP2A2::PKD1L3	Adenocarcinoma
AP2A2::PSMD13	Squamous cell carcinoma
AP2A2::TALDO1	Adenocarcinoma
AP2A2::TMEM80	Adenocarcinoma
AP2A2::TOLLIP	Malignant melanoma
AP2A2::TRIM22	Squamous cell carcinoma
AP2A2::TSPAN4	Transitional cell carcinoma
AP2A2::VPS26A	Adenocarcinoma
AP2B1::ERBB2	Adenocarcinoma
AP2B1::GAS2L2	Adenocarcinoma
AP2B1::RAB20	Squamous cell carcinoma
AP2B1::ZNF512	Adenocarcinoma
AP2M1::KLHL6	Adenocarcinoma
AP2M1::MAP3K13	Squamous cell carcinoma
AP2M1::PHF2	Adenocarcinoma
AP2M1::SEC63	Adenocarcinoma
AP2M1::TYK2	Squamous cell carcinoma
AP3B1::BRAF	Adenocarcinoma
AP3B1::CAMLG	Adenocarcinoma
AP3B1::DCTN4	Adenocarcinoma
AP3B1::IPO11	Malignant melanoma
AP3B1::LHFPL2	Malignant melanoma
AP3B2::HOMER2	Adenocarcinoma
AP3D1::ABHD17A	Adenocarcinoma
AP3D1::ALK	Benign fibrous histiocytoma
AP3D1::ARHGDIA	Adenocarcinoma
AP3D1::DOT1L	Transitional cell carcinoma
AP3D1::IRF4	Adenocarcinoma
AP3D1::KCTD19	Adenocarcinoma
AP3D1::LMNB2	Adenocarcinoma
AP3D1::PLEKHF1	Adenocarcinoma
AP3D1::ZNF682	Adenocarcinoma
AP3M2::PLAT	Adenocarcinoma
AP3S1::ARL14EPL	Adenocarcinoma
AP3S1::SPMIP3	Adenocarcinoma
AP3S2::KIF7	Adenocarcinoma
AP4B1::CIMAP3	Transitional cell carcinoma
AP4S1::HEATR5A	Squamous cell carcinoma
AP5B1::CFL1	Malignant epithelial tumor, special type
AP5S1::RNF24	Adenocarcinoma
AP5Z1::SGCA	Adenocarcinoma
APAF1::HOXC10	Adenocarcinoma
APAF1::LRRIQ1	Adenocarcinoma
APAF1::TLN1	Adenocarcinoma
APAF1::TMPO	Adenocarcinoma
APAF1::UNC13B	Adenocarcinoma
APBA1::RAD23B	Adenocarcinoma
APBA1::SUSD1	Mesenchymal tumor, NOS
APBA2::C12ORF60	Adenocarcinoma
APBA2::CHD4	Astrocytoma, grade III-IV/Glioblastoma
APBA2::GABRB3	Adenocarcinoma
APBA2::OCA2	Mesothelioma
APBA2::SOAT2	Malignant melanoma
APBB1IP::DNAJC1	Malignant melanoma
APBB1IP::SCARB1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
APBB2::DMD	Adenocarcinoma
APBB2::NSUN7	Adenocarcinoma
APBB2::ZFYVE28	Adenocarcinoma
APC2::GIGYF2	Astrocytoma, grade I-II
APC::ALDH1L1	Adenocarcinoma
APC::DTWD2	Adenocarcinoma
APC::INSRR	Adenocarcinoma
APC::KIAA0825	Adenocarcinoma
APC::KRT6A	Astrocytoma, grade III-IV/Glioblastoma
APC::MCC	Adenocarcinoma
APC::NREP	Malignant melanoma
APC::REEP2	Adenocarcinoma
APC::SLC27A6	Malignant melanoma
APCDD1::TRAPPC8	Adenocarcinoma
APH1A::RGS4	Adenocarcinoma
APH1A::SLAMF1	Adenocarcinoma
API5::FOLH1	Squamous cell carcinoma
API5::GANC	Malignant melanoma
APIP::FAM241B	Adenocarcinoma
APIP::S100A13	Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
APIP::SLC1A2	Adenocarcinoma | Squamous cell carcinoma
APLF::SPTLC1	Adenocarcinoma
APLP1::CLU	Astrocytoma, grade I-II
APLP1::DBH	Malignant epithelial tumor, special type
APLP2::C7	Adenocarcinoma
APLP2::CD40	Adenocarcinoma
APLP2::EEA1	Adenocarcinoma
APLP2::EIF2AK2	Transitional cell carcinoma
APLP2::KCNJ5	Adenocarcinoma
APLP2::OPCML	Adenocarcinoma
APLP2::PLAT	Adenocarcinoma
APLP2::PLEKHA5	Adenocarcinoma
APLP2::SLC22A10	Squamous cell carcinoma
APLP2::SPCS2	Adenocarcinoma
APLP2::TNFSF11	Adenocarcinoma
APLP2::TYK2	Benign epithelial tumor, special type
APMAP::ZNF337	Adenocarcinoma
APOA2::ITPR2	Adenocarcinoma
APOA2::TYK2	Adenocarcinoma
APOA2::VTN	Adenocarcinoma
APOB::CLU	Adenocarcinoma
APOBEC3F::SBF1	Adenocarcinoma
APOC1::IQCE	Adenocarcinoma
APOC1::RABEP1	Malignant melanoma
APOC1::SLC38A4	Adenocarcinoma
APOC3::ORM1	Adenocarcinoma
APOD::CLDN7	Adenocarcinoma
APOD::GLI1	Undifferentiated sarcoma
APOE::ARFGEF2	Adenocarcinoma
APOE::CCT5	Adenocarcinoma
APOE::CLCN3	Adenocarcinoma
APOE::DSP	Adenocarcinoma
APOE::IQGAP2	Adenocarcinoma
APOE::SNW1	Adenocarcinoma
APOL1::ACTB	Adenocarcinoma
APOL2::RAB12	Astrocytoma, grade I-II
APOL2::SCUBE1	Adenocarcinoma
APOL2::ULK2	Squamous cell carcinoma
APOL3::ISX	Squamous cell carcinoma
APOL6::CUX2	Adenocarcinoma
APOLD1::CDKN1B	Adenocarcinoma
APOLD1::CREBL2	Adenocarcinoma
APOO::CNKSR2	Squamous cell carcinoma
APOOL::DCAF8	Adenocarcinoma
APP::CCT8	Malignant melanoma
APP::EEA1	Astrocytoma, grade I-II
APP::ITM2B	Adenocarcinoma
APP::MMP9	Transitional cell carcinoma
APP::NRG1	Adenocarcinoma
APP::RAB11FIP4	Adenocarcinoma
APP::RCAN1	Adenocarcinoma
APP::SEC63	Adenocarcinoma
APP::TBK1	Adenocarcinoma
APP::TMEM50B	Squamous cell carcinoma
APP::TSPEAR	Adenocarcinoma
APPBP2::CA10	Malignant melanoma
APPBP2::CCN5	Adenocarcinoma
APPBP2::DCAF7	Adenocarcinoma
APPBP2::DNAH17	Adenocarcinoma
APPBP2::HEATR6	Adenocarcinoma
APPBP2::PECAM1	Adenocarcinoma
APPBP2::RAB5C	Malignant epithelial tumor, special type
APPBP2::SDK2	Adenocarcinoma
APPBP2::SEPTIN9	Adenocarcinoma
APPBP2::SETD2	Mesenchymal tumor, NOS
APPBP2::ZNF345	Adenocarcinoma
APPL1::ABHD6	Adenocarcinoma
APPL1::SPATA12	Adenocarcinoma
APPL2::CIT	Squamous cell carcinoma
APPL2::NR0B1	Adenocarcinoma
APPL2::RAF1	Malignant soft tissue tumor, NOS
APPL2::TUBA1C	Mesenchymal tumor, NOS
APTX::ARL5B	Squamous cell carcinoma
APTX::GNE	Adenocarcinoma
APTX::NOL6	Squamous cell carcinoma
APTX::PRSS3	Adenocarcinoma
APTX::SMU1	Squamous cell carcinoma
AQP1::ARFGEF2	Adenocarcinoma
AQP1::CFB	Adenocarcinoma
AQP1::CHI3L2	Astrocytoma, grade I-II
AQP1::TYK2	Adenocarcinoma
AQP2::FOXP1	Adenocarcinoma
AQP3::B2M	Squamous cell carcinoma
AQR::ZNF770	Mature B-cell neoplasm, NOS
AR::NR4A3	Adenocarcinoma
ARAP1::ARRB1	Adenocarcinoma
ARAP1::DYNC2H1	Malignant melanoma
ARAP1::FADD	Adenocarcinoma
ARAP1::FCHSD2	Adenocarcinoma
ARAP1::IGF2	Adenocarcinoma
ARAP1::IL12RB2	Adenocarcinoma
ARAP1::INTS5	Adenocarcinoma
ARAP1::MOGAT2	Adenocarcinoma
ARAP1::SLC22A8	Transitional cell carcinoma
ARAP1::USP35	Adenocarcinoma
ARAP2::PDS5A	Squamous cell carcinoma
ARAP2::PRRC1	Malignant epithelial tumor, special type
ARAP3::CTBP2	Adenocarcinoma
ARAP3::DIAPH1	Malignant melanoma
ARB2A::CDC73	Acute myeloblastic leukemia without maturation (FAB type M1)
ARB2A::EFNA5	Adenocarcinoma
ARB2A::ERAP2	Adenocarcinoma
ARB2A::FHIT	Adenocarcinoma
ARB2A::KIAA0825	Adenocarcinoma
ARB2A::MCTP1	Adenocarcinoma
ARB2A::PRR16	Adenocarcinoma
ARCN1::DLG2	Acute myeloblastic leukemia with maturation (FAB type M2)
ARCN1::MANEA	Adenocarcinoma
AREL1::CELA3B	Adenocarcinoma
AREL1::DPEP1	Malignant melanoma
AREL1::SYNDIG1L	Adenocarcinoma
AREL1::TMED10	Adenocarcinoma
ARF1::HSPA9	Adenocarcinoma
ARF1::IGK	Multiple myeloma
ARF3::CHFR	Adenocarcinoma
ARF3::FKBP11	Nonneoplastic epithelial disorder/lesion
ARF3::TAB2	Diffuse large B-cell lymphoma
ARF3::WNT10B	Adenocarcinoma
ARFGAP1::SPAG4	Adenocarcinoma
ARFGAP1::UQCC1	Adenocarcinoma
ARFGAP2::CELF1	Adenocarcinoma
ARFGAP2::FBRSL1	Adenocarcinoma
ARFGAP2::MTCH2	Adenocarcinoma
ARFGAP2::PACSIN3	Adenocarcinoma
ARFGAP3::ATM	Myoepithelioma/myoepithelial carcinoma/mixed tumor
ARFGAP3::FBLN1	Malignant melanoma
ARFGAP3::LSM10	Malignant epithelial tumor, special type
ARFGAP3::PACSIN2	Squamous cell carcinoma
ARFGEF1::CPA6	Adenocarcinoma
ARFGEF1::CSPP1	Adenocarcinoma
ARFGEF1::LGR5	Mesenchymal tumor, NOS
ARFGEF1::PPP1R42	Malignant epithelial tumor, special type
ARFGEF1::SHC1	Mesenchymal tumor, NOS
ARFGEF1::SORCS2	Mesenchymal tumor, NOS
ARFGEF1::YJU2	Mesenchymal tumor, NOS
ARFGEF2::BCAS3	Adenocarcinoma
ARFGEF2::CNIH2	Adenocarcinoma
ARFGEF2::HNF4A	Mesenchymal tumor, NOS
ARFGEF2::NCOA3	Adenocarcinoma
ARFGEF2::PTP4A1	Adenocarcinoma
ARFGEF2::RNF114	Adenocarcinoma
ARFGEF2::SLC9A8	Refractory anemia with ringed sideroblasts
ARFGEF2::SULF2	Adenocarcinoma
ARFGEF2::TAFA5	Adenocarcinoma
ARFGEF2::TSHZ2	Adenocarcinoma
ARFGEF2::TTLL9	Mesenchymal tumor, NOS
ARFGEF3::ARHGAP45	Adenocarcinoma
ARFGEF3::COP1	Mesenchymal tumor, NOS
ARFGEF3::GRIK2	Mesenchymal tumor, NOS
ARFGEF3::MED20	Mesenchymal tumor, NOS
ARFGEF3::TAAR6	Adenocarcinoma
ARFGEF3::TNNI3K	Adenocarcinoma
ARFGEF3::XPO5	Squamous cell carcinoma
ARFIP1::DCTD	Squamous cell carcinoma
ARFIP1::FGB	Adenocarcinoma
ARG2::IPPK	Squamous cell carcinoma
ARG2::RAD51B	Malignant melanoma
ARGLU1::CXCR4	Adenocarcinoma
ARHGAP10::AFG2A	Adenocarcinoma
ARHGAP10::EDNRA	Mesenchymal tumor, NOS
ARHGAP10::FBXW2	Adenocarcinoma
ARHGAP10::TMEM184C	Adenocarcinoma
ARHGAP12::DESI1	Adenocarcinoma
ARHGAP12::FRMD4A	Mycosis fungoides/Sézary syndrome
ARHGAP12::KIF5B	Adenocarcinoma
ARHGAP12::SORCS3	Squamous cell carcinoma
ARHGAP12::SVIL	Adenocarcinoma
ARHGAP15::KYNU	Adenocarcinoma
ARHGAP17::RAB8B	Adenocarcinoma
ARHGAP17::SNRNP25	Squamous cell carcinoma
ARHGAP17::TNRC6A	Adenocarcinoma
ARHGAP18::CEP85L	Adenocarcinoma
ARHGAP18::THEMIS	Adenocarcinoma
ARHGAP18::TMEM244	Adenocarcinoma
ARHGAP19::CYB5A	Adenocarcinoma
ARHGAP19::DRG1	Adenocarcinoma
ARHGAP19::ELP6	Adenocarcinoma
ARHGAP19::RET	Carcinoma, NOS
ARHGAP19::RRP12	Adenocarcinoma
ARHGAP1::AMBRA1	Transitional cell carcinoma
ARHGAP1::CKAP5	Adenocarcinoma
ARHGAP21::ASPHD2	Adenocarcinoma
ARHGAP21::ENKUR	Astrocytoma, grade III-IV/Glioblastoma
ARHGAP21::GPR158	Adenocarcinoma
ARHGAP21::MSRB2	Adenocarcinoma
ARHGAP21::PDCD11	Adenocarcinoma
ARHGAP21::THNSL1	Adenocarcinoma
ARHGAP23::ASIC2	Adenocarcinoma
ARHGAP23::CCL18	Astrocytoma, grade I-II
ARHGAP23::CCR7	Adenocarcinoma
ARHGAP23::CYB561	Adenocarcinoma
ARHGAP23::GOSR2	Transitional cell carcinoma
ARHGAP23::NLK	Adenocarcinoma
ARHGAP23::RPL23	Adenocarcinoma
ARHGAP23::STARD3	Adenocarcinoma
ARHGAP23::TEX14	Adenocarcinoma
ARHGAP23::TSSK6	Adenocarcinoma
ARHGAP23::ZSCAN2	Adenocarcinoma
ARHGAP24::NOA1	Adenocarcinoma
ARHGAP26::AFAP1L1	Adenocarcinoma
ARHGAP26::CAST	Adenocarcinoma
ARHGAP26::CLDN18	Adenocarcinoma
ARHGAP26::KMT2A	Acute myeloid leukemia, NOS | Skin
ARHGAP26::MEIKIN	Adenocarcinoma
ARHGAP26::VDAC1	Transitional cell carcinoma
ARHGAP27::KANSL1	Adenocarcinoma
ARHGAP28::L3MBTL4	Adenocarcinoma
ARHGAP29::ABCA4	Transitional cell carcinoma
ARHGAP29::ALG14	Adenocarcinoma
ARHGAP29::DNAJC6	Adenocarcinoma
ARHGAP29::MID2	Transitional cell carcinoma
ARHGAP31::CFAP100	Mesenchymal tumor, NOS
ARHGAP31::TIMMDC1	Adenocarcinoma
ARHGAP32::AHNAK	Adenocarcinoma
ARHGAP32::CAPRIN1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ARHGAP32::CWF19L2	Adenocarcinoma
ARHGAP32::FCHSD2	Adenocarcinoma
ARHGAP32::PRDM10	Adenocarcinoma
ARHGAP32::RAB5IF	Adenocarcinoma
ARHGAP32::TP53AIP1	Squamous cell carcinoma
ARHGAP35::BAIAP2	Adenocarcinoma
ARHGAP35::COL22A1	Adenocarcinoma
ARHGAP35::CRX	Adenocarcinoma
ARHGAP35::CYTH2	Skin | Acute myeloid leukemia, NOS
ARHGAP35::NPAS1	Adenocarcinoma
ARHGAP35::PGPEP1L	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
ARHGAP35::SAE1	Squamous cell carcinoma
ARHGAP35::SLC1A5	Adenocarcinoma
ARHGAP35::UNC13A	Adenocarcinoma
ARHGAP35::YWHAZ	Adenocarcinoma
ARHGAP39::ZNF16	Adenocarcinoma
ARHGAP39::ZNF34	Malignant epithelial tumor, special type
ARHGAP42::FAM168A	Squamous cell carcinoma
ARHGAP42::HIBCH	Adenocarcinoma
ARHGAP42::KMO	Adenocarcinoma
ARHGAP42::MAML2	Soft tissue tumor, special type
ARHGAP42::PGR	Adenocarcinoma
ARHGAP42::SBF2	Squamous cell carcinoma
ARHGAP42::TMEM123	Squamous cell carcinoma
ARHGAP42::YAP1	Squamous cell carcinoma
ARHGAP44::C17ORF78	Adenocarcinoma
ARHGAP44::C17orf78	Adenocarcinoma
ARHGAP44::DNAH2	Adenocarcinoma
ARHGAP44::SHMT1	Mesenchymal tumor, NOS
ARHGAP44::SLC13A5	Squamous cell carcinoma
ARHGAP44::ZSWIM7	Mesenchymal tumor, NOS
ARHGAP45::ABCA7	Squamous cell carcinoma
ARHGAP45::BRAF	Histiocytic sarcoma/malignant histiocytosis
ARHGAP45::CNN2	Transitional cell carcinoma
ARHGAP45::GRIN3B	Squamous cell carcinoma
ARHGAP45::STK11	Adenocarcinoma
ARHGAP5::AKAP6	Squamous cell carcinoma | Adenocarcinoma
ARHGAP5::L2HGDH	Adenocarcinoma
ARHGAP5::LSAMP	Malignant melanoma
ARHGAP5::NPAS3	Adenocarcinoma
ARHGAP5::NUBPL	Squamous cell carcinoma
ARHGAP5::PRORP	Adenocarcinoma
ARHGAP5::TPGS2	Adenocarcinoma
ARHGAP6::KDM6A	Adenocarcinoma
ARHGAP8::UTS2	Adenocarcinoma
ARHGDIA::ACVRL1	Mesenchymal tumor, NOS
ARHGDIA::ERBB3	Squamous cell carcinoma
ARHGDIA::RNF213	Adenocarcinoma
ARHGDIA::SQSTM1	Malignant melanoma
ARHGDIB::ETV6	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ARHGEF10::ADGB	Mesothelioma
ARHGEF10::DEFA6	Adenocarcinoma
ARHGEF10::RALYL	Malignant epithelial tumor, special type
ARHGEF10L::CSDE1	Adenocarcinoma
ARHGEF10L::EYA2	Adenocarcinoma
ARHGEF10L::PADI4	Squamous cell carcinoma
ARHGEF10L::PAK4	Adenocarcinoma
ARHGEF10L::PYCR1	Adenocarcinoma
ARHGEF10L::TMCO4	Adenocarcinoma
ARHGEF11::ALDH9A1	Adenocarcinoma
ARHGEF11::CD48	Mesenchymal tumor, NOS
ARHGEF11::CEP131	Adenocarcinoma
ARHGEF11::ETV3	Adenocarcinoma
ARHGEF11::ETV3L	Malignant epithelial tumor, special type
ARHGEF11::NTRK1	Astrocytoma, grade III-IV/Glioblastoma | Glioma, NOS
ARHGEF11::PLEKHA6	Malignant melanoma
ARHGEF11::SHC1	Mesenchymal tumor, NOS
ARHGEF11::SMCP	Squamous cell carcinoma
ARHGEF12::ATP5MJ	Adenocarcinoma
ARHGEF12::CEP164	Mesenchymal tumor, NOS
ARHGEF12::CNTN5	Adenocarcinoma
ARHGEF12::GRIK4	Transitional cell carcinoma | Adenocarcinoma
ARHGEF12::MCAM	Malignant epithelial tumor, special type
ARHGEF12::OAF	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
ARHGEF12::POU2F3	Adenocarcinoma
ARHGEF12::SIK3	Adenocarcinoma
ARHGEF16::DYNLT4	Adenocarcinoma
ARHGEF16::ITK	Adenocarcinoma
ARHGEF17::AAMDC	Mesenchymal tumor, NOS
ARHGEF17::CLPB	Adenocarcinoma
ARHGEF17::COA4	Adenocarcinoma
ARHGEF17::EP300	Adenocarcinoma
ARHGEF17::P2RY2	Squamous cell carcinoma
ARHGEF17::SHANK2	Adenocarcinoma
ARHGEF17::WDR74	Adenocarcinoma
ARHGEF18::AAMDC	Adenocarcinoma
ARHGEF18::ACACB	Mesenchymal tumor, NOS
ARHGEF18::CERS4	Adenocarcinoma
ARHGEF18::INSR	Skin | Adenocarcinoma | Acute myeloid leukemia, NOS
ARHGEF18::MAPKAP1	Adenocarcinoma
ARHGEF18::MYO9B	Adenocarcinoma
ARHGEF18::TECR	Squamous cell carcinoma
ARHGEF1::CBLC	Adenocarcinoma
ARHGEF1::CD79A	Adenocarcinoma
ARHGEF1::RPS19	Adenocarcinoma
ARHGEF1::SNRNP70	Squamous cell carcinoma
ARHGEF1::TMEM120A	Adenocarcinoma
ARHGEF1::UCKL1	Adenocarcinoma
ARHGEF25::AVIL	Astrocytoma, grade I-II
ARHGEF25::CPNE8	Mesenchymal tumor, NOS
ARHGEF26::LANCL1	Adenocarcinoma
ARHGEF28::SEZ6	Adenocarcinoma
ARHGEF28::UTP15	Adenocarcinoma
ARHGEF2::AGO3	Adenocarcinoma
ARHGEF2::CCT3	Adenocarcinoma
ARHGEF2::GON4L	Adenocarcinoma
ARHGEF2::NTRK1	Neuroglial neoplasm, special type | Glioma, NOS | Astrocytoma, grade III-IV/Glioblastoma
ARHGEF2::PAQR6	Adenocarcinoma
ARHGEF2::S100A7	Transitional cell carcinoma
ARHGEF2::SMG5	Squamous cell carcinoma
ARHGEF2::SSR2	Adenocarcinoma
ARHGEF2::UBQLN4	Squamous cell carcinoma
ARHGEF38::ANKH	Adenocarcinoma
ARHGEF38::COL25A1	Adenocarcinoma
ARHGEF38::ZNF622	Adenocarcinoma
ARHGEF3::ACP6	Adenocarcinoma
ARHGEF3::ANO10	Adenocarcinoma
ARHGEF3::ARF4	Adenocarcinoma
ARHGEF3::CACNA2D2	Leiomyoma
ARHGEF3::CTNND2	Adenocarcinoma
ARHGEF3::FDFT1	Adenocarcinoma
ARHGEF3::HESX1	Adenocarcinoma
ARHGEF3::LINGO3	Adenocarcinoma
ARHGEF3::LTF	Adenocarcinoma
ARHGEF3::NDUFAF6	Adenocarcinoma
ARHGEF3::RHAG	Adenocarcinoma
ARHGEF3::SNX24	Adenocarcinoma
ARHGEF3::TASOR	Adenocarcinoma
ARHGEF6::NDC1	Mesenchymal tumor, NOS
ARHGEF7::ATP11A	Alveolar rhabdomyosarcoma | Adenocarcinoma
ARHGEF7::EXOC4	Mesenchymal tumor, NOS
ARHGEF7::KLF10	Transitional cell carcinoma
ARHGEF7::PKIB	Astrocytoma, grade I-II
ARHGEF7::PTEN	Adenocarcinoma
ARHGEF7::SFTPA1	Adenocarcinoma
ARHGEF7::SPATA7	Mesenchymal tumor, NOS
ARHGEF7::ZDHHC11	Adenocarcinoma
ARHGEF9::CISD2	Adenocarcinoma
ARHGEF9::MSI2	Transitional cell carcinoma
ARID1A::BEND5	Astrocytoma, grade III-IV/Glioblastoma
ARID1A::DGKA	Malignant melanoma
ARID1A::DHDDS	Adenocarcinoma
ARID1A::FAM76A	Adenocarcinoma
ARID1A::HNRNPK	Transitional cell carcinoma
ARID1A::MAST2	Adenocarcinoma
ARID1A::NIPBL	Squamous cell carcinoma
ARID1A::NUDC	Adenocarcinoma
ARID1A::PRKCZ	Adenocarcinoma
ARID1A::PRKD1	Adenocarcinoma
ARID1A::PRPF40B	Malignant melanoma
ARID1A::RNF31	Astrocytoma, grade III-IV/Glioblastoma
ARID1A::RPL4	Squamous cell carcinoma
ARID1A::RPS6KA1	Skin | Acute myeloid leukemia, NOS | Adenocarcinoma
ARID1A::SEC11A	Adenocarcinoma
ARID1A::THBS3	Adenocarcinoma
ARID1A::THSD7B	Adenocarcinoma
ARID1A::UBE2U	Adenocarcinoma
ARID1A::WDTC1	Adenocarcinoma
ARID1A::YTHDF2	Adenocarcinoma
ARID1A::ZDHHC18	Squamous cell carcinoma | Transitional cell carcinoma
ARID1B::ENPP4	Squamous cell carcinoma
ARID1B::EZR	Adenocarcinoma
ARID1B::KIF26B	Adenocarcinoma
ARID1B::MAML2	Vascular and perivascular tumor, special type
ARID1B::NKAIN2	Adenocarcinoma
ARID1B::PLAGL1	Ependymoma
ARID1B::PLEKHG1	Adenocarcinoma
ARID1B::PREP	Astrocytoma, grade I-II
ARID1B::PRKD1	Adenocarcinoma
ARID1B::PRKN	Adenocarcinoma
ARID1B::PSMA1	Adenocarcinoma
ARID1B::RAET1G	Adenocarcinoma
ARID1B::RCN2	Malignant melanoma
ARID1B::SAMD5	Malignant melanoma
ARID1B::SASH1	Malignant melanoma
ARID1B::SMOC2	Transitional cell carcinoma
ARID1B::SNX9	Melanocytic neoplasm, special type | Adenocarcinoma
ARID1B::SYNE1	Adenocarcinoma
ARID1B::TFE3	Adenocarcinoma
ARID1B::TIAM2	Astrocytoma, grade III-IV/Glioblastoma
ARID1B::TMEM242	Adenocarcinoma
ARID1B::ZNF384	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ARID2::ALK	Adenocarcinoma
ARID2::C12ORF56	Malignant melanoma
ARID2::C12orf56	Malignant melanoma
ARID2::CCDC60	Soft tissue tumor, NOS
ARID2::LETMD1	Astrocytoma, grade III-IV/Glioblastoma
ARID2::PTPRB	Mesenchymal tumor, NOS
ARID2::SCAF11	Malignant melanoma
ARID2::SPATS1	Transitional cell carcinoma
ARID2::SPSB2	Squamous cell carcinoma
ARID2::TMEM117	Adenocarcinoma
ARID2::TMPRSS2	Adenocarcinoma
ARID2::ZNF641	Adenocarcinoma
ARID3A::MORC2	Adenocarcinoma
ARID3A::PMEPA1	Adenocarcinoma
ARID3A::PRPF31	Adenocarcinoma
ARID3A::RNF126	Multiple myeloma
ARID3A::TEX38	Adenocarcinoma
ARID3B::CDK13	Skin | Acute myeloid leukemia, NOS
ARID3B::USP47	Adenocarcinoma
ARID4A::AVEN	Chronic lymphocytic leukemia
ARID4A::KIAA0586	Adenocarcinoma
ARID4A::L3HYPDH	Transitional cell carcinoma
ARID4A::NAA30	Adenocarcinoma
ARID4A::NPAS3	Adenocarcinoma
ARID4B::B3GALNT2	Adenocarcinoma
ARID4B::CARD10	Adenocarcinoma
ARID4B::GNPAT	Adenocarcinoma
ARID4B::IGFN1	Malignant melanoma
ARID4B::ING3	Diffuse large B-cell lymphoma
ARID4B::KLHL12	Mesenchymal tumor, NOS
ARID4B::NTPCR	Transitional cell carcinoma
ARID4B::PCNX2	Adenocarcinoma
ARID4B::RPS6KC1	Diffuse large B-cell lymphoma
ARID4B::SCCPDH	Malignant melanoma
ARID4B::SOX5	Squamous cell carcinoma
ARID5A::B2M	Multiple myeloma
ARID5A::CNNM4	Adenocarcinoma
ARID5B::ABLIM1	Adenocarcinoma
ARID5B::KAT6A	Adenocarcinoma
ARID5B::SOX5	Mature B-cell neoplasm, NOS
ARIH1::BRAF	Glioma, NOS
ARIH1::SENP8	Squamous cell carcinoma
ARIH1::TMEM202	Adenocarcinoma
ARIH2::CAMP	Astrocytoma, grade III-IV/Glioblastoma
ARIH2::DHX30	Adenocarcinoma
ARIH2::RHOA	Transitional cell carcinoma
ARIH2::SLC25A20	Adenocarcinoma
ARIH2::SLMAP	Adenocarcinoma
ARIH2::TMA7	Adenocarcinoma
ARIH2::TRIO	Squamous cell carcinoma
ARK2C::LAIR2	Astrocytoma, grade I-II
ARK2C::PHLPP1	Mesenchymal tumor, NOS
ARK2C::SETBP1	Adenocarcinoma
ARK2C::ZBTB7C	Squamous cell carcinoma
ARK2N::GABRR2	Mesenchymal tumor, NOS
ARK2N::ZNF407	Adenocarcinoma
ARL11::RNASEH2B	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ARL13A::TRMT2B	Acute myeloid leukemia, NOS | Skin
ARL13B::DLG1	Astrocytoma, grade III-IV/Glioblastoma
ARL13B::EPHA6	Transitional cell carcinoma
ARL13B::NSUN3	Squamous cell carcinoma
ARL15::CDC42SE2	Adenocarcinoma
ARL15::ITGA1	Mesenchymal tumor, NOS
ARL15::MOCS2	Squamous cell carcinoma
ARL15::PARP8	Mesenchymal tumor, NOS
ARL15::STK32A	Malignant melanoma
ARL16::CSNK1D	Transitional cell carcinoma
ARL16::PHAF1	Squamous cell carcinoma
ARL16::RAB37	Malignant melanoma
ARL17A::KANSL1	Adenocarcinoma
ARL1::UBE2N	Mesenchymal tumor, NOS
ARL3::ACO1	Adenocarcinoma
ARL4D::DNAJC7	Squamous cell carcinoma
ARL5A::IL1B	Adenocarcinoma
ARL5B::CCDC102B	Astrocytoma, grade I-II
ARL5B::NSUN6	Squamous cell carcinoma
ARL5C::BECN1	Adenocarcinoma
ARL5C::LSM12	Adenocarcinoma
ARL5C::NF1	Adenocarcinoma
ARL5C::RETREG3	Adenocarcinoma
ARL6::POT1	Undifferentiated round cell sarcoma
ARL6IP1::RPS15A	Adenocarcinoma
ARL6IP6::CFLAR	Mature B-cell neoplasm, NOS
ARL8A::INSRR	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ARL8A::UBE2T	Squamous cell carcinoma
ARL8B::CLASP2	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
ARL8B::ITPR1	Squamous cell carcinoma
ARL8B::USP4	Adenocarcinoma
ARL9::RET	Carcinoma, NOS
ARMC10::BRAF	Adenocarcinoma | Carcinoma, NOS | Malignant melanoma
ARMC1::PEX19	Adenocarcinoma
ARMC1::RB1CC1	Adenocarcinoma
ARMC1::SPAG11B	Adenocarcinoma
ARMC1::UBE2W	Adenocarcinoma
ARMC2::RTN4IP1	Mesenchymal tumor, NOS
ARMC6::UBA52	Adenocarcinoma
ARMC7::CDR2L	Adenocarcinoma
ARMC7::CYB561	Adenocarcinoma
ARMC7::JPT1	Squamous cell carcinoma
ARMC7::NUP85	Adenocarcinoma
ARMC7::PNKD	Adenocarcinoma
ARMC8::CACNA2D2	Transitional cell carcinoma
ARMC8::CLDN18	Adenocarcinoma | Astrocytoma, grade I-II
ARMC8::IFT57	Adenocarcinoma
ARMC8::MRAS	Adenocarcinoma
ARMC8::TF	Adenocarcinoma
ARMC9::BLVRB	Adenocarcinoma
ARMC9::EVL	Adenocarcinoma
ARMC9::NPAS1	Adenocarcinoma
ARMC9::PARD3B	Mesenchymal tumor, NOS
ARMC9::PSMD1	Adenocarcinoma
ARMC9::SSR2	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
ARMC9::TM4SF4	Adenocarcinoma
ARMCX4::BTK	Adenocarcinoma
ARMH3::LDB1	Squamous cell carcinoma | Adenocarcinoma
ARMH3::OGA	Squamous cell carcinoma
ARMH3::PRKG1	Adenocarcinoma
ARMH3::PSD	Chronic lymphocytic leukemia
ARMH4::ARID4A	Chronic lymphocytic leukemia
ARMH4::KIAA0586	Astrocytoma, grade I-II
ARMH4::KIR2DL1	Adenocarcinoma
ARMH4::RSPO2	Adenocarcinoma
ARMT1::RMND1	Adenocarcinoma
ARNT2::CFAP144	Mesenchymal tumor, NOS
ARNT2::MS4A3	Adenocarcinoma
ARNT2::NDST1	Adenocarcinoma
ARNT2::PDLIM5	Adenocarcinoma
ARNT2::TNFAIP8L3	Adenocarcinoma
ARNT2::ZFAND3	Adenocarcinoma
ARNT::F5	Adenocarcinoma
ARNT::MRPL52	Adenocarcinoma
ARNT::RIIAD1	Adenocarcinoma
ARPC1A::TH	Transitional cell carcinoma
ARPC1A::TRRAP	Adenocarcinoma
ARPC1A::VAMP4	Adenocarcinoma
ARPC1A::ZNF789	Adenocarcinoma
ARPC1B::TRRAP	Adenocarcinoma
ARPC2::RNASEH2B	Mesothelioma
ARPC3::APAF1	Adenocarcinoma
ARPC3::TYROBP	Transitional cell carcinoma
ARPC4::GRM7	Adenocarcinoma
ARPC4::TTLL3	Nonneoplastic epithelial disorder/lesion
ARPP19::MYO5A	Transitional cell carcinoma | Adenocarcinoma
ARPP21::FRMD4A	Astrocytoma, grade I-II
ARRB1::ANKFN1	Adenocarcinoma
ARRB1::CCDC90B	Malignant melanoma
ARRB1::DLG2	Adenocarcinoma
ARRB1::GAB2	Adenocarcinoma
ARRB1::GDPD5	Adenocarcinoma
ARRB1::KLHL35	Adenocarcinoma
ARRB1::KRTAP5-11	Adenocarcinoma
ARRB1::LY9	Mesenchymal tumor, NOS
ARRB1::MYEOV	Adenocarcinoma
ARRB1::PAK1	Malignant melanoma | Adenocarcinoma
ARRB1::PICALM	Adenocarcinoma
ARRB1::PRCP	Malignant melanoma
ARRB1::RASSF3	Adenocarcinoma
ARRB1::TPCN2	Adenocarcinoma
ARRB1::UVRAG	Squamous cell carcinoma | Adenocarcinoma
ARRDC2::KCNN1	Adenocarcinoma
ARRDC3::SGCD	Adenocarcinoma
ARSB::DMGDH	Adenocarcinoma
ARSG::ANKFN1	Adenocarcinoma
ARSG::AP2B1	Adenocarcinoma
ARSG::BPTF	Adenocarcinoma
ARSG::CDK12	Adenocarcinoma
ARSG::CEP112	Adenocarcinoma
ARSG::MAP2K6	Adenocarcinoma
ARSG::PPM1D	Adenocarcinoma
ARSG::PRKCA	Adenocarcinoma
ARSG::STAT5B	Adenocarcinoma
ARSG::TEX2	Adenocarcinoma
ARSJ::DNAH9	Adenocarcinoma
ART3::NUP54	Squamous cell carcinoma
ART3::SLC25A13	Squamous cell carcinoma
ARV1::CAPN9	Malignant melanoma
AS3MT::GBF1	Adenocarcinoma
AS3MT::HERC4	Mesenchymal tumor, NOS
AS3MT::SUFU	Adenocarcinoma
ASAH1::DDX21	Adenocarcinoma
ASAH1::WWOX	Squamous cell carcinoma
ASAH2::SGMS1	Adenocarcinoma
ASAP1::ADCY2	Transitional cell carcinoma
ASAP1::CDKN2B	Malignant melanoma
ASAP1::CLVS1	Adenocarcinoma
ASAP1::FGF12	Adenocarcinoma
ASAP1::KCNH1	Adenocarcinoma
ASAP1::KHDRBS3	Adenocarcinoma
ASAP1::LMNTD1	Adenocarcinoma
ASAP1::LRRCC1	Adenocarcinoma
ASAP1::MRPL13	Transitional cell carcinoma
ASAP1::RAD51B	Adenocarcinoma
ASAP1::RIMS2	Adenocarcinoma
ASAP1::SAMD12	Adenocarcinoma
ASAP1::TRAPPC9	Mesenchymal tumor, NOS
ASAP1::USP6	Aneurysmal bone cyst
ASAP2::ERI3	Adenocarcinoma
ASAP2::MBOAT2	Adenocarcinoma
ASAP2::MGMT	Russia | Primitive neuroectodermal tumor/Medulloblastoma
ASAP2::TAF1B	Squamous cell carcinoma
ASB1::CLVS1	Adenocarcinoma
ASB1::RAMP1	Malignant epithelial tumor, special type
ASB1::RBM44	Malignant epithelial tumor, special type
ASB1::SH3BP4	Malignant melanoma
ASB1::TRAF3IP1	Adenocarcinoma
ASB3::CTPS1	Adenocarcinoma
ASB3::MTA3	Adenocarcinoma
ASB4::DYNC1I1	Adenocarcinoma
ASB7::DEXI	Adenocarcinoma
ASB7::SEMA6D	Acute myeloid leukemia, NOS | Skin
ASB8::ARID2	Refractory anemia with excess blasts-2
ASB8::DGKA	Adenocarcinoma
ASB8::NELL2	Adenocarcinoma
ASCC1::CDH23	Adenocarcinoma
ASCC1::DNAJB12	Embryonal nervous system tumor, special type
ASCC1::MAFG	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ASCC1::MICU1	Squamous cell carcinoma | Malignant epithelial tumor, special type | Adenocarcinoma
ASCC2::GGNBP2	Myoepithelioma/myoepithelial carcinoma/mixed tumor
ASCC2::MTMR3	Squamous cell carcinoma
ASCC2::SF3A1	Adenocarcinoma
ASCC3::ATL1	Adenocarcinoma
ASCC3::GRIK2	Adenocarcinoma
ASCC3::SERINC1	Astrocytoma, grade I-II
ASCC3::SIM1	Squamous cell carcinoma
ASCC3::SYNE1	Adenocarcinoma
ASCC3::TPD52L1	Adenocarcinoma
ASCC3::TXNRD2	Adenocarcinoma
ASCC3::WASF1	Mesenchymal tumor, NOS
ASF1B::GIPC1	Adenocarcinoma
ASF1B::KLF1	Diffuse large B-cell lymphoma
ASGR2::NDEL1	Adenocarcinoma
ASH1L::AIM2	Adenocarcinoma
ASH1L::ARHGEF11	Mature B-cell neoplasm, NOS
ASH1L::ARHGEF2	Adenocarcinoma | Transitional cell carcinoma
ASH1L::C1ORF87	Adenocarcinoma
ASH1L::C1orf87	Adenocarcinoma
ASH1L::CCT3	Adenocarcinoma
ASH1L::FAM78B	Adenocarcinoma
ASH1L::GATAD2B	Adenocarcinoma
ASH1L::GON4L	Transitional cell carcinoma | Adenocarcinoma
ASH1L::GPATCH4	Adenocarcinoma
ASH1L::INSRR	Adenocarcinoma
ASH1L::IQGAP3	Adenocarcinoma
ASH1L::NSL1	Adenocarcinoma
ASH1L::PKLR	Transitional cell carcinoma
ASH1L::RC3H1	Mesenchymal tumor, NOS
ASH1L::RGS7	Squamous cell carcinoma
ASH1L::RIT1	Mesenchymal tumor, NOS
ASH1L::SELL	Mesenchymal tumor, NOS
ASH1L::SLC28A3	Adenocarcinoma
ASH1L::SPRR2G	Transitional cell carcinoma
ASH1L::TBC1D13	Adenocarcinoma
ASH1L::UBQLN4	Transitional cell carcinoma
ASH1L::ZNF687	Diffuse large B-cell lymphoma | Mature B-cell neoplasm, NOS
ASH2L::CASS4	Mesenchymal tumor, NOS
ASH2L::CENPU	Adenocarcinoma
ASH2L::FAM110B	Transitional cell carcinoma
ASH2L::MGME1	Adenocarcinoma
ASH2L::PPP1R14A	Adenocarcinoma
ASH2L::ZFYVE28	Adenocarcinoma
ASIC1::ATF1	Soft tissue tumor, NOS
ASIC2::PFDN2	Meningioma
ASIC2::RASL10B	Adenocarcinoma
ASIC2::TBCD	Adenocarcinoma
ASL::CRCP	Astrocytoma, grade III-IV/Glioblastoma
ASL::GUSB	Adenocarcinoma
ASMTL::UGT1A1	Adenocarcinoma
ASMTL::UGT1A10	Adenocarcinoma
ASMTL::UGT1A3	Adenocarcinoma
ASMTL::UGT1A4	Adenocarcinoma
ASMTL::UGT1A5	Adenocarcinoma
ASMTL::UGT1A6	Adenocarcinoma
ASMTL::UGT1A7	Adenocarcinoma
ASMTL::UGT1A8	Adenocarcinoma
ASMTL::UGT1A9	Adenocarcinoma
ASNSD1::PMS1	Squamous cell carcinoma
ASPH::CHMP1A	Transitional cell carcinoma
ASPH::CLCN3	Transitional cell carcinoma
ASPH::DCLK1	Adenocarcinoma
ASPH::EIF4EBP1	Adenocarcinoma
ASPH::RP1	Adenocarcinoma
ASPH::RSF1	Adenocarcinoma
ASPH::SIPA1L1	Adenocarcinoma
ASPH::TACC1	Transitional cell carcinoma
ASPHD2::DDX17	Adenocarcinoma
ASPN::USP6	Fibroma of tendon sheath
ASPSCR1::COL5A3	Adenocarcinoma
ASPSCR1::HGS	Adenocarcinoma
ASPSCR1::TFE3	PEComa | Alveolar soft part sarcoma | Adenocarcinoma | Malignant epithelial tumor, special type
ASRGL1::CPSF7	Adenocarcinoma
ASS1::HMCN2	Adenocarcinoma
ASS1::NCS1	Adenocarcinoma
ASTN2::ARHGDIG	Astrocytoma, grade III-IV/Glioblastoma
ASTN2::CC2D1A	Adenocarcinoma
ASTN2::PDIA2	Astrocytoma, grade III-IV/Glioblastoma
ASTN2::PNMT	Adenocarcinoma
ASTN2::PTPRG	Adenocarcinoma
ASTN2::TMEM38B	Astrocytoma, grade I-II
ASTN2::TNFAIP8L1	Adenocarcinoma
ASXL1::BPIFB2	Squamous cell carcinoma
ASXL1::CCM2L	Malignant epithelial tumor, special type
ASXL1::DEFB118	Adenocarcinoma
ASXL1::EIF2S2	Squamous cell carcinoma
ASXL1::HCK	Adenocarcinoma
ASXL1::PDRG1	Adenocarcinoma
ASXL1::TM9SF4	Adenocarcinoma
ASXL1::TPX2	Adenocarcinoma
ASXL1::XKR7	Adenocarcinoma
ASXL2::DENND2A	Adenocarcinoma
ASXL2::FKBP8	Adenocarcinoma
ASXL2::HADHA	Adenocarcinoma
ASXL2::HSPH1	Adenocarcinoma
ASXL2::IDH1	Adenocarcinoma
ASXL2::KIF3C	Adenocarcinoma
ASXL2::MINPP1	Squamous cell carcinoma
ASXL2::MORC3	Adenocarcinoma
ASXL2::PFN4	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ASXL2::POMC	Adenocarcinoma
ASXL2::PPWD1	Adenocarcinoma
ASXL2::SOX5	Adenocarcinoma
ASXL2::SRBD1	Adenocarcinoma
ASXL2::WDCP	Adenocarcinoma
ASZ1::WNT2	Astrocytoma, grade I-II
ATAD1::ANKRD22	Astrocytoma, grade I-II
ATAD1::JMJD1C	Adenocarcinoma
ATAD1::KCNMA1	Astrocytoma, grade III-IV/Glioblastoma
ATAD1::LIPF	Astrocytoma, grade I-II
ATAD1::LRMDA	Mesenchymal tumor, NOS
ATAD1::PAPSS2	Astrocytoma, grade I-II
ATAD1::RNLS	Adenocarcinoma
ATAD1::SHLD2	Astrocytoma, grade III-IV/Glioblastoma
ATAD2::ERBB4	Squamous cell carcinoma
ATAD2::FAM178B	Adenocarcinoma
ATAD2::KCNQ3	Adenocarcinoma
ATAD2::KHDRBS3	Adenocarcinoma
ATAD2::LRP12	Adenocarcinoma
ATAD2::NTAQ1	Adenocarcinoma
ATAD2::PODXL	Adenocarcinoma
ATAD2::RAD51B	Adenocarcinoma
ATAD2::TATDN1	Adenocarcinoma
ATAD2B::ITSN2	Adenocarcinoma
ATAD2B::NGEF	Mature B-cell neoplasm, NOS
ATAD2B::SF3B6	Astrocytoma, grade I-II
ATAD2B::TP53I3	Malignant melanoma
ATAD3B::HADHB	Adenocarcinoma
ATAD3B::INTS11	Adenocarcinoma
ATAD3C::HSPA14	Malignant epithelial tumor, special type
ATAD3C::TTLL10	Adenocarcinoma
ATAD5::CDK12	Acute promyelocytic leukemia (FAB type M3)
ATAD5::EFCAB5	Adenocarcinoma
ATAD5::IKZF3	Adenocarcinoma
ATAD5::PSMA1	Malignant melanoma
ATAD5::PTP4A1	Transitional cell carcinoma
ATAD5::QRICH1	Mesenchymal tumor, NOS
ATAD5::SIPA1L3	Transitional cell carcinoma
ATAT1::PPP1R18	Adenocarcinoma
ATE1::ANXA10	Adenocarcinoma
ATE1::DNAJB12	Squamous cell carcinoma
ATE1::NSMCE4A	Adenocarcinoma
ATE1::ZRANB1	Adenocarcinoma
ATF1::CHIT1	Astrocytoma, grade I-II
ATF1::DIP2B	Adenocarcinoma
ATF1::GRIP1	Adenocarcinoma
ATF2::CHRNA1	Squamous cell carcinoma
ATF2::SOS2	Transitional cell carcinoma
ATF2::TECR	Astrocytoma, grade I-II
ATF3::ARF1	Multiple myeloma
ATF3::ARID5A	Multiple myeloma
ATF3::CDH20	Squamous cell carcinoma
ATF3::DUSP5	Multiple myeloma
ATF3::FGFR3	Multiple myeloma
ATF3::KLF2	Multiple myeloma
ATF3::USH2A	Adenocarcinoma
ATF4::CDK12	Adenocarcinoma
ATF6::GJA5	Adenocarcinoma
ATF6::PCP4L1	Adenocarcinoma
ATF6::SDHC	Adenocarcinoma
ATF6::SERINC3	Adenocarcinoma
ATF6::SH2D1B	Adenocarcinoma
ATF6::SPATA46	Adenocarcinoma
ATF6::TENM3	Mesenchymal tumor, NOS
ATF6::VCL	Adenocarcinoma
ATF6::VMP1	Adenocarcinoma
ATF7::ATP5MC2	Adenocarcinoma | Squamous cell carcinoma
ATF7::CALCOCO1	Adenocarcinoma
ATF7::LYZ	Mesenchymal tumor, NOS
ATF7::SPATS2	Adenocarcinoma
ATF7IP2::IQCK	Adenocarcinoma
ATF7IP2::STYXL1	Adenocarcinoma
ATF7IP::CCNY	Astrocytoma, grade I-II
ATF7IP::FAM83B	Mesenchymal tumor, NOS
ATF7IP::JAK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ATF7IP::PDGFRB	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ATF7IP::PLBD1	Transitional cell carcinoma
ATF7IP::TMPRSS2	Adenocarcinoma
ATF7IP::TXNRD1	Adenocarcinoma
ATF7IP::VIPR2	Adenocarcinoma
ATG101::CSRNP2	Malignant melanoma
ATG10::EMC7	Malignant melanoma
ATG13::AMBRA1	Squamous cell carcinoma
ATG13::CSTPP1	Adenocarcinoma
ATG13::ELP4	Adenocarcinoma
ATG13::FOLH1	Adenocarcinoma
ATG13::TSPAN18	Adenocarcinoma
ATG14::FUT8	Astrocytoma, grade III-IV/Glioblastoma
ATG14::MED6	Transitional cell carcinoma
ATG16L1::NGEF	Astrocytoma, grade I-II
ATG16L2::AKAP17A	Adenocarcinoma
ATG16L2::IKZF1	Acute myeloid leukemia, NOS | Skin
ATG16L2::KMT2A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ATG2A::EFCAB6	Adenocarcinoma
ATG2A::ESRRA	Adenocarcinoma
ATG2A::LBHD1	Adenocarcinoma
ATG2A::NRXN2	Adenocarcinoma
ATG2B::SLC22A17	Transitional cell carcinoma
ATG2B::TDRD9	Mesenchymal tumor, NOS
ATG4B::DTYMK	Astrocytoma, grade III-IV/Glioblastoma
ATG4C::AKAIN1	Adenocarcinoma
ATG4C::LEPR	Adenocarcinoma
ATG4C::NFIA	Adenocarcinoma
ATG4C::PATJ	Astrocytoma, grade I-II
ATG4D::TMEM52B	Adenocarcinoma
ATG4D::UHRF1	Adenocarcinoma
ATG5::ADGRG6	Adenocarcinoma
ATG5::AFDN	Malignant epithelial tumor, special type
ATG5::AK9	Adenocarcinoma
ATG5::CEACAM16	Astrocytoma, grade I-II
ATG5::EIF3E	Adenocarcinoma
ATG5::EPHA7	Squamous cell carcinoma
ATG5::NTM	Squamous cell carcinoma
ATG5::PDSS2	Astrocytoma, grade III-IV/Glioblastoma
ATG5::PREP	Anaplastic large cell lymphoma, systemic type
ATG5::QRSL1	Adenocarcinoma
ATG5::RSPH10B	Adenocarcinoma
ATG5::RTN4IP1	Adenocarcinoma
ATG5::SCML4	Adenocarcinoma
ATG5::SYNJ2	Squamous cell carcinoma
ATG5::TMEM200A	Adenocarcinoma
ATG7::ARMC3	Squamous cell carcinoma
ATG7::BRAF	Malignant melanoma
ATG7::FHIT	Transitional cell carcinoma
ATG7::PPARG	Astrocytoma, grade I-II
ATG7::RAF1	Neuroglial neoplasm, special type | Glomus tumor | Adenocarcinoma
ATG7::RSPH3	Squamous cell carcinoma
ATG7::SLC6A1	Adenocarcinoma
ATG7::TBC1D5	Adenocarcinoma
ATIC::ALK	Astrocytoma, grade III-IV/Glioblastoma | Anaplastic large cell lymphoma, systemic type | Inflammatory myofibroblastic tumor/myofibroblastic sarcoma | Embryonal rhabdomyosarcoma | Hodgkin disease, NOS
ATL2::CSN2	Adenocarcinoma
ATL2::DHX57	Adenocarcinoma
ATL2::HNRNPLL	Adenocarcinoma
ATL2::MAP4K4	Adenocarcinoma
ATL2::PRKD3	Adenocarcinoma
ATL3::RTN3	Adenocarcinoma
ATL3::ZDHHC14	Malignant melanoma
ATM::CARD18	Adenocarcinoma
ATM::DDX10	Adenocarcinoma
ATMIN::GPR19	Adenocarcinoma
ATN1::ENO2	Adenocarcinoma
ATN1::LRRC23	Adenocarcinoma
ATN1::SUPT16H	Adenocarcinoma
ATOH8::GNLY	Adenocarcinoma
ATOH8::LYG2	Adenocarcinoma
ATOH8::USP39	Astrocytoma, grade III-IV/Glioblastoma
ATOH8::VAMP5	Adenocarcinoma
ATOSA::CCDC102B	Mesenchymal tumor, NOS
ATOSA::CTPS1	Adenocarcinoma
ATOSB::UBE2R2	Astrocytoma, grade III-IV/Glioblastoma
ATP10B::COMMD10	Adenocarcinoma
ATP10B::NDST1	Astrocytoma, grade III-IV/Glioblastoma
ATP10D::FAM133A	Malignant melanoma
ATP10D::GABRA2	Squamous cell carcinoma
ATP10D::GABRB1	Squamous cell carcinoma
ATP11A::ADPRHL1	Mesenchymal tumor, NOS
ATP11A::COL14A1	Mesothelioma
ATP11A::DHRS12	Adenocarcinoma
ATP11A::F7	Squamous cell carcinoma
ATP11A::MCF2L	Adenocarcinoma
ATP11A::NAXD	Squamous cell carcinoma
ATP11A::SPACA7	Transitional cell carcinoma
ATP11A::TUBGCP3	Adenocarcinoma
ATP11A::ULK4	Adenocarcinoma
ATP11A::ZFTRAF1	Adenocarcinoma
ATP11B::CARS1	Adenocarcinoma
ATP11B::CCDC39	Mesenchymal tumor, NOS
ATP11B::FXR1	Squamous cell carcinoma
ATP11B::HECW1	Adenocarcinoma
ATP11B::MAP3K13	Squamous cell carcinoma
ATP11B::MCF2L2	Squamous cell carcinoma
ATP11B::MED10	Adenocarcinoma
ATP11B::NAALADL2	Squamous cell carcinoma
ATP11B::NET1	Transitional cell carcinoma
ATP11B::POU3F1	Squamous cell carcinoma
ATP11B::SI	Squamous cell carcinoma
ATP11B::TFRC	Squamous cell carcinoma
ATP11B::TPRG1	Squamous cell carcinoma
ATP11B::ZNF595	Squamous cell carcinoma
ATP11C::CXORF66	Adenocarcinoma
ATP11C::CXorf66	Adenocarcinoma
ATP11C::PREX1	Adenocarcinoma
ATP13A3::DNAJC13	Adenocarcinoma
ATP13A3::IQCG	Adenocarcinoma
ATP13A3::LRRC15	Adenocarcinoma
ATP13A3::TMEM14B	Adenocarcinoma
ATP13A3::XXYLT1	Refractory anemia with excess blasts-1
ATP13A4::NAALADL2	Squamous cell carcinoma
ATP1A1::ATG4C	Malignant melanoma
ATP1A1::CSN2	Adenocarcinoma
ATP1A1::DDX21	Adenocarcinoma
ATP1A1::FN1	Adenocarcinoma
ATP1A1::IGSF3	Adenocarcinoma
ATP1A1::NOTCH2	Adenocarcinoma
ATP1A1::RABEP1	Adenocarcinoma
ATP1A1::SORT1	Squamous cell carcinoma
ATP1A1::VANGL1	Adenocarcinoma
ATP1A2::CLU	Astrocytoma, grade I-II
ATP1A2::CPB1	Adenocarcinoma
ATP1B1::ABCA13	Adenocarcinoma
ATP1B1::FMO4	Adenocarcinoma
ATP1B1::IL26	Mesenchymal tumor, NOS
ATP1B1::NRG1	Adenocarcinoma
ATP1B1::NTRK1	Adenocarcinoma
ATP1B1::PRKACA	Malignant epithelial tumor, special type | Adenocarcinoma
ATP1B1::PRKACB	Adenocarcinoma | Malignant epithelial tumor, special type
ATP1B1::RCSD1	Adenocarcinoma
ATP1B1::SIAE	Adenocarcinoma
ATP1B1::THSD4	Adenocarcinoma
ATP1B2::SLC37A3	Mesenchymal tumor, NOS
ATP1B3::GRK7	Squamous cell carcinoma
ATP1B3::PAK2	Soft tissue tumor, special type
ATP1B3::RNF7	Squamous cell carcinoma
ATP23::HIGD1C	Astrocytoma, grade I-II
ATP23::MBD6	Astrocytoma, grade III-IV/Glioblastoma
ATP23::SRRM4	Astrocytoma, grade III-IV/Glioblastoma
ATP2A1::ATXN2L	Squamous cell carcinoma
ATP2A2::COL2A1	Mesenchymal tumor, NOS
ATP2A2::COPG1	Adenocarcinoma
ATP2A2::EP400	Squamous cell carcinoma
ATP2A2::IFT81	Adenocarcinoma
ATP2A2::RRP1	Adenocarcinoma
ATP2A2::SPRING1	Adenocarcinoma
ATP2A3::ANKFY1	Mature B-cell neoplasm, NOS
ATP2A3::FGF3	Adenocarcinoma
ATP2A3::IGK	Multiple myeloma
ATP2A3::ZZEF1	Adenocarcinoma
ATP2B1::C8orf34	Mesenchymal tumor, NOS
ATP2B1::CEP290	Squamous cell carcinoma
ATP2B1::CORO1C	Mesenchymal tumor, NOS
ATP2B1::DCDC2	Mesenchymal tumor, NOS
ATP2B1::EXOC4	Mesenchymal tumor, NOS
ATP2B1::GRIP1	Mesenchymal tumor, NOS
ATP2B1::IKBIP	Adenocarcinoma
ATP2B1::KCNC2	Adenocarcinoma
ATP2B1::LIN7A	Mesenchymal tumor, NOS
ATP2B1::RBM19	Mesenchymal tumor, NOS
ATP2B1::SHCBP1	Transitional cell carcinoma
ATP2B1::UBC	Multiple myeloma
ATP2B1::YAF2	Germ cell tumor, NOS
ATP2B2::TAMM41	Adenocarcinoma
ATP2B3::RET	Adenocarcinoma
ATP2B4::CCNI	Adenocarcinoma
ATP2B4::ERBB4	Adenocarcinoma
ATP2B4::GLI1	Mesenchymal tumor, special type
ATP2B4::MACROH2A1	Adenocarcinoma
ATP2B4::NFASC	Astrocytoma, grade III-IV/Glioblastoma
ATP2B4::OPTC	Mesenchymal tumor, NOS
ATP2B4::PRELP	Adenocarcinoma
ATP2B4::PRKCA	Benign nevus
ATP2B4::RAF1	Melanocytic neoplasm, special type
ATP2B4::RASGRF2	Melanocytic neoplasm, special type
ATP2B4::TFEB	Adenocarcinoma
ATP2C1::COL6A6	Squamous cell carcinoma
ATP2C1::CPNE4	Adenocarcinoma
ATP2C1::FCGBP	Adenocarcinoma
ATP2C1::MBNL1	Squamous cell carcinoma
ATP2C1::NDUFB4	Malignant epithelial tumor, special type
ATP2C1::TMEM241	Mesenchymal tumor, NOS
ATP2C2::WFDC1	Squamous cell carcinoma
ATP2C2::ZNF423	Astrocytoma, grade I-II
ATP5F1A::SS18	Adenocarcinoma
ATP5F1B::ANKS1A	Adenocarcinoma
ATP5F1B::CALCA	Adenocarcinoma
ATP5F1B::THSD4	Adenocarcinoma
ATP5MC1::KPNB1	Malignant epithelial tumor, special type
ATP5MC1::SKAP1	Adenocarcinoma
ATP5ME::NSD2	Adenocarcinoma
ATP5ME::SLC49A3	Skin | Acute myeloid leukemia, NOS
ATP5ME::SLK	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ATP5MG::AHCYL2	Malignant melanoma
ATP5MG::CUBN	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ATP5MG::KMT2A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ATP5MG::TEAD1	Undifferentiated carcinoma, small cell
ATP5MG::UBE4A	Squamous cell carcinoma
ATP5MJ::ACIN1	Adenocarcinoma
ATP5MJ::BRF1	Squamous cell carcinoma
ATP5PB::HAUS1	Adenocarcinoma
ATP5PB::INTS4	Adenocarcinoma
ATP5PB::PIEZO2	Squamous cell carcinoma
ATP5PD::GRB2	Adenocarcinoma
ATP5PD::JPT1	Transitional cell carcinoma
ATP5PD::LTBP3	Adenocarcinoma
ATP5PD::SPG11	Adenocarcinoma
ATP5PF::HCN1	Adenocarcinoma
ATP6AP1::ARFGEF2	Transitional cell carcinoma
ATP6AP1::CCT5	Adenocarcinoma
ATP6AP1::CPB1	Adenocarcinoma
ATP6AP1::OPN1LW	Transitional cell carcinoma
ATP6AP2::EIF3M	Adenocarcinoma
ATP6V0A1::ATF6	Adenocarcinoma
ATP6V0A1::MB	Astrocytoma, grade III-IV/Glioblastoma
ATP6V0A1::MSI2	Adenocarcinoma
ATP6V0A1::NBR1	Astrocytoma, grade I-II
ATP6V0A1::STAT3	Adenocarcinoma
ATP6V0A1::STAT5A	Transitional cell carcinoma
ATP6V0A1::STAT5B	Malignant melanoma
ATP6V0A4::TM4SF20	Malignant epithelial tumor, special type
ATP6V0A4::WASHC3	Adenocarcinoma
ATP6V0D1::CFDP1	Mesothelioma
ATP6V0D1::DUS2	Malignant melanoma
ATP6V0D1::GFOD2	Malignant melanoma
ATP6V0E1::BNIP1	Adenocarcinoma
ATP6V0E1::ERGIC1	Adenocarcinoma
ATP6V0E1::USP15	Diffuse large B-cell lymphoma
ATP6V1A::OPA1	Adenocarcinoma
ATP6V1B2::KHDRBS2	Astrocytoma, grade I-II
ATP6V1C1::EYA1	Adenocarcinoma
ATP6V1C1::VPS13B	Squamous cell carcinoma
ATP6V1D::CBS	Adenocarcinoma
ATP6V1D::ZFYVE26	Adenocarcinoma
ATP6V1E1::BID	Adenocarcinoma
ATP6V1E1::CECR2	Adenocarcinoma
ATP6V1E2::GRIK1	Squamous cell carcinoma
ATP6V1F::CPED1	Squamous cell carcinoma
ATP6V1G1::COL5A1	Malignant melanoma
ATP6V1G1::TNC	Adenocarcinoma
ATP6V1H::ALKAL1	Adenocarcinoma
ATP6V1H::CHD7	Adenocarcinoma
ATP6V1H::RORC	Adenocarcinoma
ATP6V1H::RP1	Squamous cell carcinoma
ATP6V1H::ST8SIA4	Adenocarcinoma
ATP6V1H::TCEA1	Adenocarcinoma
ATP7A::COX7B	Adenocarcinoma
ATP7A::PTPRR	Mesenchymal tumor, NOS
ATP7B::KLF5	Adenocarcinoma
ATP8A1::CRMP1	Adenocarcinoma
ATP8A1::FAM114A1	Adenocarcinoma
ATP8A1::LDB2	Adenocarcinoma
ATP8A1::PDS5A	Adenocarcinoma
ATP8A1::SHISA3	Adenocarcinoma
ATP8A2::ALG5	Transitional cell carcinoma
ATP8A2::CRYL1	Adenocarcinoma
ATP8A2::FLT1	Angiosarcoma
ATP8B1::NARS1	Adenocarcinoma
ATP8B1::SLC50A1	Adenocarcinoma
ATP8B2::ADAR	Adenocarcinoma
ATP8B4::DPH6	Adenocarcinoma
ATP8B4::LINGO1	Mesenchymal tumor, NOS
ATP8B4::MGMT	Adenocarcinoma
ATP8B4::OCA2	Adenocarcinoma
ATP9A::ARFGEF2	Adenocarcinoma
ATP9A::EPB41L1	Transitional cell carcinoma
ATP9A::LAMA5	Adenocarcinoma
ATP9A::MACROD2	Adenocarcinoma
ATP9A::SALL4	Adenocarcinoma
ATP9A::TRPC4AP	Adenocarcinoma
ATP9A::WFDC8	Adenocarcinoma
ATP9A::ZFP64	Malignant epithelial tumor, special type
ATP9B::ATRX	Mesenchymal tumor, NOS
ATP9B::LUC7L	Mesenchymal tumor, NOS
ATPAF1::OSBPL9	Transitional cell carcinoma
ATR::DBR1	Adenocarcinoma
ATR::PHF14	Astrocytoma, grade III-IV/Glioblastoma
ATR::R3HDM2	Adenocarcinoma
ATR::XRN1	Squamous cell carcinoma
ATRN::DNAAF9	Mesenchymal tumor, NOS
ATRN::RNF24	Adenocarcinoma
ATRN::TNKS2	Squamous cell carcinoma
ATRN::UQCRB	Mesenchymal tumor, NOS
ATRNL1::ATAD1	Adenocarcinoma
ATRNL1::RET	Carcinoma, NOS
ATRX::ABCB7	Mesenchymal tumor, NOS
ATRX::ARHGEF9	Mesothelioma
ATRX::BCL2	Astrocytoma, grade I-II
ATRX::CRACR2A	Mesenchymal tumor, NOS
ATRX::CYSLTR1	Adenocarcinoma
ATRX::DACH2	Squamous cell carcinoma
ATRX::LPAR4	Squamous cell carcinoma
ATRX::MAGT1	Transitional cell carcinoma | Malignant melanoma
ATRX::PASD1	Neuroblastoma
ATRX::SNTB2	Mesenchymal tumor, NOS
ATRX::ZNF304	Astrocytoma, grade I-II
ATXN10::APPL1	Adenocarcinoma
ATXN10::COL16A1	Miscellaneous hematopoietic/lymphoid neoplasm, special type | Benign epithelial tumor, special type
ATXN10::FBLN1	Adenocarcinoma
ATXN10::KRTAP9-1	Adenocarcinoma
ATXN10::PGR	Adenocarcinoma
ATXN10::PRPF19	Adenocarcinoma
ATXN10::TBC1D22A	Adenocarcinoma
ATXN10::TUBGCP6	Squamous cell carcinoma
ATXN10::WNT7B	Squamous cell carcinoma
ATXN10::ZNF354A	Malignant melanoma
ATXN1::ARG1	Adenocarcinoma
ATXN1::CDK19	Astrocytoma, grade III-IV/Glioblastoma
ATXN1::CGA	Adenocarcinoma
ATXN1::DNM3	Mesenchymal tumor, NOS
ATXN1::DTNBP1	Adenocarcinoma
ATXN1::DUX4	Malignant soft tissue tumor, NOS | Neuroglial neoplasm, special type
ATXN1::GLDN	Adenocarcinoma
ATXN1::HIGD1B	Astrocytoma, grade I-II
ATXN1::HMGCLL1	Adenocarcinoma
ATXN1::NUTM1	Malignant soft tissue tumor, NOS
ATXN1::NUTM2A	Soft tissue tumor, special type
ATXN1::PCTP	Adenocarcinoma
ATXN1::PTPRK	Adenocarcinoma
ATXN1::SLC24A1	Mesenchymal tumor, NOS
ATXN1L::NUTM2A	Soft tissue tumor, special type
ATXN2::ADAM10	Adenocarcinoma
ATXN2::BRAP	Transitional cell carcinoma
ATXN2::CCDC59	Adenocarcinoma
ATXN2::GIT2	Adenocarcinoma
ATXN2::RPL6	Astrocytoma, grade III-IV/Glioblastoma
ATXN2::STAT6	Adenocarcinoma
ATXN2::TRIM37	Adenocarcinoma
ATXN3::LGMN	Adenocarcinoma
ATXN7::SLC25A26	Malignant epithelial tumor, special type
ATXN7::ZNF385D	Adenocarcinoma
ATXN7L1::AGBL3	Adenocarcinoma
ATXN7L1::EFCAB10	Adenocarcinoma
ATXN7L3::FAM171A2	Adenocarcinoma
AUH::CPM	Mesenchymal tumor, NOS
AUNIP::PADI1	Adenocarcinoma
AUNIP::TRPM8	Adenocarcinoma
AURKA::CASTOR1	Adenocarcinoma
AURKA::MTCL2	Adenocarcinoma
AURKA::PCK1	Adenocarcinoma
AURKB::MYH10	Adenocarcinoma
AUTS2::ACTR1A	Mesenchymal tumor, NOS
AUTS2::BPI	Adenocarcinoma
AUTS2::CDH8	Adenocarcinoma
AUTS2::CFTR	Adenocarcinoma
AUTS2::MKLN1	Astrocytoma, grade I-II
AUTS2::NCOA3	Germ cell tumor, NOS
AUTS2::PNLIPRP3	Adenocarcinoma
AUTS2::SEMA3A	Mesenchymal tumor, NOS
AUTS2::TBC1D30	Astrocytoma, grade I-II
AVEN::GOLGA8B	Adenocarcinoma
AVEN::NUTM1	Acute myelomonocytic leukemia (FAB type M4)
AVEN::SCG5	Adenocarcinoma
AVIL::CPM	Astrocytoma, grade III-IV/Glioblastoma
AVIL::HIP1R	Astrocytoma, grade III-IV/Glioblastoma
AVIL::MBD6	Astrocytoma, grade I-II
AVIL::TRHDE	Malignant melanoma
AVL9::TSPAN31	Astrocytoma, grade I-II
AVL9::ZNF544	Astrocytoma, grade III-IV/Glioblastoma
AXIN1::ARHGDIG	Adenocarcinoma
AXIN1::BBX	Adenocarcinoma
AXIN1::CDH1	Adenocarcinoma
AXIN1::FAM234A	Adenocarcinoma
AXIN1::IFT140	Adenocarcinoma
AXIN1::ITCH	Adenocarcinoma
AXIN1::LUC7L	Adenocarcinoma
AXIN1::MRPL28	Adenocarcinoma
AXIN1::NPRL3	Adenocarcinoma | Malignant melanoma
AXIN1::PDCD2	Adenocarcinoma
AXIN1::PGAP6	Squamous cell carcinoma
AXIN1::TMEM207	Squamous cell carcinoma
AXIN2::EIF2AK2	Malignant melanoma
AXIN2::LRRC37A3	Adenocarcinoma
AXIN2::VWA3B	Adenocarcinoma
AXL::FBXW10B	Adenocarcinoma
AXL::MBIP	Adenocarcinoma
AXL::SQSTM1	Mesenchymal tumor, NOS
AXL::ZNF565	Adenocarcinoma
AZGP1::FAR1	Adenocarcinoma
AZGP1::GJC3	Adenocarcinoma | Schwannoma | Nonneoplastic epithelial disorder/lesion
AZGP1::TYK2	Adenocarcinoma
AZIN1::ATP6V1C1	Malignant melanoma
AZIN1::ITPR1	Astrocytoma, grade I-II
AZIN1::NCALD	Transitional cell carcinoma
AZIN1::NDUFA13	Adenocarcinoma
AZIN1::RNF19A	Malignant melanoma
AZIN1::YME1L1	Adenocarcinoma
AZIN1::ZFPM2	Adenocarcinoma
AZIN2::HPCA	Adenocarcinoma
AZIN2::PHIP	Adenocarcinoma
AZIN2::RBBP4	Adenocarcinoma
AZU1::TYK2	Acute myeloid leukemia, NOS | Skin
B2M::ARID5A	Multiple myeloma
B2M::ATF3	Multiple myeloma
B2M::CCND1	Multiple myeloma
B2M::CCT5	Diffuse large B-cell lymphoma
B2M::CSNK1E	Chronic lymphocytic leukemia
B2M::IGH	Multiple myeloma | Chronic lymphocytic leukemia
B2M::ISYNA1	Multiple myeloma
B2M::MAFK	Multiple myeloma
B2M::PATL2	Squamous cell carcinoma
B2M::PPP4R1	Malignant melanoma
B2M::RBM38	Multiple myeloma
B3GALNT1::TP63	Adenocarcinoma
B3GALNT2::GNG4	Squamous cell carcinoma
B3GALNT2::LBR	Mesenchymal tumor, NOS
B3GALNT2::LYST	Transitional cell carcinoma
B3GALT2::CFH	Squamous cell carcinoma
B3GALT4::SPPL3	Malignant epithelial tumor, special type
B3GLCT::ALOX5AP	Transitional cell carcinoma
B3GLCT::KIF13B	Adenocarcinoma
B3GLCT::MRPS35	Adenocarcinoma
B3GLCT::MTUS2	Adenocarcinoma
B3GLCT::POMP	Transitional cell carcinoma
B3GLCT::STK33	Adenocarcinoma
B3GLCT::TEX26	Transitional cell carcinoma | Malignant melanoma
B3GLCT::USPL1	Adenocarcinoma
B3GNT2::KYNU	Adenocarcinoma
B3GNT3::INSL3	Adenocarcinoma
B3GNT4::BCL7A	Adenocarcinoma
B3GNT5::ALG3	Squamous cell carcinoma
B3GNT5::CAMK2N2	Squamous cell carcinoma
B3GNTL1::CLCN4	Adenocarcinoma
B3GNTL1::LRRC3C	Adenocarcinoma
B3GNTL1::PPP1R27	Adenocarcinoma
B4GALNT1::EPYC	Mesenchymal tumor, NOS
B4GALNT1::TSFM	Astrocytoma, grade III-IV/Glioblastoma | Mesenchymal tumor, NOS
B4GALNT3::CCDC77	Adenocarcinoma
B4GALNT3::LMO3	Adenocarcinoma
B4GALNT3::SLCO4A1	Adenocarcinoma
B4GALT1::AQP7	Adenocarcinoma
B4GALT1::BAG1	Multiple myeloma | Adenocarcinoma
B4GALT1::NFX1	Adenocarcinoma
B4GALT1::PHF24	Squamous cell carcinoma
B4GALT1::RAF1	Adenocarcinoma
B4GALT1::SPATA31F3	Adenocarcinoma
B4GALT1::STRA8	Adenocarcinoma
B4GALT2::JAK1	Adenocarcinoma
B4GALT3::BCAS3	Adenocarcinoma
B4GALT3::ERO1B	Mesenchymal tumor, NOS
B4GALT3::TPM3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
B4GALT4::ACSL5	Squamous cell carcinoma
B4GALT4::CBLB	Astrocytoma, grade I-II
B4GALT5::ASIP	Adenocarcinoma
B4GALT5::EYA2	Adenocarcinoma
B4GALT5::GNAS	Adenocarcinoma
B4GALT5::MUC22	Transitional cell carcinoma
B4GALT5::PTGIS	Adenocarcinoma
B4GALT5::RNF151	Adenocarcinoma
B4GALT5::SPATA2	Adenocarcinoma
B4GALT5::TBL3	Adenocarcinoma
B4GALT5::TERT	Gonadal stromal cell tumors
B4GALT5::TOX2	Adenocarcinoma
B4GALT5::ZFP64	Squamous cell carcinoma
B4GALT7::NSD1	Adenocarcinoma | Malignant epithelial tumor, special type
B9D1::ALDH16A1	Transitional cell carcinoma
B9D1::EPN2	Astrocytoma, grade I-II
B9D1::SPECC1	Adenocarcinoma
B9D2::HNRNPL	Adenocarcinoma
B9D2::REEP6	Adenocarcinoma
BAALC::EIF3E	Adenocarcinoma
BAALC::UBR5	Malignant melanoma
BAAT::ALDOB	Adenocarcinoma
BAAT::STAT6	Adenocarcinoma
BABAM2::DPYSL5	Adenocarcinoma
BABAM2::DTNB	Transitional cell carcinoma
BABAM2::GPN1	Adenocarcinoma
BABAM2::HADHB	Adenocarcinoma
BABAM2::PRKCE	Adenocarcinoma
BABAM2::PTPN1	Adenocarcinoma
BABAM2::ZNF57	Malignant melanoma
BACE2::MX1	Adenocarcinoma
BACE2::SRGAP1	Squamous cell carcinoma
BACE2::TACR1	Mesenchymal tumor, NOS
BACE2::TMPRSS2	Adenocarcinoma
BACE2::WDR81	Adenocarcinoma
BACH1::MAP3K7CL	Transitional cell carcinoma
BACH1::OSBPL8	Mesenchymal tumor, NOS
BACH1::TENM1	Adenocarcinoma
BACH1::TTC3	Adenocarcinoma
BACH1::VPS26C	Squamous cell carcinoma
BACH2::BCL2L1	Burkitt lymphoma/leukemia
BACH2::MAP3K7	Astrocytoma, grade I-II
BACH2::PNRC1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
BACH2::ZDHHC13	Diffuse large B-cell lymphoma
BAD::MACROD1	Transitional cell carcinoma
BAD::STX5	Adenocarcinoma
BAD::TRMT112	Adenocarcinoma
BAG2::RNF114	Adenocarcinoma
BAG2::ZNF451	Adenocarcinoma
BAG4::FGFR1	Carcinoma, NOS | Squamous cell carcinoma
BAG4::LETM2	Squamous cell carcinoma
BAG4::NEDD8	Adenocarcinoma
BAG4::PLEKHA2	Adenocarcinoma
BAG4::TP53INP1	Adenocarcinoma
BAG4::WRN	Transitional cell carcinoma
BAG4::ZMAT4	Adenocarcinoma
BAG4::ZNF672	Adenocarcinoma
BAG6::LY6G5C	Adenocarcinoma
BAG6::TAF8	Squamous cell carcinoma
BAHCC1::CCDC137	Adenocarcinoma
BAHD1::KNSTRN	Adenocarcinoma
BAIAP2::ROS1	Adenocarcinoma
BAIAP2::TBCD	Squamous cell carcinoma
BAIAP2L1::ANKIB1	Adenocarcinoma | Squamous cell carcinoma
BAIAP2L1::BRAF	Adenocarcinoma | Melanocytic neoplasm, special type
BAIAP2L1::CYP3A7	Adenocarcinoma
BAIAP2L1::DMTF1	Adenocarcinoma
BAIAP2L1::LRRC23	Adenocarcinoma
BAIAP2L1::MET	Adenocarcinoma
BAIAP2L1::TSHZ2	Adenocarcinoma
BAIAP2L2::PLA2G6	Squamous cell carcinoma
BAIAP2L2::TMEM184B	Adenocarcinoma
BANK1::AGMO	Adenocarcinoma
BANK1::CFAP299	Adenocarcinoma
BANK1::GSTCD	Adenocarcinoma
BANP::JPH3	Malignant melanoma
BANP::SF3A3	Adenocarcinoma
BAP1::CCDC66	Mesothelioma
BAP1::DNAH1	Astrocytoma, grade I-II
BAP1::MLLT3	Malignant melanoma
BAP1::PBRM1	Malignant melanoma
BAP1::PLXNB1	Mesothelioma
BAP1::RILP	Mesothelioma
BAP1::TCEA3	Mesothelioma
BARD1::BNIP5	Adenocarcinoma
BARHL2::APC	Adenocarcinoma
BAX::ALDH16A1	Adenocarcinoma
BAX::DHDH	Adenocarcinoma
BAX::VAV2	Adenocarcinoma
BAX::WRAP53	Adenocarcinoma
BAZ1A::LRRC9	Adenocarcinoma
BAZ1A::NKX2-1	Adenocarcinoma
BAZ1A::RAD51B	Carcinoma, NOS
BAZ1A::RNF115	Squamous cell carcinoma
BAZ1B::BCL7B	Adenocarcinoma
BAZ1B::EDEM3	Adenocarcinoma
BAZ1B::MLXIPL	Adenocarcinoma
BAZ1B::NIPBL	Skin | Acute myeloid leukemia, NOS
BAZ1B::POMZP3	Adenocarcinoma
BAZ1B::PRMT8	Skin | Acute myeloid leukemia, NOS
BAZ1B::ZP3	Adenocarcinoma
BAZ2A::ACVR1B	Adenocarcinoma
BAZ2A::ATP5F1B	Adenocarcinoma
BAZ2A::BIN2	Adenocarcinoma
BAZ2A::NACA	Adenocarcinoma
BAZ2A::PRIM1	Squamous cell carcinoma
BAZ2B::CFAP43	Adenocarcinoma
BAZ2B::CYBRD1	Squamous cell carcinoma
BAZ2B::ITGB6	Adenocarcinoma
BAZ2B::PLA2R1	Adenocarcinoma
BAZ2B::SLC38A11	Squamous cell carcinoma
BAZ2B::STK39	Adenocarcinoma
BBC3::KLF2	Multiple myeloma
BBIP1::RET	Adenocarcinoma
BBOF1::DNAL1	Adenocarcinoma
BBOF1::PTGR2	Adenocarcinoma
BBOF1::RGS6	Adenocarcinoma
BBS2::ADAT1	Adenocarcinoma
BBS2::CDIN1	Mesenchymal tumor, NOS
BBS4::CSNK1G1	Adenocarcinoma
BBS4::TTC23	Adenocarcinoma
BBS7::PLA1A	Adenocarcinoma
BBS9::AVL9	Adenocarcinoma
BBS9::BRAF	Solitary fibrous tumor
BBS9::HDAC9	Adenocarcinoma
BBS9::KMT2E	Adenocarcinoma
BBX::ALCAM	Adenocarcinoma
BBX::DGKG	Astrocytoma, grade I-II
BBX::GALNT17	Adenocarcinoma
BBX::KPNA4	Malignant melanoma
BBX::RB1	Adenocarcinoma
BBX::SLC38A1	Malignant melanoma
BBX::SMC5	Adenocarcinoma
BBX::TBC1D23	Malignant melanoma
BBX::VSTM1	Mesenchymal tumor, NOS
BCAM::AKT2	Adenocarcinoma
BCAM::IGSF23	Adenocarcinoma
BCAM::PLAT	Adenocarcinoma
BCAM::REG3A	Adenocarcinoma
BCAM::SST	Adenocarcinoma
BCAN::NTRK1	Glioma, NOS | Astrocytoma, grade III-IV/Glioblastoma
BCAP29::BRAF	Adenocarcinoma
BCAP31::HMGB3	Malignant melanoma
BCAP31::PDZD4	Adenocarcinoma
BCAP31::SYNJ2BP	Adenocarcinoma
BCAR1::CFDP1	Adenocarcinoma
BCAR3::ABCA4	Adenocarcinoma
BCAR3::CIMAP1D	Adenocarcinoma
BCAR3::DNTTIP2	Malignant epithelial tumor, special type
BCAR3::EVI5	Transitional cell carcinoma
BCAS1::CYP24A1	Adenocarcinoma
BCAS1::IGF2	Transitional cell carcinoma | Adenocarcinoma
BCAS1::KIF16B	Adenocarcinoma
BCAS3::ABCA8	Adenocarcinoma
BCAS3::ANLN	Adenocarcinoma
BCAS3::APPBP2	Adenocarcinoma
BCAS3::ARHGAP15	Adenocarcinoma
BCAS3::ATXN7	Adenocarcinoma
BCAS3::AXIN2	Adenocarcinoma
BCAS3::BRIP1	Adenocarcinoma
BCAS3::CA10	Adenocarcinoma
BCAS3::CA4	Adenocarcinoma
BCAS3::CACNG6	Adenocarcinoma
BCAS3::CASC3	Adenocarcinoma
BCAS3::CYTH1	Adenocarcinoma
BCAS3::DISP1	Adenocarcinoma
BCAS3::EYA2	Adenocarcinoma
BCAS3::GH2	Adenocarcinoma
BCAS3::GIT1	Adenocarcinoma
BCAS3::GRIK2	Adenocarcinoma
BCAS3::HEATR6	Adenocarcinoma
BCAS3::HOXB9	Adenocarcinoma
BCAS3::KAT7	Adenocarcinoma
BCAS3::MAP3K3	Adenocarcinoma
BCAS3::MARCHF10	Squamous cell carcinoma
BCAS3::MED13	Adenocarcinoma
BCAS3::NFS1	Adenocarcinoma
BCAS3::ORMDL3	Adenocarcinoma
BCAS3::PHF21A	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
BCAS3::POLD4	Adenocarcinoma
BCAS3::PPM1D	Adenocarcinoma
BCAS3::PRKAA2	Adenocarcinoma
BCAS3::PRKCA	Adenocarcinoma
BCAS3::RAD51C	Adenocarcinoma
BCAS3::RNF169	Adenocarcinoma
BCAS3::RNFT1	Astrocytoma, grade I-II | Adenocarcinoma
BCAS3::RPS6KB1	Squamous cell carcinoma
BCAS3::SCN4A	Adenocarcinoma
BCAS3::SHANK2	Adenocarcinoma
BCAS3::SYTL2	Mesenchymal tumor, NOS
BCAS3::TACO1	Astrocytoma, grade I-II
BCAS3::TANC2	Adenocarcinoma
BCAS3::TLK2	Squamous cell carcinoma
BCAS3::VMP1	Adenocarcinoma
BCAS3::WIPI1	Adenocarcinoma
BCAS3::XRRA1	Adenocarcinoma
BCAS3::ZMYND8	Transitional cell carcinoma
BCAS4::AURKA	Adenocarcinoma
BCAS4::BCAS3	Adenocarcinoma
BCAS4::PHACTR3	Adenocarcinoma
BCAS4::PHF20	Adenocarcinoma
BCAS4::PTPN1	Adenocarcinoma
BCAS4::SLC9A8	Adenocarcinoma
BCAS4::ZMYND8	Adenocarcinoma
BCAT1::AKT2	Adenocarcinoma
BCAT1::C2CD5	Acute erythroleukemia (FAB type M6)
BCAT1::ITPR2	Adenocarcinoma
BCAT1::PRB3	Adenocarcinoma
BCAT1::RECQL	Adenocarcinoma
BCAT1::SLCO1A2	Adenocarcinoma
BCAT1::VPS72	Adenocarcinoma
BCAT2::IRF3	Astrocytoma, grade I-II
BCAT2::NUCB1	Adenocarcinoma
BCAT2::ZNF544	Adenocarcinoma
BCCIP::EDRF1	Adenocarcinoma
BCKDHA::CCDC97	Malignant epithelial tumor, special type
BCKDHA::TMEM91	Adenocarcinoma
BCKDHB::COQ3	Adenocarcinoma
BCKDHB::ME1	Adenocarcinoma
BCKDHB::NR2E1	Multiple myeloma
BCKDHB::TTK	Transitional cell carcinoma
BCL10::DPYD	Mesenchymal tumor, NOS
BCL11A::EPHA5	Squamous cell carcinoma
BCL11A::GRIP2	Acute myeloblastic leukemia with maturation (FAB type M2)
BCL11A::HACD1	Adenocarcinoma
BCL11B::MIPOL1	Transitional cell carcinoma
BCL11B::NKX2-5	Acute lymphoblastic leukemia/lymphoblastic lymphoma
BCL11B::TLX3	Bilineage or biphenotypic leukemia | Egypt | Acute lymphoblastic leukemia/lymphoblastic lymphoma
BCL11B::TRD	Acute lymphoblastic leukemia/lymphoblastic lymphoma
BCL2::IGH	Mature B-cell neoplasm, NOS
BCL2L10::GNB5	Squamous cell carcinoma
BCL2L11::ACOXL	Squamous cell carcinoma
BCL2L11::AFMID	Adenocarcinoma
BCL2L11::BRAF	Adenocarcinoma
BCL2L11::CCDC170	Adenocarcinoma
BCL2L11::CXCR4	Multiple myeloma
BCL2L12::FLT3LG	Adenocarcinoma
BCL2L12::PRMT1	Adenocarcinoma
BCL2L13::CECR2	Squamous cell carcinoma
BCL2L13::CUX2	Squamous cell carcinoma
BCL2L13::ESS2	Malignant epithelial tumor, special type
BCL2L13::GAB4	Adenocarcinoma
BCL2L13::GTPBP1	Adenocarcinoma
BCL2L13::SPECC1	Adenocarcinoma
BCL2L13::VPS8	Squamous cell carcinoma
BCL2L13::ZNF383	Transitional cell carcinoma
BCL2L14::ETV6	Adenocarcinoma
BCL2L14::GPR19	Adenocarcinoma
BCL2L1::BMP8B	Undifferentiated carcinoma, small cell
BCL2L1::EXO5	Undifferentiated carcinoma, small cell
BCL2L1::HM13	Undifferentiated carcinoma, small cell
BCL2L1::NOL4L	Transitional cell carcinoma
BCL2L1::RHAG	Adenocarcinoma
BCL2L1::RIMS3	Undifferentiated carcinoma, small cell
BCL2L1::RLF	Undifferentiated carcinoma, small cell
BCL2L1::TTLL9	Acute lymphoblastic leukemia/lymphoblastic lymphoma
BCL2L1::VWA5B1	Adenocarcinoma
BCL2L1::ZFP69B	Undifferentiated carcinoma, small cell
BCL2L1::ZNF684	Undifferentiated carcinoma, small cell
BCL2L2::RNF212B	Adenocarcinoma
BCL3::ATP9B	Adenocarcinoma
BCL3::CEACAM16	Squamous cell carcinoma
BCL3::GRIK4	Squamous cell carcinoma
BCL3::HIPK4	Squamous cell carcinoma
BCL3::IGSF23	Adenocarcinoma
BCL3::MYC	B-prolymphocytic leukemia
BCL3::ZNF233	Adenocarcinoma
BCL6::C3	Diffuse large B-cell lymphoma
BCL6::CIITA	Diffuse large B-cell lymphoma | Follicular lymphoma
BCL6::FBH1	Diffuse large B-cell lymphoma
BCL6::GRHL1	Soft tissue tumor, special type
BCL6::IGH	Mature B-cell neoplasm, NOS
BCL6::LCP1	Diffuse large B-cell lymphoma
BCL6::LPP	Diffuse large B-cell lymphoma
BCL6::MBNL1	Diffuse large B-cell lymphoma
BCL6::MYBL1	Diffuse large B-cell lymphoma
BCL6::PIM1	Diffuse large B-cell lymphoma
BCL6::RAB29	Mature B-cell neoplasm, NOS
BCL6::RAF1	Astrocytoma, grade III-IV/Glioblastoma
BCL6::RHOH	Diffuse large B-cell lymphoma
BCL6::SPECC1L	Adenocarcinoma
BCL6::TP63	Anaplastic large cell lymphoma, systemic type
BCL7A::BICRA	Adenocarcinoma
BCL7A::CFAP251	Squamous cell carcinoma
BCL7A::DAZAP1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
BCL7A::KCNIP3	Adenocarcinoma
BCL7A::MSI1	Adenocarcinoma
BCL7B::TBL2	Adenocarcinoma
BCL7B::TNFRSF12A	Adenocarcinoma
BCL7C::KRBOX5	Adenocarcinoma
BCL7C::OTOA	Adenocarcinoma
BCL9::BEST3	Mesenchymal tumor, NOS
BCL9::C1orf21	Mesenchymal tumor, NOS
BCL9::GOLPH3L	Squamous cell carcinoma
BCL9::IVL	Adenocarcinoma
BCL9::RASAL2	Adenocarcinoma
BCL9::SMCP	Adenocarcinoma
BCL9L::DGKI	Mesenchymal tumor, NOS
BCLAF1::GRM1	Chondromyxoid fibroma
BCLAF1::MAP7	Adenocarcinoma
BCLAF3::POLA1	Squamous cell carcinoma
BCOR::CCNB3	Osteogenic/bone tumor, special type | Undifferentiated sarcoma | Ewing sarcoma | Clear cell sarcoma | Undifferentiated round cell sarcoma | Soft tissue tumor, special type
BCOR::CLGN	Soft tissue tumor, special type
BCOR::CREBBP	Ependymoma | Astrocytoma, grade III-IV/Glioblastoma
BCOR::EP300	Astrocytoma, grade I-II
BCOR::L3MBTL2	Astrocytoma, grade I-II | Astrocytoma, grade III-IV/Glioblastoma | Leiomyosarcoma | Endometrial stromal sarcoma
BCOR::MAML3	Undifferentiated sarcoma | Desmoplastic small round cell tumor
BCOR::MAP7D2	Endometrial stromal sarcoma
BCOR::NUGGC	Endometrial stromal sarcoma
BCOR::NUTM2G	Endometrial stromal sarcoma
BCOR::PHEX	Adenocarcinoma
BCOR::RALGPS1	Endometrial stromal sarcoma
BCOR::RARA	Acute promyelocytic leukemia (FAB type M3)
BCOR::STAG2	Skin | Acute myeloid leukemia, NOS
BCORL1::NUTM1	Mesenchymal tumor, special type
BCORL1::PRR14L	Mesenchymal tumor, special type
BCORL1::RAB33A	Adenocarcinoma
BCORL1::UTP14A	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
BCR::ABL1	Acute undifferentiated leukemia | Nonneoplastic hematologic disorder/lesion | Diffuse large B-cell lymphoma | Acute myeloblastic leukemia with maturation (FAB type M2) | Multiple myeloma | Algeria | Acute myelomonocytic leukemia (FAB type M4) | Acute erythroleukemia (FAB type M6) | Mature B-cell neoplasm, NOS | Acute megakaryoblastic leukemia (FAB type M7) | Acute myeloblastic leukemia without maturation (FAB type M1) | Chronic myeloproliferative disorder, NOS | Mature T- and NK-cell neoplasm, NOS | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Skin | T-prolymphocytic leukemia | Bilineage or biphenotypic leukemia | Mycosis fungoides/Sézary syndrome | Myelodysplastic syndrome, NOS | Hairy cell leukemia | Acute myeloblastic leukemia with minimal differentiation (FAB type M0) | Acute myeloid leukemia, NOS | Egypt | Chronic myeloid leukemia, aberrant translocation | Acute promyelocytic leukemia (FAB type M3) | Acute monoblastic leukemia without differentiation (FAB type M5a) | Burkitt lymphoma/leukemia | Refractory anemia | Chronic myeloid leukemia, t(9;22) | Heart
BCR::ARVCF	Adenocarcinoma
BCR::CYLC2	Malignant melanoma
BCR::FGFR1	Bilineage or biphenotypic leukemia | Chronic myeloproliferative disorder, NOS | Acute myeloblastic leukemia with minimal differentiation (FAB type M0) | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Egypt | Acute myeloid leukemia, NOS | Skin
BCR::GNAZ	Squamous cell carcinoma
BCR::HIC2	Malignant epithelial tumor, special type
BCR::IRAG1	Adenocarcinoma
BCR::JAK2	Chronic myeloproliferative disorder, NOS | Acute myeloid leukemia, NOS | Skin | Acute myeloblastic leukemia without maturation (FAB type M1) | Acute lymphoblastic leukemia/lymphoblastic lymphoma
BCR::LRP5L	Osteosarcoma, NOS
BCR::MOV10L1	Adenocarcinoma
BCR::MYH11	Squamous cell carcinoma
BCR::NTRK2	Astrocytoma, grade I-II | Astrocytoma, grade III-IV/Glioblastoma | Glioma, NOS
BCR::PDGFRA	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Lymph node | Bilineage or biphenotypic leukemia | Atypical chronic myeloid leukemia | Egypt | Chronic eosinophilic leukemia/hypereosinophilic syndrome
BCR::PDGFRB	Spleen | Chronic myelomonocytic leukemia
BCR::PPIL2	Transitional cell carcinoma
BCR::RALGPS1::ABL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
BCR::RET	Spleen | Chronic myelomonocytic leukemia
BCR::TOM1	Squamous cell carcinoma
BCR::UPB1	Squamous cell carcinoma
BCR::ZNF711	Malignant melanoma
BDH1::BMT2	Transitional cell carcinoma
BDH1::ZBBX	Astrocytoma, grade I-II
BDH2::MANBA	Malignant melanoma
BDP1::ARB2A	Adenocarcinoma
BDP1::CWC27	Adenocarcinoma
BDP1::LINS1	Adenocarcinoma
BECN1::GPATCH8	Squamous cell carcinoma
BEND3::CRYBG1	Astrocytoma, grade I-II
BEND3::MTRES1	Adenocarcinoma
BEND3::SNX3	Adenocarcinoma
BEND5::NTRK2	Glioma, NOS
BEND6::TRIM38	Squamous cell carcinoma
BEND7::FRMD4A	Adenocarcinoma
BEND7::PHYH	Adenocarcinoma
BEST1::RBP4	Adenocarcinoma
BEST3::MYRFL	Mesenchymal tumor, NOS
BEST3::PTPRR	Mesenchymal tumor, NOS
BET1L::LMF1	Adenocarcinoma
BFAR::MACROD2	Multiple myeloma
BFAR::SPNS1	Astrocytoma, grade I-II
BGN::ANXA1	Squamous cell carcinoma
BGN::BRD10	Adenocarcinoma
BGN::CLCN3	Adenocarcinoma
BGN::ERBB3	Adenocarcinoma
BGN::PTP4A2	Mesothelioma
BGN::RABEP1	Malignant melanoma
BGN::SEC63	Mesenchymal tumor, NOS
BGN::TTN	Squamous cell carcinoma
BGN::UTRN	Adenocarcinoma
BGN::ZNF827	Adenocarcinoma
BGN::ZNFX1	Mesenchymal tumor, NOS
BHLHE41::RERGL	Astrocytoma, grade I-II
BHMT2::JMY	Adenocarcinoma
BICC1::DPYSL4	Adenocarcinoma
BICC1::FGFR2	Adenocarcinoma
BICC1::RAB11FIP1	Adenocarcinoma
BICC1::UBE2D1	Adenocarcinoma
BICD1::BORCS5	Germ cell tumor, NOS
BICD1::CCDC91	Adenocarcinoma
BICD1::CDK6	Adenocarcinoma
BICD1::DENND5B	Adenocarcinoma
BICD1::ETFBKMT	Adenocarcinoma
BICD1::NAPB	Adenocarcinoma
BICD1::RESF1	Malignant epithelial tumor, special type
BICD1::SOX5	Astrocytoma, grade I-II
BICD1::ZNF438	Astrocytoma, grade I-II
BICD2::ASPN	Squamous cell carcinoma
BICD2::JAK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
BICDL1::GALNT9	Adenocarcinoma
BICDL1::HLCS	Adenocarcinoma
BICDL1::KCNK1	Adenocarcinoma
BICDL2::TP53	Adenocarcinoma
BICRA::ZNF793	Squamous cell carcinoma
BICRAL::CYB5R4	Adenocarcinoma
BICRAL::H2AC6	Adenocarcinoma
BICRAL::MPHOSPH9	Astrocytoma, grade III-IV/Glioblastoma
BICRAL::PMS1	Adenocarcinoma
BICRAL::UBR2	Adenocarcinoma
BID::ATP6V1E1	Adenocarcinoma
BIN2::BRAF	Malignant melanoma
BIN2::PDGFRB	Chronic myeloproliferative disorder, NOS
BIN3::NRG1	Carcinoma, NOS
BIN3::PEBP4	Adenocarcinoma
BIN3::PHYHIP	Transitional cell carcinoma
BIRC2::ARAP1	Egypt | Bilineage or biphenotypic leukemia
BIRC2::TMEM123	Squamous cell carcinoma
BIRC2::YAP1	Adenocarcinoma
BIRC3::CCT5	Adenocarcinoma
BIRC3::MALT1	Extranodal marginal zone B-cell lymphoma | Nonneoplastic hematologic disorder/lesion | Diffuse large B-cell lymphoma | Waldenström macroglobulinemia
BIRC6::ABCC11	Adenocarcinoma
BIRC6::ALK	Adenocarcinoma
BIRC6::BABAM2	Adenocarcinoma
BIRC6::BHMT2	Undifferentiated carcinoma, small cell
BIRC6::EML4	Adenocarcinoma
BIRC6::EML6	Adenocarcinoma
BIRC6::LTBP1	Acute myeloid leukemia, NOS | Skin | Acute myeloblastic leukemia with maturation (FAB type M2)
BIRC6::MATN3	Adenocarcinoma
BIRC6::RMDN2	Adenocarcinoma
BIRC6::SLC30A6	Adenocarcinoma | Malignant epithelial tumor, special type
BIRC6::SPAST	Germ cell tumor, NOS
BIRC6::YIPF4	Adenocarcinoma
BIRC7::ZNF200	Malignant melanoma
BLM::ABHD2	Adenocarcinoma
BLMH::ABCA9	Mesenchymal tumor, NOS
BLNK::PIK3AP1	Adenocarcinoma
BLNK::TLL2	Squamous cell carcinoma
BLNK::ZNF536	Adenocarcinoma
BLOC1S3::C12ORF4	Adenocarcinoma
BLOC1S3::GEMIN7	Adenocarcinoma
BLOC1S6::IREB2	Multiple myeloma
BLOC1S6::SCMH1	Adenocarcinoma
BLOC1S6::SQOR	Adenocarcinoma
BLTP1::ADAD1	Adenocarcinoma
BLTP1::ADGRA3	Adenocarcinoma
BLTP1::CCNA2	Adenocarcinoma
BLTP1::CHODL	Adenocarcinoma
BLTP1::FSIP2	Adenocarcinoma
BLTP1::NFKB1	Mesenchymal tumor, NOS
BLTP2::ALKBH5	Squamous cell carcinoma
BLTP2::CRHR1	Squamous cell carcinoma
BLTP2::FAM222B	Adenocarcinoma
BLTP2::MYO18A	Adenocarcinoma
BLTP2::SEZ6	Squamous cell carcinoma
BLTP2::TEX14	Adenocarcinoma
BLTP3A::DAXX	Adenocarcinoma
BLTP3A::EPYC	Astrocytoma, grade III-IV/Glioblastoma
BLTP3A::OSBPL1A	Squamous cell carcinoma
BLTP3A::RIOK1	Adenocarcinoma
BLTP3B::ANKS1B	Squamous cell carcinoma
BLTP3B::ANO4	Adenocarcinoma
BLTP3B::ATP23	Mesenchymal tumor, NOS
BLTP3B::CACNG3	Mesenchymal tumor, NOS
BLTP3B::DENND1A	Adenocarcinoma
BLTP3B::DEPDC4	Adenocarcinoma
BLTP3B::PMCH	Adenocarcinoma
BLTP3B::TRHDE	Mesenchymal tumor, NOS
BLTP3B::ZDHHC17	Mesenchymal tumor, NOS
BLVRA::STK17A	Adenocarcinoma
BLVRA::SUGCT	Adenocarcinoma
BLZF1::MPC2	Adenocarcinoma
BMAL1::BTBD10	Adenocarcinoma
BMAL1::RIC8B	Mesenchymal tumor, NOS
BMAL1::TEAD1	Squamous cell carcinoma
BMAL2::CCDC91	Transitional cell carcinoma
BMAL2::ITPR2	Adenocarcinoma
BMAL2::PPFIBP1	Adenocarcinoma
BMAL2::STK38L	Squamous cell carcinoma
BMERB1::ABCC1	Adenocarcinoma
BMERB1::POMT2	Adenocarcinoma
BMERB1::RHBDL2	Adenocarcinoma
BMERB1::SMPDL3B	Adenocarcinoma
BMI1::ABI1	Adenocarcinoma
BMI1::SEC61A2	Astrocytoma, grade I-II
BMP1::FHIP2B	Adenocarcinoma
BMP2::TRIB3	Astrocytoma, grade I-II
BMP2K::ANXA3	Adenocarcinoma
BMP2K::CDS1	Squamous cell carcinoma
BMP2K::HOXD10	Acute myeloid leukemia, NOS | Skin | Acute megakaryoblastic leukemia (FAB type M7)
BMP2K::LEF1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
BMP2K::SHROOM3	Adenocarcinoma
BMP2K::SLC25A31	Adenocarcinoma
BMP2K::SLC4A4	Adenocarcinoma
BMP2K::ZNF384	Acute lymphoblastic leukemia/lymphoblastic lymphoma
BMP5::COL21A1	Adenocarcinoma
BMP6::NTRK3	Adenocarcinoma
BMP7::DYNC2LI1	Adenocarcinoma
BMP7::EEF1A2	Adenocarcinoma
BMP7::MACROD2	Transitional cell carcinoma
BMP7::PIGU	Squamous cell carcinoma
BMP7::RBM38	Adenocarcinoma
BMP8B::RLF	Undifferentiated carcinoma, small cell
BMPER::EGFR	Adenocarcinoma
BMPR1A::ENTPD1	Adenocarcinoma
BMPR1A::FGFBP3	Adenocarcinoma
BMPR1A::LIPA	Astrocytoma, grade III-IV/Glioblastoma
BMPR1A::LRMDA	Adenocarcinoma
BMPR1B::ALG6	Squamous cell carcinoma
BMPR1B::DDAH1	Adenocarcinoma
BMPR1B::ETV1	Adenocarcinoma
BMPR1B::MCC	Adenocarcinoma
BMPR1B::PDLIM5	Adenocarcinoma
BMPR2::ATG4B	Squamous cell carcinoma
BMPR2::CYP20A1	Malignant melanoma
BMPR2::FAM117B	Adenocarcinoma
BMPR2::KANSL1L	Adenocarcinoma
BMPR2::KIAA2012	Adenocarcinoma
BMPR2::MARCHF4	Adenocarcinoma
BMPR2::NOP58	Malignant epithelial tumor, special type
BMPR2::SPATS2L	Adenocarcinoma
BMS1::PHYHIPL	Adenocarcinoma
BMS1::PLEKHA7	Adenocarcinoma
BMS1::RET	Carcinoma, NOS
BMT2::ADAMTS14	Adenocarcinoma
BNIP5::ETV7	Adenocarcinoma
BNIPL::THEM5	Transitional cell carcinoma
BOC::PHLDB2	Adenocarcinoma
BOC::PLAG1	Adenoma | Lipoblastoma | Soft tissue tumor, NOS
BOC::SIDT1	Squamous cell carcinoma
BOC::SLC35A5	Adenocarcinoma
BOK::COPS9	Adenocarcinoma
BOK::ING5	Adenocarcinoma
BOK::MEOX1	Adenocarcinoma
BOLA2::CORO1A	Squamous cell carcinoma
BOLA2::MUSK	Adenocarcinoma
BOP1::CPSF1	Adenocarcinoma
BOP1::NECAB1	Mesenchymal tumor, NOS
BOP1::NIPAL2	Astrocytoma, grade I-II
BOP1::PLEC	Squamous cell carcinoma
BOP1::TONSL	Adenocarcinoma
BOP1::ZFTRAF1	Adenocarcinoma
BORCS5::CCDC91	Adenocarcinoma
BORCS5::CDR2L	Adenocarcinoma
BORCS5::HDAC7	Adenocarcinoma
BORCS5::PTPRR	Squamous cell carcinoma
BORCS7::WBP1L	Adenocarcinoma
BORCS8::TM6SF2	Squamous cell carcinoma
BPGM::AKR1B15	Squamous cell carcinoma
BPHL::UQCC2	Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
BPIFA1::CLDN7	Adenocarcinoma
BPIFB1::BPIFB4	Adenocarcinoma
BPIFB1::SNAPC5	Adenocarcinoma
BPIFB2::MUC5B	Squamous cell carcinoma
BPNT1::RAB3GAP2	Adenocarcinoma
BPNT2::ZCCHC24	Adenocarcinoma
BPTF::ABCC3	Adenocarcinoma
BPTF::ARSG	Adenocarcinoma
BPTF::BCAS3	Adenocarcinoma
BPTF::CCDC40	Adenocarcinoma
BPTF::FAM117A	Adenocarcinoma
BPTF::KPNA2	Adenocarcinoma
BPTF::NOL11	Germ cell tumor, NOS | Malignant epithelial tumor, special type | Adenocarcinoma
BPTF::NPEPPS	Adenocarcinoma
BPTF::NUTM1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
BPTF::PEBP1	Adenocarcinoma
BPTF::PIP4K2B	Adenocarcinoma
BPTF::PITPNC1	Adenocarcinoma
BPTF::PLXDC1	Adenocarcinoma
BPTF::RAD17	Adenocarcinoma
BPTF::RGS9	Adenocarcinoma
BPTF::RNF135	Adenocarcinoma
BPTF::TTYH2	Transitional cell carcinoma
BRAF::AGK	Adenocarcinoma
BRAF::AP3B1	Adenocarcinoma
BRAF::ARGLU1	Astrocytoma, grade III-IV/Glioblastoma
BRAF::ATG7	Malignant melanoma
BRAF::BRAF	Squamous cell carcinoma
BRAF::CIITA	Adenocarcinoma
BRAF::CUL1	Adenocarcinoma
BRAF::CUX1	Adenocarcinoma
BRAF::DENND2A	Astrocytoma, grade I-II
BRAF::EEA1	Benign nevus
BRAF::FAM114A2	Adenocarcinoma
BRAF::FNBP1	Osteogenic/bone tumor, special type
BRAF::GOLGA4	Benign nevus
BRAF::HIBADH	Malignant melanoma
BRAF::KIAA1549	Osteogenic/bone tumor, special type
BRAF::KMT2C	Adenocarcinoma
BRAF::LCA5	Benign nevus
BRAF::LHFPL3	Astrocytoma, grade III-IV/Glioblastoma
BRAF::MACF1	Astrocytoma, pilocytic/juvenile | Adenocarcinoma
BRAF::MRPS33	Transitional cell carcinoma
BRAF::PAG1	Astrocytoma, NOS
BRAF::PTPRN2	Meningioma
BRAF::SLC26A4	Squamous cell carcinoma
BRAF::SND1	Adenocarcinoma
BRAF::SUGCT	Adenocarcinoma
BRAF::TRIM24	Adenocarcinoma
BRAF::ZKSCAN5	Malignant melanoma
BRAP::BLMH	Acute lymphoblastic leukemia/lymphoblastic lymphoma
BRAP::CFAP65	Adenocarcinoma
BRAP::FAM216A	Squamous cell carcinoma
BRAP::KLRB1	Astrocytoma, grade I-II
BRAP::RCAN1	Acute erythroleukemia (FAB type M6)
BRCA1::NF1	Adenocarcinoma
BRCC3::CLIC2	Adenocarcinoma
BRCC3::FAM50A	Adenocarcinoma
BRD10::CMTM7	Astrocytoma, grade I-II
BRD10::CYP20A1	Adenocarcinoma
BRD10::INSL6	Adenocarcinoma
BRD10::NUDT11	Myxofibrosarcoma
BRD10::PHF20	Squamous cell carcinoma
BRD1::APOL5	Adenocarcinoma
BRD1::MAPK12	Astrocytoma, grade III-IV/Glioblastoma
BRD1::MLC1	Adenocarcinoma
BRD1::POLR2F	Adenocarcinoma
BRD1::RTN4RL1	Adenocarcinoma
BRD1::SLC3A2	Malignant melanoma
BRD1::TTLL8	Adenocarcinoma
BRD2::NUTM1	Malignant epithelial tumor, special type
BRD3::NUTM1	Malignant epithelial tumor, special type | Mesenchymal tumor, special type | Undifferentiated round cell sarcoma | Undifferentiated carcinoma | Squamous cell carcinoma
BRD3::PIP5KL1	Adenocarcinoma
BRD4::AKAP8L	Adenocarcinoma
BRD4::ARMC6	Adenocarcinoma
BRD4::CALR3	Adenocarcinoma
BRD4::CC2D1A	Adenocarcinoma
BRD4::CRTC1	Embryonal nervous system tumor, NOS
BRD4::CSE1L	Adenocarcinoma
BRD4::CSN2	Squamous cell carcinoma
BRD4::CYP4F22	Adenocarcinoma
BRD4::GNAT1	Malignant epithelial tumor, special type
BRD4::KLF2	Multiple myeloma
BRD4::LEUTX	Embryonal nervous system tumor, special type | Epithelioid sarcoma | Alveolar rhabdomyosarcoma
BRD4::MFSD12	Adenocarcinoma
BRD4::NOTCH3	Squamous cell carcinoma | Adenocarcinoma
BRD4::NUTM1	Malignant epithelial tumor, special type | Undifferentiated carcinoma | Squamous cell carcinoma | Carcinoma, NOS | Mesenchymal tumor, special type
BRD4::PGLYRP1	Adenocarcinoma
BRD4::PGLYRP2	Transitional cell carcinoma
BRD4::SLC1A6	Squamous cell carcinoma
BRD4::WDR83	Adenocarcinoma
BRD4::ZC3H15	Adenocarcinoma
BRD7::ZNF423	Adenocarcinoma
BRD8::PHF1	Endometrial stromal sarcoma
BRD9::CBFB	Squamous cell carcinoma
BRD9::CEP72	Squamous cell carcinoma
BRD9::NUTM1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
BRD9::OSMR	Malignant melanoma
BRD9::STARD3	Adenocarcinoma
BRD9::TERT	Adenocarcinoma
BRD9::TPPP	Adenocarcinoma
BRF1::FOXN3	Adenocarcinoma
BRF2::FGFR1	Myxofibrosarcoma
BRF2::KHDRBS2	Adenocarcinoma
BRIP1::CUEDC1	Adenocarcinoma
BRIP1::RELCH	Adenocarcinoma
BRIP1::SPAG9	Adenocarcinoma
BRIP1::UTP18	Adenocarcinoma
BRIP1::VMP1	Adenocarcinoma
BRK1::FANCD2	Adenocarcinoma
BRK1::PTP4A2	Adenocarcinoma
BRK1::THADA	Russia | Primitive neuroectodermal tumor/Medulloblastoma
BRK1::VHL	Heart | Chronic myeloid leukemia, t(9;22)
BRMS1L::NPAS3	Mesenchymal tumor, NOS
BRMS1L::PRORP	Adenocarcinoma
BRMS1L::ZNF839	Adenocarcinoma
BROX::SUSD4	Mesenchymal tumor, NOS
BRPF3::HLA-DMA	Adenocarcinoma
BRPF3::KCTD20	Adenocarcinoma
BRPF3::STARD9	Astrocytoma, grade III-IV/Glioblastoma
BRPF3::UNC119B	Mesenchymal tumor, NOS
BRPF3::ZFAND3	Adenocarcinoma
BRSK1::COX6B1	Adenocarcinoma
BRSK1::HSPBP1	Adenocarcinoma
BRWD1::ABCA10	Adenocarcinoma
BRWD1::ABCG1	Adenocarcinoma
BRWD1::CEP112	Adenocarcinoma
BRWD1::DSCAM	Adenocarcinoma
BRWD1::DYRK1A	Adenocarcinoma
BRWD1::ETS2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
BRWD1::GET1	Adenocarcinoma
BRWD1::HUNK	Adenocarcinoma
BRWD1::KIF2A	Adenocarcinoma
BRWD1::LCA5L	Adenocarcinoma
BRWD1::PPP2R1A	Astrocytoma, grade III-IV/Glioblastoma
BRWD1::RAPGEF4	Adenocarcinoma
BRWD1::RUNX1	Skin | Acute myeloid leukemia, NOS
BRWD1::SMC1A	Adenocarcinoma
BRWD1::WDR4	Adenocarcinoma
BRWD3::LRCH2	Squamous cell carcinoma
BRWD3::NALF1	Squamous cell carcinoma
BSCL2::DGLUCY	Adenocarcinoma
BSDC1::HDAC1	Squamous cell carcinoma
BSDC1::YARS1	Adenocarcinoma
BSDC1::ZMYM4	Adenocarcinoma
BSG::ARFGEF2	Astrocytoma, grade I-II
BSG::CCT5	Adenocarcinoma
BSG::CDC34	Mature B-cell neoplasm, NOS
BSG::EEA1	Adenocarcinoma
BSG::KLF16	Multiple myeloma
BSG::KLF2	Multiple myeloma
BSG::NCALD	Adenocarcinoma
BSG::NFIX	Adenocarcinoma
BSG::PLEKHB2	Adenocarcinoma
BSG::RNF126	Multiple myeloma
BSG::STAT6	Adenocarcinoma
BSG::UBC	Multiple myeloma
BSN::ARL8B	Astrocytoma, grade I-II
BSPRY::NPM1	Adenocarcinoma
BST2::SLC27A1	Malignant melanoma
BTAF1::HOGA1	Mesenchymal tumor, NOS
BTAF1::MARCHF5	Squamous cell carcinoma
BTAF1::PTPRR	Adenocarcinoma
BTBD10::COLEC10	Adenocarcinoma
BTBD10::PTH	Squamous cell carcinoma
BTBD10::TEAD1	Adenocarcinoma
BTBD1::BBOX1	Squamous cell carcinoma
BTBD1::HOMER2	Adenocarcinoma
BTBD1::MESP1	Adenocarcinoma
BTBD1::MRPL46	Squamous cell carcinoma
BTBD1::NTRK3	Astrocytoma, grade III-IV/Glioblastoma
BTBD2::AMZ2	Benign epithelial tumor, special type | Miscellaneous hematopoietic/lymphoid neoplasm, special type
BTBD2::BLTP1	Mesenchymal tumor, NOS
BTBD2::DOT1L	Adenocarcinoma
BTBD2::GTSE1	Malignant epithelial tumor, special type
BTBD2::ISG20L2	Adenocarcinoma
BTBD2::KLF16	Adenocarcinoma
BTBD2::LINGO3	Astrocytoma, grade I-II
BTBD2::MOB3A	Adenocarcinoma
BTBD2::NLRP11	Acute myeloid leukemia, NOS | Skin
BTBD2::OAS2	Astrocytoma, grade I-II
BTBD2::RALY	Adenocarcinoma
BTBD2::SBNO2	Adenocarcinoma
BTBD3::CCDC126	Adenocarcinoma
BTBD3::FAM221A	Adenocarcinoma
BTBD3::GCNT2	Adenocarcinoma
BTBD3::MACF1	Squamous cell carcinoma
BTBD7::GOLGA5	Multiple myeloma
BTBD7::RGS9	Adenocarcinoma
BTBD7::UBR7	Adenocarcinoma
BTBD9::ATAD1	Adenocarcinoma
BTBD9::CDC5L	Adenocarcinoma
BTBD9::CHSY1	Malignant melanoma
BTBD9::CLPSL1	Adenocarcinoma
BTBD9::DNAH8	Malignant melanoma
BTBD9::FARS2	Adenocarcinoma
BTBD9::GCLC	Mature B-cell neoplasm, NOS
BTBD9::LASP1	Adenocarcinoma
BTBD9::PLEKHB1	Squamous cell carcinoma
BTBD9::SUPT3H	Adenocarcinoma
BTBD9::TERT	Adenocarcinoma
BTC::ZBTB7B	Adenocarcinoma
BTF3L4::BRAF	Adenocarcinoma
BTF3L4::STMN1	Adenocarcinoma
BTG1::MYC	Chronic lymphocytic leukemia
BTG2::IGK	Multiple myeloma
BTN2A1::BRAF	Adenocarcinoma
BTN2A1::H2AC6	Adenocarcinoma
BTN2A1::H2BC4	Adenocarcinoma
BTN3A1::KMT2A	Acute monoblastic leukemia (FAB type M5)
BTN3A2::H2AC6	Adenocarcinoma
BTRC::CDH23	Adenocarcinoma
BTRC::HIF1AN	Adenocarcinoma
BTRC::IKZF3	Adenocarcinoma
BTRC::MICU1	Adenocarcinoma
BUB1B::ALK	Malignant epithelial tumor, special type
BUB1B::EIF2AK4	Adenocarcinoma
BUB1B::HSD17B6	Acute myeloblastic leukemia with maturation (FAB type M2)
BUB1B::PCM1	Squamous cell carcinoma
BUD13::APOA5	Adenocarcinoma
BUD13::ZW10	Acute myeloblastic leukemia with maturation (FAB type M2)
BUD23::LIMK1	Adenocarcinoma
BYSL::TFEB	Malignant epithelial tumor, special type
BZW1::WDR12	Adenocarcinoma
BZW2::ATP8A2	Adenocarcinoma
BZW2::CLCN3	Adenocarcinoma
BZW2::GAP43	Adenocarcinoma
BZW2::GUSB	Acute myeloid leukemia, NOS | Skin
BZW2::IMMP2L	Adenocarcinoma
BZW2::KLHL7	Adenocarcinoma
BZW2::RRM1	Adenocarcinoma
C10ORF88::PLPP4	Malignant melanoma
C10ORF90::ADAM12	Malignant melanoma
C10orf88::PLPP4	Malignant melanoma
C11ORF52::CFAP68	Adenocarcinoma
C11ORF68::DRAP1	Squamous cell carcinoma
C11orf65::POGLUT3	Adenocarcinoma
C12ORF4::CD9	Undifferentiated carcinoma, small cell
C12ORF56::RXYLT1	Transitional cell carcinoma
C12ORF76::IFT81	Malignant melanoma
C12orf56::APPL2	Mesenchymal tumor, NOS
C12orf76::IFT81	Malignant melanoma
C14ORF93::TIMM9	Transitional cell carcinoma
C14orf93::TIMM9	Transitional cell carcinoma
C16ORF46::RBPJ	Adenocarcinoma
C16ORF74::ATAD1	Adenocarcinoma
C16ORF74::EMC8	Squamous cell carcinoma
C16ORF87::ATXN2	Adenocarcinoma
C16ORF95::GABRA3	Adenocarcinoma
C16orf74::ATAD1	Adenocarcinoma
C16orf74::EMC8	Squamous cell carcinoma
C16orf87::ATXN2	Adenocarcinoma
C16orf87::CNOT1	Adenocarcinoma
C17ORF67::CUEDC1	Squamous cell carcinoma
C17ORF75::TOP2A	Adenocarcinoma
C17orf67::CUEDC1	Squamous cell carcinoma
C17orf75::TOP2A	Adenocarcinoma
C17orf75::ZNF207	Squamous cell carcinoma
C19ORF12::ADK	Adenocarcinoma
C19ORF12::GLYATL2	Adenocarcinoma
C19ORF12::ZNF749	Squamous cell carcinoma
C19ORF25::APC2	Adenocarcinoma
C19ORF25::MED1	Adenocarcinoma
C19ORF25::PEPD	Mesothelioma
C19ORF38::DNM2	Adenocarcinoma
C19ORF47::BLVRB	Adenocarcinoma
C19ORF47::MAP3K10	Squamous cell carcinoma
C19ORF47::NUMBL	Adenocarcinoma
C19ORF47::SCN1B	Adenocarcinoma
C19orf25::CACNA1C	Adenocarcinoma
C19orf25::MED1	Adenocarcinoma
C19orf25::PEPD	Mesothelioma
C19orf25::REEP6	Germ cell tumor, NOS
C1ORF116::LIN9	Transitional cell carcinoma
C1ORF159::ATAD3C	Malignant melanoma
C1ORF174::RAD18	Squamous cell carcinoma
C1ORF174::SNAP47	Adenocarcinoma
C1ORF185::RNF11	Astrocytoma, grade III-IV/Glioblastoma
C1ORF198::GXYLT2	Adenocarcinoma
C1ORF21::LAMC1	Squamous cell carcinoma
C1ORF87::FGGY	Malignant melanoma
C1QA::CD74	Adenocarcinoma
C1QC::ARID1A	Adenocarcinoma
C1QL1::SLC16A5	Squamous cell carcinoma
C1QTNF3::CLPTM1L	Adenocarcinoma
C1QTNF6::RAC2	Mesenchymal tumor, NOS
C1QTNF6::SYN3	Transitional cell carcinoma
C1R::COL6A1	Mesothelioma
C1S::CD4	Squamous cell carcinoma
C1S::NXPH4	Adenocarcinoma
C1S::P3H3	Germ cell tumor, NOS
C1S::PTPRO	Squamous cell carcinoma
C1orf116::LIN9	Transitional cell carcinoma
C1orf159::SDF4	Adenocarcinoma
C1orf174::SNAP47	Adenocarcinoma
C1orf198::GXYLT2	Adenocarcinoma
C1orf21::ANGPTL1	Mesenchymal tumor, NOS
C1orf21::INTS7	Mesenchymal tumor, NOS
C1orf21::LAMC1	Squamous cell carcinoma
C1orf87::FGGY	Malignant melanoma
C20ORF203::NOL4L	Skin | Acute myeloid leukemia, NOS
C21ORF58::IFNGR2	Adenocarcinoma
C21orf91::COLGALT2	Mesenchymal tumor, NOS
C22ORF39::ADAM2	Adenocarcinoma
C22ORF39::CABIN1	Adenocarcinoma
C22ORF39::GNB1L	Adenocarcinoma
C22ORF39::ZBTB16	Astrocytoma, grade I-II
C2CD2::APP	Transitional cell carcinoma
C2CD2::CORO2B	Astrocytoma, grade III-IV/Glioblastoma
C2CD2::MID2	Adenocarcinoma
C2CD2::SH3BGRL	Malignant epithelial tumor, special type
C2CD2::TFF1	Adenocarcinoma
C2CD2::ZBTB21	Adenocarcinoma
C2CD2L::DDX10	Skin | Acute myeloid leukemia, NOS
C2CD3::ABCA13	Adenocarcinoma
C2CD3::COA4	Adenocarcinoma
C2CD3::MYEOV	Transitional cell carcinoma
C2CD3::NCAM1	Adenocarcinoma
C2CD3::P2RY6	Adenocarcinoma
C2CD3::PC	Malignant melanoma
C2CD3::RNF169	Adenocarcinoma
C2CD3::SYTL1	Adenocarcinoma
C2CD3::TENM4	Adenocarcinoma
C2CD3::VPS37C	Adenocarcinoma
C2CD3::XRRA1	Adenocarcinoma
C2CD5::BCAT1	Adenocarcinoma
C2CD5::CMAS	Squamous cell carcinoma
C2CD5::IAPP	Adenocarcinoma
C2CD5::ITPR2	Adenocarcinoma
C2CD5::KLRK1	Acute myeloid leukemia, NOS | Skin
C2CD5::LGALS9B	Adenocarcinoma
C2CD5::PLCZ1	Adenocarcinoma
C2CD5::SOX5	Adenocarcinoma
C2CD5::ST8SIA1	Adenocarcinoma
C2ORF42::ACTR2	Adenocarcinoma
C2ORF42::ALK	Melanocytic neoplasm, special type
C2ORF42::BCL11A	Adenocarcinoma
C2ORF42::FAM136A	Squamous cell carcinoma
C2ORF42::MRPL33	Astrocytoma, grade I-II
C2ORF42::TGFA	Adenocarcinoma
C2ORF76::ANKRD46	Adenocarcinoma
C2ORF76::MARCO	Adenocarcinoma
C2orf15::TSGA10	Malignant epithelial tumor, special type
C2orf76::ACOXL	Squamous cell carcinoma
C2orf76::ANKRD46	Adenocarcinoma
C3::ABCF1	Adenocarcinoma
C3::DDX21	Adenocarcinoma
C3::ELK3	Adenocarcinoma
C3::EXO5	Transitional cell carcinoma
C3::HP	Adenocarcinoma
C3::MFN1	Adenocarcinoma
C3::RABEP1	Astrocytoma, grade I-II
C3::RFX2	Adenocarcinoma
C3::SEC63	Malignant epithelial tumor, special type
C3::SH2D3A	Adenocarcinoma
C3::SHANK3	Adenocarcinoma
C3::SIAE	Adenocarcinoma
C3::SUPT16H	Squamous cell carcinoma
C3::ZNF556	Adenocarcinoma
C3ORF33::PLCH1	Adenocarcinoma
C3ORF52::CD86	Squamous cell carcinoma
C3ORF52::ZBED2	Adenocarcinoma
C3ORF70::CLDN11	Astrocytoma, grade I-II
C3ORF70::LRRC15	Undifferentiated carcinoma, small cell
C3ORF70::TPRG1	Adenocarcinoma
C3orf52::CD86	Squamous cell carcinoma
C3orf52::GCSAM	Adenocarcinoma
C3orf70::TPRG1	Adenocarcinoma
C4A::SAPCD1	Adenocarcinoma
C4A::TNXB	Mesothelioma
C4B::DLK1	Adenocarcinoma
C4BPA::MAPKAPK2	Adenocarcinoma
C4ORF19::FAM114A1	Astrocytoma, grade I-II
C4ORF19::TBC1D1	Adenocarcinoma
C5::BRINP1	Adenocarcinoma
C5::RUVBL1	Adenocarcinoma
C5::SEMA4D	Adenocarcinoma
C6ORF132::GUCA1B	Transitional cell carcinoma
C6ORF132::TRERF1	Squamous cell carcinoma
C6ORF136::AKR1C1	Transitional cell carcinoma
C6ORF62::KIAA0319	Adenocarcinoma
C6ORF62::MRS2	Malignant melanoma
C6ORF62::RIPOR2	Squamous cell carcinoma
C6ORF62::TAF1B	Squamous cell carcinoma
C6orf132::GUCA1B	Transitional cell carcinoma
C6orf52::DST	Mesenchymal tumor, NOS
C6orf62::MRS2	Malignant melanoma
C6orf62::RIPOR2	Squamous cell carcinoma
C7ORF50::CD177	Adenocarcinoma
C7ORF50::INTS1	Adenocarcinoma
C7ORF57::SUGCT	Malignant melanoma
C7orf50::CD177	Adenocarcinoma
C7orf50::INTS1	Adenocarcinoma
C7orf50::MAD1L1	Malignant epithelial tumor, special type
C7orf50::MMD2	Adenocarcinoma
C7orf57::SUGCT	Malignant melanoma
C8B::PAH	Adenocarcinoma
C8ORF34::MET	Adenocarcinoma
C8ORF34::MYBL1	Astrocytoma, pilocytic/juvenile
C8ORF34::NFIB	Adenocarcinoma
C8ORF76::NKAIN3	Adenocarcinoma
C8orf34::MET	Adenocarcinoma
C8orf76::ATAD2	Adenocarcinoma
C8orf76::NKAIN3	Adenocarcinoma
C9::CERT1	Adenocarcinoma
C9ORF85::C9ORF57	Adenocarcinoma
C9ORF85::FXN	Malignant melanoma
C9orf85::C9orf57	Adenocarcinoma
CA10::ODAD4	Adenocarcinoma
CA13::E2F5	Squamous cell carcinoma
CA13::NDUFS5	Adenocarcinoma
CA13::RBKS	Adenocarcinoma
CA3::MYBL1	Adenocarcinoma
CA7::USP22	Acute myeloblastic leukemia with maturation (FAB type M2)
CAAP1::IFT74	Adenocarcinoma
CAAP1::RTL5	Astrocytoma, grade I-II
CAAP1::TNNI3K	Adenocarcinoma
CAB39::C5ORF15	Mycosis fungoides/Sézary syndrome
CAB39::GBF1	Adenocarcinoma
CAB39::PSMD1	Adenocarcinoma
CAB39::RHBDD1	Mesenchymal tumor, NOS
CAB39L::CPQ	Transitional cell carcinoma
CAB39L::EXOSC8	Adenocarcinoma
CAB39L::FNDC3A	Adenocarcinoma
CAB39L::SETDB2	Adenocarcinoma
CAB39L::USP12	Adenocarcinoma
CABIN1::GRIN2A	Transitional cell carcinoma
CABIN1::GSTT2	Malignant melanoma
CABIN1::LRRC41	Malignant melanoma
CABIN1::POLR2F	Malignant melanoma
CABIN1::SLC2A11	Malignant epithelial tumor, special type
CABIN1::SMARCB1	Adenocarcinoma
CABIN1::TRAPPC10	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CABLES1::FTO	Adenocarcinoma
CABLES1::MYO5B	Adenocarcinoma
CABLES1::RBBP8	Adenocarcinoma
CABLES1::TTC39C	Adenocarcinoma
CABP7::NF2	Mesothelioma
CABYR::OSBPL1A	Transitional cell carcinoma
CACHD1::CLIC4	Adenocarcinoma
CACHD1::RNF2	Adenocarcinoma
CACHD1::ROR1	Adenocarcinoma
CACHD1::USP32	Mesenchymal tumor, NOS
CACNA1A::GATAD2A	Skin | Acute myeloid leukemia, NOS
CACNA1A::VSTM2B	Astrocytoma, grade III-IV/Glioblastoma
CACNA1A::ZNF44	Adenocarcinoma
CACNA1C::CLEC2A	Adenocarcinoma
CACNA1C::DDX55	Adenocarcinoma
CACNA1C::DERA	Malignant melanoma
CACNA1C::EEA1	Mesenchymal tumor, NOS
CACNA1C::PIAS4	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
CACNA1C::SLC6A15	Mesenchymal tumor, NOS
CACNA1C::TSPAN8	Mesenchymal tumor, NOS
CACNA1C::WNT5B	Adenocarcinoma
CACNA1C::WWP2	Adenocarcinoma
CACNA1D::DNAH1	Adenocarcinoma
CACNA1D::GNL3	Adenocarcinoma
CACNA1D::PRKCD	Adenocarcinoma
CACNA1G::MED24	Adenocarcinoma
CACNA1G::PRAC2	Adenocarcinoma
CACNA1I::FBXW5	Transitional cell carcinoma
CACNA1I::SYNGR1	Transitional cell carcinoma
CACNA1I::TAB1	Adenocarcinoma
CACNA2D1::CDK14	Squamous cell carcinoma
CACNA2D1::HGF	Mesothelioma
CACNA2D1::NAALADL2	Squamous cell carcinoma
CACNA2D1::PTPN12	Mesenchymal tumor, NOS
CACNA2D2::THRSP	Malignant melanoma
CACNA2D3::DAP3	Adenocarcinoma
CACNA2D3::FLNB	Adenocarcinoma
CACNA2D3::FOXP1	Adenocarcinoma
CACNA2D3::IFT74	Adenocarcinoma
CACNA2D3::RAF1	Adenocarcinoma
CACNA2D3::SCAF11	Mesothelioma
CACNA2D3::SRP68	Adenocarcinoma
CACNA2D4::WDR43	Undifferentiated carcinoma, small cell
CACNB1::ARRB1	Adenocarcinoma
CACNB1::CDC6	Adenocarcinoma
CACNB1::EMSY	Adenocarcinoma
CACNB1::ERBB2	Adenocarcinoma
CACNB1::FBXL20	Adenocarcinoma
CACNB1::IGSF8	Adenocarcinoma
CACNB1::KRT222	Adenocarcinoma
CACNB1::KRT40	Adenocarcinoma
CACNB1::LASP1	Adenocarcinoma
CACNB1::MLLT6	Adenocarcinoma
CACNB1::PPP4C	Adenocarcinoma
CACNB1::RPL19	Adenocarcinoma
CACNB1::TANC2	Adenocarcinoma
CACNB4::YWHAZ	Malignant epithelial tumor, special type
CACNG4::BPTF	Adenocarcinoma
CACNG4::VMP1	Adenocarcinoma
CACNG5::PRKCA	Adenocarcinoma
CACNG6::ZNF320	Diffuse large B-cell lymphoma
CACTIN::MITF	Melanocytic neoplasm, special type
CACUL1::EIF3A	Adenocarcinoma
CACUL1::EIF6	Adenocarcinoma
CACUL1::IL1RN	Adenocarcinoma
CACUL1::VTI1A	Adenocarcinoma
CACYBP::NTRK1	Malignant peripheral nerve sheath tumor/Triton
CAD::ALK	Adenocarcinoma
CADM1::ARCN1	Adenocarcinoma
CADM1::SORL1	Adenocarcinoma
CADM2::FHIT	Adenocarcinoma
CADM2::ROBO1	Adenocarcinoma
CADM2::UBE2E2	Adenocarcinoma
CADM4::SMG9	Adenocarcinoma
CADM4::ZSCAN18	Squamous cell carcinoma
CADPS2::ATP23	Mesenchymal tumor, NOS
CADPS2::DHCR7	Adenocarcinoma
CADPS2::DNAH11	Adenocarcinoma
CADPS2::LMOD2	Adenocarcinoma
CADPS2::RPGR	Squamous cell carcinoma
CADPS::FHIT	Adenocarcinoma
CADPS::TAFA1	Malignant melanoma
CALCA::SFTPB	Adenocarcinoma
CALCB::INSC	Adenocarcinoma | Transitional cell carcinoma
CALCOCO1::TAFA2	Mesenchymal tumor, NOS
CALCOCO2::ANKRD13A	Adenocarcinoma
CALCOCO2::ARSG	Adenocarcinoma
CALCOCO2::RCOR2	Adenocarcinoma
CALCOCO2::WRAP53	Mesenchymal tumor, NOS
CALD1::ADAM22	Astrocytoma, grade III-IV/Glioblastoma
CALD1::AKR1B10	Malignant melanoma | Adenocarcinoma
CALD1::AKR1B15	Squamous cell carcinoma
CALD1::CGN	Adenocarcinoma
CALD1::EXOC4	Transitional cell carcinoma
CALD1::LRGUK	Adenocarcinoma
CALD1::SLC41A1	Malignant melanoma
CALD1::THSD4	Mesenchymal tumor, NOS
CALD1::TMEM140	Squamous cell carcinoma
CALD1::USP6	Nodular fasciitis
CALHM2::CALHM1	Adenocarcinoma
CALM1::BCL2L11	Multiple myeloma
CALM1::KIF3A	Astrocytoma, grade I-II
CALM1::UTRN	Astrocytoma, grade I-II
CALM2::TTC7A	Mesenchymal tumor, NOS
CALM3::CCDC9	Astrocytoma, grade I-II
CALM3::CHRNA4	Malignant melanoma
CALML3::ANKS1A	Transitional cell carcinoma
CALML4::ITGA11	Adenocarcinoma
CALR3::PLCB1	Mesenchymal tumor, NOS
CALR3::ZNF99	Adenocarcinoma
CALR3::ZSCAN18	Adenocarcinoma
CALR::ACACA	Adenocarcinoma
CALR::BRD2	Adenocarcinoma
CALR::PLEKHB2	Adenocarcinoma
CALR::TNNT1	Adenocarcinoma
CALR::ZNF799	Squamous cell carcinoma
CALU::LAP3	Adenocarcinoma
CALU::USP6	Nodular fasciitis
CAMK1D::ARL3	Adenocarcinoma
CAMK1D::BNIP3L	Adenocarcinoma
CAMK1D::ECHDC3	Adenocarcinoma
CAMK1D::FRMD4A	Adenocarcinoma
CAMK1D::MINDY3	Adenocarcinoma
CAMK1D::PROSER2	Adenocarcinoma
CAMK1D::TSPAN18	Adenocarcinoma
CAMK2A::CD74	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CAMK2B::SLC25A17	Adenocarcinoma
CAMK2B::SPIDR	Adenocarcinoma
CAMK2D::ANK2	Astrocytoma, grade I-II | Squamous cell carcinoma
CAMK2D::ERMAP	Malignant epithelial tumor, special type
CAMK2D::STAC3	Adenocarcinoma
CAMK2D::TLL2	Adenocarcinoma
CAMK2G::AGAP5	Adenocarcinoma
CAMK2G::DDX1	Adenocarcinoma
CAMK2G::EEIG1	Adenocarcinoma
CAMK2G::MYOZ1	Malignant epithelial tumor, special type
CAMK2G::NDUFA13	Adenocarcinoma
CAMK4::DENND1A	Adenocarcinoma
CAMKK1::ITGAE	Squamous cell carcinoma
CAMKK2::ANAPC5	Adenocarcinoma
CAMKK2::DIP2B	Mesenchymal tumor, NOS
CAMKK2::HPD	Adenocarcinoma
CAMKK2::KDM2B	Skin | Acute myeloid leukemia, NOS | Adenocarcinoma
CAMKK2::NR2C1	Astrocytoma, grade III-IV/Glioblastoma
CAMKK2::PRKRIP1	Adenocarcinoma
CAMKMT::ALK	Adenocarcinoma
CAMLG::AUTS2	Adenocarcinoma
CAMSAP1::ENTR1	Squamous cell carcinoma
CAMSAP1::KCNT1	Adenocarcinoma
CAMSAP1::LCN8	Mesenchymal tumor, NOS
CAMSAP1::RABL6	Transitional cell carcinoma
CAMSAP1::STAU2	Mesenchymal tumor, NOS
CAMSAP1::UBAC1	Squamous cell carcinoma
CAMSAP2::BCAR3	Adenocarcinoma
CAMSAP2::CARS1	Squamous cell carcinoma
CAMSAP2::DHRS3	Adenocarcinoma
CAMSAP2::KCNH1	Squamous cell carcinoma
CAMTA1::AGBL4	Multiple myeloma
CAMTA1::DHRS3	Squamous cell carcinoma
CAMTA1::THAP3	Adenocarcinoma
CAMTA1::WWTR1	Myolipoma
CAMTA2::LCK	Adenocarcinoma
CAND1::CNOT2	Squamous cell carcinoma
CAND1::DYRK2	Malignant melanoma
CAND1::EGFR	Astrocytoma, grade III-IV/Glioblastoma
CAND1::IL22	Mesenchymal tumor, NOS
CAND1::PTPRR	Malignant melanoma
CAND1::TRARG1	Adenocarcinoma
CAND1::WDR38	Adenocarcinoma
CANT1::ETV4	Adenocarcinoma | Malignant melanoma
CANT1::FBXL20	Adenocarcinoma
CANT1::MROH1	Adenocarcinoma
CANT1::PPP3CA	Adenocarcinoma
CANT1::PSMD3	Adenocarcinoma
CANT1::SEPTIN9	Adenocarcinoma
CANX::CCT4	Squamous cell carcinoma
CANX::IL1R2	Squamous cell carcinoma
CANX::PLAT	Adenocarcinoma
CANX::RUFY1	Adenocarcinoma
CAP1::BMP8B	Undifferentiated carcinoma, small cell
CAP1::KCNQ4	Squamous cell carcinoma
CAP1::MACF1	Undifferentiated carcinoma, small cell | Malignant melanoma
CAP1::NARS2	Adenocarcinoma
CAP1::NFYC	Transitional cell carcinoma
CAP1::USP6	Fibroma of tendon sheath
CAPG::GGCX	Adenocarcinoma
CAPN10::TCF3	Acute myeloid leukemia, NOS | Skin
CAPN12::LGALS7	Adenocarcinoma
CAPN13::GALNT14	Squamous cell carcinoma | Adenocarcinoma
CAPN15::DECR2	Squamous cell carcinoma
CAPN15::MCRIP2	Adenocarcinoma
CAPN15::NME4	Squamous cell carcinoma
CAPN15::NSD3	Squamous cell carcinoma
CAPN15::PGAP6	Multiple myeloma
CAPN15::SHISA9	Multiple myeloma
CAPN15::UBE2I	Multiple myeloma
CAPN1::ARL2	Adenocarcinoma
CAPN1::EIF2AK2	Squamous cell carcinoma
CAPN1::GTF2IRD1	Adenocarcinoma
CAPN1::MRPL49	Squamous cell carcinoma
CAPN1::SPDYC	Adenocarcinoma
CAPN1::SUPT16H	Transitional cell carcinoma
CAPN1::TNKS1BP1	Transitional cell carcinoma
CAPN2::BROX	Adenocarcinoma
CAPN2::SH2D1B	Malignant melanoma
CAPN2::SMARCA1	Adenocarcinoma
CAPN3::SSU72	Malignant melanoma
CAPN5::EPB41L1	Adenocarcinoma
CAPN5::HSD17B14	Adenocarcinoma
CAPN5::PELI3	Adenocarcinoma
CAPN5::XRRA1	Malignant melanoma
CAPN6::DCX	Adenocarcinoma
CAPN8::HHAT	Adenocarcinoma
CAPNS1::ARHGEF26	Adenocarcinoma
CAPNS1::CCDC149	Adenocarcinoma
CAPNS1::CHD1	Adenocarcinoma
CAPNS1::GLUL	Adenocarcinoma
CAPNS1::MAG	Adenocarcinoma
CAPNS1::MTA2	Adenocarcinoma
CAPNS1::TBCB	Adenocarcinoma
CAPNS1::UPK1A	Adenocarcinoma
CAPNS1::WDR62	Adenocarcinoma
CAPRIN1::CAT	Adenocarcinoma
CAPRIN1::CD151	Adenocarcinoma
CAPRIN1::COMMD9	Adenocarcinoma
CAPRIN1::PDGFRB	Chronic myeloproliferative disorder, NOS | Chronic eosinophilic leukemia/hypereosinophilic syndrome
CAPRIN1::ROS1	Melanocytic neoplasm, special type
CAPRIN1::SPINDOC	Astrocytoma, grade I-II
CAPRIN1::THOC1	Adenocarcinoma
CAPRIN1::TRIM44	Adenocarcinoma
CAPRIN2::AMN1	Adenocarcinoma
CAPRIN2::R3HDM2	Malignant melanoma
CAPRIN2::ST8SIA1	Adenocarcinoma
CAPS2::GLIPR1	Adenocarcinoma
CAPS2::GRID1	Adenocarcinoma
CAPS2::KCNC2	Squamous cell carcinoma
CAPS2::YEATS4	Transitional cell carcinoma
CAPZA1::CTTNBP2NL	Adenocarcinoma
CAPZA1::MIER1	Squamous cell carcinoma
CAPZA2::ABCB1	Adenocarcinoma
CAPZA2::BRAF	Astrocytoma, grade I-II
CAPZA2::C7ORF33	Adenocarcinoma
CAPZA2::CADPS2	Mature B-cell neoplasm, NOS
CAPZA2::CMSS1	Adenocarcinoma
CAPZA2::MET	Adenocarcinoma | Astrocytoma, grade III-IV/Glioblastoma
CAPZA2::STYXL1	Adenocarcinoma
CAPZA2::TRIM28	Diffuse large B-cell lymphoma
CAPZB::AKR7A3	Adenocarcinoma
CAPZB::C2ORF88	Adenocarcinoma
CAPZB::CENPS	Adenocarcinoma
CAPZB::CFL1	Adenocarcinoma
CAPZB::EMC1	Adenocarcinoma
CAPZB::MUC22	Adenocarcinoma
CAPZB::OTUD3	Adenocarcinoma
CAPZB::SCEL	Adenocarcinoma
CAPZB::TMCO4	Malignant epithelial tumor, special type | Multiple myeloma | Adenocarcinoma
CAPZB::UBR4	Astrocytoma, grade III-IV/Glioblastoma
CARD10::LGALS2	Adenocarcinoma
CARD10::POLR2F	Adenocarcinoma
CARD11::PIK3R3	Mycosis fungoides/Sézary syndrome
CARD11::POLR1H	Adenocarcinoma
CARD19::ECPAS	Adenocarcinoma
CARD19::TMOD1	Adenocarcinoma
CARD8::BCKDHA	Adenocarcinoma
CARD8::MYH14	Adenocarcinoma
CARD8::POLR3H	Malignant melanoma
CARD8::SULT2B1	Astrocytoma, grade III-IV/Glioblastoma
CARM1::C19ORF38	Adenocarcinoma
CARM1::C19orf38	Adenocarcinoma
CARM1::CASP14	Adenocarcinoma
CARM1::KLF11	Adenocarcinoma
CARM1::OLFM2	Squamous cell carcinoma
CARM1::PLA2G4C	Adenocarcinoma
CARM1::SMARCA4	Adenocarcinoma
CARM1::ZBTB32	Adenocarcinoma
CARMIL1::CDKAL1	Adenocarcinoma
CARMIL1::CTSW	Transitional cell carcinoma
CARMIL1::DCDC2	Mesothelioma
CARMIL1::LRRC1	Adenocarcinoma
CARMIL1::MEIS2	Adenocarcinoma
CARMIL1::MRS2	Adenocarcinoma
CARMIL1::SLC17A1	Adenocarcinoma
CARNMT1::KIF21A	Mesenchymal tumor, NOS
CARS1::ALK	Benign fibrous histiocytoma | Inflammatory myofibroblastic tumor/myofibroblastic sarcoma
CARS1::OSBPL5	Squamous cell carcinoma
CARS1::SLC22A18AS	Adenocarcinoma
CARS1::TSHZ3	Mesenchymal tumor, NOS
CARS2::ATP11A	Adenocarcinoma
CARTPT::MCCC2	Adenocarcinoma
CASC3::ACLY	Adenocarcinoma
CASC3::ADCY2	Squamous cell carcinoma
CASC3::CDK12	Adenocarcinoma
CASC3::CEP112	Adenocarcinoma
CASC3::ERBB2	Adenocarcinoma | Squamous cell carcinoma
CASC3::FCHSD2	Adenocarcinoma
CASC3::HNF1B	Mesenchymal tumor, NOS
CASC3::MED1	Adenocarcinoma
CASC3::MED24	Adenocarcinoma
CASC3::PPP1R1B	Multiple myeloma
CASC3::RGS9	Adenocarcinoma
CASC3::SIPA1L3	Transitional cell carcinoma
CASC3::THRA	Adenocarcinoma
CASC3::WIPF2	Adenocarcinoma
CASC3::ZNF254	Adenocarcinoma
CASD1::VWC2	Astrocytoma, grade III-IV/Glioblastoma
CASK::ERMARD	Adenocarcinoma
CASK::EYA2	Adenocarcinoma
CASK::GLIPR1L1	Adenocarcinoma
CASKIN2::PDE2A	Adenocarcinoma
CASKIN2::QRICH2	Adenocarcinoma
CASP10::CFLAR	Adenocarcinoma
CASP1::TTC6	Squamous cell carcinoma
CASP7::EDRF1	Adenocarcinoma
CASP7::LRRC27	Adenocarcinoma
CASP7::TRUB1	Adenocarcinoma
CASP7::UQCRB	Adenocarcinoma
CASP7::VTI1A	Adenocarcinoma
CASP8::CFLAR	Malignant melanoma
CASP8::FLACC1	Adenocarcinoma
CASP8::NRP2	Adenocarcinoma
CASP8::STRADB	Squamous cell carcinoma | Adenocarcinoma
CASP8::TTLL7	Squamous cell carcinoma
CASP8::UBR3	Adenocarcinoma
CASP8::VMP1	Adenocarcinoma
CASP8AP2::HACE1	Adenocarcinoma
CASS4::CAPS2	Adenocarcinoma
CAST::ARB2A	Adenocarcinoma
CAST::CDHR3	Adenocarcinoma
CAST::MCTP1	Adenocarcinoma
CAST::PLCH1	Adenocarcinoma
CAST::TAFA1	Adenocarcinoma
CASTOR2::GTF2IRD1	Astrocytoma, grade III-IV/Glioblastoma | Adenocarcinoma
CASZ1::AGTRAP	Astrocytoma, grade I-II
CASZ1::ALG14	Adenocarcinoma
CASZ1::C1ORF127	Adenocarcinoma
CASZ1::DFFA	Transitional cell carcinoma
CASZ1::EXOSC10	Adenocarcinoma
CASZ1::FBXO2	Adenocarcinoma
CASZ1::MASP2	Adenocarcinoma
CASZ1::MTOR	Adenocarcinoma
CASZ1::PRKD2	Adenocarcinoma
CASZ1::SLC9A1	Adenocarcinoma
CASZ1::SPSB1	Adenocarcinoma
CASZ1::SRM	Adenocarcinoma
CAT::CD3D	Adenocarcinoma
CAT::POLDIP3	Mature B-cell neoplasm, NOS
CAT::TRIM44	Malignant melanoma
CATSPERB::ATXN3	Adenocarcinoma
CATSPERB::FBLN5	Adenocarcinoma
CATSPERB::SPTB	Adenocarcinoma
CATSPERB::TC2N	Adenocarcinoma
CATSPERB::TRIP11	Adenocarcinoma
CATSPERG::RASSF1	Mesothelioma
CAV1::MET	Spindle cell/sclerosing rhabdomyosarcoma | Undifferentiated carcinoma, small cell
CAV2::TES	Squamous cell carcinoma
CAVIN1::HEATR6	Adenocarcinoma
CBARP::SBNO2	Carcinoma, NOS
CBFA2T2::ACOX1	Adenocarcinoma
CBFA2T2::BCL2L1	Mesenchymal tumor, NOS
CBFA2T2::CAMP	Adenocarcinoma
CBFA2T2::COMMD7	Adenocarcinoma
CBFA2T2::DCTN3	Adenocarcinoma
CBFA2T2::DOK5	Adenocarcinoma
CBFA2T2::HM13	Squamous cell carcinoma
CBFA2T2::REM1	Squamous cell carcinoma
CBFA2T2::SNTA1	Mesenchymal tumor, NOS
CBFA2T2::TOX2	Adenocarcinoma
CBFA2T3::ACSF3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CBFA2T3::GALNS	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CBFA2T3::GLIS2	Acute monoblastic leukemia (FAB type M5) | Acute myeloblastic leukemia with minimal differentiation (FAB type M0) | Acute myeloblastic leukemia without maturation (FAB type M1) | Acute megakaryoblastic leukemia (FAB type M7) | Acute monoblastic leukemia without differentiation (FAB type M5a) | Acute myeloblastic leukemia with maturation (FAB type M2) | Skin | Acute myelomonocytic leukemia (FAB type M4) | Acute myeloid leukemia, NOS
CBFA2T3::IGH	Multiple myeloma | Chronic lymphocytic leukemia
CBFB::ATP13A3	Squamous cell carcinoma
CBFB::CA7	Adenocarcinoma
CBFB::CES4A	Adenocarcinoma | Squamous cell carcinoma
CBFB::COG4	Astrocytoma, grade I-II
CBFB::GSE1	Adenocarcinoma
CBFB::HMGB1	Acute myeloblastic leukemia with maturation (FAB type M2)
CBFB::MYH11	Acute monoblastic leukemia without differentiation (FAB type M5a) | Acute monoblastic leukemia with differentiation (FAB type M5b) | Acute myeloblastic leukemia without maturation (FAB type M1) | Chronic myeloid leukemia, t(9;22) | Acute myeloblastic leukemia with minimal differentiation (FAB type M0) | Refractory anemia | Acute monoblastic leukemia (FAB type M5) | Myelodysplastic syndrome, NOS | Acute megakaryoblastic leukemia (FAB type M7) | Refractory anemia with excess of blasts (FAB) | Acute myeloblastic leukemia with maturation (FAB type M2) | Refractory anemia with ringed sideroblasts | Heart | Nonneoplastic hematologic disorder/lesion | Acute myeloid leukemia, NOS | Acute myelomonocytic leukemia (FAB type M4) | Skin
CBFB::NAE1	Adenocarcinoma
CBFB::NUTF2	Adenocarcinoma
CBFB::PLEKHG4	Adenocarcinoma
CBFB::PPP1R7	Acute myeloid leukemia, NOS | Skin
CBFB::TIGD7	Adenocarcinoma
CBL::CLNS1A	Adenocarcinoma
CBL::CXCR5	Adenocarcinoma
CBL::DDX6	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
CBL::KANK1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CBL::KMT2A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CBL::NHERF4	Adenocarcinoma
CBL::PHLDB1	Adenocarcinoma
CBL::SC5D	Adenocarcinoma
CBL::TRAPPC4	Adenocarcinoma
CBL::UBE4A	Adenocarcinoma
CBL::USP8	Superficial fibromatosis
CBL::VWA5A	Adenocarcinoma
CBLB::BCL6	Mature B-cell neoplasm, NOS
CBLB::CIP2A	Adenocarcinoma
CBLB::IL17RE	Adenocarcinoma
CBLC::PPP1R13L	Adenocarcinoma
CBLC::PVR	Squamous cell carcinoma
CBLL1::SLC26A4	Adenocarcinoma
CBR4::ERBB4	Adenocarcinoma
CBR4::GALNTL6	Malignant melanoma
CBX1::DHX40	Adenocarcinoma
CBX1::HOXB8	Squamous cell carcinoma
CBX1::SKAP1	Adenocarcinoma
CBX1::SSH2	Adenocarcinoma
CBX3::CCDC32	Adenocarcinoma
CBX3::CDK14	Transitional cell carcinoma
CBX3::GARS1	Adenocarcinoma
CBX4::EFCAB5	Adenocarcinoma
CBX4::RFK	Adenocarcinoma
CBX5::GTSF1	Adenocarcinoma
CBX5::HNRNPA1	Adenocarcinoma
CBX5::NFE2	Squamous cell carcinoma | Adenocarcinoma
CBX5::SMUG1	Adenocarcinoma
CBX5::TXNRD2	Adenocarcinoma
CBX5::WDTC1	Adenocarcinoma
CBX6::KMT2A::PYGO1	Soft tissue tumor, special type
CBX7::VPREB1	Squamous cell carcinoma
CBX8::ACTL6A	Adenocarcinoma
CBY1::GTPBP1	Adenocarcinoma
CC2D1A::BRME1	Adenocarcinoma
CC2D1A::CPNE8	Adenocarcinoma
CC2D1A::HCRT	Adenocarcinoma
CC2D1A::MRI1	Adenocarcinoma
CC2D1A::RLN3	Adenocarcinoma
CC2D1A::RNF207	Adenocarcinoma
CC2D1A::RRBP1	Transitional cell carcinoma
CC2D1A::ST3GAL4	Adenocarcinoma
CC2D1A::ZMYND8	Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
CC2D1A::ZSWIM4	Embryonal nervous system tumor, special type | Adenocarcinoma | Malignant epithelial tumor, special type
CC2D2A::BST1	Adenocarcinoma
CCAR1::HNRNPH3	Adenocarcinoma
CCAR1::MCU	Adenocarcinoma
CCAR1::TET1	Adenocarcinoma
CCAR2::FGFR2	Squamous cell carcinoma
CCAR2::NRG1	Carcinoma, NOS
CCAR2::PDLIM2	Adenocarcinoma
CCAR2::PPP3CC	Squamous cell carcinoma | Adenocarcinoma
CCAR2::SORBS3	Adenocarcinoma
CCBE1::RET	Carcinoma, NOS
CCBE1::SKAP1	Adenocarcinoma
CCDC102A::CNGB1	Adenocarcinoma
CCDC102B::AHCTF1	Malignant melanoma
CCDC106::CD37	Adenocarcinoma
CCDC112::EPB41L4A	Adenocarcinoma
CCDC113::CPNE2	Squamous cell carcinoma
CCDC117::CPB1	Adenocarcinoma
CCDC117::OSTF1	Adenocarcinoma
CCDC117::TNNI2	Adenocarcinoma
CCDC120::ERAS	Adenocarcinoma
CCDC122::LHFPL6	Adenocarcinoma
CCDC122::VPS36	Diffuse large B-cell lymphoma
CCDC124::COL28A1	Adenocarcinoma
CCDC126::BTBD3	Adenocarcinoma
CCDC126::OSBPL3	Adenocarcinoma
CCDC127::MUCL1	Mesenchymal tumor, NOS
CCDC127::SDHA	Astrocytoma, grade I-II | Squamous cell carcinoma
CCDC127::TERT	Astrocytoma, grade III-IV/Glioblastoma
CCDC12::KIF9	Mature B-cell neoplasm, NOS
CCDC12::SLC38A3	Astrocytoma, grade I-II
CCDC134::MEI1	Adenocarcinoma
CCDC138::GFRAL	Adenocarcinoma
CCDC142::M1AP	Squamous cell carcinoma
CCDC144A::PPM1E	Adenocarcinoma
CCDC148::ACTR3	Squamous cell carcinoma
CCDC148::DAPL1	Squamous cell carcinoma
CCDC148::GCG	Adenocarcinoma
CCDC148::WDSUB1	Adenocarcinoma
CCDC149::ALK	Adenocarcinoma
CCDC149::AOPEP	Adenocarcinoma
CCDC149::ARAP2	Adenocarcinoma
CCDC149::GABRB1	Adenocarcinoma
CCDC149::RBPJ	Astrocytoma, grade I-II
CCDC14::ADAM19	Adenocarcinoma
CCDC14::HADHB	Transitional cell carcinoma
CCDC14::RNF212B	Mesenchymal tumor, NOS
CCDC152::CYP2E1	Adenocarcinoma
CCDC152::HP	Adenocarcinoma
CCDC157::COL21A1	Adenocarcinoma
CCDC157::EWSR1	Malignant epithelial tumor, special type
CCDC158::MSRB3	Adenocarcinoma
CCDC167::RRP7A	Malignant melanoma
CCDC171::CNTLN	Adenocarcinoma
CCDC174::ECHDC1	Adenocarcinoma
CCDC180::NDUFA8	Adenocarcinoma
CCDC186::DCLRE1A	Adenocarcinoma
CCDC186::GFRA1	Squamous cell carcinoma
CCDC186::RET	Carcinoma, NOS | Adenocarcinoma
CCDC187::INPP5E	Adenocarcinoma
CCDC22::KRBOX4	Adenocarcinoma
CCDC24::ST3GAL3	Squamous cell carcinoma
CCDC25::PLEKHG4B	Mesenchymal tumor, NOS
CCDC28A::CLEC16A	Adenocarcinoma
CCDC28A::WASF2	Adenocarcinoma
CCDC30::ERMAP	Malignant melanoma
CCDC32::CBX3	Multiple myeloma | Adenocarcinoma | Ependymoma | Astrocytoma, grade III-IV/Glioblastoma | Mycosis fungoides/Sézary syndrome | Russia | Embryonal rhabdomyosarcoma | Osteosarcoma, NOS | Malignant peripheral nerve sheath tumor/Triton | Soft tissue tumor, special type | Primitive neuroectodermal tumor/Medulloblastoma | Gonadal stromal cell tumors | Astrocytoma, grade I-II | Alveolar rhabdomyosarcoma | Ewing sarcoma
CCDC33::RCN2	Malignant melanoma
CCDC39::MCF2L2	Squamous cell carcinoma
CCDC39::PECR	Mesenchymal tumor, NOS
CCDC3::FXYD1	Adenocarcinoma
CCDC40::ANAPC11	Adenocarcinoma
CCDC40::PRKG1	Mesenchymal tumor, NOS
CCDC43::ATP11A	Adenocarcinoma
CCDC43::YBX2	Adenocarcinoma
CCDC47::GH1	Adenocarcinoma
CCDC47::TERT	Adenocarcinoma
CCDC47::USP37	Squamous cell carcinoma
CCDC50::LSAMP	Mesenchymal tumor, NOS
CCDC50::OSTN	Malignant melanoma
CCDC50::PEX5L	Adenocarcinoma
CCDC50::TBC1D5	Mesothelioma
CCDC57::AMOTL2	Carcinoma, NOS
CCDC57::ATPAF2	Mesenchymal tumor, NOS
CCDC57::CSNK1D	Adenocarcinoma
CCDC57::DIAPH2	Adenocarcinoma
CCDC57::FASN	Adenocarcinoma
CCDC57::NPLOC4	Adenocarcinoma
CCDC57::RAB40B	Adenocarcinoma
CCDC57::RBFOX3	Adenocarcinoma
CCDC57::SECTM1	Adenocarcinoma
CCDC61::ALK	Adenocarcinoma
CCDC61::CHST1	Astrocytoma, grade I-II
CCDC61::FUT2	Adenocarcinoma
CCDC61::PPP5C	Squamous cell carcinoma
CCDC62::KNTC1	Germ cell tumor, NOS
CCDC66::FLNB	Adenocarcinoma
CCDC6::ALK	Adenocarcinoma
CCDC6::ANK3	Adenocarcinoma
CCDC6::BRAF	Astrocytoma, grade III-IV/Glioblastoma
CCDC6::CASP7	Adenocarcinoma
CCDC6::CTNNA3	Undifferentiated carcinoma, small cell
CCDC6::LIPI	Adenocarcinoma
CCDC6::PCBD1	Astrocytoma, grade I-II
CCDC6::PDGFRB	Chronic myeloproliferative disorder, NOS | Atypical chronic myeloid leukemia | Chronic eosinophilic leukemia/hypereosinophilic syndrome | Spleen | Chronic myelomonocytic leukemia | Lymph node
CCDC6::RCC1	Adenocarcinoma
CCDC6::RET	Astrocytoma, grade III-IV/Glioblastoma | Malignant melanoma | Carcinoma, NOS | Adenocarcinoma | Soft tissue tumor, NOS | Benign epithelial tumor, special type | Adenoma | Nonneoplastic epithelial disorder/lesion | Adenosquamous carcinoma
CCDC6::ROS1	Adenocarcinoma
CCDC6::SLC16A9	Adenocarcinoma
CCDC6::UBE2D1	Adenocarcinoma
CCDC73::CAV1	Adenocarcinoma
CCDC73::SLC15A4	Mesenchymal tumor, NOS
CCDC7::CCDC7	Adenocarcinoma
CCDC7::UBE2D1	Undifferentiated carcinoma, small cell
CCDC80::ANKS1A	Adenocarcinoma
CCDC80::COL1A1	Adenocarcinoma
CCDC82::MTMR2	Adenocarcinoma
CCDC85A::ALK	Adenocarcinoma
CCDC85A::EYA2	Adenocarcinoma
CCDC85C::PUM3	Multiple myeloma
CCDC85C::SETD3	Adenocarcinoma
CCDC85C::TDP1	Adenocarcinoma
CCDC88A::ALK	Ependymoma
CCDC88B::AKR1C1	Squamous cell carcinoma
CCDC88B::CATSPERZ	Squamous cell carcinoma
CCDC88B::RELT	Squamous cell carcinoma
CCDC88C::DGLUCY	Transitional cell carcinoma
CCDC88C::FLT3	Egypt | Bilineage or biphenotypic leukemia | Juvenile myelomonocytic leukemia
CCDC88C::JAK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CCDC88C::PDGFRB	Chronic eosinophilic leukemia/hypereosinophilic syndrome | Thymus | Chronic myeloproliferative disorder, NOS | Myelodysplastic/myeloproliferative disease, NOS | Mature T- and NK-cell neoplasm, special type
CCDC88C::PPP4R3A	Adenocarcinoma
CCDC88C::RASGEF1B	Squamous cell carcinoma
CCDC88C::RET	Carcinoma, NOS
CCDC88C::SUSD6	Transitional cell carcinoma
CCDC90B::CLPB	Adenocarcinoma
CCDC90B::DLG2	Malignant melanoma
CCDC90B::PLXDC1	Adenocarcinoma
CCDC91::AEBP2	Germ cell tumor, NOS
CCDC91::BRAF	Malignant melanoma
CCDC91::ETFRF1	Adenocarcinoma
CCDC91::FAR2	Astrocytoma, grade I-II
CCDC91::KRT7	Astrocytoma, grade I-II
CCDC91::NTSR1	Adenocarcinoma
CCDC91::PDZRN4	Squamous cell carcinoma
CCDC91::PTK2	Mesenchymal tumor, NOS
CCDC91::TRDN	Mesenchymal tumor, NOS
CCDC91::TSPAN11	Astrocytoma, grade I-II
CCDC92::MAN1A1	Mesenchymal tumor, NOS
CCDC97::GTF2A2	Adenocarcinoma
CCDC97::SIPA1L3	Squamous cell carcinoma
CCDC9::DHX34	Adenocarcinoma
CCDC9::NECTIN2	Adenocarcinoma
CCDC9::NUP62	Transitional cell carcinoma
CCDC9::SAE1	Adenocarcinoma
CCKBR::NGLY1	Undifferentiated carcinoma, small cell
CCL14::MYH10	Adenocarcinoma
CCL25::AR	Miscellaneous hematopoietic/lymphoid neoplasm, special type
CCL28::PLCXD3	Mesenchymal tumor, NOS
CCL3::IGL	Multiple myeloma
CCL4L2::MYO19	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CCM2::OGDH	Adenocarcinoma
CCM2::PDHA1	Adenocarcinoma
CCM2::PPIA	Adenocarcinoma
CCM2::SUGCT	Adenocarcinoma
CCN3::ENPP2	Adenocarcinoma
CCNB2::RNF111	Adenocarcinoma
CCNB2::TCF12	Adenocarcinoma
CCNC::MICAL1	Mesenchymal tumor, NOS
CCND1::ANO1	Malignant melanoma
CCND1::CDC42BPA	Mantle cell lymphoma
CCND1::FGF4	Squamous cell carcinoma
CCND1::IGK	Multiple myeloma
CCND1::TACSTD2	Carcinoma, NOS | Adenocarcinoma
CCND2::ETV6	Acute myeloid leukemia, NOS | Skin
CCND2::FGF23	Astrocytoma, grade III-IV/Glioblastoma
CCND2::NINJ2	Primitive neuroectodermal tumor/Medulloblastoma | Russia
CCND2::TRA	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CCND3::ARMC9	Multiple myeloma
CCND3::BYSL	Squamous cell carcinoma
CCND3::C6orf89	Astrocytoma, grade III-IV/Glioblastoma
CCND3::EHMT2	Adenocarcinoma
CCND3::EXOC4	Adenocarcinoma
CCND3::GRK2	Adenocarcinoma
CCND3::GUCA1B	Adenocarcinoma
CCND3::LUZP1	Malignant epithelial tumor, special type
CCND3::PPP2R5D	Adenocarcinoma
CCND3::STIL	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CCND3::TRERF1	Transitional cell carcinoma | Adenocarcinoma | Squamous cell carcinoma
CCND3::VPS52	Squamous cell carcinoma
CCNF::MALL	Adenocarcinoma
CCNF::NOL4	Astrocytoma, grade I-II
CCNF::NPW	Adenocarcinoma
CCNG1::SLCO6A1	Adenocarcinoma
CCNG2::SLC4A4	Adenocarcinoma
CCNH::MACIR	Astrocytoma, grade III-IV/Glioblastoma | Carcinoma, NOS | Adenocarcinoma
CCNI::MRPL1	Squamous cell carcinoma
CCNI::SCARB2	Adenocarcinoma
CCNK::CCDC171	Adenocarcinoma
CCNK::ZNF365	Mesenchymal tumor, NOS
CCNL2::ANKRD65	Adenocarcinoma
CCNL2::MRPL20	Transitional cell carcinoma | Squamous cell carcinoma | Adenocarcinoma
CCNL2::TYK2	Transitional cell carcinoma
CCNT1::ADCY6	Transitional cell carcinoma
CCNT1::LALBA	Transitional cell carcinoma
CCNT1::OS9	Astrocytoma, grade III-IV/Glioblastoma
CCNT1::TUBA1C	Astrocytoma, grade III-IV/Glioblastoma
CCNT2::ACMSD	Mesenchymal tumor, NOS
CCNT2::MAP3K19	Adenocarcinoma
CCNY::ADARB2	Adenocarcinoma
CCNY::AKAP10	Adenocarcinoma
CCNY::ANK3	Transitional cell carcinoma
CCNY::BRAF	Adenocarcinoma
CCNY::CDH22	Adenocarcinoma
CCNY::CREM	Squamous cell carcinoma
CCNY::DENND1A	Adenocarcinoma
CCNY::GJD4	Squamous cell carcinoma
CCNY::NRG4	Adenocarcinoma
CCNY::PARD3	Adenocarcinoma
CCNY::PTPRD	Adenocarcinoma
CCNY::VWA3B	Squamous cell carcinoma
CCNY::ZNF248	Adenocarcinoma
CCNY::ZNF496	Adenocarcinoma
CCNYL1::FRMD4B	Adenocarcinoma
CCP110::GOLPH3L	Squamous cell carcinoma
CCS::ACTN3	Adenocarcinoma
CCS::KDM2A	Adenocarcinoma
CCSAP::ABCB10	Adenocarcinoma
CCSER1::AFF1	Adenocarcinoma
CCSER1::BMP2K	Transitional cell carcinoma
CCSER1::HERC3	Adenocarcinoma
CCSER1::MMRN1	Squamous cell carcinoma | Adenocarcinoma
CCSER1::SPARCL1	Adenocarcinoma
CCSER1::UGT2A1	Squamous cell carcinoma
CCSER1::WDFY3	Adenocarcinoma
CCSER2::CSN2	Adenocarcinoma
CCSER2::CYP2C19	Adenocarcinoma
CCSER2::GHITM	Adenocarcinoma
CCSER2::RGR	Adenocarcinoma
CCT2::ATP23	Astrocytoma, grade III-IV/Glioblastoma
CCT2::BEST3	Transitional cell carcinoma
CCT2::CACNG3	Mesenchymal tumor, NOS
CCT2::CPM	Transitional cell carcinoma | Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
CCT2::CXCR5	Adenocarcinoma
CCT2::DEPDC4	Mesenchymal tumor, NOS
CCT2::FRS2	Squamous cell carcinoma
CCT2::KCNC2	Mesenchymal tumor, NOS
CCT2::KRT78	Adenocarcinoma
CCT3::ARHGEF11	Adenocarcinoma
CCT3::CD5L	Adenocarcinoma
CCT3::FAR1	Malignant melanoma
CCT3::GON4L	Adenocarcinoma
CCT3::IQGAP3	Squamous cell carcinoma | Adenocarcinoma
CCT3::KDM1A	Astrocytoma, grade I-II
CCT3::NDUFV1	Adenocarcinoma
CCT3::RAB13	Adenocarcinoma
CCT3::SQSTM1	Malignant melanoma
CCT3::STAT6	Squamous cell carcinoma
CCT3::SYT2	Adenocarcinoma
CCT3::ZBTB40	Astrocytoma, grade I-II
CCT4::BIRC6	Adenocarcinoma
CCT7::ALMS1	Adenocarcinoma
CCT7::UTRN	Squamous cell carcinoma
CCT7::WDPCP	Adenocarcinoma
CCT8::ARHGEF25	Adenocarcinoma
CCT8::BRAF	Malignant melanoma
CCT8::LHX4	Adenocarcinoma
CCZ1B::NAA11	Adenocarcinoma
CD109::SNU13	Adenocarcinoma
CD151::CRACR2B	Adenocarcinoma
CD151::DRD4	Adenocarcinoma
CD151::EPS8L2	Transitional cell carcinoma
CD151::MIPEP	Adenocarcinoma
CD164::SLC15A2	Acute myeloid leukemia, NOS | Skin
CD22::CADPS	Adenocarcinoma
CD247::GPR161	Adenocarcinoma
CD24::BEND3	Adenocarcinoma
CD24::RBM3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CD24::SCML4	Astrocytoma, grade III-IV/Glioblastoma
CD274::IGFBPL1	Adenocarcinoma
CD274::KANK1	Adenocarcinoma
CD276::PARP16	Adenocarcinoma
CD28::CTLA4	Mycosis fungoides/Sézary syndrome
CD2AP::ANKFN1	Adenocarcinoma
CD2AP::BLOC1S5	Adenocarcinoma
CD2AP::DIPK1A	Adenocarcinoma
CD2AP::DVL1	Adenocarcinoma
CD2AP::FKBP5	Malignant melanoma
CD2AP::NFKBIE	Adenocarcinoma
CD2AP::OPN5	Adenocarcinoma
CD2AP::SLC25A13	Adenocarcinoma
CD2AP::SUPT3H	Adenocarcinoma
CD2AP::TRERF1	Adenocarcinoma
CD2AP::UQCRH	Adenocarcinoma
CD2AP::USP49	Adenocarcinoma
CD302::ALPL	Adenocarcinoma
CD44::CAPRIN1	Malignant epithelial tumor, special type
CD44::CREBZF	Transitional cell carcinoma
CD44::EXT2	Mesenchymal tumor, NOS
CD44::FGFR2	Adenocarcinoma
CD44::SLC1A2	Adenocarcinoma
CD44::TRIM44	Squamous cell carcinoma
CD46::MAPKAPK2	Adenocarcinoma
CD46::PDC	Adenocarcinoma
CD46::USH2A	Adenocarcinoma
CD47::MET	Adenocarcinoma
CD47::ZFR	Adenocarcinoma
CD48::CSDE1	Multiple myeloma
CD4::PGC	Adenocarcinoma
CD55::C4BPA	Adenocarcinoma
CD55::CENPL	Malignant melanoma
CD55::NEK2	Malignant melanoma
CD55::PLD5	Malignant melanoma
CD55::RGS21	Mesenchymal tumor, NOS
CD58::RAD51B	Adenocarcinoma
CD58::WNT2B	Anaplastic large cell lymphoma, cutaneous type
CD59::C11ORF91	Nonneoplastic epithelial disorder/lesion
CD59::CSTF3	Adenocarcinoma
CD59::FBXO3	Adenocarcinoma
CD63::AARS1	Adenocarcinoma
CD63::ANKS1A	Adenocarcinoma
CD63::EIF2AK2	Adenocarcinoma
CD63::MYG1	Malignant melanoma
CD63::OS9	Transitional cell carcinoma
CD63::PKP2	Adenocarcinoma
CD63::PLAT	Adenocarcinoma
CD63::PRKCB	Melanocytic neoplasm, special type
CD63::PRKCD	Fibroblastic/myofibroblastic tumor, special type | Benign fibrous histiocytoma
CD68::PSAP	Adenocarcinoma
CD70::RFX2	Mature B-cell neoplasm, NOS
CD72::RIGI	Adenocarcinoma
CD72::TLN1	Squamous cell carcinoma
CD74::CAMK2A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CD74::CD40	Transitional cell carcinoma
CD74::CXCR5	Diffuse large B-cell lymphoma
CD74::DDX27	Adenocarcinoma
CD74::ERBB3	Adenocarcinoma
CD74::IQCE	Astrocytoma, grade I-II
CD74::MBD6	Adenocarcinoma
CD74::MET	Carcinoma, NOS
CD74::NDUFV1	Malignant epithelial tumor, special type
CD74::NRG1	Adenocarcinoma
CD74::NRG2	Adenocarcinoma
CD74::NTRK1	Adenocarcinoma
CD74::PDGFRB	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CD74::ROS1	Squamous cell carcinoma | Adenocarcinoma | Adenosquamous carcinoma | Mesothelioma
CD74::SUPT16H	Diffuse large B-cell lymphoma
CD74::THSD4	Adenocarcinoma
CD74::UTRN	Astrocytoma, grade I-II
CD80::CFAP44	Diffuse large B-cell lymphoma
CD81::ARMC3	Malignant epithelial tumor, special type
CD81::DNM1L	Malignant melanoma
CD81::KCNQ1	Adenocarcinoma
CD81::NDUFV1	Adenocarcinoma
CD81::SUPT16H	Astrocytoma, grade I-II
CD81::SURF4	Adenocarcinoma
CD81::TYK2	Benign epithelial tumor, special type
CD82::TSPAN18	Squamous cell carcinoma
CD83::EHF	Mesenchymal tumor, NOS
CD83::JARID2	Mature B-cell neoplasm, NOS
CD83::LAMA2	Adenocarcinoma
CD99::JAK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CD99L2::ARHGAP36	Adenocarcinoma
CD99L2::CXORF66	Adenocarcinoma
CD99L2::CXorf66	Adenocarcinoma
CD9::ADAMTS12	Adenocarcinoma
CD9::ANO2	Germ cell tumor, NOS
CD9::ARHGEF25	Adenocarcinoma
CD9::C6	Malignant melanoma
CD9::IQCE	Squamous cell carcinoma
CD9::NRG1	Carcinoma, NOS
CD9::PBXIP1	Adenocarcinoma
CD9::PPP3CA	Adenocarcinoma
CDADC1::FUBP3	Adenocarcinoma
CDC123::HK1	Mesothelioma
CDC123::RAB18	Adenocarcinoma
CDC14A::DEFB135	Adenocarcinoma
CDC14A::PGM1	Adenocarcinoma
CDC14B::AUH	Adenocarcinoma
CDC14B::PRXL2C	Adenocarcinoma
CDC20::DEF8	Adenocarcinoma
CDC20::RRAGC	Adenocarcinoma
CDC20B::DHX29	Adenocarcinoma
CDC23::CDC25C	Adenocarcinoma
CDC25A::PRKAR2A	Adenocarcinoma
CDC25A::RBM6	Malignant melanoma
CDC25A::SLC26A6	Adenocarcinoma
CDC25A::SPINK8	Squamous cell carcinoma
CDC25C::ETF1	Adenocarcinoma
CDC27::BRAF	Malignant melanoma
CDC27::CCT6B	Adenocarcinoma
CDC27::HLF	Squamous cell carcinoma
CDC27::HROB	Squamous cell carcinoma
CDC27::MYL4	Adenocarcinoma
CDC27::PTPRS	Malignant epithelial tumor, special type
CDC27::SNF8	Adenocarcinoma
CDC27::ST7L	Adenocarcinoma
CDC27::SYT13	Adenocarcinoma
CDC27::USP32	Adenocarcinoma
CDC34::MIER2	Malignant melanoma
CDC37::CACNA1C	Multiple myeloma
CDC37::ELL	Adenocarcinoma
CDC37::KMT2C	Adenocarcinoma
CDC37::TYK2	Adenocarcinoma
CDC37L1::BNC2	Malignant melanoma
CDC42::ALPL	Malignant melanoma
CDC42::CELA3A	Adenocarcinoma
CDC42BPA::ATP6V1G3	Astrocytoma, grade I-II
CDC42BPA::C5	Adenocarcinoma
CDC42BPA::EPRS1	Adenocarcinoma
CDC42BPA::HYOU1	Astrocytoma, grade III-IV/Glioblastoma
CDC42BPA::PRKG1	Squamous cell carcinoma
CDC42BPA::WWOX	Transitional cell carcinoma
CDC42BPA::ZNF678	Adenocarcinoma
CDC42BPB::ALK	Gastrointestinal stromal tumor
CDC42BPB::NTRK3	Gastrointestinal stromal tumor
CDC42BPB::PPP4R3A	Squamous cell carcinoma
CDC42BPB::RGS6	Malignant melanoma
CDC42BPB::SYNJ2BP	Adenocarcinoma
CDC42BPB::UNC79	Adenocarcinoma
CDC42BPB::ZFYVE1	Squamous cell carcinoma
CDC42BPG::EHD1	Transitional cell carcinoma
CDC42EP2::CAPN1	Adenocarcinoma
CDC42EP2::MRPL49	Squamous cell carcinoma
CDC42EP3::GXYLT2	Adenocarcinoma
CDC42EP4::AMZ2	Adenocarcinoma
CDC42EP4::COMMD1	Adenocarcinoma
CDC42EP4::NEUROD2	Adenocarcinoma
CDC42EP4::SDK2	Adenocarcinoma
CDC42EP4::SEPTIN10	Squamous cell carcinoma
CDC42EP5::CYTH1	Adenocarcinoma
CDC42SE1::TNKS	Adenocarcinoma
CDC42SE2::BRAF	Soft tissue tumor, special type
CDC42SE2::LYRM7	Adenocarcinoma
CDC42SE2::SPIDR	Adenocarcinoma
CDC45::RIT2	Squamous cell carcinoma
CDC5L::HSP90AB1	Adenocarcinoma
CDC5L::MLIP	Malignant melanoma
CDC5L::PAQR8	Astrocytoma, grade III-IV/Glioblastoma
CDC5L::PITPNC1	Adenocarcinoma
CDC5L::POLH	Adenocarcinoma
CDC5L::SPATS1	Adenocarcinoma
CDC5L::TMEM63B	Transitional cell carcinoma
CDC6::CCR7	Adenocarcinoma
CDC6::IKZF3	Adenocarcinoma
CDC6::JUP	Adenocarcinoma
CDC6::LRRC59	Malignant epithelial tumor, special type
CDC6::MSL1	Adenocarcinoma
CDC6::PML	Acute promyelocytic leukemia (FAB type M3)
CDC6::RNFT1	Adenocarcinoma
CDC6::SRCIN1	Adenocarcinoma
CDC73::ARB2A	Acute myeloid leukemia, NOS | Skin | Acute myeloblastic leukemia without maturation (FAB type M1)
CDC73::KCNT2	Malignant melanoma
CDC73::KIFAP3	Adenocarcinoma
CDC73::RO60	Adenocarcinoma
CDC73::SWT1	Mesenchymal tumor, NOS
CDC7::LRRC8C	Adenocarcinoma
CDCA2::ADAM28	Adenocarcinoma
CDCA2::FRMPD4	Squamous cell carcinoma
CDCA4::CLBA1	Squamous cell carcinoma
CDCA7L::PALS2	Adenocarcinoma
CDCA7L::PASD1	Mesothelioma
CDH11::KIFC3	Malignant melanoma
CDH11::PRC1	Adenocarcinoma
CDH11::USP6	Aneurysmal bone cyst
CDH12::BNIP3L	Adenocarcinoma
CDH12::ZDHHC11	Mesenchymal tumor, NOS
CDH13::MLYCD	Adenocarcinoma
CDH13::TXNDC11	Squamous cell carcinoma
CDH13::WFDC1	Adenocarcinoma
CDH17::ERLIN2	Adenocarcinoma
CDH17::RAD54B	Adenocarcinoma
CDH18::TERT	Mesenchymal tumor, NOS
CDH1::CA1	Adenocarcinoma
CDH1::CDKL3	Adenocarcinoma
CDH1::DEXI	Adenocarcinoma
CDH1::LARS1	Adenocarcinoma
CDH1::NADK2	Adenocarcinoma
CDH1::NPFFR2	Adenocarcinoma
CDH1::TRHDE	Adenocarcinoma
CDH1::VPS4A	Adenocarcinoma
CDH1::VPS50	Adenocarcinoma
CDH23::LTBP1	Adenocarcinoma
CDH23::NSD1	Adenocarcinoma
CDH24::HOMEZ	Adenocarcinoma
CDH2::EPB41L3	Mesenchymal tumor, NOS
CDH2::KIAA1328	Adenocarcinoma
CDH2::LAMA3	Adenocarcinoma
CDH3::BRAF	Malignant melanoma
CDH3::CHKA	Transitional cell carcinoma
CDH3::PHAF1	Adenocarcinoma
CDH3::SNTB2	Adenocarcinoma
CDH3::TANGO6	Squamous cell carcinoma
CDH4::FGF16	Mesenchymal tumor, NOS
CDH4::NLRP9	Adenocarcinoma
CDH4::SLA2	Adenocarcinoma
CDH6::SKP2	Adenocarcinoma
CDH8::RFX1	Squamous cell carcinoma
CDIN1::ENTREP2	Squamous cell carcinoma
CDIN1::FAM98B	Adenocarcinoma
CDIN1::FBXL2	Squamous cell carcinoma
CDIN1::LYSMD4	Adenocarcinoma
CDIN1::MEIS2	Astrocytoma, grade III-IV/Glioblastoma
CDIN1::RAC2	Malignant melanoma
CDIN1::RYR3	Squamous cell carcinoma
CDIN1::SLCO3A1	Adenocarcinoma
CDIP1::SGF29	Astrocytoma, grade I-II
CDIPT::SEZ6L2	Adenocarcinoma
CDK10::GAS8	Adenocarcinoma
CDK10::SPATA33	Adenocarcinoma
CDK10::SPG7	Adenocarcinoma
CDK11B::DMD	Squamous cell carcinoma
CDK12::AKAP1	Adenocarcinoma
CDK12::ANKRD13B	Adenocarcinoma
CDK12::APRT	Adenocarcinoma
CDK12::CACNB1	Adenocarcinoma
CDK12::CDC6	Astrocytoma, grade III-IV/Glioblastoma
CDK12::EIF4A3	Adenocarcinoma
CDK12::ERBB2	Carcinoma, NOS
CDK12::FAM20A	Adenocarcinoma
CDK12::FBXL20	Acute myeloid leukemia, NOS | Adenocarcinoma | Skin
CDK12::IKZF3	Transitional cell carcinoma | Adenocarcinoma
CDK12::JAK2	Adenocarcinoma
CDK12::JUP	Adenocarcinoma
CDK12::KCNRG	Acute promyelocytic leukemia (FAB type M3)
CDK12::KRTAP4-1	Adenocarcinoma
CDK12::MED1	Adenocarcinoma
CDK12::NEUROD2	Adenocarcinoma
CDK12::NUFIP2	Adenocarcinoma
CDK12::PLXDC1	Transitional cell carcinoma
CDK12::PPM1E	Adenocarcinoma
CDK12::SMG6	Adenocarcinoma
CDK12::TAF15	Transitional cell carcinoma
CDK13::ADCY1	Mesenchymal tumor, NOS
CDK13::AMPH	Adenocarcinoma
CDK13::CLDN12	Adenocarcinoma
CDK13::DDX56	Transitional cell carcinoma
CDK13::POU6F2	Adenocarcinoma
CDK13::RALA	Adenocarcinoma
CDK13::TAX1BP1	Adenocarcinoma
CDK13::YAE1	Malignant melanoma | Squamous cell carcinoma | Adenocarcinoma
CDK14::ALK	Diffuse large B-cell lymphoma
CDK14::DLD	Adenocarcinoma
CDK14::EBF1	Mesenchymal tumor, NOS
CDK14::GATAD1	Astrocytoma, grade III-IV/Glioblastoma
CDK14::ORC5	Squamous cell carcinoma
CDK14::SAV1	Mesothelioma
CDK14::TFEC	Malignant melanoma
CDK15::ALK	Adenocarcinoma
CDK16::L3MBTL4	Squamous cell carcinoma
CDK16::TIMP1	Malignant epithelial tumor, special type
CDK17::CFAP54	Adenocarcinoma
CDK17::USP30	Mesenchymal tumor, NOS
CDK18::CNTN2	Malignant melanoma
CDK19::AMD1	Adenocarcinoma
CDK19::CIAO2B	Squamous cell carcinoma
CDK19::KMT2A	Acute myeloid leukemia, NOS | Skin
CDK19::REV3L	Adenocarcinoma
CDK19::ZFAND3	Adenocarcinoma
CDK1::DGKH	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CDK1::NRG1	Transitional cell carcinoma
CDK1::USP24	Squamous cell carcinoma
CDK1::WDR11	Adenocarcinoma
CDK2::ALK	Malignant melanoma
CDK2::PAN2	Mesenchymal tumor, NOS
CDK2::UBE3A	Malignant melanoma
CDK2AP1::KCNQ1	Adenocarcinoma
CDK2AP1::RILPL1	Adenocarcinoma
CDK4::AVIL	Astrocytoma, grade I-II
CDK4::UBA1	Adenocarcinoma
CDK5R1::PSMD11	Adenocarcinoma
CDK5RAP1::EPS15L1	Adenocarcinoma
CDK5RAP1::GNAS	Adenocarcinoma
CDK5RAP1::TMEM248	Adenocarcinoma
CDK5RAP2::AVEN	Astrocytoma, grade III-IV/Glioblastoma
CDK5RAP2::ENG	Adenocarcinoma
CDK5RAP2::GRIN1	Astrocytoma, grade I-II
CDK5RAP2::MEGF9	Astrocytoma, grade I-II
CDK5RAP2::PDGFRA	Chronic eosinophilic leukemia/hypereosinophilic syndrome
CDK5RAP2::RCC1	Astrocytoma, grade III-IV/Glioblastoma
CDK5RAP3::KPNB1	Adenocarcinoma
CDK5RAP3::RNF43	Adenocarcinoma
CDK5RAP3::SP2	Adenocarcinoma
CDK6::ANKIB1	Adenocarcinoma
CDK6::HEPACAM2	Transitional cell carcinoma
CDK6::KMT2A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CDK6::NKX2-1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CDK6::SEMA3D	Adenocarcinoma
CDK6::STXBP6	Adenocarcinoma
CDK6::TLX3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CDK7::CCNB1	Adenocarcinoma
CDK7::RGS20	Adenocarcinoma
CDK7::RIN3	Adenocarcinoma
CDK7::SH3BGR	Adenocarcinoma
CDK8::ATP8A2	Adenocarcinoma
CDK8::GCNT7	Mesenchymal tumor, NOS
CDK8::GTF2F2	Skin | Acute myeloid leukemia, NOS | Adenocarcinoma
CDK8::IKZF3	Adenocarcinoma
CDK8::NPIPB15	Adenocarcinoma
CDKAL1::ASH1L	Squamous cell carcinoma
CDKAL1::C6ORF89	Adenocarcinoma
CDKAL1::C6orf89	Adenocarcinoma
CDKAL1::CLCN4	Squamous cell carcinoma
CDKAL1::CRHR2	Adenocarcinoma
CDKAL1::DNAH8	Transitional cell carcinoma
CDKAL1::EXOC2	Astrocytoma, grade I-II
CDKAL1::FARS2	Adenocarcinoma
CDKAL1::GUCA1A	Transitional cell carcinoma
CDKAL1::HSP90AA1	Adenocarcinoma
CDKAL1::JARID2	Mesenchymal tumor, NOS
CDKAL1::KCNMB2	Squamous cell carcinoma
CDKAL1::LIG1	Transitional cell carcinoma
CDKAL1::MICB	Malignant melanoma
CDKAL1::MSRB3	Transitional cell carcinoma
CDKAL1::OR2H1	Squamous cell carcinoma
CDKAL1::RBM24	Adenocarcinoma
CDKAL1::RCAN2	Transitional cell carcinoma
CDKAL1::SMARCA2	Adenocarcinoma
CDKAL1::TBC1D1	Transitional cell carcinoma
CDKL1::ATL1	Adenocarcinoma
CDKL2::CXCL11	Adenocarcinoma
CDKL2::G3BP2	Adenocarcinoma
CDKL3::SIL1	Malignant melanoma
CDKL5::SUV39H1	Adenocarcinoma
CDKN1A::ARF1	Multiple myeloma
CDKN1A::ATP6V0C	Multiple myeloma
CDKN1A::B2M	Multiple myeloma
CDKN1A::CD9	Adenocarcinoma
CDKN1A::DUSP5	Multiple myeloma
CDKN1A::ERAS	Adenocarcinoma
CDKN1A::IGH	Multiple myeloma
CDKN1A::JAZF1	Endometrial stromal sarcoma
CDKN1A::PAPOLA	Multiple myeloma
CDKN1A::PMEPA1	Multiple myeloma
CDKN1A::PTP4A1	Multiple myeloma
CDKN1A::SKI	Multiple myeloma
CDKN1A::UBC	Multiple myeloma
CDKN1A::YPEL5	Multiple myeloma
CDKN2A::A1BG	Adenocarcinoma
CDKN2A::CAPZB	Transitional cell carcinoma
CDKN2A::CCDC12	Undifferentiated round cell sarcoma
CDKN2A::EXD2	Transitional cell carcinoma
CDKN2A::FAM124A	Astrocytoma, grade III-IV/Glioblastoma
CDKN2A::FASTKD3	Mesothelioma
CDKN2A::FOCAD	Squamous cell carcinoma | Adenocarcinoma
CDKN2A::IGK	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CDKN2A::ITCH	Malignant peripheral nerve sheath tumor/Triton
CDKN2A::MGA	Transitional cell carcinoma
CDKN2A::MTAP	Squamous cell carcinoma | Acute lymphoblastic leukemia/lymphoblastic lymphoma
CDKN2A::MYH10	Mesenchymal tumor, NOS
CDKN2A::SOBP	Adenocarcinoma
CDKN2A::SRGAP2	Squamous cell carcinoma
CDKN2A::TRA	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CDKN2B::DGKD	Astrocytoma, grade III-IV/Glioblastoma
CDKN2D::HM13	Adenocarcinoma
CDKN2D::WDFY2	Adenocarcinoma
CDKN3::SFTA3	Adenocarcinoma
CDON::CEP126	Adenocarcinoma
CDON::DCPS	Adenocarcinoma
CDON::NF2	Adenocarcinoma
CDR2L::HID1	Adenocarcinoma
CDR2L::KSR1	Squamous cell carcinoma
CDR2L::MEF2D	Adenocarcinoma
CDR2L::PECAM1	Adenocarcinoma
CDS1::UGT1A1	Transitional cell carcinoma
CDS1::UGT1A10	Transitional cell carcinoma
CDS1::UGT1A3	Transitional cell carcinoma
CDS1::UGT1A4	Transitional cell carcinoma
CDS1::UGT1A5	Transitional cell carcinoma
CDS1::UGT1A6	Transitional cell carcinoma
CDS1::UGT1A7	Transitional cell carcinoma
CDS1::UGT1A8	Transitional cell carcinoma
CDS1::UGT1A9	Transitional cell carcinoma
CDS2::ANKRD11	Chronic lymphocytic leukemia
CDS2::MAST3	Adenocarcinoma
CDS2::POLR3E	Acute myelomonocytic leukemia (FAB type M4)
CDV3::KLHL24	Adenocarcinoma
CDV3::TMEM108	Adenocarcinoma
CDYL2::DYNLRB2	Adenocarcinoma
CDYL2::VEPH1	Adenocarcinoma
CDYL::EEF1E1	Malignant melanoma
CDYL::TBC1D22B	Malignant melanoma
CEACAM6::CCT5	Adenocarcinoma
CEACAM6::DDX27	Adenocarcinoma
CEACAM6::SIAE	Adenocarcinoma
CEACAM6::ZNFX1	Adenocarcinoma
CEACAM7::CEACAM6	Adenocarcinoma
CEBPE::IGH	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CEBPG::GPATCH1	Adenocarcinoma
CEBPG::TDRD12	Transitional cell carcinoma
CEBPZ::MAP4K3	Adenocarcinoma
CEBPZOS::FAF1	Adenocarcinoma
CEBPZOS::TAF7L	Astrocytoma, grade III-IV/Glioblastoma
CECR2::C22ORF31	Adenocarcinoma
CECR2::DGCR2	Malignant epithelial tumor, special type
CECR2::EIF4ENIF1	Adenocarcinoma
CEL::CPA1	Adenocarcinoma
CEL::NTRK1	Adenocarcinoma
CELA3A::PRSS2	Adenocarcinoma
CELF1::BBOX1	Astrocytoma, grade I-II
CELF1::CHMP4B	Squamous cell carcinoma
CELF1::DDIAS	Squamous cell carcinoma
CELF1::FNBP4	Malignant epithelial tumor, special type | Adenocarcinoma
CELF1::KBTBD4	Adenocarcinoma
CELF1::LUZP2	Adenocarcinoma
CELF1::MTCH2	Squamous cell carcinoma
CELF1::MYOM1	Adenocarcinoma
CELF1::PTPMT1	Squamous cell carcinoma
CELF1::RAPSN	Malignant epithelial tumor, special type
CELF1::STK32A	Adenocarcinoma
CELF2::MALRD1	Malignant melanoma
CELF2::ZMYND11	Adenocarcinoma
CELF5::RDH8	Astrocytoma, grade I-II
CELSR1::CD52	Adenocarcinoma
CELSR1::CERK	Adenocarcinoma
CELSR1::CFAP46	Malignant melanoma
CELSR1::KCNJ4	Adenocarcinoma
CELSR1::MAFF	Adenocarcinoma
CELSR1::PACSIN2	Squamous cell carcinoma
CELSR1::RNF215	Adenocarcinoma
CELSR1::SEZ6L	Squamous cell carcinoma
CELSR1::SHISAL1	Malignant melanoma
CELSR1::TRMU	Malignant epithelial tumor, special type
CELSR2::ELAPOR1	Malignant epithelial tumor, special type
CELSR2::FAR1	Squamous cell carcinoma
CELSR2::KCNC4	Adenocarcinoma
CELSR2::SARS1	Adenocarcinoma
CELSR2::SORT1	Adenocarcinoma | Squamous cell carcinoma
CEMIP2::HMCN1	Mesenchymal tumor, NOS
CEMIP2::PTK2B	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CEMIP::ABHD17C	Adenocarcinoma
CEMIP::ARNT2	Adenocarcinoma
CEMIP::KATNAL2	Adenocarcinoma
CEMIP::LRRC49	Adenocarcinoma
CEMIP::ZYX	Astrocytoma, grade III-IV/Glioblastoma
CENPC::ABL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CENPC::STAP1	Adenocarcinoma | Squamous cell carcinoma
CENPF::ALK	Adenocarcinoma
CENPF::EGLN1	Squamous cell carcinoma
CENPF::LAMC1	Adenocarcinoma
CENPF::SUSD4	Adenocarcinoma
CENPK::KMT2A	Acute monoblastic leukemia without differentiation (FAB type M5a)
CENPL::KLHL20	Adenocarcinoma
CENPM::AGR3	Malignant melanoma
CENPM::SNU13	Malignant melanoma
CENPN::VPS35L	Adenocarcinoma
CENPO::NCOA1	Adenocarcinoma
CENPO::UBXN2A	Adenocarcinoma | Astrocytoma, grade I-II
CENPP::PTPRD	Squamous cell carcinoma
CENPQ::MMUT	Squamous cell carcinoma
CENPS::PGD	Adenocarcinoma
CENPT::NUTF2	Diffuse large B-cell lymphoma
CENPU::CFAP97	Astrocytoma, grade III-IV/Glioblastoma
CENPV::FERMT1	Adenocarcinoma
CENPW::PDE10A	Adenocarcinoma
CEP112::APOH	Adenocarcinoma
CEP112::OTOA	Adenocarcinoma
CEP112::WIPF2	Malignant melanoma
CEP126::SHANK2	Mesenchymal tumor, NOS
CEP126::YAP1	Squamous cell carcinoma
CEP128::MOBP	Adenocarcinoma
CEP128::TSHR	Transitional cell carcinoma
CEP135::POLR2B	Astrocytoma, grade I-II
CEP135::TRIM58	Malignant melanoma
CEP162::TTC33	Transitional cell carcinoma
CEP164::APOC3	Adenocarcinoma
CEP164::BACE1	Astrocytoma, grade I-II
CEP164::EMP3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CEP164::SIDT2	Adenocarcinoma
CEP170::AKT3	Malignant melanoma
CEP170::IFI16	Adenocarcinoma
CEP170::PRKACB	Adenocarcinoma
CEP170::RAD51B	Chronic myeloid leukemia, t(9;22) | Heart | Vascular and perivascular tumor, special type
CEP170::RGS7	Adenocarcinoma
CEP170::SDCCAG8	Adenocarcinoma
CEP170::SPMIP3	Astrocytoma, grade III-IV/Glioblastoma
CEP170::TSNAX	Mesenchymal tumor, NOS
CEP170::UBE2Q1	Transitional cell carcinoma
CEP170B::ADSS1	Adenocarcinoma
CEP170B::AUNIP	Adenocarcinoma
CEP192::AFG3L2	Squamous cell carcinoma
CEP192::LDHB	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CEP192::LDLRAD4	Transitional cell carcinoma
CEP192::PIGU	Adenocarcinoma
CEP192::TPTE	Adenocarcinoma
CEP250::DPM1	Undifferentiated carcinoma, small cell
CEP250::NINL	Transitional cell carcinoma
CEP290::FGGY	Mesenchymal tumor, NOS
CEP290::MET	Malignant soft tissue tumor, NOS
CEP290::VEZT	Mesenchymal tumor, NOS
CEP295::DEUP1	Adenocarcinoma
CEP295::METTL4	Malignant melanoma
CEP295::PPDPFL	Adenocarcinoma
CEP295::SMCO4	Squamous cell carcinoma
CEP295::WDR90	Transitional cell carcinoma
CEP295NL::G6PC3	Malignant epithelial tumor, special type
CEP350::GPR161	Adenocarcinoma
CEP350::LEPROT	Adenocarcinoma
CEP350::TDRD5	Adenocarcinoma
CEP350::TOR1AIP1	Transitional cell carcinoma | Adenocarcinoma
CEP43::ABCC4	Malignant melanoma
CEP43::AFDN	Malignant melanoma
CEP43::FGFR1	Acute myeloid leukemia, NOS | Acute myelomonocytic leukemia (FAB type M4) | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Polycythemia vera | Chronic myeloproliferative disorder, NOS | Skin
CEP43::MCM9	Adenocarcinoma
CEP43::RET	Idiopathic myelofibrosis | Spleen | Chronic myelomonocytic leukemia
CEP44::ALK	Carcinoid tumor
CEP44::SPTAN1	Adenocarcinoma
CEP63::AGPS	Mesothelioma
CEP68::NR0B2	Malignant epithelial tumor, special type
CEP70::COPB2	Adenocarcinoma
CEP70::GYG1	Adenocarcinoma
CEP70::STAG1	Adenocarcinoma
CEP70::TNFSF10	Adenocarcinoma
CEP72::AHRR	Squamous cell carcinoma
CEP72::CDH9	Mesenchymal tumor, NOS
CEP72::EXOC3	Adenocarcinoma
CEP72::FNTA	Adenocarcinoma
CEP72::TAS2R1	Malignant melanoma
CEP72::TPPP	Adenocarcinoma
CEP78::GNAQ	Astrocytoma, grade III-IV/Glioblastoma
CEP83::LIN7A	Adenocarcinoma
CEP85::CLIC4	Adenocarcinoma
CEP85::FAM110D	Adenocarcinoma
CEP85::RBFOX1	Malignant melanoma
CEP85::STX12	Adenocarcinoma
CEP85L::CSMD1	Mesenchymal tumor, NOS
CEP85L::EYS	Astrocytoma, grade I-II
CEP85L::FAM184A	Astrocytoma, grade III-IV/Glioblastoma
CEP85L::JAK2	Mesenchymal tumor, NOS
CEP85L::PDGFRB	Chronic eosinophilic leukemia/hypereosinophilic syndrome | Acute lymphoblastic leukemia/lymphoblastic lymphoma
CEP85L::ROS1	Astrocytoma, grade III-IV/Glioblastoma | Angiosarcoma
CEP85L::SCML4	Undifferentiated carcinoma, small cell
CEP85L::SYTL3	Astrocytoma, grade III-IV/Glioblastoma
CEP85L::TMEM120B	Mesenchymal tumor, NOS
CEP89::BRAF	Melanocytic neoplasm, special type
CEP89::CEACAM1	Mesenchymal tumor, NOS
CEP95::RBM11	Adenocarcinoma
CEP95::RGS9	Adenocarcinoma
CEPT1::DENND5B	Meningioma
CEPT1::MOV10	Adenocarcinoma
CEPT1::PHF24	Adenocarcinoma
CEPT1::WDR3	Meningioma
CERCAM::STXBP1	Adenocarcinoma
CERK::CCNL2	Adenocarcinoma
CERK::NSMAF	Adenocarcinoma
CERK::SCUBE1	Adenocarcinoma
CERK::SHISAL1	Malignant melanoma
CERK::SLC25A17	Adenocarcinoma
CERS2::GOLPH3L	Adenocarcinoma
CERS2::SETDB1	Transitional cell carcinoma
CERS4::SPAG17	Adenocarcinoma
CERS5::LIMA1	Squamous cell carcinoma | Adenocarcinoma
CERS5::MYRFL	Adenocarcinoma
CERS5::SAMD11	Adenocarcinoma
CERS6::ABCB11	Adenocarcinoma
CERS6::G6PC2	Squamous cell carcinoma
CERS6::GAD1	Adenocarcinoma
CERS6::PSMD14	Transitional cell carcinoma
CERS6::RNF25	Adenocarcinoma
CERS6::STK39	Adenocarcinoma
CERT1::ELOVL7	Malignant melanoma
CES2::GPATCH2	Adenocarcinoma
CES2::PLEKHG4	Transitional cell carcinoma
CES2::SLC9A5	Transitional cell carcinoma
CES4A::PDP2	Adenocarcinoma
CFAP20DC::CRTAP	Malignant melanoma
CFAP20DC::FHIT	Malignant melanoma
CFAP20DC::GPR34	Adenocarcinoma
CFAP251::JUP	Adenocarcinoma
CFAP276::UQCR10	Ependymoma
CFAP298::BACE2	Transitional cell carcinoma
CFAP298::CLDN14	Adenocarcinoma
CFAP298::URB1	Adenocarcinoma
CFAP299::RERE	Adenocarcinoma
CFAP36::ACYP2	Adenocarcinoma
CFAP410::UMODL1	Adenocarcinoma
CFAP44::TGFBR2	Adenocarcinoma
CFAP46::MSI2	Acute myeloblastic leukemia without maturation (FAB type M1)
CFAP47::CFAP47	Adenocarcinoma
CFAP54::CCDC60	Mesothelioma
CFAP54::CPM	Mesenchymal tumor, NOS
CFAP54::NAV3	Mesenchymal tumor, NOS
CFAP54::SLC5A8	Mesenchymal tumor, NOS
CFAP58::INA	Adenocarcinoma
CFAP68::SIK3	Acute monoblastic leukemia (FAB type M5)
CFAP74::NUMB	Adenocarcinoma
CFAP97::AADAT	Adenocarcinoma
CFAP97::CCDC110	Adenocarcinoma
CFB::CCT5	Adenocarcinoma
CFB::NDUFV1	Adenocarcinoma
CFB::SERPINA1	Adenocarcinoma
CFB::STAT6	Adenocarcinoma
CFDP1::CHST6	Adenocarcinoma
CFDP1::WWOX	Transitional cell carcinoma
CFH::CRB1	Transitional cell carcinoma
CFL1::LRRC41	Malignant melanoma
CFLAR::AGBL5	Adenocarcinoma
CFLAR::NDUFB3	Malignant epithelial tumor, special type
CFTR::ASZ1	Astrocytoma, grade I-II
CFTR::WNT2	Astrocytoma, grade I-II
CGGBP1::MITF	Squamous cell carcinoma
CGGBP1::SCN11A	Adenocarcinoma
CGNL1::TCF12	Adenocarcinoma
CGREF1::TRMT44	Adenocarcinoma
CGRRF1::WDHD1	Adenocarcinoma
CHAF1A::YJU2	Adenocarcinoma
CHAF1B::DOP1B	Squamous cell carcinoma
CHAMP1::COL4A2	Adenocarcinoma
CHAMP1::PTPRK	Mesenchymal tumor, NOS
CHAMP1::UNC79	Squamous cell carcinoma
CHAT::RET	Carcinoma, NOS
CHCHD10::DRICH1	Diffuse large B-cell lymphoma
CHCHD1::SUFU	Adenocarcinoma
CHCHD3::BDH1	Adenocarcinoma
CHCHD3::CSMD1	Mesenchymal tumor, NOS
CHCHD3::ITPKA	Adenocarcinoma
CHCHD3::MET	Squamous cell carcinoma
CHCHD3::MKLN1	Malignant melanoma
CHCHD3::NUP205	Astrocytoma, grade I-II
CHCHD3::STMP1	Astrocytoma, grade I-II
CHCHD6::EPHB1	Adenocarcinoma
CHCHD6::MYLK	Adenocarcinoma
CHCHD6::MYO1A	Malignant melanoma
CHCHD6::PLXNA1	Transitional cell carcinoma
CHCHD6::SLC49A4	Adenocarcinoma
CHCHD6::UBA5	Malignant melanoma
CHCHD7::PLAG1	Adenocarcinoma | Myoepithelioma/myoepithelial carcinoma/mixed tumor | Lipoblastoma | Soft tissue tumor, special type | Adenoma
CHD1::LIX1	Adenocarcinoma
CHD1::MTOR	Acute myeloblastic leukemia without maturation (FAB type M1) | Acute myeloid leukemia, NOS | Skin
CHD1::POLK	Malignant melanoma
CHD1::RGMB	Adenocarcinoma
CHD1::RUNX1	Acute myelomonocytic leukemia (FAB type M4)
CHD1::SLCO6A1	Adenocarcinoma
CHD1L::LCE1A	Adenocarcinoma
CHD2::ACSBG1	Malignant melanoma
CHD2::CSNK1G1	Astrocytoma, grade I-II
CHD2::DNAAF4	Mesenchymal tumor, NOS
CHD2::HOMER2	Adenocarcinoma
CHD2::PDXK	Adenocarcinoma
CHD2::PML	Acute myeloid leukemia, NOS | Skin
CHD2::SUCLA2	Acute myeloid leukemia, NOS | Skin
CHD2::ZNF880	Malignant melanoma
CHD3::RAD51C	Adenocarcinoma
CHD3::TNFSF12	Adenocarcinoma
CHD4::AFF2	Undifferentiated round cell sarcoma
CHD4::CLEC9A	Adenocarcinoma
CHD4::CPM	Mesenchymal tumor, NOS
CHD4::DTX1	Adenocarcinoma
CHD4::SPSB2	Adenocarcinoma
CHD6::ABHD12	Adenocarcinoma
CHD6::ATP9A	Adenocarcinoma
CHD6::CHRNB4	Adenocarcinoma
CHD6::CNBD2	Adenocarcinoma
CHD6::CTNNBL1	Squamous cell carcinoma
CHD6::DHX58	Adenocarcinoma
CHD6::EFCAB11	Adenocarcinoma
CHD6::FAT3	Adenocarcinoma
CHD6::MCUR1	Adenocarcinoma
CHD6::MYH7B	Mesenchymal tumor, NOS
CHD6::NCOA5	Adenocarcinoma
CHD6::P2RY8	Adenocarcinoma
CHD6::PTPRT	Adenocarcinoma
CHD6::SNX21	Adenocarcinoma
CHD6::SPEN	Benign epithelial tumor, special type | Miscellaneous hematopoietic/lymphoid neoplasm, special type
CHD6::TOP1	Malignant soft tissue tumor, NOS
CHD6::TSHZ2	Adenocarcinoma
CHD6::WFDC11	Adenocarcinoma
CHD6::ZNF235	Adenocarcinoma
CHD7::ANK1	Adenocarcinoma
CHD7::ASPH	Adenocarcinoma
CHD7::EMID1	Adenocarcinoma
CHD7::KAT6A	Adenocarcinoma
CHD7::MIX23	Adenocarcinoma
CHD7::NSD3	Adenocarcinoma
CHD7::RAB2A	Adenocarcinoma
CHD7::SNAP23	Mature B-cell neoplasm, NOS
CHD7::TACC1	Adenocarcinoma
CHD7::TCF7L2	Adenocarcinoma
CHD7::TOX	Astrocytoma, grade III-IV/Glioblastoma | Adenocarcinoma
CHD7::VGLL3	Soft tissue tumor, special type | Schwannoma
CHD7::ZC2HC1A	Adenocarcinoma
CHD8::AP1S1	Adenocarcinoma
CHD8::CBLN3	Adenocarcinoma
CHD8::CRACD	Astrocytoma, grade I-II
CHD8::DNAJC11	Adenocarcinoma
CHD8::IMPG1	Adenocarcinoma
CHD8::NDRG2	Malignant melanoma
CHD8::RAB2B	Adenocarcinoma
CHD8::TG	Mesenchymal tumor, NOS
CHD8::TOX4	Adenocarcinoma | Squamous cell carcinoma
CHD9::DLC1	Adenocarcinoma
CHD9::KSR1	Adenocarcinoma
CHD9::MMP2	Mesothelioma
CHD9::RAD51B	Adenocarcinoma
CHD9::RBL2	Malignant melanoma
CHD9::SPG7	Adenocarcinoma
CHD9::VGLL3	Soft tissue tumor, special type
CHDH::ACTR8	Adenocarcinoma
CHEK1::EXOC6	Adenocarcinoma
CHEK2::C22ORF31	Squamous cell carcinoma
CHEK2::C22orf31	Squamous cell carcinoma
CHEK2::LARGE1	Squamous cell carcinoma
CHEK2::PARVB	Adenocarcinoma
CHEK2::THOC5	Malignant epithelial tumor, special type
CHERP::CPAMD8	Adenocarcinoma
CHERP::HSH2D	Malignant melanoma
CHERP::MED26	Adenocarcinoma
CHERP::RHAG	Astrocytoma, grade I-II
CHERP::RPTOR	Adenocarcinoma
CHFR::OSBPL8	Adenocarcinoma
CHFR::ZNF565	Mesenchymal tumor, NOS
CHGB::CLU	Embryonal nervous system tumor, special type
CHGB::IGF2	Embryonal nervous system tumor, special type
CHGB::LIMCH1	Embryonal nervous system tumor, special type
CHI3L1::APOA2	Adenocarcinoma
CHI3L1::CBS	Adenocarcinoma
CHI3L1::PTPRZ1	Astrocytoma, grade III-IV/Glioblastoma
CHI3L1::SFTPB	Adenocarcinoma
CHI3L1::THSD4	Mesenchymal tumor, NOS
CHI3L1::UTRN	Astrocytoma, grade I-II
CHIA::CIMAP3	Nonneoplastic epithelial disorder/lesion
CHIC1::CDX4	Adenocarcinoma
CHIC2::ADGRL3	Astrocytoma, grade III-IV/Glioblastoma
CHIC2::ETV6	Refractory anemia with excess of blasts (FAB) | Acute myeloblastic leukemia with minimal differentiation (FAB type M0) | Acute myeloblastic leukemia without maturation (FAB type M1) | Aggressive NK-cell leukemia
CHIC2::MANBA	Adenocarcinoma
CHIC2::PDGFRA	Astrocytoma, grade III-IV/Glioblastoma
CHIC2::SIPA1L3	Malignant melanoma
CHIC2::SPINK2	Adenocarcinoma
CHIC2::TSGA10	Malignant epithelial tumor, special type
CHID1::ANO9	Malignant melanoma
CHID1::CORO7	Astrocytoma, grade III-IV/Glioblastoma
CHID1::RRBP1	Adenocarcinoma
CHKA::CCNB3	Adenocarcinoma
CHKA::GDPD5	Adenocarcinoma
CHKA::HNF1B	Adenocarcinoma
CHKA::KMT5B	Adenocarcinoma
CHKA::NADSYN1	Malignant melanoma
CHKA::PAK1	Malignant melanoma
CHKA::PC	Adenocarcinoma
CHKA::SHANK2	Malignant melanoma
CHKA::UBE2QL1	Adenocarcinoma
CHKA::XRRA1	Adenocarcinoma
CHKB::CDK11B	Adenocarcinoma
CHL1::RAD18	Adenocarcinoma
CHM::ABCB7	Adenocarcinoma
CHM::KCNIP4	Squamous cell carcinoma
CHM::KLHL4	Squamous cell carcinoma
CHML::RGS7	Adenocarcinoma
CHML::SLC39A11	Adenocarcinoma
CHMP1A::FANCA	Adenocarcinoma
CHMP1A::SPIRE2	Astrocytoma, grade III-IV/Glioblastoma
CHMP1A::VPS9D1	Adenocarcinoma
CHMP3::CD8A	Adenocarcinoma
CHMP3::REEP1	Squamous cell carcinoma
CHMP3::RNF103	Adenocarcinoma
CHMP4B::CBFA2T2	Adenocarcinoma
CHMP4B::EDEM2	Adenocarcinoma
CHMP4B::EFCAB8	Squamous cell carcinoma
CHMP4B::SYCP2L	Adenocarcinoma
CHMP4B::ZNF341	Adenocarcinoma
CHMP4C::ITGB1	Transitional cell carcinoma
CHMP5::GALT	Squamous cell carcinoma
CHMP5::SPINK4	Squamous cell carcinoma
CHMP5::VMP1	Adenocarcinoma
CHMP6::RPTOR	Acute myeloid leukemia, NOS | Skin
CHN1::TSGA10	Adenocarcinoma
CHN2::SKAP2	Adenocarcinoma
CHN2::TAX1BP1	Adenocarcinoma
CHN2::TSPAN33	Astrocytoma, grade III-IV/Glioblastoma
CHP1::ARHGAP42	Adenocarcinoma
CHP1::RAD51	Adenocarcinoma
CHP1::RAD51B	Adenocarcinoma
CHP1::SMAD3	Adenocarcinoma
CHPT1::ATXN2	Mesenchymal tumor, NOS
CHPT1::GNPTAB	Adenocarcinoma
CHPT1::MYBPC1	Adenocarcinoma
CHPT1::SCYL2	Adenocarcinoma
CHPT1::TXNRD1	Mesenchymal tumor, NOS
CHPT1::UTP20	Undifferentiated carcinoma, small cell
CHRAC1::SNTG1	Transitional cell carcinoma
CHRDL2::COPB1	Adenocarcinoma
CHRM3::CASQ1	Squamous cell carcinoma
CHRM3::ERICH6	Adenocarcinoma
CHRM3::FMN2	Squamous cell carcinoma
CHRM3::SYT14	Adenocarcinoma
CHRNA7::PRR16	Adenocarcinoma
CHRNA9::RHOH	Adenocarcinoma
CHRNB3::RB1CC1	Adenocarcinoma
CHRNE::KLF2	Multiple myeloma
CHST10::MAP4K4	Squamous cell carcinoma
CHST11::ATP1B4	Acute myeloblastic leukemia with maturation (FAB type M2) | Skin | Acute myeloid leukemia, NOS
CHST11::HCFC2	Squamous cell carcinoma
CHST11::HSP90B1	Adenocarcinoma
CHST11::KDM2B	Neuroglial neoplasm, special type
CHST11::PTPRR	Mesenchymal tumor, NOS
CHST11::RFX4	Squamous cell carcinoma
CHST11::TXNRD1	Squamous cell carcinoma
CHST12::PLA2G4E	Malignant melanoma
CHST3::CDH23	Adenocarcinoma
CHST5::TMEM231	Adenocarcinoma
CHST6::FA2H	Adenocarcinoma
CHST8::FAM174C	Squamous cell carcinoma
CHST8::KCNJ15	Adenocarcinoma
CHST8::PDCD5	Adenocarcinoma
CHST8::ZNF146	Adenocarcinoma
CHST9::DLGAP3	Squamous cell carcinoma
CHST9::ZNF675	Squamous cell carcinoma
CHSY1::BTBD9	Malignant melanoma
CHSY1::PCSK6	Squamous cell carcinoma
CHSY1::PPP1CA	Squamous cell carcinoma
CHSY1::SPOCK2	Adenocarcinoma
CHSY3::DDX46	Astrocytoma, grade I-II
CHSY3::NINJ2	Adenocarcinoma
CHTF18::RHOT2	Adenocarcinoma
CHTF8::TBC1D22A	Adenocarcinoma
CHTOP::NTRK1	Astrocytoma, grade III-IV/Glioblastoma
CHTOP::S100A1	Malignant epithelial tumor, special type
CHTOP::S100A13	Transitional cell carcinoma
CHUK::RHOQ	Adenocarcinoma
CIAO1::SERTAD2	Squamous cell carcinoma
CIAO1::SH2D6	Transitional cell carcinoma
CIAO1::TMEM127	Adenocarcinoma
CIAO2A::CSNK1G1	Alveolar rhabdomyosarcoma | Adenocarcinoma
CIAO2A::SNX1	Adenocarcinoma
CIAO2A::STIM1	Adenocarcinoma
CIAO2B::CYFIP1	Adenocarcinoma
CIAO3::RBBP6	Adenocarcinoma
CIB2::ACSBG1	Adenocarcinoma
CIC::CD177	Adenocarcinoma
CIC::COQ8B	Adenocarcinoma
CIC::DLK1	Embryonal nervous system tumor, special type
CIC::DUX4	Ewing sarcoma | Malignant soft tissue tumor, NOS | Russia | Primitive neuroectodermal tumor/Medulloblastoma | Undifferentiated round cell sarcoma | Angiosarcoma
CIC::EXOSC5	Mycosis fungoides/Sézary syndrome
CIC::FBXO4	Malignant soft tissue tumor, NOS
CIC::FOXO4	Undifferentiated round cell sarcoma
CIC::KLK11	Adenocarcinoma
CIC::LEUTX	Angiosarcoma | Embryonal nervous system tumor, NOS | Astrocytoma, grade I-II | Neuroglial neoplasm, special type | Astrocytoma, grade III-IV/Glioblastoma | Mesenchymal tumor, special type | Glioma, NOS | Malignant soft tissue tumor, NOS
CIC::LMNA	Adenocarcinoma
CIC::MEGF8	Adenocarcinoma
CIC::NUTM1	Russia | Mesenchymal tumor, NOS | Primitive neuroectodermal tumor/Medulloblastoma | Undifferentiated round cell sarcoma | Glioma, NOS | Embryonal nervous system tumor, NOS | Neuroglial neoplasm, special type | Malignant soft tissue tumor, NOS | Undifferentiated carcinoma
CIC::NUTM2A	Skin | Acute erythroleukemia (FAB type M6) | Acute myeloid leukemia, NOS | Undifferentiated round cell sarcoma
CIC::RPS19	Adenocarcinoma
CIC::ZFP57	Adenocarcinoma
CIDEB::ADCY4	Transitional cell carcinoma
CIDEB::PTEN	Adenocarcinoma
CIITA::BCL6	Follicular lymphoma | Diffuse large B-cell lymphoma
CIITA::BCOR	Soft tissue tumor, special type
CIITA::CD274	Mediastinal large B-cell lymphoma
CIITA::CREBBP	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CIITA::DEXI	Schwannoma
CIITA::DLG2	Mature B-cell neoplasm, NOS
CIITA::FCHSD2	Adenocarcinoma
CIITA::IGH	Mature B-cell neoplasm, NOS
CIITA::PDCD1LG2	Mediastinal large B-cell lymphoma
CIITA::PIERCE2	Hodgkin disease, NOS | Mediastinal large B-cell lymphoma
CIITA::PIP4K2B	Skin | Acute myeloid leukemia, NOS
CIITA::PRDM16	Diffuse large B-cell lymphoma
CIITA::RALGDS	Mediastinal large B-cell lymphoma
CIITA::RMI2	Mediastinal large B-cell lymphoma
CIITA::SNX29	Mediastinal large B-cell lymphoma
CIITA::VWA3A	Adenocarcinoma
CILK1::FAM83B	Adenocarcinoma
CILK1::TUBB	Adenocarcinoma
CIMAP1B::PPP6R2	Adenocarcinoma
CIMAP2::TTC4	Squamous cell carcinoma
CIPC::LRRC74A	Transitional cell carcinoma | Adenocarcinoma
CIPC::NGFR	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
CIR1::AGPS	Diffuse large B-cell lymphoma
CIR1::NFE2L2	Squamous cell carcinoma
CIR1::SCRN3	Adenocarcinoma
CIRBP::APC2	Adenocarcinoma
CIRBP::CNN2	Transitional cell carcinoma
CIRBP::ERAS	Adenocarcinoma
CIRBP::FAM174C	Nonneoplastic hematologic disorder/lesion | Nonneoplastic epithelial disorder/lesion
CIRBP::UGP2	Adenocarcinoma
CIRBP::WDR18	Adenocarcinoma
CISD1::GABRA1	Squamous cell carcinoma
CISD3::STARD3	Adenocarcinoma
CIT::FAM222A	Squamous cell carcinoma
CIT::LYZ	Mesenchymal tumor, NOS
CIT::RFC5	Undifferentiated carcinoma, small cell
CIT::SPPL3	Adenocarcinoma
CITED2::DYNLRB1	Multiple myeloma
CITED2::NR4A3	Mesothelioma
CITED2::PRDM10	Fibroblastic/myofibroblastic tumor, special type
CITED2::SRF	Vascular and perivascular tumor, NOS
CIZ1::SLC16A3	Mesenchymal tumor, NOS
CKAP2::SMCO2	Adenocarcinoma
CKAP5::DAAM1	Malignant melanoma
CKAP5::TMEM135	Astrocytoma, grade I-II
CKAP5::VMP1	Adenocarcinoma
CKB::CYB5R3	Adenocarcinoma
CKB::EIF2AK2	Astrocytoma, grade I-II
CKB::SCN2A	Astrocytoma, grade I-II
CKB::SUPT16H	Adenocarcinoma
CKM::SIAE	Squamous cell carcinoma
CKS1B::SHC1	Adenocarcinoma
CKS2::PCSK5	Astrocytoma, grade I-II
CLASP1::FBXO11	Adenocarcinoma
CLASP1::HK2	Adenocarcinoma
CLASP2::GLB1	Squamous cell carcinoma
CLASP2::IL17RD	Leiomyoma
CLASP2::NMNAT3	Adenocarcinoma
CLASP2::STT3B	Mesenchymal tumor, NOS
CLASRP::EXOC3L2	Adenocarcinoma
CLASRP::PPP1R37	Adenocarcinoma
CLASRP::PVR	Adenocarcinoma
CLASRP::RELB	Adenocarcinoma
CLASRP::TMEM217	Adenocarcinoma
CLASRP::TOMM40	Adenocarcinoma
CLASRP::ZNF524	Adenocarcinoma
CLCF1::PPP1CA	Adenocarcinoma | Squamous cell carcinoma
CLCN3::PALLD	Adenocarcinoma
CLCN3::SMAD1	Adenocarcinoma
CLCN3::SMNDC1	Adenocarcinoma
CLCN3::TDO2	Transitional cell carcinoma
CLCN3::UBE2D3	Adenocarcinoma
CLCN4::SHROOM2	Malignant epithelial tumor, special type
CLCN4::TFAP2A	Squamous cell carcinoma
CLCN5::NBDY	Malignant epithelial tumor, special type
CLCN5::PAGE1	Adenocarcinoma
CLCN6::BRAF	Astrocytoma, pilocytic/juvenile
CLCN6::RAF1	Malignant melanoma
CLCN7::IFT140	Malignant melanoma
CLCN7::SEC63	Malignant melanoma
CLDN10::TTC12	Squamous cell carcinoma
CLDN11::MECOM	Adenocarcinoma
CLDN12::SPCS3	Adenocarcinoma
CLDN12::STEAP1	Squamous cell carcinoma
CLDN18::ARHGAP26	Adenocarcinoma | Malignant epithelial tumor, special type
CLDN18::ARHGAP6	Malignant epithelial tumor, special type | Adenocarcinoma
CLDN1::FNDC3B	Adenocarcinoma
CLDN4::UTRN	Adenocarcinoma
CLDN7::TMEM256	Adenocarcinoma
CLDN7::UTS2R	Adenocarcinoma
CLDND1::ARPP21	Mesothelioma
CLEC12A::CLEC2A	Adenocarcinoma
CLEC16A::ATF7IP2	Adenocarcinoma
CLEC16A::GRIN2A	Adenocarcinoma
CLEC16A::LITAF	Squamous cell carcinoma | Adenocarcinoma
CLEC16A::NTAN1	Adenocarcinoma
CLEC16A::RMI2	Squamous cell carcinoma
CLEC16A::TXNDC11	Astrocytoma, grade III-IV/Glioblastoma
CLEC2B::MYRFL	Mesenchymal tumor, NOS
CLEC2D::ERC1	Adenocarcinoma
CLEC2D::NPM1	Adenocarcinoma
CLEC6A::CLEC4D	Germ cell tumor, NOS
CLHC1::FAM98A	Adenocarcinoma
CLIC1::H2BC4	Adenocarcinoma
CLIC1::MSH5	Malignant melanoma
CLIC1::NUDT3	Malignant melanoma
CLIC2::MAMLD1	Mesenchymal tumor, NOS
CLIC2::VPS39	Adenocarcinoma
CLIC4::ARFGAP3	Adenocarcinoma
CLIC4::CCDC28B	Adenocarcinoma
CLIC4::GRHL3	Adenocarcinoma
CLIC4::KMT2A	Leiomyosarcoma
CLIC4::NCMAP	Adenocarcinoma
CLIC4::PACSIN2	Adenocarcinoma
CLIC4::PLOD1	Astrocytoma, grade III-IV/Glioblastoma
CLIC4::RCAN3	Adenocarcinoma
CLIC4::SLC45A1	Adenocarcinoma
CLIC4::SRRM1	Astrocytoma, grade III-IV/Glioblastoma
CLIC4::UBAP2L	Adenocarcinoma
CLIC5::SUPT3H	Adenocarcinoma | Acute lymphoblastic leukemia/lymphoblastic lymphoma
CLIC6::ITSN1	Adenocarcinoma
CLINT1::EDIL3	Myelodysplastic syndrome, NOS
CLINT1::MARCHF11	Adenocarcinoma
CLINT1::MEF2C	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CLINT1::UCHL3	Malignant melanoma
CLIP1::ALK	Carcinoma, NOS | Adenocarcinoma | Soft tissue tumor, NOS
CLIP1::FKBP5	Mesenchymal tumor, NOS
CLIP1::LTK	Adenocarcinoma
CLIP1::NTRK1	Adenocarcinoma
CLIP1::RAF1	Fibroblastic/myofibroblastic tumor, special type
CLIP1::RET	Carcinoma, NOS
CLIP1::ROS1	Astrocytoma, grade III-IV/Glioblastoma | Astrocytoma, grade I-II | Melanocytic neoplasm, special type
CLIP1::RSRC2	Malignant melanoma | Adenocarcinoma
CLIP1::SLC8B1	Adenocarcinoma
CLIP1::TNIK	Adenocarcinoma
CLIP1::UBC	Multiple myeloma
CLIP1::ZCCHC8	Squamous cell carcinoma
CLIP2::AUTS2	Acute myeloid leukemia, NOS | Skin
CLIP2::BRAF	Melanocytic neoplasm, special type
CLIP2::BUD23	Adenocarcinoma
CLIP2::CACNA1C	Acute myeloid leukemia, NOS | Skin
CLIP2::EGFR	Glioma, NOS
CLIP2::GTF2I	Malignant melanoma | Adenocarcinoma
CLIP2::MET	Astrocytoma, grade I-II
CLIP2::NTRK2	Glioma, NOS
CLIP2::RET	Fibroblastic/myofibroblastic tumor, special type
CLIP2::RORB	Malignant melanoma
CLIP4::ALK	Adenocarcinoma | Squamous cell carcinoma
CLIP4::BABAM2	Adenocarcinoma
CLIP4::TMEM18	Malignant melanoma
CLIP4::TOGARAM2	Adenocarcinoma
CLK1::NAPRT	Adenocarcinoma
CLK1::ORC2	Adenocarcinoma
CLK2::ASH1L	Adenocarcinoma
CLK2::CD244	Adenocarcinoma
CLK2::PPP1R12B	Adenocarcinoma
CLK4::ZNF354A	Adenocarcinoma
CLMN::EVL	Adenocarcinoma
CLMN::SOS2	Malignant melanoma
CLMN::VTI1B	Adenocarcinoma
CLMN::WDR20	Transitional cell carcinoma
CLN3::SIVA1	Adenocarcinoma
CLN5::FBXL3	Skin | Acute myeloid leukemia, NOS
CLN6::ALDH1A2	Adenocarcinoma
CLN6::CALML4	Adenocarcinoma
CLN6::FBXL17	Adenocarcinoma
CLN6::INSYN1	Adenocarcinoma
CLN6::PAQR5	Adenocarcinoma
CLNK::WDR70	Malignant melanoma
CLNS1A::AQP11	Adenocarcinoma
CLNS1A::DCBLD1	Squamous cell carcinoma
CLNS1A::GAB2	Adenocarcinoma
CLNS1A::SMIM15	Adenocarcinoma
CLNS1A::TRIM49C	Adenocarcinoma
CLOCK::AASDH	Multiple myeloma
CLOCK::NMU	Adenocarcinoma | Astrocytoma, grade I-II
CLOCK::PDGFRA	Adenocarcinoma
CLOCK::PHF21A	Adenocarcinoma
CLOCK::SRD5A3	Squamous cell carcinoma
CLOCK::UGT2A3	Transitional cell carcinoma
CLPB::BRD10	Malignant melanoma
CLPB::C2CD3	Adenocarcinoma
CLPB::CTNNA2	Embryonal nervous system tumor, special type
CLPB::FCHSD2	Squamous cell carcinoma
CLPB::GOLGA8B	Adenocarcinoma
CLPB::MRPL21	Adenocarcinoma
CLPB::MTUS2	Adenocarcinoma
CLPB::ODAD2	Adenocarcinoma
CLPB::PDE2A	Adenocarcinoma
CLPB::PTPN1	Adenocarcinoma
CLPB::SCGB3A2	Adenocarcinoma
CLPB::SHANK2	Adenocarcinoma
CLPB::STARD10	Adenocarcinoma
CLPB::TMEM134	Adenocarcinoma
CLPTM1::AP1M1	Adenocarcinoma
CLPTM1::CBLC	Adenocarcinoma
CLPTM1::CEACAM16	Squamous cell carcinoma
CLPTM1::CYP2A7	Adenocarcinoma
CLPTM1::IGSF23	Adenocarcinoma
CLPTM1::NECTIN2	Mesenchymal tumor, NOS
CLPTM1::OPA3	Squamous cell carcinoma
CLPTM1::RPS5	Adenocarcinoma
CLPTM1L::ARFGEF2	Squamous cell carcinoma
CLPTM1L::CDHR2	Adenocarcinoma
CLPTM1L::PDCD6	Adenocarcinoma
CLPTM1L::PPP2R5E	Astrocytoma, grade III-IV/Glioblastoma
CLPTM1L::SCUBE1	Adenocarcinoma
CLPTM1L::SLC6A18	Adenocarcinoma
CLPTM1L::TEAD1	Adenocarcinoma
CLPTM1L::VARS1	Malignant melanoma
CLPX::IGDCC4	Adenocarcinoma
CLPX::PARP16	Adenocarcinoma
CLPX::PDCD7	Adenocarcinoma
CLRN3::DOCK1	Adenocarcinoma
CLSTN1::ANXA1	Adenocarcinoma
CLSTN1::CTNNBIP1	Adenocarcinoma
CLSTN1::IFFO2	Adenocarcinoma
CLSTN1::PLEKHG5	Adenocarcinoma
CLSTN1::SERTAD1	Adenocarcinoma
CLSTN1::SPA17	Adenocarcinoma
CLSTN2::CCDC39	Adenocarcinoma
CLSTN2::PCOLCE2	Adenocarcinoma
CLSTN3::C1S	Adenocarcinoma
CLSTN3::LRRC23	Adenocarcinoma
CLSTN3::PEX5	Adenocarcinoma
CLSTN3::PLCZ1	Adenocarcinoma
CLTA::GNE	Squamous cell carcinoma
CLTA::RIN2	Adenocarcinoma
CLTA::UBE2R2	Astrocytoma, grade III-IV/Glioblastoma
CLTA::ZCCHC7	Adenocarcinoma
CLTB::SIL1	Adenocarcinoma
CLTC::ALK	Plasma cell neoplasm, special type | Inflammatory myofibroblastic tumor/myofibroblastic sarcoma | Diffuse large B-cell lymphoma | Adenocarcinoma | Anaplastic large cell lymphoma, systemic type | Carcinoma, NOS | Benign fibrous histiocytoma
CLTC::BCAS3	Adenocarcinoma
CLTC::BDNF	Mesothelioma
CLTC::CEP95	Adenocarcinoma
CLTC::CTDSP1	Adenocarcinoma
CLTC::DNAH17	Mesenchymal tumor, NOS
CLTC::EPB41L3	Adenocarcinoma
CLTC::ETV1	Malignant epithelial tumor, special type
CLTC::ETV4	Adenocarcinoma
CLTC::FOSB	Pseudomyogenic hemangioendothelioma
CLTC::NIBAN3	Adenocarcinoma
CLTC::OTOP3	Adenocarcinoma
CLTC::PRKCA	Adenocarcinoma
CLTC::PRR11	Adenocarcinoma
CLTC::PTRH2	Adenocarcinoma
CLTC::ROS1	Adenocarcinoma
CLTC::SYK	Miscellaneous hematopoietic/lymphoid neoplasm, special type | Soft tissue tumor, special type
CLTC::TFE3	Adenocarcinoma
CLTC::TFEB	Adenocarcinoma
CLTC::USP32	Adenocarcinoma
CLTC::VMP1	Adenocarcinoma
CLTCL1::ALK	Anaplastic large cell lymphoma, systemic type
CLTCL1::DGCR8	Malignant melanoma
CLU::AGT	Ependymoma
CLU::APOL3	Adenocarcinoma
CLU::CCT5	Adenocarcinoma
CLU::DDX21	Adenocarcinoma
CLU::EPB41L1	Adenocarcinoma
CLU::MT1G	Adenocarcinoma
CLU::MT2A	Astrocytoma, grade I-II
CLU::MYH9	Transitional cell carcinoma
CLU::PEBP1	Astrocytoma, grade I-II
CLU::PPP1R12B	Mesenchymal tumor, NOS
CLU::RBP4	Adenocarcinoma
CLU::RPS4X	Adenocarcinoma
CLU::SEC63	Adenocarcinoma
CLU::SF3B2	Mesenchymal tumor, NOS
CLUAP1::NAA60	Adenocarcinoma
CLUH::DLG5	Adenocarcinoma
CLUH::IGF2	Adenocarcinoma
CLVS1::RAB2A	Adenocarcinoma
CLYBL::UBAC2	Squamous cell carcinoma
CMBL::DARS2	Squamous cell carcinoma
CMBL::NDUFAF6	Adenocarcinoma
CMC1::ERC2	Astrocytoma, grade I-II
CMC1::GLB1	Adenocarcinoma
CMC1::SLC4A7	Diffuse large B-cell lymphoma
CMC1::VPS37C	Adenocarcinoma
CMC1::WDR72	Adenocarcinoma
CMC1::ZCWPW2	Adenocarcinoma | Squamous cell carcinoma
CMC2::PZP	Adenocarcinoma
CMIP::BCO1	Adenocarcinoma | Transitional cell carcinoma
CMIP::CDYL2	Adenocarcinoma
CMIP::DOK4	Adenocarcinoma
CMIP::SUGP2	Adenocarcinoma
CMIP::UBE2G1	Adenocarcinoma
CMKLR1::HNF1A	Epithelioid sarcoma
CMPK1::SH2D1B	Adenocarcinoma
CMPK1::TNNT1	Squamous cell carcinoma
CMSS1::AXIN1	Malignant melanoma
CMSS1::CRYBG3	Transitional cell carcinoma
CMSS1::ENPP6	Adenocarcinoma
CMSS1::FLT1	Acute myeloid leukemia, NOS | Skin
CMSS1::KRT1	Mesenchymal tumor, NOS
CMSS1::LNP1	Adenocarcinoma | Malignant melanoma
CMSS1::TBKBP1	Adenocarcinoma
CMSS1::XRRA1	Adenocarcinoma
CMTM4::CMTM3	Adenocarcinoma
CMTM4::DYNC1LI2	Squamous cell carcinoma
CMTM4::KLHL24	Adenocarcinoma
CMTM4::PLA2G15	Adenocarcinoma
CMTM4::SULT1E1	Squamous cell carcinoma
CMTM4::TRIM40	Adenocarcinoma
CMTM7::CLDN11	Malignant melanoma
CMTM7::CMTM8	Transitional cell carcinoma
CMTM7::FHIT	Malignant melanoma
CMTM7::GPD1L	Adenocarcinoma
CMTM7::METTL2B	Adenocarcinoma
CMTM8::GPD1L	Adenocarcinoma
CMTM8::NR1D2	Adenocarcinoma
CMTM8::RAF1	Adenocarcinoma
CMTM8::RPN1	Malignant melanoma
CMTM8::STT3B	Adenocarcinoma
CMTM8::ZNF385D	Adenocarcinoma
CMTR1::GPX6	Adenocarcinoma
CMTR1::PPARD	Mesenchymal tumor, NOS
CMTR1::SMIM13	Adenocarcinoma
CMTR1::ZFAND3	Adenocarcinoma
CMYA5::SRRM1	Astrocytoma, grade III-IV/Glioblastoma
CNBD1::PTPN2	Transitional cell carcinoma
CNBP::ALDH1L1	Astrocytoma, grade I-II
CNBP::USP6	Aneurysmal bone cyst
CNDP2::NPC1	Adenocarcinoma
CNEP1R1::ANK1	Adenocarcinoma
CNIH2::MS4A4A	Malignant melanoma
CNIH4::VPS39	Adenocarcinoma
CNKSR1::MAN1C1	Adenocarcinoma
CNKSR3::FBXO5	Mesenchymal tumor, NOS
CNKSR3::PLP1	Mesenchymal tumor, NOS
CNN1::CBS	Mesenchymal tumor, NOS
CNN1::CCT5	Adenocarcinoma
CNN1::NIBAN2	Adenocarcinoma
CNN1::TPM2	Mesenchymal tumor, NOS
CNN2::ARID3A	Adenocarcinoma
CNN2::C2CD4C	Astrocytoma, grade I-II
CNN2::TTC7A	Squamous cell carcinoma
CNN2::WDR18	Adenocarcinoma
CNN3::ALG14	Astrocytoma, grade III-IV/Glioblastoma | Adenocarcinoma
CNN3::CACHD1	Malignant melanoma
CNNM2::NOTCH4	Adenocarcinoma
CNNM2::RBP4	Adenocarcinoma
CNNM2::SUFU	Adenocarcinoma
CNNM2::WBP1L	Adenocarcinoma
CNNM3::ANKRD23	Skin | Acute myeloid leukemia, NOS
CNNM4::NEURL3	Transitional cell carcinoma
CNNM4::PARD3B	Adenocarcinoma
CNOT1::CETP	Adenocarcinoma
CNOT1::GOT2	Transitional cell carcinoma
CNOT1::HERPUD1	Adenocarcinoma
CNOT1::NDRG4	Astrocytoma, grade III-IV/Glioblastoma
CNOT1::PHKB	Adenocarcinoma
CNOT1::PRRX2	Adenocarcinoma
CNOT1::PSMB2	Adenocarcinoma
CNOT1::RASSF8	Adenocarcinoma
CNOT1::SLC38A7	Adenocarcinoma
CNOT2::ASTN2	Liposarcoma, dedifferentiated
CNOT2::DPY19L2	Soft tissue tumor, NOS
CNOT2::ERBB3	Astrocytoma, grade III-IV/Glioblastoma
CNOT2::FBXO4	Malignant melanoma
CNOT2::NUP107	Adenocarcinoma
CNOT2::PDE3A	Adenocarcinoma
CNOT2::RAB3IP	Adenocarcinoma
CNOT2::RBMS2	Astrocytoma, grade III-IV/Glioblastoma
CNOT2::SLC45A4	Adenocarcinoma
CNOT2::SLCO1A2	Astrocytoma, grade I-II
CNOT2::SRGAP1	Adenocarcinoma
CNOT2::TSPAN8	Adenocarcinoma
CNOT2::YEATS4	Malignant melanoma
CNOT2::YLPM1	Astrocytoma, grade III-IV/Glioblastoma
CNOT2::ZDHHC17	Transitional cell carcinoma
CNOT3::KMT2B	Adenocarcinoma
CNOT4::AKR1B10	Malignant melanoma
CNOT4::CALD1	Adenocarcinoma
CNOT4::ENAM	Adenocarcinoma
CNOT6::FGF18	Adenocarcinoma
CNOT6::TSPAN8	Mesenchymal tumor, NOS
CNOT8::OPRPN	Malignant epithelial tumor, special type
CNOT9::ARPC2	Adenocarcinoma
CNOT9::CYP27A1	Adenocarcinoma
CNOT9::WNT6	Squamous cell carcinoma
CNP::NCALD	Astrocytoma, grade I-II
CNPY3::CXCR5	Adenocarcinoma
CNPY3::RPL7L1	Adenocarcinoma
CNPY3::TPO	Adenocarcinoma
CNPY4::COPS6	Adenocarcinoma
CNRIP1::ZNF638	Astrocytoma, grade I-II
CNST::LNX1	Malignant melanoma
CNST::RAP1GAP	Astrocytoma, grade I-II
CNST::RGS7	Astrocytoma, grade I-II
CNST::SCCPDH	Adenocarcinoma
CNST::SMYD3	Adenocarcinoma
CNTFR::ARMT1	Squamous cell carcinoma
CNTFR::KIF24	Squamous cell carcinoma
CNTLN::COQ8B	Adenocarcinoma
CNTLN::RFX3	Adenocarcinoma
CNTN1::PDZRN4	Astrocytoma, grade I-II
CNTN1::RET	Carcinoma, NOS
CNTN1::TMEM117	Mesenchymal tumor, NOS
CNTN1::TSPAN8	Adenocarcinoma
CNTN2::PKP1	Mesenchymal tumor, NOS
CNTN4::RHOA	Leiomyoma
CNTN5::ME3	Malignant melanoma
CNTN5::TTYH1	Squamous cell carcinoma
CNTNAP2::BRAF	Squamous cell carcinoma
CNTNAP2::GCFC2	Adenocarcinoma
CNTNAP2::GSTK1	Adenocarcinoma
CNTNAP2::RET	Carcinoma, NOS
CNTNAP3::NTRK2	Astrocytoma, grade III-IV/Glioblastoma
CNTNAP3B::SHB	Adenocarcinoma
CNTRL::ABL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CNTRL::FGFR1	Acute myelomonocytic leukemia (FAB type M4) | Chronic myeloproliferative disorder, NOS
CNTRL::JAK2	Egypt | Bilineage or biphenotypic leukemia
CNTRL::KIT	Acute myeloid leukemia, NOS | Skin
CNTRL::PCID2	Adenocarcinoma
COA1::AMPH	Adenocarcinoma
COA1::BLVRA	Adenocarcinoma
COA1::GCK	Adenocarcinoma
COA1::HECW1	Astrocytoma, grade III-IV/Glioblastoma
COA1::MRPS24	Adenocarcinoma
COA6::SLC35F3	Adenocarcinoma
COA8::ASPG	Adenocarcinoma
COA8::ATP9A	Adenocarcinoma
COA8::MARK3	Adenocarcinoma
COASY::HSD17B1	Adenocarcinoma
COBL::DUSP14	Adenocarcinoma
COBL::FKBP9	Transitional cell carcinoma
COBL::SEPTIN14	Astrocytoma, grade III-IV/Glioblastoma | Transitional cell carcinoma
COBLL1::FIGN	Adenocarcinoma
COBLL1::FMNL2	Mesenchymal tumor, NOS
COBLL1::NUDT15	Squamous cell carcinoma
COBLL1::SCN3A	Transitional cell carcinoma | Squamous cell carcinoma
COBLL1::SLC38A11	Squamous cell carcinoma
COBLL1::SMYD3	Squamous cell carcinoma
COG2::PCNX2	Adenocarcinoma
COG3::PSMB7	Malignant melanoma
COG4::AARS1	Adenocarcinoma
COG4::MELTF	Adenocarcinoma
COG4::MTSS2	Adenocarcinoma
COG4::PMFBP1	Mesenchymal tumor, NOS
COG4::VAC14	Adenocarcinoma
COG5::CBLL1	Adenocarcinoma
COG5::CCDC122	Adenocarcinoma
COG5::CEP41	Adenocarcinoma
COG5::DNAH7	Adenocarcinoma
COG5::DPP6	Adenocarcinoma
COG5::FOXP1	Transitional cell carcinoma
COG5::FOXP2	Adenocarcinoma
COG5::TBC1D30	Adenocarcinoma
COG6::DNAJC15	Adenocarcinoma
COG6::GPC5	Adenocarcinoma
COG6::LHFPL6	Adenocarcinoma
COG6::MAPK8	Adenocarcinoma
COG6::STXBP4	Adenocarcinoma
COG8::TERF2	Adenocarcinoma
COIL::CA4	Transitional cell carcinoma
COIL::CDR2L	Adenocarcinoma
COL11A1::ARL5C	Adenocarcinoma
COL11A1::COL1A2	Dermatofibrosarcoma protuberans/Bednar tumor/giant cell fibroblastoma
COL11A1::DPH5	Adenocarcinoma
COL12A1::GRM1	Chondromyxoid fibroma
COL12A1::TDRD3	Adenocarcinoma
COL14A1::DEPTOR	Adenocarcinoma
COL14A1::PLEKHA2	Adenocarcinoma
COL14A1::SREBF2	Adenocarcinoma
COL15A1::ANKS6	Adenocarcinoma
COL16A1::ATF7IP	Adenocarcinoma
COL16A1::CPSF6	Squamous cell carcinoma
COL16A1::SPOCD1	Squamous cell carcinoma
COL16A1::TSGA10IP	Malignant melanoma
COL17A1::CFAP43	Squamous cell carcinoma
COL18A1::ADARB1	Adenocarcinoma
COL18A1::HSPA5	Squamous cell carcinoma
COL18A1::KRTAP10-9	Adenocarcinoma
COL18A1::MYOF	Adenocarcinoma
COL18A1::SNW1	Malignant epithelial tumor, special type
COL1A1::AEBP1	Adenocarcinoma
COL1A1::BASP1	Adenocarcinoma
COL1A1::BGN	Squamous cell carcinoma
COL1A1::CAMTA1	Nodular fasciitis
COL1A1::COL1A2	Adenocarcinoma
COL1A1::CPB1	Adenocarcinoma
COL1A1::DACH1	Malignant melanoma
COL1A1::FGD2	Adenocarcinoma
COL1A1::FLNA	Adenocarcinoma
COL1A1::FMNL3	Adenocarcinoma
COL1A1::FYN	Osteoblastoma
COL1A1::GORASP2	Adenocarcinoma
COL1A1::HSP90AB1	Adenocarcinoma
COL1A1::MMP2	Adenocarcinoma
COL1A1::PDGFB	Adenocarcinoma | Fibrosarcoma | Malignant peripheral nerve sheath tumor/Triton | Dermatofibrosarcoma protuberans/Bednar tumor/giant cell fibroblastoma | Fibroblastic/myofibroblastic tumor, NOS | Solitary fibrous tumor
COL1A1::PLAG1	Lipoblastoma
COL1A1::USP6	Aneurysmal bone cyst | Soft tissue tumor, special type | Fibroma of tendon sheath | Nodular fasciitis | Osteogenic/bone tumor, NOS
COL1A2::ALK	Benign fibrous histiocytoma
COL1A2::FSTL1	Malignant epithelial tumor, special type
COL1A2::HSPA8	Squamous cell carcinoma
COL1A2::LAMP2	Adenocarcinoma
COL1A2::PDGFB	Dermatofibrosarcoma protuberans/Bednar tumor/giant cell fibroblastoma
COL1A2::PLAG1	Lipoblastoma
COL1A2::USP6	Nodular fasciitis
COL1A2::WNT2	Adenocarcinoma
COL21A1::CLXN	Squamous cell carcinoma
COL21A1::DST	Squamous cell carcinoma
COL21A1::TFEB	Adenocarcinoma
COL22A1::RAD54B	Adenocarcinoma
COL22A1::ZFAT	Squamous cell carcinoma
COL23A1::FAM193B	Adenocarcinoma
COL24A1::MCOLN3	Acute myelomonocytic leukemia (FAB type M4)
COL25A1::MCUB	Adenocarcinoma
COL26A1::BET1	Adenocarcinoma
COL26A1::GGCT	Astrocytoma, grade III-IV/Glioblastoma
COL27A1::C9ORF43	Malignant epithelial tumor, special type
COL27A1::C9orf43	Malignant epithelial tumor, special type
COL27A1::CUL9	Adenocarcinoma
COL27A1::ESR1	Atypical lipomatous tumor/atypical lipoma/well-differentiated liposarcoma
COL27A1::ZNF618	Adenocarcinoma
COL28A1::MTMR1	Adenocarcinoma
COL2A1::ZNF609	Adenocarcinoma
COL3A1::ANXA1	Squamous cell carcinoma
COL3A1::C7	Astrocytoma, grade I-II
COL3A1::CCT5	Adenocarcinoma
COL3A1::COL16A1	Adenocarcinoma
COL3A1::ERBB3	Adenocarcinoma
COL3A1::IL34	Soft tissue tumor, special type
COL3A1::MMP14	Adenocarcinoma
COL3A1::PDGFRA	Soft tissue tumor, special type
COL3A1::PLAG1	Fibroblastic/myofibroblastic tumor, NOS | Lipoblastoma
COL3A1::PLAT	Adenocarcinoma
COL3A1::RPS4X	Squamous cell carcinoma
COL3A1::SEC63	Malignant epithelial tumor, special type
COL3A1::STAT6	Adenocarcinoma
COL3A1::SUPT16H	Adenocarcinoma
COL3A1::USP6	Fibroma of tendon sheath
COL3A1::UTRN	Adenocarcinoma
COL3A1::VMP1	Adenocarcinoma
COL3A1::ZNF43	Adenocarcinoma
COL4A1::CAMK2D	Adenocarcinoma
COL4A1::ELK3	Squamous cell carcinoma
COL4A1::VEGFD	Vascular and perivascular tumor, NOS
COL4A1::ZNF675	Adenocarcinoma
COL4A1::ZNF827	Adenocarcinoma
COL4A2::CCT5	Adenocarcinoma
COL4A2::CDC16	Squamous cell carcinoma
COL4A2::EEA1	Adenocarcinoma
COL4A2::ELK3	Transitional cell carcinoma
COL4A2::NRAP	Squamous cell carcinoma
COL4A2::NUBPL	Mesenchymal tumor, NOS
COL4A5::RNF128	Squamous cell carcinoma
COL4A5::RTL9	Adenocarcinoma
COL4A5::XRCC4	Squamous cell carcinoma
COL5A1::DDX21	Malignant epithelial tumor, special type
COL5A1::PTGES2	Transitional cell carcinoma
COL5A1::SPATA31D3	Squamous cell carcinoma
COL5A1::UVRAG	Squamous cell carcinoma
COL5A2::SFTPB	Adenocarcinoma
COL5A3::THRAP3	Squamous cell carcinoma
COL6A1::CIRBP	Astrocytoma, grade III-IV/Glioblastoma
COL6A1::CLCN3	Adenocarcinoma
COL6A1::EIF2AK2	Squamous cell carcinoma
COL6A1::PLAT	Adenocarcinoma
COL6A2::DDX27	Transitional cell carcinoma
COL6A2::ELK3	Squamous cell carcinoma
COL6A2::FOXP1	Adenocarcinoma
COL6A2::MYH9	Squamous cell carcinoma
COL6A2::PRDX2	Adenocarcinoma
COL6A3::COL1A1	Adenocarcinoma
COL6A3::CSF1	Diffuse-type giant cell tumor | Localized giant cell tumor of tendon sheath
COL6A3::DDX3X	Adenocarcinoma
COL6A3::PDGFD	Dermatofibrosarcoma protuberans/Bednar tumor/giant cell fibroblastoma
COL7A1::ANXA1	Squamous cell carcinoma
COL7A1::SLC26A6	Adenocarcinoma
COL7A1::UCN2	Squamous cell carcinoma
COL7A1::UQCRC1	Adenocarcinoma
COL9A3::ACTG1	Adenocarcinoma
COL9A3::ELK3	Adenocarcinoma
COLEC11::SOX7	Mesenchymal tumor, NOS
COLEC12::CLUL1	Astrocytoma, grade I-II
COLEC12::ORM1	Adenocarcinoma
COLGALT1::COPE	Astrocytoma, grade I-II
COLGALT1::CYP4F11	Squamous cell carcinoma
COLGALT1::FMNL1	Adenocarcinoma
COLGALT1::LY6G5B	Astrocytoma, grade I-II
COLGALT1::MVB12A	Adenocarcinoma
COLGALT1::PGLS	Squamous cell carcinoma
COLGALT1::PTN	Squamous cell carcinoma
COMMD10::AP3S1	Astrocytoma, grade I-II | Adenocarcinoma
COMMD10::CHSY3	Adenocarcinoma
COMMD10::DGKI	Adenocarcinoma
COMMD10::NUP107	Mesenchymal tumor, NOS
COMMD1::FARS2	Transitional cell carcinoma
COMMD1::PAPOLG	Diffuse large B-cell lymphoma
COMMD6::PCDH9	Astrocytoma, grade I-II
COMMD7::MMP24	Adenocarcinoma
COMMD7::SUN5	Adenocarcinoma
COMMD9::C11ORF91	Malignant melanoma
COMMD9::CD59	Malignant melanoma
COMMD9::CDKL2	Adenocarcinoma
COMMD9::CKAP5	Adenocarcinoma
COMMD9::CYP19A1	Adenocarcinoma
COMT::CERK	Adenocarcinoma
COMT::YPEL1	Adenocarcinoma
COMT::ZDHHC11	Malignant melanoma
COMT::ZDHHC8	Malignant melanoma
COP1::AKT3	Adenocarcinoma
COP1::DDR2	Malignant melanoma
COP1::GRM1	Mesenchymal tumor, NOS
COP1::KIF14	Adenocarcinoma
COP1::LRRC52	Adenocarcinoma
COP1::MSH4	Adenocarcinoma
COP1::SRGAP2	Adenocarcinoma
COP1::TNFSF18	Acute lymphoblastic leukemia/lymphoblastic lymphoma
COP1::XPR1	Adenocarcinoma
COPA::CISD3	Adenocarcinoma
COPA::STAC2	Adenocarcinoma
COPB1::CYP2R1	Adenocarcinoma
COPB1::SPON1	Transitional cell carcinoma
COPB1::TLDC2	Adenocarcinoma
COPE::TMED1	Mesenchymal tumor, NOS
COPE::TMEM59L	Adenocarcinoma
COPG1::RAB7A	Diffuse large B-cell lymphoma
COPG2::CEP41	Adenocarcinoma
COPG2::PODXL	Adenocarcinoma
COPS2::CTTN	Transitional cell carcinoma
COPS2::DPH6	Adenocarcinoma
COPS2::NIBAN3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
COPS3::TEKT3	Adenocarcinoma
COPS3::TOM1L2	Alveolar rhabdomyosarcoma
COPS4::NFXL1	Adenocarcinoma
COPS4::TBC1D9	Undifferentiated round cell sarcoma
COPS7A::CLSTN3	Adenocarcinoma
COPS7A::GNB3	Astrocytoma, grade I-II
COPS7A::RPLP0	Squamous cell carcinoma
COPS7A::ZDHHC11B	Adenocarcinoma
COPS7B::PTMA	Adenocarcinoma
COPS8::RIN3	Squamous cell carcinoma
COPZ1::C19ORF18	Adenocarcinoma
COPZ1::GNPTAB	Mesenchymal tumor, NOS
COPZ1::HNRNPA1	Adenocarcinoma
COPZ1::HOXC4	Adenocarcinoma
COPZ1::HOXC9	Adenocarcinoma
COPZ1::ONECUT2	Adenocarcinoma
COPZ1::PPP1R1A	Astrocytoma, grade I-II
COQ10A::NABP2	Adenocarcinoma
COQ10A::USP5	Astrocytoma, grade III-IV/Glioblastoma
COQ4::DNM1	Adenocarcinoma
COQ6::ACOT4	Adenocarcinoma
COQ6::FLRT1	Astrocytoma, grade I-II
COQ7::OSBPL2	Adenocarcinoma
COQ8A::ARF1	Multiple myeloma
COQ8A::EPHX1	Adenocarcinoma
COQ8B::AKAP8	Adenocarcinoma
COQ8B::NUMBL	Adenocarcinoma | Astrocytoma, grade III-IV/Glioblastoma | Squamous cell carcinoma
COQ9::CCL17	Adenocarcinoma
CORO1B::ERBB2	Adenocarcinoma
CORO1B::TMEM134	Adenocarcinoma
CORO1C::ANKS1B	Adenocarcinoma
CORO1C::ATXN2	Adenocarcinoma
CORO1C::C12ORF42	Adenocarcinoma
CORO1C::C12orf42	Adenocarcinoma
CORO1C::KIF5A	Glioma, NOS
CORO1C::PACRG	Adenocarcinoma
CORO1C::RBFOX1	Mesenchymal tumor, NOS
CORO1C::RFLNA	Astrocytoma, grade I-II
CORO1C::UBC	Multiple myeloma
CORO1C::ZNF664	Astrocytoma, grade I-II
CORO2A::AOPEP	Malignant melanoma
CORO2A::KBTBD4	Adenocarcinoma
CORO2A::NCBP1	Adenocarcinoma
CORO2B::SLC22A23	Malignant melanoma
CORO6::SLC20A2	Malignant melanoma
CORO7::CLEC16A	Adenocarcinoma
CORO7::GFOD2	Adenocarcinoma
CORO7::NFKB2	Multiple myeloma
CORO7::RMI2	Adenocarcinoma
CORO7::TRAF7	Astrocytoma, grade I-II
COTL1::PREX2	Squamous cell carcinoma
COX10::INPP5K	Adenocarcinoma
COX14::GPD1	Astrocytoma, grade III-IV/Glioblastoma
COX14::LIMA1	Adenocarcinoma
COX14::PTEN	Mesenchymal tumor, special type
COX14::SPATS2	Astrocytoma, grade III-IV/Glioblastoma
COX14::USP9X	Adenocarcinoma
COX18::INPP4B	Adenocarcinoma
COX18::TBCD	Adenocarcinoma
COX18::ZFAT	Squamous cell carcinoma
COX19::DNAAF5	Diffuse large B-cell lymphoma
COX20::SDCCAG8	Adenocarcinoma
COX20::SMR3B	Adenocarcinoma
COX6A1::PPP1R12A	Mesenchymal tumor, NOS
COX6B1::CEP89	Adenocarcinoma
COX6B1::SERTAD1	Adenocarcinoma
COX6B1::TTYH1	Adenocarcinoma
COX6C::DDX27	Adenocarcinoma
COX6C::EIF2AK2	Adenocarcinoma
COX6C::RGS22	Adenocarcinoma
COX6C::TDRD12	Transitional cell carcinoma
COX6C::ZFPM2	Adenocarcinoma
COX7A2::USP18	Adenocarcinoma
COX7B2::PIP4K2A	Squamous cell carcinoma
COX7C::PLEKHA5	Malignant melanoma
CP::COMMD2	Adenocarcinoma
CP::MRAS	Squamous cell carcinoma
CP::SOX5	Adenocarcinoma
CP::WWTR1	Adenocarcinoma
CPA1::SCYL1	Adenocarcinoma
CPAMD8::HAUS8	Adenocarcinoma
CPAMD8::LILRB3	Adenocarcinoma
CPAMD8::SAP18	Adenocarcinoma
CPAMD8::SKAP1	Squamous cell carcinoma
CPAMD8::SMIM7	Adenocarcinoma
CPB1::ANXA1	Adenocarcinoma
CPB1::AP3S2	Adenocarcinoma
CPB1::ATP5MC3	Adenocarcinoma
CPB1::DDX21	Adenocarcinoma
CPB1::MGP	Adenocarcinoma
CPB1::NDUFV1	Adenocarcinoma
CPB1::SNW1	Adenocarcinoma
CPB2::LCP1	Adenocarcinoma
CPB2::ZC3H13	Adenocarcinoma
CPD::AATF	Adenocarcinoma
CPD::ADAP2	Adenocarcinoma
CPD::EFCAB5	Adenocarcinoma | Mature B-cell neoplasm, NOS
CPD::ERBB2	Carcinoma, NOS | Adenocarcinoma
CPD::GSDMB	Adenocarcinoma
CPD::HDAC5	Adenocarcinoma
CPD::MYL4	Adenocarcinoma
CPD::NDUFS4	Acute myeloid leukemia, NOS | Skin
CPD::NF1	Squamous cell carcinoma
CPD::NSRP1	Angiosarcoma
CPD::ORMDL3	Adenocarcinoma
CPD::PDE4D	Transitional cell carcinoma
CPD::PIGW	Adenocarcinoma
CPD::RABIF	Adenocarcinoma
CPD::SKAP1	Adenocarcinoma
CPD::TBX2	Adenocarcinoma
CPD::TMEM132E	Mesenchymal tumor, NOS
CPD::WNT3	Adenocarcinoma
CPE::ALK	Adenosquamous carcinoma
CPE::ARHGEF4	Astrocytoma, grade I-II
CPE::GNAS	Malignant epithelial tumor, special type | Adenocarcinoma
CPE::PLEKHA5	Astrocytoma, grade I-II
CPE::SMIM14	Adenocarcinoma
CPEB1::CRTC3	Malignant melanoma
CPEB2::LDB2	Adenocarcinoma
CPEB3::PRIM1	Adenocarcinoma
CPEB3::RET	Carcinoma, NOS
CPEB4::SHISA5	Adenocarcinoma
CPEB4::STK32A	Adenocarcinoma
CPED1::BCO2	Adenocarcinoma
CPLANE1::NPR3	Squamous cell carcinoma
CPLANE1::NUP155	Adenocarcinoma
CPLANE1::SEMA5A	Malignant melanoma
CPLANE1::SKP2	Adenocarcinoma
CPLX1::GAK	Astrocytoma, grade I-II
CPM::AVIL	Mesenchymal tumor, NOS
CPM::BEST3	Mesenchymal tumor, NOS
CPM::CCT2	Mesenchymal tumor, NOS
CPM::DNM3	Mesenchymal tumor, NOS
CPM::GOLT1B	Adenocarcinoma
CPM::KCNMA1	Adenocarcinoma
CPM::MYRFL	Mesenchymal tumor, NOS
CPM::NUP107	Astrocytoma, grade III-IV/Glioblastoma
CPN1::ACTR1A	Adenocarcinoma
CPN1::PKD2L1	Adenocarcinoma
CPNE1::ASIP	Transitional cell carcinoma
CPNE1::DMD	Adenocarcinoma
CPNE1::GNAS	Adenocarcinoma
CPNE1::LPO	Adenocarcinoma
CPNE1::MROH8	Adenocarcinoma
CPNE1::NDUFV1	Adenocarcinoma
CPNE1::PI3	Adenocarcinoma
CPNE1::ZNF618	Adenocarcinoma
CPNE2::HS1BP3	Astrocytoma, grade III-IV/Glioblastoma
CPNE2::MT1E	Adenocarcinoma
CPNE2::NUP93	Adenocarcinoma
CPNE2::PSME3IP1	Adenocarcinoma
CPNE3::ANGPT1	Astrocytoma, grade I-II
CPNE3::PSKH2	Adenocarcinoma
CPNE4::ABCC5	Adenocarcinoma
CPNE4::ACAD11	Adenocarcinoma
CPNE4::MRPL3	Adenocarcinoma
CPNE6::CARMIL3	Adenocarcinoma
CPNE8::CADM2	Adenocarcinoma
CPNE8::CILP	Mesothelioma
CPNE8::CNTN1	Adenocarcinoma
CPNE8::MGST1	Adenocarcinoma
CPNE8::PRMT8	Mesenchymal tumor, NOS
CPQ::COL14A1	Squamous cell carcinoma
CPQ::ERICH5	Adenocarcinoma
CPQ::OC90	Adenocarcinoma
CPQ::PRKDC	Adenocarcinoma
CPQ::RABGEF1	Malignant melanoma
CPS1::MAP2	Adenocarcinoma
CPS1::PLCD4	Adenocarcinoma
CPS1::PLEKHM3	Mesenchymal tumor, NOS
CPS1::SGO2	Mesenchymal tumor, NOS
CPS1::SPPL3	Adenocarcinoma
CPSF1::AHNAK	Adenocarcinoma
CPSF1::ARHGAP39	Adenocarcinoma
CPSF1::RECQL4	Adenocarcinoma
CPSF1::TONSL	Adenocarcinoma
CPSF1::VPS28	Squamous cell carcinoma
CPSF6::AOPEP	Adenocarcinoma
CPSF6::CCNL2	Mesenchymal tumor, NOS
CPSF6::CHMP1A	Transitional cell carcinoma
CPSF6::CLDN11	Adenocarcinoma
CPSF6::COL16A1	Squamous cell carcinoma
CPSF6::COL9A1	Mesenchymal tumor, NOS
CPSF6::CPM	Mesenchymal tumor, NOS
CPSF6::DCN	Adenocarcinoma
CPSF6::EEA1	Adenocarcinoma
CPSF6::EXOC3	Transitional cell carcinoma
CPSF6::FGFR1	Chronic myeloproliferative disorder, NOS
CPSF6::GRM8	Mesenchymal tumor, NOS
CPSF6::ITPR2	Acute myeloid leukemia, NOS | Skin
CPSF6::LAMA2	Mesenchymal tumor, NOS
CPSF6::MDM1	Adenocarcinoma
CPSF6::MYRFL	Adenocarcinoma
CPSF6::NAV3	Adenocarcinoma
CPSF6::NTRK1	Soft tissue tumor, special type
CPSF6::NUP107	Malignant melanoma
CPSF6::OSBPL8	Adenocarcinoma
CPSF6::OXLD1	Mesenchymal tumor, NOS
CPSF6::PDGFRB	Thymus | Myelodysplastic/myeloproliferative disease, NOS
CPSF6::PTPRB	Astrocytoma, grade I-II
CPSF6::RARG	Acute promyelocytic leukemia (FAB type M3) | Acute myeloid leukemia, special type
CPSF6::SEC61B	Malignant melanoma
CPSF6::SH3YL1	Adenocarcinoma
CPSF6::SMR3B	Adenocarcinoma
CPSF6::TMTC2	Mesenchymal tumor, NOS
CPSF6::TSPAN31	Mesenchymal tumor, NOS
CPSF6::UBC	Multiple myeloma
CPSF6::ZBTB1	Adenocarcinoma
CPSF7::BSCL2	Adenocarcinoma
CPT1A::ADAM2	Adenocarcinoma
CPT1A::ANPEP	Adenocarcinoma
CPT1A::CHKA	Adenocarcinoma
CPT1A::FGF3	Squamous cell carcinoma
CPT1A::GAL3ST3	Transitional cell carcinoma
CPT1A::GDPD4	Adenocarcinoma
CPT1A::KCNG1	Adenocarcinoma
CPT1A::KMT5B	Malignant melanoma | Squamous cell carcinoma
CPT1A::KRT8	Adenocarcinoma
CPT1A::LPCAT2	Adenocarcinoma
CPT1A::LPXN	Squamous cell carcinoma
CPT1A::MAPK8IP3	Adenocarcinoma
CPT1A::MRPL21	Squamous cell carcinoma
CPT1A::MS4A18	Adenocarcinoma
CPT1A::MYEOV	Adenocarcinoma
CPT1A::P4HA3	Squamous cell carcinoma
CPT1A::PPFIA1	Adenocarcinoma
CPT1A::RNFT1	Adenocarcinoma
CPT1A::SHANK2	Squamous cell carcinoma
CPT1A::SYT12	Squamous cell carcinoma
CPT1A::TRIM24	Adenocarcinoma
CPT1B::SEC14L3	Adenocarcinoma
CPT2::SCP2	Adenocarcinoma
CR1L::C1ORF116	Adenocarcinoma
CR1L::C1orf116	Adenocarcinoma
CRACD::ITSN1	Adenocarcinoma
CRACD::NMU	Astrocytoma, grade III-IV/Glioblastoma
CRACD::PDGFRA	Astrocytoma, grade I-II
CRACD::SCFD2	Astrocytoma, grade I-II
CRACD::STMN1	Adenocarcinoma
CRACR2A::C12ORF4	Astrocytoma, grade III-IV/Glioblastoma
CRACR2A::C12orf4	Astrocytoma, grade III-IV/Glioblastoma
CRACR2A::SOX5	Adenocarcinoma
CRACR2A::SYT10	Mesenchymal tumor, NOS
CRACR2B::WDTC1	Adenocarcinoma
CRADD::GRIP1	Mesenchymal tumor, NOS
CRADD::MRPL42	Adenocarcinoma
CRAMP1::CLCN7	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CRAMP1::IFT140	Adenocarcinoma
CRAMP1::TMEM204	Mesenchymal tumor, NOS
CRAMP1::TVP23A	Astrocytoma, grade III-IV/Glioblastoma
CRAT::TTLL11	Mesenchymal tumor, NOS
CRB1::IGFN1	Astrocytoma, grade I-II
CRB2::RECK	Astrocytoma, grade III-IV/Glioblastoma
CRB3::RTP1	Adenocarcinoma
CRB3::SAFB	Adenocarcinoma
CRBN::GRM7	Adenocarcinoma
CRCP::ADAM22	Squamous cell carcinoma
CRCP::CYYR1	Adenocarcinoma
CRCP::PIK3AP1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CRCP::RELN	Adenocarcinoma
CRCT1::SPRR2A	Squamous cell carcinoma
CREB1::FASTKD2	Adenocarcinoma
CREB1::PARD3B	Astrocytoma, grade III-IV/Glioblastoma
CREB1::SUCNR1	Adenocarcinoma
CREB3::TMEM8B	Adenocarcinoma
CREB3L1::ATG13	Adenocarcinoma
CREB3L2::ATP6V0A4	Adenocarcinoma
CREB3L2::CPA2	Adenocarcinoma
CREB3L2::LASP1	Adenocarcinoma
CREB3L2::PPARG	Adenocarcinoma
CREB3L2::SHANK2	Adenocarcinoma
CREB3L3::PKN3	Adenocarcinoma
CREB3L4::FCER1A	Mesenchymal tumor, NOS
CREB5::ABCA13	Astrocytoma, grade III-IV/Glioblastoma
CREB5::APH1A	Malignant epithelial tumor, special type
CREB5::JAZF1	Malignant melanoma
CREB5::KCNH2	Astrocytoma, grade III-IV/Glioblastoma
CREB5::USP42	Adenocarcinoma
CREBBP::ABCA3	Multiple myeloma
CREBBP::ADCY9	Adenocarcinoma | Transitional cell carcinoma
CREBBP::ATG10	Squamous cell carcinoma
CREBBP::B2M	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CREBBP::BCOR	Endometrial stromal sarcoma
CREBBP::BCORL1	Neuroglial neoplasm, special type | Oligodendroglioma | Ossifying fibromyxoid tumor
CREBBP::CASKIN1	Transitional cell carcinoma
CREBBP::CIAO3	Adenocarcinoma
CREBBP::CRAMP1	Adenocarcinoma
CREBBP::DEXI	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CREBBP::DNAJA3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CREBBP::ELOB	Squamous cell carcinoma
CREBBP::GLYR1	Adenocarcinoma
CREBBP::GOLGA6L2	Astrocytoma, grade III-IV/Glioblastoma | Astrocytoma, grade I-II
CREBBP::HCN1	Squamous cell carcinoma
CREBBP::IFT140	Adenocarcinoma
CREBBP::KAT6A	Skin | Acute monoblastic leukemia (FAB type M5) | Acute myeloid leukemia, NOS
CREBBP::LUC7L	Adenocarcinoma
CREBBP::MEFV	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CREBBP::NAA60	Squamous cell carcinoma
CREBBP::NLRC3	Adenocarcinoma | Transitional cell carcinoma
CREBBP::NUBP1	Adenocarcinoma
CREBBP::PRSS22	Transitional cell carcinoma
CREBBP::PRSS33	Squamous cell carcinoma
CREBBP::RANBP3	Adenocarcinoma
CREBBP::RHBDF1	Undifferentiated carcinoma, small cell
CREBBP::SLX4	Squamous cell carcinoma | Undifferentiated carcinoma, small cell
CREBBP::SRCAP	Acute myeloid leukemia, NOS | Skin
CREBBP::SRGAP2B	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CREBBP::SRL	Adenocarcinoma
CREBBP::SRRM2	Astrocytoma, grade III-IV/Glioblastoma | Astrocytoma, grade I-II
CREBBP::TEDC2	Malignant melanoma
CREBBP::TP53TG3	Adenocarcinoma
CREBBP::TRAP1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CREBBP::TRIM69	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CREBBP::WRAP53	Mesenchymal tumor, NOS
CREBBP::ZNF384	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CREBBP::ZNF500	Adenocarcinoma
CREBBP::ZNF597	Adenocarcinoma
CREBL2::GPR19	Transitional cell carcinoma
CREBRF::AK7	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CREBRF::CSNK1A1	Astrocytoma, grade I-II
CREBRF::SLIT3	Adenocarcinoma
CREBZF::PHF1	Ossifying fibromyxoid tumor
CREG1::MPC2	Adenocarcinoma
CRELD1::FANCD2	Astrocytoma, grade I-II
CRELD1::FANCD2OS	Germ cell tumor, NOS
CRELD1::JAGN1	Miscellaneous hematopoietic/lymphoid neoplasm, special type
CREM::BCAT1	Multiple myeloma
CRHR1::CENPP	Adenocarcinoma
CRHR1::SPOP	Malignant epithelial tumor, special type
CRIM1::AFF3	Mesothelioma
CRIM1::EEF1B2	Adenocarcinoma
CRIM1::HAAO	Adenocarcinoma
CRIM1::TACR1	Adenocarcinoma
CRIM1::TBC1D25	Adenocarcinoma
CRIM1::VIT	Adenocarcinoma
CRIP1::AP1G2	Adenocarcinoma
CRIP2::MTA1	Adenocarcinoma
CRIP2::SERINC2	Adenocarcinoma
CRIPT::BIRC6	Adenocarcinoma
CRISPLD1::LY96	Transitional cell carcinoma
CRISPLD1::MSC	Mesenchymal tumor, NOS
CRISPLD1::PLAG1	Adenoma
CRISPLD2::MPZL2	Malignant melanoma
CRK::GEMIN4	Adenocarcinoma
CRK::GTF2I	Adenocarcinoma
CRK::MYO1C	Adenocarcinoma
CRK::PITPNA	Adenocarcinoma
CRK::SLC43A2	Adenocarcinoma
CRK::SMG6	Adenocarcinoma
CRK::STX8	Squamous cell carcinoma
CRKL::GRAMD4	Malignant melanoma
CRKL::HPS4	Adenocarcinoma
CRKL::MAPK1	Adenocarcinoma
CRKL::RGS6	Adenocarcinoma
CRKL::SLC25A18	Adenocarcinoma
CRLF3::AATF	Transitional cell carcinoma
CRLF3::ATAD5	Adenocarcinoma
CRLF3::CRHR1	Malignant melanoma
CRLF3::OPA3	Malignant melanoma
CRLS1::CDS2	Adenocarcinoma
CRLS1::CES5A	Adenocarcinoma
CRLS1::KCNK17	Undifferentiated carcinoma, small cell
CRLS1::NFX1	Adenocarcinoma
CRLS1::SEL1L2	Adenocarcinoma
CRLS1::TRMT6	Adenocarcinoma
CROCC2::TMEM232	Adenocarcinoma
CRP::DDX27	Adenocarcinoma
CRPPA::MEOX2	Astrocytoma, grade I-II
CRTAC1::CCT5	Malignant melanoma
CRTC1::HNRNPM	Astrocytoma, grade III-IV/Glioblastoma
CRTC1::KCNN1	Adenocarcinoma
CRTC1::KLHL26	Astrocytoma, grade III-IV/Glioblastoma
CRTC1::LYPD4	Squamous cell carcinoma
CRTC1::MAML2	Mucoepidermoid carcinoma | Adenocarcinoma | Warthin tumor | Benign epithelial tumor, special type | Malignant epithelial tumor, special type
CRTC1::MRTFB	Osteogenic/bone tumor, special type | Soft tissue tumor, special type
CRTC1::NCOA2	Mesenchymal tumor, special type
CRTC1::SS18	Undifferentiated round cell sarcoma
CRTC1::SSBP4	Adenocarcinoma
CRTC1::TRIM11	Melanocytic neoplasm, special type
CRTC2::CREB3L4	Acute myeloblastic leukemia with maturation (FAB type M2)
CRTC2::KHDC4	Adenocarcinoma
CRTC3::IQGAP1	Malignant melanoma | Adenocarcinoma | Hepatoblastoma
CRTC3::MAML2	Mucoepidermoid carcinoma | Malignant epithelial tumor, special type
CRTC3::MESP2	Malignant epithelial tumor, special type
CRTC3::PTEN	Adenocarcinoma
CRY1::HPSE2	Adenocarcinoma
CRY1::SVOP	Adenocarcinoma
CRY2::CSTPP1	Malignant epithelial tumor, special type
CRYBG1::ARMC2	Adenocarcinoma
CRYBG1::BEND3	Adenocarcinoma
CRYBG1::MYB	Adenocarcinoma
CRYBG1::STAT6	Adenocarcinoma
CRYBG3::ARL6	Adenocarcinoma
CRYBG3::IL20RB	Squamous cell carcinoma
CRYBG3::MYBPC1	Squamous cell carcinoma
CRYL1::GJA3	Adenocarcinoma
CRYL1::GJB6	Adenocarcinoma
CRYL1::MLNR	Mesenchymal tumor, NOS
CRYL1::SPACA7	Adenocarcinoma
CRYM::XYLT1	Mesenchymal tumor, NOS
CRYZ::VPS13D	Adenocarcinoma
CS::COQ10A	Adenocarcinoma
CS::DGKD	Adenocarcinoma
CS::MUCL1	Squamous cell carcinoma
CS::PRIM1	Adenocarcinoma
CS::SMARCC2	Adenocarcinoma
CSAD::ITGB7	Adenocarcinoma
CSAD::MYH7	Skin | Acute myeloid leukemia, NOS
CSAD::NPFF	Squamous cell carcinoma
CSAD::ZYG11B	Adenocarcinoma
CSDC2::ACO2	Adenocarcinoma
CSDE1::CYB5B	Squamous cell carcinoma
CSDE1::DDX27	Adenocarcinoma
CSDE1::DENND2C	Adenocarcinoma
CSDE1::RBFOX1	Adenocarcinoma
CSDE1::ST7L	Adenocarcinoma
CSE1L::ARFGEF2	Adenocarcinoma
CSE1L::LETM2	Adenocarcinoma
CSF1::CD101	Localized giant cell tumor of tendon sheath
CSF1::CD96	Diffuse-type giant cell tumor
CSF1::CDH17	Localized giant cell tumor of tendon sheath | Diffuse-type giant cell tumor
CSF1::COL6A3	Localized giant cell tumor of tendon sheath | Diffuse-type giant cell tumor
CSF1::FN1	Localized giant cell tumor of tendon sheath
CSF1::GSTM5	Adenocarcinoma
CSF1::NOTCH2	Localized giant cell tumor of tendon sheath
CSF1::PRG4	Localized giant cell tumor of tendon sheath
CSF1::S100A10	Localized giant cell tumor of tendon sheath
CSF1::TNC	Localized giant cell tumor of tendon sheath
CSF1::VCAM1	Diffuse-type giant cell tumor
CSF2RA::CRLF2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CSF3R::SPTAN1	Chronic myeloproliferative disorder, NOS
CSGALNACT1::TMEM150A	Adenocarcinoma
CSGALNACT2::AGAP9	Adenocarcinoma
CSGALNACT2::SLC16A9	Adenocarcinoma
CSK::TMEM266	Malignant melanoma
CSKMT::DPF2	Astrocytoma, grade III-IV/Glioblastoma
CSKMT::HK1	Adenocarcinoma
CSMD1::CDIN1	Squamous cell carcinoma
CSMD1::MEAF6	Ossifying fibromyxoid tumor
CSMD1::PLAG1	Adenoma
CSMD2::DNAH14	Adenocarcinoma
CSMD2::FYB1	Adenocarcinoma
CSMD2::IFI44L	Adenocarcinoma
CSMD2::IL2RA	Astrocytoma, grade III-IV/Glioblastoma
CSMD2::TMEM222	Astrocytoma, grade III-IV/Glioblastoma
CSMD3::ADCY8	Mesenchymal tumor, NOS
CSMD3::ANGPT1	Squamous cell carcinoma
CSMD3::MYC	Undifferentiated carcinoma, small cell
CSMD3::RIMS2	Adenocarcinoma
CSN1S1::CSN2	Adenocarcinoma
CSN1S1::MGP	Adenocarcinoma
CSN2::CSN1S1	Adenocarcinoma
CSN2::LALBA	Adenocarcinoma
CSN3::FDCSP	Adenocarcinoma
CSNK1A1::ACACA	Adenocarcinoma
CSNK1A1::ARHGEF37	Squamous cell carcinoma
CSNK1A1::CAMK2A	Adenocarcinoma
CSNK1A1::FOXL2NB	Adenocarcinoma
CSNK1A1::MYO15B	Adenocarcinoma
CSNK1A1::PDE6A	Adenocarcinoma
CSNK1A1::SCGB3A2	Adenocarcinoma
CSNK1D::ALDH3A2	Mesenchymal tumor, NOS
CSNK1D::ASPSCR1	Adenocarcinoma
CSNK1D::DUS1L	Transitional cell carcinoma
CSNK1D::GSDMA	Mesenchymal tumor, NOS
CSNK1D::METRNL	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CSNK1D::POLR2E	Adenocarcinoma
CSNK1D::RNF213	Astrocytoma, grade I-II
CSNK1D::SCPEP1	Squamous cell carcinoma
CSNK1D::SECTM1	Adenocarcinoma | Squamous cell carcinoma
CSNK1E::DDX17	Adenocarcinoma | Astrocytoma, grade III-IV/Glioblastoma
CSNK1E::DMC1	Adenocarcinoma
CSNK1E::DNAL4	Adenocarcinoma
CSNK1E::DYNLRB1	Adenocarcinoma
CSNK1E::FAM227A	Adenocarcinoma
CSNK1E::KDELR3	Adenocarcinoma
CSNK1E::MB	Adenocarcinoma
CSNK1E::PHF5A	Malignant melanoma
CSNK1E::PLA2G6	Squamous cell carcinoma
CSNK1E::SPATA21	Adenocarcinoma
CSNK1E::SPRR3	Adenocarcinoma
CSNK1G1::AP4E1	Adenocarcinoma
CSNK1G1::CS	Adenocarcinoma
CSNK1G1::INTS2	Squamous cell carcinoma
CSNK1G1::MESP1	Malignant melanoma
CSNK1G1::PPIB	Squamous cell carcinoma
CSNK1G2::PDE5A	Mesenchymal tumor, NOS
CSNK1G2::REXO1	Multiple myeloma
CSNK1G2::RNF126	Multiple myeloma
CSNK1G3::TNK1	Acute myeloid leukemia, NOS | Skin
CSNK2A1::KIF16B	Squamous cell carcinoma
CSNK2A1::SLC52A3	Adenocarcinoma
CSNK2A1::SMARCA2	Astrocytoma, grade III-IV/Glioblastoma
CSNK2A1::SNRPB	Adenocarcinoma
CSNK2B::CCT5	Malignant epithelial tumor, special type
CSNK2B::VARS1	Adenocarcinoma
CSPG4::MYO1D	Mesenchymal tumor, NOS
CSPP1::CLVS1	Malignant melanoma
CSPP1::CPA6	Adenocarcinoma
CSPP1::MAN1A2	Adenocarcinoma
CSPP1::PPP1R42	Transitional cell carcinoma
CSPP1::TERF1	Adenocarcinoma
CSPP1::VRK1	Adenocarcinoma
CSRNP2::GLS2	Adenocarcinoma
CSRNP2::PCSK7	Carcinoma, NOS
CSRP1::PALLD	Mesenchymal tumor, NOS
CSRP1::RASGEF1B	Adenocarcinoma
CSRP2::NAV3	Malignant melanoma
CST3::CCT5	Astrocytoma, grade I-II
CSTA::CASR	Squamous cell carcinoma
CSTF1::BLM	Malignant melanoma
CSTF1::RTF2	Malignant epithelial tumor, special type
CSTF3::CCDC73	Squamous cell carcinoma
CSTF3::HSP90AA1	Squamous cell carcinoma
CSTF3::LMO2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CSTPP1::C11orf24	Adenocarcinoma
CSTPP1::CD5	Adenocarcinoma
CSTPP1::F2	Adenocarcinoma
CSTPP1::LRP4	Squamous cell carcinoma
CSTPP1::NUP98	Adenocarcinoma
CSTPP1::PACSIN3	Adenocarcinoma
CSTPP1::PPME1	Adenocarcinoma
CSTPP1::RTN4	Adenocarcinoma
CTBP1::FAM193A	Astrocytoma, grade I-II
CTBP1::MAEA	Adenocarcinoma
CTBP1::POLN	Adenocarcinoma
CTBP1::RNF4	Astrocytoma, grade I-II
CTBP2::ADAM12	Adenocarcinoma
CTBP2::CTNNB1	Adenocarcinoma
CTBP2::EEF1AKMT2	Adenocarcinoma
CTBP2::FBXO17	Adenocarcinoma
CTBP2::IL1RAPL1	Adenocarcinoma
CTBP2::KCNMA1	Adenocarcinoma
CTBP2::MGMT	Astrocytoma, grade I-II
CTBP2::OSTM1	Adenocarcinoma
CTBS::GNG5	Nonneoplastic mesenchymal disorder/lesion | Adenocarcinoma | Nonneoplastic hematologic disorder/lesion | Malignant epithelial tumor, special type | Schwannoma | Nonneoplastic epithelial disorder/lesion
CTCF::CES2	Malignant melanoma
CTCF::E2F4	Squamous cell carcinoma
CTCF::GFOD2	Squamous cell carcinoma
CTCF::HNRNPDL	Adenocarcinoma
CTCF::HSD11B2	Adenocarcinoma
CTCF::NCOA2	Mesenchymal tumor, special type | Soft tissue tumor, special type
CTCF::NCOA3	Mesenchymal tumor, special type
CTCF::NETO2	Acute myeloblastic leukemia with maturation (FAB type M2)
CTCF::NUTF2	Adenocarcinoma
CTCF::PARD6A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CTCF::PSKH1	Malignant epithelial tumor, special type
CTCF::SLC7A6	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CTCF::SPSB1	Adenocarcinoma
CTCFL::POLR3H	Adenocarcinoma
CTDNEP1::SHBG	Adenocarcinoma
CTDP1::NFATC1	Acute myeloid leukemia, NOS | Skin
CTDP1::SLC66A2	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Acute myeloid leukemia, NOS | Skin
CTDSP1::CFLAR	Acute myelomonocytic leukemia (FAB type M4) | Acute myeloblastic leukemia without maturation (FAB type M1)
CTDSP2::ARHGAP9	Malignant melanoma
CTDSP2::B4GALNT1	Astrocytoma, grade I-II
CTDSP2::COL15A1	Astrocytoma, grade I-II | Oligodendroglioma
CTDSP2::DCUN1D4	Astrocytoma, grade III-IV/Glioblastoma
CTDSP2::GLI1	Astrocytoma, grade III-IV/Glioblastoma | Astrocytoma, grade I-II
CTDSP2::INHBE	Astrocytoma, grade III-IV/Glioblastoma
CTDSP2::MAGEB16	Adenocarcinoma
CTDSP2::MDM2	Astrocytoma, grade III-IV/Glioblastoma
CTDSP2::METTL1	Adenocarcinoma
CTDSP2::MYG1	Astrocytoma, grade III-IV/Glioblastoma
CTDSP2::OS9	Astrocytoma, grade III-IV/Glioblastoma
CTDSP2::PLAG1	Lipoblastoma
CTDSP2::RTN4IP1	Adenocarcinoma
CTDSP2::TAFA2	Liposarcoma, dedifferentiated
CTDSP2::TSPAN31	Astrocytoma, grade III-IV/Glioblastoma
CTDSPL2::CKMT1A	Adenocarcinoma
CTDSPL2::FBXO42	Adenocarcinoma
CTDSPL2::GOLM2	Adenocarcinoma
CTDSPL::CPS1	Adenocarcinoma
CTDSPL::ITGA9	Adenocarcinoma
CTDSPL::RAF1	Malignant melanoma | Melanocytic neoplasm, special type
CTDSPL::TMCC1	Adenocarcinoma
CTDSPL::TNRC6B	Benign epithelial tumor, special type | Miscellaneous hematopoietic/lymphoid neoplasm, special type
CTDSPL::WRN	Transitional cell carcinoma
CTF1::BCL7C	Adenocarcinoma
CTIF::AJUBA	Mesenchymal tumor, NOS
CTIF::ARK2N	Adenocarcinoma
CTIF::CCDC107	Malignant epithelial tumor, special type
CTIF::GRM4	Adenocarcinoma
CTIF::KATNAL2	Adenocarcinoma
CTIF::LOXHD1	Adenocarcinoma
CTIF::MOB2	Adenocarcinoma
CTIF::MOCOS	Squamous cell carcinoma
CTIF::PSTPIP2	Squamous cell carcinoma
CTIF::SDHAF4	Adenocarcinoma
CTIF::SMAD2	Adenocarcinoma
CTIF::WASF2	Adenocarcinoma
CTLA4::CD28	Peripheral T-cell lymphoma, unspecified | Adult T-cell lymphoma/leukemia (HTLV-1+)
CTNNA1::ALK	Malignant epithelial tumor, special type | Adenocarcinoma
CTNNA1::AP3B1	Squamous cell carcinoma
CTNNA1::COTL1	Adenocarcinoma
CTNNA1::CYSTM1	Mesenchymal tumor, NOS
CTNNA1::DNAH14	Adenocarcinoma
CTNNA1::EGR1	Adenocarcinoma
CTNNA1::GLRA1	Adenocarcinoma
CTNNA1::HEYL	Squamous cell carcinoma
CTNNA1::KDM3B	Adenocarcinoma
CTNNA1::LARP1	Transitional cell carcinoma
CTNNA1::MGME1	Adenocarcinoma
CTNNA1::PAK2	Soft tissue tumor, special type
CTNNA1::PKD2L2	Adenocarcinoma
CTNNA1::PLEKHG4B	Adenocarcinoma
CTNNA1::RAF1	Malignant melanoma
CTNNA1::REEP2	Adenocarcinoma
CTNNA1::SCUBE1	Adenocarcinoma
CTNNA1::SEC24A	Adenocarcinoma
CTNNA1::SLC38A9	Adenocarcinoma
CTNNA1::SRSF4	Adenocarcinoma
CTNNA1::WNT8A	Adenocarcinoma
CTNNA2::ALK	Adenocarcinoma
CTNNA2::REG3G	Adenocarcinoma
CTNNA3::ARHGAP21	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CTNNA3::BORCS5	Adenocarcinoma
CTNNA3::DNAJC12	Multiple myeloma
CTNNA3::IGF2	Squamous cell carcinoma
CTNNA3::LRRC74A	Adenocarcinoma
CTNNA3::MGMT	Adenocarcinoma
CTNNA3::RSF1	Adenocarcinoma
CTNNA3::SGMS1	Adenocarcinoma
CTNNAL1::ABITRAM	Adenocarcinoma
CTNNAL1::EPB41L4B	Adenocarcinoma
CTNNB1::DOCK3	Mesothelioma
CTNNB1::IGF2BP2	Malignant epithelial tumor, special type
CTNNB1::IQCE	Malignant melanoma
CTNNB1::PLAG1	Myoepithelioma/myoepithelial carcinoma/mixed tumor | Benign epithelial tumor, special type | Malignant epithelial tumor, special type | Adenoma | Carcinoma, NOS | Adenocarcinoma
CTNNB1::PRKD2	Adenocarcinoma
CTNNB1::SEM1	Transitional cell carcinoma
CTNNB1::SLC38A5	Adenocarcinoma
CTNNB1::TCOF1	Squamous cell carcinoma
CTNNB1::THRB	Adenocarcinoma
CTNNB1::USP6	Fibroma of tendon sheath | Nodular fasciitis | Aneurysmal bone cyst
CTNNBIP1::CLSTN1	Nonneoplastic epithelial disorder/lesion
CTNNBIP1::LZIC	Adenocarcinoma
CTNNBIP1::UBE4B	Squamous cell carcinoma
CTNNBL1::ETFA	Adenocarcinoma
CTNNBL1::RAF1	Adenocarcinoma
CTNNBL1::TSHZ2	Adenocarcinoma
CTNNBL1::TTI1	Adenocarcinoma
CTNND1::ALK	Adenocarcinoma
CTNND1::BTBD18	Adenocarcinoma
CTNND1::CLPB	Adenocarcinoma
CTNND1::DDAH2	Adenocarcinoma
CTNND1::DOCK8	Adenocarcinoma
CTNND1::DTX4	Adenocarcinoma
CTNND1::LARGE2	Squamous cell carcinoma
CTNND1::PACS1	Malignant melanoma
CTNND1::RAB6A	Adenocarcinoma
CTNND1::SLC22A10	Squamous cell carcinoma
CTNND1::STARD10	Adenocarcinoma
CTNND1::TIMM10	Adenocarcinoma
CTNND1::TMX2	Adenocarcinoma
CTNND1::ZDHHC5	Adenocarcinoma
CTNND1::ZNFX1	Transitional cell carcinoma
CTNND2::DAP	Malignant epithelial tumor, special type
CTNND2::GPI	Adenocarcinoma
CTNND2::MTMR12	Astrocytoma, grade I-II
CTNND2::NRBP1	Astrocytoma, grade I-II
CTNND2::P4HA2	Adenocarcinoma
CTNND2::POLR1A	Malignant melanoma
CTNND2::PPARGC1B	Malignant melanoma
CTNND2::TERT	Adipocytic tumor, special type
CTNND2::TRIO	Neuroblastoma
CTNS::OLFM2	Mesenchymal tumor, NOS
CTPS1::ASB3	Adenocarcinoma
CTPS1::HIVEP3	Adenocarcinoma
CTPS1::NFYC	Russia | Adenocarcinoma | Primitive neuroectodermal tumor/Medulloblastoma
CTPS1::TMEM53	Adenocarcinoma
CTPS2::RBBP7	Adenocarcinoma
CTPS2::RGN	Mesenchymal tumor, NOS
CTPS2::TMSB15A	Adenocarcinoma
CTRB2::IGF2	Adenocarcinoma
CTRC::NTRK1	Adenocarcinoma
CTRC::PRSS2	Adenocarcinoma
CTSA::WFDC3	Squamous cell carcinoma
CTSB::ALK	Adenocarcinoma
CTSB::ARFGEF2	Adenocarcinoma
CTSB::BACE2	Ewing sarcoma
CTSB::CBS	Adenocarcinoma
CTSB::DEFB135	Adenocarcinoma
CTSB::DEFB136	Squamous cell carcinoma
CTSB::EIF4A2	Adenocarcinoma
CTSB::FAR1	Adenocarcinoma
CTSB::FOXP1	Adenocarcinoma
CTSB::PLAG1	Angiofibroma
CTSB::PLAT	Adenocarcinoma
CTSB::STING1	Adenocarcinoma
CTSC::GRM5	Adenocarcinoma
CTSC::MMP12	Squamous cell carcinoma
CTSC::RAB38	Nonneoplastic epithelial disorder/lesion | Adenocarcinoma | Nonneoplastic hematologic disorder/lesion | Mycosis fungoides/Sézary syndrome | Astrocytoma, grade III-IV/Glioblastoma | Acute lymphoblastic leukemia/lymphoblastic lymphoma
CTSD::APOA2	Adenocarcinoma
CTSD::ARFGEF2	Adenocarcinoma
CTSD::EEA1	Adenocarcinoma
CTSD::IFITM10	Adenocarcinoma | Nonneoplastic epithelial disorder/lesion
CTSD::PRKAR1B	Adenocarcinoma
CTSF::RANBP3	Malignant melanoma
CTSH::RASGRF1	Adenocarcinoma
CTSO::NAA15	Adenocarcinoma
CTSS::HP1BP3	Acute myeloid leukemia, NOS | Skin
CTSS::TDRD10	Malignant melanoma
CTSW::FIBP	Transitional cell carcinoma
CTSZ::ZHX3	Adenocarcinoma
CTTN::ANO1	Squamous cell carcinoma | Adenocarcinoma
CTTN::CBS	Squamous cell carcinoma
CTTN::CLASP2	Malignant melanoma
CTTN::DDX27	Transitional cell carcinoma
CTTN::DSG1	Squamous cell carcinoma
CTTN::FHIT	Squamous cell carcinoma
CTTN::FOLR1	Astrocytoma, grade I-II
CTTN::INPPL1	Adenocarcinoma
CTTN::KIRREL3	Adenocarcinoma
CTTN::MRGPRF	Squamous cell carcinoma
CTTN::MYEOV	Adenocarcinoma
CTTN::PLEKHA5	Adenocarcinoma
CTTN::PPFIA1	Mesenchymal tumor, NOS
CTTN::PPP6R3	Adenocarcinoma | Malignant melanoma
CTTN::PSME2	Adenocarcinoma
CTTN::SHANK2	Transitional cell carcinoma
CTTN::ST8SIA1	Adenocarcinoma
CTTNBP2::BRAF	Astrocytoma, pilocytic/juvenile
CTTNBP2::MET	Carcinoma, NOS | Glioma, NOS
CTTNBP2NL::SUCLA2	Adenocarcinoma
CTU1::TMEM143	Squamous cell carcinoma
CTU2::MLYCD	Adenocarcinoma
CTU2::ZC3H18	Squamous cell carcinoma
CTXN1::BLVRB	Adenocarcinoma
CUBN::ALDH16A1	Malignant melanoma
CUEDC1::COPZ2	Adenocarcinoma
CUEDC1::HSF5	Adenocarcinoma
CUEDC1::LRP8	Mesenchymal tumor, NOS
CUEDC1::ROPN1B	Adenocarcinoma
CUEDC2::ARL3	Adenocarcinoma
CUEDC2::POLR3A	Malignant epithelial tumor, special type
CUL1::BRAF	Adenocarcinoma
CUL1::DPP6	Acute promyelocytic leukemia (FAB type M3)
CUL1::GIMAP5	Adenocarcinoma
CUL1::MMUT	Adenocarcinoma
CUL2::CYP2C18	Adenocarcinoma
CUL2::PARD3	Adenocarcinoma
CUL2::RB1CC1	Squamous cell carcinoma
CUL3::IRS1	Adenocarcinoma
CUL3::PCMTD1	Adenocarcinoma
CUL3::SPAG16	Squamous cell carcinoma
CUL4A::DLEU7	Adenocarcinoma
CUL4A::F7	Adenocarcinoma
CUL4A::SUPT16H	Adenocarcinoma
CUL4A::TFDP1	Adenocarcinoma
CUL4A::TMCO3	Squamous cell carcinoma | Adenocarcinoma
CUL4A::TMEM255B	Squamous cell carcinoma
CUL4B::DAPK2	Adenocarcinoma
CUL5::BBOX1	Mature B-cell neoplasm, NOS
CUL5::ELMOD1	Adenocarcinoma
CUL5::OPCML	Adenocarcinoma
CUL5::RAB39A	Adenocarcinoma
CUL5::SHANK2	Adenocarcinoma
CUL7::RRP36	Adenocarcinoma
CUL7::USP10	Adenocarcinoma
CUL9::KIF6	Adenocarcinoma
CUTA::GRM4	Adenocarcinoma
CUTC::BRME1	Adenocarcinoma
CUX1::AFP	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CUX1::AGR3	Leiomyoma
CUX1::AHCYL2	Squamous cell carcinoma
CUX1::ALK	Adenocarcinoma
CUX1::BRAF	Soft tissue tumor, special type | Adenocarcinoma | Benign nevus | Malignant melanoma
CUX1::CAV2	Squamous cell carcinoma
CUX1::CDK14	Adenocarcinoma
CUX1::CLCN3	Adenocarcinoma
CUX1::COL26A1	Adenocarcinoma
CUX1::DGKB	Astrocytoma, grade III-IV/Glioblastoma
CUX1::EHBP1L1	Squamous cell carcinoma
CUX1::FGFR1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CUX1::MARCHF10	Adenocarcinoma
CUX1::MET	Adenocarcinoma
CUX1::NUTM1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CUX1::POP7	Mesenchymal tumor, NOS
CUX1::RAF1	Malignant melanoma
CUX1::RET	Carcinoma, NOS
CUX1::SH2B2	Squamous cell carcinoma | Adenocarcinoma
CUX1::THSD7A	Squamous cell carcinoma
CUX1::YEATS2	Adenocarcinoma
CUX1::ZNF398	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CUX2::ANAPC11	Adenocarcinoma
CUX2::CABP1	Adenocarcinoma
CUX2::IFT81	Malignant epithelial tumor, special type
CWC15::SEC22B	Adenocarcinoma
CWC25::B4GALNT2	Adenocarcinoma
CWC25::FBXO47	Adenocarcinoma
CWC25::JUP	Adenocarcinoma
CWC25::LASP1	Adenocarcinoma
CWC25::LPCAT1	Adenocarcinoma
CWC25::MED24	Adenocarcinoma
CWC25::PLXDC1	Adenocarcinoma
CWC25::PRKAR1A	Adenocarcinoma
CWC25::RETREG3	Miscellaneous hematopoietic/lymphoid neoplasm, special type | Benign epithelial tumor, special type
CWC25::ROBO2	Adenocarcinoma
CWC25::SLC35B1	Adenocarcinoma
CWC25::SPMAP1	Adenocarcinoma
CWC27::PLPP1	Adenocarcinoma
CWC27::RANBP17	Adenocarcinoma
CWC27::RNF180	Adenocarcinoma
CWF19L1::HSPA12A	Astrocytoma, grade I-II
CWF19L2::JAML	Squamous cell carcinoma
CWF19L2::SLN	Adenocarcinoma
CWF19L2::VAV1	Adenocarcinoma
CWH43::OCIAD1	Adenocarcinoma
CXADR::APP	Adenocarcinoma
CXADR::CMC4	Adenocarcinoma
CXADR::FAM184B	Squamous cell carcinoma
CXADR::HERC1	Adenocarcinoma
CXADR::MTCP1	Adenocarcinoma
CXCL13::UTRN	Squamous cell carcinoma
CXCL14::C7	Adenocarcinoma
CXCL14::SUPT16H	Squamous cell carcinoma
CXCL16::TEKT1	Adenocarcinoma
CXCL17::EXOSC5	Adenocarcinoma
CXCL1::AFP	Squamous cell carcinoma
CXCR4::BCL2L11	Multiple myeloma
CXCR4::BMI1	Multiple myeloma
CXCR4::CFLAR	Diffuse large B-cell lymphoma
CXCR4::DDX5	Multiple myeloma
CXCR4::GNAS	Chronic lymphocytic leukemia
CXCR4::IGH	Multiple myeloma
CXCR4::KLF2	Multiple myeloma
CXCR4::MAML2	Chronic lymphocytic leukemia
CXCR4::SKI	Multiple myeloma
CXCR4::TSC22D3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
CXCR4::UBC	Multiple myeloma
CXCR4::UBXN4	Chronic lymphocytic leukemia
CYB561::GNA13	Adenocarcinoma
CYB561::GNAS	Malignant epithelial tumor, special type
CYB561::PHB1	Adenocarcinoma
CYB561::SQSTM1	Adenocarcinoma
CYB561::USP32	Adenocarcinoma
CYB561::XBP1	Adenocarcinoma
CYB561D2::ERC2	Adenocarcinoma
CYB561D2::RBM6	Adenocarcinoma
CYB561D2::SLC38A3	Adenocarcinoma
CYB5A::DCC	Malignant melanoma
CYB5B::CALB2	Adenocarcinoma
CYB5B::SSPN	Adenocarcinoma
CYB5B::TERF2	Adenocarcinoma
CYB5D2::ANKFY1	Adenocarcinoma
CYB5R3::ARFGAP3	Adenocarcinoma
CYB5R3::RBX1	Malignant melanoma
CYB5R3::TXNIP	Adenocarcinoma
CYB5R4::CNTN6	Adenocarcinoma
CYB5R4::FNDC1	Adenocarcinoma
CYB5R4::RIPPLY2	Miscellaneous hematopoietic/lymphoid neoplasm, special type | Benign epithelial tumor, special type
CYB5R4::UBE3D	Adenocarcinoma
CYB5RL::TTC39A	Adenocarcinoma
CYBA::CSNK1G2	Multiple myeloma
CYBA::IGK	Multiple myeloma
CYBC1::ABCA7	Adenocarcinoma
CYBC1::HEXD	Squamous cell carcinoma
CYBRD1::SLC38A11	Adenocarcinoma
CYC1::DLK1	Adenocarcinoma
CYC1::FGA	Adenocarcinoma
CYC1::SLC52A2	Transitional cell carcinoma
CYFIP1::ACACA	Adenocarcinoma
CYFIP1::ENTREP2	Adenocarcinoma
CYFIP1::TUBGCP5	Adenocarcinoma
CYFIP1::ZNFX1	Malignant melanoma
CYGB::NBEAL2	Skin | Acute myeloid leukemia, NOS
CYLD::CYRIB	Adenocarcinoma
CYP1A2::SPG21	Adenocarcinoma
CYP20A1::CCDC178	Squamous cell carcinoma
CYP27A1::STK36	Adenocarcinoma
CYP2C18::HELLS	Adenocarcinoma
CYP2C19::TBC1D12	Adenocarcinoma
CYP2C9::APOH	Adenocarcinoma
CYP2D6::SULT4A1	Adenocarcinoma
CYP2E1::GLUL	Adenocarcinoma
CYP2E1::REG3A	Adenocarcinoma
CYP2S1::UPF1	Squamous cell carcinoma
CYP39A1::FGGY	Adenocarcinoma
CYP39A1::LEMD2	Adenocarcinoma
CYP39A1::VPS33A	Mesenchymal tumor, NOS
CYP3A43::ZSCAN25	Adenocarcinoma
CYP3A5::AZGP1	Adenocarcinoma
CYP3A5::GJC3	Adenocarcinoma
CYP4B1::PLA2G1B	Adenocarcinoma
CYP4F11::CIB3	Squamous cell carcinoma
CYP4F12::MYO9B	Transitional cell carcinoma
CYP4F12::PTGER1	Adenocarcinoma
CYP4Z1::ALYREF	Adenocarcinoma
CYP51A1::ANKIB1	Adenocarcinoma
CYP51A1::BAIAP2L1	Adenocarcinoma
CYP7B1::EPS15	Mesenchymal tumor, NOS
CYP7B1::NCOA2	Malignant peripheral nerve sheath tumor/Triton
CYP7B1::SULF1	Malignant melanoma
CYREN::STMP1	Adenocarcinoma
CYRIA::PRR4	Adenocarcinoma
CYRIA::RAD51AP2	Adenocarcinoma
CYRIA::RIF1	Neuroblastoma
CYRIB::AK5	Transitional cell carcinoma
CYRIB::ASAP1	Adenocarcinoma
CYRIB::GNAL	Adenocarcinoma
CYRIB::KAT6A	Adenocarcinoma
CYRIB::MGAM	Adenocarcinoma
CYRIB::MRPL13	Transitional cell carcinoma
CYRIB::PREX2	Adenocarcinoma
CYRIB::PSKH2	Adenocarcinoma
CYRIB::SH3GL1	Malignant epithelial tumor, special type
CYSTM1::GNPDA1	Astrocytoma, grade III-IV/Glioblastoma
CYSTM1::MATR3	Adenocarcinoma
CYTH1::EIF3H	Adenocarcinoma
CYTH1::KCNJ4	Adenocarcinoma
CYTH1::KSR1	Adenocarcinoma
CYTH1::LGALS3BP	Adenocarcinoma
CYTH1::MACROD1	Astrocytoma, grade I-II
CYTH1::MRC2	Adenocarcinoma
CYTH1::PRPSAP1	Adenocarcinoma
CYTH1::USP36	Adenocarcinoma
CYTH3::ATP8B3	Adenocarcinoma
CYTH3::FAM220A	Adenocarcinoma
CYTH3::GRID1	Malignant melanoma
CYTH3::MAD1L1	Adenocarcinoma
CYTH3::RAB40B	Astrocytoma, grade III-IV/Glioblastoma
CYTH3::SPARCL1	Adenocarcinoma
CYTH3::SPATA18	Adenocarcinoma
CYTIP::MGAT5	Squamous cell carcinoma
CZIB::ALG6	Adenocarcinoma
D2HGDH::CUL3	Astrocytoma, grade I-II
D2HGDH::MLPH	Adenocarcinoma
DAAM1::BRAF	Soft tissue tumor, special type
DAAM1::HS6ST3	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
DAAM1::MNAT1	Mesenchymal tumor, NOS
DAAM1::MYG1	Malignant melanoma
DAAM1::PRKCH	Malignant melanoma
DAAM1::SYNCRIP	Astrocytoma, grade III-IV/Glioblastoma
DAB1::CFAP54	Mesenchymal tumor, NOS
DAB1::DRAM1	Mesenchymal tumor, NOS
DAB1::ITGB3BP	Adenocarcinoma
DAB1::OMA1	Mesenchymal tumor, NOS
DAB1::TENT5C	Meningioma
DAB1::TTC22	Mesenchymal tumor, NOS
DAB2::ARSB	Adenocarcinoma
DAB2::CERT1	Adenocarcinoma
DAB2::FASTKD3	Mesenchymal tumor, NOS
DAB2::OXCT1	Malignant melanoma
DAB2IP::HTN3	Adenocarcinoma
DAB2IP::LAMC3	Adenocarcinoma
DAB2IP::SLC44A4	Adenocarcinoma
DAB2IP::WDR38	Adenocarcinoma
DACH1::KLF12	Adenocarcinoma
DACH1::TNFSF11	Mesenchymal tumor, NOS
DAD1::ARMH4	Transitional cell carcinoma
DAD1::RAB2B	Adenocarcinoma
DAG1::CORO1B	Adenocarcinoma
DAG1::LARS2	Adenocarcinoma
DAG1::MAP4	Adenocarcinoma
DAG1::ZNF589	Adenocarcinoma
DAGLA::INCENP	Adenocarcinoma
DAGLA::MS4A10	Squamous cell carcinoma
DAGLA::POLD3	Adenocarcinoma
DAGLA::SAXO4	Adenocarcinoma
DAGLB::ASNS	Wilms tumor
DALRD3::IMPDH2	Malignant epithelial tumor, special type
DALRD3::PRKAR2A	Transitional cell carcinoma
DAND5::GCDH	Squamous cell carcinoma
DAP3::ATF3	Adenocarcinoma
DAP3::ATP8B2	Adenocarcinoma
DAP3::OBSCN	Adenocarcinoma
DAP3::RPRD2	Mesenchymal tumor, NOS
DAP3::TIPRL	Transitional cell carcinoma
DAP::CCT5	Transitional cell carcinoma
DAP::CDH12	Malignant melanoma
DAP::CTNND2	Adenocarcinoma
DAP::RGL2	Adenocarcinoma
DAP::SEMA5A	Malignant melanoma | Mesenchymal tumor, NOS
DAP::SNX9	Adenocarcinoma
DAPK1::AGTPBP1	Adenocarcinoma
DAPK1::GRIN2D	Adenocarcinoma
DAPK1::WSCD1	Adenocarcinoma
DAPK2::CIAO2A	Adenocarcinoma
DAPK2::WDR1	Squamous cell carcinoma
DAPP1::COL4A3	Squamous cell carcinoma
DAPP1::SLC4A4	Squamous cell carcinoma
DARS1::MGAT5	Adenocarcinoma
DARS1::THSD7B	Adenocarcinoma
DARS2::ZFR	Squamous cell carcinoma
DAZAP1::ARHGAP45	Adenocarcinoma
DAZAP1::ATP5F1D	Multiple myeloma
DAZAP1::ERBB2	Gastrointestinal stromal tumor
DAZAP1::HIVEP3	Astrocytoma, grade III-IV/Glioblastoma
DAZAP1::MEF2D	Acute lymphoblastic leukemia/lymphoblastic lymphoma
DAZAP1::SBNO2	Benign epithelial tumor, special type | Miscellaneous hematopoietic/lymphoid neoplasm, special type
DAZAP1::ZNF226	Adenocarcinoma
DBF4::GLUL	Astrocytoma, grade III-IV/Glioblastoma
DBF4B::DYNC2H1	Adenocarcinoma
DBN1::ZNF346	Adenocarcinoma
DBNDD1::CRIP2	Adenocarcinoma
DBNDD1::TPGS1	Adenocarcinoma
DBNL::EEA1	Squamous cell carcinoma
DBP::CA11	Malignant melanoma
DBT::CCDC18	Malignant melanoma
DBT::SASS6	Adenocarcinoma
DBX1::PAX5	Acute lymphoblastic leukemia/lymphoblastic lymphoma
DCAF10::PAX5	Squamous cell carcinoma
DCAF10::RBM20	Ependymoma
DCAF11::PSME1	Adenocarcinoma
DCAF12::CNBD1	Adenocarcinoma
DCAF12::DENND4C	Adenocarcinoma
DCAF12::EXOSC2	Transitional cell carcinoma
DCAF12::KIF24	Adenocarcinoma
DCAF15::BRME1	Squamous cell carcinoma
DCAF15::CEBPG	Adenocarcinoma
DCAF1::C2CD3	Adenocarcinoma
DCAF1::DBR1	Undifferentiated carcinoma, small cell
DCAF1::POC1A	Adenocarcinoma
DCAF4::IFT140	Adenocarcinoma
DCAF4::RGS6	Adenocarcinoma
DCAF5::C14orf39	Adenocarcinoma
DCAF5::DPY19L2	Adenocarcinoma
DCAF5::ERH	Squamous cell carcinoma | Adenocarcinoma
DCAF5::MYO1D	Adenocarcinoma
DCAF5::NOXRED1	Adenocarcinoma
DCAF5::PTK2B	Adenocarcinoma
DCAF5::RAB5B	Adenocarcinoma
DCAF5::RAD51B	Adenocarcinoma
DCAF5::RDH11	Adenocarcinoma
DCAF6::BCAS3	Transitional cell carcinoma
DCAF6::HMCN1	Mesenchymal tumor, NOS
DCAF6::ILDR2	Adenocarcinoma
DCAF6::LETM1	Adenocarcinoma
DCAF6::MPZL1	Adenocarcinoma
DCAF6::RCSD1	Adenocarcinoma
DCAF6::SLC19A2	Adenocarcinoma
DCAF6::TIPRL	Adenocarcinoma
DCAF6::YEATS4	Mesenchymal tumor, NOS
DCAF7::MAP3K3	Adenocarcinoma
DCAF7::PRR11	Adenocarcinoma
DCAF7::RGS9	Adenocarcinoma
DCAF7::VMP1	Adenocarcinoma
DCAF8::AIG1	Malignant melanoma
DCAF8::DNM3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
DCAF8::ETV3	Malignant melanoma
DCAF8::FCRLA	Transitional cell carcinoma
DCAF8::NME7	Squamous cell carcinoma
DCAKD::ADAMTS7	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
DCAKD::C1QL1	Astrocytoma, grade I-II
DCAKD::MAP3K14	Squamous cell carcinoma
DCAKD::PLCD3	Adenocarcinoma
DCAKD::SMAP1	Malignant melanoma
DCBLD1::CCT2	Mesenchymal tumor, NOS
DCBLD1::NUS1	Malignant melanoma
DCBLD1::ZNF550	Transitional cell carcinoma
DCBLD2::ABI3BP	Squamous cell carcinoma
DCBLD2::KALRN	Squamous cell carcinoma
DCBLD2::ST3GAL6	Adenocarcinoma
DCBLD2::STXBP5L	Adenocarcinoma
DCC::RET	Carcinoma, NOS
DCDC2::GPLD1	Adenocarcinoma
DCDC2::MRS2	Transitional cell carcinoma
DCHS2::FAM241A	Malignant melanoma
DCHS2::FGG	Adenocarcinoma
DCK::GRSF1	Adenocarcinoma
DCLK1::CLDN10	Mesenchymal tumor, NOS
DCLK1::COL3A1	Adenocarcinoma
DCLK1::RCBTB1	Adenocarcinoma
DCLK1::SERPINE3	Adenocarcinoma
DCLK2::LRBA	Adenocarcinoma
DCLK2::UST	Malignant melanoma
DCLRE1B::DNAJB4	Adenocarcinoma
DCLRE1C::NMT2	Transitional cell carcinoma
DCP1A::HYAL3	Adenocarcinoma
DCP2::C8ORF34	Malignant melanoma
DCP2::C8orf34	Malignant melanoma
DCP2::HIF1A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
DCP2::IL17B	Adenocarcinoma
DCP2::REEP5	Adenocarcinoma
DCP2::SRP19	Adenocarcinoma
DCP2::TBCA	Transitional cell carcinoma
DCPS::CCND1	Adenocarcinoma
DCPS::ST3GAL4	Schwannoma
DCPS::TIRAP	Malignant melanoma
DCPS::YAP1	Adenocarcinoma
DCTD::ECE2	Astrocytoma, grade III-IV/Glioblastoma
DCTN1::ALK	Melanocytic neoplasm, special type | Spindle cell/sclerosing rhabdomyosarcoma | Carcinoma, NOS | Mesenchymal tumor, special type | Inflammatory myofibroblastic tumor/myofibroblastic sarcoma | Adenocarcinoma | Benign fibrous histiocytoma
DCTN1::M1AP	Adenocarcinoma
DCTN1::WDR54	Mesothelioma
DCTN2::DDX23	Squamous cell carcinoma
DCTN2::DENND3	Astrocytoma, grade I-II
DCTN2::EEA1	Mesenchymal tumor, NOS
DCTN2::SRGAP1	Mesenchymal tumor, NOS
DCTN2::TSPAN31	Astrocytoma, grade I-II
DCTN2::USP15	Adenocarcinoma
DCTN3::LINGO2	Squamous cell carcinoma
DCTN5::UBFD1	Adenocarcinoma
DCUN1D1::ATP11B	Undifferentiated carcinoma, small cell
DCUN1D1::CCDC50	Adenocarcinoma
DCUN1D2::ATP11A	Mesenchymal tumor, NOS
DCUN1D2::CORT	Astrocytoma, grade III-IV/Glioblastoma
DCUN1D3::CRYM	Adenocarcinoma
DCUN1D3::DNAH3	Adenocarcinoma
DCUN1D3::LDAF1	Transitional cell carcinoma
DCUN1D4::GPM6B	Squamous cell carcinoma
DCUN1D4::IKZF1	Mesenchymal tumor, NOS
DCUN1D4::PTPRT	Malignant melanoma
DCUN1D4::SGCB	Astrocytoma, grade I-II
DCUN1D4::USP46	Malignant melanoma
DCX::PASD1	Adenocarcinoma
DCXR::SIRT7	Adenocarcinoma
DDA1::MYO9B	Adenocarcinoma
DDA1::TMIGD1	Adenocarcinoma
DDAH1::DNAI3	Mesothelioma
DDAH1::TRABD2B	Adenocarcinoma
DDAH1::ZNHIT6	Adenocarcinoma
DDAH2::MSH5	Adenocarcinoma
DDAH2::SLC44A4	Adenocarcinoma
DDB1::CPSF7	Adenocarcinoma
DDB1::SDHA	Mesenchymal tumor, NOS
DDB1::STX3	Squamous cell carcinoma
DDB1::TMEM258	Adenocarcinoma
DDB2::LRRC9	Malignant melanoma
DDC::KIAA0040	Adenocarcinoma
DDHD1::PLEKHG3	Squamous cell carcinoma
DDHD2::EIF4EBP1	Squamous cell carcinoma
DDHD2::GPAT4	Adenocarcinoma
DDHD2::NRG1	Adenocarcinoma
DDHD2::PLPP5	Squamous cell carcinoma
DDI2::C4BPB	Adenocarcinoma
DDI2::DNAJC16	Transitional cell carcinoma
DDI2::EFHD2	Adenocarcinoma
DDI2::FBXO15	Transitional cell carcinoma
DDI2::MTOR	Adenocarcinoma
DDIT3::ERGIC2	Soft tissue tumor, NOS
DDIT3::GLI1	Mesenchymal tumor, NOS | Astrocytoma, grade III-IV/Glioblastoma
DDIT4::EIF2AK2	Squamous cell carcinoma
DDOST::IGK	Multiple myeloma
DDR1::MRPS18B	Adenocarcinoma
DDR1::PAK1	Adenocarcinoma
DDR1::TUBB	Adenocarcinoma
DDR2::ATF6	Adenocarcinoma
DDR2::CHD1L	Mesenchymal tumor, NOS
DDR2::FMO4	Malignant melanoma
DDR2::GAB1	Adenocarcinoma
DDR2::VPS45	Malignant soft tissue tumor, NOS
DDT::ACP3	Adenocarcinoma
DDT::GHRL	Adenocarcinoma
DDT::PAK1	Adenocarcinoma
DDT::SEC13	Adenocarcinoma
DDT::TPST2	Adenocarcinoma
DDTL::CABIN1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
DDTL::GHRL	Adenocarcinoma
DDTL::SEC13	Adenocarcinoma
DDX10::ATM	Adenocarcinoma
DDX10::BMAL1	Adenocarcinoma
DDX10::OTUD4	Adenocarcinoma
DDX10::SKA3	Adenocarcinoma
DDX11::DERA	Adenocarcinoma
DDX11::ITGA10	Adenocarcinoma
DDX17::ARFGEF2	Adenocarcinoma
DDX17::CDH10	Malignant melanoma
DDX17::CPT1B	Malignant melanoma
DDX17::DMC1	Adenocarcinoma
DDX17::EIF2AK2	Adenocarcinoma
DDX17::ENTHD1	Adenocarcinoma
DDX17::ETV1	Adenocarcinoma
DDX17::POLR3H	Malignant melanoma
DDX17::USP6	Aneurysmal bone cyst
DDX19A::ABCC11	Adenocarcinoma
DDX19A::IL15RA	Adenocarcinoma
DDX19A::UTP4	Adenocarcinoma
DDX19B::KCTD19	Adenocarcinoma
DDX19B::ST3GAL2	Adenocarcinoma
DDX1::CFAP20DC	Squamous cell carcinoma
DDX20::TBX15	Skin | Acute myeloid leukemia, NOS | Acute erythroleukemia (FAB type M6)
DDX21::STOX1	Adenocarcinoma
DDX23::ARF3	Adenocarcinoma
DDX23::NMNAT2	Adenocarcinoma
DDX23::RND1	Adenocarcinoma
DDX23::SLC25A10	Adenocarcinoma
DDX23::SMAGP	Adenocarcinoma
DDX27::ATP9A	Malignant melanoma
DDX31::AK8	Adenocarcinoma
DDX39A::ADGRE3	Adenocarcinoma
DDX39B::ATP6V1G2	Adenocarcinoma
DDX39B::ETV7	Adenocarcinoma
DDX39B::NCR3	Squamous cell carcinoma
DDX39B::PPP1R18	Adenocarcinoma
DDX39B::PRPH2	Adenocarcinoma
DDX39B::TSBP1	Adenocarcinoma
DDX3X::MLLT10	Skin | Acute myeloid leukemia, NOS | Acute lymphoblastic leukemia/lymphoblastic lymphoma
DDX3X::PRKD1	Adenocarcinoma
DDX3Y::DAZ1	Malignant epithelial tumor, special type
DDX42::ACE	Adenocarcinoma
DDX42::B4GALNT2	Adenocarcinoma
DDX42::BRIP1	Adenocarcinoma
DDX42::DCAF7	Adenocarcinoma
DDX42::HSF5	Adenocarcinoma
DDX42::RGS9	Acute myeloid leukemia, NOS | Skin
DDX42::RNF43	Adenocarcinoma
DDX42::RPS6KB1	Adenocarcinoma
DDX46::CAMLG	Adenocarcinoma
DDX46::CDC25C	Adenocarcinoma
DDX46::SEC24A	Adenocarcinoma
DDX47::CREBL2	Adenocarcinoma
DDX49::NCAN	Adenocarcinoma
DDX52::ARL17A	Adenocarcinoma
DDX52::ARL17B	Adenocarcinoma
DDX52::IKZF3	Adenocarcinoma
DDX52::PLXDC1	Adenocarcinoma
DDX52::PSMD3	Adenocarcinoma
DDX52::SSH2	Adenocarcinoma
DDX52::STAT5B	Adenocarcinoma
DDX52::TMIGD1	Adenocarcinoma
DDX54::IQCD	Adenocarcinoma
DDX5::ADAM18	Adenocarcinoma
DDX5::ART1	Adenocarcinoma
DDX5::BMI1	Multiple myeloma
DDX5::CCND1	Multiple myeloma
DDX5::DEPTOR	Adenocarcinoma
DDX5::EFCAB3	Adenocarcinoma
DDX5::ETV4	Adenocarcinoma
DDX5::IGH	Chronic lymphocytic leukemia | Multiple myeloma
DDX5::KLF2	Multiple myeloma
DDX5::OAZ1	Multiple myeloma
DDX5::PFKP	Adenocarcinoma
DDX5::RSAD1	Adenocarcinoma
DDX5::SEMA4D	Multiple myeloma
DDX5::SKAP1	Adenocarcinoma
DDX5::TFEB	Carcinoma, NOS
DDX5::UBC	Multiple myeloma
DDX60L::CPE	Adenocarcinoma
DDX60L::DSCAM	Adenocarcinoma
DDX6::ALK	Malignant epithelial tumor, special type
DDX6::CEP164	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
DDX6::FOXR1	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Multiple myeloma | Adenocarcinoma
DDX6::LNX2	Adenocarcinoma
DDX6::SLC37A4	Squamous cell carcinoma
DDX6::TSPAN18	Astrocytoma, grade I-II
DDX6::USP28	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
DEAF1::CHID1	Adenocarcinoma
DEAF1::GATD1	Adenocarcinoma
DEAF1::HRAS	Adenocarcinoma
DEAF1::PIDD1	Adenocarcinoma
DEAF1::SH3GL1	Transitional cell carcinoma
DEAF1::TMEM80	Adenocarcinoma
DECR1::FAM110B	Adenocarcinoma
DECR1::RIPK2	Adenocarcinoma
DECR1::STAU2	Adenocarcinoma
DEDD2::BLVRB	Multiple myeloma
DEDD2::GSK3A	Squamous cell carcinoma
DEDD2::LIPE	Adenocarcinoma
DEDD::UFC1	Squamous cell carcinoma
DEF8::FBXO31	Adenocarcinoma
DEFB110::PKHD1	Malignant melanoma
DEGS2::WARS1	Adenocarcinoma
DEK::AFF2	Squamous cell carcinoma | Adenosquamous carcinoma
DEK::KDM1B	Adenocarcinoma
DEK::KIF25	Transitional cell carcinoma
DEK::NUP210L	Adenocarcinoma
DEK::NUP214	Chronic myeloproliferative disorder, NOS | Skin | Idiopathic myelofibrosis | Acute myelomonocytic leukemia (FAB type M4) | Acute erythroleukemia (FAB type M6) | Acute myeloid leukemia, NOS | Acute myeloblastic leukemia with maturation (FAB type M2) | Acute myeloblastic leukemia without maturation (FAB type M1)
DEK::NUP214::PRRC2B	Acute monoblastic leukemia (FAB type M5)
DELE1::NMI	Adenocarcinoma
DENND11::AGK	Skin | Acute myeloid leukemia, NOS
DENND1A::ANXA4	Adenocarcinoma
DENND1A::ASTN2	Astrocytoma, grade I-II
DENND1A::CADPS2	Adenocarcinoma
DENND1A::CDK5RAP2	Mesenchymal tumor, NOS
DENND1A::ENG	Squamous cell carcinoma
DENND1A::LRRC69	Adenocarcinoma
DENND1A::NDUFA8	Squamous cell carcinoma
DENND1A::PBX3	Adenocarcinoma
DENND1A::PRRX2	Squamous cell carcinoma
DENND1A::PSMB7	Malignant epithelial tumor, special type
DENND1A::RRAGB	Squamous cell carcinoma
DENND1A::SCUBE1	Malignant epithelial tumor, special type
DENND1A::SLC26A7	Adenocarcinoma
DENND1A::ZCCHC7	Acute lymphoblastic leukemia/lymphoblastic lymphoma
DENND1B::ATP6V1G3	Adenocarcinoma
DENND1B::CCSER1	Adenocarcinoma
DENND1B::CRB1	Mesenchymal tumor, NOS
DENND1B::RCOR3	Adenocarcinoma
DENND1B::RGL1	Squamous cell carcinoma
DENND1B::RRP15	Adenocarcinoma
DENND1B::TSPAN31	Mesenchymal tumor, NOS
DENND1B::VAV3	Multiple myeloma
DENND1B::ZCCHC7	Acute lymphoblastic leukemia/lymphoblastic lymphoma
DENND2B::DENND5A	Adenocarcinoma | Malignant melanoma
DENND2B::HBG2	Mesothelioma
DENND2B::TMEM9B	Squamous cell carcinoma
DENND2C::AMPD1	Adenocarcinoma
DENND2C::BCL2L15	Adenocarcinoma
DENND3::PTK2	Astrocytoma, grade III-IV/Glioblastoma
DENND3::UBC	Multiple myeloma
DENND4A::DPP8	Adenocarcinoma
DENND4A::HBD	Adenocarcinoma
DENND4A::RAB11A	Adenocarcinoma
DENND4A::SLC24A1	Squamous cell carcinoma
DENND4B::RAB13	Adenocarcinoma
DENND4C::ACER2	Transitional cell carcinoma
DENND4C::ANP32B	Adenocarcinoma
DENND4C::NFIL3	Adenocarcinoma
DENND4C::RHOBTB2	Adenocarcinoma
DENND5A::ECHDC2	Skin | Acute myeloid leukemia, NOS
DENND5A::PGPEP1L	Adenocarcinoma
DENND5A::SBF2	Adenocarcinoma
DENND5A::SCUBE2	Adenocarcinoma
DENND5B::INTS13	Malignant epithelial tumor, special type
DENND5B::NUP54	Adenocarcinoma
DENND5B::PLCZ1	Astrocytoma, grade I-II
DENND5B::SINHCAF	Adenocarcinoma
DENND5B::TSPAN9	Squamous cell carcinoma
DENND6A::FHIT	Adenocarcinoma
DENR::KNTC1	Adenocarcinoma
DEPDC1::NNMT	Malignant melanoma
DEPDC1B::ELOVL7	Adenocarcinoma
DEPDC1B::ERCC8	Adenocarcinoma
DEPDC1B::NPBWR1	Adenocarcinoma
DEPDC5::BID	Adenocarcinoma
DEPDC5::CDH19	Adenocarcinoma
DEPDC5::DRG1	Adenocarcinoma
DEPDC5::GOLGA7B	Adenocarcinoma
DEPDC5::OSBP2	Adenocarcinoma
DEPDC5::SFI1	Adenocarcinoma
DEPTOR::ENPP2	Adenocarcinoma
DEPTOR::SAMD12	Squamous cell carcinoma
DERA::CA3	Mesenchymal tumor, NOS
DERA::DNAJA2	Mesenchymal tumor, NOS
DERA::GLI1	Pericytoma
DERA::LRP6	Adenocarcinoma
DERA::MGST1	Squamous cell carcinoma
DERA::NT5DC1	Adenocarcinoma
DERA::STRAP	Astrocytoma, grade I-II
DERL1::C6ORF132	Adenocarcinoma
DERL1::C6orf132	Adenocarcinoma
DERL1::TSC1	Adenocarcinoma
DERL2::NLRP1	Adenocarcinoma
DES::ALK	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma | Soft tissue tumor, special type
DESI2::CATSPERE	Squamous cell carcinoma
DESI2::PGBD5	Malignant melanoma
DEXI::CDH1	Adenocarcinoma
DFFA::ARID1A	Adenocarcinoma
DFFB::SLC25A33	Astrocytoma, grade III-IV/Glioblastoma
DGAT1::UBASH3A	Malignant epithelial tumor, special type
DGAT2::TMEM126A	Malignant melanoma
DGCR2::ACOT7	Germ cell tumor, NOS
DGCR2::ANO1	Squamous cell carcinoma
DGCR2::CLTCL1	Adenocarcinoma
DGCR2::DESI1	Adenocarcinoma
DGCR2::EHBP1	Adenocarcinoma
DGCR2::GNB1L	Malignant melanoma
DGCR2::IRX4	Malignant melanoma
DGCR2::SEC63	Adenocarcinoma
DGCR2::SERINC2	Transitional cell carcinoma
DGCR2::SLC25A1	Adenocarcinoma
DGCR8::CCL4L2	Adenocarcinoma
DGCR8::COMT	Transitional cell carcinoma
DGCR8::CRKL	Squamous cell carcinoma
DGCR8::ESS2	Adenocarcinoma
DGCR8::ITGA2	Malignant melanoma
DGCR8::SGSM1	Squamous cell carcinoma
DGKA::DSG1	Adenocarcinoma
DGKB::ETV1	Adenocarcinoma
DGKD::ATG16L1	Squamous cell carcinoma
DGKD::INPP5D	Adenocarcinoma
DGKD::NDUFA10	Mesenchymal tumor, NOS
DGKD::SAG	Adenocarcinoma
DGKD::SLC25A17	Malignant epithelial tumor, special type
DGKD::SP140	Adenocarcinoma
DGKD::SPP2	Astrocytoma, grade III-IV/Glioblastoma
DGKE::EPN3	Squamous cell carcinoma
DGKE::KRT222	Adenocarcinoma
DGKG::BST1	Acute myeloid leukemia, NOS | Skin
DGKG::CRYGS	Adenocarcinoma
DGKG::U2SURP	Skin | Acute myeloid leukemia, NOS
DGKH::HEPACAM	Mature B-cell neoplasm, NOS
DGKH::MED13L	Adenocarcinoma
DGKI::CSMD3	Astrocytoma, grade I-II
DGKQ::POLN	Adenocarcinoma
DGKZ::CHRM4	Skin | Acute myeloid leukemia, NOS
DGUOK::ACTG2	Transitional cell carcinoma
DGUOK::C2ORF78	Adenocarcinoma
DGUOK::C2orf78	Adenocarcinoma
DGUOK::STAMBP	Transitional cell carcinoma | Squamous cell carcinoma
DHCR24::CBS	Adenocarcinoma
DHCR24::EPHX1	Adenocarcinoma
DHCR24::ERCC6L2	Adenocarcinoma
DHCR24::FADS2	Adenocarcinoma
DHCR24::FKBP5	Adenocarcinoma
DHCR24::LRP11	Adenocarcinoma
DHCR24::NDUFV1	Adenocarcinoma
DHCR24::PCNX2	Squamous cell carcinoma
DHCR24::PRKCSH	Adenocarcinoma
DHCR24::SFTPC	Adenocarcinoma
DHCR24::SIAE	Adenocarcinoma
DHCR24::TADA2B	Adenocarcinoma
DHCR24::THBS1	Squamous cell carcinoma
DHCR24::TUT4	Adenocarcinoma
DHCR7::KRTAP5-11	Adenocarcinoma
DHCR7::USP15	Adenocarcinoma
DHDDS::PSMB2	Adenocarcinoma
DHH::RHEBL1	Acute myeloid leukemia, NOS | Skin | Acute megakaryoblastic leukemia (FAB type M7)
DHPS::CACNA1A	Adenocarcinoma
DHPS::HOOK2	Adenocarcinoma
DHRS12::KLF5	Adenocarcinoma
DHRS12::RASL11A	Transitional cell carcinoma
DHRS12::TSC22D1	Adenocarcinoma
DHRS13::PHF12	Adenocarcinoma
DHRS1::METTL3	Squamous cell carcinoma
DHRS1::RABGGTA	Adenocarcinoma
DHRS2::GAPDH	Transitional cell carcinoma
DHRS2::GSTM2	Transitional cell carcinoma
DHRS2::IL25	Transitional cell carcinoma
DHRS4::MANBA	Adenocarcinoma
DHRS4::SCFD1	Transitional cell carcinoma
DHRS4L2::RNF31	Transitional cell carcinoma
DHRS9::IGK	Multiple myeloma
DHRSX::RPS4Y1	Adenocarcinoma
DHRSX::SYAP1	Astrocytoma, grade I-II
DHTKD1::CDC123	Squamous cell carcinoma
DHX15::CCDC149	Adenocarcinoma
DHX15::ETV1	Adenocarcinoma
DHX15::RBPJ	Squamous cell carcinoma
DHX16::HLA-E	Astrocytoma, grade I-II
DHX16::MDC1	Adenocarcinoma
DHX16::PPP1R18	Adenocarcinoma
DHX30::ABHD14B	Adenocarcinoma
DHX30::FBXW12	Adenocarcinoma
DHX30::LIMD1	Adenocarcinoma
DHX30::MAP4	Astrocytoma, grade I-II
DHX30::NT5DC2	Adenocarcinoma
DHX30::RPLP1	Squamous cell carcinoma
DHX30::ZDHHC3	Adenocarcinoma
DHX33::NLRP1	Adenocarcinoma
DHX34::ARHGAP35	Squamous cell carcinoma
DHX34::C5AR1	Squamous cell carcinoma
DHX34::PPP5C	Adenocarcinoma
DHX34::SAE1	Adenocarcinoma
DHX35::DNTTIP1	Adenocarcinoma
DHX35::ITCH	Adenocarcinoma
DHX35::MYO7A	Transitional cell carcinoma
DHX35::TOX2	Malignant melanoma
DHX35::VSTM2L	Adenocarcinoma
DHX40::ACSM2B	Adenocarcinoma
DHX40::CEP112	Mesenchymal tumor, NOS
DHX40::GH1	Adenocarcinoma
DHX40::RNFT1	Squamous cell carcinoma
DHX40::SCN4A	Adenocarcinoma
DHX40::UNC5D	Adenocarcinoma
DHX57::DNAJC5B	Adenocarcinoma
DHX57::SOS1	Adenocarcinoma
DHX58::KAT2A	Astrocytoma, grade III-IV/Glioblastoma
DHX58::RETREG3	Adenocarcinoma
DHX8::ARL4D	Adenocarcinoma
DHX8::ETV4	Skin | Acute myeloid leukemia, NOS
DHX8::FMO5	Transitional cell carcinoma
DHX8::GPATCH8	Adenocarcinoma
DHX8::KRTAP4-1	Squamous cell carcinoma
DHX8::MSI2	Adenocarcinoma
DHX8::MYO18A	Adenocarcinoma
DHX8::PCTP	Adenocarcinoma
DHX8::PPY	Adenocarcinoma
DHX8::SPACA3	Mesenchymal tumor, NOS
DHX8::ST6GALNAC2	Squamous cell carcinoma
DHX8::TDRD3	Adenocarcinoma
DHX9::FBXO7	Adenocarcinoma
DHX9::NPL	Acute lymphoblastic leukemia/lymphoblastic lymphoma
DHX9::PRELID1	Adenocarcinoma
DHX9::RAF1	Adenocarcinoma
DHX9::RASAL2	Adenocarcinoma
DHX9::TAL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
DHX9::ZBTB37	Malignant melanoma
DIAPH1::CYSTM1	Squamous cell carcinoma
DIAPH1::NTRK1	Adenocarcinoma
DIAPH1::PDGFRB	Chronic myeloproliferative disorder, NOS
DIAPH2::ALK	Adenocarcinoma
DIAPH2::F8	Astrocytoma, grade I-II
DIAPH2::KMT2A	Leiomyosarcoma
DIAPH2::MAGEA11	Adenocarcinoma
DIAPH2::NRP2	Adenocarcinoma
DIAPH2::PLAC1	Mesenchymal tumor, NOS
DIAPH3::PCDH9	Mesothelioma
DIAPH3::TDRD3	Adenocarcinoma
DICER1::CLMN	Adenocarcinoma
DICER1::EIF5	Adenocarcinoma
DICER1::HSD17B4	Adenocarcinoma
DICER1::PAPOLA	Squamous cell carcinoma
DICER1::SAMD4A	Adenocarcinoma
DICER1::UVRAG	Adenocarcinoma
DIDO1::LRRC4B	Adenocarcinoma
DIDO1::REPS1	Adenocarcinoma
DIDO1::RPS4X	Squamous cell carcinoma
DIP2A::C16ORF46	Transitional cell carcinoma
DIP2A::C16orf46	Transitional cell carcinoma
DIP2A::COL6A2	Adenocarcinoma
DIP2A::NRIP1	Squamous cell carcinoma
DIP2A::PRH1	Adenocarcinoma
DIP2A::PRR4	Adenocarcinoma
DIP2A::THOC2	Adenocarcinoma
DIP2A::YBEY	Adenocarcinoma
DIP2B::BCAT1	Malignant melanoma
DIP2B::BRAF	Malignant melanoma
DIP2B::ERBB2	Transitional cell carcinoma
DIP2B::LARP4	Squamous cell carcinoma
DIP2B::PRELID1	Adenocarcinoma
DIP2B::R3HDM2	Mesenchymal tumor, NOS
DIP2B::RTTN	Astrocytoma, grade I-II | Oligodendroglioma
DIP2B::SPATS2	Transitional cell carcinoma
DIP2B::TAF8	Astrocytoma, grade III-IV/Glioblastoma
DIP2B::TBC1D15	Malignant melanoma
DIP2B::TMBIM6	Astrocytoma, grade III-IV/Glioblastoma
DIP2C::APOLD1	Adenocarcinoma
DIP2C::GDI2	Transitional cell carcinoma
DIP2C::INPP5A	Adenocarcinoma
DIP2C::LARP4B	Malignant melanoma
DIP2C::ORC4	Mesenchymal tumor, NOS
DIP2C::PLD5	Adenocarcinoma
DIP2C::RTKN2	Malignant epithelial tumor, special type
DIP2C::TBX18	Malignant melanoma
DIP2C::TECTA	Squamous cell carcinoma
DIP2C::TMEM94	Adenocarcinoma
DIP2C::TUBB8	Adenocarcinoma
DIP2C::YY1	Adenocarcinoma
DIP2C::ZMYND11	Squamous cell carcinoma
DIPK1A::EVI5	Multiple myeloma
DIPK1A::LRRC8D	Squamous cell carcinoma
DIPK1A::NTNG1	Adenocarcinoma
DIPK1A::TGFBR3	Adenocarcinoma
DIPK2A::SLC9A9	Adenocarcinoma
DIRAS2::GNA14	Transitional cell carcinoma
DIS3::KLF12	Adenocarcinoma
DIS3L2::AGAP1	Adenocarcinoma
DIS3L2::ARMC9	Transitional cell carcinoma
DIS3L2::DNM1	Adenocarcinoma
DIS3L2::EFHD1	Adenocarcinoma
DIS3L2::FAM124B	Squamous cell carcinoma
DIS3L2::MICU1	Adenocarcinoma
DIS3L2::NBAS	Astrocytoma, grade III-IV/Glioblastoma
DIS3L2::SP100	Adenocarcinoma
DIS3L2::SPHKAP	Adenocarcinoma
DIS3L2::UBE2E3	Adenocarcinoma
DIS3L::CLU	Ependymoma
DISC1::LYPLAL1	Adenocarcinoma
DISC1::MDM1	Mesenchymal tumor, NOS
DISP2::PHGR1	Squamous cell carcinoma
DIXDC1::ARCN1	Adenocarcinoma
DIXDC1::CFAP68	Malignant epithelial tumor, special type | Adenocarcinoma
DIXDC1::GAB2	Adenocarcinoma
DKK3::PPFIA1	Adenocarcinoma
DLD::BCAP29	Adenocarcinoma
DLD::SCEL	Adenocarcinoma
DLD::SHPRH	Mesenchymal tumor, NOS
DLEC1::TENM4	Undifferentiated carcinoma, small cell
DLG1::BBX	Adenocarcinoma
DLG1::BDH1	Squamous cell carcinoma
DLG1::BRAF	Adenocarcinoma
DLG1::CBFA2T2	Mesenchymal tumor, NOS
DLG1::CRYBG3	Adenocarcinoma
DLG1::DYNC2I1	Mesenchymal tumor, NOS
DLG1::EHHADH	Astrocytoma, grade III-IV/Glioblastoma
DLG1::FAIM	Mesenchymal tumor, NOS
DLG1::GCNT1	Adenocarcinoma
DLG1::HRG	Squamous cell carcinoma
DLG1::MUSK	Adenocarcinoma
DLG1::MYO9B	Transitional cell carcinoma
DLG1::PAK2	Soft tissue tumor, special type | Adenocarcinoma | Squamous cell carcinoma
DLG1::PCSK5	Adenocarcinoma
DLG1::RRP1	Adenocarcinoma
DLG1::RUBCN	Astrocytoma, grade III-IV/Glioblastoma
DLG1::TM4SF19	Adenocarcinoma
DLG1::TMEM44	Squamous cell carcinoma
DLG1::ZIC1	Squamous cell carcinoma
DLG2::ATP23	Mesenchymal tumor, NOS
DLG3::MED12	Transitional cell carcinoma
DLG3::UNC5D	Adenocarcinoma
DLG4::BBS2	Malignant melanoma
DLG4::GAS7	Adenocarcinoma
DLG4::KRT8	Mesenchymal tumor, NOS
DLG4::MARCHF10	Adenocarcinoma
DLG4::SHBG	Adenocarcinoma
DLG5::ANAPC16	Adenocarcinoma
DLG5::PCDH15	Adenocarcinoma
DLG5::POLR3A	Squamous cell carcinoma
DLG5::RET	Adenocarcinoma
DLG5::TMPRSS2	Adenocarcinoma
DLGAP1::ARHGAP28	Adenocarcinoma
DLGAP1::ATP23	Adenocarcinoma
DLGAP1::ENOSF1	Adenocarcinoma
DLGAP1::LRRC23	Squamous cell carcinoma
DLGAP1::METTL4	Mesenchymal tumor, NOS
DLGAP1::RAB31	Adenocarcinoma
DLGAP4::ADNP	Squamous cell carcinoma
DLGAP4::BPI	Adenocarcinoma
DLGAP4::COMMD7	Acute myeloid leukemia, NOS | Skin
DLGAP4::PEDS1	Adenocarcinoma
DLGAP4::PROCR	Adenocarcinoma
DLGAP4::RGMA	Adenocarcinoma
DLGAP4::SRC	Acute myeloblastic leukemia with maturation (FAB type M2)
DLGAP4::TP53TG5	Malignant epithelial tumor, special type
DLGAP4::TUBD1	Adenocarcinoma
DLGAP5::L2HGDH	Adenocarcinoma
DLK1::CCT5	Malignant epithelial tumor, special type
DLK1::PENK	Malignant epithelial tumor, special type
DLK1::STAT6	Adenocarcinoma
DLK1::THSD4	Adenocarcinoma
DLL1::ROS1	Astrocytoma, grade III-IV/Glioblastoma
DLL3::SUPT5H	Astrocytoma, grade I-II
DLST::AHSA1	Squamous cell carcinoma
DLST::YLPM1	Adenocarcinoma
DMBT1::ARMS2	Adenocarcinoma
DMC1::DNAL4	Adenocarcinoma
DMC1::FAM227A	Adenocarcinoma
DMD::LIX1L	Mesenchymal tumor, NOS
DMD::TMEM117	Mesenchymal tumor, NOS
DMD::TSPAN7	Malignant epithelial tumor, special type
DMGDH::NMNAT2	Adenocarcinoma
DMKN::NUMBL	Adenocarcinoma
DMPK::RCN3	Adenocarcinoma
DMRT1::BCL6	Diffuse large B-cell lymphoma
DMTF1::ABCB1	Epithelioid sarcoma
DMTF1::GRM3	Squamous cell carcinoma
DMTF1::SEMA3D	Astrocytoma, grade I-II
DMTN::NPM2	Adenocarcinoma | Germ cell tumor, NOS
DMTN::SCN2A	Astrocytoma, grade I-II
DMTN::SFTPC	Adenocarcinoma
DMWD::KDM4C	Adenocarcinoma
DMXL1::ARHGAP15	Transitional cell carcinoma
DMXL1::NANS	Mesenchymal tumor, NOS
DMXL2::CDKN2A	Astrocytoma, grade III-IV/Glioblastoma
DMXL2::PTPRR	Malignant melanoma
DNAAF11::EXT1	Adenocarcinoma
DNAAF4::LSAMP	Malignant melanoma
DNAAF4::RFX7	Adenocarcinoma
DNAAF5::BRAT1	Malignant melanoma
DNAAF5::LAMA5	Mesenchymal tumor, NOS
DNAAF5::PLCXD2	Adenocarcinoma
DNAAF5::SMYD3	Squamous cell carcinoma
DNAAF5::ZNRF3	Transitional cell carcinoma
DNAAF9::ADRA1D	Adenocarcinoma
DNAAF9::ASPH	Adenocarcinoma
DNAAF9::CEACAM16	Adenocarcinoma
DNAAF9::EIF2S2	Transitional cell carcinoma
DNAAF9::EVI5	Adenocarcinoma
DNAAF9::TDRD10	Adenocarcinoma
DNAH10::LIN7A	Mesenchymal tumor, NOS
DNAH11::VDAC3	Adenocarcinoma
DNAH14::ARF1	Malignant melanoma
DNAH14::CNIH3	Adenocarcinoma
DNAH14::EPHX1	Adenocarcinoma
DNAH14::IKZF1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
DNAH14::MET	Carcinoma, NOS
DNAH17::ERBB2	Carcinoma, NOS
DNAH17::NCAN	Adenocarcinoma
DNAH1::ALAS1	Adenocarcinoma
DNAH1::CACNA1D	Adenocarcinoma
DNAH1::PRKCD	Adenocarcinoma
DNAH2::WRAP53	Adenocarcinoma
DNAH7::ZCWPW2	Adenocarcinoma
DNAH8::TMEM217	Astrocytoma, grade III-IV/Glioblastoma
DNAI4::LRRC40	Adenocarcinoma
DNAI7::PLEKHA5	Adenocarcinoma
DNAJA1::GALNTL6	Astrocytoma, grade I-II
DNAJA2::COL14A1	Adenocarcinoma
DNAJA2::LPCAT2	Adenocarcinoma
DNAJA3::CREBBP	Acute lymphoblastic leukemia/lymphoblastic lymphoma
DNAJA3::ZDHHC16	Adenocarcinoma
DNAJA4::CLIC4	Malignant melanoma
DNAJB12::CTNNA3	Adenocarcinoma
DNAJB12::SLC25A16	Adenocarcinoma
DNAJB1::EPS15L1	Adenocarcinoma
DNAJB1::MED26	Adenocarcinoma
DNAJB1::PRKACA	Malignant epithelial tumor, special type | Adenocarcinoma
DNAJB1::TECR	Adenocarcinoma
DNAJB1::TRPM4	Adenocarcinoma
DNAJB4::NEXN	Adenocarcinoma
DNAJB6::AGT	Squamous cell carcinoma
DNAJB6::SHH	Primitive neuroectodermal tumor/Medulloblastoma | Russia
DNAJB6::UBE3C	Adenocarcinoma
DNAJC11::CAMTA1	Adenocarcinoma
DNAJC11::KRT13	Transitional cell carcinoma
DNAJC11::NOTCH2	Adenocarcinoma
DNAJC11::UTS2	Adenocarcinoma
DNAJC13::UBA5	Squamous cell carcinoma
DNAJC14::SMARCC2	Adenocarcinoma
DNAJC15::RNASEH2B	Chronic lymphocytic leukemia
DNAJC15::UFM1	Adenocarcinoma
DNAJC16::FHAD1	Squamous cell carcinoma
DNAJC17::CIB2	Adenocarcinoma
DNAJC17::INO80	Adenocarcinoma
DNAJC17::PPP1R14D	Adenocarcinoma
DNAJC17::RAB10	Adenocarcinoma
DNAJC17::TRIP4	Mesenchymal tumor, NOS
DNAJC19::ADK	Squamous cell carcinoma
DNAJC1::BRCA1	Adenocarcinoma
DNAJC1::DCLRE1C	Adenocarcinoma
DNAJC1::EBLN1	Adenocarcinoma
DNAJC1::NDUFAF6	Adenocarcinoma
DNAJC1::PLEKHF2	Adenocarcinoma
DNAJC1::RERGL	Embryonal rhabdomyosarcoma
DNAJC1::SFTPD	Adenocarcinoma
DNAJC1::SKIDA1	Adenocarcinoma | Squamous cell carcinoma
DNAJC21::SGCZ	Adenocarcinoma
DNAJC22::NTN4	Adenocarcinoma
DNAJC28::GART	Malignant epithelial tumor, special type
DNAJC2::ALDH1A1	Adenocarcinoma
DNAJC2::CDK14	Squamous cell carcinoma
DNAJC2::PSMC2	Adenocarcinoma
DNAJC2::RELN	Adenocarcinoma
DNAJC2::SLC26A5	Squamous cell carcinoma | Adenocarcinoma
DNAJC2::ZNF385D	Adenocarcinoma
DNAJC3::CLDN10	Mature B-cell neoplasm, NOS | Adenocarcinoma
DNAJC3::GPC6	Adenocarcinoma
DNAJC3::MCF2L	Adenocarcinoma
DNAJC4::CDC42EP2	Adenocarcinoma
DNAJC4::IGF2	Adenocarcinoma
DNAJC4::NUDT22	Adenocarcinoma
DNAJC4::PLAAT4	Malignant epithelial tumor, special type
DNAJC5::TPD52L2	Adenocarcinoma
DNAJC6::PDE1C	Adenocarcinoma
DNAJC7::GHDC	Adenocarcinoma
DNAJC7::SCGB2A2	Adenocarcinoma
DNAJC7::TBCD	Adenocarcinoma
DNAJC8::KDF1	Squamous cell carcinoma
DNAJC8::ZNF3	Adenocarcinoma
DNAJC9::CFAP70	Adenocarcinoma
DNALI1::ARHGEF6	Adenocarcinoma
DNASE2::GADD45GIP1	Adenocarcinoma
DNASE2::MAST1	Adenocarcinoma
DNASE2::SMR3B	Adenocarcinoma
DNASE2::TRMT1	Adenocarcinoma
DNER::RET	Carcinoma, NOS
DNER::TRIP12	Adenocarcinoma
DNM1::FGFR2	Adenocarcinoma
DNM1::LCN2	Squamous cell carcinoma
DNM1L::BICD1	Malignant melanoma
DNM1L::CAP2	Astrocytoma, grade I-II
DNM1L::FGD4	Adenocarcinoma
DNM1L::ITPR2	Adenocarcinoma
DNM1L::TSPAN11	Adenocarcinoma
DNM2::ANGPTL4	Adenocarcinoma
DNM2::ARHGAP25	Transitional cell carcinoma
DNM2::ARHGEF7	Mesenchymal tumor, NOS
DNM2::ATG4D	Adenocarcinoma
DNM2::C19ORF38	Adenocarcinoma
DNM2::CNN1	Adenocarcinoma
DNM2::DAND5	Adenocarcinoma
DNM2::FDX2	Malignant melanoma
DNM2::HEPACAM2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
DNM2::ILF3	Undifferentiated carcinoma, small cell | Adenocarcinoma
DNM2::KCNN1	Undifferentiated carcinoma, small cell
DNM2::MRPL4	Malignant epithelial tumor, special type
DNM2::NFIX	Adenocarcinoma
DNM2::P2RY11	Adenocarcinoma
DNM2::PDE4A	Adenocarcinoma | Astrocytoma, grade I-II
DNM2::PIN1	Adenocarcinoma
DNM2::PRKCSH	Adenocarcinoma
DNM2::PTH2R	Mesenchymal tumor, NOS
DNM2::QTRT1	Adenocarcinoma
DNM2::RELB	Adenocarcinoma
DNM2::RFX1	Adenocarcinoma
DNM2::RFX2	Transitional cell carcinoma
DNM2::SBNO2	Adenocarcinoma
DNM2::SHFL	Malignant melanoma
DNM2::SLC44A2	Adenocarcinoma
DNM2::SLC47A1	Adenocarcinoma
DNM2::SMARCA4	Acute myeloid leukemia, NOS | Skin
DNM2::TGIF1	Adenocarcinoma
DNM2::ZGLP1	Malignant melanoma
DNM3::CD247	Mesenchymal tumor, NOS
DNM3::SHISA9	Mesenchymal tumor, NOS
DNM3::TPH2	Mesenchymal tumor, NOS
DNM3::UHRF1	Mesenchymal tumor, NOS
DNMBP::COP1	Mesenchymal tumor, NOS
DNMBP::CPN1	Malignant melanoma
DNMBP::EFCAB14	Transitional cell carcinoma
DNMBP::TPTE2	Squamous cell carcinoma
DNMT1::ADGRE1	Transitional cell carcinoma
DNMT1::AP1M1	Adenocarcinoma
DNMT1::FDX2	Malignant melanoma
DNMT1::ICAM3	Adenocarcinoma
DNMT1::KLF1	Adenocarcinoma
DNMT1::OLFM2	Adenocarcinoma
DNMT1::RAVER1	Adenocarcinoma
DNMT1::ZNF563	Adenocarcinoma
DNMT3A::ADCY3	Adenocarcinoma
DNMT3A::DTNB	Malignant melanoma
DNMT3A::GTF3C2	Adenocarcinoma
DNMT3A::HADHA	Adenocarcinoma
DNMT3A::TRPC6	Adenocarcinoma
DNMT3B::COMMD7	Malignant epithelial tumor, special type
DNMT3B::DUSP15	Transitional cell carcinoma
DNMT3B::MDM4	Skin | Acute myeloid leukemia, NOS
DNMT3B::MMP9	Adenocarcinoma
DNMT3B::PAX5	Acute lymphoblastic leukemia/lymphoblastic lymphoma
DNMT3B::ZCCHC7	Acute lymphoblastic leukemia/lymphoblastic lymphoma
DNPEP::TNKS	Squamous cell carcinoma
DNTT::BLNK	Acute lymphoblastic leukemia/lymphoblastic lymphoma
DNTTIP2::GCLM	Adenocarcinoma
DOC2B::APBB2	Adenocarcinoma
DOC2B::RPH3AL	Adenocarcinoma
DOCK10::IL1RN	Astrocytoma, grade I-II
DOCK11::IL13RA1	Squamous cell carcinoma
DOCK1::AP3M1	Adenocarcinoma
DOCK1::APBA1	Adenocarcinoma
DOCK1::DACT3	Adenocarcinoma
DOCK1::DPCD	Astrocytoma, grade III-IV/Glioblastoma
DOCK1::GANC	Adenocarcinoma
DOCK1::MGMT	Adenocarcinoma
DOCK1::NPS	Adenocarcinoma
DOCK1::PCDH15	Adenocarcinoma
DOCK1::PLPP4	Adenocarcinoma
DOCK1::RBFOX2	Transitional cell carcinoma
DOCK1::RET	Carcinoma, NOS
DOCK1::STK32C	Mesenchymal tumor, NOS
DOCK2::LMAN2	Malignant melanoma
DOCK2::PDGFRB	Acute lymphoblastic leukemia/lymphoblastic lymphoma
DOCK3::CSNK1A1	Mesenchymal tumor, NOS
DOCK3::INKA1	Astrocytoma, grade I-II
DOCK3::SLC9A5	Adenocarcinoma
DOCK3::SMARCC1	Adenocarcinoma
DOCK3::TKT	Adenocarcinoma
DOCK3::TMIGD2	Miscellaneous hematopoietic/lymphoid neoplasm, special type | Benign epithelial tumor, special type
DOCK4::BCAP29	Adenocarcinoma
DOCK4::DUS4L	Adenocarcinoma
DOCK4::IMMP2L	Adenocarcinoma
DOCK4::NRCAM	Adenocarcinoma
DOCK4::TPH2	Squamous cell carcinoma
DOCK6::NFIX	Adenocarcinoma
DOCK6::SF3A1	Adenocarcinoma
DOCK6::TMEM205	Germ cell tumor, NOS
DOCK6::YJU2B	Acute myeloid leukemia, NOS | Skin
DOCK7::ADAM32	Mesenchymal tumor, NOS
DOCK7::ANGPTL3	Adenocarcinoma
DOCK7::NMT2	Mesenchymal tumor, NOS
DOCK7::PATJ	Adenocarcinoma
DOCK7::PPP1R12B	Adenocarcinoma
DOCK7::SLC45A3	Adenocarcinoma
DOCK8::GLIPR2	Adenocarcinoma
DOCK8::JAK2	Adenocarcinoma
DOCK8::OSBP	Adenocarcinoma
DOCK9::BAZ1A	Adenocarcinoma
DOCK9::GPR183	Adenocarcinoma
DOCK9::SLC15A1	Transitional cell carcinoma
DOCK9::SPACA7	Adenocarcinoma
DOCK9::USH2A	Adenocarcinoma
DOK4::PLLP	Adenocarcinoma
DOK5::CLEC17A	Adenocarcinoma
DOK5::SLC2A1	Adenocarcinoma
DOK5::TSHZ2	Adenocarcinoma
DOK7::HTT	Adenocarcinoma
DOK7::TFRC	Adenocarcinoma
DOLPP1::SPTAN1	Adenocarcinoma
DOLPP1::TBC1D13	Adenocarcinoma
DOP1A::RNF144B	Adenocarcinoma
DOP1A::SMIM8	Adenocarcinoma
DOP1B::CBR3	Adenocarcinoma | Malignant melanoma
DOP1B::ELF2	Adenocarcinoma
DOP1B::NFIC	Adenocarcinoma
DOP1B::PIBF1	Squamous cell carcinoma
DOP1B::SH3BGR	Adenocarcinoma
DOP1B::TRPM2	Adenocarcinoma
DOT1L::BTBD2	Adenocarcinoma
DOT1L::CSNK1G2	Adenocarcinoma
DOT1L::EPB41L2	Adenocarcinoma
DOT1L::GCGR	Adenocarcinoma
DOT1L::LSM7	Adenocarcinoma
DOT1L::OAZ1	Adenocarcinoma
DOT1L::ONECUT3	Adenocarcinoma
DOT1L::PLEKHF1	Adenocarcinoma
DOT1L::PSG11	Mesenchymal tumor, NOS
DOT1L::SSBP3	Mesenchymal tumor, NOS
DOT1L::TECR	Astrocytoma, grade I-II
DOT1L::TLE6	Adenocarcinoma
DPEP1::IGK	Multiple myeloma
DPEP1::TCF25	Adenocarcinoma
DPF2::CDC42EP2	Squamous cell carcinoma
DPF2::CFL1	Squamous cell carcinoma
DPF2::POLA2	Astrocytoma, grade III-IV/Glioblastoma
DPF2::PPP1R10	Malignant melanoma
DPF2::TRIM49C	Adenocarcinoma
DPF3::TDP1	Astrocytoma, grade I-II
DPH1::RPA1	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
DPH6::AQR	Adenocarcinoma
DPH6::SHC4	Adenocarcinoma
DPH7::PTP4A3	Adenocarcinoma
DPH7::PTPA	Adenocarcinoma
DPH7::ZMYND19	Astrocytoma, grade III-IV/Glioblastoma | Squamous cell carcinoma | Adenocarcinoma
DPM1::CD63	Osteosarcoma, NOS
DPM1::CYP4F12	Adenocarcinoma
DPM1::EZR	Adenocarcinoma
DPM1::GRID1	Acute myeloblastic leukemia with maturation (FAB type M2) | Skin | Acute myeloid leukemia, NOS
DPM1::KIF16B	Malignant melanoma
DPM1::TAF4	Adenocarcinoma
DPP10::NTRK3	Malignant melanoma
DPP3::FAM163A	Mesenchymal tumor, NOS
DPP3::FEZ1	Adenocarcinoma
DPP3::FKBP2	Adenocarcinoma
DPP3::KDM2A	Adenocarcinoma
DPP3::PACS1	Adenocarcinoma
DPP3::SPATA6	Transitional cell carcinoma
DPP4::PDK1	Adenocarcinoma
DPP4::THSD7B	Adenocarcinoma
DPP6::GGNBP2	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
DPP6::IFIT3	Embryonal nervous system tumor, special type
DPP6::RET	Carcinoma, NOS
DPP7::EXD3	Adenocarcinoma
DPP8::PARP16	Transitional cell carcinoma
DPP8::TICRR	Adenocarcinoma
DPP9::DHX8	Adenocarcinoma
DPP9::PTPRS	Adenocarcinoma
DPP9::TSPOAP1	Carcinoma, NOS
DPPA5::KHDC3L	Germ cell tumor, NOS
DPY19L1::CDKAL1	Squamous cell carcinoma
DPY19L1::HOXA11	Acute lymphoblastic leukemia/lymphoblastic lymphoma
DPY19L1::NRXN2	Adenocarcinoma
DPY19L1::SDK1	Squamous cell carcinoma
DPY19L2::MRPL1	Adenocarcinoma
DPY19L2::NUP107	Mesenchymal tumor, NOS
DPY19L3::GPR68	Malignant melanoma
DPY19L3::TDRD12	Malignant epithelial tumor, special type
DPY19L4::SDC2	Adenocarcinoma
DPY19L4::SNTG1	Adenocarcinoma
DPY30::IMMT	Adenocarcinoma
DPY30::MCU	Adenocarcinoma
DPYD::ALKBH3	Adenocarcinoma
DPYD::CSNK1G1	Adenocarcinoma
DPYD::EDIL3	Adenocarcinoma
DPYD::RGS5	Adenocarcinoma
DPYD::STAB2	Adenocarcinoma
DPYD::TGFBR3	Adenocarcinoma
DPYSL2::BNIP3L	Squamous cell carcinoma
DPYSL2::FSTL5	Mesenchymal tumor, NOS
DPYSL2::GFAP	Ependymoma
DPYSL2::HMBOX1	Mesenchymal tumor, NOS
DPYSL3::ANKS1A	Transitional cell carcinoma
DPYSL3::IL17B	Malignant melanoma
DPYSL3::JAKMIP2	Astrocytoma, grade III-IV/Glioblastoma
DR1::CCDC18	Adenocarcinoma
DR1::HIPK1	Mycosis fungoides/Sézary syndrome
DRAM1::NTN4	Mesenchymal tumor, NOS
DRAM1::NUP107	Transitional cell carcinoma
DRAM1::OVOL2	Adenocarcinoma
DRAM1::SYCP3	Adenocarcinoma
DRAM2::TTF2	Adenocarcinoma
DRG1::MYH9	Astrocytoma, grade III-IV/Glioblastoma
DRG1::MYO18B	Squamous cell carcinoma
DRG1::RNF185	Mature B-cell neoplasm, NOS
DRG2::ZNF624	Adenocarcinoma
DROSHA::DNAH5	Malignant melanoma
DROSHA::SPEF2	Adenocarcinoma
DROSHA::TERT	Malignant melanoma
DROSHA::UGT3A2	Adenocarcinoma
DSC2::NINL	Adenocarcinoma
DSCAML1::KMT2A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
DSCAML1::MPZL2	Astrocytoma, grade I-II
DSCAML1::POGLUT3	Astrocytoma, grade I-II
DSE::GRIN2A	Mesenchymal tumor, NOS
DSE::PKIB	Astrocytoma, grade I-II
DSE::PLEKHG1	Mesenchymal tumor, NOS
DSG1::DSP	Squamous cell carcinoma
DSG1::TNXB	Adenocarcinoma
DSG2::DSG4	Squamous cell carcinoma
DSG2::TTR	Adenocarcinoma | Squamous cell carcinoma
DSN1::MROH8	Mesenchymal tumor, NOS
DSN1::MTCL2	Adenocarcinoma
DSP::FARS2	Adenocarcinoma
DSP::HDLBP	Adenocarcinoma
DSP::LY86	Adenocarcinoma
DSP::RCAN2	Squamous cell carcinoma
DSP::RET	Carcinoma, NOS
DSP::UTRN	Adenocarcinoma
DST::AKAP6	Squamous cell carcinoma
DST::BMP5	Squamous cell carcinoma
DST::BRAF	Soft tissue tumor, special type
DST::EYS	Astrocytoma, grade III-IV/Glioblastoma | Adenocarcinoma
DST::FBLN5	Squamous cell carcinoma
DST::FUT5	Adenocarcinoma
DST::HCST	Adenocarcinoma
DST::HMGN1	Squamous cell carcinoma
DST::KIAA0319L	Adenocarcinoma
DST::MLIP	Malignant melanoma
DST::TRIM38	Squamous cell carcinoma
DSTN::ARPC5	Squamous cell carcinoma
DSTN::BANF2	Adenocarcinoma
DSTN::CCDC127	Astrocytoma, grade III-IV/Glioblastoma
DSTN::CCT6A	Adenocarcinoma
DSTN::DTD1	Adenocarcinoma
DSTN::DZANK1	Adenocarcinoma
DSTN::KIZ	Adenocarcinoma
DSTN::MYO5C	Adenocarcinoma
DSTN::SLC24A3	Adenocarcinoma
DSTN::TCFL5	Adenocarcinoma
DSTYK::BRAF	Malignant melanoma
DSTYK::CCSAP	Adenocarcinoma
DSTYK::CSRP1	Malignant epithelial tumor, special type
DSTYK::INTS3	Adenocarcinoma
DSTYK::LEMD1	Adenocarcinoma
DSTYK::NAV1	Adenocarcinoma
DSTYK::NUAK2	Adenocarcinoma
DSTYK::NUCKS1	Acute myeloid leukemia, NOS | Skin | Adenocarcinoma
DTD1::KIF16B	Adenocarcinoma
DTD1::MACROD2	Adenocarcinoma
DTD1::PDGFRB	Chronic eosinophilic leukemia/hypereosinophilic syndrome
DTD1::POU2F3	Adenocarcinoma
DTD1::RALGAPA2	Squamous cell carcinoma
DTD1::SEC23B	Adenocarcinoma
DTD1::TASP1	Squamous cell carcinoma
DTD1::TTC29	Adenocarcinoma
DTD2::CGRRF1	Malignant melanoma
DTL::AGBL4	Adenocarcinoma
DTL::INTS7	Adenocarcinoma
DTNA::CD82	Astrocytoma, grade I-II
DTNA::LDLRAD4	Adenocarcinoma
DTNA::ZNF521	Adenocarcinoma
DTNB::ADCY3	Malignant melanoma
DTNB::ASXL2	Adenocarcinoma
DTNB::CNOT4	Squamous cell carcinoma
DTNB::EXOC4	Mesenchymal tumor, NOS
DTNB::RBKS	Adenocarcinoma
DTNB::SPTLC1	Adenocarcinoma
DTNBP1::DNAH8	Adenocarcinoma
DTNBP1::PITPNC1	Germ cell tumor, NOS
DTNBP1::RSBN1L	Adenocarcinoma
DTWD1::FAM227B	Adenocarcinoma
DTWD2::AFF4	Adenocarcinoma
DTWD2::SLMAP	Adenocarcinoma
DTX2::POR	Adenocarcinoma
DTX2::SRRT	Adenocarcinoma
DTX2::ZP3	Squamous cell carcinoma
DTX3::PLEKHA5	Astrocytoma, grade I-II
DTX3L::FAM162A	Squamous cell carcinoma
DTX4::ABTB2	Astrocytoma, grade I-II
DTX4::CCDC102B	Adenocarcinoma
DTX4::FAM111B	Adenocarcinoma
DTX4::MS4A1	Adenocarcinoma
DUS1L::ASPSCR1	Adenocarcinoma
DUS1L::CCDC57	Squamous cell carcinoma | Adenocarcinoma
DUS1L::RPL13A	Adenocarcinoma
DUS2::BEAN1	Adenocarcinoma
DUS2::CARMIL2	Adenocarcinoma
DUS2::HSD11B2	Malignant melanoma
DUS2::UNC5C	Adenocarcinoma
DUS4L::ANKRD7	Squamous cell carcinoma
DUS4L::BCAP29	Adenocarcinoma
DUSP10::PRDM16	Acute monoblastic leukemia without differentiation (FAB type M5a)
DUSP10::SUSD4	Adenocarcinoma
DUSP12::CR2	Squamous cell carcinoma
DUSP12::NAV1	Adenocarcinoma
DUSP14::ATP6V0A1	Squamous cell carcinoma
DUSP14::EME1	Adenocarcinoma
DUSP14::HEATR6	Adenocarcinoma
DUSP14::PHB1	Adenocarcinoma
DUSP16::BORCS5	Adenocarcinoma
DUSP16::GPR19	Transitional cell carcinoma
DUSP16::GPRC5D	Adenocarcinoma
DUSP16::HEBP1	Adenocarcinoma
DUSP16::PDE2A	Malignant melanoma
DUSP1::MFN1	Adenocarcinoma
DUSP22::BEND6	Mesenchymal tumor, NOS
DUSP22::HDHD5	Malignant melanoma
DUSP22::IRF4	Anaplastic large cell lymphoma, cutaneous type | Anaplastic large cell lymphoma, systemic type | Mature T- and NK-cell neoplasm, special type
DUSP22::PTK7	Adenocarcinoma
DUSP22::TP53TG3	Malignant epithelial tumor, special type
DUSP4::IGH	Multiple myeloma
DUSP5::IGK	Multiple myeloma
DUSP7::PBRM1	Adenocarcinoma
DUSP8::MYEOV	Undifferentiated carcinoma, small cell
DUX4::ERG	Acute lymphoblastic leukemia/lymphoblastic lymphoma
DUX4::FRG2B	Acute lymphoblastic leukemia/lymphoblastic lymphoma
DUX4::IGH	Acute lymphoblastic leukemia/lymphoblastic lymphoma
DVL1::CCNL2	Adenocarcinoma
DVL1::ITPA	Adenocarcinoma
DVL1::OPTN	Malignant epithelial tumor, special type
DVL1::PLCH2	Mesenchymal tumor, NOS
DVL2::CST6	Adenocarcinoma
DVL2::TFE3	PEComa | Alveolar soft part sarcoma | Adenocarcinoma
DVL2::TMEM256	Adenocarcinoma
DVL3::ECE2	Adenocarcinoma
DVL3::RFX6	Adenocarcinoma
DVL3::SCN11A	Undifferentiated carcinoma, small cell
DVL3::VPS8	Squamous cell carcinoma
DYM::ACAA2	Adenocarcinoma
DYM::C10orf105	Adenocarcinoma
DYM::C18orf32	Adenocarcinoma
DYM::CFAP53	Mesenchymal tumor, NOS
DYM::CTIF	Adenocarcinoma
DYM::DAZAP1	Adenocarcinoma
DYM::KATNAL2	Adenocarcinoma
DYM::MYO5B	Adenocarcinoma
DYM::OAS3	Mesenchymal tumor, NOS
DYM::RPL17	Malignant melanoma
DYM::SLC14A2	Adenocarcinoma
DYM::TMC7	Malignant melanoma
DYNC1H1::CDHR3	Squamous cell carcinoma
DYNC1H1::CSN2	Adenocarcinoma
DYNC1H1::EIF5	Squamous cell carcinoma
DYNC1H1::ERBB3	Squamous cell carcinoma
DYNC1H1::EVL	Adenocarcinoma
DYNC1H1::GZMB	Multiple myeloma
DYNC1H1::PPP2R5C	Adenocarcinoma
DYNC1H1::SIAE	Adenocarcinoma
DYNC1I1::ALB	Adenocarcinoma
DYNC1I1::ASB4	Adenocarcinoma
DYNC1I1::CXCL11	Squamous cell carcinoma
DYNC1I1::ZC3HAV1	Adenocarcinoma
DYNC1I2::BABAM2	Adenocarcinoma
DYNC1I2::BRAF	Malignant melanoma
DYNC1LI1::GADL1	Astrocytoma, grade III-IV/Glioblastoma
DYNC1LI1::MRPS11	Adenocarcinoma
DYNC1LI2::NAE1	Adenocarcinoma
DYNC1LI2::ZNF610	Mature B-cell neoplasm, NOS
DYNC2H1::CCDC60	Adenocarcinoma
DYNC2H1::CEP126	Squamous cell carcinoma
DYNC2H1::CFAP300	Transitional cell carcinoma
DYNC2H1::ENDOD1	Squamous cell carcinoma
DYNC2H1::KCNQ5	Adenocarcinoma
DYNC2H1::MMP1	Squamous cell carcinoma
DYNC2H1::NARS2	Malignant melanoma
DYNC2H1::YAP1	Adenocarcinoma
DYNC2I1::VIPR2	Adenocarcinoma
DYNC2I2::NDUFV1	Benign epithelial tumor, special type
DYNC2I2::ZER1	Adenocarcinoma
DYNC2LI1::KCNN3	Mesenchymal tumor, NOS
DYNLL1::COQ5	Squamous cell carcinoma
DYNLL1::GLI2	Germ cell tumor, special type
DYNLL1::RNF10	Adenocarcinoma
DYNLL2::SEPTIN4	Adenocarcinoma
DYNLRB1::ARCN1	Adenocarcinoma
DYNLRB1::CNBD2	Adenocarcinoma
DYNLRB1::ERGIC3	Adenocarcinoma
DYNLRB1::ITCH	Adenocarcinoma
DYNLRB1::RALY	Adenocarcinoma
DYNLT1::DUSP15	Adenocarcinoma
DYNLT3::U2AF2	Adenocarcinoma
DYRK1A::APP	Squamous cell carcinoma
DYRK1A::BRWD1	Adenocarcinoma
DYRK1A::DENND3	Adenocarcinoma
DYRK1A::GLIS2	Skin | Acute myeloid leukemia, NOS
DYRK1A::HUNK	Adenocarcinoma
DYRK1A::IFNGR2	Squamous cell carcinoma
DYRK1A::KCNJ6	Adenocarcinoma
DYRK1A::KDM4B	Adenocarcinoma
DYRK1A::MRPS6	Adenocarcinoma
DYRK1A::PHF6	Adenocarcinoma
DYRK1A::PKNOX1	Adenocarcinoma
DYRK1A::RUNX1	Squamous cell carcinoma
DYRK1A::TRAPPC10	Multiple myeloma
DYRK1A::TTC3	Acute myeloid leukemia, NOS | Adenocarcinoma | Skin
DYRK1A::ZBTB46	Adenocarcinoma
DYRK1B::DPF1	Malignant epithelial tumor, special type
DYRK1B::GAPDHS	Adenocarcinoma
DYRK2::CNTN2	Mesenchymal tumor, NOS
DYSF::ALK	Adenocarcinoma
DZANK1::DTD1	Adenocarcinoma
DZANK1::RRBP1	Astrocytoma, grade I-II
DZIP1::PCCA	Adenocarcinoma
DZIP1L::A4GNT	Adenocarcinoma
DZIP1L::NME9	Adenocarcinoma
E2F3::AKIRIN2	Adenocarcinoma
E2F3::CDKAL1	Adenocarcinoma
E2F3::FBXO9	Adenocarcinoma
E2F3::MYL4	Transitional cell carcinoma
E2F3::WRNIP1	Adenocarcinoma
E2F4::RPL14	Acute lymphoblastic leukemia/lymphoblastic lymphoma
E2F5::CA3	Adenocarcinoma
E2F5::LRRCC1	Squamous cell carcinoma
E2F6::FKBP4	Undifferentiated pleomorphic sarcoma
E2F6::LYRM4	Adenocarcinoma
E2F6::STK36	Adenocarcinoma
E2F7::PTPRR	Mesenchymal tumor, NOS
E2F8::CSRP3	Transitional cell carcinoma
EAF1::BTD	Adenocarcinoma
EAF1::CAND2	Adenocarcinoma
EAF1::SPATA16	Adenocarcinoma
EAF2::RGS9	Adenocarcinoma
EAPP::SNX6	Adenocarcinoma
EAPP::USP13	Squamous cell carcinoma
EARS2::COG7	Adenocarcinoma
EARS2::VMP1	Adenocarcinoma
EBAG9::PKHD1L1	Adenocarcinoma
EBF1::JAK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
EBF1::JMJD1C	Acute lymphoblastic leukemia/lymphoblastic lymphoma
EBF1::PDGFRB	Acute lymphoblastic leukemia/lymphoblastic lymphoma
EBF4::TMC2	Astrocytoma, grade III-IV/Glioblastoma
EBNA1BP2::FMO3	Adenocarcinoma
EBNA1BP2::RRAGC	Primitive neuroectodermal tumor/Medulloblastoma | Russia
EBPL::LPAR6	Squamous cell carcinoma
EBPL::MIPEP	Adenocarcinoma
ECD::CFAP70	Squamous cell carcinoma
ECD::CXCL12	Adenocarcinoma
ECD::MRPS16	Adenocarcinoma
ECD::PCDH15	Squamous cell carcinoma
ECE1::CFAP144	Malignant melanoma
ECE1::EIF4G3	Astrocytoma, grade I-II
ECE1::NIPAL3	Adenocarcinoma
ECE1::PCP4	Adenocarcinoma
ECE1::PLA2G5	Malignant melanoma
ECE1::RAP1GAP	Adenocarcinoma
ECE1::SLC48A1	Adenocarcinoma
ECE1::SRSF10	Adenocarcinoma
ECE1::TRAF3IP2	Malignant melanoma
ECE1::WNT4	Adenocarcinoma
ECE2::HTR3C	Squamous cell carcinoma
ECE2::PSMD2	Squamous cell carcinoma
ECHDC1::FYN	Adenocarcinoma
ECHDC1::MYO6	Squamous cell carcinoma
ECI1::CDKN3	Adenocarcinoma
ECPAS::CARD19	Adenocarcinoma
ECPAS::PACS1	Adenocarcinoma
ECPAS::SHOC1	Adenocarcinoma
ECPAS::WNK2	Adenocarcinoma
ECPAS::ZNF484	Adenocarcinoma
ECSIT::ELOF1	Malignant melanoma
ECSIT::RGL3	Adenocarcinoma
ECT2::CSTF3	Undifferentiated carcinoma, small cell
ECT2::DGKG	Squamous cell carcinoma
ECT2::KALRN	Squamous cell carcinoma
EDA::FAAH2	Adenocarcinoma
EDA::MID1	Adenocarcinoma
EDA::TEX11	Mesenchymal tumor, NOS
EDARADD::TGFBR3	Adenocarcinoma
EDC3::COX5A	Adenocarcinoma
EDC3::CYP11A1	Adenocarcinoma
EDC3::CYP1A1	Adenocarcinoma
EDC3::SCAMP2	Adenocarcinoma
EDC3::SLC6A11	Germ cell tumor, NOS
EDC3::SNX29	Adenocarcinoma
EDEM1::GPD1L	Adenocarcinoma
EDEM1::ITPR1	Adenocarcinoma
EDEM2::DOK5	Adenocarcinoma
EDEM2::NOL4L	Adenocarcinoma
EDEM2::PEX14	Adenocarcinoma
EDEM2::UQCC1	Malignant melanoma
EDEM3::DPT	Malignant epithelial tumor, special type
EDEM3::HHAT	Adenocarcinoma
EDF1::ASPSCR1	Malignant epithelial tumor, special type
EDF1::DPP7	Adenocarcinoma
EDF1::EHMT1	Multiple myeloma
EDF1::NOTCH1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
EDF1::RABL6	Multiple myeloma
EDF1::RALGDS	Multiple myeloma
EDIL3::MAN1C1	Mesothelioma
EDIL3::MKLN1	Acute myeloblastic leukemia without maturation (FAB type M1)
EDNRB::COL4A1	Adenocarcinoma
EEA1::BRAF	Benign nevus
EEA1::CRADD	Transitional cell carcinoma
EEA1::LRRIQ1	Adenocarcinoma
EEA1::MPG	Adenocarcinoma
EEA1::PAH	Adenocarcinoma
EEA1::RET	Carcinoma, NOS | Adenocarcinoma
EEA1::TMCC3	Adenocarcinoma
EEA1::UBE2N	Adenocarcinoma
EEA1::UBL3	Adenocarcinoma
EED::HIKESHI	Squamous cell carcinoma | Adenocarcinoma
EED::TPCN2	Adenocarcinoma
EEF1A1::MPO	Skin | Acute myeloid leukemia, NOS
EEF1A1::NTRK3	Malignant soft tissue tumor, NOS
EEF1A1::PLAG1	Low-grade fibromyxoid sarcoma | Lipoblastoma
EEF1A2::DKKL1	Adenocarcinoma
EEF1A2::ZBTB46	Adenocarcinoma
EEF1AKMT2::CTBP2	Adenocarcinoma
EEF1AKMT2::FAM53B	Nonneoplastic hematologic disorder/lesion | Nonneoplastic epithelial disorder/lesion
EEF1AKMT3::CDKAL1	Transitional cell carcinoma
EEF1AKMT3::CNOT2	Astrocytoma, grade III-IV/Glioblastoma
EEF1AKMT3::CPM	Astrocytoma, grade III-IV/Glioblastoma
EEF1AKMT3::GLI1	Astrocytoma, grade I-II
EEF1AKMT3::INHBC	Astrocytoma, grade I-II
EEF1AKMT3::INHBE	Astrocytoma, grade III-IV/Glioblastoma
EEF1AKMT3::LTA4H	Mesenchymal tumor, NOS
EEF1AKMT3::LYZ	Astrocytoma, grade III-IV/Glioblastoma
EEF1AKMT3::MBD6	Malignant melanoma
EEF1AKMT3::METTL1	Astrocytoma, grade III-IV/Glioblastoma
EEF1AKMT3::PIP4K2C	Malignant melanoma
EEF1AKMT3::PTPRR	Mesenchymal tumor, NOS
EEF1AKMT3::RASSF3	Squamous cell carcinoma
EEF1D::GFUS	Adenocarcinoma
EEF1D::PUF60	Adenocarcinoma
EEF1D::STAU2	Adenocarcinoma
EEF1D::TSNARE1	Adenocarcinoma
EEF1E1::EYS	Adenocarcinoma
EEF1G::ALK	Anaplastic large cell lymphoma, systemic type
EEF1G::CHCHD3	Multiple myeloma
EEF1G::IGK	Multiple myeloma
EEF1G::NXF1	Malignant melanoma
EEF1G::OOEP	Acute lymphoblastic leukemia/lymphoblastic lymphoma
EEF1G::PPP6R3	Squamous cell carcinoma
EEF1G::SLC22A6	Adenocarcinoma
EEF2::ANKS1A	Adenocarcinoma
EEF2::ARFGEF2	Adenocarcinoma
EEF2::CBS	Adenocarcinoma
EEF2::CLCN3	Transitional cell carcinoma
EEF2::DDX21	Germ cell tumor, NOS
EEF2::DDX27	Adenocarcinoma
EEF2::EEA1	Mesenchymal tumor, NOS
EEF2::EIF2AK2	Transitional cell carcinoma
EEF2::ERBB3	Adenocarcinoma
EEF2::FAR1	Adenocarcinoma
EEF2::IGL	Multiple myeloma
EEF2::LAMA4	Mesenchymal tumor, NOS
EEF2::LIPF	Adenocarcinoma
EEF2::PABPC1	Malignant melanoma
EEF2::PLEKHA5	Adenocarcinoma
EEF2::SEC63	Adenocarcinoma
EEF2::SIAE	Adenocarcinoma
EEF2::SLC25A23	Adenocarcinoma
EEF2::SMARCA4	Mesenchymal tumor, NOS
EEF2::THSD4	Adenocarcinoma
EEF2::TYK2	Diffuse large B-cell lymphoma
EEF2K::ACSM3	Adenocarcinoma
EEF2K::FAM241B	Squamous cell carcinoma
EEF2K::KCTD1	Adenocarcinoma
EEF2K::SDR42E2	Adenocarcinoma
EEF2K::UQCRC2	Adenocarcinoma
EEF2K::VWA3A	Adenocarcinoma
EEFSEC::CD96	Mesenchymal tumor, NOS
EEFSEC::NSMCE2	Transitional cell carcinoma
EEFSEC::PDHX	Acute lymphoblastic leukemia/lymphoblastic lymphoma
EEFSEC::PPP2R3A	Squamous cell carcinoma
EEIG1::ARFGEF2	Squamous cell carcinoma
EEIG1::CIZ1	Adenocarcinoma
EEIG1::DYNC2I2	Adenocarcinoma
EEIG1::EMSY	Adenocarcinoma
EEIG1::NAIF1	Adenocarcinoma
EEIG1::PHF19	Malignant melanoma
EEIG1::PTGES2	Adenocarcinoma | Astrocytoma, grade III-IV/Glioblastoma
EEIG1::RAD23B	Mesenchymal tumor, NOS
EEIG1::WDR93	Adenocarcinoma
EEIG2::SLC25A24	Transitional cell carcinoma
EEIG2::TLCD4	Adenocarcinoma
EEIG2::TRAPPC8	Malignant melanoma
EFCAB11::ASB2	Adenocarcinoma
EFCAB11::C14orf180	Adenocarcinoma
EFCAB11::TTC7B	Adenocarcinoma
EFCAB12::MBD4	Adenocarcinoma
EFCAB13::MYL4	Adenocarcinoma
EFCAB2::FKBP3	Adenocarcinoma
EFCAB2::SDCCAG8	Adenocarcinoma
EFCAB5::ACACA	Adenocarcinoma
EFCAB6::CYB5R3	Malignant melanoma
EFCAB6::OSBP2	Adenocarcinoma
EFCAB8::TNNC2	Adenocarcinoma
EFEMP2::C6ORF132	Adenocarcinoma
EFEMP2::C6orf132	Adenocarcinoma
EFHB::PLCL2	Adenocarcinoma
EFHB::TYR	Undifferentiated carcinoma, small cell
EFHC1::ADGRL3	Adenocarcinoma
EFHC1::IL17A	Adenocarcinoma
EFHC1::MAPK14	Squamous cell carcinoma
EFHD1::EIF4E2	Adenocarcinoma
EFHD2::CTRB2	Adenocarcinoma
EFHD2::CXCR5	Transitional cell carcinoma
EFHD2::FHAD1	Adenocarcinoma
EFL1::CACNA2D3	Adenocarcinoma
EFL1::CDADC1	Squamous cell carcinoma
EFL1::GLDN	Adenocarcinoma
EFL1::KHDRBS2	Squamous cell carcinoma
EFNA1::ADAM15	Adenocarcinoma
EFNA1::CPB1	Adenocarcinoma
EFNA1::FLAD1	Squamous cell carcinoma
EFNA3::CKS1B	Squamous cell carcinoma
EFNA3::FLAD1	Squamous cell carcinoma
EFNA3::HJV	Adenocarcinoma
EFNA3::PIK3C2G	Adenocarcinoma
EFNA3::USP21	Adenocarcinoma
EFNA4::C20ORF96	Adenocarcinoma
EFNA4::C20orf96	Adenocarcinoma
EFNA4::FLAD1	Adenocarcinoma | Squamous cell carcinoma
EFNA5::MCC	Transitional cell carcinoma
EFNB1::RAF1	Malignant melanoma
EFR3A::ASAP1	Adenocarcinoma
EFR3A::ATAD2	Adenocarcinoma
EFR3A::PHF20L1	Adenocarcinoma
EFR3A::SLFN12L	Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
EFR3A::SMIM18	Adenocarcinoma
EFR3A::ZFAT	Adenocarcinoma
EFR3B::NCAN	Squamous cell carcinoma
EFR3B::NCOA1	Adenocarcinoma
EFTUD2::C1QL1	Adenocarcinoma
EFTUD2::DUSP3	Adenocarcinoma
EFTUD2::GFAP	Adenocarcinoma
EFTUD2::KIF18B	Adenocarcinoma
EFTUD2::KRT24	Squamous cell carcinoma
EFTUD2::PLCD3	Adenocarcinoma
EFTUD2::PLEKHM1	Malignant epithelial tumor, special type
EFTUD2::SIN3A	Adenocarcinoma
EGF::ENPEP	Adenocarcinoma
EGFL7::FOSB	Pseudomyogenic hemangioendothelioma
EGFL7::METRNL	Acute lymphoblastic leukemia/lymphoblastic lymphoma
EGFR::ACADM	Squamous cell carcinoma
EGFR::BRAF	Fibroblastic/myofibroblastic tumor, special type
EGFR::CHODL	Squamous cell carcinoma
EGFR::COBL	Astrocytoma, grade III-IV/Glioblastoma
EGFR::DYM	Squamous cell carcinoma
EGFR::EGFR	Astrocytoma, grade III-IV/Glioblastoma | Carcinoma, NOS
EGFR::ERBB4	Adenocarcinoma
EGFR::ERP44	Astrocytoma, grade III-IV/Glioblastoma
EGFR::GNS	Astrocytoma, grade III-IV/Glioblastoma
EGFR::GRB10	Transitional cell carcinoma
EGFR::GYG1	Transitional cell carcinoma
EGFR::INSL4	Adenocarcinoma
EGFR::LANCL2	Astrocytoma, grade III-IV/Glioblastoma
EGFR::LYST	Adenocarcinoma
EGFR::MYRFL	Astrocytoma, grade III-IV/Glioblastoma
EGFR::PKD1L1	Astrocytoma, grade III-IV/Glioblastoma
EGFR::POLD1	Adenocarcinoma
EGFR::PPARGC1A	Squamous cell carcinoma
EGFR::PPM1H	Astrocytoma, grade III-IV/Glioblastoma
EGFR::PSPH	Astrocytoma, grade III-IV/Glioblastoma
EGFR::PURB	Adenocarcinoma
EGFR::R3HDM2	Astrocytoma, grade III-IV/Glioblastoma
EGFR::RAD51	Adenocarcinoma
EGFR::RCL1	Adenocarcinoma
EGFR::SEC61G	Astrocytoma, grade III-IV/Glioblastoma
EGFR::SEPTIN14	Adenocarcinoma | Astrocytoma, grade III-IV/Glioblastoma | Astrocytoma, grade I-II | Squamous cell carcinoma | Malignant epithelial tumor, special type
EGFR::SHC1	Adenocarcinoma
EGFR::SPMIP7	Astrocytoma, grade I-II
EGFR::TEAD2	Squamous cell carcinoma
EGFR::TEAD3	Astrocytoma, grade III-IV/Glioblastoma
EGFR::VOPP1	Astrocytoma, grade III-IV/Glioblastoma | Squamous cell carcinoma
EGFR::VSTM2A	Astrocytoma, grade III-IV/Glioblastoma | Squamous cell carcinoma | Astrocytoma, grade I-II
EGLN1::C1ORF131	Squamous cell carcinoma
EGLN1::PGBD5	Adenocarcinoma
EGLN1::PTPRF	Squamous cell carcinoma
EGLN2::PLD3	Squamous cell carcinoma
EGLN3::SLC25A21	Adenocarcinoma
EGLN3::TERT	Adenocarcinoma
EGR1::FAR1	Squamous cell carcinoma
EGR1::GRIA1	Fibroblastic/myofibroblastic tumor, special type
EGR1::PLAT	Adenocarcinoma
EHBP1::ALK	Melanocytic neoplasm, special type
EHBP1::BCL11A	Adenocarcinoma
EHBP1::COMMD1	Adenocarcinoma
EHBP1::CTNND2	Adenocarcinoma
EHBP1::FAM161A	Squamous cell carcinoma
EHBP1::GAREM2	Adenocarcinoma
EHBP1::MDH1	Squamous cell carcinoma | Adenocarcinoma
EHBP1::MET	Adenocarcinoma
EHBP1::VAV2	Squamous cell carcinoma
EHBP1L1::FRMD8	Squamous cell carcinoma
EHBP1L1::MTCH2	Adenocarcinoma
EHBP1L1::POLA2	Adenocarcinoma
EHD1::ATG2A	Adenocarcinoma
EHD1::BATF2	Adenocarcinoma
EHD1::DGCR6	Adenocarcinoma
EHD1::GRK3	Astrocytoma, grade I-II
EHD4::FSIP1	Adenocarcinoma
EHD4::GPR176	Malignant melanoma
EHF::BDNF	Adenocarcinoma
EHF::CAT	Adenocarcinoma
EHF::COA8	Transitional cell carcinoma
EHF::CSN2	Adenocarcinoma
EHHADH::ABCC5	Adenocarcinoma
EHHADH::SENP5	Squamous cell carcinoma
EHMT1::ARRDC1	Adenocarcinoma
EHMT1::ATP13A1	Adenocarcinoma
EHMT1::GFI1B	Squamous cell carcinoma
EHMT1::GRIN1	Adenocarcinoma
EHMT1::PPP1R37	Transitional cell carcinoma
EHMT1::SPATA17	Adenocarcinoma
EHMT1::TSC1	Adenocarcinoma
EHMT1::ZMYND19	Adenocarcinoma
EHMT2::ATF6B	Mesenchymal tumor, NOS
EHMT2::CRB1	Adenocarcinoma
EHMT2::NELFE	Adenocarcinoma
EI24::FEZ1	Astrocytoma, grade I-II
EI24::NECTIN1	Undifferentiated carcinoma, small cell
EID2::ACTMAP	Adenocarcinoma
EID2::TDRD12	Malignant epithelial tumor, special type
EIF1::ERBB2	Carcinoma, NOS
EIF1::IGK	Multiple myeloma
EIF1::MED28	Adenocarcinoma
EIF1::USP6	Aneurysmal bone cyst
EIF1AD::CATSPER1	Adenocarcinoma
EIF2A::ANKUB1	Adenocarcinoma
EIF2A::B2M	Adenocarcinoma
EIF2AK1::ANKS1B	Adenocarcinoma
EIF2AK1::COL28A1	Primitive neuroectodermal tumor/Medulloblastoma | Russia
EIF2AK1::GCK	Adenocarcinoma
EIF2AK1::GLCCI1	Astrocytoma, grade I-II
EIF2AK1::MAP2K5	Adenocarcinoma
EIF2AK1::OGDH	Primitive neuroectodermal tumor/Medulloblastoma | Russia
EIF2AK1::PHF14	Mesenchymal tumor, NOS
EIF2AK2::CEBPZ	Adenocarcinoma | Transitional cell carcinoma
EIF2AK2::RMDN2	Adenocarcinoma
EIF2AK2::STRN	Adenocarcinoma
EIF2AK3::NBAS	Malignant melanoma
EIF2AK3::PRKD3	Adenocarcinoma
EIF2AK4::ANKRD34C	Squamous cell carcinoma
EIF2AK4::AVEN	Adenocarcinoma
EIF2AK4::BUB1B	Adenocarcinoma
EIF2AK4::EPB42	Squamous cell carcinoma
EIF2AK4::FEM1B	Squamous cell carcinoma
EIF2AK4::IVD	Malignant epithelial tumor, special type
EIF2AK4::PKM	Astrocytoma, grade I-II
EIF2AK4::TMOD3	Adenocarcinoma
EIF2B1::ACSS3	Adenocarcinoma
EIF2B2::YLPM1	Adenocarcinoma
EIF2B3::CNTNAP2	Adenocarcinoma
EIF2B3::HYI	Adenocarcinoma
EIF2B3::SCMH1	Germ cell tumor, NOS
EIF2B3::ZBTB5	Adenocarcinoma
EIF2S1::GPHN	Adenocarcinoma
EIF2S1::PLEKHH1	Squamous cell carcinoma
EIF2S2::ADRA1D	Squamous cell carcinoma
EIF2S2::DEFB123	Adenocarcinoma
EIF2S2::KCNB1	Malignant melanoma
EIF2S2::LETM2	Squamous cell carcinoma
EIF2S2::NCOA6	Squamous cell carcinoma
EIF2S2::SKAP1	Adenocarcinoma
EIF2S3::PRDX4	Adenocarcinoma
EIF3A::IGH	Multiple myeloma
EIF3A::SFXN4	Adenocarcinoma
EIF3A::TBC1D1	Squamous cell carcinoma
EIF3B::AMZ1	Adenocarcinoma
EIF3B::C3ORF33	Adenocarcinoma
EIF3B::LYPD8	Adenocarcinoma
EIF3D::IQCE	Malignant melanoma
EIF3D::MYH9	Squamous cell carcinoma
EIF3D::PLEKHB2	Adenocarcinoma
EIF3E::PHF20L1	Adenocarcinoma
EIF3E::RSPO2	Adenoma | Adenocarcinoma
EIF3E::RUNX1	Acute myelomonocytic leukemia (FAB type M4)
EIF3G::SFTPB	Adenocarcinoma
EIF3G::ZNF560	Squamous cell carcinoma
EIF3H::CIT	Adenocarcinoma
EIF3H::EFR3A	Adenocarcinoma
EIF3H::PAG1	Malignant melanoma
EIF3H::RAD21	Adenocarcinoma
EIF3H::RIPOR3	Adenocarcinoma
EIF3H::ZNF596	Adenocarcinoma
EIF3K::CIC	Astrocytoma, grade III-IV/Glioblastoma
EIF3K::CYP39A1	Adenocarcinoma
EIF3K::PPP2R2A	Squamous cell carcinoma
EIF3L::ADA2	Malignant melanoma
EIF3L::AK7	Adenocarcinoma
EIF3L::ASCC2	Adenocarcinoma
EIF3L::CDC42EP1	Adenocarcinoma
EIF3L::LTO1	Adenocarcinoma
EIF3L::TRIOBP	Adenocarcinoma | Transitional cell carcinoma | Squamous cell carcinoma
EIF3L::VPS13B	Adenocarcinoma
EIF3M::CSTF3	Adenocarcinoma
EIF3M::MPPED2	Squamous cell carcinoma
EIF3M::UEVLD	Mesenchymal tumor, NOS
EIF4A1::PHOSPHO1	Astrocytoma, grade III-IV/Glioblastoma
EIF4A2::BCL6	Diffuse large B-cell lymphoma | Follicular lymphoma
EIF4A2::ETV5	Adenocarcinoma
EIF4A2::KNG1	Adenocarcinoma
EIF4A2::MECOM	Acute myeloid leukemia, NOS | Skin
EIF4E2::DIS3L2	Adenocarcinoma
EIF4E3::MGA	Acute myeloid leukemia, NOS | Skin
EIF4EBP1::ADAM12	Adenocarcinoma
EIF4EBP1::ADAM18	Mesenchymal tumor, NOS
EIF4EBP1::POLR1D	Adenocarcinoma
EIF4EBP1::PRKAA1	Squamous cell carcinoma
EIF4ENIF1::COMT	Adenocarcinoma
EIF4ENIF1::SHANK3	Adenocarcinoma
EIF4G1::ABCC5	Adenocarcinoma
EIF4G1::ABCF3	Adenocarcinoma
EIF4G1::AEBP1	Malignant melanoma
EIF4G1::ANKS1A	Adenocarcinoma
EIF4G1::PTH2R	Adenocarcinoma
EIF4G1::SNW1	Adenocarcinoma
EIF4G2::ARFGEF2	Malignant melanoma
EIF4G2::EIF2AK2	Adenocarcinoma
EIF4G2::ERBB3	Astrocytoma, grade I-II
EIF4G2::MRNIP	Adenocarcinoma
EIF4G2::NUCB2	Adenocarcinoma
EIF4G2::PLAG1	Adenoma
EIF4G2::RSPO2	Adenocarcinoma
EIF4G2::UTRN	Squamous cell carcinoma
EIF4G2::ZNFX1	Adenocarcinoma
EIF4G3::C7ORF50	Adenocarcinoma
EIF4G3::C7orf50	Adenocarcinoma
EIF4G3::CFAP74	Adenocarcinoma
EIF4G3::DDOST	Adenocarcinoma
EIF4G3::ECE1	Adenocarcinoma
EIF4G3::LAMC1	Malignant epithelial tumor, special type
EIF4G3::LIN28A	Squamous cell carcinoma
EIF4G3::LRRC8D	Adenocarcinoma
EIF4G3::NSUN4	Adenocarcinoma
EIF4G3::PPP2R3A	Adenocarcinoma
EIF4G3::RAP1GAP	Adenocarcinoma
EIF4G3::SNX9	Adenocarcinoma
EIF4H::AARS2	Adenocarcinoma
EIF4H::ELN	Adenocarcinoma
EIF4H::GTF2I	Astrocytoma, grade III-IV/Glioblastoma
EIF5::EVI5	Adenocarcinoma
EIF5::NOTCH2	Adenocarcinoma
EIF5A2::PRKCI	Squamous cell carcinoma
EIF5A::MKS1	Squamous cell carcinoma
EIF5A::USP6	Nodular fasciitis
EIF5B::C2ORF15	Adenocarcinoma
EIF5B::LYG1	Squamous cell carcinoma
EIF5B::MGAT4A	Adenocarcinoma
EIF6::BANF2	Transitional cell carcinoma
EIPR1::MYT1L	Squamous cell carcinoma
EIPR1::SH3YL1	Adenocarcinoma
EIPR1::SLC5A6	Adenocarcinoma
ELAC1::MRO	Adenocarcinoma
ELAC1::SMAD4	Adenocarcinoma
ELAC2::COX10	Adenocarcinoma
ELAC2::RABEP1	Adenocarcinoma
ELAC2::SPTBN1	Fibroma
ELAPOR1::CSN2	Adenocarcinoma
ELAPOR2::ABCA13	Adenocarcinoma
ELAPOR2::TMEM243	Russia | Primitive neuroectodermal tumor/Medulloblastoma
ELAVL1::ATXN10	Malignant epithelial tumor, special type
ELAVL1::HDGFL2	Adenocarcinoma
ELAVL1::PRR36	Squamous cell carcinoma
ELAVL1::TIMM44	Nonneoplastic epithelial disorder/lesion
ELAVL1::TYK2	Acute myeloid leukemia, NOS | Skin
ELAVL2::CFTR	Adenocarcinoma
ELF1::DCLK1	Adenocarcinoma
ELF1::FOXO1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ELF1::MTIF3	Adenocarcinoma
ELF1::RNF144A	Adenocarcinoma
ELF1::SPATC1L	Skin | Acute myeloid leukemia, NOS
ELF1::UBL3	Transitional cell carcinoma
ELF1::VWA8	Transitional cell carcinoma
ELF2::ICA1L	Squamous cell carcinoma
ELF2::KMT2A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ELF2::MGARP	Adenocarcinoma
ELF2::NDUFC1	Adenocarcinoma
ELF2::NR1I3	Adenocarcinoma
ELF3::DDX21	Adenocarcinoma
ELF3::GPR37L1	Adenocarcinoma
ELF3::SLC39A6	Adenocarcinoma
ELF4::ERG	Skin | Acute myeloid leukemia, NOS
ELF5::CAT	Adenocarcinoma
ELF5::EXT2	Adenocarcinoma
ELK1::PCBP3	Malignant epithelial tumor, special type
ELK3::AMDHD1	Adenocarcinoma
ELK3::CDK17	Mesenchymal tumor, NOS
ELK3::DDIT4L	Adenocarcinoma
ELK3::ETV6	Acute myeloid leukemia, NOS | Skin
ELK3::KRT78	Mesenchymal tumor, NOS
ELK3::LIN7A	Mesenchymal tumor, NOS
ELK3::PTPRR	Mesenchymal tumor, NOS
ELK3::SBNO1	Mesenchymal tumor, NOS
ELK3::TSPAN8	Mesenchymal tumor, NOS
ELK4::ERG	Adenocarcinoma
ELK4::SLC26A9	Adenocarcinoma
ELK4::VCL	Adenocarcinoma
ELK4::ZNF350	Adenocarcinoma
ELL2::CAST	Adenocarcinoma
ELL2::SKIC3	Adenocarcinoma
ELL::ARL4D	Malignant epithelial tumor, special type
ELL::CISD3	Adenocarcinoma
ELL::CLIP2	Adenocarcinoma
ELL::CRLF1	Squamous cell carcinoma
ELL::FKBP8	Benign epithelial tumor, special type
ELL::GRIN2B	Adenocarcinoma
ELL::INSR	Adenocarcinoma
ELL::KMT2A	Acute myelomonocytic leukemia (FAB type M4) | Acute myeloblastic leukemia with maturation (FAB type M2)
ELL::LDLRAD1	Squamous cell carcinoma
ELL::LRRC25	Adenocarcinoma
ELL::MKNK2	Adenocarcinoma
ELL::MVB12A	Adenocarcinoma
ELL::PBX4	Adenocarcinoma
ELL::RABGGTA	Miscellaneous hematopoietic/lymphoid neoplasm, special type | Benign epithelial tumor, special type
ELL::SMIM7	Adenocarcinoma
ELMO1::BANK1	Refractory anemia with excess blasts-1
ELMO1::HDAC9	Adenocarcinoma
ELMO1::NKX2-1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ELMO1::RET	Carcinoma, NOS
ELMO1::SCIN	Squamous cell carcinoma
ELMO1::SFTA3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ELMO1::TNRC18	Mycosis fungoides/Sézary syndrome
ELMO2::MYBL2	Mesothelioma
ELMO2::RAE1	Adenocarcinoma
ELMO2::STAP1	Adenocarcinoma
ELMO3::PHAF1	Adenocarcinoma
ELMO3::ZDHHC1	Adenocarcinoma
ELMOD1::HPS3	Undifferentiated carcinoma, small cell
ELMOD3::TCF7L1	Adenocarcinoma
ELMOD3::TTC27	Adenocarcinoma
ELN::FADS2	Adenocarcinoma
ELN::IQCE	Germ cell tumor, NOS
ELN::METTL2A	Adenocarcinoma
ELN::METTL2B	Adenocarcinoma
ELOA::IFT140	Adenocarcinoma
ELOA::TUT4	Adenocarcinoma
ELOC::ASPH	Adenocarcinoma
ELOC::PKN2	Squamous cell carcinoma
ELOC::STAU2	Transitional cell carcinoma
ELOF1::RDH8	Adenocarcinoma
ELOVL2::ERVFRD-1	Adenocarcinoma
ELOVL2::SMOC2	Adenocarcinoma
ELOVL5::CRYL1	Adenocarcinoma
ELOVL5::FAR1	Adenocarcinoma
ELOVL5::GLO1	Adenocarcinoma
ELOVL5::HMGCLL1	Malignant melanoma
ELOVL5::PFKFB3	Adenocarcinoma
ELOVL5::SLC25A27	Squamous cell carcinoma
ELP1::CTNNAL1	Astrocytoma, grade I-II
ELP1::EPB41L4B	Adenocarcinoma
ELP1::TBC1D2	Adenocarcinoma
ELP2::GALNT1	Adenocarcinoma
ELP2::MAPRE2	Adenocarcinoma
ELP2::RPRD1A	Adenocarcinoma
ELP3::FZD3	Adenocarcinoma
ELP3::MYO5C	Squamous cell carcinoma
ELP3::PNOC	Adenocarcinoma
ELP3::RBPMS	Adenocarcinoma
ELP4::CFTR	Adenocarcinoma
ELP4::EIF3M	Squamous cell carcinoma
ELP4::FREM1	Adenocarcinoma
ELP5::ZNF614	Adenocarcinoma
EMC10::ASPDH	Squamous cell carcinoma
EMC10::MBOAT7	Adenocarcinoma
EMC1::UBR4	Adenocarcinoma
EMC2::TANK	Transitional cell carcinoma
EMC3::RHOA	Adenocarcinoma
EMC6::CEACAM19	Adenocarcinoma
EMC7::CD27	Mesenchymal tumor, NOS
EME1::ERBB2	Adenocarcinoma
EME2::CLUAP1	Adenocarcinoma
EMID1::CBY1	Adenocarcinoma
EMID1::KREMEN1	Malignant epithelial tumor, special type
EMILIN2::PAX5	Acute lymphoblastic leukemia/lymphoblastic lymphoma
EMILIN2::PDGFB	Dermatofibrosarcoma protuberans/Bednar tumor/giant cell fibroblastoma
EMILIN2::PDGFD	Dermatofibrosarcoma protuberans/Bednar tumor/giant cell fibroblastoma
EMILIN2::SMCHD1	Adenocarcinoma
EML1::ABL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
EML1::ADAMDEC1	Squamous cell carcinoma
EML1::BASP1	Mesenchymal tumor, NOS
EML1::CCNK	Malignant epithelial tumor, special type | Adenocarcinoma
EML1::FBLN5	Astrocytoma, grade I-II
EML1::GPI	Mesenchymal tumor, NOS
EML1::SPATA7	Transitional cell carcinoma
EML1::TTLL5	Squamous cell carcinoma
EML2::DMWD	Adenocarcinoma
EML2::FBXO46	Adenocarcinoma
EML3::ATL3	Adenocarcinoma
EML3::INTS5	Squamous cell carcinoma | Mesothelioma
EML4::ALK	Oligodendroglioma | Chronic lymphocytic leukemia | Adenocarcinoma | Benign fibrous histiocytoma | Hodgkin disease, NOS | Undifferentiated round cell sarcoma | Mesenchymal tumor, special type | Mesoblastic nephroma | Diffuse large B-cell lymphoma | Nonneoplastic epithelial disorder/lesion | Peripheral T-cell lymphoma, unspecified | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Astrocytoma, grade III-IV/Glioblastoma | Carcinoma, NOS | Inflammatory myofibroblastic tumor/myofibroblastic sarcoma | Follicular lymphoma | Nonneoplastic hematologic disorder/lesion | Adenosquamous carcinoma | Carcinoid tumor | Squamous cell carcinoma | Malignant epithelial tumor, special type | Mesothelioma | Malignant melanoma | Fibrosarcoma
EML4::ALK::WDR43	Adenocarcinoma
EML4::BRAF	Undifferentiated pleomorphic sarcoma | Melanocytic neoplasm, special type
EML4::CASK	Astrocytoma, grade III-IV/Glioblastoma
EML4::COX7A2L	Adenocarcinoma
EML4::EPHA3	Adenocarcinoma
EML4::MET	Squamous cell carcinoma | Adenocarcinoma
EML4::NTRK3	Mesoblastic nephroma | Fibroblastic/myofibroblastic tumor, special type | Glioma, NOS | Astrocytoma, grade III-IV/Glioblastoma | Adenocarcinoma | Fibrosarcoma | Soft tissue tumor, special type
EML4::PKDCC	Malignant epithelial tumor, special type | Adenocarcinoma
EML4::RET	Adenocarcinoma | Carcinoma, NOS
EML4::VPS54	Adenocarcinoma
EML6::ALK	Adenocarcinoma
EML6::SPTBN1	Embryonal nervous system tumor, special type
EMP1::ETV6	Adenocarcinoma
EMP1::USP6	Fibroma of tendon sheath
EMP2::BFAR	Adenocarcinoma
EMP2::NUBP1	Adenocarcinoma
EMP2::SNN	Squamous cell carcinoma
EMP2::SORL1	Squamous cell carcinoma
EMP2::TERF2	Squamous cell carcinoma
EMP2::TVP23A	Adenocarcinoma
EMP3::CKM	Malignant epithelial tumor, special type
EMSY::ACER3	Adenocarcinoma
EMSY::BBS9	Adenocarcinoma
EMSY::CAPN5	Adenocarcinoma
EMSY::CDH23	Adenocarcinoma
EMSY::LRP5	Adenocarcinoma
EMSY::MYO7A	Adenocarcinoma
EMSY::SHANK2	Adenocarcinoma
EMSY::UVRAG	Adenocarcinoma
ENAH::AEBP2	Squamous cell carcinoma
ENAH::LIN9	Malignant melanoma
ENAH::PTPN14	Adenocarcinoma
ENAH::SCCPDH	Malignant melanoma
ENAH::UCHL5	Transitional cell carcinoma
ENDOD1::BBS1	Adenocarcinoma
ENDOD1::RAB30	Malignant melanoma
ENDOD1::YAP1	Soft tissue tumor, special type
ENDOV::IKZF3	Adenocarcinoma
ENDOV::RNF213	Adenocarcinoma
ENDOV::SLC26A11	Adenocarcinoma
ENDOV::TMEM104	Adenocarcinoma
ENG::AK1	Astrocytoma, grade III-IV/Glioblastoma | Adenocarcinoma
ENG::NOL9	Adenocarcinoma
ENGASE::RBFOX3	Squamous cell carcinoma
ENGASE::TNRC6C	Adenocarcinoma
ENO1::COP1	Adenocarcinoma
ENO1::DDX27	Squamous cell carcinoma
ENO1::SIAE	Adenocarcinoma
ENO1::SNW1	Adenocarcinoma
ENO1::UTRN	Adenocarcinoma
ENO1::UVRAG	Squamous cell carcinoma
ENO2::ACRBP	Undifferentiated carcinoma, small cell
ENO2::PIANP	Adenocarcinoma
ENOSF1::PPT1	Mesenchymal tumor, NOS
ENOX1::ETFA	Meningioma
ENOX1::FNDC3A	Adenocarcinoma
ENOX1::RAD51B	Adenocarcinoma
ENOX1::TSC22D1	Adenocarcinoma
ENOX1::TYRO3	Meningioma
ENOX2::OSBPL5	Adenocarcinoma
ENOX2::SMARCA1	Adenocarcinoma
ENPP1::CDX1	Adenocarcinoma
ENPP1::INSR	Mesenchymal tumor, NOS
ENPP1::RIPPLY2	Adenocarcinoma
ENPP1::SEC63	Adenocarcinoma
ENPP5::EPYC	Adenocarcinoma
ENSA::AADACL2	Adenocarcinoma
ENSA::ARNT	Adenocarcinoma
ENSA::CTSS	Adenocarcinoma
ENSA::KLHDC9	Malignant epithelial tumor, special type
ENSA::RPRD2	Transitional cell carcinoma
ENTHD1::RNF212	Malignant melanoma
ENTPD1::CC2D2B	Adenocarcinoma
ENTPD4::PSD3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ENTPD5::AHI1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ENTPD5::ALDH6A1	Adenocarcinoma
ENTPD5::MICU1	Adenocarcinoma
ENTPD5::NUBPL	Transitional cell carcinoma
ENTPD5::OLFM2	Malignant melanoma
ENTPD5::TSHR	Mesenchymal tumor, NOS
ENTPD6::TBC1D10B	Adenocarcinoma
ENTPD7::IDE	Astrocytoma, grade III-IV/Glioblastoma
ENTREP2::GABRG3	Transitional cell carcinoma
ENY2::NSF	Adenocarcinoma
EOGT::SYNPR	Mesothelioma
EOMES::SLC4A7	Adenocarcinoma
EP300::BCOR	Astrocytoma, grade III-IV/Glioblastoma | Leiomyosarcoma | Astrocytoma, grade I-II | Endometrial stromal sarcoma
EP300::BCORL1	Ependymoma
EP300::CARD8	Adenocarcinoma
EP300::EP300	Acute megakaryoblastic leukemia (FAB type M7)
EP300::FBLN1	Malignant melanoma
EP300::HAUS8	Transitional cell carcinoma
EP300::HOXA7	Acute megakaryoblastic leukemia (FAB type M7)
EP300::IPO5	Adenocarcinoma
EP300::KAT6A	Acute myelomonocytic leukemia (FAB type M4)
EP300::MCHR1	Transitional cell carcinoma
EP300::NXPE2	Adenocarcinoma
EP300::PAICS	Adenocarcinoma
EP300::PCBP3	Adenocarcinoma
EP300::RBX1	Adenocarcinoma
EP300::TNRC6B	Astrocytoma, grade I-II
EP300::TTC28	Squamous cell carcinoma
EP300::VGLL3	Spindle cell/sclerosing rhabdomyosarcoma
EP300::XPNPEP3	Adenocarcinoma
EP300::ZNF384	Egypt | Bilineage or biphenotypic leukemia | Acute lymphoblastic leukemia/lymphoblastic lymphoma
EP400::DPYSL5	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
EP400::PHF1	Ossifying fibromyxoid tumor
EP400::SDHC	Adenocarcinoma
EP400::SFSWAP	Adenocarcinoma
EP400::TMPRSS12	Transitional cell carcinoma
EP400::TRIM29	Malignant epithelial tumor, special type
EP400::WHAMM	Adenocarcinoma
EPAS1::CRIPT	Squamous cell carcinoma
EPAS1::SYPL2	Adenocarcinoma
EPAS1::TMEM247	Adenocarcinoma
EPB41::ATP5IF1	Adenocarcinoma
EPB41::CFAP107	Mesothelioma
EPB41::GMEB1	Transitional cell carcinoma
EPB41::HGSNAT	Transitional cell carcinoma
EPB41::ITPR1	Malignant melanoma
EPB41::PIGV	Transitional cell carcinoma
EPB41::POLR2L	Adenocarcinoma
EPB41::PRAMEF12	Mesothelioma
EPB41::TRNAU1AP	Adenocarcinoma
EPB41::USP49	Adenocarcinoma
EPB41::YTHDF2	Malignant epithelial tumor, special type
EPB41L1::ATP9A	Transitional cell carcinoma
EPB41L1::BCL2A1	Adenocarcinoma
EPB41L1::BICD1	Adenocarcinoma
EPB41L1::CEP250	Adenocarcinoma
EPB41L1::CNBD2	Squamous cell carcinoma | Adenocarcinoma
EPB41L1::DEFB123	Adenocarcinoma
EPB41L1::GHRH	Adenocarcinoma
EPB41L1::HTR3C	Adenocarcinoma
EPB41L1::IFT52	Squamous cell carcinoma
EPB41L1::NDRG3	Adenocarcinoma
EPB41L1::NNAT	Adenocarcinoma
EPB41L1::PHF20	Malignant epithelial tumor, special type | Adenocarcinoma
EPB41L1::RBBP8	Transitional cell carcinoma
EPB41L1::ROMO1	Adenocarcinoma
EPB41L1::TGM3	Squamous cell carcinoma
EPB41L1::TUBD1	Adenocarcinoma
EPB41L2::ADGB	Mesenchymal tumor, NOS
EPB41L2::BRAF	Soft tissue tumor, special type
EPB41L2::FRMD1	Adenocarcinoma
EPB41L2::LAMA2	Squamous cell carcinoma
EPB41L2::MAP4K1	Adenocarcinoma
EPB41L2::MYLIP	Astrocytoma, grade I-II
EPB41L2::OSTM1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
EPB41L2::PTPRK	Mesenchymal tumor, NOS
EPB41L2::STAT3	Adenocarcinoma
EPB41L3::LAMA1	Adenocarcinoma
EPB41L3::LRRC34	Squamous cell carcinoma
EPB41L4A::ATG10	Adenocarcinoma
EPB41L4A::MCC	Adenocarcinoma
EPB41L4A::PLAC8L1	Adenocarcinoma
EPB41L4A::REEP5	Adenocarcinoma
EPB41L4A::SCN9A	Astrocytoma, grade I-II
EPB41L4B::PTBP3	Transitional cell carcinoma
EPB41L4B::PTPN3	Adenocarcinoma
EPB41L5::FZR1	Mesenchymal tumor, NOS
EPB42::RPUSD2	Mesothelioma
EPC1::AKR1E2	Adenocarcinoma
EPC1::ARHGAP28	Adenocarcinoma
EPC1::ASXL2	Adult T-cell lymphoma/leukemia (HTLV-1+)
EPC1::BCOR	Endometrial stromal sarcoma
EPC1::DIP2C	Malignant melanoma
EPC1::EED	Endometrial stromal sarcoma
EPC1::EZH2	Endometrial stromal sarcoma
EPC1::KDM2B	Endometrial stromal sarcoma
EPC1::PHF1	Ossifying fibromyxoid tumor | Endometrial stromal sarcoma
EPC1::PTGR2	Adenocarcinoma
EPC1::QPCT	Squamous cell carcinoma
EPC1::SUZ12	Ossifying fibromyxoid tumor | Endometrial stromal sarcoma
EPC2::KIF5C	Glioma, NOS
EPC2::MBD5	Adenocarcinoma
EPC2::THSD7B	Adenocarcinoma
EPCAM::ABCG8	Adenocarcinoma
EPCAM::DLEC1	Adenocarcinoma
EPG5::RAB38	Adenocarcinoma
EPG5::ST8SIA5	Squamous cell carcinoma
EPHA10::COL8A2	Adenocarcinoma
EPHA2::ARHGEF19	Adenocarcinoma
EPHA2::CTSD	Adenocarcinoma
EPHA2::FBXO42	Adenocarcinoma
EPHA2::LSM14B	Malignant epithelial tumor, special type
EPHA2::MRPL37	Adenocarcinoma
EPHA3::ABCA9	Benign epithelial tumor, special type | Miscellaneous hematopoietic/lymphoid neoplasm, special type
EPHA4::COL4A3	Squamous cell carcinoma
EPHA5::RUFY3	Adenocarcinoma
EPHA6::CNTN6	Adenocarcinoma
EPHA6::ROS1	Adenocarcinoma
EPHA6::TOP6BL	Adenocarcinoma
EPHA6::TRMT10C	Adenocarcinoma
EPHA6::TSC22D2	Adenocarcinoma
EPHA7::PIGH	Adenocarcinoma
EPHB1::BFSP2	Astrocytoma, grade I-II
EPHB2::ASAP3	Astrocytoma, grade III-IV/Glioblastoma
EPHB2::INTS11	Astrocytoma, grade III-IV/Glioblastoma
EPHB2::MAST2	Adenocarcinoma
EPHB2::NTRK1	Astrocytoma, grade I-II
EPHB2::PDZD4	Astrocytoma, grade I-II
EPHB2::SYNC	Squamous cell carcinoma
EPHB2::ZBTB40	Adenocarcinoma
EPHB3::P2RY12	Squamous cell carcinoma
EPHB3::PAK2	Soft tissue tumor, special type
EPHB3::PAX2	Mesenchymal tumor, NOS
EPHB4::MET	Carcinoma, NOS
EPHX1::RAD51B	Adenocarcinoma
EPHX1::SEC63	Adenocarcinoma
EPHX2::BNIP3L	Adenocarcinoma
EPHX2::PTK2B	Transitional cell carcinoma
EPN1::COL1A1	Adenocarcinoma
EPN1::NOVA2	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
EPN1::U2AF2	Squamous cell carcinoma
EPN2::AKAP10	Adenocarcinoma
EPN2::KCNJ12	Transitional cell carcinoma
EPN2::KCNJ18	Transitional cell carcinoma
EPN2::MAP2K3	Transitional cell carcinoma
EPN2::MYOCD	Multiple myeloma
EPN2::PIBF1	Mesenchymal tumor, NOS
EPN2::SLC5A10	Adenocarcinoma
EPN3::AGPAT3	Adenocarcinoma
EPN3::SEMA4G	Adenocarcinoma
EPOP::CPD	Adenocarcinoma
EPOR::LAIR1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
EPPK1::ZC3H3	Adenocarcinoma
EPPK1::ZFTRAF1	Adenocarcinoma
EPRS1::C3ORF84	Adenocarcinoma
EPRS1::DNAH14	Adenocarcinoma
EPRS1::USH2A	Malignant melanoma
EPRS1::USP19	Adenocarcinoma
EPS15::BRAF	Adenocarcinoma
EPS15::C1ORF159	Malignant melanoma
EPS15::C1ORF185	Astrocytoma, grade III-IV/Glioblastoma
EPS15::C1orf159	Malignant melanoma
EPS15::CC2D1B	Transitional cell carcinoma
EPS15::CCDC18	Transitional cell carcinoma
EPS15::CCT4	Malignant epithelial tumor, special type
EPS15::KMT2A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
EPS15::NTRK1	Adenocarcinoma
EPS15::OSBPL9	Squamous cell carcinoma
EPS15::PATJ	Adenocarcinoma
EPS15::TRABD2B	Astrocytoma, grade III-IV/Glioblastoma
EPS15::TTC39A	Adenocarcinoma
EPS15L1::AKAP8	Adenocarcinoma
EPS15L1::BRAF	Adenocarcinoma
EPS15L1::BRD4	Adenocarcinoma
EPS15L1::CALR3	Adenocarcinoma
EPS15L1::CIB3	Adenocarcinoma
EPS15L1::CLNS1A	Adenocarcinoma
EPS15L1::CPAMD8	Adenocarcinoma
EPS15L1::RABGAP1	Adenocarcinoma
EPS15L1::ZNF451	Astrocytoma, grade I-II
EPS15L1::ZNF473	Squamous cell carcinoma
EPS15L1::ZNF568	Malignant melanoma
EPS15L1::ZNF675	Adenocarcinoma
EPS8::A2M	Adenocarcinoma
EPS8::GYS2	Adenocarcinoma
EPS8::MED21	Squamous cell carcinoma
EPS8::PIK3C2G	Transitional cell carcinoma
EPS8::PLEKHA5	Adenocarcinoma
EPS8::PRH2	Adenocarcinoma
EPS8::RERGL	Adenocarcinoma
EPS8L2::AGPAT2	Squamous cell carcinoma
EPS8L2::B4GALNT4	Adenocarcinoma
EPS8L2::DCDC1	Adenocarcinoma
EPS8L2::RIOK1	Adenocarcinoma
EPSTI1::TSC22D1	Miscellaneous hematopoietic/lymphoid neoplasm, special type
ERAL1::DIDO1	Adenocarcinoma
ERAP2::FAM81B	Adenocarcinoma
ERBB2::ABI3	Adenocarcinoma
ERBB2::ARHGAP23	Carcinoma, NOS
ERBB2::ARL5C	Adenocarcinoma
ERBB2::CACNG4	Carcinoma, NOS
ERBB2::CASC3	Carcinoma, NOS
ERBB2::CCL23	Carcinoma, NOS
ERBB2::CDK12	Adenocarcinoma
ERBB2::CLDN7	Adenocarcinoma
ERBB2::CNIH4	Adenocarcinoma
ERBB2::CTTN	Adenocarcinoma | Squamous cell carcinoma | Transitional cell carcinoma
ERBB2::DNAJC7	Adenocarcinoma
ERBB2::GRB7	Embryonal nervous system tumor, NOS
ERBB2::IKZF3	Squamous cell carcinoma | Adenocarcinoma | Carcinoma, NOS
ERBB2::ISYNA1	Carcinoma, NOS
ERBB2::JUP	Adenocarcinoma | Squamous cell carcinoma
ERBB2::KRT38	Carcinoma, NOS
ERBB2::KRTAP4-7	Carcinoma, NOS
ERBB2::MED1	Adenocarcinoma
ERBB2::MIEN1	Carcinoma, NOS
ERBB2::NARS2	Adenocarcinoma
ERBB2::NEUROD2	Squamous cell carcinoma | Carcinoma, NOS
ERBB2::NOL12	Adenocarcinoma
ERBB2::PGAP3	Adenocarcinoma
ERBB2::PPM1D	Carcinoma, NOS
ERBB2::PPM1E	Carcinoma, NOS
ERBB2::PPP1R1B	Transitional cell carcinoma | Squamous cell carcinoma | Adenocarcinoma
ERBB2::PSMB3	Adenocarcinoma
ERBB2::PTPA	Carcinoma, NOS
ERBB2::RAD23B	Carcinoma, NOS
ERBB2::SDF4	Adenocarcinoma
ERBB2::SHC1	Carcinoma, NOS
ERBB2::SLC29A3	Adenocarcinoma
ERBB2::SLC39A11	Adenocarcinoma
ERBB2::SRCIN1	Adenocarcinoma
ERBB2::STARD3	Carcinoma, NOS | Adenocarcinoma
ERBB2::SUPT16H	Adenocarcinoma
ERBB2::TATDN1	Transitional cell carcinoma
ERBB2::TCAP	Squamous cell carcinoma | Carcinoma, NOS
ERBB2::TMEM104	Carcinoma, NOS
ERBB2::TNS4	Carcinoma, NOS
ERBB2::TSPAN11	Adenocarcinoma
ERBB2::UTP18	Carcinoma, NOS
ERBB2::WIPF2	Adenocarcinoma
ERBB2::WSB1	Adenocarcinoma
ERBB2::ZAN	Adenocarcinoma
ERBB3::COX4I2	Adenocarcinoma
ERBB3::CPB1	Adenocarcinoma
ERBB3::CRADD	Epithelioid sarcoma
ERBB3::CSN2	Adenocarcinoma
ERBB3::FOXA1	Adenocarcinoma
ERBB3::IKZF4	Adenocarcinoma
ERBB3::RPL30	Malignant melanoma
ERBB3::SUOX	Squamous cell carcinoma
ERBB4::RBM33	Adenocarcinoma
ERBB4::SDCCAG8	Adenocarcinoma
ERBB4::SLC25A10	Adenocarcinoma
ERBIN::ARL15	Malignant melanoma
ERBIN::ASXL1	Adenocarcinoma
ERBIN::MAST4	Adenocarcinoma
ERBIN::MYOM2	Transitional cell carcinoma
ERBIN::NLN	Adenocarcinoma
ERBIN::PPWD1	Adenocarcinoma
ERBIN::RASGRF2	Melanocytic neoplasm, special type
ERBIN::TMEM232	Malignant melanoma
ERBIN::TRAPPC13	Adenocarcinoma
ERBIN::ZBTB10	Adenocarcinoma
ERC1::AFDN	Adenocarcinoma
ERC1::ALK	Atypical lipomatous tumor/atypical lipoma/well-differentiated liposarcoma | Malignant soft tissue tumor, NOS
ERC1::ANKRD26	Squamous cell carcinoma
ERC1::ANO2	Undifferentiated carcinoma, small cell
ERC1::APOLD1	Adenocarcinoma
ERC1::BRAF	Adenocarcinoma
ERC1::ETV6	Adenocarcinoma
ERC1::GABRB1	Adenocarcinoma
ERC1::GPC5	Adenocarcinoma
ERC1::GRK3	Squamous cell carcinoma
ERC1::HEBP1	Squamous cell carcinoma
ERC1::METTL4	Malignant melanoma
ERC1::MRPL51	Squamous cell carcinoma
ERC1::MRPS9	Mesenchymal tumor, NOS
ERC1::PDGFRB	Myelodysplastic/myeloproliferative disease, NOS | Acute monoblastic leukemia without differentiation (FAB type M5a) | Thymus
ERC1::PHC1	Astrocytoma, grade I-II
ERC1::PIK3C2G	Adenocarcinoma
ERC1::PRKD1	Adenocarcinoma
ERC1::RET	Carcinoma, NOS | Adenocarcinoma
ERC1::ROS1	Melanocytic neoplasm, special type
ERC1::SPI1	Squamous cell carcinoma
ERC1::TACC3	Adenocarcinoma
ERC1::TOMM34	Adenocarcinoma
ERC1::UTRN	Adenocarcinoma
ERC1::VWF	Adenocarcinoma
ERC1::WNK1	Adenocarcinoma
ERC1::ZNF492	Adenocarcinoma
ERC2::ARHGEF3	Adenocarcinoma
ERC2::DNAH12	Adenocarcinoma
ERC2::ELP6	Adenocarcinoma
ERCC1::CEACAM5	Adenocarcinoma
ERCC2::MYH14	Malignant epithelial tumor, special type
ERCC2::NOVA2	Transitional cell carcinoma
ERCC2::REDIC1	Astrocytoma, grade I-II
ERCC3::MAP3K2	Adenocarcinoma
ERCC6::PREX1	Adenocarcinoma
ERCC6L2::ATP8A1	Adenocarcinoma
ERCC6L2::GTF3C4	Astrocytoma, grade I-II
ERCC6L2::IPPK	Adenocarcinoma
ERCC6L2::PTPRD	Transitional cell carcinoma
ERCC6L2::ROS1	Adenocarcinoma
ERCC6L2::SF3B1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ERCC6L2::TGFB1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ERCC6L2::TRPM6	Adenocarcinoma
ERF::CIC	Multiple myeloma
ERF::GSK3A	Astrocytoma, grade III-IV/Glioblastoma
ERF::IGH	Multiple myeloma
ERG::ABCC4	Adenocarcinoma
ERG::CDHR2	Adenocarcinoma
ERG::DUX4	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ERG::DYRK1A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ERG::FUS	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ERG::GMPR	Adenocarcinoma
ERG::KCNJ6	Adenocarcinoma
ERG::MAPK11	Squamous cell carcinoma
ERG::PLEKHH1	Adenocarcinoma
ERG::RPS18	Adenocarcinoma
ERG::SKOR2	Adenocarcinoma
ERG::SON	Adenocarcinoma
ERG::SRPK2	Adenocarcinoma
ERG::TAF8	Adenocarcinoma
ERG::TMPRSS2	Adenocarcinoma
ERG::ZNRF3	Adenocarcinoma
ERGIC1::ADGRV1	Malignant melanoma
ERGIC1::JAKMIP2	Adenocarcinoma
ERGIC1::KCNIP1	Adenocarcinoma
ERGIC1::MIEN1	Adenocarcinoma
ERGIC1::RANBP17	Squamous cell carcinoma | Adenocarcinoma
ERGIC3::MAP1LC3A	Adenocarcinoma
ERGIC3::TRMT6	Adenocarcinoma
ERI2::CRYM	Adenocarcinoma
ERI2::DNAH3	Adenocarcinoma
ERI2::LDAF1	Transitional cell carcinoma
ERI2::ZNF160	Astrocytoma, grade III-IV/Glioblastoma
ERI3::CMPK1	Adenocarcinoma
ERI3::EIF2B3	Adenocarcinoma
ERI3::HTATSF1	Adenocarcinoma
ERICH1::IYD	Squamous cell carcinoma
ERICH1::PCM1	Adenocarcinoma
ERICH1::PTPRR	Malignant melanoma
ERICH5::MATN2	Adenocarcinoma
ERLEC1::ACYP2	Adenocarcinoma
ERLEC1::CHAC2	Adenocarcinoma
ERLIN1::DOCK1	Diffuse large B-cell lymphoma
ERLIN1::HPSE2	Adenocarcinoma
ERLIN2::ADRB3	Adenocarcinoma
ERLIN2::FGFR1	Adenocarcinoma | Mesenchymal tumor, special type
ERLIN2::RAB11FIP1	Adenocarcinoma
ERMARD::GRM3	Malignant melanoma
ERMP1::BRD10	Adenocarcinoma
ERMP1::PLGRKT	Adenocarcinoma
ERMP1::RBBP8	Squamous cell carcinoma
ERN1::CPNE2	Adenocarcinoma
ERN1::DDX42	Adenocarcinoma
ERN1::EIF3C	Adenocarcinoma
ERN1::MYCBPAP	Adenocarcinoma
ERN1::SMTNL2	Adenocarcinoma
ERN1::TEX2	Adenocarcinoma
ERN1::UBC	Multiple myeloma
ERO1A::FERMT2	Adenocarcinoma
ERO1A::GPR137C	Adenocarcinoma
ERO1A::NRG1	Adenocarcinoma
ERO1A::TXNDC16	Adenocarcinoma
ERO1B::HEATR1	Adenocarcinoma
ERP27::IGF2	Adenocarcinoma
ERP29::NHSL1	Squamous cell carcinoma
ERP44::CHRDL2	Squamous cell carcinoma
ERP44::SPTLC1	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
ERRFI1::CACNA1E	Adenocarcinoma
ERRFI1::CUBN	Russia | Primitive neuroectodermal tumor/Medulloblastoma
ERRFI1::LUZP1	Transitional cell carcinoma
ERRFI1::NCF2	Adenocarcinoma
ERRFI1::VAMP3	Astrocytoma, grade III-IV/Glioblastoma
ESCO1::ABHD3	Adenocarcinoma
ESCO1::ARHGAP28	Adenocarcinoma
ESCO1::CNDP2	Primitive neuroectodermal tumor/Medulloblastoma | Russia
ESCO1::CPNE1	Transitional cell carcinoma
ESCO1::GREB1L	Adenocarcinoma
ESCO1::KANK1	Adenocarcinoma
ESCO1::LAMA3	Squamous cell carcinoma
ESCO1::RIPOR3	Adenocarcinoma
ESCO1::SNRPD1	Adenocarcinoma
ESCO2::EPHX2	Adenocarcinoma
ESCO2::PTK2B	Adenocarcinoma
ESD::FAM124A	Mesenchymal tumor, NOS
ESF1::RBM19	Germ cell tumor, NOS
ESPN::DDX39B	Adenocarcinoma
ESPN::FBLIM1	Squamous cell carcinoma
ESR1::AKAP12	Adenocarcinoma
ESR1::ARMT1	Adenocarcinoma
ESR1::ASPH	Adenocarcinoma
ESR1::BNC2	Adenocarcinoma
ESR1::CCDC170	Carcinoma, NOS | Ependymoma | Adenocarcinoma
ESR1::COA5	Adenocarcinoma
ESR1::GNAS	Adenocarcinoma
ESR1::MTHFD1L	Adenocarcinoma
ESR1::MYCT1	Adenocarcinoma
ESR1::NCOA2	Mesenchymal tumor, special type | Adenocarcinoma
ESR1::NCOA3	Mesenchymal tumor, special type
ESR1::NR4A3	Soft tissue tumor, NOS
ESR1::PCDH11X	Adenocarcinoma
ESR1::PDE7B	Adenocarcinoma
ESR1::PLEKHG1	Adenocarcinoma
ESR1::POLH	Adenocarcinoma
ESR1::POLR2E	Adenocarcinoma
ESR1::RAB32	Adenocarcinoma
ESR1::SIM1	Mesenchymal tumor, NOS
ESR1::SYNE1	Adenocarcinoma
ESR1::TFB1M	Squamous cell carcinoma
ESR1::USP25	Adenocarcinoma
ESR1::UTRN	Adenocarcinoma
ESR1::VTA1	Adenocarcinoma
ESR1::YAP1	Adenocarcinoma
ESR1::ZBTB2	Adenocarcinoma
ESRP1::INTS8	Adenocarcinoma
ESRP1::RAF1	Adenocarcinoma
ESRP2::SLC7A6	Adenocarcinoma
ESRRA::CATSPERZ	Adenocarcinoma | Malignant melanoma
ESRRA::KCNK4	Adenocarcinoma
ESRRA::ZNF317	Adenocarcinoma
ESRRG::ACBD3	Adenocarcinoma | Diffuse large B-cell lymphoma
ESRRG::ADCY10	Adenocarcinoma
ESRRG::MTARC2	Adenocarcinoma
ESYT1::MED14	Adenocarcinoma
ESYT1::PA2G4	Transitional cell carcinoma
ESYT2::ATRN	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ESYT2::CNTNAP2	Squamous cell carcinoma
ESYT2::CPED1	Adenocarcinoma
ESYT2::NBPF15	Transitional cell carcinoma
ESYT2::NCAPG2	Malignant melanoma
ESYT2::PPP1R3A	Adenocarcinoma
ESYT2::VIPR2	Adenocarcinoma
ESYT2::ZNF595	Squamous cell carcinoma
ESYT3::ARMC8	Adenocarcinoma
ESYT3::FAIM	Adenocarcinoma
ESYT3::RPN1	Squamous cell carcinoma
ETF1::HSPA9	Adenocarcinoma
ETF1::TRAPPC13	Adenocarcinoma
ETFA::BRAF	Adenocarcinoma
ETFA::IMP3	Malignant melanoma
ETFA::METTL9	Adenocarcinoma
ETFA::STRA6	Adenocarcinoma
ETFB::LIM2	Adenocarcinoma
ETFRF1::IRAG2	Adenocarcinoma | Mature B-cell neoplasm, NOS
ETHE1::BMP5	Adenocarcinoma
ETHE1::CADM4	Squamous cell carcinoma
ETHE1::PLAUR	Adenocarcinoma
ETHE1::POU2F2	Adenocarcinoma
ETHE1::UGT2A3	Adenocarcinoma
ETHE1::UPK3A	Adenocarcinoma
ETHE1::ZNF235	Adenocarcinoma
ETNK1::CMAS	Squamous cell carcinoma
ETNK1::GLT1D1	Adenocarcinoma
ETNK1::ITPR2	Adenocarcinoma
ETNK1::MYO9B	Adenocarcinoma
ETNK1::PPFIBP1	Adenocarcinoma
ETNK1::RCAN2	Adenocarcinoma
ETNK2::REN	Adenocarcinoma
ETS1::NEGR1	Squamous cell carcinoma
ETS1::SLC5A7	Malignant soft tissue tumor, NOS
ETS1::UBE2V2	Mesenchymal tumor, NOS
ETS2::ERG	Acute promyelocytic leukemia (FAB type M3)
ETS2::ETV6	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ETS2::GET1	Adenocarcinoma
ETV1::BTBD9	Mesenchymal tumor, NOS
ETV1::CACNA2D1	Mesenchymal tumor, NOS
ETV3::MNDA	Adenocarcinoma
ETV3::NCOA2	Histiocytic sarcoma/malignant histiocytosis | Malignant soft tissue tumor, NOS | Dendritic cell neoplasm
ETV3::SEC22B	Malignant melanoma
ETV4::AHRR	Angiofibroma
ETV4::CCL16	Adenocarcinoma
ETV4::CHID1	Adenocarcinoma
ETV4::LSM12	Adenocarcinoma
ETV4::TCAP	Adenocarcinoma
ETV5::DGKG	Adenocarcinoma
ETV6::ABL1	Acute undifferentiated leukemia | Algeria | Chronic myelomonocytic leukemia | Myelodysplastic/myeloproliferative disease, NOS | Atypical chronic myeloid leukemia | Lymph node | Acute myeloblastic leukemia with maturation (FAB type M2) | Acute myeloid leukemia, NOS | Thymus | Spleen | Skin | Acute myeloblastic leukemia without maturation (FAB type M1) | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Chronic myeloproliferative disorder, NOS | Chronic eosinophilic leukemia/hypereosinophilic syndrome
ETV6::ABL2	Acute promyelocytic leukemia (FAB type M3) | Acute myelomonocytic leukemia (FAB type M4) | Acute lymphoblastic leukemia/lymphoblastic lymphoma
ETV6::ACSL6	Refractory anemia with excess blasts-2 | Lymph node | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Atypical chronic myeloid leukemia | Acute myeloid leukemia, NOS | Thymus | Skin | Polycythemia vera | Acute eosinophilic leukemia | Acute myeloblastic leukemia with maturation (FAB type M2) | Chronic eosinophilic leukemia/hypereosinophilic syndrome | Myelodysplastic/myeloproliferative disease, NOS
ETV6::ALK	Benign fibrous histiocytoma
ETV6::AMPH	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ETV6::ANLN	Acute myeloid leukemia, NOS | Skin
ETV6::APOLD1	Adenocarcinoma
ETV6::ARNT	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Acute myeloblastic leukemia with maturation (FAB type M2)
ETV6::BAZ2A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ETV6::BCL2L14	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ETV6::BHMT	Acute myeloblastic leukemia with maturation (FAB type M2)
ETV6::BMAL2	Acute myeloblastic leukemia with maturation (FAB type M2) | Acute myeloid leukemia, NOS | Skin
ETV6::BORCS5	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ETV6::CACNA1C	Osteosarcoma, NOS | Adenocarcinoma
ETV6::CDK2AP1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ETV6::CDKN1B	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ETV6::CDX2	Acute myeloblastic leukemia without maturation (FAB type M1)
ETV6::CHIC2	Skin | Acute myeloid leukemia, NOS
ETV6::CIDEA	Mesothelioma
ETV6::CIMAP2	Bilineage or biphenotypic leukemia | Egypt
ETV6::CLEC2B	Adenocarcinoma
ETV6::CREBBP	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ETV6::CTNNB1	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Acute monoblastic leukemia without differentiation (FAB type M5a)
ETV6::CYP3A4	Acute myeloid leukemia, NOS | Skin
ETV6::DUSP16	Adenocarcinoma
ETV6::EBF1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ETV6::EIF4B	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ETV6::ELMO1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ETV6::EPB41L2	Mesenchymal tumor, NOS
ETV6::ETV6	Germ cell tumor, NOS
ETV6::EVX2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ETV6::FAAP100	Acute myelomonocytic leukemia (FAB type M4)
ETV6::FGFR1	Egypt | Bilineage or biphenotypic leukemia
ETV6::FGFR2	Egypt | Bilineage or biphenotypic leukemia
ETV6::FGFR3	Peripheral T-cell lymphoma, unspecified
ETV6::FLT3	Chronic myelomonocytic leukemia | Chronic myeloproliferative disorder, NOS | Bilineage or biphenotypic leukemia | Egypt | Acute myeloid leukemia, NOS | Skin | Spleen
ETV6::FRK	Acute myelomonocytic leukemia (FAB type M4)
ETV6::GOT1	Skin | Acute myeloblastic leukemia without maturation (FAB type M1) | Acute myeloid leukemia, NOS
ETV6::GSK3A	Adenocarcinoma
ETV6::HIC1	Acute myeloid leukemia, NOS | Skin
ETV6::IGH	Diffuse large B-cell lymphoma
ETV6::INO80D	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ETV6::ITLN1	Malignant melanoma
ETV6::ITPR2	Adenocarcinoma
ETV6::JAK2	Atypical chronic myeloid leukemia | Lymph node | Acute lymphoblastic leukemia/lymphoblastic lymphoma
ETV6::LMBR1	Acute myeloid leukemia, NOS | Skin
ETV6::LMBR1L	Acute myeloid leukemia, NOS | Skin
ETV6::LPXN	Acute myeloblastic leukemia with maturation (FAB type M2)
ETV6::LYN	Idiopathic myelofibrosis | Skin | Acute myeloblastic leukemia with maturation (FAB type M2) | Acute myeloid leukemia, NOS
ETV6::MACROD2	Squamous cell carcinoma
ETV6::MAML3	Malignant epithelial tumor, special type
ETV6::MECOM	Atypical chronic myeloid leukemia | Acute myeloblastic leukemia with minimal differentiation (FAB type M0) | Heart | Acute myeloid leukemia, NOS | Chronic myeloid leukemia, t(9;22) | Acute monoblastic leukemia without differentiation (FAB type M5a) | Lymph node | Skin
ETV6::MEIS2	Skin | Acute myeloid leukemia, NOS
ETV6::MET	Malignant epithelial tumor, special type
ETV6::NCOA2	Egypt | Bilineage or biphenotypic leukemia | Acute myeloblastic leukemia with minimal differentiation (FAB type M0) | Acute myeloid leukemia, NOS | Skin | Acute lymphoblastic leukemia/lymphoblastic lymphoma
ETV6::NID1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ETV6::NOM1	Skin | Acute myeloid leukemia, NOS
ETV6::NTRK2	Adenocarcinoma
ETV6::NTRK3	Acute myeloblastic leukemia with maturation (FAB type M2) | Hemangioma/lymphangioma | Astrocytoma, grade III-IV/Glioblastoma | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Undifferentiated round cell sarcoma | Melanocytic neoplasm, special type | Undifferentiated carcinoma, small cell | Astrocytoma, pilocytic/juvenile | Acute monoblastic leukemia (FAB type M5) | Fibrosarcoma | Malignant epithelial tumor, special type | Adenocarcinoma | Carcinoid tumor | Chronic eosinophilic leukemia/hypereosinophilic syndrome | Benign nevus | Glioma, NOS | Soft tissue tumor, special type | Gastrointestinal stromal tumor | Inflammatory myofibroblastic tumor/myofibroblastic sarcoma | Acute monoblastic leukemia with differentiation (FAB type M5b) | Oligodendroglioma | Mesoblastic nephroma | Acute myeloblastic leukemia with minimal differentiation (FAB type M0) | Malignant melanoma
ETV6::NUFIP1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ETV6::PDE6H	Adenocarcinoma
ETV6::PDGFRA	Chronic eosinophilic leukemia/hypereosinophilic syndrome
ETV6::PDGFRB	Chronic myeloproliferative disorder, NOS | Chronic eosinophilic leukemia/hypereosinophilic syndrome | Egypt | Acute myeloblastic leukemia with minimal differentiation (FAB type M0) | Skin | Acute myeloid leukemia, NOS | Spleen | Bilineage or biphenotypic leukemia | Chronic myelomonocytic leukemia | Acute lymphoblastic leukemia/lymphoblastic lymphoma
ETV6::PER1	Skin | Acute myeloid leukemia, NOS
ETV6::PLEKHG6	Adenocarcinoma
ETV6::PMEL	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ETV6::PRDM16	Acute myelomonocytic leukemia (FAB type M4)
ETV6::PRH2	Transitional cell carcinoma
ETV6::PTPRO	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ETV6::PTPRR	Acute myeloblastic leukemia with maturation (FAB type M2)
ETV6::QSOX1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ETV6::RBFOX2	Skin | Acute myeloid leukemia, NOS
ETV6::RET	Adenocarcinoma | Malignant epithelial tumor, special type
ETV6::RIMBP2	Astrocytoma, grade III-IV/Glioblastoma
ETV6::RNF217	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ETV6::RUNX1	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Nonneoplastic hematologic disorder/lesion | Acute monoblastic leukemia without differentiation (FAB type M5a) | Egypt | Bilineage or biphenotypic leukemia
ETV6::SMCO2	Acute myeloblastic leukemia with maturation (FAB type M2) | Skin | Acute myeloid leukemia, NOS
ETV6::SNUPN	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ETV6::STK3	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
ETV6::SYK	Bilineage or biphenotypic leukemia | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Myelodysplastic syndrome, NOS | Egypt | Myelodysplastic/myeloproliferative disease, NOS | Thymus
ETV6::TMTC1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ETV6::TNFRSF8	Squamous cell carcinoma
ETV6::YTHDF2	Adenocarcinoma
ETV6::ZNF385A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
EVA1A::TTC28	Squamous cell carcinoma
EVA1C::ABCG1	Adenocarcinoma
EVA1C::CBR3	Adenocarcinoma
EVA1C::CEP112	Adenocarcinoma
EVA1C::HUNK	Adenocarcinoma
EVA1C::MRAP	Adenocarcinoma
EVA1C::MROH8	Adenocarcinoma
EVA1C::TCP10L	Mesothelioma
EVA1C::TMEM50B	Adenocarcinoma
EVC2::CPM	Mesenchymal tumor, NOS
EVC2::STK32B	Malignant melanoma
EVC::DYNC2I1	Adenocarcinoma
EVC::MGST1	Adenocarcinoma
EVI5::BRAF	Fibroblastic/myofibroblastic tumor, special type
EVI5::FUBP1	Mature B-cell neoplasm, NOS
EVI5::GFI1	Adenocarcinoma
EVI5::HFM1	Adenocarcinoma
EVI5L::PGPEP1	Mesenchymal tumor, NOS
EVI5L::PTPRS	Adenocarcinoma
EVI5L::VAV1	Adenocarcinoma
EVL::EML1	Adenocarcinoma
EVL::NKX2-1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
EVL::SFTA3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
EVL::TRAF3	Adenocarcinoma
EVPL::MAP2K6	Adenocarcinoma
EVPL::SAP30BP	Adenocarcinoma
EVPL::SRP68	Adenocarcinoma
EWSR1::ABR	Squamous cell carcinoma
EWSR1::ATF1	Soft tissue tumor, special type | Osteogenic/bone tumor, NOS | Angiomatoid fibrous histiocytoma | Gonadal stromal cell tumors | Malignant melanoma | Clear cell sarcoma | Malignant epithelial tumor, special type | Mesenchymal tumor, special type | Myoepithelioma/myoepithelial carcinoma/mixed tumor | Mesenchymal tumor, NOS | Adenocarcinoma | Fibroblastic/myofibroblastic tumor, special type | Muscle tumor, special type | Carcinoma, NOS | Ewing sarcoma | Mesothelioma | Neuroglial neoplasm, special type
EWSR1::BEND2	Neuroglial neoplasm, special type | Soft tissue tumor, special type | Adenocarcinoma | Aneurysmal bone cyst | Malignant epithelial tumor, special type | Carcinoid tumor
EWSR1::BRMS1L	Malignant soft tissue tumor, NOS
EWSR1::CDADC1	Adenocarcinoma
EWSR1::CREB1	Mesenchymal tumor, special type | Inflammatory myofibroblastic tumor/myofibroblastic sarcoma | Soft tissue tumor, special type | Ossifying fibromyxoid tumor | Clear cell sarcoma | Angiomatoid fibrous histiocytoma | Fibroblastic/myofibroblastic tumor, special type
EWSR1::CREB3L1	Low-grade fibromyxoid sarcoma | Undifferentiated round cell sarcoma | Sclerosing epithelioid fibrosarcoma | Myxofibrosarcoma | Osteosarcoma, small cell
EWSR1::CREB3L2	Low-grade fibromyxoid sarcoma | Malignant soft tissue tumor, NOS | Sclerosing epithelioid fibrosarcoma
EWSR1::CREB3L3	Mesenchymal tumor, special type | Sclerosing epithelioid fibrosarcoma
EWSR1::CREM	Fibroblastic/myofibroblastic tumor, special type | Malignant melanoma | Mesothelioma | Malignant peripheral nerve sheath tumor/Triton | Mesenchymal tumor, special type | Soft tissue tumor, special type | Soft tissue tumor, NOS | Clear cell sarcoma | Gonadal stromal cell tumors | Adenocarcinoma | Malignant epithelial tumor, special type | Angiomatoid fibrous histiocytoma | Mesenchymal tumor, NOS
EWSR1::CTBP1	Embryonal nervous system tumor, NOS | Mesenchymal tumor, special type
EWSR1::DDIT3	Liposarcoma, myxoid/round cell
EWSR1::ERG	Undifferentiated round cell sarcoma | Desmoplastic small round cell tumor | Ewing sarcoma
EWSR1::ETV1	Ewing sarcoma
EWSR1::ETV4	Ewing sarcoma
EWSR1::EZHIP	Neuroglial neoplasm, special type
EWSR1::FEV	Ewing sarcoma | Bilineage or biphenotypic leukemia | Egypt
EWSR1::FLI1	Embryonal nervous system tumor, special type | Giant cell tumor of bone | Primitive neuroectodermal tumor/Medulloblastoma | Slovakia | Embryonal rhabdomyosarcoma | Peripheral neuroepithelioma | Ewing sarcoma | Neuroblastoma | Malignant epithelial tumor, special type | Undifferentiated sarcoma | Alveolar rhabdomyosarcoma | Russia
EWSR1::GFI1B	Angiofibroma
EWSR1::GORASP2	Adenosquamous carcinoma
EWSR1::HOXB13	Fibroblastic/myofibroblastic tumor, NOS
EWSR1::HOXB8	Acute megakaryoblastic leukemia (FAB type M7)
EWSR1::KLF15	Myoepithelioma/myoepithelial carcinoma/mixed tumor | Malignant epithelial tumor, special type
EWSR1::KLF17	Myoepithelioma/myoepithelial carcinoma/mixed tumor
EWSR1::LARP4	Adenocarcinoma
EWSR1::MYB	Adenoid cystic carcinoma | Adenocarcinoma
EWSR1::NACC1	Soft tissue tumor, special type
EWSR1::NCAPH2	Astrocytoma, grade I-II
EWSR1::NF2	Rhabdomyosarcoma, NOS | Mesothelioma
EWSR1::NFATC1	Vascular and perivascular tumor, special type | Hemangioma/lymphangioma
EWSR1::NFATC2	Vascular and perivascular tumor, special type | Undifferentiated round cell sarcoma | Ewing sarcoma | Myoepithelioma/myoepithelial carcinoma/mixed tumor | Malignant soft tissue tumor, NOS | Osteogenic/bone tumor, special type
EWSR1::NR4A2	Chondrosarcoma, myxoid
EWSR1::NR4A3	Chondrosarcoma, myxoid | Osteosarcoma, NOS | Soft tissue tumor, special type | Mesothelioma
EWSR1::PATZ1	Neuroglial neoplasm, special type | Primitive neuroectodermal tumor/Medulloblastoma | Astrocytoma, NOS | Undifferentiated sarcoma | Alveolar rhabdomyosarcoma | Adenocarcinoma | Ependymoma | Undifferentiated round cell sarcoma | Astrocytoma, grade III-IV/Glioblastoma | Russia | Ewing sarcoma
EWSR1::PBX1	Soft tissue tumor, special type | Myoepithelioma/myoepithelial carcinoma/mixed tumor | Myxofibrosarcoma
EWSR1::PBX3	Leiomyoma | Myoepithelioma/myoepithelial carcinoma/mixed tumor | Osteogenic/bone tumor, special type
EWSR1::PLAGL1	Mesenchymal tumor, special type | Embryonal nervous system tumor, special type | Ependymoma
EWSR1::POU2AF3	Soft tissue tumor, special type | Mesenchymal tumor, special type
EWSR1::POU5F1	Undifferentiated round cell sarcoma | Benign epithelial tumor, special type | Myoepithelioma/myoepithelial carcinoma/mixed tumor | Mucoepidermoid carcinoma
EWSR1::RORB	Malignant soft tissue tumor, NOS | Giant cell tumor of bone
EWSR1::SELENOM	Adenocarcinoma
EWSR1::SMAD3	Fibroblastic/myofibroblastic tumor, special type
EWSR1::SMARCA5	Ewing sarcoma
EWSR1::SMR3B	Adenocarcinoma
EWSR1::SMTN	Adenocarcinoma
EWSR1::SP3	Undifferentiated round cell sarcoma
EWSR1::SSX1	Undifferentiated sarcoma
EWSR1::SSX2	Osteosarcoma, NOS
EWSR1::SSX3	Mesenchymal tumor, special type
EWSR1::STRADA	Mature B-cell neoplasm, NOS
EWSR1::TCF7L2	Adenocarcinoma
EWSR1::TEF	Mature B-cell neoplasm, NOS
EWSR1::TFCP2	Rhabdomyosarcoma, NOS | Spindle cell/sclerosing rhabdomyosarcoma | Desmoplastic small round cell tumor
EWSR1::TFE3	Adenocarcinoma
EWSR1::TFEB	Adenocarcinoma
EWSR1::UBP1	Spindle cell/sclerosing rhabdomyosarcoma
EWSR1::VEZF1	Undifferentiated round cell sarcoma | Malignant peripheral nerve sheath tumor/Triton
EWSR1::VGLL1	Neuroglial neoplasm, special type | Myoepithelioma/myoepithelial carcinoma/mixed tumor
EWSR1::WT1	Soft tissue tumor, special type | Desmoplastic small round cell tumor | Adenocarcinoma
EWSR1::YY1	Mesothelioma
EWSR1::ZBTB41	Spindle cell/sclerosing rhabdomyosarcoma
EWSR1::ZBTB44	Soft tissue tumor, special type
EWSR1::ZNF384	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Acute undifferentiated leukemia | Algeria
EWSR1::ZNF444	Myoepithelioma/myoepithelial carcinoma/mixed tumor | Undifferentiated round cell sarcoma
EXD2::GMEB2	Adenocarcinoma
EXD2::RAD51B	Adenocarcinoma
EXD3::PNPLA7	Squamous cell carcinoma
EXD3::ZMYND19	Adenocarcinoma
EXO1::WDR64	Adenocarcinoma
EXO5::MTF1	Mesenchymal tumor, NOS
EXOC1::ARL9	Adenocarcinoma
EXOC1::IDO1	Adenocarcinoma
EXOC1::NUP107	Astrocytoma, grade III-IV/Glioblastoma
EXOC1::XKR3	Adenocarcinoma
EXOC2::DUSP22	Anaplastic large cell lymphoma, systemic type
EXOC2::FRMD4B	Squamous cell carcinoma
EXOC2::GCNT2	Mesenchymal tumor, NOS
EXOC2::GMDS	Adenocarcinoma
EXOC2::MDGA1	Malignant melanoma
EXOC2::OOEP	Transitional cell carcinoma
EXOC2::RNF144B	Adenocarcinoma
EXOC2::SH3RF3	Adenocarcinoma
EXOC3::ERGIC1	Neuroblastoma
EXOC3::TAGLN	Mesenchymal tumor, NOS
EXOC3::TRIP13	Malignant melanoma
EXOC4::ATM	Adenocarcinoma
EXOC4::BRAF	Adenocarcinoma
EXOC4::CHCHD3	Adenocarcinoma
EXOC4::GALNT17	Mesenchymal tumor, NOS
EXOC4::LRGUK	Adenocarcinoma
EXOC4::NPFFR2	Adenocarcinoma
EXOC4::PTAFR	Adenocarcinoma
EXOC4::PTPRN2	Malignant melanoma
EXOC4::RAB4B	Astrocytoma, grade III-IV/Glioblastoma
EXOC4::SLC25A13	Adenocarcinoma
EXOC4::SUPT3H	Adenocarcinoma
EXOC4::TRHDE	Acute promyelocytic leukemia (FAB type M3)
EXOC4::TRUB2	Adenocarcinoma
EXOC5::CCDC198	Adenocarcinoma
EXOC5::SLC35F4	Adenocarcinoma
EXOC6::DTNB	Squamous cell carcinoma
EXOC6::EYS	Benign epithelial tumor, special type
EXOC6::FFAR4	Squamous cell carcinoma
EXOC6B::CASP10	Malignant melanoma
EXOC6B::CPQ	Astrocytoma, grade III-IV/Glioblastoma
EXOC6B::HNRNPLL	Transitional cell carcinoma
EXOC6B::PCCB	Squamous cell carcinoma
EXOC6B::SFXN5	Adenocarcinoma
EXOC6B::SLC4A5	Adenocarcinoma
EXOC7::ACHE	Adenocarcinoma
EXOC7::CYTH1	Adenocarcinoma
EXOC7::FOXJ1	Adenocarcinoma
EXOC7::PRPSAP1	Osteosarcoma, NOS
EXOC7::ST6GALNAC2	Adenocarcinoma
EXOC7::USP22	Adenocarcinoma
EXOSC10::MTOR	Adenocarcinoma
EXOSC1::CCDC144A	Adenocarcinoma
EXOSC1::SORCS1	Adenocarcinoma
EXOSC4::NEIL2	Mesothelioma
EXOSC5::FCGBP	Adenocarcinoma
EXOSC5::LEUTX	Astrocytoma, grade I-II
EXOSC7::ZDHHC3	Squamous cell carcinoma
EXPH5::SLC35F2	Adenocarcinoma
EXT1::NALF1	Transitional cell carcinoma
EXT1::NTAQ1	Transitional cell carcinoma
EXT1::OC90	Adenocarcinoma
EXT1::PTK2	Adenocarcinoma
EXT1::RSF1	Adenocarcinoma
EXT1::SAMD12	Squamous cell carcinoma | Adenocarcinoma
EXT1::TINAGL1	Adenocarcinoma
EXT1::TSNARE1	Adenocarcinoma
EXT2::ALKBH3	Malignant melanoma
EXT2::ALX4	Adenocarcinoma
EXT2::PRMT9	Squamous cell carcinoma
EXT2::TTC17	Adenocarcinoma
EXTL2::DPH5	Adenocarcinoma
EXTL3::MIDN	Adenocarcinoma
EXTL3::PNOC	Adenocarcinoma
EXTL3::RBPMS	Adenocarcinoma
EXTL3::SARAF	Adenocarcinoma
EYA1::NFIB	Adenocarcinoma
EYA2::LHX2	Astrocytoma, grade I-II
EYA2::MYLK2	Malignant epithelial tumor, special type
EYA2::PI3	Adenocarcinoma
EYA2::SERINC3	Adenocarcinoma
EYA2::SLC2A10	Adenocarcinoma
EYA2::SYS1	Adenocarcinoma
EYA3::GUCA1C	Adenocarcinoma
EYA3::POP4	Adenocarcinoma
EYA3::SUSD6	Adenocarcinoma
EYA3::SYTL1	Adenocarcinoma
EYA3::TMEM61	Adenocarcinoma
EYA4::MAP3K5	Mesenchymal tumor, NOS
EYA4::PKIB	Mesenchymal tumor, NOS
EYS::ADGRB3	Adenocarcinoma
EYS::CAMSAP3	Astrocytoma, grade I-II
EYS::DEK	Squamous cell carcinoma
EYS::FILIP1	Adenocarcinoma
EYS::STX11	Astrocytoma, grade I-II
EZH1::IGFBP5	Adenocarcinoma
EZH1::MAP3K14	Adenocarcinoma
EZH1::PDSS2	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
EZH1::TOP2A	Adenocarcinoma
EZH1::ZC3H3	Adenocarcinoma
EZH2::AUTS2	Squamous cell carcinoma
EZH2::PUS7	Acute myeloid leukemia, NOS | Skin
EZH2::TMEM176B	Adenocarcinoma
EZH2::ZNF425	Malignant epithelial tumor, special type
EZR::C1ORF50	Adenocarcinoma
EZR::C1orf50	Adenocarcinoma
EZR::RB1CC1	Adenocarcinoma
EZR::ROS1	Adenocarcinoma | Squamous cell carcinoma | Glioma, NOS
EZR::SLC22A2	Adenocarcinoma
EZR::SNX9	Adenocarcinoma
EZR::ZNF596	Adenocarcinoma
F11::NTRK1	Adenocarcinoma
F11R::DOCK6	Transitional cell carcinoma
F11R::LSM14A	Adenocarcinoma
F11R::NECTIN4	Adenocarcinoma
F11R::NOS1AP	Adenocarcinoma
F11R::NR1I3	Squamous cell carcinoma
F11R::NTRK1	Squamous cell carcinoma
F11R::PFDN2	Squamous cell carcinoma
F11R::RBM4	Adenocarcinoma
F11R::SPTA1	Squamous cell carcinoma
F11R::USF1	Squamous cell carcinoma
F13B::NR1I3	Adenocarcinoma
F2::FOXH1	Adenocarcinoma
F3::TOP6BL	Squamous cell carcinoma
F5::SCYL3	Adenocarcinoma
FA2H::GLG1	Adenocarcinoma
FA2H::KARS1	Adenocarcinoma
FAAH2::NBDY	Adenocarcinoma
FAAH2::SSPN	Adenocarcinoma
FAAH::RAD54L	Adenocarcinoma
FAAP100::NPLOC4	Squamous cell carcinoma
FAAP20::ZC3H11A	Adenocarcinoma
FABP3::ADGRB2	Transitional cell carcinoma
FADS1::SHANK2	Adenocarcinoma
FADS1::TMEM138	Squamous cell carcinoma
FADS2::EIF3F	Adenocarcinoma
FADS2::GDPD4	Malignant melanoma
FADS2::SHANK2	Adenocarcinoma
FAF1::CHIA	Transitional cell carcinoma
FAF1::DCAF6	Adenocarcinoma
FAF1::EPS15	Transitional cell carcinoma
FAF1::HCRTR1	Adenocarcinoma
FAF1::HOOK1	Adenocarcinoma
FAF1::ITGB3BP	Transitional cell carcinoma
FAF1::LRRC7	Adenocarcinoma
FAF1::NFIA	Adenocarcinoma
FAF1::OSBPL9	Squamous cell carcinoma
FAF1::PTRH2	Adenocarcinoma
FAF1::RAD51B	Adenocarcinoma
FAF1::SKI	Adenocarcinoma
FAF1::TESK2	Adenocarcinoma
FAF1::TTC39A	Adenocarcinoma
FAF2::KIAA1191	Adenocarcinoma
FAF2::METTL2A	Adenocarcinoma
FAHD2B::DROSHA	Squamous cell carcinoma
FAM107B::PRKCQ	Diffuse large B-cell lymphoma
FAM110B::DIABLO	Adenocarcinoma
FAM110B::PLAG1	Adenoma
FAM110B::PREX2	Adenocarcinoma
FAM110B::SNTG1	Adenocarcinoma
FAM111A::MYB	Acute lymphoblastic leukemia/lymphoblastic lymphoma
FAM111B::GLYATL1	Adenocarcinoma
FAM111B::MS4A5	Adenocarcinoma
FAM114A1::DAB1	Adenocarcinoma
FAM114A1::EEPD1	Squamous cell carcinoma
FAM114A1::IQCE	Adenocarcinoma
FAM114A1::KCNIP4	Adenocarcinoma
FAM114A2::BRAF	Adenocarcinoma
FAM114A2::FBN2	Malignant melanoma
FAM117A::VMP1	Adenocarcinoma
FAM117B::ATIC	Adenocarcinoma
FAM117B::BMPR2	Adenocarcinoma
FAM117B::SEC62	Acute lymphoblastic leukemia/lymphoblastic lymphoma
FAM117B::UGCG	Adenocarcinoma
FAM118A::NUP50	Adenocarcinoma
FAM118A::SBF1	Transitional cell carcinoma
FAM118A::ST13	Malignant melanoma
FAM118A::ST7L	Adenocarcinoma
FAM118A::UPK3A	Adenocarcinoma
FAM118A::VAPB	Mesenchymal tumor, NOS
FAM118B::DCPS	Malignant melanoma
FAM118B::DDX25	Adenocarcinoma
FAM118B::ST3GAL4	Adenocarcinoma
FAM120A::CARD19	Adenocarcinoma
FAM120A::COL27A1	Malignant epithelial tumor, special type
FAM120A::MAP4	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
FAM120A::RABGAP1	Acute myeloid leukemia, NOS | Skin
FAM120A::SUSD1	Mesenchymal tumor, NOS
FAM120A::WNK2	Adenocarcinoma
FAM120B::SFI1	Adenocarcinoma
FAM124A::SPRYD7	Mesothelioma
FAM131A::BRAF	Adenosquamous carcinoma
FAM131A::HTR3D	Adenocarcinoma
FAM131A::NAA50	Adenocarcinoma
FAM131B::BRAF	Astrocytoma, pilocytic/juvenile
FAM133B::CDK6	Adenocarcinoma | Acute lymphoblastic leukemia/lymphoblastic lymphoma
FAM135A::ADGRG5	Adenocarcinoma
FAM135A::C6orf163	Adenocarcinoma
FAM135A::FBXL4	Mesenchymal tumor, NOS
FAM135A::LAMA2	Adenocarcinoma
FAM135A::LMO3	Adenocarcinoma
FAM13A::ABCG2	Malignant melanoma
FAM13A::GAB1	Adenocarcinoma
FAM13B::CDC25C	Adenocarcinoma
FAM13B::ECSCR	Malignant epithelial tumor, special type
FAM13C::FAM149B1	Astrocytoma, grade III-IV/Glioblastoma
FAM13C::S100P	Squamous cell carcinoma | Adenocarcinoma
FAM13C::SUFU	Astrocytoma, grade III-IV/Glioblastoma
FAM13C::ZNF365	Transitional cell carcinoma
FAM149B1::ADK	Astrocytoma, grade III-IV/Glioblastoma
FAM149B1::KCNMA1	Adenocarcinoma
FAM149B1::USP6NL	Adenocarcinoma
FAM156A::XAGE2	Astrocytoma, grade I-II
FAM162A::CASR	Adenocarcinoma | Transitional cell carcinoma
FAM162A::CSTA	Adenocarcinoma
FAM162B::ZUP1	Nonneoplastic epithelial disorder/lesion
FAM168A::C2CD3	Adenocarcinoma
FAM168A::C5	Malignant epithelial tumor, special type
FAM168A::COA4	Adenocarcinoma
FAM168A::DCAF8	Adenocarcinoma
FAM168A::DNAJB13	Adenocarcinoma
FAM168A::MYEOV	Malignant melanoma
FAM168A::OSBPL5	Mesenchymal tumor, NOS
FAM168A::P4HA3	Adenocarcinoma
FAM168A::PARVA	Adenocarcinoma
FAM168A::PPME1	Adenocarcinoma
FAM168A::PRKCQ	Adenocarcinoma
FAM168A::PTCRA	Adenocarcinoma
FAM168A::PXDNL	Malignant melanoma
FAM168A::RAB6A	Adenocarcinoma
FAM168A::RNF121	Malignant melanoma
FAM168A::SLC13A2	Adenocarcinoma
FAM168A::SNX29	Astrocytoma, grade III-IV/Glioblastoma
FAM168A::SYT12	Mesenchymal tumor, NOS
FAM168A::TMEM135	Squamous cell carcinoma
FAM168A::TPCN2	Adenocarcinoma
FAM168A::UVRAG	Adenocarcinoma
FAM168B::ACTB	Adenocarcinoma
FAM168B::ANKRD42	Adenocarcinoma
FAM169A::ANKRD31	Transitional cell carcinoma
FAM171A1::ANKRD26	Astrocytoma, grade I-II
FAM171A1::ITGA8	Adenocarcinoma
FAM171A1::MINDY3	Primitive neuroectodermal tumor/Medulloblastoma | Russia
FAM171B::KYNU	Adenocarcinoma
FAM171B::ZNF75D	Squamous cell carcinoma
FAM174B::LRRC49	Squamous cell carcinoma
FAM174B::PHF20	Adenocarcinoma
FAM174C::PALM	Astrocytoma, grade I-II
FAM177A1::AP4S1	Squamous cell carcinoma
FAM177A1::IQSEC3	Adenocarcinoma
FAM177A1::PRORP	Adenocarcinoma
FAM177A1::PSMA6	Squamous cell carcinoma
FAM180A::AHCYL2	Mesenchymal tumor, NOS
FAM186A::DIP2B	Mycosis fungoides/Sézary syndrome
FAM193A::FGFR3	Malignant melanoma
FAM193A::HTT	Adenocarcinoma
FAM193A::MSANTD1	Mature B-cell neoplasm, NOS
FAM193A::NMU	Malignant melanoma
FAM193A::PLPP5	Adenocarcinoma
FAM193A::PPP2R2C	Astrocytoma, grade I-II
FAM193A::RGS12	Miscellaneous hematopoietic/lymphoid neoplasm, special type
FAM193A::TBC1D10C	Adenocarcinoma
FAM193A::TNIP2	Squamous cell carcinoma
FAM193A::ZFYVE28	Adenocarcinoma
FAM193B::SGCD	Adenocarcinoma
FAM200A::CYP3A5	Adenocarcinoma
FAM200C::SLU7	Adenocarcinoma
FAM204A::AP1G2	Transitional cell carcinoma
FAM20B::RALGPS2	Adenocarcinoma
FAM20C::MKRN1	Squamous cell carcinoma
FAM210A::PSMG2	Adenocarcinoma
FAM216A::IGF1	Mesothelioma
FAM217B::CDH12	Adenocarcinoma
FAM217B::PRPF6	Adenocarcinoma
FAM217B::SLC13A2	Adenocarcinoma
FAM219A::CSTPP1	Adenocarcinoma
FAM219A::MRTFB	Astrocytoma, grade I-II
FAM219A::NLGN1	Malignant melanoma
FAM219A::PAX5	Adenocarcinoma
FAM219A::POLN	Astrocytoma, grade III-IV/Glioblastoma
FAM219A::S1PR5	Squamous cell carcinoma
FAM220A::SCGB1A1	Mesenchymal tumor, NOS
FAM221A::KLHL7	Diffuse large B-cell lymphoma
FAM221A::MUC4	Adenocarcinoma
FAM222A::MSI1	Squamous cell carcinoma
FAM222B::ALDH6A1	Astrocytoma, grade I-II
FAM222B::BPTF	Adenocarcinoma
FAM222B::CAT	Adenocarcinoma
FAM222B::CHD7	Adenocarcinoma
FAM222B::CRLF3	Malignant melanoma
FAM222B::DHRS13	Squamous cell carcinoma
FAM222B::DOP1B	Adenocarcinoma
FAM222B::FLOT2	Adenocarcinoma | Transitional cell carcinoma
FAM222B::GIP	Adenocarcinoma
FAM222B::GYS2	Adenocarcinoma
FAM222B::HAO2	Adenocarcinoma
FAM222B::MYO18A	Adenocarcinoma
FAM222B::NEK8	Adenocarcinoma
FAM222B::PHF12	Adenocarcinoma
FAM222B::PRPSAP1	Mesenchymal tumor, NOS
FAM222B::RAB5C	Adenocarcinoma
FAM222B::SEZ6	Adenocarcinoma
FAM222B::STXBP4	Adenocarcinoma
FAM222B::TLCD1	Squamous cell carcinoma
FAM222B::TRIM37	Adenocarcinoma
FAM222B::UNC5D	Adenocarcinoma
FAM222B::VPS35L	Adenocarcinoma
FAM227B::FGF7	Squamous cell carcinoma
FAM228B::SNTG2	Malignant melanoma
FAM228B::UBXN2A	Transitional cell carcinoma
FAM234A::ALDOB	Adenocarcinoma
FAM234A::LUC7L	Squamous cell carcinoma
FAM234B::TMEM52B::TTLL9	Adenocarcinoma
FAM234B::TSPAN8	Mesenchymal tumor, NOS
FAM234B::YBX3	Squamous cell carcinoma
FAM32A::TPM4	Adenocarcinoma
FAM3C::CADPS2	Adenocarcinoma
FAM3C::SUSD2	Adenocarcinoma
FAM3D::EFHD2	Adenocarcinoma
FAM47E::TMEM184B	Adenocarcinoma
FAM50B::PPP1R3G	Squamous cell carcinoma
FAM53A::STPG1	Transitional cell carcinoma
FAM53B::BBIP1	Adenocarcinoma
FAM53B::KCNN1	Adenocarcinoma
FAM53B::LY86	Adenocarcinoma
FAM53B::NKX1-2	Adenocarcinoma
FAM53B::NUAK2	Adenocarcinoma
FAM53B::PROSER2	Diffuse large B-cell lymphoma
FAM53B::SGK2	Adenocarcinoma
FAM76A::GPR3	Adenocarcinoma
FAM76A::WDTC1	Adenocarcinoma
FAM78B::RAB3IP	Mesenchymal tumor, NOS
FAM83A::LYN	Adenocarcinoma
FAM83B::COL21A1	Squamous cell carcinoma
FAM83B::HTR1E	Squamous cell carcinoma
FAM83D::SF3B3	Adenocarcinoma
FAM83D::SPECC1L	Adenocarcinoma
FAM83E::HSD17B14	Adenocarcinoma
FAM83F::BAIAP2L2	Benign epithelial tumor, special type | Miscellaneous hematopoietic/lymphoid neoplasm, special type
FAM83F::FST	Squamous cell carcinoma
FAM83G::B9D1	Adenocarcinoma
FAM83G::ERCC6	Adenocarcinoma
FAM83G::GRAP	Squamous cell carcinoma
FAM83G::TRIM16	Adenocarcinoma
FAM83G::TTC19	Adenocarcinoma
FAM83H::ZFTRAF1	Adenocarcinoma
FAM86C1P::STX8	Malignant melanoma
FAM8A1::CAP2	Adenocarcinoma
FAM91A1::ANXA13	Transitional cell carcinoma
FAM91A1::CTDSP1	Adenocarcinoma
FAM91A1::TRMT12	Adenocarcinoma
FAM98A::BABAM2	Mesenchymal tumor, NOS
FAM98B::EFL1	Adenocarcinoma
FAM98B::FRMD5	Adenocarcinoma
FAM98B::RASGRP1	Adenocarcinoma
FAM98C::BLVRB	Squamous cell carcinoma
FAM98C::PPP5C	Mesenchymal tumor, NOS
FAM98C::SPINT2	Adenocarcinoma
FANCA::ANKRD11	Adenocarcinoma
FANCA::CACNA2D4	Adenocarcinoma
FANCA::SPIRE2	Adenocarcinoma
FANCC::ACOT11	Squamous cell carcinoma
FANCC::AOPEP	Squamous cell carcinoma
FANCC::DDX31	Astrocytoma, grade I-II
FANCC::PSIP1	Adenocarcinoma
FANCC::PTBP3	Fibroma
FANCC::ROR2	Adenocarcinoma
FANCC::SLC28A3	Adenocarcinoma
FANCD2::ARPC4	Malignant melanoma
FANCD2::CINP	Adenocarcinoma
FANCD2::MTMR14	Adenocarcinoma
FANCD2::WDR93	Adenocarcinoma
FANCI::ABHD2	Transitional cell carcinoma
FANCI::HADHB	Malignant epithelial tumor, special type
FANCL::NRXN1	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
FANCM::PRPF39	Squamous cell carcinoma
FANK1::STOX1	Astrocytoma, grade III-IV/Glioblastoma
FAR1::PSMB7	Adenocarcinoma
FAR2::AGMO	Transitional cell carcinoma
FAR2::NFE2	Adenocarcinoma
FARP1::ABCC2	Adenocarcinoma
FARP1::GALR2	Malignant melanoma
FARP1::GPC6	Squamous cell carcinoma
FARP1::IPO5	Adenocarcinoma
FARP1::NALCN	Adenocarcinoma
FARP1::NME1	Astrocytoma, grade I-II
FARP1::SIAE	Adenocarcinoma
FARP1::SLC15A1	Adenocarcinoma
FARP1::UCHL3	Adenocarcinoma
FARP2::INHA	Adenocarcinoma
FARP2::PPP1R7	Adenocarcinoma
FARP2::SEPTIN2	Adenocarcinoma
FARS2::AKR1E2	Adenocarcinoma
FARS2::BATF2	Astrocytoma, grade III-IV/Glioblastoma
FARS2::CDYL	Malignant melanoma
FARS2::DTNBP1	Adenocarcinoma
FARS2::GCNT2	Astrocytoma, grade I-II
FARS2::HSD17B11	Adenocarcinoma
FARS2::KPNA4	Mesenchymal tumor, NOS
FARS2::LYRM4	Malignant melanoma
FARS2::PHACTR1	Squamous cell carcinoma
FARS2::RIPK1	Adenocarcinoma
FARS2::RREB1	Adenocarcinoma
FARS2::SYCP2L	Malignant melanoma
FARSA::AP1G2	Squamous cell carcinoma
FARSA::EFCAB6	Squamous cell carcinoma
FARSA::LYL1	Adenocarcinoma
FARSA::NARS2	Transitional cell carcinoma
FARSA::SYCE2	Nonneoplastic epithelial disorder/lesion
FAS::CTNND2	Adenocarcinoma
FASN::CCDC57	Adenocarcinoma
FASN::LOXL4	Malignant melanoma
FASN::NUCKS1	Adenocarcinoma
FASN::ZNF595	Adenocarcinoma
FASTK::GNGT1	Astrocytoma, grade I-II
FASTKD5::LZTS3	Adenocarcinoma
FAT1::ACSL1	Squamous cell carcinoma
FAT1::CFAP97	Squamous cell carcinoma
FAT1::IRF2	Squamous cell carcinoma
FAT1::NPY1R	Adenocarcinoma
FAT1::NTRK3	Squamous cell carcinoma
FAT1::SORBS2	Squamous cell carcinoma
FAT1::STAT6	Adenocarcinoma
FAT1::USP6	Aneurysmal bone cyst
FAT2::ATOX1	Squamous cell carcinoma
FAT3::CDH26	Adenocarcinoma
FAT3::DPP3	Adenocarcinoma
FAU::SRRM1	Adenocarcinoma
FAXC::ASCC3	Adenocarcinoma
FAXC::MYRFL	Mesenchymal tumor, NOS
FAXC::PDE4B	Adenocarcinoma
FBF1::ACOX1	Adenocarcinoma
FBF1::HELZ	Adenocarcinoma
FBH1::FRMD4A	Adenocarcinoma
FBH1::ITGA8	Adenocarcinoma
FBL::RASGRP4	Malignant melanoma
FBL::RYR1	Malignant melanoma
FBL::SEC63	Germ cell tumor, NOS
FBL::ZNF829	Adenocarcinoma
FBLIM1::CELA2B	Adenocarcinoma
FBLIM1::DDI2	Germ cell tumor, NOS
FBLIM1::DNAH14	Squamous cell carcinoma
FBLIM1::EFHD2	Adenocarcinoma
FBLN1::PAK4	Squamous cell carcinoma
FBLN1::SMC1B	Transitional cell carcinoma
FBLN2::LMCD1	Adenocarcinoma
FBN1::EIF3B	Mesenchymal tumor, NOS
FBN1::TEX9	Mesothelioma
FBN1::THSD4	Astrocytoma, grade I-II
FBN1::URI1	Mesenchymal tumor, NOS
FBN2::TMPRSS6	Malignant epithelial tumor, special type
FBRS::AHSP	Adenocarcinoma
FBRS::ZNF689	Squamous cell carcinoma
FBRSL1::CKAP4	Squamous cell carcinoma
FBRSL1::GALNT9	Adenocarcinoma
FBRSL1::NOC4L	Mature B-cell neoplasm, NOS | Adenocarcinoma
FBRSL1::PAX5	Acute lymphoblastic leukemia/lymphoblastic lymphoma
FBRSL1::SFSWAP	Astrocytoma, grade III-IV/Glioblastoma
FBXL13::TSC22D1	Skin | Acute myeloid leukemia, NOS
FBXL17::SPINK14	Adenocarcinoma
FBXL17::TMEM232	Malignant melanoma
FBXL18::ACTB	Adenocarcinoma | Mature B-cell neoplasm, NOS
FBXL18::ELFN1	Malignant melanoma
FBXL18::PHF12	Adenocarcinoma
FBXL18::RNF216	Adenocarcinoma
FBXL18::WDR83OS	Astrocytoma, grade III-IV/Glioblastoma
FBXL19::DNAAF8	Adenocarcinoma
FBXL19::KRBOX5	Malignant melanoma
FBXL19::RNF40	Squamous cell carcinoma
FBXL20::ABCA6	Adenocarcinoma
FBXL20::ABRACL	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
FBXL20::ARL5C	Adenocarcinoma
FBXL20::BTBD1	Mesenchymal tumor, NOS
FBXL20::CANT1	Adenocarcinoma
FBXL20::CASS4	Adenocarcinoma
FBXL20::CD163L1	Adenocarcinoma
FBXL20::CDC6	Adenocarcinoma
FBXL20::CDK12	Adenocarcinoma
FBXL20::CEP112	Adenocarcinoma
FBXL20::CEP95	Adenocarcinoma
FBXL20::ERBB2	Adenocarcinoma
FBXL20::FBXO47	Adenocarcinoma
FBXL20::GDPD5	Adenocarcinoma
FBXL20::GRB7	Adenocarcinoma | Squamous cell carcinoma
FBXL20::GSDMB	Squamous cell carcinoma | Adenocarcinoma
FBXL20::IKZF3	Adenocarcinoma
FBXL20::INTS13	Adenocarcinoma
FBXL20::KRT27	Transitional cell carcinoma
FBXL20::LRSAM1	Adenocarcinoma
FBXL20::MIEN1	Adenocarcinoma
FBXL20::MSL1	Adenocarcinoma
FBXL20::MYO1D	Adenocarcinoma
FBXL20::NOTCH2	Adenocarcinoma
FBXL20::ORMDL3	Squamous cell carcinoma | Adenocarcinoma
FBXL20::PIP4K2B	Adenocarcinoma
FBXL20::PITPNC1	Adenocarcinoma
FBXL20::PPM1E	Adenocarcinoma
FBXL20::RHBDF2	Adenocarcinoma
FBXL20::RPL23	Adenocarcinoma
FBXL20::SIRT6	Adenocarcinoma
FBXL20::SNF8	Adenocarcinoma
FBXL20::SNX11	Adenocarcinoma
FBXL20::SOCS7	Adenocarcinoma
FBXL20::SOX5	Adenocarcinoma
FBXL20::SYNRG	Adenocarcinoma
FBXL20::TADA2A	Adenocarcinoma
FBXL20::TANC2	Adenocarcinoma
FBXL20::THRSP	Adenocarcinoma
FBXL20::TLK2	Adenocarcinoma
FBXL20::TRIM49B	Adenocarcinoma
FBXL20::TTC17	Adenocarcinoma
FBXL20::UNC45B	Squamous cell carcinoma
FBXL20::UVRAG	Malignant epithelial tumor, special type
FBXL20::WIPF2	Adenocarcinoma
FBXL2::KIF9	Transitional cell carcinoma
FBXL3::KLF5	Adenocarcinoma
FBXL3::MYCBP2	Adenocarcinoma
FBXL3::ZNF76	Malignant epithelial tumor, special type
FBXL4::BTN3A3	Transitional cell carcinoma
FBXL5::RAB28	Adenocarcinoma
FBXL7::AGXT2	Malignant melanoma
FBXL7::CCT5	Malignant epithelial tumor, special type
FBXL7::CDH10	Mesenchymal tumor, NOS
FBXL7::FOSL2	Malignant melanoma
FBXL7::MRPL51	Mesenchymal tumor, NOS
FBXL7::NRDC	Mesenchymal tumor, NOS
FBXL7::PTPN3	Mesenchymal tumor, NOS
FBXL7::RETREG1	Adenocarcinoma
FBXL7::TERT	Gonadal stromal cell tumors
FBXO11::ALK	Adenocarcinoma
FBXO11::INTS9	Adenocarcinoma
FBXO16::ADAM32	Adenocarcinoma
FBXO17::ACTN4	Squamous cell carcinoma
FBXO17::LGALS7	Adenocarcinoma
FBXO17::NFE2L2	Adenocarcinoma
FBXO17::OSBPL6	Transitional cell carcinoma
FBXO17::SIPA1L3	Adenocarcinoma
FBXO21::CHPT1	Transitional cell carcinoma
FBXO22::SNX33	Adenocarcinoma
FBXO25::BET1L	Gonadal stromal cell tumors
FBXO27::RYR1	Astrocytoma, grade III-IV/Glioblastoma
FBXO28::LYZL2	Squamous cell carcinoma
FBXO31::TTC28	Adenocarcinoma
FBXO31::USP10	Adenocarcinoma
FBXO31::ZNRF1	Transitional cell carcinoma
FBXO32::ANXA13	Adenocarcinoma | Squamous cell carcinoma
FBXO32::PLAG1	Adenoma
FBXO33::CNGB3	Adenocarcinoma
FBXO33::SERINC5	Malignant melanoma
FBXO34::ATG7	Adenocarcinoma
FBXO34::HECTD1	Adenocarcinoma
FBXO34::LGALS3	Adenocarcinoma
FBXO34::NID2	Adenocarcinoma
FBXO34::RALYL	Adenocarcinoma
FBXO34::SORCS3	Adenocarcinoma
FBXO36::ALCAM	Adenocarcinoma
FBXO38::CDC42SE2	Adenocarcinoma
FBXO38::MTREX	Malignant melanoma
FBXO38::SPINK6	Adenocarcinoma
FBXO42::CBARP	Squamous cell carcinoma
FBXO42::CPLANE2	Adenocarcinoma
FBXO42::EPHA2	Squamous cell carcinoma
FBXO42::LAPTM5	Adenocarcinoma
FBXO42::RUNX1	Adenocarcinoma
FBXO42::SPATA21	Malignant epithelial tumor, special type
FBXO46::ARG2	Adenocarcinoma
FBXO46::LGALS4	Adenocarcinoma
FBXO46::MEIOSIN	Diffuse large B-cell lymphoma
FBXO46::MYBL1	Anaplastic large cell lymphoma, systemic type
FBXO46::SYMPK	Adenocarcinoma
FBXO46::ZNF90	Adenocarcinoma
FBXO7::PDPK1	Adenocarcinoma
FBXO8::PALLD	Mesenchymal tumor, NOS
FBXO9::CD74	Adenocarcinoma
FBXW11::KCNIP1	Squamous cell carcinoma
FBXW11::NUP210L	Adenocarcinoma
FBXW11::RBM11	Malignant melanoma
FBXW11::STK10	Adenocarcinoma
FBXW11::TTC33	Malignant melanoma
FBXW2::LTBP2	Adenocarcinoma
FBXW2::MEGF9	Squamous cell carcinoma
FBXW2::NXNL2	Mesenchymal tumor, NOS
FBXW4::ARMH3	Adenocarcinoma
FBXW4::OGA	Adenocarcinoma
FBXW5::ENTPD2	Adenocarcinoma
FBXW7::ARHGAP10	Transitional cell carcinoma
FBXW7::CTNNA2	Multiple myeloma
FBXW7::INPP4B	Squamous cell carcinoma
FBXW7::MGST2	Adenocarcinoma
FBXW7::PITPNA	Multiple myeloma
FBXW7::SETD7	Adenocarcinoma
FBXW7::SH3D19	Adenocarcinoma
FBXW7::TMEM126B	Astrocytoma, grade I-II
FBXW7::TMEM154	Adenocarcinoma
FBXW8::CDK17	Adenocarcinoma
FBXW8::CHST11	Adenocarcinoma
FBXW8::SRI	Adenocarcinoma
FBXW9::PRDX2	Astrocytoma, grade III-IV/Glioblastoma
FCF1::FOXN3	Squamous cell carcinoma
FCGBP::PLEKHB2	Adenocarcinoma
FCGR2A::SPTA1	Adenocarcinoma
FCGRT::BCAT2	Astrocytoma, grade III-IV/Glioblastoma
FCGRT::PRMT1	Adenocarcinoma
FCGRT::RPL13A	Transitional cell carcinoma
FCHO2::SLC25A17	Malignant melanoma
FCHO2::SPINK6	Multiple myeloma
FCHO2::TNPO1	Adenocarcinoma
FCHSD1::BRAF	Melanocytic neoplasm, special type
FCHSD1::NCKAP1L	Squamous cell carcinoma
FCHSD2::ABL1	Malignant epithelial tumor, special type
FCHSD2::ARHGEF17	Adenocarcinoma
FCHSD2::ATP6V1H	Malignant melanoma
FCHSD2::C2CD3	Adenocarcinoma
FCHSD2::CDC42EP2	Malignant epithelial tumor, special type
FCHSD2::CHRM1	Adenocarcinoma
FCHSD2::CPT1A	Adenocarcinoma
FCHSD2::DTX4	Adenocarcinoma
FCHSD2::FAM168A	Multiple myeloma | Adenocarcinoma
FCHSD2::GLOD4	Squamous cell carcinoma
FCHSD2::GLYAT	Germ cell tumor, NOS
FCHSD2::GUCY1A2	Squamous cell carcinoma
FCHSD2::LDLRAD3	Squamous cell carcinoma
FCHSD2::NBPF4	Adenocarcinoma
FCHSD2::NUMA1	Squamous cell carcinoma
FCHSD2::PLEKHB1	Adenocarcinoma
FCHSD2::PPFIA1	Transitional cell carcinoma
FCHSD2::RALYL	Adenocarcinoma
FCHSD2::RNF169	Adenocarcinoma
FCHSD2::SHANK2	Adenocarcinoma
FCHSD2::STARD10	Squamous cell carcinoma
FCHSD2::TCIRG1	Adenocarcinoma
FCHSD2::THRA	Adenocarcinoma
FCHSD2::TPCN2	Malignant melanoma
FCHSD2::UQCC3	Adenocarcinoma
FCHSD2::ZNF564	Adenocarcinoma
FCN2::COL5A1	Adenocarcinoma
FCRL1::RASAL2	Adenocarcinoma
FCRL4::IQGAP3	Meningioma
FCSK::ABCB5	Adenocarcinoma
FCSK::PDPR	Adenocarcinoma
FDCSP::PRR27	Adenocarcinoma
FDCSP::RTL9	Squamous cell carcinoma
FDFT1::CLVS1	Adenocarcinoma
FDFT1::DEFB135	Adenocarcinoma
FDFT1::GATA4	Adenocarcinoma
FDFT1::INTS9	Adenocarcinoma
FDFT1::NEIL2	Adenocarcinoma
FDFT1::TNKS	Transitional cell carcinoma
FDFT1::YWHAZ	Adenocarcinoma
FDPS::IPO9	Adenocarcinoma
FDX1::KNCN	Squamous cell carcinoma
FDXACB1::CRYAB	Adenocarcinoma
FECH::NCMAP	Transitional cell carcinoma
FEM1A::SELENOM	Adenocarcinoma
FEN1::GDPD4	Malignant melanoma
FER::COMMD10	Mesenchymal tumor, NOS
FER::FBXL17	Malignant melanoma
FER::RACK1	Multiple myeloma
FERMT1::CDRT4	Adenocarcinoma
FERMT1::MCM8	Adenocarcinoma
FERMT1::RBBP8	Adenocarcinoma
FERMT1::TVP23C	Adenocarcinoma
FEZ2::RAB10	Adenocarcinoma
FGA::CPS1	Adenocarcinoma
FGA::ZNFX1	Adenocarcinoma
FGB::FGA	Adenocarcinoma
FGB::HP	Adenocarcinoma
FGB::PLEKHA5	Adenocarcinoma
FGB::STAT6	Adenocarcinoma
FGD1::PFKFB1	Adenocarcinoma
FGD3::NOL8	Adenocarcinoma
FGD3::SYK	Transitional cell carcinoma
FGD4::ABCC9	Adenocarcinoma
FGD4::BICD1	Malignant melanoma
FGD4::CACNA1C	Adenocarcinoma
FGD4::CCDC91	Astrocytoma, grade I-II
FGD4::CD4	Adenocarcinoma
FGD4::CNTN5	Adenocarcinoma
FGD4::DNM1L	Adenocarcinoma
FGD4::FAR2	Adenocarcinoma
FGD4::LRRK2	Astrocytoma, grade III-IV/Glioblastoma
FGD4::MRPS35	Adenocarcinoma
FGD4::RESF1	Germ cell tumor, NOS
FGD4::SLCO1A2	Adenocarcinoma
FGD4::VPS13D	Adenocarcinoma
FGD5::KPNA3	Adenocarcinoma
FGD5::RET	Carcinoma, NOS
FGD5::SLC6A6	Mesenchymal tumor, NOS
FGD6::NUP37	Adenocarcinoma
FGD6::PTPRR	Mesenchymal tumor, NOS
FGD6::TBC1D30	Mesenchymal tumor, NOS
FGD6::VEZT	Squamous cell carcinoma
FGF12::LAMP3	Astrocytoma, grade I-II
FGF12::LRRC15	Squamous cell carcinoma
FGF12::SYN3	Adenocarcinoma
FGF12::ZNF595	Squamous cell carcinoma
FGF13::CSE1L	Adenocarcinoma
FGF13::DACH2	Adenocarcinoma
FGF13::DYM	Adenocarcinoma
FGF13::NEUROD2	Adenocarcinoma
FGF13::NLRP3	Adenocarcinoma
FGF13::SGK1	Diffuse large B-cell lymphoma
FGF13::STK26	Adenocarcinoma
FGF20::RP1	Adenocarcinoma
FGF2::FREM3	Mesenchymal tumor, NOS
FGF3::LGR4	Squamous cell carcinoma
FGFR1::ADAM18	Adenocarcinoma
FGFR1::ADGRA2	Adenocarcinoma
FGFR1::AGAP1	Mesenchymal tumor, special type
FGFR1::ANK1	Rhabdomyosarcoma, NOS
FGFR1::AZIN1	Astrocytoma, grade III-IV/Glioblastoma
FGFR1::BCR	Adenocarcinoma | Skin | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Acute myeloid leukemia, NOS
FGFR1::CKAP5	Fibroblastic/myofibroblastic tumor, special type
FGFR1::CSMD1	Adenocarcinoma
FGFR1::DNM1L	Adenocarcinoma
FGFR1::DOCK3	Mesenchymal tumor, special type
FGFR1::EBF2	Soft tissue tumor, special type
FGFR1::ERO1A	Mesenchymal tumor, special type
FGFR1::FAM110B	Astrocytoma, grade III-IV/Glioblastoma
FGFR1::FGFR1	Malignant soft tissue tumor, NOS
FGFR1::FN1	Mesenchymal tumor, special type
FGFR1::IMMP2L	Adenocarcinoma
FGFR1::LETM2	Squamous cell carcinoma
FGFR1::LRRFIP1	Skin | Acute myeloid leukemia, NOS
FGFR1::NRG1	Astrocytoma, grade III-IV/Glioblastoma
FGFR1::NTM	Transitional cell carcinoma
FGFR1::PARD6B	Soft tissue tumor, special type
FGFR1::PLAG1	Carcinoma, NOS | Adenoma | Myoepithelioma/myoepithelial carcinoma/mixed tumor | Adenocarcinoma | Soft tissue tumor, special type
FGFR1::SCARA5	Mesenchymal tumor, special type
FGFR1::SLC20A2	Adenocarcinoma
FGFR1::SQSTM1	Acute myelomonocytic leukemia (FAB type M4)
FGFR1::TACC1	Undifferentiated sarcoma | Primitive neuroectodermal tumor/Medulloblastoma | Astrocytoma, pilocytic/juvenile | Leiomyosarcoma | Soft tissue tumor, special type | Rhabdomyosarcoma, NOS | Glioma, NOS | Neuroglial neoplasm, special type | Astrocytoma, grade III-IV/Glioblastoma | Russia
FGFR1::TG	Adenocarcinoma
FGFR1::TIMP3	Mesenchymal tumor, special type
FGFR1::TLN1	Mesenchymal tumor, special type
FGFR1::TPR	Adenocarcinoma
FGFR1::TTLL1	Adenocarcinoma
FGFR1::TTLL4	Mesenchymal tumor, special type
FGFR1::USP33	Mesenchymal tumor, special type
FGFR1::USP6	Aneurysmal bone cyst
FGFR1::ZMYM2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
FGFR1OP2::FGFR1	Acute myeloid leukemia, NOS | Skin
FGFR1OP2::INTS13	Mesenchymal tumor, NOS
FGFR1OP2::TEC	Malignant melanoma
FGFR2::ACACA	Adenocarcinoma
FGFR2::AFF3	Adenocarcinoma
FGFR2::AHCYL1	Adenocarcinoma
FGFR2::AP1M1	Adenocarcinoma
FGFR2::ARHGAP24	Adenocarcinoma
FGFR2::ATE1	Squamous cell carcinoma | Adenocarcinoma
FGFR2::BEND3	Adenocarcinoma
FGFR2::BICC1	Malignant epithelial tumor, special type | Adenocarcinoma
FGFR2::BTBD16	Adenosquamous carcinoma
FGFR2::CASP7	Adenocarcinoma
FGFR2::CCAR2	Squamous cell carcinoma
FGFR2::CCDC170	Adenocarcinoma
FGFR2::CCDC186	Adenocarcinoma
FGFR2::CCDC6	Adenocarcinoma
FGFR2::CCDC7	Adenocarcinoma
FGFR2::CEP55	Adenocarcinoma
FGFR2::CFAP57	Adenocarcinoma
FGFR2::CIT	Adenocarcinoma | Carcinoma, NOS
FGFR2::CPQ	Osteosarcoma, NOS
FGFR2::CREB5	Adenocarcinoma
FGFR2::CTNNA3	Adenocarcinoma
FGFR2::DCTN2	Undifferentiated round cell sarcoma
FGFR2::DLG5	Astrocytoma, grade I-II
FGFR2::EIF4A2	Squamous cell carcinoma
FGFR2::ENPP2	Adenocarcinoma
FGFR2::ERC1	Carcinoma, NOS | Adenocarcinoma
FGFR2::FAM76A	Adenocarcinoma
FGFR2::FN1	Mesenchymal tumor, special type
FGFR2::FRK	Adenocarcinoma
FGFR2::GBE1	Adenocarcinoma
FGFR2::GOLGA4	Adenocarcinoma
FGFR2::INA	Adenocarcinoma
FGFR2::IQCG	Adenocarcinoma
FGFR2::KCTD1	Adenocarcinoma
FGFR2::KIAA1217	Gastrointestinal stromal tumor
FGFR2::KIF1A	Adenocarcinoma
FGFR2::KRT8	Adenocarcinoma
FGFR2::LZTFL1	Carcinoma, NOS
FGFR2::MATR3	Adenocarcinoma
FGFR2::MBIP	Adenocarcinoma
FGFR2::MCU	Adenocarcinoma
FGFR2::MTUS2	Adenocarcinoma
FGFR2::NCALD	Adenocarcinoma
FGFR2::NDC80	Malignant epithelial tumor, special type
FGFR2::NOL4	Adenocarcinoma
FGFR2::NPM1	Undifferentiated carcinoma, large cell | Adenocarcinoma
FGFR2::NRAP	Adenocarcinoma
FGFR2::OFD1	Adenocarcinoma | Carcinoma, NOS
FGFR2::OGA	Adenocarcinoma
FGFR2::OGDH	Undifferentiated carcinoma
FGFR2::PHLDB2	Adenocarcinoma
FGFR2::PIBF1	Adenocarcinoma
FGFR2::PLPP4	Adenocarcinoma
FGFR2::PLXNA2	Adenocarcinoma
FGFR2::POC1B	Carcinoma, NOS | Adenocarcinoma
FGFR2::PPHLN1	Adenocarcinoma
FGFR2::PRDX3	Adenocarcinoma
FGFR2::SHTN1	Embryonal nervous system tumor, special type | Carcinoma, NOS | Adenocarcinoma
FGFR2::SIRT2	Adenocarcinoma
FGFR2::SMN1	Adenocarcinoma
FGFR2::SORBS1	Carcinoma, NOS
FGFR2::TACC2	Gastrointestinal stromal tumor | Adenocarcinoma
FGFR2::TACC3	Adenocarcinoma
FGFR2::TBC1D4	Adenocarcinoma
FGFR2::TNC	Adenocarcinoma
FGFR2::TP73	Carcinoma, NOS
FGFR2::TRIM15	Adenocarcinoma
FGFR2::TTC28	Adenocarcinoma
FGFR2::TXLNA	Adenocarcinoma | Carcinoma, NOS
FGFR2::USP10	Adenocarcinoma
FGFR2::USP33	Adenocarcinoma
FGFR2::VPS26A	Adenocarcinoma
FGFR2::VPS35	Glioma, NOS
FGFR2::WAC	Adenocarcinoma
FGFR2::ZCCHC24	Neuroglial neoplasm, special type
FGFR3::AMBRA1	Astrocytoma, grade III-IV/Glioblastoma
FGFR3::BAIAP2L1	Transitional cell carcinoma
FGFR3::BRAP	Astrocytoma, grade III-IV/Glioblastoma
FGFR3::DHX8	Adenocarcinoma
FGFR3::DOT1L	Multiple myeloma
FGFR3::ELAVL3	Astrocytoma, grade I-II
FGFR3::FASN	Astrocytoma, grade III-IV/Glioblastoma
FGFR3::FBXO28	Astrocytoma, grade I-II
FGFR3::IER5L	Squamous cell carcinoma
FGFR3::IGH	Multiple myeloma
FGFR3::JAKMIP1	Transitional cell carcinoma
FGFR3::KLF15	Carcinoma, NOS
FGFR3::KLF2	Multiple myeloma
FGFR3::MAEA	Squamous cell carcinoma
FGFR3::MLLT10	Adenocarcinoma
FGFR3::NOC4L	Multiple myeloma
FGFR3::NSD2	Adenocarcinoma
FGFR3::PHLDB3	Carcinoma, NOS
FGFR3::PIDD1	Multiple myeloma
FGFR3::PMFBP1	Transitional cell carcinoma
FGFR3::RENBP	Astrocytoma, grade III-IV/Glioblastoma
FGFR3::SOX13	Astrocytoma, grade III-IV/Glioblastoma
FGFR3::SPDYE4	Adenocarcinoma
FGFR3::TACC3	Transitional cell carcinoma | Astrocytoma, grade III-IV/Glioblastoma | Mucoepidermoid carcinoma | Astrocytoma, pilocytic/juvenile | Squamous cell carcinoma | Carcinoma, NOS | Glioma, NOS | Astrocytoma, grade I-II | Adenocarcinoma | Adenosquamous carcinoma
FGFR3::TLE5	Adenocarcinoma
FGFR3::TNIP2	Transitional cell carcinoma
FGFR3::TPRG1	Squamous cell carcinoma
FGFRL1::CTBP1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
FGG::CLCN3	Adenocarcinoma
FGG::HP	Adenocarcinoma
FGGY::ATP2B4	Mesenchymal tumor, NOS
FGGY::CC2D1B	Mesenchymal tumor, NOS
FGGY::CDH17	Adenocarcinoma
FGGY::HOOK1	Adenocarcinoma
FGGY::KIF2C	Squamous cell carcinoma
FGGY::RPS6KA1	Adenocarcinoma
FGL1::ETV1	Carcinoma, NOS
FHDC1::ARFIP1	Adenocarcinoma
FHIP1A::ADAM2	Squamous cell carcinoma
FHIP1A::CCNA2	Adenocarcinoma
FHIP1A::DDX60	Adenocarcinoma
FHIP1A::HPF1	Squamous cell carcinoma
FHIP1A::IL15	Adenocarcinoma
FHIP1A::MYO18B	Squamous cell carcinoma
FHIP1B::APBB1	Adenocarcinoma
FHIP1B::DTD1	Adenocarcinoma
FHIP1B::PIGU	Adenocarcinoma
FHIP2A::ADK	Embryonal nervous system tumor, special type
FHIP2A::FANK1	Adenocarcinoma
FHIP2A::SHROOM3	Adenocarcinoma
FHIP2A::TECTB	Adenocarcinoma
FHIP2A::VTI1A	Adenocarcinoma
FHIP2B::DMTN	Adenocarcinoma
FHIT::ARHGEF3	Malignant melanoma
FHIT::CADPS	Adenocarcinoma | Mature B-cell neoplasm, NOS
FHIT::CAMK4	Adenocarcinoma
FHIT::KHDRBS3	Diffuse large B-cell lymphoma
FHIT::PTPRG	Astrocytoma, grade I-II
FHIT::STT3B	Adenocarcinoma
FHIT::SYNPR	Adenocarcinoma
FHIT::TAFA4	Adenocarcinoma
FHIT::TKT	Adenocarcinoma
FHL2::GLI2	Germ cell tumor, special type
FHOD3::ELP2	Adenocarcinoma
FHOD3::ESRRB	Adenocarcinoma
FHOD3::GALNT1	Squamous cell carcinoma
FHOD3::MOCOS	Adenocarcinoma | Squamous cell carcinoma
FHOD3::MS4A15	Squamous cell carcinoma
FHOD3::MTUS2	Adenocarcinoma
FHOD3::MYOM1	Adenocarcinoma
FIG4::HS3ST5	Adenocarcinoma
FIG4::PPP1R14C	Malignant melanoma
FIG4::SEC63	Acute myeloblastic leukemia without maturation (FAB type M1)
FIG4::WASF1	Adenocarcinoma
FIGN::STK25	Adenocarcinoma
FIGNL1::IKZF1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
FILIP1::KCNQ5	Malignant melanoma
FILIP1L::IMPG2	Squamous cell carcinoma
FIP1L1::KIT	Chronic myelomonocytic leukemia | Spleen
FIP1L1::PDGFRA	Mastocytosis | Polycythemia vera | Chronic eosinophilic leukemia/hypereosinophilic syndrome | Acute myeloid leukemia, special type | Spleen | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Chronic myelomonocytic leukemia
FIP1L1::RARA	Juvenile myelomonocytic leukemia | Acute promyelocytic leukemia (FAB type M3)
FIP1L1::ROS1	Melanocytic neoplasm, special type
FIP1L1::SBNO2	Adenocarcinoma
FIP1L1::SCFD2	Adenocarcinoma
FIP1L1::SLC38A8	Adenocarcinoma
FIP1L1::SORCS1	Adenocarcinoma
FIRRM::OR5H14	Mesothelioma
FIRRM::RPL5	Adenocarcinoma
FKBP10::ERBB2	Adenocarcinoma
FKBP10::JUP	Squamous cell carcinoma
FKBP10::KRT40	Adenocarcinoma
FKBP11::PRKAG1	Adenocarcinoma
FKBP15::RET	Skin | Adenocarcinoma | Acute myeloid leukemia, NOS
FKBP1A::CDS2	Squamous cell carcinoma
FKBP1A::CTDP1	Adenocarcinoma
FKBP2::CCDC88B	Adenocarcinoma
FKBP2::SPINDOC	Adenocarcinoma
FKBP3::FANCM	Squamous cell carcinoma
FKBP3::NUB1	Adenocarcinoma
FKBP5::ANKS1A	Adenocarcinoma
FKBP5::BYSL	Transitional cell carcinoma
FKBP5::RUNX2	Skin | Acute myeloid leukemia, NOS
FKBP5::SRPK1	Germ cell tumor, NOS
FKBP5::TMPRSS2::ERG	Adenocarcinoma
FKBP5::VPS54	Adenocarcinoma
FKBP8::DAND5	Adenocarcinoma
FKBP8::HAUS8	Adenocarcinoma
FKBP8::MEF2B	Adenocarcinoma
FKBP8::SLC1A6	Astrocytoma, grade III-IV/Glioblastoma
FKRP::XPOT	Transitional cell carcinoma
FKTN::CLUL1	Skin | Acute myeloid leukemia, NOS
FKTN::TMEM38B	Adenocarcinoma
FKTN::ULK4	Adenocarcinoma
FLAD1::UBAP2L	Adenocarcinoma
FLCN::COPS3	Mesenchymal tumor, NOS
FLI1::VAV2	Leiomyosarcoma
FLNA::ABCA2	Adenocarcinoma
FLNA::ACTG2	Adenocarcinoma
FLNA::ATP5MC3	Adenocarcinoma
FLNA::CMC4	Squamous cell carcinoma
FLNA::EIF2AK2	Adenocarcinoma
FLNA::MTCP1	Squamous cell carcinoma
FLNA::TKTL1	Adenocarcinoma
FLNB::FGR	Adenocarcinoma
FLNB::GON4L	Adenocarcinoma
FLNB::RAD18	Adenocarcinoma
FLNB::RHBDF1	Transitional cell carcinoma
FLNB::SLMAP	Adenocarcinoma
FLNB::VPS8	Adenocarcinoma
FLOT2::ERBB2	Carcinoma, NOS
FLOT2::MYO18A	Adenocarcinoma
FLOT2::PEX12	Adenocarcinoma
FLOT2::PHF12	Adenocarcinoma
FLOT2::RAD51B	Adenocarcinoma
FLOT2::SUPT6H	Adenocarcinoma
FLRT3::SEL1L2	Adenocarcinoma
FLT1::HMGB1	Adenocarcinoma
FLT1::STAU1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
FLT3::ETV6	Acute myelomonocytic leukemia (FAB type M4)
FLT3::FLT3	Acute megakaryoblastic leukemia (FAB type M7)
FLT3LG::ALDH16A1	Squamous cell carcinoma
FLT3LG::RPS11	Acute myelomonocytic leukemia (FAB type M4) | Skin | Acute myeloid leukemia, NOS
FLVCR1::TATDN3	Osteosarcoma, NOS
FLVCR2::BATF	Adenocarcinoma
FLVCR2::JDP2	Adenocarcinoma
FLYWCH1::FAR1	Adenocarcinoma
FLYWCH1::TVP23A	Adenocarcinoma
FLYWCH2::SLC37A3	Adenocarcinoma
FMN1::AVEN	Malignant melanoma
FMN1::COL22A1	Adenocarcinoma
FMN1::KANSL1	Malignant melanoma
FMN1::PATL2	Adenocarcinoma
FMN1::SNAP23	Malignant melanoma
FMN1::SNRPN	Adenocarcinoma
FMN1::TRPM1	Malignant melanoma
FMN1::UBALD2	Malignant melanoma
FMN2::CHCHD6	Adenocarcinoma
FMNL1::NMT1	Adenocarcinoma
FMNL2::GALNT13	Adenocarcinoma
FMNL2::GPBAR1	Adenocarcinoma
FMNL2::KRT32	Adenocarcinoma
FMNL2::NTAQ1	Adenocarcinoma
FMNL3::AGAP2	Mesenchymal tumor, NOS
FMNL3::CPNE8	Malignant melanoma
FMNL3::HECTD4	Mesenchymal tumor, NOS
FMNL3::TUBA1B	Astrocytoma, grade III-IV/Glioblastoma
FMO2::MROH9	Squamous cell carcinoma
FMOD::ARFGEF2	Adenocarcinoma
FMOD::THSD4	Adenocarcinoma
FMR1::AFF2	Astrocytoma, grade I-II
FMR1::ALK	Soft tissue tumor, special type | Mesenchymal tumor, special type
FN1::ACVR2A	Osteochondroma | Chondrosarcoma, NOS | Synovial chondromatosis
FN1::ALK	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma | Mesenchymal tumor, special type | Leiomyoma
FN1::ARFGEF2	Adenocarcinoma
FN1::ATP2B4	Adenocarcinoma
FN1::EGF	Fibroblastic/myofibroblastic tumor, special type
FN1::EIF2AK2	Adenocarcinoma
FN1::FGF1	Mesenchymal tumor, special type
FN1::FGFR1	Soft tissue tumor, special type | Osteogenic/bone tumor, special type | Mesenchymal tumor, special type
FN1::FGFR2	Mesenchymal tumor, special type | Soft tissue tumor, special type
FN1::FGFR3	Mesenchymal tumor, special type
FN1::IGF1R	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma
FN1::MERTK	Soft tissue tumor, special type
FN1::NFATC2	Synovial chondromatosis
FN1::NTRK1	Soft tissue tumor, special type
FN1::NUBP1	Localized giant cell tumor of tendon sheath
FN1::PDGFRB	Soft tissue tumor, special type
FN1::PECR	Squamous cell carcinoma
FN1::PRG4	Localized giant cell tumor of tendon sheath | Soft tissue tumor, special type
FN1::ROS1	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma
FN1::TEK	Soft tissue tumor, special type
FN1::TGFA	Fibroblastic/myofibroblastic tumor, special type
FN1::TIMP1	Vascular and perivascular tumor, NOS
FN1::UTRN	Squamous cell carcinoma
FN1::WDSUB1	Adenocarcinoma
FN1::ZNFX1	Transitional cell carcinoma
FN3K::HEXD	Adenocarcinoma
FN3K::MYO16	Squamous cell carcinoma
FN3KRP::KCNQ1	Adenocarcinoma
FNBP1::BRAF	Malignant melanoma
FNBP1::KMT2A	Acute myeloid leukemia, NOS | Skin
FNBP1L::CHFR	Adenocarcinoma
FNBP1L::DR1	Transitional cell carcinoma
FNBP1L::EFCAB8	Squamous cell carcinoma
FNBP1L::NAV2	Squamous cell carcinoma
FNBP1L::NCR2	Adenocarcinoma
FNBP1L::ZNF605	Adenocarcinoma
FNBP4::INSL3	Adenocarcinoma
FNBP4::MYBPC3	Adenocarcinoma
FNBP4::NECTIN1	Squamous cell carcinoma
FNBP4::SVIL	Transitional cell carcinoma
FNDC11::PTK6	Adenocarcinoma
FNDC3A::DGLUCY	Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
FNDC3A::HIPK2	Multiple myeloma
FNDC3A::LPAR6	Mesenchymal tumor, NOS
FNDC3A::RB1	Adenocarcinoma
FNDC3A::ZMYM2	Adenocarcinoma
FNDC3B::ATP13A4	Adenocarcinoma
FNDC3B::BCHE	Adenocarcinoma
FNDC3B::BCL6	Skin | Acute myeloid leukemia, NOS
FNDC3B::CLDN11	Transitional cell carcinoma
FNDC3B::EMP3	Transitional cell carcinoma
FNDC3B::FGF12	Mesenchymal tumor, NOS
FNDC3B::KHDRBS3	Adenocarcinoma
FNDC3B::KLF13	Squamous cell carcinoma
FNDC3B::MECOM	Skin | Acute myeloid leukemia, NOS
FNDC3B::NAALADL2	Squamous cell carcinoma
FNDC3B::NLGN1	Adenocarcinoma
FNDC3B::PGM5	Malignant melanoma
FNDC3B::PIK3CA	Adenocarcinoma | Fibrosarcoma
FNDC3B::PRKCI	Adenocarcinoma
FNDC3B::RARA	Acute promyelocytic leukemia (FAB type M3)
FNDC3B::RARB	Acute promyelocytic leukemia (FAB type M3)
FNDC3B::SLC7A14	Squamous cell carcinoma
FNDC3B::SPATA16	Squamous cell carcinoma
FNDC3B::SUCNR1	Malignant melanoma
FNDC3B::TMEM212	Adenocarcinoma
FNDC3B::TNIK	Adenocarcinoma
FNDC3B::TPRG1	Squamous cell carcinoma
FNDC3B::UCK2	Adenocarcinoma
FNIP1::ACSL6	Transitional cell carcinoma | Adenocarcinoma
FNIP1::AHDC1	Malignant epithelial tumor, special type
FNIP1::CYP3A4	Adenocarcinoma
FNIP1::FBXO38	Adenocarcinoma
FNIP1::IL5	Transitional cell carcinoma
FNIP1::MEIKIN	Adenocarcinoma
FNIP1::SUSD4	Adenocarcinoma
FNIP2::EXOC4	Mesenchymal tumor, NOS
FNIP2::LARP7	Adenocarcinoma
FNIP2::LRAT	Adenocarcinoma
FNIP2::LRBA	Adenocarcinoma
FNIP2::RXFP1	Malignant epithelial tumor, special type
FNIP2::SHISAL2A	Astrocytoma, grade I-II
FNIP2::SLC35A3	Adenocarcinoma
FNTA::KMT2C	Adenocarcinoma
FNTA::OVOL1	Adenocarcinoma
FNTA::SPIDR	Adenocarcinoma
FNTA::ZMAT4	Adenocarcinoma
FNTB::MNAT1	Squamous cell carcinoma
FNTB::PEBP4	Adenocarcinoma
FNTB::RAB15	Adenocarcinoma
FOCAD::C10ORF90	Adenocarcinoma
FOCAD::C10orf90	Adenocarcinoma
FOCAD::CD2	Adenocarcinoma
FOCAD::CDKN2A	Squamous cell carcinoma
FOCAD::DENND4C	Adenocarcinoma
FOCAD::ELAVL2	Squamous cell carcinoma
FOCAD::FBXO10	Adenocarcinoma
FOCAD::GGT5	Adenocarcinoma
FOCAD::HABP4	Malignant epithelial tumor, special type
FOCAD::HACD4	Adenocarcinoma
FOCAD::IFT74	Malignant melanoma
FOCAD::MOB3B	Astrocytoma, grade III-IV/Glioblastoma
FOCAD::PDZRN4	Adenocarcinoma
FOCAD::PSIP1	Adenocarcinoma
FOCAD::UQCC5	Malignant melanoma
FOS::ANKH	Osteoblastoma | Osteoid osteoma
FOS::CEMIP	Osteoid osteoma
FOS::GLI1	Malignant soft tissue tumor, NOS
FOS::IGK	Multiple myeloma
FOS::LMNA	Epithelioid hemangioendothelioma | Vascular and perivascular tumor, special type
FOS::MBNL1	Epithelioid hemangioendothelioma
FOS::MYO1B	Osteoid osteoma
FOS::RUNX2	Osteoblastoma
FOS::VIM	Vascular and perivascular tumor, special type | Epithelioid hemangioendothelioma
FOSB::BBC3	Multiple myeloma
FOSB::DDX5	Multiple myeloma
FOSB::IGH	Multiple myeloma
FOSB::IGK	Multiple myeloma
FOSB::ITPKC	Squamous cell carcinoma
FOSB::KLF6	Multiple myeloma
FOSB::UBC	Multiple myeloma
FOSB::YPEL5	Multiple myeloma
FOSL1::JPT1	Transitional cell carcinoma
FOSL1::SYT7	Malignant melanoma
FOSL2::BABAM2	Squamous cell carcinoma | Adenocarcinoma
FOSL2::PPDPF	Squamous cell carcinoma
FOSL2::RUNX1	Acute myeloid leukemia, NOS | Skin
FOSL2::SNX17	Adenocarcinoma
FOSL2::USP6	Aneurysmal bone cyst
FOXA1::AIMP1	Adenocarcinoma
FOXA1::MIPOL1	Adenocarcinoma
FOXA3::RGS6	Squamous cell carcinoma
FOXG1::NPAS3	Squamous cell carcinoma
FOXJ2::LPCAT3	Squamous cell carcinoma
FOXJ2::MEF2D	Acute lymphoblastic leukemia/lymphoblastic lymphoma
FOXJ3::CAMTA1	Adenocarcinoma
FOXJ3::CLIC6	Adenocarcinoma
FOXJ3::EIF4G3	Adenocarcinoma
FOXJ3::ELAVL4	Adenocarcinoma
FOXJ3::EVL	Adenocarcinoma
FOXJ3::HIVEP3	Germ cell tumor, NOS
FOXJ3::LMO2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
FOXJ3::LRRC41	Adenocarcinoma
FOXJ3::PGM1	Adenocarcinoma
FOXJ3::RCOR1	Mesenchymal tumor, NOS
FOXJ3::SCMH1	Adenocarcinoma
FOXJ3::SVBP	Transitional cell carcinoma | Adenocarcinoma
FOXJ3::TUFT1	Adenocarcinoma
FOXJ3::ZFYVE9	Adenocarcinoma
FOXJ3::ZMYND12	Malignant epithelial tumor, special type
FOXJ3::ZNF362	Adenocarcinoma
FOXK1::GRHL1	Benign epithelial tumor, special type
FOXK1::GRHL2	Benign epithelial tumor, special type
FOXK1::RNPEP	Adenocarcinoma
FOXK1::SDK1	Adenocarcinoma
FOXK1::THSD7A	Malignant melanoma
FOXK1::ZNF671	Adenocarcinoma
FOXK2::ABCA5	Adenocarcinoma
FOXK2::ABR	Mesenchymal tumor, NOS
FOXK2::AMBRA1	Squamous cell carcinoma
FOXK2::APOBEC1	Mesenchymal tumor, NOS
FOXK2::ARFGAP1	Adenocarcinoma
FOXK2::ASIP	Multiple myeloma
FOXK2::CHRM4	Squamous cell carcinoma
FOXK2::CLIP2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
FOXK2::FN3KRP	Squamous cell carcinoma
FOXK2::GNG7	Adenocarcinoma
FOXK2::HEXD	Undifferentiated carcinoma, small cell | Adenocarcinoma
FOXK2::LONP2	Adenocarcinoma
FOXK2::MADCAM1	Adenocarcinoma
FOXK2::MS4A12	Malignant melanoma
FOXK2::MYO18A	Adenocarcinoma
FOXK2::NARF	Adenocarcinoma
FOXK2::OGFOD3	Transitional cell carcinoma
FOXK2::PITPNC1	Adenocarcinoma
FOXK2::PTPRN2	Adenocarcinoma
FOXK2::RNF213	Adenocarcinoma
FOXK2::SKAP1	Adenocarcinoma
FOXK2::SPECC1	Mesenchymal tumor, NOS
FOXK2::TNFSF13	Adenocarcinoma
FOXK2::TP63	Anaplastic large cell lymphoma, cutaneous type
FOXL2NB::PROS1	Malignant melanoma
FOXM1::ANO2	Malignant epithelial tumor, special type
FOXM1::DCP1B	Adenocarcinoma
FOXM1::SLC2A14	Astrocytoma, grade III-IV/Glioblastoma
FOXN1::PRKDC	Squamous cell carcinoma
FOXN2::PLB1	Squamous cell carcinoma
FOXN2::SPTBN1	Squamous cell carcinoma
FOXN3::BRAF	Soft tissue tumor, special type
FOXN3::CDKL1	Adenocarcinoma
FOXN3::KCNQ1	Adenocarcinoma
FOXN3::SLC25A21	Adenocarcinoma
FOXO1::ELF1	Squamous cell carcinoma
FOXO1::FGFR1	Alveolar rhabdomyosarcoma
FOXO1::MRPS31	Adenocarcinoma
FOXO1::PDGFRB	Adenocarcinoma
FOXO1::STK24	Ependymoma
FOXO1::WDFY2	Adenocarcinoma
FOXO3::AFG1L	Adenocarcinoma
FOXO3::CHD7	Adenocarcinoma
FOXO3::FXR1	Adenocarcinoma
FOXO3::GMDS	Adenocarcinoma
FOXO3::PPP1R9A	Adenocarcinoma
FOXO4::OGT	Soft tissue tumor, special type
FOXP1::ABL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
FOXP1::ACTN4	Diffuse large B-cell lymphoma
FOXP1::ACTR3B	Adenocarcinoma
FOXP1::ARMC8	Adenocarcinoma
FOXP1::BIRC3	Diffuse large B-cell lymphoma
FOXP1::COQ10B	Adenocarcinoma
FOXP1::EIF4E3	Adenocarcinoma
FOXP1::ETV1	Adenocarcinoma
FOXP1::FHIT	Miscellaneous hematopoietic/lymphoid neoplasm, special type | Benign epithelial tumor, special type
FOXP1::HOXA10	Acute myelomonocytic leukemia (FAB type M4)
FOXP1::HRH1	Adenocarcinoma
FOXP1::IGH	Diffuse large B-cell lymphoma
FOXP1::NF2	Acute myeloid leukemia, NOS | Skin
FOXP1::PDGFRA	Chronic eosinophilic leukemia/hypereosinophilic syndrome
FOXP1::PPP1R2	Acute myeloblastic leukemia with maturation (FAB type M2)
FOXP1::PTPRD	Adenocarcinoma
FOXP1::PXDNL	Squamous cell carcinoma
FOXP1::RIMOC1	Adenocarcinoma
FOXP1::RTL5	Adenocarcinoma
FOXP1::RUFY1	Adenocarcinoma
FOXP1::SH3RF2	Adenocarcinoma
FOXP1::UBA3	Squamous cell carcinoma
FOXP1::UGGT1	Adenocarcinoma
FOXP1::ZNF860	Mature B-cell neoplasm, NOS
FOXP2::CAV2	Adenocarcinoma
FOXP2::ENKUR	Adenocarcinoma
FOXP2::EPM2A	Mesenchymal tumor, NOS
FOXP2::MET	Myxofibrosarcoma | Carcinoma, NOS
FOXP2::ZNF680	Adenocarcinoma
FOXP4::CCND3	Squamous cell carcinoma
FOXP4::DNAH8	Adenocarcinoma
FOXP4::GUCA1A	Adenocarcinoma
FOXP4::UBR2	Adenocarcinoma
FOXRED2::IFT27	Adenocarcinoma
FPGS::GARNL3	Adenocarcinoma
FRA10AC1::GCA	Adenocarcinoma
FRA10AC1::PDE6C	Adenocarcinoma
FRAS1::ART3	Malignant epithelial tumor, special type
FRAS1::CCSER1	Adenocarcinoma
FRAS1::DCK	Adenocarcinoma
FRAS1::MGMT	Adenocarcinoma
FRAS1::MGST2	Adenocarcinoma
FRAS1::MOB1B	Adenocarcinoma
FRAS1::MRPL1	Squamous cell carcinoma
FRAS1::SHROOM3	Adenocarcinoma
FREM1::SLAMF7	Transitional cell carcinoma
FREM1::UNC13B	Transitional cell carcinoma
FREM2::MTRF1	Astrocytoma, grade III-IV/Glioblastoma
FREM2::SNAP29	Malignant melanoma
FRK::BEND3	Adenocarcinoma
FRK::DTNBP1	Adenocarcinoma
FRK::PPP1R36	Adenocarcinoma
FRK::SYT1	Mesenchymal tumor, NOS
FRMD3::BRD4	Adenocarcinoma
FRMD3::U2AF1	Malignant epithelial tumor, special type
FRMD4A::APBB1IP	Malignant melanoma
FRMD4A::FAM107B	Mesothelioma
FRMD4A::MALRD1	Astrocytoma, grade I-II
FRMD4A::MCM10	Adenocarcinoma
FRMD4A::OR13A1	Astrocytoma, grade I-II
FRMD4A::PLXDC2	Malignant melanoma
FRMD4A::PTEN	Adenocarcinoma
FRMD4A::RET	Carcinoma, NOS
FRMD4A::TMEM45B	Adenocarcinoma
FRMD4B::ABCA5	Malignant melanoma
FRMD4B::DAZL	Malignant melanoma
FRMD4B::LMOD3	Adenocarcinoma
FRMD4B::OXCT1	Adenocarcinoma
FRMD4B::PPP2R3A	Squamous cell carcinoma
FRMD4B::TRAK1	Adenocarcinoma
FRMD5::AGO3	Adenocarcinoma
FRMD5::ARNT2	Astrocytoma, grade I-II
FRMD5::MFAP1	Adenocarcinoma
FRMD6::ABHD12B	Squamous cell carcinoma
FRMD6::BPIFB1	Squamous cell carcinoma
FRMD6::GNG2	Mesothelioma
FRMD6::PLAG1	Adenocarcinoma
FRMD6::RTN4	Transitional cell carcinoma
FRMD6::SCFD1	Adenocarcinoma
FRMD8::DPF2	Adenocarcinoma
FRMD8::MARK2	Adenocarcinoma
FRMD8::MAST1	Adenocarcinoma
FRMD8::MUC6	Adenocarcinoma
FRMD8::PACS1	Squamous cell carcinoma
FRMD8::POLA2	Squamous cell carcinoma
FRMD8::PSMD9	Adenocarcinoma
FRMD8::VPS51	Adenocarcinoma
FRMPD3::PRPS1	Astrocytoma, grade I-II
FRRS1::PALMD	Transitional cell carcinoma
FRS2::ACSS2	Adenocarcinoma
FRS2::ACSS3	Mesenchymal tumor, NOS
FRS2::ADGRE1	Mesenchymal tumor, NOS
FRS2::AKAP12	Mesenchymal tumor, NOS
FRS2::ATXN1	Mesenchymal tumor, NOS
FRS2::AVIL	Mesenchymal tumor, NOS
FRS2::BEST3	Transitional cell carcinoma
FRS2::C1orf141	Mesenchymal tumor, NOS
FRS2::CFAP54	Mesenchymal tumor, NOS
FRS2::CHMP1A	Mesenchymal tumor, NOS
FRS2::COP1	Mesenchymal tumor, NOS
FRS2::CPM	Mesenchymal tumor, NOS
FRS2::DNM2	Mesenchymal tumor, NOS
FRS2::DRAM1	Transitional cell carcinoma
FRS2::DTX3	Astrocytoma, grade III-IV/Glioblastoma
FRS2::FBRSL1	Mesenchymal tumor, NOS
FRS2::GLI1	Astrocytoma, grade III-IV/Glioblastoma
FRS2::GLIPR1L2	Mesenchymal tumor, NOS
FRS2::GRIP1	Astrocytoma, grade I-II
FRS2::HMGA2	Mesenchymal tumor, NOS
FRS2::KICS2	Mesenchymal tumor, NOS
FRS2::KIF5A	Astrocytoma, grade III-IV/Glioblastoma
FRS2::LACRT	Transitional cell carcinoma
FRS2::LEMD3	Mesenchymal tumor, NOS | Squamous cell carcinoma
FRS2::LYZ	Adenocarcinoma
FRS2::MDM1	Adenocarcinoma
FRS2::MDM2	Adenocarcinoma
FRS2::MMP19	Adenocarcinoma
FRS2::MSRB3	Astrocytoma, grade III-IV/Glioblastoma
FRS2::NELL2	Astrocytoma, grade III-IV/Glioblastoma
FRS2::NRG3	Adenocarcinoma
FRS2::NTN4	Adenocarcinoma
FRS2::NUP107	Transitional cell carcinoma
FRS2::OS9	Adenocarcinoma
FRS2::OSBPL8	Adenocarcinoma
FRS2::PARP1	Mesenchymal tumor, NOS
FRS2::PIP4K2C	Adenocarcinoma
FRS2::PLEKHG7	Mesenchymal tumor, NOS
FRS2::PPP1R9A	Adenocarcinoma
FRS2::PTPRB	Adenocarcinoma
FRS2::PTPRQ	Mesenchymal tumor, NOS
FRS2::PTPRR	Transitional cell carcinoma | Mesenchymal tumor, NOS
FRS2::RAP1B	Adenocarcinoma
FRS2::RASSF3	Adenocarcinoma
FRS2::RER1	Mesenchymal tumor, NOS
FRS2::SBF2	Mesenchymal tumor, NOS
FRS2::SBNO1	Mesenchymal tumor, NOS
FRS2::SCAF11	Transitional cell carcinoma
FRS2::TBC1D15	Mesenchymal tumor, NOS
FRS2::TBC1D30	Mesenchymal tumor, NOS
FRS2::TBK1	Mesenchymal tumor, NOS
FRS2::THEMIS	Mesenchymal tumor, NOS
FRS2::TMTC2	Mesenchymal tumor, NOS
FRS2::TSPAN8	Adenocarcinoma
FRS2::ZFC3H1	Mesenchymal tumor, NOS
FRYL::CNGA1	Adenocarcinoma
FRYL::CORIN	Adenocarcinoma
FRYL::DTD1	Adenocarcinoma
FRYL::KMT2A	Skin | Acute myeloid leukemia, NOS
FRYL::LCORL	Squamous cell carcinoma
FRYL::LNX1	Adenocarcinoma
FRYL::NKAIN3	Transitional cell carcinoma
FRYL::OCIAD2	Adenocarcinoma
FRYL::SH2D1A	Adenocarcinoma
FRYL::TAFA2	Adenocarcinoma
FRYL::UNC13B	Mesenchymal tumor, NOS
FRYL::ZNF606	Adenocarcinoma
FSCN1::CD36	Astrocytoma, grade III-IV/Glioblastoma
FSCN1::EIF2AK1	Transitional cell carcinoma
FSCN1::FAR1	Squamous cell carcinoma
FSCN1::FBXL18	Squamous cell carcinoma
FSD1::SHD	Adenocarcinoma
FSD1L::ADAMTS13	Adenocarcinoma
FSD1L::OTUD7B	Mesenchymal tumor, NOS
FSIP1::GPR176	Embryonal nervous system tumor, special type
FSTL1::CPOX	Mesenchymal tumor, NOS
FSTL3::CCND1	Chronic lymphocytic leukemia
FSTL4::SIL1	Adenocarcinoma
FSTL4::SLC22A4	Transitional cell carcinoma
FSTL4::SLIT3	Adenocarcinoma
FTCD::SPATC1L	Adenocarcinoma
FTH1::EIF5A	Adenocarcinoma
FTH1::RAB1A	Adenocarcinoma
FTL::ADD3	Adenocarcinoma
FTL::CLU	Adenocarcinoma | Astrocytoma, grade III-IV/Glioblastoma
FTL::FADS2	Adenocarcinoma
FTL::IGK	Multiple myeloma
FTL::KBTBD2	Adenocarcinoma
FTL::MYH9	Adenocarcinoma
FTL::SFTPA2	Adenocarcinoma
FTL::SPP1	Astrocytoma, grade III-IV/Glioblastoma
FTO::LITAF	Multiple myeloma
FTO::RBL2	Adenocarcinoma
FTO::TMEM231	Transitional cell carcinoma
FTO::ZNF423	Adenocarcinoma
FTO::ZNF536	Squamous cell carcinoma
FTSJ1::QTRT1	Malignant epithelial tumor, special type
FTSJ3::SCN4A	Adenocarcinoma
FUBP1::DNAJB4	Adenocarcinoma
FUBP1::ETV1	Adenocarcinoma
FUBP1::LRRC7	Adenocarcinoma
FUBP1::SLC44A5	Adenocarcinoma
FUBP1::TFE3	Adenocarcinoma
FUBP3::CDADC1	Adenocarcinoma
FUCA1::TCEA3	Adenocarcinoma
FUOM::DOCK1	Adenocarcinoma
FUS::ATF1	Mesothelioma | Angiomatoid fibrous histiocytoma
FUS::CHD1	Adenocarcinoma
FUS::CREB3L1	Low-grade fibromyxoid sarcoma
FUS::CREB3L2	Low-grade fibromyxoid sarcoma | Sclerosing epithelioid fibrosarcoma | Fibrosarcoma
FUS::CREM	Sclerosing epithelioid fibrosarcoma | Malignant epithelial tumor, special type | Mesenchymal tumor, special type | Angiomatoid fibrous histiocytoma | Soft tissue tumor, NOS | Soft tissue tumor, special type
FUS::DDIT3	Liposarcoma, pleomorphic | Liposarcoma, myxoid/round cell | Atypical lipomatous tumor/atypical lipoma/well-differentiated liposarcoma
FUS::ERG	Acute monoblastic leukemia without differentiation (FAB type M5a) | Acute myeloid leukemia, NOS | Acute myeloblastic leukemia with maturation (FAB type M2) | Acute myelomonocytic leukemia (FAB type M4) | Skin | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Acute monoblastic leukemia (FAB type M5) | Acute myeloblastic leukemia without maturation (FAB type M1) | Acute megakaryoblastic leukemia (FAB type M7) | Ewing sarcoma | Refractory anemia with excess blasts-1 | Acute monoblastic leukemia with differentiation (FAB type M5b)
FUS::ETV1	Soft tissue tumor, NOS
FUS::ETV4	Ewing sarcoma
FUS::FEV	Ewing sarcoma | Skin | Acute myeloid leukemia, NOS
FUS::FLI1	Acute myeloid leukemia, NOS | Ewing sarcoma | Skin
FUS::IL9R	Adenocarcinoma
FUS::KAT8	Adenocarcinoma
FUS::KLF17	Myoepithelioma/myoepithelial carcinoma/mixed tumor
FUS::MYB	Adenoid cystic carcinoma
FUS::NACC1	Malignant soft tissue tumor, NOS | Soft tissue tumor, special type
FUS::NFATC2	Vascular and perivascular tumor, special type | Aneurysmal bone cyst | Osteogenic/bone tumor, special type | Undifferentiated round cell sarcoma | Ewing sarcoma
FUS::NFATC4	Undifferentiated round cell sarcoma
FUS::NR4A3	Chondrosarcoma, myxoid
FUS::POU2AF3	Soft tissue tumor, special type
FUS::POU5F1	Myoepithelioma/myoepithelial carcinoma/mixed tumor
FUS::PRSS36	Squamous cell carcinoma
FUS::PYCARD	Adenocarcinoma
FUS::SET	Acute lymphoblastic leukemia/lymphoblastic lymphoma
FUS::TFCP2	Rhabdomyosarcoma, NOS | Spindle cell/sclerosing rhabdomyosarcoma
FUS::TMEM114	Adenocarcinoma
FUT10::CSMD1	Adenocarcinoma
FUT10::GAB2	Adenocarcinoma
FUT10::NDUFV2	Adenocarcinoma
FUT10::NRG1	Adenocarcinoma
FUT10::RNF122	Squamous cell carcinoma
FUT10::TDRP	Adenocarcinoma
FUT2::RASIP1	Malignant epithelial tumor, special type
FUT8::AGBL4	Adenocarcinoma
FUT8::CCDC85C	Adenocarcinoma
FUT8::FNTB	Adenocarcinoma
FUT8::PCNX1	Astrocytoma, grade III-IV/Glioblastoma
FUT8::SIPA1L1	Astrocytoma, grade I-II
FUT9::FBXO21	Adenocarcinoma
FUZ::ZNF528	Astrocytoma, grade III-IV/Glioblastoma
FXN::SMC5	Adenocarcinoma
FXR1::BRAF	Astrocytoma, pilocytic/juvenile
FXR1::FGF10	Squamous cell carcinoma
FXR1::KLHL24	Squamous cell carcinoma
FXR1::MCCC1	Squamous cell carcinoma
FXR1::NAALADL2	Squamous cell carcinoma
FXR1::RIMS2	Adenocarcinoma
FXR1::RPH3A	Adenocarcinoma
FXR1::ST6GAL1	Adenocarcinoma
FXR1::TBL1XR1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
FXR1::ZFYVE16	Adenocarcinoma
FXR2::CAB39L	Mesenchymal tumor, NOS
FXR2::TARBP1	Adenocarcinoma
FXR2::TP53	Germ cell tumor, NOS
FXYD3::FAR1	Adenocarcinoma
FXYD3::TARM1	Transitional cell carcinoma
FXYD3::ZNFX1	Transitional cell carcinoma
FXYD5::FXYD3	Adenocarcinoma | Mesothelioma
FXYD5::HNRNPUL1	Adenocarcinoma
FXYD6::CD3G	Adenocarcinoma
FXYD6::KMT2A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
FXYD6::OSBP2	Astrocytoma, grade I-II
FXYD6::ZEB2	Astrocytoma, grade I-II
FYCO1::ATG7	Adenocarcinoma
FYCO1::RAF1	Astrocytoma, grade I-II | Astrocytoma, pilocytic/juvenile
FYCO1::RET	Adenocarcinoma
FYN::CDK19	Malignant melanoma
FYN::LAMA4	Adenocarcinoma
FYN::TRAF3IP2	Adenocarcinoma
FYTTD1::ALDH1A3	Astrocytoma, grade I-II
FYTTD1::DDOST	Adenocarcinoma
FYTTD1::DNAJC7	Adenocarcinoma
FYTTD1::IFIT1	Adenocarcinoma
FYTTD1::RPL35A	Squamous cell carcinoma
FYTTD1::WRN	Squamous cell carcinoma
FZD4::LAMTOR1	Adenocarcinoma
FZD6::BAALC	Squamous cell carcinoma
FZD6::DPYS	Transitional cell carcinoma
FZD6::SDC2	Adenocarcinoma
FZD6::SDCCAG8	Malignant melanoma
FZR1::CELF5	Adenocarcinoma
FZR1::CNN1	Squamous cell carcinoma
FZR1::GNG7	Squamous cell carcinoma
FZR1::MAN2B1	Malignant melanoma
FZR1::MFSD12	Malignant melanoma
FZR1::NCLN	Adenocarcinoma
FZR1::NFIC	Adenocarcinoma
FZR1::TBC1D17	Astrocytoma, grade I-II
FZR1::ZBTB7A	Multiple myeloma
G2E3::AP4S1	Adenocarcinoma
G2E3::NAP1L1	Adenocarcinoma
G3BP1::GLRA1	Adenocarcinoma
G3BP1::LMNB1	Adenocarcinoma
G3BP1::PCDH9	Squamous cell carcinoma
G3BP1::PDE4D	Malignant melanoma
G3BP1::SLC36A1	Squamous cell carcinoma
G3BP2::NAAA	Adenocarcinoma
G3BP2::PTPN1	Adenocarcinoma
G6PD::F8	Adenocarcinoma
G6PD::STAT6	Adenocarcinoma
GAB1::ABL1	Soft tissue tumor, special type | Perineurioma | Angiofibroma
GAB1::ABL2	Glioma, NOS
GAB1::PPP2R2C	Adenocarcinoma
GAB2::AAMDC	Adenocarcinoma
GAB2::ALG8	Adenocarcinoma
GAB2::BRAF	Histiocytic sarcoma/malignant histiocytosis
GAB2::CHKA	Adenocarcinoma
GAB2::ELMO2	Malignant melanoma
GAB2::FGF7	Malignant melanoma
GAB2::LRRC32	Adenocarcinoma
GAB2::MYO7A	Adenocarcinoma
GAB2::NARS2	Undifferentiated carcinoma, small cell
GAB2::NUDC	Malignant melanoma
GAB2::PLXDC1	Adenocarcinoma
GAB2::PTPRT	Malignant melanoma
GAB2::TENM4	Adenocarcinoma
GAB2::THRSP	Adenocarcinoma
GAB2::TRIP12	Malignant melanoma
GABARAP::GPS2	Squamous cell carcinoma
GABARAP::MYOCD	Adenocarcinoma
GABARAP::NUP205	Adenocarcinoma
GABBR2::ANKS6	Adenocarcinoma
GABPA::JAM2	Adenocarcinoma
GABPB1::AFG2B	Adenocarcinoma
GABPB1::B2M	Multiple myeloma
GABPB1::CCDC9B	Malignant melanoma
GABPB1::CSNK1G3	Adenocarcinoma
GABPB1::GALK2	Adenocarcinoma
GABPB1::LMCD1	Carcinoma, NOS
GABPB1::TRPM7	Transitional cell carcinoma
GABPB2::BNIPL	Adenocarcinoma
GABPB2::MLLT11	Adenocarcinoma
GABPB2::OR10J1	Adenocarcinoma
GABPB2::PRUNE1	Adenocarcinoma
GABRA3::DIAPH2	Adenocarcinoma
GABRA3::SARNP	Malignant melanoma
GABRA5::CCN3	Adenocarcinoma
GABRB3::TJP1	Adenocarcinoma
GABRE::SERINC2	Transitional cell carcinoma
GABRG1::DHX8	Malignant melanoma
GABRG3::OCA2	Squamous cell carcinoma
GABRG3::RET	Adenocarcinoma
GABRP::KCNIP1	Adenocarcinoma | Squamous cell carcinoma
GABRP::RANBP17	Adenocarcinoma
GABRR2::ME1	Squamous cell carcinoma
GADD45B::IGK	Multiple myeloma
GADD45GIP1::CSTF1	Adenocarcinoma
GADD45GIP1::DAND5	Adenocarcinoma
GADL1::RET	Carcinoma, NOS
GAGE2E::GLOD5	Adenocarcinoma
GAK::LUC7L3	Transitional cell carcinoma
GAK::MAGI1	Adenocarcinoma
GAK::MEX3D	Adenocarcinoma
GAK::SPON2	Transitional cell carcinoma
GALE::PITHD1	Adenocarcinoma
GALK2::MAPK6	Adenocarcinoma
GALK2::NAPSA	Adenocarcinoma
GALK2::RAB11A	Acute myeloblastic leukemia without maturation (FAB type M1)
GALK2::TERB2	Squamous cell carcinoma
GALM::HDDC2	Diffuse large B-cell lymphoma
GALNS::TSNAXIP1	Astrocytoma, grade III-IV/Glioblastoma
GALNT10::FAXDC2	Adenocarcinoma
GALNT10::IQCA1	Adenocarcinoma
GALNT11::ABCB8	Adenocarcinoma
GALNT11::CNTNAP2	Squamous cell carcinoma
GALNT11::DPP6	Adenocarcinoma
GALNT11::EZH2	Adenocarcinoma
GALNT11::FKBP3	Adenocarcinoma
GALNT11::LMBR1	Malignant melanoma
GALNT11::ORAI1	Adenocarcinoma
GALNT11::PRKAG2	Adenocarcinoma
GALNT11::PTPRN2	Mesenchymal tumor, NOS
GALNT12::MEGF9	Adenocarcinoma
GALNT12::ROR2	Mesenchymal tumor, NOS
GALNT13::SMYD1	Mesenchymal tumor, NOS
GALNT14::BABAM2	Adenocarcinoma
GALNT14::FAM98A	Adenocarcinoma
GALNT14::FHIT	Adenocarcinoma
GALNT14::NRXN1	Adenocarcinoma
GALNT14::SF3B6	Adenocarcinoma
GALNT16::DOCK1	Adenocarcinoma
GALNT16::RAD51B	Adenocarcinoma
GALNT17::AUTS2	Malignant epithelial tumor, special type
GALNT17::PPP1R9A	Astrocytoma, grade III-IV/Glioblastoma
GALNT18::BECN1	Transitional cell carcinoma
GALNT18::DENND2B	Squamous cell carcinoma
GALNT18::DENND5B	Adenocarcinoma
GALNT18::E2F8	Adenocarcinoma
GALNT18::IER3IP1	Transitional cell carcinoma
GALNT18::PPP1R1B	Adenocarcinoma
GALNT18::PRDM2	Malignant melanoma
GALNT18::TH	Malignant epithelial tumor, special type
GALNT1::TAF4B	Astrocytoma, grade I-II
GALNT2::AFG1L	Adenocarcinoma
GALNT2::EYS	Squamous cell carcinoma
GALNT2::IGF2	Adenocarcinoma
GALNT2::KIF26B	Adenocarcinoma
GALNT2::PGBD5	Adenocarcinoma
GALNT2::PRKCQ	Adenocarcinoma
GALNT2::RGS7	Malignant melanoma
GALNT3::TTC21B	Adenocarcinoma
GALNT7::CEP44	Adenocarcinoma
GALNT7::GAB1	Adenocarcinoma
GALNT7::ORC4	Adenocarcinoma
GALNT7::SAP30	Adenocarcinoma | Squamous cell carcinoma
GALNT7::SPCS3	Adenocarcinoma
GALNT7::TTC29	Adenocarcinoma
GALT::WDR72	Mesenchymal tumor, NOS
GAN::GRM7	Squamous cell carcinoma
GANAB::LBHD1	Adenocarcinoma
GANAB::SLC22A8	Adenocarcinoma
GANAB::SSRP1	Adenocarcinoma
GANAB::STXBP5L	Undifferentiated carcinoma, small cell
GANAB::UBXN1	Adenocarcinoma
GANAB::ZNF76	Adenocarcinoma
GANC::RORA	Transitional cell carcinoma
GANC::SNAP23	Adenocarcinoma
GAPDH::ACTB	Squamous cell carcinoma
GAPDH::APOA2	Adenocarcinoma
GAPDH::BCL6	Diffuse large B-cell lymphoma
GAPDH::COL3A1	Squamous cell carcinoma
GAPDH::HSPB1	Malignant melanoma
GAPDH::KRT13	Adenocarcinoma
GAPDH::MRPS18B	Adenocarcinoma
GAPDH::NCAPD2	Adenocarcinoma
GAPDH::TNC	Squamous cell carcinoma
GAPVD1::PTGR1	Acute myeloid leukemia, NOS | Skin
GAREM1::DNAH9	Adenocarcinoma
GAREM1::DSG4	Adenocarcinoma
GAREM1::GTF2H1	Adenocarcinoma
GAREM1::NEDD4L	Adenocarcinoma
GAREM1::PIEZO2	Squamous cell carcinoma
GAREM1::PTPRM	Malignant melanoma
GARIN2::SF3B4	Multiple myeloma
GARNL3::RALGPS1	Malignant epithelial tumor, special type
GARRE1::C19ORF47	Squamous cell carcinoma
GARRE1::SLC7A9	Mesenchymal tumor, NOS
GARRE1::UQCRC1	Adenocarcinoma
GARS1::HOXA13	Malignant melanoma
GART::PCP4	Squamous cell carcinoma
GART::TMEM50B	Squamous cell carcinoma
GAS2::RET	Carcinoma, NOS
GAS2::SOX6	Adenocarcinoma
GAS2L1::EWSR1	Adenocarcinoma
GAS2L1::NTRK1	Soft tissue tumor, special type
GAS2L1::SMTN	Transitional cell carcinoma
GAS2L3::KRT2	Mesenchymal tumor, NOS
GAS2L3::MED13L	Transitional cell carcinoma
GAS2L3::OS9	Mesenchymal tumor, NOS
GAS2L3::SND1	Adenocarcinoma
GAS6::ATP4B	Squamous cell carcinoma
GAS6::GPC5	Adenocarcinoma
GAS6::IGH	Multiple myeloma
GAS6::TMEM255B	Acute promyelocytic leukemia (FAB type M3) | Acute myeloblastic leukemia with minimal differentiation (FAB type M0) | Acute myeloblastic leukemia without maturation (FAB type M1)
GAS7::ATP8B4	Mesenchymal tumor, NOS
GAS7::CHMP4A	Astrocytoma, grade III-IV/Glioblastoma
GAS7::MYH1	Adenocarcinoma | Acute myeloblastic leukemia with maturation (FAB type M2)
GAS7::TTLL9	Adenocarcinoma
GAS8::SPIRE2	Adenocarcinoma
GAS8::WDR59	Adenocarcinoma
GASK1B::TMEM144	Diffuse large B-cell lymphoma
GATA2::DNAJB8	Acute myeloid leukemia, NOS | Skin
GATA2::HOXA10	Acute megakaryoblastic leukemia (FAB type M7)
GATA2::HOXA9	Acute megakaryoblastic leukemia (FAB type M7)
GATA2::MECOM	Acute myeloid leukemia, NOS | Skin | Chronic myeloid leukemia, t(9;22) | Heart | Myelodysplastic syndrome, NOS
GATA3::TAF3	Adenocarcinoma
GATA4::ERI1	Adenocarcinoma
GATA4::SFTPD	Adenocarcinoma
GATA4::TRIB1	Adenocarcinoma
GATA6::BLK	Adenocarcinoma
GATA6::DPF1	Adenocarcinoma
GATA6::FOXO1	Epithelioid hemangioendothelioma | Hemangioma/lymphangioma
GATA6::RBBP8	Adenocarcinoma
GATAD2A::CHERP	Adenocarcinoma
GATAD2A::CHST1	Adenocarcinoma
GATAD2A::GIPC1	Diffuse large B-cell lymphoma
GATAD2A::KXD1	Mesenchymal tumor, NOS
GATAD2A::LYN	Acute lymphoblastic leukemia/lymphoblastic lymphoma
GATAD2A::MAU2	Adenocarcinoma
GATAD2A::NCAN	Adenocarcinoma
GATAD2A::PRKACA	Adenocarcinoma
GATAD2A::RETREG3	Adenocarcinoma
GATAD2A::RPL28	Squamous cell carcinoma
GATAD2A::SSBP4	Adenocarcinoma
GATAD2A::UBA52	Adenocarcinoma
GATAD2A::ZNF350	Adenocarcinoma
GATAD2A::ZNF93	Adenocarcinoma
GATAD2B::ACSS3	Mesenchymal tumor, NOS
GATAD2B::ASH1L	Adenocarcinoma
GATAD2B::CRTC2	Adenocarcinoma
GATAD2B::DCAF8	Adenocarcinoma
GATAD2B::ERI3	Transitional cell carcinoma
GATAD2B::FAHD2B	Adenocarcinoma
GATAD2B::GRM8	Mesenchymal tumor, NOS
GATAD2B::IGSF8	Adenocarcinoma
GATAD2B::KCNN3	Adenocarcinoma
GATAD2B::LAMC3	Adenocarcinoma
GATAD2B::LELP1	Adenocarcinoma
GATAD2B::MMRN1	Mesenchymal tumor, special type
GATAD2B::MTCP1	Chronic myelomonocytic leukemia | Spleen
GATAD2B::NENF	Adenocarcinoma
GATAD2B::NUP210L	Adenocarcinoma
GATAD2B::PRC1	Multiple myeloma
GATAD2B::PRKAB2	Squamous cell carcinoma
GATAD2B::S100A11	Squamous cell carcinoma
GATAD2B::S100A3	Malignant melanoma
GATAD2B::S100A4	Malignant melanoma
GATAD2B::S100A8	Adenocarcinoma
GATAD2B::SLC9C2	Adenocarcinoma
GATAD2B::TNFSF18	Astrocytoma, grade III-IV/Glioblastoma
GATB::SH3D19	Adenocarcinoma
GATC::BICDL1	Adenocarcinoma
GATD1::ALOX5AP	Malignant melanoma
GATD1::RAD51B	Leiomyosarcoma
GATM::RAF1	Adenocarcinoma
GATM::SLC30A4	Adenocarcinoma
GBA1::SCAMP3	Adenocarcinoma
GBA2::ATP6V1C1	Adenocarcinoma
GBE1::MKRN2OS	Adenocarcinoma
GBE1::TAFA1	Malignant melanoma
GBE1::TRPS1	Mesenchymal tumor, special type
GBE1::ZNF385D	Squamous cell carcinoma
GBE1::ZNF569	Malignant epithelial tumor, special type
GBF1::AGBL1	Adenocarcinoma
GBF1::CTDSP2	Mesenchymal tumor, NOS
GBF1::NOLC1	Adenocarcinoma
GBF1::NT5C2	Adenocarcinoma
GBF1::SFTPD	Adenocarcinoma
GBF1::TRPC6	Mesenchymal tumor, NOS
GBF1::UBE2R2	Transitional cell carcinoma
GBF1::WBP1L	Adenocarcinoma
GBX1::PRKAG2	Adenocarcinoma
GC::CPE	Adenocarcinoma
GC::DSP	Adenocarcinoma
GCC2::ALK	Carcinoma, NOS | Adenocarcinoma | Inflammatory myofibroblastic tumor/myofibroblastic sarcoma
GCC2::ANXA4	Adenocarcinoma
GCC2::PDGFRB	Chronic eosinophilic leukemia/hypereosinophilic syndrome
GCDH::RPS6	Multiple myeloma
GCN1::CCND2	Squamous cell carcinoma
GCN1::CD74	Diffuse large B-cell lymphoma
GCN1::METTL1	Adenocarcinoma
GCN1::MSI1	Adenocarcinoma
GCN1::PLA2G1B	Malignant melanoma | Adenocarcinoma
GCNT2::OSM	Adenocarcinoma
GCNT2::PDE4B	Adenocarcinoma
GCNT2::TXNDC5	Malignant melanoma
GCOM1::ADGRL1	Adenocarcinoma
GDA::C9ORF85	Adenocarcinoma
GDA::DIPK1B	Adenocarcinoma
GDA::EPS8L2	Adenocarcinoma
GDA::SIAE	Adenocarcinoma
GDAP2::ADORA3	Adenocarcinoma
GDAP2::SLAIN1	Adenocarcinoma
GDAP2::SPAG17	Adenocarcinoma
GDE1::FLYWCH2	Adenocarcinoma
GDE1::TIAL1	Adenocarcinoma
GDF11::BLOC1S1	Adenocarcinoma
GDF11::HOXC8	Astrocytoma, grade I-II
GDF15::MAST3	Adenocarcinoma
GDI1::TBC1D8	Astrocytoma, grade III-IV/Glioblastoma
GDI2::CPVL	Astrocytoma, grade I-II | Oligodendroglioma
GDI2::IL2RA	Adenocarcinoma
GDI2::ZNF526	Transitional cell carcinoma
GDNF::FYB1	Squamous cell carcinoma
GDPD1::COX8A	Adenocarcinoma
GDPD1::SMG8	Transitional cell carcinoma | Adenocarcinoma
GDPD5::ACER3	Malignant melanoma
GDPD5::SERPINH1	Malignant melanoma
GDPD5::WNT11	Adenocarcinoma
GEM::PLAG1	Benign epithelial tumor, special type | Adenoma
GEMIN2::MIA2	Adenocarcinoma
GEMIN4::CRTC3	Adenocarcinoma
GEMIN7::SLC39A14	Adenocarcinoma
GET1::BACE2	Adenocarcinoma
GET1::ERG	Adenocarcinoma
GET1::KCNJ15	Adenocarcinoma
GET1::NLK	Adenocarcinoma
GET1::SH3BGR	Nonneoplastic epithelial disorder/lesion
GET3::DHPS	Adenocarcinoma
GET3::RLN3	Adenocarcinoma
GET4::DNAAF5	Squamous cell carcinoma
GET4::MAFK	Multiple myeloma
GET4::TNRC18	Acute lymphoblastic leukemia/lymphoblastic lymphoma
GFER::TRAF7	Mesothelioma
GFM1::KLHL6	Squamous cell carcinoma
GFM1::MLF1	Adenocarcinoma
GFM1::RARRES1	Adenocarcinoma
GFM1::TMCC1	Transitional cell carcinoma
GFOD1::BCAS1	Adenocarcinoma
GFOD1::CYP39A1	Adenocarcinoma
GFOD1::EYA4	Mesenchymal tumor, NOS
GFOD1::EYS	Malignant melanoma
GFOD2::TK2	Adenocarcinoma
GFOD2::TMEM241	Adenocarcinoma
GFOD2::TRIO	Malignant melanoma
GFPT1::ALK	Adenocarcinoma
GFPT1::NF1	Adenocarcinoma
GFPT1::NFU1	Malignant melanoma | Squamous cell carcinoma
GFPT2::BRD8	Malignant melanoma
GFPT2::PPFIA2	Mesenchymal tumor, NOS
GFRA1::DGKB	Adenocarcinoma
GFRA3::TTC8	Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
GGA1::CDC42EP1	Embryonal nervous system tumor, special type
GGA1::TRIOBP	Adenocarcinoma
GGA2::PRKCB	Skin | Acute myeloid leukemia, NOS | Astrocytoma, grade I-II
GGA2::TNFAIP8L2	Astrocytoma, grade I-II
GGA3::ATF7	Adenocarcinoma
GGA3::NUP85	Adenocarcinoma
GGA3::SMIM5	Adenocarcinoma
GGACT::DCLK1	Adenocarcinoma
GGACT::INCA1	Mesenchymal tumor, NOS
GGACT::PCCA	Transitional cell carcinoma
GGCT::ZNRF2	Squamous cell carcinoma
GGCX::KCMF1	Adenocarcinoma
GGH::ZFAND1	Adenocarcinoma
GGNBP2::MYO19	Acute lymphoblastic leukemia/lymphoblastic lymphoma
GGNBP2::NEBL	Squamous cell carcinoma
GGNBP2::NR1D1	Adenocarcinoma
GGNBP2::ZDHHC16	Adenocarcinoma
GGNBP2::ZMAT4	Transitional cell carcinoma
GGT1::PRODH	Adenocarcinoma
GGT5::USP18	Astrocytoma, grade III-IV/Glioblastoma
GGT6::PELP1	Adenocarcinoma
GGT7::SLA2	Adenocarcinoma
GHITM::NRG3	Adenocarcinoma
GHR::ALK	Adenocarcinoma
GHR::BRAF	Adenocarcinoma
GHR::C6	Squamous cell carcinoma
GHR::FGFR4	Adenocarcinoma
GHR::GPR68	Squamous cell carcinoma
GHRL::SEC13	Adenocarcinoma
GID4::DRC3	Adenocarcinoma
GID4::FDXR	Adenocarcinoma
GID4::RAI1	Adenocarcinoma
GIGYF2::ASB18	Adenocarcinoma
GIGYF2::ATG16L1	Squamous cell carcinoma
GIGYF2::C6ORF52	Adenocarcinoma
GIGYF2::CHRND	Adenocarcinoma
GIGYF2::COG4	Adenocarcinoma
GIGYF2::DIS3L2	Adenocarcinoma
GIGYF2::ECEL1	Astrocytoma, grade III-IV/Glioblastoma
GIGYF2::EFHD1	Adenocarcinoma
GIGYF2::EIF4E2	Adenocarcinoma
GIGYF2::HSCB	Adenocarcinoma
GIGYF2::MROH2A	Transitional cell carcinoma
GIGYF2::NGEF	Astrocytoma, grade III-IV/Glioblastoma | Astrocytoma, grade I-II
GIGYF2::PPP1R7	Astrocytoma, grade III-IV/Glioblastoma
GIGYF2::SP2	Adenocarcinoma
GIGYF2::THAP4	Astrocytoma, grade III-IV/Glioblastoma
GIGYF2::TMEM163	Adenocarcinoma
GIGYF2::TRPM8	Astrocytoma, grade III-IV/Glioblastoma
GIN1::PKHD1L1	Adenocarcinoma
GINM1::PPIL4	Diffuse large B-cell lymphoma
GINM1::SLC35F1	Adenocarcinoma
GINS1::DEFB123	Squamous cell carcinoma
GINS1::SYNDIG1	Squamous cell carcinoma
GINS2::C16orf74	Transitional cell carcinoma
GINS2::EMC8	Adenocarcinoma
GINS4::UQCRC2	Adenocarcinoma
GIPC1::CYP4F22	Adenocarcinoma
GIPC1::ILVBL	Adenocarcinoma
GIPC1::PKN1	Undifferentiated carcinoma, small cell
GIPC1::UBE2D2	Squamous cell carcinoma
GIPC1::UBL3	Adenocarcinoma
GIPR::LGALS7	Malignant melanoma
GIPR::PRR12	Adenocarcinoma
GIPR::RBM42	Adenocarcinoma
GIT1::SHMT1	Diffuse large B-cell lymphoma
GIT2::ANAPC7	Mature B-cell neoplasm, NOS
GIT2::BRAF	Astrocytoma, pilocytic/juvenile
GIT2::PDGFRB	Chronic eosinophilic leukemia/hypereosinophilic syndrome | Chronic myeloproliferative disorder, NOS
GIT2::SLC2A13	Germ cell tumor, NOS
GIT2::SMYD5	Malignant melanoma
GJA1::STAT6	Adenocarcinoma
GJC1::SKAP1	Adenocarcinoma
GK5::CENPL	Adenocarcinoma
GK5::MBNL1	Adenocarcinoma
GK5::PAQR9	Adenocarcinoma
GK5::XRN1	Adenocarcinoma
GKAP1::ARIH1	Adenocarcinoma
GKAP1::KIF27	Nonneoplastic hematologic disorder/lesion | Nonneoplastic epithelial disorder/lesion
GKAP1::NTRK2	Astrocytoma, grade III-IV/Glioblastoma | Glioma, NOS | Astrocytoma, pilocytic/juvenile
GLA::HNRNPH2	Adenocarcinoma
GLB1::CMTM7	Adenocarcinoma
GLB1::INSC	Astrocytoma, grade I-II
GLB1::PSD2	Adenocarcinoma
GLB1::SUSD5	Malignant epithelial tumor, special type
GLB1L::TUBA4A	Adenocarcinoma
GLCCI1::BRAF	Malignant epithelial tumor, special type
GLCCI1::DGKB	Malignant melanoma
GLCCI1::ICA1	Transitional cell carcinoma
GLCE::NOX5	Adenocarcinoma
GLCE::SPESP1	Adenocarcinoma
GLE1::ODF2	Adenocarcinoma
GLE1::SLC27A4	Malignant melanoma
GLE1::SPTAN1	Transitional cell carcinoma
GLG1::BCAR1	Adenocarcinoma
GLG1::CFDP1	Squamous cell carcinoma | Astrocytoma, grade I-II | Adenocarcinoma
GLG1::COG4	Adenocarcinoma
GLG1::FA2H	Adenocarcinoma
GLG1::FBXW8	Malignant melanoma
GLI1::AARS1	Mesenchymal tumor, NOS
GLI1::CPM	Astrocytoma, grade III-IV/Glioblastoma
GLI1::DCTN2	Astrocytoma, grade III-IV/Glioblastoma
GLI1::MDM4	Astrocytoma, grade III-IV/Glioblastoma
GLI2::EPB41L5	Primitive neuroectodermal tumor/Medulloblastoma | Russia
GLI2::MARCO	Mesenchymal tumor, NOS
GLI2::NYAP2	Russia | Primitive neuroectodermal tumor/Medulloblastoma
GLI2::SPOP	Mesenchymal tumor, NOS
GLI3::CROT	Squamous cell carcinoma
GLI3::FAM3B	Adenocarcinoma
GLI3::HIBADH	Adenocarcinoma
GLI3::PGC	Mesenchymal tumor, NOS
GLI3::RET	Carcinoma, NOS
GLI3::SUGCT	Adenocarcinoma
GLI3::TMEM243	Astrocytoma, grade I-II
GLI3::VSTM2A	Adenocarcinoma
GLIPR1::CDK17	Mesenchymal tumor, NOS
GLIPR1::TRMT10C	Squamous cell carcinoma
GLIPR1L1::RAB3IP	Mesenchymal tumor, NOS
GLIPR1L2::NDUFA12	Astrocytoma, grade III-IV/Glioblastoma
GLIPR2::GALT	Squamous cell carcinoma
GLIPR2::RECK	Adenocarcinoma
GLIS1::FAF1	Malignant melanoma
GLIS2::PHF21A	Neuroblastoma
GLIS3::ARHGAP1	Adenocarcinoma
GLIS3::CTNNA2	Squamous cell carcinoma
GLIS3::GOLM1	Adenocarcinoma
GLIS3::IL17REL	Mesenchymal tumor, NOS
GLIS3::NF1	Adenocarcinoma
GLIS3::PLGRKT	Adenocarcinoma
GLIS3::PUM3	Astrocytoma, grade I-II
GLIS3::RCL1	Adenocarcinoma
GLIS3::TERT	Mesenchymal tumor, NOS
GLMP::CCT3	Adenocarcinoma
GLO1::KIF6	Adenocarcinoma
GLO1::UBR2	Mesenchymal tumor, NOS
GLOD4::EIF5A	Adenocarcinoma
GLOD4::NPLOC4	Mesenchymal tumor, NOS
GLRX3::LRMDA	Adenocarcinoma
GLRX3::SGMS1	Adenocarcinoma
GLS::ANKAR	Adenocarcinoma
GLS::MYO1B	Squamous cell carcinoma
GLT1D1::CTNNA2	Mesothelioma
GLT8D1::PLXNB1	Mesothelioma
GLT8D2::YY1	Mesenchymal tumor, NOS
GLUL::CYP3A4	Adenocarcinoma
GLUL::DDX27	Adenocarcinoma
GLUL::EIF2AK2	Adenocarcinoma
GLUL::MBP	Astrocytoma, grade I-II
GLUL::NDUFV1	Adenocarcinoma
GLUL::SEC63	Astrocytoma, grade I-II
GLUL::STAT6	Adenocarcinoma
GLUL::TAL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
GLUL::UNC13A	Astrocytoma, grade I-II
GLYAT::NLRC5	Adenocarcinoma
GLYCTK::ALAS1	Adenocarcinoma
GLYR1::ADCY9	Astrocytoma, grade III-IV/Glioblastoma
GLYR1::C16ORF89	Adenocarcinoma
GLYR1::C16orf89	Adenocarcinoma
GLYR1::SRL	Adenocarcinoma
GMCL1::AAK1	Adenocarcinoma
GMCL1::ANXA4	Adenocarcinoma
GMCL1::DYSF	Germ cell tumor, NOS
GMDS::BCAS3	Adenocarcinoma
GMDS::CAP2	Squamous cell carcinoma
GMDS::CCND3	Adenocarcinoma
GMDS::DNAH8	Adenocarcinoma
GMDS::EXOC2	Mesenchymal tumor, NOS
GMDS::FARS2	Malignant melanoma
GMDS::KIF6	Squamous cell carcinoma
GMDS::METTL24	Adenocarcinoma
GMDS::MRPS18B	Transitional cell carcinoma
GMDS::PPP1R11	Diffuse large B-cell lymphoma
GMDS::TMEM132B	Adenocarcinoma
GMDS::TMTC2	Adenocarcinoma
GMDS::VAPB	Adenocarcinoma
GMEB1::TRNAU1AP	Adenocarcinoma
GMEB2::RALY	Adenocarcinoma
GMEB2::STMN3	Adenocarcinoma
GML::ERICH5	Adenocarcinoma
GMPR::NDUFAF6	Adenocarcinoma
GMPS::SYNPR	Endometrial stromal sarcoma
GNA11::SLC30A6	Adenocarcinoma
GNA11::TMCO3	Mesenchymal tumor, NOS
GNA12::ADSS2	Adenocarcinoma
GNA12::AMACR	Transitional cell carcinoma
GNA12::CARD11	Transitional cell carcinoma
GNA12::CUL1	Mesenchymal tumor, NOS
GNA12::PHC3	Squamous cell carcinoma
GNA12::SHANK2	Malignant melanoma
GNA12::URI1	Transitional cell carcinoma
GNA12::ZC4H2	Transitional cell carcinoma
GNA13::ALPK2	Mature B-cell neoplasm, NOS
GNA13::ASPSCR1	Adenocarcinoma
GNA13::BMI1	Squamous cell carcinoma
GNA13::CCDC171	Squamous cell carcinoma
GNA13::CEP112	Squamous cell carcinoma
GNA13::MXRA7	Malignant epithelial tumor, special type
GNA13::MYO1D	Acute myelomonocytic leukemia (FAB type M4)
GNA13::NR3C1	Astrocytoma, grade I-II
GNA13::SLC39A11	Adenocarcinoma
GNA13::TOM1	Adenocarcinoma
GNA14::TNFSF8	Adenocarcinoma
GNA14::TRMO	Adenocarcinoma
GNAI1::BRAF	Astrocytoma, pilocytic/juvenile
GNAI2::SLC38A3	Adenocarcinoma
GNAI2::SLC39A11	Adenocarcinoma
GNAI3::BRAF	Astrocytoma, pilocytic/juvenile
GNAI3::CASQ2	Adenocarcinoma
GNAI3::CTTNBP2NL	Adenocarcinoma
GNAI3::CYB561D1	Adenocarcinoma
GNAI3::ELAPOR1	Adenocarcinoma
GNAI3::GPR61	Astrocytoma, grade I-II
GNAI3::SARS1	Adenocarcinoma
GNAL::CSNK1E	Adenocarcinoma
GNAO1::FTO	Mesenchymal tumor, NOS
GNAQ::FBP1	Adenocarcinoma
GNAQ::QNG1	Adenocarcinoma
GNAQ::VEPH1	Adenocarcinoma
GNAS::AP1G2	Adenocarcinoma
GNAS::ARFGEF2	Adenocarcinoma
GNAS::BIRC6	Astrocytoma, grade I-II
GNAS::CLCN3	Adenocarcinoma
GNAS::CLIP1	Adenocarcinoma
GNAS::CPB1	Adenocarcinoma
GNAS::EEA1	Squamous cell carcinoma
GNAS::EIF2AK2	Embryonal nervous system tumor, special type
GNAS::ELK3	Adenocarcinoma
GNAS::FN1	Adenocarcinoma
GNAS::FOXP1	Benign epithelial tumor, special type
GNAS::GAPDH	Squamous cell carcinoma
GNAS::HEG1	Adenocarcinoma
GNAS::IGF2	Adenocarcinoma
GNAS::IGK	Multiple myeloma
GNAS::ITGAV	Squamous cell carcinoma
GNAS::LRCH1	Adenocarcinoma
GNAS::NECTIN2	Adenocarcinoma
GNAS::PLXNC1	Embryonal nervous system tumor, special type
GNAS::PSAP	Adenocarcinoma
GNAS::RTF2	Adenocarcinoma
GNAS::SEC63	Adenocarcinoma
GNAS::SIAE	Adenocarcinoma
GNAS::SMAP2	Squamous cell carcinoma
GNAS::SNW1	Squamous cell carcinoma
GNAS::SUPT16H	Transitional cell carcinoma
GNAS::THSD4	Adenocarcinoma
GNAS::TSPAN7	Adenocarcinoma
GNAS::ZNFX1	Adenocarcinoma
GNAZ::MIF	Adenocarcinoma
GNB1::CALML6	Squamous cell carcinoma
GNB1::CASZ1	Malignant melanoma
GNB1::CDK11A	Transitional cell carcinoma
GNB1::CDK11B	Malignant epithelial tumor, special type
GNB1::CFAP74	Adenocarcinoma
GNB1::FAAP20	Transitional cell carcinoma
GNB1::KIFAP3	Adenocarcinoma
GNB1::LDHB	Germ cell tumor, NOS
GNB1::NADK	Adenocarcinoma | Squamous cell carcinoma
GNB1::OMA1	Astrocytoma, grade III-IV/Glioblastoma
GNB1::TRH	Adenocarcinoma
GNB1::TSC2	Adenocarcinoma
GNB1::TXN	Adenocarcinoma
GNB1::TXNDC11	Adenocarcinoma
GNB1L::CTSC	Squamous cell carcinoma
GNB1L::DNTTIP1	Adenocarcinoma
GNB1L::HIRA	Adenocarcinoma
GNB1L::TXNRD2	Squamous cell carcinoma
GNB2::CTSD	Adenocarcinoma
GNB3::METAP2	Astrocytoma, grade III-IV/Glioblastoma
GNB5::BNIP2	Transitional cell carcinoma
GNB5::PDE6D	Adenocarcinoma
GNE::BICC1	Malignant melanoma
GNE::ERP27	Adenocarcinoma
GNE::ROCK1	Squamous cell carcinoma
GNG10::UGCG	Adenocarcinoma
GNG12::CYP4X1	Adenocarcinoma
GNG12::DIRAS3	Adenocarcinoma
GNG12::PLXNA2	Mesenchymal tumor, NOS
GNG12::SPATA6	Adenocarcinoma
GNG4::SH3D19	Adenocarcinoma
GNG7::ARHGEF18	Adenocarcinoma
GNG7::LSM7	Astrocytoma, grade I-II
GNG7::PLA2G2A	Malignant melanoma
GNG7::PSMD1	Adenocarcinoma
GNG7::SCAMP4	Diffuse large B-cell lymphoma
GNG7::SGTA	Astrocytoma, grade III-IV/Glioblastoma
GNG7::TACC3	Astrocytoma, grade I-II
GNGT1::CALCR	Squamous cell carcinoma
GNGT1::NUDT5	Transitional cell carcinoma
GNL1::REPS1	Mesenchymal tumor, NOS
GNL1::SOCS1	Squamous cell carcinoma
GNL2::DNAH3	Adenocarcinoma
GNL3::BAP1	Mesothelioma
GNL3::CLCN3	Adenocarcinoma
GNL3::MANF	Squamous cell carcinoma
GNL3L::GABRB3	Mesenchymal tumor, NOS
GNL3L::PAGE5	Adenocarcinoma
GNL3L::XAGE3	Squamous cell carcinoma
GNPAT::CAPN9	Transitional cell carcinoma
GNPAT::PCNX2	Adenocarcinoma
GNPAT::TAL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
GNPAT::TRIM67	Transitional cell carcinoma | Adenocarcinoma
GNPDA1::RNGTT	Adenocarcinoma
GNPDA2::COX7B2	Multiple myeloma
GNPDA2::GRID2	Adenocarcinoma
GNPDA2::TIAM2	Adenocarcinoma
GNPTAB::ATF7IP	Acute lymphoblastic leukemia/lymphoblastic lymphoma
GNPTAB::CCDC60	Mesenchymal tumor, NOS
GNPTAB::CNOT2	Transitional cell carcinoma
GNPTAB::TRHDE	Mesenchymal tumor, NOS
GNPTAB::USP36	Adenocarcinoma
GNPTG::HAGH	Adenocarcinoma
GNPTG::RAB40C	Malignant epithelial tumor, special type
GNS::CYP27B1	Adenocarcinoma
GNS::NUP107	Mesenchymal tumor, NOS | Astrocytoma, grade III-IV/Glioblastoma
GNS::RAB3IP	Malignant melanoma
GNS::RASSF3	Mesenchymal tumor, NOS
GNS::SLC16A7	Mesenchymal tumor, NOS
GNS::TAFA2	Malignant melanoma
GNS::TBC1D30	Squamous cell carcinoma
GOLGA1::WDR38	Adenocarcinoma
GOLGA2::TULP1	Malignant melanoma
GOLGA3::ANKLE2	Adenocarcinoma
GOLGA3::CHFR	Squamous cell carcinoma
GOLGA3::RPS11	Multiple myeloma
GOLGA3::RTN2	Transitional cell carcinoma
GOLGA3::ZNF891	Adenocarcinoma
GOLGA4::ACAA1	Adenocarcinoma
GOLGA4::ANO1	Adenocarcinoma
GOLGA4::BRAF	Benign nevus
GOLGA4::CTDSPL	Adenocarcinoma
GOLGA4::FAM135B	Mesenchymal tumor, NOS
GOLGA4::HSPA8	Adenocarcinoma
GOLGA4::JAK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
GOLGA4::MET	Glioma, NOS
GOLGA4::MLH1	Adenocarcinoma
GOLGA4::PDGFRB	Chronic myeloproliferative disorder, NOS
GOLGA4::RAF1	Malignant melanoma | Fibroblastic/myofibroblastic tumor, special type | Adenocarcinoma | Benign nevus
GOLGA4::RRM1	Transitional cell carcinoma
GOLGA4::STAC	Adenocarcinoma
GOLGA5::JAK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
GOLGA5::RET	Melanocytic neoplasm, special type | Adenocarcinoma
GOLGA5::RIN3	Adenocarcinoma | Malignant melanoma
GOLGA5::RNF212B	Squamous cell carcinoma
GOLGA7::SLC25A44	Adenocarcinoma
GOLGA8A::AQR	Adenocarcinoma
GOLGA8B::ACTC1	Adenocarcinoma
GOLGB1::BRAF	Adenocarcinoma
GOLGB1::FLT3	Chronic myeloproliferative disorder, special type
GOLGB1::GK5	Adenocarcinoma
GOLGB1::ILDR1	Adenocarcinoma
GOLGB1::IQCB1	Adenocarcinoma
GOLGB1::IQCG	Mycosis fungoides/Sézary syndrome
GOLGB1::JAK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
GOLGB1::MIX23	Adenocarcinoma
GOLGB1::PDGFRB	Myelodysplastic/myeloproliferative disease, NOS | Thymus
GOLIM4::MECOM	Malignant melanoma
GOLIM4::NCEH1	Adenocarcinoma
GOLIM4::PRDX1	Adenocarcinoma
GOLIM4::RNF175	Squamous cell carcinoma
GOLIM4::SLC40A1	Squamous cell carcinoma
GOLIM4::SPATA16	Adenocarcinoma
GOLIM4::ZBBX	Adenocarcinoma
GOLM1::NAA35	Adenocarcinoma
GOLM1::TUT7	Adenocarcinoma
GOLM2::CTDSPL2	Adenocarcinoma
GOLM2::LRRC8D	Mesenchymal tumor, NOS
GOLM2::TGM5	Adenocarcinoma
GOLPH3::IKZF3	Adenocarcinoma
GOLPH3::LRTM1	Squamous cell carcinoma
GOLPH3::SLC6A19	Adenocarcinoma
GOLPH3L::ARNT	Adenocarcinoma
GOLPH3L::CHRM3	Adenocarcinoma
GOLPH3L::CTSS	Adenocarcinoma
GOLPH3L::HORMAD1	Adenocarcinoma
GOLPH3L::THEM4	Adenocarcinoma
GOLT1A::KISS1	Adenocarcinoma
GOLT1B::IAPP	Squamous cell carcinoma
GON4L::ARHGEF2	Squamous cell carcinoma | Malignant epithelial tumor, special type | Adenocarcinoma | Transitional cell carcinoma
GON4L::CCT3	Adenocarcinoma
GON4L::IQGAP3	Adenocarcinoma
GON4L::MED27	Malignant melanoma
GON4L::MEX3A	Squamous cell carcinoma
GON4L::MTX1	Adenocarcinoma
GON4L::PIPOX	Adenocarcinoma
GON4L::PMVK	Adenocarcinoma
GON4L::RIT1	Adenocarcinoma
GON4L::SERPINB7	Squamous cell carcinoma
GON4L::SMG5	Alveolar rhabdomyosarcoma
GON4L::SYT11	Adenocarcinoma
GOPC::ABLIM1	Adenocarcinoma
GOPC::ROS1	Astrocytoma, pilocytic/juvenile | Ependymoma | Melanocytic neoplasm, special type | Astrocytoma, grade III-IV/Glioblastoma | Oligodendroglioma | Adenocarcinoma | Astrocytoma, grade I-II | Malignant epithelial tumor, special type
GORASP2::ERICH2	Adenocarcinoma
GORASP2::GAD1	Adenocarcinoma
GORASP2::MYO3B	Adenocarcinoma
GORASP2::WIPF1	Adenocarcinoma
GOSR1::AP2B1	Adenocarcinoma
GOSR1::C17ORF75	Refractory anemia with excess blasts-1
GOSR1::CPD	Adenocarcinoma
GOSR1::DGAT2	Adenocarcinoma
GOSR1::JUP	Astrocytoma, grade I-II
GOSR1::NF1	Adenocarcinoma
GOSR1::TAOK1	Adenocarcinoma
GOSR1::ZNF207	Acute myeloid leukemia, NOS | Acute myeloblastic leukemia with minimal differentiation (FAB type M0) | Skin
GOSR2::OMG	Adenocarcinoma
GOSR2::RHOT1	Adenocarcinoma
GOSR2::UTP6	Adenocarcinoma
GOT2::MMP2	Malignant melanoma
GP2::LYZ	Adenocarcinoma
GP2::PRSS2	Adenocarcinoma
GPAA1::CD24	Adenocarcinoma
GPAA1::GRINA	Adenocarcinoma
GPALPP1::MEF2A	Adenocarcinoma
GPALPP1::VWA8	Adenocarcinoma
GPAM::ADORA3	Adenocarcinoma
GPAM::TMIGD3	Adenocarcinoma
GPAM::VTI1A	Adenocarcinoma
GPANK1::ABHD16A	Embryonal rhabdomyosarcoma
GPAT3::COPS4	Mesenchymal tumor, NOS
GPAT3::MRPS18C	Adenocarcinoma
GPAT4::ADAM9	Adenocarcinoma
GPAT4::FNTA	Adenocarcinoma
GPAT4::KCNB2	Adenocarcinoma
GPAT4::LY6H	Malignant melanoma
GPATCH11::DYM	Malignant melanoma
GPATCH1::FCGRT	Adenocarcinoma
GPATCH1::UPK1B	Adenocarcinoma
GPATCH3::CAMTA1	Adenocarcinoma
GPATCH3::KDF1	Adenocarcinoma
GPATCH3::SPNS2	Adenocarcinoma
GPATCH8::ATXN7L3	Diffuse large B-cell lymphoma
GPATCH8::COMTD1	Adenocarcinoma
GPATCH8::KIAA1958	Skin | Acute myeloid leukemia, NOS
GPATCH8::KRT25	Adenocarcinoma
GPATCH8::MEOX1	Adenocarcinoma
GPATCH8::METTL16	Mesenchymal tumor, NOS
GPATCH8::MYO1D	Adenocarcinoma
GPATCH8::NAGS	Adenocarcinoma
GPATCH8::NPLOC4	Adenocarcinoma
GPATCH8::PYY	Adenocarcinoma
GPATCH8::STAC2	Transitional cell carcinoma
GPATCH8::TP53BP1	Chronic lymphocytic leukemia
GPATCH8::VXN	Adenocarcinoma
GPATCH8::ZMYM4	Adenocarcinoma
GPBP1::BDNF	Adenocarcinoma
GPBP1::GOLGA8B	Adenocarcinoma
GPBP1::MTRR	Adenocarcinoma
GPBP1L1::MOB3C	Malignant epithelial tumor, special type
GPBP1L1::PVR	Astrocytoma, grade I-II
GPBP1L1::TRAPPC9	Adenocarcinoma
GPBP1L1::UTP14A	Adenocarcinoma
GPBP1L1::ZMPSTE24	Adenocarcinoma
GPC1::ALK	Malignant epithelial tumor, special type
GPC1::ANKFN1	Squamous cell carcinoma
GPC1::ATP23	Mesenchymal tumor, NOS
GPC1::MFN1	Squamous cell carcinoma
GPC3::GPC4	Adenocarcinoma
GPC3::PPARG	Transitional cell carcinoma
GPC4::GPC3	Adenocarcinoma
GPC5::CMBL	Adenocarcinoma
GPC6::GPC5	Adenocarcinoma
GPC6::ITGBL1	Squamous cell carcinoma
GPC6::NBEA	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
GPC6::SMG1	Squamous cell carcinoma
GPD1L::CMTM7	Squamous cell carcinoma
GPD1L::CNOT10	Adenocarcinoma
GPD1L::STT3B	Transitional cell carcinoma
GPD2::GALNT5	Adenocarcinoma
GPD2::NR4A2	Squamous cell carcinoma
GPD2::R3HDM1	Astrocytoma, grade I-II
GPHN::ARG2	Adenocarcinoma
GPHN::ATP6V1D	Squamous cell carcinoma
GPHN::DCAF5	Squamous cell carcinoma
GPHN::PRKCH	Malignant melanoma
GPHN::PRKD1	Adenocarcinoma | Astrocytoma, grade I-II
GPHN::RAD51B	Adenocarcinoma
GPHN::RET	Embryonal nervous system tumor, special type
GPHN::SLC8A3	Adenocarcinoma
GPI::DLGAP2	Adenocarcinoma
GPI::EYS	Squamous cell carcinoma
GPI::UTRN	Adenocarcinoma
GPI::ZNF875	Transitional cell carcinoma
GPLD1::BANK1	Adenocarcinoma
GPLD1::PCNP	Adenocarcinoma
GPLD1::RIPOR2	Adenocarcinoma
GPLD1::TDP2	Astrocytoma, grade III-IV/Glioblastoma
GPM6B::CHD1	Astrocytoma, grade I-II
GPN1::KLHL29	Squamous cell carcinoma
GPN2::KDF1	Adenocarcinoma
GPNMB::DDX27	Malignant melanoma
GPNMB::IRF6	Squamous cell carcinoma
GPNMB::KLHL7	Squamous cell carcinoma
GPNMB::NUP42	Adenocarcinoma
GPR107::ATRAID	Adenocarcinoma
GPR107::ERBB2	Carcinoma, NOS
GPR107::GARNL3	Adenocarcinoma
GPR107::VPS13A	Adenocarcinoma
GPR137::PLAAT4	Malignant epithelial tumor, special type
GPR137C::FERMT2	Adenocarcinoma
GPR141::ONECUT1	Skin | Acute myeloid leukemia, NOS
GPR146::DTNBP1	Squamous cell carcinoma
GPR155::CHN1	Adenocarcinoma
GPR155::CHRNA1	Adenocarcinoma
GPR155::CIR1	Mycosis fungoides/Sézary syndrome
GPR156::EPB41L2	Astrocytoma, grade I-II
GPR156::FSTL1	Adenocarcinoma
GPR157::GON4L	Adenocarcinoma
GPR158::KIAA1217	Malignant melanoma
GPR158::MYO16	Adenocarcinoma
GPR160::MED24	Adenocarcinoma
GPR160::NCEH1	Undifferentiated carcinoma, small cell
GPR160::PDCD10	Adenocarcinoma
GPR160::PLSCR1	Mature B-cell neoplasm, NOS
GPR160::PRKCI	Adenocarcinoma
GPR160::SEC62	Adenocarcinoma
GPR160::SFXN5	Adenocarcinoma
GPR160::SLC7A14	Adenocarcinoma
GPR161::EFL1	Mesenchymal tumor, NOS
GPR161::MPC2	Squamous cell carcinoma
GPR173::TGM7	Adenocarcinoma
GPR179::ETV4	Adenocarcinoma
GPR180::DZIP1	Endometrial stromal sarcoma
GPR180::GPC6	Malignant melanoma
GPR35::ANKMY1	Adenocarcinoma
GPR35::MELK	Adenocarcinoma
GPR35::TIA1	Malignant epithelial tumor, special type
GPR37L1::ELF3	Adenocarcinoma
GPR37L1::PRKCA	Astrocytoma, grade I-II
GPR39::MGAT5	Squamous cell carcinoma
GPR39::ZNF112	Adenocarcinoma
GPR39::ZNF285	Adenocarcinoma
GPR63::NPC1L1	Malignant melanoma
GPR78::POLN	Transitional cell carcinoma
GPR89A::RNF115	Adenocarcinoma
GPR89B::HOOK3	Adenocarcinoma
GPRC5A::NRG1	Adenocarcinoma
GPRC5B::C16ORF96	Adenocarcinoma
GPRC5B::C16orf96	Adenocarcinoma
GPRC5C::CLDN4	Adenocarcinoma
GPRC5C::KIF19	Adenocarcinoma
GPRC5C::MET	Carcinoma, NOS
GPRC6A::RET	Carcinoma, NOS
GPRIN1::TM2D1	Mesenchymal tumor, NOS
GPRIN2::NPY4R	Adenocarcinoma
GPRIN2::TIMM23	Adenocarcinoma
GPS1::BHLHE40	Adenocarcinoma
GPS1::BLVRA	Adenocarcinoma
GPS1::CENPX	Adenocarcinoma
GPS2::GRHL1	Benign epithelial tumor, special type
GPS2::GRHL2	Benign epithelial tumor, special type
GPS2::GRHL3	Benign epithelial tumor, special type
GPS2::MPP2	Adenocarcinoma
GPS2::RBFOX3	Adenocarcinoma
GPSM1::NUP214	Astrocytoma, grade I-II
GPT2::HSD17B2	Adenocarcinoma
GPX3::CHD4	Adenocarcinoma
GPX3::CLCN3	Adenocarcinoma
GPX3::EIF2AK2	Adenocarcinoma
GPX3::SEC63	Adenocarcinoma
GPX3::SQSTM1	Adenocarcinoma
GPX4::MIDN	Transitional cell carcinoma
GPX4::SEC63	Adenocarcinoma
GPX4::SPNS3	Adenocarcinoma
GPX8::TTLL1	Adenocarcinoma
GRAMD1A::CCDC88A	Adenocarcinoma
GRAMD1A::KRTDAP	Adenocarcinoma
GRAMD1A::RAB3IP	Mesenchymal tumor, NOS
GRAMD1C::CCDC80	Adenocarcinoma
GRAMD2A::PKM	Squamous cell carcinoma
GRAMD2A::SENP8	Mesothelioma
GRAMD4::DRC3	Malignant epithelial tumor, special type
GRAMD4::FBLN1	Adenocarcinoma
GRAMD4::RIBC2	Adenocarcinoma
GRAP2::ADSL	Malignant melanoma
GRAP2::BRD1	Malignant melanoma
GRB10::CSTF3	Adenocarcinoma
GRB10::EEPD1	Astrocytoma, grade III-IV/Glioblastoma
GRB10::MAD1L1	Adenocarcinoma
GRB10::PDE3A	Acute erythroleukemia (FAB type M6)
GRB10::PIP4K2C	Mesenchymal tumor, NOS
GRB10::SCIN	Adenocarcinoma
GRB10::SCMH1	Mesenchymal tumor, NOS
GRB10::SDK1	Acute megakaryoblastic leukemia (FAB type M7)
GRB10::SLC2A13	Adenocarcinoma
GRB10::STEAP1B	Transitional cell carcinoma
GRB10::ZPBP	Adenocarcinoma
GRB14::PSMD1	Adenocarcinoma
GRB2::ACOX1	Adenocarcinoma | Malignant epithelial tumor, special type
GRB2::CD24	Adenocarcinoma
GRB2::CKB	Adenocarcinoma
GRB2::DYNLT2B	Squamous cell carcinoma
GRB2::GALK1	Adenocarcinoma
GRB2::PADI1	Adenocarcinoma
GRB2::PCYT1A	Squamous cell carcinoma
GRB2::SHISA5	Astrocytoma, grade III-IV/Glioblastoma
GRB2::SLC25A19	Adenocarcinoma
GRB2::SS18L1	Adenocarcinoma
GRB2::TEX14	Adenocarcinoma
GRB2::VMP1	Malignant melanoma
GRB7::ACACA	Transitional cell carcinoma
GRB7::ACTN3	Adenocarcinoma
GRB7::BRIP1	Adenocarcinoma
GRB7::CD300E	Transitional cell carcinoma
GRB7::CDK12	Adenocarcinoma
GRB7::ERBB2	Transitional cell carcinoma
GRB7::IKZF3	Adenocarcinoma
GRB7::ITGB3	Adenocarcinoma
GRB7::KRT27	Adenocarcinoma
GRB7::MIEN1	Adenocarcinoma
GRB7::PECAM1	Adenocarcinoma
GRB7::PGAP3	Adenocarcinoma
GRB7::PIP4K2B	Adenocarcinoma
GRB7::PLXDC1	Transitional cell carcinoma
GREB1::CTNNB1	Endometrial stromal sarcoma | Mesenchymal tumor, special type
GREB1::E2F6	Acute lymphoblastic leukemia/lymphoblastic lymphoma
GREB1::NCOA1	Mesenchymal tumor, special type
GREB1::NCOA2	Mesenchymal tumor, special type | Undifferentiated sarcoma
GREB1::NR4A3	Mesenchymal tumor, special type | Leiomyosarcoma
GREB1::PDE1A	Adenocarcinoma
GREB1::SS18	Mesenchymal tumor, special type
GREB1L::CEP192	Adenocarcinoma
GREB1L::TMEM241	Multiple myeloma
GRHL2::ANKRD46	Adenocarcinoma
GRHL2::BAALC	Adenocarcinoma
GRHL2::CDPF1	Squamous cell carcinoma
GRHL2::COL14A1	Adenocarcinoma
GRHL2::CRMP1	Squamous cell carcinoma
GRHL2::CYRIA	Transitional cell carcinoma
GRHL2::ERG	Adenocarcinoma | Adenosquamous carcinoma
GRHL2::KCNRG	Squamous cell carcinoma
GRHL2::LRRC63	Adenocarcinoma
GRHL2::MATN2	Adenocarcinoma
GRHL2::NCALD	Adenocarcinoma
GRHL2::NRBP2	Adenocarcinoma
GRHL2::PAGE3	Adenocarcinoma
GRHL2::POLR2K	Adenocarcinoma
GRHL2::PRXL2A	Adenocarcinoma
GRHL2::RSPO2	Adenocarcinoma
GRHL2::SNAP25	Adenocarcinoma
GRHL2::SPAG1	Squamous cell carcinoma
GRHL2::TPD52	Adenocarcinoma
GRHL2::TRAPPC9	Adenocarcinoma
GRHL2::TRIM13	Squamous cell carcinoma
GRHL2::TSPAN14	Adenocarcinoma
GRHL2::ZFHX4	Adenocarcinoma
GRHPR::BCL6	Follicular lymphoma
GRHPR::C3	Diffuse large B-cell lymphoma
GRHPR::GATA3	Adenocarcinoma
GRHPR::ZCCHC7	Adenocarcinoma
GRIA1::RAD17	Malignant melanoma
GRIA4::NAALAD2	Astrocytoma, grade I-II
GRID1::AFAP1L2	Mesenchymal tumor, NOS
GRID1::CXCL12	Malignant melanoma
GRID1::DPM1	Acute myeloblastic leukemia with maturation (FAB type M2)
GRID1::GLUD1	Transitional cell carcinoma
GRID1::HECTD2	Malignant melanoma
GRID1::PGPEP1L	Adenocarcinoma
GRIK2::ARMC2	Adenocarcinoma
GRIK2::CDKAL1	Adenocarcinoma
GRIK2::EYS	Astrocytoma, grade I-II
GRIK2::GPC1	Malignant melanoma
GRIK2::MANEA	Malignant melanoma
GRIK2::RNF217	Mesenchymal tumor, NOS
GRIK2::SOBP	Adenocarcinoma
GRIK2::WASF1	Mesenchymal tumor, NOS
GRIK4::EHBP1L1	Malignant melanoma
GRIK4::KMT2A	Soft tissue tumor, special type
GRIK4::SESN1	Adenocarcinoma
GRIK4::TMPRSS4	Adenocarcinoma
GRIK5::HECTD4	Adenocarcinoma
GRIK5::ZNF829	Adenocarcinoma
GRIN2A::HAPSTR1	Adenocarcinoma
GRIN2A::MTHFD1L	Mesenchymal tumor, NOS
GRIN2A::RASSF8	Astrocytoma, grade I-II
GRIN2B::CIT	Soft tissue tumor, NOS
GRIN2B::CYP4F3	Adenocarcinoma
GRIN2B::MANSC1	Adenocarcinoma
GRIN2C::ERBB2	Carcinoma, NOS
GRINA::MUC6	Adenocarcinoma
GRIP1::DAZL	Mesenchymal tumor, NOS
GRIP1::HSD17B6	Mesenchymal tumor, NOS
GRIP1::NR2E3	Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
GRIP1::RXYLT1	Mesenchymal tumor, NOS
GRIP1::TNIP1	Adenocarcinoma
GRIP1::XCL1	Squamous cell carcinoma
GRIPAP1::NTRK1	Adenocarcinoma
GRIPAP1::RET	Carcinoma, NOS
GRIPAP1::SYP	Adenocarcinoma
GRIPAP1::TFE3	Adenocarcinoma
GRK2::BAIAP2	Adenocarcinoma
GRK2::IGHMBP2	Adenocarcinoma
GRK2::IQGAP1	Adenocarcinoma
GRK2::POLD4	Adenocarcinoma
GRK2::STAT6	Acute myeloid leukemia, NOS | Skin
GRK2::TPCN2	Adenocarcinoma
GRK3::AP1B1	Acute myeloid leukemia, NOS | Skin | Transitional cell carcinoma
GRK3::CHEK2	Adenocarcinoma
GRK3::EP300	Malignant melanoma
GRK3::NBPF14	Adenocarcinoma
GRK3::RHBDL3	Transitional cell carcinoma
GRK3::SF3A1	Adenocarcinoma
GRK3::SYCE3	Miscellaneous hematopoietic/lymphoid neoplasm, special type
GRK3::ZNRF3	Adenocarcinoma
GRK5::PDZD8	Squamous cell carcinoma
GRK5::SUMF1	Mesenchymal tumor, NOS
GRK6::DBN1	Adenocarcinoma
GRK6::ZNF346	Adenocarcinoma
GRM1::CNOT2	Mesenchymal tumor, NOS
GRM3::MET	Carcinoma, NOS
GRM7::MBD2	Adenocarcinoma
GRN::CDKN3	Transitional cell carcinoma
GRN::CLCN3	Squamous cell carcinoma
GRN::COL11A1	Squamous cell carcinoma
GRN::ERBB3	Adenocarcinoma
GRN::FAR1	Transitional cell carcinoma
GRN::NCALD	Adenocarcinoma
GRN::PLAT	Squamous cell carcinoma
GRN::ZC3H3	Transitional cell carcinoma
GRPEL2::AFAP1L1	Adenocarcinoma
GRSF1::ELFN2	Adenocarcinoma
GRTP1::ADPRHL1	Adenocarcinoma
GRTP1::COL4A2	Adenocarcinoma
GRTP1::SPATC1L	Mesenchymal tumor, NOS
GSAP::AGK	Adenocarcinoma
GSAP::FMNL2	Adenocarcinoma
GSAP::STYXL1	Astrocytoma, grade III-IV/Glioblastoma
GSDMB::NT5C3B	Adenocarcinoma
GSDMC::CYRIB	Adenocarcinoma
GSE1::C16ORF74	Malignant melanoma
GSE1::CDH13	Adenocarcinoma
GSE1::CRISPLD2	Adenocarcinoma
GSE1::EMC8	Squamous cell carcinoma
GSE1::GLYR1	Adenocarcinoma
GSE1::HSD17B2	Adenocarcinoma
GSE1::KIAA0513	Adenocarcinoma
GSE1::METTL23	Adenocarcinoma
GSE1::NONO	Adenocarcinoma
GSE1::NOTCH3	Adenocarcinoma
GSE1::TPM4	Carcinoma, NOS
GSE1::USP10	Adenocarcinoma
GSK3A::CNFN	Adenocarcinoma
GSK3A::CXCL17	Adenocarcinoma
GSK3A::NTF4	Adenocarcinoma
GSK3A::ZNF564	Adenocarcinoma
GSK3B::ARNT	Adenocarcinoma
GSK3B::ATP11B	Adenocarcinoma
GSK3B::BEST3	Mesenchymal tumor, NOS
GSK3B::CD80	Adenocarcinoma
GSK3B::CFAP91	Adenocarcinoma
GSK3B::COL8A1	Adenocarcinoma
GSK3B::COX17	Adenocarcinoma
GSK3B::FGFR1	Adenocarcinoma
GSK3B::FSTL1	Adenocarcinoma
GSK3B::GPR156	Adenocarcinoma
GSK3B::IMPG2	Squamous cell carcinoma
GSK3B::LSAMP	Adenocarcinoma
GSK3B::PLA1A	Adenocarcinoma
GSK3B::RASSF2	Adenocarcinoma
GSK3B::SEMA5B	Adenocarcinoma
GSK3B::TIAM1	Acute myeloid leukemia, NOS | Skin
GSK3B::TMEM31	Adenocarcinoma
GSK3B::TSC22D2	Adenocarcinoma
GSK3B::WNK2	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
GSKIP::CLDN6	Adenocarcinoma
GSKIP::TRIP11	Soft tissue tumor, NOS
GSN::AKAP13	Adenocarcinoma
GSN::CTNNB1	Adenocarcinoma
GSN::DDX27	Squamous cell carcinoma
GSN::FAR1	Adenocarcinoma
GSN::HLA-DPB1	Adenocarcinoma
GSN::HLA-F	Adenocarcinoma
GSN::HSPA8	Transitional cell carcinoma
GSN::TRA2A	Adenocarcinoma
GSN::UTRN	Squamous cell carcinoma
GSN::UVRAG	Adenocarcinoma
GSR::CSMD1	Adenocarcinoma
GSR::OTOA	Squamous cell carcinoma
GSR::RBPMS	Adenocarcinoma
GSR::STMN2	Adenocarcinoma
GSS::ACSS2	Adenocarcinoma
GSS::TTI1	Adenocarcinoma
GSTA4::NADSYN1	Adenocarcinoma
GSTO1::INA	Adenocarcinoma
GSTP1::ARFGEF2	Malignant melanoma
GSTP1::ATP5MC3	Squamous cell carcinoma
GSTP1::ELP4	Transitional cell carcinoma
GSTP1::SF3B2	Malignant melanoma
GSTT1::NF2	Mesothelioma
GTDC1::STON1	Mature B-cell neoplasm, NOS
GTF2A1::NCOA2	Mesenchymal tumor, special type
GTF2A1::POMT2	Adenocarcinoma
GTF2A1::PRORP	Adenocarcinoma
GTF2A2::MYO1E	Adenocarcinoma
GTF2B::BPI	Adenocarcinoma
GTF2B::KYAT3	Adenocarcinoma
GTF2B::ODF2L	Adenocarcinoma
GTF2E2::ACE	Adenocarcinoma
GTF2E2::ADAM32	Adenocarcinoma
GTF2E2::EIF4EBP1	Adenocarcinoma
GTF2E2::FBXO16	Adenocarcinoma
GTF2E2::FGFR1	Adenocarcinoma
GTF2E2::FUT10	Adenocarcinoma
GTF2E2::GSR	Adenocarcinoma
GTF2E2::HEATR4	Adenocarcinoma
GTF2E2::NARS2	Adenocarcinoma
GTF2E2::RBPMS	Adenocarcinoma
GTF2E2::ROBO2	Adenocarcinoma
GTF2F1::ACP5	Malignant melanoma
GTF2F2::CTIF	Adenocarcinoma
GTF2F2::GPALPP1	Squamous cell carcinoma | Adenocarcinoma
GTF2F2::GPC5	Adenocarcinoma
GTF2F2::NBEA	Adenocarcinoma
GTF2F2::RSF1	Squamous cell carcinoma
GTF2F2::S100A3	Transitional cell carcinoma
GTF2F2::S100A4	Transitional cell carcinoma
GTF2H1::HPS5	Adenocarcinoma
GTF2H1::PSMA1	Squamous cell carcinoma
GTF2H3::DDX55	Adenocarcinoma
GTF2H3::NCOR2	Malignant melanoma
GTF2H3::NUAK1	Mesenchymal tumor, NOS
GTF2H3::PGC	Astrocytoma, grade III-IV/Glioblastoma
GTF2H5::SNX9	Squamous cell carcinoma
GTF2I::BRAF	Malignant melanoma | Astrocytoma, pilocytic/juvenile
GTF2I::BUD23	Adenocarcinoma
GTF2I::CLIP2	Adenocarcinoma
GTF2I::EIF4H	Adenocarcinoma
GTF2I::FLAD1	Adenocarcinoma
GTF2I::GTF2IRD1	Adenocarcinoma
GTF2I::NCOA2	Soft tissue tumor, special type
GTF2I::NOS1AP	Malignant melanoma
GTF2I::NTRK1	Glioma, NOS
GTF2I::NTRK2	Glioma, NOS
GTF2I::PGPEP1	Adenocarcinoma
GTF2I::POM121	Adenocarcinoma
GTF2I::RALGPS1	Mesenchymal tumor, special type
GTF2I::RARA	Skin | Acute promyelocytic leukemia (FAB type M3) | Acute myeloid leukemia, NOS
GTF2I::USP6	Aneurysmal bone cyst
GTF2IRD1::ALK	Adenocarcinoma
GTF2IRD1::CCDC146	Adenocarcinoma
GTF2IRD1::CLIP2	Malignant epithelial tumor, special type | Adenocarcinoma
GTF2IRD1::DUS3L	Adenocarcinoma
GTF2IRD1::HSPB1	Squamous cell carcinoma
GTF2IRD1::LIMK1	Adenocarcinoma
GTF2IRD1::POLD2	Malignant epithelial tumor, special type
GTF2IRD1::RHBDD2	Adenocarcinoma
GTF2IRD1::SEM1	Squamous cell carcinoma
GTF2IRD1::ZAN	Adenocarcinoma
GTF3C2::WDR35	Adenocarcinoma
GTF3C3::COL5A2	Adenocarcinoma
GTF3C4::LMX1B	Adenocarcinoma
GTF3C5::PHF2	Malignant melanoma
GTF3C6::AFG1L	Adenocarcinoma
GTPBP10::BARD1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
GTPBP10::VPS50	Adenocarcinoma
GTPBP1::CD101	Malignant epithelial tumor, special type
GTPBP1::CDC42EP1	Adenocarcinoma
GTPBP1::FAM227A	Squamous cell carcinoma
GTPBP1::TOMM22	Adenocarcinoma
GTPBP2::H2BC11	Adenocarcinoma
GTPBP2::POLH	Adenocarcinoma
GTPBP2::RSPH9	Adenocarcinoma
GTPBP2::USP49	Malignant melanoma
GTPBP2::VEGFA	Adenocarcinoma
GTPBP3::RBM42	Malignant melanoma
GTSE1::ATXN10	Adenocarcinoma
GTSE1::TTC38	Squamous cell carcinoma | Malignant melanoma
GUCA2A::ERG	Adenocarcinoma
GUCD1::LHFPL7	Adenocarcinoma
GUCD1::MB	Malignant melanoma
GUCY1A1::SIK3	Transitional cell carcinoma
GUCY1A2::NLK	Transitional cell carcinoma
GUCY1B1::PTPRG	Mesenchymal tumor, NOS
GUCY2C::ART4	Adenocarcinoma
GUK1::ARF1	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Mature B-cell neoplasm, NOS
GUK1::TARBP1	Adenocarcinoma
GUK1::TMEM216	Adenocarcinoma
GUK1::TPPP	Adenocarcinoma
GUK1::USH2A	Adenocarcinoma
GULP1::BOLL	Transitional cell carcinoma
GULP1::FSIP2	Adenocarcinoma
GULP1::KCNJ13	Adenocarcinoma
GULP1::NCKAP1	Adenocarcinoma
GULP1::NUP35	Adenocarcinoma
GULP1::TFPI	Adenocarcinoma
GXYLT1::YAF2	Adenocarcinoma | Acute lymphoblastic leukemia/lymphoblastic lymphoma
GXYLT2::NEK3	Malignant melanoma
GXYLT2::PRICKLE2	Malignant melanoma
GXYLT2::VAV1	Adenocarcinoma
GYS1::EML2	Adenocarcinoma
GYS1::HOMER3	Adenocarcinoma
GZMM::HNRNPM	Squamous cell carcinoma
H1-0::ACTB	Adenocarcinoma
H2AC15::SCGN	Adenocarcinoma
H2AC6::C6ORF89	Adenocarcinoma
H2AC6::H4C5	Adenocarcinoma
H2AC6::HP1BP3	Transitional cell carcinoma
H2AC6::LHFPL2	Adenocarcinoma
H2AC6::SLC17A4	Adenocarcinoma
H2AC6::TNFRSF21	Malignant melanoma
H2AC8::CLVS2	Adenocarcinoma
H2AJ::ARFGEF2	Adenocarcinoma
H2AX::WDR18	Acute erythroleukemia (FAB type M6)
H2AZ2::CDC45	Adenocarcinoma
H2AZ2::UBASH3A	Adenocarcinoma
H2BC21::NDUFV1	Adenocarcinoma
H2BC5::MDN1	Adenocarcinoma
H2BC9::H2AC6	Adenocarcinoma
H3-3B::CCT5	Astrocytoma, grade I-II
H3-3B::PLAG1	Nodular fasciitis
H3-3B::TRIM47	Adenocarcinoma
H3C4::H2BC5	Squamous cell carcinoma
H4C16::CLEC1A	Squamous cell carcinoma
H4C16::ERP27	Adenocarcinoma
H4C16::LRP6	Adenocarcinoma
H4C16::MGP	Adenocarcinoma
H4C16::PCCB	Adenocarcinoma
H4C16::RERG	Adenocarcinoma
H4C5::H4C2	Adenocarcinoma
H4C9::BCL6	Mature B-cell neoplasm, NOS | Diffuse large B-cell lymphoma | Follicular lymphoma | Adenocarcinoma
H6PD::CA6	Transitional cell carcinoma
H6PD::CRISP3	Adenocarcinoma
H6PD::HIVEP3	Adenocarcinoma
HABP2::LAPTM4B	Adenocarcinoma
HACD2::MYLK	Mature B-cell neoplasm, NOS
HACD2::RSRC1	Adenocarcinoma
HACD3::ANKDD1A	Adenocarcinoma
HACD3::RAB11A	Squamous cell carcinoma
HACD3::URM1	Adenocarcinoma
HACE1::ASCC3	Squamous cell carcinoma
HACE1::FBLN1	Adenocarcinoma
HACE1::LIN28B	Multiple myeloma
HACL1::COLQ	Nonneoplastic epithelial disorder/lesion | Nonneoplastic hematologic disorder/lesion
HACL1::METTL6	Squamous cell carcinoma
HACL1::RAF1	Adenocarcinoma
HADH::HPGD	Adenocarcinoma
HADH::ZP2	Adenocarcinoma
HADHA::DNAJC27	Transitional cell carcinoma
HADHA::PRKAR1B	Squamous cell carcinoma
HADHB::CENPO	Squamous cell carcinoma
HAGH::ZNF598	Adenocarcinoma
HAMP::GPI	Adenocarcinoma
HAND2::SLC30A9	Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
HAO1::ALK	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma
HAP1::CDC6	Adenocarcinoma
HAP1::GAST	Adenocarcinoma
HAP1::WIPF2	Adenocarcinoma
HAPLN1::EDIL3	Malignant melanoma
HAPLN3::RLBP1	Adenocarcinoma
HAPLN4::MEF2B	Adenocarcinoma
HAPSTR1::ABAT	Adenocarcinoma
HAPSTR1::ACSM2A	Adenocarcinoma
HARBI1::PTPRS	Astrocytoma, grade III-IV/Glioblastoma
HARBI1::TNS3	Astrocytoma, grade I-II
HARS1::CLINT1	Adenocarcinoma
HARS1::FAM53C	Adenocarcinoma
HARS1::TMCO6	Squamous cell carcinoma
HARS2::ZMAT2	Nonneoplastic epithelial disorder/lesion | Acute myeloid leukemia, NOS | Skin | Adenocarcinoma
HAS2::HHLA1	Adenocarcinoma
HAS2::PLAG1	Lipoblastoma
HAS3::SNTB2	Squamous cell carcinoma
HAT1::EXOC6B	Adenocarcinoma
HAUS1::RAB10	Malignant epithelial tumor, special type
HAUS2::SNAP23	Astrocytoma, grade I-II
HAUS4::CAT	Adenocarcinoma
HAUS6::MORC1	Adenocarcinoma
HAUS6::PLIN2	Adenocarcinoma
HAUS6::PMPCA	Squamous cell carcinoma
HAUS8::BRME1	Adenocarcinoma
HAUS8::CARS1	Transitional cell carcinoma
HAUS8::QTRT1	Mesenchymal tumor, NOS
HAUS8::SGTA	Adenocarcinoma
HAUS8::TEX101	Astrocytoma, grade I-II
HAUS8::ZNF846	Adenocarcinoma
HAVCR1::TIMD4	Adenocarcinoma
HBA1::CD74	Acute lymphoblastic leukemia/lymphoblastic lymphoma
HBA1::IGK	Multiple myeloma
HBA2::PCBP4	Astrocytoma, grade III-IV/Glioblastoma
HBB::IGH	Multiple myeloma
HBB::IGK	Multiple myeloma
HBEGF::RBM27	Fibroblastic/myofibroblastic tumor, special type
HBG1::HBE1	Skin | Acute myeloid leukemia, NOS
HBG2::TRIM22	Squamous cell carcinoma
HBP1::ATXN7L1	Adenocarcinoma
HBP1::LHFPL3	Adenocarcinoma
HBP1::PIK3CG	Adenocarcinoma
HBP1::PRKAR2B	Adenocarcinoma
HBP1::SLC26A5	Adenocarcinoma
HBS1L::AHI1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
HBS1L::ARMC2	Adenocarcinoma
HBS1L::IL9	Adenocarcinoma
HCFC1::EPHA5	Squamous cell carcinoma
HCFC1::IRAK1	Adenocarcinoma
HCFC1::MECP2	Adenocarcinoma
HCFC1::MRFAP1	Malignant melanoma
HCFC2::ANKS1B	Astrocytoma, grade I-II
HCK::CCM2L	Squamous cell carcinoma
HCN1::SPEF2	Malignant melanoma
HCN2::BSG	Astrocytoma, grade I-II
HCN2::C2CD6	Squamous cell carcinoma
HDAC10::MORN5	Adenocarcinoma
HDAC11::CDH18	Mesenchymal tumor, NOS
HDAC11::COLQ	Astrocytoma, grade III-IV/Glioblastoma
HDAC1::EIF3I	Adenocarcinoma
HDAC1::KPNA6	Adenocarcinoma
HDAC1::LCK	Adenocarcinoma
HDAC1::LRRC42	Astrocytoma, grade I-II
HDAC1::PEPD	Transitional cell carcinoma
HDAC1::PTPRU	Adenocarcinoma
HDAC1::SERINC2	Astrocytoma, grade III-IV/Glioblastoma
HDAC1::ZBTB8B	Adenocarcinoma
HDAC2::ROS1	Adenocarcinoma
HDAC2::RSPO3	Adenocarcinoma
HDAC2::TRDN	Adenocarcinoma
HDAC4::BRAT1	Astrocytoma, grade I-II
HDAC4::GAS8	Adenocarcinoma
HDAC4::GHR	Acute lymphoblastic leukemia/lymphoblastic lymphoma
HDAC4::PDE11A	Malignant melanoma
HDAC4::SATB2	Transitional cell carcinoma
HDAC4::SNX18	Adenocarcinoma
HDAC4::THAP4	Adenocarcinoma
HDAC4::UPB1	Adenocarcinoma
HDAC5::MSR1	Adenocarcinoma
HDAC5::MYO18A	Astrocytoma, grade I-II
HDAC5::PPY	Adenocarcinoma
HDAC5::SCPEP1	Multiple myeloma
HDAC5::SLC13A2	Miscellaneous hematopoietic/lymphoid neoplasm, special type | Benign epithelial tumor, special type
HDAC7::ACSS3	Mesenchymal tumor, NOS
HDAC7::COL2A1	Adenocarcinoma
HDAC7::IRAK4	Adenocarcinoma
HDAC7::SRGAP1	Mesenchymal tumor, NOS
HDAC7::VDR	Adenocarcinoma
HDAC7::VSTM2B	Adenocarcinoma
HDAC8::CITED1	Adenocarcinoma
HDAC8::PHKA1	Adenocarcinoma
HDAC8::RPS4X	Adenocarcinoma
HDAC9::C1ORF105	Malignant epithelial tumor, special type
HDAC9::C1orf105	Malignant epithelial tumor, special type
HDAC9::C8ORF34	Squamous cell carcinoma
HDAC9::C8orf34	Squamous cell carcinoma
HDAC9::CPQ	Astrocytoma, grade I-II
HDAC9::LINGO2	Malignant melanoma
HDAC9::PPL	Adenocarcinoma
HDAC9::SNX10	Adenocarcinoma
HDDC2::FAM47E	Adenocarcinoma
HDDC2::SRSF11	Adenocarcinoma
HDDC2::STBD1	Adenocarcinoma
HDDC2::TPD52L1	Transitional cell carcinoma
HDGF::METTL25B	Adenocarcinoma
HDGF::S100A10	Adenocarcinoma
HDHD2::SNF8	Adenocarcinoma
HDLBP::ANKS1A	Adenocarcinoma
HDLBP::BIRC6	Squamous cell carcinoma
HDLBP::CADM2	Adenocarcinoma
HDLBP::CLASP2	Adenocarcinoma
HDLBP::DDX27	Adenocarcinoma
HDLBP::DSP	Adenocarcinoma
HDLBP::EEA1	Malignant melanoma
HDLBP::FGFR1	Adenocarcinoma
HDLBP::NSRP1	Adenocarcinoma
HDLBP::SMARCE1	Adenocarcinoma
HDLBP::SPON2	Adenocarcinoma
HDLBP::STAT6	Adenocarcinoma
HDLBP::TMC1	Adenocarcinoma
HDLBP::TMPRSS2	Adenocarcinoma
HDX::ERICH1	Mesenchymal tumor, NOS
HEATR3::CHRNB3	Adenocarcinoma
HEATR5A::COL1A1	Adenocarcinoma
HEATR5B::CENPE	Acute myelomonocytic leukemia (FAB type M4)
HEATR5B::MYB	Adenocarcinoma
HEATR5B::NCALD	Malignant melanoma
HEATR6::CHCT1	Adenocarcinoma
HEATR6::FGF10	Adenocarcinoma
HEATR6::GALNT13	Adenocarcinoma
HEATR6::MIEN1	Adenocarcinoma
HEATR6::PPME1	Adenocarcinoma
HEATR6::STXBP4	Mesenchymal tumor, NOS
HEATR6::USP32	Adenocarcinoma
HEATR6::WEE1	Adenocarcinoma
HEBP1::CREBL2	Adenocarcinoma
HEBP1::NCK1	Squamous cell carcinoma
HEBP1::ZBTB46	Adenocarcinoma
HECTD1::DHRS4L2	Adenocarcinoma
HECTD1::HEATR5A	Adenocarcinoma
HECTD1::PRPF39	Adenocarcinoma
HECTD1::SCFD1	Adenocarcinoma
HECTD2::GLRX3	Adenocarcinoma
HECTD2::PCGF5	Adenocarcinoma
HECTD4::ABTB3	Mesenchymal tumor, NOS
HECTD4::AMDHD1	Mesenchymal tumor, NOS
HECTD4::ANAPC5	Adenocarcinoma
HECTD4::BRAP	Squamous cell carcinoma
HECTD4::CRY1	Astrocytoma, grade I-II
HECTD4::FMNL2	Squamous cell carcinoma
HECTD4::HSPB8	Adenocarcinoma
HECTD4::LTA4H	Mesenchymal tumor, NOS
HECTD4::PEBP1	Squamous cell carcinoma
HECTD4::PKP2	Adenocarcinoma
HECTD4::PPP1CC	Acute lymphoblastic leukemia/lymphoblastic lymphoma
HECTD4::REC114	Adenocarcinoma
HECTD4::RPH3A	Adenocarcinoma
HECTD4::RPL6	Adenocarcinoma
HECTD4::SBNO1	Adenocarcinoma
HECTD4::SRRM4	Adenocarcinoma
HECTD4::TMEM241	Adenocarcinoma
HECTD4::YAP1	Mesenchymal tumor, NOS
HECW1::COA1	Astrocytoma, grade III-IV/Glioblastoma
HECW2::PRKCE	Embryonal nervous system tumor, special type
HEG1::SLC12A8	Adenocarcinoma
HEG1::YAP1	Squamous cell carcinoma
HELB::GRIP1	Squamous cell carcinoma
HELB::MGAT4C	Mesenchymal tumor, NOS
HELLS::CSMD1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
HELLS::TBC1D12	Adenocarcinoma
HELZ2::ADA	Adenocarcinoma
HELZ2::FNDC11	Squamous cell carcinoma
HELZ2::GMEB2	Adenocarcinoma
HELZ::ABCA10	Transitional cell carcinoma
HELZ::CACNG4	Adenocarcinoma
HELZ::CEP112	Transitional cell carcinoma
HELZ::OAZ1	Mesenchymal tumor, NOS
HELZ::PITPNC1	Adenocarcinoma
HELZ::PRCD	Adenocarcinoma
HELZ::PSMD12	Squamous cell carcinoma
HELZ::RBFOX3	Adenocarcinoma
HELZ::SNTA1	Adenocarcinoma
HELZ::TAF15	Adenocarcinoma
HELZ::TTYH2	Adenocarcinoma
HELZ::WIPF2	Squamous cell carcinoma
HENMT1::MYBPHL	Adenocarcinoma
HEPH::ZC3H12B	Adenocarcinoma
HEPHL1::GUCY1A2	Squamous cell carcinoma
HERC1::CSNK1G1	Adenocarcinoma
HERC1::DAPK2	Adenocarcinoma | Transitional cell carcinoma
HERC1::INTS14	Transitional cell carcinoma
HERC1::MYO5A	Adenocarcinoma
HERC1::PCLAF	Adenocarcinoma
HERC1::SNX6	Adenocarcinoma
HERC1::USP3	Adenocarcinoma
HERC2::IGFBP6	Malignant melanoma
HERC2::SLC12A2	Adenocarcinoma
HERC2::TMEM145	Adenocarcinoma
HERC3::RASGEF1B	Adenocarcinoma
HERC4::CCDC6	Adenocarcinoma
HERC4::CDKAL1	Transitional cell carcinoma
HERC4::CTNNA3	Squamous cell carcinoma
HERC4::PBLD	Adenocarcinoma
HERC4::RUFY2	Adenocarcinoma
HERC4::TMPRSS15	Embryonal rhabdomyosarcoma
HERC6::CABP4	Squamous cell carcinoma
HERPUD1::ERG	Adenocarcinoma
HERPUD1::IGK	Multiple myeloma
HERPUD1::RAF1	Adenocarcinoma
HERPUD1::THADA	Malignant epithelial tumor, special type
HERPUD2::AOAH	Adenocarcinoma
HES4::AFF1	Adenocarcinoma
HEXA::BBS4	Squamous cell carcinoma
HEXA::MYO9A	Malignant melanoma
HEXB::FAM169A	Adenocarcinoma
HEXB::SUPT16H	Adenocarcinoma
HEXD::CYBC1	Astrocytoma, grade I-II
HEXD::SLC16A3	Adenocarcinoma
HEY1::NCOA2	Chondrosarcoma, mesenchymal | Mesenchymal tumor, special type | Undifferentiated round cell sarcoma | Soft tissue tumor, special type | Osteosarcoma, NOS
HEYL::COL9A2	Adenocarcinoma
HFM1::ETV1	Epithelioid hemangioendothelioma | Undifferentiated round cell sarcoma
HGD::CACNA1D	Adenocarcinoma
HGD::RABL3	Adenocarcinoma
HGS::ARFGEF2	Acute myeloid leukemia, NOS | Skin
HGS::BAIAP2	Adenocarcinoma
HGS::GNAO1	Squamous cell carcinoma
HGS::IGK	Multiple myeloma
HGSNAT::FUT10	Transitional cell carcinoma
HGSNAT::GPAT4	Squamous cell carcinoma
HGSNAT::MBOAT1	Adenocarcinoma
HGSNAT::VSTM2B	Adenocarcinoma
HHAT::CD34	Adenocarcinoma
HHAT::COP1	Adenocarcinoma
HHAT::DESI2	Squamous cell carcinoma
HHAT::KIF5B	Adenocarcinoma
HHAT::SERTAD4	Adenocarcinoma
HHIPL1::CCNK	Mesenchymal tumor, NOS
HHIPL2::TLR5	Adenocarcinoma
HIBADH::BRAF	Malignant melanoma
HIBADH::SUGCT	Astrocytoma, grade III-IV/Glioblastoma
HIBCH::CTNNA2	Adenocarcinoma
HIBCH::DLX1	Adenocarcinoma
HIBCH::INPP1	Squamous cell carcinoma
HIBCH::MFSD6	Squamous cell carcinoma
HIBCH::NEMP2	Squamous cell carcinoma
HIBCH::STAT1	Adenocarcinoma
HIC2::SNX2	Malignant melanoma
HID1::DNAH17	Adenocarcinoma
HID1::JPT1	Adenocarcinoma
HID1::SRP68	Squamous cell carcinoma
HID1::STIM2	Adenocarcinoma
HID1::SUMO2	Transitional cell carcinoma
HIF1A::ARMH4	Mesenchymal tumor, NOS
HIF1A::LRRC9	Adenocarcinoma
HIF1A::MNAT1	Adenocarcinoma
HIF1A::PRKCH	Adenocarcinoma
HIF1A::VRK1	Astrocytoma, grade I-II
HIKESHI::TENM1	Adenocarcinoma
HILPDA::SND1	Adenocarcinoma
HINT2::NPR2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
HINT3::WDR70	Squamous cell carcinoma
HIP1::ALK	Adenocarcinoma
HIP1::PDGFRB	Chronic myelomonocytic leukemia | Spleen
HIP1::SLC30A5	Malignant melanoma
HIP1::STYXL1	Adenocarcinoma
HIP1R::KCNMB4	Astrocytoma, grade I-II
HIP1R::MTRFR	Adenocarcinoma
HIPK1::LRRC42	Adenocarcinoma
HIPK2::ADCK2	Adenocarcinoma
HIPK2::ARHGEF5	Adenocarcinoma
HIPK2::ARPC1A	Malignant melanoma
HIPK2::CPSF4	Adenocarcinoma
HIPK2::DENND2A	Adenocarcinoma
HIPK2::ELP5	Acute myeloid leukemia, NOS | Skin
HIPK2::GRM8	Squamous cell carcinoma
HIPK2::MYCBP2	Adenocarcinoma
HIPK2::PARP12	Adenocarcinoma
HIPK2::STRIP2	Mesenchymal tumor, NOS
HIPK2::TMEM130	Transitional cell carcinoma
HIPK2::YAP1	Desmoid-type fibromatosis
HIPK3::CAT	Adenocarcinoma
HIPK3::DPAGT1	Mesothelioma
HIPK3::LARGE2	Squamous cell carcinoma
HIPK3::TOLLIP	Adenocarcinoma
HIRA::ADAM2	Adenocarcinoma
HIRA::BCL2L13	Squamous cell carcinoma
HIRA::CABIN1	Adenocarcinoma
HIRA::NSMCE2	Mesenchymal tumor, NOS
HIRA::ZBTB16	Astrocytoma, grade I-II
HIVEP1::DST	Adenocarcinoma
HIVEP1::MAPK1	Adenocarcinoma
HIVEP1::PTCRA	Adenocarcinoma
HIVEP1::TXNDC5	Malignant melanoma
HIVEP2::AHI1	Transitional cell carcinoma
HIVEP2::MAP7	Mesenchymal tumor, NOS
HIVEP2::MTHFD1L	Adenocarcinoma
HIVEP2::MYRFL	Mesenchymal tumor, NOS
HIVEP2::PREP	Adenocarcinoma
HIVEP2::SMAP1	Adenocarcinoma
HIVEP2::SMOC2	Adenocarcinoma
HIVEP3::ASCC3	Adenocarcinoma
HIVEP3::CREB3L4	Adenocarcinoma
HIVEP3::DOT1L	Malignant melanoma
HIVEP3::FYB2	Malignant melanoma
HIVEP3::GPBP1L1	Adenocarcinoma
HIVEP3::RPH3AL	Squamous cell carcinoma
HIVEP3::ZMYND12	Transitional cell carcinoma
HJURP::EIF4E2	Adenocarcinoma
HK1::CTNNA3	Adenocarcinoma
HK1::SUPV3L1	Adenocarcinoma
HK1::UTP23	Adenocarcinoma
HK2::ONECUT3	Adenocarcinoma
HK2::ZNF121	Adenocarcinoma
HKDC1::SUPV3L1	Adenocarcinoma
HLA-A::IGK	Multiple myeloma
HLA-A::KIFC3	Malignant melanoma
HLA-A::ROS1	Melanocytic neoplasm, special type | Adenocarcinoma
HLA-B::CBS	Adenocarcinoma
HLA-B::CCT5	Squamous cell carcinoma
HLA-B::CFB	Mesothelioma
HLA-B::CLCN3	Adenocarcinoma
HLA-B::EIF2AK2	Transitional cell carcinoma
HLA-B::IGLL5	Multiple myeloma
HLA-B::IQCE	Malignant melanoma
HLA-B::RNASEH2B	Adenocarcinoma
HLA-B::SNW1	Adenocarcinoma
HLA-B::UBR5	Adenocarcinoma
HLA-C::CFB	Adenocarcinoma
HLA-C::DDX21	Adenocarcinoma
HLA-C::EIF2AK2	Transitional cell carcinoma
HLA-C::FADS2	Adenocarcinoma
HLA-C::FOXP1	Adenocarcinoma
HLA-C::TCOF1	Squamous cell carcinoma
HLA-C::TYK2	Adenocarcinoma
HLA-DOA::MUC21	Squamous cell carcinoma
HLA-DPA1::SQSTM1	Adenocarcinoma
HLA-DPA1::TRIP12	Malignant melanoma
HLA-DPB1::MLN	Adenocarcinoma
HLA-DQB2::MET	Adenocarcinoma
HLA-DRA::EEA1	Malignant melanoma
HLA-DRA::SNW1	Malignant melanoma
HLA-DRB1::MET	Carcinoma, NOS
HLA-DRB5::MET	Carcinoma, NOS
HLA-E::HLA-B	Squamous cell carcinoma
HLCS::ATP5PO	Malignant epithelial tumor, special type
HLCS::CD53	Adenocarcinoma
HLCS::GRIK1	Adenocarcinoma
HLCS::IL10RB	Adenocarcinoma
HLCS::KIAA1755	Adenocarcinoma
HLCS::SLC37A1	Adenocarcinoma
HLCS::STRA8	Adenocarcinoma
HLCS::TSPEAR	Squamous cell carcinoma
HLCS::YBEY	Astrocytoma, grade I-II
HLTF::OTOL1	Squamous cell carcinoma
HLTF::TM4SF1	Adenocarcinoma
HLTF::WWTR1	Adenocarcinoma
HM13::CPQ	Adenocarcinoma
HM13::DEFB123	Adenocarcinoma
HM13::TSPAN31	Acute lymphoblastic leukemia/lymphoblastic lymphoma
HM13::ZBTB46	Adenocarcinoma
HMBOX1::ALK	Mesenchymal tumor, special type
HMBOX1::BNIP3L	Mesenchymal tumor, NOS
HMBOX1::CLU	Astrocytoma, grade I-II
HMBOX1::ELP3	Adenocarcinoma
HMBOX1::FSTL5	Mesenchymal tumor, NOS
HMBOX1::JAK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
HMBOX1::MCM3	Mesenchymal tumor, NOS
HMBOX1::NRG1	Soft tissue tumor, special type
HMBOX1::NTRK2	Astrocytoma, grade III-IV/Glioblastoma
HMBOX1::NTRK3	Osteogenic/bone tumor, special type
HMBOX1::PNOC	Adenocarcinoma
HMBOX1::SCARA3	Adenocarcinoma
HMBOX1::ZFAND3	Undifferentiated carcinoma, small cell
HMBS::EHBP1	Adenocarcinoma
HMBS::FOXR1	Adenocarcinoma
HMCES::TYK2	Adenocarcinoma
HMCN1::ETNK1	Squamous cell carcinoma
HMCN1::RNF2	Adenocarcinoma | Squamous cell carcinoma
HMCN1::ZSWIM4	Mesenchymal tumor, NOS
HMG20A::RCN2	Squamous cell carcinoma
HMG20A::SCAMP5	Adenocarcinoma
HMGA1::EEA1	Malignant melanoma
HMGA1::LAMA4	Chondroid hamartoma
HMGA1::PPEF1	Adenocarcinoma
HMGA1::RAD51B	Leiomyoma
HMGA2::ACKR3	Lipoma
HMGA2::AICDA	Adenoma
HMGA2::AKAP9	Adenoma
HMGA2::ARFGAP2	Mesenchymal tumor, NOS
HMGA2::BNC2	Leiomyoma
HMGA2::C12ORF42	Soft tissue tumor, special type
HMGA2::C1orf87	Mesenchymal tumor, NOS
HMGA2::CADM2	Adenoma
HMGA2::CCNB1IP1	Leiomyoma
HMGA2::CHMP1A	Adenocarcinoma
HMGA2::COG5	Leiomyoma
HMGA2::COL14A1	Osteogenic/bone tumor, special type
HMGA2::COX6C	Leiomyoma
HMGA2::DAB1	Mesenchymal tumor, NOS
HMGA2::DYRK2	Soft tissue tumor, special type
HMGA2::EBF1	Lipoma
HMGA2::EFCAB6	Chronic myeloproliferative disorder, NOS
HMGA2::EGFR	Astrocytoma, grade III-IV/Glioblastoma
HMGA2::FAM186B	Adenoma
HMGA2::FHIT	Adenoma
HMGA2::GABRA3	Malignant melanoma
HMGA2::GNS	Malignant melanoma
HMGA2::GRIP1	Lipoma
HMGA2::GSN	Lipoblastoma | Lipoma
HMGA2::HNRNPM	Adenocarcinoma
HMGA2::KALRN	Adenocarcinoma
HMGA2::KERA	Adipocytic tumor, NOS
HMGA2::KITLG	Liposarcoma, dedifferentiated
HMGA2::LEMD3	Soft tissue tumor, NOS
HMGA2::LHFPL6	Lipoma
HMGA2::LPP	Lipoma | Chondroma | Chondroid hamartoma
HMGA2::LRMDA	Adenocarcinoma
HMGA2::NAA11	Leiomyoma
HMGA2::NCOR2	Fibroblastic/myofibroblastic tumor, NOS | Soft tissue tumor, special type | Localized giant cell tumor of tendon sheath | Giant cell tumor of bone
HMGA2::NEGR1	Spindle cell/sclerosing rhabdomyosarcoma
HMGA2::NELL2	Mesenchymal tumor, NOS
HMGA2::NFIB	Lipoma | Adenoma
HMGA2::NR2C1	Mesenchymal tumor, NOS
HMGA2::NUP107	Astrocytoma, grade III-IV/Glioblastoma
HMGA2::PCBP2	Mesenchymal tumor, NOS
HMGA2::PLPP3	Lipoma
HMGA2::PLXNC1	Carcinoma, NOS
HMGA2::PPFIA2	Mesenchymal tumor, NOS
HMGA2::PTGER3	Leiomyoma
HMGA2::RAD51B	Leiomyoma | Leiomyosarcoma | Malignant soft tissue tumor, NOS
HMGA2::SARNP	Mesenchymal tumor, NOS
HMGA2::SETBP1	Lipoma | Adipocytic tumor, special type
HMGA2::SLC6A15	Adenoma
HMGA2::SNRPF	Soft tissue tumor, NOS
HMGA2::SOX5	Osteochondroma
HMGA2::TRAF3IP2	Leiomyoma
HMGA2::TUBGCP6	Soft tissue tumor, NOS
HMGA2::WIF1	Malignant epithelial tumor, special type | Adenoma | Mesenchymal tumor, special type | Carcinoma, NOS | Benign epithelial tumor, special type
HMGA2::YAP1	Soft tissue tumor, special type
HMGB1::CRYL1	Adenocarcinoma
HMGCL::S100PBP	Astrocytoma, grade I-II
HMGCLL1::ADGRB3	Ependymoma
HMGCS1::OXCT1	Astrocytoma, grade I-II
HMGCS1::SLC38A9	Adenocarcinoma
HMGCS1::UNC13A	Transitional cell carcinoma
HMGN1::RORA	Adenocarcinoma
HMGN1::UBE2G2	Malignant melanoma
HMGN2::PTMA	Acute lymphoblastic leukemia/lymphoblastic lymphoma
HMGN2::SMPDL3B	Adenocarcinoma
HMGN2::WDTC1	Adenocarcinoma
HMGN3::NDUFB4	Astrocytoma, grade III-IV/Glioblastoma
HMGN3::PAQR8	Adenocarcinoma
HMGXB3::CAPN1	Squamous cell carcinoma
HMGXB3::PAM	Malignant melanoma
HMGXB3::PPARGC1B	Adenocarcinoma | Transitional cell carcinoma
HMGXB4::MGMT	Malignant melanoma
HMOX2::CDIP1	Adenocarcinoma
HNF1B::ANAPC16	Adenocarcinoma
HNF1B::CASC3	Adenocarcinoma
HNF1B::ERBB2	Carcinoma, NOS
HNF1B::NOTCH1	Adenocarcinoma
HNF4A::MYBL2	Mesenchymal tumor, NOS
HNF4A::TTPAL	Adenocarcinoma
HNF4G::TERF2	Adenocarcinoma
HNF4G::TPD52	Adenocarcinoma
HNMT::SPOPL	Adenocarcinoma
HNRNPA1::ALK	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma
HNRNPA1::CSN2	Adenocarcinoma
HNRNPA2B1::CANT1	Adenocarcinoma
HNRNPA2B1::CLASP2	Adenocarcinoma
HNRNPA2B1::DDX5	Chronic lymphocytic leukemia
HNRNPA2B1::DSP	Squamous cell carcinoma
HNRNPA2B1::ETV1	Adenocarcinoma
HNRNPA2B1::HSD17B10	Adenocarcinoma
HNRNPA2B1::PLAG1	Lipoma
HNRNPA2B1::RABEP1	Squamous cell carcinoma
HNRNPA2B1::SIAE	Adenocarcinoma
HNRNPA2B1::SKAP2	Adenocarcinoma | Squamous cell carcinoma
HNRNPA2B1::SLCO1A2	Primitive neuroectodermal tumor/Medulloblastoma | Russia
HNRNPA2B1::UBAP2L	Adenocarcinoma
HNRNPAB::F12	Adenocarcinoma
HNRNPAB::SAMM50	Malignant melanoma
HNRNPC::CHD8	Adenocarcinoma
HNRNPC::PAPOLA	Transitional cell carcinoma
HNRNPC::PLAG1	Lipoblastoma
HNRNPC::RARA	Acute promyelocytic leukemia (FAB type M3)
HNRNPC::RARG	Acute promyelocytic leukemia (FAB type M3)
HNRNPC::RIOK2	Adenocarcinoma
HNRNPC::TTC39B	Adenocarcinoma
HNRNPC::WRN	Adenocarcinoma
HNRNPC::ZBTB7C	Adenocarcinoma
HNRNPC::ZNF219	Acute lymphoblastic leukemia/lymphoblastic lymphoma
HNRNPD::CFAP299	Adenocarcinoma
HNRNPD::PRKG2	Mesothelioma
HNRNPD::SCD5	Squamous cell carcinoma
HNRNPF::ATAD1	Adenocarcinoma
HNRNPF::TMLHE	Transitional cell carcinoma
HNRNPF::ZNF33B	Adenocarcinoma
HNRNPF::ZNF569	Adenocarcinoma
HNRNPH1::DDX5	Chronic lymphocytic leukemia
HNRNPH1::ERG	Skin | Acute myeloid leukemia, NOS
HNRNPH1::INSR	Mesenchymal tumor, NOS
HNRNPH1::MLLT10	Acute lymphoblastic leukemia/lymphoblastic lymphoma
HNRNPH1::RNF130	Adenocarcinoma
HNRNPH1::VAPA	Adenocarcinoma
HNRNPH2::CLTRN	Adenocarcinoma
HNRNPH3::ALK	Adenocarcinoma
HNRNPH3::ATAD1	Adenocarcinoma
HNRNPH3::KLK1	Adenocarcinoma
HNRNPH3::SLC29A3	Adenocarcinoma
HNRNPH3::TFE3	Alveolar soft part sarcoma
HNRNPK::PFKP	Adenocarcinoma
HNRNPK::SLC16A11	Adenocarcinoma
HNRNPL::ACTN4	Adenocarcinoma
HNRNPL::CCER2	Adenocarcinoma
HNRNPL::RPS19BP1	Adenocarcinoma
HNRNPL::SELENOW	Adenocarcinoma
HNRNPL::SIRT2	Adenocarcinoma
HNRNPL::TPRX1	Adenocarcinoma
HNRNPLL::NFATC3	Squamous cell carcinoma
HNRNPLL::SERTAD2	Astrocytoma, grade I-II
HNRNPM::CERS4	Adenocarcinoma
HNRNPM::DMD	Mesenchymal tumor, NOS
HNRNPM::KDM4B	Adenocarcinoma
HNRNPM::LEUTX	Undifferentiated round cell sarcoma
HNRNPM::MCOLN1	Malignant epithelial tumor, special type
HNRNPM::PC	Squamous cell carcinoma
HNRNPM::PIAS4	Astrocytoma, grade III-IV/Glioblastoma
HNRNPM::RFX2	Adenocarcinoma
HNRNPM::SLC25A23	Adenocarcinoma
HNRNPR::CNR2	Adenocarcinoma
HNRNPR::E2F2	Squamous cell carcinoma
HNRNPU::IGK	Multiple myeloma
HNRNPU::NTRK3	Glioma, NOS
HNRNPU::SLC36A4	Adenocarcinoma
HNRNPU::ZBTB18	Acute lymphoblastic leukemia/lymphoblastic lymphoma
HNRNPUL1::ATG10	Adenocarcinoma
HNRNPUL1::BCKDHA	Squamous cell carcinoma
HNRNPUL1::BRSK1	Squamous cell carcinoma
HNRNPUL1::CLIP3	Adenocarcinoma
HNRNPUL1::CNN1	Transitional cell carcinoma
HNRNPUL1::DAB1	Mesothelioma
HNRNPUL1::GNG8	Squamous cell carcinoma
HNRNPUL1::IFNL4	Adenocarcinoma
HNRNPUL1::SLC8A2	Adenocarcinoma
HNRNPUL1::TOMM40	Malignant melanoma
HNRNPUL2::AHNAK	Adenocarcinoma
HNRNPUL2::EML3	Malignant melanoma
HNRNPUL2::TTC9C	Adenocarcinoma
HOGA1::UBTD1	Adenocarcinoma
HOMER1::DMGDH	Squamous cell carcinoma
HOMER1::MAST2	Astrocytoma, grade I-II
HOMER2::BTBD1	Adenocarcinoma
HOMER2::TM6SF1	Adenocarcinoma
HOOK1::ALK	Adenocarcinoma
HOOK1::FGGY	Adenocarcinoma
HOOK1::IVD	Adenocarcinoma
HOOK1::RAB6A	Adenocarcinoma
HOOK2::ACTN3	Adenocarcinoma
HOOK2::GADD45GIP1	Squamous cell carcinoma
HOOK2::MAST1	Adenocarcinoma
HOOK2::NFIX	Adenocarcinoma
HOOK2::RTBDN	Squamous cell carcinoma
HOOK2::ZC3H8	Adenocarcinoma
HOOK3::ARFGEF1	Osteosarcoma, NOS
HOOK3::BAALC	Transitional cell carcinoma
HOOK3::C2CD3	Adenocarcinoma
HOOK3::FGFR1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
HOOK3::GPAT4	Adenocarcinoma
HOOK3::GTF2E2	Adenocarcinoma
HOOK3::IKBKB	Adenocarcinoma
HOOK3::MTFR1	Adenocarcinoma
HOOK3::NTRK2	Astrocytoma, grade III-IV/Glioblastoma
HOOK3::PLEKHA2	Adenocarcinoma
HOOK3::RET	Adenocarcinoma
HOOK3::TADA2A	Adenocarcinoma
HOOK3::TGS1	Adenocarcinoma
HOOK3::TM2D2	Adenocarcinoma
HOPX::IGFBP7	Astrocytoma, grade III-IV/Glioblastoma
HOPX::PDCL2	Astrocytoma, grade III-IV/Glioblastoma
HOXA10::CSN1S1	Adenocarcinoma
HOXA10::POLR1F	Acute myeloid leukemia, NOS | Skin
HOXA10::POLR2E	Acute lymphoblastic leukemia/lymphoblastic lymphoma
HOXA10::TRB	Acute lymphoblastic leukemia/lymphoblastic lymphoma
HOXA11::BZW2	Acute megakaryoblastic leukemia (FAB type M7)
HOXA11::ETV6	Skin | Acute myeloid leukemia, NOS
HOXA3::HIBADH	Adenocarcinoma
HOXA3::MATCAP2	Astrocytoma, grade I-II
HOXA3::PARP8	Malignant melanoma
HOXA9::ANGPT1	Acute megakaryoblastic leukemia (FAB type M7)
HOXB3::EPHA5	Malignant melanoma
HOXB3::FAP	Adenocarcinoma
HOXB3::MAPT	Transitional cell carcinoma
HOXB3::PITPNC1	Mature B-cell neoplasm, NOS | Diffuse large B-cell lymphoma
HOXB3::SKAP1	Adenocarcinoma
HOXB3::TCF12	Adenocarcinoma
HOXB6::EPHA5	Malignant melanoma
HOXB6::PITPNC1	Diffuse large B-cell lymphoma
HOXB6::SKAP1	Adenocarcinoma
HOXC10::C6ORF89	Malignant melanoma
HOXC10::PYM1	Astrocytoma, grade III-IV/Glioblastoma
HOXC4::ADAMTS20	Adenoid cystic carcinoma
HOXC4::HOXC12	Adenocarcinoma
HOXC4::KBTBD12	Adenocarcinoma
HOXC6::HOXC12	Adenocarcinoma
HOXC6::KBTBD12	Adenocarcinoma
HOXC6::PYM1	Astrocytoma, grade III-IV/Glioblastoma
HOXC9::PYM1	Astrocytoma, grade III-IV/Glioblastoma
HOXD10::CIR1	Adenocarcinoma
HOXD10::WIPF1	Adenocarcinoma
HOXD11::AGAP3	Skin | Acute myeloid leukemia, NOS
HOXD11::CIR1	Adenocarcinoma
HOXD11::NOC4L	Adenocarcinoma
HOXD3::CHN1	Adenocarcinoma
HOXD3::MTX2	Malignant melanoma
HP1BP3::EIF4G3	Adenocarcinoma
HP1BP3::EMC1	Astrocytoma, grade III-IV/Glioblastoma
HP1BP3::PINK1	Adenocarcinoma
HP1BP3::THAP4	Adenocarcinoma
HP1BP3::TMCO4	Astrocytoma, grade I-II
HP::EEA1	Adenocarcinoma
HP::SAA1	Adenocarcinoma
HPCAL1::CPSF3	Adenocarcinoma
HPCAL1::CYS1	Adenocarcinoma
HPD::CYP2E1	Adenocarcinoma
HPGD::GUCY1A1	Transitional cell carcinoma
HPN::ABCG1	Adenocarcinoma
HPN::PPP2R5C	Adenocarcinoma
HPRT1::CTPS2	Adenocarcinoma
HPRT1::LRRC2	Transitional cell carcinoma
HPS1::PYROXD2	Transitional cell carcinoma
HPS3::CPB1	Adenocarcinoma
HPS3::JADE1	Adenocarcinoma
HPS3::P2RY14	Malignant melanoma
HPS4::CABIN1	Adenocarcinoma
HPS4::UBE2L3	Malignant melanoma
HPS5::ANO5	Adenocarcinoma
HPS5::APOO	Adenocarcinoma
HPS5::SETD5	Adenocarcinoma
HPSE2::CWF19L1	Astrocytoma, grade I-II
HRAS::MELK	Adenocarcinoma
HRAS::SCT	Adenocarcinoma
HRH1::SLC6A11	Adenocarcinoma
HRH1::TSEN2	Transitional cell carcinoma
HS2ST1::CDK6	Skin | Acute myeloid leukemia, NOS
HS2ST1::GBP6	Adenocarcinoma
HS2ST1::NXNL2	Adenocarcinoma
HS2ST1::PRDX1	Adenocarcinoma
HS2ST1::SH3GLB1	Adenocarcinoma
HS2ST1::STRIP1	Adenocarcinoma
HS3ST1::CNTN5	Adenocarcinoma
HS3ST3B1::TMEM92	Mesenchymal tumor, NOS
HS3ST4::CACNG3	Adenocarcinoma
HS6ST2::NPFFR2	Transitional cell carcinoma
HS6ST2::TENM1	Adenocarcinoma
HS6ST3::ACTR1A	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
HS6ST3::EFNA5	Malignant melanoma
HS6ST3::EIF4EBP1	Squamous cell carcinoma
HS6ST3::NALF1	Mesenchymal tumor, NOS
HSD11B1::AMACR	Adenocarcinoma
HSD11B1::EPHX1	Adenocarcinoma
HSD11B1L::SAFB	Squamous cell carcinoma
HSD17B10::USP11	Adenocarcinoma
HSD17B11::HSD17B13	Nonneoplastic epithelial disorder/lesion
HSD17B11::SPARCL1	Adenocarcinoma
HSD17B11::UGT2A3	Adenocarcinoma
HSD17B12::MYO7A	Undifferentiated carcinoma, small cell
HSD17B12::RPS6KB1	Squamous cell carcinoma
HSD17B12::TP53I11	Squamous cell carcinoma
HSD17B12::WT1	Adenocarcinoma
HSD17B14::PLEKHA4	Adenocarcinoma
HSD17B14::SAFB	Adenocarcinoma
HSD17B3::ENPP2	Adenocarcinoma
HSD17B4::TNFAIP8	Squamous cell carcinoma
HSD17B7::NPHP1	Adenocarcinoma
HSDL1::CORO1A	Adenocarcinoma
HSDL2::FRMD3	Adenocarcinoma
HSDL2::TEX10	Mesothelioma
HSF1::ADAMTS12	Adenocarcinoma
HSF1::MICALL1	Adenocarcinoma
HSF1::MROH1	Adenocarcinoma
HSF1::RERE	Adenocarcinoma
HSP90AA1::BCL6	Diffuse large B-cell lymphoma
HSP90AA1::MOK	Squamous cell carcinoma
HSP90AA1::SENP8	Adenocarcinoma
HSP90AB1::CAPN11	Adenocarcinoma
HSP90AB1::MRPL14	Transitional cell carcinoma
HSP90AB1::PCGF2	Adenocarcinoma
HSP90AB1::PTCHD4	Astrocytoma, grade III-IV/Glioblastoma
HSP90AB1::SLC29A1	Adenocarcinoma
HSP90AB1::TAF3	Adenocarcinoma
HSP90B1::CFB	Adenocarcinoma
HSP90B1::LRRC28	Multiple myeloma
HSP90B1::SUPT16H	Adenocarcinoma
HSP90B1::TEX261	Adenocarcinoma
HSP90B1::UTRN	Squamous cell carcinoma
HSPA12A::SHTN1	Adenocarcinoma
HSPA12B::BABAM2	Malignant epithelial tumor, special type
HSPA14::C10ORF67	Squamous cell carcinoma
HSPA14::C10orf67	Squamous cell carcinoma
HSPA14::MRPS35	Adenocarcinoma
HSPA1B::MYLK	Adenocarcinoma
HSPA1B::SLC1A3	Astrocytoma, grade I-II
HSPA5::MARCHF1	Multiple myeloma
HSPA8::BRAF	Malignant soft tissue tumor, NOS
HSPA8::JAML	Acute lymphoblastic leukemia/lymphoblastic lymphoma
HSPA8::NR4A3	Chondrosarcoma, myxoid
HSPA8::VSTM5	Squamous cell carcinoma
HSPA9::ARL15	Adenocarcinoma
HSPA9::DDX19A	Adenocarcinoma
HSPB1::CAMKK2	Adenocarcinoma
HSPB1::CLDN7	Squamous cell carcinoma
HSPB1::DDX27	Squamous cell carcinoma
HSPB1::MYO1B	Squamous cell carcinoma
HSPB1::PLAT	Squamous cell carcinoma
HSPB1::SF3B2	Squamous cell carcinoma
HSPB1::STAT6	Squamous cell carcinoma
HSPB1::THSD4	Squamous cell carcinoma
HSPB1::TTN	Squamous cell carcinoma
HSPB1::TYK2	Adenocarcinoma
HSPB8::INIP	Mesenchymal tumor, NOS
HSPBP1::VRK3	Adenocarcinoma
HSPBP1::ZNF418	Adenocarcinoma
HSPD1::CMKLR2	Adenocarcinoma
HSPE1::MOB4	Adenocarcinoma
HSPG2::FGFR1	Vascular and perivascular tumor, special type
HSPG2::MATN2	Adenocarcinoma
HSPG2::MYBPHL	Adenocarcinoma
HSPG2::NTNG1	Adenocarcinoma
HSPG2::PLXNB1	Carcinoma, NOS
HSPG2::SH3BGRL3	Malignant epithelial tumor, special type
HSPG2::SIAE	Adenocarcinoma
HSPG2::SUSD6	Adenocarcinoma
HSPG2::VIM	Malignant melanoma
HSPH1::DDX27	Astrocytoma, grade I-II
HSPH1::KIAA0825	Adenocarcinoma
HSPH1::PLEKHA5	Squamous cell carcinoma
HTATIP2::CA1	Squamous cell carcinoma
HTATSF1::BRS3	Adenocarcinoma
HTN3::MSANTD3	Acinic cell carcinoma
HTR4::ST3GAL1	PEComa
HTR7::LRMDA	Adenocarcinoma
HTR7::VAC14	Malignant epithelial tumor, special type
HTRA1::ARMS2	Adenocarcinoma
HTRA1::C7	Adenocarcinoma
HTRA1::SH3PXD2A	Schwannoma
HTRA1::TYK2	Adenocarcinoma
HTT::ADD1	Alveolar rhabdomyosarcoma
HTT::CFAP99	Adenocarcinoma
HTT::ESYT2	Adenocarcinoma
HTT::GRK4	Adenocarcinoma | Squamous cell carcinoma | Transitional cell carcinoma
HTT::PKN1	Melanocytic neoplasm, special type
HTT::WDR19	Adenocarcinoma
HTT::ZFYVE28	Adenocarcinoma
HUNK::MAMLD1	Adenocarcinoma
HUNK::MRAP	Adenocarcinoma
HUWE1::BICD1	Transitional cell carcinoma
HUWE1::CLCN5	Adenocarcinoma
HUWE1::GUF1	Squamous cell carcinoma
HUWE1::PHF8	Adenocarcinoma
HVCN1::GOLGA3	Mesenchymal tumor, NOS
HYAL2::SEMA3B	Miscellaneous hematopoietic/lymphoid neoplasm, special type
HYCC1::TRA2A	Malignant melanoma
HYCC2::COQ10B	Mesenchymal tumor, NOS
HYCC2::FLACC1	Adenocarcinoma
HYDIN::PSMD11	Adenocarcinoma
HYI::NFIA	Adenocarcinoma
HYKK::DNAJA4	Adenocarcinoma
HYOU1::HMGA1	Adenocarcinoma
HYOU1::NLRX1	Astrocytoma, grade I-II
HYOU1::POU2AF3	Adenocarcinoma
HYOU1::SZRD1	Germ cell tumor, NOS
IAH1::ALK	Undifferentiated carcinoma, small cell
IARS1::NOL8	Adenocarcinoma
IARS2::DCAF17	Adenocarcinoma
IBTK::NCK1	Adenocarcinoma
ICA1::HGF	Transitional cell carcinoma
ICAM1::HNRNPM	Squamous cell carcinoma
ICAM1::PRR14L	Adenocarcinoma
ICAM1::TYK2	Multiple myeloma
ICAM3::TYK2	Adenocarcinoma
ICAM5::CCL25	Multiple myeloma
ICE1::TERT	Adenocarcinoma
ICE2::ALDH1A2	Astrocytoma, grade III-IV/Glioblastoma
ICE2::CIB1	Adenocarcinoma
ICMT::ACOT7	Germ cell tumor, NOS | Adenocarcinoma
ICMT::GPR153	Adenocarcinoma
ICMT::NPHP4	Malignant melanoma
ICMT::RPS6KA3	Squamous cell carcinoma
ICOS::CD28	Mycosis fungoides/Sézary syndrome | Adult T-cell lymphoma/leukemia (HTLV-1+) | Peripheral T-cell lymphoma, unspecified
ICOSLG::KCNJ6	Adenocarcinoma
ID4::LRATD1	Squamous cell carcinoma
IDE::CAMK1D	Adenocarcinoma
IDH2::ZNF710	Adenocarcinoma
IDH3A::DHX32	Mesenchymal tumor, NOS
IDH3A::SH2D7	Squamous cell carcinoma
IDI1::AKR1C3	Adenocarcinoma
IDS::PHACTR1	Astrocytoma, grade I-II
IDUA::FLACC1	Adenocarcinoma
IER2::IGK	Multiple myeloma
IER2::STX10	Adenocarcinoma
IER3IP1::FECH	Skin | Acute myeloid leukemia, NOS
IER3IP1::HDHD2	Meningioma
IFFO2::UBR4	Adenocarcinoma
IFI16::GOLPH3L	Adenocarcinoma
IFI27::CPNE3	Adenocarcinoma
IFI27::NDUFV1	Adenocarcinoma
IFI44L::SLC44A3	Adenocarcinoma
IFI6::STPG1	Adenocarcinoma
IFIT1::LIPA	Adenocarcinoma
IFIT5::HK1	Adenocarcinoma
IFITM10::CFL1	Adenocarcinoma
IFITM10::DENND5A	Adenocarcinoma
IFNAR1::DCLRE1C	Adenocarcinoma
IFNAR1::IL10RB	Adenocarcinoma
IFNAR1::KMT2B	Adenocarcinoma
IFNAR2::IL10RB	Nonneoplastic epithelial disorder/lesion
IFNGR1::SMCHD1	Adenocarcinoma
IFNGR2::GART	Acute myeloblastic leukemia with maturation (FAB type M2)
IFNGR2::NUDCD3	Adenocarcinoma
IFNLR1::STPG1	Adenocarcinoma
IFT122::HMCES	Adenocarcinoma
IFT122::PITPNB	Adenocarcinoma
IFT140::ABCA3	Malignant epithelial tumor, special type
IFT172::RBKS	Adenocarcinoma
IFT20::SUZ12	Adenocarcinoma
IFT20::VTN	Squamous cell carcinoma
IFT25::NDC1	Squamous cell carcinoma
IFT25::SSBP3	Adenocarcinoma
IFT25::TUT4	Squamous cell carcinoma
IFT43::RBM25	Adenocarcinoma
IFT43::TTLL5	Adenocarcinoma
IFT52::HCK	Adenocarcinoma
IFT52::MXRA8	Transitional cell carcinoma
IFT74::CACNA2D3	Adenocarcinoma
IFT74::HECTD4	Mesothelioma
IFT74::LDLRAD3	Adenocarcinoma
IFT74::WNK2	Squamous cell carcinoma
IFT80::ILDR1	Adenocarcinoma
IFT80::RARRES1	Astrocytoma, grade I-II
IFT80::TNIK	Adenocarcinoma
IFT81::ACACB	Adenocarcinoma
IFT81::GLIPR1L2	Malignant melanoma
IFT81::HECTD4	Diffuse large B-cell lymphoma
IFT81::INSR	Mesenchymal tumor, NOS
IFT81::TSPAN8	Mesenchymal tumor, NOS
IFT88::WASF3	Adenocarcinoma
IGDCC3::GLDN	Astrocytoma, grade I-II
IGDCC4::ORAI3	Malignant melanoma
IGF1R::ADPGK	Adenocarcinoma
IGF1R::ARID1B	Adenocarcinoma
IGF1R::CDIN1	Adenocarcinoma
IGF1R::EFL1	Adenocarcinoma
IGF1R::MAP7	Mesenchymal tumor, NOS
IGF1R::PPP4R1	Adenocarcinoma
IGF1R::PRPS1	Adenocarcinoma
IGF1R::RAB27A	Adenocarcinoma
IGF1R::ROS1	Adenocarcinoma
IGF1R::TRIP4	Adenocarcinoma
IGF1R::TTC23	Transitional cell carcinoma
IGF1R::WDR93	Adenocarcinoma
IGF2::AP1G2	Transitional cell carcinoma
IGF2::ASCL2	Malignant epithelial tumor, special type
IGF2::CCT5	Malignant epithelial tumor, special type
IGF2::CTNNA3	Squamous cell carcinoma
IGF2::DDX27	Malignant epithelial tumor, special type
IGF2::EIF2AK2	Adenocarcinoma
IGF2::MCM8	Adenocarcinoma
IGF2::MTHFD1	Malignant epithelial tumor, special type
IGF2::REG3A	Adenocarcinoma
IGF2::SERPINA1	Adenocarcinoma
IGF2::SNW1	Adenocarcinoma
IGF2::TMEM184A	Squamous cell carcinoma | Adenocarcinoma | Transitional cell carcinoma
IGF2::YY1	Malignant epithelial tumor, special type
IGF2BP1::BAIAP2	Adenocarcinoma
IGF2BP2::IFITM1	Malignant epithelial tumor, special type
IGF2BP2::IFITM2	Malignant epithelial tumor, special type
IGF2BP2::LSM12	Nodal marginal zone B-cell lymphoma
IGF2BP2::NCEH1	Adenocarcinoma
IGF2BP2::ST6GAL1	Squamous cell carcinoma
IGF2BP3::ACSM1	Adenocarcinoma
IGF2BP3::CBX4	Adenocarcinoma
IGF2BP3::P2RY14	Adenocarcinoma
IGF2BP3::PRKCA	Squamous cell carcinoma
IGF2BP3::THADA	Adenocarcinoma
IGF2R::ACVR2A	Adenocarcinoma
IGF2R::AFDN	Adenocarcinoma
IGF2R::ARFGEF2	Adenocarcinoma
IGF2R::CNTNAP2	Astrocytoma, grade III-IV/Glioblastoma
IGF2R::PREP	Adenocarcinoma
IGF2R::QKI	Malignant melanoma
IGF2R::SLC22A3	Adenocarcinoma
IGF2R::SYTL3	Squamous cell carcinoma
IGF2R::WTAP	Adenocarcinoma
IGFBP2::CLCN3	Malignant epithelial tumor, special type
IGFBP2::HP	Adenocarcinoma
IGFBP2::RPL37A	Adenocarcinoma
IGFBP3::CLCN3	Adenocarcinoma
IGFBP4::UTRN	Squamous cell carcinoma
IGFBP5::ALK	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma
IGFBP5::AMD1	Adenocarcinoma
IGFBP5::ARHGEF4	Adenocarcinoma
IGFBP5::CXCR5	Adenocarcinoma
IGFBP5::SIAE	Adenocarcinoma
IGFBP5::TYK2	Adenocarcinoma
IGFBP7::CNST	Malignant melanoma
IGFBP7::SPATA22	Malignant melanoma
IGFBPL1::ATOSB	Mesenchymal tumor, NOS
IGFN1::KANK1	Astrocytoma, grade I-II
IGH::B2M	Multiple myeloma
IGH::BACH2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
IGH::BANK1	Mature B-cell neoplasm, NOS
IGH::BCAS2	Diffuse large B-cell lymphoma
IGH::BCL10	Extranodal marginal zone B-cell lymphoma
IGH::BCL11A	Chronic lymphocytic leukemia
IGH::BCL2	Hodgkin disease, nodular sclerosis | Hodgkin disease, NOS | Chronic lymphocytic leukemia | Acute myeloid leukemia, NOS | Hodgkin disease, lymphocyte predominance | Dendritic cell neoplasm | Nonneoplastic hematologic disorder/lesion | Skin | Diffuse large B-cell lymphoma | B-prolymphocytic leukemia | Extranodal marginal zone B-cell lymphoma | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Hodgkin disease, mixed cellularity | Burkitt lymphoma/leukemia | Mature B-cell neoplasm, NOS | Histiocytic sarcoma/malignant histiocytosis | Follicular lymphoma
IGH::BCL2A1	Diffuse large B-cell lymphoma
IGH::BCL3	Bilineage or biphenotypic leukemia | Follicular lymphoma | Splenic marginal zone B-cell lymphoma | Nodal marginal zone B-cell lymphoma | Hodgkin disease, NOS | Mature B-cell neoplasm, NOS | Egypt | Diffuse large B-cell lymphoma | Chronic lymphocytic leukemia
IGH::BCL6	Burkitt lymphoma/leukemia | Extranodal marginal zone B-cell lymphoma | Diffuse large B-cell lymphoma | Hodgkin disease, lymphocyte predominance | Hodgkin disease, nodular sclerosis | Mature B-cell neoplasm, NOS | Follicular lymphoma | Mediastinal large B-cell lymphoma
IGH::BCL9	Acute lymphoblastic leukemia/lymphoblastic lymphoma
IGH::BMI1	Chronic lymphocytic leukemia
IGH::BRAF	Hairy cell leukemia
IGH::CALR	Multiple myeloma
IGH::CBFA2T3	Chronic lymphocytic leukemia | Burkitt lymphoma/leukemia | Diffuse large B-cell lymphoma
IGH::CCND1	Plasma cell leukemia | Hairy cell leukemia | Chronic lymphocytic leukemia | Heart | Diffuse large B-cell lymphoma | Mantle cell lymphoma | Chronic myeloid leukemia, t(9;22) | Primary amyloidosis | Mature B-cell neoplasm, NOS | Monoclonal gammopathy of undetermined significance | B-prolymphocytic leukemia | Multiple myeloma | Hodgkin disease, NOS
IGH::CCND2	Mantle cell lymphoma
IGH::CCND3	Multiple myeloma | Mantle cell lymphoma | Diffuse large B-cell lymphoma | Mature B-cell neoplasm, NOS | Extranodal marginal zone B-cell lymphoma | Plasma cell leukemia | Splenic marginal zone B-cell lymphoma | Acute lymphoblastic leukemia/lymphoblastic lymphoma
IGH::CCNE1	Diffuse large B-cell lymphoma
IGH::CD274	Diffuse large B-cell lymphoma
IGH::CD44	Follicular lymphoma | Extranodal marginal zone B-cell lymphoma | Diffuse large B-cell lymphoma
IGH::CD74	Multiple myeloma
IGH::CDK6	Chronic lymphocytic leukemia
IGH::CEBPA	Acute lymphoblastic leukemia/lymphoblastic lymphoma
IGH::CEBPB	Acute lymphoblastic leukemia/lymphoblastic lymphoma
IGH::CEBPD	Acute lymphoblastic leukemia/lymphoblastic lymphoma
IGH::CEBPE	Acute lymphoblastic leukemia/lymphoblastic lymphoma
IGH::CEBPG	Acute lymphoblastic leukemia/lymphoblastic lymphoma
IGH::CHST11	Chronic lymphocytic leukemia
IGH::CNN3	Extranodal marginal zone B-cell lymphoma
IGH::CRLF2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
IGH::CXCR4	Multiple myeloma
IGH::DCP2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
IGH::DDX6	Nodal marginal zone B-cell lymphoma | Acute lymphoblastic leukemia/lymphoblastic lymphoma
IGH::DUX4	Acute lymphoblastic leukemia/lymphoblastic lymphoma
IGH::EBF1	Diffuse large B-cell lymphoma
IGH::EGFR	Multiple myeloma
IGH::EPOR	Acute lymphoblastic leukemia/lymphoblastic lymphoma
IGH::ERVW-1	Chronic lymphocytic leukemia
IGH::ETV6	Diffuse large B-cell lymphoma | Acute lymphoblastic leukemia/lymphoblastic lymphoma
IGH::FCGR2B	Follicular lymphoma
IGH::FCRL4	Multiple myeloma
IGH::FGFR3	B-prolymphocytic leukemia | Plasma cell leukemia | Chronic lymphocytic leukemia | Multiple myeloma | Monoclonal gammopathy of undetermined significance
IGH::FOS	Multiple myeloma
IGH::FOSB	Multiple myeloma
IGH::FOXP1	Diffuse large B-cell lymphoma | Extranodal marginal zone B-cell lymphoma | Follicular lymphoma
IGH::GANAB	Multiple myeloma
IGH::GNAS	Multiple myeloma
IGH::GPR34	Extranodal marginal zone B-cell lymphoma | Diffuse large B-cell lymphoma | Nodal marginal zone B-cell lymphoma
IGH::H1-10	Multiple myeloma
IGH::HLA-C	Multiple myeloma
IGH::HLA-E	Multiple myeloma
IGH::ID4	Acute lymphoblastic leukemia/lymphoblastic lymphoma
IGH::IER2	Multiple myeloma
IGH::IGF2BP1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
IGH::IGL	Diffuse large B-cell lymphoma | Chronic lymphocytic leukemia
IGH::IL3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
IGH::IMMP2L	Diffuse large B-cell lymphoma
IGH::IRF4	Follicular lymphoma | Diffuse large B-cell lymphoma | Multiple myeloma
IGH::IRF8	Diffuse large B-cell lymphoma
IGH::ITM2C	Multiple myeloma
IGH::JAK2	Multiple myeloma
IGH::JUN	Multiple myeloma
IGH::JUNB	Multiple myeloma
IGH::JUND	Multiple myeloma
IGH::KDM4C	Extranodal marginal zone B-cell lymphoma
IGH::LHX2	Heart | Chronic myeloid leukemia, t(9;22)
IGH::LHX4	Chronic myeloid leukemia, t(9;22) | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Heart
IGH::LTA4H	Multiple myeloma
IGH::MAF	Plasma cell leukemia | Monoclonal gammopathy of undetermined significance | Multiple myeloma
IGH::MAFB	Multiple myeloma
IGH::MALT1	Extranodal marginal zone B-cell lymphoma | Mature B-cell neoplasm, NOS | Chronic lymphocytic leukemia | Diffuse large B-cell lymphoma
IGH::MRPL21	Multiple myeloma
IGH::MTCP1	Chronic lymphocytic leukemia
IGH::MUC1	Mature B-cell neoplasm, NOS
IGH::MYC	Chronic lymphocytic leukemia | Mature B-cell neoplasm, special type | Mantle cell lymphoma | Monoclonal gammopathy of undetermined significance | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Nonneoplastic hematologic disorder/lesion | Burkitt lymphoma/leukemia | Hodgkin disease, nodular sclerosis | Mature B-cell neoplasm, NOS | Follicular lymphoma | Multiple myeloma | Diffuse large B-cell lymphoma | B-prolymphocytic leukemia | Plasma cell leukemia
IGH::MYCN	Mantle cell lymphoma
IGH::NECTIN2	Diffuse large B-cell lymphoma
IGH::NFKB2	Mature B-cell neoplasm, NOS
IGH::NOL4	Diffuse large B-cell lymphoma
IGH::NSD2	Multiple myeloma | Plasma cell leukemia | Monoclonal gammopathy of undetermined significance
IGH::NT5DC2	Multiple myeloma
IGH::PAFAH1B2	Mature B-cell neoplasm, NOS
IGH::PAX5	Waldenström macroglobulinemia | Diffuse large B-cell lymphoma | Mature B-cell neoplasm, NOS | Lymphoplasmacytic lymphoma | Primary effusion lymphoma | Splenic marginal zone B-cell lymphoma
IGH::PCSK7	Mature B-cell neoplasm, NOS
IGH::PDIA4	Multiple myeloma
IGH::PPIB	Multiple myeloma
IGH::PPP1R15A	Multiple myeloma
IGH::PTMA	Multiple myeloma
IGH::RBM38	Multiple myeloma
IGH::RHOB	Multiple myeloma
IGH::RHOH	Nodal marginal zone B-cell lymphoma | Splenic marginal zone B-cell lymphoma | Multiple myeloma
IGH::RPL8	Multiple myeloma
IGH::SOX4	Multiple myeloma
IGH::SOX5	Follicular lymphoma
IGH::SPIB	Diffuse large B-cell lymphoma
IGH::SSR4	Multiple myeloma
IGH::TENM2	Extranodal marginal zone B-cell lymphoma
IGH::TERT	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Chronic lymphocytic leukemia
IGH::TNFRSF17	Multiple myeloma
IGH::TNFSF13	Diffuse large B-cell lymphoma
IGH::TRA	Mature T- and NK-cell neoplasm, NOS | T-prolymphocytic leukemia | Angioimmunoblastic T-cell lymphoma | Acute lymphoblastic leukemia/lymphoblastic lymphoma
IGH::TRD	Acute lymphoblastic leukemia/lymphoblastic lymphoma
IGH::UBALD2	Multiple myeloma
IGH::WWOX	Multiple myeloma
IGH::XBP1	Multiple myeloma
IGH::YPEL5	Multiple myeloma
IGH::ZEB2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
IGHMBP2::C22ORF23	Adenocarcinoma
IGHMBP2::CATSPERZ	Adenocarcinoma
IGHMBP2::CPT1A	Adenocarcinoma
IGHMBP2::GPR137	Adenocarcinoma
IGHMBP2::PITPNM1	Adenocarcinoma
IGHMBP2::SPMIP7	Adenocarcinoma
IGK::ACTB	Multiple myeloma
IGK::ADA2	Multiple myeloma
IGK::B2M	Multiple myeloma
IGK::BCL10	Extranodal marginal zone B-cell lymphoma
IGK::BCL2	Diffuse large B-cell lymphoma | Burkitt lymphoma/leukemia | Follicular lymphoma | Chronic lymphocytic leukemia
IGK::BCL3	Mature B-cell neoplasm, NOS
IGK::BCL6	Mature B-cell neoplasm, NOS | Follicular lymphoma
IGK::CANX	Multiple myeloma
IGK::CCL3	Multiple myeloma
IGK::CCND1	Mature B-cell neoplasm, NOS
IGK::CCND2	Mantle cell lymphoma
IGK::CD74	Multiple myeloma
IGK::CDK6	Chronic lymphocytic leukemia | Splenic marginal zone B-cell lymphoma | Mature B-cell neoplasm, NOS
IGK::CDKN1A	Multiple myeloma
IGK::CITED2	Multiple myeloma
IGK::CXCL8	Multiple myeloma
IGK::EEF2	Multiple myeloma
IGK::ETV6	Acute lymphoblastic leukemia/lymphoblastic lymphoma
IGK::EZR	Multiple myeloma
IGK::FGFR3	Multiple myeloma
IGK::FOSB	Multiple myeloma
IGK::FRZB	Multiple myeloma
IGK::GADD45A	Multiple myeloma
IGK::H1-10	Multiple myeloma
IGK::HDLBP	Multiple myeloma
IGK::HLA-A	Multiple myeloma
IGK::HLA-B	Multiple myeloma
IGK::HLA-C	Multiple myeloma
IGK::HLA-E	Multiple myeloma
IGK::HLA-F	Multiple myeloma
IGK::HSP90B1	Multiple myeloma
IGK::HSPA5	Multiple myeloma
IGK::ITM2C	Multiple myeloma
IGK::JUN	Multiple myeloma
IGK::JUND	Multiple myeloma
IGK::KDSR	Follicular lymphoma
IGK::MCL1	Multiple myeloma
IGK::MEF2D	Multiple myeloma
IGK::MYC	Mantle cell lymphoma | Burkitt lymphoma/leukemia | Diffuse large B-cell lymphoma | B-prolymphocytic leukemia | Follicular lymphoma
IGK::NFKBIA	Multiple myeloma
IGK::PDIA4	Multiple myeloma
IGK::RACK1	Multiple myeloma
IGK::RPL37A	Multiple myeloma
IGK::RPL8	Multiple myeloma
IGK::RPS23	Multiple myeloma
IGK::SEC61A1	Multiple myeloma
IGK::SSR4	Multiple myeloma
IGK::ST6GALNAC4	Multiple myeloma
IGK::TPD52	Acute lymphoblastic leukemia/lymphoblastic lymphoma
IGK::TRIB1	Multiple myeloma
IGK::TSC22D3	Multiple myeloma
IGK::ZC3H12D	Diffuse large B-cell lymphoma
IGK::ZFP36	Multiple myeloma
IGL::BCL2	Chronic lymphocytic leukemia | Follicular lymphoma | Mature B-cell neoplasm, NOS
IGL::BCL3	Follicular lymphoma | Diffuse large B-cell lymphoma
IGL::BCL6	Follicular lymphoma | Burkitt lymphoma/leukemia | Diffuse large B-cell lymphoma | Hodgkin disease, lymphocyte predominance | Mature B-cell neoplasm, NOS
IGL::BCL9	Follicular lymphoma
IGL::CCND1	Mantle cell lymphoma | Mature B-cell neoplasm, NOS
IGL::CCND2	Mantle cell lymphoma | Chronic lymphocytic leukemia
IGL::CCND3	Multiple myeloma
IGL::CDK6	Chronic lymphocytic leukemia
IGL::FGFR3	Chronic lymphocytic leukemia
IGL::HLA-B	Multiple myeloma
IGL::HLA-C	Multiple myeloma
IGL::HSPA5	Multiple myeloma
IGL::IRF4	Diffuse large B-cell lymphoma
IGL::MAF	Multiple myeloma
IGL::MYC	Diffuse large B-cell lymphoma | Burkitt lymphoma/leukemia | Extranodal marginal zone B-cell lymphoma | Multiple myeloma
IGL::PRDM16	Splenic marginal zone B-cell lymphoma
IGL::REL	Hodgkin disease, NOS | Follicular lymphoma
IGLL5::BMI1	Multiple myeloma
IGLL5::GLCCI1	Multiple myeloma
IGLL5::SSR4	Multiple myeloma
IGSF11::UPK1B	Adenocarcinoma
IGSF1::DSCAM	Adenocarcinoma
IGSF1::PLAC1	Adenocarcinoma
IGSF3::GGT1	Adenocarcinoma | Malignant epithelial tumor, special type
IGSF3::KDM2A	Adenocarcinoma
IGSF3::MAN1A2	Adenocarcinoma
IGSF3::PARL	Squamous cell carcinoma
IGSF3::SYCP1	Adenocarcinoma
IGSF3::TBX15	Adenocarcinoma
IGSF9::SLAMF9	Adenocarcinoma
IGSF9B::OPCML	Mesenchymal tumor, NOS
IHH::NHEJ1	Adenocarcinoma
IHO1::NR3C2	Mesenchymal tumor, NOS
IK::CAMTA1	Undifferentiated round cell sarcoma
IKBIP::ANKS1B	Adenocarcinoma
IKBIP::NR2C1	Adenocarcinoma
IKBKB::ANK1	Adenocarcinoma
IKBKB::FADD	Adenocarcinoma
IKBKB::GOT1L1	Adenocarcinoma
IKBKB::LETM2	Adenocarcinoma
IKBKB::NRG1	Adenocarcinoma
IKBKB::UNC5D	Transitional cell carcinoma
IKBKE::ACSM1	Adenocarcinoma
IKBKG::ALK	Undifferentiated round cell sarcoma
IKBKG::GAB3	Squamous cell carcinoma
IKBKG::RET	Adenocarcinoma
IKZF1::ABCA13	Acute lymphoblastic leukemia/lymphoblastic lymphoma
IKZF1::BCL6	Diffuse large B-cell lymphoma
IKZF1::CDK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
IKZF1::CIITA	Acute lymphoblastic leukemia/lymphoblastic lymphoma
IKZF1::ETV6	Acute lymphoblastic leukemia/lymphoblastic lymphoma
IKZF1::LRBA	Adenocarcinoma
IKZF1::NOTCH1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
IKZF1::NUTM1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
IKZF1::PHF14	Adenocarcinoma
IKZF1::PRDM16	Myelodysplastic syndrome, NOS
IKZF1::SETD5	Acute lymphoblastic leukemia/lymphoblastic lymphoma
IKZF1::STXBP4	Skin | Acute myeloid leukemia, NOS
IKZF1::TRPV2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
IKZF1::TUT1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
IKZF1::VWC2	Mature B-cell neoplasm, NOS
IKZF1::ZEB2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
IKZF2::BCL11B	Adult T-cell lymphoma/leukemia (HTLV-1+)
IKZF2::ERBB4	Adenocarcinoma | Peripheral T-cell lymphoma, unspecified
IKZF2::GLI2	Mycosis fungoides/Sézary syndrome
IKZF2::MICU2	Adenocarcinoma
IKZF3::BCAS3	Adenocarcinoma
IKZF3::ERBB2	Carcinoma, NOS
IKZF3::ETV3	Diffuse large B-cell lymphoma
IKZF3::MED24	Transitional cell carcinoma
IKZF3::PNMT	Adenocarcinoma
IKZF3::SRCIN1	Transitional cell carcinoma
IKZF3::SYDE1	Adenocarcinoma
IKZF4::DGKA	Adenocarcinoma
IKZF5::ADAM32	Squamous cell carcinoma
IL11RA::WDR72	Mesenchymal tumor, NOS
IL12RB2::DAB1	Adenocarcinoma
IL12RB2::PDE4B	Adenocarcinoma
IL12RB2::SDC3	Malignant melanoma
IL13RA1::DOCK11	Adenocarcinoma
IL13RA1::WDR44	Adenocarcinoma
IL17D::IFT88	Malignant melanoma
IL17RA::SCARF2	Squamous cell carcinoma
IL17RC::TTLL3	Malignant melanoma | Adenocarcinoma
IL17RE::SLC3A2	Adenocarcinoma
IL18R1::MCOLN2	Squamous cell carcinoma
IL1R1::IL1R2	Adenocarcinoma
IL1R1::MAP4K4	Adenocarcinoma
IL1RAP::COL6A5	Squamous cell carcinoma
IL1RAP::SIRPG	Adenocarcinoma
IL1RAP::TMEM207	Squamous cell carcinoma
IL1RAP::TP63	Squamous cell carcinoma
IL1RAP::TPRG1	Squamous cell carcinoma
IL1RAPL1::MAGEB10	Adenocarcinoma
IL1RAPL2::RET	Carcinoma, NOS
IL1RAPL2::STK39	Adenocarcinoma
IL1RL2::IL1R2	Adenocarcinoma
IL20RA::CPM	Mesenchymal tumor, NOS
IL20RB::HEBP1	Squamous cell carcinoma
IL20RB::NCK1	Squamous cell carcinoma
IL20RB::NR4A1	Squamous cell carcinoma
IL20RB::RASSF8	Squamous cell carcinoma
IL21R::BCL6	Diffuse large B-cell lymphoma
IL22RA1::STPG1	Transitional cell carcinoma
IL23R::GNG12	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
IL27RA::RLN3	Adenocarcinoma
IL2::TNFRSF17	Mature T- and NK-cell neoplasm, NOS
IL32::TNFRSF12A	Adenocarcinoma
IL33::ZNG1A	Adenocarcinoma
IL34::ARG2	Adenocarcinoma
IL34::CNGB1	Adenocarcinoma
IL34::ST3GAL2	Adenocarcinoma
IL3::IGH	Acute lymphoblastic leukemia/lymphoblastic lymphoma
IL4I1::AP2A1	Squamous cell carcinoma
IL4I1::DYRK1B	Adenocarcinoma
IL4I1::KCNQ2	Adenocarcinoma
IL4I1::TBC1D17	Squamous cell carcinoma
IL4I1::VSTM2B	Transitional cell carcinoma
IL4R::ACMSD	Mesenchymal tumor, NOS
IL4R::NSMCE1	Malignant melanoma
IL6R::RAF1	Malignant melanoma
IL6R::TDRD10	Adenocarcinoma
IL6ST::ANKRD55	Adenocarcinoma
IL6ST::DDX4	Adenocarcinoma
IL6ST::DHX29	Adenocarcinoma
IL6ST::KDM1B	Adenocarcinoma
IL6ST::LAMC2	Adenocarcinoma
IL6ST::ZNF706	Adenocarcinoma
IL9R::VAMP7	Transitional cell carcinoma | Acute lymphoblastic leukemia/lymphoblastic lymphoma
ILF2::KCNN3	Adenocarcinoma
ILF3::AP1M2	Squamous cell carcinoma
ILF3::ATG4D	Transitional cell carcinoma
ILF3::C19ORF38	Adenocarcinoma
ILF3::C3	Adenocarcinoma
ILF3::CATSPERD	Endometrial stromal sarcoma
ILF3::DENND2D	Adenocarcinoma
ILF3::MAPK13	Transitional cell carcinoma
ILF3::OR1M1	Malignant melanoma
ILF3::PDE4A	Adenocarcinoma
ILF3::SLC44A2	Adenocarcinoma
ILF3::SMARCA4	Adenocarcinoma
ILF3::TP53	Adenocarcinoma
ILF3::WNT5B	Adenocarcinoma
ILF3::ZNF177	Adenocarcinoma
ILF3::ZNF441	Adenocarcinoma
ILF3::ZNF627	Adenocarcinoma
ILK::PLPPR1	Adenocarcinoma
ILKAP::PER2	Adenocarcinoma
ILRUN::DEFB110	Adenocarcinoma
ILRUN::FKBP5	Malignant epithelial tumor, special type
ILRUN::KIF6	Adenocarcinoma
ILRUN::LRRC1	Adenocarcinoma
ILRUN::NUDT3	Adenocarcinoma
ILRUN::PINX1	Adenocarcinoma
ILRUN::PRAMEF19	Malignant melanoma
ILRUN::SPDEF	Adenocarcinoma
ILVBL::SLC1A6	Adenocarcinoma
ILVBL::SYDE1	Adenocarcinoma
ILVBL::TECR	Adenocarcinoma
IMMP2L::DOCK4	Adenocarcinoma
IMMP2L::DYNC1I1	Astrocytoma, grade III-IV/Glioblastoma
IMMT::REEP1	Adenocarcinoma
IMPA1::RSPO2	Adenocarcinoma
IMPA2::GALNT1	Adenocarcinoma
IMPA2::GNAL	Adenocarcinoma
IMPDH1::GRM8	Mesothelioma
IMPG1::NSD3	Adenocarcinoma
IMPG2::SENP7	Adenocarcinoma
INAVA::KIF21B	Adenocarcinoma
INCENP::ANKFN1	Adenocarcinoma
INCENP::CCS	Squamous cell carcinoma
ING1::NAXD	Diffuse large B-cell lymphoma
ING2::IDH1	Adenocarcinoma
ING3::BCOR	Endometrial stromal sarcoma
ING3::PHF1	Endometrial stromal sarcoma
ING4::A2ML1	Malignant melanoma
ING4::C17ORF50	Acute lymphoblastic leukemia/lymphoblastic lymphoma
INHA::STK11IP	Adenocarcinoma
INIP::SHOC1	Squamous cell carcinoma
INIP::SNX30	Malignant melanoma
INKA2::BCAS4	Malignant epithelial tumor, special type
INKA2::DHRS3	Mesenchymal tumor, NOS
INMT::MINDY4	Nonneoplastic epithelial disorder/lesion
INO80::EXD1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
INO80::PRKCA	Adenocarcinoma
INO80::THSD4	Adenocarcinoma
INO80C::POLA1	Mesothelioma
INO80C::SETBP1	Acute myeloblastic leukemia with maturation (FAB type M2)
INPP1::HECW2	Adenocarcinoma
INPP4A::BICC1	Superficial fibromatosis
INPP4A::EEF1E1	Mesenchymal tumor, NOS
INPP4A::HJURP	Adenocarcinoma
INPP4A::MGAT4A	Transitional cell carcinoma
INPP4A::VWA3B	Adenocarcinoma
INPP4B::DEPTOR	Adenocarcinoma
INPP4B::ELF2	Adenocarcinoma
INPP4B::NAA15	Squamous cell carcinoma
INPP5A::AFAP1L2	Astrocytoma, grade I-II
INPP5A::CFAP46	Transitional cell carcinoma
INPP5A::CSTA	Adenocarcinoma
INPP5A::DLG2	Adenocarcinoma
INPP5A::FAM149B1	Adenocarcinoma
INPP5A::FRMD4A	Adenocarcinoma
INPP5A::JAKMIP3	Adenocarcinoma
INPP5A::KIF20B	Adenocarcinoma
INPP5A::LRRC27	Malignant melanoma | Malignant epithelial tumor, special type | Adenocarcinoma
INPP5A::PPIP5K1	Adenocarcinoma
INPP5B::FAF1	Adenocarcinoma
INPP5B::PLEKHO1	Adenocarcinoma
INPP5B::SF3A3	Adenocarcinoma | Undifferentiated carcinoma, small cell
INPP5B::TRIT1	Adenocarcinoma
INPP5D::ABL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
INPP5D::ALK	Adenocarcinoma
INPP5D::GIGYF2	Adenocarcinoma
INPP5D::PKNOX2	Adenocarcinoma
INPP5E::EDF1	Malignant epithelial tumor, special type
INPP5E::SEC16A	Squamous cell carcinoma
INPP5F::BAG3	Mature B-cell neoplasm, NOS
INPP5F::DENND10	Adenocarcinoma
INPP5F::GRK5	Malignant melanoma
INPP5K::RPA1	Adenocarcinoma
INSIG1::DPP6	Adenocarcinoma
INSL6::JAK2	Adenocarcinoma
INSR::ASF1B	Adenocarcinoma
INSR::CEP89	Mesenchymal tumor, NOS
INSR::EIF6	Adenocarcinoma
INSR::ERCC1	Adenocarcinoma
INSR::MGAT4C	Mesenchymal tumor, NOS
INSR::S1PR2	Adenocarcinoma
INSR::WDR62	Adenocarcinoma
INTS10::ALK	Adenocarcinoma
INTS11::AURKAIP1	Squamous cell carcinoma
INTS11::CCNL2	Malignant epithelial tumor, special type
INTS11::GNB1	Adenocarcinoma
INTS11::MXRA8	Adenocarcinoma
INTS11::PRAMEF2	Astrocytoma, grade III-IV/Glioblastoma
INTS12::CXXC4	Squamous cell carcinoma
INTS12::PPA2	Adenocarcinoma
INTS14::SLC24A1	Transitional cell carcinoma
INTS15::GRID2IP	Adenocarcinoma
INTS1::GET4	Adenocarcinoma
INTS1::PRKAR1B	Adenocarcinoma | Transitional cell carcinoma
INTS1::SUN1	Adenocarcinoma
INTS1::TMEM184A	Adenocarcinoma
INTS2::ACACA	Adenocarcinoma
INTS2::AXIN2	Adenocarcinoma
INTS2::GLIS3	Adenocarcinoma
INTS2::LIMD2	Adenocarcinoma
INTS2::VMP1	Adenocarcinoma
INTS2::ZNF652	Adenocarcinoma
INTS3::CHTOP	Adenocarcinoma
INTS4::ALG8	Malignant melanoma
INTS4::EMSY	Adenocarcinoma
INTS4::GAB2	Adenocarcinoma
INTS4::GDPD4	Adenocarcinoma
INTS4::KCTD14	Adenocarcinoma
INTS4::KCTD21	Adenocarcinoma
INTS4::KMT2A	Undifferentiated pleomorphic sarcoma
INTS4::LGALS3BP	Adenocarcinoma
INTS4::NARS2	Adenocarcinoma
INTS4::PGR	Malignant melanoma
INTS4::PLAUR	Adenocarcinoma
INTS4::POLD3	Adenocarcinoma
INTS4::PPFIA1	Adenocarcinoma
INTS4::PTPRT	Adenocarcinoma
INTS4::RSF1	Adenocarcinoma
INTS4::SLCO2B1	Adenocarcinoma
INTS4::TENM4	Adenocarcinoma
INTS5::C11ORF98	Squamous cell carcinoma
INTS5::LBHD1	Squamous cell carcinoma
INTS5::SYT12	Adenocarcinoma
INTS6::BZW2	Squamous cell carcinoma
INTS6::DCBLD2	Adenocarcinoma
INTS6::NEK5	Malignant epithelial tumor, special type
INTS7::DTL	Adenocarcinoma
INTS8::DPY19L4	Adenocarcinoma
INTS8::ESRP1	Malignant melanoma
INTS9::AZIN1	Adenocarcinoma
INTS9::PHYHIP	Adenocarcinoma
INVS::RPA3	Adenocarcinoma
IP6K1::ECSIT	Adenocarcinoma
IP6K1::HYAL3	Adenocarcinoma
IP6K1::MON1A	Transitional cell carcinoma | Adenocarcinoma
IP6K1::RHOA	Transitional cell carcinoma
IP6K1::RYBP	Embryonal rhabdomyosarcoma
IP6K1::TRAIP	Adenocarcinoma | Squamous cell carcinoma
IP6K1::UBA7	Adenocarcinoma
IP6K2::COL7A1	Adenocarcinoma
IP6K2::PRKAR2A	Adenocarcinoma
IP6K2::RHOA	Adenocarcinoma
IPMK::CXCL12	Adenocarcinoma
IPO11::CENPJ	Adenocarcinoma
IPO11::GJE1	Adenocarcinoma
IPO11::KIF2A	Adenocarcinoma
IPO11::SLC6A19	Adenocarcinoma
IPO11::TNFAIP8	Adenocarcinoma
IPO13::CFAP57	Adenocarcinoma
IPO13::EIF2B3	Adenocarcinoma
IPO7::AKIP1	Adenocarcinoma
IPO7::CTR9	Malignant melanoma
IPO7::RENBP	Adenocarcinoma
IPO7::TMEM41B	Adenocarcinoma
IPO7::WEE1	Squamous cell carcinoma
IPO8::CDH13	Adenocarcinoma
IPO8::KRT86	Adenocarcinoma
IPO8::TMTC1	Adenocarcinoma
IPO9::CSRP1	Squamous cell carcinoma
IPO9::S100A13	Malignant melanoma
IPP::GPBP1L1	Adenocarcinoma
IPP::MAST2	Adenocarcinoma
IPP::SLC22A7	Adenocarcinoma
IPPK::ASPN	Adenocarcinoma
IPPK::BICD2	Squamous cell carcinoma
IPPK::CDC42SE1	Transitional cell carcinoma
IPPK::IARS1	Squamous cell carcinoma | Adenocarcinoma
IPPK::VTI1B	Squamous cell carcinoma
IPPK::ZNF484	Adenocarcinoma
IQCB1::CACNG4	Adenocarcinoma
IQCB1::ILDR1	Adenocarcinoma
IQCB1::RUVBL1	Adenocarcinoma
IQCH::CTNND2	Mesenchymal tumor, NOS
IQCH::MAP2K5	Adenocarcinoma | Squamous cell carcinoma
IQCJ::BCHE	Squamous cell carcinoma
IQCK::ABCC1	Squamous cell carcinoma
IQCK::VPS35L	Adenocarcinoma
IQCN::FKBP8	Malignant epithelial tumor, special type
IQGAP1::ABHD2	Adenocarcinoma
IQGAP1::AGBL1	Adenocarcinoma
IQGAP1::AKAP13	Astrocytoma, grade III-IV/Glioblastoma
IQGAP1::CCDC63	Adenocarcinoma
IQGAP1::CIB1	Adenocarcinoma
IQGAP1::MESP2	Adenocarcinoma
IQGAP1::NGRN	Adenocarcinoma
IQGAP1::RASGRF1	Mesenchymal tumor, NOS | Malignant soft tissue tumor, NOS
IQGAP1::SEMA4B	Adenocarcinoma
IQGAP1::SPPL2A	Squamous cell carcinoma
IQGAP1::WDR93	Adenocarcinoma
IQGAP1::ZNF710	Adenocarcinoma
IQGAP1::ZNF774	Adenocarcinoma
IQGAP2::ACOT12	Adenocarcinoma
IQGAP2::ATRNL1	Squamous cell carcinoma
IQGAP2::SCAMP1	Acute myeloid leukemia, NOS | Skin
IQGAP2::TSLP	Acute lymphoblastic leukemia/lymphoblastic lymphoma
IQGAP3::ETV3	Adenocarcinoma
IQGAP3::SH2D2A	Adenocarcinoma
IQSEC1::GSTM3	Adenocarcinoma
IQSEC1::RAF1	Malignant epithelial tumor, special type
IQSEC1::SCCPDH	Adenocarcinoma
IQSEC1::WNT7A	Transitional cell carcinoma
IQSEC3::KDM5A	Diffuse large B-cell lymphoma
IQUB::ASB15	Adenocarcinoma
IRAG2::BCL6	Follicular lymphoma
IRAG2::C12ORF42	Mature B-cell neoplasm, NOS
IRAG2::MYC	Mature B-cell neoplasm, NOS
IRAK1::MECP2	Transitional cell carcinoma
IRAK1BP1::NOL4L	Malignant epithelial tumor, special type
IRAK2::BRK1	Adenocarcinoma | Astrocytoma, grade III-IV/Glioblastoma
IRAK2::CDKAL1	Transitional cell carcinoma
IRAK2::GHRL	Squamous cell carcinoma
IRAK2::SRGAP3	Squamous cell carcinoma
IRAK2::VHL	Adenocarcinoma
IRAK3::DYRK2	Mesenchymal tumor, NOS
IRAK3::PIP4K2C	Skin | Acute myeloid leukemia, NOS
IREB2::C6ORF52	Malignant melanoma
IREB2::CTSH	Adenocarcinoma
IREB2::DIAPH3	Malignant melanoma
IREB2::LEO1	Adenocarcinoma
IREB2::WDR93	Adenocarcinoma
IRF1::CEP20	Adenocarcinoma
IRF1::LPAR6	Mature B-cell neoplasm, NOS
IRF2::ENPP6	Malignant melanoma | Adenocarcinoma
IRF2::MORN1	Squamous cell carcinoma
IRF2::NTRK3	Malignant epithelial tumor, special type
IRF2BP1::RARA	Acute promyelocytic leukemia (FAB type M3)
IRF2BP2::CDX1	Chondromyxoid fibroma | Chondrosarcoma, mesenchymal
IRF2BP2::CDX2	Myoepithelioma/myoepithelial carcinoma/mixed tumor
IRF2BP2::IGK	Multiple myeloma
IRF2BP2::NTRK1	Adenocarcinoma | Fibrohistiocytic tumor, special type
IRF2BP2::RARA	Acute promyelocytic leukemia (FAB type M3)
IRF2BP2::RUNX2	Benign epithelial tumor, special type | Squamous cell carcinoma
IRF2BP2::SP2	Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
IRF4::DOT1L	Squamous cell carcinoma
IRF4::EFNA2	Adenocarcinoma
IRF4::LTBR	Multiple myeloma
IRF6::C1ORF21	Squamous cell carcinoma
IRF6::GRHL3	Transitional cell carcinoma
IRF6::SRGAP2	Squamous cell carcinoma
IRF7::RCC1	Adenocarcinoma
IRF9::RNF31	Adenocarcinoma
IRF9::THTPA	Angiosarcoma
IRS2::MYO16	Adenocarcinoma
IRX1::ADAMTS16	Malignant melanoma
IRX2::TERT	Clear cell sarcoma
ISCA1::LINGO2	Malignant epithelial tumor, special type
ISCA1::WWP1	Mesenchymal tumor, NOS
ISG20L2::HDGF	Adenocarcinoma
ISL2::PEAK1	Malignant melanoma
ISM2::SPTLC2	Adenocarcinoma
ISOC1::CCDC192	Adenocarcinoma
ISOC1::RET	Carcinoma, NOS
IST1::AP1G1	Adenocarcinoma
IST1::DHX38	Adenocarcinoma
ISY1::MASP1	Astrocytoma, grade I-II
ISYNA1::PABPC1	Transitional cell carcinoma
ISYNA1::SUGP2	Adenocarcinoma
ITCH::AHCY	Transitional cell carcinoma | Adenocarcinoma
ITCH::ARFGAP1	Transitional cell carcinoma
ITCH::ASIP	Adenocarcinoma
ITCH::BPIFB4	Adenocarcinoma
ITCH::CASS4	Squamous cell carcinoma
ITCH::CBFA2T2	Adenocarcinoma
ITCH::CFAP47	Malignant melanoma
ITCH::DEFB118	Squamous cell carcinoma
ITCH::DEFB123	Adenocarcinoma
ITCH::EYA2	Adenocarcinoma
ITCH::HM13	Squamous cell carcinoma
ITCH::JMJD4	Malignant melanoma
ITCH::MANBAL	Adenocarcinoma
ITCH::MYL9	Adenocarcinoma
ITCH::NBPF26	Adenocarcinoma
ITCH::NDUFA1	Transitional cell carcinoma
ITCH::PIGU	Adenocarcinoma
ITCH::RALY	Adenocarcinoma
ITCH::RPRD1B	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ITCH::SRC	Adenocarcinoma
ITCH::SRSF2	Adenocarcinoma
ITCH::TAB1	Adenocarcinoma
ITCH::TSHZ2	Adenocarcinoma
ITFG1::PHKB	Adenocarcinoma
ITFG1::SLC45A2	Adenocarcinoma
ITFG2::TULP3	Squamous cell carcinoma
ITFG2::ZNF831	Adenocarcinoma
ITGA10::PEX11B	Mesenchymal tumor, NOS
ITGA11::ADAMTSL3	Mesenchymal tumor, NOS
ITGA2::CEACAM21	Squamous cell carcinoma
ITGA2::GPX8	Squamous cell carcinoma
ITGA2::MYO18B	Adenocarcinoma
ITGA2::NDUFS4	Squamous cell carcinoma
ITGA2::PARP8	Squamous cell carcinoma
ITGA2::RNF180	Adenocarcinoma
ITGA3::CPB1	Adenocarcinoma
ITGA3::EIF2AK2	Adenocarcinoma
ITGA3::KHK	Adenocarcinoma
ITGA3::MIEN1	Adenocarcinoma
ITGA3::NDUFV1	Squamous cell carcinoma
ITGA4::NTRK3	Adenocarcinoma
ITGA4::UBE2E2	Astrocytoma, grade I-II
ITGA5::GTSF1	Adenocarcinoma | Squamous cell carcinoma
ITGA6::HAT1	Adenocarcinoma
ITGA6::MAP3K20	Adenocarcinoma
ITGA6::MYEOV	Adenocarcinoma
ITGA6::MYO3B	Adenocarcinoma
ITGA6::PDK1	Adenocarcinoma
ITGA6::RAPGEF4	Adenocarcinoma
ITGA6::UBE3B	Squamous cell carcinoma
ITGA7::MSRB3	Adenocarcinoma
ITGA8::MINDY3	Mesenchymal tumor, NOS
ITGA8::RET	Adenocarcinoma
ITGA8::USP9Y	Embryonal rhabdomyosarcoma
ITGA9::CTDSPL	Squamous cell carcinoma | Adenocarcinoma
ITGA9::GOLGA4	Adenocarcinoma
ITGA9::HMOX2	Adenocarcinoma
ITGA9::NDUFA8	Mesothelioma
ITGA9::POPDC2	Astrocytoma, grade III-IV/Glioblastoma
ITGA9::RFTN1	Adenocarcinoma
ITGA9::ROS1	Adenocarcinoma
ITGA9::SEC13	Adenocarcinoma
ITGA9::STAC	Adenocarcinoma
ITGA9::ZNF48	Germ cell tumor, NOS
ITGAV::ALK	Adenocarcinoma
ITGAV::ANKHD1	Adenocarcinoma
ITGAV::ARHGAP15	Mesenchymal tumor, NOS
ITGAV::DEFB132	Adenocarcinoma
ITGAV::FARP2	Squamous cell carcinoma
ITGAV::IFT172	Adenocarcinoma
ITGAV::PDE11A	Adenocarcinoma
ITGAV::PTPRD	Adenocarcinoma
ITGAV::TRIR	Adenocarcinoma
ITGAX::PHKG2	Transitional cell carcinoma
ITGB1::DYM	Adenocarcinoma
ITGB1::NRG1	Adenocarcinoma
ITGB1::PLAG1	Benign epithelial tumor, special type
ITGB1::WDFY4	Adenocarcinoma
ITGB1BP1::COL5A1	Squamous cell carcinoma
ITGB2::CD74	Squamous cell carcinoma
ITGB3::MYL4	Adenocarcinoma
ITGB3BP::TTC39A	Adenocarcinoma
ITGB4::ADK	Adenocarcinoma
ITGB4::ENDOV	Adenocarcinoma
ITGB4::LLGL2	Adenocarcinoma
ITGB4::MYO15B	Adenocarcinoma
ITGB4::NARF	Adenocarcinoma
ITGB4::OTOP2	Squamous cell carcinoma
ITGB4::PLEKHB2	Squamous cell carcinoma
ITGB4::PTN	Squamous cell carcinoma
ITGB4::RECQL5	Adenocarcinoma
ITGB4::SAP30BP	Adenocarcinoma
ITGB4::SLC16A5	Adenocarcinoma
ITGB4::SMIM6	Squamous cell carcinoma | Adenocarcinoma
ITGB4::TSPAN10	Adenocarcinoma
ITGB5::FGL1	Squamous cell carcinoma
ITGB5::HDAC9	Adenocarcinoma
ITGB5::PARP14	Adenocarcinoma
ITGB5::PDLIM5	Adenocarcinoma
ITGB5::SLC12A8	Adenocarcinoma
ITGB5::ZNF148	Adenocarcinoma
ITGB6::BAZ2B	Adenocarcinoma
ITGB6::CD302	Adenocarcinoma
ITGB6::CNOT2	Mesenchymal tumor, NOS
ITGB6::COMMD1	Adenocarcinoma
ITGB6::RBMS1	Adenocarcinoma
ITGB6::SH3PXD2B	Adenocarcinoma
ITGB8::ABCB5	Malignant epithelial tumor, special type
ITGB8::ATM	Adenocarcinoma
ITGBL1::KIF5C	Glioma, NOS
ITIH2::RET	Adenosquamous carcinoma
ITIH2::TAF3	Adenocarcinoma
ITK::FER	Peripheral T-cell lymphoma, unspecified
ITK::SYK	Peripheral T-cell lymphoma, unspecified | Angioimmunoblastic T-cell lymphoma
ITLN1::C3	Mesothelioma
ITLN1::DCN	Mesothelioma
ITLN1::NDUFV1	Mesothelioma
ITM2B::ARFGEF2	Adenocarcinoma
ITM2B::CBS	Adenocarcinoma
ITM2B::ESD	Squamous cell carcinoma
ITM2B::JADE2	Adenocarcinoma
ITM2B::MATR3	Adenocarcinoma
ITM2B::RB1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ITM2B::RPL30	Squamous cell carcinoma
ITM2B::TTC3	Malignant melanoma
ITM2C::FOXP1	Benign epithelial tumor, special type
ITM2C::IGK	Multiple myeloma
ITM2C::SEPTIN9	Astrocytoma, grade I-II
ITM2C::THSD4	Squamous cell carcinoma
ITM2C::TYK2	Astrocytoma, grade I-II
ITPA::SLC22A24	Adenocarcinoma
ITPK1::ACO1	Adenocarcinoma
ITPK1::AKR1A1	Adenocarcinoma
ITPK1::BTBD7	Adenocarcinoma
ITPK1::CEP170B	Squamous cell carcinoma
ITPK1::FBP2	Meningioma
ITPK1::GON7	Adenocarcinoma
ITPK1::SPINK4	Adenocarcinoma
ITPKA::NUSAP1	Adenocarcinoma
ITPKA::RTF1	Squamous cell carcinoma
ITPKB::ZC3HAV1	Adenocarcinoma
ITPKC::LTBP4	Malignant epithelial tumor, special type
ITPKC::PPFIA3	Adenocarcinoma
ITPKC::SPTBN4	Adenocarcinoma
ITPR1::BHLHE40	Adenocarcinoma | Astrocytoma, grade I-II
ITPR1::NR2C2	Leiomyoma
ITPR1::SETMAR	Adenocarcinoma
ITPR1::SUMF1	Squamous cell carcinoma
ITPR2::ADIPOR2	Astrocytoma, grade I-II
ITPR2::ANO2	Adenocarcinoma
ITPR2::BHLHE41	Adenocarcinoma
ITPR2::CLEC2A	Adenocarcinoma
ITPR2::CLIC1	Adenocarcinoma
ITPR2::DCDC2	Adenocarcinoma
ITPR2::DDX11	Adenocarcinoma
ITPR2::ETV6	Adenocarcinoma
ITPR2::MRPS35	Adenocarcinoma
ITPR2::RAD17	Adenocarcinoma
ITPR2::RASSF3	Adenocarcinoma
ITPR2::TM7SF3	Adenocarcinoma
ITPR3::CARMIL1	Adenocarcinoma
ITPR3::PNPLA1	Diffuse large B-cell lymphoma
ITPR3::SYNGAP1	Adenocarcinoma
ITPR3::ZBTB17	Adenocarcinoma
ITPRID1::DEFB118	Adenocarcinoma
ITPRID2::ALK	Adenocarcinoma
ITPRID2::PTPN4	Adenocarcinoma
ITPRIPL1::IL36G	Squamous cell carcinoma
ITSN1::CHODL	Squamous cell carcinoma
ITSN1::CRACD	Adenocarcinoma
ITSN1::CRYZL1	Transitional cell carcinoma
ITSN1::GET1	Adenocarcinoma
ITSN1::HNRNPUL1	Mesenchymal tumor, NOS
ITSN1::KCNE2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ITSN1::MAP3K7CL	Miscellaneous hematopoietic/lymphoid neoplasm, special type | Benign epithelial tumor, special type
ITSN1::MATN1	Squamous cell carcinoma
ITSN1::MRAP	Adenocarcinoma
ITSN1::NEBL	Adenocarcinoma
ITSN1::ZNF490	Squamous cell carcinoma
ITSN2::ALK	Adenocarcinoma
ITSN2::ATRNL1	Adenocarcinoma
ITSN2::DNAJC27	Adenocarcinoma
ITSN2::DTNB	Adenocarcinoma
ITSN2::HADHA	Adenocarcinoma
ITSN2::KIDINS220	Malignant melanoma
ITSN2::MYO10	Malignant melanoma
ITSN2::NMT1	Adenocarcinoma
ITSN2::TBC1D10B	Acute myeloid leukemia, NOS | Skin
IVD::ECE1	Malignant epithelial tumor, special type
IVNS1ABP::BAHCC1	Squamous cell carcinoma
IYD::BIRC6	Adenocarcinoma
IZUMO2::CYTH2	Adenocarcinoma
JADE1::C4ORF33	Adenocarcinoma
JADE1::LARP1B	Adenocarcinoma
JADE2::SGCD	Adenocarcinoma
JADE2::UBE2B	Undifferentiated carcinoma, small cell | Adenocarcinoma
JADE3::CP	Adenocarcinoma
JADE3::MTA3	Adenocarcinoma
JADE3::SSX2	Adenocarcinoma
JAG1::SLX4IP	Squamous cell carcinoma
JAGN1::CPNE9	Malignant epithelial tumor, special type
JAGN1::ZC3H4	Astrocytoma, grade III-IV/Glioblastoma
JAK1::HSD11B1	Adenocarcinoma
JAK1::PDE4B	Adenocarcinoma
JAK1::WLS	Adenocarcinoma
JAK1::ZC3H7B	Adenocarcinoma
JAK2::CSTF3	Adenocarcinoma
JAK2::DOCK8	Malignant melanoma
JAK2::EBF1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
JAK2::GLDC	Squamous cell carcinoma
JAK2::PAX5	Acute lymphoblastic leukemia/lymphoblastic lymphoma
JAK2::PKNOX2	Mesenchymal tumor, NOS
JAK2::PTPRD	Ependymoma
JAK2::RCL1	Squamous cell carcinoma
JAK2::SNX29	Acute lymphoblastic leukemia/lymphoblastic lymphoma
JAK2::TPM3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
JAK3::INSL3	Adenocarcinoma | Anaplastic large cell lymphoma, cutaneous type
JAM3::SEC13	Astrocytoma, grade I-II
JARID2::ATM	Adenocarcinoma
JARID2::BMP6	Adenocarcinoma
JARID2::CDKAL1	Transitional cell carcinoma
JARID2::DNM3	Mesenchymal tumor, NOS
JARID2::DTNBP1	Squamous cell carcinoma
JARID2::GMPR	Transitional cell carcinoma
JARID2::HFE	Squamous cell carcinoma
JARID2::HIVEP1	Transitional cell carcinoma
JARID2::HSD3B1	Adenocarcinoma
JARID2::MDGA1	Squamous cell carcinoma
JARID2::MRS2	Malignant melanoma
JARID2::NEDD9	Malignant melanoma
JARID2::NUDC	Germ cell tumor, NOS
JARID2::PPP1R10	Transitional cell carcinoma
JARID2::RNGTT	Adenocarcinoma
JARID2::SGCZ	Transitional cell carcinoma
JAZF1::BCORL1	Mesenchymal tumor, special type
JAZF1::CPT1C	Astrocytoma, grade III-IV/Glioblastoma
JAZF1::CREB5	Malignant melanoma
JAZF1::EVX1	Mesenchymal tumor, NOS
JAZF1::GXYLT2	Endometrial stromal sarcoma
JAZF1::NUDT5	Soft tissue tumor, special type
JAZF1::PHF1	Soft tissue tumor, special type | Endometrial stromal sarcoma
JAZF1::PPP4R2	Endometrial stromal sarcoma
JAZF1::SFRP4	Squamous cell carcinoma
JAZF1::SNX13	Astrocytoma, grade I-II
JAZF1::SUZ12	Nonneoplastic epithelial disorder/lesion | Endometrial stromal sarcoma
JDP2::FLVCR2	Squamous cell carcinoma
JDP2::PLEKHH1	Adenocarcinoma
JDP2::VRTN	Adenocarcinoma
JDP2::YLPM1	Adenocarcinoma
JDP2::ZC2HC1C	Adenocarcinoma
JKAMP::DAAM1	Adenocarcinoma
JMJD1C::ANK3	Adenocarcinoma
JMJD1C::CTNNA3	Adenocarcinoma
JMJD1C::EGR2	Adenocarcinoma
JMJD1C::GABPB1	Adenocarcinoma
JMJD1C::LIPF	Adenocarcinoma
JMJD1C::NRBF2	Astrocytoma, grade III-IV/Glioblastoma
JMJD1C::RPL5	Adenocarcinoma
JMJD1C::TMEM178B	Adenocarcinoma
JMJD1C::TSN	Acute lymphoblastic leukemia/lymphoblastic lymphoma
JMJD1C::VTI1A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
JMJD1C::YWHAZ	Adenocarcinoma
JMJD1C::ZNF365	Adenocarcinoma
JMJD7::RTF1	Adenocarcinoma
JMY::DMGDH	Adenocarcinoma
JMY::TENT2	Adenocarcinoma
JOSD1::RPS19BP1	Adenocarcinoma
JPH1::LY96	Adenocarcinoma
JPH3::OSGIN1	Squamous cell carcinoma
JPT1::ARMC7	Adenocarcinoma
JPT1::CALM1	Adenocarcinoma
JPT1::GGA3	Adenocarcinoma
JPT1::NUP85	Squamous cell carcinoma
JPT1::RECQL5	Adenocarcinoma
JPT1::USH1G	Adenocarcinoma
JPT2::CRAMP1	Adenocarcinoma
JPT2::NHERF2	Squamous cell carcinoma
JPT2::WDR18	Squamous cell carcinoma
JTB::CYP1B1	Adenocarcinoma
JUN::EEF1A1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
JUN::IGH	Multiple myeloma
JUN::IGK	Multiple myeloma
JUN::IGL	Multiple myeloma
JUNB::IGK	Multiple myeloma
JUNB::SEC63	Adenocarcinoma
JUP::AARSD1	Adenocarcinoma
JUP::ACLY	Transitional cell carcinoma
JUP::CAMTA2	Adenocarcinoma
JUP::CCT5	Squamous cell carcinoma
JUP::EIF2AK2	Squamous cell carcinoma
JUP::KLHL11	Adenocarcinoma
JUP::NDUFV1	Squamous cell carcinoma
JUP::NT5C3B	Squamous cell carcinoma
JUP::P3H4	Squamous cell carcinoma | Adenocarcinoma
JUP::PTN	Squamous cell carcinoma
JUP::RFX5	Adenocarcinoma
JUP::SCGB2B2	Adenocarcinoma
JUP::TTLL6	Adenocarcinoma
KALRN::CREB5	Adenocarcinoma
KANK1::ALK	Adenocarcinoma
KANK1::DOCK8	Adenocarcinoma | Undifferentiated carcinoma, small cell
KANK1::KCNV2	Mesothelioma
KANK1::NFX1	Transitional cell carcinoma
KANK1::NTRK2	Astrocytoma, grade III-IV/Glioblastoma | Undifferentiated sarcoma
KANK1::NTRK3	Adenocarcinoma | Malignant melanoma | Benign epithelial tumor, special type
KANK1::PDGFRB	Essential thrombocythemia
KANK1::TPD52L3	Adenocarcinoma
KANK1::UHRF2	Adenocarcinoma
KANK2::ALK	Leiomyosarcoma
KANK2::DOCK6	Adenocarcinoma
KANK3::SPC24	Adenocarcinoma
KANSL1::AARS1	Malignant melanoma
KANSL1::ARL17A	Nonneoplastic epithelial disorder/lesion | Astrocytoma, grade III-IV/Glioblastoma | Adenocarcinoma | Russia | Heart | Chronic myeloid leukemia, t(9;22) | Wilms tumor | Primitive neuroectodermal tumor/Medulloblastoma | Ependymoma | Osteosarcoma, NOS | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Nonneoplastic hematologic disorder/lesion | Embryonal rhabdomyosarcoma
KANSL1::ARL17B	Nonneoplastic epithelial disorder/lesion | Nonneoplastic hematologic disorder/lesion | Skin | Adenocarcinoma | Acute myeloid leukemia, NOS
KANSL1::CMC4	Acute monoblastic leukemia (FAB type M5)
KANSL1::DYNLL2	Adenocarcinoma
KANSL1::FMN1	Malignant melanoma
KANSL1::GAST	Adenocarcinoma
KANSL1::KDM2A	Adenocarcinoma
KANSL1::LAYN	Adenocarcinoma
KANSL1::LRRC8D	Skin | Acute myeloid leukemia, NOS
KANSL1::MBTD1	Adenocarcinoma
KANSL1::MTCP1	Acute monoblastic leukemia (FAB type M5)
KANSL1::NSD3	Squamous cell carcinoma
KANSL1::NSF	Transitional cell carcinoma
KANSL1::ORMDL3	Adenocarcinoma
KANSL1::OSBPL7	Adenocarcinoma
KANSL1::PARD3B	Squamous cell carcinoma
KANSL1::PPP1R1B	Adenocarcinoma
KANSL1::PYY	Mesenchymal tumor, NOS
KANSL1::SPOP	Malignant epithelial tumor, special type
KANSL1::UNC45B	Squamous cell carcinoma
KANSL1::VAT1	Malignant melanoma
KANSL1L::ACADL	Adenocarcinoma
KANSL1L::ERBB4	Adenocarcinoma
KANSL1L::RAPGEF4	Adenocarcinoma
KANSL3::ANKRD36	Adenocarcinoma
KANSL3::BPIFB2	Squamous cell carcinoma
KANSL3::KCNIP3	Adenocarcinoma
KANSL3::SHE	Adenocarcinoma
KANSL3::TSGA10	Adenocarcinoma
KANSL3::UFC1	Adenocarcinoma
KARS1::PLGRKT	Malignant epithelial tumor, special type
KARS1::WDR59	Adenocarcinoma
KAT14::OVOL2	Adenocarcinoma
KAT2A::STAT5B	Transitional cell carcinoma
KAT6A::ADAM2	Adenocarcinoma
KAT6A::ANK1	Adenocarcinoma
KAT6A::ASXL2	Myelodysplastic syndrome, NOS
KAT6A::CREBBP	Acute monoblastic leukemia with differentiation (FAB type M5b) | Acute myelomonocytic leukemia (FAB type M4) | Acute monoblastic leukemia (FAB type M5) | Acute myeloblastic leukemia with maturation (FAB type M2) | Skin | Acute myeloid leukemia, NOS | Acute monoblastic leukemia without differentiation (FAB type M5a)
KAT6A::CSMD1	Squamous cell carcinoma
KAT6A::EP300	Acute myelomonocytic leukemia (FAB type M4) | Skin | Acute monoblastic leukemia (FAB type M5) | Acute myeloid leukemia, NOS
KAT6A::FGFR1	Squamous cell carcinoma | Adenocarcinoma
KAT6A::GOT1L1	Adenocarcinoma
KAT6A::GPAT4	Squamous cell carcinoma
KAT6A::IKBKB	Adenocarcinoma
KAT6A::KANSL1	Endometrial stromal sarcoma | Myoepithelioma/myoepithelial carcinoma/mixed tumor
KAT6A::KLK4	Adenocarcinoma
KAT6A::LEUTX	Acute monoblastic leukemia (FAB type M5) | Acute myeloid leukemia, NOS | Skin | Acute myelomonocytic leukemia (FAB type M4)
KAT6A::MSR1	Adenocarcinoma
KAT6A::NCOA2	Acute monoblastic leukemia (FAB type M5) | Egypt | Mastocytosis | Bilineage or biphenotypic leukemia | Acute myelomonocytic leukemia (FAB type M4) | Acute myeloid leukemia, NOS | Acute monoblastic leukemia without differentiation (FAB type M5a) | Skin
KAT6A::NCOA3	Acute monoblastic leukemia (FAB type M5)
KAT6A::NEFL	Multiple myeloma
KAT6A::NRG1	Adenocarcinoma
KAT6A::RAB11FIP1	Adenocarcinoma
KAT6A::SLC20A2	Squamous cell carcinoma
KAT6A::SMIM19	Squamous cell carcinoma
KAT6A::TFE3	Adenocarcinoma
KAT6A::TRAPPC9	Adenocarcinoma
KAT6A::VDAC3	Adenocarcinoma
KAT6A::VPS13B	Transitional cell carcinoma
KAT6B::ADK	Adenocarcinoma
KAT6B::CCDC172	Adenocarcinoma
KAT6B::CORO7	Adenocarcinoma
KAT6B::CREBBP	Acute myelomonocytic leukemia (FAB type M4) | Acute monoblastic leukemia without differentiation (FAB type M5a) | Acute monoblastic leukemia with differentiation (FAB type M5b) | Myelodysplastic syndrome, NOS
KAT6B::DDX4	Adenocarcinoma
KAT6B::KANSL1	Leiomyoma | Endometrial stromal sarcoma
KAT6B::RTKN2	Adenocarcinoma
KAT6B::SH3BP5L	Adenocarcinoma
KAT7::AXIN2	Adenocarcinoma
KAT7::F10	Mesenchymal tumor, NOS
KAT7::IGF2BP1	Adenocarcinoma
KAT7::NPLOC4	Adenocarcinoma
KAT7::SPOP	Adenocarcinoma
KATNA1::LATS1	Adenocarcinoma
KATNA1::PPP2R1A	Adenocarcinoma
KATNA1::RALYL	Mesenchymal tumor, NOS
KATNAL1::CUL4A	Malignant melanoma
KATNAL1::UBE2L5	Malignant melanoma
KATNAL1::WASF3	Adenocarcinoma
KATNB1::DRC7	Adenocarcinoma
KATNBL1::EMC7	Squamous cell carcinoma
KATNBL1::TNPO3	Astrocytoma, grade III-IV/Glioblastoma
KATNIP::LSM1	Squamous cell carcinoma
KATNIP::NECAB2	Adenocarcinoma
KAZN::FGF12	Squamous cell carcinoma
KAZN::FHAD1	Adenocarcinoma
KAZN::MTOR	Adenocarcinoma
KAZN::PDGFRB	Acute myeloid leukemia, NOS | Skin
KAZN::PHGDH	Mesenchymal tumor, NOS
KAZN::ST3GAL3	Adenocarcinoma
KBTBD2::COBL	Transitional cell carcinoma
KBTBD2::NT5C3A	Adenocarcinoma
KBTBD2::PDE1C	Squamous cell carcinoma
KBTBD6::TEX29	Transitional cell carcinoma
KCMF1::DNAH6	Adenocarcinoma
KCMF1::GGCX	Adenocarcinoma
KCMF1::PRKDC	Adenocarcinoma
KCMF1::RAB1A	Adenocarcinoma
KCMF1::TMSB10	Adenocarcinoma
KCNA6::C3AR1	Astrocytoma, grade I-II
KCNAB1::KHDRBS1	Mesenchymal tumor, NOS
KCNAB1::LRTM1	Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
KCNAB2::ACOT7	Malignant melanoma
KCNAB2::KIF1B	Astrocytoma, grade I-II
KCNAB2::POLB	Squamous cell carcinoma
KCNB1::ZFPM2	Astrocytoma, grade I-II
KCNC3::ASPDH	Adenocarcinoma
KCNC3::NAPSA	Adenocarcinoma
KCNC3::PRKDC	Squamous cell carcinoma
KCNC3::ZNF530	Astrocytoma, grade I-II
KCNC4::GSTM4	Adenocarcinoma
KCND3::PPM1E	Adenocarcinoma
KCNE2::HTN3	Adenocarcinoma
KCNH1::LPGAT1	Adenocarcinoma
KCNH2::TMEM176B	Malignant epithelial tumor, special type
KCNH7::SLC38A11	Adenocarcinoma
KCNIP1::KCTD14	Squamous cell carcinoma
KCNIP4::GRK4	Astrocytoma, grade III-IV/Glioblastoma
KCNJ10::CISD2	Astrocytoma, grade I-II
KCNJ3::GALNT13	Adenocarcinoma
KCNJ6::ARHGEF26	Adenocarcinoma
KCNK13::TDP1	Astrocytoma, grade I-II
KCNK17::DNAH8	Transitional cell carcinoma
KCNK17::KIF6	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KCNK1::BICDL1	Adenocarcinoma
KCNK5::KIF6	Squamous cell carcinoma
KCNK5::PDE4DIP	Adenocarcinoma
KCNK5::RUNX2	Adenocarcinoma
KCNMA1::DLG5	Adenocarcinoma
KCNMA1::DOCK1	Adenocarcinoma
KCNMA1::ECD	Adenocarcinoma
KCNMA1::FARP1	Adenocarcinoma
KCNMA1::HIVEP3	Embryonal nervous system tumor, special type
KCNMA1::MSMB	Adenocarcinoma
KCNMA1::RFX2	Adenocarcinoma
KCNMA1::SERTAD1	Adenocarcinoma
KCNMB2::NRXN1	Squamous cell carcinoma
KCNMB4::ALDH3B2	Adenocarcinoma
KCNMB4::CCND3	Osteosarcoma, NOS
KCNMB4::CNOT2	Germ cell tumor, NOS
KCNMB4::GDF3	Mesenchymal tumor, NOS
KCNMB4::GLIPR1L2	Mesenchymal tumor, NOS
KCNMB4::KICS2	Astrocytoma, grade III-IV/Glioblastoma
KCNMB4::MSRB3	Transitional cell carcinoma
KCNMB4::PRICKLE1	Astrocytoma, grade III-IV/Glioblastoma
KCNMB4::PTPRR	Transitional cell carcinoma
KCNMB4::RTKN2	Adenocarcinoma
KCNN1::GATA6	Adenocarcinoma
KCNN1::SLC27A1	Adenocarcinoma
KCNN3::DCST2	Adenocarcinoma
KCNN3::PBXIP1	Adenocarcinoma
KCNN3::YEATS4	Mesenchymal tumor, NOS
KCNQ1::AMPD3	Adenocarcinoma
KCNQ1::B4GALNT4	Malignant epithelial tumor, special type
KCNQ1::CD81	Adenocarcinoma
KCNQ1::DUSP8	Adenocarcinoma
KCNQ1::GALNTL6	Adenocarcinoma
KCNQ1::LSP1	Malignant epithelial tumor, special type
KCNQ1::METTL15	Squamous cell carcinoma
KCNQ1::MMP26	Adenocarcinoma
KCNQ1::SCT	Adenocarcinoma
KCNQ1::TSPAN32	Adenocarcinoma
KCNQ3::DNAAF11	Squamous cell carcinoma
KCNQ3::ZHX2	Benign epithelial tumor, special type
KCNQ5::ALK	Malignant melanoma
KCNQ5::AMPH	Squamous cell carcinoma
KCNQ5::CRYL1	Transitional cell carcinoma
KCNQ5::DST	Squamous cell carcinoma
KCNQ5::RIMS1	Adenocarcinoma
KCNQ5::RNF217	Malignant melanoma
KCTD10::GLTP	Adenocarcinoma
KCTD10::TPCN1	Adenocarcinoma
KCTD13::ICA1	Adenocarcinoma
KCTD13::QPRT	Adenocarcinoma
KCTD15::MSI2	Malignant melanoma
KCTD16::NTRK2	Glioma, NOS
KCTD18::PLCL1	Adenocarcinoma
KCTD18::SNED1	Adenocarcinoma
KCTD1::SPTBN1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KCTD1::TWSG1	Adenocarcinoma
KCTD20::BRPF3	Adenocarcinoma
KCTD20::ETV7	Transitional cell carcinoma
KCTD20::ILRUN	Adenocarcinoma
KCTD20::JARID2	Adenocarcinoma
KCTD20::PNPLA1	Squamous cell carcinoma
KCTD20::STK38	Adenocarcinoma
KCTD20::ZNF311	Adenocarcinoma
KCTD21::NARS2	Adenocarcinoma
KCTD21::RSF1	Malignant melanoma
KCTD21::TENM4	Adenocarcinoma
KCTD2::ARHGAP23	Adenocarcinoma
KCTD2::ARHGEF12	Malignant melanoma
KCTD2::TMEM104	Adenocarcinoma
KCTD3::TXNDC16	Adenocarcinoma
KCTD5::CCNF	Adenocarcinoma
KCTD5::TSC2	Adenocarcinoma
KCTD7::KLK3	Adenocarcinoma
KCTD8::NTRK2	Glioma, NOS
KCTD8::WDR19	Mesenchymal tumor, NOS
KCTD9::NRG1	Adenocarcinoma
KDELR1::SULT2B1	Adenocarcinoma
KDELR2::GOPC	Adenocarcinoma
KDELR2::ROS1	Adenocarcinoma
KDM1A::EPHB2	Adenocarcinoma
KDM1A::TMEM115	Adenocarcinoma
KDM1B::PITPNC1	Adenocarcinoma
KDM2A::CCDC170	Adenocarcinoma
KDM2A::DDR2	Adenocarcinoma
KDM2A::FAM83B	Adenocarcinoma
KDM2A::FBXO3	Adenocarcinoma
KDM2A::GDPD4	Adenocarcinoma
KDM2A::GLB1L2	Undifferentiated carcinoma, small cell
KDM2A::GRIP1	Adenocarcinoma
KDM2A::GSTP1	Transitional cell carcinoma
KDM2A::IKZF1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KDM2A::MAP3K3	Adenocarcinoma
KDM2A::NDUFV1	Adenocarcinoma
KDM2A::PACS1	Adenocarcinoma
KDM2A::PGA3	Squamous cell carcinoma
KDM2A::PPP6R3	Adenocarcinoma
KDM2A::RBM14	Adenocarcinoma
KDM2A::RHOD	Squamous cell carcinoma | Multiple myeloma | Adenocarcinoma
KDM2A::RPS6KB2	Adenocarcinoma
KDM2A::SLC5A4	Mesenchymal tumor, NOS
KDM2A::SYNDIG1	Adenocarcinoma
KDM2A::SYT12	Astrocytoma, grade III-IV/Glioblastoma
KDM2A::TOP6BL	Adenocarcinoma
KDM2A::WWTR1	Ossifying fibromyxoid tumor
KDM2A::YAP1	Glioma, NOS
KDM2B::AFF4	Chronic lymphocytic leukemia
KDM2B::CCDC60	Astrocytoma, grade III-IV/Glioblastoma
KDM2B::CORO1C	Mesenchymal tumor, NOS
KDM2B::CREBBP	Endometrial stromal sarcoma | Soft tissue tumor, special type
KDM2B::DUX4	Soft tissue tumor, special type
KDM2B::KSR2	Astrocytoma, grade III-IV/Glioblastoma
KDM2B::LRRIQ1	Mesenchymal tumor, NOS
KDM2B::MORN3	Mature B-cell neoplasm, NOS
KDM2B::NUTM2B	Neuroglial neoplasm, special type | Soft tissue tumor, special type
KDM2B::ORAI1	Germ cell tumor, NOS
KDM2B::RHOF	Adenocarcinoma
KDM2B::SLC9A5	Adenocarcinoma
KDM2B::SNRNP35	Malignant melanoma
KDM2B::UTY	Chronic lymphocytic leukemia
KDM3A::CRIM1	Adenocarcinoma
KDM3A::LTBP1	Adenocarcinoma
KDM3A::MRPL35	Adenocarcinoma
KDM3A::PUS10	Squamous cell carcinoma
KDM3A::RFX8	Adenocarcinoma
KDM3A::SUCLG2	Adenocarcinoma
KDM3B::ETF1	Adenocarcinoma
KDM4A::CFAP57	Adenocarcinoma
KDM4A::CREB3L4	Adenocarcinoma
KDM4A::EGLN1	Squamous cell carcinoma
KDM4A::FAF1	Mesenchymal tumor, NOS
KDM4A::HYI	Adenocarcinoma
KDM4A::MPL	Adenocarcinoma
KDM4A::OPRD1	Adenocarcinoma
KDM4A::PNKD	Adenocarcinoma
KDM4A::PTCH2	Squamous cell carcinoma
KDM4A::PTPRF	Adenocarcinoma
KDM4A::RYBP	Adenocarcinoma
KDM4A::SZT2	Adenocarcinoma
KDM4B::AKAP8L	Adenocarcinoma
KDM4B::ASTN2	Adenocarcinoma
KDM4B::ATCAY	Adenocarcinoma
KDM4B::C19ORF44	Adenocarcinoma
KDM4B::C19orf44	Adenocarcinoma
KDM4B::CHAF1A	Astrocytoma, grade I-II
KDM4B::CUL2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KDM4B::DKKL1	Adenocarcinoma
KDM4B::DOCK6	Adenocarcinoma
KDM4B::FOXA3	Malignant melanoma
KDM4B::MPND	Adenocarcinoma
KDM4B::PHYHIPL	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
KDM4B::SBNO2	Astrocytoma, grade I-II
KDM4B::SLC25A42	Malignant melanoma
KDM4B::SNTG1	Astrocytoma, grade III-IV/Glioblastoma
KDM4B::TMPRSS9	Skin | Acute myeloid leukemia, NOS
KDM4B::TNFAIP8L1	Adenocarcinoma
KDM4B::UBA52	Adenocarcinoma
KDM4B::UBXN6	Adenocarcinoma
KDM4B::UHRF1	Adenocarcinoma
KDM4B::UVRAG	Malignant epithelial tumor, special type
KDM4B::YJU2	Adenocarcinoma
KDM4C::A1BG	Transitional cell carcinoma
KDM4C::ARMC2	Adenocarcinoma
KDM4C::DMRT3	Squamous cell carcinoma
KDM4C::FGF7	Squamous cell carcinoma
KDM4C::INSL4	Adenocarcinoma
KDM4C::JAK2	Adenocarcinoma
KDM4C::KLK7	Adenocarcinoma
KDM4C::PHF24	Astrocytoma, grade I-II
KDM4C::PTPRD	Adenocarcinoma
KDM4C::RFX3	Adenocarcinoma
KDM4C::UNC13B	Mycosis fungoides/Sézary syndrome
KDM5A::ANO2	Adenocarcinoma
KDM5A::ATN1	Adenocarcinoma
KDM5A::CCDC77	Adenocarcinoma
KDM5A::IQSEC3	Malignant melanoma
KDM5A::NINJ2	Adenocarcinoma
KDM5A::NUP98	Acute myelomonocytic leukemia (FAB type M4)
KDM5A::RAE1	Adenocarcinoma
KDM5B::ITPKB	Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
KDM5B::PPP1R12B	Mesenchymal tumor, NOS
KDM5B::RABGAP1L	Adenocarcinoma
KDM5B::RASAL2	Malignant melanoma
KDM5B::UAP1	Astrocytoma, grade I-II
KDM5C::HSD17B10	Adenocarcinoma
KDM5C::HUWE1	Squamous cell carcinoma
KDM5C::MAGT1	Astrocytoma, grade I-II
KDM5C::PPP4R1	Adenocarcinoma
KDM6A::ANOS1	Transitional cell carcinoma
KDM6A::ARHGAP6	Adenocarcinoma
KDM6A::DCAF7	Adenocarcinoma
KDM6A::DLL1	Squamous cell carcinoma
KDM6A::DMD	Adenocarcinoma
KDM6A::ETFBKMT	Adenocarcinoma
KDM6A::FUNDC1	Adenocarcinoma
KDM6A::NDUFB11	Adenocarcinoma
KDM6A::PDHX	Adenocarcinoma
KDM6A::RPS6KA3	Mesenchymal tumor, NOS
KDM6A::YEATS4	Adenocarcinoma
KDM6A::ZNF674	Adenocarcinoma
KDM6B::DNAH2	Adenocarcinoma
KDM6B::TMEM95	Adenocarcinoma
KDM6B::TP53	Adenocarcinoma
KDM7A::AGK	Adenocarcinoma
KDM7A::ATP5MF	Malignant melanoma
KDM7A::BRAF	Adenocarcinoma
KDM7A::CDC16	Acute myeloblastic leukemia with maturation (FAB type M2)
KDM7A::SND1	Adenocarcinoma
KDSR::SERPINB5	Adenocarcinoma
KEAP1::AP1M2	Adenocarcinoma
KEAP1::EYA2	Adenocarcinoma
KHDC1::NLK	Adenocarcinoma
KHDC1::OOEP	Adenocarcinoma
KHDC1::SLC17A5	Adenocarcinoma
KHDC4::ACBD3	Adenocarcinoma
KHDC4::ARHGEF2	Transitional cell carcinoma
KHDC4::ASH1L	Adenocarcinoma
KHDC4::CCT3	Adenocarcinoma
KHDC4::CD276	Squamous cell carcinoma
KHDC4::PHC1	Adenocarcinoma
KHDC4::RPS15A	Adenocarcinoma
KHDC4::SMG5	Adenocarcinoma
KHDRBS1::LCK	Adenocarcinoma
KHDRBS1::MET	Adenocarcinoma
KHDRBS1::NDC1	Malignant epithelial tumor, special type
KHDRBS1::NTRK1	Soft tissue tumor, NOS
KHDRBS1::NTRK3	Angiosarcoma | Fibroblastic/myofibroblastic tumor, special type
KHDRBS1::SERINC2	Adenocarcinoma
KHDRBS2::LMBRD1	Adenocarcinoma
KHDRBS3::ADI1	Adenocarcinoma
KHDRBS3::ANXA13	Malignant melanoma
KHDRBS3::CMTM6	Astrocytoma, grade I-II
KHDRBS3::EFR3A	Adenocarcinoma
KHDRBS3::PACRG	Malignant melanoma
KHSRP::CD70	Adenocarcinoma
KHSRP::TFE3	Adenocarcinoma
KHSRP::ZNF441	Squamous cell carcinoma
KIAA0232::INPP4B	Adenocarcinoma
KIAA0232::LRCH3	Adenocarcinoma
KIAA0232::MAN2B2	Adenocarcinoma
KIAA0232::MRFAP1	Adenocarcinoma
KIAA0232::TBC1D14	Adenocarcinoma
KIAA0319L::CIB2	Adenocarcinoma
KIAA0319L::CLSPN	Adenocarcinoma
KIAA0319L::DLGAP3	Squamous cell carcinoma
KIAA0319L::EIF4G3	Adenocarcinoma
KIAA0319L::GNB1	Adenocarcinoma
KIAA0319L::GOLGA1	Adenocarcinoma
KIAA0319L::LRRIQ1	Adenocarcinoma
KIAA0319L::ODF2L	Adenocarcinoma
KIAA0319L::PAGE2B	Adenocarcinoma
KIAA0319L::PHC2	Adenocarcinoma
KIAA0319L::PSMB2	Adenocarcinoma
KIAA0319L::TPMT	Adenocarcinoma
KIAA0319L::UBA6	Adenocarcinoma
KIAA0319L::YTHDF2	Adenocarcinoma
KIAA0513::ANKRD11	Astrocytoma, grade III-IV/Glioblastoma
KIAA0586::PALS1	Astrocytoma, grade III-IV/Glioblastoma
KIAA0753::HSBP1L1	Adenocarcinoma
KIAA0753::PER1	Adenocarcinoma
KIAA0753::PHF23	Adenocarcinoma
KIAA0753::TP53	Adenocarcinoma
KIAA0825::ADGRV1	Adenocarcinoma
KIAA0825::HSPH1	Adenocarcinoma
KIAA0825::MCTP1	Adenocarcinoma
KIAA0895L::NPIPA5	Acute myeloblastic leukemia with maturation (FAB type M2)
KIAA0930::ANK3	Adenocarcinoma
KIAA0930::SMC1B	Squamous cell carcinoma
KIAA1191::CLTB	Adenocarcinoma
KIAA1191::FAF2	Adenocarcinoma
KIAA1191::NOP16	Squamous cell carcinoma
KIAA1217::ALK	Adenocarcinoma
KIAA1217::C10orf67	Malignant melanoma
KIAA1217::FBH1	Astrocytoma, grade I-II
KIAA1217::FCN1	Adenocarcinoma
KIAA1217::LPP	Squamous cell carcinoma
KIAA1217::PFKFB3	Adenocarcinoma
KIAA1217::RET	Adenocarcinoma | Fibroblastic/myofibroblastic tumor, special type | Carcinoma, NOS
KIAA1217::RNF10	Adenocarcinoma
KIAA1217::SPAG6	Transitional cell carcinoma
KIAA1217::THNSL1	Squamous cell carcinoma
KIAA1328::DCC	Transitional cell carcinoma
KIAA1328::LIMCH1	Astrocytoma, grade I-II
KIAA1328::QSER1	Adenocarcinoma
KIAA1328::SUPT3H	Squamous cell carcinoma
KIAA1549::BRAF	Astrocytoma, grade I-II | Soft tissue tumor, special type | Undifferentiated round cell sarcoma | Glioma, NOS | Rhabdoid tumor | Mesenchymal tumor, special type | Astrocytoma, pilocytic/juvenile | Ependymoma | Astrocytoma, grade III-IV/Glioblastoma | Fibrosarcoma | Adenocarcinoma | Oligodendroglioma | Embryonal nervous system tumor, special type | Fibroblastic/myofibroblastic tumor, NOS | Mesoblastic nephroma
KIAA1549L::WARS2	Squamous cell carcinoma
KIAA1614::XPR1	Malignant epithelial tumor, special type
KIAA1671::C16ORF87	Adenocarcinoma
KIAA1671::CHEK2	Adenocarcinoma
KIAA1671::CLPTM1	Adenocarcinoma
KIAA1671::CNIH3	Adenocarcinoma
KIAA1671::CRKL	Adenocarcinoma
KIAA1671::EIF4ENIF1	Adenocarcinoma
KIAA1671::HTR1E	Adenocarcinoma
KIAA1671::MYO18B	Adenocarcinoma
KIAA1671::NF2	Adenocarcinoma
KIAA1671::NLN	Adenocarcinoma
KIAA1671::SEC14L2	Adenocarcinoma
KIAA1671::SNRPD3	Adenocarcinoma
KIAA1671::USP18	Astrocytoma, grade III-IV/Glioblastoma
KIAA1755::CNBD2	Malignant melanoma
KIAA1755::HS6ST2	Adenocarcinoma
KIAA1958::DYNC2I2	Adenocarcinoma
KIAA1958::HSDL2	Squamous cell carcinoma | Adenocarcinoma
KIAA1958::SETD4	Adenocarcinoma
KIAA2013::CNTNAP2	Adenocarcinoma
KICS2::CPM	Mesenchymal tumor, NOS
KICS2::NXF3	Mesenchymal tumor, NOS
KICS2::USP15	Mesenchymal tumor, NOS
KIDINS220::ALK	Adenocarcinoma
KIDINS220::C3ORF70	Astrocytoma, grade III-IV/Glioblastoma
KIDINS220::C3orf70	Astrocytoma, grade III-IV/Glioblastoma
KIDINS220::COLEC11	Mesenchymal tumor, NOS
KIDINS220::EYS	Transitional cell carcinoma
KIDINS220::MYT1L	Adenocarcinoma
KIDINS220::SOX7	Mesenchymal tumor, NOS
KIF11::FFAR4	Squamous cell carcinoma
KIF11::HIF1AN	Mesenchymal tumor, NOS
KIF11::STAT4	Adenocarcinoma
KIF13A::ALK	Adenocarcinoma
KIF13A::CCHCR1	Squamous cell carcinoma
KIF13A::F13A1	Squamous cell carcinoma
KIF13A::KDM1B	Transitional cell carcinoma
KIF13A::PTPRK	Adenocarcinoma
KIF13A::RET	Carcinoma, NOS | Adenocarcinoma
KIF13A::TPMT	Adenocarcinoma
KIF13A::UBE2K	Mesenchymal tumor, NOS
KIF13B::CSGALNACT1	Adenocarcinoma
KIF13B::DNAAF9	Adenocarcinoma
KIF13B::EPB41L4B	Adenocarcinoma
KIF13B::EPN2	Adenocarcinoma
KIF13B::EYA2	Adenocarcinoma
KIF13B::FUT10	Malignant melanoma
KIF13B::IFT52	Adenocarcinoma
KIF13B::MET	Adenocarcinoma
KIF13B::NRG1	Adenocarcinoma
KIF13B::PNOC	Adenocarcinoma
KIF13B::PPP2R5B	Transitional cell carcinoma
KIF13B::SARAF	Adenocarcinoma
KIF13B::SLC25A21	Squamous cell carcinoma
KIF13B::SMTN	Adenocarcinoma
KIF13B::TENM4	Adenocarcinoma
KIF13B::TMEM217	Adenocarcinoma
KIF13B::TTC28	Multiple myeloma
KIF14::DDX59	Squamous cell carcinoma
KIF15::BCL2L1	Adenocarcinoma
KIF15::TLE4	Adenocarcinoma
KIF15::ZKSCAN7	Adenocarcinoma
KIF16B::CCDC178	Adenocarcinoma
KIF16B::HIPK3	Adenocarcinoma
KIF16B::MLIP	Mesenchymal tumor, NOS
KIF16B::PCSK2	Adenocarcinoma
KIF16B::PLCB1	Adenocarcinoma
KIF16B::RRBP1	Adenocarcinoma | Transitional cell carcinoma
KIF16B::SNX5	Adenocarcinoma
KIF18B::C1QL1	Adenocarcinoma
KIF18B::MEIOC	Adenocarcinoma
KIF18B::TUBG1	Adenocarcinoma
KIF1A::MAB21L4	Adenocarcinoma
KIF1A::USP6	Nodular fasciitis
KIF1B::AGTRAP	Adenocarcinoma
KIF1B::CCNQ	Adenocarcinoma
KIF1B::EPB41	Astrocytoma, grade III-IV/Glioblastoma
KIF1B::HAGH	Malignant epithelial tumor, special type
KIF1B::MYO5B	Adenocarcinoma
KIF1B::NF1	Transitional cell carcinoma
KIF1B::PGD	Adenocarcinoma
KIF1B::RERE	Adenocarcinoma
KIF1B::SHISA4	Adenocarcinoma
KIF1B::UBE4B	Adenocarcinoma | Astrocytoma, grade III-IV/Glioblastoma
KIF1C::NDEL1	Adenocarcinoma
KIF1C::RNF167	Adenocarcinoma
KIF20B::LIPJ	Adenocarcinoma
KIF21A::COPS7B	Mesenchymal tumor, NOS
KIF21A::CPM	Germ cell tumor, NOS
KIF21A::LMF1	Adenocarcinoma
KIF21A::MIPOL1	Squamous cell carcinoma
KIF21A::ODAD1	Adenocarcinoma
KIF21A::SLC2A13	Adenocarcinoma
KIF21A::TMTC2	Adenocarcinoma
KIF21A::TSPAN8	Squamous cell carcinoma
KIF21B::ANP32B	Astrocytoma, grade I-II
KIF21B::F13B	Astrocytoma, grade I-II
KIF21B::NTRK1	Glioma, NOS
KIF22::PRKCB	Adenocarcinoma
KIF23::PAQR5	Adenocarcinoma
KIF23::PIAS1	Adenocarcinoma
KIF24::FAAH	Squamous cell carcinoma
KIF24::ZCCHC7	Malignant epithelial tumor, special type
KIF26A::ATP5MJ	Adenocarcinoma
KIF26A::CKB	Adenocarcinoma
KIF26B::AKT3	Squamous cell carcinoma
KIF26B::CATSPERE	Adenocarcinoma
KIF26B::FMN2	Astrocytoma, grade I-II
KIF26B::SDCCAG8	Malignant epithelial tumor, special type
KIF26B::SMYD3	Squamous cell carcinoma
KIF26B::UBE2Q1	Adenocarcinoma
KIF27::QNG1	Adenocarcinoma
KIF27::TRPM6	Mesenchymal tumor, NOS
KIF27::UBQLN1	Malignant melanoma | Transitional cell carcinoma | Adenocarcinoma
KIF2A::ADAMTS19	Squamous cell carcinoma
KIF2A::RNF180	Adenocarcinoma
KIF2A::SNX2	Adenocarcinoma
KIF2C::ARMH1	Squamous cell carcinoma
KIF3A::PDLIM4	Adenocarcinoma
KIF3B::NINL	Squamous cell carcinoma
KIF3B::POFUT1	Adenocarcinoma
KIF3B::PXMP4	Squamous cell carcinoma
KIF3B::REM1	Adenocarcinoma
KIF3B::SCFD2	Mesenchymal tumor, NOS
KIF3B::TOX2	Adenocarcinoma
KIF3B::TRB	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KIF3C::ADCY3	Adenocarcinoma
KIF3C::RBKS	Adenocarcinoma
KIF3C::SNTG2	Adenocarcinoma
KIF3C::SRM	Malignant epithelial tumor, special type
KIF5A::ATP23	Astrocytoma, grade I-II
KIF5A::AVIL	Astrocytoma, grade III-IV/Glioblastoma
KIF5A::DTX1	Adenocarcinoma
KIF5A::NAV3	Mesenchymal tumor, NOS
KIF5A::TSPAN31	Astrocytoma, grade I-II
KIF5B::ALK	Adenocarcinoma | Fibroblastic/myofibroblastic tumor, special type | Histiocytic sarcoma/malignant histiocytosis | Inflammatory myofibroblastic tumor/myofibroblastic sarcoma
KIF5B::EPC1	Adenocarcinoma
KIF5B::FGFR1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KIF5B::HHAT	Adenocarcinoma
KIF5B::HPS4	Adenocarcinoma
KIF5B::MET	Adenocarcinoma
KIF5B::NTRK1	Adenocarcinoma
KIF5B::NTRK2	Glioma, NOS | Adenocarcinoma | Neuroglial neoplasm, special type
KIF5B::PDGFRA	Chronic eosinophilic leukemia/hypereosinophilic syndrome
KIF5B::RAF1	Soft tissue tumor, NOS
KIF5B::RET	Carcinoma, NOS | Malignant epithelial tumor, special type | Melanocytic neoplasm, special type | Adenocarcinoma | Squamous cell carcinoma | Mesenchymal tumor, NOS | Glioma, NOS | Fibrosarcoma | Adenosquamous carcinoma
KIF5B::SVIL	Astrocytoma, grade I-II
KIF5B::ZEB1	Adenocarcinoma
KIF5C::DOCK9	Glioma, NOS
KIF5C::GULP1	Mesenchymal tumor, NOS
KIF5C::NTRK3	Astrocytoma, grade III-IV/Glioblastoma
KIF5C::STK39	Adenocarcinoma
KIF5C::TTN	Adenocarcinoma
KIF9::GYG1	Adenocarcinoma
KIFAP3::COPA	Malignant melanoma
KIFAP3::FIRRM	Mesenchymal tumor, NOS
KIFAP3::MPC2	Mesenchymal tumor, NOS
KIFAP3::NTMT2	Adenocarcinoma
KIFAP3::STYXL2	Adenocarcinoma
KIFC1::PHF1	Carcinoma, NOS
KIFC3::CNGB1	Adenocarcinoma
KIN::ITIH5	Adenocarcinoma
KIRREL1::CD1A	Squamous cell carcinoma
KIRREL1::CD48	Malignant melanoma
KIRREL1::DDR2	Malignant melanoma
KIRREL1::HMMR	Adenocarcinoma
KIRREL1::PRKCA	Benign fibrous histiocytoma
KIRREL1::PYHIN1	Squamous cell carcinoma
KIRREL1::RBP7	Adenocarcinoma
KIRREL1::SNUPN	Adenocarcinoma
KIRREL1::TMCO1	Adenocarcinoma
KIRREL3::SIK3	Astrocytoma, pilocytic/juvenile
KIT::DNAJB14	Squamous cell carcinoma
KIT::FAR1	Malignant melanoma
KIT::HOPX	Astrocytoma, grade I-II
KIT::PDGFRA	Adenocarcinoma
KIT::SLC4A4	Squamous cell carcinoma
KIT::UGT2B7	Malignant melanoma
KITLG::CCDC6	Squamous cell carcinoma
KITLG::ST8SIA6	Mesenchymal tumor, NOS
KITLG::TNNC1	Squamous cell carcinoma
KIZ::ABHD13	Adenocarcinoma
KIZ::SLPI	Squamous cell carcinoma
KLC1::ALK	Adenocarcinoma | Adenosquamous carcinoma
KLC1::COA8	Adenocarcinoma
KLC1::MARK3	Adenocarcinoma
KLC1::ROS1	Astrocytoma, grade I-II
KLC1::TERT	Pleomorphic rhabdomyosarcoma
KLC3::CLPTM1	Transitional cell carcinoma
KLF10::AZIN1	Multiple myeloma
KLF10::NUBPL	Adenocarcinoma
KLF11::TMEM247	Adenocarcinoma
KLF12::CAMK2G	Mesenchymal tumor, NOS
KLF12::COMMD6	Squamous cell carcinoma
KLF12::MED4	Chronic lymphocytic leukemia
KLF12::MET	Astrocytoma, grade III-IV/Glioblastoma
KLF12::UCHL3	Mesenchymal tumor, NOS
KLF13::B2M	Multiple myeloma
KLF13::DTX2	Adenocarcinoma
KLF13::IGK	Multiple myeloma
KLF15::ABI3BP	Adenocarcinoma
KLF15::SLC41A3	Adenocarcinoma
KLF16::RNF126	Adenocarcinoma
KLF2::ACTG1	Multiple myeloma
KLF2::BBC3	Multiple myeloma
KLF2::FGFR3	Multiple myeloma
KLF2::IGH	Multiple myeloma
KLF2::OAZ1	Multiple myeloma
KLF2::RNF126	Multiple myeloma
KLF3::FAM114A1	Adenocarcinoma
KLF3::SCFD2	Adenocarcinoma
KLF3::USP6	Aneurysmal bone cyst
KLF5::PIBF1	Squamous cell carcinoma
KLF5::SUPT16H	Transitional cell carcinoma
KLF6::CREM	Adenocarcinoma
KLF6::IGH	Multiple myeloma
KLF6::IGK	Multiple myeloma
KLF6::IGL	Multiple myeloma
KLF6::ODAD2	Adenocarcinoma
KLF7::ALS2	Squamous cell carcinoma
KLF7::PARD3B	Adenocarcinoma | Malignant melanoma
KLF7::RFTN2	Mesothelioma
KLF9::ACTL7B	Adenocarcinoma
KLF9::FOXRED2	Adenocarcinoma
KLHDC10::SND1	Adenocarcinoma
KLHDC2::SNTB1	Adenocarcinoma
KLHDC4::CA5A	Squamous cell carcinoma
KLHDC4::MAF	Adenocarcinoma
KLHDC4::SLC7A5	Transitional cell carcinoma
KLHDC4::SPG7	Adenocarcinoma
KLHDC8A::GPR37L1	Astrocytoma, grade III-IV/Glioblastoma
KLHDC8B::RABEP1	Adenocarcinoma
KLHL12::RABGAP1L	Malignant melanoma
KLHL14::CCDC178	Adenocarcinoma
KLHL14::MARK2	Adenocarcinoma
KLHL18::HEMK1	Transitional cell carcinoma
KLHL18::NUP210	Mesothelioma
KLHL18::TEX264	Adenocarcinoma
KLHL1::HNRNPF	Mesenchymal tumor, NOS
KLHL20::TPTE	Adenocarcinoma
KLHL21::DNAJC11	Adenocarcinoma
KLHL22::DENND5A	Squamous cell carcinoma
KLHL22::KIAA1549L	Squamous cell carcinoma
KLHL22::RANGAP1	Adenocarcinoma
KLHL22::UBE2L3	Adenocarcinoma
KLHL22::ZNF74	Squamous cell carcinoma
KLHL24::ATP11B	Adenocarcinoma
KLHL24::B3GNT5	Squamous cell carcinoma
KLHL24::CEP89	Squamous cell carcinoma
KLHL24::MCF2L2	Squamous cell carcinoma
KLHL26::KXD1	Adenocarcinoma
KLHL26::PGPEP1	Adenocarcinoma
KLHL26::TMEM59L	Adenocarcinoma
KLHL29::PSMA8	Squamous cell carcinoma
KLHL29::UBXN2A	Squamous cell carcinoma
KLHL2::ARHGEF7	Squamous cell carcinoma
KLHL2::CPE	Adenocarcinoma
KLHL2::GALNTL6	Adenocarcinoma
KLHL32::ROBO1	Adenocarcinoma
KLHL3::BMERB1	Adenocarcinoma
KLHL42::MRPS35	Transitional cell carcinoma
KLHL5::HLA-F	Adenocarcinoma
KLHL5::LNX1	Transitional cell carcinoma
KLHL5::SLC16A2	Squamous cell carcinoma
KLHL5::TMEM156	Transitional cell carcinoma
KLHL5::UBE2K	Adenocarcinoma
KLHL7::BRAF	Mesoblastic nephroma | Adenocarcinoma | Astrocytoma, grade III-IV/Glioblastoma
KLHL7::DNAH11	Adenocarcinoma
KLHL7::TMEM106B	Astrocytoma, grade III-IV/Glioblastoma
KLK2::CCT5	Adenocarcinoma
KLK2::ETV1	Adenocarcinoma
KLK2::ETV4	Adenocarcinoma
KLK2::FGFR2	Malignant melanoma | Adenocarcinoma
KLK2::NDUFV1	Adenocarcinoma
KLK2::PLAT	Adenocarcinoma
KLK2::STAT6	Adenocarcinoma
KLK2::ZNFX1	Adenocarcinoma
KLK4::KLK3	Adenocarcinoma
KLK4::ZNF827	Adenocarcinoma
KLK5::CDH23	Adenocarcinoma
KMT2A::ABI1	Skin | Acute myelomonocytic leukemia (FAB type M4) | Acute monoblastic leukemia with differentiation (FAB type M5b) | Acute monoblastic leukemia without differentiation (FAB type M5a) | Acute myeloid leukemia, NOS
KMT2A::ABI2	Skin | Acute monoblastic leukemia (FAB type M5) | Acute myeloid leukemia, NOS
KMT2A::ACACA	Acute myeloid leukemia, NOS | Acute myeloblastic leukemia with maturation (FAB type M2) | Skin
KMT2A::ACTN2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A::ACTN4	Refractory anemia with excess blasts-2 | Acute myeloid leukemia, NOS | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Skin
KMT2A::AFDN	Acute monoblastic leukemia with differentiation (FAB type M5b) | Acute myeloblastic leukemia without maturation (FAB type M1) | Acute myeloid leukemia, NOS | Acute megakaryoblastic leukemia (FAB type M7) | Skin | Acute myeloblastic leukemia with maturation (FAB type M2) | Acute myelomonocytic leukemia (FAB type M4) | Acute monoblastic leukemia (FAB type M5) | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Acute monoblastic leukemia without differentiation (FAB type M5a)
KMT2A::AFF1	Acute megakaryoblastic leukemia (FAB type M7) | Post-transplant lymphoproliferative disorder | Acute monoblastic leukemia (FAB type M5) | Acute myelomonocytic leukemia (FAB type M4) | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Acute myeloblastic leukemia with minimal differentiation (FAB type M0) | Bilineage or biphenotypic leukemia | Acute myeloid leukemia, NOS | Skin | Egypt | Nonneoplastic hematologic disorder/lesion | Acute myeloblastic leukemia without maturation (FAB type M1)
KMT2A::AFF3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A::AFF4	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Acute myeloid leukemia, NOS | Skin
KMT2A::AHCYL2	Skin | Acute myeloid leukemia, NOS
KMT2A::AHDC1	Leiomyosarcoma
KMT2A::AKAP13	Skin | Acute myeloid leukemia, NOS
KMT2A::AP2A2	Skin | Acute myeloid leukemia, NOS
KMT2A::ARHGAP26	Acute monoblastic leukemia (FAB type M5) | Acute monoblastic leukemia with differentiation (FAB type M5b) | Juvenile myelomonocytic leukemia | Acute myeloid leukemia, NOS | Skin
KMT2A::ARHGEF12	Acute myelomonocytic leukemia (FAB type M4) | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Acute myeloid leukemia, NOS | Burkitt lymphoma/leukemia | Skin | Acute monoblastic leukemia without differentiation (FAB type M5a) | Mature B-cell neoplasm, NOS
KMT2A::ARHGEF17	Acute myeloid leukemia, NOS | Skin
KMT2A::ASXL2	Acute myeloid leukemia, NOS | Skin
KMT2A::ATP5MG	Squamous cell carcinoma | Adenocarcinoma
KMT2A::BCAS4	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A::BCL9L	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A::BCOR	Chondrosarcoma, dedifferentiated | Carcinoid tumor
KMT2A::BTBD18	Skin | Acute myeloid leukemia, NOS | Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A::BTK	Acute monoblastic leukemia with differentiation (FAB type M5b)
KMT2A::BUD13	Acute myeloid leukemia, NOS | Skin
KMT2A::C2CD3	Skin | Acute myeloid leukemia, NOS | Malignant peripheral nerve sheath tumor/Triton
KMT2A::CASP8AP2	Acute myeloblastic leukemia with maturation (FAB type M2) | Acute myeloid leukemia, NOS | Skin
KMT2A::CBL	Acute myeloid leukemia, NOS | Acute monoblastic leukemia without differentiation (FAB type M5a) | Skin | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Acute myeloblastic leukemia without maturation (FAB type M1)
KMT2A::CCNJL	Nonneoplastic hematologic disorder/lesion
KMT2A::CD86	Squamous cell carcinoma
KMT2A::CEP164	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A::CEP170B	Acute myeloid leukemia, NOS | Acute myeloblastic leukemia without maturation (FAB type M1) | Skin
KMT2A::CIP2A	Skin | Acute monoblastic leukemia (FAB type M5) | Acute myeloid leukemia, NOS
KMT2A::CLIP2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A::CLTA	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A::CLTC	Skin | Acute myeloid leukemia, NOS
KMT2A::CPT1A	Malignant peripheral nerve sheath tumor/Triton
KMT2A::CREBBP	Chronic myelomonocytic leukemia | Skin | Myelodysplastic syndrome, NOS | Acute monoblastic leukemia without differentiation (FAB type M5a) | Spleen | Acute myelomonocytic leukemia (FAB type M4) | Acute myeloid leukemia, NOS | Acute myeloblastic leukemia with maturation (FAB type M2) | Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A::CT45A2	Skin | Bilineage or biphenotypic leukemia | Acute myeloid leukemia, NOS | Egypt
KMT2A::CT45A3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A::DAB2IP	Acute monoblastic leukemia (FAB type M5)
KMT2A::DCP1A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A::DCP1B	Chronic neutrophilic leukemia
KMT2A::DCPS	Acute myeloid leukemia, NOS | Skin
KMT2A::DOCK10	Undifferentiated pleomorphic sarcoma
KMT2A::DSCAML1	Mycosis fungoides/Sézary syndrome
KMT2A::EDC4	Skin | Acute myeloid leukemia, NOS
KMT2A::EEFSEC	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A::ELL	Acute myelomonocytic leukemia (FAB type M4) | Spleen | Bilineage or biphenotypic leukemia | Egypt | Acute myeloid leukemia, NOS | Skin | Chronic myeloproliferative disorder, NOS | Acute myeloblastic leukemia with maturation (FAB type M2) | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Chronic myelomonocytic leukemia | Refractory anemia with excess of blasts (FAB) | Acute monoblastic leukemia with differentiation (FAB type M5b) | Acute myeloid leukemia, special type | Acute monoblastic leukemia (FAB type M5) | Myelodysplastic syndrome, NOS
KMT2A::ELP4	Angiosarcoma
KMT2A::ENAH	Skin | Acute myeloid leukemia, NOS
KMT2A::EP300	Acute monoblastic leukemia with differentiation (FAB type M5b) | Chronic myelomonocytic leukemia | Spleen | Skin | Acute myelomonocytic leukemia (FAB type M4) | Acute myeloblastic leukemia without maturation (FAB type M1) | Acute myeloid leukemia, NOS
KMT2A::EPS15	Acute myeloid leukemia, NOS | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Acute monoblastic leukemia without differentiation (FAB type M5a) | Acute myelomonocytic leukemia (FAB type M4) | Bilineage or biphenotypic leukemia | Egypt | Acute monoblastic leukemia (FAB type M5) | Skin
KMT2A::FER1L5	Nonneoplastic hematologic disorder/lesion
KMT2A::FLNA	Acute myeloid leukemia, NOS | Acute myelomonocytic leukemia (FAB type M4) | Skin
KMT2A::FLNC	Skin | Acute myeloid leukemia, NOS
KMT2A::FNBP1	Skin | Acute myeloid leukemia, NOS | Acute myelomonocytic leukemia (FAB type M4)
KMT2A::FOXO3	Algeria | Acute undifferentiated leukemia | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Acute myeloblastic leukemia with maturation (FAB type M2)
KMT2A::FOXO4	Acute myelomonocytic leukemia (FAB type M4) | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Skin | Acute myeloid leukemia, NOS
KMT2A::FOXR1	Neuroblastoma
KMT2A::FRYL	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Acute myeloblastic leukemia without maturation (FAB type M1)
KMT2A::FYN	Adenocarcinoma
KMT2A::GAS7	Acute myelomonocytic leukemia (FAB type M4) | Acute myeloid leukemia, NOS | Skin | Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A::GIGYF2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A::GIMAP8	Acute undifferentiated leukemia | Algeria
KMT2A::GMPS	Skin | Acute myelomonocytic leukemia (FAB type M4) | Acute myeloid leukemia, NOS
KMT2A::GPHN	Acute undifferentiated leukemia | Algeria | Acute monoblastic leukemia (FAB type M5)
KMT2A::HABP4	Nonneoplastic hematologic disorder/lesion
KMT2A::IGHMBP2	Astrocytoma, grade I-II
KMT2A::ITPR2	Myelodysplastic syndrome, NOS
KMT2A::ITSN1	Acute myeloid leukemia, NOS | Skin
KMT2A::KIF2A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A::KNL1	Acute myeloid leukemia, NOS | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Acute myeloblastic leukemia with maturation (FAB type M2) | Acute myelomonocytic leukemia (FAB type M4) | Myelodysplastic syndrome, NOS | Skin
KMT2A::LAMC3	Skin | Acute myeloid leukemia, NOS
KMT2A::LASP1	Acute myelomonocytic leukemia (FAB type M4) | Acute monoblastic leukemia (FAB type M5) | Acute monoblastic leukemia with differentiation (FAB type M5b)
KMT2A::LPP	Acute monoblastic leukemia without differentiation (FAB type M5a)
KMT2A::MAML1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A::MAML2	Skin | Myelodysplastic/myeloproliferative disease, NOS | Mucoepidermoid carcinoma | Acute myeloid leukemia, NOS | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Acute myeloblastic leukemia with maturation (FAB type M2) | Thymus
KMT2A::MAP3K5	Nonneoplastic hematologic disorder/lesion
KMT2A::MAPRE1	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Mycosis fungoides/Sézary syndrome
KMT2A::MATR3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A::ME2	Acute myeloid leukemia, NOS | Skin
KMT2A::MLLT1	Acute monoblastic leukemia with differentiation (FAB type M5b) | Skin | Acute monoblastic leukemia without differentiation (FAB type M5a) | Egypt | Plasma cell neoplasm, special type | Acute myelomonocytic leukemia (FAB type M4) | Dendritic cell neoplasm | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Acute myeloblastic leukemia with maturation (FAB type M2) | Acute megakaryoblastic leukemia (FAB type M7) | Bilineage or biphenotypic leukemia | Acute myeloid leukemia, NOS | Acute myeloblastic leukemia with minimal differentiation (FAB type M0) | Acute monoblastic leukemia (FAB type M5)
KMT2A::MLLT10	Acute myeloblastic leukemia with maturation (FAB type M2) | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Acute myeloblastic leukemia with minimal differentiation (FAB type M0) | Acute monoblastic leukemia without differentiation (FAB type M5a) | Acute megakaryoblastic leukemia (FAB type M7) | Bilineage or biphenotypic leukemia | Algeria | Skin | Acute myeloid leukemia, NOS | Egypt | Acute myelomonocytic leukemia (FAB type M4) | Acute undifferentiated leukemia | Acute monoblastic leukemia (FAB type M5) | Acute monoblastic leukemia with differentiation (FAB type M5b) | Acute myeloblastic leukemia without maturation (FAB type M1)
KMT2A::MLLT11	Acute myeloblastic leukemia without maturation (FAB type M1) | Skin | Acute monoblastic leukemia (FAB type M5) | Acute myeloid leukemia, NOS | Acute myelomonocytic leukemia (FAB type M4) | Acute monoblastic leukemia with differentiation (FAB type M5b) | Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A::MLLT3	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Myelodysplastic syndrome, NOS | Acute monoblastic leukemia with differentiation (FAB type M5b) | Nonneoplastic hematologic disorder/lesion | Acute myeloblastic leukemia with minimal differentiation (FAB type M0) | Skin | Acute monoblastic leukemia without differentiation (FAB type M5a) | Acute myelomonocytic leukemia (FAB type M4) | Acute myeloid leukemia, NOS | Acute megakaryoblastic leukemia (FAB type M7) | Acute myeloblastic leukemia without maturation (FAB type M1) | Acute monoblastic leukemia (FAB type M5)
KMT2A::MLLT6	Acute monoblastic leukemia with differentiation (FAB type M5b) | Skin | Acute myeloid leukemia, NOS | Acute monoblastic leukemia (FAB type M5) | Acute monoblastic leukemia without differentiation (FAB type M5a) | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Acute myelomonocytic leukemia (FAB type M4) | Acute megakaryoblastic leukemia (FAB type M7)
KMT2A::MON2	Acute myeloid leukemia, NOS | Skin
KMT2A::MRTFA	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A::MYH11	Acute myeloid leukemia, NOS | Refractory anemia with excess blasts-2 | Skin
KMT2A::MYO1F	Acute myeloid leukemia, NOS | Skin | Acute monoblastic leukemia (FAB type M5)
KMT2A::MYOM3	Leiomyosarcoma
KMT2A::NCKIPSD	Acute monoblastic leukemia with differentiation (FAB type M5b)
KMT2A::NEBL	Skin | Bilineage or biphenotypic leukemia | Acute myeloid leukemia, NOS | Egypt
KMT2A::NKD1	Nonneoplastic hematologic disorder/lesion
KMT2A::NOX4	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A::NRIP3	Acute monoblastic leukemia (FAB type M5) | Acute myeloid leukemia, NOS | Skin
KMT2A::NUP153	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A::NUTM2A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A::PDS5A	Skin | Acute myeloid leukemia, NOS | Acute monoblastic leukemia without differentiation (FAB type M5a)
KMT2A::PFDN4	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A::PICALM	Skin | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Acute monoblastic leukemia with differentiation (FAB type M5b) | Acute myeloid leukemia, NOS
KMT2A::PRPF19	Acute myelomonocytic leukemia (FAB type M4) | Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A::PRRC1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A::RALGAPA2	Osteosarcoma, NOS
KMT2A::RANBP3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A::RARA	Skin | Acute myeloid leukemia, NOS
KMT2A::RUNDC3B	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A::SARNP	Acute myelomonocytic leukemia (FAB type M4)
KMT2A::SEPTIN11	Chronic neutrophilic leukemia | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Acute myeloid leukemia, NOS | Skin
KMT2A::SEPTIN14	Acute myelomonocytic leukemia (FAB type M4)
KMT2A::SEPTIN2	Acute myeloblastic leukemia with maturation (FAB type M2) | Acute myelomonocytic leukemia (FAB type M4) | Skin | Acute myeloid leukemia, NOS
KMT2A::SEPTIN3	Acute myeloid leukemia, NOS | Skin
KMT2A::SEPTIN5	Acute myeloblastic leukemia without maturation (FAB type M1) | Acute myeloid leukemia, NOS | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Acute myeloblastic leukemia with maturation (FAB type M2) | Acute monoblastic leukemia (FAB type M5) | Skin
KMT2A::SEPTIN6	Acute myeloblastic leukemia with maturation (FAB type M2) | Acute myeloblastic leukemia without maturation (FAB type M1) | Acute promyelocytic leukemia (FAB type M3) | Acute monoblastic leukemia (FAB type M5) | Acute myeloid leukemia, NOS | Acute monoblastic leukemia with differentiation (FAB type M5b) | Skin | Acute myelomonocytic leukemia (FAB type M4)
KMT2A::SEPTIN9	Acute megakaryoblastic leukemia (FAB type M7) | Acute myeloid leukemia, NOS | Acute myeloblastic leukemia with minimal differentiation (FAB type M0) | Acute monoblastic leukemia with differentiation (FAB type M5b) | Refractory anemia with excess blasts-1 | Skin | Acute myelomonocytic leukemia (FAB type M4) | Acute myeloblastic leukemia with maturation (FAB type M2) | Acute monoblastic leukemia (FAB type M5) | Acute myeloblastic leukemia without maturation (FAB type M1)
KMT2A::SH3GL1	Skin | Acute myeloid leukemia, NOS
KMT2A::SLC22A10	Transitional cell carcinoma
KMT2A::SLC25A24	Nonneoplastic hematologic disorder/lesion
KMT2A::SMAP1	Skin | Acute myeloid leukemia, NOS
KMT2A::SNX9	Acute monoblastic leukemia without differentiation (FAB type M5a)
KMT2A::SORBS2	Skin | Acute monoblastic leukemia (FAB type M5) | Acute myeloid leukemia, NOS
KMT2A::STK4	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A::SUGP2	Acute monoblastic leukemia with differentiation (FAB type M5b)
KMT2A::TCF12	Acute myeloid leukemia, NOS | Skin | Refractory anemia with ringed sideroblasts
KMT2A::TET1	Acute myelomonocytic leukemia (FAB type M4) | Skin | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Acute myeloid leukemia, NOS | Acute myeloblastic leukemia with maturation (FAB type M2)
KMT2A::TFE3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A::TIRAP	Skin | Acute myeloid leukemia, NOS
KMT2A::TMPRSS13	Endometrial stromal sarcoma
KMT2A::TNRC18	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A::TOP3A	Acute myeloid leukemia, NOS | Skin
KMT2A::UBE4A	Myelodysplastic/myeloproliferative disease, NOS | Thymus
KMT2A::USO1	Skin | Acute myeloid leukemia, NOS
KMT2A::USP10	Acute monoblastic leukemia without differentiation (FAB type M5a)
KMT2A::USP2	Bilineage or biphenotypic leukemia | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Acute myeloblastic leukemia with maturation (FAB type M2) | Egypt
KMT2A::USP46	Nonneoplastic hematologic disorder/lesion
KMT2A::USP8	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2A::VAV1	Acute myeloid leukemia, NOS | Skin
KMT2A::YAP1	Sclerosing epithelioid fibrosarcoma
KMT2A::ZC3H13	Essential thrombocythemia
KMT2A::ZDHHC7	Malignant melanoma
KMT2A::ZFYVE19	Acute myeloblastic leukemia with maturation (FAB type M2)
KMT2B::CEACAM16	Adenocarcinoma
KMT2B::GPS2	Soft tissue tumor, special type
KMT2B::RPRD1A	Adenocarcinoma
KMT2B::ZBTB32	Adenocarcinoma
KMT2C::ACTR3B	Acute myeloid leukemia, NOS | Skin | Acute monoblastic leukemia (FAB type M5)
KMT2C::AGK	Squamous cell carcinoma
KMT2C::AUTS2	Adenocarcinoma
KMT2C::CALN1	Adenocarcinoma
KMT2C::CLIP2	Adenocarcinoma
KMT2C::CNTNAP2	Adenocarcinoma
KMT2C::DNAH11	Squamous cell carcinoma
KMT2C::EMP1	Adenocarcinoma
KMT2C::FUT9	Adenocarcinoma
KMT2C::GALNTL5	Adenocarcinoma
KMT2C::GTF2IRD1	Squamous cell carcinoma
KMT2C::IRF5	Malignant melanoma
KMT2C::LHFPL3	Malignant melanoma
KMT2C::LIPJ	Adenocarcinoma
KMT2C::LMTK3	Adenocarcinoma
KMT2C::NDUFAF4	Adenocarcinoma
KMT2C::PTPRN2	Adenocarcinoma
KMT2C::RHEB	Adenocarcinoma
KMT2C::SND1	Adenocarcinoma
KMT2C::SYTL5	Adenocarcinoma
KMT2C::XRCC2	Malignant melanoma
KMT2D::ARF3	Adenocarcinoma
KMT2D::BCOR	Undifferentiated sarcoma | Endometrial stromal sarcoma
KMT2D::CUX2	Squamous cell carcinoma
KMT2D::DDX23	Squamous cell carcinoma
KMT2D::LMBR1L	Adenocarcinoma
KMT2D::PLXNC1	Skin | Acute myeloid leukemia, NOS
KMT2D::PTPRR	Adenocarcinoma
KMT2D::RB1	Endometrial stromal sarcoma
KMT2D::RHEBL1	Adenocarcinoma
KMT2D::SEC31A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2E::ASNS	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KMT2E::DRAM1	Adenocarcinoma
KMT2E::KANSL1	Adenocarcinoma
KMT2E::LHFPL3	Adenocarcinoma | Malignant melanoma
KMT2E::MAP2K3	Mesenchymal tumor, NOS
KMT2E::MAPT	Adenocarcinoma
KMT2E::PTPRZ1	Adenocarcinoma
KMT2E::RAPGEF1	Adenocarcinoma
KMT2E::TUFT1	Adenocarcinoma
KMT2E::ZBTB8A	Adenocarcinoma
KMT5A::RILPL2	Adenocarcinoma
KMT5A::UBC	Multiple myeloma
KMT5B::C11ORF24	Adenocarcinoma
KMT5B::C11orf24	Adenocarcinoma
KMT5B::CHKA	Transitional cell carcinoma
KMT5B::CPEB4	Mesenchymal tumor, NOS
KMT5B::CPSF7	Adenocarcinoma
KMT5B::MYO1D	Transitional cell carcinoma
KMT5B::OR5M1	Adenocarcinoma
KMT5B::OR5M10	Adenocarcinoma
KMT5B::RNPS1	Adenocarcinoma
KMT5B::RTN3	Adenocarcinoma
KMT5B::SLITRK4	Squamous cell carcinoma
KMT5B::STXBP1	Adenocarcinoma
KMT5B::SUPT5H	Adenocarcinoma
KMT5B::TESMIN	Adenocarcinoma
KMT5B::UNC93B1	Transitional cell carcinoma
KNL1::LIPC	Squamous cell carcinoma
KNSTRN::BUB1B	Adenocarcinoma
KNTC1::KMT2A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KNTC1::MLXIP	Squamous cell carcinoma
KNTC1::TMT1A	Astrocytoma, grade III-IV/Glioblastoma
KNTC1::WASHC3	Astrocytoma, grade I-II
KPNA1::CD86	Adenocarcinoma
KPNA1::CHRNA9	Squamous cell carcinoma
KPNA1::GMPS	Adenocarcinoma
KPNA1::NCK1	Mesothelioma
KPNA1::SMC1B	Adenocarcinoma
KPNA3::EBPL	Adenocarcinoma
KPNA3::FGF2	Transitional cell carcinoma
KPNA3::MLNR	Transitional cell carcinoma
KPNA3::PCDH9	Adenocarcinoma
KPNA3::RESF1	Adenocarcinoma
KPNA3::SLC7A1	Squamous cell carcinoma
KPNA3::SPRYD7	Transitional cell carcinoma | Malignant epithelial tumor, special type
KPNA3::WDFY2	Adenocarcinoma
KPNA4::ATR	Squamous cell carcinoma
KPNA4::IFT80	Squamous cell carcinoma
KPNA4::PALM2	Diffuse large B-cell lymphoma
KPNA4::PTPRD	Transitional cell carcinoma
KPNA4::TRIM59	Adenocarcinoma
KPNA4::WWTR1	Malignant melanoma
KPNA6::RAB11FIP4	Adenocarcinoma
KPNA6::RHCE	Squamous cell carcinoma
KPNA6::TMEM39B	Astrocytoma, grade I-II | Adenocarcinoma
KPNA6::TRAIP	Mesenchymal tumor, NOS
KPNA6::ZCCHC17	Squamous cell carcinoma
KPNB1::ACE	Acute myeloblastic leukemia with maturation (FAB type M2)
KPNB1::SKAP1	Adenocarcinoma
KRAS::CDH13	Adenocarcinoma
KRAS::ETFRF1	Malignant melanoma
KRAS::KMT2A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KRAS::LMNTD1	Adenocarcinoma
KRAS::RERGL	Adenocarcinoma
KRAS::SLC2A14	Adenocarcinoma
KRBA2::YBX2	Transitional cell carcinoma
KRBOX1::POMGNT2	Transitional cell carcinoma
KRBOX5::IGK	Acute lymphoblastic leukemia/lymphoblastic lymphoma
KRBOX5::POLN	Adenocarcinoma
KREMEN1::EMID1	Transitional cell carcinoma
KREMEN1::ENTHD1	Adenocarcinoma
KREMEN1::HSCB	Squamous cell carcinoma
KREMEN1::MAPK1	Squamous cell carcinoma
KRI1::DNM2	Adenocarcinoma
KRI1::ODAD3	Adenocarcinoma
KRIT1::CDK6	Adenocarcinoma
KRIT1::GNGT1	Astrocytoma, grade III-IV/Glioblastoma
KRT10::ARFGEF2	Malignant melanoma
KRT10::CLASP2	Malignant melanoma
KRT13::AP1G2	Squamous cell carcinoma
KRT13::DDX21	Squamous cell carcinoma
KRT13::FAR1	Squamous cell carcinoma
KRT13::PLAT	Squamous cell carcinoma
KRT13::STAT6	Squamous cell carcinoma
KRT13::SUPT16H	Squamous cell carcinoma
KRT13::THSD4	Squamous cell carcinoma
KRT14::ARFGEF2	Squamous cell carcinoma
KRT14::CYP2C18	Squamous cell carcinoma
KRT14::DSP	Squamous cell carcinoma
KRT14::SUPT16H	Squamous cell carcinoma
KRT14::TYK2	Squamous cell carcinoma
KRT15::BIRC6	Squamous cell carcinoma
KRT15::PTN	Squamous cell carcinoma
KRT16::CCT5	Squamous cell carcinoma
KRT17::NDUFV1	Squamous cell carcinoma
KRT18::PLEC	Adenocarcinoma
KRT19::ANKS1A	Adenocarcinoma
KRT19::C7	Mesothelioma
KRT19::CCT5	Squamous cell carcinoma
KRT19::CLDN7	Squamous cell carcinoma
KRT19::COL5A1	Adenocarcinoma
KRT19::CTNND1	Squamous cell carcinoma
KRT19::EIF2AK2	Adenocarcinoma
KRT19::IKZF3	Adenocarcinoma
KRT19::PFKP	Squamous cell carcinoma
KRT19::PLEKHA5	Squamous cell carcinoma
KRT19::SLC38A5	Squamous cell carcinoma
KRT1::ANKS1A	Squamous cell carcinoma
KRT5::AAAS	Adenocarcinoma
KRT5::ANKS1A	Squamous cell carcinoma
KRT5::DSP	Squamous cell carcinoma
KRT5::FOS	Squamous cell carcinoma
KRT5::HLA-DRA	Squamous cell carcinoma
KRT5::MAP7	Squamous cell carcinoma
KRT5::PLAT	Squamous cell carcinoma
KRT5::TYK2	Squamous cell carcinoma
KRT6A::COP1	Squamous cell carcinoma
KRT6A::CXCR5	Squamous cell carcinoma
KRT6A::ELK3	Squamous cell carcinoma
KRT6A::ERBB3	Squamous cell carcinoma
KRT6A::STAT6	Squamous cell carcinoma
KRT81::EMP2	Adenocarcinoma
KRT8::RAF1	Carcinoma, NOS
KRTAP9-9::ERBB2	Carcinoma, NOS
KSR1::EFCAB5	Adenocarcinoma
KSR1::MSI2	Adenocarcinoma
KSR1::NOS2	Adenocarcinoma
KSR1::PIPOX	Adenocarcinoma
KSR1::TENM1	Acute myeloblastic leukemia with maturation (FAB type M2) | Acute myeloid leukemia, NOS | Skin
KSR2::CEP290	Mesenchymal tumor, NOS
KSR2::P2RX4	Adenocarcinoma
KSR2::SETMAR	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
KSR2::TAOK3	Adenocarcinoma
KTN1::ALK	Ependymoma
KTN1::ANKS1A	Transitional cell carcinoma
KTN1::CCT5	Adenocarcinoma
KTN1::DRGX	Transitional cell carcinoma
KTN1::LGALS3	Adenocarcinoma
KTN1::ME3	Adenocarcinoma
KTN1::PRKCSH	Adenocarcinoma
KTN1::PRKD1	Adenocarcinoma
KTN1::RET	Adenocarcinoma
KXD1::CRLF1	Squamous cell carcinoma
KYAT1::ARL1	Myxofibrosarcoma
KYAT3::DAP3	Astrocytoma, grade I-II
L2HGDH::LMBRD1	Adenocarcinoma
L2HGDH::MAP4K5	Adenocarcinoma
L3MBTL2::EFCAB6	Malignant melanoma
L3MBTL2::MELTF	Squamous cell carcinoma
L3MBTL2::TEF	Transitional cell carcinoma
L3MBTL3::PTPRK	Acute lymphoblastic leukemia/lymphoblastic lymphoma
L3MBTL3::SGSM2	Skin | Acute myeloid leukemia, NOS
L3MBTL3::WDR37	Transitional cell carcinoma
L3MBTL4::LAMA1	Adenocarcinoma
L3MBTL4::LDLRAD4	Adenocarcinoma
L3MBTL4::TRDMT1	Transitional cell carcinoma
LACTB2::CYP7B1	Malignant melanoma
LACTB2::ITPR2	Adenocarcinoma
LACTB2::NCOA2	Adenocarcinoma
LACTB2::XKR9	Adenocarcinoma
LAD1::PKP1	Adenocarcinoma
LALBA::CSN2	Adenocarcinoma
LAMA2::C6ORF58	Adenocarcinoma
LAMA2::C6orf58	Adenocarcinoma
LAMA2::GRIK2	Mesenchymal tumor, NOS
LAMA2::NUP107	Mesenchymal tumor, NOS
LAMA2::SLC11A2	Mesenchymal tumor, NOS
LAMA2::UQCRB	Mesenchymal tumor, NOS
LAMA3::ADHFE1	Squamous cell carcinoma
LAMA3::ANO2	Adenocarcinoma
LAMA3::APOBEC1	Adenocarcinoma
LAMA3::CABLES1	Adenocarcinoma
LAMA3::COX8C	Adenocarcinoma
LAMA3::GAREM1	Adenocarcinoma
LAMA3::GNAL	Adenocarcinoma
LAMA3::MIB1	Adenocarcinoma
LAMA3::NDUFS8	Adenocarcinoma
LAMA3::OSBPL1A	Adenocarcinoma
LAMA3::PSMA8	Adenocarcinoma
LAMA3::RMC1	Squamous cell carcinoma | Adenocarcinoma
LAMA3::SNRPD1	Squamous cell carcinoma
LAMA3::TTC39C	Squamous cell carcinoma
LAMA3::ZNF521	Adenocarcinoma
LAMA4::PSAP	Adenocarcinoma
LAMA4::TSPAN18	Astrocytoma, grade I-II
LAMA5::AATK	Adenocarcinoma
LAMA5::CABLES2	Adenocarcinoma
LAMA5::CLCN7	Adenocarcinoma
LAMA5::CYSTM1	Adenocarcinoma
LAMA5::DAPL1	Adenocarcinoma
LAMA5::MYRFL	Adenocarcinoma
LAMA5::NCOR2	Adenocarcinoma
LAMA5::PSMD3	Astrocytoma, grade III-IV/Glioblastoma
LAMA5::RBBP8NL	Adenocarcinoma
LAMA5::RNF114	Adenocarcinoma
LAMA5::SEC63	Malignant epithelial tumor, special type
LAMA5::UBN1	Adenocarcinoma
LAMA5::WFDC2	Adenocarcinoma
LAMB1::ATXN7L1	Squamous cell carcinoma
LAMB1::CAPZA2	Diffuse large B-cell lymphoma
LAMB1::HBP1	Mesenchymal tumor, NOS
LAMB1::NRCAM	Mesenchymal tumor, NOS
LAMB1::PARP14	Adenocarcinoma
LAMB1::PUS7	Squamous cell carcinoma
LAMB1::TYK2	Mesenchymal tumor, NOS
LAMB3::NAB1	Squamous cell carcinoma
LAMB3::NAMPT	Squamous cell carcinoma
LAMC1::NMNAT2	Wilms tumor
LAMC1::SUSD4	Adenocarcinoma
LAMC1::UTRN	Adenocarcinoma
LAMC2::NMNAT2	Adenocarcinoma
LAMC2::OAS2	Squamous cell carcinoma
LAMC2::POC1B	Squamous cell carcinoma
LAMC2::RABGAP1L	Adenocarcinoma
LAMC2::WASHC3	Squamous cell carcinoma
LAMC3::EIF2B3	Astrocytoma, grade I-II
LAMC3::NPHP3	Adenocarcinoma
LAMP1::CUL4A	Squamous cell carcinoma
LAMP1::MCF2L	Adenocarcinoma
LAMP2::NKAP	Adenocarcinoma
LAMP2::UPF3B	Adenocarcinoma
LAMTOR1::AKT1	Carcinoma, NOS
LAMTOR1::NSD3	Adenocarcinoma
LAMTOR1::PRKCD	Benign fibrous histiocytoma
LAMTOR1::UVRAG	Squamous cell carcinoma
LAMTOR4::AP4M1	Squamous cell carcinoma
LANCL2::CHODL	Squamous cell carcinoma
LANCL2::PEX1	Astrocytoma, grade III-IV/Glioblastoma
LANCL2::PSPH	Astrocytoma, grade III-IV/Glioblastoma
LANCL2::SEPTIN14	Astrocytoma, grade III-IV/Glioblastoma
LANCL2::TFDP2	Adenocarcinoma
LANCL2::TTC3	Astrocytoma, grade I-II
LANCL2::VOPP1	Astrocytoma, grade I-II | Astrocytoma, grade III-IV/Glioblastoma
LAP3::DDX1	Transitional cell carcinoma
LAP3::GALNS	Adenocarcinoma
LAPTM4A::NMD3	Adenocarcinoma
LAPTM4A::PUM2	Adenocarcinoma
LAPTM4A::SDC1	Adenocarcinoma
LAPTM4B::ARFGEF1	Adenocarcinoma
LAPTM4B::ARMC9	Adenocarcinoma
LAPTM4B::CPQ	Adenocarcinoma
LARGE1::AFF2	Neuroglial neoplasm, special type
LARGE1::ATP6V1E1	Adenocarcinoma
LARGE1::CBX7	Adenocarcinoma
LARGE1::CRKL	Astrocytoma, grade I-II
LARGE1::EIF4ENIF1	Transitional cell carcinoma
LARGE1::GRAMD4	Germ cell tumor, NOS
LARGE1::KCNJ4	Transitional cell carcinoma
LARGE1::OPA3	Adenocarcinoma
LARGE1::SLC5A4	Transitional cell carcinoma
LARGE1::SNW1	Adenocarcinoma
LARP1::FTL	Adenocarcinoma
LARP1::MAFF	Astrocytoma, grade I-II
LARP1B::ABHD18	Transitional cell carcinoma
LARP1B::SLC25A31	Adenocarcinoma
LARP4::HPD	Adenocarcinoma
LARP4::MUCL1	Adenocarcinoma
LARP4::PTPRM	Adenocarcinoma
LARP4::RYR3	Adenocarcinoma
LARP4::SPRYD3	Squamous cell carcinoma
LARP4::TMBIM6	Malignant melanoma
LARP4B::ADARB2	Adenocarcinoma
LARP4B::IDI2	Adenocarcinoma
LARP4B::KIRREL3	Ependymoma
LARP4B::PAMR1	Malignant melanoma
LARP4B::PFKFB3	Adenocarcinoma
LARP4B::SMCO3	Squamous cell carcinoma
LARP4B::WASHC2C	Adenocarcinoma
LARP7::ALPK1	Adenocarcinoma
LARS2::ANO10	Diffuse large B-cell lymphoma
LARS2::LIMD1	Adenocarcinoma
LARS2::SEC22A	Adenocarcinoma
LARS2::TBL1XR1	Diffuse large B-cell lymphoma
LAS1L::MSN	Adenocarcinoma
LASP1::ARHGAP23	Adenocarcinoma
LASP1::CDK12	Adenocarcinoma
LASP1::RBX1	Adenocarcinoma
LASP1::WIPF2	Adenocarcinoma
LATS1::AFG1L	Squamous cell carcinoma
LATS1::NUP43	Adenocarcinoma
LATS2::MYLK	Mesenchymal tumor, NOS
LBH::FLT4	Malignant melanoma
LBHD1::BSCL2	Astrocytoma, grade I-II
LBP::BPI	Adenocarcinoma
LCLAT1::ALK	Adenocarcinoma
LCLAT1::EPHA3	Malignant melanoma
LCLAT1::ERBB4	Russia | Primitive neuroectodermal tumor/Medulloblastoma
LCLAT1::FMNL2	Adenocarcinoma
LCMT1::CTNNA2	Adenocarcinoma
LCN2::KMT5B	Adenocarcinoma
LCN2::LMX1B	Adenocarcinoma
LCN2::LRSAM1	Adenocarcinoma
LCN2::ZNFX1	Adenocarcinoma
LCOR::CC2D2B	Adenocarcinoma
LCOR::CPNE8	Adenocarcinoma
LCOR::HPSE2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
LCOR::MAP2K6	Transitional cell carcinoma
LCOR::PNLIPRP3	Adenocarcinoma
LCOR::RBM20	Adenocarcinoma
LCOR::RET	Carcinoma, NOS
LCORL::CDKAL1	Transitional cell carcinoma
LCORL::PPARGC1A	Skin | Acute myeloid leukemia, NOS
LCP1::BCL6	Follicular lymphoma | Diffuse large B-cell lymphoma
LCP2::SLC34A1	Malignant melanoma
LDAF1::DNAH3	Adenocarcinoma
LDAF1::NDUFAB1	Mesenchymal tumor, NOS
LDAH::MBOAT2	Adenocarcinoma
LDAH::RTN4	Malignant melanoma
LDB1::PCGF6	Adenocarcinoma
LDHA::PLA2G2A	Adenocarcinoma
LDHA::USP6	Nodular fasciitis
LDHB::CCT5	Astrocytoma, grade I-II
LDHB::CTNNA2	Adenocarcinoma
LDHB::PEX1	Adenocarcinoma
LDHB::RARB	Malignant epithelial tumor, special type
LDHC::SERGEF	Adenocarcinoma
LDLR::ANGPTL4	Malignant epithelial tumor, special type
LDLR::C19ORF38	Adenocarcinoma
LDLR::C19orf38	Adenocarcinoma
LDLR::CALR	Squamous cell carcinoma
LDLR::DNM2	Squamous cell carcinoma
LDLR::HSH2D	Squamous cell carcinoma
LDLR::LRPAP1	Adenocarcinoma
LDLR::MRPL4	Adenocarcinoma
LDLR::RET	Adenocarcinoma
LDLR::ROS1	Adenocarcinoma
LDLR::SMARCA4	Adenocarcinoma
LDLR::TERT	Gonadal stromal cell tumors
LDLR::TNPO2	Adenocarcinoma
LDLR::YJU2B	Adenocarcinoma
LDLR::ZGLP1	Adenocarcinoma
LDLR::ZNF333	Adenocarcinoma
LDLRAD1::FGGY	Adenocarcinoma
LDLRAD1::TMEM59	Adenocarcinoma
LDLRAD3::CD44	Adenocarcinoma
LDLRAD3::DEPDC7	Mesenchymal tumor, NOS
LDLRAD3::ELP4	Adenocarcinoma
LDLRAD3::PAMR1	Transitional cell carcinoma
LDLRAD3::PHF21A	Malignant melanoma
LDLRAD3::SNCB	Squamous cell carcinoma
LDLRAD3::TCP11L1	Adenocarcinoma
LDLRAD3::TM7SF3	Adenocarcinoma
LDLRAD3::TRIM44	Malignant melanoma
LDLRAD3::VWA5B2	Malignant melanoma
LDLRAD4::CD226	Adenocarcinoma
LDLRAD4::DLGAP1	Adenocarcinoma
LDLRAD4::FAM210A	Adenocarcinoma
LDLRAD4::IMPA2	Adenocarcinoma
LDLRAD4::INTS8	Adenocarcinoma
LDLRAD4::NOVA1	Adenocarcinoma
LDLRAD4::PHACTR3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
LDLRAP1::MACO1	Transitional cell carcinoma
LEAP2::TRAF6	Adenocarcinoma
LEF1::TAF8	Acute lymphoblastic leukemia/lymphoblastic lymphoma
LEMD3::KCNC2	Mesenchymal tumor, NOS
LEMD3::LYZ	Adenocarcinoma
LEMD3::RASSF6	Adenocarcinoma
LEMD3::TSPAN8	Squamous cell carcinoma
LEMD3::XPOT	Adenocarcinoma
LENG1::ACSBG2	Adenocarcinoma
LENG1::NIT2	Squamous cell carcinoma
LENG8::FAAP20	Adenocarcinoma
LENG8::LAIR1	Adenocarcinoma
LENG8::SIPA1L3	Adenocarcinoma
LEO1::FBN1	Adenocarcinoma
LEO1::POC1A	Skin | Acute myeloid leukemia, NOS
LEO1::SLC12A1	Astrocytoma, grade III-IV/Glioblastoma
LEPR::MEF2D	Adenocarcinoma
LEPR::SGIP1	Adenocarcinoma
LEPROT::NFIA	Adenocarcinoma
LEPROT::SGIP1	Adenocarcinoma
LETM1::FMC1	Adenocarcinoma
LETM1::MXD4	Adenocarcinoma
LETM1::NELFA	Adenocarcinoma
LETM1::POLN	Adenocarcinoma
LETM1::SLBP	Adenocarcinoma
LETM1::USP15	Adenocarcinoma
LETM2::ERCC2	Squamous cell carcinoma
LETM2::KCNU1	Squamous cell carcinoma
LETMD1::LARP4	Transitional cell carcinoma
LGALS12::PLAC9	Adenocarcinoma
LGALS13::PTPRH	Astrocytoma, grade I-II
LGALS2::SEZ6L	Malignant melanoma
LGALS3::KIR2DL3	Adenocarcinoma
LGALS3::SOCS4	Adenocarcinoma
LGALS3BP::CLSPN	Squamous cell carcinoma
LGALS3BP::DCBLD2	Malignant melanoma
LGALS3BP::ELK3	Adenocarcinoma
LGALS8::EDARADD	Adenocarcinoma
LGALS8::RHBG	Transitional cell carcinoma
LGALS8::TRIM67	Adenocarcinoma
LGALS9::BLTP2	Adenocarcinoma
LGMN::NAP1L1	Adenocarcinoma
LGR5::CNOT2	Transitional cell carcinoma
LGR5::PPFIA2	Mesenchymal tumor, NOS
LGR5::PTPRR	Transitional cell carcinoma
LGR5::TAFA2	Mesenchymal tumor, NOS
LGR6::GPR37L1	Adenocarcinoma
LGR6::NAV1	Adenocarcinoma
LGR6::RNF152	Adenocarcinoma
LGR6::RNPEP	Adenocarcinoma
LHCGR::GTF2A1L	Adenocarcinoma
LHFPL2::ARSB	Mature B-cell neoplasm, NOS
LHFPL2::CSNK1A1	Astrocytoma, grade I-II
LHFPL2::H2AC6	Adenocarcinoma
LHFPL2::KCNIP1	Adenocarcinoma
LHFPL2::PTPRK	Adenocarcinoma
LHFPL3::EEA1	Astrocytoma, grade I-II
LHFPL3::NTRK2	Neuroglial neoplasm, special type
LHPP::FANK1	Astrocytoma, grade III-IV/Glioblastoma
LHPP::TANGO6	Squamous cell carcinoma
LHX1::ERBB2	Carcinoma, NOS
LHX4::BRINP2	Chronic lymphocytic leukemia
LIFR::BCAS3	Squamous cell carcinoma
LIFR::C9	Adenocarcinoma
LIFR::PLAG1	Benign epithelial tumor, special type | Myoepithelioma/myoepithelial carcinoma/mixed tumor | Adenocarcinoma | Adenoma
LIFR::PNPLA8	Astrocytoma, grade I-II
LIFR::RAB5IF	Mesothelioma
LIFR::TTC33	Adenocarcinoma
LIG1::NTF4	Malignant melanoma
LIG3::HAP1	Adenocarcinoma
LIG3::KXD1	Adenocarcinoma
LIG3::ZFAT	Adenocarcinoma
LILRA2::CCBE1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
LILRB3::LILRB4	Acute myeloid leukemia, NOS | Skin
LIMA1::ANO6	Adenocarcinoma
LIMA1::RGL1	Adenocarcinoma
LIMA1::ROS1	Melanocytic neoplasm, special type
LIMA1::TAOK3	Transitional cell carcinoma
LIMA1::TRAPPC9	Adenocarcinoma
LIMA1::USP22	Adenocarcinoma
LIMCH1::APBB2	Adenocarcinoma
LIMCH1::CWH43	Transitional cell carcinoma
LIMCH1::DNM1L	Adenocarcinoma
LIMCH1::HOPX	Adenocarcinoma
LIMCH1::OCIAD2	Squamous cell carcinoma
LIMCH1::UCHL1	Transitional cell carcinoma | Adenocarcinoma
LIMD1::LARS2	Adenocarcinoma
LIME1::SLC2A4RG	Adenocarcinoma
LIMK1::GNAT3	Mesenchymal tumor, NOS
LIMK2::ATXN10	Squamous cell carcinoma
LIMK2::CDC45	Transitional cell carcinoma
LIMK2::MED15	Benign epithelial tumor, special type | Miscellaneous hematopoietic/lymphoid neoplasm, special type
LIMK2::OSBP2	Adenocarcinoma
LIMK2::RUFY1	Adenocarcinoma
LIMS1::CCDC138	Transitional cell carcinoma
LIMS1::CIAO1	Transitional cell carcinoma
LIMS1::LIMS4	Skin | Acute myeloid leukemia, NOS
LIMS1::PTP4A2	Adenocarcinoma
LIMS1::STARD7	Adenocarcinoma
LIN28A::CD52	Germ cell tumor, NOS
LIN28B::STX7	Diffuse large B-cell lymphoma
LIN28B::USP45	Adenocarcinoma
LIN52::AHSA1	Adenocarcinoma
LIN52::BBOF1	Adenocarcinoma
LIN52::SYNE2	Adenocarcinoma
LIN54::PLAC8	Adenocarcinoma
LIN54::RASGEF1B	Adenocarcinoma
LIN7A::GRIP1	Mesenchymal tumor, NOS
LIN7A::NAV3	Adenocarcinoma
LIN7A::NUP107	Mesenchymal tumor, NOS
LIN7A::PPP1R12A	Mesenchymal tumor, NOS
LIN7A::R3HDM2	Adenocarcinoma
LIN7A::TMEM132D	Mesenchymal tumor, NOS
LIN7A::TRHDE	Adenocarcinoma
LIN9::KDM5B	Oligodendroglioma | Astrocytoma, grade I-II
LINGO2::DCTN3	Transitional cell carcinoma
LINGO2::TLN1	Squamous cell carcinoma
LINS1::WRAP53	Adenocarcinoma
LIPA::TMEM132A	Transitional cell carcinoma
LIPC::CCNA2	Adenocarcinoma
LIPC::TCF12	Adenocarcinoma
LIPE::CEACAM1	Malignant melanoma
LIPE::CXCL17	Adenocarcinoma
LIPF::CLCN3	Adenocarcinoma
LIPG::UCMA	Transitional cell carcinoma
LIPH::EHHADH	Adenocarcinoma
LIPI::NTRK1	Adenocarcinoma
LIPN::MINPP1	Astrocytoma, grade I-II
LITAF::CXCL17	Squamous cell carcinoma
LLGL1::ALKBH5	Adenocarcinoma
LLGL1::MARCHF10	Adenocarcinoma
LLGL1::TLN2	Mesenchymal tumor, NOS
LLGL2::AP2B1	Transitional cell carcinoma
LLGL2::CA10	Adenocarcinoma
LLGL2::CDR2L	Malignant melanoma
LLGL2::CPNE4	Adenocarcinoma
LLGL2::EXOC7	Transitional cell carcinoma
LLGL2::FAM222B	Adenocarcinoma
LLGL2::ITGB4	Adenocarcinoma
LLGL2::TANC2	Adenocarcinoma
LLGL2::TMEM104	Adenocarcinoma
LLPH::ADK	Adenocarcinoma
LMAN1::NBEAL1	Mesenchymal tumor, NOS
LMAN2::AP3S1	Adenocarcinoma
LMAN2::DBN1	Adenocarcinoma
LMAN2::DOCK2	Malignant melanoma
LMAN2::F12	Adenocarcinoma
LMAN2::MCC	Adenocarcinoma
LMAN2::MXD3	Nonneoplastic epithelial disorder/lesion
LMAN2::NOP16	Squamous cell carcinoma
LMAN2::NSD1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
LMAN2::PAPOLA	Acute lymphoblastic leukemia/lymphoblastic lymphoma
LMAN2::RUBCN	Adenocarcinoma
LMAN2::SPOCK1	Adenocarcinoma
LMAN2L::FAM178B	Squamous cell carcinoma
LMAN2L::FER1L5	Squamous cell carcinoma
LMAN2L::MRPS5	Adenocarcinoma
LMBR1::CHMP1A	Adenocarcinoma
LMBR1::EPHA1	Adenocarcinoma
LMBR1::KIAA0825	Malignant melanoma
LMBR1::PRSS1	Adenocarcinoma
LMBR1::PTPRN2	Adenocarcinoma
LMBR1::TPRG1	Adenocarcinoma
LMBR1::UBE3C	Mesenchymal tumor, NOS
LMBR1L::KCNK6	Transitional cell carcinoma
LMBR1L::SSU72	Malignant melanoma
LMBR1L::TUBA1B	Malignant epithelial tumor, special type
LMBR1L::VDR	Adenocarcinoma
LMBRD1::COL9A1	Squamous cell carcinoma
LMBRD1::EYS	Adenocarcinoma
LMBRD1::GLO1	Adenocarcinoma
LMBRD1::LGSN	Adenocarcinoma
LMBRD1::REPS1	Adenocarcinoma
LMBRD1::ZBTB45	Astrocytoma, grade I-II
LMBRD2::ADAMTS12	Adenocarcinoma
LMBRD2::CTNND2	Malignant melanoma
LMBRD2::ERG	Astrocytoma, grade I-II
LMBRD2::ICE1	Malignant melanoma
LMBRD2::KCNMB1	Astrocytoma, grade I-II
LMBRD2::NADK2	Adenocarcinoma
LMCD1::ZNF589	Adenocarcinoma
LMF1::CCDC154	Astrocytoma, grade I-II
LMF1::UMOD	Adenocarcinoma
LMNA::ALK	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma
LMNA::FLAD1	Adenocarcinoma
LMNA::FOSB	Meningioma
LMNA::IGFBP2	Adenocarcinoma
LMNA::IGK	Multiple myeloma
LMNA::NTRK1	Soft tissue tumor, NOS | Rhabdomyosarcoma, NOS | Soft tissue tumor, special type | Glioma, NOS | Mesoblastic nephroma | Fibrosarcoma | Malignant melanoma | Carcinoma, NOS | Adenocarcinoma | Malignant peripheral nerve sheath tumor/Triton | Russia | Solitary fibrous tumor | Malignant soft tissue tumor, NOS | Dermatofibrosarcoma protuberans/Bednar tumor/giant cell fibroblastoma | Undifferentiated pleomorphic sarcoma | Melanocytic neoplasm, special type | Gastrointestinal stromal tumor | Primitive neuroectodermal tumor/Medulloblastoma | Fibroblastic/myofibroblastic tumor, special type
LMNA::PRPF3	Adenocarcinoma
LMNA::PTN	Adenocarcinoma
LMNA::RAB4B	Malignant melanoma
LMNA::RAF1	Malignant melanoma
LMNA::SYT11	Adenocarcinoma
LMNB1::HOMER1	Adenocarcinoma
LMNB1::PPP2R2B	Acute lymphoblastic leukemia/lymphoblastic lymphoma
LMNB2::GNG7	Multiple myeloma | Adenocarcinoma
LMNB2::IGH	Multiple myeloma
LMNB2::SGTA	Multiple myeloma
LMO1::RIC3	Algeria | Acute undifferentiated leukemia
LMO1::TRA	Acute lymphoblastic leukemia/lymphoblastic lymphoma
LMO2::CD59	Squamous cell carcinoma
LMO2::TRA	Acute lymphoblastic leukemia/lymphoblastic lymphoma
LMO3::BORCS5	Ewing sarcoma
LMO3::EPS8	Adenocarcinoma
LMO7::ALK	Adenocarcinoma
LMO7::BRAF	Adenocarcinoma
LMO7::EXT2	Carcinoma, NOS
LMO7::ITGBL1	Adenocarcinoma
LMO7::KLF12	Adenocarcinoma
LMO7::MED4	Adenocarcinoma
LMO7::UCHL3	Adenocarcinoma
LMTK2::BRI3	Squamous cell carcinoma
LMTK2::IMMP2L	Squamous cell carcinoma
LMTK2::PCLO	Squamous cell carcinoma
LMTK3::DBP	Adenocarcinoma
LMTK3::NOSIP	Squamous cell carcinoma
LMX1A::LELP1	Adenocarcinoma
LMX1B::RAD51B	Adenocarcinoma
LNPEP::CAST	Adenocarcinoma
LNPEP::FLT4	Malignant melanoma
LNPEP::GPBP1	Adenocarcinoma
LNPEP::PPIP5K2	Adenocarcinoma
LNX1::FIP1L1	Adenocarcinoma
LNX1::GABRB1	Adenocarcinoma
LNX1::IFT122	Squamous cell carcinoma
LNX1::SOD3	Astrocytoma, grade I-II
LNX1::USP46	Astrocytoma, grade III-IV/Glioblastoma
LONP1::CARD8	Malignant melanoma
LONP1::CATSPERD	Adenocarcinoma | Multiple myeloma
LONP1::DDX27	Adenocarcinoma
LONP1::DUS3L	Adenocarcinoma
LONP1::ELOF1	Astrocytoma, grade III-IV/Glioblastoma
LONP1::FUT6	Adenocarcinoma
LONP1::MAP2K7	Adenocarcinoma
LONP1::RAD51	Squamous cell carcinoma
LONP1::RANBP3	Adenocarcinoma
LONP1::SAFB2	Adenocarcinoma
LONP1::ZNF780B	Adenocarcinoma
LONP2::C22ORF39	Adenocarcinoma
LONP2::CHRM3	Astrocytoma, grade I-II
LONP2::EGLN3	Squamous cell carcinoma
LONP2::HIRA	Adenocarcinoma
LONP2::PLEKHB2	Germ cell tumor, NOS
LONRF1::PSMB7	Malignant melanoma
LOXHD1::HDHD2	Acute myeloblastic leukemia with maturation (FAB type M2)
LOXL3::M1AP	Adenocarcinoma
LPAR1::AGO3	Adenocarcinoma
LPAR3::ST6GALNAC3	Adenocarcinoma
LPAR5::EP300	Acute lymphoblastic leukemia/lymphoblastic lymphoma
LPAR6::ITM2B	Acute lymphoblastic leukemia/lymphoblastic lymphoma
LPAR6::TPP2	Transitional cell carcinoma
LPCAT1::CLPTM1L	Adenocarcinoma
LPCAT1::DAP	Adenocarcinoma
LPCAT1::MED13	Mesenchymal tumor, NOS
LPCAT1::SDHA	Adenocarcinoma
LPCAT1::TERT	Adenocarcinoma | Malignant epithelial tumor, special type
LPCAT2::CACTIN	Adenocarcinoma
LPCAT2::DNAJA2	Adenocarcinoma
LPCAT3::LRRC23	Adenocarcinoma
LPCAT3::MAP3K13	Adenocarcinoma
LPCAT3::MYO15A	Adenocarcinoma
LPCAT4::MTMR10	Squamous cell carcinoma
LPCAT4::SPRED1	Adenocarcinoma
LPIN1::CFAP20DC	Adenocarcinoma
LPIN1::GREB1	Malignant epithelial tumor, special type
LPIN1::SARS1	Adenocarcinoma
LPIN1::TBC1D7	Transitional cell carcinoma
LPIN1::TIMM17A	Squamous cell carcinoma
LPIN2::COPS3	Adenocarcinoma
LPIN2::DLGAP1	Adenocarcinoma
LPIN2::MYOM1	Adenocarcinoma
LPIN2::PARP4	Adenocarcinoma
LPIN2::RFPL1	Adenocarcinoma
LPIN2::SLC39A6	Adenocarcinoma
LPIN2::TRAT1	Adenocarcinoma
LPP::ABHD17C	Adenocarcinoma
LPP::ADIPOQ	Adenocarcinoma
LPP::AK1	Adenocarcinoma
LPP::BCL6	Diffuse large B-cell lymphoma
LPP::CASR	Adenocarcinoma
LPP::CHRD	Squamous cell carcinoma
LPP::CLPTM1L	Adenocarcinoma
LPP::CLSTN2	Squamous cell carcinoma
LPP::DDX51	Adenocarcinoma
LPP::F2	Adenocarcinoma
LPP::GOLIM4	Squamous cell carcinoma
LPP::KCNIP4	Mesenchymal tumor, NOS
LPP::LIPJ	Adenocarcinoma
LPP::MBNL1	Adenocarcinoma
LPP::P3H2	Squamous cell carcinoma
LPP::PLAAT1	Mesenchymal tumor, NOS
LPP::RNF168	Transitional cell carcinoma
LPP::RTP1	Adenocarcinoma
LPP::SEC62	Squamous cell carcinoma
LPP::SPATA16	Adenocarcinoma
LPP::ST6GAL1	Squamous cell carcinoma
LPP::TP63	Adenocarcinoma
LPP::TPRG1	Undifferentiated carcinoma, small cell
LPP::WWTR1	Adenocarcinoma
LPP::ZNRF1	Malignant epithelial tumor, special type
LRAT::NAALADL2	Mesenchymal tumor, NOS
LRAT::VTI1A	Adenocarcinoma
LRATD2::MYC	Multiple myeloma
LRBA::ASIC5	Adenocarcinoma
LRBA::CHCHD3	Adenocarcinoma
LRBA::DDX60L	Adenocarcinoma
LRBA::DLG2	Adenocarcinoma
LRBA::DRD3	Adenocarcinoma
LRBA::ESF1	Adenocarcinoma
LRBA::FBXW7	Adenocarcinoma
LRBA::GATB	Adenocarcinoma
LRBA::GRIK3	Adenocarcinoma
LRBA::HJV	Adenocarcinoma
LRBA::IGH	Adenocarcinoma
LRBA::NFKB1	Adenocarcinoma
LRBA::PPARGC1A	Adenocarcinoma
LRBA::RXFP1	Transitional cell carcinoma
LRBA::SH3D19	Acute myeloid leukemia, NOS | Squamous cell carcinoma | Acute myeloblastic leukemia without maturation (FAB type M1) | Skin
LRBA::SPPL3	Adenocarcinoma
LRBA::TBC1D9	Malignant melanoma
LRCH1::INTS6	Acute myeloid leukemia, NOS | Skin
LRCH1::NUDT15	Adenocarcinoma
LRCH1::PHF11	Transitional cell carcinoma
LRCH1::TBC1D31	Adenocarcinoma
LRCH3::BRSK2	Undifferentiated carcinoma, small cell
LRCH3::FMN2	Malignant epithelial tumor, special type
LRCH3::MED12L	Adenocarcinoma
LRCH3::RAF1	Malignant melanoma
LRCH3::SLC16A13	Adenocarcinoma
LRCH3::TMEM41A	Adenocarcinoma
LRCH4::ACOT12	Adenocarcinoma
LRFN1::DLL3	Adenocarcinoma
LRFN3::FXYD7	Adenocarcinoma
LRFN3::GMFG	Squamous cell carcinoma
LRFN5::DPF3	Astrocytoma, grade I-II
LRGUK::PRKCA	Adenocarcinoma
LRIG1::PAK2	Soft tissue tumor, special type
LRIG1::PPM1L	Adenocarcinoma
LRIG1::SLC25A26	Adenocarcinoma
LRIG1::SLC26A7	Adenocarcinoma
LRIG1::SUCLG2	Adenocarcinoma
LRIG3::ATF7	Adenocarcinoma
LRIG3::ATP23	Mesenchymal tumor, NOS
LRIG3::ATP5F1B	Malignant melanoma
LRIG3::DTX3	Adenocarcinoma
LRIG3::MON2	Alveolar rhabdomyosarcoma
LRIG3::PIP4K2C	Adenocarcinoma
LRIG3::ROS1	Adenocarcinoma | Glioma, NOS
LRIG3::SLC16A7	Mesenchymal tumor, NOS
LRMDA::ADK	Squamous cell carcinoma
LRMDA::CYP2C19	Adenocarcinoma
LRMDA::IQCH	Adenocarcinoma
LRMDA::MIEN1	Adenocarcinoma
LRMDA::MYO1D	Adenocarcinoma
LRMDA::NRG3	Adenocarcinoma
LRMDA::P4HA1	Transitional cell carcinoma
LRMDA::PLEKHG6	Adenocarcinoma
LRMDA::RTKN2	Adenocarcinoma
LRMDA::RUFY2	Adenocarcinoma
LRMDA::VCL	Adenocarcinoma
LRP10::MSL1	Squamous cell carcinoma
LRP11::ULBP2	Adenocarcinoma
LRP12::CCL28	Adenocarcinoma
LRP12::KCNB2	Adenocarcinoma
LRP12::LAPTM4B	Adenocarcinoma
LRP12::RALGPS1	Malignant melanoma
LRP12::RIMS2	Adenocarcinoma
LRP12::SLC25A32	Mesothelioma
LRP12::TRAPPC9	Adenocarcinoma
LRP12::VPS13B	Adenocarcinoma
LRP1::ATF1	Mesenchymal tumor, NOS
LRP1::BCAN	Astrocytoma, grade I-II
LRP1::CAND1	Mesenchymal tumor, NOS
LRP1::KLK3	Adenocarcinoma
LRP1::MCRS1	Mesenchymal tumor, NOS
LRP1::NEMP1	Malignant melanoma
LRP1::OS9	Adenocarcinoma
LRP1::SLC39A5	Malignant epithelial tumor, special type
LRP1::SNRNP25	Osteosarcoma, NOS
LRP1::SYT1	Astrocytoma, grade III-IV/Glioblastoma
LRP1::TAFA2	Mesenchymal tumor, NOS
LRP1::XPO5	Astrocytoma, grade III-IV/Glioblastoma
LRP1B::ADAP1	Squamous cell carcinoma
LRP1B::ARFGAP3	Adenocarcinoma
LRP1B::GULP1	Neuroblastoma
LRP1B::HECW2	Squamous cell carcinoma
LRP2::FASTKD1	Squamous cell carcinoma | Adenocarcinoma
LRP3::LSM14A	Adenocarcinoma
LRP3::THAP8	Adenocarcinoma
LRP3::VAV1	Astrocytoma, grade I-II
LRP4::CELF1	Adenocarcinoma
LRP4::CFL1	Adenocarcinoma
LRP4::PRDM11	Astrocytoma, grade I-II
LRP5::ALKBH5	Adenocarcinoma
LRP5::ATG16L2	Astrocytoma, grade III-IV/Glioblastoma
LRP5::CASQ2	Adenocarcinoma
LRP5::CHD6	Adenocarcinoma
LRP5::CHRM1	Adenocarcinoma
LRP5::CLPB	Squamous cell carcinoma
LRP5::DLG2	Adenocarcinoma
LRP5::DRAP1	Adenocarcinoma
LRP5::GAL	Adenocarcinoma
LRP5::HSCB	Squamous cell carcinoma
LRP5::MADD	Adenocarcinoma
LRP5::MOGAT2	Adenocarcinoma
LRP5::NOX4	Adenocarcinoma
LRP5::RBFOX1	Transitional cell carcinoma
LRP5::SLC22A6	Adenocarcinoma
LRP5::TOP6BL	Adenocarcinoma
LRP5::UVRAG	Malignant melanoma
LRP5::VPS26B	Adenocarcinoma
LRP5::VPS37C	Astrocytoma, grade I-II
LRP5::ZNF317	Squamous cell carcinoma
LRP5::ZNF507	Adenocarcinoma
LRP5L::SGSM3	Mesenchymal tumor, NOS
LRP6::DUSP16	Malignant epithelial tumor, special type
LRP6::GPR19	Adenocarcinoma
LRP6::HEBP1	Adenocarcinoma
LRP6::LRRC23	Germ cell tumor, NOS
LRP6::MAGOHB	Skin | Acute myeloid leukemia, NOS
LRP6::MANSC1	Germ cell tumor, NOS | Adenocarcinoma
LRP6::NINJ2	Astrocytoma, grade I-II
LRP6::PTPRO	Adenocarcinoma
LRP8::PAX8	Adenocarcinoma
LRP8::RAD51C	Adenocarcinoma
LRP8::SLC1A7	Adenocarcinoma
LRP8::TMEM217	Adenocarcinoma
LRP8::USP24	Adenocarcinoma
LRPAP1::TMEM175	Adenocarcinoma
LRPPRC::CYTIP	Adenocarcinoma
LRPPRC::EIF4G2	Adenocarcinoma
LRPPRC::NRXN1	Adenocarcinoma
LRR1::KCNH5	Adenocarcinoma
LRR1::MTHFD1	Adenocarcinoma
LRRC14::UPK1B	Adenocarcinoma
LRRC19::SNAPC3	Squamous cell carcinoma
LRRC1::DAAM2	Adenocarcinoma
LRRC1::FRY	Adenocarcinoma
LRRC1::HSP90AB1	Mesothelioma
LRRC1::MLIP	Adenocarcinoma | Squamous cell carcinoma
LRRC1::SH3GL1	Astrocytoma, grade I-II
LRRC1::SUPT3H	Astrocytoma, grade I-II
LRRC1::TINAG	Squamous cell carcinoma
LRRC20::NODAL	Adenocarcinoma
LRRC23::LPCAT3	Squamous cell carcinoma
LRRC28::EIF4EBP1	Adenocarcinoma
LRRC28::MEF2A	Adenocarcinoma
LRRC37A3::GNA13	Adenocarcinoma
LRRC37B::RAB11FIP4	Adenocarcinoma
LRRC37B::RAD51C	Adenocarcinoma
LRRC37B::SUZ12	Adenocarcinoma
LRRC40::MICOS10	Mesothelioma
LRRC41::SHISAL2A	Adenocarcinoma
LRRC41::TAL1	Adenocarcinoma
LRRC45::GCGR	Undifferentiated carcinoma, small cell
LRRC45::GNB1	Adenocarcinoma
LRRC4C::ALK	Adenocarcinoma
LRRC56::DEAF1	Germ cell tumor, NOS
LRRC58::FSTL1	Adenocarcinoma
LRRC58::LSAMP	Adenocarcinoma
LRRC59::B4GALNT2	Adenocarcinoma
LRRC59::NEUROD2	Adenocarcinoma
LRRC59::NUP107	Adenocarcinoma
LRRC59::SPAG9	Adenocarcinoma
LRRC61::DOCK4	Adenocarcinoma
LRRC61::TFCP2	Adenocarcinoma
LRRC71::NTRK1	Adenocarcinoma
LRRC75A::PEMT	Adenocarcinoma
LRRC7::RRP15	Adenocarcinoma
LRRC8A::DNAH6	Adenocarcinoma
LRRC8A::GON4L	Adenocarcinoma
LRRC8A::KYAT1	Adenocarcinoma
LRRC8A::MEN1	Adenocarcinoma
LRRC8D::FYB2	Adenocarcinoma
LRRC8D::PALMD	Malignant melanoma
LRRC8D::TMEM9	Squamous cell carcinoma
LRRC8E::EVI5L	Adenocarcinoma
LRRC8E::MFSD12	Adenocarcinoma
LRRCC1::MTG2	Adenocarcinoma
LRRCC1::ZC2HC1A	Adenocarcinoma
LRRD1::BAIAP2L1	Adenocarcinoma
LRRFIP1::CARD10	Benign epithelial tumor, special type | Miscellaneous hematopoietic/lymphoid neoplasm, special type
LRRFIP1::DBF4B	Malignant melanoma
LRRFIP1::FGFR1	Skin | Acute myeloid leukemia, NOS
LRRFIP1::RAMP1	Adenocarcinoma
LRRFIP1::WDR81	Adenocarcinoma
LRRFIP2::ALK	Benign fibrous histiocytoma
LRRFIP2::DEPTOR	Malignant melanoma
LRRFIP2::EPHA3	Adenocarcinoma
LRRFIP2::RAF1	Fibroblastic/myofibroblastic tumor, special type | Malignant melanoma
LRRFIP2::ROS1	Melanocytic neoplasm, special type
LRRFIP2::SETD2	Adenocarcinoma
LRRIQ1::BLTP3B	Adenocarcinoma
LRRIQ4::MIEN1	Adenocarcinoma
LRRK1::ADAMTS17	Adenocarcinoma
LRRK1::ST3GAL3	Multiple myeloma
LRRK2::CCT2	Adenocarcinoma
LRRK2::GXYLT1	Astrocytoma, grade I-II
LRRN2::CTSS	Adenocarcinoma
LRRN2::LEMD1	Astrocytoma, grade III-IV/Glioblastoma
LRRN2::SNRPE	Astrocytoma, grade III-IV/Glioblastoma
LRRN4::MCM8	Adenocarcinoma
LRRTM4::ALK	Adenocarcinoma
LRSAM1::DENND1A	Adenocarcinoma
LRSAM1::GARNL3	Squamous cell carcinoma
LRSAM1::SH2D3C	Adenocarcinoma
LRTOMT::FOLR1	Adenocarcinoma
LRTOMT::METTL25	Atypical lipomatous tumor/atypical lipoma/well-differentiated liposarcoma
LRTOMT::NFIC	Adenocarcinoma
LRTOMT::UVRAG	Adenocarcinoma
LRWD1::CCDC107	Adenocarcinoma
LSAMP::C3orf70	Adenocarcinoma
LSAMP::CELSR1	Astrocytoma, grade III-IV/Glioblastoma
LSAMP::COL4A5	Malignant melanoma
LSAMP::GAP43	Adenocarcinoma
LSAMP::IGSF11	Malignant melanoma
LSAMP::MIX23	Mesenchymal tumor, NOS
LSAMP::STAG1	Neuroblastoma
LSG1::EIF2B5	Squamous cell carcinoma
LSM10::CLSTN1	Adenocarcinoma
LSM12::HDAC5	Adenocarcinoma
LSM12::ITGA2B	Malignant epithelial tumor, special type
LSM14A::ABL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
LSM14A::ACTN4	Adenocarcinoma
LSM14A::BRAF	Melanocytic neoplasm, special type
LSM14A::FXYD3	Adenocarcinoma
LSM14A::KNDC1	Squamous cell carcinoma
LSM14A::NR4A3	Chondrosarcoma, myxoid
LSM14A::RET	Adenocarcinoma | Carcinoma, NOS
LSM14A::SIPA1L3	Adenocarcinoma
LSM14A::TDRD12	Adenocarcinoma
LSM14A::TMTC2	Mesenchymal tumor, NOS
LSM14A::URI1	Squamous cell carcinoma
LSM1::ASH2L	Adenocarcinoma
LSM1::NRG1	Malignant soft tissue tumor, NOS
LSM1::NSD3	Adenocarcinoma | Squamous cell carcinoma
LSM1::NSMCE2	Adenocarcinoma
LSM2::HSPA1L	Adenocarcinoma
LSM3::MRPL22	Transitional cell carcinoma
LSM4::GRK2	Malignant melanoma
LSM4::RCC1	Malignant epithelial tumor, special type
LSM4::TRHDE	Adenocarcinoma
LSM7::GNG7	Adenocarcinoma
LSM8::MET	Adenocarcinoma
LSMEM1::MET	Carcinoma, NOS
LSP1::BCL2L11	Multiple myeloma
LSP1::IGH	Multiple myeloma
LSP1::SF1	Multiple myeloma
LSP1::SYT8	Adenocarcinoma
LSR::GRAMD1A	Adenocarcinoma
LSR::HDLBP	Adenocarcinoma
LSR::NLRP2	Adenocarcinoma
LSS::EIF4ENIF1	Mesenchymal tumor, NOS
LSS::MCM3AP	Mature B-cell neoplasm, NOS
LTA4H::ABTB3	Mesenchymal tumor, NOS
LTA4H::CNOT2	Adenocarcinoma
LTA4H::SLC25A24	Adenocarcinoma
LTA4H::STAB2	Mesenchymal tumor, NOS
LTBP1::ALK	Adenocarcinoma | Glioma, NOS
LTBP1::BABAM2	Adenocarcinoma
LTBP1::BIRC6	Squamous cell carcinoma | Acute myeloblastic leukemia with maturation (FAB type M2)
LTBP1::CDH23	Adenocarcinoma
LTBP1::LMBR1	Mesenchymal tumor, special type
LTBP1::PLB1	Transitional cell carcinoma
LTBP1::TTC27	Adenocarcinoma
LTBP1::UCMA	Mesenchymal tumor, NOS
LTBP1::VWA8	Mesenchymal tumor, special type
LTBP1::YIPF4	Adenocarcinoma
LTBP1::ZDHHC2	Adenocarcinoma
LTBP2::NEK9	Adenocarcinoma
LTBP3::CERS3	Squamous cell carcinoma
LTBP3::TSPAN32	Squamous cell carcinoma
LTBP4::CTSD	Adenocarcinoma
LTBP4::MYO1B	Adenocarcinoma
LTBP4::POU2F2	Malignant epithelial tumor, special type
LTBP4::SUPT16H	Squamous cell carcinoma
LTBR::ITFG2	Adenocarcinoma
LTBR::PRSS3	Adenocarcinoma
LTF::C7	Adenocarcinoma
LTF::CFB	Adenocarcinoma
LTF::CHD1	Adenocarcinoma
LTF::FOXP1	Adenocarcinoma
LTF::NCALD	Adenocarcinoma
LTF::SEC63	Adenocarcinoma
LTF::ZNFX1	Squamous cell carcinoma
LTN1::MX1	Skin | Acute myeloid leukemia, NOS
LTN1::RWDD2B	Adenocarcinoma
LTO1::CCND1	Squamous cell carcinoma
LTO1::NARS2	Adenocarcinoma
LTO1::RNF169	Adenocarcinoma
LTO1::SHANK2	Transitional cell carcinoma
LTV1::ATG5	Adenocarcinoma
LTV1::EPM2A	Squamous cell carcinoma
LUC7L2::ETV1	Adenocarcinoma
LUC7L2::IGSF22	Malignant melanoma
LUC7L2::JAKMIP1	Adenocarcinoma
LUC7L2::KLRG2	Acute myeloid leukemia, NOS | Skin
LUC7L2::MRPS33	Adenocarcinoma
LUC7L2::SLC25A13	Adenocarcinoma
LUC7L3::ABCC3	Adenocarcinoma
LUC7L3::ACSF2	Adenocarcinoma
LUC7L3::CACNA1G	Adenocarcinoma
LUC7L3::CEP250	Malignant epithelial tumor, special type
LUC7L3::CHCT1	Adenocarcinoma
LUC7L3::IKZF3	Adenocarcinoma
LUC7L3::MPRIP	Adenocarcinoma
LUC7L3::MYCBPAP	Malignant epithelial tumor, special type
LUC7L3::SPATA20	Adenocarcinoma | Squamous cell carcinoma
LUC7L3::TFE3	Adenocarcinoma
LUC7L::AXIN1	Squamous cell carcinoma | Adenocarcinoma
LUC7L::CORIN	Transitional cell carcinoma
LUC7L::CPM	Astrocytoma, grade III-IV/Glioblastoma
LUC7L::SLC27A5	Transitional cell carcinoma
LUC7L::STX8	Adenocarcinoma
LUC7L::STXBP1	Adenocarcinoma
LUM::USP6	Aneurysmal bone cyst
LURAP1L::TYRP1	Adenocarcinoma
LUZP1::IFNLR1	Adenocarcinoma
LUZP1::NEDD4L	Transitional cell carcinoma
LUZP1::SORL1	Astrocytoma, grade I-II
LY6D::TSNARE1	Adenocarcinoma
LY6E::LY6D	Squamous cell carcinoma
LY6E::PLEKHB2	Malignant melanoma
LY6G5B::MICB	Adenocarcinoma
LY6G5C::ABHD16A	Skin | Acute myeloid leukemia, NOS
LY75::CCDC148	Adenocarcinoma
LYAR::CORO1B	Adenocarcinoma
LYAR::CTBP1	Adenocarcinoma
LYAR::LUC7L	Malignant melanoma
LYL1::TRB	Acute lymphoblastic leukemia/lymphoblastic lymphoma
LYN::NTRK3	Squamous cell carcinoma
LYN::PLAG1	Acute myeloid leukemia, NOS | Skin
LYN::TGS1	Oligodendroglioma | Multiple myeloma | Astrocytoma, grade I-II | Squamous cell carcinoma
LYN::VPS13B	Adenocarcinoma
LYPD1::NCKAP5	Squamous cell carcinoma
LYPD3::CCT5	Squamous cell carcinoma
LYPD6::EPC2	Adenocarcinoma
LYPD6::LY75	Adenocarcinoma
LYPD6B::LRBA	Adenocarcinoma
LYPD6B::MBD5	Squamous cell carcinoma
LYPLA1::ANO3	Transitional cell carcinoma
LYPLA1::TPD52	Adenocarcinoma
LYRM4::EYS	Adenocarcinoma
LYRM4::FARS2	Squamous cell carcinoma
LYRM4::HOXD13	Adenocarcinoma
LYRM4::PHACTR1	Malignant melanoma
LYRM9::HAP1	Adenocarcinoma
LYRM9::NSRP1	Adenocarcinoma
LYSMD1::MFSD4A	Adenocarcinoma
LYSMD2::MYO5A	Adenocarcinoma
LYSMD2::SCG3	Squamous cell carcinoma
LYSMD2::SLC24A5	Adenocarcinoma
LYST::DISC1	Squamous cell carcinoma
LYST::NARS2	Astrocytoma, grade I-II
LYST::NID1	Squamous cell carcinoma | Malignant melanoma | Adenocarcinoma
LYST::SLC3A2	Malignant melanoma
LYZ::ANXA1	Acute myeloid leukemia, NOS | Skin
LYZ::BIRC6	Squamous cell carcinoma
LYZ::CLDN18	Adenocarcinoma
LYZ::DDX21	Adenocarcinoma
LYZ::IRAK1	Skin | Acute myeloid leukemia, NOS
LYZ::NDUFV1	Adenocarcinoma
LYZ::SMG1	Acute myeloid leukemia, NOS | Skin
LYZ::STAT6	Acute myeloid leukemia, NOS | Skin
LYZ::STK10	Acute myeloid leukemia, NOS | Skin
LYZ::SUPT16H	Adenocarcinoma
LYZ::TYK2	Acute myeloid leukemia, NOS | Skin
MACF1::AKIRIN1	Adenocarcinoma | Squamous cell carcinoma
MACF1::ALB	Adenocarcinoma
MACF1::BRAF	Adenocarcinoma
MACF1::CCDC146	Adenocarcinoma
MACF1::CMTM4	Adenocarcinoma
MACF1::FAF1	Adenocarcinoma
MACF1::FOXJ3	Adenocarcinoma
MACF1::GRIK3	Adenocarcinoma
MACF1::HDAC5	Adenocarcinoma
MACF1::INPP5B	Squamous cell carcinoma
MACF1::LATS2	Adenocarcinoma
MACF1::LSAMP	Adenocarcinoma
MACF1::NIBAN1	Adenocarcinoma
MACF1::OR6C4	Adenocarcinoma
MACF1::PATJ	Adenocarcinoma
MACF1::PTPRU	Adenocarcinoma
MACF1::RHBDL2	Squamous cell carcinoma
MACF1::SHISA6	Mesenchymal tumor, NOS
MACROD1::BAD	Malignant melanoma | Squamous cell carcinoma | Adenocarcinoma
MACROD1::NRXN2	Transitional cell carcinoma
MACROD1::PARP1	Malignant melanoma
MACROD1::PDE2A	Adenocarcinoma
MACROD1::PITPNM1	Adenocarcinoma
MACROD1::PLAAT3	Adenocarcinoma
MACROD1::PPIB	Malignant epithelial tumor, special type
MACROD1::TBC1D22A	Adenocarcinoma
MACROD1::TCN1	Squamous cell carcinoma
MACROD1::TRPT1	Adenocarcinoma
MACROD2::AOPEP	Adenocarcinoma
MACROD2::DCLK2	Adenocarcinoma
MACROD2::DGAT2	Adenocarcinoma
MACROD2::FLRT3	Adenocarcinoma
MACROD2::KIF16B	Adenocarcinoma
MACROD2::MPHOSPH8	Squamous cell carcinoma
MACROD2::SPTLC3	Malignant melanoma | Embryonal nervous system tumor, special type
MACROD2::TASP1	Adenocarcinoma
MACROD2::UBOX5	Squamous cell carcinoma
MACROH2A1::CNOT6	Adenocarcinoma
MACROH2A1::HMHB1	Endometrial stromal sarcoma
MACROH2A1::MECOM	Acute myelomonocytic leukemia (FAB type M4)
MACROH2A2::SRGN	Adenocarcinoma
MAD1L1::BRAF	Melanocytic neoplasm, special type | Adenocarcinoma
MAD1L1::CARD11	Adenocarcinoma
MAD1L1::RPA3	Mesenchymal tumor, NOS
MAD1L1::SERGEF	Squamous cell carcinoma
MADD::ASIP	Adenocarcinoma
MADD::DDB2	Squamous cell carcinoma
MADD::PIK3C2A	Transitional cell carcinoma
MADD::POU2AF1	Adenocarcinoma
MAEA::CTBP1	Mature B-cell neoplasm, NOS | Acute myeloid leukemia, NOS | Skin | Multiple myeloma | Adenocarcinoma
MAEA::TMEM71	Adenocarcinoma
MAF1::TMEM205	Adenocarcinoma
MAF::IGFBP7	Adenocarcinoma
MAFF::OSBP2	Mesenchymal tumor, NOS
MAFF::RCOR1	Adenocarcinoma
MAFF::STK16	Adenocarcinoma
MAFK::ACTB	Multiple myeloma
MAFK::KCTD5	Adenocarcinoma
MAFK::PDGFA	Multiple myeloma
MAGED1::CYP4F2	Squamous cell carcinoma
MAGED2::MPHOSPH8	Adenocarcinoma
MAGED2::NDUFV1	Adenocarcinoma
MAGED2::SCAMP4	Adenocarcinoma
MAGED2::ZFAT	Adenocarcinoma
MAGI1::DPH3	Squamous cell carcinoma
MAGI1::LRIG1	Adenocarcinoma
MAGI1::MITF	Benign epithelial tumor, special type
MAGI1::PARD6G	Adenocarcinoma
MAGI1::SUCLG2	Adenocarcinoma
MAGI1::TBC1D30	Adenocarcinoma
MAGI2::VWC2	Astrocytoma, grade I-II
MAGI3::AKT3	Adenocarcinoma
MAGI3::ATF6	Adenocarcinoma
MAGI3::DENND5A	Adenocarcinoma
MAGI3::NOTCH2	Adenocarcinoma
MAGI3::RAP1A	Adenocarcinoma
MAGI3::SPAG17	Adenocarcinoma
MAGOHB::YBX3	Adenocarcinoma
MAK16::ANGPT2	Adenocarcinoma
MAK::ELOVL2	Adenocarcinoma
MAK::INTS12	Adenocarcinoma
MAL2::ARFGEF1	Adenocarcinoma
MAL2::B2M	Adenocarcinoma
MAL2::CCN3	Adenocarcinoma
MAL2::FER1L6	Adenocarcinoma
MALRD1::CLTC	Osteosarcoma, NOS
MALRD1::DTD2	Astrocytoma, grade I-II
MALRD1::GPR158	Adenocarcinoma
MALRD1::PIP4K2A	Astrocytoma, grade I-II
MALRD1::RET	Carcinoma, NOS
MALSU1::GPNMB	Malignant melanoma
MALT1::MAP4	Diffuse large B-cell lymphoma
MALT1::NOL4	Squamous cell carcinoma
MALT1::SLC26A4	Adenocarcinoma
MAMDC2::MRPS28	Squamous cell carcinoma
MAMDC2::TPD52	Squamous cell carcinoma
MAML1::BCOR	Malignant soft tissue tumor, NOS
MAML2::ANKMY2	Astrocytoma, grade I-II
MAML2::ATG13	Astrocytoma, grade I-II
MAML2::BCAS4	Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
MAML2::CNTN5	Adenocarcinoma
MAML2::RRAGB	Astrocytoma, NOS
MAML2::YAP1	Benign epithelial tumor, special type | Malignant melanoma | Meningioma
MAML3::CCDC170	Mesenchymal tumor, NOS
MAML3::CCNG2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MAML3::CLGN	Adenocarcinoma
MAML3::FAM171A2	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
MAML3::GPATCH8	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
MAML3::GTSF1	Adenocarcinoma
MAML3::LSG1	Adenocarcinoma
MAML3::MED24	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
MAML3::SCOC	Adenocarcinoma
MAML3::SLC25A39	Malignant epithelial tumor, special type
MAML3::TTBK2	Acute myeloid leukemia, NOS | Skin
MAMLD1::BEND2	Neuroglial neoplasm, special type | Astrocytoma, grade III-IV/Glioblastoma
MAMLD1::VGLL3	Soft tissue tumor, special type
MAMSTR::IGF2	Adenocarcinoma
MAMSTR::RASIP1	Adenocarcinoma
MAMSTR::SULT2B1	Adenocarcinoma
MAN1A1::ARHGAP18	Adenocarcinoma
MAN1A1::FMNL3	Mesenchymal tumor, NOS
MAN1A1::IFNGR2	Transitional cell carcinoma
MAN1A1::KDM6A	Multiple myeloma
MAN1A1::LCOR	Adenocarcinoma
MAN1A1::MAGT1	Mesenchymal tumor, NOS
MAN1A1::MCM9	Mesothelioma
MAN1A1::MYB	Adenoid cystic carcinoma
MAN1A1::PDSS2	Adenocarcinoma
MAN1A1::ROS1	Leiomyosarcoma
MAN1A2::ALDOC	Squamous cell carcinoma
MAN1A2::CD101	Adenocarcinoma
MAN1A2::PDE4DIP	Malignant melanoma
MAN1A2::PTGFRN	Adenocarcinoma
MAN1A2::RNF216	Adenocarcinoma
MAN1A2::TTF2	Adenocarcinoma
MAN1A2::VANGL1	Adenocarcinoma
MAN1A2::ZNF697	Malignant melanoma
MAN1C1::CFAP46	Adenocarcinoma
MAN1C1::MACO1	Transitional cell carcinoma
MAN1C1::TMEM50A	Transitional cell carcinoma
MAN2A1::ATAD3C	Adenocarcinoma
MAN2A1::FER	Astrocytoma, grade III-IV/Glioblastoma | Adenocarcinoma
MAN2A1::HSPA4	Transitional cell carcinoma
MAN2A1::HTR4	Mesenchymal tumor, NOS
MAN2A1::TRIM9	Mesenchymal tumor, NOS
MAN2A2::BLM	Adenocarcinoma
MAN2B1::FBXW9	Adenocarcinoma
MAN2B1::RTBDN	Adenocarcinoma | Transitional cell carcinoma
MAN2B2::TACC3	Transitional cell carcinoma
MAN2C1::GAMT	Adenocarcinoma
MAN2C1::MESP2	Adenocarcinoma
MAN2C1::PTPN9	Transitional cell carcinoma
MANBA::LIMCH1	Squamous cell carcinoma
MANBAL::UBR5	Transitional cell carcinoma
MANF::SETD2	Adenocarcinoma
MAP1A::NUP188	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MAP1B::CFAP20DC	Adenocarcinoma
MAP1B::NDFIP1	Malignant epithelial tumor, special type
MAP1B::PTCD2	Squamous cell carcinoma
MAP1B::SLC27A2	Adenocarcinoma
MAP1B::SUPT16H	Squamous cell carcinoma
MAP1LC3A::ASIP	Adenocarcinoma
MAP1S::CEACAM6	Adenocarcinoma
MAP1S::CRTC1	Malignant epithelial tumor, special type
MAP1S::ECH1	Mesothelioma
MAP2::DCAF17	Astrocytoma, grade I-II
MAP2::DEPTOR	Adenocarcinoma
MAP2::ICA1L	Squamous cell carcinoma
MAP2K1::CUX1	Adenocarcinoma
MAP2K1::LCE1C	Squamous cell carcinoma
MAP2K1::TIPIN	Acute myelomonocytic leukemia (FAB type M4)
MAP2K1::UCKL1	Adenocarcinoma
MAP2K2::CAMKK1	Adenocarcinoma
MAP2K2::DAPK3	Adenocarcinoma
MAP2K2::INSR	Adenocarcinoma
MAP2K2::MLLT10	Acute megakaryoblastic leukemia (FAB type M7)
MAP2K2::PSMA1	Adenocarcinoma
MAP2K2::PSMD9	Squamous cell carcinoma
MAP2K2::ZDHHC12	Adenocarcinoma
MAP2K3::NKAIN3	Adenocarcinoma
MAP2K3::SSR3	Squamous cell carcinoma
MAP2K3::UBE2G1	Acute myeloid leukemia, NOS | Skin
MAP2K4::CD79B	Adenocarcinoma
MAP2K4::DNAH9	Adenocarcinoma
MAP2K4::MYH3	Adenocarcinoma
MAP2K4::NIPSNAP1	Adenocarcinoma
MAP2K4::PSMD12	Squamous cell carcinoma
MAP2K5::ADAMTSL3	Adenocarcinoma
MAP2K5::C15ORF61	Transitional cell carcinoma
MAP2K5::C15orf61	Transitional cell carcinoma
MAP2K5::IQCH	Adenocarcinoma
MAP2K5::MYRFL	Mesenchymal tumor, NOS
MAP2K5::RAB27A	Squamous cell carcinoma
MAP2K5::SMAD6	Adenocarcinoma
MAP2K7::PRDM15	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MAP2K7::SH3GL1	Adenocarcinoma
MAP3K10::ALDH16A1	Adenocarcinoma
MAP3K10::C19ORF47	Squamous cell carcinoma
MAP3K10::C19orf47	Squamous cell carcinoma
MAP3K10::PCMTD2	Adenocarcinoma
MAP3K10::SUPT5H	Astrocytoma, grade I-II
MAP3K12::ATF7	Adenocarcinoma
MAP3K12::GDF11	Adenocarcinoma
MAP3K13::C1R	Adenocarcinoma
MAP3K13::CD37	Astrocytoma, grade III-IV/Glioblastoma
MAP3K13::CLPTM1L	Adenocarcinoma
MAP3K13::EHHADH	Adenocarcinoma
MAP3K13::FETUB	Mesenchymal tumor, NOS
MAP3K13::LIPH	Adenocarcinoma
MAP3K13::NSUN2	Adenocarcinoma
MAP3K13::P2RX5	Adenocarcinoma
MAP3K13::UTS2B	Astrocytoma, grade I-II
MAP3K13::VPS8	Adenocarcinoma
MAP3K14::ACBD4	Squamous cell carcinoma
MAP3K14::AIF1	Multiple myeloma
MAP3K14::HDAC5	Malignant melanoma
MAP3K14::NDEL1	Squamous cell carcinoma
MAP3K14::SRP68	Mesenchymal tumor, NOS
MAP3K1::CSNK2A2	Diffuse large B-cell lymphoma
MAP3K1::OR4N2	Transitional cell carcinoma
MAP3K1::PARN	Adenocarcinoma
MAP3K2::IWS1	Adenocarcinoma
MAP3K2::SHANK2	Adenocarcinoma
MAP3K2::SUPT3H	Adenocarcinoma
MAP3K2::TMEM163	Refractory cytopenia with multilineage dysplasia
MAP3K3::BRIP1	Adenocarcinoma
MAP3K3::DBF4B	Adenocarcinoma
MAP3K3::FCHSD2	Squamous cell carcinoma
MAP3K3::TANC2	Astrocytoma, grade I-II
MAP3K3::TNS3	Mesothelioma
MAP3K4::FNDC1	Adenocarcinoma
MAP3K4::FRMD1	Squamous cell carcinoma
MAP3K4::METTL24	Astrocytoma, grade I-II
MAP3K4::PLG	Adenocarcinoma
MAP3K4::SERINC1	Adenocarcinoma
MAP3K4::XAF1	Mesenchymal tumor, NOS
MAP3K5::ARFIP1	Squamous cell carcinoma
MAP3K5::CLVS2	Adenocarcinoma
MAP3K5::MAP7	Adenocarcinoma
MAP3K5::NDUFB9	Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
MAP3K5::NFIB	Adenoid cystic carcinoma
MAP3K5::NKAIN2	Squamous cell carcinoma
MAP3K5::OSTM1	Malignant melanoma
MAP3K5::PERP	Transitional cell carcinoma | Squamous cell carcinoma
MAP3K5::PREP	Malignant melanoma
MAP3K5::TCF12	Adenocarcinoma
MAP3K6::AHDC1	Adenocarcinoma
MAP3K6::KLK3	Adenocarcinoma
MAP3K7::COL12A1	Astrocytoma, grade I-II
MAP3K7::MYB	Mycosis fungoides/Sézary syndrome
MAP3K7::PDGFRB	Adenocarcinoma
MAP3K7CL::ERG	Dermatofibrosarcoma protuberans/Bednar tumor/giant cell fibroblastoma
MAP3K7CL::VAMP7	Adenocarcinoma
MAP3K8::ABLIM1	Melanocytic neoplasm, special type
MAP3K8::AFAP1L2	Mesothelioma
MAP3K8::ANKRD22	Mesothelioma
MAP3K8::ARHGEF18	Mesothelioma
MAP3K8::CCNY	Melanocytic neoplasm, special type
MAP3K8::CDC42EP3	Melanocytic neoplasm, special type
MAP3K8::CUBN	Melanocytic neoplasm, special type
MAP3K8::DIP2C	Melanocytic neoplasm, special type
MAP3K8::FAM117A	Mesothelioma
MAP3K8::LYZL2	Malignant melanoma
MAP3K8::MROH2B	Adenocarcinoma
MAP3K8::MTPAP	Mesothelioma
MAP3K8::PIP4K2A	Melanocytic neoplasm, special type
MAP3K8::PITRM1	Mesothelioma
MAP3K8::SFMBT2	Melanocytic neoplasm, special type
MAP3K8::SLC4A4	Melanocytic neoplasm, special type
MAP3K8::SPAG16	Mesothelioma
MAP3K8::SPECC1	Melanocytic neoplasm, special type
MAP3K8::STX7	Melanocytic neoplasm, special type
MAP3K8::SVIL	Mesothelioma | Melanocytic neoplasm, special type
MAP3K8::TFDP2	Mesothelioma
MAP3K8::UBL3	Melanocytic neoplasm, special type
MAP3K8::VRK2	Mesothelioma
MAP3K9::MED6	Adenocarcinoma
MAP3K9::ROS1	Adenocarcinoma
MAP4::CAMP	Adenocarcinoma
MAP4::CCDC12	Adenocarcinoma
MAP4::CCDC85B	Adenocarcinoma
MAP4::CDC25A	Adenocarcinoma
MAP4::CHD1	Adenocarcinoma
MAP4::DHX30	Adenocarcinoma
MAP4::DNAH12	Adenocarcinoma
MAP4::GTF2H5	Adenocarcinoma
MAP4::HADHA	Adenocarcinoma
MAP4::LRRC43	Adenocarcinoma
MAP4::MON1A	Adenocarcinoma
MAP4::NME6	Transitional cell carcinoma | Germ cell tumor, NOS
MAP4::PLXNB1	Adenocarcinoma
MAP4::QRICH1	Adenocarcinoma
MAP4::RAF1	Osteosarcoma, NOS | Malignant melanoma
MAP4::RBM42	Mesenchymal tumor, NOS
MAP4::RHOA	Adenocarcinoma
MAP4::SHISA5	Adenocarcinoma
MAP4::SPINK8	Adenocarcinoma
MAP4::TENM4	Germ cell tumor, NOS
MAP4::ULK2	Squamous cell carcinoma
MAP4K2::NETO2	Adenocarcinoma
MAP4K3::CDKL4	Adenocarcinoma
MAP4K3::EML4	Squamous cell carcinoma
MAP4K3::HACD4	Adenocarcinoma
MAP4K3::PRKCE	Adenocarcinoma
MAP4K3::SMC6	Adenocarcinoma
MAP4K3::SRGAP2	Adenocarcinoma
MAP4K3::TMEM178A	Adenocarcinoma
MAP4K4::IL1R1	Malignant melanoma
MAP4K4::LYG2	Adenocarcinoma
MAP4K4::MBNL2	Malignant melanoma
MAP4K4::MUCL1	Adenocarcinoma
MAP4K4::REV1	Adenocarcinoma
MAP4K4::SYF2	Adenocarcinoma
MAP4K4::TSSK6	Adenocarcinoma
MAP4K5::ADCK1	Transitional cell carcinoma
MAP4K5::DMAC2L	Squamous cell carcinoma
MAP4K5::L2HGDH	Adenocarcinoma
MAP4K5::NIN	Adenocarcinoma
MAP4K5::PYGL	Adenocarcinoma
MAP4K5::RPEL1	Squamous cell carcinoma
MAP4K5::SAV1	Adenocarcinoma
MAP4K5::SOS2	Adenocarcinoma
MAP7::AHI1	Adenocarcinoma
MAP7::AKAP12	Adenocarcinoma
MAP7::ARG1	Adenocarcinoma
MAP7::CITED2	Adenocarcinoma
MAP7::CNKSR3	Adenocarcinoma
MAP7::ECHDC1	Adenocarcinoma
MAP7::MAP3K5	Malignant epithelial tumor, special type | Adenocarcinoma
MAP7::NFIB	Adenocarcinoma
MAP7::NRG3	Adenocarcinoma
MAP7::OPRM1	Adenocarcinoma
MAP7::POLR2J	Adenocarcinoma
MAP7::TPD52L1	Adenocarcinoma
MAP7::ZBTB20	Adenocarcinoma
MAP7D1::AGO3	Adenocarcinoma
MAP7D2::SH3KBP1	Adenocarcinoma
MAP9::TAT	Astrocytoma, grade I-II
MAPK12::MORN5	Adenocarcinoma
MAPK12::SSTR3	Adenocarcinoma
MAPK14::ANK1	Squamous cell carcinoma
MAPK14::EHMT1	Mesenchymal tumor, NOS
MAPK14::MICU2	Adenocarcinoma
MAPK14::SIN3A	Malignant melanoma
MAPK1::ARHGEF7	Adenocarcinoma
MAPK1::CDKN1A	Mature B-cell neoplasm, NOS
MAPK1::EEF1AKMT3	Astrocytoma, grade III-IV/Glioblastoma
MAPK1::KCNJ4	Adenocarcinoma
MAPK1::NOTCH1	Squamous cell carcinoma
MAPK1::PRODH	Adenocarcinoma
MAPK1::SSU72	Acute myeloid leukemia, NOS | Squamous cell carcinoma | Skin
MAPK1::TOP3B	Adenocarcinoma
MAPK1::YDJC	Adenocarcinoma
MAPK1IP1L::ARF6	Adenocarcinoma
MAPK1IP1L::KRTAP4-1	Adenocarcinoma
MAPK6::SCAMP2	Astrocytoma, grade I-II
MAPK6::TMOD3	Astrocytoma, grade I-II
MAPK6::USO1	Adenocarcinoma
MAPK8::ARFIP1	Squamous cell carcinoma
MAPK8::C10orf53	Adenocarcinoma
MAPK8::KIRREL2	Adenocarcinoma
MAPK8::PARG	Squamous cell carcinoma
MAPK8IP3::HS3ST6	Skin | Acute myeloid leukemia, NOS
MAPK8IP3::JPT2	Adenocarcinoma
MAPK8IP3::TELO2	Adenocarcinoma
MAPK8IP3::TMEM204	Squamous cell carcinoma
MAPK9::DGKB	Adenocarcinoma
MAPK9::UBL7	Adenocarcinoma
MAPK9::ZFP2	Squamous cell carcinoma
MAPKAP1::AP1G2	Transitional cell carcinoma
MAPKAP1::DENND1A	Squamous cell carcinoma
MAPKAP1::PRRC2B	Adenocarcinoma
MAPKAP1::UHRF1	Adenocarcinoma
MAPKAP1::VAV2	Adenocarcinoma
MAPKAPK2::CR1	Adenocarcinoma
MAPKAPK2::IL19	Transitional cell carcinoma
MAPKAPK2::NR1I3	Multiple myeloma
MAPKAPK2::PLA2G2A	Adenocarcinoma
MAPKAPK2::SRGAP2	Squamous cell carcinoma
MAPKAPK3::HEMK1	Adenocarcinoma
MAPKAPK3::S1PR5	Malignant epithelial tumor, special type
MAPKAPK5::ACAD10	Squamous cell carcinoma | Multiple myeloma | Adenocarcinoma | Malignant melanoma | Undifferentiated round cell sarcoma | Chronic lymphocytic leukemia
MAPKAPK5::ALDH2	Adenocarcinoma
MAPKAPK5::CCDC38	Mesenchymal tumor, NOS
MAPKAPK5::GAP43	Adenocarcinoma
MAPKAPK5::GNPTAB	Adenocarcinoma
MAPKAPK5::GRIN2B	Soft tissue tumor, NOS
MAPKAPK5::PTPN11	Adenocarcinoma
MAPKAPK5::SMARCD1	Adenocarcinoma
MAPKAPK5::TRAFD1	Adenocarcinoma
MAPKAPK5::UNC119B	Mesenchymal tumor, NOS
MAPKBP1::EHD4	Mesothelioma
MAPKBP1::EPB42	Mesothelioma
MAPKBP1::RPUSD2	Mesothelioma
MAPKBP1::VPS39	Transitional cell carcinoma
MAPRE1::PLAGL2	Malignant melanoma
MAPRE1::POFUT1	Adenocarcinoma
MAPRE1::TM9SF4	Adenocarcinoma
MAPRE1::TMEM131	Squamous cell carcinoma
MAPRE1::UQCC1	Transitional cell carcinoma
MAPRE1::USP28	Adenocarcinoma
MAPRE3::ALK	Adenocarcinoma
MAPT::MARCHF10	Adenocarcinoma
MAPT::RPL26	Adenocarcinoma
MARCHF1::HSPA5	Multiple myeloma
MARCHF1::PTPN13	Squamous cell carcinoma
MARCHF2::CERS4	Adenocarcinoma
MARCHF2::OR7G2	Adenocarcinoma
MARCHF2::PLVAP	Adenocarcinoma
MARCHF2::TNNT3	Adenocarcinoma
MARCHF3::OPCML	Malignant melanoma
MARCHF3::SRFBP1	Astrocytoma, grade I-II
MARCHF6::IRX4	Squamous cell carcinoma
MARCHF6::MTRR	Adenocarcinoma
MARCHF6::UVRAG	Adenocarcinoma
MARCHF8::DEFB119	Astrocytoma, grade I-II
MARCHF8::MSMB	Squamous cell carcinoma
MARCHF8::PRKG1	Adenocarcinoma
MARCHF9::CD2AP	Astrocytoma, grade III-IV/Glioblastoma
MARCHF9::KCNC2	Transitional cell carcinoma
MARCHF9::OS9	Astrocytoma, grade III-IV/Glioblastoma
MARCHF9::SLCO1B1	Astrocytoma, grade I-II
MARCKSL1::PIK3CD	Primitive neuroectodermal tumor/Medulloblastoma | Russia
MARF1::EEF2K	Transitional cell carcinoma
MARF1::IQCK	Transitional cell carcinoma
MARK1::C1ORF115	Adenocarcinoma
MARK1::RHOU	Malignant melanoma
MARK2::BATF2	Malignant melanoma
MARK2::BPIFA2	Squamous cell carcinoma
MARK2::BUB1B	Squamous cell carcinoma
MARK2::DLAT	Adenocarcinoma
MARK2::FAM168A	Adenocarcinoma
MARK2::GLYATL2	Adenocarcinoma
MARK2::RTN3	Adenocarcinoma
MARK2::SPINDOC	Transitional cell carcinoma | Adenocarcinoma | Squamous cell carcinoma
MARK3::BAG5	Transitional cell carcinoma | Adenocarcinoma
MARK3::BCAS3	Adenocarcinoma
MARK3::CERS6	Adenocarcinoma
MARK3::EIF5	Squamous cell carcinoma
MARK3::ENTPD5	Squamous cell carcinoma
MARK3::FBLN5	Squamous cell carcinoma
MARK3::GLIS3	Adenocarcinoma
MARK3::KIF26A	Adenocarcinoma
MARK3::MIA2	Adenocarcinoma
MARK3::SLC25A21	Adenocarcinoma
MARK3::TDRD9	Squamous cell carcinoma
MARK3::TSGA10IP	Malignant epithelial tumor, special type
MARK4::CLASRP	Adenocarcinoma
MARK4::DPF1	Astrocytoma, grade III-IV/Glioblastoma
MARK4::LYPD5	Adenocarcinoma
MARS1::CTDSP2	Adenocarcinoma
MARS1::GOLT1B	Osteogenic/bone tumor, special type
MARS1::MSRB3	Mesenchymal tumor, NOS
MARS1::NOP2	Transitional cell carcinoma
MARS1::OS9	Astrocytoma, grade I-II
MARVELD2::PIK3R1	Adenocarcinoma
MARVELD2::WDR19	Adenocarcinoma
MASP2::EXOSC10	Adenocarcinoma
MAST1::TNFRSF19	Adenocarcinoma
MAST2::ARMH1	Adenocarcinoma
MAST2::C6ORF52	Adenocarcinoma
MAST2::C6orf52	Adenocarcinoma
MAST2::CARD16	Squamous cell carcinoma
MAST2::CHIT1	Adenocarcinoma
MAST2::CLDN14	Adenocarcinoma
MAST2::COQ6	Adenocarcinoma
MAST2::MMACHC	Adenocarcinoma
MAST2::MMEL1	Adenocarcinoma
MAST2::NASP	Diffuse large B-cell lymphoma | Adenocarcinoma
MAST2::NDC1	Adenocarcinoma
MAST2::OMA1	Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
MAST2::PSMA5	Adenocarcinoma
MAST2::ST3GAL3	Adenocarcinoma
MAST2::TM4SF1	Adenocarcinoma
MAST3::ARRDC2	Adenocarcinoma
MAST3::MAP1S	Adenocarcinoma
MAST3::PDE4C	Adenocarcinoma
MAST4::MRPS27	Adenocarcinoma
MAST4::NLN	Adenocarcinoma
MAST4::PLIN2	Adenocarcinoma
MAST4::PPWD1	Adenocarcinoma
MAST4::ST8SIA4	Transitional cell carcinoma
MAST4::UBE2V2	Astrocytoma, grade I-II
MAT2B::FBXL17	Adenocarcinoma
MAT2B::HMMR	Adenocarcinoma
MAT2B::SFXN1	Adenocarcinoma
MATN2::LAPTM4B	Squamous cell carcinoma | Adenocarcinoma
MATN2::RSPO2	Adenocarcinoma
MATN2::SFMBT1	Transitional cell carcinoma
MATN3::PUM2	Adenocarcinoma
MATR3::CTNNA1	Adenocarcinoma
MATR3::KDM3B	Adenocarcinoma
MATR3::PCDHA13	Adenocarcinoma
MATR3::PCDHA2	Adenocarcinoma
MATR3::PCDHAC1	Adenocarcinoma
MATR3::PCDHAC2	Adenocarcinoma
MATR3::PSD2	Squamous cell carcinoma
MATR3::TFE3	Adenocarcinoma
MAU2::MAP1S	Malignant epithelial tumor, special type
MAX::ACTN1	Mesenchymal tumor, NOS
MAX::RUNX2	Squamous cell carcinoma
MAX::TEX10	Adenocarcinoma
MAZ::NCOA2	Malignant soft tissue tumor, NOS | Soft tissue tumor, special type
MB21D2::CEP19	Astrocytoma, grade I-II
MB21D2::CTLA4	Mesenchymal tumor, NOS
MB21D2::FGF12	Squamous cell carcinoma
MB::TRDN	Adenocarcinoma
MBD1::CFAP53	Nonneoplastic epithelial disorder/lesion
MBD2::AKAIN1	Adenocarcinoma
MBD2::DOCK2	Adenocarcinoma
MBD3::GAK	Adenocarcinoma
MBD3::PALM	Adenocarcinoma
MBD3::ZNF823	Transitional cell carcinoma
MBD4::TMCC1	Squamous cell carcinoma
MBD5::ACOD1	Adenocarcinoma
MBD5::ACVR2A	Squamous cell carcinoma
MBD5::GRM7	Adenocarcinoma
MBIP::RET	Carcinoma, NOS
MBLAC1::ANXA6	Acute myeloblastic leukemia with maturation (FAB type M2)
MBNL1::ABL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MBNL1::ANXA3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MBNL1::BCL6	Follicular lymphoma
MBNL1::BRAF	Astrocytoma, NOS
MBNL1::DCUN1D1	Squamous cell carcinoma
MBNL1::DZIP1L	Adenocarcinoma
MBNL1::HIPK3	Undifferentiated carcinoma, small cell
MBNL1::LMO2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MBNL1::LSG1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MBNL1::MEIS2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MBNL1::NAALADL2	Adenocarcinoma
MBNL1::NMNAT3	Adenocarcinoma
MBNL1::PAX5	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MBNL1::SERP1	Malignant melanoma
MBNL1::SGSM3	Adenocarcinoma
MBNL1::SLC41A3	Mature B-cell neoplasm, NOS
MBNL1::TAL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MBNL2::GLI3	Squamous cell carcinoma
MBNL2::HS6ST3	Adenocarcinoma
MBNL2::MADD	Mesenchymal tumor, NOS
MBNL2::PLAC8	Transitional cell carcinoma
MBOAT1::C1ORF210	Adenocarcinoma
MBOAT1::DCDC2	Transitional cell carcinoma
MBOAT1::F13A1	Malignant melanoma
MBOAT1::FYN	Adenocarcinoma
MBOAT1::HBS1L	Adenocarcinoma
MBOAT1::TPMT	Adenocarcinoma
MBOAT2::ADI1	Adenocarcinoma
MBOAT2::ARHGAP25	Adenocarcinoma
MBOAT2::BRAT1	Adenocarcinoma
MBOAT2::IGSF1	Adenocarcinoma
MBOAT2::PRKCE	Adenocarcinoma
MBOAT2::TPCN2	Transitional cell carcinoma
MBOAT2::YWHAE	Adenocarcinoma
MBOAT7::LILRB5	Adenocarcinoma
MBOAT7::TARM1	Squamous cell carcinoma
MBP::AEBP2	Squamous cell carcinoma
MBP::ARFGEF2	Astrocytoma, grade I-II
MBP::CBLN2	Adenocarcinoma
MBP::MYO1D	Astrocytoma, grade I-II
MBP::SLC1A3	Astrocytoma, grade I-II
MBP::TGIF1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MBTD1::EFCAB3	Adenocarcinoma
MBTD1::EZHIP	Endometrial stromal sarcoma
MBTD1::MYO7A	Adenocarcinoma
MBTD1::PHB1	Adenocarcinoma
MBTD1::PHF1	Endometrial stromal sarcoma
MBTD1::SRCIN1	Transitional cell carcinoma
MBTD1::SYBU	Adenocarcinoma
MBTD1::THRA	Adenocarcinoma
MBTD1::UTP18	Adenocarcinoma
MBTD1::ZMYND11	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
MBTPS1::CDH5	Adenocarcinoma
MBTPS1::SERF2	Adenocarcinoma
MBTPS1::SLC38A8	Adenocarcinoma
MBTPS1::TAF1C	Adenocarcinoma
MBTPS2::CNKSR2	Adenocarcinoma
MBTPS2::EDEM2	Adenocarcinoma
MBTPS2::YY2	Adenocarcinoma
MCAT::GTSE1	Malignant melanoma
MCC::ATG10	Adenocarcinoma
MCC::BRAF	Soft tissue tumor, special type
MCC::DBN1	Adenocarcinoma
MCC::PSMD6	Adenocarcinoma
MCC::PXK	Adenocarcinoma
MCC::SLC9A9	Adenocarcinoma
MCCC1::ADAMTSL3	Squamous cell carcinoma
MCCC1::FXR1	Squamous cell carcinoma
MCCC1::KLHL6	Adenocarcinoma
MCCC1::LAMP3	Adenocarcinoma
MCCC1::MCF2L2	Adenocarcinoma
MCCC1::MED10	Adenocarcinoma
MCCC2::NNT	Malignant melanoma
MCEE::ANXA4	Adenocarcinoma
MCF2L2::DMRT1	Malignant melanoma
MCF2L::ATP11A	Mesenchymal tumor, NOS
MCF2L::F10	Squamous cell carcinoma
MCF2L::GAS6	Adenocarcinoma
MCF2L::GRK1	Adenocarcinoma
MCF2L::LAMA5	Adenocarcinoma
MCF2L::STK24	Transitional cell carcinoma
MCFD2::SRBD1	Adenocarcinoma
MCFD2::TTC7A	Malignant epithelial tumor, special type
MCL1::AR	Adenocarcinoma
MCL1::ARNT	Adenocarcinoma
MCL1::CTSS	Adenocarcinoma
MCL1::IGK	Multiple myeloma
MCM10::OPTN	Adenocarcinoma
MCM3::ADGRF1	Transitional cell carcinoma
MCM3::PKHD1	Squamous cell carcinoma
MCM3AP::APP	Adenocarcinoma
MCM5::HMOX1	Malignant epithelial tumor, special type | Adenocarcinoma
MCM5::LYN	Adenocarcinoma
MCM5::RALGAPB	Adenocarcinoma
MCM5::TOM1	Adenocarcinoma
MCM6::DARS1	Adenocarcinoma
MCM6::RAB3GAP1	Squamous cell carcinoma
MCM7::TSC22D4	Adenocarcinoma
MCM9::FAM184A	Adenocarcinoma
MCM9::ROS1	Adenocarcinoma
MCMBP::ZNF23	Adenocarcinoma
MCOLN2::CDK1	Adenocarcinoma
MCPH1::AGPAT5	Adenocarcinoma
MCPH1::COLEC10	Adenocarcinoma
MCPH1::CSMD1	Adenocarcinoma
MCRIP2::C16ORF96	Skin | Acute myeloid leukemia, NOS
MCRIP2::CCT5	Adenocarcinoma
MCRIP2::RAB11FIP3	Adenocarcinoma
MCRS1::C1QL4	Adenocarcinoma
MCRS1::SRRM4	Mesenchymal tumor, NOS
MCTP1::CBLB	Adenocarcinoma
MCTP1::TNC	Squamous cell carcinoma
MCTP2::CPEB1	Adenocarcinoma
MCTP2::PARP6	Squamous cell carcinoma
MCTP2::RIMKLB	Malignant epithelial tumor, special type
MCU::CDH23	Adenocarcinoma
MCU::CHCHD1	Adenocarcinoma
MCU::CNNM2	Adenocarcinoma
MCU::NFIX	Adenocarcinoma
MCUB::C4BPA	Adenocarcinoma
MCUR1::S100A10	Adenocarcinoma
MDGA1::PTK7	Astrocytoma, grade III-IV/Glioblastoma
MDGA2::NCOA6	Adenocarcinoma
MDH1::COMMD1	Adenocarcinoma
MDH2::PAWR	Adenocarcinoma
MDH2::STYXL1	Squamous cell carcinoma
MDK::ERBB2	Adenocarcinoma
MDK::ERBB3	Squamous cell carcinoma
MDK::PARP1	Adenocarcinoma
MDK::SEC63	Malignant epithelial tumor, special type
MDM1::ABCC1	Adenocarcinoma
MDM1::FRS2	Transitional cell carcinoma
MDM1::INSR	Mesenchymal tumor, NOS
MDM1::LGR5	Adenocarcinoma
MDM1::NAV3	Mesenchymal tumor, NOS
MDM1::PDZRN4	Mesenchymal tumor, NOS
MDM1::RBMS2	Mesenchymal tumor, NOS
MDM2::CACNA1C	Astrocytoma, grade III-IV/Glioblastoma
MDM2::DIP2B	Mesenchymal tumor, NOS
MDM2::EGFR	Astrocytoma, grade III-IV/Glioblastoma
MDM2::FGF18	Mesenchymal tumor, NOS
MDM2::MYRFL	Mesenchymal tumor, NOS
MDM2::NUP107	Adenocarcinoma
MDM2::PPM1H	Astrocytoma, grade III-IV/Glioblastoma
MDM2::PTPRR	Mesenchymal tumor, NOS
MDM2::RUNX2	Osteosarcoma, NOS
MDM2::SLAMF9	Mesenchymal tumor, NOS
MDM2::TMEM167A	Adenocarcinoma
MDM2::XPOT	Adenocarcinoma
MDM4::DNMT3B	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
MDN1::BACH2	Adenocarcinoma
MDN1::BEND3	Adenocarcinoma
MDN1::CYB5R4	Astrocytoma, grade I-II
ME1::GABRR2	Squamous cell carcinoma
ME1::PGM3	Squamous cell carcinoma
ME1::SNAP91	Adenocarcinoma | Squamous cell carcinoma
ME1::UBE3D	Adenocarcinoma | Squamous cell carcinoma
ME2::DCC	Adenocarcinoma
ME2::DPP10	Adenocarcinoma
ME2::IQCE	Refractory anemia with excess blasts-2
ME2::MRO	Squamous cell carcinoma
ME3::SYTL2	Adenocarcinoma
MEA1::LRRC1	Adenocarcinoma
MEA1::THSD4	Adenocarcinoma
MEAF6::PHF1	Endometrial stromal sarcoma | Ossifying fibromyxoid tumor | Mesenchymal tumor, special type
MEAF6::SUZ12	Ossifying fibromyxoid tumor
MEAK7::CYBA	Squamous cell carcinoma
MECOM::ANKRD10	Adenocarcinoma
MECOM::ARMC8	Squamous cell carcinoma
MECOM::CD86	Mesenchymal tumor, NOS
MECOM::CDK6	Acute myeloid leukemia, NOS | Skin
MECOM::CLDN11	Adenocarcinoma
MECOM::FRMD5	Adenocarcinoma
MECOM::GOLIM4	Malignant melanoma
MECOM::LMAN2L	Adenocarcinoma
MECOM::LRRC31	Adenocarcinoma
MECOM::LRRC34	Adenocarcinoma
MECOM::NCEH1	Malignant epithelial tumor, special type
MECOM::RPN1	Skin | Acute myeloid leukemia, NOS
MECOM::SLC7A14	Adenocarcinoma
MECP2::F8	Adenocarcinoma
MECP2::TMLHE	Adenocarcinoma
MECR::NAALADL2	Adenocarcinoma
MED10::KIF21A	Adenocarcinoma
MED10::MCCC1	Adenocarcinoma
MED12::HOXA9	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MED12::PRDM10	Fibroblastic/myofibroblastic tumor, special type
MED12::RPL14	Adenocarcinoma
MED12L::GOLIM4	Squamous cell carcinoma
MED12L::PABPC1L	Transitional cell carcinoma
MED13::ABCA9	Adenocarcinoma
MED13::BAHCC1	Squamous cell carcinoma
MED13::BCAS3	Adenocarcinoma
MED13::DDX42	Adenocarcinoma
MED13::EPHB2	Astrocytoma, grade III-IV/Glioblastoma
MED13::INTS2	Squamous cell carcinoma
MED13::ITGA3	Adenocarcinoma
MED13::KCNJ2	Adenocarcinoma
MED13::MILR1	Adenocarcinoma
MED13::MYO15B	Adenocarcinoma
MED13::TANC2	Adenocarcinoma
MED13::TEX2	Adenocarcinoma
MED13::TLDC2	Adenocarcinoma
MED13::VMP1	Multiple myeloma | Adenocarcinoma
MED13L::CD4	Adenocarcinoma
MED13L::CDK17	Mesenchymal tumor, NOS
MED13L::COL23A1	Adenocarcinoma
MED13L::COX6A1	Adenocarcinoma
MED13L::DGKH	Adenocarcinoma
MED13L::GTF2IRD1	Adenocarcinoma
MED13L::HRK	Adenocarcinoma
MED13L::IQCD	Squamous cell carcinoma
MED13L::LAG3	Adenocarcinoma
MED13L::METTL9	Malignant melanoma
MED13L::MYBPC1	Astrocytoma, grade I-II
MED13L::PRIM1	Adenocarcinoma
MED13L::PTPRR	Adenocarcinoma
MED13L::RAC2	Adenocarcinoma
MED13L::RNFT2	Adenocarcinoma
MED13L::TAOK3	Transitional cell carcinoma
MED13L::TRAFD1	Adenocarcinoma
MED13L::WSCD2	Transitional cell carcinoma
MED14::HOXA9	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MED14::SRPX	Adenocarcinoma
MED15::AHRR	Malignant melanoma
MED15::ATF1	Malignant melanoma | Melanocytic neoplasm, special type
MED15::BCL2L13	Malignant melanoma
MED15::COMT	Astrocytoma, grade III-IV/Glioblastoma
MED15::FKBP10	Adenocarcinoma
MED15::GNB1L	Transitional cell carcinoma
MED15::GPATCH2L	Adenocarcinoma
MED15::KLHL22	Squamous cell carcinoma
MED15::PI4KA	Squamous cell carcinoma
MED15::TANGO2	Transitional cell carcinoma
MED15::TFE3	Adenocarcinoma
MED16::CCND1	Multiple myeloma
MED16::KLF2	Multiple myeloma
MED16::MEX3D	Transitional cell carcinoma
MED16::PALM	Astrocytoma, grade I-II
MED16::POLR2E	Adenocarcinoma
MED16::R3HDM4	Adenocarcinoma
MED17::LMO1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MED1::ABCC3	Adenocarcinoma
MED1::ACSF2	Adenocarcinoma
MED1::ANKFN1	Adenocarcinoma
MED1::ARHGAP23	Adenocarcinoma
MED1::CAP2	Adenocarcinoma
MED1::CCL2	Adenocarcinoma
MED1::CDK12	Adenocarcinoma
MED1::CIMAP1D	Adenocarcinoma
MED1::CLPB	Adenocarcinoma
MED1::EYS	Adenocarcinoma
MED1::FBXO47	Adenocarcinoma
MED1::GDPD1	Adenocarcinoma
MED1::GRB7	Adenocarcinoma
MED1::GSDMB	Adenocarcinoma
MED1::IKZF3	Adenocarcinoma
MED1::KRT222	Malignant melanoma
MED1::LMNTD1	Adenocarcinoma
MED1::MRPL45	Adenocarcinoma
MED1::NGFR	Adenocarcinoma
MED1::NSF	Adenocarcinoma
MED1::PHOSPHO1	Adenocarcinoma
MED1::PIP4K2B	Adenocarcinoma
MED1::RHBDL3	Adenocarcinoma
MED1::SLC39A11	Squamous cell carcinoma
MED1::STAC2	Adenocarcinoma
MED1::STARD3	Adenocarcinoma
MED1::STXBP4	Adenocarcinoma
MED1::TMPRSS9	Adenocarcinoma
MED20::C6ORF132	Adenocarcinoma
MED20::CCND3	Malignant epithelial tumor, special type
MED20::PGC	Adenocarcinoma
MED20::RNF182	Adenocarcinoma
MED20::TLL2	Squamous cell carcinoma
MED20::TRERF1	Malignant epithelial tumor, special type
MED21::PIP5K1C	Mesenchymal tumor, NOS
MED22::SURF6	Mycosis fungoides/Sézary syndrome | Nonneoplastic epithelial disorder/lesion
MED23::ADAM22	Skin | Acute myeloid leukemia, NOS
MED23::ANO2	Squamous cell carcinoma
MED23::BEND3	Adenocarcinoma
MED23::KLHL32	Adenocarcinoma
MED23::RNF217	Squamous cell carcinoma
MED24::CEP112	Adenocarcinoma
MED24::CEP95	Adenocarcinoma
MED24::CSF3	Adenocarcinoma
MED24::IKZF3	Adenocarcinoma
MED24::KRT40	Adenocarcinoma
MED24::MIEN1	Squamous cell carcinoma
MED24::NR1D1	Adenocarcinoma
MED24::PPP1R1B	Squamous cell carcinoma
MED24::SLC4A1	Adenocarcinoma
MED24::SSH2	Adenocarcinoma
MED24::STAC2	Adenocarcinoma
MED24::TBC1D3K	Adenocarcinoma
MED24::TMED10	Adenocarcinoma
MED24::TNS4	Adenocarcinoma
MED25::AP2A1	Adenocarcinoma
MED25::KASH5	Adenocarcinoma
MED25::MAPK15	Adenocarcinoma
MED25::SIGLEC12	Adenocarcinoma
MED25::ST8SIA6	Malignant melanoma
MED25::TBC1D17	Adenocarcinoma
MED25::TRPM4	Adenocarcinoma
MED26::C19ORF44	Adenocarcinoma
MED26::CERS1	Adenocarcinoma
MED26::FAM32A	Acute erythroleukemia (FAB type M6)
MED26::GADD45GIP1	Miscellaneous hematopoietic/lymphoid neoplasm, special type
MED26::GDF1	Adenocarcinoma
MED26::HSH2D	Adenocarcinoma
MED26::SLC1A6	Adenocarcinoma
MED26::TMEM221	Astrocytoma, grade I-II
MED26::ZNF99	Adenocarcinoma
MED26::ZSCAN18	Adenocarcinoma
MED27::FLRT1	Astrocytoma, grade III-IV/Glioblastoma
MED27::TG	Malignant melanoma
MED29::ADAM18	Squamous cell carcinoma
MED29::MYO1D	Adenocarcinoma
MED29::SAMD4B	Adenocarcinoma
MED31::FBXW10	Malignant melanoma
MED4::DCLK1	Adenocarcinoma
MED4::HTR2A	Astrocytoma, grade III-IV/Glioblastoma
MED6::MAP3K9	Adenocarcinoma
MED8::ELOVL1	Mature B-cell neoplasm, NOS | Adenocarcinoma
MED8::SCMH1	Adenocarcinoma
MED9::NT5M	Adenocarcinoma
MED9::PEMT	Multiple myeloma
MEF2A::GRM1	Chondromyxoid fibroma
MEF2A::LRRC28	Malignant melanoma
MEF2A::NFATC2	Adenocarcinoma
MEF2A::NTRK3	Leiomyosarcoma
MEF2A::NUP107	Malignant melanoma
MEF2A::PLPPR1	Adenocarcinoma
MEF2A::SKIC8	Malignant melanoma
MEF2A::SV2B	Mesenchymal tumor, NOS
MEF2A::USP6	Aneurysmal bone cyst
MEF2C::KMT2A	Acute monoblastic leukemia (FAB type M5)
MEF2C::SS18	Adenocarcinoma
MEF2C::SS18L1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MEF2D::ADAMTS4	Adenocarcinoma
MEF2D::APOA2	Adenocarcinoma
MEF2D::ARID1B	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MEF2D::BCL9	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MEF2D::CD55	Mesenchymal tumor, NOS
MEF2D::CSF1R	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MEF2D::DAZAP1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MEF2D::FOXJ2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MEF2D::HNRNPH1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MEF2D::HNRNPM	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MEF2D::HNRNPUL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MEF2D::IGK	Multiple myeloma
MEF2D::INSRR	Adenocarcinoma
MEF2D::NCOA2	Leiomyoma
MEF2D::NTRK1	Embryonal rhabdomyosarcoma | Glioma, NOS
MEF2D::SORL1	Astrocytoma, grade I-II
MEF2D::SS18	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MEF2D::STAT6	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MEF2D::ZDHHC5	Astrocytoma, grade III-IV/Glioblastoma
MEGF11::RPL4	Astrocytoma, grade I-II
MEGF6::WRAP73	Adenocarcinoma
MEGF8::ITPKC	Mesenchymal tumor, NOS
MEGF8::PRR19	Adenocarcinoma
MEGF9::PSMD5	Transitional cell carcinoma
MEGF9::TTLL5	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
MEI1::MRTFA	Malignant melanoma
MEI1::SYTL5	Multiple myeloma
MEIS1::ARHGAP25	Malignant melanoma
MEIS1::NCOA1	Mesenchymal tumor, special type
MEIS1::NCOA2	Mesenchymal tumor, special type | Spindle cell/sclerosing rhabdomyosarcoma
MEIS2::BBS2	Mesenchymal tumor, NOS
MEIS2::MYO5A	Adenocarcinoma
MEIS2::SGCG	Skin | Acute myeloid leukemia, NOS
MEIS2::TRPM1	Adenocarcinoma
MEIS2::ZNF143	Astrocytoma, grade III-IV/Glioblastoma
MEIS3::YJU2	Adenocarcinoma
MELK::CNTFR	Transitional cell carcinoma
MELK::DCTN3	Transitional cell carcinoma
MELK::MS4A12	Squamous cell carcinoma
MELK::RGP1	Adenocarcinoma
MELK::SIK3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MELK::TMEM88	Adenocarcinoma
MELTF::DERL2	Squamous cell carcinoma
MELTF::FYTTD1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MELTF::IGSF11	Transitional cell carcinoma
MELTF::TNK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MEMO1::DPY30	Adenocarcinoma
MEMO1::IMMT	Adenocarcinoma
MEMO1::MCU	Adenocarcinoma
MEN1::CDC42BPG	Adenocarcinoma
MEN1::PTPRJ	Squamous cell carcinoma
MEP1A::BAG6	Adenocarcinoma
MESD::CASK	Diffuse large B-cell lymphoma
MESD::TMPRSS2	Adenocarcinoma
MEST::CKS1B	Adenocarcinoma
MEST::STRIP2	Adenocarcinoma
MET::ATXN7L1	Adenocarcinoma
MET::C8ORF34	Adenocarcinoma
MET::C8orf34	Adenocarcinoma
MET::CAV1	Adenocarcinoma
MET::CNTNAP5	Adenocarcinoma
MET::DYNC1I1	Adenocarcinoma
MET::TFG	Adenocarcinoma
MET::TM4SF4	Squamous cell carcinoma
MET::UBE2H	Adenocarcinoma
MET::WNT2	Adenocarcinoma
METAP1::EIF4E	Adenocarcinoma
METAP1D::HAT1	Squamous cell carcinoma | Adenocarcinoma
METAP2::VEZT	Adenocarcinoma
METRNL::DYNLL2	Transitional cell carcinoma
METRNL::PPP1R1B	Adenocarcinoma
METRNL::SKI	Acute lymphoblastic leukemia/lymphoblastic lymphoma
METTL13::DNM3	Meningioma
METTL13::EIF4G3	Adenocarcinoma
METTL15::SLC1A3	Adenocarcinoma
METTL16::CLEC10A	Mesenchymal tumor, NOS
METTL16::DHX8	Squamous cell carcinoma
METTL16::FXR2	Mesenchymal tumor, NOS
METTL16::KDM6B	Adenocarcinoma
METTL16::RFLNB	Squamous cell carcinoma
METTL16::RTN4RL1	Adenocarcinoma
METTL16::VPS53	Transitional cell carcinoma
METTL1::NELL2	Astrocytoma, grade III-IV/Glioblastoma
METTL21A::PLEKHM3	Adenocarcinoma
METTL22::PMM2	Squamous cell carcinoma
METTL23::RNF157	Transitional cell carcinoma
METTL23::SAP30BP	Adenocarcinoma
METTL24::BYSL	Squamous cell carcinoma
METTL24::REPS1	Mesenchymal tumor, NOS
METTL24::SLC22A16	Adenocarcinoma
METTL24::TBPL1	Adenocarcinoma
METTL25::AMDHD1	Atypical lipomatous tumor/atypical lipoma/well-differentiated liposarcoma
METTL25::ATP2B1	Mesenchymal tumor, NOS
METTL25::CPM	Mesenchymal tumor, NOS
METTL25::FGD6	Atypical lipomatous tumor/atypical lipoma/well-differentiated liposarcoma
METTL25::GALNT9	Mesenchymal tumor, NOS
METTL25::GTPBP10	Mesenchymal tumor, NOS
METTL25::PTPRQ	Mesenchymal tumor, NOS
METTL25B::ARNT	Adenocarcinoma
METTL25B::CTSS	Adenocarcinoma
METTL25B::NTRK1	Adenocarcinoma
METTL2B::CA10	Adenocarcinoma
METTL3::SALL2	Transitional cell carcinoma
METTL4::STXBP5L	Squamous cell carcinoma
METTL5::MERTK	Malignant melanoma
METTL5::TLK1	Adenocarcinoma
METTL8::RFTN2	Squamous cell carcinoma
MEX3C::ATP9B	Astrocytoma, grade III-IV/Glioblastoma
MEX3D::DCTN6	Adenocarcinoma
MEX3D::LEPROTL1	Adenocarcinoma
MEX3D::TCF3	Adenocarcinoma
MFAP1::STRC	Adenocarcinoma
MFF::COL4A3	Squamous cell carcinoma
MFGE8::IGF1R	Adenocarcinoma
MFGE8::RLBP1	Adenocarcinoma
MFHAS1::NBDY	Adenocarcinoma
MFHAS1::ZFAT	Adenocarcinoma
MFN1::HEG1	Adenocarcinoma
MFN1::KMT2C	Squamous cell carcinoma
MFN2::PLOD1	Adenocarcinoma
MFSD10::ATAD3B	Adenocarcinoma
MFSD11::HELZ	Adenocarcinoma
MFSD11::PRCD	Transitional cell carcinoma
MFSD12::CLASP2	Malignant melanoma
MFSD12::NPEPPS	Malignant melanoma
MFSD12::RPL36	Adenocarcinoma
MFSD13A::GBF1	Adenocarcinoma
MFSD14A::PALMD	Squamous cell carcinoma
MFSD14B::PTPDC1	Adenocarcinoma
MFSD1::CLDN11	Mesenchymal tumor, NOS
MFSD1::GFM1	Adenocarcinoma
MFSD1::SPTSSB	Mesenchymal tumor, NOS
MFSD2A::LAPTM5	Astrocytoma, grade I-II
MFSD2A::SLC5A9	Squamous cell carcinoma
MFSD6::C2ORF88	Adenocarcinoma
MFSD6::C2orf88	Adenocarcinoma
MFSD6::CALCRL	Astrocytoma, grade III-IV/Glioblastoma
MFSD6::CXorf66	Adenocarcinoma
MFSD6::GLS	Adenocarcinoma
MFSD6::INPP1	Adenocarcinoma
MFSD6::PMS1	Adenocarcinoma
MFSD8::HIPK2	Adenocarcinoma
MFSD8::TXK	Acute myeloblastic leukemia with maturation (FAB type M2)
MGA::ANKLE1	Adenocarcinoma
MGA::CDKN2A	Transitional cell carcinoma
MGA::CFAP251	Mesothelioma
MGA::NUSAP1	Adenocarcinoma
MGA::NUTM1	Soft tissue tumor, special type | Undifferentiated round cell sarcoma | Malignant soft tissue tumor, NOS | Mesenchymal tumor, special type | Malignant epithelial tumor, special type
MGA::PBX4	Adenocarcinoma
MGA::PLA2G4D	Mesothelioma
MGA::RTF1	Adenocarcinoma
MGA::SCD	Adenocarcinoma
MGA::SPTBN5	Squamous cell carcinoma
MGA::ZFAND6	Adenocarcinoma
MGAM2::IFT56	Malignant melanoma
MGAT1::FLT4	Astrocytoma, grade III-IV/Glioblastoma
MGAT3::SYNGR1	Squamous cell carcinoma
MGAT3::WWC1	Adenocarcinoma
MGAT4A::CRACDL	Adenocarcinoma
MGAT4A::CXCR4	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MGAT4A::FAM178B	Adenocarcinoma
MGAT4B::ETF1	Malignant melanoma
MGAT4B::MRNIP	Adenocarcinoma
MGAT4B::RNF130	Mesenchymal tumor, NOS
MGAT4C::PLD1	Squamous cell carcinoma
MGAT4C::PPFIA2	Mesenchymal tumor, NOS
MGAT5::CXCR4	Chronic lymphocytic leukemia
MGAT5::GPR39	Adenocarcinoma | Acute lymphoblastic leukemia/lymphoblastic lymphoma
MGAT5::HNMT	Adenocarcinoma
MGAT5::MBD5	Adenocarcinoma
MGAT5B::CYP11A1	Transitional cell carcinoma
MGAT5B::VMP1	Adenocarcinoma
MGLL::ANAPC13	Adenocarcinoma
MGLL::SLCO2A1	Adenocarcinoma
MGMT::C8ORF34	Primitive neuroectodermal tumor/Medulloblastoma | Russia
MGMT::DOCK1	Adenocarcinoma
MGMT::LGI4	Adenocarcinoma
MGMT::RET	Carcinoma, NOS
MGP::ESR1	Adenocarcinoma
MGP::REPS2	Adenocarcinoma
MGRN1::C16ORF96	Squamous cell carcinoma | Malignant melanoma | Adenocarcinoma
MGRN1::DNAJA3	Adenocarcinoma
MGRN1::MSI2	Adenocarcinoma
MGRN1::RNPS1	Malignant epithelial tumor, special type
MGRN1::SNX29	Squamous cell carcinoma
MGST1::ADTRP	Adenocarcinoma
MGST1::COL27A1	Mesenchymal tumor, NOS
MGST1::IPO8	Adenocarcinoma
MGST1::SLCO1A2	Adenocarcinoma
MGST2::LRBA	Adenocarcinoma
MGST3::SLAMF7	Adenocarcinoma
MGST3::UCK2	Transitional cell carcinoma
MGST3::ZMAT5	Squamous cell carcinoma
MIA2::GEMIN2	Adenocarcinoma
MIA2::KHDRBS3	Adenocarcinoma
MIA2::MIA2	Squamous cell carcinoma
MIA2::MIPOL1	Adenocarcinoma
MIA2::PNN	Adenocarcinoma
MIA2::PSMA3	Adenocarcinoma
MIB1::ANKRD29	Adenocarcinoma
MIB1::CABYR	Transitional cell carcinoma
MIB1::GREB1L	Adenocarcinoma
MIB1::HLTF	Mesenchymal tumor, NOS
MIB1::MYO5B	Adenocarcinoma
MIB1::SMCHD1	Adenocarcinoma
MIB1::SNRPD1	Adenocarcinoma
MIB2::ACVR1B	Adenocarcinoma
MIB2::PLEKHN1	Adenocarcinoma
MIB2::SMIM13	Adenocarcinoma
MICA::LY6G6C	Adenocarcinoma
MICA::NCR3	Astrocytoma, grade I-II | Mesothelioma
MICA::TMEM232	Adenocarcinoma
MICAL1::AK9	Adenocarcinoma
MICAL2::HS2ST1	Squamous cell carcinoma
MICAL2::NELL1	Mesenchymal tumor, NOS
MICAL2::RRAS2	Transitional cell carcinoma
MICAL3::ATAD1	Adenocarcinoma
MICAL3::CCDC188	Adenocarcinoma
MICAL3::FXYD6	Astrocytoma, grade I-II
MICAL3::PDGFB	Adenocarcinoma
MICAL3::PTGER3	Malignant epithelial tumor, special type
MICAL3::SLC25A18	Adenocarcinoma
MICALL1::DNAL4	Mesenchymal tumor, NOS
MICALL1::EIF3L	Adenocarcinoma | Squamous cell carcinoma
MICALL1::IFT122	Adenocarcinoma
MICALL1::PRLR	Malignant melanoma
MICALL1::SHC1	Adenocarcinoma
MICALL2::CA3	Adenocarcinoma
MICALL2::HDAC9	Malignant melanoma
MICALL2::KLK1	Adenocarcinoma
MICALL2::PSMG3	Squamous cell carcinoma
MICALL2::SDK1	Adenocarcinoma
MICALL2::UCKL1	Adenocarcinoma
MICALL2::ZFAND2A	Adenocarcinoma
MICOS10::DENND2C	Malignant melanoma
MICOS10::GSE1	Adenocarcinoma
MICOS10::RCC2	Adenocarcinoma
MICOS10::SLC66A1	Malignant melanoma
MICU1::ARHGAP22	Adenocarcinoma
MICU1::C10ORF105	Adenocarcinoma
MICU1::DNAJB12	Squamous cell carcinoma | Adenocarcinoma
MICU1::NRG3	Transitional cell carcinoma
MICU1::PLA2G12B	Malignant epithelial tumor, special type
MICU1::TSPAN15	Adenocarcinoma
MICU1::TSPAN3	Adenocarcinoma
MICU2::ATP8A2	Adenocarcinoma
MICU2::CD101	Adenocarcinoma
MICU2::HDHD5	Mesenchymal tumor, NOS
MICU3::TGFBR3	Malignant melanoma
MID1::ARHGAP6	Adenocarcinoma
MID1::DOCK11	Adenocarcinoma
MID1::ILRUN	Malignant melanoma
MID1::PIR	Adenocarcinoma
MID1::S100A2	Adenocarcinoma
MID1::SPAG17	Adenocarcinoma
MIDEAS::ACOT1	Adenocarcinoma
MIDEAS::ALDH6A1	Adenocarcinoma
MIDEAS::ANO1	Squamous cell carcinoma
MIDEAS::ENTPD5	Adenocarcinoma
MIDEAS::FAM161B	Adenocarcinoma
MIDEAS::MRTFA	Adenocarcinoma
MIDEAS::NUBPL	Transitional cell carcinoma
MIDEAS::NUMB	Squamous cell carcinoma
MIDEAS::VSX2	Adenocarcinoma
MIDEAS::ZFYVE1	Squamous cell carcinoma
MIDN::ABCA7	Adenocarcinoma
MIDN::ARHGAP45	Adenocarcinoma
MIDN::ARID3A	Adenocarcinoma
MIDN::C19ORF38	Adenocarcinoma
MIDN::MAP7D1	Adenocarcinoma
MIDN::SBNO2	Adenocarcinoma
MIEF1::TAB1	Adenocarcinoma
MIEF2::ANKRD30A	Adenocarcinoma
MIEF2::RAI1	Adenocarcinoma
MIEN1::BARX2	Adenocarcinoma
MIEN1::ERBB2	Carcinoma, NOS
MIEN1::TEX2	Adenocarcinoma
MIEN1::WIPF2	Adenocarcinoma
MIER1::LEPR	Malignant melanoma
MIER2::CDK5RAP1	Transitional cell carcinoma
MIER2::NMRK2	Adenocarcinoma
MIER2::RPL26	Adenocarcinoma
MIER2::RSRC2	Adenocarcinoma
MIER2::SHC2	Malignant melanoma
MIER3::ABCC12	Adenocarcinoma
MIER3::BRAF	Benign nevus
MIER3::KIF2A	Adenocarcinoma
MIER3::PDE4D	Astrocytoma, grade I-II
MIF4GD::SDK2	Squamous cell carcinoma
MIGA1::IFI44L	Squamous cell carcinoma
MIGA1::PIGU	Adenocarcinoma
MIGA2::BRAF	Histiocytic sarcoma/malignant histiocytosis
MIGA2::NUP188	Adenocarcinoma
MIGA2::P4HB	Malignant epithelial tumor, special type
MIIP::CMYA5	Astrocytoma, grade III-IV/Glioblastoma
MILR1::KCNJ2	Adenocarcinoma
MINDY1::POGZ	Adenocarcinoma
MINDY1::TBKBP1	Astrocytoma, grade I-II
MINDY3::CACNB2	Astrocytoma, grade I-II
MINDY3::CRYGD	Adenocarcinoma
MINDY3::SIL1	Primitive neuroectodermal tumor/Medulloblastoma | Russia
MINDY4::BRAF	Adenocarcinoma
MINDY4::HIBADH	Adenocarcinoma
MINDY4::SUGCT	Adenocarcinoma
MINDY4::ZNRF2	Adenocarcinoma
MINK1::ALOX12	Squamous cell carcinoma
MINK1::NQO2	Adenocarcinoma
MINK1::SPNS2	Adenocarcinoma
MINK1::SPNS3	Adenocarcinoma
MINK1::USO1	Adenocarcinoma
MINPP1::ASXL2	Squamous cell carcinoma
MINPP1::LIPJ	Adenocarcinoma
MINPP1::RET	Carcinoma, NOS
MIOS::ADAP1	Adenocarcinoma
MIOS::GTF2IRD2B	Adenocarcinoma
MIPEP::C1QTNF9B	Adenocarcinoma
MIPEP::GATAD2A	Astrocytoma, grade I-II
MIPEP::MYO16	Adenocarcinoma
MIPEP::POLR1D	Adenocarcinoma
MIPEP::SKIL	Adenocarcinoma
MIPEP::TNFRSF19	Adenocarcinoma
MIPOL1::CASC3	Adenocarcinoma
MIPOL1::DGKB	Adenocarcinoma
MIPOL1::NLGN1	Transitional cell carcinoma
MIPOL1::NPAS3	Adenocarcinoma
MIPOL1::PRORP	Transitional cell carcinoma
MIPOL1::SCFD1	Malignant melanoma
MIPOL1::SFTA3	Adenocarcinoma
MIPOL1::SKIL	Adenocarcinoma
MISP::C2ORF42	Adenocarcinoma
MITF::ARL6IP5	Adenocarcinoma
MITF::CREM	Clear cell sarcoma | Melanocytic neoplasm, special type
MITF::FOXP1	Malignant melanoma
MITF::FRMD4B	Malignant melanoma
MITF::MORC1	Malignant melanoma
MITF::MTERF3	Adenocarcinoma
MITF::PRICKLE2	Malignant melanoma
MITF::PSMD6	Malignant melanoma
MKKS::MMP24	Squamous cell carcinoma
MKLN1::AMTN	Adenocarcinoma
MKLN1::CDK14	Malignant melanoma
MKLN1::DNM3	Mesenchymal tumor, NOS
MKLN1::EXOC4	Adenocarcinoma
MKLN1::GRM8	Malignant melanoma
MKLN1::IMMP2L	Adenocarcinoma
MKLN1::KCNMB1	Malignant melanoma
MKLN1::NRF1	Malignant melanoma
MKNK1::EFCAB14	Adenocarcinoma
MKNK2::AP3D1	Adenocarcinoma
MKNK2::DOT1L	Multiple myeloma
MKNK2::FAM151A	Adenocarcinoma
MKNK2::MOB3A	Squamous cell carcinoma
MKNK2::RNF126	Skin | Acute myeloid leukemia, NOS
MKNK2::ZFR2	Adenocarcinoma
MKRN1::BRAF	Adenocarcinoma | Gastrointestinal stromal tumor | Undifferentiated carcinoma | Squamous cell carcinoma | Astrocytoma, pilocytic/juvenile
MKRN1::DENND2A	Astrocytoma, grade I-II | Transitional cell carcinoma
MKRN1::MRPS33	Adenocarcinoma
MKRN1::NLGN1	Mesenchymal tumor, NOS
MKRN2::C12ORF75	Squamous cell carcinoma
MKRN2::CCDC191	Adenocarcinoma
MKRN2::FOLH1	Adenocarcinoma
MKRN2::PPARG	Transitional cell carcinoma
MKS1::CCR7	Adenocarcinoma
MKS1::KSR1	Adenocarcinoma
MKS1::SPAG9	Adenocarcinoma
MKX::RET	Carcinoma, NOS
MLEC::STX2	Mesenchymal tumor, NOS
MLF1::NPM1	Acute myeloid leukemia, NOS | Skin
MLF1::RSRC1	Transitional cell carcinoma
MLF2::LPCAT3	Adenocarcinoma
MLF2::PTMS	Adenocarcinoma
MLH1::GOLGA4	Adenocarcinoma
MLIP::LRRC1	Adenocarcinoma
MLKL::TMEM231	Squamous cell carcinoma
MLLT10::ASCC1	Adenocarcinoma
MLLT10::BAZ2B	Skin | Acute myeloid leukemia, NOS
MLLT10::BUD13	Acute myeloid leukemia, NOS | Skin
MLLT10::CAPS2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MLLT10::CEP164	Acute monoblastic leukemia (FAB type M5)
MLLT10::CLP1	Acute monoblastic leukemia (FAB type M5)
MLLT10::CNTNAP3B	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MLLT10::DDX3X	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MLLT10::DNAJC1	Acute monoblastic leukemia without differentiation (FAB type M5a)
MLLT10::DSCAML1	Skin | Acute myeloid leukemia, NOS
MLLT10::EED	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MLLT10::FAM171A1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MLLT10::FDX1	Acute myelomonocytic leukemia (FAB type M4)
MLLT10::HEATR3	Acute myeloid leukemia, NOS | Skin
MLLT10::KCNJ6	Adenocarcinoma
MLLT10::KMT2A	Acute myelomonocytic leukemia (FAB type M4) | Acute monoblastic leukemia (FAB type M5)
MLLT10::MINPP1	Adenocarcinoma
MLLT10::NAV1	Adenocarcinoma
MLLT10::PICALM	Acute myeloblastic leukemia without maturation (FAB type M1) | Skin | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Egypt | Bilineage or biphenotypic leukemia | Acute myeloid leukemia, NOS | Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
MLLT10::PPP2R1B	Acute monoblastic leukemia (FAB type M5)
MLLT10::RNF169	Acute monoblastic leukemia (FAB type M5)
MLLT10::SCN4B	Acute myeloid leukemia, NOS | Skin
MLLT10::SKIDA1	Adenocarcinoma
MLLT10::SLC16A1	Malignant melanoma
MLLT10::SNTG1	Adenocarcinoma
MLLT10::TENT4B	Acute myeloid leukemia, NOS | Skin
MLLT10::UBE4A	Skin | Acute myeloid leukemia, NOS
MLLT10::WAC	Astrocytoma, grade I-II
MLLT1::CRLF1	Mesenchymal tumor, NOS
MLLT1::MAD1L1	Malignant melanoma
MLLT1::PRLR	Adenocarcinoma
MLLT1::ZNF439	Malignant melanoma
MLLT3::BNC2	Mesenchymal tumor, NOS
MLLT3::CISD3	Adenocarcinoma
MLLT3::DENND4C	Malignant melanoma
MLLT3::IZUMO3	Astrocytoma, grade III-IV/Glioblastoma
MLLT3::PALM2	Astrocytoma, grade I-II
MLLT3::PLGRKT	Squamous cell carcinoma
MLLT3::SLC28A3	Adenocarcinoma
MLLT3::SYT10	Mesothelioma
MLLT3::TYRP1	Astrocytoma, grade I-II
MLLT6::AATF	Adenocarcinoma
MLLT6::ACE	Adenocarcinoma
MLLT6::KIRREL3	Adenocarcinoma
MLLT6::KMT2A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MLLT6::LASP1	Adenocarcinoma
MLLT6::MRPL45	Russia | Primitive neuroectodermal tumor/Medulloblastoma
MLLT6::PLXDC1	Adenocarcinoma
MLLT6::PNMT	Transitional cell carcinoma
MLLT6::PPP1R12A	Astrocytoma, grade I-II
MLLT6::TCAP	Transitional cell carcinoma
MLPH::ALK	Melanocytic neoplasm, special type | Malignant melanoma | Benign fibrous histiocytoma
MLPH::RAMP1	Adenocarcinoma
MLXIP::ANKS1B	Mesenchymal tumor, NOS
MLXIP::ASH2L	Mesenchymal tumor, NOS
MLXIP::TSPAN8	Mesenchymal tumor, NOS
MLYCD::MGRN1	Adenocarcinoma
MMACHC::TTC23L	Adenocarcinoma
MMD::APPBP2	Squamous cell carcinoma
MMD::ERBB2	Carcinoma, NOS
MMD::HDAC5	Adenocarcinoma
MMD::NOL4L	Adenocarcinoma
MMD::PRKCA	Adenocarcinoma
MMP11::GAS2L1	Adenocarcinoma
MMP11::ZNF714	Squamous cell carcinoma
MMP13::SUPT16H	Mesenchymal tumor, NOS
MMP14::CCT5	Mesenchymal tumor, NOS
MMP14::PPM1A	Transitional cell carcinoma
MMP14::RBM23	Adenocarcinoma
MMP15::CDH5	Transitional cell carcinoma
MMP15::DRC7	Adenocarcinoma
MMP16::ZFHX4	Adenocarcinoma
MMP1::DCUN1D5	Squamous cell carcinoma
MMP26::GUCY2F	Adenocarcinoma
MMP28::KCNJ12	Adenocarcinoma
MMP28::KCNJ18	Adenocarcinoma
MMP9::UTRN	Squamous cell carcinoma
MMS19::CRTAC1	Astrocytoma, grade III-IV/Glioblastoma | Adenocarcinoma
MMS19::MICU1	Squamous cell carcinoma
MMS19::NDUFV1	Adenocarcinoma
MMUT::SUPT3H	Adenocarcinoma
MMUT::YJU2B	Adenocarcinoma
MN1::BEND2	Russia | Ependymoma | Primitive neuroectodermal tumor/Medulloblastoma | Neuroglial neoplasm, special type | Glioma, NOS | Soft tissue tumor, special type
MN1::CXXC5	Primitive neuroectodermal tumor/Medulloblastoma | Russia
MN1::ETV6	Refractory anemia with excess blasts-2 | Acute erythroleukemia (FAB type M6) | Acute myeloid leukemia, NOS | Acute myeloblastic leukemia with minimal differentiation (FAB type M0) | Refractory anemia with excess of blasts (FAB) | Skin | Chronic myeloproliferative disorder, NOS | Acute myeloblastic leukemia with maturation (FAB type M2) | Acute myelomonocytic leukemia (FAB type M4)
MN1::FLI1	Acute megakaryoblastic leukemia (FAB type M7)
MN1::GTSE1	Neuroglial neoplasm, special type
MN1::PATZ1	Astrocytoma, grade I-II | Embryonal nervous system tumor, special type | Astrocytoma, grade III-IV/Glioblastoma
MN1::TAF3	Undifferentiated round cell sarcoma | Soft tissue tumor, NOS
MN1::ZNF341	Undifferentiated round cell sarcoma
MNAT1::AP5M1	Squamous cell carcinoma
MNAT1::PCNX4	Adenocarcinoma
MNAT1::RASGEF1B	Adenocarcinoma
MNAT1::SIX1	Adenocarcinoma
MNAT1::SPSB1	Squamous cell carcinoma
MND1::ARFIP1	Adenocarcinoma
MND1::TRIM2	Adenocarcinoma
MNX1::ETV6	Acute promyelocytic leukemia (FAB type M3) | Acute myeloblastic leukemia with minimal differentiation (FAB type M0) | Acute megakaryoblastic leukemia (FAB type M7) | Acute myeloblastic leukemia with maturation (FAB type M2) | Acute myeloid leukemia, NOS | Skin | Acute myeloblastic leukemia without maturation (FAB type M1)
MOB1A::DUSP11	Adenocarcinoma
MOB1A::GRIN2A	Adenocarcinoma
MOB1B::AMBN	Adenocarcinoma
MOB1B::MUC7	Adenocarcinoma
MOB1B::PLPP4	Adenocarcinoma
MOB1B::RUFY3	Transitional cell carcinoma
MOB2::PRR33	Adenocarcinoma
MOB3A::DAND5	Squamous cell carcinoma
MOB3A::PRDM13	Astrocytoma, grade I-II
MOB3A::STK11	Squamous cell carcinoma
MOB3A::VCL	Adenocarcinoma
MOB3B::C9ORF72	Adenocarcinoma
MOB3B::CAAP1	Adenocarcinoma
MOB3B::PTPRD	Astrocytoma, grade I-II
MOB3B::SLC24A2	Astrocytoma, grade I-II
MOB3C::ATPAF1	Adenocarcinoma
MOB3C::EFCAB14	Adenocarcinoma
MOB4::COQ10B	Squamous cell carcinoma
MOCS1::LEMD3	Adenocarcinoma
MOCS3::NIPAL3	Adenocarcinoma
MOK::ANKRD66	Adenocarcinoma
MOK::CINP	Adenocarcinoma
MOK::HSP90AA1	Adenocarcinoma | Transitional cell carcinoma
MOK::MUCL1	Mesenchymal tumor, NOS
MOK::PRND	Squamous cell carcinoma
MON1A::MBTD1	Benign epithelial tumor, special type
MON2::MARS1	Astrocytoma, grade III-IV/Glioblastoma
MON2::PIP4K2C	Adenocarcinoma
MON2::RCC1L	Squamous cell carcinoma
MON2::STAT6	Adenocarcinoma
MON2::USP15	Adenocarcinoma
MORC2::PATZ1	Squamous cell carcinoma
MORC2::TOM1	Adenocarcinoma
MORC3::DOP1B	Transitional cell carcinoma
MORC3::FAM3B	Squamous cell carcinoma
MORC3::IL10RB	Adenocarcinoma
MORC3::PCP4	Transitional cell carcinoma
MORF4L1::B2M	Mycosis fungoides/Sézary syndrome
MORN1::CMPK1	Adenocarcinoma
MOSMO::NRG2	Adenocarcinoma
MOSMO::OTOA	Adenocarcinoma
MOSPD2::ARHGAP6	Mesenchymal tumor, NOS
MOV10::SYCP1	Adenocarcinoma
MOV10::ZNHIT6	Adenocarcinoma
MOV10L1::NAV2	Adenocarcinoma
MPC1::PXT1	Adenocarcinoma
MPC2::DNM3	Mesenchymal tumor, NOS
MPC2::NUDT12	Mesenchymal tumor, NOS
MPDU1::CTDNEP1	Adenocarcinoma
MPDU1::DNAH9	Mesenchymal tumor, NOS
MPDU1::GLP2R	Adenocarcinoma
MPDU1::GUCD1	Transitional cell carcinoma
MPDU1::SPEM1	Mesenchymal tumor, NOS
MPDZ::ITPK1	Adenocarcinoma
MPDZ::LURAP1L	Adenocarcinoma
MPDZ::NFIB	Adenocarcinoma
MPDZ::PLIN2	Adenocarcinoma
MPDZ::ZPBP	Squamous cell carcinoma
MPG::SNRNP25	Adenocarcinoma
MPHOSPH10::ATP6V1B1	Adenocarcinoma
MPHOSPH6::PLXDC2	Malignant melanoma
MPHOSPH8::ATP8A2	Adenocarcinoma
MPHOSPH9::C6ORF89	Astrocytoma, grade III-IV/Glioblastoma
MPHOSPH9::C6orf89	Astrocytoma, grade III-IV/Glioblastoma
MPHOSPH9::CCDC92	Adenocarcinoma
MPHOSPH9::CDC6	Squamous cell carcinoma
MPHOSPH9::CDK2AP1	Squamous cell carcinoma
MPHOSPH9::CRACR2A	Astrocytoma, grade III-IV/Glioblastoma
MPHOSPH9::PTPRR	Adenocarcinoma
MPHOSPH9::VPS37B	Transitional cell carcinoma
MPI::ARIH1	Adenocarcinoma
MPLKIP::H1-5	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MPLKIP::NLRP11	Astrocytoma, grade III-IV/Glioblastoma
MPLKIP::TRA2A	Adenocarcinoma
MPND::RAB8A	Adenocarcinoma
MPND::RABEP1	Adenocarcinoma
MPND::YJU2	Adenocarcinoma
MPND::ZNF585A	Adenocarcinoma
MPO::ANXA1	Acute myeloid leukemia, NOS | Skin
MPO::FAR1	Acute myeloid leukemia, NOS | Skin
MPO::NTNG2	Skin | Acute myeloid leukemia, NOS
MPO::STAT6	Skin | Acute myeloid leukemia, NOS
MPO::TYK2	Skin | Acute myeloid leukemia, NOS
MPO::ZNF296	Acute myeloblastic leukemia without maturation (FAB type M1)
MPP2::PPY	Adenocarcinoma
MPP7::MGMT	Adenocarcinoma
MPP7::PRR4	Adenocarcinoma
MPP7::RNF169	Adenocarcinoma
MPP7::ZEB1	Adenocarcinoma
MPPE1::PIEZO2	Adenocarcinoma
MPPED1::SCFD2	Malignant epithelial tumor, special type
MPPED2::AMOTL1	Astrocytoma, grade I-II
MPRIP::ALK	Adenocarcinoma
MPRIP::COPS3	Adenocarcinoma
MPRIP::ERBB2	Carcinoma, NOS
MPRIP::HOXB13	Malignant epithelial tumor, special type
MPRIP::MED9	Transitional cell carcinoma
MPRIP::NTRK1	Adenocarcinoma | Gastrointestinal stromal tumor
MPRIP::OAZ2	Mesenchymal tumor, NOS
MPRIP::P4HA1	Malignant melanoma
MPRIP::PDGFRB	Myelodysplastic/myeloproliferative disease, NOS | Thymus
MPRIP::RAF1	Malignant melanoma
MPRIP::RET	Adenocarcinoma
MPRIP::SPAG6	Multiple myeloma
MPRIP::SREBF1	Adenocarcinoma
MPRIP::TNFRSF13B	Mesenchymal tumor, NOS
MPRIP::TOM1L2	Transitional cell carcinoma
MPRIP::TP53	Undifferentiated carcinoma, small cell
MPRIP::TRAT1	Malignant melanoma
MPV17L::XPO6	Astrocytoma, grade I-II
MPZL1::ILDR2	Adenocarcinoma
MPZL1::PDE4DIP	Adenocarcinoma
MPZL1::PRKCA	Benign nevus
MPZL1::RCSD1	Transitional cell carcinoma | Adenocarcinoma
MPZL1::TNFSF4	Mesenchymal tumor, NOS
MRAS::NME9	Adenocarcinoma
MRC1::ALOX5	Adenocarcinoma
MRC1::PDGFRB	Miscellaneous hematopoietic/lymphoid neoplasm, special type
MRC2::PHYHIPL	Adenocarcinoma
MRC2::RND2	Astrocytoma, grade III-IV/Glioblastoma
MRC2::VEZF1	Adenocarcinoma
MRC2::VMP1	Squamous cell carcinoma
MRE11::YAP1	Astrocytoma, grade I-II
MREG::ARL4D	Squamous cell carcinoma
MREG::DNAH2	Mesenchymal tumor, NOS
MREG::SMARCAL1	Mesenchymal tumor, NOS
MREG::SPAG17	Mesenchymal tumor, NOS
MRGPRF::KMT2A	Leiomyosarcoma
MRI1::MYO1F	Adenocarcinoma
MRM3::ALOX15B	Adenocarcinoma
MRNIP::APOA2	Adenocarcinoma
MRNIP::RNF130	Adenocarcinoma
MRNIP::SLC36A4	Adenocarcinoma
MROH1::ARMC2	Adenocarcinoma
MROH1::CYC1	Adenocarcinoma
MROH1::DYNLT2B	Squamous cell carcinoma
MROH1::GPAA1	Adenocarcinoma
MROH1::PKMYT1	Adenocarcinoma
MROH1::PPM1E	Adenocarcinoma
MROH1::XRCC5	Adenocarcinoma
MROH1::ZNF623	Adenocarcinoma
MROH1::ZNF707	Adenocarcinoma
MROH2B::MRPS30	Adenocarcinoma
MRPL10::MTPAP	Transitional cell carcinoma
MRPL10::SKAP1	Adenocarcinoma
MRPL11::ST8SIA1	Adenocarcinoma
MRPL12::USP32	Adenocarcinoma
MRPL13::RNF130	Adenocarcinoma
MRPL18::C6orf118	Mesenchymal tumor, NOS
MRPL21::CPT1A	Transitional cell carcinoma
MRPL21::FAM168A	Adenocarcinoma | Squamous cell carcinoma
MRPL21::GDPD4	Malignant melanoma
MRPL21::KDM2A	Adenocarcinoma
MRPL21::LRP5	Adenocarcinoma
MRPL21::MYO1B	Adenocarcinoma
MRPL21::SHANK2	Squamous cell carcinoma
MRPL21::SSH3	Adenocarcinoma
MRPL21::TADA2A	Adenocarcinoma
MRPL24::ARHGEF11	Adenocarcinoma
MRPL24::CCT3	Astrocytoma, grade I-II
MRPL27::EFCAB3	Astrocytoma, grade III-IV/Glioblastoma
MRPL30::CCDC57	Adenocarcinoma
MRPL30::CTSB	Adenocarcinoma
MRPL30::FAM178B	Squamous cell carcinoma
MRPL32::SPMIP7	Adenocarcinoma
MRPL33::HADHB	Adenocarcinoma
MRPL33::RBKS	Adenocarcinoma
MRPL33::SLC4A1AP	Adenocarcinoma
MRPL33::ZNF512	Adenocarcinoma
MRPL35::CTNNA2	Squamous cell carcinoma
MRPL35::DNAH6	Malignant melanoma
MRPL37::ARHGEF10L	Adenocarcinoma
MRPL37::MASP2	Adenocarcinoma
MRPL37::SLC52A1	Adenocarcinoma
MRPL39::SLC35G6	Adenocarcinoma
MRPL40::TMCC3	Adenocarcinoma
MRPL42::POLR3B	Transitional cell carcinoma
MRPL42::ZMIZ1	Adenocarcinoma
MRPL44::ABCG1	Adenocarcinoma
MRPL45::ARHGAP23	Adenocarcinoma
MRPL48::ATG16L2	Transitional cell carcinoma
MRPL48::CHKA	Adenocarcinoma
MRPL48::DTX4	Adenocarcinoma
MRPL48::GDPD5	Squamous cell carcinoma
MRPL48::LRP5	Adenocarcinoma
MRPL48::NARS2	Malignant melanoma
MRPL48::PLEKHB1	Adenocarcinoma
MRPL48::PRSS23	Transitional cell carcinoma
MRPL48::SUGP2	Malignant melanoma
MRPL48::TPCN2	Adenocarcinoma
MRPL49::ARL2	Adenocarcinoma
MRPL49::SLC25A45	Undifferentiated carcinoma, small cell
MRPL50::ERP44	Astrocytoma, grade III-IV/Glioblastoma
MRPL50::PGAP4	Adenocarcinoma
MRPL52::C14ORF93	Malignant melanoma
MRPL52::TSKS	Adenocarcinoma
MRPL52::USP22	Adenocarcinoma
MRPL54::TJP3	Adenocarcinoma
MRPS10::HPR	Adenocarcinoma
MRPS16::CFAP70	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Adenocarcinoma
MRPS17::PSPH	Squamous cell carcinoma
MRPS18A::CDIP1	Adenocarcinoma
MRPS18A::KIF6	Adenocarcinoma
MRPS18C::ENOPH1	Adenocarcinoma
MRPS21::CA14	Adenocarcinoma
MRPS22::SLC9A9	Adenocarcinoma
MRPS23::CUEDC1	Adenocarcinoma
MRPS23::FAM117A	Mesenchymal tumor, NOS
MRPS23::TRIM37	Transitional cell carcinoma
MRPS23::VEZF1	Adenocarcinoma
MRPS27::H2BC15	Adenocarcinoma
MRPS28::ADAMTS16	Squamous cell carcinoma
MRPS28::AZIN1	Adenocarcinoma
MRPS28::H2AC6	Adenocarcinoma
MRPS28::MAMDC2	Squamous cell carcinoma
MRPS28::NKAIN3	Malignant melanoma
MRPS28::POGZ	Adenocarcinoma
MRPS35::ETFRF1	Adenocarcinoma
MRPS35::INTS13	Adenocarcinoma
MRPS35::PPFIBP1	Squamous cell carcinoma | Adenocarcinoma
MRPS35::SMCO2	Adenocarcinoma
MRPS35::ST6GALNAC5	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
MRPS5::NEB	Adenocarcinoma
MRPS5::TACR1	Adenocarcinoma
MRPS6::MYO3A	Squamous cell carcinoma
MRPS7::GGA3	Adenocarcinoma
MRPS7::SLC16A5	Squamous cell carcinoma
MRRF::ECPAS	Squamous cell carcinoma
MRRF::NR4A1	Mesenchymal tumor, NOS
MRRF::TTLL11	Adenocarcinoma
MRS2::C6ORF62	Malignant melanoma
MRS2::C6orf62	Malignant melanoma
MRS2::DCDC2	Transitional cell carcinoma
MRS2::RIPOR2	Adenocarcinoma
MRTFA::APOL4	Adenocarcinoma
MRTFA::ARAP1	Malignant melanoma
MRTFA::ARHGEF28	Adenocarcinoma
MRTFA::CSNK1E	Malignant melanoma
MRTFA::ENTHD1	Adenocarcinoma
MRTFA::INPP5D	Malignant epithelial tumor, special type
MRTFA::MCHR1	Adenocarcinoma
MRTFA::NTNG1	Adenocarcinoma
MRTFA::SCGB1C1	Adenocarcinoma
MRTFA::SCGB1C2	Adenocarcinoma
MRTFA::SDCBP2	Malignant melanoma
MRTFA::SERPIND1	Malignant epithelial tumor, special type
MRTFA::SLC25A17	Adenocarcinoma | Squamous cell carcinoma
MRTFA::SPIDR	Adenocarcinoma
MRTFA::TAFA5	Malignant melanoma
MRTFA::TMEM218	Adenocarcinoma
MRTFA::WFIKKN2	Adenocarcinoma
MRTFB::CACNA1H	Adenocarcinoma
MRTFB::CLEC16A	Adenocarcinoma
MRTFB::FRMD4A	Transitional cell carcinoma
MRTFB::FSTL3	Adenocarcinoma
MRTFB::GID4	Adenocarcinoma
MRTFB::RBFOX1	Adenocarcinoma
MRTFB::SCNN1B	Adenocarcinoma
MRTFB::SHISA9	Adenocarcinoma
MRTFB::SNX29	Adenocarcinoma
MRTFB::ZNF200	Astrocytoma, grade I-II
MS4A7::ATG2A	Adenocarcinoma
MS4A7::C2CD3	Squamous cell carcinoma
MSH2::CCDC57	Squamous cell carcinoma
MSH2::EPCAM	Adenocarcinoma
MSH2::M1AP	Adenocarcinoma
MSH2::SLC3A1	Adenocarcinoma
MSH2::SLCO6A1	Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
MSH2::SPTLC1	Malignant epithelial tumor, special type
MSH2::TMEM247	Adenocarcinoma
MSH2::TTC7A	Adenocarcinoma
MSH3::RASGEF1C	Astrocytoma, grade I-II
MSH4::RABGGTB	Adenocarcinoma
MSH5::BSCL2	Adenocarcinoma
MSH6::ETV6	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MSI1::KRT78	Mesenchymal tumor, NOS
MSI2::AKAP1	Squamous cell carcinoma
MSI2::ARL17B	Squamous cell carcinoma
MSI2::BCAS3	Transitional cell carcinoma
MSI2::BRD7	Transitional cell carcinoma
MSI2::CA10	Adenocarcinoma
MSI2::CCDC178	Adenocarcinoma
MSI2::CHCT1	Adenocarcinoma
MSI2::CISD3	Malignant epithelial tumor, special type
MSI2::DHX40	Adenocarcinoma
MSI2::EFCAB5	Adenocarcinoma
MSI2::EVX1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MSI2::HEATR6	Adenocarcinoma
MSI2::HNF1B	Adenocarcinoma
MSI2::HOXA9	Heart | Chronic myeloid leukemia, t(9;22)
MSI2::ICAM2	Squamous cell carcinoma
MSI2::NPEPPS	Adenocarcinoma
MSI2::PCTP	Adenocarcinoma
MSI2::PPM1E	Adenocarcinoma
MSI2::PRR15L	Adenocarcinoma
MSI2::RAD51C	Adenocarcinoma
MSI2::RNF135	Adenocarcinoma
MSI2::SLC39A11	Adenocarcinoma
MSI2::SMYD3	Adenocarcinoma
MSI2::SYNPO2	Squamous cell carcinoma
MSI2::TEX2	Adenocarcinoma
MSI2::TLK2	Acute myeloblastic leukemia with maturation (FAB type M2)
MSI2::TOB1	Adenocarcinoma
MSI2::TRIM25	Adenocarcinoma
MSI2::UBE3C	Skin | Acute myeloid leukemia, NOS
MSI2::UTP18	Squamous cell carcinoma
MSI2::WIPF2	Adenocarcinoma
MSI2::YPEL2	Transitional cell carcinoma | Adenocarcinoma
MSL1::CDK12	Adenocarcinoma
MSL1::SHANK2	Squamous cell carcinoma
MSL2::CEP70	Adenocarcinoma
MSL2::MECOM	Mesothelioma
MSL2::OPRM1	Squamous cell carcinoma
MSL2::PPP2R3A	Adenocarcinoma
MSL2::STAG1	Adenocarcinoma
MSL2::TBL1XR1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MSL2::UBASH3B	Adenocarcinoma
MSLN::CLCN3	Adenocarcinoma
MSLN::MCRIP2	Adenocarcinoma
MSLN::UVRAG	Mesothelioma
MSMB::ANXA1	Adenocarcinoma
MSMB::KLK3	Adenocarcinoma
MSMB::NCOA4	Adenocarcinoma | Basal cell carcinoma
MSMB::RAB30	Adenocarcinoma
MSMB::SUPT16H	Adenocarcinoma
MSMO1::CPE	Transitional cell carcinoma
MSMO1::DDX60	Adenocarcinoma
MSN::ALK	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma | Anaplastic large cell lymphoma, systemic type
MSN::HTR3D	Squamous cell carcinoma
MSN::NLRC4	Adenocarcinoma
MSN::RLN2	Adenoid cystic carcinoma
MSN::ROS1	Adenocarcinoma
MSRA::AGPAT5	Adenocarcinoma
MSRA::CSGALNACT1	Malignant melanoma
MSRA::DEFB135	Adenocarcinoma
MSRA::ESCO2	Adenocarcinoma
MSRA::SPAG11B	Mesenchymal tumor, NOS
MSRB1::ALB	Adenocarcinoma
MSRB2::MALRD1	Adenocarcinoma
MSRB3::ACTR5	Mesenchymal tumor, NOS
MSRB3::BCL2L14	Squamous cell carcinoma
MSRB3::CNOT2	Mesenchymal tumor, NOS
MSRB3::JAZF1	Astrocytoma, grade I-II
MST1::SRRD	Adenocarcinoma
MST1R::FNDC3B	Adenocarcinoma
MT1G::PRKAR1A	Adenocarcinoma
MT1X::MT1HL1	Squamous cell carcinoma
MTA1::PACS2	Squamous cell carcinoma
MTA2::CDHR5	Adenocarcinoma
MTA2::HNRNPUL2	Transitional cell carcinoma
MTA2::MS4A18	Astrocytoma, grade I-II
MTA2::UBXN1	Squamous cell carcinoma
MTA3::GEMIN6	Astrocytoma, grade I-II
MTAP::CDKN2A	Adenocarcinoma
MTAP::EEF1A2	Squamous cell carcinoma
MTAP::EXOC6B	Adenocarcinoma
MTAP::LINGO2	Transitional cell carcinoma | Mesothelioma
MTAP::MTMR6	Mature B-cell neoplasm, NOS
MTAP::PCDH7	Adenocarcinoma
MTAP::POC1B	Adenocarcinoma
MTAP::PTPRD	Adenocarcinoma
MTAP::RAF1	Undifferentiated sarcoma | Soft tissue tumor, special type
MTAP::SMU1	Mature B-cell neoplasm, NOS
MTARC1::VPS33A	Mesenchymal tumor, NOS
MTARC2::HLX	Adenocarcinoma
MTARC2::RAB3IP	Adenocarcinoma
MTBP::SLC66A1	Adenocarcinoma
MTBP::UBXN2A	Adenocarcinoma
MTCH2::AGBL2	Adenocarcinoma
MTCH2::FHIT	Adenocarcinoma
MTCH2::FNBP4	Vascular and perivascular tumor, NOS | Adenocarcinoma
MTCH2::NDUFS3	Malignant melanoma
MTCH2::RAG2	Adenocarcinoma
MTCH2::TENM4	Undifferentiated carcinoma, small cell
MTCL1::CCT8	Adenocarcinoma
MTCL1::DLGAP1	Adenocarcinoma
MTCL1::LRRC41	Adenocarcinoma
MTCL2::GPI	Adenocarcinoma
MTCL2::MROH8	Adenocarcinoma
MTCL2::RALY	Malignant melanoma
MTCL2::RBL1	Squamous cell carcinoma | Adenocarcinoma
MTCL2::RPS6KA5	Transitional cell carcinoma
MTCL2::SAMHD1	Adenocarcinoma
MTCL3::NPC1L1	Malignant melanoma
MTDH::CALB1	Adenocarcinoma
MTDH::EIF3E	Multiple myeloma
MTDH::MATN2	Squamous cell carcinoma | Adenocarcinoma
MTDH::SNX31	Adenocarcinoma
MTDH::SPIDR	Adenocarcinoma
MTERF1::PHTF2	Squamous cell carcinoma
MTERF1::VOPP1	Astrocytoma, grade III-IV/Glioblastoma
MTERF2::CRY1	Adenocarcinoma
MTERF3::CCDC178	Astrocytoma, grade I-II
MTERF3::FNTA	Transitional cell carcinoma
MTERF3::HSD17B6	Mesenchymal tumor, NOS
MTERF4::SPAG16	Adenocarcinoma
MTF1::PABPC4	Adenocarcinoma
MTF1::SERINC2	Adenocarcinoma
MTF1::SF3A3	Adenocarcinoma | Astrocytoma, grade III-IV/Glioblastoma
MTF2::ARL3	Adenocarcinoma
MTF2::BRDT	Adenocarcinoma
MTF2::CTNND2	Squamous cell carcinoma
MTF2::DIPK1A	Adenocarcinoma
MTF2::FNBP1L	Adenocarcinoma
MTF2::GPSM2	Adenocarcinoma
MTF2::RPL5	Adenocarcinoma
MTFR1::LIG1	Mesenchymal tumor, NOS
MTFR1::PEX2	Adenocarcinoma
MTFR1::YIPF7	Adenocarcinoma
MTG1::ADGRA1	Adenocarcinoma
MTG1::CYP2E1	Soft tissue tumor, special type
MTG1::ZNF511	Adenocarcinoma
MTHFD1::PAPLN	Transitional cell carcinoma
MTHFD1::SYNE2	Undifferentiated carcinoma, small cell
MTHFD1L::IFT81	Mesenchymal tumor, NOS
MTHFD1L::PLEKHG1	Adenocarcinoma
MTHFD1L::RGS17	Adenocarcinoma
MTHFD1L::RNF216	Squamous cell carcinoma
MTHFD1L::THEMIS	Adenocarcinoma
MTHFD1L::ZBTB2	Multiple myeloma
MTHFR::EXOSC10	Adenocarcinoma
MTHFS::ACAN	Adenocarcinoma
MTHFS::BCL2A1	Adenocarcinoma
MTIF2::PLEKHH2	Carcinoma, NOS
MTIF2::PPP3R1	Adenocarcinoma
MTM1::VBP1	Adenocarcinoma
MTMR12::CARD6	Adenocarcinoma
MTMR12::CDH18	Squamous cell carcinoma
MTMR12::CPLANE1	Squamous cell carcinoma
MTMR12::MAEL	Mesenchymal tumor, NOS
MTMR12::SPEF2	Adenocarcinoma
MTMR12::TERT	Adenocarcinoma
MTMR12::ZFR	Adenocarcinoma
MTMR1::FATE1	Adenocarcinoma
MTMR1::HS1BP3	Adenocarcinoma
MTMR2::CEP57	Superficial fibromatosis
MTMR2::CLNS1A	Adenocarcinoma
MTMR2::DPM1	Astrocytoma, grade III-IV/Glioblastoma
MTMR2::MAML2	Astrocytoma, grade I-II
MTMR2::MMP8	Adenocarcinoma
MTMR2::TCP11L1	Adenocarcinoma
MTMR3::CABP7	Adenocarcinoma
MTMR3::CLIP2	Adenocarcinoma
MTMR3::EMID1	Malignant melanoma
MTMR3::GJB1	Adenocarcinoma
MTMR3::HEXIM2	Adenocarcinoma
MTMR3::HORMAD2	Adenocarcinoma
MTMR3::MB	Malignant melanoma
MTMR3::NF2	Adenocarcinoma
MTMR3::RNF215	Squamous cell carcinoma
MTMR3::SCNN1B	Adenocarcinoma
MTMR3::THOC5	Adenocarcinoma
MTMR3::TSHZ2	Adenocarcinoma
MTMR3::YJU2B	Adenocarcinoma
MTMR3::ZNRF3	Adenocarcinoma
MTMR4::INSR	Adenocarcinoma
MTMR6::CDX2	Astrocytoma, grade III-IV/Glioblastoma
MTMR6::DDX21	Adenocarcinoma
MTMR8::ZC4H2	Adenocarcinoma
MTOR::CAMTA1	Astrocytoma, grade III-IV/Glioblastoma
MTOR::CDC42	Adenocarcinoma
MTOR::CHD1	Acute myeloblastic leukemia without maturation (FAB type M1)
MTOR::CR1	Astrocytoma, grade I-II
MTOR::CR1L	Astrocytoma, grade I-II
MTOR::GARNL3	Adenocarcinoma
MTOR::MAD2L2	Malignant epithelial tumor, special type
MTOR::TP53BP1	Carcinoma, NOS | Astrocytoma, grade III-IV/Glioblastoma | Adenocarcinoma
MTPAP::ALKBH3	Adenocarcinoma
MTPAP::CUBN	Adenocarcinoma
MTR::IFI16	Adenocarcinoma
MTRES1::BEND3	Adenocarcinoma
MTRES1::PDSS2	Transitional cell carcinoma
MTREX::BASP1	Adenocarcinoma
MTREX::CCNO	Adenocarcinoma
MTREX::CETN3	Adenocarcinoma
MTREX::CKS1B	Mesothelioma
MTREX::F2R	Adenocarcinoma
MTREX::GPBP1	Mesenchymal tumor, NOS
MTREX::IGF2R	Astrocytoma, grade III-IV/Glioblastoma
MTREX::MACROD2	Mesenchymal tumor, NOS
MTREX::PCDHGA10	Adenocarcinoma
MTREX::PCDHGA11	Adenocarcinoma
MTREX::PCDHGA12	Adenocarcinoma
MTREX::PCDHGA8	Adenocarcinoma
MTREX::PCDHGA9	Adenocarcinoma
MTREX::PCDHGB4	Adenocarcinoma
MTREX::PCDHGB5	Adenocarcinoma
MTREX::PCDHGB6	Adenocarcinoma
MTREX::PCDHGB7	Adenocarcinoma
MTREX::PCDHGC3	Adenocarcinoma
MTREX::PCDHGC4	Adenocarcinoma
MTREX::PCDHGC5	Adenocarcinoma
MTREX::SCCPDH	Adenocarcinoma
MTREX::SIK3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MTREX::SV2C	Adenocarcinoma
MTREX::USP28	Adenocarcinoma
MTRFR::EIF4EBP1	Mesenchymal tumor, NOS
MTRFR::SLC11A2	Squamous cell carcinoma
MTRR::FASTKD3	Malignant melanoma
MTRR::NMD3	Squamous cell carcinoma
MTRR::SLC30A5	Adenocarcinoma
MTSS1::DDX27	Adenocarcinoma
MTSS1::ERBB2	Adenocarcinoma | Transitional cell carcinoma
MTSS1::FBXO32	Squamous cell carcinoma
MTSS1::NSD3	Malignant melanoma
MTSS1::ST3GAL1	Adenocarcinoma
MTSS1::TATDN1	Transitional cell carcinoma
MTSS1::WASHC5	Adenocarcinoma
MTSS1::ZC2HC1A	Adenocarcinoma
MTSS2::VAC14	Squamous cell carcinoma
MTURN::PLEKHA8	Squamous cell carcinoma
MTUS1::ASAH1	Adenocarcinoma
MTUS1::FGL1	Adenocarcinoma
MTUS1::NRG1	Soft tissue tumor, special type
MTUS2::PIBF1	Adenocarcinoma
MTUS2::PTPN14	Adenocarcinoma
MTUS2::SIRT7	Mesenchymal tumor, NOS
MUC12::MUC3A	Adenocarcinoma
MUC13::SIAE	Adenocarcinoma
MUC16::OR7D4	Adenocarcinoma
MUC16::OR7G3	Adenocarcinoma
MUC16::RARA	Adenocarcinoma
MUC16::RNASEH2B	Adenocarcinoma
MUC16::SBNO2	Adenocarcinoma
MUC16::THADA	Adenocarcinoma
MUC16::ZC3H4	Adenocarcinoma
MUC16::ZSWIM4	Adenocarcinoma
MUC1::ENTREP3	Adenocarcinoma
MUC1::GBA1	Adenocarcinoma
MUC1::PKLR	Adenocarcinoma
MUC1::SIAE	Adenocarcinoma
MUC2::CLCN3	Adenocarcinoma
MUC3A::FBXL13	Squamous cell carcinoma
MUC4::PCYT1A	Adenocarcinoma
MUC4::TNK2	Squamous cell carcinoma
MUC5AC::CAPN2	Adenocarcinoma
MUC5AC::IRF8	Adenocarcinoma
MUC5B::SMR3B	Adenocarcinoma
MUC5B::ZNFX1	Adenocarcinoma
MUCL1::CHI3L2	Adenocarcinoma
MUS81::TOP6BL	Adenocarcinoma
MVB12A::MYO9B	Adenocarcinoma
MVB12A::NWD1	Adenocarcinoma
MVB12B::MAMDC2	Malignant melanoma
MVB12B::MED27	Malignant melanoma
MVB12B::TG	Malignant melanoma
MVB12B::TMC1	Adenocarcinoma
MVK::CPM	Mesenchymal tumor, NOS
MVP::KIF22	Adenocarcinoma
MVP::SEZ6L2	Transitional cell carcinoma
MVP::TMEM219	Adenocarcinoma
MVP::ZNF267	Squamous cell carcinoma
MX1::ERG	Squamous cell carcinoma
MX2::FAM3B	Adenocarcinoma
MXD1::ANTXR1	Adenocarcinoma
MXD1::NUTM1	Mesenchymal tumor, special type
MXD4::NUTM1	Undifferentiated round cell sarcoma | Mesenchymal tumor, special type | Undifferentiated sarcoma
MXI1::ADD3	Squamous cell carcinoma
MXI1::KLK3	Adenocarcinoma
MXI1::NUTM1	Mesenchymal tumor, special type | Undifferentiated sarcoma | Malignant epithelial tumor, special type
MXI1::NUTM2B	Undifferentiated carcinoma
MXI1::TMEM254	Adenocarcinoma
MXRA8::CDK11A	Squamous cell carcinoma
MXRA8::CDK11B	Squamous cell carcinoma
MXRA8::DDX27	Transitional cell carcinoma
MXRA8::SUPT16H	Mesenchymal tumor, NOS
MYB::AHI1	Embryonal rhabdomyosarcoma | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Adenocarcinoma
MYB::BDP1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MYB::CA10	Astrocytoma, NOS
MYB::CHMP1A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MYB::ESR1	Neuroglial neoplasm, special type
MYB::GATA1	Acute monoblastic leukemia without differentiation (FAB type M5a) | Acute myeloid leukemia, NOS | Acute monoblastic leukemia (FAB type M5) | Skin | Acute erythroleukemia (FAB type M6) | Acute basophilic leukemia
MYB::MAML2	Astrocytoma, pilocytic/juvenile
MYB::MNX1	Acute myelomonocytic leukemia (FAB type M4)
MYB::MPDZ	Adenoid cystic carcinoma
MYB::NFIB	Adenocarcinoma | Benign epithelial tumor, special type | Adenoid cystic carcinoma
MYB::PAIP1	Dendritic cell neoplasm
MYB::PCDHGA1	Astrocytoma, pilocytic/juvenile
MYB::PDCD1LG2	Adenoid cystic carcinoma
MYB::PEX7	Refractory anemia with excess blasts-2
MYB::PLAGL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MYB::QKI	Astrocytoma, grade I-II | Neuroglial neoplasm, special type
MYB::SMR3B	Adenocarcinoma
MYB::TYK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MYB::UMAD1	Adenocarcinoma
MYBBP1A::ANKFY1	Squamous cell carcinoma
MYBBP1A::CAMTA2	Adenocarcinoma
MYBBP1A::FGF11	Squamous cell carcinoma
MYBBP1A::MYH10	Adenocarcinoma
MYBL1::ACTN1	Adenoid cystic carcinoma
MYBL1::C8ORF34	Adenocarcinoma
MYBL1::MMP16	Astrocytoma, grade III-IV/Glioblastoma | Adenocarcinoma
MYBL1::NFIB	Adenocarcinoma | Adenoid cystic carcinoma
MYBL1::RAD51B	Adenoid cystic carcinoma
MYBL1::YTHDF3	Adenoid cystic carcinoma
MYBL2::IFT52	Adenocarcinoma
MYBL2::TOX2	Transitional cell carcinoma
MYBPC1::NPY	Adenocarcinoma
MYBPC1::PXN	Astrocytoma, grade I-II
MYBPC2::DES	Squamous cell carcinoma
MYC::ARHGEF17	Adenocarcinoma
MYC::BCL7A	Burkitt lymphoma/leukemia
MYC::DMD	Follicular lymphoma
MYC::PDLIM5	Adenocarcinoma
MYC::PLAG1	Adenoma
MYC::SUPT3H	Acute myeloid leukemia, special type
MYC::ZBTB5	Diffuse large B-cell lymphoma
MYC::ZCCHC7	Diffuse large B-cell lymphoma
MYCBP2::CPB2	Transitional cell carcinoma
MYCBP2::IFT122	Multiple myeloma
MYCBP2::OBI1	Adenocarcinoma
MYCBP2::PIBF1	Astrocytoma, grade I-II
MYCBP2::SLC52A3	Adenocarcinoma
MYCBP2::SPPL2A	Adenocarcinoma
MYCBP2::TAF6L	Adenocarcinoma
MYCBP::EHD2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MYCBP::SLC25A33	Mycosis fungoides/Sézary syndrome
MYCN::GULP1	Neuroblastoma
MYDGF::FAM187B	Astrocytoma, grade I-II
MYEOV::PIEZO1	Adenocarcinoma
MYG1::ESPL1	Adenocarcinoma
MYH10::ALK	Mesenchymal tumor, special type
MYH10::CCDC42	Adenocarcinoma
MYH10::CDKN2A	Mesenchymal tumor, NOS
MYH10::NRG1	Undifferentiated carcinoma
MYH10::OLFM4	Mesenchymal tumor, NOS
MYH10::RET	Soft tissue tumor, special type | Fibroblastic/myofibroblastic tumor, special type
MYH10::RHBDD2	Malignant melanoma
MYH10::TEKT3	Mesenchymal tumor, NOS
MYH11::CBFB	Acute myeloblastic leukemia without maturation (FAB type M1) | Acute myelomonocytic leukemia (FAB type M4) | Acute myeloblastic leukemia with maturation (FAB type M2)
MYH11::TYK2	Adenocarcinoma
MYH11::YME1L1	Squamous cell carcinoma
MYH11::ZNF827	Adenocarcinoma
MYH13::RET	Adenocarcinoma
MYH14::FBLN2	Malignant epithelial tumor, special type
MYH14::GPR19	Adenocarcinoma
MYH14::NR1H2	Adenocarcinoma
MYH3::CYP3A5	Adenocarcinoma
MYH6::GOLGA3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MYH9::ALK	Adenocarcinoma | Anaplastic large cell lymphoma, systemic type
MYH9::ANKS1A	Adenocarcinoma
MYH9::BIRC6	Adenocarcinoma
MYH9::C22ORF31	Adenocarcinoma
MYH9::CACNA1C	Acute myeloid leukemia, NOS | Skin
MYH9::CACNG2	Adenocarcinoma
MYH9::CD74	Adenocarcinoma
MYH9::DDX21	Adenocarcinoma
MYH9::DNASE1	Adenocarcinoma
MYH9::EGFR	Mesenchymal tumor, special type
MYH9::EIF3D	Adenocarcinoma
MYH9::EMID1	Adenocarcinoma
MYH9::FOXRED2	Adenocarcinoma
MYH9::HSP90AA1	Adenocarcinoma
MYH9::IL2RB	Acute myeloid leukemia, NOS | Skin | Acute lymphoblastic leukemia/lymphoblastic lymphoma
MYH9::JAK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MYH9::KLK3	Adenocarcinoma
MYH9::LARGE1	Astrocytoma, grade III-IV/Glioblastoma
MYH9::LTK	Soft tissue tumor, NOS
MYH9::LTO1	Adenocarcinoma
MYH9::NDUFV1	Squamous cell carcinoma
MYH9::NFYC	Adenocarcinoma
MYH9::NTRK3	Benign nevus
MYH9::PLA2G6	Adenocarcinoma
MYH9::PLAT	Adenocarcinoma
MYH9::PLCXD3	Skin | Acute myeloid leukemia, NOS
MYH9::PVALB	Adenocarcinoma
MYH9::RBFOX2	Squamous cell carcinoma
MYH9::RET	Carcinoma, NOS
MYH9::ROS1	Adenocarcinoma | Melanocytic neoplasm, special type
MYH9::SORCS1	Adenocarcinoma
MYH9::TRIOBP	Transitional cell carcinoma
MYH9::TXN2	Adenocarcinoma
MYH9::USP6	Nodular fasciitis | Fibroma of tendon sheath | Soft tissue tumor, special type
MYL12A::AKAIN1	Mesenchymal tumor, NOS
MYL12A::LPIN2	Adenocarcinoma
MYL12A::MYOM1	Adenocarcinoma
MYL12A::USP6	Nodular fasciitis
MYL12B::ACAP1	Adenocarcinoma
MYL3::NSUN3	Undifferentiated carcinoma, small cell
MYL6::ABI3BP	Mesenchymal tumor, NOS
MYL6::DGKA	Adenocarcinoma
MYL6::SF3B2	Adenocarcinoma
MYL6::SMARCC2	Adenocarcinoma
MYL6::STAT6	Adenocarcinoma
MYL6::SUPT16H	Squamous cell carcinoma
MYL6::WDR13	Adenocarcinoma
MYL6::ZNF761	Adenocarcinoma
MYL6::ZNFX1	Squamous cell carcinoma
MYL6B::RAB5B	Malignant melanoma
MYL6B::VWA3A	Astrocytoma, grade III-IV/Glioblastoma
MYL9::AAR2	Adenocarcinoma
MYLIP::GMPR	Squamous cell carcinoma
MYLIP::KHDC1L	Adenocarcinoma
MYLIP::OR5V1	Adenocarcinoma
MYLK::BRAF	Undifferentiated pleomorphic sarcoma
MYLK::CCDC14	Adenocarcinoma
MYLK::NXPH1	Adenocarcinoma
MYLK::PARP1	Mesenchymal tumor, NOS
MYLK::PLXND1	Adenocarcinoma
MYLK::SIAE	Adenocarcinoma
MYLK::TM7SF2	Adenocarcinoma
MYLK::TXK	Neuroblastoma
MYLK::USP48	Mesenchymal tumor, NOS
MYLK::VAMP4	Mesenchymal tumor, NOS
MYNN::NLGN1	Squamous cell carcinoma
MYO10::DNAH5	Adenocarcinoma
MYO10::FAM186A	Malignant melanoma
MYO10::GPC5	Adenocarcinoma
MYO10::MARCHF11	Malignant melanoma
MYO10::NOL7	Adenocarcinoma
MYO10::NPR3	Adenocarcinoma
MYO10::PFDN2	Transitional cell carcinoma
MYO10::RETREG1	Malignant melanoma
MYO10::SLC12A7	Malignant melanoma
MYO10::ST6GALNAC3	Adenocarcinoma
MYO10::ZNF622	Adenocarcinoma
MYO15A::TOP3A	Adenocarcinoma
MYO15B::IGSF5	Adenocarcinoma
MYO15B::LLGL2	Astrocytoma, grade I-II
MYO15B::MAP3K3	Adenocarcinoma
MYO15B::NUP85	Squamous cell carcinoma
MYO15B::SAP30BP	Adenocarcinoma
MYO15B::SEPTIN9	Adenocarcinoma
MYO16::IRS2	Russia | Primitive neuroectodermal tumor/Medulloblastoma
MYO18A::ALDOB	Adenocarcinoma
MYO18A::BCAS3	Miscellaneous hematopoietic/lymphoid neoplasm, special type | Benign epithelial tumor, special type
MYO18A::ERBB2	Adenocarcinoma
MYO18A::FGFR1	Chronic myeloproliferative disorder, NOS
MYO18A::FLT3	Atypical chronic myeloid leukemia | Lymph node
MYO18A::IGF2	Adenocarcinoma
MYO18A::JAGN1	Transitional cell carcinoma
MYO18A::KMT2A	Acute myeloblastic leukemia without maturation (FAB type M1)
MYO18A::LRRC37B	Adenocarcinoma
MYO18A::MSI2	Adenocarcinoma
MYO18A::MYO1D	Adenocarcinoma
MYO18A::NF1	Adenocarcinoma
MYO18A::NUFIP2	Adenocarcinoma
MYO18A::PDGFRB	Chronic myeloproliferative disorder, special type | Chronic eosinophilic leukemia/hypereosinophilic syndrome
MYO18A::RARA	Squamous cell carcinoma
MYO18A::RNF135	Transitional cell carcinoma
MYO18A::SERGEF	Adenocarcinoma
MYO18A::SSH2	Adenocarcinoma
MYO18A::ZBTB46	Adenocarcinoma
MYO18B::ABL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
MYO18B::UBE2R2	Astrocytoma, grade III-IV/Glioblastoma
MYO19::CNP	Adenocarcinoma
MYO19::GRB7	Adenocarcinoma
MYO19::SLC11A1	Adenocarcinoma
MYO19::SSH2	Adenocarcinoma
MYO19::STK32C	Squamous cell carcinoma
MYO1B::ABCC4	Adenocarcinoma
MYO1B::GLS	Transitional cell carcinoma
MYO1B::ITGAV	Adenocarcinoma
MYO1B::NCKAP1	Squamous cell carcinoma
MYO1B::SPAG16	Adenocarcinoma
MYO1B::STAT4	Squamous cell carcinoma
MYO1B::ZNF536	Squamous cell carcinoma
MYO1C::SMG6	Squamous cell carcinoma
MYO1C::SMTNL2	Adenocarcinoma
MYO1D::ACACA	Adenocarcinoma
MYO1D::ASIC2	Adenocarcinoma
MYO1D::CLTC	Adenocarcinoma
MYO1D::FCMR	Adenocarcinoma
MYO1D::HNF1B	Adenocarcinoma
MYO1D::MT4	Malignant melanoma
MYO1D::ORMDL3	Adenocarcinoma
MYO1D::PIGS	Adenocarcinoma
MYO1D::PLA2G6	Adenocarcinoma
MYO1D::PLXDC1	Squamous cell carcinoma
MYO1D::SSH2	Adenocarcinoma
MYO1D::TEX2	Adenocarcinoma
MYO1D::TMIGD1	Adenocarcinoma
MYO1E::ADAM10	Malignant melanoma
MYO1E::AOPEP	Adenocarcinoma
MYO1E::BNIP2	Adenocarcinoma
MYO1E::FOXB1	Transitional cell carcinoma
MYO1E::GPR176	Adenocarcinoma
MYO1E::GTF2A2	Adenocarcinoma
MYO1E::TMCO3	Adenocarcinoma
MYO1F::LRSAM1	Adenocarcinoma
MYO3B::TSHZ2	Adenocarcinoma
MYO5A::ATOSA	Malignant melanoma
MYO5A::BRAF	Malignant melanoma
MYO5A::DCBLD2	Malignant melanoma
MYO5A::FER	Glioma, NOS
MYO5A::FGFR1	Astrocytoma, grade I-II
MYO5A::NEDD4	Mesenchymal tumor, NOS
MYO5A::NTRK3	Melanocytic neoplasm, special type | Embryonal nervous system tumor, special type | Malignant melanoma | Benign nevus | Astrocytoma, grade I-II
MYO5A::OIP5	Adenocarcinoma
MYO5A::ROS1	Melanocytic neoplasm, special type
MYO5A::TRPM1	Malignant melanoma
MYO5B::CFAP53	Transitional cell carcinoma
MYO5B::CLUL1	Adenocarcinoma
MYO5B::COX6C	Adenocarcinoma
MYO5B::DCC	Transitional cell carcinoma
MYO5B::DYM	Adenocarcinoma
MYO5B::LPIN2	Adenocarcinoma
MYO5B::MBD1	Squamous cell carcinoma
MYO5C::HAUS8	Adenocarcinoma
MYO5C::ROS1	Adenocarcinoma
MYO6::CADM2	Adenocarcinoma
MYO6::CRYL1	Mesothelioma
MYO6::DEPTOR	Adenocarcinoma
MYO6::IBTK	Adenocarcinoma
MYO6::MSR1	Adenocarcinoma
MYO6::NEGR1	Adenocarcinoma
MYO6::NFIB	Adenoid cystic carcinoma
MYO6::SENP6	Adenocarcinoma
MYO7A::GAB2	Adenocarcinoma
MYO7A::PSMC3	Undifferentiated carcinoma, small cell
MYO7A::ZBTB20	Adenocarcinoma
MYO7A::ZNF512	Malignant epithelial tumor, special type
MYO9A::CELF6	Transitional cell carcinoma
MYO9A::CRAMP1	Adenocarcinoma
MYO9A::GRAMD2A	Adenocarcinoma
MYO9A::GRB2	Adenocarcinoma
MYO9A::HEXA	Adenocarcinoma
MYO9A::PARP6	Adenocarcinoma
MYO9A::PKM	Adenocarcinoma
MYO9A::PMS1	Squamous cell carcinoma
MYO9A::TMEM59	Adenocarcinoma
MYO9B::ATP13A1	Adenocarcinoma
MYO9B::DDA1	Adenocarcinoma
MYO9B::DOCK6	Malignant melanoma
MYO9B::FCHO1	Adenocarcinoma
MYO9B::KLF2	Multiple myeloma
MYO9B::MEGF8	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
MYO9B::NEK8	Adenocarcinoma
MYO9B::PNN	Adenocarcinoma
MYO9B::SPC24	Squamous cell carcinoma
MYO9B::TECR	Adenocarcinoma
MYO9B::ZNF430	Adenocarcinoma
MYOF::C10ORF90	Adenocarcinoma
MYORG::KIF24	Astrocytoma, grade I-II
MYOZ2::PNKD	Adenocarcinoma
MYPN::PLXDC2	Mesenchymal tumor, NOS
MYRF::SAXO4	Adenocarcinoma
MYRF::STX5	Mesenchymal tumor, NOS
MYRFL::MDM2	Adenocarcinoma
MYRIP::BABAM1	Adenocarcinoma
MYRIP::BRAF	Adenocarcinoma
MYRIP::MLH1	Adenocarcinoma
MYRIP::S100A2	Adenocarcinoma
MYSM1::ALG14	Adenocarcinoma
MYSM1::APOM	Adenocarcinoma
MYSM1::ATG4C	Germ cell tumor, NOS
MYSM1::DAB1	Squamous cell carcinoma
MYT1::ST8SIA1	Astrocytoma, grade I-II
MYT1::TCEA2	Squamous cell carcinoma
MYT1L::POMC	Adenocarcinoma
MYZAP::ADGRL1	Adenocarcinoma
MZF1::TEKTL1	Squamous cell carcinoma
MZF1::TRIM28	Adenocarcinoma
MZT1::BRAF	Malignant melanoma
MZT1::TERF1	Adenocarcinoma
N4BP1::ABCC12	Adenocarcinoma
N4BP1::DDX19B	Squamous cell carcinoma
N4BP1::EEA1	Mesenchymal tumor, NOS
N4BP1::GPATCH2	Mesenchymal tumor, NOS
N4BP1::NAV3	Mesenchymal tumor, NOS
N4BP2L1::HMGB1	Chronic lymphocytic leukemia
N4BP2L2::SUCLA2	Adenocarcinoma
N4BP2L2::ZAR1L	Adenocarcinoma
N4BP2L2::ZMYM5	Malignant melanoma
NAA15::HHIP	Adenocarcinoma
NAA15::LPAR1	Astrocytoma, grade III-IV/Glioblastoma
NAA15::MGST2	Adenocarcinoma | Squamous cell carcinoma
NAA15::SLC10A7	Adenocarcinoma
NAA15::STPG2	Adenocarcinoma
NAA16::EPSTI1	Embryonal rhabdomyosarcoma
NAA16::FREM2	Embryonal rhabdomyosarcoma
NAA16::VWA8	Adenocarcinoma
NAA20::ATP8B4	Adenocarcinoma
NAA20::RIN2	Adenocarcinoma
NAA25::ATXN2	Adenocarcinoma
NAA25::SLC25A21	Squamous cell carcinoma
NAA25::TBX5	Adenocarcinoma
NAA25::WSCD2	Adenocarcinoma
NAA30::TERT	Astrocytoma, grade III-IV/Glioblastoma
NAA35::LAMC3	Transitional cell carcinoma
NAA35::MRPS2	Adenocarcinoma
NAA35::WDR74	Adenocarcinoma
NAA38::RABEP1	Adenocarcinoma
NAA40::RTN3	Adenocarcinoma
NAA50::CD47	Adenocarcinoma
NAA50::MRPS35	Undifferentiated carcinoma, small cell
NAA60::CLDN9	Adenocarcinoma
NAA60::CLUAP1	Nonneoplastic epithelial disorder/lesion
NAA60::IL32	Astrocytoma, grade III-IV/Glioblastoma
NAA60::IST1	Adenocarcinoma
NAALADL1::PATL1	Squamous cell carcinoma
NAALADL2::ABCC5	Squamous cell carcinoma
NAALADL2::CCDC39	Adenocarcinoma
NAALADL2::DRD3	Squamous cell carcinoma
NAALADL2::EPHB3	Squamous cell carcinoma
NAALADL2::FBXO45	Adenocarcinoma
NAALADL2::MCCC1	Squamous cell carcinoma
NAALADL2::NCKAP5	Squamous cell carcinoma
NAALADL2::NLGN1	Adenocarcinoma
NAALADL2::PEX5L	Adenocarcinoma
NAALADL2::RSRC1	Adenocarcinoma
NAALADL2::SENP2	Squamous cell carcinoma
NAALADL2::SLC25A3	Adenocarcinoma
NAALADL2::SLC9A9	Astrocytoma, grade III-IV/Glioblastoma
NAALADL2::SMC5	Squamous cell carcinoma
NAALADL2::TIGIT	Astrocytoma, grade I-II
NAALADL2::VPS13C	Malignant melanoma
NAB1::GULP1	Squamous cell carcinoma
NAB1::MFSD6	Adenocarcinoma
NAB1::STEAP3	Malignant melanoma
NAB2::NCOA2	Soft tissue tumor, NOS
NAB2::PDGFRB	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma
NAB2::RARA	Acute promyelocytic leukemia (FAB type M3)
NAB2::STAT6	Astrocytoma, grade III-IV/Glioblastoma | Solitary fibrous tumor | Mesenchymal tumor, special type | Fibroblastic/myofibroblastic tumor, special type
NABP1::RARA	Acute promyelocytic leukemia (FAB type M3)
NACA2::LSR	Adenocarcinoma
NACA::CSN2	Adenocarcinoma
NACA::R3HDM2	Adenocarcinoma
NACA::USP6	Nodular fasciitis
NACC2::NOTCH1	Chronic eosinophilic leukemia/hypereosinophilic syndrome
NACC2::NTRK2	Glioma, NOS | Astrocytoma, grade III-IV/Glioblastoma | Astrocytoma, pilocytic/juvenile
NADK2::CDH1	Adenocarcinoma
NADK2::FOXP1	Adenocarcinoma
NADK2::RANBP3L	Adenocarcinoma
NADK::CFAP74	Adenocarcinoma
NADK::GNB1	Astrocytoma, grade I-II
NADK::HNRNPR	Miscellaneous hematopoietic/lymphoid neoplasm, special type
NADK::MROH1	Adenocarcinoma
NADK::TOM1L2	Adenocarcinoma
NADSYN1::DHCR7	Adenocarcinoma
NADSYN1::DLG2	Adenocarcinoma
NADSYN1::GSTP1	Squamous cell carcinoma
NADSYN1::KRTAP5-10	Squamous cell carcinoma | Miscellaneous hematopoietic/lymphoid neoplasm, special type
NADSYN1::MYEOV	Squamous cell carcinoma
NADSYN1::PAK1	Adenocarcinoma
NADSYN1::PLET1	Squamous cell carcinoma
NADSYN1::PPP6R3	Malignant melanoma
NADSYN1::SHANK2	Adenocarcinoma
NADSYN1::SPAG9	Adenocarcinoma
NADSYN1::TRIM9	Adenocarcinoma
NAGA::TCF20	Adenocarcinoma
NAGA::WBP2NL	Adenocarcinoma
NAGLU::FBXL20	Adenocarcinoma
NAGS::MAST2	Malignant melanoma
NAGS::PYY	Adenocarcinoma
NAIP::OCLN	Undifferentiated carcinoma, small cell | Adenocarcinoma | Endometrial stromal sarcoma
NALF1::FGF14	Squamous cell carcinoma
NALF1::TUBGCP2	Adenocarcinoma
NANS::NCBP1	Adenocarcinoma
NANS::WNK2	Adenocarcinoma
NAP1L1::MLLT10	Acute lymphoblastic leukemia/lymphoblastic lymphoma
NAP1L1::OSTF1	Mesenchymal tumor, NOS
NAP1L1::PTPRR	Mesenchymal tumor, NOS
NAP1L1::SLCO1B1	Adenocarcinoma
NAP1L1::STK38L	Adenocarcinoma
NAP1L4::ATP11B	Adenocarcinoma
NAP1L4::CARS1	Adenocarcinoma
NAP1L4::CFTR	Adenocarcinoma
NAP1L4::RPAP1	Adenocarcinoma
NAPA::BCL6	Follicular lymphoma
NAPA::CTSB	Adenocarcinoma
NAPA::PLAC1	Mesenchymal tumor, NOS
NAPB::CST9L	Adenocarcinoma
NAPB::INO80C	Adenocarcinoma
NAPEPLD::RELN	Adenocarcinoma
NAPG::GREB1L	Adenocarcinoma
NAPG::PIEZO2	Squamous cell carcinoma
NAPSA::CLCN3	Adenocarcinoma
NAPSA::COL1A1	Adenocarcinoma
NAPSA::COL1A2	Adenocarcinoma
NAPSA::DDX27	Adenocarcinoma
NAPSA::RNF213	Adenocarcinoma
NAPSA::SEC63	Adenocarcinoma
NAPSA::UQCRC2	Adenocarcinoma
NARF::CTDSP1	Adenocarcinoma
NARF::HEXD	Squamous cell carcinoma
NARF::KRT24	Malignant epithelial tumor, special type
NARF::OLFML2B	Adenocarcinoma
NARF::P4HB	Malignant epithelial tumor, special type
NARF::USP36	Adenocarcinoma
NARS2::ALG8	Squamous cell carcinoma
NARS2::INTS4	Adenocarcinoma
NARS2::ME3	Adenocarcinoma
NARS2::NDUFC2	Adenocarcinoma
NARS2::PAK1	Malignant melanoma | Adenocarcinoma
NARS2::PLXDC1	Adenocarcinoma
NARS2::SERINC3	Adenocarcinoma
NARS2::TOP1	Adenocarcinoma
NASP::EDN2	Mesothelioma
NASP::PIK3R3	Adenocarcinoma
NASP::WIPF1	Adenocarcinoma
NAT10::CAPRIN1	Adenocarcinoma
NAT10::SPMAP1	Adenocarcinoma
NAT8L::DBNDD1	Astrocytoma, grade III-IV/Glioblastoma
NAV1::IPO9	Adenocarcinoma
NAV1::JPT2	Squamous cell carcinoma
NAV1::NTRK2	Astrocytoma, pilocytic/juvenile
NAV2::ARL14EP	Malignant melanoma
NAV2::CNTN5	Adenocarcinoma
NAV2::EHF	Adenocarcinoma
NAV2::ERC1	Malignant melanoma
NAV2::PACSIN3	Adenocarcinoma
NAV2::TCF7L1	Adenocarcinoma
NAV2::WDFY1	Adenocarcinoma
NAV3::ARHGAP9	Astrocytoma, grade III-IV/Glioblastoma
NAXD::ADPRHL1	Primitive neuroectodermal tumor/Medulloblastoma | Russia
NAXD::MYO16	Malignant epithelial tumor, special type
NAXE::HAPLN2	Astrocytoma, grade I-II
NAXE::RHBG	Adenocarcinoma
NBAS::ALB	Adenocarcinoma
NBAS::BAZ2B	Neuroblastoma
NBAS::CCNT2	Neuroblastoma
NBAS::DDX1	Squamous cell carcinoma
NBAS::RASGRP3	Adenocarcinoma
NBAS::SLC66A3	Malignant epithelial tumor, special type
NBAS::SNORC	Astrocytoma, grade III-IV/Glioblastoma
NBAS::SPIRE1	Malignant epithelial tumor, special type
NBAS::THADA	Adenocarcinoma
NBEA::ALG5	Adenocarcinoma
NBEA::ALK	Mesothelioma | Adenocarcinoma
NBEA::BRCA2	Mesenchymal tumor, NOS
NBEA::COLGALT2	Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
NBEA::FNDC3A	Mesenchymal tumor, NOS
NBEA::NDFIP2	Adenocarcinoma
NBEA::POSTN	Adenocarcinoma
NBEAL1::CARF	Adenocarcinoma
NBEAL1::CYP20A1	Adenocarcinoma
NBEAL1::MLLT3	Squamous cell carcinoma
NBEAL1::TANK	Adenocarcinoma
NBEAL2::ATP2A3	Adenocarcinoma
NBEAL2::SETD2	Mesothelioma
NBEAL2::TMC2	Adenocarcinoma
NBL1::MICOS10	Adenocarcinoma
NBL1::STAT6	Adenocarcinoma
NBN::RIPK2	Transitional cell carcinoma
NBN::SLC26A7	Adenocarcinoma
NBPF10::NME7	Adenocarcinoma
NBPF12::USP32	Adenocarcinoma
NBPF19::UBE2Q1	Adenocarcinoma
NBPF1::ANKRD13C	Adenocarcinoma
NBPF1::IGF1R	Gastrointestinal stromal tumor
NBPF20::ESRRA	Adenocarcinoma
NBPF26::MACF1	Adenocarcinoma
NBPF26::PHTF1	Malignant melanoma
NBPF26::RASSF5	Adenocarcinoma
NBPF26::TMEM150C	Adenocarcinoma
NBPF3::EPHB2	Astrocytoma, grade III-IV/Glioblastoma
NBR1::MEIOC	Adenocarcinoma
NBR1::PALB2	Malignant melanoma
NBR1::RUNDC3A	Adenocarcinoma
NCALD::LAPTM4B	Astrocytoma, grade I-II
NCALD::NSMCE2	Squamous cell carcinoma
NCALD::PLAG1	Carcinoma, NOS | Adenoma | Benign epithelial tumor, special type
NCALD::RRM2B	Adenocarcinoma
NCALD::SLC5A11	Adenocarcinoma
NCALD::SYBU	Adenocarcinoma
NCALD::UBR5	Squamous cell carcinoma | Adenocarcinoma
NCAM1::POU2AF1	Adenocarcinoma
NCAM1::TTC12	Astrocytoma, grade I-II
NCAM2::APOL2	Squamous cell carcinoma
NCAM2::CRYL1	Adenocarcinoma
NCAM2::RORB	Mesenchymal tumor, NOS
NCAM2::TMPRSS15	Astrocytoma, grade I-II
NCAN::NOSIP	Astrocytoma, grade I-II
NCAN::NR2F6	Adenocarcinoma
NCAPD2::MRPL48	Adenocarcinoma
NCAPD2::PRPF3	Adenocarcinoma
NCAPD2::VWF	Adenocarcinoma
NCAPD3::JAM3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
NCAPD3::KBTBD3	Transitional cell carcinoma
NCAPG2::ERGIC1	Adenocarcinoma
NCAPG2::N4BP2	Adenocarcinoma
NCAPG2::ORC5	Adenocarcinoma
NCAPH::KCNIP3	Squamous cell carcinoma
NCBP1::KMT2A	Acute myeloblastic leukemia without maturation (FAB type M1)
NCBP3::ATP2A3	Malignant melanoma
NCBP3::CAMKK1	Adenocarcinoma
NCEH1::BCL2L1	Squamous cell carcinoma
NCEH1::EEF1G	Adenocarcinoma
NCEH1::FNDC3B	Squamous cell carcinoma
NCEH1::LRCH4	Adenocarcinoma
NCEH1::SPATA16	Squamous cell carcinoma | Adenocarcinoma | Mature B-cell neoplasm, NOS
NCF2::PAPPA2	Adenocarcinoma
NCK1::HEBP1	Squamous cell carcinoma
NCK1::PCCB	Transitional cell carcinoma
NCK1::RAB6B	Adenocarcinoma
NCK1::STAG1	Squamous cell carcinoma
NCK2::KDM4C	Adenocarcinoma
NCK2::MRPS9	Adenocarcinoma
NCK2::NUP93	Mesothelioma
NCK2::SFXN5	Adenocarcinoma
NCKAP1::LYPD6B	Adenocarcinoma
NCKAP1::PARD3	Squamous cell carcinoma
NCKAP5::ARHGAP15	Malignant melanoma
NCKAP5::ARHGEF4	Squamous cell carcinoma
NCKAP5::DYNC2H1	Astrocytoma, grade I-II
NCKAP5::ERBB4	Squamous cell carcinoma
NCKAP5::MZT2A	Adenocarcinoma
NCKAP5::NMI	Adenocarcinoma
NCKAP5::TMEM163	Squamous cell carcinoma
NCKAP5L::BCDIN3D	Adenocarcinoma
NCKAP5L::C12ORF60	Malignant epithelial tumor, special type
NCKAP5L::PDE6H	Malignant epithelial tumor, special type
NCKAP5L::PRKAG1	Squamous cell carcinoma
NCKIPSD::CELSR3	Heart | Chronic myeloid leukemia, t(9;22)
NCKIPSD::IP6K2	Squamous cell carcinoma
NCKIPSD::SFMBT1	Benign epithelial tumor, special type
NCL::ARMC9	Adenocarcinoma
NCL::RBM25	Squamous cell carcinoma
NCL::SQSTM1	Adenocarcinoma
NCL::STAT6	Adenocarcinoma
NCLN::ACSBG2	Adenocarcinoma
NCLN::FZR1	Osteogenic/bone tumor, special type
NCOA1::ALK	Malignant melanoma
NCOA1::CENPA	Adenocarcinoma
NCOA1::DTNB	Alveolar rhabdomyosarcoma
NCOA1::FAM228B	Malignant epithelial tumor, special type
NCOA1::GOLGB1	Adenocarcinoma
NCOA1::LPIN1	Adenocarcinoma
NCOA1::MAGI1	Adenocarcinoma
NCOA1::PSD2	Adenocarcinoma
NCOA1::UBXN2A	Malignant melanoma
NCOA2::ALKAL1	Transitional cell carcinoma
NCOA2::ARFGEF1	Adenocarcinoma
NCOA2::CYRIB	Adenocarcinoma
NCOA2::DCUN1D5	Squamous cell carcinoma
NCOA2::EIF3E	Squamous cell carcinoma
NCOA2::EIF4EBP1	Adenocarcinoma
NCOA2::ETV4	Angiofibroma
NCOA2::LEPROTL1	Adenocarcinoma
NCOA2::MEIS1	Spindle cell/sclerosing rhabdomyosarcoma
NCOA2::NCALD	Adenocarcinoma
NCOA2::SGSM3	Adenocarcinoma
NCOA2::ST18	Malignant melanoma
NCOA2::XKR9	Adenocarcinoma
NCOA2::ZNF704	Adenocarcinoma
NCOA3::ARHGAP26	Squamous cell carcinoma
NCOA3::DNM2	Adenocarcinoma
NCOA3::DUSP15	Transitional cell carcinoma
NCOA3::EYA2	Adenocarcinoma | Multiple myeloma
NCOA3::FBXW7	Multiple myeloma
NCOA3::GGT7	Squamous cell carcinoma
NCOA3::KCTD20	Adenocarcinoma
NCOA3::LRRC49	Adenocarcinoma
NCOA3::MICALL1	Adenocarcinoma
NCOA3::MLLT6	Adenocarcinoma
NCOA3::PADI1	Adenocarcinoma
NCOA3::PARD3B	Adenocarcinoma
NCOA3::PTPRT	Mesenchymal tumor, NOS
NCOA3::SGK2	Adenocarcinoma
NCOA3::SPINT1	Adenocarcinoma
NCOA3::SULF2	Malignant epithelial tumor, special type
NCOA3::TRERF1	Multiple myeloma
NCOA4::ARHGAP44	Adenocarcinoma
NCOA4::CD96	Squamous cell carcinoma
NCOA4::MSMB	Transitional cell carcinoma
NCOA4::OR13A1	Adenocarcinoma
NCOA4::RET	Carcinoma, NOS | Adenoma | Malignant epithelial tumor, special type | Soft tissue tumor, special type | Benign epithelial tumor, special type | Soft tissue tumor, NOS | Germ cell tumor, special type | Adenocarcinoma
NCOA4::RSU1	Adenocarcinoma
NCOA4::SRSF7	Adenocarcinoma
NCOA5::CDH4	Adenocarcinoma
NCOA6::AHCY	Squamous cell carcinoma
NCOA6::ETV6	Bilineage or biphenotypic leukemia | Egypt
NCOA6::GGT7	Adenocarcinoma
NCOA6::GSS	Adenocarcinoma
NCOA6::LSM1	Mesenchymal tumor, NOS
NCOA6::PRDM14	Acute lymphoblastic leukemia/lymphoblastic lymphoma
NCOA6::PSMD13	Adenocarcinoma
NCOA6::RALGAPA2	Adenocarcinoma
NCOA6::SLC10A1	Adenocarcinoma
NCOA6::TCFL5	Adenocarcinoma
NCOA6::TRPC4AP	Adenocarcinoma
NCOA7::NKAIN2	Adenocarcinoma
NCOR1::ACACA	Adenocarcinoma
NCOR1::ACER3	Adenocarcinoma
NCOR1::CCDC144A	Adenocarcinoma
NCOR1::CDRT4	Transitional cell carcinoma
NCOR1::DPM1	Adenocarcinoma
NCOR1::FBXO3	Adenocarcinoma
NCOR1::HIC1	Adenocarcinoma
NCOR1::LYN	Acute lymphoblastic leukemia/lymphoblastic lymphoma
NCOR1::MAP2K1	Undifferentiated pleomorphic sarcoma
NCOR1::MAPK7	Liposarcoma, dedifferentiated
NCOR1::MPRIP	Malignant epithelial tumor, special type
NCOR1::NFIA	Acute lymphoblastic leukemia/lymphoblastic lymphoma
NCOR1::PIGL	Adenocarcinoma
NCOR1::PKD1L1	Adenocarcinoma
NCOR1::PRR11	Malignant epithelial tumor, special type
NCOR1::RHOU	Adenocarcinoma
NCOR1::RNF43	Adenocarcinoma
NCOR1::RSF1	Adenocarcinoma
NCOR1::TFDP2	Adenocarcinoma
NCOR1::ZNF287	Adenocarcinoma
NCOR1::ZNF595	Adenocarcinoma
NCOR2::CABLES2	Adenocarcinoma
NCOR2::DDX27	Squamous cell carcinoma
NCOR2::DHX37	Adenocarcinoma | Astrocytoma, grade III-IV/Glioblastoma
NCOR2::ELN	Adenocarcinoma
NCOR2::FMR1NB	Adenocarcinoma
NCOR2::GATA4	Astrocytoma, grade I-II
NCOR2::ITGB5	Adenocarcinoma
NCOR2::KIRREL3	Adenocarcinoma
NCOR2::MORN3	Diffuse large B-cell lymphoma
NCOR2::NUP37	Mesenchymal tumor, NOS
NCOR2::PGC	Adenocarcinoma
NCOR2::PIP4K2B	Adenocarcinoma
NCOR2::RABGAP1	Adenocarcinoma
NCOR2::RILPL2	Adenocarcinoma
NCOR2::RNF123	Adenocarcinoma
NCOR2::S100A4	Malignant melanoma
NCOR2::SCARB1	Acute myelomonocytic leukemia (FAB type M4) | Undifferentiated carcinoma, small cell | Adenocarcinoma
NCOR2::TMEM132D	Astrocytoma, grade I-II
NCOR2::UBC	Multiple myeloma
NCS1::GPR107	Adenocarcinoma
NCS1::TOR1B	Squamous cell carcinoma
NCSTN::ATP1A4	Adenocarcinoma
NCSTN::CCT3	Adenocarcinoma
NCSTN::SPRR2G	Adenocarcinoma
NCSTN::SREBF1	Adenocarcinoma
NCSTN::TMBIM6	Adenocarcinoma
NDC1::GLIS1	Transitional cell carcinoma
NDC1::SSBP3	Adenocarcinoma
NDC1::YIPF1	Adenocarcinoma
NDC80::PPP4R1	Transitional cell carcinoma
NDC80::TTC39C	Adenocarcinoma
NDE1::PDGFRB	Spleen | Chronic myelomonocytic leukemia
NDEL1::CHD3	Astrocytoma, grade I-II
NDEL1::DHX30	Adenocarcinoma
NDEL1::KCNB1	Adenocarcinoma
NDEL1::KIF1C	Adenocarcinoma
NDEL1::WSCD1	Adenocarcinoma
NDFIP1::NDUFAF2	Adenocarcinoma
NDRG1::C9	Adenocarcinoma
NDRG1::CLCN3	Adenocarcinoma
NDRG1::DACT3	Adenocarcinoma
NDRG1::ERG	Adenocarcinoma
NDRG1::FOXP1	Adenocarcinoma
NDRG1::LARP1	Squamous cell carcinoma
NDRG1::MYC	Carcinoma, NOS | Adenocarcinoma
NDRG1::OC90	Adenocarcinoma
NDRG1::PLAG1	Benign epithelial tumor, special type
NDRG1::PLEKHA5	Adenocarcinoma
NDRG1::RABEP1	Adenocarcinoma
NDRG1::SNTB1	Adenocarcinoma
NDRG1::SNW1	Transitional cell carcinoma
NDRG1::ST3GAL1	Adenocarcinoma
NDRG1::STAT6	Squamous cell carcinoma
NDRG1::UBC	Multiple myeloma
NDRG2::KIF3A	Astrocytoma, grade I-II
NDRG2::RABEP1	Astrocytoma, grade I-II
NDRG2::SEC63	Astrocytoma, grade I-II
NDRG2::SPARC	Astrocytoma, grade I-II
NDRG3::BCAS4	Adenocarcinoma
NDRG3::CPLX1	Squamous cell carcinoma
NDST1::FAM114A2	Malignant melanoma
NDST1::TCOF1	Squamous cell carcinoma
NDST2::RUNX1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
NDST2::ZSWIM8	Adenocarcinoma
NDST3::ZNF483	Astrocytoma, grade III-IV/Glioblastoma
NDUFA10::ANXA4	Malignant melanoma
NDUFA10::COPS9	Adenocarcinoma
NDUFA10::SGPP2	Squamous cell carcinoma
NDUFA10::TMEM207	Squamous cell carcinoma
NDUFA11::ZNF846	Squamous cell carcinoma
NDUFA12::NUP107	Mesenchymal tumor, NOS
NDUFA12::USP44	Neuroblastoma
NDUFA13::AZIN1	Adenocarcinoma
NDUFA13::NCAN	Adenocarcinoma
NDUFA4::SCIN	Acute lymphoblastic leukemia/lymphoblastic lymphoma
NDUFA4L2::AVIL	Astrocytoma, grade III-IV/Glioblastoma
NDUFA7::PRKCG	Squamous cell carcinoma
NDUFA7::SH2D3A	Adenocarcinoma
NDUFA8::DNAJC25	Adenocarcinoma
NDUFA9::C12orf4	Mesenchymal tumor, NOS
NDUFA9::DYRK4	Acute lymphoblastic leukemia/lymphoblastic lymphoma
NDUFAF2::ANKRD31	Adenocarcinoma
NDUFAF2::MAST4	Adenocarcinoma
NDUFAF2::UBC	Adenocarcinoma
NDUFAF5::ESF1	Adenocarcinoma
NDUFAF5::MACROD2	Adenocarcinoma
NDUFAF6::BCAS4	Adenocarcinoma
NDUFAF6::CIBAR1	Adenocarcinoma
NDUFAF6::DPY19L4	Squamous cell carcinoma
NDUFAF6::INTS8	Transitional cell carcinoma
NDUFAF6::LRRCC1	Malignant melanoma
NDUFAF6::LSM1	Adenocarcinoma
NDUFAF6::MYC	Adenocarcinoma
NDUFAF6::RALYL	Adenocarcinoma
NDUFAF7::PRKD3	Acute myeloid leukemia, NOS | Skin
NDUFAF7::SAMD4B	Adenocarcinoma
NDUFB1::PPP4R3A	Adenocarcinoma
NDUFB2::DPP6	Adenocarcinoma
NDUFB5::NAALADL2	Adenocarcinoma
NDUFB8::SEC31B	Nonneoplastic epithelial disorder/lesion
NDUFB9::CSMD3	Mesenchymal tumor, NOS
NDUFB9::NSMCE2	Transitional cell carcinoma
NDUFB9::TDRKH	Adenocarcinoma
NDUFC2::AAMDC	Malignant melanoma
NDUFS1::KRTAP6-2	Adenocarcinoma
NDUFS1::SLC25A51	Primitive neuroectodermal tumor/Medulloblastoma | Russia
NDUFS2::PSMD4	Transitional cell carcinoma
NDUFS2::SLC24A2	Mesenchymal tumor, NOS
NDUFS3::ERO1B	Adenocarcinoma
NDUFS4::BASP1	Adenocarcinoma
NDUFS4::EXTL3	Squamous cell carcinoma
NDUFS4::GZMA	Squamous cell carcinoma
NDUFS4::HMGCR	Malignant melanoma
NDUFS4::TMPRSS2	Adenocarcinoma
NDUFS4::UBE2D2	Adenocarcinoma
NDUFS6::ACTB	Adenocarcinoma
NDUFS6::C7	Squamous cell carcinoma
NDUFS7::CNN2	Astrocytoma, grade I-II
NDUFS7::STK11	Adenocarcinoma
NDUFV2::CHST9	Adenocarcinoma
NDUFV2::TRIM5	Adenocarcinoma
NEBL::CAMK1D	Transitional cell carcinoma
NEBL::DNAJC1	Adenocarcinoma
NEBL::FBXO11	Adenocarcinoma
NEBL::PRL	Transitional cell carcinoma
NEBL::SKIDA1	Adenocarcinoma
NEBL::TMEM26	Adenocarcinoma
NEBL::ZNHIT3	Squamous cell carcinoma
NECAB3::ARHGAP40	Adenocarcinoma
NECAB3::PXMP4	Adenocarcinoma
NECAP1::ANK1	Transitional cell carcinoma
NECAP2::EPHA2	Adenocarcinoma
NECAP2::PCBP1	Adenocarcinoma
NECTIN2::BCAM	Adenocarcinoma
NECTIN2::CCL21	Adenocarcinoma
NECTIN2::CEACAM19	Adenocarcinoma
NECTIN2::GAMT	Adenocarcinoma
NECTIN2::IGSF23	Adenocarcinoma | Transitional cell carcinoma
NECTIN2::LMNA	Adenocarcinoma
NECTIN2::NOC4L	Adenocarcinoma
NECTIN2::SCN1B	Adenocarcinoma
NECTIN2::SOX6	Adenocarcinoma
NECTIN2::ZMAT2	Adenocarcinoma
NECTIN3::KCNMB3	Mesothelioma
NECTIN4::NTRK1	Squamous cell carcinoma
NECTIN4::PFDN2	Adenocarcinoma | Transitional cell carcinoma
NEDD1::GPHN	Mesenchymal tumor, NOS
NEDD1::GRIP1	Mesenchymal tumor, NOS
NEDD1::PPFIA2	Mesenchymal tumor, NOS
NEDD1::TMTC2	Mesenchymal tumor, NOS
NEDD4::ADAMTSL3	Adenocarcinoma
NEDD4::GABRA5	Transitional cell carcinoma
NEDD4::RDH10	Squamous cell carcinoma
NEDD4::RFX7	Adenocarcinoma
NEDD4L::ALPK2	Adenocarcinoma
NEDD4L::APCDD1	Adenocarcinoma
NEDD4L::BCL2	Adenocarcinoma
NEDD4L::CDH19	Squamous cell carcinoma
NEDD4L::DCLK2	Adenocarcinoma
NEDD4L::HYI	Transitional cell carcinoma
NEDD4L::IMMP2L	Malignant melanoma
NEDD4L::MORC3	Adenocarcinoma
NEDD4L::SERPINB5	Adenocarcinoma
NEDD4L::SPINT2	Adenocarcinoma
NEDD4L::TBC1D17	Adenocarcinoma
NEDD4L::TLN2	Adenocarcinoma
NEDD4L::UBE2G1	Squamous cell carcinoma
NEDD4L::ZC3H7A	Adenocarcinoma
NEDD4L::ZNF396	Adenocarcinoma
NEDD8::NRL	Adenocarcinoma
NEDD9::ADTRP	Adenocarcinoma
NEDD9::DTNBP1	Malignant melanoma
NEDD9::ERVFRD-1	Squamous cell carcinoma
NEDD9::GOLGB1	Adenocarcinoma
NEDD9::SCT	Malignant epithelial tumor, special type
NEDD9::TMEM170B	Multiple myeloma
NEGR1::CYP2J2	Malignant melanoma
NEGR1::ERICH3	Adenocarcinoma
NEGR1::ETS1	Squamous cell carcinoma
NEGR1::NSF	Malignant epithelial tumor, special type
NEGR1::ZFYVE9	Mesenchymal tumor, NOS
NEGR1::ZRANB2	Astrocytoma, grade III-IV/Glioblastoma
NEIL2::GATA4	Germ cell tumor, NOS
NEIL2::TTC7B	Transitional cell carcinoma
NEIL3::AGA	Transitional cell carcinoma
NEK11::ALKAL1	Squamous cell carcinoma
NEK11::ATP2C1	Adenocarcinoma
NEK11::BDH1	Astrocytoma, grade I-II
NEK11::COL6A6	Adenocarcinoma
NEK1::CBR4	Adenocarcinoma
NEK1::CLCN3	Acute megakaryoblastic leukemia (FAB type M7)
NEK3::GXYLT2	Malignant melanoma
NEK4::SETD2	Transitional cell carcinoma
NEK4::SFMBT1	Undifferentiated carcinoma, small cell
NEK4::STIMATE	Adenocarcinoma
NEK6::PTGS1	Adenocarcinoma
NEK6::RASEF	Adenocarcinoma
NEK7::ATP2B4	Squamous cell carcinoma
NEK7::CADM3	Transitional cell carcinoma
NEK7::CD1C	Adenocarcinoma
NEK7::CRB1	Adenocarcinoma
NEK7::INTS7	Adenocarcinoma
NEK7::RAB3GAP2	Squamous cell carcinoma
NEK7::SMYD3	Mesenchymal tumor, NOS
NEK9::TMED10	Adenocarcinoma
NEK9::TRIM9	Adenocarcinoma
NELFA::LETM1	Diffuse large B-cell lymphoma
NELFA::POLN	Adenocarcinoma
NELFA::QDPR	Astrocytoma, grade III-IV/Glioblastoma
NELFB::EXD3	Astrocytoma, grade I-II
NELFB::FBXW5	Adenocarcinoma
NELL1::CCDC83	Adenocarcinoma
NELL1::NAV3	Atypical lipomatous tumor/atypical lipoma/well-differentiated liposarcoma
NELL1::SMCO4	Malignant melanoma
NELL1::SYT1	Atypical lipomatous tumor/atypical lipoma/well-differentiated liposarcoma
NELL2::ATF7	Adenocarcinoma
NELL2::ATXN7L3B	Adenoid cystic carcinoma
NELL2::MUC19	Squamous cell carcinoma
NELL2::MUC21	Mesenchymal tumor, NOS
NELL2::OS9	Astrocytoma, grade III-IV/Glioblastoma
NEMF::CDKL1	Adenocarcinoma
NEMF::KLHDC2	Adenocarcinoma
NEMF::L2HGDH	Adenocarcinoma
NEMF::SOS2	Adenocarcinoma | Mature B-cell neoplasm, NOS
NEMF::VCPKMT	Adenocarcinoma
NEMP1::CTDSP2	Adenocarcinoma
NEMP1::OR6C4	Adenocarcinoma
NEMP1::SMARCC2	Adenocarcinoma
NEO1::BBS4	Mesenchymal tumor, NOS
NEO1::CNRIP1	Adenocarcinoma
NEO1::NR2E3	Adenocarcinoma
NEO1::THSD4	Adenocarcinoma
NEO1::ZFAT	Mesenchymal tumor, NOS
NES::UVRAG	Malignant melanoma
NET1::ACSM3	Adenocarcinoma
NET1::RIMKLB	Germ cell tumor, NOS
NET1::TUBAL3	Adenocarcinoma
NET1::USP6NL	Transitional cell carcinoma
NET1::ZMYND11	Adenocarcinoma
NETO2::CHD9	Adenocarcinoma
NETO2::CTCF	Acute myeloblastic leukemia with maturation (FAB type M2)
NEU3::NDUFV1	Adenocarcinoma
NEU3::POLA2	Adenocarcinoma
NEU3::SNTG1	Adenocarcinoma
NEURL1::PDCD11	Squamous cell carcinoma
NEURL3::FAM178B	Transitional cell carcinoma
NEURL4::MSI2	Malignant melanoma
NEURL4::SOX15	Mesenchymal tumor, NOS
NEXMIF::PBDC1	Adenocarcinoma
NEXN::AK5	Adenocarcinoma
NEXN::GIPC2	Astrocytoma, grade I-II
NF1::ABCB5	Adenocarcinoma
NF1::ACACA	Adenocarcinoma
NF1::ADAP2	Adenocarcinoma
NF1::AGTR1	Squamous cell carcinoma
NF1::ANKFN1	Adenocarcinoma
NF1::ARL5C	Adenocarcinoma
NF1::ASIC2	Mesenchymal tumor, NOS | Adenocarcinoma
NF1::ATAD5	Adenocarcinoma
NF1::BCAS3	Transitional cell carcinoma
NF1::BRCA1	Adenocarcinoma
NF1::CACNA1G	Adenocarcinoma
NF1::CCR7	Adenocarcinoma
NF1::CDK5RAP3	Adenocarcinoma
NF1::CLTC	Adenocarcinoma
NF1::EPHA1	Adenocarcinoma
NF1::EZH2	Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
NF1::GFPT1	Adenocarcinoma
NF1::IGLL5	Multiple myeloma
NF1::IKZF3	Adenocarcinoma
NF1::LRRC37B	Acute myeloblastic leukemia without maturation (FAB type M1) | Acute myeloid leukemia, NOS | Skin
NF1::MAP2K4	Adenocarcinoma
NF1::NLE1	Adenocarcinoma
NF1::NRF1	Adenocarcinoma
NF1::PDS5B	Adenocarcinoma
NF1::POLDIP2	Adenocarcinoma
NF1::PSMD11	Adenocarcinoma | Acute lymphoblastic leukemia/lymphoblastic lymphoma
NF1::RAB11FIP4	Astrocytoma, grade III-IV/Glioblastoma | Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type | Adenocarcinoma
NF1::RBX1	Adenocarcinoma
NF1::RHOT1	Squamous cell carcinoma | Astrocytoma, grade I-II | Synovial sarcoma
NF1::RNF135	Germ cell tumor, NOS | Squamous cell carcinoma
NF1::RPTOR	Mesenchymal tumor, NOS
NF1::SCIMP	Malignant peripheral nerve sheath tumor/Triton
NF1::SLC46A1	Squamous cell carcinoma
NF1::SPACA3	Transitional cell carcinoma
NF1::SUZ12	Adenocarcinoma
NF1::TEX14	Adenocarcinoma
NF1::TPMT	Adenocarcinoma
NF1::TRMT61B	Astrocytoma, grade I-II
NF1::TSPAN18	Adenocarcinoma
NF1::YPEL5	Adenocarcinoma
NF2::CABP7	Mesothelioma | Adenocarcinoma
NF2::CLTCL1	Adenocarcinoma
NF2::EFCAB6	Malignant melanoma
NF2::EIF3D	Adenocarcinoma
NF2::GRAP2	Adenocarcinoma
NF2::HSD3B2	Adenocarcinoma
NF2::MORC2	Squamous cell carcinoma
NF2::MTMR3	Squamous cell carcinoma
NF2::OSBP2	Squamous cell carcinoma
NF2::PI4KA	Mesothelioma
NF2::PIAS1	Mesothelioma
NF2::PIEZO2	Mesothelioma
NF2::RHOT1	Mesothelioma
NF2::SPATA13	Meningioma
NF2::TCF20	Meningioma
NF2::ZMAT5	Adenocarcinoma
NFASC::ATP2B2	Astrocytoma, grade I-II
NFASC::ATP2B4	Astrocytoma, grade I-II
NFASC::CCNDBP1	Malignant melanoma
NFASC::LRRN2	Astrocytoma, grade III-IV/Glioblastoma
NFASC::NTRK1	Astrocytoma, grade III-IV/Glioblastoma
NFASC::PPP1R12B	Astrocytoma, grade I-II
NFASC::PRELP	Astrocytoma, grade III-IV/Glioblastoma
NFASC::RTN3	Astrocytoma, grade III-IV/Glioblastoma
NFASC::SOX13	Astrocytoma, grade III-IV/Glioblastoma
NFAT5::CCDC113	Transitional cell carcinoma
NFAT5::CDH3	Squamous cell carcinoma
NFAT5::CHST4	Transitional cell carcinoma
NFAT5::CRYM	Adenocarcinoma
NFAT5::CSMD2	Adenocarcinoma
NFAT5::DENND2C	Malignant melanoma
NFAT5::DYNLRB2	Mesenchymal tumor, NOS
NFAT5::FHOD1	Adenocarcinoma
NFAT5::FHOD3	Transitional cell carcinoma
NFAT5::HHAT	Adenocarcinoma
NFAT5::IST1	Adenocarcinoma
NFAT5::NOB1	Squamous cell carcinoma
NFAT5::NQO1	Adenocarcinoma
NFAT5::NUP93	Mesothelioma
NFAT5::PITPNM2	Adenocarcinoma
NFAT5::PLCG2	Adenocarcinoma
NFAT5::SLC7A6	Adenocarcinoma
NFAT5::SNTB2	Adenocarcinoma
NFAT5::TCF7L2	Adenocarcinoma
NFAT5::VPS4A	Adenocarcinoma
NFATC1::CTDP1	Multiple myeloma
NFATC2::DOK5	Malignant melanoma
NFATC2::EYA2	Germ cell tumor, special type
NFATC2::MED24	Adenocarcinoma
NFATC2::NUTM2B	Adenocarcinoma
NFATC2::PHACTR3	Malignant melanoma
NFATC2IP::HS3ST4	Adenocarcinoma
NFATC2IP::KATNIP	Mesenchymal tumor, NOS
NFATC2IP::VPS35L	Adenocarcinoma
NFATC3::PLA2G15	Adenocarcinoma | Acute myeloid leukemia, NOS | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Skin | Nonneoplastic epithelial disorder/lesion
NFATC3::PRMT7	Mesothelioma
NFATC3::SLC7A6	Squamous cell carcinoma
NFATC3::SPATA33	Adenocarcinoma
NFE2::C12ORF60	Adenocarcinoma
NFE2::STARD7	Adenocarcinoma
NFE2L1::CARM1	Adenocarcinoma
NFE2L1::COPZ2	Squamous cell carcinoma
NFE2L1::ENG	Adenocarcinoma
NFE2L1::FBXL20	Adenocarcinoma
NFE2L1::LRRC46	Squamous cell carcinoma
NFE2L1::NPEPPS	Adenocarcinoma
NFE2L1::PNPO	Adenocarcinoma
NFE2L1::SLC39A11	Malignant melanoma
NFE2L1::SP2	Adenocarcinoma
NFE2L2::AGPS	Transitional cell carcinoma
NFE2L2::FBXO27	Adenocarcinoma
NFE2L2::GAPVD1	Adenocarcinoma
NFE2L2::GPR37L1	Squamous cell carcinoma
NFE2L2::NEMP2	Adenocarcinoma
NFE2L2::PDE11A	Squamous cell carcinoma
NFE2L2::RFTN2	Squamous cell carcinoma
NFE2L2::USP33	Malignant melanoma
NFE2L2::VMP1	Adenocarcinoma
NFE2L2::ZC3H13	Squamous cell carcinoma
NFE2L3::NPY	Adenocarcinoma
NFE2L3::TPST1	Squamous cell carcinoma
NFIA::AGBL4	Malignant melanoma
NFIA::CBFA2T3	Malignant soft tissue tumor, NOS | Acute myeloid leukemia, special type | Acute erythroleukemia (FAB type M6)
NFIA::CDK2AP1	Benign epithelial tumor, special type | Miscellaneous hematopoietic/lymphoid neoplasm, special type
NFIA::CLCA1	Adenocarcinoma
NFIA::CYP2J2	Adenocarcinoma
NFIA::DCLK1	Adenocarcinoma
NFIA::EHF	Adenocarcinoma
NFIA::FGGY	Adenocarcinoma
NFIA::LTV1	Adenocarcinoma
NFIA::PRKD1	Adenocarcinoma
NFIA::RAF1	Astrocytoma, pilocytic/juvenile
NFIA::RNLS	Astrocytoma, grade III-IV/Glioblastoma
NFIA::RUNX1T1	Acute erythroleukemia (FAB type M6)
NFIA::ST6GALNAC3	Adenocarcinoma
NFIA::ZNF253	Adenocarcinoma
NFIB::AIG1	Adenoid cystic carcinoma
NFIB::CHCHD7	Adenoma
NFIB::EPB41L2	Adenocarcinoma
NFIB::FREM1	Squamous cell carcinoma
NFIB::HEATR5B	Adenocarcinoma
NFIB::MAN1A1	Adenoid cystic carcinoma
NFIB::MCMDC2	Adenocarcinoma
NFIB::MYB	Adenocarcinoma
NFIB::MYBL1	Adenocarcinoma
NFIB::PLAG1	Adenoma
NFIB::STRN	Adenocarcinoma
NFIB::XRCC4	Adenoid cystic carcinoma
NFIB::ZDHHC21	Adenocarcinoma
NFIC::CELF5	Astrocytoma, grade I-II
NFIC::CRB3	Adenocarcinoma
NFIC::HMG20B	Adenocarcinoma
NFIC::IL4I1	Mesenchymal tumor, NOS
NFIC::LSM7	Squamous cell carcinoma
NFIC::RPS3	Adenocarcinoma
NFIC::SAMD1	Osteogenic/bone tumor, special type
NFIC::SFRP1	Adenocarcinoma
NFIC::SMIM24	Adenocarcinoma
NFIC::SPATA33	Adenocarcinoma
NFIC::TLE6	Squamous cell carcinoma
NFIC::UNC13A	Mesenchymal tumor, NOS
NFIC::WDR18	Adenocarcinoma
NFIX::ANXA1	Adenocarcinoma
NFIX::CALR	Adenocarcinoma
NFIX::CAPN12	Adenocarcinoma
NFIX::CRYBB3	Transitional cell carcinoma
NFIX::DAND5	Adenocarcinoma
NFIX::DNM2	Squamous cell carcinoma
NFIX::DOCK6	Adenocarcinoma
NFIX::GATAD2A	Adenocarcinoma | Undifferentiated carcinoma, small cell
NFIX::GCDH	Adenocarcinoma
NFIX::HNF1B	Adenocarcinoma
NFIX::LRP4	Adenocarcinoma
NFIX::MAST1	Adenocarcinoma
NFIX::PKN1	Malignant epithelial tumor, special type
NFIX::RAD23A	Adenocarcinoma
NFIX::RALGPS1	Squamous cell carcinoma
NFIX::RFX1	Adenocarcinoma
NFIX::SEMA3A	Mesenchymal tumor, NOS
NFIX::STAT6	Solitary fibrous tumor
NFIX::VDR	Adenocarcinoma
NFIX::WDR26	Squamous cell carcinoma
NFKB1::BANK1	Mesenchymal tumor, NOS
NFKB1::FHIP1A	Adenocarcinoma
NFKB1::KLHDC10	Adenocarcinoma
NFKB1::KMT2A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
NFKB1::LHFPL3	Adenocarcinoma
NFKB1::MANBA	Astrocytoma, grade I-II
NFKB1::PPP3CA	Multiple myeloma
NFKB2::GBF1	Adenocarcinoma
NFKBIA::IGH	Multiple myeloma
NFKBIA::TTC6	Adenocarcinoma
NFKBIB::LGALS7B	Adenocarcinoma
NFKBIB::TEAD1	Adenocarcinoma
NFKBID::TYROBP	Adenocarcinoma
NFKBID::ZNF585B	Adenocarcinoma
NFKBIE::FBXO9	Adenocarcinoma
NFKBIE::SLC29A1	Adenocarcinoma
NFKBIZ::ZBED2	Squamous cell carcinoma
NFRKB::CRTAM	Adenocarcinoma
NFRKB::FEN1	Squamous cell carcinoma
NFRKB::NOX4	Adenocarcinoma
NFX1::ACO1	Squamous cell carcinoma
NFX1::ARHGEF39	Squamous cell carcinoma
NFX1::DNAJA1	Adenocarcinoma | Malignant epithelial tumor, special type
NFX1::ELAVL2	Malignant melanoma
NFX1::NOL6	Squamous cell carcinoma
NFX1::SPINK4	Adenocarcinoma
NFX1::SPMIP6	Astrocytoma, grade III-IV/Glioblastoma
NFX1::TMEM8B	Squamous cell carcinoma
NFX1::UBE2R2	Squamous cell carcinoma
NFX1::ZNF616	Adenocarcinoma
NFXL1::COPS4	Adenocarcinoma
NFXL1::ERAP2	Adenocarcinoma
NFYA::AKT2	Adenocarcinoma
NFYA::TREML2	Adenocarcinoma
NFYA::TSPO2	Squamous cell carcinoma
NFYC::CAP1	Adenocarcinoma
NFYC::CTPS1	Squamous cell carcinoma
NFYC::FAF1	Mesenchymal tumor, NOS
NFYC::PLXNA2	Adenocarcinoma
NFYC::SLC15A3	Adenocarcinoma
NFYC::SLC4A4	Adenocarcinoma
NFYC::ST3GAL3	Adenocarcinoma
NFYC::ZBTB7B	Adenocarcinoma
NGEF::INPP5D	Acute lymphoblastic leukemia/lymphoblastic lymphoma
NGLY1::CCKBR	Undifferentiated carcinoma, small cell
NGRN::ZNF710	Adenocarcinoma
NHEJ1::DNPEP	Adenocarcinoma
NHEJ1::HIBCH	Adenocarcinoma
NHEJ1::ZNF124	Squamous cell carcinoma
NHERF1::FBH1	Adenocarcinoma
NHERF1::RAB37	Adenocarcinoma | Squamous cell carcinoma
NHERF1::RABEP1	Adenocarcinoma
NHERF1::TTYH2	Adenocarcinoma
NHLRC2::ATRNL1	Adenocarcinoma
NHLRC2::ENKUR	Adenocarcinoma
NHS::F11R	Mesenchymal tumor, NOS
NHSL1::ARFGEF3	Mesenchymal tumor, NOS
NHSL1::CDIP1	Mesenchymal tumor, NOS
NHSL1::LAMA2	Mesenchymal tumor, NOS
NHSL1::PRDM1	Mesenchymal tumor, NOS
NHSL1::REPS1	Squamous cell carcinoma
NHSL1::SLCO2B1	Transitional cell carcinoma
NHSL1::SPATA13	Adenocarcinoma
NHSL1::VTA1	Adenocarcinoma
NHSL3::PEX10	Adenocarcinoma
NHSL3::RBBP4	Adenocarcinoma
NIBAN1::NRXN2	Squamous cell carcinoma
NIBAN2::C9ORF50	Adenocarcinoma
NIBAN2::CLDN4	Adenocarcinoma
NIBAN2::ERBB3	Adenocarcinoma
NIBAN2::IDNK	Adenocarcinoma
NIBAN2::NDUFV1	Adenocarcinoma
NIBAN2::OLFM1	Adenocarcinoma
NIBAN2::PTRH1	Adenocarcinoma
NIBAN2::PYROXD1	Adenocarcinoma
NIBAN2::SEC16A	Adenocarcinoma
NIBAN2::SHMT1	Squamous cell carcinoma
NIBAN2::SNRNP25	Malignant melanoma
NIBAN2::VPS35L	Mesenchymal tumor, NOS
NIBAN3::COPS2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
NID1::HEATR1	Adenocarcinoma
NIF3L1::ORC2	Adenocarcinoma
NIFK::BTBD2	Adenocarcinoma
NIN::JAK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
NIN::NEMF	Adenocarcinoma
NIN::PDGFRB	Chronic myeloproliferative disorder, NOS
NIN::SAV1	Squamous cell carcinoma
NIN::STXBP6	Squamous cell carcinoma
NIN::TMX1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
NIN::TOGARAM1	Adenocarcinoma
NIN::TPM1	Adenocarcinoma
NIN::UNC79	Acute lymphoblastic leukemia/lymphoblastic lymphoma
NINL::GINS1	Squamous cell carcinoma
NINL::NAA20	Adenocarcinoma
NINL::NIPSNAP2	Adenocarcinoma
NINL::TGM2	Adenocarcinoma
NINL::TTLL9	Squamous cell carcinoma
NIPAL2::EBAG9	Adenocarcinoma
NIPAL2::RGS22	Adenocarcinoma
NIPAL2::RNF19A	Adenocarcinoma
NIPAL3::GRHL3	Squamous cell carcinoma
NIPAL3::PPP4R1	Transitional cell carcinoma
NIPBL::ANKRD17	Adenocarcinoma
NIPBL::ATP2A2	Adenocarcinoma
NIPBL::BASP1	Malignant melanoma
NIPBL::BEND2	Osteosarcoma, NOS | Mesenchymal tumor, special type
NIPBL::BMAL2	Adenocarcinoma
NIPBL::CLSPN	Adenocarcinoma
NIPBL::CPLANE1	Adenocarcinoma
NIPBL::ETV6	Acute lymphoblastic leukemia/lymphoblastic lymphoma
NIPBL::FGF10	Squamous cell carcinoma
NIPBL::HOXA9	Acute megakaryoblastic leukemia (FAB type M7)
NIPBL::HOXB9	Skin | Acute megakaryoblastic leukemia (FAB type M7) | Acute myeloid leukemia, NOS
NIPBL::KHDC1	Squamous cell carcinoma
NIPBL::L3MBTL4	Mesenchymal tumor, NOS
NIPBL::MAPRE1	Squamous cell carcinoma
NIPBL::MRPS30	Transitional cell carcinoma
NIPBL::MYO10	Adenocarcinoma
NIPBL::NACC1	Malignant epithelial tumor, special type | Adenocarcinoma
NIPBL::NR4A3	Mesothelioma
NIPBL::NRG1	Squamous cell carcinoma
NIPBL::NUP155	Malignant melanoma
NIPBL::ROPN1L	Malignant melanoma
NIPBL::SLC1A3	Adenocarcinoma
NIPBL::SLC30A9	Adenocarcinoma
NIPBL::SPEF2	Transitional cell carcinoma | Malignant epithelial tumor, special type | Malignant melanoma | Squamous cell carcinoma | Adenocarcinoma
NIPBL::STK24	Squamous cell carcinoma
NIPBL::TAS2R1	Adenocarcinoma
NIPBL::WDR70	Adenocarcinoma
NIPBL::ZNF384	Acute lymphoblastic leukemia/lymphoblastic lymphoma
NIPSNAP1::NF2	Transitional cell carcinoma
NIPSNAP2::PHYHIPL	Adenocarcinoma
NIPSNAP2::PSPH	Squamous cell carcinoma
NIPSNAP3A::TMEFF1	Adenocarcinoma
NISCH::DNAH1	Adenocarcinoma
NISCH::PBRM1	Transitional cell carcinoma
NISCH::ZFTRAF1	Astrocytoma, grade III-IV/Glioblastoma
NIT1::C1orf105	Mesenchymal tumor, NOS
NIT1::TIGAR	Mesenchymal tumor, NOS
NIT2::CMSS1	Squamous cell carcinoma
NIT2::LNP1	Germ cell tumor, NOS
NKAIN1::PFAS	Adenocarcinoma
NKAIN2::MS4A12	Squamous cell carcinoma
NKAIN3::SLCO5A1	Adenocarcinoma
NKAIN3::TOX	Malignant melanoma
NKAIN3::WRN	Malignant epithelial tumor, special type
NKAIN4::IGF2	Adenocarcinoma
NKAPD1::DLAT	Adenocarcinoma
NKD1::ADCY7	Adenocarcinoma
NKD1::NOD2	Astrocytoma, grade I-II
NKD1::SPATC1L	Mesenchymal tumor, NOS
NKD2::ICE1	Adenocarcinoma
NKRF::UBE2A	Adenocarcinoma
NKX2-1::BCL11B	Acute lymphoblastic leukemia/lymphoblastic lymphoma
NKX2-1::DIO2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
NKX2-1::SFTA3	Nonneoplastic epithelial disorder/lesion
NKX2-1::SLC25A21	Squamous cell carcinoma
NKX2-1::TRA	Acute lymphoblastic leukemia/lymphoblastic lymphoma
NKX2-3::TRD	Chronic lymphocytic leukemia
NKX2-5::BCL11B	Acute lymphoblastic leukemia/lymphoblastic lymphoma
NKX3-1::SEC63	Adenocarcinoma
NLE1::BAIAP2	Adenocarcinoma
NLE1::FNDC8	Squamous cell carcinoma
NLGN1::CCDC50	Mesothelioma
NLGN1::FNDC3B	Malignant melanoma
NLGN1::KASH5	Astrocytoma, grade III-IV/Glioblastoma
NLGN1::NAALADL2	Adenocarcinoma
NLGN1::NDUFB5	Astrocytoma, grade III-IV/Glioblastoma
NLGN1::SEMA5B	Malignant melanoma
NLGN1::SERPINI1	Astrocytoma, grade I-II
NLGN4X::ACTN4	Adenocarcinoma
NLGN4X::DMD	Adenocarcinoma
NLGN4Y::SHISA6	Mesenchymal tumor, NOS
NLGN4Y::VAMP7	Squamous cell carcinoma
NLK::BCAS3	Adenocarcinoma
NLK::DOK5	Adenocarcinoma
NLK::DSTN	Acute erythroleukemia (FAB type M6)
NLK::DUSP14	Adenocarcinoma
NLK::ELMO1	Astrocytoma, grade I-II
NLK::KALRN	Adenocarcinoma
NLK::KSR1	Adenocarcinoma
NLK::LGALS9	Adenocarcinoma
NLK::NF1	Adenocarcinoma
NLK::PPP1R1B	Adenocarcinoma
NLK::RAD51D	Squamous cell carcinoma
NLK::SMURF2	Transitional cell carcinoma
NLK::VBP1	Adenocarcinoma
NLN::CTNNA1	Adenocarcinoma
NLN::MAST4	Transitional cell carcinoma
NLRC4::ALK	Adenocarcinoma
NLRC5::CETP	Multiple myeloma
NLRC5::CYB5B	Squamous cell carcinoma
NLRC5::FTO	Adenocarcinoma
NLRC5::MYL12B	Acute myeloblastic leukemia without maturation (FAB type M1)
NLRC5::NUP93	Adenocarcinoma
NLRP1::C1QBP	Adenocarcinoma
NMD3::CASD1	Adenocarcinoma
NMD3::PRKRA	Squamous cell carcinoma
NMD3::USP40	Adenocarcinoma
NME2::ACBD4	Adenocarcinoma
NME2::CCL4L2	Adenocarcinoma
NME2::CEP112	Adenocarcinoma
NME2::TEX14	Adenocarcinoma
NME6::NT5DC2	Mesothelioma
NME6::SPINK8	Squamous cell carcinoma
NME7::ASH1L	Adenocarcinoma
NME7::CCDC181	Mesenchymal tumor, NOS
NME7::KIFAP3	Adenocarcinoma
NME7::KMO	Adenocarcinoma
NME7::MKLN1	Mesenchymal tumor, NOS
NME7::TIPRL	Transitional cell carcinoma
NME8::RET	Adenocarcinoma
NMI::SLC9A4	Adenocarcinoma
NMNAT2::ATF6	Astrocytoma, grade I-II
NMNAT3::CCDC50	Adenocarcinoma
NMNAT3::PLA1A	Malignant melanoma
NMNAT3::SELENOT	Malignant melanoma
NMRAL1::PRKCB	Adenocarcinoma
NMT1::HIGD1B	Adenocarcinoma
NMT1::NLK	Astrocytoma, grade I-II
NMT1::NME1	Squamous cell carcinoma
NMT2::ITGA8	Adenocarcinoma
NMUR1::PDE6D	Adenocarcinoma
NNT::AMIGO2	Squamous cell carcinoma
NNT::NIM1K	Adenocarcinoma
NNT::PRLR	Adenocarcinoma
NOA1::ATP10D	Transitional cell carcinoma
NOA1::N4BP1	Adenocarcinoma
NOA1::PPP3CA	Adenocarcinoma
NOA1::SPINK2	Adenocarcinoma
NOC2L::C1ORF159	Squamous cell carcinoma
NOC2L::CCNL2	Adenocarcinoma
NOC2L::ELOA	Transitional cell carcinoma
NOC2L::LRRC38	Mesenchymal tumor, NOS
NOC3L::PLCE1	Adenocarcinoma
NOC4L::FBRSL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Multiple myeloma
NOC4L::SDS	Astrocytoma, grade III-IV/Glioblastoma
NOC4L::STAB2	Squamous cell carcinoma
NOCT::GATB	Adenocarcinoma
NOCT::MGST2	Malignant epithelial tumor, special type
NOL10::HDAC1	Adenocarcinoma
NOL10::PDIA6	Adenocarcinoma
NOL10::ROCK2	Adenocarcinoma
NOL10::SND1	Adenocarcinoma
NOL11::CARD11	Adenocarcinoma
NOL11::CMBL	Adenocarcinoma
NOL11::HSF5	Adenocarcinoma
NOL12::GGA1	Squamous cell carcinoma
NOL12::LGALS1	Transitional cell carcinoma
NOL12::STARD3	Adenocarcinoma
NOL12::UNC13C	Adenocarcinoma
NOL4L::CDK5RAP1	Adenocarcinoma
NOL4L::COMMD7	Adenocarcinoma
NOL4L::EFCAB8	Malignant melanoma
NOL4L::OTULINL	Mesenchymal tumor, NOS
NOL4L::PRKD1	Adenocarcinoma
NOL7::ERVFRD-1	Adenocarcinoma
NOL8::FXN	Germ cell tumor, NOS
NOL9::DNAJC11	Squamous cell carcinoma
NOL9::ESPN	Adenocarcinoma
NOL9::TRNAU1AP	Adenocarcinoma
NOLC1::HTR7	Malignant epithelial tumor, special type
NOM1::ETV6	Acute myeloid leukemia, NOS | Skin
NOM1::RNF32	Adenocarcinoma
NOM1::UVRAG	Mesenchymal tumor, NOS
NOMO1::CSNK1A1	Squamous cell carcinoma
NOMO1::MYH11	Adenocarcinoma
NOMO2::FBRS	Adenocarcinoma
NOMO2::PRR14	Adenocarcinoma
NOMO3::ABCC1	Adenocarcinoma
NOMO3::INO80E	Adenocarcinoma
NOMO3::TFAP4	Adenocarcinoma
NONO::TFE3	PEComa | Adenocarcinoma | Schwannoma | Malignant epithelial tumor, special type | Soft tissue tumor, special type | Acute lymphoblastic leukemia/lymphoblastic lymphoma
NONO::ZFP36L2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
NOP14::CDK18	Adenocarcinoma
NOP14::LYAR	Adenocarcinoma
NOP2::PIANP	Adenocarcinoma
NOP2::TCF3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
NOP53::IGK	Multiple myeloma
NOP58::BMPR2	Squamous cell carcinoma
NOP58::KIAA2012	Adenocarcinoma | Squamous cell carcinoma
NOPCHAP1::RIC8B	Adenocarcinoma
NOS1::UBC	Malignant melanoma
NOS1AP::AHI1	Transitional cell carcinoma
NOS1AP::ATF6	Adenocarcinoma
NOS1AP::C1ORF226	Adenocarcinoma
NOS1AP::COLGALT2	Adenocarcinoma
NOS1AP::DARS2	Adenocarcinoma
NOS1AP::DCAF6	Adenocarcinoma
NOS1AP::F5	Adenocarcinoma
NOS1AP::LRRC52	Transitional cell carcinoma
NOS1AP::MROH9	Adenocarcinoma
NOS1AP::NTRK1	Adenocarcinoma | Leiomyosarcoma
NOS1AP::NTRK2	Glioma, NOS
NOS1AP::PBX1	Adenocarcinoma
NOS1AP::POM121C	Malignant melanoma
NOS2::AATF	Adenocarcinoma
NOS2::ERBB2	Adenocarcinoma
NOS2::MYO18A	Adenocarcinoma
NOSIP::RCN3	Malignant epithelial tumor, special type
NOSIP::STK11	Mesothelioma
NOSIP::TSKS	Adenocarcinoma
NOTCH1::BLTP3B	Mesenchymal tumor, NOS
NOTCH1::CHST9	Squamous cell carcinoma
NOTCH1::EDF1	Skin | Acute myeloid leukemia, NOS
NOTCH1::ENTR1	Squamous cell carcinoma | Astrocytoma, grade I-II
NOTCH1::EXD3	Adenocarcinoma
NOTCH1::GABBR2	Adenocarcinoma
NOTCH1::GNB1	Malignant melanoma
NOTCH1::HNF1B	Adenocarcinoma
NOTCH1::LCN10	Adenocarcinoma
NOTCH1::LCN15	Adenocarcinoma | Mature B-cell neoplasm, NOS
NOTCH1::MAPK1	Squamous cell carcinoma
NOTCH1::NUP214	Adenocarcinoma
NOTCH1::ROS1	Angiosarcoma
NOTCH1::SPTAN1	Adenocarcinoma
NOTCH1::TMEM117	Adenocarcinoma
NOTCH2::ADAM30	Adenocarcinoma
NOTCH2::CEP128	Glomus tumor
NOTCH2::CWH43	Squamous cell carcinoma
NOTCH2::MNDA	Adenocarcinoma
NOTCH2::PSMA5	Adenocarcinoma
NOTCH2::REG4	Malignant melanoma
NOTCH2::SEC22B	Adenocarcinoma | Squamous cell carcinoma
NOTCH2::SPAG17	Adenocarcinoma | Squamous cell carcinoma
NOTCH2NLA::FCGR3B	Adenocarcinoma
NOTCH2NLA::HJV	Malignant epithelial tumor, special type
NOTCH2NLA::NBPF10	Nonneoplastic epithelial disorder/lesion | Nonneoplastic hematologic disorder/lesion
NOTCH2NLA::RAD51B	Adenocarcinoma
NOTCH2NLA::UBE2H	Adenocarcinoma
NOTCH2NLA::UCK2	Malignant melanoma
NOTCH3::BRD4	Adenocarcinoma
NOTCH3::C3	Adenocarcinoma
NOTCH3::CACNA1A	Mesenchymal tumor, NOS
NOTCH3::DEFB132	Squamous cell carcinoma
NOTCH3::HFM1	Malignant soft tissue tumor, NOS
NOTCH3::HOXD10	Adenocarcinoma
NOTCH3::HOXD11	Adenocarcinoma
NOTCH3::SETBP1	Meningioma
NOTCH3::SPECC1	Adenocarcinoma
NOTCH3::UBTF	Squamous cell carcinoma
NOVA1::CCSER1	Transitional cell carcinoma
NOVA1::DTD2	Astrocytoma, grade I-II
NOVA2::LEUTX	Astrocytoma, grade I-II
NOX4::SMCO4	Adenocarcinoma
NOXO1::ECI1	Adenocarcinoma
NPAS2::CNOT11	Transitional cell carcinoma
NPAS2::GNLY	Adenocarcinoma
NPAS2::PACSIN2	Adenocarcinoma
NPAS3::AKAP6	Adenocarcinoma
NPAS3::ARHGAP5	Adenocarcinoma
NPAS3::OXA1L	Squamous cell carcinoma
NPAS3::RB1	Adenocarcinoma
NPAS3::RET	Carcinoma, NOS
NPAS3::TERT	Astrocytoma, grade III-IV/Glioblastoma
NPAT::OAF	Mesenchymal tumor, NOS
NPAT::SLN	Adenocarcinoma
NPC1::ANKRD29	Adenocarcinoma
NPC1::FGD4	Adenocarcinoma
NPC1::GREB1L	Adenocarcinoma
NPC1::MAGI1	Multiple myeloma
NPC1::OSBPL1A	Adenocarcinoma
NPC2::LTBP2	Adenocarcinoma
NPC2::RAD51B	Adenocarcinoma
NPEPL1::DSN1	Squamous cell carcinoma
NPEPPS::CREB3L1	Malignant epithelial tumor, special type
NPEPPS::EPHA6	Undifferentiated carcinoma, small cell
NPEPPS::FAM117A	Adenocarcinoma
NPEPPS::GNGT2	Adenocarcinoma
NPEPPS::HDAC5	Miscellaneous hematopoietic/lymphoid neoplasm, special type
NPEPPS::IKZF3	Transitional cell carcinoma
NPEPPS::KPNB1	Adenocarcinoma
NPEPPS::MYO18A	Astrocytoma, grade III-IV/Glioblastoma
NPEPPS::OMG	Adenocarcinoma
NPEPPS::TBC1D3	Adenocarcinoma | Malignant epithelial tumor, special type
NPHP1::DDR2	Adenocarcinoma
NPHP3::LSAMP	Malignant melanoma
NPHP4::ACOT7	Astrocytoma, grade I-II
NPHP4::CDKN2A	Malignant melanoma
NPHP4::FGGY	Mature B-cell neoplasm, NOS
NPHP4::GARIN3	Adenocarcinoma
NPL::LAMC1	Malignant melanoma
NPLOC4::ALYREF	Adenocarcinoma
NPLOC4::CYP4B1	Adenocarcinoma
NPLOC4::FASN	Adenocarcinoma
NPLOC4::HEXD	Adenocarcinoma
NPLOC4::NOTUM	Adenocarcinoma
NPLOC4::OXLD1	Squamous cell carcinoma
NPLOC4::P4HB	Squamous cell carcinoma
NPLOC4::PDE6G	Adenocarcinoma
NPLOC4::RBPMS2	Adenocarcinoma
NPLOC4::SIRT7	Adenocarcinoma
NPM1::ALK	Hodgkin disease, NOS | Hodgkin disease, mixed cellularity | Peripheral T-cell lymphoma, unspecified | Mature B-cell neoplasm, NOS | Hodgkin disease, nodular sclerosis | Mycosis fungoides/Sézary syndrome | Anaplastic large cell lymphoma, systemic type | Follicular lymphoma | Mature T- and NK-cell neoplasm, NOS | Nonneoplastic hematologic disorder/lesion | Diffuse large B-cell lymphoma | Anaplastic large cell lymphoma, cutaneous type
NPM1::CCDC28A	Acute myeloblastic leukemia with maturation (FAB type M2)
NPM1::MLF1	Acute myeloblastic leukemia with maturation (FAB type M2) | Chronic myeloproliferative disorder, NOS | Acute myeloid leukemia, NOS | Skin | Acute myelomonocytic leukemia (FAB type M4) | Acute myeloblastic leukemia without maturation (FAB type M1) | Acute erythroleukemia (FAB type M6) | Refractory anemia with excess blasts-2
NPM1::RAB4A	Adenocarcinoma
NPM1::RARA	Acute promyelocytic leukemia (FAB type M3)
NPM1::RARG::NPM1	Acute promyelocytic leukemia (FAB type M3)
NPM1::ROS1	Adenocarcinoma
NPM1::TYK2	Anaplastic large cell lymphoma, cutaneous type | Anaplastic large cell lymphoma, systemic type | Subcutaneous panniculitis-like T-cell lymphoma
NPM1::VIM	Astrocytoma, grade I-II
NPNT::GSTCD	Astrocytoma, grade I-II
NPR2::GCKR	Adenocarcinoma
NPRL3::KIFC2	Transitional cell carcinoma
NPRL3::LUC7L	Transitional cell carcinoma
NPRL3::PRR35	Malignant epithelial tumor, special type
NPRL3::UBE2L3	Transitional cell carcinoma
NPSR1::SUGCT	Adenocarcinoma
NPTN::CLUAP1	Adenocarcinoma
NPTN::ECI1	Adenocarcinoma
NPTN::HMG20A	Malignant melanoma
NPTN::NRG1	Adenocarcinoma
NPTX1::FBXO7	Malignant melanoma
NPTXR::CHEK2	Mesothelioma
NPTXR::GTPBP1	Adenocarcinoma
NPTXR::LGALS1	Astrocytoma, grade I-II
NPTXR::PDXP	Astrocytoma, grade I-II
NPTXR::SH3BP1	Astrocytoma, grade I-II
NPY::DDX21	Adenocarcinoma
NPY::FOXP1	Adenocarcinoma
NPY::IGF2	Malignant epithelial tumor, special type
NQO1::JAG1	Adenocarcinoma
NQO1::SEC31A	Transitional cell carcinoma
NR1D1::MAML1	Soft tissue tumor, special type
NR1D1::MAML2	Soft tissue tumor, special type
NR1D1::USP6	Fibroma of tendon sheath
NR1D2::UBE2E2	Adenocarcinoma
NR1H2::ZNF610	Adenocarcinoma
NR2C1::BCL7A	Mesenchymal tumor, NOS
NR2C1::PTPRB	Adenocarcinoma
NR2C2::ASCC1	Adenocarcinoma
NR2C2::CFAP410	Leiomyoma
NR2C2::COLQ	Adenocarcinoma
NR2C2::FGD5	Miscellaneous hematopoietic/lymphoid neoplasm, special type | Adenocarcinoma
NR2C2::KIF15	Adenocarcinoma
NR2C2::PARL	Adenocarcinoma
NR2C2AP::MAP1S	Adenocarcinoma
NR2F2::DCC	Astrocytoma, grade III-IV/Glioblastoma
NR2F2::MSI2	Adenocarcinoma
NR2F6::ABHD8	Adenocarcinoma
NR2F6::MAST3	Adenocarcinoma
NR2F6::OCEL1	Adenocarcinoma
NR2F6::PLVAP	Adenocarcinoma
NR2F6::UNC13A	Adenocarcinoma
NR2F6::USHBP1	Squamous cell carcinoma
NR3C1::HMHB1	Astrocytoma, grade III-IV/Glioblastoma
NR3C2::SPATA17	Adenocarcinoma
NR3C2::SPPL3	Adenocarcinoma
NR4A1::IL20RB	Squamous cell carcinoma
NR4A2::GPD2	Squamous cell carcinoma
NR4A3::PGR	Muscle tumor, special type
NR5A1::NR6A1	Adenocarcinoma
NR6A1::DEAF1	Transitional cell carcinoma
NR6A1::GOLGA1	Malignant melanoma
NR6A1::OBP2B	Acute megakaryoblastic leukemia (FAB type M7)
NR6A1::TRHDE	Liposarcoma, dedifferentiated
NRAP::SLC35A4	Adenocarcinoma
NRAS::CLDN14	Adenocarcinoma
NRBF2::CYP26A1	Adenocarcinoma
NRBF2::REEP3	Transitional cell carcinoma
NRBF2::SAE1	Adenocarcinoma
NRBP1::DROSHA	Astrocytoma, grade I-II
NRBP1::RPS16	Adenocarcinoma
NRBP2::TMEM245	Acute lymphoblastic leukemia/lymphoblastic lymphoma
NRBP2::VPS28	Adenocarcinoma
NRCAM::BNC2	Adenocarcinoma
NRCAM::BRAF	Malignant epithelial tumor, special type
NRCAM::CFTR	Adenocarcinoma
NRCAM::CUX1	Squamous cell carcinoma
NRCAM::SEM1	Malignant melanoma
NRCAM::TLN1	Astrocytoma, grade I-II
NRDC::KCNK9	Squamous cell carcinoma
NRDC::USP24	Adenocarcinoma
NRDC::VPS53	Astrocytoma, grade I-II
NRDE2::CATSPERB	Transitional cell carcinoma
NREP::COMMD10	Adenocarcinoma
NRF1::ADAD2	Squamous cell carcinoma
NRF1::BRAF	Soft tissue tumor, special type | Adenocarcinoma | Neuroglial neoplasm, special type | Transitional cell carcinoma
NRF1::CYSTM1	Acute myeloid leukemia, NOS | Skin
NRF1::MLXIPL	Adenocarcinoma
NRF1::MTMR1	Squamous cell carcinoma
NRF1::PDIA4	Adenocarcinoma
NRF1::PPP2R5A	Adenocarcinoma
NRF1::RHEB	Malignant melanoma
NRF1::STRIP2	Adenocarcinoma
NRG1::APP	Adenocarcinoma
NRG1::KRT78	Transitional cell carcinoma
NRG1::PLPBP	Mesothelioma
NRG1::PMEPA1	Malignant epithelial tumor, special type
NRG1::STMN2	Adenocarcinoma
NRG2::CYSTM1	Adenocarcinoma
NRG2::RNF14	Adenocarcinoma
NRG3::ERBB2	Carcinoma, NOS
NRG3::SCD	Adenocarcinoma
NRG4::LINGO1	Adenocarcinoma
NRG4::SCNN1D	Adenocarcinoma
NRIP1::BCL2L1	Skin | Acute myeloid leukemia, NOS
NRIP1::C21ORF91	Transitional cell carcinoma
NRIP1::CSNK1G1	Mesenchymal tumor, NOS
NRIP1::DECR1	Transitional cell carcinoma
NRIP1::DSCAM	Mesenchymal tumor, NOS
NRIP1::GDPD1	Squamous cell carcinoma
NRIP1::HIBADH	Adenocarcinoma
NRIP1::IGSF8	Mesothelioma
NRIP1::MECOM	Skin | Refractory anemia with excess blasts-2 | Acute myeloid leukemia, NOS | Acute myeloblastic leukemia with maturation (FAB type M2) | Refractory anemia with ringed sideroblasts
NRIP1::RSPO2	Adenoma
NRIP1::SH3BGR	Adenocarcinoma
NRIP1::SHCBP1	Adenocarcinoma
NRIP3::DENND2B	Squamous cell carcinoma
NRN1::GNG7	Diffuse large B-cell lymphoma
NRP1::ANP32E	Chronic lymphocytic leukemia
NRP1::CUL2	Astrocytoma, grade I-II
NRP1::PTEN	Adenocarcinoma
NRP1::VSTM4	Adenocarcinoma
NRP2::ALK	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma
NRP2::C2ORF66	Endometrial stromal sarcoma
NRP2::KLF7	Adenocarcinoma
NRP2::PARD3B	Squamous cell carcinoma | Adenocarcinoma | Malignant melanoma
NRSN2::OSBPL1A	Malignant melanoma
NRXN1::PLEKHG4B	Squamous cell carcinoma
NRXN2::NSD1	Malignant epithelial tumor, special type
NRXN3::ADCK1	Astrocytoma, grade I-II | Adenocarcinoma
NRXN3::IFT74	Astrocytoma, grade I-II
NRXN3::TSHR	Astrocytoma, grade I-II
NSA2::FIS1	Adenocarcinoma
NSA2::HEXB	Adenocarcinoma
NSA2::PCDHA13	Malignant melanoma
NSA2::PCDHA3	Malignant melanoma
NSA2::PCDHAC1	Malignant melanoma
NSA2::PCDHAC2	Malignant melanoma
NSD1::ARHGAP26	Mesenchymal tumor, NOS
NSD1::C11ORF58	Squamous cell carcinoma
NSD1::C11orf58	Squamous cell carcinoma
NSD1::CDH23	Adenocarcinoma
NSD1::DPEP2	Squamous cell carcinoma
NSD1::EFNA5	Adenocarcinoma
NSD1::FAT2	Transitional cell carcinoma
NSD1::FGF18	Mesenchymal tumor, NOS
NSD1::FGFR4	Carcinoma, NOS | Adenocarcinoma
NSD1::NCKIPSD	Adenocarcinoma
NSD1::NUP98	Acute myeloblastic leukemia with maturation (FAB type M2) | Acute myelomonocytic leukemia (FAB type M4) | Acute myeloid leukemia, NOS | Skin
NSD1::PCDHB15	Adenocarcinoma
NSD1::PRKN	Astrocytoma, grade III-IV/Glioblastoma
NSD1::RNF130	Astrocytoma, grade I-II
NSD1::UNC5A	Adenocarcinoma
NSD1::ZNF346	Adenocarcinoma
NSD2::CFAP99	Adenocarcinoma
NSD2::CPLX1	Astrocytoma, grade I-II
NSD2::DOK7	Adenocarcinoma
NSD2::FAM53A	Adenocarcinoma
NSD2::FGFR3	Carcinoma, NOS
NSD2::GSDMB	Adenocarcinoma
NSD2::IGH	Multiple myeloma
NSD2::NAT8L	Adenocarcinoma
NSD2::NUP210L	Malignant epithelial tumor, special type
NSD2::PHTF2	Squamous cell carcinoma
NSD2::PIBF1	Squamous cell carcinoma
NSD2::QKI	Astrocytoma, grade I-II
NSD2::TACC3	Adenocarcinoma
NSD2::YIPF7	Adenocarcinoma
NSD3::ADAM18	Adenocarcinoma
NSD3::ADAM32	Adenocarcinoma
NSD3::ANK1	Adenocarcinoma
NSD3::ASH2L	Squamous cell carcinoma
NSD3::CSMD1	Adenocarcinoma
NSD3::DDHD2	Adenocarcinoma
NSD3::DUSP26	Adenocarcinoma
NSD3::FGFR1	Squamous cell carcinoma | Adenocarcinoma
NSD3::FOXO1	Rhabdomyosarcoma, NOS
NSD3::GAB2	Adenocarcinoma
NSD3::LETM2	Squamous cell carcinoma
NSD3::LSM1	Adenocarcinoma | Squamous cell carcinoma
NSD3::MUCL1	Adenocarcinoma
NSD3::NCOA2	Adenocarcinoma
NSD3::NEGR1	Adenocarcinoma
NSD3::NUTM1	Malignant peripheral nerve sheath tumor/Triton | Undifferentiated carcinoma | Squamous cell carcinoma | Malignant epithelial tumor, special type | Adenocarcinoma
NSD3::PLAT	Adenocarcinoma
NSD3::PLEKHA2	Adenocarcinoma
NSD3::PSD3	Adenocarcinoma
NSD3::PURG	Malignant epithelial tumor, special type
NSD3::RAB11FIP1	Adenocarcinoma
NSD3::RSF1	Adenocarcinoma
NSD3::SNX20	Adenocarcinoma
NSD3::TACC1	Squamous cell carcinoma
NSD3::TCEA1	Squamous cell carcinoma
NSD3::UNC5D	Adenocarcinoma
NSD3::ZMAT4	Adenocarcinoma
NSD3::ZNF721	Adenocarcinoma
NSF::EED	Adenocarcinoma
NSF::EFCAB13	Adenocarcinoma
NSF::NFE2L1	Malignant melanoma
NSF::STRADA	Squamous cell carcinoma
NSFL1C::EPSTI1	Adenocarcinoma
NSFL1C::HOOK2	Mesenchymal tumor, NOS
NSL1::PACC1	Adenocarcinoma
NSL1::STIP1	Transitional cell carcinoma
NSMAF::CLVS1	Adenocarcinoma
NSMAF::DEPTOR	Adenocarcinoma
NSMAF::LETM2	Adenocarcinoma
NSMAF::TOX	Mature B-cell neoplasm, NOS | Adenocarcinoma
NSMCE1::IL4R	Malignant melanoma
NSMCE1::PEX11G	Squamous cell carcinoma
NSMCE2::COL22A1	Mesenchymal tumor, NOS
NSMCE2::DCLRE1C	Adenocarcinoma
NSMCE2::EXT1	Mesenchymal tumor, NOS
NSMCE2::NUTM1	Malignant epithelial tumor, special type
NSMCE2::PACRG	Squamous cell carcinoma
NSMCE2::PBX3	Adenocarcinoma
NSMCE2::SNTB1	Adenocarcinoma
NSMCE2::TAF2	Mesenchymal tumor, NOS
NSMCE2::TBC1D31	Adenocarcinoma
NSMCE4A::ATE1	Adenocarcinoma
NSMF::ZMYND19	Adenocarcinoma
NSRP1::ANKRD13B	Adenocarcinoma
NSRP1::CDK12	Adenocarcinoma
NSRP1::EFCAB5	Transitional cell carcinoma
NSRP1::METTL23	Adenocarcinoma
NSRP1::SKAP1	Adenocarcinoma
NSRP1::SLC6A13	Adenocarcinoma
NSRP1::WDR27	Mesenchymal tumor, NOS
NSRP1::ZNF536	Mesothelioma
NSUN2::STK39	Astrocytoma, grade III-IV/Glioblastoma
NSUN2::TBL1Y	Transitional cell carcinoma
NSUN4::BMPR1B	Adenocarcinoma
NSUN4::FAAH	Adenocarcinoma
NSUN5::BAZ1B	Adenocarcinoma
NSUN5::BCL7B	Adenocarcinoma
NSUN6::ARMS2	Adenocarcinoma
NSUN6::PITPNC1	Osteosarcoma, NOS
NT5C2::ARL3	Adenocarcinoma
NT5C2::ASAH2	Adenocarcinoma
NT5C2::ATP5MK	Adenocarcinoma
NT5C2::C10ORF120	Adenocarcinoma
NT5C2::C10orf120	Adenocarcinoma
NT5C2::KMT2A	Acute monoblastic leukemia (FAB type M5)
NT5C2::LRIT1	Mesothelioma
NT5C::JPT1	Adenocarcinoma
NT5DC1::DSE	Adenocarcinoma
NT5DC1::RDH11	Adenocarcinoma
NT5DC1::SEC63	Squamous cell carcinoma
NT5DC1::SLC35F1	Adenocarcinoma
NT5DC3::KNTC1	Adenocarcinoma
NT5DC3::PTPRR	Mesenchymal tumor, NOS
NT5E::ASCC3	Adenocarcinoma
NT5M::ZNF652	Adenocarcinoma
NTAN1::SLC17A5	Squamous cell carcinoma
NTAQ1::ATAD2	Squamous cell carcinoma
NTAQ1::CCN5	Transitional cell carcinoma
NTAQ1::CDHR2	Adenocarcinoma
NTF3::PLAG1	Adenoma
NTHL1::KLRC3	Astrocytoma, grade I-II
NTM::CARD18	Adenocarcinoma
NTM::CCDC86	Astrocytoma, grade I-II
NTM::CTNNA2	Mesenchymal tumor, NOS
NTM::SORL1	Mesenchymal tumor, NOS
NTN1::HDLBP	Adenocarcinoma
NTN1::PKD2L2	Adenocarcinoma
NTN1::RANGAP1	Adenocarcinoma
NTN1::STX8	Squamous cell carcinoma
NTN4::CCDC38	Adenocarcinoma
NTN4::KIFAP3	Mesenchymal tumor, NOS
NTN4::LETMD1	Mesenchymal tumor, NOS
NTN4::NUP107	Mesenchymal tumor, NOS
NTN4::PAH	Adenocarcinoma
NTN4::TRHDE	Mesenchymal tumor, NOS
NTNG1::BCAS1	Adenocarcinoma
NTNG1::CALN1	Malignant melanoma
NTNG2::LPIN1	Adenocarcinoma
NTPCR::LRRC28	Astrocytoma, grade III-IV/Glioblastoma
NTPCR::SMIM22	Adenocarcinoma
NTRK1::ARHGEF11	Adenocarcinoma
NTRK1::DYNC2H1	Mesenchymal tumor, NOS
NTRK1::EPS15	Adenocarcinoma
NTRK1::FMN2	Adenocarcinoma
NTRK1::GPATCH4	Malignant epithelial tumor, special type
NTRK1::LMNA	Adenocarcinoma
NTRK1::SQSTM1	Adenocarcinoma
NTRK1::TPM3	Osteogenic/bone tumor, special type | Adenocarcinoma
NTRK2::AFAP1	Astrocytoma, grade I-II
NTRK2::LAP3	Astrocytoma, grade I-II
NTRK2::RASEF	Adenocarcinoma
NTRK3::AJUBA	Adenocarcinoma
NTRK3::CSNK1G1	Adenocarcinoma
NTRK3::EML4	Mesenchymal tumor, special type
NTRK3::ETV6	Adenocarcinoma
NTRK3::FRY	Astrocytoma, grade I-II
NTRK3::KANK2	Astrocytoma, pilocytic/juvenile
NTRK3::LOXL2	Astrocytoma, grade I-II
NTRK3::LRRC28	Adenocarcinoma
NTRK3::PEAK1	Astrocytoma, grade I-II
NTRK3::RBPMS	Adenocarcinoma
NTRK3::RUNX1	Adenocarcinoma
NTRK3::SCAPER	Melanocytic neoplasm, special type
NTRK3::UPF2	Osteogenic/bone tumor, special type
NTSR1::OSBPL2	Adenocarcinoma
NUAK1::BLTP3B	Mesenchymal tumor, NOS
NUAK1::MTRFR	Mesenchymal tumor, NOS
NUAK2::CYB5R1	Astrocytoma, grade I-II
NUAK2::DSTYK	Adenocarcinoma
NUAK2::LEMD1	Adenocarcinoma | Squamous cell carcinoma
NUB1::ABCB8	Squamous cell carcinoma
NUB1::BRAF	Adenocarcinoma
NUBP1::UMODL1	Adenocarcinoma
NUBP2::P4HB	Malignant melanoma
NUBP2::RHBDL1	Mesenchymal tumor, NOS
NUBPL::ANKRD46	Adenocarcinoma
NUBPL::DOCK2	Adenocarcinoma
NUBPL::NF1	Angiosarcoma
NUBPL::PSMA6	Adenocarcinoma
NUBPL::SCFD1	Adenocarcinoma
NUCB1::FAM83E	Adenocarcinoma
NUCB1::RUVBL2	Acute myeloid leukemia, NOS | Skin
NUCKS1::CNTN2	Adenocarcinoma
NUCKS1::PM20D1	Astrocytoma, grade III-IV/Glioblastoma | Adenocarcinoma
NUCKS1::RAB29	Malignant melanoma
NUCKS1::SDCCAG8	Malignant epithelial tumor, special type
NUDC::IGFN1	Adenocarcinoma
NUDCD1::EIF3H	Adenocarcinoma
NUDCD1::MROH1	Adenocarcinoma
NUDCD1::OR10J1	Adenocarcinoma
NUDCD1::SYBU	Undifferentiated carcinoma, small cell
NUDCD1::TMEM184C	Adenocarcinoma
NUDCD1::VWA8	Adenocarcinoma
NUDCD3::FGFR1	Egypt | Bilineage or biphenotypic leukemia
NUDCD3::IFNGR2	Adenocarcinoma
NUDCD3::ROS1	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma
NUDT14::BRF1	Squamous cell carcinoma
NUDT16L1::FAHD1	Astrocytoma, grade III-IV/Glioblastoma
NUDT17::POLR3C	Adenocarcinoma
NUDT19::DPY19L3	Transitional cell carcinoma
NUDT19::LSM14A	Adenocarcinoma
NUDT19::SLC7A9	Adenocarcinoma
NUDT19::TDRD12	Adenocarcinoma
NUDT21::BBS2	Adenocarcinoma
NUDT22::VPS51	Astrocytoma, grade I-II
NUDT2::GLIPR2	Astrocytoma, grade III-IV/Glioblastoma
NUDT2::UBAP1	Transitional cell carcinoma
NUDT3::CDH12	Squamous cell carcinoma
NUDT3::DDR1	Astrocytoma, grade I-II
NUDT3::DNAH8	Squamous cell carcinoma
NUDT3::MAP4	Astrocytoma, grade III-IV/Glioblastoma
NUDT3::MAPK8	Adenocarcinoma
NUDT3::MOCS1	Adenocarcinoma
NUDT3::SPDEF	Adenocarcinoma
NUDT3::TCP11	Malignant epithelial tumor, special type
NUDT4::ADD1	Adenocarcinoma
NUDT4::ATAD5	Adenocarcinoma
NUDT4::MRPL42	Adenocarcinoma
NUDT7::IFT57	Adenocarcinoma
NUDT9::FAM13A	Adenocarcinoma
NUF2::PHEX	Mesenchymal tumor, NOS
NUF2::TIMM17A	Adenocarcinoma
NUFIP1::FAAH	Squamous cell carcinoma
NUFIP2::CPD	Adenocarcinoma
NUFIP2::VTN	Transitional cell carcinoma
NUFIP2::ZFP69B	Transitional cell carcinoma
NUGGC::PURG	Adenocarcinoma
NUMA1::AATF	Adenocarcinoma
NUMA1::ABHD12	Squamous cell carcinoma
NUMA1::ADARB2	Adenocarcinoma
NUMA1::ALK	Adenocarcinoma
NUMA1::C2CD3	Malignant melanoma
NUMA1::CADM2	Adenocarcinoma
NUMA1::CCT5	Malignant epithelial tumor, special type
NUMA1::CLPB	Adenocarcinoma
NUMA1::CNTNAP3	Malignant melanoma
NUMA1::CRYM	Adenocarcinoma
NUMA1::DHCR7	Adenocarcinoma
NUMA1::EIF2AK2	Astrocytoma, grade I-II
NUMA1::FAM83B	Adenocarcinoma
NUMA1::FOLR1	Astrocytoma, grade I-II
NUMA1::FOXP1	Adenocarcinoma
NUMA1::IQSEC3	Adenocarcinoma
NUMA1::NTRK1	Soft tissue tumor, special type
NUMA1::PDE2A	Adenocarcinoma
NUMA1::PITPNM1	Adenocarcinoma
NUMA1::PPP2R5B	Adenocarcinoma
NUMA1::PTH	Adenocarcinoma
NUMA1::RARA	Acute promyelocytic leukemia (FAB type M3)
NUMA1::SFMBT1	Benign fibrous histiocytoma
NUMA1::SFN	Squamous cell carcinoma
NUMA1::SHANK2	Adenocarcinoma
NUMA1::TBC1D10A	Adenocarcinoma
NUMA1::TRPT1	Adenocarcinoma
NUMA1::UBA2	Astrocytoma, grade I-II
NUMA1::YAP1	Malignant melanoma
NUMB::ALDH6A1	Adenocarcinoma
NUMB::DNM2	Malignant epithelial tumor, special type
NUMB::GPR68	Squamous cell carcinoma
NUMB::HEATR4	Adenocarcinoma | Mature B-cell neoplasm, NOS
NUMB::IFI16	Squamous cell carcinoma
NUMB::SLC39A9	Malignant melanoma
NUMB::TSHR	Malignant melanoma
NUMB::TTLL5	Transitional cell carcinoma
NUMBL::CYP2F1	Astrocytoma, grade I-II
NUP107::CPM	Transitional cell carcinoma
NUP107::CYP27B1	Astrocytoma, grade III-IV/Glioblastoma
NUP107::LGR5	Liposarcoma, dedifferentiated
NUP107::MDM2	Adenocarcinoma
NUP107::PAAF1	Mesenchymal tumor, NOS
NUP107::PAPPA	Liposarcoma, dedifferentiated
NUP107::SHD	Adenocarcinoma
NUP107::TMBIM4	Transitional cell carcinoma
NUP133::CDH6	Transitional cell carcinoma
NUP133::PARPBP	Adenocarcinoma
NUP153::ABL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
NUP153::CFAP20DC	Adenocarcinoma
NUP153::DTNBP1	Transitional cell carcinoma
NUP153::GCNT2	Adenocarcinoma
NUP153::MAK	Astrocytoma, grade I-II
NUP153::MESP1	Malignant melanoma
NUP153::NEDD9	Adenocarcinoma
NUP153::NTNG2	Adenocarcinoma
NUP153::RNF2	Adenocarcinoma
NUP153::TMEM138	Adenocarcinoma
NUP153::TSBP1	Adenocarcinoma
NUP153::ZNF280C	Adenocarcinoma
NUP153::ZNF280D	Adenocarcinoma
NUP155::ANKH	Malignant melanoma
NUP155::TRIO	Transitional cell carcinoma
NUP155::ZFYVE26	Adenocarcinoma
NUP160::AGBL2	Adenocarcinoma
NUP160::GALNT18	Adenocarcinoma
NUP160::RBM6	Malignant epithelial tumor, special type
NUP160::SLC43A3	Angiosarcoma
NUP188::ASTN2	Adenocarcinoma
NUP188::MYMK	Transitional cell carcinoma
NUP188::PHYHD1	Adenocarcinoma
NUP188::SPTAN1	Adenocarcinoma
NUP188::TBC1D13	Malignant epithelial tumor, special type
NUP205::ASH1L	Adenocarcinoma
NUP205::CCDC136	Adenocarcinoma
NUP205::DVL2	Adenocarcinoma
NUP205::GIMAP8	Mesenchymal tumor, NOS
NUP205::SERPINA12	Mesenchymal tumor, NOS
NUP205::WDR91	Adenocarcinoma
NUP210::FBLN2	Adenocarcinoma
NUP210::MAST1	Malignant epithelial tumor, special type
NUP210::RSRC1	Undifferentiated carcinoma, small cell
NUP210::WNT7A	Adenocarcinoma
NUP210L::ERBB2	Carcinoma, NOS
NUP210L::TPM3	Malignant epithelial tumor, special type
NUP214::ABL1	Refractory anemia with excess blasts-2 | Acute myeloid leukemia, NOS | Adenocarcinoma | Acute megakaryoblastic leukemia (FAB type M7) | Skin | Acute lymphoblastic leukemia/lymphoblastic lymphoma
NUP214::AIF1L	Adenocarcinoma
NUP214::BRAF	Adenocarcinoma
NUP214::CACNA1B	Adenocarcinoma
NUP214::RAC1	Acute myeloblastic leukemia with maturation (FAB type M2)
NUP214::SEC14L2	Adenocarcinoma
NUP214::TOM1L2	Adenocarcinoma
NUP214::XKR3	Heart | Chronic myeloid leukemia, t(9;22)
NUP35::KCNH7	Adenocarcinoma
NUP35::NCKAP1	Squamous cell carcinoma
NUP37::ACSS3	Malignant melanoma
NUP42::EPCAM	Adenocarcinoma
NUP42::GSDME	Adenocarcinoma
NUP43::SHPRH	Mesenchymal tumor, NOS
NUP50::CDK5RAP1	Adenocarcinoma
NUP50::RBFOX2	Adenocarcinoma
NUP54::CXCL9	Adenocarcinoma
NUP58::CCDC169	Adenocarcinoma
NUP58::KL	Malignant melanoma
NUP58::SPATA13	Mesenchymal tumor, NOS
NUP62::AP2A1	Squamous cell carcinoma
NUP62::DYRK1B	Adenocarcinoma
NUP62::KCNQ2	Adenocarcinoma
NUP62::TBC1D17	Squamous cell carcinoma
NUP62::VSTM2B	Transitional cell carcinoma
NUP85::GPC3	Adenocarcinoma
NUP85::IL34	Adenocarcinoma
NUP85::KCTD2	Transitional cell carcinoma
NUP85::NR5A2	Squamous cell carcinoma
NUP85::TMEM94	Adenocarcinoma
NUP85::ZDHHC18	Transitional cell carcinoma
NUP88::NLRP1	Transitional cell carcinoma
NUP93::GNAO1	Astrocytoma, grade I-II
NUP93::GPT2	Adenocarcinoma
NUP93::MT1H	Squamous cell carcinoma
NUP93::SUGCT	Acute lymphoblastic leukemia/lymphoblastic lymphoma
NUP93::THADA	Malignant epithelial tumor, special type
NUP98::ADD3	Acute myeloid leukemia, NOS | Skin | Acute lymphoblastic leukemia/lymphoblastic lymphoma
NUP98::ASH1L	Skin | Acute myeloid leukemia, NOS
NUP98::BPTF	Skin | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Acute megakaryoblastic leukemia (FAB type M7) | Acute myeloid leukemia, NOS
NUP98::BRWD3	Acute myeloid leukemia, NOS | Skin
NUP98::CADM1	Acute megakaryoblastic leukemia (FAB type M7)
NUP98::CCDC28A	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Acute megakaryoblastic leukemia (FAB type M7)
NUP98::DDX10	Acute monoblastic leukemia (FAB type M5) | Acute monoblastic leukemia with differentiation (FAB type M5b) | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Acute myeloid leukemia, NOS | Heart | Acute myelomonocytic leukemia (FAB type M4) | Chronic myeloid leukemia, t(9;22) | Refractory anemia | Acute erythroleukemia (FAB type M6) | Spleen | Myelodysplastic syndrome, NOS | Acute myeloblastic leukemia without maturation (FAB type M1) | Skin | Chronic myelomonocytic leukemia
NUP98::DNHD1	Transitional cell carcinoma
NUP98::EMX1	Acute myelomonocytic leukemia (FAB type M4)
NUP98::HHEX	Acute myeloblastic leukemia with maturation (FAB type M2)
NUP98::HMGB3	Acute myeloid leukemia, NOS | Acute myelomonocytic leukemia (FAB type M4) | Skin | Acute myeloblastic leukemia without maturation (FAB type M1)
NUP98::HOXA11	Acute myelomonocytic leukemia (FAB type M4) | Heart | Acute myeloblastic leukemia with maturation (FAB type M2) | Juvenile myelomonocytic leukemia | Chronic myeloid leukemia, t(9;22)
NUP98::HOXA13	Acute myeloblastic leukemia with maturation (FAB type M2) | Myelodysplastic syndrome, NOS | Acute myeloid leukemia, NOS | Skin
NUP98::HOXA9	Skin | Acute myeloid leukemia, NOS | Atypical chronic myeloid leukemia | Lymph node | Myelodysplastic syndrome, NOS | Chronic myelomonocytic leukemia | Chronic myeloid leukemia, t(9;22) | Acute myelomonocytic leukemia (FAB type M4) | Acute myeloblastic leukemia with maturation (FAB type M2) | Heart | Spleen | Acute myeloblastic leukemia without maturation (FAB type M1)
NUP98::HOXC11	Chronic myelomonocytic leukemia | Acute myeloid leukemia, NOS | Acute myeloblastic leukemia with maturation (FAB type M2) | Acute monoblastic leukemia with differentiation (FAB type M5b) | Skin | Spleen | Acute myeloblastic leukemia without maturation (FAB type M1)
NUP98::HOXC13	Acute myeloblastic leukemia with maturation (FAB type M2) | Acute myelomonocytic leukemia (FAB type M4)
NUP98::HOXD11	Acute myelomonocytic leukemia (FAB type M4)
NUP98::HOXD13	Acute myelomonocytic leukemia (FAB type M4) | Acute erythroleukemia (FAB type M6) | Heart | Chronic myeloid leukemia, t(9;22) | Acute myeloid leukemia, NOS | Skin
NUP98::IQCG	Egypt | Bilineage or biphenotypic leukemia
NUP98::JADE2	Acute myeloid leukemia, NOS | Skin
NUP98::KAT7	Acute myeloid leukemia, NOS | Skin
NUP98::KDM5A	Acute monoblastic leukemia (FAB type M5) | Acute myeloblastic leukemia with minimal differentiation (FAB type M0) | Skin | Acute myeloid leukemia, NOS | Acute megakaryoblastic leukemia (FAB type M7)
NUP98::KMT2A	Acute myeloblastic leukemia without maturation (FAB type M1) | Acute myeloblastic leukemia with maturation (FAB type M2)
NUP98::LNP1	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Acute myeloblastic leukemia with maturation (FAB type M2)
NUP98::MLLT1	Bilineage or biphenotypic leukemia | Egypt
NUP98::MLXIP	Adenocarcinoma
NUP98::NSD1	Refractory anemia with excess blasts-1 | Acute myeloid leukemia, NOS | Acute myeloblastic leukemia with maturation (FAB type M2) | Acute monoblastic leukemia with differentiation (FAB type M5b) | Skin | Acute myeloblastic leukemia without maturation (FAB type M1) | Bilineage or biphenotypic leukemia | Egypt | Acute myelomonocytic leukemia (FAB type M4) | Acute megakaryoblastic leukemia (FAB type M7) | Acute monoblastic leukemia (FAB type M5)
NUP98::NSD3	Skin | Acute myeloid leukemia, NOS | Acute myeloblastic leukemia without maturation (FAB type M1)
NUP98::PHF23	Acute monoblastic leukemia without differentiation (FAB type M5a) | Acute myeloblastic leukemia with minimal differentiation (FAB type M0) | Acute myeloblastic leukemia without maturation (FAB type M1) | Acute myelomonocytic leukemia (FAB type M4) | Skin | Acute myeloid leukemia, NOS
NUP98::POU1F1	Acute myelomonocytic leukemia (FAB type M4)
NUP98::PRRX1	Chronic myeloid leukemia, t(9;22) | Heart | Skin | Acute myeloblastic leukemia with maturation (FAB type M2) | Acute myeloid leukemia, NOS
NUP98::PRRX2	Skin | Acute myeloid leukemia, NOS | Acute myelomonocytic leukemia (FAB type M4)
NUP98::PSIP1	Acute myeloblastic leukemia with maturation (FAB type M2) | Heart | Chronic myeloid leukemia, t(9;22) | Acute myeloblastic leukemia without maturation (FAB type M1) | Acute myelomonocytic leukemia (FAB type M4) | Egypt | Bilineage or biphenotypic leukemia | Acute myeloid leukemia, NOS | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Skin
NUP98::RAP1GDS1	Acute myeloblastic leukemia with minimal differentiation (FAB type M0) | Acute lymphoblastic leukemia/lymphoblastic lymphoma
NUP98::RARA	Acute promyelocytic leukemia (FAB type M3)
NUP98::RARG	Acute myeloid leukemia, NOS | Acute promyelocytic leukemia (FAB type M3) | Skin
NUP98::RHOG	Adenocarcinoma
NUP98::SET	Skin | Acute myeloid leukemia, NOS
NUP98::SETBP1	Skin | Acute myeloid leukemia, NOS | Acute lymphoblastic leukemia/lymphoblastic lymphoma
NUP98::TMEM117	Adenocarcinoma
NUP98::TNRC18	Acute myelomonocytic leukemia (FAB type M4)
NUP98::TOP1	Acute monoblastic leukemia (FAB type M5) | Acute myeloblastic leukemia without maturation (FAB type M1) | Acute myelomonocytic leukemia (FAB type M4) | Acute monoblastic leukemia with differentiation (FAB type M5b) | Acute myeloid leukemia, NOS | Refractory anemia with excess blasts-2 | Refractory anemia with excess of blasts (FAB) | Acute myeloblastic leukemia with maturation (FAB type M2) | Skin
NUP98::TOP2B	Acute monoblastic leukemia without differentiation (FAB type M5a)
NUP98::VRK1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
NUP98::ZNF512B	Acute myeloid leukemia, NOS | Skin
NUP98::ZNF91	Acute myelomonocytic leukemia (FAB type M4)
NUS1::DCBLD1	Adenocarcinoma
NUS1::ROS1	Liposarcoma, NOS
NUTF2::TSNAXIP1	Adenocarcinoma
NUTM1::CIC	Undifferentiated round cell sarcoma
NUTM2A::CIC	Undifferentiated round cell sarcoma
NVL::C2ORF72	Malignant epithelial tumor, special type
NVL::C2orf72	Embryonal nervous system tumor, special type
NVL::FMN2	Acute megakaryoblastic leukemia (FAB type M7)
NVL::GPKOW	Adenocarcinoma
NVL::LARS2	Transitional cell carcinoma
NVL::NEK2	Adenocarcinoma
NVL::SUSD4	Adenocarcinoma
NVL::WDR26	Adenocarcinoma | Malignant epithelial tumor, special type
NVL::ZPBP2	Adenocarcinoma
NXF1::C11ORF98	Malignant melanoma
NXF1::GANAB	Acute lymphoblastic leukemia/lymphoblastic lymphoma
NXF1::IDH3B	Malignant epithelial tumor, special type
NXF1::LBHD1	Malignant melanoma
NXF1::STX5	Malignant epithelial tumor, special type
NXF1::TAF6L	Adenocarcinoma
NXF1::WDR74	Squamous cell carcinoma
NXN::ABR	Adenocarcinoma
NXN::PRPSAP2	Mesenchymal tumor, NOS
NXN::SLC43A2	Adenocarcinoma
NXN::SMG6	Adenocarcinoma
NXN::WRAP53	Squamous cell carcinoma
NXN::WWOX	Adenocarcinoma
NXPH3::KAT7	Adenocarcinoma
NXT1::VPS16	Adenocarcinoma
NXT2::COL4A5	Adenocarcinoma
NYAP2::KCNU1	Adenocarcinoma
OAF::APOA5	Adenocarcinoma
OAF::SLC26A11	Squamous cell carcinoma
OAF::ZPR1	Adenocarcinoma
OAS1::RPH3A	Squamous cell carcinoma
OAS2::HECTD4	Squamous cell carcinoma
OAS3::ANXA1	Squamous cell carcinoma
OAS3::RPH3A	Adenocarcinoma
OAT::CDYL	Adenocarcinoma
OAZ1::AMH	Adenocarcinoma
OAZ1::ATP6V0C	Multiple myeloma
OAZ1::B2M	Multiple myeloma
OAZ1::BCL2L11	Multiple myeloma
OAZ1::BTBD2	Chronic lymphocytic leukemia
OAZ1::CCND1	Multiple myeloma
OAZ1::CCNG2	Multiple myeloma
OAZ1::CSNK1G2	Mature B-cell neoplasm, NOS | Multiple myeloma | Chronic lymphocytic leukemia
OAZ1::DAZAP1	Mature B-cell neoplasm, NOS | Multiple myeloma
OAZ1::DOT1L	Multiple myeloma
OAZ1::EEF2	Multiple myeloma
OAZ1::FGFR3	Multiple myeloma
OAZ1::IGH	Multiple myeloma
OAZ1::IGK	Multiple myeloma
OAZ1::ISYNA1	Multiple myeloma
OAZ1::KDM4B	Multiple myeloma
OAZ1::KLF16	Multiple myeloma
OAZ1::KLF2	Multiple myeloma
OAZ1::LIMD2	Multiple myeloma
OAZ1::MAFK	Multiple myeloma
OAZ1::MKNK2	Multiple myeloma
OAZ1::ONECUT3	Adenocarcinoma
OAZ1::PGAP6	Multiple myeloma
OAZ1::PTOV1	Multiple myeloma
OAZ1::REXO1	Multiple myeloma
OAZ1::RNF126	Multiple myeloma | Chronic lymphocytic leukemia | Acute lymphoblastic leukemia/lymphoblastic lymphoma
OAZ1::RNF166	Multiple myeloma
OAZ1::SBNO2	Multiple myeloma
OAZ1::SCAMP4	Multiple myeloma
OAZ1::SCO2	Multiple myeloma
OAZ1::SERINC2	Multiple myeloma
OAZ1::SF3A2	Adenocarcinoma
OAZ1::SGTA	Multiple myeloma
OAZ1::SNN	Multiple myeloma
OAZ1::TCF3	Multiple myeloma | Chronic lymphocytic leukemia
OAZ1::TMEM259	Multiple myeloma
OAZ1::UBC	Multiple myeloma
OAZ1::YBX2	Adenocarcinoma
OAZ1::ZBTB7A	Multiple myeloma
OAZ2::CIAO2A	Squamous cell carcinoma
OAZ2::RBPMS2	Astrocytoma, grade I-II
OAZ2::SPAST	Adenocarcinoma
OBSCN::CASZ1	Squamous cell carcinoma
OBSCN::DISC1	Malignant melanoma
OBSCN::IGSF21	Adenocarcinoma
OBSCN::KCNK2	Malignant melanoma
OBSCN::NLRP3	Adenocarcinoma
OBSCN::SPAG17	Adenocarcinoma
OBSL1::IGF2	Malignant epithelial tumor, special type
OCA2::HERC2	Malignant melanoma
OCEL1::SMARCA4	Adenocarcinoma
OCEL1::USE1	Adenocarcinoma
OCIAD1::GLIPR2	Squamous cell carcinoma
OCIAD1::KIT	Malignant melanoma
OCIAD2::NFXL1	Transitional cell carcinoma
OCLN::ADGRV1	Adenocarcinoma
OCLN::ARHGAP26	Adenocarcinoma
OCLN::CCNB1	Transitional cell carcinoma
OCLN::CDK14	Adenocarcinoma
OCLN::NUDT3	Malignant epithelial tumor, special type
OCLN::RAD17	Adenocarcinoma
OCLN::RASGRF1	Adenocarcinoma
ODAD4::ARHGDIA	Adenocarcinoma
ODF2::COQ4	Adenocarcinoma
ODF2::SLC27A4	Adenocarcinoma
ODF2::SLC2A8	Adenocarcinoma
ODF2::URM1	Squamous cell carcinoma
ODF2L::F8	Malignant melanoma
ODR4::EGLN1	Adenocarcinoma
ODR4::TPR	Alveolar rhabdomyosarcoma
OFD1::FGFR2	Adenocarcinoma
OFD1::JAK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
OGA::KCNIP2	Adenocarcinoma
OGA::RNLS	Acute lymphoblastic leukemia/lymphoblastic lymphoma
OGFOD3::EIF1	Squamous cell carcinoma
OGFOD3::WDR45B	Astrocytoma, grade I-II
OGFR::ADRM1	Skin | Acute myeloid leukemia, NOS
OGT::ACTB	Adenocarcinoma
OGT::FOXO3	Soft tissue tumor, special type
OGT::GCNA	Transitional cell carcinoma
OGT::NONO	Adenocarcinoma
OGT::POLA1	Adenocarcinoma
OIP5::GPR176	Adenocarcinoma
OIP5::NUSAP1	Adenocarcinoma
OLA1::CAB39	Adenocarcinoma
OLA1::CIR1	Adenocarcinoma
OLA1::GPR155	Adenocarcinoma
OLA1::METTL8	Adenocarcinoma
OLA1::ORMDL3	Adenocarcinoma
OLA1::PDE11A	Adenocarcinoma
OLFM2::CECR2	Malignant epithelial tumor, special type
OLFM2::CEP112	Adenocarcinoma
OLFM2::COL5A3	Squamous cell carcinoma
OLFM2::CRTC1	Malignant epithelial tumor, special type
OLFM2::EIF3G	Adenocarcinoma
OLFM2::EXOSC10	Adenocarcinoma
OLFM2::PLEKHG4B	Adenocarcinoma
OLFM2::PSENEN	Adenocarcinoma
OLFM2::TBC1D21	Adenocarcinoma
OLFM2::TMEM205	Adenocarcinoma
OLFM4::CLCN3	Adenocarcinoma
OLFM4::DYNC1H1	Adenocarcinoma
OLFM4::RET	Adenocarcinoma
OLFM4::STAT6	Adenocarcinoma
OLFM4::TOP2B	Adenocarcinoma
OLR1::XIAP	Acute myeloblastic leukemia with maturation (FAB type M2)
OMA1::ITGB3BP	Adenocarcinoma
OMD::USP6	Aneurysmal bone cyst
ONECUT1::REC114	Adenocarcinoma
ONECUT2::NEDD4L	Adenocarcinoma
OPA1::ATP13A4	Squamous cell carcinoma
OPA1::EHHADH	Squamous cell carcinoma
OPA1::PIGX	Adenocarcinoma
OPA1::PPP2R3A	Squamous cell carcinoma
OPA3::EIF1	Astrocytoma, grade III-IV/Glioblastoma
OPA3::EML2	Squamous cell carcinoma
OPA3::RDH8	Adenocarcinoma
OPA3::TNPO1	Adenocarcinoma
OPALIN::RET	Adenocarcinoma
OPHN1::MAOA	Adenocarcinoma
OPHN1::RUNX1	Acute myelomonocytic leukemia (FAB type M4)
OPHN1::TNMD	Transitional cell carcinoma
OPLAH::EEF1D	Adenocarcinoma
OPN3::FH	Adenocarcinoma
OPN3::RGS7	Adenocarcinoma
OPN3::SLC39A11	Adenocarcinoma
OPRD1::PTP4A2	Malignant epithelial tumor, special type
OPRM1::ROS1	Adenocarcinoma
OPTN::BRAF	Adenocarcinoma
OPTN::RET	Carcinoma, NOS
OR51E2::ADPRM	Adenocarcinoma
OR51E2::ETV1	Adenocarcinoma
OR51E2::RRM1	Adenocarcinoma
OR9Q1::OR4C46	Squamous cell carcinoma
ORAI2::CUX1	Astrocytoma, grade I-II
ORAI2::SH2B2	Malignant epithelial tumor, special type
ORAI2::SLC47A2	Adenocarcinoma
ORC2::CPEB1	Adenocarcinoma
ORC2::FLACC1	Adenocarcinoma
ORC2::RPLP2	Adenocarcinoma
ORC2::TRAK2	Malignant epithelial tumor, special type
ORC3::RIMS1	Adenocarcinoma
ORC4::MAPK4	Malignant melanoma
ORC5::FGGY	Adenocarcinoma
ORC5::R3HDM2	Adenocarcinoma
ORC6::VPS35	Adenocarcinoma
ORM2::ATP5MC3	Adenocarcinoma
ORMDL1::RALGDS	Adenocarcinoma
ORMDL2::SARNP	Mesenchymal tumor, NOS
ORMDL3::ANXA1	Adenocarcinoma
ORMDL3::PPP1R1B	Adenocarcinoma
ORMDL3::ZPBP2	Adenocarcinoma
OS9::ATP23	Astrocytoma, grade III-IV/Glioblastoma
OS9::CPSF6	Astrocytoma, grade III-IV/Glioblastoma
OS9::ERBB3	Adenocarcinoma
OS9::HDLBP	Adenocarcinoma
OS9::KICS2	Astrocytoma, grade III-IV/Glioblastoma
OS9::KIF5A	Astrocytoma, grade I-II | Astrocytoma, grade III-IV/Glioblastoma
OS9::MUCL1	Adenocarcinoma
OS9::MYG1	Adenocarcinoma
OS9::SRGAP1	Astrocytoma, grade III-IV/Glioblastoma
OSBP2::CHCHD3	Adenocarcinoma
OSBP2::CHD1L	Adenocarcinoma
OSBP2::EFCAB6	Adenocarcinoma
OSBP2::MRPL43	Malignant melanoma
OSBP2::NF2	Squamous cell carcinoma
OSBP2::TST	Adenocarcinoma
OSBP::BRAF	Soft tissue tumor, special type
OSBP::CBLIF	Adenocarcinoma
OSBP::GAL	Adenocarcinoma
OSBP::PAPSS2	Ependymoma
OSBPL10::CNN3	Squamous cell carcinoma
OSBPL10::GPD1L	Transitional cell carcinoma
OSBPL10::STX8	Malignant epithelial tumor, special type
OSBPL10::UBP1	Squamous cell carcinoma
OSBPL11::CHCHD6	Adenocarcinoma
OSBPL1A::FBRS	Adenocarcinoma
OSBPL1A::LETM2	Adenocarcinoma
OSBPL1A::MRPL11	Squamous cell carcinoma
OSBPL1A::MYO16	Squamous cell carcinoma
OSBPL1A::RIOK3	Squamous cell carcinoma
OSBPL1A::SS18	Squamous cell carcinoma
OSBPL1A::SSBP1	Adenocarcinoma
OSBPL1A::ZNF521	Adenocarcinoma
OSBPL2::ADCK1	Adenocarcinoma
OSBPL2::CDH4	Transitional cell carcinoma
OSBPL2::DLGAP4	Adenocarcinoma
OSBPL2::EDEM2	Adenocarcinoma
OSBPL2::HM13	Adenocarcinoma
OSBPL2::PLD1	Adenocarcinoma
OSBPL2::TPX2	Adenocarcinoma
OSBPL3::ANO1	Adenocarcinoma
OSBPL3::AOC1	Mesenchymal tumor, NOS
OSBPL3::CORIN	Adenocarcinoma
OSBPL3::GABRG3	Adenocarcinoma
OSBPL3::NPVF	Adenocarcinoma
OSBPL3::SLC2A1	Mesenchymal tumor, NOS
OSBPL5::ADGRG5	Adenocarcinoma
OSBPL5::CTBP1	Malignant melanoma
OSBPL5::MRGPRE	Adenocarcinoma
OSBPL5::RHOG	Adenocarcinoma
OSBPL5::SLC22A18AS	Malignant melanoma
OSBPL5::TRPM5	Adenocarcinoma
OSBPL6::SPHKAP	Adenocarcinoma
OSBPL8::ACSS3	Squamous cell carcinoma
OSBPL8::ATF1	Soft tissue tumor, NOS
OSBPL8::CSRP2	Mesenchymal tumor, NOS
OSBPL8::FAM186A	Mesenchymal tumor, NOS
OSBPL8::GSDMA	Adenocarcinoma
OSBPL8::NTS	Mesenchymal tumor, NOS
OSBPL8::PTPRQ	Mesenchymal tumor, NOS
OSBPL8::PTPRR	Adenocarcinoma
OSBPL8::RAB3IP	Adenocarcinoma
OSBPL8::SYT1	Mesenchymal tumor, NOS
OSBPL8::TSHZ2	Adenocarcinoma
OSBPL8::TSPAN8	Adenocarcinoma
OSBPL8::ZDHHC17	Mesenchymal tumor, NOS
OSBPL9::AGBL4	Transitional cell carcinoma
OSBPL9::BRAF	Adenocarcinoma
OSBPL9::C1ORF87	Adenocarcinoma
OSBPL9::C1orf87	Adenocarcinoma
OSBPL9::CERS5	Transitional cell carcinoma
OSBPL9::CYP4Z1	Adenocarcinoma
OSBPL9::FGGY	Adenocarcinoma
OSBPL9::FKBP5	Mesenchymal tumor, NOS
OSBPL9::SERINC5	Adenocarcinoma
OSCP1::NF1	Mesothelioma
OSCP1::WDTC1	Malignant epithelial tumor, special type
OSGIN1::PATZ1	Adenocarcinoma
OSGIN2::DECR1	Transitional cell carcinoma | Adenocarcinoma
OSGIN2::RIPK2	Squamous cell carcinoma | Adenocarcinoma
OSMR::DNM3	Mesenchymal tumor, NOS
OSMR::NCKAP5	Adenocarcinoma
OSR1::PLAG1	Adenoma
OSTF1::SMARCA4	Mesenchymal tumor, NOS
OSTM1::CEP85L	Adenocarcinoma
OSTM1::SNX3	Adenocarcinoma
OTOGL::TRPV4	Mesenchymal tumor, NOS
OTUB1::COX8A	Adenocarcinoma
OTUB1::DLG2	Malignant melanoma
OTUB1::GBA1	Squamous cell carcinoma
OTUB1::KMT5B	Adenocarcinoma
OTUB1::RPS6KA4	Squamous cell carcinoma
OTUD3::HES2	Squamous cell carcinoma
OTUD4::CHCHD2	Transitional cell carcinoma
OTUD4::CPE	Malignant melanoma
OTUD5::GRIPAP1	Adenocarcinoma
OTUD5::PCSK1N	Adenocarcinoma
OTUD7A::ASCC3	Astrocytoma, grade III-IV/Glioblastoma
OTUD7A::FMN1	Astrocytoma, grade III-IV/Glioblastoma
OTUD7B::CTSS	Squamous cell carcinoma
OTUD7B::H2BC18	Malignant melanoma
OTUD7B::HORMAD1	Squamous cell carcinoma
OTULIN::OTULINL	Adenocarcinoma
OTULINL::DNAH5	Adenocarcinoma
OTX1::EHBP1	Adenocarcinoma
OVOL2::CBLN4	Transitional cell carcinoma
OVOL2::DZANK1	Adenocarcinoma
OVOL2::TMEM131L	Adenocarcinoma
OXCT1::GHR	Malignant melanoma
OXCT1::SLCO2B1	Acute myelomonocytic leukemia (FAB type M4)
OXCT1::TMEM17	Squamous cell carcinoma
OXNAD1::LRRTM4	Adenocarcinoma
OXR1::CLEC18C	Adenocarcinoma
OXR1::COX6C	Undifferentiated carcinoma, small cell
OXR1::CSMD3	Adenocarcinoma
OXR1::MET	Adenocarcinoma
OXR1::MRPS28	Adenocarcinoma
OXR1::NR4A3	Adenocarcinoma
OXR1::RSPO2	Squamous cell carcinoma
OXR1::VPS13B	Squamous cell carcinoma
OXSR1::ATXN7	Malignant melanoma
OXSR1::CTDSPL	Adenocarcinoma
OXSR1::DLEC1	Adenocarcinoma
OXSR1::MYD88	Squamous cell carcinoma
OXSR1::PDCD6IP	Mesenchymal tumor, NOS
OXSR1::SLC22A14	Squamous cell carcinoma
P2RX4::ZNF664	Adenocarcinoma
P2RX5::MAP3K13	Adenocarcinoma
P2RY6::MRPS35	Transitional cell carcinoma
P2RY8::CD99	Acute lymphoblastic leukemia/lymphoblastic lymphoma
P2RY8::CRLF2	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Bilineage or biphenotypic leukemia | Egypt
P2RY8::IGH	Multiple myeloma | Acute lymphoblastic leukemia/lymphoblastic lymphoma
P2RY8::NTRK1	Adenocarcinoma
P2RY8::PAX5	Acute lymphoblastic leukemia/lymphoblastic lymphoma
P2RY8::ZBED1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
P3H1::ERI3	Adenocarcinoma
P3H2::TP63	Astrocytoma, grade I-II
P3H3::CCT5	Mesenchymal tumor, NOS
P3H4::ACLY	Adenocarcinoma
P3H4::ERBB2	Carcinoma, NOS
P3H4::URI1	Adenocarcinoma
P4HA1::ANK3	Adenocarcinoma
P4HA1::CCDC102A	Adenocarcinoma
P4HA1::CFAP70	Adenocarcinoma
P4HA1::CTNNA3	Adenocarcinoma
P4HA1::LAMA3	Adenocarcinoma
P4HA1::LRMDA	Adenocarcinoma
P4HA1::MSS51	Squamous cell carcinoma
P4HA1::NODAL	Adenocarcinoma
P4HA1::ROS1	Adenocarcinoma
P4HA1::TRIM77	Squamous cell carcinoma
P4HA2::TBCK	Angiofibroma
P4HB::AMBP	Adenocarcinoma
P4HB::C7	Adenocarcinoma
P4HB::CCT5	Adenocarcinoma
P4HB::CELA3A	Adenocarcinoma
P4HB::CENPX	Squamous cell carcinoma
P4HB::CLCN3	Transitional cell carcinoma
P4HB::COL1A2	Squamous cell carcinoma
P4HB::CPB1	Adenocarcinoma
P4HB::CTSF	Adenocarcinoma
P4HB::CXCR5	Adenocarcinoma
P4HB::ERBB3	Adenocarcinoma
P4HB::FAR1	Adenocarcinoma
P4HB::IGK	Multiple myeloma
P4HB::L3MBTL4	Squamous cell carcinoma
P4HB::MYO6	Adenocarcinoma
P4HB::NDUFV1	Adenocarcinoma
P4HB::PLAT	Squamous cell carcinoma
P4HB::PLEKHA5	Adenocarcinoma
P4HB::SEC63	Malignant melanoma
P4HB::SNU13	Adenocarcinoma
P4HB::SNW1	Adenocarcinoma
P4HB::SOS1	Astrocytoma, grade I-II
P4HB::TPT1	Adenocarcinoma
P4HB::YBX3	Squamous cell carcinoma
P4HB::ZFP91	Adenocarcinoma
P4HB::ZNFX1	Transitional cell carcinoma
P4HTM::MEIOB	Adenocarcinoma
PA2G4::MARK1	Mesenchymal tumor, NOS
PA2G4::RAB5B	Adenocarcinoma
PAAF1::ALG1	Astrocytoma, grade I-II
PAAF1::NCR3	Mesenchymal tumor, NOS
PAAF1::RELT	Adenocarcinoma
PABIR2::GPC4	Adenocarcinoma
PABIR2::PCBP2	Adenocarcinoma
PABIR2::PHYKPL	Adenocarcinoma
PABIR2::UCKL1	Adenocarcinoma
PABPC1::ALK	Diffuse large B-cell lymphoma
PABPC1::CNGB3	Adenocarcinoma
PABPC1::KHDRBS3	Astrocytoma, grade I-II
PABPC1::VPS13B	Transitional cell carcinoma
PABPC1::ZFPM2	Adenocarcinoma
PABPC1::ZNF706	Adenocarcinoma
PABPC1L::PKIG	Adenocarcinoma
PABPC1L::YWHAB	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PABPC4::IGH	Multiple myeloma
PABPC4::MACF1	Mesenchymal tumor, NOS
PABPN1::BCL2L2	Adenocarcinoma
PACC1::PSAP	Squamous cell carcinoma
PACC1::RCOR3	Adenocarcinoma
PACRG::QKI	Astrocytoma, grade I-II
PACS1::CHKA	Squamous cell carcinoma
PACS1::FAM32A	Adenocarcinoma
PACS1::FOLH1	Squamous cell carcinoma
PACS1::HAUS3	Adenocarcinoma
PACS1::KDM2A	Undifferentiated carcinoma, small cell
PACS1::MS4A18	Adenocarcinoma
PACS1::PPP2R5B	Malignant epithelial tumor, special type
PACS1::RHOD	Adenocarcinoma
PACS1::SLN	Adenocarcinoma
PACS1::STPG1	Transitional cell carcinoma
PACS1::ZDHHC24	Adenocarcinoma
PACS2::C14ORF180	Adenocarcinoma
PACS2::DSG2	Malignant epithelial tumor, special type
PACS2::RAD51B	Adenocarcinoma
PACSIN2::A4GALT	Squamous cell carcinoma
PACSIN2::ARFGAP3	Nonneoplastic epithelial disorder/lesion
PACSIN2::CERK	Malignant melanoma
PACSIN2::EEFSEC	Malignant melanoma
PACSIN2::LGALS1	Adenocarcinoma
PACSIN2::MCAT	Adenocarcinoma
PACSIN2::NUP42	Adenocarcinoma
PACSIN2::RAI14	Malignant melanoma
PACSIN2::SGSM3	Malignant melanoma
PACSIN2::SPON1	Malignant epithelial tumor, special type
PACSIN2::TTLL1	Adenocarcinoma
PACSIN2::TTLL12	Adenocarcinoma
PACSIN2::ZNF823	Adenocarcinoma
PACSIN3::CTSD	Adenocarcinoma
PADI2::EXD3	Adenocarcinoma
PADI3::EIF4G3	Adenocarcinoma
PAEP::FAR1	Adenocarcinoma
PAF1::MED29	Adenocarcinoma
PAF1::YWHAG	Adenocarcinoma
PAFAH1B1::ABR	Malignant melanoma
PAFAH1B1::CTDNEP1	Malignant melanoma
PAFAH1B1::NTN1	Adenocarcinoma
PAFAH1B1::SMYD4	Adenocarcinoma
PAFAH1B1::USP6	Aneurysmal bone cyst
PAFAH1B1::VPS53	Adenocarcinoma
PAFAH1B2::CSN2	Adenocarcinoma
PAFAH1B2::FOXR1	Bilineage or biphenotypic leukemia | Egypt | Multiple myeloma | Neuroblastoma
PAFAH1B2::GPR137	Adenocarcinoma
PAFAH1B2::MRPL2	Adenocarcinoma
PAFAH2::STMN1	Miscellaneous hematopoietic/lymphoid neoplasm, special type
PAG1::ABL2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAG1::FAM13C	Malignant melanoma
PAG1::GAD2	Squamous cell carcinoma
PAG1::VIRMA	Transitional cell carcinoma
PAGE2B::ALAS2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAGR1::KIF22	Squamous cell carcinoma
PAH::METAP2	Adenocarcinoma
PAH::NINJ2	Adenocarcinoma
PAICS::PDGFRA	Astrocytoma, grade I-II
PAIP1::DAB2	Adenocarcinoma
PAIP1::TMEM267	Squamous cell carcinoma
PAIP2::CDC25C	Adenocarcinoma
PAIP2::CXXC5	Malignant epithelial tumor, special type
PAIP2::SIL1	Mesenchymal tumor, NOS
PAK1::AAMDC	Adenocarcinoma
PAK1::ARHGAP42	Malignant melanoma
PAK1::ARHGEF18	Adenocarcinoma
PAK1::CNIH4	Adenocarcinoma
PAK1::CWF19L2	Adenocarcinoma
PAK1::ERG	Adenocarcinoma
PAK1::EYS	Malignant melanoma
PAK1::FAT3	Undifferentiated carcinoma, small cell
PAK1::KCTD14	Adenocarcinoma
PAK1::KCTD21	Adenocarcinoma
PAK1::LARGE2	Adenocarcinoma
PAK1::LNP1	Squamous cell carcinoma
PAK1::MYO7A	Adenocarcinoma
PAK1::NARS2	Adenocarcinoma
PAK1::PDGFD	Malignant melanoma
PAK1::POU5F1B	Adenocarcinoma
PAK1::PRSS23	Adenocarcinoma
PAK1::RAD9A	Malignant melanoma
PAK1::SHANK2	Adenocarcinoma
PAK1::THRSP	Adenocarcinoma
PAK1::ZNF595	Adenocarcinoma
PAK1IP1::MEP1A	Malignant melanoma
PAK2::ANKUB1	Squamous cell carcinoma
PAK2::BDH1	Squamous cell carcinoma
PAK2::DLG1	Adenocarcinoma
PAK2::ECE2	Squamous cell carcinoma
PAK2::PIGX	Adenocarcinoma
PAK2::RAF1	Soft tissue tumor, NOS
PAK2::SENP5	Malignant melanoma
PAK2::ST6GAL1	Adenocarcinoma
PAK2::VGLL3	Squamous cell carcinoma
PAK3::SH2D1A	Squamous cell carcinoma
PAK4::ACP7	Adenocarcinoma
PAK4::B9D1	Adenocarcinoma
PAK4::CACNG6	Adenocarcinoma
PAK4::CATSPERG	Adenocarcinoma
PAK4::CYP2A6	Adenocarcinoma
PAK4::LSM4	Adenocarcinoma
PAK4::MROH7	Adenocarcinoma
PAK4::RPGR	Malignant epithelial tumor, special type
PAK4::SPINT2	Adenocarcinoma
PAK4::TTC4	Adenocarcinoma
PAK4::ZNF837	Adenocarcinoma
PALLD::ANXA10	Mesenchymal tumor, NOS
PALLD::NAA15	Adenocarcinoma
PALLD::TMEM53	Transitional cell carcinoma
PALM2::MLLT3	Astrocytoma, grade I-II
PALM::NCLN	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PALM::SGTA	Adenocarcinoma
PALMD::CCDC171	Adenocarcinoma
PALS1::CEP128	Adenocarcinoma
PALS1::GARIN2	Adenocarcinoma
PALS1::GPHN	Adenocarcinoma | Transitional cell carcinoma
PALS1::RAD51B	Adenocarcinoma
PALS1::RDH11	Adenocarcinoma
PALS1::SRGAP2	Adenocarcinoma
PALS2::HIBADH	Malignant melanoma
PALS2::OSBPL3	Squamous cell carcinoma
PAM16::CORO7	Adenocarcinoma
PAM16::PITPNM3	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
PAMR1::GLI1	Rhabdomyosarcoma, NOS
PAMR1::SLC1A2	Astrocytoma, grade I-II
PAN2::MIP	Adenocarcinoma
PAN3::FLT3	Acute myeloid leukemia, NOS | Skin | Adenocarcinoma
PAN3::FNDC3A	Adenocarcinoma
PAN3::KATNAL1	Adenocarcinoma
PAN3::LATS2	Adenocarcinoma
PAN3::MICU2	Mesenchymal tumor, NOS
PAN3::MTMR6	Adenocarcinoma
PAN3::NTRK2	Squamous cell carcinoma
PAN3::RFC3	Adenocarcinoma
PAN3::XPO4	Transitional cell carcinoma
PANK1::ABCC2	Adenocarcinoma
PANK1::C8ORF34	Adenocarcinoma
PANK1::C8orf34	Adenocarcinoma
PANK1::CRYBB1	Mesenchymal tumor, NOS
PANK1::PDK3	Adenocarcinoma
PANK2::ATRN	Adenocarcinoma
PANK2::HSPA12B	Adenocarcinoma
PANK2::LANCL1	Mesenchymal tumor, NOS
PANK2::PAK5	Adenocarcinoma
PANK4::RGS6	Squamous cell carcinoma
PANX1::CEP126	Squamous cell carcinoma
PANX1::DEUP1	Squamous cell carcinoma
PANX1::HEPHL1	Squamous cell carcinoma
PAPLN::MYL4	Squamous cell carcinoma
PAPOLA::AK7	Adenocarcinoma
PAPOLA::GALNT5	Adenocarcinoma
PAPOLA::GSKIP	Adenocarcinoma
PAPOLA::HIP1R	Adenocarcinoma
PAPOLA::NPAS3	Squamous cell carcinoma
PAPOLG::ABCA12	Adenocarcinoma
PAPPA2::ACBD6	Adenocarcinoma
PAPPA2::ASTN1	Adenocarcinoma
PAPPA2::RPS19	Transitional cell carcinoma
PAPSS1::BRAF	Malignant melanoma
PAPSS2::ATAD1	Adenocarcinoma | Astrocytoma, grade I-II
PAPSS2::BID	Squamous cell carcinoma
PAPSS2::MINPP1	Adenocarcinoma
PAPSS2::SFRP5	Adenocarcinoma
PAQR3::ANTXR2	Adenocarcinoma
PAQR6::SMG5	Acute myeloid leukemia, NOS | Skin
PAQR8::MAPK14	Squamous cell carcinoma
PARD3::ADAMTS17	Adenocarcinoma
PARD3::ALK	Adenocarcinoma
PARD3::ARHGAP12	Adenocarcinoma
PARD3::ARHGAP24	Adenocarcinoma
PARD3::ARMC3	Adenocarcinoma
PARD3::CAMK1D	Adenocarcinoma
PARD3::COLQ	Adenocarcinoma
PARD3::CUL2	Adenocarcinoma
PARD3::FAM83B	Malignant melanoma
PARD3::HTRA1	Squamous cell carcinoma
PARD3::IL2RA	Adenocarcinoma
PARD3::LYAR	Astrocytoma, grade I-II
PARD3::MINDY3	Astrocytoma, grade I-II
PARD3::MTA1	Adenocarcinoma
PARD3::NRXN1	Adenocarcinoma
PARD3::NSUN6	Squamous cell carcinoma
PARD3::ODAD2	Squamous cell carcinoma
PARD3::PARD6G	Adenocarcinoma
PARD3::PKNOX2	Ependymoma
PARD3::RET	Carcinoma, NOS
PARD3::ZNF521	Adenocarcinoma
PARD3B::CRELD2	Adenocarcinoma
PARD3B::MAP2	Adenocarcinoma
PARD3B::NUTM1	Embryonal nervous system tumor, special type
PARD3B::PIP5K1B	Adenocarcinoma
PARD3B::PTH2R	Adenocarcinoma
PARD3B::SLC40A1	Malignant melanoma
PARD3B::SLC50A1	Adenocarcinoma
PARD3B::TACC1	Adenocarcinoma
PARD3B::VWC2L	Squamous cell carcinoma
PARD3B::WWOX	Adenocarcinoma
PARD6B::CASS4	Adenocarcinoma
PARD6B::CD48	Adenocarcinoma
PARD6B::PRPF6	Adenocarcinoma
PARD6B::PTPN1	Adenocarcinoma
PARD6G::CHST1	Squamous cell carcinoma
PARD6G::LDLRAD4	Adenocarcinoma
PARD6G::RFTN2	Squamous cell carcinoma
PARD6G::SLC14A2	Adenocarcinoma
PARG::BMS1	Osteogenic/bone tumor, special type | Acute lymphoblastic leukemia/lymphoblastic lymphoma
PARK7::MICOS10	Astrocytoma, grade III-IV/Glioblastoma
PARL::ABCC5	Transitional cell carcinoma | Squamous cell carcinoma
PARM1::CCSER1	Multiple myeloma
PARN::ABCA3	Adenocarcinoma
PARN::CACHD1	Astrocytoma, grade III-IV/Glioblastoma
PARN::PLA2G10	Astrocytoma, grade I-II
PARN::RRN3	Adenocarcinoma
PARN::SMG1	Adenocarcinoma
PARP11::ITPR2	Astrocytoma, grade I-II
PARP11::NINJ2	Astrocytoma, grade III-IV/Glioblastoma
PARP11::PIK3C2G	Malignant melanoma
PARP12::BRAF	Adenocarcinoma
PARP14::SLC49A4	Transitional cell carcinoma
PARP14::TASP1	Adenocarcinoma
PARP14::TFE3	Adenocarcinoma
PARP16::PHF13	Adenocarcinoma
PARP1::LIN9	Squamous cell carcinoma
PARP1::MIXL1	Malignant melanoma
PARP4::CERS1	Miscellaneous hematopoietic/lymphoid neoplasm, special type
PARP4::COL9A1	Squamous cell carcinoma
PARP4::GDF1	Benign epithelial tumor, special type | Miscellaneous hematopoietic/lymphoid neoplasm, special type
PARP6::MYO9A	Adenocarcinoma
PARP8::ANKRD55	Adenocarcinoma
PARP8::CRYL1	Squamous cell carcinoma
PARP8::EIF5A2	Adenocarcinoma
PARP8::ELL2	Adenocarcinoma
PARP8::KIF6	Squamous cell carcinoma
PARP8::SHISAL2B	Malignant epithelial tumor, special type
PARPBP::MYBPC1	Teratoma (mature and immature)
PARS2::NOTCH2	Adenocarcinoma
PARVA::ESRRB	Adenocarcinoma
PARVA::MICAL2	Adenocarcinoma
PARVA::POLD3	Adenocarcinoma
PARVA::SPON1	Adenocarcinoma
PARVA::USP47	Mesenchymal tumor, NOS
PARVB::ATP6V1D	Squamous cell carcinoma
PARVB::PPARA	Malignant melanoma
PARVB::SAMM50	Adenocarcinoma
PASD1::ZFX	Adenocarcinoma
PASK::BOK	Adenocarcinoma
PATJ::AGBL4	Meningioma
PATJ::CACHD1	Adenocarcinoma
PATJ::CENPS	Squamous cell carcinoma
PATJ::DYNC2H1	Squamous cell carcinoma
PATJ::ERI3	Adenocarcinoma
PATJ::GLIS1	Adenocarcinoma
PATJ::KANK4	Adenocarcinoma
PATJ::MAP2K5	Adenocarcinoma
PATJ::NEGR1	Adenocarcinoma
PATJ::NFIA	Adenocarcinoma
PATJ::PDE4B	Adenocarcinoma
PATJ::PRSS50	Squamous cell carcinoma
PATJ::RAF1	Adenocarcinoma
PATJ::SGIP1	Adenocarcinoma
PATJ::SRR	Adenocarcinoma
PATJ::ST6GALNAC5	Adenocarcinoma
PATL1::TECTA	Astrocytoma, grade III-IV/Glioblastoma
PATZ1::PKIB	Adenocarcinoma
PAWR::AMDHD1	Atypical lipomatous tumor/atypical lipoma/well-differentiated liposarcoma
PAWR::CLEC2A	Adenocarcinoma
PAWR::GNS	Undifferentiated carcinoma, small cell
PAWR::MTARC1	Mesenchymal tumor, NOS
PAWR::PPP1R12A	Adenocarcinoma
PAWR::PTPRR	Adenocarcinoma
PAX3::FOXO1	Alveolar rhabdomyosarcoma | Embryonal rhabdomyosarcoma | Nonneoplastic mesenchymal disorder/lesion | Mesenchymal tumor, special type | Pleomorphic rhabdomyosarcoma
PAX3::FOXO4	Alveolar rhabdomyosarcoma
PAX3::FOXO6	Mesenchymal tumor, special type
PAX3::INO80D	Adenocarcinoma
PAX3::MAML3	Alveolar rhabdomyosarcoma | Mesenchymal tumor, special type | Malignant peripheral nerve sheath tumor/Triton
PAX3::MYOCD	Rhabdomyosarcoma, NOS
PAX3::NCOA1	Alveolar rhabdomyosarcoma | Mesenchymal tumor, special type | Astrocytoma, NOS
PAX3::NCOA2	Soft tissue tumor, special type | Alveolar rhabdomyosarcoma | Embryonal rhabdomyosarcoma
PAX5::ALDH18A1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::ARHGAP22	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::ASXL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::AUTS2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::BCOR	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::BRD1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::CBFA2T2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::CBFA2T3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::CDH13	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::CREB3L1	Sclerosing epithelioid fibrosarcoma
PAX5::DACH1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::DACH2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::DMRTA2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::DNAJA1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::ELN	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::ESRRA	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::ESRRB	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::ETV6	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::FBRS	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::FBRSL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::FKBP15	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::FOXP1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::GOLGA6A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::GREB1L	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::GRM3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::GSDMA	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::HACD4	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::HIPK1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::JAK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::KANK1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::KIDINS220	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::KIF3B	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::MAPT	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::MBNL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::MLLT3	Chronic myeloid leukemia, t(9;22) | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Heart
PAX5::MPRIP	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::NCOA5	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::NCOA6	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::NCOR1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::NOL4L	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::P2RY8	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::PEG10	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::PIK3AP1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::PML	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::POM121	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::PROC	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::RHOXF2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::RNF38	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::SLCO1B3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::SP2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::TAF3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::TAOK1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::TMEM14B	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::TMEM9B	Adenocarcinoma
PAX5::WDR5	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::ZCCHC7	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::ZNF276	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::ZNF318	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX5::ZNF521	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PAX7::FOXO1	Alveolar rhabdomyosarcoma
PAX7::PPARGC1A	Mesenchymal tumor, special type
PAX8::GLIS1	Adenocarcinoma | Benign epithelial tumor, special type
PAX8::GLIS3	Benign epithelial tumor, special type
PAX8::IL36B	Adenocarcinoma
PAX8::NFE2L2	Adenocarcinoma
PAX8::PPARG	Rhabdomyosarcoma, NOS | Adenoma | Adenocarcinoma
PAX8::ZNF512	Adenocarcinoma
PAXBP1::ABI3BP	Adenocarcinoma
PAXBP1::ADAMTS1	Adenocarcinoma
PAXBP1::TP53I3	Adenocarcinoma
PAXIP1::GIMAP2	Adenocarcinoma
PAXIP1::NCAPG2	Squamous cell carcinoma
PBLD::DNAJC12	Adenocarcinoma
PBLD::LRRC28	Adenocarcinoma
PBRM1::BAP1	Mesothelioma
PBRM1::CACNA2D3	Adenocarcinoma
PBRM1::CYB561D2	Mesothelioma
PBRM1::FBXW12	Mesothelioma
PBRM1::GLT8D1	Squamous cell carcinoma
PBRM1::IGSF11	Adenocarcinoma
PBRM1::KYNU	Astrocytoma, grade I-II
PBRM1::NEK4	Malignant melanoma
PBRM1::NT5DC2	Adenocarcinoma
PBRM1::STIMATE	Adenocarcinoma
PBRM1::TKT	Adenocarcinoma
PBRM1::WDR82	Adenocarcinoma
PBX1::COP1	Mesenchymal tumor, NOS
PBX1::COPG2	Adenocarcinoma
PBX1::CTNNA3	Adenocarcinoma
PBX1::DHX40	Adenocarcinoma
PBX1::DISC1	Adenocarcinoma
PBX1::HMGA1	Leiomyoma
PBX1::ILDR2	Adenocarcinoma
PBX1::KMT2A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PBX1::LRRC52	Adenocarcinoma
PBX1::PHF24	Mesenchymal tumor, NOS
PBX1::RHBG	Adenocarcinoma
PBX1::SLC30A10	Adenocarcinoma
PBX3::MVB12B	Adenocarcinoma
PBX3::NSF	Adenocarcinoma
PBX3::PPFIA1	Adenocarcinoma
PBX3::SH3GL2	Mesothelioma
PBX4::COX6B1	Astrocytoma, grade III-IV/Glioblastoma
PBX4::LPAR2	Adenocarcinoma
PBXIP1::ACBD6	Adenocarcinoma
PBXIP1::ARHGEF2	Adenocarcinoma
PBXIP1::PMVK	Astrocytoma, grade III-IV/Glioblastoma
PC::ACTN4	Adenocarcinoma
PC::ACY3	Astrocytoma, grade I-II
PC::ANO1	Adenocarcinoma
PC::CAT	Adenocarcinoma
PC::CTTN	Mesenchymal tumor, NOS
PC::DCDC2	Adenocarcinoma
PC::FOLR1	Astrocytoma, grade I-II
PC::KDM2A	Squamous cell carcinoma
PC::LTO1	Adenocarcinoma
PC::MS4A4E	Adenocarcinoma
PC::MX2	Adenocarcinoma
PC::PPP6R3	Adenocarcinoma
PC::THRSP	Adenocarcinoma
PCBD2::IGL	Multiple myeloma
PCBP1::UTRN	Adenocarcinoma
PCBP2::AMHR2	Squamous cell carcinoma
PCBP2::BLTP3B	Astrocytoma, grade III-IV/Glioblastoma
PCBP2::CCT5	Squamous cell carcinoma
PCBP2::EEA1	Adenocarcinoma
PCBP2::HMGA2	Malignant melanoma
PCBP2::ITGB7	Transitional cell carcinoma
PCBP2::MFN1	Adenocarcinoma
PCBP2::PFDN5	Adenocarcinoma
PCBP2::PRRC2B	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PCBP2::R3HCC1L	Malignant melanoma
PCBP2::STAT3	Adenocarcinoma
PCBP2::TIMELESS	Adenocarcinoma
PCBP2::TMED2	Adenocarcinoma
PCBP2::TNFRSF1A	Adenocarcinoma
PCBP2::YWHAE	Transitional cell carcinoma
PCBP3::GRIK1	Adenocarcinoma
PCBP3::PDHX	Adenocarcinoma
PCBP4::POC1A	Squamous cell carcinoma
PCBP4::RPL29	Adenocarcinoma
PCCA::ARL4D	Adenocarcinoma
PCCA::CLYBL	Transitional cell carcinoma | Adenocarcinoma
PCCA::COPG2	Adenocarcinoma
PCCA::DIAPH3	Adenocarcinoma
PCCA::DNAJC3	Mesenchymal tumor, NOS
PCCA::FARP1	Adenocarcinoma
PCCA::FSIP2	Squamous cell carcinoma
PCCA::MBNL2	Adenocarcinoma
PCCA::NALCN	Adenocarcinoma
PCCA::ZIC2	Adenocarcinoma
PCCB::DLG1	Adenocarcinoma
PCCB::EPHB1	Squamous cell carcinoma
PCDH15::DUSP13B	Adenocarcinoma
PCDH9::SLC22A16	Embryonal rhabdomyosarcoma
PCDHA11::ANKHD1	Adenocarcinoma
PCDHGA6::JMJD1C	Malignant melanoma
PCDHGB4::TYK2	Astrocytoma, grade I-II
PCDHGC3::QKI	Astrocytoma, grade III-IV/Glioblastoma
PCF11::DDIAS	Adenocarcinoma
PCF11::DOCK2	Adenocarcinoma
PCF11::KDM2A	Adenocarcinoma
PCF11::SPON1	Adenocarcinoma
PCGF3::FANCI	Squamous cell carcinoma
PCGF3::HTT	Adenocarcinoma
PCGF3::MYL5	Transitional cell carcinoma
PCGF3::NPTXR	Astrocytoma, grade I-II
PCGF3::PDE6B	Squamous cell carcinoma
PCGF3::PIGG	Adenocarcinoma
PCGF3::SPATA24	Transitional cell carcinoma
PCGF3::TACC3	Mature B-cell neoplasm, NOS
PCGF5::RNLS	Malignant melanoma
PCGF5::RPP30	Adenocarcinoma
PCID2::ATP4B	Squamous cell carcinoma
PCID2::DZIP1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PCID2::GRTP1	Squamous cell carcinoma
PCID2::SNRPA	Astrocytoma, grade I-II
PCID2::TMCO3	Adenocarcinoma
PCIF1::UBE2C	Adenocarcinoma
PCIF1::ZSWIM1	Adenocarcinoma
PCLAF::TRIP4	Adenocarcinoma
PCLO::CDK14	Adenocarcinoma
PCLO::PHTF2	Germ cell tumor, NOS
PCM1::BRAF	Adenocarcinoma
PCM1::FGFR1	Bilineage or biphenotypic leukemia | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Egypt
PCM1::JAK2	Idiopathic myelofibrosis | Lymph node | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Atypical chronic myeloid leukemia | Acute myeloblastic leukemia with maturation (FAB type M2) | Acute myelomonocytic leukemia (FAB type M4) | Chronic eosinophilic leukemia/hypereosinophilic syndrome | Acute myeloblastic leukemia without maturation (FAB type M1) | Peripheral T-cell lymphoma, unspecified | Acute promyelocytic leukemia (FAB type M3) | Mature T- and NK-cell neoplasm, special type | Chronic myeloproliferative disorder, NOS | Myelodysplastic/myeloproliferative disease, NOS | Acute erythroleukemia (FAB type M6) | Thymus
PCM1::MET	Adenocarcinoma
PCM1::NAT1	Adenocarcinoma
PCM1::NRG1	Adenocarcinoma | Carcinoma, NOS
PCM1::PDGFRB	Myelodysplastic/myeloproliferative disease, NOS | Chronic myeloproliferative disorder, NOS | Thymus
PCM1::PEBP4	Squamous cell carcinoma
PCM1::RET	Adenocarcinoma
PCM1::SLC6A2	Adenocarcinoma
PCM1::TEX15	Adenocarcinoma
PCMT1::CCT2	Malignant melanoma
PCMT1::HSP90B1	Adenocarcinoma
PCMT1::SLC22A2	Adenocarcinoma
PCMTD1::ARHGAP26	Squamous cell carcinoma
PCMTD1::CCNL2	Adenocarcinoma
PCMTD1::FBXO3	Adenocarcinoma
PCMTD1::KLHDC8A	Adenocarcinoma
PCMTD1::MRPL15	Adenocarcinoma
PCMTD1::PLAG1	Lipoblastoma | Soft tissue tumor, special type
PCMTD1::PRKAR1B	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PCMTD1::PXDNL	Adenocarcinoma
PCMTD1::RB1CC1	Adenocarcinoma
PCMTD1::RHOT1	Transitional cell carcinoma
PCMTD1::SLCO5A1	Malignant melanoma
PCMTD1::ST18	Adenocarcinoma
PCMTD1::WDR97	Adenocarcinoma
PCMTD1::WRN	Adenocarcinoma
PCMTD2::CHD6	Adenocarcinoma
PCMTD2::DNAJC5	Adenocarcinoma
PCMTD2::MACROD2	Adenocarcinoma
PCMTD2::MYT1	Malignant melanoma
PCMTD2::SNX6	Adenocarcinoma
PCMTD2::WASHC1	Adenocarcinoma
PCNA::TMEM230	Adenocarcinoma
PCNP::ATR	Adenocarcinoma
PCNT::DIP2A	Astrocytoma, grade I-II
PCNT::MCOLN1	Adenocarcinoma
PCNT::NSMCE2	Mesenchymal tumor, NOS
PCNT::POC1A	Squamous cell carcinoma
PCNX1::CYP2J2	Adenocarcinoma
PCNX1::FRMD6	Transitional cell carcinoma
PCNX1::MKKS	Adenocarcinoma
PCNX1::RAD51B	Adenocarcinoma | Squamous cell carcinoma
PCNX1::TTC9	Squamous cell carcinoma
PCNX1::TTLL5	Squamous cell carcinoma
PCNX2::CDCA7	Adenocarcinoma
PCNX2::COG2	Adenocarcinoma
PCNX2::PTPN14	Adenocarcinoma
PCNX2::SPRR1B	Adenocarcinoma
PCNX2::TAOK3	Adenocarcinoma
PCNX2::TP73	Squamous cell carcinoma
PCNX3::ERBB3	Squamous cell carcinoma
PCNX3::PACS1	Squamous cell carcinoma
PCNX3::RCE1	Astrocytoma, grade I-II
PCNX3::SNX32	Adenocarcinoma
PCNX3::TOP6BL	Astrocytoma, grade I-II
PCNX4::GOLGA7	Adenocarcinoma
PCOLCE2::RPL8	Multiple myeloma
PCP4L1::NDUFS2	Transitional cell carcinoma
PCP4L1::SDHC	Gonadal stromal cell tumors
PCSK5::COL18A1	Embryonal nervous system tumor, special type
PCSK5::DENND1A	Mesenchymal tumor, NOS
PCSK5::LRBA	Adenocarcinoma
PCSK5::OSTF1	Adenocarcinoma
PCSK5::RIGI	Adenocarcinoma
PCSK6::LINS1	Adenocarcinoma
PCTP::CALCOCO2	Adenocarcinoma
PCTP::MEI4	Adenocarcinoma
PCYT1A::DYNLT2B	Transitional cell carcinoma
PCYT1A::EPHA6	Adenocarcinoma
PCYT1B::SIAH1	Astrocytoma, grade I-II
PCYT2::RAC3	Adenocarcinoma
PDAP1::ZNF789	Malignant epithelial tumor, special type
PDCD10::CNKSR2	Adenocarcinoma
PDCD10::HSF1	Malignant epithelial tumor, special type
PDCD11::FBXL15	Mesenchymal tumor, NOS
PDCD1LG2::TPGS2	Adenocarcinoma
PDCD2L::CACNA1A	Adenocarcinoma
PDCD2L::GARRE1	Squamous cell carcinoma
PDCD4::DUSP5	Multiple myeloma
PDCD6::FRS2	Mesenchymal tumor, NOS
PDCD6::SDHA	Squamous cell carcinoma
PDCD6::TERT	Malignant epithelial tumor, special type | Adenocarcinoma
PDCD6IP::DUSP16	Skin | Acute myeloid leukemia, NOS
PDCD6IP::GADL1	Adenocarcinoma
PDCD6IP::SRSF1	Adenocarcinoma
PDCD7::TAF15	Adenocarcinoma
PDCL::NCS1	Germ cell tumor, NOS
PDE10A::BRAF	Soft tissue tumor, special type
PDE10A::DDX23	Mesenchymal tumor, NOS
PDE10A::POLB	Adenocarcinoma
PDE10A::PSMB1	Adenocarcinoma
PDE10A::SMOC2	Adenocarcinoma
PDE10A::ZNF695	Astrocytoma, grade III-IV/Glioblastoma
PDE12::KCNJ4	Adenocarcinoma
PDE12::PPFIBP2	Undifferentiated carcinoma, small cell
PDE12::ROBO2	Malignant melanoma
PDE1A::PPP1R1C	Adenocarcinoma
PDE1C::VOPP1	Astrocytoma, grade III-IV/Glioblastoma
PDE2A::PLAG1	Malignant soft tissue tumor, NOS
PDE3A::CCT2	Adenocarcinoma
PDE3A::MUCL1	Mesenchymal tumor, NOS
PDE3B::ATP11B	Squamous cell carcinoma
PDE3B::MICAL2	Transitional cell carcinoma
PDE3B::PLCXD3	Malignant melanoma
PDE3B::ZNF212	Malignant melanoma
PDE4A::MIPOL1	Squamous cell carcinoma
PDE4A::S1PR5	Squamous cell carcinoma
PDE4B::GADD45A	Adenocarcinoma
PDE4B::JAK1	Adenocarcinoma
PDE4B::MOB3C	Adenocarcinoma
PDE4C::IQCN	Adenocarcinoma
PDE4D::ARB2A	Adenocarcinoma
PDE4D::C5orf47	Adenocarcinoma
PDE4D::CCNB1	Adenocarcinoma
PDE4D::COP1	Adenocarcinoma
PDE4D::CRABP1	Adenocarcinoma
PDE4D::DEPDC1B	Adenocarcinoma
PDE4D::EFNA5	Malignant melanoma
PDE4D::ELOVL7	Adenocarcinoma
PDE4D::ERCC8	Adenocarcinoma
PDE4D::FGF14	Adenocarcinoma
PDE4D::FYB1	Adenocarcinoma
PDE4D::INTS10	Adenocarcinoma
PDE4D::KHDRBS3	Squamous cell carcinoma
PDE4D::MCTP1	Squamous cell carcinoma
PDE4D::NOA1	Mesenchymal tumor, NOS
PDE4D::PCCB	Adenocarcinoma
PDE4D::PLK2	Mesothelioma
PDE4D::PLPP1	Adenocarcinoma
PDE4D::RAB24	Adenocarcinoma
PDE4D::RAB3C	Adenocarcinoma | Squamous cell carcinoma
PDE4D::RGS7BP	Squamous cell carcinoma
PDE4D::RNF180	Adenocarcinoma
PDE4DIP::OLFML2B	Malignant soft tissue tumor, NOS
PDE4DIP::OSMR	Malignant melanoma
PDE4DIP::PDGFRB	Myelodysplastic/myeloproliferative disease, NOS | Thymus
PDE4DIP::RHEX	Adenocarcinoma
PDE4DIP::TTC28	Adenocarcinoma
PDE5A::C4ORF3	Squamous cell carcinoma
PDE5A::NTRK2	Astrocytoma, grade III-IV/Glioblastoma
PDE7A::ADHFE1	Mature B-cell neoplasm, NOS
PDE7A::ARMC1	Squamous cell carcinoma
PDE7A::COPS5	Adenocarcinoma
PDE7A::KIAA1217	Adenocarcinoma
PDE7A::NCAM2	Adenocarcinoma
PDE7A::NKAIN3	Adenocarcinoma
PDE7A::NRG1	Squamous cell carcinoma
PDE7A::PREX2	Adenocarcinoma
PDE7A::TRIM55	Adenocarcinoma
PDE7A::VXN	Mature B-cell neoplasm, NOS
PDE7A::YPEL2	Adenocarcinoma
PDE7B::KIF21A	Mesenchymal tumor, NOS
PDE8A::ATF5	Mesenchymal tumor, NOS
PDE8A::BNC1	Malignant melanoma
PDE8A::CIB1	Adenocarcinoma
PDE8A::SLCO3A1	Malignant melanoma
PDE9A::ABCG1	Adenocarcinoma
PDE9A::DHRS7	Astrocytoma, grade I-II
PDE9A::MUS81	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PDE9A::SLC37A1	Adenocarcinoma
PDE9A::TMPRSS2	Adenocarcinoma
PDE9A::TOP2A	Adenocarcinoma
PDE9A::VWF	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PDGFA::GET4	Mesenchymal tumor, NOS
PDGFA::NT5C3A	Adenocarcinoma
PDGFA::OCA2	Malignant melanoma
PDGFB::APOBEC3C	Astrocytoma, grade III-IV/Glioblastoma
PDGFB::DGCR2	Astrocytoma, grade I-II
PDGFB::RPL3	Adenocarcinoma
PDGFC::G3BP2	Adenocarcinoma
PDGFD::DCUN1D5	Transitional cell carcinoma
PDGFRA::CCT2	Astrocytoma, grade III-IV/Glioblastoma
PDGFRA::FIP1L1	Adenocarcinoma | Astrocytoma, grade I-II
PDGFRA::GRID2	Astrocytoma, grade III-IV/Glioblastoma
PDGFRA::LNX1	Astrocytoma, grade I-II
PDGFRA::MACROD2	Undifferentiated pleomorphic sarcoma
PDGFRA::SCFD2	Astrocytoma, grade III-IV/Glioblastoma
PDGFRA::USP35	Mesenchymal tumor, special type | Soft tissue tumor, special type
PDGFRA::USP8	Mesenchymal tumor, NOS | Fibroblastic/myofibroblastic tumor, special type | Soft tissue tumor, special type | Cartilage tumor, special type
PDGFRB::DTD1	Chronic eosinophilic leukemia/hypereosinophilic syndrome
PDGFRB::FAR1	Adenocarcinoma
PDGFRL::VPS37A	Adenocarcinoma
PDHB::CACNA2D3	Astrocytoma, grade I-II
PDHB::CFAP20DC	Adenocarcinoma
PDHX::CAT	Adenocarcinoma
PDHX::EHF	Adenocarcinoma
PDHX::EIF3M	Adenocarcinoma
PDHX::ELF5	Adenocarcinoma
PDHX::KDM6A	Adenocarcinoma
PDHX::STK32B	Squamous cell carcinoma
PDIA3::MFAP1	Adenocarcinoma
PDIA3::RPAP1	Adenocarcinoma
PDIA4::CBX5	Adenocarcinoma
PDIA4::FAR1	Squamous cell carcinoma
PDIA4::HACE1	Adenocarcinoma
PDIA4::SCHIP1	Squamous cell carcinoma
PDIA4::SIAE	Adenocarcinoma
PDIA4::TADA2A	Adenocarcinoma
PDIA5::CASR	Adenocarcinoma
PDIA5::IQCB1	Astrocytoma, grade III-IV/Glioblastoma
PDIA5::NLGN1	Adenocarcinoma
PDIA5::SLC49A4	Adenocarcinoma | Squamous cell carcinoma
PDIA6::DKK3	Squamous cell carcinoma
PDIA6::FBRSL1	Squamous cell carcinoma
PDIA6::TPM2	Adenocarcinoma
PDK2::CDK12	Adenocarcinoma
PDK3::CADPS	Adenocarcinoma
PDK3::NAV3	Malignant melanoma
PDLIM1::SORBS1	Adenocarcinoma | Squamous cell carcinoma
PDLIM1::TNRC6A	Squamous cell carcinoma
PDLIM2::SORBS3	Adenocarcinoma
PDLIM3::ENPP6	Adenocarcinoma
PDLIM3::SORBS2	Adenocarcinoma
PDLIM3::ZFYVE28	Astrocytoma, grade I-II
PDLIM5::ART3	Adenocarcinoma
PDLIM5::CCSER1	Malignant epithelial tumor, special type
PDLIM5::SHISA5	Adenocarcinoma
PDLIM5::SMARCAD1	Adenocarcinoma
PDLIM5::STPG2	Mesenchymal tumor, NOS
PDLIM5::TIMM23	Astrocytoma, grade III-IV/Glioblastoma
PDLIM5::USP8	Undifferentiated round cell sarcoma
PDLIM7::FAM193B	Transitional cell carcinoma
PDLIM7::USP6	Nodular fasciitis
PDP1::INA	Mesenchymal tumor, NOS
PDPK1::CCNF	Adenocarcinoma
PDPK1::JPT2	Malignant melanoma
PDPK1::PRSS21	Adenocarcinoma
PDPK1::UBALD1	Squamous cell carcinoma
PDPN::PRKCB	Benign fibrous histiocytoma
PDRG1::ARF3::RUNX1T1	Adenocarcinoma
PDRG1::NOL4L	Malignant epithelial tumor, special type
PDS5A::RBM47	Adenocarcinoma
PDS5B::ATP8A2	Malignant melanoma
PDS5B::COL4A1	Mesenchymal tumor, NOS
PDS5B::CRYBB1	Adenocarcinoma
PDS5B::POLR1G	Adenocarcinoma
PDS5B::PSPC1	Adenocarcinoma
PDS5B::TBC1D4	Adenocarcinoma
PDS5B::UBR2	Adenocarcinoma
PDSS2::AIG1	Multiple myeloma
PDSS2::CCDC178	Adenocarcinoma
PDSS2::LMBRD1	Adenocarcinoma
PDSS2::SMARCA4	Adenocarcinoma
PDSS2::SOBP	Multiple myeloma | Adenocarcinoma
PDSS2::TRPV2	Carcinoma, NOS
PDXDC1::ADGRG1	Adenocarcinoma
PDXDC1::BFAR	Astrocytoma, grade I-II
PDXDC1::LMF1	Adenocarcinoma
PDXDC1::MMP14	Adenocarcinoma
PDXDC1::NAV2	Squamous cell carcinoma
PDXDC1::NPIPA3	Adenocarcinoma
PDXDC1::RAB11FIP4	Adenocarcinoma
PDXK::ABCG1	Transitional cell carcinoma
PDXK::EYS	Squamous cell carcinoma
PDXK::KLF10	Adenocarcinoma
PDXK::LCA5L	Adenocarcinoma
PDXK::LIN7A	Mesenchymal tumor, NOS
PDXK::RRP1B	Adenocarcinoma
PDXP::SLC17A9	Transitional cell carcinoma
PDZD2::COL27A1	Adenocarcinoma
PDZD2::KCNB2	Adenocarcinoma
PDZD4::CMC4	Mesenchymal tumor, NOS
PDZD7::ETV6	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PDZD8::ENO4	Malignant melanoma
PDZD8::PCLAF	Squamous cell carcinoma
PDZRN3::ADAM19	Adenocarcinoma
PDZRN3::CACNA2D3	Mesenchymal tumor, NOS
PDZRN3::EIF4E3	Adenocarcinoma
PDZRN3::FCAMR	Adenocarcinoma
PDZRN3::FOXP1	Adenocarcinoma
PDZRN3::RAF1	Adenocarcinoma | Soft tissue tumor, special type
PDZRN3::THRB	Adenocarcinoma
PDZRN3::TMC1	Astrocytoma, grade I-II
PDZRN4::CPM	Astrocytoma, grade III-IV/Glioblastoma
PEA15::SIAE	Astrocytoma, grade I-II
PEAK1::ANGPT1	Adenocarcinoma
PEAK1::CIB2	Transitional cell carcinoma
PEAK1::LINGO1	Adenocarcinoma
PEAK1::NRG4	Malignant melanoma
PEAK1::PSTPIP1	Malignant melanoma
PEAK1::USP31	Squamous cell carcinoma
PEAK1::VPS33B	Transitional cell carcinoma
PEAR1::NTRK1	Angiosarcoma
PEBP1::DENND4B	Adenocarcinoma
PEBP4::UNC5D	Adenocarcinoma
PEDS1::KCNC3	Adenocarcinoma
PEDS1::PXMP4	Adenocarcinoma
PEF1::OSBPL9	Adenocarcinoma
PEG10::COL1A2	Adenocarcinoma
PEG3::DENR	Adenocarcinoma
PELI1::ACTG2	Adenocarcinoma
PELI1::AFTPH	Multiple myeloma
PELI1::APLF	Adenocarcinoma
PELI1::IGK	Multiple myeloma
PELI1::KRT8	Adenocarcinoma
PELI1::UBC	Multiple myeloma
PELI2::C14ORF39	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PELI2::FBXO33	Squamous cell carcinoma
PELI2::FOXN3	Mesenchymal tumor, NOS
PELI2::GPHN	Malignant melanoma
PELI2::KTN1	Adenocarcinoma
PELP1::CAMTA2	Adenocarcinoma
PELP1::CHRNE	Squamous cell carcinoma
PELP1::SPAG7	Adenocarcinoma
PELP1::YBX2	Adenocarcinoma
PEMT::ANKRD6	Angiosarcoma
PEMT::B4GALNT2	Adenocarcinoma
PEMT::CCDC103	Adenocarcinoma
PEMT::IGF2BP1	Adenocarcinoma
PEMT::NEU3	Adenocarcinoma
PEMT::PRKCA	Adenocarcinoma
PEMT::RAI1	Squamous cell carcinoma
PEMT::SCUBE1	Malignant melanoma
PEMT::TOM1L2	Adenocarcinoma
PEMT::TOP3A	Adenocarcinoma
PENK::PLAT	Embryonal nervous system tumor, special type
PEPD::CEBPG	Adenocarcinoma
PEPD::CHST8	Adenocarcinoma
PEPD::GRAMD1A	Malignant melanoma
PEPD::NDUFB7	Adenocarcinoma
PEPD::NME7	Squamous cell carcinoma
PEPD::SKAP1	Adenocarcinoma
PEPD::ZNF829	Adenocarcinoma
PER1::ENOPH1	Adenocarcinoma
PER2::HDAC4	Malignant melanoma
PER2::SEPTIN2	Adenocarcinoma
PER3::CAMTA1	Squamous cell carcinoma
PER3::CELA2A	Astrocytoma, grade I-II
PER3::CELA2B	Astrocytoma, grade I-II
PER3::DNAJC11	Adenocarcinoma
PER3::GNAL	Adenocarcinoma
PER3::PGD	Astrocytoma, grade III-IV/Glioblastoma
PERP::CASK	Adenocarcinoma
PERP::DDX27	Squamous cell carcinoma
PERP::PLAT	Squamous cell carcinoma
PERP::TULP1	Adenocarcinoma
PEX11A::MESP1	Adenocarcinoma
PEX13::CHMP3	Squamous cell carcinoma
PEX13::NRXN1	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
PEX14::CASZ1	Squamous cell carcinoma
PEX14::CLP1	Astrocytoma, grade III-IV/Glioblastoma
PEX14::EPHA2	Adenocarcinoma
PEX14::HMOX2	Adenocarcinoma
PEX14::KIF1B	Adenocarcinoma
PEX14::PRG4	Squamous cell carcinoma
PEX14::RBP7	Adenocarcinoma
PEX16::AMBRA1	Adenocarcinoma
PEX19::AIG1	Malignant melanoma
PEX1::AKAP9	Squamous cell carcinoma
PEX1::CDK6	Adenocarcinoma
PEX1::NBEA	Adenocarcinoma
PEX1::RAB34	Adenocarcinoma
PEX26::RTCB	Malignant melanoma
PEX3::PHACTR2	Adenocarcinoma
PEX3::SLC35F1	Mesenchymal tumor, NOS
PEX5::CLSTN3	Adenocarcinoma
PEX5::LPL	Squamous cell carcinoma
PEX5::PRB1	Transitional cell carcinoma
PEX5::PRB2	Transitional cell carcinoma
PEX6::MBD3L1	Adenocarcinoma
PEX6::PPP2R5D	Adenocarcinoma
PEX7::MED23	Adenocarcinoma
PEX7::TCF21	Adenocarcinoma
PFDN1::DNMT3L	Malignant epithelial tumor, special type
PFDN2::APOA2	Adenocarcinoma
PFDN2::COPA	Adenocarcinoma
PFDN2::RXRG	Malignant melanoma
PFDN4::TSHZ2	Adenocarcinoma
PFKFB1::ALAS2	Adenocarcinoma
PFKFB2::GDAP1L1	Adenocarcinoma
PFKFB2::TMEM259	Adenocarcinoma
PFKFB3::AKR1C1	Transitional cell carcinoma
PFKFB3::GDI2	Transitional cell carcinoma
PFKFB3::TASOR2	Adenocarcinoma
PFKFB3::ZNF831	Malignant melanoma
PFKFB4::ARHGAP39	Adenocarcinoma
PFKFB4::COL7A1	Squamous cell carcinoma
PFKFB4::MYRIP	Adenocarcinoma
PFKFB4::RAF1	Adenocarcinoma
PFKFB4::TMEM89	Adenocarcinoma
PFKFB4::UQCRC1	Adenocarcinoma
PFKL::AIRE	Astrocytoma, grade I-II | Adenocarcinoma
PFKP::CAMK2G	Transitional cell carcinoma
PFKP::PSG1	Transitional cell carcinoma
PGAM5::CCL28	Adenocarcinoma
PGAP1::HSPD1	Adenocarcinoma
PGAP1::NCKAP5	Squamous cell carcinoma
PGAP1::SPAG16	Adenocarcinoma
PGAP1::VWC2L	Adenocarcinoma
PGAP1::ZDBF2	Squamous cell carcinoma
PGAP3::AATF	Adenocarcinoma
PGAP3::BPTF	Adenocarcinoma
PGAP3::DNAAF11	Transitional cell carcinoma
PGAP3::ERBB2	Carcinoma, NOS | Squamous cell carcinoma
PGAP3::GRB7	Squamous cell carcinoma
PGAP3::IFI35	Adenocarcinoma
PGAP3::IKZF3	Adenocarcinoma
PGAP3::MYOCD	Transitional cell carcinoma
PGAP3::PNMT	Squamous cell carcinoma
PGAP3::PPM1D	Adenocarcinoma
PGAP3::PPP1R1B	Adenocarcinoma
PGAP3::PTPN12	Adenocarcinoma
PGAP3::STAC2	Adenocarcinoma
PGAP3::STARD3	Adenocarcinoma | Transitional cell carcinoma
PGAP3::TOP2A	Adenocarcinoma
PGAP6::YBX3	Adenocarcinoma
PGBD2::KIRREL3	Adenocarcinoma
PGBD2::UBE4A	Astrocytoma, grade I-II
PGC::CHGB	Adenocarcinoma
PGC::SFTPB	Adenocarcinoma
PGC::UBB	Adenocarcinoma
PGD::CAMTA1	Astrocytoma, grade III-IV/Glioblastoma
PGD::CLSTN1	Squamous cell carcinoma
PGD::NTSR1	Squamous cell carcinoma
PGD::PEX14	Squamous cell carcinoma
PGD::RBP7	Adenocarcinoma
PGGT1B::CCDC112	Malignant melanoma
PGGT1B::KIAA0825	Adenocarcinoma
PGK1::ATP7A	Adenocarcinoma
PGLS::GTPBP3	Adenocarcinoma
PGLYRP4::S100A2	Squamous cell carcinoma
PGM1::CHN1	Mesothelioma
PGM1::SLC16A12	Adenocarcinoma
PGM2L1::CHRDL2	Adenocarcinoma
PGM2L1::POLD3	Adenocarcinoma
PGM2L1::PPME1	Adenocarcinoma
PGM2L1::RAB6A	Squamous cell carcinoma
PGM2L1::RBBP5	Adenocarcinoma
PGM2L1::UVRAG	Adenocarcinoma
PGPEP1::ALPL	Adenocarcinoma
PGPEP1::KDM4C	Adenocarcinoma
PGR::NR4A3	Leiomyosarcoma
PGS1::AFMID	Mature B-cell neoplasm, NOS
PGS1::BIRC5	Adenocarcinoma
PGS1::BPTF	Adenocarcinoma
PGS1::CXCR5	Adenocarcinoma
PGS1::DNAH17	Osteosarcoma, NOS
PGS1::KIF22	Adenocarcinoma
PGS1::NAT9	Transitional cell carcinoma
PGS1::SYNGR2	Adenocarcinoma
PGS1::TM9SF1	Adenocarcinoma
PHACTR1::ALK	Adenocarcinoma
PHACTR1::BCL11A	Adenocarcinoma
PHACTR2::AIG1	Adenocarcinoma
PHACTR2::PEX3	Adenocarcinoma
PHACTR2::PLAGL1	Squamous cell carcinoma
PHACTR3::BCAS1	Mesenchymal tumor, NOS
PHACTR3::PTPRM	Adenocarcinoma
PHACTR3::SYCP2	Adenocarcinoma
PHACTR4::FAM76A	Astrocytoma, grade I-II
PHACTR4::LRRC42	Adenocarcinoma
PHACTR4::MED18	Malignant epithelial tumor, special type
PHACTR4::RCC1	Adenocarcinoma
PHACTR4::SCMH1	Adenocarcinoma
PHACTR4::SESN2	Adenocarcinoma
PHAF1::ARL16	Squamous cell carcinoma
PHAF1::CMTM4	Adenocarcinoma
PHAF1::CRTC3	Adenocarcinoma
PHAF1::DNAAF1	Adenocarcinoma
PHAF1::GNAO1	Adenocarcinoma
PHAF1::MDFI	Adenocarcinoma
PHAF1::PDP2	Adenocarcinoma
PHAF1::SLC9A5	Mesothelioma
PHB1::LSM1	Adenocarcinoma
PHB2::RBP5	Squamous cell carcinoma
PHC1::FGF10	Malignant melanoma
PHC2::CSMD2	Adenocarcinoma
PHC2::HSP90AA1	Adenocarcinoma
PHC2::MFSD11	Mesenchymal tumor, NOS
PHC2::NLRP4	Adenocarcinoma
PHC2::ZSCAN20	Adenocarcinoma
PHC3::EIF5A2	Adenocarcinoma
PHC3::FNDC3B	Adenocarcinoma | Squamous cell carcinoma
PHC3::GNA12	Squamous cell carcinoma
PHC3::IFT122	Squamous cell carcinoma
PHC3::NCEH1	Adenocarcinoma
PHC3::NFKBIL1	Malignant epithelial tumor, special type
PHC3::SLC7A14	Squamous cell carcinoma
PHETA2::RAI14	Malignant melanoma
PHF10::AFDN	Adenocarcinoma
PHF10::ERMARD	Mesenchymal tumor, NOS
PHF11::SETDB2	Squamous cell carcinoma
PHF12::ANO1	Adenocarcinoma
PHF12::CDK12	Adenocarcinoma
PHF12::DNM2	Adenocarcinoma
PHF12::LIG3	Adenocarcinoma
PHF12::MYO18A	Adenocarcinoma
PHF12::PIPOX	Transitional cell carcinoma
PHF12::PLXDC1	Adenocarcinoma
PHF12::SEZ6	Adenocarcinoma
PHF12::TMEM97	Adenocarcinoma
PHF13::ESPN	Astrocytoma, grade III-IV/Glioblastoma
PHF14::MEOX2	Adenocarcinoma
PHF19::FOXP2	Meningioma
PHF19::IGSF8	Astrocytoma, grade I-II
PHF1::BRD8	Endometrial stromal sarcoma
PHF1::FOXR1	Ossifying fibromyxoid tumor
PHF1::FOXR2	Ossifying fibromyxoid tumor
PHF1::NUTM2B	Endometrial stromal sarcoma
PHF1::TFE3	Soft tissue tumor, special type | Ossifying fibromyxoid tumor | Malignant epithelial tumor, special type
PHF20::ADNP	Adenocarcinoma
PHF20::CEP250	Adenocarcinoma
PHF20::DLGAP4	Adenocarcinoma
PHF20::DYNLRB1	Adenocarcinoma
PHF20::EPB41L1	Adenocarcinoma | Transitional cell carcinoma
PHF20::NTRK1	Adenocarcinoma
PHF20::RPN2	Adenocarcinoma
PHF20::SPAG4	Adenocarcinoma
PHF20::TOX2	Adenocarcinoma
PHF20L1::SAMD12	Adenocarcinoma
PHF21A::ACSL6	Adenocarcinoma
PHF21A::ALKBH3	Adenocarcinoma
PHF21A::AMBRA1	Adenocarcinoma
PHF21A::ARHGAP1	Transitional cell carcinoma
PHF21A::CAMK1D	Adenocarcinoma
PHF21A::CCDC178	Adenocarcinoma
PHF21A::CKAP5	Squamous cell carcinoma
PHF21A::CNP	Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
PHF21A::GLIS2	Squamous cell carcinoma | Skin | Acute myeloid leukemia, NOS
PHF21A::LEUTX	Adenocarcinoma
PHF21A::NUTF2	Transitional cell carcinoma
PHF21A::ODAD4	Malignant epithelial tumor, special type
PHF21A::PACSIN3	Adenocarcinoma
PHF21A::TMEM123	Squamous cell carcinoma
PHF21B::CLTCL1	Adenocarcinoma
PHF21B::NOC4L	Adenocarcinoma
PHF21B::WNT7B	Adenocarcinoma
PHF23::TOM1	Adenocarcinoma
PHF2::WNK2	Adenocarcinoma
PHF3::AKR1C1	Adenocarcinoma
PHF3::ENPP3	Adenocarcinoma
PHF3::EYS	Adenocarcinoma | Astrocytoma, grade III-IV/Glioblastoma
PHF3::FNTA	Adenocarcinoma
PHF3::NUS1	Adenocarcinoma
PHF3::QKI	Malignant melanoma
PHF3::R3HCC1	Adenocarcinoma
PHF3::SYT4	Mesenchymal tumor, NOS
PHF8::FAM120C	Adenocarcinoma
PHF8::SLCO1C1	Squamous cell carcinoma
PHGDH::ANXA1	Astrocytoma, grade I-II
PHGDH::HMGCS2	Squamous cell carcinoma
PHGDH::NEGR1	Adenocarcinoma
PHGDH::WDPCP	Squamous cell carcinoma
PHGR1::DISP2	Adenocarcinoma
PHIP::BRAF	Fibrosarcoma | Benign nevus
PHIP::FTO	Adenocarcinoma
PHIP::HMGN3	Adenocarcinoma
PHIP::MYO6	Mesenchymal tumor, NOS
PHIP::NUP153	Skin | Acute myeloid leukemia, NOS
PHIP::PATJ	Adenocarcinoma
PHKA1::HDAC8	Astrocytoma, grade I-II
PHKA2::ADGRG2	Adenocarcinoma
PHKA2::FBXO36	Squamous cell carcinoma
PHKB::ERBIN	Astrocytoma, grade I-II
PHKB::PDE3A	Adenocarcinoma
PHKB::SCN8A	Mesenchymal tumor, NOS
PHKG2::RPL27	Adenocarcinoma
PHLDA3::MYBPH	Adenocarcinoma
PHLDB1::IL10RA	Astrocytoma, grade I-II
PHLDB1::KMT2A	Undifferentiated pleomorphic sarcoma
PHLDB1::RNF121	Adenocarcinoma
PHLDB1::SPAG9	Mesenchymal tumor, NOS
PHLDB1::UBE4A	Mesothelioma
PHLDB2::CD96	Squamous cell carcinoma
PHLDB2::KCNAB1	Transitional cell carcinoma
PHLDB2::RAB7A	Adenocarcinoma
PHLDB2::RIMS2	Squamous cell carcinoma
PHLDB2::TAGLN3	Squamous cell carcinoma
PHLDB2::TMPRSS7	Adenocarcinoma
PHLDB3::ETHE1	Adenocarcinoma
PHLPP1::ADAMTS13	Astrocytoma, grade I-II
PHLPP1::CBLN2	Adenocarcinoma
PHLPP1::WDR12	Squamous cell carcinoma
PHLPP2::KIF22	Adenocarcinoma
PHOSPHO1::KRT23	Adenocarcinoma
PHOX2A::CLPB	Malignant epithelial tumor, special type
PHRF1::GCGR	Adenocarcinoma
PHRF1::LRRC56	Adenocarcinoma
PHRF1::PTDSS2	Squamous cell carcinoma
PHRF1::RASSF7	Adenocarcinoma
PHRF1::TSPAN4	Adenocarcinoma
PHTF1::ESRRG	Mesothelioma
PHTF1::PTPN22	Squamous cell carcinoma
PHTF1::RSBN1	Squamous cell carcinoma
PHTF2::BET1	Transitional cell carcinoma
PHTF2::KBTBD2	Mesenchymal tumor, NOS
PHTF2::RAB1A	Adenocarcinoma
PHTF2::RSBN1L	Squamous cell carcinoma
PHTF2::RUNDC3B	Adenocarcinoma
PHYHD1::LRRC8A	Adenocarcinoma
PHYHD1::ZER1	Adenocarcinoma
PHYHIPL::RET	Carcinoma, NOS
PI15::GDAP1	Adenocarcinoma
PI3::CLCN3	Squamous cell carcinoma
PI4K2A::AS3MT	Adenocarcinoma
PI4K2A::UBTD1	Adenocarcinoma
PI4K2A::ZDHHC16	Adenocarcinoma
PI4K2B::INSR	Mesenchymal tumor, NOS
PI4KA::ABRAXAS1	Adenocarcinoma
PI4KA::CDH10	Malignant melanoma
PI4KA::CLTCL1	Malignant melanoma
PI4KA::DEPDC5	Malignant epithelial tumor, special type
PI4KA::MYO18B	Malignant melanoma
PI4KA::PHF21B	Malignant melanoma
PI4KA::PRODH	Squamous cell carcinoma
PI4KA::RREB1	Squamous cell carcinoma
PI4KA::SNAP29	Adenocarcinoma
PI4KA::TAFA5	Adenocarcinoma
PI4KA::TTC39C	Transitional cell carcinoma
PI4KA::VPREB3	Astrocytoma, grade I-II
PI4KA::ZNF274	Adenocarcinoma
PI4KB::CDC42SE1	Germ cell tumor, NOS
PI4KB::SELENBP1	Adenocarcinoma | Squamous cell carcinoma
PI4KB::SH3D21	Adenocarcinoma
PI4KB::SYT11	Adenocarcinoma
PIAS1::HMCN2	Adenocarcinoma
PIAS1::MAP2K5	Squamous cell carcinoma
PIAS1::ZNF609	Adenocarcinoma
PIAS2::IER3IP1	Adenocarcinoma
PIAS2::SKOR2	Malignant melanoma
PIAS3::REN	Adenocarcinoma
PIAS3::TSPOAP1	Mesenchymal tumor, NOS
PIAS4::GLYATL2	Astrocytoma, grade III-IV/Glioblastoma
PIAS4::YJU2	Squamous cell carcinoma
PIAS4::ZBTB7A	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Multiple myeloma
PIAS4::ZFR2	Astrocytoma, grade I-II
PIAS4::ZNF787	Mesenchymal tumor, NOS
PIBF1::C11orf65	Squamous cell carcinoma
PIBF1::RET	Adenocarcinoma | Carcinoma, NOS
PICALM::CCDC81	Undifferentiated carcinoma, small cell
PICALM::DDX21	Adenocarcinoma
PICALM::ME3	Adenocarcinoma
PICALM::MLLT10	Acute myelomonocytic leukemia (FAB type M4) | Acute eosinophilic leukemia | Acute myeloid leukemia, NOS | Skin | Acute myeloblastic leukemia without maturation (FAB type M1) | Acute myeloblastic leukemia with maturation (FAB type M2) | Acute megakaryoblastic leukemia (FAB type M7) | Acute myeloblastic leukemia with minimal differentiation (FAB type M0) | Egypt | Acute monoblastic leukemia without differentiation (FAB type M5a) | Acute monoblastic leukemia (FAB type M5) | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Bilineage or biphenotypic leukemia
PICALM::PPME1	Astrocytoma, grade I-II
PICALM::RET	Adenocarcinoma
PICALM::SYTL2	Undifferentiated round cell sarcoma
PICK1::CTSB	Adenocarcinoma
PICK1::EIF4ENIF1	Adenocarcinoma
PICK1::GCAT	Squamous cell carcinoma
PICK1::MYPOP	Adenocarcinoma
PICK1::PDCD6	Adenocarcinoma
PICK1::POLR2F	Adenocarcinoma
PICK1::SH3BP1	Adenocarcinoma
PID1::DNER	Adenocarcinoma | Astrocytoma, grade III-IV/Glioblastoma
PID1::MRPS6	Mesenchymal tumor, NOS
PIEZO1::APRT	Adenocarcinoma | Squamous cell carcinoma
PIEZO1::CBFA2T3	Adenocarcinoma | Acute myeloblastic leukemia with maturation (FAB type M2)
PIEZO1::GALNS	Adenocarcinoma
PIEZO1::KCTD19	Mesothelioma
PIEZO1::KLHDC4	Mesenchymal tumor, NOS
PIEZO1::MNS1	Adenocarcinoma
PIEZO1::PMFBP1	Transitional cell carcinoma
PIEZO1::RSPO2	Adenoma
PIEZO1::TMEM219	Adenocarcinoma
PIEZO2::IMPA2	Mesenchymal tumor, NOS
PIGF::CALM2	Malignant epithelial tumor, special type
PIGF::CHMP3	Adenocarcinoma
PIGF::STPG4	Malignant epithelial tumor, special type
PIGG::SPINK2	Astrocytoma, grade III-IV/Glioblastoma
PIGG::SUGCT	Astrocytoma, grade I-II
PIGK::CSGALNACT1	Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
PIGK::SPATA6	Meningioma
PIGK::ST6GALNAC3	Adenocarcinoma
PIGK::TGFBR3	Squamous cell carcinoma
PIGL::RABEP1	Squamous cell carcinoma
PIGL::TBC1D26	Adenocarcinoma
PIGN::CTNNA2	Adenocarcinoma
PIGN::MAB21L3	Squamous cell carcinoma
PIGN::TMEM241	Adenocarcinoma
PIGO::CA9	Astrocytoma, grade III-IV/Glioblastoma
PIGS::PPP1R27	Adenocarcinoma
PIGS::SPAG5	Transitional cell carcinoma | Adenocarcinoma
PIGT::SRSF6	Adenocarcinoma
PIGU::ACSS2	Squamous cell carcinoma
PIGU::ALG5	Adenocarcinoma
PIGU::BCAS3	Adenocarcinoma
PIGU::CIMIP1	Adenocarcinoma
PIGU::MAP1LC3A	Adenocarcinoma
PIGU::NCOA6	Astrocytoma, grade III-IV/Glioblastoma
PIGU::PITPNC1	Adenocarcinoma
PIGU::PTPRT	Adenocarcinoma
PIGU::UQCC1	Adenocarcinoma
PIGU::XRCC4	Adenocarcinoma
PIGZ::EPHB3	Adenocarcinoma
PIGZ::MELTF	Adenocarcinoma
PIGZ::PRPSAP2	Adenocarcinoma
PIH1D1::ALDH16A1	Adenocarcinoma
PIK3AP1::AVPI1	Adenocarcinoma
PIK3AP1::NDRG1	Adenocarcinoma
PIK3AP1::TM9SF3	Squamous cell carcinoma
PIK3C2A::PLEKHA7	Adenocarcinoma
PIK3C2A::TEAD1	Adenocarcinoma
PIK3C2B::C1ORF116	Adenocarcinoma
PIK3C2B::DSTYK	Astrocytoma, grade III-IV/Glioblastoma
PIK3C2B::KISS1	Squamous cell carcinoma
PIK3C2B::LRRN2	Adenocarcinoma
PIK3C2G::CTDSP2	Mesenchymal tumor, NOS
PIK3C2G::PPFIBP1	Adenocarcinoma
PIK3C3::TRPC6	Squamous cell carcinoma
PIK3CA::KCNMB3	Adenocarcinoma
PIK3CA::TNFSF10	Multiple myeloma
PIK3CA::YLPM1	Squamous cell carcinoma
PIK3CB::BFSP2	Squamous cell carcinoma
PIK3CB::CEP70	Adenocarcinoma
PIK3CB::COPB2	Adenocarcinoma
PIK3CB::EPHB1	Astrocytoma, grade III-IV/Glioblastoma
PIK3CB::ESYT3	Squamous cell carcinoma
PIK3CB::GRM7	Adenocarcinoma
PIK3CB::HHLA2	Adenocarcinoma
PIK3CB::KCNAB1	Adenocarcinoma
PIK3CB::PCCB	Adenocarcinoma | Acute myeloid leukemia, NOS | Skin
PIK3CB::RASA2	Adenocarcinoma
PIK3CB::SEMA5B	Adenocarcinoma
PIK3CB::TSPO	Adenocarcinoma
PIK3R1::GINS3	Malignant epithelial tumor, special type
PIK3R1::HAPLN1	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
PIK3R1::KANK1	Adenoid cystic carcinoma
PIK3R1::MRPL42	Adenocarcinoma
PIK3R1::NDUFB7	Adenocarcinoma
PIK3R1::SH3TC2	Astrocytoma, grade III-IV/Glioblastoma
PIK3R3::LRRC41	Malignant epithelial tumor, special type | Adenocarcinoma
PIK3R3::MOB3C	Squamous cell carcinoma
PIK3R3::MYO18A	Adenocarcinoma
PIK3R3::RDH10	Adenocarcinoma
PIK3R3::TRPM8	Adenocarcinoma
PIK3R3::ZSWIM5	Squamous cell carcinoma
PIK3R4::ASTE1	Adenocarcinoma
PIK3R4::KALRN	Malignant melanoma
PIKFYVE::BPTF	Adenocarcinoma
PIKFYVE::MLPH	Transitional cell carcinoma
PIKFYVE::NHEJ1	Squamous cell carcinoma
PIKFYVE::TMEM119	Adenocarcinoma
PIKFYVE::ZNF124	Squamous cell carcinoma
PILRB::AP4M1	Adenocarcinoma
PILRB::IMMP2L	Adenocarcinoma
PILRB::MAGI2	Adenocarcinoma
PIM1::BCL6	Diffuse large B-cell lymphoma
PIM3::BRD1	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Multiple myeloma
PIM3::CRELD2	Adenocarcinoma | Mature B-cell neoplasm, NOS
PIM3::FRMD8	Adenocarcinoma
PIM3::IGH	Multiple myeloma
PIM3::KLF2	Multiple myeloma
PIM3::METRNL	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PIM3::SBF1	Multiple myeloma
PIM3::SCO2	Mature B-cell neoplasm, NOS | Multiple myeloma | Acute lymphoblastic leukemia/lymphoblastic lymphoma
PIM3::SLC7A5	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PIM3::ZBED4	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PIN1::PDE4C	Adenocarcinoma
PIN1::PPP2R3C	Adenocarcinoma
PIN4::HDAC8	Adenocarcinoma
PIN4::LPCAT2	Adenocarcinoma
PINX1::HGSNAT	Adenocarcinoma
PINX1::XKR6	Squamous cell carcinoma
PIP4K2A::ABLIM1	Adenocarcinoma
PIP4K2A::ARHGAP21	Adenocarcinoma
PIP4K2A::ITFG1	Transitional cell carcinoma
PIP4K2B::CWC25	Adenocarcinoma
PIP4K2B::ERBB2	Adenocarcinoma
PIP4K2B::FBXL20	Adenocarcinoma
PIP4K2B::KPNB1	Adenocarcinoma
PIP4K2B::MED24	Adenocarcinoma
PIP4K2B::MLLT6	Adenocarcinoma
PIP4K2B::RAD51C	Adenocarcinoma
PIP4K2B::RPL23	Adenocarcinoma
PIP4K2B::SHANK2	Adenocarcinoma
PIP4K2B::SLC6A4	Adenocarcinoma
PIP4K2B::TMEM132E	Adenocarcinoma
PIP4K2C::DCTN2	Astrocytoma, grade III-IV/Glioblastoma
PIP4P2::LCLAT1	Adenocarcinoma
PIP5K1A::C1ORF56	Adenocarcinoma
PIP5K1A::C1orf56	Adenocarcinoma
PIP5K1A::ITLN1	Adenocarcinoma
PIP5K1A::MLLT11	Adenocarcinoma
PIP5K1A::SCNM1	Squamous cell carcinoma
PIP5K1A::SLC20A2	Squamous cell carcinoma
PIP5K1A::TNFAIP8L2	Squamous cell carcinoma
PIP5K1B::MAP7D1	Adenocarcinoma
PIP5K1B::PGM5	Adenocarcinoma
PIP5K1B::TJP2	Adenocarcinoma
PIP5K1C::C3	Adenocarcinoma
PIP5K1C::MATK	Squamous cell carcinoma
PIP5K1C::PALM	Adenocarcinoma
PIP5K1C::PPM1H	Mesenchymal tumor, NOS
PIP5K1C::TJP3	Astrocytoma, grade I-II
PIR::ACE2	Adenocarcinoma
PIR::CLTRN	Transitional cell carcinoma
PIR::VEGFD	Nonneoplastic epithelial disorder/lesion
PISD::MED15	Adenocarcinoma
PISD::PRR14L	Squamous cell carcinoma
PISD::RBL1	Squamous cell carcinoma
PITPNA::KCNIP4	Adenocarcinoma
PITPNA::LLGL2	Adenocarcinoma
PITPNA::NXN	Adenocarcinoma
PITPNA::PRPF8	Adenocarcinoma
PITPNA::SLC43A2	Adenocarcinoma
PITPNB::FAM25C	Transitional cell carcinoma
PITPNB::SBF1	Adenocarcinoma
PITPNB::TANGO2	Squamous cell carcinoma
PITPNC1::ANXA10	Adenocarcinoma
PITPNC1::B4GALNT2	Adenocarcinoma
PITPNC1::BPTF	Adenocarcinoma
PITPNC1::CA10	Adenocarcinoma
PITPNC1::CACNG4	Alveolar rhabdomyosarcoma
PITPNC1::EXOC3L4	Adenocarcinoma
PITPNC1::IKZF3	Adenocarcinoma
PITPNC1::KHDRBS3	Adenocarcinoma
PITPNC1::MARCHF10	Adenocarcinoma
PITPNC1::MBTD1	Adenocarcinoma
PITPNC1::PRKCA	Adenocarcinoma
PITPNC1::RHOT1	Adenocarcinoma
PITPNC1::SKAP1	Squamous cell carcinoma
PITPNC1::THUMPD1	Adenocarcinoma
PITPNM1::CABP2	Adenocarcinoma
PITPNM1::NUMA1	Adenocarcinoma
PITPNM2::ARHGEF25	Mesenchymal tumor, NOS
PITPNM2::KCTD3	Squamous cell carcinoma
PITPNM2::MPHOSPH9	Malignant epithelial tumor, special type
PITPNM2::PGD	Adenocarcinoma
PITPNM2::SBNO1	Adenocarcinoma
PITPNM2::UBE3B	Mesothelioma
PITPNM3::P2RX5	Adenocarcinoma
PITPNM3::PELP1	Adenocarcinoma
PITPNM3::SLC38A9	Adenocarcinoma
PITPNM3::STX8	Adenocarcinoma
PITX1::P4HA2	Squamous cell carcinoma
PIWIL4::THRSP	Mesenchymal tumor, NOS
PJA2::ADGRV1	Squamous cell carcinoma
PJA2::TMEM232	Malignant melanoma
PKD1::RPS15A	Adenocarcinoma
PKD1::SLIT1	Astrocytoma, pilocytic/juvenile
PKD1::UBE2I	Squamous cell carcinoma
PKD1::ZNF598	Adenocarcinoma
PKDCC::CXXC5	Adenocarcinoma
PKHD1::CAGE1	Adenocarcinoma
PKHD1::ESR1	Astrocytoma, grade I-II
PKHD1::RCAN2	Adenocarcinoma
PKHD1::SSR1	Adenocarcinoma
PKIB::BLK	Adenocarcinoma
PKIB::HDDC2	Squamous cell carcinoma
PKIB::SLC35F1	Adenocarcinoma
PKIB::TRDN	Squamous cell carcinoma
PKIG::PRR30	Adenocarcinoma
PKM::ACP3	Adenocarcinoma
PKM::CELF6	Squamous cell carcinoma
PKM::CLCN3	Adenocarcinoma
PKM::ERBB3	Astrocytoma, grade I-II
PKM::FOXP1	Squamous cell carcinoma
PKM::MCTP2	Adenocarcinoma
PKM::PTN	Adenocarcinoma
PKM::SLC1A3	Astrocytoma, grade I-II
PKM::TNNT1	Squamous cell carcinoma
PKM::TRPV3	Adenocarcinoma
PKM::USP6	Fibroma of tendon sheath
PKM::USP7	Adenocarcinoma
PKMYT1::CLDN6	Adenocarcinoma
PKMYT1::FLYWCH1	Squamous cell carcinoma
PKN1::ADGRE3	Adenocarcinoma
PKN1::ANXA4	Adenocarcinoma
PKN1::LDLR	Adenocarcinoma
PKN1::RPLP0	Malignant melanoma
PKN2::COL24A1	Adenocarcinoma
PKN2::VAV3	Adenocarcinoma
PKNOX1::H2BW2	Adenocarcinoma
PKNOX1::NDUFV3	Adenocarcinoma
PKNOX1::PDE9A	Transitional cell carcinoma
PKNOX2::ALK	Adenocarcinoma
PKP1::CLCN3	Squamous cell carcinoma
PKP1::JUP	Squamous cell carcinoma
PKP1::UBE2T	Adenocarcinoma
PKP2::DNM1L	Adenocarcinoma
PKP2::MAP3K20	Transitional cell carcinoma
PKP2::MRPS35	Adenocarcinoma
PKP2::SARNP	Adenocarcinoma
PKP3::C11ORF98	Adenocarcinoma
PKP3::KRT1	Squamous cell carcinoma
PKP3::SORL1	Diffuse large B-cell lymphoma
PKP4::CCDC148	Adenocarcinoma
PKP4::PDE1A	Adenocarcinoma
PKP4::TANC1	Squamous cell carcinoma
PLA2G10::CLEC16A	Adenocarcinoma
PLA2G12A::ELOVL6	Transitional cell carcinoma
PLA2G2A::CLCN3	Adenocarcinoma
PLA2G2A::FBLN1	Adenocarcinoma
PLA2G2A::ITGA6	Adenocarcinoma
PLA2G2A::MBTPS1	Adenocarcinoma
PLA2G2A::PLAT	Adenocarcinoma
PLA2G2A::TAF15	Adenocarcinoma
PLA2G6::BAIAP2L2	Adenocarcinoma
PLA2G6::DNAL4	Adenocarcinoma
PLA2G6::EEF1D	Adenocarcinoma
PLA2G6::SCARF2	Squamous cell carcinoma
PLA2G6::TMEM184B	Malignant melanoma | Adenocarcinoma
PLA2R1::ITGB6	Squamous cell carcinoma
PLA2R1::RBMS1	Adenocarcinoma
PLAA::HACD4	Adenocarcinoma
PLAA::LINGO2	Squamous cell carcinoma
PLAA::MOB3B	Alveolar rhabdomyosarcoma
PLAA::RUSC2	Squamous cell carcinoma
PLAAT3::SGPP2	Astrocytoma, grade I-II
PLAAT4::TGFBI	Transitional cell carcinoma
PLAAT5::RBM19	Germ cell tumor, NOS
PLAC1::DSCAM	Adenocarcinoma
PLAG1::EWSR1	Embryonal nervous system tumor, NOS
PLAG1::RBPMS	Leiomyoma
PLAG1::TCF4	Embryonal nervous system tumor, NOS
PLAGL1::EP300	Ependymoma
PLAGL1::FOXO1	Malignant soft tissue tumor, NOS | Ependymoma
PLAGL1::MAML2	Ependymoma
PLAT::EFCAB8	Squamous cell carcinoma
PLAT::KICS2	Malignant melanoma
PLAT::SUPT16H	Squamous cell carcinoma
PLAU::ZMAT2	Malignant melanoma
PLAUR::AAMDC	Adenocarcinoma
PLAUR::BABAM1	Adenocarcinoma
PLAUR::EXOC3L2	Acute promyelocytic leukemia (FAB type M3)
PLAUR::MARK4	Acute myeloid leukemia, NOS | Skin
PLAUR::SMG9	Squamous cell carcinoma
PLAUR::WDR45	Mesenchymal tumor, NOS
PLAUR::XRCC1	Adenocarcinoma
PLAUR::ZNF576	Adenocarcinoma
PLB1::ALK	Undifferentiated carcinoma, large cell | Adenocarcinoma | Inflammatory myofibroblastic tumor/myofibroblastic sarcoma
PLB1::BABAM2	Transitional cell carcinoma
PLB1::CAB39	Adenocarcinoma
PLBD1::CREBL2	Transitional cell carcinoma
PLBD1::GRIN2B	Adenocarcinoma
PLBD2::CIDEC	Adenocarcinoma
PLBD2::FBXO21	Malignant melanoma
PLCB1::CDKAL1	Adenocarcinoma
PLCB1::DTD1	Astrocytoma, grade I-II
PLCB1::GPCPD1	Adenocarcinoma
PLCB1::ITPA	Squamous cell carcinoma
PLCB1::MCM8	Squamous cell carcinoma
PLCB1::PSMF1	Adenocarcinoma
PLCB1::RBL1	Squamous cell carcinoma
PLCB1::SMOX	Adenocarcinoma
PLCB1::STK25	Embryonal rhabdomyosarcoma
PLCB1::TRMT6	Adenocarcinoma
PLCB1::WTIP	Adenocarcinoma
PLCB2::MAPKBP1	Mesothelioma
PLCB3::BAD	Adenocarcinoma
PLCB3::PGA5	Adenocarcinoma
PLCB3::VEGFB	Adenocarcinoma
PLCB4::BMP2	Adenocarcinoma
PLCB4::GNAS	Adenocarcinoma
PLCB4::MACROD2	Adenocarcinoma
PLCB4::RASA3	Adenocarcinoma
PLCD3::NF1	Adenocarcinoma
PLCD4::VIL1	Adenocarcinoma
PLCE1::CYP2C19	Adenocarcinoma
PLCE1::RET	Carcinoma, NOS
PLCE1::SH3PXD2A	Adenocarcinoma
PLCG1::BPIFB1	Adenocarcinoma
PLCG1::EYA2	Adenocarcinoma
PLCG1::TAF4	Adenocarcinoma
PLCG2::ADCY9	Acute myeloid leukemia, NOS | Skin
PLCG2::CMIP	Squamous cell carcinoma
PLCG2::WWOX	Adenocarcinoma
PLCH1::C3orf33	Adenocarcinoma
PLCH1::MUC13	Transitional cell carcinoma
PLCH1::SKIL	Adenocarcinoma
PLCH2::PRKCZ	Adenocarcinoma
PLCL2::TSEN2	Adenocarcinoma
PLCXD2::CD96	Malignant epithelial tumor, special type
PLCXD2::RIMS2	Squamous cell carcinoma
PLCXD2::TMPRSS7	Adenocarcinoma
PLCXD3::ALK	Squamous cell carcinoma
PLCZ1::PTHLH	Adenocarcinoma
PLD1::AGBL1	Adenocarcinoma
PLD1::FNDC3B	Squamous cell carcinoma
PLD1::LMBR1	Adenocarcinoma
PLD1::SLC7A14	Adenocarcinoma
PLD1::TNFSF10	Squamous cell carcinoma
PLD2::ZZEF1	Adenocarcinoma
PLD3::ACTN4	Adenocarcinoma
PLD3::CD79A	Adenocarcinoma
PLD3::EML2	Adenocarcinoma
PLD3::GNAS	Malignant epithelial tumor, special type
PLD3::NCALD	Adenocarcinoma
PLD3::RPS9	Adenocarcinoma
PLD3::SIRT2	Adenocarcinoma
PLD3::TYK2	Transitional cell carcinoma
PLD4::AHNAK2	Skin | Acute myeloid leukemia, NOS
PLD5::PLA2R1	Malignant melanoma
PLD6::COPS3	Adenocarcinoma
PLEC::EIF2AK2	Adenocarcinoma
PLEC::ENPP2	Adenocarcinoma
PLEC::HAX1	Adenocarcinoma
PLEC::IGH	Multiple myeloma
PLEC::JPH1	Mesenchymal tumor, NOS
PLEC::KANSL1	Adenocarcinoma
PLEC::KSR1	Adenocarcinoma
PLEC::NDUFV1	Adenocarcinoma
PLEC::PLEKHM2	Adenocarcinoma
PLEC::SLC10A1	Adenocarcinoma
PLEC::TNNI1	Adenocarcinoma
PLEK2::TMEM229B	Adenocarcinoma
PLEKHA1::BTBD16	Squamous cell carcinoma
PLEKHA1::CYP2C19	Adenocarcinoma
PLEKHA1::FAM187B	Adenocarcinoma
PLEKHA2::ADAM9	Diffuse large B-cell lymphoma
PLEKHA2::BLTP3A	Adenocarcinoma
PLEKHA2::IDO2	Adenocarcinoma
PLEKHA2::KCNU1	Adenocarcinoma
PLEKHA2::OSBPL11	Adenocarcinoma
PLEKHA2::SHANK2	Adenocarcinoma
PLEKHA3::MTX2	Adenocarcinoma
PLEKHA3::OSBPL6	Adenocarcinoma
PLEKHA5::ACRBP	Adenocarcinoma
PLEKHA5::DCTN2	Squamous cell carcinoma
PLEKHA5::FGF6	Adenocarcinoma
PLEKHA5::GPC6	Adenocarcinoma
PLEKHA5::PIK3C2G	Transitional cell carcinoma
PLEKHA5::RASGEF1C	Adenocarcinoma
PLEKHA5::RERGL	Adenocarcinoma
PLEKHA5::SLCO1B1	Adenocarcinoma
PLEKHA5::ST8SIA1	Adenocarcinoma
PLEKHA5::UHRF1	Mesenchymal tumor, NOS
PLEKHA6::DCAF5	Astrocytoma, grade I-II
PLEKHA6::DTX3	Astrocytoma, grade III-IV/Glioblastoma
PLEKHA6::KISS1	Transitional cell carcinoma
PLEKHA6::LRRN2	Astrocytoma, grade I-II
PLEKHA6::MT3	Astrocytoma, grade I-II
PLEKHA6::NTRK1	Carcinoma, NOS | Adenocarcinoma
PLEKHA6::NUCKS1	Malignant melanoma
PLEKHA6::PIK3C2B	Astrocytoma, grade III-IV/Glioblastoma
PLEKHA7::ABCC8	Astrocytoma, grade I-II
PLEKHA7::ALK	Adenocarcinoma
PLEKHA7::AP2A2	Adenocarcinoma
PLEKHA7::KHDC3L	Adenocarcinoma
PLEKHA7::MMP9	Adenocarcinoma
PLEKHA7::PIK3C2A	Squamous cell carcinoma | Adenocarcinoma
PLEKHA7::SERGEF	Adenocarcinoma | Transitional cell carcinoma
PLEKHA7::SMPD1	Adenocarcinoma
PLEKHA7::TRIM21	Transitional cell carcinoma
PLEKHA7::USH1C	Adenocarcinoma
PLEKHA8::OSBPL3	Adenocarcinoma
PLEKHA8::PRR15	Astrocytoma, grade I-II
PLEKHB1::NUMA1	Adenocarcinoma
PLEKHB1::PACS1	Adenocarcinoma
PLEKHB2::ARHGEF4	Adenocarcinoma
PLEKHB2::BIRC6	Adenocarcinoma
PLEKHB2::FAM168B	Adenocarcinoma
PLEKHB2::GABRR1	Mesenchymal tumor, NOS
PLEKHF1::C19ORF12	Adenocarcinoma
PLEKHF1::C19orf12	Adenocarcinoma
PLEKHF1::FBL	Transitional cell carcinoma
PLEKHF1::SLC35A4	Adenocarcinoma
PLEKHF2::NDUFAF6	Adenocarcinoma
PLEKHF2::TP53INP1	Adenocarcinoma
PLEKHF2::TRIQK	Astrocytoma, grade III-IV/Glioblastoma
PLEKHG1::CCDC170	Adenocarcinoma
PLEKHG1::DTYMK	Malignant melanoma
PLEKHG1::ESR1	Adenocarcinoma
PLEKHG1::GJA1	Mesothelioma
PLEKHG1::SAMD5	Adenocarcinoma
PLEKHG3::MTHFD1	Transitional cell carcinoma
PLEKHG4B::ADCY2	Adenocarcinoma
PLEKHG4B::AHRR	Squamous cell carcinoma
PLEKHG4B::MELK	Adenocarcinoma
PLEKHG4B::MXI1	Adenocarcinoma
PLEKHG4B::PDCD6	Squamous cell carcinoma
PLEKHG5::DNAJC11	Adenocarcinoma
PLEKHG5::KHDRBS1	Adenocarcinoma
PLEKHG5::SAMD4B	Adenocarcinoma
PLEKHG5::TNFRSF8	Adenocarcinoma
PLEKHG6::TMBIM1	Adenocarcinoma
PLEKHH1::GPHN	Transitional cell carcinoma
PLEKHH1::L2HGDH	Transitional cell carcinoma
PLEKHH1::PALS1	Transitional cell carcinoma | Adenocarcinoma
PLEKHH1::RAD51B	Adenocarcinoma
PLEKHH1::ZFYVE26	Adenocarcinoma
PLEKHH2::ALK	Adenocarcinoma | Dermatofibrosarcoma protuberans/Bednar tumor/giant cell fibroblastoma | Mesenchymal tumor, special type
PLEKHH2::THADA	Squamous cell carcinoma
PLEKHH2::VSNL1	Adenocarcinoma
PLEKHH2::ZBTB1	Astrocytoma, grade I-II
PLEKHJ1::LINGO3	Squamous cell carcinoma
PLEKHJ1::TCF3	Adenocarcinoma
PLEKHJ1::TCF7L1	Adenocarcinoma
PLEKHM1::GAA	Adenocarcinoma
PLEKHM1::NT5C3B	Adenocarcinoma
PLEKHM2::ALK	Undifferentiated carcinoma, small cell
PLEKHM2::IGF2BP2	Adenocarcinoma
PLEKHM2::LPCAT2	Adenocarcinoma
PLEKHM2::TMEM51	Astrocytoma, grade III-IV/Glioblastoma
PLEKHM2::ZSWIM5	Adenocarcinoma
PLEKHM3::MAP2	Adenocarcinoma
PLEKHN1::KLHL17	Squamous cell carcinoma
PLEKHO2::ANKDD1A	Nonneoplastic epithelial disorder/lesion
PLEKHO2::TRIP4	Astrocytoma, grade I-II
PLEKHO2::ZNF609	Adenocarcinoma
PLEKHS1::PDCD4	Adenocarcinoma
PLGRKT::CD274	Squamous cell carcinoma
PLGRKT::GLIS3	Adenocarcinoma
PLGRKT::JAK2	Squamous cell carcinoma
PLIN1::ACSL6	Adenocarcinoma
PLIN2::CA10	Adenocarcinoma
PLIN3::ARRDC5	Adenocarcinoma
PLIN3::BRSK1	Adenocarcinoma
PLK5::ATN1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PLLP::CNGB1	Adenocarcinoma
PLOD1::FBXL7	Malignant melanoma
PLOD2::ABCG1	Adenocarcinoma
PLOD2::PLSCR4	Adenocarcinoma
PLOD2::RBM6	Spindle cell/sclerosing rhabdomyosarcoma
PLP1::SCAF8	Mesenchymal tumor, NOS
PLP1::SGK1	Astrocytoma, grade I-II
PLPBP::CHMP1A	Transitional cell carcinoma
PLPBP::DDHD2	Adenocarcinoma
PLPBP::TTLL10	Adenocarcinoma
PLPBP::ZNF622	Squamous cell carcinoma
PLPP1::ANKRD55	Adenocarcinoma
PLPP1::ARL15	Adenocarcinoma
PLPP1::CDC20B	Adenocarcinoma
PLPP1::CDC42SE2	Adenocarcinoma
PLPP1::CNTLN	Adenocarcinoma
PLPP1::DIAPH1	Adenocarcinoma
PLPP1::HCN1	Adenocarcinoma
PLPP1::MAPK1	Adenocarcinoma
PLPP1::MCIDAS	Transitional cell carcinoma
PLPP1::MLPH	Adenocarcinoma
PLPP1::SLC38A9	Transitional cell carcinoma
PLPP1::SMN1	Adenocarcinoma
PLPP1::SPEF2	Squamous cell carcinoma
PLPP1::SREK1IP1	Adenocarcinoma
PLPP2::CDC34	Adenocarcinoma
PLPP3::RAF1	Melanocytic neoplasm, special type
PLPP5::DDHD2	Adenocarcinoma
PLPP5::SARAF	Adenocarcinoma
PLPPR2::ANGPTL8	Germ cell tumor, NOS
PLRG1::FGG	Adenocarcinoma
PLRG1::SRGAP2B	Adenocarcinoma
PLS1::CLDN18	Adenocarcinoma
PLS1::PIK3CB	Adenocarcinoma
PLS1::TEX264	Adenocarcinoma
PLS1::TFDP2	Squamous cell carcinoma
PLS3::BICDL1	Adenocarcinoma
PLSCR1::MACROD2	Squamous cell carcinoma
PLTP::EEF2	Benign epithelial tumor, special type
PLVAP::ABCF1	Adenocarcinoma
PLVAP::CLCN3	Adenocarcinoma
PLVAP::FOXP1	Adenocarcinoma
PLXDC1::ACE	Mesenchymal tumor, NOS
PLXDC1::ERBB2	Carcinoma, NOS
PLXDC1::KRT36	Squamous cell carcinoma
PLXDC1::STAC2	Adenocarcinoma
PLXDC1::TAF13	Adenocarcinoma
PLXDC2::MALRD1	Astrocytoma, grade I-II
PLXDC2::MDH1B	Adenocarcinoma
PLXDC2::PDCD11	Mesenchymal tumor, NOS
PLXDC2::RET	Carcinoma, NOS
PLXDC2::ST8SIA6	Adenocarcinoma
PLXDC2::SYNE1	Adenocarcinoma
PLXDC2::THNSL1	Malignant melanoma
PLXDC2::VAMP5	Transitional cell carcinoma
PLXDC2::VAMP8	Transitional cell carcinoma
PLXNA1::CHCHD6	Adenocarcinoma
PLXNA1::CPNE4	Adenocarcinoma
PLXNA1::CTSD	Adenocarcinoma
PLXNA1::DZIP1L	Adenocarcinoma
PLXNA1::TNK2	Malignant melanoma
PLXNA2::DUSP10	Adenocarcinoma
PLXNA3::ATP6AP1	Adenocarcinoma
PLXNA3::TKTL1	Adenocarcinoma
PLXNA4::TRHDE	Mesenchymal tumor, NOS
PLXNB1::COL7A1	Adenocarcinoma
PLXNB1::HINT1	Transitional cell carcinoma
PLXNB1::ITIH3	Mesothelioma
PLXNB1::SLC26A6	Adenocarcinoma
PLXNB2::DLG2	Adenocarcinoma
PLXNB2::MAST4	Adenocarcinoma
PLXNB2::NDUFA4L2	Adenocarcinoma
PLXNB2::P4HTM	Adenocarcinoma
PLXNB2::SCO2	Mature B-cell neoplasm, NOS | Multiple myeloma
PLXNB2::ST3GAL1	Squamous cell carcinoma
PLXNB2::SUPT16H	Adenocarcinoma
PLXNB2::TMPRSS6	Adenocarcinoma
PLXNB2::UTRN	Adenocarcinoma
PLXNB3::PYM1	Malignant melanoma
PLXNC1::CEP83	Mesenchymal tumor, NOS
PLXNC1::CRADD	Squamous cell carcinoma | Malignant melanoma
PLXNC1::INSR	Mesenchymal tumor, NOS
PLXNC1::TXNRD1	Mesenchymal tumor, NOS
PLXND1::NEK11	Mesenchymal tumor, NOS
PLXND1::TMCC1	Adenocarcinoma
PMEPA1::ARFGEF2	Squamous cell carcinoma
PMEPA1::ATP6V0D1	Adenocarcinoma
PMEPA1::EMILIN3	Adenocarcinoma
PMEPA1::ETV4	Adenocarcinoma
PMEPA1::FAM83C	Adenocarcinoma
PMEPA1::PIGP	Adenocarcinoma
PMEPA1::PTGIS	Adenocarcinoma
PMEPA1::RALY	Adenocarcinoma
PMEPA1::TRPC4AP	Adenocarcinoma
PMF1::RAB25	Squamous cell carcinoma
PMF1::SYT11	Adenocarcinoma
PML::ADAMTS17::RARA	Acute promyelocytic leukemia (FAB type M3)
PML::AGBL3	Adenocarcinoma
PML::CDC6::RARA	Acute promyelocytic leukemia (FAB type M3)
PML::POLN	Adenocarcinoma
PML::RARA	Acute myeloblastic leukemia without maturation (FAB type M1) | Heart | Acute myelomonocytic leukemia (FAB type M4) | Chronic myeloid leukemia, t(9;22) | Skin | Acute myeloblastic leukemia with maturation (FAB type M2) | Acute erythroleukemia (FAB type M6) | Nonneoplastic hematologic disorder/lesion | Acute myeloid leukemia, NOS | Acute promyelocytic leukemia (FAB type M3) | Egypt | Bilineage or biphenotypic leukemia
PML::RARG	Acute promyelocytic leukemia (FAB type M3)
PMM1::SHISA8	Malignant epithelial tumor, special type
PMM2::ABAT	Mesenchymal tumor, NOS
PMM2::PPP2R3C	Adenocarcinoma
PMM2::UBFD1	Adenocarcinoma
PMPCB::PRKAR2B	Adenocarcinoma
PMPCB::WWOX	Adenocarcinoma
PMS1::GCG	Adenocarcinoma
PMS1::HIBCH	Squamous cell carcinoma
PMS2::AIMP2	Adenocarcinoma
PMS2::DNAH11	Astrocytoma, grade I-II
PMS2::USP42	Mesothelioma
PMVK::FNBP1	Adenocarcinoma
PMVK::PBXIP1	Adenocarcinoma
PMVK::PYGO2	Adenocarcinoma
PNCK::HCFC1	Adenocarcinoma
PNISR::GRM1	Fibroma
PNISR::TAF1D	Adenocarcinoma
PNKD::ARPC2	Adenocarcinoma
PNLDC1::KLHL32	Malignant melanoma
PNLIP::CELA2A	Adenocarcinoma
PNLIP::PLA2G1B	Adenocarcinoma
PNMA5::BCAP31	Squamous cell carcinoma
PNN::EIF3M	Adenocarcinoma
PNO1::SHROOM3	Squamous cell carcinoma
PNPLA2::EPS8L2	Adenocarcinoma
PNPLA6::ATP13A1	Malignant melanoma
PNPLA6::ECSIT	Adenocarcinoma
PNPLA7::DPH7	Adenocarcinoma
PNPLA7::EXD3	Adenocarcinoma
PNPLA7::SNAPC4	Adenocarcinoma
PNPLA7::TPRN	Adenocarcinoma
PNPLA8::CFTR	Adenocarcinoma
PNPO::NPEPPS	Adenocarcinoma
PNPT1::ALK	Adenocarcinoma
PNRC2::BSDC1	Squamous cell carcinoma
POC1A::TLR9	Adenocarcinoma
POC1A::TNNC1	Adenocarcinoma
POC1A::TWF2	Adenocarcinoma
POC1B::KRT78	Malignant melanoma
POC1B::METTL25	Mesenchymal tumor, NOS
POC1B::TNR	Mesenchymal tumor, NOS
POC5::CUL5	Malignant melanoma
POC5::PRKD1	Carcinoma, NOS
POC5::RAF1	Adenocarcinoma
PODXL2::LSAMP	Adenocarcinoma
PODXL::PCDH15	Adenocarcinoma
PODXL::TYW1B	Adenocarcinoma
PODXL::ZNF467	Adenocarcinoma
POFUT1::FDFT1	Squamous cell carcinoma
POFUT1::HCK	Adenocarcinoma | Acute lymphoblastic leukemia/lymphoblastic lymphoma
POFUT1::ITCH	Adenocarcinoma
POFUT1::MAPRE1	Malignant melanoma
POFUT1::PRICKLE2	Malignant melanoma
POFUT2::LRP2	Adenocarcinoma
POFUT2::SLC19A1	Adenocarcinoma
POFUT2::WDR4	Adenocarcinoma
POGK::FMOD	Adenocarcinoma
POGK::SPAG17	Adenocarcinoma
POGZ::C1ORF21	Adenocarcinoma
POGZ::GBA1	Adenocarcinoma
POGZ::HHIPL2	Malignant melanoma
POGZ::PI4KB	Adenocarcinoma
POGZ::SLC6A13	Squamous cell carcinoma
POGZ::THEM4	Adenocarcinoma
POLA1::CXORF58	Transitional cell carcinoma
POLA1::CXorf58	Transitional cell carcinoma
POLA1::MAP3K15	Adenocarcinoma
POLA1::TIMELESS	Adenocarcinoma
POLA1::TSPAN7	Adenocarcinoma
POLA2::CAPN1	Adenocarcinoma
POLA2::PPFIA1	Adenocarcinoma
POLA2::VPS51	Adenocarcinoma
POLB::ASH2L	Adenocarcinoma
POLB::DNAAF11	Acute lymphoblastic leukemia/lymphoblastic lymphoma
POLB::HOOK3	Adenocarcinoma
POLB::IKBKB	Adenocarcinoma
POLB::UNC5D	Adenocarcinoma
POLB::UVRAG	Adenocarcinoma
POLD2::GCK	Adenocarcinoma
POLD3::COL3A1	Adenocarcinoma
POLD3::EFCAB5	Malignant melanoma
POLD3::ENC1	Malignant melanoma
POLD3::PPME1	Adenocarcinoma
POLD3::TENM4	Adenocarcinoma
POLDIP2::BRIP1	Adenocarcinoma
POLDIP2::VTN	Adenocarcinoma
POLDIP3::ARFGAP3	Adenocarcinoma
POLDIP3::MED15	Malignant melanoma
POLDIP3::SH3BGRL2	Adenocarcinoma
POLDIP3::TTLL1	Adenocarcinoma
POLE2::RPS29	Adenocarcinoma
POLE2::SOS2	Mature B-cell neoplasm, NOS
POLE::ANKLE2	Mature B-cell neoplasm, NOS | Adenocarcinoma
POLE::ANKS1B	Transitional cell carcinoma
POLE::FBRSL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
POLE::GOLGA3	Adenocarcinoma
POLG2::DDX5	Squamous cell carcinoma
POLG::CGNL1	Adenocarcinoma
POLH::C12orf71	Mesenchymal tumor, NOS
POLH::EZR	Squamous cell carcinoma
POLH::PKHD1	Adenocarcinoma
POLK::ANKDD1B	Adenocarcinoma
POLK::HSD17B4	Malignant melanoma
POLK::MTREX	Adenocarcinoma
POLM::OGDH	Adenocarcinoma
POLR1A::ACO2	Malignant melanoma
POLR1A::CTNNA2	Adenocarcinoma
POLR1A::REEP1	Adenocarcinoma | Mature B-cell neoplasm, NOS
POLR1A::SETD2	Mesothelioma
POLR1B::NRXN2	Malignant epithelial tumor, special type
POLR1C::C6ORF226	Adenocarcinoma
POLR1C::MDGA1	Adenocarcinoma
POLR1D::ERBB2	Adenocarcinoma
POLR1D::RPL21	Adenocarcinoma
POLR1D::SMYD2	Transitional cell carcinoma
POLR2A::ALOX12	Adenocarcinoma
POLR2A::ASAP2	Astrocytoma, grade III-IV/Glioblastoma
POLR2A::FBN3	Acute megakaryoblastic leukemia (FAB type M7)
POLR2A::NAA38	Adenocarcinoma
POLR2A::SLC16A13	Adenocarcinoma
POLR2A::SMR3B	Adenocarcinoma
POLR2A::WRAP53	Astrocytoma, grade III-IV/Glioblastoma
POLR2B::CEP135	Astrocytoma, grade I-II
POLR2B::FIP1L1	Adenocarcinoma
POLR2B::REST	Squamous cell carcinoma
POLR2C::HS3ST4	Adenocarcinoma
POLR2D::TFCP2L1	Adenocarcinoma
POLR2E::ZNF420	Transitional cell carcinoma
POLR2F::EIF3L	Adenocarcinoma
POLR2F::GGA1	Adenocarcinoma
POLR2F::MICALL1	Adenocarcinoma
POLR2F::MXI1	Malignant melanoma
POLR2F::PSMD3	Malignant melanoma
POLR2H::CHFR	Adenocarcinoma
POLR2J2::DAD1	Adenocarcinoma
POLR2J3::LGALS4	Adenocarcinoma
POLR2J3::ORC5	Transitional cell carcinoma
POLR2J::DNAJC2	Adenocarcinoma
POLR2L::TSPAN4	Adenocarcinoma
POLR2M::ADGRL1	Adenocarcinoma
POLR3A::TP53BP2	Adenocarcinoma
POLR3A::TTC6	Adenocarcinoma
POLR3B::PDS5B	Adenocarcinoma
POLR3B::RBM19	Mesenchymal tumor, NOS
POLR3B::TCP11L2	Astrocytoma, grade I-II
POLR3E::MOSMO	Adenocarcinoma | Squamous cell carcinoma
POLR3E::RMI2	Adenocarcinoma
POLR3F::DTD1	Adenocarcinoma
POLR3H::CTNND2	Malignant melanoma
POLR3H::ENTHD1	Adenocarcinoma
POLR3K::EMC10	Squamous cell carcinoma
POLR3K::L3MBTL4	Adenocarcinoma
POLRMT::PALM	Adenocarcinoma
POM121C::HIP1	Malignant epithelial tumor, special type
POM121C::TMEM248	Mesenchymal tumor, NOS
POMK::ANK1	Squamous cell carcinoma
POMK::CHRNA6	Adenocarcinoma
POMK::LSS	Malignant melanoma
POMK::NKAIN3	Adenocarcinoma
POMK::ST6GAL1	Squamous cell carcinoma
POMT1::NUP214	Adenocarcinoma
POMT1::PLPP7	Adenocarcinoma
PON1::ALK	Carcinoma, NOS
PON2::TYW1B	Malignant epithelial tumor, special type
PON3::LCN1	Acinic cell carcinoma
POP1::ERICH5	Adenocarcinoma
POP1::MATN2	Adenocarcinoma
POP1::TATDN1	Adenocarcinoma
POR::CTTNBP2	Adenocarcinoma
POR::MDH2	Adenocarcinoma
POR::PIBF1	Adenocarcinoma
POR::RHBDD2	Adenocarcinoma
POSTN::COL1A2	Adenocarcinoma
POSTN::PTN	Adenocarcinoma
POSTN::TM9SF3	Adenocarcinoma
POSTN::TRIM33	Adenocarcinoma
POSTN::YY1	Adenocarcinoma
POT1::RTKN2	Transitional cell carcinoma
POTEI::FOSB	Pseudomyogenic hemangioendothelioma
POU1F1::TMPRSS15	Squamous cell carcinoma
POU2AF1::BCL6	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Mature B-cell neoplasm, NOS
POU2AF1::BCO2	Adenocarcinoma
POU2AF1::BTG4	Squamous cell carcinoma
POU2F1::CD247	Adenocarcinoma
POU2F1::FMO1	Adenocarcinoma
POU2F1::LCE2A	Adenocarcinoma
POU2F1::MAEL	Adenocarcinoma
POU2F1::PDGFRA	Acute myeloblastic leukemia without maturation (FAB type M1)
POU2F1::RPRD2	Adenocarcinoma
POU2F1::ZFYVE28	Benign epithelial tumor, special type | Miscellaneous hematopoietic/lymphoid neoplasm, special type
POU6F1::SMAGP	Adenocarcinoma
POU6F2::AOAH	Astrocytoma, grade III-IV/Glioblastoma
PPA1::LRRC20	Adenocarcinoma
PPA1::MGAT4C	Adenocarcinoma
PPA1::MICU1	Adenocarcinoma
PPA2::INTS12	Adenocarcinoma
PPA2::SORCS2	Adenocarcinoma
PPA2::STPG2	Mesenchymal tumor, NOS
PPA2::TBCK	Adenocarcinoma
PPAN::GIPC2	Adenocarcinoma
PPARA::ATXN10	Malignant epithelial tumor, special type
PPARA::BCL2L13	Malignant melanoma
PPARA::FBLN1	Adenocarcinoma
PPARA::NFIC	Mesenchymal tumor, NOS
PPARA::POLDIP3	Adenocarcinoma
PPARA::RAB2A	Adenocarcinoma
PPARA::SAMM50	Adenocarcinoma
PPARA::SLC16A7	Squamous cell carcinoma
PPARD::ANKS1A	Adenocarcinoma
PPARD::CERS3	Transitional cell carcinoma
PPARD::MAPK14	Acute myeloid leukemia, NOS | Skin
PPARD::SLC22A7	Mesenchymal tumor, NOS
PPARD::SRGAP1	Mesenchymal tumor, NOS
PPARD::WDR27	Adenocarcinoma
PPARD::WNK4	Adenocarcinoma
PPARG::CDKAL1	Transitional cell carcinoma
PPARG::CRYBA4	Transitional cell carcinoma
PPARG::IQSEC1	Transitional cell carcinoma
PPARG::MKRN2OS	Transitional cell carcinoma
PPARG::PAX8	Adenocarcinoma
PPARG::SYN2	Transitional cell carcinoma
PPARGC1A::VGLL3	Spindle cell/sclerosing rhabdomyosarcoma
PPARGC1B::ARHGEF37	Squamous cell carcinoma
PPARGC1B::IL17B	Adenocarcinoma
PPARGC1B::TCOF1	Adenocarcinoma
PPAT::IGFBP7	Adenocarcinoma
PPAT::KIF16B	Malignant melanoma
PPCDC::CLK3	Adenocarcinoma
PPCDC::LMAN1L	Adenocarcinoma
PPCDC::SCAMP2	Adenocarcinoma
PPCS::CCDC30	Skin | Acute myeloid leukemia, NOS
PPFIA1::ALDH3B1	Squamous cell carcinoma
PPFIA1::ALDH3B2	Adenocarcinoma
PPFIA1::ALK	Adenocarcinoma
PPFIA1::ANO1	Squamous cell carcinoma
PPFIA1::ARHGAP32	Adenocarcinoma
PPFIA1::B4GALT2	Multiple myeloma
PPFIA1::BBOX1	Mesenchymal tumor, NOS
PPFIA1::C11ORF24	Adenocarcinoma
PPFIA1::C11orf24	Adenocarcinoma
PPFIA1::CBLB	Adenocarcinoma
PPFIA1::CD82	Adenocarcinoma
PPFIA1::CRPPA	Adenocarcinoma
PPFIA1::DYNC2H1	Transitional cell carcinoma
PPFIA1::FADD	Adenocarcinoma
PPFIA1::FGFR1	Squamous cell carcinoma
PPFIA1::FRMD8	Adenocarcinoma
PPFIA1::GSTP1	Adenocarcinoma
PPFIA1::HSD3B2	Adenocarcinoma
PPFIA1::INTS4	Adenocarcinoma
PPFIA1::KDM2A	Adenocarcinoma
PPFIA1::LRP5	Adenocarcinoma
PPFIA1::LRRC4C	Squamous cell carcinoma
PPFIA1::MARK2	Adenocarcinoma
PPFIA1::MS4A5	Adenocarcinoma
PPFIA1::MYEOV	Adenocarcinoma
PPFIA1::NADSYN1	Malignant melanoma
PPFIA1::NFKB2	Mycosis fungoides/Sézary syndrome
PPFIA1::OAF	Squamous cell carcinoma
PPFIA1::RBFOX2	Squamous cell carcinoma
PPFIA1::RBM14	Squamous cell carcinoma
PPFIA1::RBM4	Squamous cell carcinoma
PPFIA1::RHOD	Adenocarcinoma
PPFIA1::SHANK2	Transitional cell carcinoma | Squamous cell carcinoma
PPFIA1::SLC39A11	Adenocarcinoma
PPFIA1::SRD5A3	Malignant melanoma
PPFIA1::TESMIN	Squamous cell carcinoma
PPFIA1::TMEM229B	Adenocarcinoma
PPFIA1::TSKU	Malignant melanoma
PPFIA1::XRRA1	Adenocarcinoma
PPFIA1::ZNF717	Malignant melanoma
PPFIA2::ACSS3	Mesenchymal tumor, NOS
PPFIA2::DPY19L2	Astrocytoma, grade III-IV/Glioblastoma
PPFIA2::GRIP1	Mesenchymal tumor, NOS
PPFIA2::KCNMB4	Mesenchymal tumor, NOS
PPFIA2::MGAT4C	Mesenchymal tumor, NOS
PPFIA2::NTRK3	Liposarcoma, dedifferentiated
PPFIA2::OTOGL	Mesenchymal tumor, NOS
PPFIA2::TRHDE	Mesenchymal tumor, NOS
PPFIA3::ANK1	Squamous cell carcinoma
PPFIA3::IZUMO1	Squamous cell carcinoma
PPFIBP1::ADIPOR2	Adenocarcinoma
PPFIBP1::ALK	Benign fibrous histiocytoma | Inflammatory myofibroblastic tumor/myofibroblastic sarcoma
PPFIBP1::CACNA1C	Transitional cell carcinoma
PPFIBP1::JAK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PPFIBP1::NCAM2	Skin | Acute myeloid leukemia, NOS
PPFIBP1::PDILT	Adenocarcinoma
PPFIBP1::ROS1	Melanocytic neoplasm, special type
PPFIBP1::SLCO1B1	Germ cell tumor, NOS
PPFIBP1::SMCO2	Adenocarcinoma
PPFIBP1::SNU13	Adenocarcinoma
PPFIBP1::TSPAN11	Adenocarcinoma
PPFIBP1::WNT7A	Adenocarcinoma
PPFIBP1::ZNF329	Squamous cell carcinoma
PPFIBP2::OLFML1	Adenocarcinoma
PPFIBP2::RET	Adenocarcinoma
PPFIBP2::TSG101	Squamous cell carcinoma
PPHLN1::GARRE1	Mesenchymal tumor, NOS
PPHLN1::MSRB3	Astrocytoma, grade III-IV/Glioblastoma
PPHLN1::NRG1	Soft tissue tumor, special type
PPHLN1::TIMELESS	Adenocarcinoma
PPIA::OGDH	Adenocarcinoma
PPIB::SFTPB	Adenocarcinoma
PPID::SFRP2	Adenocarcinoma
PPIF::REEP3	Adenocarcinoma
PPIF::SNX31	Transitional cell carcinoma
PPIG::CRIM1	Adenocarcinoma
PPIG::FAM117B	Squamous cell carcinoma
PPIG::SCN9A	Adenocarcinoma
PPIG::SSB	Malignant epithelial tumor, special type | Squamous cell carcinoma
PPIH::CCDC30	Malignant melanoma
PPIL2::KIAA1671	Squamous cell carcinoma
PPIL2::TBX1	Adenocarcinoma
PPIL4::CLEC4A	Mesenchymal tumor, NOS
PPIP5K1::CATSPER2	Adenocarcinoma
PPIP5K1::FRMD5	Adenocarcinoma
PPIP5K2::CAPN12	Transitional cell carcinoma
PPIP5K2::PRODH	Malignant melanoma
PPL::ADCY9	Adenocarcinoma
PPL::APOL3	Adenocarcinoma
PPL::NTRK1	Adenocarcinoma
PPL::RBKS	Adenocarcinoma
PPL::SP2	Adenocarcinoma
PPL::UTRN	Squamous cell carcinoma
PPM1A::COQ8B	Astrocytoma, grade I-II
PPM1A::PRKCH	Adenocarcinoma
PPM1B::ABCG8	Adenocarcinoma
PPM1B::IQCA1	Adenocarcinoma
PPM1B::MTA3	Adenocarcinoma
PPM1B::SRBD1	Squamous cell carcinoma
PPM1D::ATP5MC1	Adenocarcinoma
PPM1D::CCND1	Adenocarcinoma
PPM1D::CHCT1	Squamous cell carcinoma
PPM1D::EFCAB3	Adenocarcinoma
PPM1D::NUP85	Astrocytoma, grade I-II
PPM1D::TRIM37	Adenocarcinoma
PPM1E::SPAG5	Adenocarcinoma
PPM1E::VMP1	Adenocarcinoma
PPM1G::IFT172	Squamous cell carcinoma | Adenocarcinoma
PPM1G::KATNA1	Mesenchymal tumor, NOS
PPM1G::LPAR1	Mesenchymal tumor, NOS
PPM1H::AVIL	Astrocytoma, grade III-IV/Glioblastoma
PPM1H::C12ORF56	Adenocarcinoma
PPM1H::C12orf56	Adenocarcinoma
PPM1H::CAPN11	Astrocytoma, grade III-IV/Glioblastoma
PPM1H::DNAJC15	Transitional cell carcinoma
PPM1H::DYRK2	Adenocarcinoma
PPM1H::FAM234B	Adenocarcinoma
PPM1H::IL26	Astrocytoma, grade III-IV/Glioblastoma
PPM1H::KICS2	Squamous cell carcinoma
PPM1H::KIF13B	Adenocarcinoma
PPM1H::MDM2	Astrocytoma, grade III-IV/Glioblastoma
PPM1H::PDZRN4	Mesenchymal tumor, NOS
PPM1H::RAP1B	Astrocytoma, grade III-IV/Glioblastoma
PPM1H::SLC35E3	Astrocytoma, grade III-IV/Glioblastoma
PPM1H::SLC6A15	Adenocarcinoma
PPM1H::SRGAP1	Adenocarcinoma
PPM1H::SV2C	Astrocytoma, grade III-IV/Glioblastoma
PPM1H::TAFA2	Adenocarcinoma
PPM1H::TSPAN8	Squamous cell carcinoma
PPM1H::USP15	Adenocarcinoma
PPM1H::WIF1	Adenocarcinoma
PPM1L::B3GNT5	Squamous cell carcinoma
PPM1L::MCF2L2	Squamous cell carcinoma
PPME1::AQP11	Adenocarcinoma
PPME1::FYCO1	Undifferentiated carcinoma, small cell
PPME1::KANK1	Transitional cell carcinoma
PPME1::MRPL48	Adenocarcinoma
PPME1::NARS2	Adenocarcinoma
PPME1::NSD3	Adenocarcinoma
PPME1::TENM4	Adenocarcinoma
PPME1::UVRAG	Malignant melanoma
PPME1::YIF1A	Transitional cell carcinoma
PPP1CA::PPP2R3C	Squamous cell carcinoma
PPP1CA::TMEM134	Adenocarcinoma
PPP1CB::ALK	Astrocytoma, grade III-IV/Glioblastoma | Astrocytoma, grade I-II | Soft tissue tumor, special type
PPP1CB::BABAM2	Adenocarcinoma
PPP1CB::CCT5	Adenocarcinoma
PPP1CB::DRAM1	Squamous cell carcinoma
PPP1CB::EIF2B4	Malignant melanoma
PPP1CB::FOSL2	Adenocarcinoma
PPP1CB::PI4KB	Adenocarcinoma
PPP1CB::PLB1	Adenocarcinoma
PPP1CB::SSPN	Adenocarcinoma
PPP1CB::YPEL5	Chronic lymphocytic leukemia
PPP1CC::KCNC2	Mesenchymal tumor, NOS
PPP1R10::FLOT1	Transitional cell carcinoma
PPP1R10::FOSB	Osteoblastoma
PPP1R10::MUS81	Malignant melanoma
PPP1R12A::ATP23	Squamous cell carcinoma
PPP1R12A::DNAH10	Mesenchymal tumor, NOS
PPP1R12A::IMMT	Adenocarcinoma
PPP1R12A::LIN7A	Transitional cell carcinoma | Alveolar rhabdomyosarcoma
PPP1R12A::METTL25	Mesenchymal tumor, NOS
PPP1R12A::MGAT4C	Adenocarcinoma
PPP1R12A::NDUFAF2	Adenocarcinoma
PPP1R12A::PTPRQ	Spindle cell/sclerosing rhabdomyosarcoma
PPP1R12A::SEPTIN10	Adenocarcinoma
PPP1R12A::TBC1D30	Squamous cell carcinoma
PPP1R12A::TPGS2	Squamous cell carcinoma
PPP1R12B::CAMSAP2	Adenocarcinoma
PPP1R12B::LGR6	Squamous cell carcinoma
PPP1R12B::LRRN2	Adenocarcinoma
PPP1R12B::RETREG2	Adenocarcinoma
PPP1R12B::SNX27	Adenocarcinoma
PPP1R12B::SUSD4	Squamous cell carcinoma
PPP1R12B::TIMM17A	Adenocarcinoma
PPP1R12C::CIC	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PPP1R12C::CLEC11A	Malignant epithelial tumor, special type
PPP1R12C::KISS1	Adenocarcinoma
PPP1R12C::PPP6R1	Adenocarcinoma
PPP1R12C::PTPRH	Adenocarcinoma
PPP1R12C::RPL28	Malignant melanoma
PPP1R12C::ZNF233	Adenocarcinoma
PPP1R12C::ZNF460	Adenocarcinoma
PPP1R12C::ZNF579	Adenocarcinoma
PPP1R13B::ADAM18	Malignant epithelial tumor, special type
PPP1R13B::ATP5MJ	Adenocarcinoma | Angiosarcoma
PPP1R13B::BAG5	Adenocarcinoma
PPP1R13B::CCDC88C	Adenocarcinoma
PPP1R13B::L2HGDH	Adenocarcinoma
PPP1R13B::PPP1R16A	Adenocarcinoma
PPP1R13B::PYM1	Mesenchymal tumor, NOS
PPP1R13B::ZP3	Adenocarcinoma
PPP1R13L::CCDC9	Adenocarcinoma
PPP1R13L::MBOAT7	Adenocarcinoma
PPP1R13L::OPA3	Adenocarcinoma
PPP1R13L::RAB44	Adenocarcinoma
PPP1R14C::AKIRIN2	Malignant melanoma
PPP1R15A::EMP3	Squamous cell carcinoma
PPP1R15A::IGK	Multiple myeloma
PPP1R15A::IGL	Multiple myeloma
PPP1R15B::PIK3C2B	Adenocarcinoma
PPP1R16A::ADCK5	Adenocarcinoma
PPP1R16A::CLDN4	Adenocarcinoma
PPP1R16A::MROH1	Adenocarcinoma
PPP1R16A::SLC52A2	Adenocarcinoma
PPP1R16B::CTNNBL1	Adenocarcinoma
PPP1R16B::TTI1	Adenocarcinoma
PPP1R18::FXR2	Osteosarcoma, NOS
PPP1R18::MDC1	Adenocarcinoma
PPP1R18::NDUFV1	Adenocarcinoma
PPP1R18::TNXB	Mesenchymal tumor, NOS
PPP1R1B::ANXA1	Adenocarcinoma
PPP1R1B::ERBB2	Carcinoma, NOS
PPP1R1B::GRB7	Adenocarcinoma
PPP1R1B::MIEN1	Adenocarcinoma
PPP1R1B::PIPOX	Adenocarcinoma
PPP1R1B::STARD3	Adenocarcinoma | Skin | Acute myeloid leukemia, NOS
PPP1R1C::EIF2B2	Adenocarcinoma
PPP1R21::ALK	Adenocarcinoma
PPP1R21::DNAH6	Adenocarcinoma
PPP1R21::GTF2A1L	Squamous cell carcinoma
PPP1R21::WARS2	Adenocarcinoma
PPP1R21::ZBTB20	Adenocarcinoma
PPP1R2::APOD	Adenocarcinoma
PPP1R2::CLDN1	Squamous cell carcinoma
PPP1R2::GMNC	Squamous cell carcinoma
PPP1R37::ALOX15B	Adenocarcinoma
PPP1R37::APOC2	Malignant melanoma
PPP1R37::APOC4	Malignant epithelial tumor, special type
PPP1R37::BCAM	Adenocarcinoma
PPP1R37::BCL3	Adenocarcinoma
PPP1R37::BICRA	Squamous cell carcinoma
PPP1R37::CACNG1	Adenocarcinoma
PPP1R37::CEACAM19	Adenocarcinoma
PPP1R37::CLASRP	Adenocarcinoma
PPP1R37::CLPTM1	Malignant melanoma
PPP1R37::DAAM2	Adenocarcinoma
PPP1R37::GEMIN7	Mesenchymal tumor, NOS
PPP1R37::IGSF23	Adenocarcinoma
PPP1R37::KLC3	Undifferentiated carcinoma, small cell
PPP1R37::NECTIN2	Adenocarcinoma
PPP1R37::NWD1	Adenocarcinoma
PPP1R37::PAFAH1B3	Adenocarcinoma
PPP1R37::PPP6R1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PPP1R37::RHPN2	Adenocarcinoma
PPP1R37::RTN2	Adenocarcinoma
PPP1R37::ZNF224	Squamous cell carcinoma
PPP1R37::ZNF225	Squamous cell carcinoma
PPP1R37::ZNF383	Mesenchymal tumor, NOS
PPP1R3B::CSMD1	Adenocarcinoma
PPP1R3E::MYH6	Adenocarcinoma
PPP1R3F::CCDC120	Adenocarcinoma
PPP1R3G::FAM50B	Squamous cell carcinoma
PPP1R9A::CYP3A43	Astrocytoma, grade III-IV/Glioblastoma
PPP1R9A::FBXO16	Adenocarcinoma
PPP1R9A::FOXO3	Adenocarcinoma
PPP1R9A::SUCO	Adenocarcinoma
PPP1R9B::CLTC	Adenocarcinoma
PPP1R9B::COL1A1	Squamous cell carcinoma
PPP2CA::C5ORF15	Adenocarcinoma
PPP2CA::CDH3	Adenocarcinoma
PPP2CA::CDKL3	Adenocarcinoma
PPP2CA::PMPCA	Adenocarcinoma
PPP2CA::VDAC1	Adenocarcinoma
PPP2CB::DLC1	Adenocarcinoma
PPP2CB::MYOC	Transitional cell carcinoma
PPP2CB::PURG	Adenocarcinoma
PPP2R1A::CENPP	Adenocarcinoma
PPP2R1A::SMIM17	Squamous cell carcinoma
PPP2R1A::TGFB1	Adenocarcinoma
PPP2R1A::ZNF610	Adenocarcinoma
PPP2R1A::ZNF665	Astrocytoma, grade III-IV/Glioblastoma
PPP2R1B::ALG9	Adenocarcinoma
PPP2R1B::IDH2	Astrocytoma, grade I-II
PPP2R1B::KMT2A	Atypical lipomatous tumor/atypical lipoma/well-differentiated liposarcoma
PPP2R1B::NNMT	Malignant melanoma
PPP2R1B::SIK3	Acute monoblastic leukemia (FAB type M5)
PPP2R2A::APP	Adenocarcinoma
PPP2R2A::ATCAY	Adenocarcinoma
PPP2R2A::CHEK2	Teratoma (mature and immature)
PPP2R2A::CSN2	Adenocarcinoma
PPP2R2A::DHTKD1	Adenocarcinoma
PPP2R2A::DPYSL2	Adenocarcinoma
PPP2R2A::EIF3H	Malignant melanoma
PPP2R2A::LGI3	Adenocarcinoma
PPP2R2A::MATR3	Adenocarcinoma
PPP2R2A::MTUS1	Adenocarcinoma
PPP2R2A::PLAG1	Lipoblastoma
PPP2R2A::PRKD1	Adenocarcinoma
PPP2R2A::SMIM19	Mesenchymal tumor, NOS
PPP2R2A::ZDHHC2	Adenocarcinoma
PPP2R2B::CCT3	Astrocytoma, grade III-IV/Glioblastoma
PPP2R2B::DPYSL3	Astrocytoma, grade I-II
PPP2R2C::CTBP1	Astrocytoma, grade I-II
PPP2R3A::PCCB	Adenocarcinoma
PPP2R3A::SPSB4	Squamous cell carcinoma
PPP2R3A::TOPBP1	Adenocarcinoma
PPP2R3C::NFKBIA	Adenocarcinoma
PPP2R3C::SPTSSA	Astrocytoma, grade I-II
PPP2R5A::CHRM3	Adenocarcinoma
PPP2R5A::SPATA17	Germ cell tumor, NOS
PPP2R5B::KDM2A	Adenocarcinoma
PPP2R5B::MAJIN	Adenocarcinoma
PPP2R5C::CCDC28B	Adenocarcinoma
PPP2R5C::FOXN3	Adenocarcinoma
PPP2R5C::PRKD1	Adenocarcinoma
PPP2R5C::SCN1B	Adenocarcinoma
PPP2R5C::SLC38A6	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PPP2R5C::UPF2	Adenocarcinoma
PPP2R5D::ASCC3	Adenocarcinoma
PPP2R5D::BICRAL	Adenocarcinoma | Squamous cell carcinoma
PPP2R5D::MEP1A	Adenocarcinoma
PPP2R5D::UBR2	Transitional cell carcinoma
PPP2R5E::C14ORF39	Adenocarcinoma
PPP2R5E::C14orf39	Adenocarcinoma
PPP2R5E::MBIP	Adenocarcinoma
PPP2R5E::PLEKHH1	Squamous cell carcinoma
PPP2R5E::STRN3	Adenocarcinoma
PPP2R5E::XRCC3	Adenocarcinoma
PPP3CA::BPNT1	Adenocarcinoma
PPP3CA::BRD2	Adenocarcinoma
PPP3CA::COL25A1	Adenocarcinoma
PPP3CA::FSTL5	Multiple myeloma
PPP3CA::HMGXB3	Mesenchymal tumor, NOS
PPP3CA::INTS12	Adenocarcinoma
PPP3CA::MAK	Adenocarcinoma
PPP3CA::PPIL1	Adenocarcinoma
PPP3CA::RASGEF1B	Adenocarcinoma
PPP3CA::SEPTIN11	Adenocarcinoma
PPP3CA::SPARCL1	Adenocarcinoma
PPP3CB::CAMK2G	Adenocarcinoma
PPP3CB::USP54	Adenocarcinoma
PPP3CB::VMP1	Adenocarcinoma
PPP3CC::GPR141	Adenocarcinoma
PPP3CC::PIWIL2	Mesothelioma | Squamous cell carcinoma | Adenocarcinoma
PPP3CC::SLC39A14	Adenocarcinoma
PPP3CC::XPO7	Adenocarcinoma
PPP3R1::CNRIP1	Adenocarcinoma
PPP3R1::DNAAF10	Adenocarcinoma
PPP3R1::SPATS2L	Adenocarcinoma
PPP3R1::TTC27	Adenocarcinoma
PPP3R1::WDPCP	Adenocarcinoma
PPP4C::MVP	Germ cell tumor, NOS
PPP4R1::CCNB3	Adenocarcinoma
PPP4R1::CDH7	Adenocarcinoma
PPP4R1::DPP4	Adenocarcinoma
PPP4R1::MTCL1	Adenocarcinoma
PPP4R1::NUP93	Mesenchymal tumor, NOS
PPP4R1::PAWR	Squamous cell carcinoma
PPP4R2::AHRR	Adenocarcinoma
PPP4R2::FBXW7	Mesenchymal tumor, NOS
PPP4R2::FOXP1	Adenocarcinoma
PPP4R2::KIDINS220	Adenocarcinoma
PPP4R3A::CCDC88C	Adenocarcinoma
PPP4R3A::FBLN5	Adenocarcinoma
PPP4R3A::FBXO34	Adenocarcinoma
PPP4R3A::HEATR3	Undifferentiated carcinoma, small cell
PPP4R3A::IGH	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PPP4R3B::ALK	Adenocarcinoma
PPP4R3B::EFEMP1	Adenocarcinoma
PPP4R3B::GRM3	Squamous cell carcinoma
PPP4R3B::IL18RAP	Astrocytoma, grade I-II
PPP4R3B::KYNU	Mesenchymal tumor, NOS
PPP4R3B::PNPT1	Adenocarcinoma
PPP4R4::MYH6	Transitional cell carcinoma
PPP4R4::UNC79	Adenocarcinoma
PPP5C::AP2S1	Adenocarcinoma
PPP5C::DYNC1I2	Adenocarcinoma
PPP5C::GADD45GIP1	Squamous cell carcinoma
PPP5C::HIF3A	Squamous cell carcinoma
PPP6C::DENND1A	Malignant melanoma
PPP6C::SPINDOC	Astrocytoma, grade III-IV/Glioblastoma
PPP6R1::AURKC	Adenocarcinoma
PPP6R1::DPRX	Adenocarcinoma
PPP6R2::AURKC	Mesenchymal tumor, NOS
PPP6R2::CBX1	Adenocarcinoma
PPP6R2::EMID1	Adenocarcinoma
PPP6R2::GRK3	Astrocytoma, grade I-II
PPP6R2::MPV17	Adenocarcinoma
PPP6R2::SAMM50	Benign epithelial tumor, special type
PPP6R2::SCO2	Mature B-cell neoplasm, NOS
PPP6R2::SELENOO	Transitional cell carcinoma
PPP6R2::SIM2	Acute myeloblastic leukemia with maturation (FAB type M2)
PPP6R2::TRABD	Malignant melanoma
PPP6R2::ZDHHC6	Malignant epithelial tumor, special type
PPP6R3::ACER3	Malignant melanoma
PPP6R3::APLP2	Adenocarcinoma
PPP6R3::ARHGAP1	Squamous cell carcinoma
PPP6R3::ATP6V0D2	Mesenchymal tumor, NOS
PPP6R3::CNTN5	Squamous cell carcinoma
PPP6R3::DPP3	Germ cell tumor, NOS
PPP6R3::EIF4G3	Malignant melanoma
PPP6R3::FADD	Adenocarcinoma
PPP6R3::GAL	Malignant epithelial tumor, special type
PPP6R3::INTS4	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PPP6R3::LRP5	Adenocarcinoma | Squamous cell carcinoma
PPP6R3::MARK2	Adenocarcinoma
PPP6R3::MGAM	Squamous cell carcinoma
PPP6R3::POLD3	Adenocarcinoma
PPP6R3::RACK1	Adenocarcinoma
PPP6R3::RHOD	Adenocarcinoma
PPP6R3::SHANK2	Transitional cell carcinoma
PPP6R3::SLC3A2	Adenocarcinoma
PPP6R3::SPTBN2	Adenocarcinoma
PPP6R3::SSH2	Adenocarcinoma
PPP6R3::SSH3	Adenocarcinoma
PPP6R3::TESMIN	Adenocarcinoma
PPP6R3::TOP6BL	Squamous cell carcinoma
PPP6R3::USP6	Nodular fasciitis
PPP6R3::YAP1	Transitional cell carcinoma
PPRC1::NOLC1	Nonneoplastic epithelial disorder/lesion
PPT1::BCL2L1	Undifferentiated carcinoma, small cell
PPT1::HIVEP3	Malignant epithelial tumor, special type
PPT2::TNF	Adenocarcinoma
PPTC7::ARPC3	Adenocarcinoma
PPTC7::FLACC1	Adenocarcinoma
PPTC7::GPN3	Squamous cell carcinoma | Adenocarcinoma
PPTC7::HVCN1	Adenocarcinoma
PPTC7::IGF1	Adenocarcinoma
PPWD1::NLN	Adenocarcinoma
PQBP1::ERAS	Squamous cell carcinoma
PRAME::ACO2	Malignant melanoma
PRAME::HDLBP	Malignant melanoma
PRC1::KIF7	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PRC1::VPS33B	Adenocarcinoma
PRCC::HAPLN2	Adenocarcinoma
PRCC::METTL25B	Adenocarcinoma
PRCC::MITF	Adenocarcinoma
PRCC::NUGGC	Adenocarcinoma
PRCC::RHBG	Adenocarcinoma | Transitional cell carcinoma
PRCC::TFE3	Alveolar soft part sarcoma | Vascular and perivascular tumor, special type | Adenocarcinoma | Soft tissue tumor, special type
PRCC::TMED5	Adenocarcinoma
PRCP::CTDSPL	Undifferentiated carcinoma, small cell
PRCP::DLG2	Malignant melanoma | Adenocarcinoma
PRCP::FCHSD2	Malignant melanoma
PRCP::NDC80	Multiple myeloma
PRCP::RAB30	Adenocarcinoma
PRDM10::NT5E	Adenocarcinoma
PRDM11::ACCS	Adenocarcinoma
PRDM11::MRPS9	Adenocarcinoma
PRDM16::BBX	Adenocarcinoma
PRDM16::NARS2	Adenocarcinoma
PRDM16::SKI	NA
PRDM1::SLC22A16	Adenocarcinoma
PRDM2::FBLIM1	Adenocarcinoma
PRDM2::LRRC38	Miscellaneous hematopoietic/lymphoid neoplasm, special type | Benign epithelial tumor, special type
PRDM6::NIPAL4	Adenocarcinoma
PRDX1::AKR1A1	Adenocarcinoma
PRDX1::DDX27	Squamous cell carcinoma
PRDX1::NTRK1	Melanocytic neoplasm, special type | Adenocarcinoma
PRDX1::TMEM53	Adenocarcinoma
PRDX5::LGR5	Transitional cell carcinoma
PRDX6::CLCN3	Squamous cell carcinoma
PRDX6::DARS2	Malignant epithelial tumor, special type
PRELID2::MAPK9	Neuroblastoma
PRELID2::MEGF10	Squamous cell carcinoma
PRELID2::PAIP1	Malignant melanoma
PRELID3B::PTPRT	Adenocarcinoma
PRELID3B::TRAPPC10	Adenocarcinoma
PREP::ARMC2	Adenocarcinoma
PREP::ATG5	Adenocarcinoma
PREP::CRYBG1	Adenocarcinoma
PREP::DCBLD1	Adenocarcinoma
PREP::LDLRAD4	Adenocarcinoma
PREP::PLN	Adenocarcinoma
PREP::POPDC3	Squamous cell carcinoma
PREP::PTPRK	Squamous cell carcinoma
PREP::QRSL1	Adenocarcinoma
PREP::SIM1	Squamous cell carcinoma
PREP::TPCN2	Adenocarcinoma
PREX1::EHBP1	Adenocarcinoma
PREX1::KCNB1	Malignant epithelial tumor, special type
PREX1::MFN1	Adenocarcinoma
PREX1::STAU1	Germ cell tumor, NOS
PREX2::C8ORF34	Adenocarcinoma
PREX2::FAM110B	Adenocarcinoma
PRICKLE1::FGD4	Adenocarcinoma
PRICKLE1::LRIG3	Mesenchymal tumor, NOS
PRICKLE2::ADAMTS9	Malignant melanoma
PRICKLE3::CACNA1F	Adenocarcinoma
PRIM1::NACA	Heart | Chronic myeloid leukemia, t(9;22)
PRIM1::USP9X	Adenocarcinoma
PRIM2::COL21A1	Adenocarcinoma
PRIM2::COL22A1	Adenocarcinoma
PRIM2::MAD2L1BP	Adenocarcinoma
PRIM2::NKAIN2	Squamous cell carcinoma
PRKAA1::PTPN22	Adenocarcinoma
PRKAA1::RPL37	Adenocarcinoma
PRKAA1::TBC1D5	Adenocarcinoma
PRKAA1::TTC33	Nonneoplastic hematologic disorder/lesion | Nonneoplastic epithelial disorder/lesion
PRKAA1::UBLCP1	Acute myeloblastic leukemia without maturation (FAB type M1)
PRKAA2::USP24	Malignant melanoma
PRKAB2::FBP2	Adenocarcinoma
PRKACA::ASF1B	Squamous cell carcinoma | Adenocarcinoma
PRKACA::PRKACB	Adenocarcinoma
PRKACB::ASH2L	Adenocarcinoma
PRKAG2::ACTR3C	Adenocarcinoma
PRKAG2::ADCK2	Adenocarcinoma
PRKAG2::CA10	Adenocarcinoma
PRKAG2::ETV3	Skin | Acute myeloid leukemia, NOS
PRKAG2::KMT2C	Adenocarcinoma
PRKAG2::NUB1	Adenocarcinoma
PRKAG2::ORC5	Adenocarcinoma
PRKAG2::VPS50	Adenocarcinoma
PRKAG2::WASL	Mesothelioma
PRKAR1A::ALK	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma | Benign fibrous histiocytoma
PRKAR1A::BCAS3	Adenocarcinoma
PRKAR1A::CWF19L1	Multiple myeloma
PRKAR1A::FOXP1	Adenocarcinoma
PRKAR1A::MET	Adenocarcinoma
PRKAR1A::PITPNC1	Adenocarcinoma
PRKAR1A::RARA	Acute promyelocytic leukemia (FAB type M3)
PRKAR1A::RET	Carcinoma, NOS | Adenocarcinoma | Fibrosarcoma
PRKAR1A::ZBTB20	Adenocarcinoma
PRKAR1B::ALK	Adenocarcinoma
PRKAR1B::BRAF	Gastrointestinal stromal tumor
PRKAR1B::GNA12	Adenocarcinoma
PRKAR2A::ALK	Benign fibrous histiocytoma
PRKAR2A::CACNA1D	Adenocarcinoma
PRKAR2A::CACNA2D3	Miscellaneous hematopoietic/lymphoid neoplasm, special type | Benign epithelial tumor, special type
PRKAR2A::NOTCH2	Adenocarcinoma
PRKAR2A::NTRK2	Glioma, NOS
PRKAR2A::QRICH1	Adenocarcinoma
PRKAR2A::RAF1	Adenocarcinoma | Malignant melanoma
PRKAR2A::SLC25A20	Adenocarcinoma
PRKAR2A::SPINK8	Astrocytoma, grade III-IV/Glioblastoma
PRKAR2A::USP4	Miscellaneous hematopoietic/lymphoid neoplasm, special type
PRKAR2B::BRAF	Astrocytoma, grade I-II | Neuroglial neoplasm, special type | Adenocarcinoma
PRKAR2B::HMCN1	Squamous cell carcinoma
PRKAR2B::MET	Adenocarcinoma
PRKCA::BAIAP2	Malignant melanoma
PRKCA::CACNG1	Malignant melanoma
PRKCA::CACNG5	Adenocarcinoma
PRKCA::CDH8	Adenocarcinoma
PRKCA::CEP112	Adenocarcinoma
PRKCA::CRYBA1	Adenocarcinoma
PRKCA::EFNA3	Adenocarcinoma
PRKCA::GPRC5B	Astrocytoma, NOS
PRKCA::IGF2BP1	Adenocarcinoma
PRKCA::IGF2BP3	Squamous cell carcinoma
PRKCA::MARCHF10	Adenocarcinoma
PRKCA::NF1	Transitional cell carcinoma
PRKCA::PHB1	Adenocarcinoma
PRKCA::PI4KA	Mesenchymal tumor, NOS
PRKCA::PITPNC1	Malignant melanoma | Adenocarcinoma
PRKCA::PPP4R4	Adenocarcinoma
PRKCA::RAB40B	Mesenchymal tumor, NOS
PRKCA::RASGRF2	Adenocarcinoma
PRKCA::RGS9	Adenocarcinoma
PRKCA::RPS6KB1	Adenocarcinoma
PRKCA::SDK1	Squamous cell carcinoma
PRKCA::ST6GALNAC2	Adenocarcinoma
PRKCA::TMEM100	Adenocarcinoma
PRKCB::ALK	Adenocarcinoma
PRKCD::KIF9	Adenocarcinoma
PRKCD::SLC4A8	Squamous cell carcinoma
PRKCE::ADGRG6	Malignant melanoma
PRKCE::ALK	Adenocarcinoma
PRKCE::CAMKMT	Adenocarcinoma
PRKCE::MSH2	Adenocarcinoma
PRKCE::QPCT	Adenocarcinoma
PRKCE::RTN4	Adenocarcinoma
PRKCE::WWTR1	Leiomyoma
PRKCH::ARMH4	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PRKCH::MNAT1	Astrocytoma, grade I-II
PRKCI::CLDN11	Adenocarcinoma
PRKCI::GPR160	Adenocarcinoma
PRKCI::SAMD7	Adenocarcinoma
PRKCI::TNIK	Adenocarcinoma
PRKCSH::IGK	Multiple myeloma
PRKCSH::PGPEP1	Malignant melanoma
PRKCZ::ATAD3C	Adenocarcinoma
PRKCZ::CUBN	Russia | Primitive neuroectodermal tumor/Medulloblastoma
PRKCZ::FAM171A1	Primitive neuroectodermal tumor/Medulloblastoma | Russia
PRKCZ::GABRD	Adenocarcinoma
PRKCZ::LMNTD1	Adenocarcinoma
PRKCZ::TP53TG5	Adenocarcinoma
PRKD2::CKM	Adenocarcinoma
PRKD2::GLUD1	Adenocarcinoma
PRKD2::HPSE2	Adenocarcinoma
PRKD2::KLHL26	Adenocarcinoma
PRKD2::MYH14	Adenocarcinoma
PRKD2::RCN3	Squamous cell carcinoma
PRKD2::STRN4	Mesenchymal tumor, NOS
PRKD3::CEBPZ	Adenocarcinoma
PRKD3::TMEM51	Mesenchymal tumor, NOS
PRKDC::ARHGAP23	Adenocarcinoma
PRKDC::CA3	Embryonal nervous system tumor, special type
PRKDC::CEP290	Adenocarcinoma
PRKDC::CLVS1	Adenocarcinoma
PRKDC::CPA6	Multiple myeloma
PRKDC::DEFB103B	Adenocarcinoma
PRKDC::GSR	Adenocarcinoma
PRKDC::MYO5A	Adenocarcinoma
PRKDC::PPDPFL	Squamous cell carcinoma
PRKDC::PRIM2	Squamous cell carcinoma
PRKDC::SPIDR	Squamous cell carcinoma | Adenocarcinoma
PRKDC::UBE2V2	Adenocarcinoma
PRKG1::RET	Adenocarcinoma
PRKG2::PDGFRB	Mastocytosis | Chronic myeloproliferative disorder, NOS
PRKN::AKAP12	Astrocytoma, grade I-II
PRKN::LANCL1	Squamous cell carcinoma
PRKN::SMOX	Mesothelioma
PRKN::STRADA	Astrocytoma, grade I-II
PRKRA::AGPS	Adenocarcinoma
PRKRA::SEC31A	Adenocarcinoma
PRKRIP1::CRACR2B	Adenocarcinoma
PRKRIP1::SH2B2	Adenocarcinoma
PRKRIP1::WDTC1	Adenocarcinoma
PRKX::CLCN4	Astrocytoma, grade I-II
PRLR::AGXT2	Adenocarcinoma
PRLR::CDH12	Adenocarcinoma
PRLR::CLPTM1L	Adenocarcinoma
PRLR::KDM3B	Adenocarcinoma
PRLR::PLCXD3	Adenocarcinoma
PRMT1::FLT3LG	Adenocarcinoma
PRMT1::KASH5	Adenocarcinoma
PRMT1::PTOV1	Adenocarcinoma
PRMT1::TLE6	Acute myeloid leukemia, NOS | Skin
PRMT2::DIP2A	Adenocarcinoma
PRMT2::DPF1	Adenocarcinoma
PRMT2::GET1	Squamous cell carcinoma
PRMT2::STX18	Adenocarcinoma
PRMT3::MALRD1	Malignant melanoma
PRMT3::TCN1	Squamous cell carcinoma
PRMT7::EXOC4	Mesenchymal tumor, NOS
PRMT7::NFATC3	Adenocarcinoma
PROM1::TAPT1	Adenocarcinoma
PRORP::AKAP6	Adenocarcinoma
PRORP::FAM177A1	Adenocarcinoma
PROSER1::MIPEP	Adenocarcinoma
PROSER3::IGFLR1	Adenocarcinoma
PRPF18::CACNB2	Adenocarcinoma
PRPF18::CCDC3	Adenocarcinoma
PRPF19::DDB1	Adenocarcinoma
PRPF19::NLRP14	Mesenchymal tumor, NOS
PRPF19::RAB1B	Adenocarcinoma
PRPF19::RARG::PRPF19	Acute promyelocytic leukemia (FAB type M3)
PRPF31::CACNG7	Adenocarcinoma
PRPF31::SPRYD4	Adenocarcinoma
PRPF31::ZNF547	Adenocarcinoma
PRPF38A::ABCD3	Malignant melanoma
PRPF38A::CDNF	Mesenchymal tumor, NOS
PRPF39::FANCM	Adenocarcinoma
PRPF39::PSMA6	Adenocarcinoma
PRPF39::TOGARAM1	Squamous cell carcinoma
PRPF3::CTSS	Adenocarcinoma
PRPF3::OTUD7B	Mesenchymal tumor, NOS
PRPF3::TARS2	Malignant melanoma
PRPF40B::CDH4	Mesenchymal tumor, NOS
PRPF40B::SPATS2	Adenocarcinoma
PRPF4B::CDYL	Adenocarcinoma
PRPF4B::F13A1	Malignant melanoma
PRPF4B::FAM50B	Adenocarcinoma
PRPF6::DCAF5	Adenocarcinoma
PRPF6::DNAJC5	Adenocarcinoma
PRPF6::GATA5	Adenocarcinoma
PRPF6::SDC4	Adenocarcinoma
PRPF6::STAT6	Adenocarcinoma
PRPS1::NCBP2L	Adenocarcinoma
PRPSAP1::SRSF2	Adenocarcinoma
PRPSAP1::ST6GALNAC2	Adenocarcinoma
PRPSAP2::CYP27B1	Squamous cell carcinoma
PRPSAP2::EEPD1	Adenocarcinoma
PRPSAP2::PLLP	Squamous cell carcinoma
PRR11::IKZF3	Adenocarcinoma
PRR11::SKA2	Adenocarcinoma
PRR11::SUZ12	Squamous cell carcinoma
PRR12::CDC42EP5	Squamous cell carcinoma
PRR12::FDX2	Malignant melanoma
PRR12::FLT3LG	Squamous cell carcinoma | Adenocarcinoma
PRR12::PRRG2	Adenocarcinoma
PRR12::SNRNP70	Squamous cell carcinoma
PRR12::SYMPK	Adenocarcinoma
PRR14::GSG1L	Adenocarcinoma
PRR14L::CC2D1A	Adenocarcinoma
PRR14L::POLD4	Adenocarcinoma
PRR14L::SOX10	Squamous cell carcinoma
PRR15L::CBX1	Adenocarcinoma
PRR15L::CDK5RAP3	Mesothelioma
PRR15L::GPATCH8	Adenocarcinoma
PRR15L::KCNH4	Adenocarcinoma
PRR15L::RAB5C	Adenocarcinoma
PRR15L::RSPO2	Adenocarcinoma
PRR16::MALRD1	Adenocarcinoma
PRR16::SCAMP1	Astrocytoma, grade I-II
PRR19::PPP1R37	Adenocarcinoma
PRR4::DUSP16	Adenocarcinoma
PRR4::SPSB2	Squamous cell carcinoma
PRR5::CSNK1E	Malignant melanoma
PRR5L::ITPA	Adenocarcinoma
PRR5L::TRIM44	Adenocarcinoma
PRRC1::NCALD	Adenocarcinoma
PRRC1::SPINK6	Adenocarcinoma
PRRC2A::AIF1	Adenocarcinoma
PRRC2A::COL1A1	Squamous cell carcinoma
PRRC2A::FKBPL	Mesothelioma
PRRC2A::NCR3	Adenocarcinoma
PRRC2A::SFN	Squamous cell carcinoma
PRRC2A::TREM2	Mesenchymal tumor, NOS
PRRC2B::ALK	Astrocytoma, grade I-II | Mesenchymal tumor, special type
PRRC2B::BCR	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PRRC2B::D2HGDH	Adenocarcinoma
PRRC2B::MGMT	Hodgkin disease, NOS
PRRC2B::NR1H3	Astrocytoma, grade I-II
PRRC2B::NTNG2	Adenocarcinoma
PRRC2B::NUP155	Adenocarcinoma
PRRC2B::NUP214	Adenocarcinoma
PRRC2B::PITPNC1	Adenocarcinoma
PRRC2B::POMT1	Adenocarcinoma
PRRC2B::PRCD	Adenocarcinoma
PRRC2B::SET	Adenocarcinoma
PRRC2B::SPACA9	Adenocarcinoma
PRRC2B::UHRF2	Squamous cell carcinoma
PRRC2C::CENPL	Adenocarcinoma
PRRC2C::COL3A1	Adenocarcinoma
PRRC2C::COP1	Adenocarcinoma
PRRC2C::FASLG	Adenocarcinoma
PRRC2C::FMO1	Squamous cell carcinoma
PRRC2C::FMO3	Adenocarcinoma
PRRC2C::NAA25	Squamous cell carcinoma
PRRC2C::NLRP8	Transitional cell carcinoma
PRRC2C::PRLR	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PRRC2C::PRRX1	Adenocarcinoma
PRRG2::AGPAT2	Adenocarcinoma
PRRG2::FCGRT	Adenocarcinoma
PRRG2::KASH5	Adenocarcinoma
PRRG4::CROT	Adenocarcinoma
PRRG4::QSER1	Squamous cell carcinoma
PRRG4::RAPGEFL1	Adenocarcinoma
PRRG4::ZNF215	Mesenchymal tumor, NOS
PRRX1::NCOA1	Fibroblastic/myofibroblastic tumor, special type | Fibroblastic/myofibroblastic tumor, NOS
PRRX1::NCOA2	Fibroblastic/myofibroblastic tumor, special type
PRRX2::NTMT1	Squamous cell carcinoma
PRSS12::TSPAN5	Adenocarcinoma
PRSS1::PNLIP	Adenocarcinoma
PRSS23::CCDC81	Adenocarcinoma
PRSS23::LGALS12	Squamous cell carcinoma
PRSS2::CELA3A	Adenocarcinoma
PRSS2::CPA1	Adenocarcinoma
PRSS2::PRSS1	Skin | Acute myeloid leukemia, NOS
PRTG::DPH6	Squamous cell carcinoma
PRTG::PYGO1	Adenocarcinoma
PRTG::TCF12	Adenocarcinoma
PRUNE1::C1orf54	Adenocarcinoma
PRUNE1::LCE2A	Transitional cell carcinoma
PRUNE1::LCE4A	Transitional cell carcinoma
PRUNE1::PI4KB	Adenocarcinoma
PRUNE1::RAB7A	Adenocarcinoma
PRUNE2::GNA14	Adenocarcinoma
PRUNE2::GNAQ	Adenocarcinoma
PRUNE2::HDAC9	Adenocarcinoma
PRX::BLVRB	Adenocarcinoma
PRX::IGF2	Malignant epithelial tumor, special type
PRXL2A::DYDC2	Adenocarcinoma
PRXL2A::JCHAIN	Adenocarcinoma
PRXL2A::YTHDC1	Adenocarcinoma
PSAP::ABCA1	Malignant melanoma
PSAP::ARFGEF2	Malignant melanoma
PSAP::ASCC1	Squamous cell carcinoma
PSAP::C1S	Adenocarcinoma
PSAP::C3	Malignant melanoma
PSAP::C7	Malignant melanoma
PSAP::DDX27	Malignant melanoma
PSAP::FADS2	Adenocarcinoma
PSAP::FAR1	Adenocarcinoma
PSAP::FOXP1	Adenocarcinoma
PSAP::IGH	Multiple myeloma
PSAP::IGK	Multiple myeloma
PSAP::IQCE	Malignant melanoma
PSAP::KIF3A	Adenocarcinoma
PSAP::OFD1	Malignant epithelial tumor, special type
PSAP::PCID2	Adenocarcinoma
PSAP::PLEKHB2	Adenocarcinoma
PSAP::PTN	Adenocarcinoma
PSAP::QKI	Malignant melanoma
PSAP::SIAE	Adenocarcinoma
PSAP::TCERG1	Malignant melanoma
PSAP::TSPAN8	Adenocarcinoma
PSAP::TYK2	Adenocarcinoma
PSAT1::CEP78	Adenocarcinoma
PSAT1::MICB	Adenocarcinoma
PSCA::AVL9	Transitional cell carcinoma
PSD3::ANO1	Squamous cell carcinoma
PSD3::CSGALNACT1	Adenocarcinoma
PSD3::INTS10	Squamous cell carcinoma
PSD3::NEFL	Adenocarcinoma
PSD3::PAGE4	Adenocarcinoma
PSD3::PCM1	Embryonal rhabdomyosarcoma
PSD4::ACTR3	Adenocarcinoma
PSD4::IL1RN	Squamous cell carcinoma | Adenocarcinoma
PSEN1::ACSM1	Adenocarcinoma
PSEN1::NT5DC3	Malignant melanoma
PSEN1::RBM25	Adenocarcinoma
PSEN1::STK4	Malignant melanoma
PSENEN::IGFLR1	Squamous cell carcinoma
PSIP1::NUP98	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PSIP1::TBL1X	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
PSKH1::C16orf87	Adenocarcinoma
PSKH1::DAP	Squamous cell carcinoma
PSKH1::NUTF2	Adenocarcinoma
PSKH1::PSMB10	Squamous cell carcinoma
PSKH1::TSNAXIP1	Squamous cell carcinoma
PSMA1::CCT5	Adenocarcinoma
PSMA1::SERGEF	Malignant melanoma
PSMA3::ACTR10	Adenocarcinoma
PSMA3::STRADA	Adenocarcinoma
PSMA3::ZNFX1	Adenocarcinoma
PSMA5::FOXP1	Adenocarcinoma
PSMA6::FAM177A1	Squamous cell carcinoma
PSMA6::PRKD1	Astrocytoma, grade I-II
PSMA6::SNX6	Squamous cell carcinoma
PSMB2::C1ORF94	Adenocarcinoma
PSMB2::DENND6B	Adenocarcinoma
PSMB3::CFAP92	Transitional cell carcinoma
PSMB3::CISD3	Adenocarcinoma
PSMB3::CWC25	Adenocarcinoma
PSMB3::FAM117A	Adenocarcinoma
PSMB5::HOMEZ	Adenocarcinoma
PSMB6::ENO3	Adenocarcinoma
PSMB7::GOLGA1	Adenocarcinoma
PSMB7::NR6A1	Mesenchymal tumor, NOS
PSMB7::PID1	Malignant melanoma
PSMC3IP::SPECC1	Adenocarcinoma
PSMC4::FRS2	Mesenchymal tumor, NOS
PSMC5::PECAM1	Adenocarcinoma
PSMC6::GPR137C	Squamous cell carcinoma
PSMC6::KANSL2	Squamous cell carcinoma
PSMD11::CCL15	Adenocarcinoma
PSMD11::CDK12	Adenocarcinoma
PSMD11::CEP112	Adenocarcinoma
PSMD11::DPRX	Transitional cell carcinoma
PSMD11::KRTAP2-1	Transitional cell carcinoma
PSMD11::PITPNC1	Adenocarcinoma
PSMD11::RHOT1	Squamous cell carcinoma | Adenocarcinoma
PSMD11::SLC4A4	Transitional cell carcinoma
PSMD12::NEXMIF	Adenocarcinoma
PSMD12::PITPNC1	Adenocarcinoma
PSMD12::PRKCA	Adenocarcinoma
PSMD12::SEC24B	Astrocytoma, grade III-IV/Glioblastoma
PSMD12::TLK2	Adenocarcinoma
PSMD13::HSD17B12	Transitional cell carcinoma
PSMD14::CCDC148	Squamous cell carcinoma
PSMD1::ARMC9	Adenocarcinoma
PSMD1::ARSG	Adenocarcinoma
PSMD1::ATP2C1	Squamous cell carcinoma
PSMD1::DNER	Astrocytoma, grade III-IV/Glioblastoma
PSMD1::NHEJ1	Adenocarcinoma
PSMD1::TRPM8	Adenocarcinoma
PSMD2::ECE2	Adenocarcinoma
PSMD3::CASC3	Adenocarcinoma
PSMD3::CDK12	Adenocarcinoma
PSMD3::CHD2	Skin | Acute myeloid leukemia, NOS
PSMD3::EPOP	Adenocarcinoma
PSMD3::SRCIN1	Adenocarcinoma
PSMD3::TOP6BL	Adenocarcinoma
PSMD3::UNC45B	Astrocytoma, grade I-II
PSMD3::ZPBP2	Adenocarcinoma
PSMD4::COPA	Adenocarcinoma
PSMD4::S100A10	Adenocarcinoma
PSMD5::C5	Adenocarcinoma
PSMD7::PDPR	Adenocarcinoma
PSMD8::MAP2K5	Transitional cell carcinoma
PSMD8::MAP3K10	Adenocarcinoma
PSMD8::SPINT2	Adenocarcinoma
PSMD8::TJP3	Malignant epithelial tumor, special type
PSME1::AP1G2	Adenocarcinoma
PSME3::GPR37L1	Adenocarcinoma
PSME3::TM9SF2	Adenocarcinoma
PSME3IP1::CCDC102A	Adenocarcinoma
PSME3IP1::CES2	Malignant melanoma
PSME3IP1::VPS35L	Adenocarcinoma
PSME4::PPP1CB	Squamous cell carcinoma
PSME4::SLC22A16	Adenocarcinoma
PSMF1::ABRA	Adenocarcinoma
PSMF1::CHST8	Mesenchymal tumor, NOS
PSMG2::OSBPL1A	Adenocarcinoma
PSMG2::PTPN2	Squamous cell carcinoma
PSMG2::SETMAR	Adenocarcinoma
PSMG4::EEF1E1	Adenocarcinoma
PSMG4::WNK2	Mycosis fungoides/Sézary syndrome
PSPC1::ACTR8	Transitional cell carcinoma
PSPC1::ARHGEF2	Adenocarcinoma
PSPC1::CRYL1	Astrocytoma, grade III-IV/Glioblastoma
PSPC1::METTL21C	Adenocarcinoma
PSPC1::MPHOSPH8	Transitional cell carcinoma
PSPC1::TFE3	Soft tissue tumor, special type
PSPC1::ZMYM5	Adenocarcinoma
PSPH::PHKG1	Adenocarcinoma
PSRC1::MYBPHL	Adenocarcinoma
PSTK::YME1L1	Adenocarcinoma
PSTPIP1::RCN2	Adenocarcinoma
PTAR1::ABHD17B	Adenocarcinoma
PTAR1::PIP5K1B	Mesenchymal tumor, NOS
PTBP1::AP3D1	Adenocarcinoma
PTBP1::FGF22	Adenocarcinoma
PTBP1::FOSB	Osteoblastoma
PTBP1::KLF16	Multiple myeloma
PTBP1::KLF2	Multiple myeloma
PTBP1::MAML2	Vascular and perivascular tumor, special type
PTBP1::OAZ1	Multiple myeloma
PTBP1::PALM	Mature B-cell neoplasm, NOS | Diffuse large B-cell lymphoma
PTBP1::RNF126	Chronic lymphocytic leukemia | Multiple myeloma | Adenocarcinoma
PTBP1::SBNO2	Multiple myeloma
PTBP1::SCGB1C1	Mesothelioma
PTBP1::TMEM259	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Multiple myeloma
PTBP1::UBE3C	Adenocarcinoma
PTBP1::ZBTB7A	Multiple myeloma
PTBP2::CASQ1	Adenocarcinoma
PTBP2::KAZN	Adenocarcinoma
PTBP3::ASTN2	Adenocarcinoma
PTBP3::ENDOG	Adenocarcinoma
PTBP3::GDF15	Squamous cell carcinoma
PTBP3::SVEP1	Malignant melanoma | Adenocarcinoma
PTCD1::PEX11G	Malignant epithelial tumor, special type
PTCH1::FANCC	Adenocarcinoma
PTCH1::GLI1	Soft tissue tumor, special type | Germ cell tumor, special type | Soft tissue tumor, NOS | Malignant soft tissue tumor, NOS | Vascular and perivascular tumor, special type | Pericytoma
PTCH1::GLI2	Mesenchymal tumor, special type
PTCH1::IPPK	Mesenchymal tumor, NOS
PTCHD4::CD2AP	Adenocarcinoma
PTCHD4::ESR1	Adenocarcinoma
PTDSS1::NIPAL2	Transitional cell carcinoma
PTDSS1::PTK2	Adenocarcinoma
PTDSS1::SPRYD3	Adenocarcinoma
PTDSS2::IFITM1	Adenocarcinoma
PTDSS2::IFITM2	Adenocarcinoma
PTEN::ATAD1	Astrocytoma, grade I-II
PTEN::BTRC	Squamous cell carcinoma
PTEN::C1ORF226	Adenocarcinoma
PTEN::C1orf226	Adenocarcinoma
PTEN::CTNNA3	Adenocarcinoma
PTEN::EXTL2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PTEN::GRID1	Adenocarcinoma
PTEN::HECTD2	Adenocarcinoma
PTEN::KCNMB4	Adenocarcinoma
PTEN::KIF20B	Squamous cell carcinoma
PTEN::LIPF	Transitional cell carcinoma
PTEN::NR2F1	Russia | Primitive neuroectodermal tumor/Medulloblastoma
PTEN::NRP1	Adenocarcinoma
PTEN::PRAMEF2	Adenocarcinoma
PTEN::PYGB	Astrocytoma, grade I-II
PTEN::RALGAPA2	Adenocarcinoma
PTEN::RNLS	Transitional cell carcinoma
PTEN::RUFY2	Adenocarcinoma
PTEN::SGMS1	Adenocarcinoma
PTEN::THAP9	Primitive neuroectodermal tumor/Medulloblastoma | Russia
PTEN::WNK1	Adenocarcinoma
PTGDS::CLU	Astrocytoma, grade I-II
PTGDS::EEA1	Astrocytoma, grade I-II
PTGDS::INF2	Astrocytoma, grade I-II
PTGDS::NOC4L	Malignant melanoma
PTGES2::CIZ1	Adenocarcinoma
PTGES2::DENND1A	Adenocarcinoma
PTGES2::MLXIP	Transitional cell carcinoma
PTGES3::ITPR2	Astrocytoma, grade I-II
PTGES3::NACA	Squamous cell carcinoma
PTGES3::PTPRB	Soft tissue tumor, special type
PTGES3::SPATS2	Adenocarcinoma
PTGES3L::RGS9	Squamous cell carcinoma
PTGFRN::AGBL4	Adenocarcinoma
PTGFRN::CD2	Squamous cell carcinoma
PTGFRN::NOTCH2	Adenocarcinoma
PTGIS::IFT52	Malignant melanoma
PTGR1::PTBP3	Adenocarcinoma
PTGR1::SHOC1	Adenocarcinoma
PTGR2::NDUFB2	Adenocarcinoma
PTK2::ANGPT1	Adenocarcinoma
PTK2::ANKRD11	Adenocarcinoma
PTK2::CACNG8	Adenocarcinoma
PTK2::DENND3	Astrocytoma, grade III-IV/Glioblastoma | Adenocarcinoma
PTK2::EIF3E	Transitional cell carcinoma
PTK2::GFUS	Adenocarcinoma
PTK2::MKLN1	Adenocarcinoma
PTK2::NCR3	Adenocarcinoma
PTK2::PKHD1L1	Adenocarcinoma | Undifferentiated carcinoma, small cell
PTK2::PPP2R5E	Adenocarcinoma
PTK2::RNF139	Adenocarcinoma
PTK2::SLC30A8	Adenocarcinoma
PTK2::SLC45A4	Adenocarcinoma
PTK2::TRAPPC9	Adenocarcinoma | Malignant melanoma
PTK2::UBE2H	Squamous cell carcinoma
PTK2::UGT2A3	Transitional cell carcinoma
PTK2::UTP23	Adenocarcinoma
PTK2::VPS13B	Transitional cell carcinoma
PTK2B::ICA1L	Malignant melanoma
PTK2B::SLC5A1	Germ cell tumor, NOS
PTK7::ANKS1A	Squamous cell carcinoma
PTK7::CNOT2	Mesenchymal tumor, NOS
PTK7::DENND4A	Adenocarcinoma
PTK7::DLK2	Adenocarcinoma
PTK7::FGFR1	Squamous cell carcinoma
PTK7::GNMT	Transitional cell carcinoma
PTK7::KLHDC3	Adenocarcinoma
PTK7::PTCRA	Adenocarcinoma
PTK7::SRF	Germ cell tumor, NOS
PTK7::VEGFA	Adenocarcinoma
PTMA::PRSS16	Miscellaneous hematopoietic/lymphoid neoplasm, special type
PTMA::SAP30BP	Adenocarcinoma
PTMS::EIF4G1	Adenocarcinoma
PTMS::SUPT16H	Germ cell tumor, NOS
PTMS::TAF3	Adenocarcinoma
PTN::MET	Astrocytoma, grade III-IV/Glioblastoma
PTOV1::CA10	Adenocarcinoma
PTOV1::NPAS1	Adenocarcinoma
PTP4A1::EYS	Adenocarcinoma
PTP4A1::NOTCH3	Adenocarcinoma
PTP4A2::ARFGEF2	Transitional cell carcinoma
PTP4A2::GGNBP2	Multiple myeloma
PTPA::AGTPBP1	Adenocarcinoma
PTPA::CRAT	Adenocarcinoma
PTPA::MIGA2	Adenocarcinoma
PTPA::NEK6	Adenocarcinoma
PTPA::NUP188	Adenocarcinoma
PTPA::PAX5	Mesenchymal tumor, NOS
PTPA::PHYHD1	Adenocarcinoma
PTPN11::CUX2	Malignant epithelial tumor, special type
PTPN11::EPYC	Mesenchymal tumor, NOS
PTPN11::PLAGL1	Mesenchymal tumor, NOS
PTPN11::ZNF706	Transitional cell carcinoma
PTPN12::ADGRB1	Malignant melanoma
PTPN12::DYNC1I1	Astrocytoma, grade I-II
PTPN12::GGNBP2	Adenocarcinoma
PTPN12::GSAP	Adenocarcinoma
PTPN12::HSP90AA1	Adenocarcinoma
PTPN12::RHBDD2	Adenocarcinoma
PTPN13::AFF1	Squamous cell carcinoma
PTPN13::C4ORF36	Squamous cell carcinoma
PTPN13::C4orf36	Squamous cell carcinoma
PTPN14::ANKRD44	Adenocarcinoma
PTPN14::NSL1	Transitional cell carcinoma
PTPN1::BCAS4	Adenocarcinoma
PTPN1::ELP6	Adenocarcinoma
PTPN1::P2RX4	Squamous cell carcinoma
PTPN1::PREX1	Adenocarcinoma
PTPN1::PRR11	Adenocarcinoma
PTPN1::ROMO1	Adenocarcinoma
PTPN1::SLC9A8	Adenocarcinoma
PTPN21::EML5	Malignant epithelial tumor, special type
PTPN21::SIPA1L1	Adenocarcinoma
PTPN21::TTC8	Adenocarcinoma
PTPN23::CCDC14	Adenocarcinoma
PTPN23::ICA1L	Adenocarcinoma
PTPN23::ISY1	Malignant melanoma
PTPN23::KLHL18	Adenocarcinoma
PTPN23::RTP3	Adenocarcinoma
PTPN23::STAT4	Squamous cell carcinoma
PTPN2::FOXA1	Adenocarcinoma
PTPN2::FTL	Squamous cell carcinoma
PTPN2::L3MBTL4	Adenocarcinoma
PTPN2::MYL12B	Adenocarcinoma
PTPN2::PTPRD	Adenocarcinoma
PTPN2::UBLCP1	Acute myeloblastic leukemia with maturation (FAB type M2)
PTPN3::ASTN2	Mesothelioma
PTPN4::CFAP221	Adenocarcinoma
PTPN4::GRID1	Squamous cell carcinoma
PTPN4::LCT	Transitional cell carcinoma
PTPN6::LRRC23	Transitional cell carcinoma
PTPN6::P3H3	Transitional cell carcinoma
PTPN9::AGBL1	Adenocarcinoma
PTPN9::ASH1L	Astrocytoma, grade III-IV/Glioblastoma
PTPN9::CSPG4	Astrocytoma, grade I-II
PTPN9::SCAPER	Adenocarcinoma
PTPN9::SLC12A1	Mesenchymal tumor, NOS
PTPRA::ANAPC10	Adenocarcinoma
PTPRA::ATE1	Adenocarcinoma
PTPRA::CDK5RAP1	Adenocarcinoma
PTPRA::N4BP1	Adenocarcinoma
PTPRA::PRSS1	Adenocarcinoma
PTPRA::PSMF1	Adenocarcinoma
PTPRA::SDAD1	Squamous cell carcinoma
PTPRA::SUPT16H	Astrocytoma, grade I-II
PTPRA::TADA2A	Adenocarcinoma
PTPRD::CYGB	Squamous cell carcinoma
PTPRD::IDO1	Squamous cell carcinoma
PTPRD::RAC2	Adenocarcinoma
PTPRD::TRHDE	Mesenchymal tumor, NOS
PTPRE::SH3PXD2A	Adenocarcinoma
PTPRF::ARTN	Adenocarcinoma
PTPRF::CFAP74	Malignant melanoma
PTPRF::DHRS4	Adenocarcinoma
PTPRF::DHRS4L2	Adenocarcinoma
PTPRF::GUCA2A	Adenocarcinoma
PTPRF::HIVEP3	Adenocarcinoma
PTPRF::LEFTY2	Adenocarcinoma
PTPRF::LRP12	Squamous cell carcinoma
PTPRF::METTL16	Adenocarcinoma
PTPRF::MICALL2	Adenocarcinoma
PTPRF::NDUFV1	Squamous cell carcinoma
PTPRF::PARD3	Adenocarcinoma
PTPRF::PDE4B	Adenocarcinoma
PTPRF::PHF20	Adenocarcinoma
PTPRF::RPS6KA3	Adenocarcinoma
PTPRG::BRD8	Adenocarcinoma
PTPRG::CADPS	Adenocarcinoma
PTPRG::CEP15	Adenocarcinoma
PTPRG::CLASP2	Mesenchymal tumor, NOS
PTPRG::FHIT	Adenocarcinoma
PTPRG::FRMD4B	Adenocarcinoma
PTPRG::MCM3AP	Squamous cell carcinoma
PTPRG::PPP4R2	Alveolar rhabdomyosarcoma
PTPRG::RAF1	Malignant soft tissue tumor, NOS
PTPRG::SYNPR	Malignant melanoma
PTPRH::PPP6R1	Adenocarcinoma
PTPRJ::C2CD2L	Acute myeloid leukemia, NOS | Skin
PTPRJ::DDB2	Adenocarcinoma
PTPRJ::FCER1G	Adenocarcinoma
PTPRJ::MADD	Adenocarcinoma
PTPRJ::PPP2CB	Adenocarcinoma
PTPRJ::STK33	Adenocarcinoma
PTPRJ::TAF3	Adenocarcinoma
PTPRK::ARHGAP18	Adenocarcinoma
PTPRK::BCKDHB	Adenocarcinoma
PTPRK::ECHDC1	Adenocarcinoma
PTPRK::EPB41L2	Adenocarcinoma
PTPRK::EYA4	Malignant melanoma
PTPRK::EYS	Adenocarcinoma
PTPRK::FBXO5	Adenocarcinoma
PTPRK::FGF7	Adenocarcinoma
PTPRK::HECA	Adenocarcinoma
PTPRK::IL20RA	Adenocarcinoma
PTPRK::MTRES1	Adenocarcinoma
PTPRK::MTRF1L	Adenocarcinoma
PTPRK::OXR1	Adenocarcinoma
PTPRK::PEX5L	Mesenchymal tumor, NOS
PTPRK::PLN	Adenocarcinoma
PTPRK::POPDC3	Transitional cell carcinoma
PTPRK::RAD51B	Adenocarcinoma
PTPRK::RSPO3	Adenoma | Adenocarcinoma
PTPRK::SAMD3	Transitional cell carcinoma
PTPRK::SLC35F1	Adenocarcinoma
PTPRK::SMNDC1	Adenocarcinoma
PTPRK::SPARCL1	Adenocarcinoma
PTPRK::STXBP6	Adenocarcinoma
PTPRM::ELP4	Adenocarcinoma
PTPRM::KCTD1	Adenocarcinoma
PTPRM::MC2R	Adenocarcinoma
PTPRM::RELCH	Adenocarcinoma
PTPRM::TWSG1	Adenocarcinoma
PTPRM::ZNF595	Adenocarcinoma
PTPRN2::DNAJC2	Adenocarcinoma
PTPRN2::GALNT11	Adenocarcinoma
PTPRN2::GNAS	Adenocarcinoma
PTPRN2::IMMP2L	Adenocarcinoma
PTPRN2::LRRC37B	Adenocarcinoma
PTPRN::IGF2	Malignant epithelial tumor, special type
PTPRR::ATP2B1	Transitional cell carcinoma
PTPRR::C12ORF54	Malignant melanoma
PTPRR::C12orf54	Malignant melanoma
PTPRR::CHPT1	Transitional cell carcinoma
PTPRR::CPM	Mesenchymal tumor, NOS
PTPRR::KCNC2	Mesenchymal tumor, NOS
PTPRR::NAV3	Mesenchymal tumor, NOS
PTPRR::SLC6A15	Mesenchymal tumor, NOS
PTPRR::TAFA2	Mesenchymal tumor, NOS
PTPRR::TPH2	Transitional cell carcinoma
PTPRR::VWC2	Astrocytoma, grade I-II
PTPRS::ANGPTL4	Mesenchymal tumor, NOS
PTPRS::MBD3	Adenocarcinoma
PTPRS::PGAP6	Malignant melanoma
PTPRS::POU2F2	Astrocytoma, grade I-II
PTPRS::RGS6	Adenocarcinoma
PTPRS::TPM4	Adenocarcinoma
PTPRS::ZNF627	Mesenchymal tumor, NOS
PTPRT::EXD2	Adenocarcinoma
PTPRT::NCOA3	Adenocarcinoma
PTPRT::OSGIN2	Astrocytoma, grade I-II
PTPRT::RNLS	Adenocarcinoma
PTPRU::KAZN	Adenocarcinoma
PTPRU::NOS1AP	Adenocarcinoma
PTPRU::SBSPON	Adenocarcinoma
PTPRU::UBIAD1	Astrocytoma, grade III-IV/Glioblastoma
PTPRZ1::BRAF	Astrocytoma, pilocytic/juvenile
PTPRZ1::CPED1	Astrocytoma, grade I-II
PTPRZ1::DOCK4	Malignant melanoma
PTPRZ1::ETV1	Oligodendroglioma | Astrocytoma, grade III-IV/Glioblastoma | Astrocytoma, pilocytic/juvenile
PTPRZ1::FYN	Astrocytoma, grade I-II
PTPRZ1::MDFIC	Adenocarcinoma
PTPRZ1::MET	Astrocytoma, grade III-IV/Glioblastoma | Astrocytoma, grade I-II | Carcinoma, NOS
PTPRZ1::NFAM1	Melanocytic neoplasm, special type
PTPRZ1::SRRM3	Malignant melanoma
PTPRZ1::TSPAN33	Squamous cell carcinoma
PTPRZ1::UBE2H	Adenocarcinoma
PTRH2::PEX5L	Adenocarcinoma
PTRH2::RHBDL3	Adenocarcinoma
PTRH2::RNFT1	Squamous cell carcinoma
PTRH2::STXBP4	Adenocarcinoma
PTTG1IP::CLDN4	Adenocarcinoma
PTTG1IP::SIM2	Adenocarcinoma
PUF60::NRBP2	Adenocarcinoma
PUF60::TFE3	Soft tissue tumor, NOS
PUF60::ZNF250	Adenocarcinoma
PUM1::ADGRB2	Adenocarcinoma
PUM1::CRACD	Squamous cell carcinoma
PUM1::CSMD2	Adenocarcinoma
PUM1::EIF4G3	Squamous cell carcinoma
PUM1::GFPT1	Adenocarcinoma
PUM1::HNRNPR	Mesenchymal tumor, NOS
PUM1::HOXA11	Acute lymphoblastic leukemia/lymphoblastic lymphoma
PUM1::HS2ST1	Malignant melanoma
PUM1::KANSL1	Adenocarcinoma
PUM1::LAPTM5	Adenocarcinoma | Transitional cell carcinoma
PUM1::NKAIN1	Adenocarcinoma
PUM1::PLAG1	Mesenchymal tumor, NOS
PUM1::PTPRK	Adenocarcinoma
PUM1::RAP1A	Squamous cell carcinoma
PUM1::RNF207	Adenocarcinoma
PUM1::RPH3AL	Adenocarcinoma
PUM1::SDC3	Adenocarcinoma | Transitional cell carcinoma
PUM1::SDCCAG8	Adenocarcinoma
PUM1::SLC66A1	Transitional cell carcinoma
PUM1::SNRNP40	Adenocarcinoma
PUM1::TRERF1	Adenocarcinoma
PUM1::YARS1	Adenocarcinoma
PUM2::CYRIA	Adenocarcinoma
PUM2::HS1BP3	Adenocarcinoma
PUM2::IL1RN	Adenocarcinoma
PUM2::IST1	Adenocarcinoma
PUM2::LDAH	Astrocytoma, grade III-IV/Glioblastoma
PUM2::MIPOL1	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
PUM2::MTFR1L	Adenocarcinoma
PUM2::TTLL4	Adenocarcinoma
PUM2::WDR35	Adenocarcinoma
PUM3::CEP152	Squamous cell carcinoma
PURG::UBAP1	Squamous cell carcinoma
PUS1::CTNNBIP1	Squamous cell carcinoma
PUS1::GALNT9	Mature B-cell neoplasm, NOS
PUS1::ICOSLG	Adenocarcinoma
PUS1::SFSWAP	Adenocarcinoma
PUS7::EFCAB10	Adenocarcinoma
PUS7L::SMCO2	Adenocarcinoma
PUSL1::AGRN	Squamous cell carcinoma
PVR::HPN	Adenocarcinoma
PVR::IGSF23	Adenocarcinoma
PVR::SIRT2	Malignant epithelial tumor, special type
PVR::ZNF233	Adenocarcinoma
PWP1::CCDC63	Mesenchymal tumor, NOS
PWP2::SFSWAP	Adenocarcinoma
PWP2::TRAPPC10	Squamous cell carcinoma
PWWP2A::IQGAP2	Adenocarcinoma
PWWP2A::ROS1	Melanocytic neoplasm, special type
PXDN::MYT1L	Adenocarcinoma
PXDN::TRIP12	Astrocytoma, grade III-IV/Glioblastoma
PXDN::UTRN	Transitional cell carcinoma
PXDN::XIRP2	Endometrial stromal sarcoma
PXDNL::ATP6V1H	Adenocarcinoma
PXDNL::MSI2	Adenocarcinoma
PXDNL::PCMTD1	Mature B-cell neoplasm, NOS
PXDNL::USP8	Malignant melanoma
PXK::FLNB	Adenocarcinoma
PXK::RPP14	Adenocarcinoma
PXK::TTC7A	Adenocarcinoma
PXK::USP4	Miscellaneous hematopoietic/lymphoid neoplasm, special type
PXMP2::ADGRD1	Osteosarcoma, NOS
PXN::COQ5	Adenocarcinoma
PXN::GATC	Adenocarcinoma
PXN::GCN1	Adenocarcinoma
PXN::MSI1	Adenocarcinoma | Squamous cell carcinoma
PXN::MYBPC1	Astrocytoma, grade I-II
PXN::PLA2G1B	Adenocarcinoma
PXN::RAB35	Squamous cell carcinoma
PYCR1::NOTUM	Adenocarcinoma
PYGB::CNBD2	Adenocarcinoma
PYGB::ENTPD6	Adenocarcinoma
PYGB::KIZ	Adenocarcinoma
PYGB::PCSK2	Transitional cell carcinoma
PYGL::ABHD12B	Refractory anemia with excess blasts-2
PYGL::TRIM9	Squamous cell carcinoma
PYGO1::FBN1	Mesenchymal tumor, NOS
PYM1::CS	Adenocarcinoma
PYM1::SARNP	Adenocarcinoma
PYM1::SLC16A7	Adenocarcinoma
PYROXD1::SLC2A14	Adenocarcinoma
PZP::CPNE4	Adenocarcinoma
QKI::AKAP7	Astrocytoma, grade I-II
QKI::ATG5	Adenocarcinoma
QKI::BRAF	Benign nevus | Adenocarcinoma
QKI::MRPL14	Adenocarcinoma
QKI::NTRK2	Astrocytoma, pilocytic/juvenile | Glioma, NOS
QKI::PACRG	Adenocarcinoma
QKI::RAF1	Glioma, NOS | Neuroglial neoplasm, special type | Astrocytoma, pilocytic/juvenile
QKI::TAF12	Adenocarcinoma
QKI::ZNF214	Adenocarcinoma
QPCTL::ETHE1	Astrocytoma, grade I-II
QRICH1::ACOT2	Adenocarcinoma
QRICH1::C3ORF62	Diffuse large B-cell lymphoma
QRICH1::C3orf62	Diffuse large B-cell lymphoma
QRICH1::MDGA1	Adenocarcinoma
QRICH1::PRKAR2A	Transitional cell carcinoma
QRICH1::SHISA5	Adenocarcinoma
QRICH1::TRAIP	Adenocarcinoma
QRICH1::USP4	Adenocarcinoma
QRSL1::ATG5	Adenocarcinoma
QRSL1::CD24	Adenocarcinoma
QSER1::DEPDC7	Adenocarcinoma
QSER1::GAS2	Adenocarcinoma
QSER1::KIAA1328	Adenocarcinoma
QSER1::PRRG4	Transitional cell carcinoma
QSOX1::LHX4	Squamous cell carcinoma
QSOX1::NFASC	Adenocarcinoma
QSOX1::SMR3B	Adenocarcinoma
QSOX1::TOR1AIP1	Transitional cell carcinoma
QSOX2::CTU2	Adenocarcinoma
QTRT1::ILF3	Adenocarcinoma
QTRT2::HMG20A	Adenocarcinoma
QTRT2::NAA50	Transitional cell carcinoma
R3HCC1::ENTPD4	Adenocarcinoma
R3HCC1::GRIK5	Adenocarcinoma
R3HCC1L::PCBP2	Malignant melanoma
R3HDM1::ANKRD30BL	Adenocarcinoma
R3HDM2::ANKRD24	Adenocarcinoma
R3HDM2::ATP23	Astrocytoma, grade III-IV/Glioblastoma
R3HDM2::AVIL	Adenocarcinoma
R3HDM2::CAPRIN2	Adenocarcinoma
R3HDM2::GLI1	Astrocytoma, grade I-II
R3HDM2::INHBE	Malignant melanoma
R3HDM2::KIF21A	Mesenchymal tumor, NOS
R3HDM2::KIF5A	Astrocytoma, grade I-II
R3HDM2::MARS1	Astrocytoma, grade III-IV/Glioblastoma
R3HDM2::METTL24	Malignant melanoma
R3HDM2::MYRFL	Adenocarcinoma
R3HDM2::NFE2	Carcinoma, NOS
R3HDM2::NTN4	Mesenchymal tumor, NOS
R3HDM2::OS9	Adenocarcinoma
R3HDM2::PIP4K2C	Astrocytoma, grade III-IV/Glioblastoma
R3HDM2::PLEKHA5	Adenocarcinoma
R3HDM2::PPM1H	Malignant melanoma
R3HDM2::PRDM9	Malignant melanoma
R3HDM2::SORBS2	Astrocytoma, grade III-IV/Glioblastoma
R3HDM2::SUPT6H	Adenocarcinoma
R3HDM2::TSFM	Astrocytoma, grade III-IV/Glioblastoma
R3HDM2::USP15	Malignant melanoma
R3HDM2::ZNF385A	Transitional cell carcinoma
R3HDM4::JAK3	Adenocarcinoma
R3HDM4::NLRP1	Malignant melanoma
R3HDM4::PLEKHA4	Adenocarcinoma
R3HDM4::S100A9	Squamous cell carcinoma
R3HDM4::TMEM259	Astrocytoma, grade III-IV/Glioblastoma | Transitional cell carcinoma
RAB10::ARHGAP39	Adenocarcinoma
RAB10::DNAJC17	Adenocarcinoma
RAB10::NCOA1	Adenocarcinoma
RAB10::SDC1	Adenocarcinoma
RAB11A::DENND4A	Adenocarcinoma
RAB11A::PPP6R3	Squamous cell carcinoma
RAB11B::ANGPTL4	Adenocarcinoma
RAB11B::GEMIN7	Adenocarcinoma
RAB11B::HAUS3	Adenocarcinoma
RAB11FIP1::ATP6V1H	Adenocarcinoma
RAB11FIP1::FGFR1	Squamous cell carcinoma
RAB11FIP1::GFI1B	Adenocarcinoma
RAB11FIP1::HTRA4	Adenocarcinoma
RAB11FIP1::KCNU1	Transitional cell carcinoma
RAB11FIP1::UNC5D	Adenocarcinoma
RAB11FIP1::ZDHHC24	Adenocarcinoma
RAB11FIP3::CAPN15	Adenocarcinoma
RAB11FIP3::MCRIP2	Adenocarcinoma
RAB11FIP3::NAA60	Adenocarcinoma
RAB11FIP3::PLEC	Adenocarcinoma
RAB11FIP3::RGS11	Squamous cell carcinoma
RAB11FIP3::SLMAP	Adenocarcinoma
RAB11FIP4::ARHGAP23	Adenocarcinoma
RAB11FIP4::ASIC2	Transitional cell carcinoma
RAB11FIP4::NF1	Adenocarcinoma
RAB11FIP4::NPLOC4	Adenocarcinoma
RAB11FIP4::RAD51C	Adenocarcinoma
RAB11FIP5::UBE2E3	Adenocarcinoma
RAB12::MYO5B	Adenocarcinoma
RAB12::PPP4R1	Adenocarcinoma
RAB12::TAFA2	Adenocarcinoma
RAB12::TWSG1	Malignant melanoma
RAB14::C5	Squamous cell carcinoma
RAB14::STOM	Adenocarcinoma
RAB17::HDAC4	Adenocarcinoma
RAB18::KIAA1549L	Malignant melanoma
RAB18::ZBTB20	Squamous cell carcinoma
RAB18::ZNF669	Adenocarcinoma
RAB1A::C7ORF50	Adenocarcinoma
RAB1A::C7orf50	Adenocarcinoma
RAB1A::PHTF2	Adenocarcinoma
RAB1A::SPRED2	Adenocarcinoma
RAB1A::USP6	Fibroma of tendon sheath
RAB1A::XPO1	Diffuse large B-cell lymphoma
RAB1B::ARFGEF2	Adenocarcinoma
RAB1B::MTMR2	Adenocarcinoma
RAB1B::XBP1	Adenocarcinoma
RAB20::MYO16	Adenocarcinoma
RAB21::DNM3	Mesenchymal tumor, NOS
RAB21::FRS2	Adenocarcinoma
RAB21::KSR1	Adenocarcinoma
RAB21::MDM1	Adenocarcinoma
RAB21::MGAT4C	Mesenchymal tumor, NOS
RAB21::MYBPC1	Mesenchymal tumor, NOS
RAB21::SLC4A8	Mesenchymal tumor, NOS
RAB21::TBC1D15	Diffuse large B-cell lymphoma
RAB22A::L3MBTL1	Malignant melanoma
RAB22A::MYO9B	Adenocarcinoma
RAB22A::NEUROD2	Adenocarcinoma
RAB22A::NLRP5	Adenocarcinoma
RAB22A::VAPB	Adenocarcinoma
RAB25::ASH1L	Adenocarcinoma
RAB25::PMF1	Squamous cell carcinoma
RAB26::E4F1	Adenocarcinoma
RAB27A::ASTN2	Astrocytoma, grade III-IV/Glioblastoma
RAB27A::DNAAF4	Transitional cell carcinoma
RAB27A::NEDD4	Adenocarcinoma
RAB27A::SQOR	Adenocarcinoma
RAB27B::PXDC1	Adenocarcinoma
RAB27B::WDR7	Transitional cell carcinoma
RAB28::MGME1	Adenocarcinoma
RAB28::STAP1	Squamous cell carcinoma
RAB29::IGH	Mature B-cell neoplasm, NOS
RAB2A::BCS1L	Soft tissue tumor, NOS
RAB2A::CHD7	Adenocarcinoma
RAB2A::CLVS1	Skin | Acute myeloid leukemia, NOS
RAB2A::PLAG1	Leiomyoma | Lipoblastoma
RAB2A::PLEKHA6	Squamous cell carcinoma
RAB2A::STMN2	Adenocarcinoma
RAB2A::TRAPPC9	Adenocarcinoma
RAB2B::AZIN1	Adenocarcinoma
RAB30::AQP11	Squamous cell carcinoma
RAB30::CCDC90B	Squamous cell carcinoma
RAB30::CPT1A	Astrocytoma, grade I-II
RAB30::DLG2	Malignant melanoma
RAB30::DPP3	Transitional cell carcinoma
RAB31::PIEZO2	Adenocarcinoma
RAB32::ADGB	Malignant melanoma
RAB33B::NAA15	Malignant epithelial tumor, special type
RAB33B::SEC24D	Adenocarcinoma
RAB34::NUFIP2	Adenocarcinoma
RAB35::GCN1	Transitional cell carcinoma
RAB38::CA10	Adenocarcinoma
RAB39A::TECTA	Adenocarcinoma
RAB3A::RAD23A	Adenocarcinoma
RAB3B::MYSM1	Mesenchymal tumor, NOS
RAB3B::NRDC	Adenocarcinoma
RAB3B::PKN2	Mesenchymal tumor, NOS
RAB3D::DMBT1	Squamous cell carcinoma
RAB3D::MLLT1	Adenocarcinoma
RAB3D::SMARCA4	Adenocarcinoma
RAB3D::SPC24	Adenocarcinoma
RAB3D::TMEM205	Adenocarcinoma
RAB3GAP1::ACMSD	Adenocarcinoma
RAB3GAP1::ARHGAP15	Adenocarcinoma
RAB3GAP1::CCNT2	Squamous cell carcinoma
RAB3GAP1::LRP1B	Adenocarcinoma
RAB3GAP1::MAP4K3	Adenocarcinoma
RAB3GAP1::MARCHF7	Malignant epithelial tumor, special type
RAB3GAP2::BPNT1	Adenocarcinoma | Transitional cell carcinoma
RAB3GAP2::CNIH4	Adenocarcinoma
RAB3GAP2::DLGAP1	Adenocarcinoma
RAB3GAP2::NEK7	Squamous cell carcinoma
RAB3IL1::AHNAK	Adenocarcinoma
RAB3IL1::NRG1	Adenocarcinoma
RAB3IP::AVIL	Mesenchymal tumor, NOS
RAB3IP::BEST3	Adenocarcinoma
RAB3IP::CCDC92	Mesenchymal tumor, NOS
RAB3IP::CD63	Transitional cell carcinoma
RAB3IP::ERBB3	Astrocytoma, grade III-IV/Glioblastoma
RAB3IP::FRS2	Adenocarcinoma
RAB3IP::GYS2	Astrocytoma, grade I-II
RAB3IP::HMGA2	Rhabdomyosarcoma, NOS
RAB3IP::IGFBP5	Adenocarcinoma
RAB3IP::KCNC2	Mesenchymal tumor, NOS
RAB3IP::MSRB3	Adenocarcinoma
RAB3IP::MYL4	Adenocarcinoma
RAB3IP::NUCB2	Mesenchymal tumor, NOS
RAB3IP::NUP107	Transitional cell carcinoma
RAB3IP::OS9	Transitional cell carcinoma
RAB3IP::PDGFRA	Malignant soft tissue tumor, NOS
RAB40B::TAF15	Adenocarcinoma
RAB40B::YBX2	Adenocarcinoma
RAB40C::CPB1	Adenocarcinoma
RAB40C::HBM	Malignant epithelial tumor, special type
RAB40C::HBZ	Malignant epithelial tumor, special type
RAB40C::IRF3	Malignant melanoma
RAB40C::MYH11	Squamous cell carcinoma
RAB40C::PRR35	Astrocytoma, grade III-IV/Glioblastoma | Adenocarcinoma
RAB40C::PTRH1	Astrocytoma, grade I-II
RAB40C::RAB11FIP3	Adenocarcinoma
RAB40C::RAD51B	Adenocarcinoma
RAB4A::CNIH3	Adenocarcinoma
RAB4A::SNRPB	Transitional cell carcinoma
RAB4A::WDR47	Adenocarcinoma
RAB4B::COQ8B	Squamous cell carcinoma
RAB4B::EXOC4	Astrocytoma, grade III-IV/Glioblastoma
RAB4B::FBXL12	Adenocarcinoma
RAB5A::PLCL2	Mesenchymal tumor, NOS
RAB5B::ALK	Malignant melanoma
RAB5B::DGKA	Malignant epithelial tumor, special type
RAB5C::RETREG3	Adenocarcinoma
RAB5IF::LIFR	Mesothelioma
RAB6A::B4GALNT3	Astrocytoma, grade I-II
RAB6A::GDPD5	Adenocarcinoma
RAB6A::H2AC6	Adenocarcinoma
RAB6A::MICA	Mesenchymal tumor, NOS
RAB6A::MRPL48	Adenocarcinoma
RAB6A::NCAM1	Ependymoma
RAB6A::RP1	Malignant melanoma
RAB6A::SHANK2	Adenocarcinoma
RAB6A::TPCN2	Adenocarcinoma
RAB6A::TUT1	Adenocarcinoma
RAB6A::USP43	Adenocarcinoma
RAB6B::VEPH1	Squamous cell carcinoma
RAB7A::ANXA1	Squamous cell carcinoma
RAB7A::CHCHD6	Adenocarcinoma
RAB7A::CLCN3	Adenocarcinoma
RAB7A::EEFSEC	Adenocarcinoma
RAB7A::KBTBD12	Transitional cell carcinoma
RAB7A::LRCH3	Adenocarcinoma
RAB7A::PARP15	Adenocarcinoma
RAB7A::RABEP1	Astrocytoma, grade I-II
RAB7A::TRMT1	Malignant epithelial tumor, special type
RAB7A::WDR5	Adenocarcinoma
RAB8A::EIF4G2	Adenocarcinoma
RAB8A::PLVAP	Adenocarcinoma
RAB8A::TPM4	Adenocarcinoma
RAB8B::ANKDD1A	Malignant epithelial tumor, special type
RAB8B::TLN2	Adenocarcinoma
RAB9A::EGFL6	Adenocarcinoma | Squamous cell carcinoma
RAB9A::EXOC2	Astrocytoma, grade III-IV/Glioblastoma
RAB9A::TRAPPC2	Squamous cell carcinoma
RABEP1::ASPA	Adenocarcinoma
RABEP1::MINK1	Adenocarcinoma
RABEP1::NUP88	Adenocarcinoma
RABEP1::PDGFRB	Chronic myelomonocytic leukemia | Spleen
RABEP1::PIGL	Squamous cell carcinoma
RABEP1::RNF167	Squamous cell carcinoma
RABEP1::RORB	Adenocarcinoma
RABEP1::RPAIN	Squamous cell carcinoma
RABEP1::ZFP3	Adenocarcinoma
RABEP1::ZMYND15	Adenocarcinoma
RABEP2::BRAF	Adenocarcinoma
RABEP2::SRCAP	Adenocarcinoma
RABEPK::PIK3R1	Squamous cell carcinoma
RABGAP1::CAPZB	Astrocytoma, grade III-IV/Glioblastoma
RABGAP1::HCN1	Malignant melanoma
RABGAP1::NIPSNAP3B	Adenocarcinoma
RABGAP1::PBX3	Malignant melanoma
RABGAP1::PNPLA7	Adenocarcinoma
RABGAP1::RC3H2	Squamous cell carcinoma
RABGAP1::TTLL11	Squamous cell carcinoma
RABGAP1L::ACBD6	Adenocarcinoma
RABGAP1L::DARS2	Malignant melanoma
RABGAP1L::DGKB	Astrocytoma, grade I-II
RABGAP1L::KLHL20	Adenocarcinoma
RABGAP1L::KMT2A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RABGAP1L::LGR6	Adenocarcinoma
RABGAP1L::MGST3	Adenocarcinoma
RABGAP1L::NTRK1	Adenocarcinoma
RABGAP1L::RBKS	Endometrial stromal sarcoma
RABGAP1L::TUBB1	Diffuse large B-cell lymphoma
RABGAP1L::ZBTB37	Diffuse large B-cell lymphoma
RABGGTA::DHRS1	Schwannoma
RABGGTB::FOXJ3	Squamous cell carcinoma
RABL2A::IL1RN	Adenocarcinoma
RABL2A::IL36G	Adenocarcinoma
RABL6::DIPK1B	Adenocarcinoma
RABL6::EDEM2	Adenocarcinoma
RABL6::TMEM141	Adenocarcinoma
RAC1::COL12A1	Acute myeloblastic leukemia with maturation (FAB type M2)
RAC2::TP73	Skin | Acute myeloid leukemia, NOS
RAC3::ABCA8	Adenocarcinoma
RACGAP1::CERS5	Squamous cell carcinoma
RACGAP1::FAIM2	Adenocarcinoma
RACGAP1::LIMA1	Adenocarcinoma
RACGAP1::PYM1	Adenocarcinoma
RACK1::APOB	Adenocarcinoma
RACK1::CDYL2	Multiple myeloma
RACK1::DDX21	Adenocarcinoma
RACK1::DECR1	Astrocytoma, grade I-II
RACK1::HLTF	Malignant melanoma
RAD17::CNTN5	Astrocytoma, grade I-II
RAD17::SEC24A	Adenocarcinoma
RAD18::BRAF	Malignant melanoma
RAD18::CD86	Adenocarcinoma
RAD18::HNRNPF	Adenocarcinoma
RAD1::RET	Carcinoma, NOS
RAD1::SPEF2	Malignant melanoma
RAD23A::RNASEH2A	Adenocarcinoma
RAD50::CADPS	Astrocytoma, grade I-II
RAD50::PDLIM4	Adenocarcinoma
RAD50::SLC22A4	Adenocarcinoma
RAD50::TCOF1	Adenocarcinoma
RAD51AP1::ATN1	Squamous cell carcinoma
RAD51AP1::DYRK4	Adenocarcinoma
RAD51AP1::SLCO1C1	Squamous cell carcinoma
RAD51AP1::ST8SIA1	Astrocytoma, grade I-II
RAD51B::BAZ1A	Adenocarcinoma
RAD51B::DACT1	Squamous cell carcinoma
RAD51B::DCAF5	Adenocarcinoma
RAD51B::GPHN	Squamous cell carcinoma | Adenocarcinoma
RAD51B::IFT43	Malignant melanoma
RAD51B::KMT2A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RAD51B::LMX1B	Adenocarcinoma
RAD51B::MARK3	Squamous cell carcinoma
RAD51B::NUDT3	Leiomyoma
RAD51B::OPHN1	PEComa
RAD51B::PEX7	Adenocarcinoma
RAD51B::PLAG1	Leiomyosarcoma | Lipoblastoma
RAD51B::RRAGB	PEComa
RAD51B::SIPA1L1	Transitional cell carcinoma
RAD51B::SIVA1	Adenocarcinoma
RAD51B::SMOC1	Transitional cell carcinoma
RAD51B::TMPRSS4	Adenocarcinoma
RAD51B::UVRAG	Adenocarcinoma
RAD51C::ATXN7	Adenocarcinoma
RAD51C::BCAS3	Adenocarcinoma
RAD51D::MAP2K4	Mesothelioma
RAD51D::SLCO6A1	Squamous cell carcinoma
RAD52::KDM5A	Adenocarcinoma
RAD52::RASSF8	Adenocarcinoma
RAD52::RIMKLB	Adenocarcinoma
RAD54B::MATN2	Adenocarcinoma
RAD54L2::DCAF1	Adenocarcinoma
RAD54L2::ERC2	Adenocarcinoma
RAD54L2::SLC25A26	Adenocarcinoma
RAD54L::MAST2	Adenocarcinoma
RAD9A::AHNAK	Transitional cell carcinoma
RAD9A::CLPB	Malignant melanoma
RAD9A::IKZF3	Adenocarcinoma
RAD9A::KDM2A	Malignant epithelial tumor, special type | Adenocarcinoma
RAD9A::MUS81	Adenocarcinoma
RAD9A::RBM14	Adenocarcinoma
RAD9A::SSH3	Adenocarcinoma
RAE1::ADNP	Malignant melanoma
RAE1::CIMIP1	Adenocarcinoma
RAF1::AGGF1	Malignant melanoma | Adenocarcinoma
RAF1::C9ORF153	Adenocarcinoma
RAF1::C9orf153	Adenocarcinoma
RAF1::CDH3	Malignant melanoma
RAF1::DAZL	Adenocarcinoma
RAF1::DCAF1	Carcinoma, NOS
RAF1::EIF3L	Diffuse large B-cell lymphoma
RAF1::GOLGA4	Malignant melanoma | Benign nevus
RAF1::GXYLT2	Adenocarcinoma
RAF1::IQSEC1	Transitional cell carcinoma
RAF1::LSAMP	Carcinoma, NOS
RAF1::NXPH1	Transitional cell carcinoma
RAF1::PHC3	Adenocarcinoma
RAF1::RPL32	Squamous cell carcinoma
RAF1::SHE	Malignant melanoma
RAF1::SLC25A20	Malignant melanoma
RAF1::SSUH2	Adenocarcinoma
RAF1::TBL1XR1	Neuroglial neoplasm, special type
RAF1::TDRD10	Malignant melanoma
RAF1::TMEM40	Carcinoma, NOS | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Adenocarcinoma
RAF1::TRAK1	Malignant melanoma
RAF1::XPC	Adenocarcinoma
RAG1::HAND1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RAI14::ASB4	Adenocarcinoma
RAI14::C5orf34	Malignant melanoma
RAI14::CLPTM1L	Adenocarcinoma
RAI14::CYB5R3	Malignant melanoma
RAI14::MAPK9	Malignant melanoma
RAI14::RET	Carcinoma, NOS
RAI14::SCP2	Adenocarcinoma
RAI14::TTC23L	Adenocarcinoma
RAI1::ATP5MC1	Miscellaneous hematopoietic/lymphoid neoplasm, special type | Benign epithelial tumor, special type
RAI1::IFT20	Squamous cell carcinoma
RAI1::IGF2BP1	Adenocarcinoma
RAI1::LRRC4C	Squamous cell carcinoma
RAI1::MAN1A2	Adenocarcinoma
RAI1::MED9	Adenocarcinoma
RAI1::MRGPRF	Adenocarcinoma
RAI1::MTUS2	Adenocarcinoma
RAI1::MXRA7	Astrocytoma, grade III-IV/Glioblastoma
RAI1::NKX2-2	Adenocarcinoma
RAI1::NOS2	Malignant melanoma
RAI1::PEMT	Squamous cell carcinoma
RAI1::PEX1	Adenocarcinoma
RAI1::SIMC1	Malignant melanoma
RAI1::SPNS2	Adenocarcinoma
RAI2::PPP2R1B	Adenocarcinoma
RALA::CAMK2B	Transitional cell carcinoma
RALA::SUGCT	Squamous cell carcinoma
RALA::YAE1	Malignant epithelial tumor, special type
RALB::URM1	Adenocarcinoma
RALBP1::RAB31	Adenocarcinoma
RALBP1::TWSG1	Adenocarcinoma
RALGAPA1::FOXA1	Adenocarcinoma
RALGAPA1::SLC25A21	Adenocarcinoma
RALGAPA2::ACSM1	Adenocarcinoma
RALGAPA2::BSCL2	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
RALGAPA2::BTBD3	Adenocarcinoma
RALGAPA2::DNAAF9	Transitional cell carcinoma
RALGAPA2::NINL	Adenocarcinoma
RALGAPA2::PCK1	Adenocarcinoma
RALGAPA2::RSRP1	Adenocarcinoma
RALGAPA2::ZNFX1	Adenocarcinoma
RALGAPB::CBFA2T2	Squamous cell carcinoma
RALGAPB::CNBD2	Adenocarcinoma
RALGAPB::CTCFL	Squamous cell carcinoma
RALGAPB::CTNNBL1	Adenocarcinoma
RALGAPB::DSN1	Malignant melanoma
RALGAPB::EPB41L1	Adenocarcinoma
RALGAPB::ITCH	Adenocarcinoma
RALGAPB::KCNB1	Adenocarcinoma
RALGAPB::LBP	Adenocarcinoma
RALGAPB::RPRD1B	Adenocarcinoma
RALGAPB::TMC2	Adenocarcinoma
RALGDS::BRD3	Multiple myeloma
RALGPS1::EXOC6B	Adenocarcinoma
RALGPS1::GAPVD1	Adenocarcinoma
RALGPS1::LMX1B	Squamous cell carcinoma
RALGPS1::MVB12B	Adenocarcinoma
RALGPS1::NUP210L	Mesenchymal tumor, NOS
RALGPS1::TYRP1	Adenocarcinoma
RALGPS1::ZNF79	Adenocarcinoma
RALGPS2::LAMB3	Adenocarcinoma
RALGPS2::NTRK3	Osteosarcoma, NOS
RALGPS2::QSOX1	Adenocarcinoma
RALGPS2::RASAL2	Squamous cell carcinoma | Adenocarcinoma
RALY::ASXL1	Squamous cell carcinoma
RALY::ATRN	Mesenchymal tumor, NOS
RALY::CDK5RAP1	Adenocarcinoma
RALY::CHMP4B	Adenocarcinoma
RALY::DEFB123	Adenocarcinoma
RALY::EDEM2	Adenocarcinoma
RALY::MAP1LC3A	Adenocarcinoma
RALY::PAK5	Malignant melanoma
RALY::PXMP4	Squamous cell carcinoma
RALY::RPN2	Squamous cell carcinoma
RALY::SLC24A3	Adenocarcinoma | Squamous cell carcinoma
RALY::TBKBP1	Adenocarcinoma
RALY::TMEM248	Adenocarcinoma
RALY::TTI1	Transitional cell carcinoma
RALY::WDR53	Adenocarcinoma
RAMAC::IGF1R	Malignant melanoma
RAMP1::MLPH	Adenocarcinoma
RAMP1::PPP1R7	Miscellaneous hematopoietic/lymphoid neoplasm, special type
RAMP1::RBM44	Adenocarcinoma
RANBP10::LCAT	Adenocarcinoma
RANBP10::RRP15	Adenocarcinoma
RANBP10::SLC12A4	Adenocarcinoma
RANBP10::SLC7A6	Adenocarcinoma
RANBP10::ZFHX3	Adenocarcinoma
RANBP17::GABRP	Adenocarcinoma
RANBP17::SPDL1	Adenocarcinoma
RANBP17::TLX3	Transitional cell carcinoma
RANBP2::ABL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RANBP2::ALK	Chronic myelomonocytic leukemia | Spleen | Acute myelomonocytic leukemia (FAB type M4) | Myelodysplastic syndrome, NOS | Acute myeloblastic leukemia with maturation (FAB type M2) | Anaplastic large cell lymphoma, systemic type | Skin | Inflammatory myofibroblastic tumor/myofibroblastic sarcoma | Acute myeloid leukemia, NOS | Diffuse large B-cell lymphoma | Juvenile myelomonocytic leukemia
RANBP2::BMP5	Adenocarcinoma
RANBP2::SULT1C3	Adenocarcinoma
RANBP3::ALDH16A1	Astrocytoma, grade I-II
RANBP3::ANKRD24	Transitional cell carcinoma
RANBP3::EEF1AKMT1	Adenocarcinoma
RANBP3::KLK2	Adenocarcinoma
RANBP3::MLLT1	Adenocarcinoma
RANBP3::PIP5K1C	Adenocarcinoma
RANBP3::PRM1	Astrocytoma, grade III-IV/Glioblastoma
RANBP3::RFX2	Adenocarcinoma
RANBP9::ATXN1	Astrocytoma, grade I-II
RANBP9::BLOC1S5	Astrocytoma, grade I-II
RANBP9::CDKAL1	Adenocarcinoma
RANBP9::NEDD9	Squamous cell carcinoma
RANBP9::PHACTR1	Squamous cell carcinoma
RANBP9::PROCR	Adenocarcinoma
RANBP9::TPMT	Adenocarcinoma
RANBP9::TXNDC5	Astrocytoma, grade I-II
RANGAP1::ARHGAP8	Malignant melanoma
RANGAP1::CERK	Malignant melanoma
RANGAP1::DESI1	Adenocarcinoma
RANGAP1::FAM53A	Malignant melanoma
RANGAP1::FNTA	Squamous cell carcinoma
RANGAP1::HECTD4	Adenocarcinoma
RANGAP1::PBX2	Malignant melanoma
RANGAP1::PMM1	Adenocarcinoma
RANGAP1::POLR3H	Adenocarcinoma
RANGAP1::SNU13	Transitional cell carcinoma
RANGRF::LRP5	Adenocarcinoma
RAP1A::ABCD3	Adenocarcinoma
RAP1A::AK6	Adenocarcinoma
RAP1A::C1ORF162	Adenocarcinoma
RAP1A::C1orf162	Adenocarcinoma
RAP1A::CD2	Squamous cell carcinoma
RAP1A::TAF9	Adenocarcinoma
RAP1B::CPM	Astrocytoma, grade III-IV/Glioblastoma
RAP1B::CSAD	Adenocarcinoma
RAP1B::CTDSP2	Astrocytoma, grade III-IV/Glioblastoma
RAP1B::DPT	Mesenchymal tumor, NOS
RAP1B::GLIPR1L1	Adenocarcinoma
RAP1B::MRPL14	Astrocytoma, grade III-IV/Glioblastoma
RAP1B::NUP107	Transitional cell carcinoma
RAP1B::SCYL2	Mesenchymal tumor, NOS
RAP1B::SNUPN	Malignant melanoma
RAP1GAP2::CCDC144A	Acute myeloid leukemia, NOS | Skin
RAP1GAP2::SGSM2	Adenocarcinoma
RAP1GAP2::TEKT1	Adenocarcinoma
RAP1GAP2::XAF1	Acute myeloid leukemia, NOS | Skin
RAP1GAP::CELA3B	Adenocarcinoma
RAP1GAP::GOLGB1	Adenocarcinoma
RAP1GAP::NIT2	Adenocarcinoma
RAP1GAP::NSDHL	Astrocytoma, grade I-II
RAP1GAP::USP48	Adenocarcinoma
RAP1GDS1::ASTN2	Adenocarcinoma
RAP1GDS1::CDK12	Adenocarcinoma
RAP1GDS1::GSTCD	Squamous cell carcinoma
RAP1GDS1::H2AZ1	Adenocarcinoma
RAP1GDS1::SCD5	Adenocarcinoma
RAP2B::ANAPC16	Squamous cell carcinoma
RAP2B::ASCC1	Squamous cell carcinoma
RAPGEF1::CPNE5	Adenocarcinoma
RAPGEF1::MCU	Squamous cell carcinoma
RAPGEF1::MED27	Adenocarcinoma | Malignant epithelial tumor, special type | Astrocytoma, grade I-II
RAPGEF1::REXO4	Mesenchymal tumor, NOS
RAPGEF1::SEC16A	Astrocytoma, grade I-II
RAPGEF1::TTF1	Adenocarcinoma
RAPGEF1::WDR83	Adenocarcinoma
RAPGEF1::ZMYND19	Malignant melanoma
RAPGEF2::DDX60L	Adenocarcinoma
RAPGEF2::OCIAD2	Transitional cell carcinoma
RAPGEF2::PRDM5	Malignant melanoma
RAPGEF2::RAB3IP	Adenocarcinoma
RAPGEF2::SPMIP2	Adenocarcinoma
RAPGEF5::BAALC	Mesenchymal tumor, NOS
RAPGEF5::CFDP1	Adenocarcinoma
RAPGEF5::CRPPA	Malignant melanoma
RAPGEF5::MRPS22	Squamous cell carcinoma
RAPGEF5::MYMK	Adenocarcinoma
RAPGEF5::NPY	Adenocarcinoma
RAPGEF5::PLPP4	Adenocarcinoma
RAPGEF5::STEAP1B	Adenocarcinoma
RAPGEF6::POU4F3	Adenocarcinoma
RAPGEF6::SUSD4	Adenocarcinoma
RAPGEFL1::CDK12	Transitional cell carcinoma
RAPGEFL1::GSDMA	Adenocarcinoma
RAPGEFL1::IKZF3	Adenocarcinoma
RAPGEFL1::MAPT	Adenocarcinoma
RAPGEFL1::NFE2L1	Adenocarcinoma
RARA::ANKRD34C	Acute promyelocytic leukemia (FAB type M3)
RARA::CA10	Adenocarcinoma
RARA::CCDC33	Acute promyelocytic leukemia (FAB type M3)
RARA::CDC6	Adenocarcinoma
RARA::CDK12	Adenocarcinoma
RARA::CERS4	Adenocarcinoma
RARA::COL10A1	Adenocarcinoma
RARA::HOXB3	Adenocarcinoma
RARA::IGFBP4	Adenocarcinoma
RARA::LGALS16	Adenocarcinoma
RARA::LTBP1	Adenocarcinoma
RARA::LYRM9	Adenocarcinoma
RARA::MSL1	Adenocarcinoma
RARA::MYO1D	Adenocarcinoma
RARA::NARS2	Adenocarcinoma
RARA::NHERF1	Malignant epithelial tumor, special type
RARA::NPEPPS	Malignant epithelial tumor, special type
RARA::PCTP	Adenocarcinoma
RARA::PGAP3	Adenocarcinoma
RARA::PKIA	Adenocarcinoma
RARA::PLEKHA6	Adenocarcinoma
RARA::PML	Acute myeloid leukemia, NOS | Skin
RARA::POLDIP2	Adenocarcinoma
RARA::PRR11	Adenocarcinoma
RARA::PSMD3	Adenocarcinoma
RARA::PSME3	Adenocarcinoma
RARA::SKAP1	Adenocarcinoma
RARA::SNX15	Acute promyelocytic leukemia (FAB type M3)
RARA::STAC2	Adenocarcinoma
RARA::STAT3	Adenocarcinoma
RARA::STAT5B	Acute promyelocytic leukemia (FAB type M3)
RARA::TSPYL4	Adenocarcinoma
RARA::WIPF2	Adenocarcinoma
RARA::ZNF595	Adenocarcinoma
RARB::OSBPL10	Malignant melanoma
RARB::PRDM8	Mesenchymal tumor, NOS
RARB::TAFA4	Adenocarcinoma
RARG::BCAS1	Transitional cell carcinoma
RARG::CPSF6	Acute promyelocytic leukemia (FAB type M3)
RARG::HNRNPC	Acute promyelocytic leukemia (FAB type M3)
RARG::HNRNPM	Acute promyelocytic leukemia (FAB type M3)
RARRES1::RSRC1	Transitional cell carcinoma
RARS1::MAD1L1	Adenocarcinoma
RARS1::NBPF19	Adenocarcinoma
RARS2::IP6K3	Adenocarcinoma
RARS2::SMAP1	Adenocarcinoma
RASA1::CDH12	Adenocarcinoma
RASA1::FAM174A	Adenocarcinoma
RASA1::FNIP1	Adenocarcinoma
RASA1::RAPGEF6	Adenocarcinoma
RASA1::RGS18	Squamous cell carcinoma
RASA1::VDAC1	Adenocarcinoma
RASA1::XRCC4	Mesenchymal tumor, NOS
RASA2::ACP3	Adenocarcinoma
RASA2::KALRN	Squamous cell carcinoma
RASA2::NELFB	Adenocarcinoma
RASA2::NICN1	Undifferentiated carcinoma, small cell
RASA2::PXYLP1	Squamous cell carcinoma | Adenocarcinoma
RASA2::SPSB4	Squamous cell carcinoma
RASA2::SUCNR1	Adenocarcinoma
RASA2::ZBTB38	Adenocarcinoma
RASA3::KCNG2	Astrocytoma, grade I-II
RASA3::SCARA3	Adenocarcinoma
RASA4::DRICH1	Malignant epithelial tumor, special type
RASAL1::DDX54	Squamous cell carcinoma | Adenocarcinoma
RASAL2::ANKRD45	Transitional cell carcinoma
RASAL2::COPA	Adenocarcinoma
RASAL2::GALNTL6	Adenocarcinoma
RASAL2::KIF14	Malignant melanoma
RASAL2::LIMK2	Squamous cell carcinoma
RASAL2::NUF2	Adenocarcinoma
RASAL2::RABGAP1L	Adenocarcinoma
RASAL2::RET	Adenocarcinoma | Undifferentiated sarcoma
RASAL2::RHBDF1	Mesenchymal tumor, NOS
RASAL2::RPS14	Multiple myeloma
RASAL2::SOAT1	Squamous cell carcinoma
RASAL2::ZNF695	Adenocarcinoma
RASD1::VPS4A	Adenocarcinoma
RASEF::OSTF1	Adenocarcinoma
RASGEF1A::RET	Carcinoma, NOS
RASGRF1::HOMER2	Adenocarcinoma
RASGRP1::CD47	Adenocarcinoma
RASGRP1::LRRC4C	Adenocarcinoma
RASGRP1::NFIC	Malignant melanoma
RASGRP1::TBC1D3G	Adenocarcinoma
RASL10B::USP22	Adenocarcinoma
RASL11A::DHRS12	Transitional cell carcinoma
RASSF1::PDZRN3	PEComa
RASSF3::CCDC120	Adenocarcinoma
RASSF3::DAZAP2	Adenocarcinoma
RASSF3::GLTP	Adenocarcinoma
RASSF3::GYS2	Adenocarcinoma
RASSF3::ITGA7	Malignant melanoma
RASSF3::PPP3CA	Adenocarcinoma
RASSF3::SNX10	Astrocytoma, grade I-II
RASSF3::STK10	Mesenchymal tumor, NOS
RASSF3::TBK1	Malignant melanoma | Adenocarcinoma
RASSF3::TSPAN8	Adenocarcinoma
RASSF3::TTYH2	Adenocarcinoma
RASSF3::XPOT	Adenocarcinoma
RASSF4::TMEM72	Adenocarcinoma
RASSF5::IKBKE	Squamous cell carcinoma
RASSF6::LEMD3	Adenocarcinoma
RASSF7::DEAF1	Squamous cell carcinoma
RASSF7::EPS8L2	Transitional cell carcinoma
RASSF8::BMAL2	Squamous cell carcinoma
RASSF8::CMAS	Transitional cell carcinoma
RASSF8::ETNK1	Squamous cell carcinoma
RASSF8::IRAG2	Adenocarcinoma
RASSF8::RAD52	Adenocarcinoma
RASSF8::RERGL	Adenocarcinoma
RASSF8::SLC47A2	Adenocarcinoma
RASSF8::ST8SIA1	Malignant epithelial tumor, special type
RAVER1::BTBD2	Diffuse large B-cell lymphoma
RAVER1::DOCK6	Astrocytoma, grade III-IV/Glioblastoma
RAVER1::ICAM3	Squamous cell carcinoma
RAVER1::TMEM259	Adenocarcinoma
RAVER1::TYK2	Adenocarcinoma
RB1::AGMO	Acute megakaryoblastic leukemia (FAB type M7)
RB1::CDADC1	Transitional cell carcinoma
RB1::CLEC2B	Mesenchymal tumor, NOS
RB1::CNIH3	Squamous cell carcinoma
RB1::CUEDC1	Skin | Acute myeloid leukemia, NOS
RB1::DIAPH3	Mesenchymal tumor, NOS
RB1::ELMOD3	Adenocarcinoma
RB1::ESR2	Mesenchymal tumor, NOS
RB1::FNDC3A	Acute megakaryoblastic leukemia (FAB type M7)
RB1::FRYL	Mesenchymal tumor, NOS
RB1::GADD45GIP1	Squamous cell carcinoma
RB1::HTR2C	Squamous cell carcinoma
RB1::ITM2B	Malignant melanoma
RB1::KCNRG	Adenocarcinoma
RB1::MED4	Malignant melanoma
RB1::RARB	Adenocarcinoma
RB1::RNASEH2B	Undifferentiated pleomorphic sarcoma
RB1::RUBCNL	Mesenchymal tumor, NOS
RB1::STIM1	Osteosarcoma, NOS
RB1::TRIM13	Adenocarcinoma
RB1::WDFY2	Transitional cell carcinoma | Acute lymphoblastic leukemia/lymphoblastic lymphoma
RB1::XKR5	Adenocarcinoma
RB1CC1::CHRNB3	Adenocarcinoma
RB1CC1::MMP16	Adenocarcinoma
RB1CC1::PTPN3	Adenocarcinoma
RB1CC1::SNX16	Malignant melanoma
RB1CC1::ST18	Adenocarcinoma
RBBP4::HIVEP3	Adenocarcinoma
RBBP4::ZMYM4	Adenocarcinoma
RBBP5::DSTYK	Adenocarcinoma
RBBP7::NDUFAF4	Mesenchymal tumor, NOS
RBBP7::TTC24	Mesenchymal tumor, NOS
RBBP8::ALK	Adenocarcinoma
RBBP8::ANXA4	Squamous cell carcinoma
RBBP8::HYCC1	Astrocytoma, grade I-II
RBBP8::TAF4B	Squamous cell carcinoma
RBBP8::TP53	Transitional cell carcinoma
RBCK1::ANO9	Adenocarcinoma
RBCK1::CLCN7	Adenocarcinoma
RBCK1::MACROD2	Adenocarcinoma
RBCK1::MYO18A	Adenocarcinoma
RBCK1::TRIB3	Acute promyelocytic leukemia (FAB type M3) | Adenocarcinoma
RBFA::TXNL4A	Adenocarcinoma
RBFA::XRCC5	Astrocytoma, grade I-II
RBFOX2::CACNG2	Adenocarcinoma
RBFOX2::CIMIP4	Adenocarcinoma
RBFOX2::CORO1C	Mesenchymal tumor, NOS
RBFOX2::EEF2KMT	Adenocarcinoma
RBFOX2::LGALS2	Astrocytoma, grade III-IV/Glioblastoma
RBFOX2::MB	Malignant epithelial tumor, special type
RBFOX2::MED15	Malignant melanoma
RBFOX2::MPPED1	Astrocytoma, grade I-II
RBFOX2::MRTFA	Malignant melanoma
RBFOX2::MYH9	Malignant epithelial tumor, special type | Adenocarcinoma
RBFOX2::NTSR1	Adenocarcinoma
RBFOX2::RAC2	Adenocarcinoma
RBFOX2::SELENOM	Adenocarcinoma
RBFOX2::TMEM184B	Adenocarcinoma
RBFOX2::TMEM241	Mesenchymal tumor, NOS
RBFOX2::TST	Malignant epithelial tumor, special type
RBKS::FAM228B	Malignant melanoma
RBL1::BCAS1	Adenocarcinoma
RBL1::CPNE1	Adenocarcinoma
RBL1::CSTA	Adenocarcinoma
RBL1::CTNNBL1	Adenocarcinoma
RBL1::DLGAP4	Skin | Acute myeloid leukemia, NOS
RBL1::GPCPD1	Transitional cell carcinoma
RBL1::NDRG3	Adenocarcinoma
RBL1::PISD	Squamous cell carcinoma
RBM10::CMAS	Adenocarcinoma
RBM10::ERAS	Squamous cell carcinoma
RBM10::JADE3	Adenocarcinoma
RBM10::SEC16B	Squamous cell carcinoma
RBM10::TFE3	Adenocarcinoma | Vascular and perivascular tumor, special type
RBM10::YAP1	Adenocarcinoma
RBM11::LIPI	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RBM12::GNAS	Adenocarcinoma
RBM12::LPO	Adenocarcinoma
RBM12::MROH8	Adenocarcinoma
RBM12::NFS1	Adenocarcinoma
RBM12::ZNF618	Adenocarcinoma
RBM12B::RSPO2	Squamous cell carcinoma
RBM14::BBS1	Adenocarcinoma
RBM14::CCS	Adenocarcinoma
RBM14::FGF3	Adenocarcinoma
RBM14::KDM2A	Adenocarcinoma
RBM14::MERTK	Adenocarcinoma
RBM15::MRTFA	Acute myeloblastic leukemia without maturation (FAB type M1) | Acute myeloid leukemia, NOS | Skin | Acute megakaryoblastic leukemia (FAB type M7)
RBM15::ZYG11B	Squamous cell carcinoma
RBM17::PRKACB	Squamous cell carcinoma
RBM17::PSAP	Transitional cell carcinoma
RBM17::TWSG1	Adenocarcinoma
RBM18::RAB14	Adenocarcinoma
RBM19::CLK2	Adenocarcinoma
RBM19::PTPRQ	Malignant melanoma
RBM23::SLC7A8	Adenocarcinoma
RBM25::DCAF4	Adenocarcinoma
RBM25::PRKD1	Adenocarcinoma
RBM25::VRTN	Mycosis fungoides/Sézary syndrome | Squamous cell carcinoma
RBM27::LARS1	Diffuse large B-cell lymphoma
RBM27::SLC35E2B	Transitional cell carcinoma
RBM28::AOAH	Adenocarcinoma
RBM28::KMT2C	Adenocarcinoma
RBM33::CDK14	Squamous cell carcinoma
RBM33::PTPRN2	Squamous cell carcinoma
RBM33::TMEM120A	Adenocarcinoma
RBM34::CARD10	Adenocarcinoma
RBM38::CAPN5	Malignant melanoma
RBM38::DNAJC5B	Adenocarcinoma
RBM38::FRMD4B	Squamous cell carcinoma
RBM38::LSM7	Mesenchymal tumor, NOS
RBM38::PMEPA1	Multiple myeloma
RBM38::RAE1	Adenocarcinoma
RBM38::SPO11	Adenocarcinoma
RBM39::C20ORF203	Transitional cell carcinoma
RBM39::CRYZL1	Mesenchymal tumor, NOS
RBM39::EDEM2	Malignant melanoma
RBM39::OCA2	Mesenchymal tumor, NOS
RBM39::PRDM5	Transitional cell carcinoma
RBM39::SMARCB1	Malignant epithelial tumor, special type
RBM39::VAPB	Multiple myeloma
RBM39::VMP1	Adenocarcinoma
RBM39::WFDC13	Adenocarcinoma
RBM45::DGUOK	Adenocarcinoma
RBM47::APBB2	Adenocarcinoma
RBM47::ATP8A1	Adenocarcinoma
RBM47::EXOC1	Adenocarcinoma
RBM47::IDO2	Adenocarcinoma
RBM47::LEF1	Adenocarcinoma
RBM47::NRL	Adenocarcinoma
RBM48::PPP1R3A	Adenocarcinoma
RBM4::ACTN3	Adenocarcinoma
RBM4::MTMR4	Adenocarcinoma
RBM4B::FADD	Mesenchymal tumor, NOS
RBM4B::FCHSD2	Transitional cell carcinoma
RBM4B::PITPNM1	Mesenchymal tumor, NOS
RBM5::CYB561D2	Adenocarcinoma
RBM6::ARIH2	Adenocarcinoma
RBM6::BCL6	Mature B-cell neoplasm, NOS
RBM6::CSF1R	Acute megakaryoblastic leukemia (FAB type M7)
RBM6::DOCK3	Miscellaneous hematopoietic/lymphoid neoplasm, special type
RBM6::IDH2	Squamous cell carcinoma
RBM6::INKA1	Squamous cell carcinoma
RBM6::P4HA2	Adenocarcinoma
RBM6::RNF123	Adenocarcinoma
RBM6::SLC38A3	Adenocarcinoma
RBM6::TTC7A	Mesenchymal tumor, NOS
RBM8A::FCAMR	Adenocarcinoma
RBMS1::CCDC148	Adenocarcinoma
RBMS1::GLI2	Mycosis fungoides/Sézary syndrome
RBMS1::METTL8	Adenocarcinoma
RBMS1::NT5DC4	Mesenchymal tumor, NOS
RBMS1::ORC4	Malignant melanoma
RBMS1::SLC20A1	Mesenchymal tumor, NOS
RBMS1::XIRP2	Adenocarcinoma
RBMS2::ERBB3	Adenocarcinoma
RBMS2::LITAF	Astrocytoma, grade III-IV/Glioblastoma
RBMS2::NACA	Squamous cell carcinoma
RBMS2::TNFAIP3	Adenocarcinoma
RBMS3::BRAF	Adenocarcinoma
RBMS3::NMNAT3	Astrocytoma, grade I-II
RBMS3::PLGRKT	Astrocytoma, grade I-II
RBMS3::RAF1	Soft tissue tumor, special type
RBMX::TFE3	PEComa
RBMXL1::DAP3	Astrocytoma, grade I-II
RBP1::NMNAT3	Squamous cell carcinoma
RBP4::FGB	Adenocarcinoma
RBP4::GPC3	Adenocarcinoma
RBP7::NMNAT1	Adenocarcinoma
RBPJ::C16ORF46	Adenocarcinoma
RBPJ::C16orf46	Adenocarcinoma
RBPJ::SEL1L3	Mesenchymal tumor, NOS
RBPJ::ZCCHC4	Adenocarcinoma
RBPMS::FGFR1	Acute myeloblastic leukemia with maturation (FAB type M2) | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Skin | Acute myeloid leukemia, NOS
RBPMS::MET	Fibrosarcoma | Mesenchymal tumor, NOS | Adenocarcinoma | Fibroblastic/myofibroblastic tumor, special type
RBPMS::NRG1	Adenocarcinoma
RBPMS::NTRK2	Astrocytoma, grade III-IV/Glioblastoma
RBPMS::NTRK3	Fibroblastic/myofibroblastic tumor, special type | Adenocarcinoma
RBPMS::PAK5	Adenocarcinoma
RBPMS::PLAG1	Leiomyoma
RBPMS::PRKD2	Adenocarcinoma
RBPMS::RET	Carcinoma, NOS
RBPMS::RILPL1	Adenocarcinoma
RBPMS::ROS1	Adenocarcinoma
RBX1::EIF4A1	Squamous cell carcinoma
RBX1::ZNF442	Malignant melanoma
RC3H1::AKAP13	Mycosis fungoides/Sézary syndrome
RC3H1::CENPL	Adenocarcinoma
RC3H2::GNA14	Adenocarcinoma
RC3H2::MRRF	Adenocarcinoma
RC3H2::NRF1	Adenocarcinoma
RC3H2::RGS3	Adenocarcinoma
RC3H2::STK35	Adenocarcinoma
RCAN1::CD180	Astrocytoma, grade III-IV/Glioblastoma
RCAN1::GART	Adenocarcinoma
RCAN1::RUNX1	Adenocarcinoma
RCAN1::SPRY1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RCAN2::RAPGEF4	Undifferentiated carcinoma, small cell
RCBTB1::DOCK9	Adenocarcinoma
RCBTB2::B3GALT1	Astrocytoma, grade I-II
RCBTB2::EPSTI1	Squamous cell carcinoma
RCBTB2::RB1	Adenocarcinoma
RCC1::ABHD12B	Germ cell tumor, NOS
RCC1::ADAM23	Squamous cell carcinoma
RCC1::BCL6	Mature B-cell neoplasm, NOS
RCC1::HENMT1	Germ cell tumor, NOS
RCC1::IRF4	Chronic lymphocytic leukemia
RCC1::ITGB3BP	Squamous cell carcinoma
RCC1::LCK	Acute myeloid leukemia, special type
RCC1::PCMT1	Germ cell tumor, NOS
RCC1::PGA3	Adenocarcinoma
RCC1::PHACTR4	Adenocarcinoma
RCC1::PICALM	Chronic myeloid leukemia, t(9;22) | Heart
RCC1::RPL22	Malignant melanoma
RCC1::SERINC2	Squamous cell carcinoma | Adenocarcinoma
RCC1::UBE2D2	Adenocarcinoma
RCC1::USP6	Fibroma of tendon sheath
RCC1::ZNF217	Mature B-cell neoplasm, NOS
RCC1L::DENND1A	Adenocarcinoma
RCC1L::HIP1	Adenocarcinoma
RCC2::PADI4	Adenocarcinoma
RCCD1::BLM	Adenocarcinoma
RCCD1::COL19A1	Adenocarcinoma
RCL1::CDC37L1	Transitional cell carcinoma
RCL1::INSL6	Adenocarcinoma
RCL1::PLGRKT	Squamous cell carcinoma
RCL1::SMCP	Malignant epithelial tumor, special type
RCN3::FLT3LG	Adenocarcinoma
RCOR1::AMN	Adenocarcinoma
RCOR1::EMC3	Germ cell tumor, NOS
RCOR1::GRHL1	Soft tissue tumor, special type
RCOR1::GRHL2	Soft tissue tumor, special type
RCOR1::KIT	Adenocarcinoma
RCOR1::LSAMP	Squamous cell carcinoma
RCOR1::PPP2R5C	Adenocarcinoma
RCOR1::TECPR2	Transitional cell carcinoma
RCOR1::WDR70	Liposarcoma, dedifferentiated
RCOR3::FLVCR1	Acute myeloid leukemia, NOS | Skin
RCOR3::RPS6KC1	Adenocarcinoma
RCSD1::ABL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RCSD1::ABL2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RDH10::NEDD4	Squamous cell carcinoma
RDH13::EXOC3L2	Adenocarcinoma
RDH13::FBXO3	Adenocarcinoma
RDH13::NLRP9	Adenocarcinoma
RDH13::PPP6R1	Adenocarcinoma
RDH13::RUSC1	Adenocarcinoma
RECK::ACER3	Malignant melanoma
RECK::ALX3	Malignant melanoma
RECK::DPP7	Adenocarcinoma
RECK::MYO18B	Astrocytoma, grade III-IV/Glioblastoma
RECK::TMEM8B	Adenocarcinoma
RECQL4::CPSF1	Adenocarcinoma
RECQL5::CACNA1G	Adenocarcinoma
RECQL5::CCDC47	Adenocarcinoma
RECQL5::SEC14L1	Adenocarcinoma
RECQL5::TRIM65	Adenocarcinoma
RECQL5::UNC13D	Adenocarcinoma
RECQL5::WBP2	Adenocarcinoma
RECQL::PEMT	Adenocarcinoma
REEP3::RTKN2	Adenocarcinoma
REEP5::ARHGEF3	Adenocarcinoma
REG1A::PLEKHB2	Adenocarcinoma
REG1B::CPA1	Adenocarcinoma
REG1B::IGF2	Adenocarcinoma
REG3A::ALK	Adenocarcinoma
REG3A::COP1	Adenocarcinoma
REG3A::CTRB2	Adenocarcinoma
REG3A::SERPINA1	Adenocarcinoma
REG3G::CEL	Adenocarcinoma
REG3G::CPA1	Adenocarcinoma
REG3G::PRSS1	Adenocarcinoma
REL::MAN1A2	Squamous cell carcinoma
REL::MVP	Adenocarcinoma
REL::PAPOLG	Multiple myeloma
REL::PUS10	Diffuse large B-cell lymphoma
REL::RAB1A	Squamous cell carcinoma
REL::SANBR	Adenocarcinoma
RELB::IGSF23	Adenocarcinoma
RELB::PPP1R37	Transitional cell carcinoma
RELB::WDR88	Acute myeloblastic leukemia with maturation (FAB type M2)
RELB::ZNF227	Adenocarcinoma
RELCH::NFATC1	Malignant melanoma
RELCH::RET	Carcinoma, NOS | Adenocarcinoma
RELN::CHRM2	Squamous cell carcinoma
RELN::ORC5	Adenocarcinoma
RELN::SLC25A26	Adenocarcinoma
RELT::CATSPERZ	Squamous cell carcinoma
RELT::KMT2A	Skin | Acute myeloid leukemia, NOS
RELT::PAAF1	Squamous cell carcinoma
REPS2::APOO	Adenocarcinoma
REPS2::GATAD2B	Mesenchymal tumor, NOS
REPS2::GLRA2	Mesenchymal tumor, NOS
REPS2::HBQ1	Adenocarcinoma
REPS2::NHS	Adenocarcinoma
REPS2::SMARCA1	Adenocarcinoma
REPS2::TXLNG	Adenocarcinoma
RER1::DDX21	Adenocarcinoma
RER1::DNAH7	Astrocytoma, grade I-II
RERE::CYP4A11	Adenocarcinoma
RERE::ENO1	Adenocarcinoma
RERE::ERI3	Primitive neuroectodermal tumor/Medulloblastoma | Russia
RERE::EXOSC7	Adenocarcinoma
RERE::GPR157	Adenocarcinoma
RERE::MAP4	Mature B-cell neoplasm, NOS
RERE::OOEP	Adenocarcinoma
RERE::PEX10	Mature B-cell neoplasm, NOS
RERE::PIK3CD	Adenocarcinoma
RERE::SLC2A5	Undifferentiated carcinoma, small cell | Adenocarcinoma
RERE::SLC2A7	Adenocarcinoma
RERE::SLC45A1	Astrocytoma, grade III-IV/Glioblastoma
RERE::TPM3	Adenocarcinoma
RERE::USP5	Adenocarcinoma
RERE::UTS2	Adenocarcinoma
RERE::VAMP3	Astrocytoma, grade I-II
RERE::ZNF345	Adenocarcinoma
RERE::ZNF692	Astrocytoma, grade I-II
RERE::ZSWIM5	Adenocarcinoma
RESF1::A2ML1	Malignant melanoma
RESF1::BORCS5	Adenocarcinoma
RESF1::ITPR2	Squamous cell carcinoma
RESF1::MLIP	Astrocytoma, grade I-II
RESF1::SOX5	Adenocarcinoma
RET::ANK3	Adenocarcinoma
RET::CCDC6	Adenocarcinoma
RET::ERC1	Adenocarcinoma
RET::GRB2	Embryonal nervous system tumor, special type
RET::KIF5B	Adenocarcinoma
RET::MRLN	Adenocarcinoma
RET::NCOA4	Adenocarcinoma
RET::PCGF5	Adenocarcinoma
RET::RELCH	Adenocarcinoma
RET::TRIM33	Malignant soft tissue tumor, NOS
RETREG1::ANKH	Malignant melanoma
RETREG1::CDH18	Neuroblastoma
RETREG1::ERBB2	Adenocarcinoma
RETREG1::SALL1	Adenocarcinoma
RETREG1::SLC6A19	Adenocarcinoma
RETREG1::SNTG2	Malignant melanoma
RETREG1::TERT	Adenocarcinoma
RETREG1::TPPP	Adenocarcinoma
RETREG3::AP2B1	Adenocarcinoma
RETREG3::BLTP2	Mesenchymal tumor, NOS
RETREG3::BRCA1	Adenocarcinoma
REV1::AFF3	Adenocarcinoma
REV1::LYG1	Transitional cell carcinoma
REV1::LYG2	Transitional cell carcinoma
REV1::TMEM131	Squamous cell carcinoma
REV3L::ARHGEF25	Adenocarcinoma
REV3L::FN3KRP	Astrocytoma, grade I-II
REV3L::FYN	Adenocarcinoma | Malignant melanoma
REV3L::GTF2H5	Squamous cell carcinoma
REV3L::LAMA4	Adenocarcinoma
REV3L::RPL28	Adenocarcinoma
REV3L::SOBP	Adenocarcinoma
REV3L::TMEM117	Mesenchymal tumor, NOS
REV3L::TRAF3IP2	Adenocarcinoma
REX1BD::NT5DC2	Adenocarcinoma
REXO2::NXPE1	Adenocarcinoma
RFC1::CORIN	Adenocarcinoma
RFC1::EHBP1	Squamous cell carcinoma
RFC1::PDS5A	Diffuse large B-cell lymphoma
RFC1::SMIM14	Malignant melanoma
RFC2::FANCL	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
RFC4::EHHADH	Adenocarcinoma
RFFL::ADAM32	Adenocarcinoma
RFFL::NLK	Adenocarcinoma
RFFL::NR1D1	Adenocarcinoma
RFFL::PEX12	Adenocarcinoma
RFFL::RAD51D	Transitional cell carcinoma
RFLNA::DDX55	Squamous cell carcinoma
RFLNA::EIF2S2	Adenocarcinoma
RFT1::DCP1A	Adenocarcinoma
RFT1::NEK4	Transitional cell carcinoma
RFT1::TKT	Adenocarcinoma
RFT1::UQCRC2	Adenocarcinoma
RFTN1::DAZL	Adenocarcinoma
RFTN1::MYC	Diffuse large B-cell lymphoma
RFTN1::TMEM40	Transitional cell carcinoma
RFTN1::ZNF438	Adenocarcinoma
RFWD3::STK31	Adenocarcinoma
RFX1::CCDC107	Adenocarcinoma
RFX1::TBC1D10A	Adenocarcinoma
RFX2::ACTL8	Squamous cell carcinoma
RFX2::EPOR	Adenocarcinoma
RFX2::MLLT1	Adenocarcinoma
RFX2::PATL1	Squamous cell carcinoma
RFX2::YJU2	Adenocarcinoma
RFX3::ARID4B	Malignant melanoma
RFX3::DDAH2	Squamous cell carcinoma
RFX3::GLDC	Adenocarcinoma
RFX3::JAK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RFX3::PLGRKT	Adenocarcinoma
RFX3::RELB	Adenocarcinoma
RFX3::SLC24A2	Adenocarcinoma
RFX3::SMARCA2	Adenocarcinoma
RFX3::TFDP1	Adenocarcinoma
RFX5::POGZ	Adenocarcinoma
RFX7::DNAAF4	Adenocarcinoma
RFX7::LIPC	Transitional cell carcinoma
RFX7::PCSK6	Mesenchymal tumor, NOS
RFXANK::SUGP1	Adenocarcinoma
RFXAP::SMAD9	Diffuse large B-cell lymphoma
RGL1::HMCN1	Malignant melanoma
RGL1::NMNAT2	Mesenchymal tumor, NOS
RGL1::POU2F1	Mesenchymal tumor, NOS
RGL1::RASAL2	Adenocarcinoma
RGL2::DAXX	Adenocarcinoma
RGL3::ECSIT	Adenocarcinoma
RGMA::ADAMTSL3	Astrocytoma, grade I-II
RGMA::RHCG	Astrocytoma, grade I-II
RGMB::CCDC112	Astrocytoma, grade I-II
RGPD5::NBEA	Adenocarcinoma
RGS10::TIAL1	Squamous cell carcinoma
RGS10::ZMYM1	Adenocarcinoma
RGS12::NSG1	Malignant melanoma
RGS12::PDZRN3	Adenocarcinoma
RGS12::THY1	Adenocarcinoma
RGS12::USP2	Adenocarcinoma
RGS17::BCL9	Egypt | Bilineage or biphenotypic leukemia
RGS17::LAMA2	Malignant melanoma
RGS17::PDLIM5	Mesenchymal tumor, NOS
RGS20::MCPH1	Malignant melanoma
RGS22::NIPAL2	Adenocarcinoma
RGS22::SYCP1	Adenocarcinoma
RGS3::ABCA1	Adenocarcinoma
RGS3::BSPRY	Adenocarcinoma
RGS3::MIER3	Adenocarcinoma
RGS4::DLK1	Malignant epithelial tumor, special type
RGS4::SERPINF2	Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
RGS6::AKAP6	Astrocytoma, grade III-IV/Glioblastoma
RGS6::NPAS3	Astrocytoma, grade I-II
RGS7::C8orf34	Astrocytoma, grade I-II
RHBDD1::EFR3A	Adenocarcinoma
RHBDD1::IRS1	Multiple myeloma
RHBDD2::EGFR	Transitional cell carcinoma
RHBDF1::NPRL3	Astrocytoma, grade I-II
RHBDF2::BRIP1	Transitional cell carcinoma
RHBDF2::JMJD6	Adenocarcinoma
RHBDF2::ST6GALNAC2	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
RHBDL2::AHCYL2	Squamous cell carcinoma
RHBDL2::PABPC4	Adenocarcinoma
RHBDL3::CTLA4	Astrocytoma, grade III-IV/Glioblastoma
RHBG::CCT3	Adenocarcinoma
RHCG::ANXA2	Squamous cell carcinoma
RHCG::C7	Adenocarcinoma
RHEB::ACTA2	Adenocarcinoma
RHEB::ASPHD2	Acute myeloid leukemia, NOS | Skin
RHEB::IFNAR1	Malignant melanoma
RHEB::PRKAG2	Astrocytoma, grade III-IV/Glioblastoma
RHEX::NDUFS6	Adenocarcinoma
RHEX::SRGAP2	Adenocarcinoma
RHNO1::ITFG2	Adenocarcinoma | Chronic lymphocytic leukemia
RHOA::ARCN1	Adenocarcinoma
RHOA::CACNA2D2	Transitional cell carcinoma
RHOA::COL7A1	Adenocarcinoma
RHOA::DCAF1	Transitional cell carcinoma
RHOA::DNAH1	Malignant melanoma
RHOA::EMC3	Adenocarcinoma
RHOA::GMPPB	Adenocarcinoma
RHOA::HMOX2	Astrocytoma, grade III-IV/Glioblastoma
RHOA::NICN1	Adenocarcinoma
RHOA::PFKFB4	Adenocarcinoma
RHOA::PRSS50	Acute myeloid leukemia, NOS | Skin
RHOA::SMCO1	Adenocarcinoma
RHOB::ANXA1	Adenocarcinoma
RHOB::EIF2AK2	Adenocarcinoma
RHOB::GATA3	Adenocarcinoma
RHOBTB1::ATP6V1C2	Adenocarcinoma
RHOBTB2::PNOC	Adenocarcinoma
RHOBTB3::ARSK	Adenocarcinoma
RHOBTB3::CRNKL1	Adenocarcinoma
RHOC::DDX21	Transitional cell carcinoma
RHOD::PFDN4	Adenocarcinoma
RHOF::CLIP1	Adenocarcinoma
RHOF::HEXD	Adenocarcinoma
RHOG::GPBP1L1	Acute myeloid leukemia, NOS | Skin
RHOG::NUP98	Adenocarcinoma
RHOG::RHOD	Adenocarcinoma
RHOG::STIM1	Adenocarcinoma
RHOH::BCL6	Mature B-cell neoplasm, NOS | Follicular lymphoma
RHOH::CHRNA9	Adenocarcinoma
RHOH::N4BP2	Adenocarcinoma
RHOJ::C6ORF52	Astrocytoma, grade III-IV/Glioblastoma
RHOJ::C6orf52	Astrocytoma, grade III-IV/Glioblastoma
RHOQ::CALM2	Transitional cell carcinoma
RHOQ::STPG4	Transitional cell carcinoma
RHOT1::ASIC2	Astrocytoma, grade III-IV/Glioblastoma
RHOT1::CA10	Adenocarcinoma
RHOT1::FGFR1	Adenocarcinoma
RHOT1::LRRC37B	Adenocarcinoma
RHOT1::NF2	Mesothelioma
RHOT1::RHBDL3	Squamous cell carcinoma
RHOT2::DPEP1	Malignant epithelial tumor, special type
RHOT2::RAB11FIP3	Adenocarcinoma
RHPN2::ANKRD27	Adenocarcinoma
RHPN2::BLVRB	Adenocarcinoma
RHPN2::BRSK1	Adenocarcinoma
RHPN2::CHN2	Astrocytoma, grade III-IV/Glioblastoma
RHPN2::CLASRP	Adenocarcinoma
RHPN2::GRIN2D	Adenocarcinoma
RHPN2::MACROD1	Malignant epithelial tumor, special type
RHPN2::PEPD	Adenocarcinoma | Transitional cell carcinoma
RHPN2::SLC7A10	Adenocarcinoma
RHPN2::TSHZ3	Adenocarcinoma
RHPN2::VSTM2B	Adenocarcinoma
RHPN2::ZNF677	Adenocarcinoma
RIC1::AARD	Adenocarcinoma
RIC1::BNC2	Squamous cell carcinoma
RIC1::DCAF10	Adenocarcinoma
RIC1::EPYC	Squamous cell carcinoma
RIC1::JAK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Undifferentiated carcinoma, small cell
RIC1::KANK1	Adenocarcinoma
RIC1::KDM4C	Mesenchymal tumor, NOS
RIC1::LARS1	Adenocarcinoma
RIC1::MLANA	Squamous cell carcinoma
RIC1::PDCD1LG2	Squamous cell carcinoma
RIC1::PFN2	Squamous cell carcinoma
RIC1::SLC1A1	Squamous cell carcinoma
RIC3::TRB	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RIC8B::ORAI1	Adenocarcinoma
RIC8B::RFX4	Adenocarcinoma
RIC8B::SPINDOC	Adenocarcinoma
RICTOR::ANKRD31	Adenocarcinoma
RICTOR::C9	Adenocarcinoma
RICTOR::CCDC152	Undifferentiated pleomorphic sarcoma
RICTOR::DTNBP1	Adenocarcinoma
RICTOR::FGF10	Squamous cell carcinoma | Adenocarcinoma
RICTOR::FYB1	Squamous cell carcinoma
RICTOR::HCN1	Transitional cell carcinoma
RICTOR::ISL1	Adenocarcinoma
RICTOR::LHFPL6	Malignant melanoma
RICTOR::MINPP1	Adenocarcinoma
RICTOR::NUP155	Adenocarcinoma
RICTOR::RANBP3L	Adenocarcinoma
RIF1::PDE11A	Adenocarcinoma
RIF1::PKD1L1	Adenocarcinoma
RIF1::TNFAIP6	Mesenchymal tumor, NOS
RIGI::CHRM3	Astrocytoma, grade I-II
RIGI::PRSS3	Adenocarcinoma
RIGI::RBMS1	Transitional cell carcinoma
RILPL1::NCOR2	Adenocarcinoma
RILPL1::SARNP	Adenocarcinoma
RILPL2::SBNO1	Adenocarcinoma
RIMBP2::CEP83	Adenocarcinoma
RIMKLB::A2ML1	Adenocarcinoma
RIMKLB::CEP112	Adenocarcinoma
RIMKLB::CLEC4D	Adenocarcinoma
RIMKLB::ELP3	Malignant melanoma
RIMKLB::ITFG2	Astrocytoma, grade I-II
RIMKLB::KMT5A	Adenocarcinoma
RIMKLB::PIP4K2A	Astrocytoma, grade I-II
RIMS1::NFIB	Adenoid cystic carcinoma
RIMS2::ATP6V1C1	Adenocarcinoma
RIMS2::BAALC	Adenocarcinoma
RIMS2::NSMCE2	Multiple myeloma
RIMS2::ODF1	Adenocarcinoma
RIMS2::PTGIS	Adenocarcinoma
RIMS4::AKAP10	Adenocarcinoma
RIN1::RHOD	Adenocarcinoma
RIN2::BRAF	Astrocytoma, pilocytic/juvenile
RIN3::CCDC88C	Squamous cell carcinoma
RINL::SYK	Mycosis fungoides/Sézary syndrome
RIOK1::EYS	Squamous cell carcinoma
RIOK3::ARMH3	Mesothelioma
RIOK3::OSBPL1A	Adenocarcinoma
RIOK3::RMC1	Mesothelioma
RIOK3::TAF4B	Squamous cell carcinoma
RIOK3::ZNF521	Adenocarcinoma
RIPK1::BCKDHB	Adenocarcinoma
RIPK1::NQO2	Adenocarcinoma
RIPK1::SERPINB9	Astrocytoma, grade III-IV/Glioblastoma
RIPK1::TTC27	Adenocarcinoma
RIPOR1::LRRC36	Adenocarcinoma
RIPOR1::ZP3	Malignant epithelial tumor, special type
RIPOR2::VPS54	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RIPOR3::ZNF335	Adenocarcinoma
RIT1::CCT3	Adenocarcinoma
RIT1::LMNA	Adenocarcinoma
RIT1::TARS2	Adenocarcinoma
RITA1::GRHL2	Squamous cell carcinoma
RLF::BCL2L1	Undifferentiated carcinoma, small cell
RLF::C1QTNF12	Undifferentiated carcinoma, small cell
RLF::C2ORF81	Adenocarcinoma
RLF::CAP1	Squamous cell carcinoma
RLF::COL9A2	Undifferentiated carcinoma, small cell
RLF::EBNA1BP2	Adenocarcinoma
RLF::GPATCH8	Adenocarcinoma
RLF::HM13	Undifferentiated carcinoma, small cell
RLF::MFSD2A	Adenocarcinoma
RLF::MYCL	Undifferentiated carcinoma, small cell
RLF::PPT1	Undifferentiated carcinoma, small cell
RLF::RTN4RL1	Adenocarcinoma
RLF::SFPQ	Adenocarcinoma
RLF::SMAP2	Undifferentiated carcinoma, small cell
RLF::UBE2J2	Undifferentiated carcinoma, small cell
RLF::ZMPSTE24	Adenocarcinoma
RLIG1::IRAK4	Adenocarcinoma
RLN1::RLN2	Adenocarcinoma
RLN2::CD274	Squamous cell carcinoma
RMC1::PSPC1	Squamous cell carcinoma
RMC1::RIOK3	Squamous cell carcinoma
RMDN1::AKAP6	Adenocarcinoma
RMDN1::ESRP1	Adenocarcinoma
RMDN2::ALK	Adenocarcinoma
RMDN2::DRG1	Adenocarcinoma
RMDN3::SKA2	Adenocarcinoma
RMDN3::SMIM14	Adenocarcinoma
RMI1::LCN2	Mesenchymal tumor, NOS
RMI1::STX17	Astrocytoma, grade III-IV/Glioblastoma
RMI2::CLEC16A	Malignant epithelial tumor, special type
RMND1::MTHFD1L	Mesenchymal tumor, NOS
RMND1::SYNE1	Adenocarcinoma | Malignant epithelial tumor, special type
RMND1::TIAM2	Mesenchymal tumor, NOS
RMND1::ZDHHC14	Adenocarcinoma
RMND5A::CD8A	Adenocarcinoma
RNASE10::CD38	Squamous cell carcinoma
RNASEH1::DYSF	Malignant melanoma
RNASEH2A::BEST2	Squamous cell carcinoma
RNASEH2B::AGXT2	Mesenchymal tumor, NOS
RND3::ALK	Soft tissue tumor, special type
RND3::ATF3	Multiple myeloma
RND3::IGH	Multiple myeloma
RND3::KLHL24	Multiple myeloma
RNF10::CCDC60	Astrocytoma, grade I-II
RNF10::FBL	Adenocarcinoma
RNF10::FBXO21	Adenocarcinoma
RNF10::OASL	Squamous cell carcinoma
RNF10::SIRT4	Adenocarcinoma
RNF10::SLC26A5	Adenocarcinoma
RNF10::SYPL1	Adenocarcinoma
RNF111::AQP9	Transitional cell carcinoma
RNF111::CCNB2	Adenocarcinoma
RNF111::MAPKAP1	Mesothelioma
RNF111::SLTM	Squamous cell carcinoma
RNF111::TCF12	Adenocarcinoma
RNF111::TLN2	Adenocarcinoma
RNF114::PTPN1	Adenocarcinoma
RNF115::FAM72D	Adenocarcinoma
RNF115::HJV	Adenocarcinoma
RNF115::LIX1L	Adenocarcinoma
RNF115::NOTCH2NLA	Adenocarcinoma
RNF115::PIAS3	Squamous cell carcinoma
RNF115::PRPF3	Malignant melanoma
RNF11::C8A	Adenocarcinoma
RNF11::TMEM61	Adenocarcinoma
RNF121::ANO1	Adenocarcinoma
RNF121::CYSLTR2	Adenocarcinoma
RNF121::ESRRG	Adenocarcinoma
RNF121::FADS2	Adenocarcinoma
RNF121::MRPL21	Malignant melanoma
RNF121::PCDH9	Squamous cell carcinoma
RNF121::PPFIA1	Squamous cell carcinoma
RNF121::PPP6R3	Squamous cell carcinoma | Adenocarcinoma
RNF121::PXDNL	Malignant melanoma
RNF121::SF1	Adenocarcinoma
RNF121::SLC22A8	Adenocarcinoma
RNF121::TRIM37	Neuroblastoma
RNF121::VASP	Adenocarcinoma
RNF121::VPS37C	Adenocarcinoma
RNF121::VWA5A	Adenocarcinoma
RNF122::IDO2	Squamous cell carcinoma
RNF122::NEGR1	Adenocarcinoma
RNF122::NSD3	Adenocarcinoma
RNF123::ARIH2	Adenocarcinoma
RNF123::CHMP2B	Adenocarcinoma
RNF126::ARHGAP35	Adenocarcinoma
RNF126::CIMAP1D	Adenocarcinoma
RNF126::DAZAP1	Multiple myeloma
RNF126::MED16	Astrocytoma, grade I-II
RNF126::NDUFA11	Endometrial stromal sarcoma
RNF126::PRSS57	Squamous cell carcinoma
RNF126::PTBP1	Multiple myeloma
RNF126::UBC	Multiple myeloma
RNF128::RADX	Adenocarcinoma
RNF130::BRAF	Astrocytoma, pilocytic/juvenile
RNF130::DNAJC19	Squamous cell carcinoma
RNF130::HRH2	Malignant melanoma
RNF130::MGAT4B	Adenocarcinoma
RNF130::RASGEF1C	Adenocarcinoma
RNF130::TBC1D9B	Squamous cell carcinoma
RNF135::RAB11FIP4	Adenocarcinoma
RNF138::RNF125	Adenocarcinoma | Acute lymphoblastic leukemia/lymphoblastic lymphoma
RNF138::VWC2	Adenocarcinoma
RNF139::ASPH	Adenocarcinoma
RNF139::EIF2A	Adenocarcinoma
RNF13::ATP8A2	Adenocarcinoma
RNF13::CLDN16	Adenocarcinoma
RNF13::PAK2	Soft tissue tumor, special type
RNF13::TM4SF4	Malignant epithelial tumor, special type | Adenocarcinoma | Astrocytoma, grade III-IV/Glioblastoma
RNF144A::HDLBP	Adenocarcinoma
RNF144A::LAPTM4A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RNF144A::MSH2	Malignant melanoma
RNF144B::CFAP206	Adenocarcinoma
RNF144B::KDM1B	Malignant melanoma
RNF144B::LYRM4	Adenocarcinoma
RNF144B::PPP3CA	Adenocarcinoma
RNF145::PDE4D	Malignant melanoma
RNF146::C6ORF58	Adenocarcinoma
RNF149::MAP4K4	Adenocarcinoma
RNF150::TTC29	Adenoid cystic carcinoma
RNF152::PIGN	Squamous cell carcinoma
RNF157::CA10	Malignant melanoma
RNF157::RHBDF2	Malignant melanoma
RNF167::PIGL	Adenocarcinoma
RNF167::PLD2	Squamous cell carcinoma
RNF168::PCYT1A	Astrocytoma, grade I-II
RNF168::SMCO1	Adenocarcinoma | Acute lymphoblastic leukemia/lymphoblastic lymphoma
RNF168::TNIK	Adenocarcinoma
RNF169::ANAPC15	Adenocarcinoma
RNF169::CALCOCO2	Adenocarcinoma
RNF169::CBX1	Adenocarcinoma
RNF169::POLD3	Transitional cell carcinoma | Adenocarcinoma
RNF170::ADAM32	Adenocarcinoma
RNF170::CRYBB1	Adenocarcinoma
RNF170::CSMD1	Adenocarcinoma
RNF170::GOLGA7	Adenocarcinoma
RNF170::HOOK3	Adenocarcinoma
RNF170::SFRP1	Adenocarcinoma
RNF180::AKAP13	Chronic lymphocytic leukemia
RNF180::CWC27	Adenocarcinoma
RNF180::GPX8	Squamous cell carcinoma
RNF180::IPO11	Adenocarcinoma
RNF183::CD47	Adenocarcinoma
RNF185::DEPDC5	Malignant melanoma
RNF185::EIF4ENIF1	Adenocarcinoma
RNF185::FARP1	Adenocarcinoma
RNF185::INPP5J	Adenocarcinoma
RNF185::ISX	Adenocarcinoma
RNF185::NKX1-1	Malignant epithelial tumor, special type
RNF185::SFI1	Adenocarcinoma
RNF185::SMTN	Adenocarcinoma
RNF187::OBSCN	Adenocarcinoma
RNF19A::ANKRD46	Squamous cell carcinoma
RNF19A::COX6C	Adenocarcinoma
RNF19A::F10	Adenocarcinoma
RNF19A::FAM177A1	Adenocarcinoma
RNF19A::KHDRBS2	Adenocarcinoma
RNF19A::NCALD	Transitional cell carcinoma
RNF19A::PABPC1	Transitional cell carcinoma
RNF19A::PRSS3	Squamous cell carcinoma
RNF19A::RALYL	Adenocarcinoma
RNF19A::RIDA	Adenocarcinoma
RNF19A::RRM2B	Adenocarcinoma
RNF19A::SLC41A3	Adenocarcinoma
RNF19A::SNX31	Adenocarcinoma
RNF19A::STK3	Adenocarcinoma
RNF19A::TRIQK	Squamous cell carcinoma
RNF20::PLPPR1	Adenocarcinoma
RNF213::AKAP8L	Adenocarcinoma
RNF213::ALK	Anaplastic large cell lymphoma, systemic type
RNF213::BAIAP2	Transitional cell carcinoma
RNF213::CARD14	Adenocarcinoma
RNF213::CEP104	Germ cell tumor, NOS
RNF213::DGKG	Adenocarcinoma
RNF213::ETV5	Adenocarcinoma
RNF213::FAM20C	Multiple myeloma
RNF213::HSD17B14	Adenocarcinoma
RNF213::IL22RA1	Transitional cell carcinoma
RNF213::MYC	Carcinoma, NOS | Anaplastic large cell lymphoma, systemic type
RNF213::MYH6	Adenocarcinoma
RNF213::NVL	Adenocarcinoma
RNF213::PPP1R27	Malignant epithelial tumor, special type
RNF213::RPTOR	Adenocarcinoma
RNF213::SLC26A11	Adenocarcinoma | Astrocytoma, grade III-IV/Glioblastoma | Chronic myeloid leukemia, t(9;22) | Heart
RNF213::TBCD	Malignant melanoma
RNF213::UVSSA	Malignant epithelial tumor, special type
RNF214::KMT2A	Acute myelomonocytic leukemia (FAB type M4)
RNF214::PAFAH1B2	Adenocarcinoma
RNF214::SIDT2	Adenocarcinoma
RNF215::GRIN2B	Adenocarcinoma
RNF215::SEC14L3	Adenocarcinoma
RNF216::EIF2AK1	Adenocarcinoma
RNF216::JAZF1	Adenocarcinoma
RNF216::MTHFD1L	Squamous cell carcinoma
RNF216::RSPH10B2	Malignant epithelial tumor, special type
RNF216::ST14	Adenocarcinoma
RNF217::ANKRD6	Mesenchymal tumor, NOS
RNF217::HDDC2	Squamous cell carcinoma
RNF217::NKAIN2	Adenocarcinoma
RNF217::PRDM1	Adenocarcinoma
RNF217::PTPRK	Squamous cell carcinoma
RNF217::RSPO3	Mesenchymal tumor, NOS
RNF220::MAST2	Adenocarcinoma
RNF24::CDS2	Adenocarcinoma
RNF24::ISM1	Adenocarcinoma
RNF24::MMP24	Squamous cell carcinoma
RNF24::SNRPD3	Adenocarcinoma
RNF26::FOXR1	Adenocarcinoma
RNF2::CACHD1	Adenocarcinoma
RNF2::MRC2	Malignant epithelial tumor, special type
RNF34::WDFY2	Malignant melanoma
RNF38::GLIPR2	Adenocarcinoma
RNF38::GRHPR	Malignant epithelial tumor, special type
RNF38::LCE5A	Malignant melanoma
RNF38::LMOD2	Adenocarcinoma
RNF38::PAX5	Transitional cell carcinoma
RNF38::PDCD1LG2	Mature B-cell neoplasm, NOS
RNF38::SPINK4	Squamous cell carcinoma
RNF40::IL21R	Squamous cell carcinoma
RNF40::PLK1	Adenocarcinoma
RNF41::ANKRD52	Squamous cell carcinoma
RNF41::CS	Adenocarcinoma
RNF41::MSRB3	Transitional cell carcinoma
RNF41::MYO1C	Adenocarcinoma
RNF41::PRIM1	Adenocarcinoma
RNF41::SARNP	Adenocarcinoma
RNF43::HSF5	Adenocarcinoma
RNF43::LIMCH1	Adenocarcinoma
RNF43::MRPS23	Adenocarcinoma
RNF43::NFE2L1	Adenocarcinoma
RNF43::RARA	Adenocarcinoma
RNF43::SUPT4H1	Adenocarcinoma
RNF44::NXF3	Adenocarcinoma
RNF4::CFAP99	Transitional cell carcinoma
RNF4::FSIP1	Adenocarcinoma
RNF4::GATAD2A	Transitional cell carcinoma
RNF4::RGS12	Adenocarcinoma
RNF4::SPINK2	Adenocarcinoma
RNF4::ZFYVE28	Transitional cell carcinoma
RNF6::NAALADL2	Adenocarcinoma
RNF6::USP18	Astrocytoma, grade I-II
RNF8::H2AC6	Adenocarcinoma
RNFT1::PAAF1	Adenocarcinoma
RNFT1::VMP1	Adenocarcinoma
RNGTT::AHI1	Malignant melanoma
RNGTT::BACH2	Adenocarcinoma
RNGTT::MDN1	Adenocarcinoma
RNGTT::RRAGD	Adenocarcinoma
RNGTT::SRSF12	Adenocarcinoma
RNGTT::TBC1D32	Malignant melanoma
RNH1::COL5A1	Mesenchymal tumor, NOS
RNH1::DEAF1	Adenocarcinoma
RNH1::HRAS	Squamous cell carcinoma
RNH1::MYBPC1	Adenocarcinoma
RNH1::SCT	Adenocarcinoma
RNH1::TOLLIP	Adenocarcinoma
RNLS::GRID1	Adenocarcinoma
RNPC3::JAK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RNPC3::KIAA0825	Adenocarcinoma
RNPEP::MICALL1	Squamous cell carcinoma
RNPEP::TIMM17A	Adenocarcinoma
RNPS1::UBA2	Adenocarcinoma
RO60::CACNA1S	Adenocarcinoma
ROBO1::ADGRL3	Transitional cell carcinoma
ROBO1::BRAF	Soft tissue tumor, special type
ROBO1::HECW2	Adenocarcinoma
ROBO1::HMCN1	Malignant melanoma
ROBO1::MED12L	Squamous cell carcinoma
ROBO1::MYO1D	Squamous cell carcinoma
ROBO1::RET	Adenocarcinoma
ROBO1::SEMA5B	Malignant melanoma
ROBO1::THAP4	Malignant melanoma
ROBO2::ERLIN2	Squamous cell carcinoma
ROBO2::PTPRB	Adenocarcinoma
ROBO2::TNNT2	Mesenchymal tumor, NOS
ROCK1::ABHD3	Squamous cell carcinoma | Adenocarcinoma
ROCK1::ANKRD29	Adenocarcinoma
ROCK1::B4GALT6	Squamous cell carcinoma
ROCK1::CABYR	Adenocarcinoma
ROCK1::CAMK2B	Squamous cell carcinoma
ROCK1::CDH2	Squamous cell carcinoma
ROCK1::CHST9	Adenocarcinoma
ROCK1::CIDEA	Adenocarcinoma
ROCK1::CMKLR1	Adenocarcinoma
ROCK1::DCC	Squamous cell carcinoma
ROCK1::FABP2	Transitional cell carcinoma
ROCK1::GATA6	Adenocarcinoma
ROCK1::GUCA2B	Transitional cell carcinoma
ROCK1::LAMA3	Adenocarcinoma
ROCK1::LAMP5	Mesenchymal tumor, NOS
ROCK1::LRIG3	Adenocarcinoma
ROCK1::MAP1B	Malignant melanoma
ROCK1::OSBPL1A	Adenocarcinoma
ROCK1::RBM47	Adenocarcinoma
ROCK1::RNF38	Squamous cell carcinoma
ROCK1::RPL29	Squamous cell carcinoma
ROCK1::THNSL1	Adenocarcinoma
ROCK2::ASAP2	Adenocarcinoma
ROCK2::BTNL2	Adenocarcinoma
ROCK2::CARD19	Adenocarcinoma
ROCK2::DTNB	Adenocarcinoma
ROCK2::LPIN1	Squamous cell carcinoma
ROCK2::MEIS1	Adenocarcinoma
ROCK2::NCOA1	Adenocarcinoma
ROCK2::NTSR2	Adenocarcinoma
ROCK2::PPP2CA	Adenocarcinoma
ROCK2::SH3YL1	Squamous cell carcinoma
ROPN1L::SEMA5A	Squamous cell carcinoma
ROR1::DNAJC6	Adenocarcinoma
ROR1::IL12RB2	Malignant melanoma
ROR1::UBE2U	Adenocarcinoma
ROR2::FAM50B	Malignant epithelial tumor, special type
ROR2::KCNC2	Adenocarcinoma
RORA::ALMS1	Adenocarcinoma
RORA::ANXA2	Adenocarcinoma
RORA::ARNT2	Adenocarcinoma
RORA::CLSTN2	Oligodendroglioma | Astrocytoma, grade I-II
RORA::FSTL1	Mesenchymal tumor, NOS
RORA::ICE2	Adenocarcinoma
RORA::LHFPL6	Undifferentiated pleomorphic sarcoma
RORA::LOXL1	Mesenchymal tumor, NOS
RORA::NUP210L	Adenocarcinoma
RORA::PTPN9	Mesenchymal tumor, NOS
RORA::STARD9	Adenocarcinoma
RORC::S100A7	Adenocarcinoma
ROS1::ADGRG6	Adenocarcinoma
ROS1::ANKS1A	Astrocytoma, pilocytic/juvenile
ROS1::CD74	Adenocarcinoma
ROS1::CENPW	Adenocarcinoma
ROS1::CEP85L	Adenocarcinoma
ROS1::CLTC	Adenocarcinoma
ROS1::FBXO9	Adenocarcinoma
ROS1::GIT2	Histiocytic sarcoma/malignant histiocytosis
ROS1::GOPC	Adenocarcinoma
ROS1::GPM6A	Adenocarcinoma
ROS1::GRIK2	Adenocarcinoma
ROS1::PRKN	Carcinoma, NOS
ROS1::SDC4	Adenocarcinoma
ROS1::SLC34A2	Adenocarcinoma | Astrocytoma, grade III-IV/Glioblastoma
ROS1::UTRN	Liposarcoma, dedifferentiated
RP1::EIF3H	Adenocarcinoma
RP2::C1orf43	Adenocarcinoma
RP2::CHST7	Malignant melanoma
RPA1::WDR81	Adenocarcinoma
RPAIN::FHIT	Adenocarcinoma
RPAIN::LRRC27	Adenocarcinoma
RPAIN::STX8	Mesenchymal tumor, NOS
RPAP1::SYTL1	Malignant melanoma
RPAP1::TMEM87A	Adenocarcinoma
RPAP3::ADAM32	Squamous cell carcinoma
RPAP3::AVIL	Mesenchymal tumor, NOS
RPAP3::HDAC7	Transitional cell carcinoma
RPAP3::KRT74	Mesenchymal tumor, NOS
RPAP3::SCAF11	Undifferentiated carcinoma, small cell
RPAP3::SYT1	Malignant epithelial tumor, special type
RPE::PRDM5	Malignant epithelial tumor, special type
RPF1::PRKACB	Malignant melanoma
RPF2::GTF3C6	Adenocarcinoma
RPGRIP1L::KLHL22	Adenocarcinoma
RPH3AL::ALOX15B	Adenocarcinoma
RPH3AL::BZW2	Endometrial stromal sarcoma
RPH3AL::OXTR	Adenocarcinoma
RPL10::DLK1	Adenocarcinoma
RPL11::CAMTA1	Adenocarcinoma
RPL11::ELOA	Adenocarcinoma | Mycosis fungoides/Sézary syndrome
RPL11::PNRC2	Malignant epithelial tumor, special type
RPL11::SIAE	Adenocarcinoma
RPL13::MPO	Skin | Acute myeloid leukemia, NOS
RPL18::ABCF1	Squamous cell carcinoma
RPL18::AR	Adenocarcinoma
RPL18::CFB	Squamous cell carcinoma
RPL18::COL1A1	Squamous cell carcinoma
RPL18::DDX27	Malignant epithelial tumor, special type
RPL18::FAR1	Malignant melanoma
RPL18::IGK	Multiple myeloma
RPL18::PLEKHB2	Transitional cell carcinoma
RPL18::RABEP1	Squamous cell carcinoma
RPL18::SLC38A5	Malignant melanoma
RPL18::SQSTM1	Adenocarcinoma
RPL18::TAGLN	Adenocarcinoma
RPL18::ZNF827	Malignant melanoma
RPL18A::HELZ	Adenocarcinoma
RPL19::CACNB1	Adenocarcinoma
RPL19::CCL11	Adenocarcinoma
RPL19::ITLN1	Mesothelioma
RPL19::RPS16	Adenocarcinoma
RPL22::ACOT7	Adenocarcinoma
RPL22::DNAJC11	Adenocarcinoma
RPL22::PRDM16	Mesenchymal tumor, NOS
RPL22::RER1	Squamous cell carcinoma
RPL23::BRD2	Adenocarcinoma
RPL23::MUCL1	Adenocarcinoma
RPL23::TCAP	Adenocarcinoma
RPL24::SLC9A9	Squamous cell carcinoma
RPL26::CYSTM1	Adenocarcinoma
RPL26::ESF1	Diffuse large B-cell lymphoma
RPL27::NBR1	Miscellaneous hematopoietic/lymphoid neoplasm, special type | Astrocytoma, grade I-II
RPL27A::IGLL5	Multiple myeloma
RPL28::GSE1	Squamous cell carcinoma
RPL28::IGK	Multiple myeloma
RPL29::ACY1	Adenocarcinoma
RPL32::ATP5MC2	Adenocarcinoma
RPL32::WNT7A	Adenocarcinoma
RPL34::DHRS12	Adenocarcinoma
RPL35A::LPP	Adenocarcinoma
RPL36::MFSD12	Adenocarcinoma
RPL36::RANBP3	Astrocytoma, grade III-IV/Glioblastoma
RPL36::TTYH1	Astrocytoma, grade III-IV/Glioblastoma
RPL36AL::MAP4K5	Transitional cell carcinoma
RPL37::TTC33	Adenocarcinoma
RPL37A::DDX27	Malignant melanoma
RPL37A::NDUFV1	Adenocarcinoma
RPL38::BCAS3	Astrocytoma, grade I-II
RPL38::DDX21	Transitional cell carcinoma
RPL38::DDX52	Skin | Acute myeloid leukemia, NOS
RPL38::KIF19	Adenocarcinoma
RPL41::NACA	Astrocytoma, grade III-IV/Glioblastoma
RPL41::SMARCC2	Transitional cell carcinoma
RPL4::MAP3K13	Multiple myeloma
RPL5::CCDC18	Transitional cell carcinoma | Adenocarcinoma
RPL5::GALNT18	Adenocarcinoma
RPL7L1::CDK8	Squamous cell carcinoma
RPL7L1::FOXP4	Adenocarcinoma
RPL7L1::HIPK3	Mesothelioma
RPL7L1::KLC4	Adenocarcinoma
RPL7L1::UBR2	Malignant melanoma
RPL8::ABCF1	Adenocarcinoma
RPL8::CFB	Adenocarcinoma
RPL8::DDX21	Adenocarcinoma
RPL8::FMN1	Malignant melanoma
RPL8::GLG1	Malignant melanoma
RPL8::KRT4	Adenocarcinoma
RPL8::NCALD	Squamous cell carcinoma
RPL8::NDUFV1	Adenocarcinoma
RPL8::NOVA1	Astrocytoma, grade I-II
RPL8::PCOLCE2	Multiple myeloma
RPL8::RABEP1	Squamous cell carcinoma
RPL8::SCARB1	Adenocarcinoma
RPL8::SLC1A3	Mesenchymal tumor, NOS
RPL8::SNW1	Adenocarcinoma
RPLP1::TMEFF2	Adenocarcinoma
RPLP2::ACP3	Adenocarcinoma
RPLP2::DEAF1	Adenocarcinoma
RPLP2::TALDO1	Adenocarcinoma
RPN1::ALDOA	Adenocarcinoma
RPN1::MAP6D1	Adenocarcinoma
RPN1::MECOM	Skin | Acute myeloblastic leukemia with minimal differentiation (FAB type M0) | Acute myeloblastic leukemia with maturation (FAB type M2) | Acute myeloblastic leukemia without maturation (FAB type M1) | Acute myeloid leukemia, NOS
RPN1::PRDM16	Spleen | Skin | Acute erythroleukemia (FAB type M6) | Acute myeloblastic leukemia with maturation (FAB type M2) | Acute myeloblastic leukemia without maturation (FAB type M1) | Refractory anemia with ringed sideroblasts | Myelodysplastic syndrome, NOS | Acute myeloid leukemia, NOS | Acute monoblastic leukemia without differentiation (FAB type M5a) | Refractory anemia with excess blasts-2 | Acute myelomonocytic leukemia (FAB type M4) | Chronic myelomonocytic leukemia
RPN1::SLC22A13	Malignant melanoma
RPN1::UTRN	Astrocytoma, grade I-II
RPN2::ERBB3	Squamous cell carcinoma
RPN2::MYL9	Squamous cell carcinoma
RPN2::PMEPA1	Adenocarcinoma
RPN2::RERE	Adenocarcinoma
RPN2::STAU1	Adenocarcinoma
RPN2::STK17A	Adenocarcinoma
RPN2::STK39	Astrocytoma, grade I-II
RPN2::ZBTB46	Malignant epithelial tumor, special type
RPP14::ABHD6	Malignant melanoma
RPP14::FLNB	Adenocarcinoma
RPP30::PYHIN1	Adenocarcinoma
RPP38::GPR158	Adenocarcinoma
RPP40::LYRM4	Adenocarcinoma
RPRD1A::CHMP2B	Mesenchymal tumor, NOS
RPRD1A::GAREM1	Adenocarcinoma
RPRD1A::RALGAPA2	Adenocarcinoma
RPRD1A::SLC39A6	Adenocarcinoma
RPRD1B::ANKRD17	Adenocarcinoma
RPRD1B::CTNNBL1	Adenocarcinoma
RPRD1B::ID1	Adenocarcinoma
RPRD1B::MEF2B	Adenocarcinoma
RPRD1B::RALY	Adenocarcinoma
RPRD2::BOLA1	Squamous cell carcinoma
RPRD2::CA14	Adenocarcinoma
RPRD2::LCE1C	Mesenchymal tumor, NOS
RPRD2::PRPF3	Squamous cell carcinoma | Malignant melanoma
RPRD2::S100A2	Astrocytoma, grade I-II
RPRD2::SHC1	Adenocarcinoma
RPRD2::VPS45	Adenocarcinoma
RPS10::HPR	Adenocarcinoma
RPS10::ITPR3	Squamous cell carcinoma
RPS11::FLT3LG	Acute myeloid leukemia, NOS | Acute myelomonocytic leukemia (FAB type M4) | Skin
RPS11::GOLGA3	Multiple myeloma
RPS11::TEAD2	Astrocytoma, grade III-IV/Glioblastoma
RPS14::AP1G2	Adenocarcinoma
RPS14::MB21D2	Transitional cell carcinoma
RPS15::COA6	Adenocarcinoma
RPS15::DLGAP5	Adenocarcinoma
RPS15::PLEC	Adenocarcinoma
RPS15A::ARL6IP1	Adenocarcinoma
RPS17::CHAF1B	Adenocarcinoma
RPS19::CEACAM3	Adenocarcinoma
RPS19::CEACAM5	Squamous cell carcinoma
RPS19::DMRTC2	Adenocarcinoma
RPS19BP1::KCNE1	Adenocarcinoma
RPS20::LYN	Squamous cell carcinoma
RPS27A::MS4A4A	Adenocarcinoma
RPS29::MAP3K3	Adenocarcinoma
RPS29::RPL36AL	Adenocarcinoma
RPS3::IGK	Multiple myeloma
RPS3::TSKU	Adenocarcinoma
RPS4X::CPB1	Adenocarcinoma
RPS4Y1::CDH13	Astrocytoma, grade III-IV/Glioblastoma
RPS5::CALD1	Adenocarcinoma
RPS5::DDX21	Squamous cell carcinoma
RPS5::MPO	Acute myeloid leukemia, NOS | Skin
RPS6::OAZ1	Adenocarcinoma
RPS6::RACK1	Adenocarcinoma
RPS6KA1::LIN28A	Adenocarcinoma
RPS6KA1::RASGRP3	Adenocarcinoma
RPS6KA2::CEP43	Adenocarcinoma
RPS6KA2::KIFC1	Mesenchymal tumor, NOS
RPS6KA2::MCHR2	Astrocytoma, grade I-II
RPS6KA2::NFIB	Adenoid cystic carcinoma
RPS6KA2::PSMG4	Adenocarcinoma
RPS6KA3::BMX	Adenocarcinoma
RPS6KA3::DDX53	Adenocarcinoma
RPS6KA3::EIF1AX	Adenocarcinoma
RPS6KA3::FAM156B	Squamous cell carcinoma
RPS6KA3::KDM6A	Mesenchymal tumor, NOS
RPS6KA3::PISD	Adenocarcinoma
RPS6KA4::CATSPERZ	Malignant melanoma
RPS6KA4::CCDC88B	Adenocarcinoma
RPS6KA5::BMP4	Malignant melanoma
RPS6KA5::C14ORF132	Adenocarcinoma
RPS6KA5::C14orf132	Adenocarcinoma
RPS6KA5::HOXB2	Adenocarcinoma
RPS6KA5::ITPK1	Squamous cell carcinoma
RPS6KA6::HDX	Adenocarcinoma
RPS6KB1::DIAPH3	Adenocarcinoma
RPS6KB1::EFCAB3	Adenocarcinoma
RPS6KB1::FKBP10	Squamous cell carcinoma
RPS6KB1::MAP3K3	Adenocarcinoma
RPS6KB1::RNF213	Adenocarcinoma
RPS6KB1::SNF8	Adenocarcinoma
RPS6KB1::TEX2	Adenocarcinoma
RPS6KB1::TUBD1	Adenocarcinoma
RPS6KB1::VMP1	Adenocarcinoma
RPS6KB2::PAAF1	Adenocarcinoma
RPS6KB2::PCNX3	Squamous cell carcinoma
RPS6KB2::ST3GAL2	Transitional cell carcinoma
RPS6KB2::VSIR	Adenocarcinoma
RPS6KC1::AKT3	Adenocarcinoma
RPS6KC1::CATSPERE	Adenocarcinoma
RPS6KC1::CD34	Adenocarcinoma
RPS6KC1::LYST	Astrocytoma, grade III-IV/Glioblastoma
RPS6KC1::SDCCAG8	Adenocarcinoma
RPS6KC1::TFPI	Adenocarcinoma
RPS6KC1::VASH2	Adenocarcinoma
RPS8::ARMH1	Adenocarcinoma
RPS8::MPO	Acute myeloid leukemia, NOS | Skin
RPS9::TSEN34	Adenocarcinoma
RPTOR::ANKFN1	Adenocarcinoma
RPTOR::CD163	Adenocarcinoma
RPTOR::DGKZ	Adenocarcinoma
RPTOR::FAHD2B	Adenocarcinoma
RPTOR::GAA	Adenocarcinoma
RPTOR::GPC3	Mesenchymal tumor, NOS
RPTOR::IQCH	Adenocarcinoma
RPTOR::RAB34	Malignant melanoma
RPTOR::RNF213	Adenocarcinoma
RPTOR::SLC38A10	Adenocarcinoma
RPTOR::STXBP4	Squamous cell carcinoma
RPUSD2::ZFYVE19	Adenocarcinoma
RPUSD3::EMC3	Transitional cell carcinoma
RRAGC::EIF2B3	Adenocarcinoma
RRAGC::RHBDL2	Malignant epithelial tumor, special type
RRAS2::FHIT	Adenocarcinoma
RRAS2::PSMA1	Adenocarcinoma
RRBP1::ALK	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma
RRBP1::ARFGEF2	Adenocarcinoma
RRBP1::CEP83	Multiple myeloma
RRBP1::CHID1	Adenocarcinoma
RRBP1::DTD1	Mesothelioma
RRBP1::MACROD2	Adenocarcinoma
RRBP1::OVOL2	Adenocarcinoma
RRBP1::PCSK2	Adenocarcinoma
RRBP1::RBBP8	Adenocarcinoma
RRBP1::RET	Adenocarcinoma
RRBP1::SIRPA	Acute erythroleukemia (FAB type M6)
RRBP1::SNTA1	Adenocarcinoma
RRBP1::SNX5	Adenocarcinoma
RRBP1::TASP1	Adenocarcinoma
RRBP1::USP6	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma
RRBP1::VDAC3	Adenocarcinoma
RRBP1::YWHAE	Adenocarcinoma
RREB1::EEF1E1	Astrocytoma, grade III-IV/Glioblastoma
RREB1::F13A1	Adenocarcinoma
RREB1::GABARAPL1	Adenocarcinoma
RREB1::GPX6	Adenocarcinoma
RREB1::LY86	Adenocarcinoma
RREB1::LYRM4	Astrocytoma, grade I-II
RREB1::MRTFB	Soft tissue tumor, special type | Mesenchymal tumor, special type
RREB1::TFE3	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma
RREB1::WRAP53	Adenocarcinoma
RRM1::STIM1	Adenocarcinoma
RRM2::RREB1	Adenocarcinoma
RRM2::RRM2	Adenocarcinoma
RRM2::UQCC1	Adenocarcinoma
RRM2B::ZFPM2	Adenocarcinoma
RRM2B::ZNF704	Squamous cell carcinoma
RRP12::CRTAC1	Adenocarcinoma
RRP12::EXOSC1	Squamous cell carcinoma
RRP12::IGK	Multiple myeloma
RRP1::DLG1	Adenocarcinoma
RRP1::PDXK	Squamous cell carcinoma
RRP1B::SLX9	Adenocarcinoma
RRP36::ADGRF1	Adenocarcinoma
RRP36::PPP2R5D	Adenocarcinoma
RRP7A::PACSIN2	Adenocarcinoma
RRP8::PPFIBP2	Adenocarcinoma
RSAD2::ELMOD3	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
RSBN1::PTPN22	Squamous cell carcinoma
RSBN1L::DTNBP1	Adenocarcinoma
RSBN1L::HGF	Malignant melanoma
RSBN1L::PTPN12	Adenocarcinoma
RSBN1L::RHBDD2	Adenocarcinoma
RSBN1L::SHANK2	Adenocarcinoma
RSF1::ADAM2	Adenocarcinoma
RSF1::ARRB1	Malignant melanoma
RSF1::CLNS1A	Adenocarcinoma
RSF1::CNTN4	Undifferentiated carcinoma, small cell
RSF1::FBXW4	Adenocarcinoma
RSF1::HSPA13	Adenocarcinoma
RSF1::INTS4	Malignant melanoma
RSF1::KCTD21	Adenocarcinoma
RSF1::KLC2	Astrocytoma, grade I-II
RSF1::NARS2	Malignant melanoma
RSF1::NEU3	Adenocarcinoma
RSF1::OR5AP2	Malignant melanoma
RSF1::PHF12	Adenocarcinoma
RSF1::PRRC2C	Mesenchymal tumor, NOS
RSF1::TENM4	Adenocarcinoma | Squamous cell carcinoma
RSF1::TRPC6	Malignant melanoma
RSL1D1::CCP110	Transitional cell carcinoma
RSL24D1::RAB27A	Adenocarcinoma
RSPH3::MIF4GD	Squamous cell carcinoma
RSPH3::NOTCH4	Mesenchymal tumor, NOS
RSPO2::OXR1	Squamous cell carcinoma
RSPRY1::MT4	Adenocarcinoma
RSPRY1::OGFOD1	Adenocarcinoma
RSPRY1::ZFHX3	Acute erythroleukemia (FAB type M6)
RSRC1::ALK	Adenocarcinoma
RSRC1::CCSER1	Adenocarcinoma
RSRC1::MFSD1	Adenocarcinoma
RSRC1::MLF1	Adenocarcinoma
RSRC1::NLGN1	Adenocarcinoma
RSRC2::LIN7A	Adenocarcinoma
RSRC2::SBNO1	Adenocarcinoma
RSRC2::VPS37B	Adenocarcinoma
RSRP1::CAPZA1	Adenocarcinoma
RSRP1::EIF4G3	Astrocytoma, grade III-IV/Glioblastoma
RSRP1::TMEM50A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RSRP1::TRIP12	Adenocarcinoma
RSU1::BAALC	Transitional cell carcinoma
RSU1::CAMTA1	Primitive neuroectodermal tumor/Medulloblastoma | Russia
RSU1::FANCI	Mesenchymal tumor, NOS
RSU1::LARP4B	Adenocarcinoma
RSU1::PARG	Adenocarcinoma
RSU1::ZMYND11	Adenocarcinoma
RTCB::FAM83F	Malignant melanoma
RTEL1::STMN3	Adenocarcinoma
RTF1::CATSPER2	Adenocarcinoma
RTF1::EHD4	Adenocarcinoma
RTF1::GANC	Malignant melanoma
RTF1::JMJD7	Malignant melanoma
RTF1::NRG4	Astrocytoma, grade III-IV/Glioblastoma
RTF1::RPAP1	Mature B-cell neoplasm, NOS
RTF1::SNX24	Adenocarcinoma
RTF2::ARHGAP26	Adenocarcinoma
RTF2::CNBD2	Adenocarcinoma
RTF2::PARD6B	Adenocarcinoma
RTF2::PCNT	Adenocarcinoma
RTF2::TSHZ2	Adenocarcinoma
RTKN::CTF1	Squamous cell carcinoma
RTKN::M1AP	Astrocytoma, grade I-II
RTL10::HIRA	Adenocarcinoma
RTL9::BCOR	Soft tissue tumor, special type | Endometrial stromal sarcoma
RTN1::C14ORF39	Adenocarcinoma
RTN3::COX8A	Adenocarcinoma
RTN3::CSMD1	Adenocarcinoma
RTN3::NDUFS8	Adenocarcinoma
RTN3::PLAAT5	Adenocarcinoma
RTN3::SLC22A9	Adenocarcinoma
RTN3::STIP1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RTN4::DTNB	Adenocarcinoma
RTN4::MITD1	Squamous cell carcinoma
RTN4IP1::QRSL1	Adenocarcinoma | Squamous cell carcinoma
RTN4R::DNAH2	Squamous cell carcinoma
RTN4R::SLC35G2	Squamous cell carcinoma
RTN4RL2::CTNND1	Adenocarcinoma
RTN4RL2::P2RX3	Mesenchymal tumor, NOS
RTRAF::STXBP6	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RTTN::CD226	Adenocarcinoma
RTTN::DOK6	Mesothelioma
RTTN::MAPK4	Astrocytoma, grade III-IV/Glioblastoma
RUBCNL::CUBN	Mesenchymal tumor, NOS
RUBCNL::FOXO1	Adenocarcinoma
RUBCNL::LCP1	Adenocarcinoma
RUFY1::RAF1	Malignant melanoma
RUFY2::RET	Adenocarcinoma | Carcinoma, NOS
RUFY3::ENAM	Adenocarcinoma
RUNDC1::BRAF	Embryonal nervous system tumor, special type
RUNDC1::CPB1	Adenocarcinoma
RUNDC1::RGS9	Squamous cell carcinoma
RUNX1::ADAMTS19	Acute myelomonocytic leukemia (FAB type M4)
RUNX1::AFF3	Acute myeloid leukemia, NOS | Skin | Acute lymphoblastic leukemia/lymphoblastic lymphoma
RUNX1::ARHGDIB	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RUNX1::ATF7IP	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RUNX1::BAZ2A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RUNX1::CBFA2T2	Acute myeloblastic leukemia with minimal differentiation (FAB type M0) | Acute myeloblastic leukemia without maturation (FAB type M1) | Skin | Acute myeloid leukemia, NOS
RUNX1::CBFA2T3	Myelodysplastic syndrome, NOS | Acute myeloid leukemia, NOS | Acute myeloblastic leukemia without maturation (FAB type M1) | Chronic myeloid leukemia, t(9;22) | Skin | Acute myelomonocytic leukemia (FAB type M4) | Egypt | Heart | Bilineage or biphenotypic leukemia | Acute myeloblastic leukemia with maturation (FAB type M2)
RUNX1::CEP76	Adenocarcinoma
RUNX1::CLCA2	Acute myeloblastic leukemia with maturation (FAB type M2)
RUNX1::CLDN14	Adenocarcinoma
RUNX1::CLIC6	Skin | Acute myeloid leukemia, NOS
RUNX1::CPNE8	Acute myeloblastic leukemia with maturation (FAB type M2)
RUNX1::CRYZL1	Skin | Acute myeloid leukemia, NOS
RUNX1::DDX47	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RUNX1::DSCAM	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Refractory anemia with excess blasts-1
RUNX1::DTD1	Adenocarcinoma
RUNX1::DYRK1A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RUNX1::ERG	Adenocarcinoma
RUNX1::ETS2	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Chronic myeloid leukemia, t(9;22) | Heart
RUNX1::ETV6	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RUNX1::EVX1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RUNX1::FAM117A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RUNX1::FNBP1	Acute myeloblastic leukemia without maturation (FAB type M1)
RUNX1::GRIK2	Acute monoblastic leukemia (FAB type M5)
RUNX1::IFNAR1	Malignant melanoma
RUNX1::KCNMA1	Acute myeloid leukemia, NOS | Skin
RUNX1::KIAA1549L	Acute myeloblastic leukemia without maturation (FAB type M1)
RUNX1::KIF2C	Refractory anemia with excess blasts-2
RUNX1::KMT2C	Acute myeloblastic leukemia with maturation (FAB type M2)
RUNX1::KRR1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RUNX1::LIPA	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RUNX1::LPXN	Skin | Acute myeloid leukemia, NOS
RUNX1::MACROD1	Acute myeloid leukemia, NOS | Skin
RUNX1::MECOM	Acute myeloblastic leukemia with maturation (FAB type M2) | Heart | Acute myelomonocytic leukemia (FAB type M4) | Acute myeloid leukemia, NOS | Chronic myeloid leukemia, t(9;22) | Myelodysplastic syndrome, NOS | Skin
RUNX1::MLYCD	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RUNX1::MRPL47	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RUNX1::NDC1	Acute myeloid leukemia, NOS | Skin
RUNX1::NOL4L	Acute myeloblastic leukemia with maturation (FAB type M2)
RUNX1::PCNT	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RUNX1::PDCD6	Chronic lymphocytic leukemia
RUNX1::PDZD7	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RUNX1::PLAG1	Skin | Acute myeloid leukemia, NOS
RUNX1::PRDM16	Heart | Refractory anemia with excess blasts-2 | Chronic myeloid leukemia, t(9;22) | Acute myelomonocytic leukemia (FAB type M4) | Acute megakaryoblastic leukemia (FAB type M7) | Acute monoblastic leukemia (FAB type M5) | Acute myeloblastic leukemia with minimal differentiation (FAB type M0) | Acute lymphoblastic leukemia/lymphoblastic lymphoma
RUNX1::PRDX4	Acute myeloblastic leukemia with maturation (FAB type M2)
RUNX1::PROS1	Adenocarcinoma
RUNX1::PRPF38A	Acute myeloid leukemia, NOS | Skin
RUNX1::PRRC1	Acute myelomonocytic leukemia (FAB type M4)
RUNX1::PTGR3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RUNX1::PTHLH	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RUNX1::RCAN1	Squamous cell carcinoma | Skin | Acute myeloid leukemia, NOS
RUNX1::RPL22	Acute myelomonocytic leukemia (FAB type M4)
RUNX1::RUNX1T1	Chronic myeloid leukemia, t(9;22) | Acute myeloid leukemia, NOS | Acute promyelocytic leukemia (FAB type M3) | Myelodysplastic syndrome, NOS | Nonneoplastic hematologic disorder/lesion | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Heart | Acute myeloblastic leukemia with maturation (FAB type M2) | Acute myeloblastic leukemia with minimal differentiation (FAB type M0) | Acute myelomonocytic leukemia (FAB type M4) | Acute monoblastic leukemia with differentiation (FAB type M5b) | Acute myeloblastic leukemia without maturation (FAB type M1) | Acute monoblastic leukemia (FAB type M5) | Skin
RUNX1::SEPTIN7	Acute myeloid leukemia, NOS | Skin
RUNX1::SH3D19	Acute myeloblastic leukemia without maturation (FAB type M1)
RUNX1::SIN3A	Spleen | Chronic myelomonocytic leukemia
RUNX1::STX2	Egypt | Bilineage or biphenotypic leukemia
RUNX1::SV2B	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RUNX1::TACC1	Skin | Acute myeloid leukemia, NOS
RUNX1::TCF12	Acute myeloid leukemia, NOS | Skin | Chronic myeloproliferative disorder, NOS | Chronic myelomonocytic leukemia | Acute myeloblastic leukemia with maturation (FAB type M2) | Spleen
RUNX1::THOC6	Acute myelomonocytic leukemia (FAB type M4)
RUNX1::TMEM50B	Acute myeloblastic leukemia without maturation (FAB type M1)
RUNX1::TRPS1	Acute myelomonocytic leukemia (FAB type M4)
RUNX1::UBL7	Chronic myelomonocytic leukemia | Spleen
RUNX1::UGGT2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RUNX1::UPK3B::DTX2	Acute myeloid leukemia, NOS | Skin
RUNX1::URB1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
RUNX1::USP42	Acute monoblastic leukemia (FAB type M5) | Acute myeloblastic leukemia with maturation (FAB type M2) | Acute myeloid leukemia, NOS | Acute myeloblastic leukemia without maturation (FAB type M1) | Refractory anemia with excess blasts-2 | Skin | Acute monoblastic leukemia without differentiation (FAB type M5a) | Acute myeloblastic leukemia with minimal differentiation (FAB type M0) | Acute myelomonocytic leukemia (FAB type M4)
RUNX1::WSB2	Acute myeloid leukemia, NOS | Skin
RUNX1::YTHDF2	Acute myeloblastic leukemia with maturation (FAB type M2)
RUNX1::ZFPM2	Refractory anemia with excess blasts-1 | Acute myeloid leukemia, NOS | Skin
RUNX1::ZMAT4	Adenocarcinoma
RUNX1::ZNF423	Acute myeloid leukemia, NOS | Skin
RUNX1::ZNF687	Acute myeloblastic leukemia without maturation (FAB type M1)
RUNX1T1::E2F5	Mesenchymal tumor, NOS
RUNX1T1::PLAG1	Lipoblastoma
RUNX1T1::RUNX1	Acute myeloid leukemia, NOS | Skin
RUNX1T1::ZC2HC1A	Adenocarcinoma
RUNX2::IFT88	Adenocarcinoma
RUNX2::MAX	Squamous cell carcinoma
RUNX2::USP6	Aneurysmal bone cyst
RUSC1::TYK2	Adenocarcinoma
RUSC2::ABAT	Astrocytoma, grade I-II
RUSC2::SHB	Transitional cell carcinoma
RUSF1::USP7	Multiple myeloma
RUVBL1::TMCC1	Squamous cell carcinoma
RUVBL2::NCAM2	Acute myelomonocytic leukemia (FAB type M4)
RWDD1::CALHM4	Squamous cell carcinoma
RWDD1::CEP85L	Mesenchymal tumor, NOS
RWDD1::WASF1	Adenocarcinoma
RWDD2B::MX2	Transitional cell carcinoma
RWDD3::CCDC18	Adenocarcinoma
RWDD3::TLCD4	Adenocarcinoma
RWDD4::SORBS2	Squamous cell carcinoma
RXRA::ALG9	Adenocarcinoma
RXRA::BCAS3	Squamous cell carcinoma
RXRA::KCNT2	Adenocarcinoma
RXRA::NOTCH1	Mastocytosis
RXRA::PRRC2B	Squamous cell carcinoma
RXRA::RALGDS	Multiple myeloma
RXRA::WDR5	Adenocarcinoma
RXRG::FAM78B	Malignant melanoma
RXYLT1::PTDSS1	Mesenchymal tumor, NOS
RYBP::ARL13B	Adenocarcinoma
RYBP::CNTN4	Adenocarcinoma
RYBP::FHIT	Adenocarcinoma
RYBP::ROBO2	Adenocarcinoma
RYBP::TADA3	Adenocarcinoma
RYK::ATP5PO	Lymph node | Atypical chronic myeloid leukemia
RYK::KALRN	Adenocarcinoma
RYK::RABL3	Adenocarcinoma
RYK::UPK1B	Adenocarcinoma
RYR1::SEMA4A	Squamous cell carcinoma
RYR1::ZNF383	Adenocarcinoma
RYR2::GPR137B	Adenocarcinoma
RYR2::WLS	Astrocytoma, grade I-II
RYR3::AVEN	Squamous cell carcinoma
RYR3::BUB1B	Astrocytoma, grade I-II
RYR3::DAB1	Astrocytoma, grade III-IV/Glioblastoma
RYR3::LARP4	Adenocarcinoma
S100A13::GBA1	Adenocarcinoma
S100A2::CHD1	Squamous cell carcinoma
S100A2::CXCR5	Squamous cell carcinoma
S100A2::DDX21	Transitional cell carcinoma
S100A2::FXYD3	Squamous cell carcinoma
S100A2::NDUFV1	Squamous cell carcinoma
S100A2::RPL30	Squamous cell carcinoma
S100A4::ELK3	Malignant melanoma
S100A4::S100A3	Adenocarcinoma
S100A6::ABCF1	Adenocarcinoma
S100A6::BCL7A	Adenocarcinoma
S100A6::CD40	Adenocarcinoma
S100A6::COL6A1	Adenocarcinoma
S100A6::CRYBG2	Transitional cell carcinoma
S100A6::DDX27	Adenocarcinoma
S100A6::ERBB3	Adenocarcinoma
S100A6::IGK	Multiple myeloma
S100A6::PLEKHB2	Adenocarcinoma
S100A6::THSD4	Mesenchymal tumor, NOS
S100A6::VIM	Malignant melanoma
S100A7A::S100A9	Squamous cell carcinoma
S100A8::CCT5	Squamous cell carcinoma
S100A8::FADS2	Squamous cell carcinoma
S100A8::IGK	Multiple myeloma
S100A8::MYO6	Squamous cell carcinoma
S100A8::SUPT16H	Squamous cell carcinoma
S100A8::TNNT1	Adenocarcinoma
S100A9::FOXP1	Squamous cell carcinoma
S100A9::NDUFV1	Squamous cell carcinoma
S100A9::PLAT	Squamous cell carcinoma
S100A9::TCOF1	Squamous cell carcinoma
S100B::TCTN1	Malignant melanoma
S100P::BZW2	Squamous cell carcinoma
S100P::CHD1	Adenocarcinoma
S100PBP::RBBP4	Adenocarcinoma
S1PR2::FDX2	Adenocarcinoma
S1PR2::RAVER1	Adenocarcinoma
SAC3D1::SNX15	Adenocarcinoma
SACS::MIPEP	Squamous cell carcinoma
SACS::MYO16	Mesenchymal tumor, NOS
SACS::PHF3	Squamous cell carcinoma
SAE1::ARHGAP35	Adenocarcinoma
SAE1::BAX	Adenocarcinoma
SAE1::FGF9	Adenocarcinoma
SAE1::GRAP2	Adenocarcinoma
SAE1::GRIN2D	Adenocarcinoma
SAE1::HAS1	Mesenchymal tumor, NOS
SAE1::RPA2	Adenocarcinoma
SAE1::TBKBP1	Adenocarcinoma
SAE1::WDR18	Adenocarcinoma
SAE1::ZBTB45	Adenocarcinoma
SAFB2::AP2A1	Malignant melanoma
SAFB2::INSR	Mature B-cell neoplasm, NOS
SAFB2::KHSRP	Adenocarcinoma
SAFB2::LONP1	Adenocarcinoma | Germ cell tumor, NOS
SAFB2::SCAF1	Adenocarcinoma
SAFB::ARRDC5	Adenocarcinoma
SAFB::MICOS13	Squamous cell carcinoma
SAFB::RFX2	Adenocarcinoma
SAMD12::ATAD2	Adenocarcinoma
SAMD12::COL14A1	Adenocarcinoma
SAMD12::FDCSP	Adenocarcinoma
SAMD12::RTN1	Squamous cell carcinoma
SAMD12::SAMHD1	Squamous cell carcinoma
SAMD12::SNTB1	Adenocarcinoma
SAMD12::SYBU	Adenocarcinoma
SAMD12::TG	Squamous cell carcinoma
SAMD12::TMEM74	Adenocarcinoma
SAMD12::USP37	Adenocarcinoma
SAMD12::ZBTB10	Adenocarcinoma
SAMD13::PRKACB	Transitional cell carcinoma
SAMD14::DDX42	Adenocarcinoma
SAMD3::GRIK2	Malignant melanoma
SAMD4A::CGRRF1	Astrocytoma, grade I-II
SAMD4A::LRBA	Adenocarcinoma
SAMD4A::TIMM9	Adenocarcinoma
SAMD4B::FBXO27	Transitional cell carcinoma
SAMD4B::GMFG	Adenocarcinoma
SAMD4B::SIPA1L3	Adenocarcinoma
SAMD4B::SLFN5	Squamous cell carcinoma
SAMD4B::SPTBN4	Adenocarcinoma
SAMD5::SASH1	Fibroblastic/myofibroblastic tumor, special type
SAMD8::ADK	Transitional cell carcinoma
SAMD8::KAT6B	Adenocarcinoma
SAMD8::LHX1	Squamous cell carcinoma
SAMD8::LRMDA	Adenocarcinoma
SAMD9::CDKAL1	Acute myeloblastic leukemia with maturation (FAB type M2)
SAMD9::VPS50	Squamous cell carcinoma
SAMHD1::DDX27	Adenocarcinoma
SAMHD1::HCK	Adenocarcinoma
SAMHD1::RBL1	Adenocarcinoma
SAMHD1::RPN2	Adenocarcinoma
SAMHD1::SCAND1	Adenocarcinoma
SAMHD1::YIF1B	Squamous cell carcinoma
SAMM50::PIP4K2C	Mesenchymal tumor, NOS
SAMM50::TXNRD2	Adenocarcinoma
SANBR::C2ORF74	Nonneoplastic epithelial disorder/lesion
SAP130::BIN1	Malignant melanoma
SAP30::GALNT7	Transitional cell carcinoma
SAP30BP::CD300LD	Acute myeloid leukemia, NOS | Skin
SAP30BP::CDRT4	Ependymoma
SAP30BP::KCTD2	Adenocarcinoma
SAP30BP::LLGL2	Adenocarcinoma
SAP30BP::MRPL58	Adenocarcinoma
SAP30BP::MYO15B	Transitional cell carcinoma
SAP30BP::PPY	Malignant melanoma
SAP30BP::SMIM6	Adenocarcinoma
SAP30BP::TMEM94	Adenocarcinoma
SAP30BP::TSEN54	Squamous cell carcinoma
SAP30BP::UNK	Adenocarcinoma
SAR1A::CDK12	Adenocarcinoma
SAR1A::HNRNPF	Malignant melanoma
SAR1A::LRRC20	Adenocarcinoma
SAR1A::NODAL	Adenocarcinoma
SAR1A::NPFFR1	Adenocarcinoma
SAR1A::USP6	Aneurysmal bone cyst
SARAF::MSRB3	Adenocarcinoma
SARAF::NRG1	Adenocarcinoma
SARAF::TNKS	Adenocarcinoma
SARM1::NTRK1	Mesenchymal tumor, special type
SARNP::BLOC1S1	Adenocarcinoma
SARNP::KCNN4	Adenocarcinoma
SARNP::MMP19	Malignant epithelial tumor, special type
SARNP::PAN2	Transitional cell carcinoma
SARNP::PTGES3	Adenocarcinoma
SARNP::PTMS	Adenocarcinoma
SARNP::VAMP8	Squamous cell carcinoma
SARS1::ELAPOR1	Adenocarcinoma
SARS2::SIPA1L3	Adenocarcinoma
SART1::CNTN5	Squamous cell carcinoma
SART3::CORO1C	Adenocarcinoma
SART3::DAO	Adenocarcinoma
SART3::PAH	Mesenchymal tumor, NOS
SART3::PDGFRB	Chronic eosinophilic leukemia/hypereosinophilic syndrome
SART3::RARG	Acute promyelocytic leukemia (FAB type M3)
SASH1::ADGB	Adenocarcinoma
SASH1::AFDN	Astrocytoma, grade I-II
SASH1::ARID1B	Adenocarcinoma
SASH1::DPF3	Squamous cell carcinoma
SASH1::GPLD1	Adenocarcinoma
SASH1::LPIN3	Adenocarcinoma
SASH1::PACRG	Squamous cell carcinoma
SASH1::PLN	Adenocarcinoma
SASH1::SAMD5	Undifferentiated carcinoma, small cell
SASH1::STAB2	Mesenchymal tumor, NOS
SAT1::CTTN	Adenocarcinoma
SATB1::GOLGA5	Adenocarcinoma
SATB1::GRM7	Astrocytoma, grade III-IV/Glioblastoma
SATB1::PDGFRB	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SATB1::RET	Adenocarcinoma
SATB1::STAC	Adenocarcinoma
SAV1::ATL1	Adenocarcinoma
SAV1::PELI2	Squamous cell carcinoma
SAYSD1::PACSIN1	Astrocytoma, grade I-II
SBF1::FBLN1	Transitional cell carcinoma
SBF1::FLNA	Adenocarcinoma
SBF1::MLC1	Adenocarcinoma
SBF1::PLXNB2	Adenocarcinoma
SBF1::SCO2	Adenocarcinoma
SBF1::SYCE3	Adenocarcinoma
SBF1::TENM4	Malignant melanoma
SBF2::CALM3	Astrocytoma, grade I-II
SBF2::CNTN5	Malignant melanoma
SBF2::CSTPP1	Adenocarcinoma
SBF2::EIF4G2	Squamous cell carcinoma
SBF2::FEZ1	Adenocarcinoma
SBF2::IRAG1	Squamous cell carcinoma
SBF2::MDM2	Adenocarcinoma
SBF2::MRGPRX3	Malignant melanoma
SBF2::PAGE4	Squamous cell carcinoma
SBF2::PDE3B	Adenocarcinoma
SBF2::PGAP2	Adenocarcinoma
SBF2::PRMT3	Squamous cell carcinoma
SBNO1::CLSPN	Adenocarcinoma
SBNO1::DDX55	Adenocarcinoma
SBNO1::EIF2B1	Adenocarcinoma
SBNO1::RILPL2	Astrocytoma, grade I-II
SBNO2::ADARB1	Adenocarcinoma
SBNO2::ARHGAP45	Squamous cell carcinoma
SBNO2::ARHGEF1	Adenocarcinoma
SBNO2::C1D	Malignant epithelial tumor, special type
SBNO2::CACNA2D2	Adenocarcinoma
SBNO2::CBARP	Adenocarcinoma
SBNO2::CEBPG	Astrocytoma, grade I-II
SBNO2::CLEC4M	Astrocytoma, grade I-II
SBNO2::CRIP2	Adenocarcinoma
SBNO2::GAMT	Adenocarcinoma
SBNO2::ISYNA1	Multiple myeloma
SBNO2::NANOS3	Miscellaneous hematopoietic/lymphoid neoplasm, special type | Benign epithelial tumor, special type
SBNO2::PIAS4	Adenocarcinoma
SBNO2::PLPPR3	Adenocarcinoma
SBNO2::RAP1GAP	Malignant melanoma
SBNO2::RNF126	Multiple myeloma
SBNO2::SERINC2	Adenocarcinoma
SBNO2::TPGS1	Adenocarcinoma
SBNO2::TULP2	Adenocarcinoma
SC5D::ARHGEF12	Adenocarcinoma
SC5D::SPA17	Mesenchymal tumor, NOS
SCAF11::ADCY8	Squamous cell carcinoma
SCAF11::PDGFRA	Adenocarcinoma
SCAF1::ETV7	Astrocytoma, grade I-II
SCAF1::FLT3LG	Squamous cell carcinoma
SCAF1::MAP4K1	Adenocarcinoma
SCAF1::TRAPPC6A	Astrocytoma, grade III-IV/Glioblastoma
SCAF4::HLCS	Adenocarcinoma
SCAF4::TTC6	Adenocarcinoma
SCAF8::GINM1	Adenocarcinoma
SCAF8::GREB1	Adenocarcinoma
SCAF8::IL20RA	Mesenchymal tumor, NOS
SCAF8::SAMD5	Adenocarcinoma
SCAF8::VWA8	Adenocarcinoma
SCAI::CA8	Adenocarcinoma
SCAI::PPP6C	Adenocarcinoma
SCAI::TOX3	Adenocarcinoma
SCAMP1::ARSB	Adenocarcinoma
SCAMP2::DBN1	Astrocytoma, grade I-II
SCAMP2::PLAUR	Malignant melanoma
SCAMP2::SCAPER	Adenocarcinoma
SCAMP2::SLC12A8	Adenocarcinoma
SCAMP2::SLCO3A1	Mesenchymal tumor, NOS
SCAMP2::WDR72	Malignant melanoma
SCAMP4::COX8A	Adenocarcinoma
SCAMP4::DAZAP1	Transitional cell carcinoma
SCAP::ELP6	Adenocarcinoma
SCAP::SLC25A20	Adenocarcinoma
SCAP::SMARCC1	Squamous cell carcinoma
SCAPER::CEP120	Adenocarcinoma
SCAPER::GLCE	Mesenchymal tumor, NOS
SCAPER::LINGO1	Adenocarcinoma
SCAPER::TLN2	Adenocarcinoma
SCAPER::TMEM266	Squamous cell carcinoma
SCAPER::TSPAN3	Adenocarcinoma | Malignant melanoma
SCAPER::ZNF592	Astrocytoma, grade I-II
SCARA3::TPM2	Mesenchymal tumor, NOS
SCARB1::DHX37	Adenocarcinoma
SCARB1::EEA1	Adenocarcinoma
SCARB1::EIF3D	Adenocarcinoma
SCARB1::RIMBP2	Astrocytoma, grade I-II
SCARB1::SFSWAP	Astrocytoma, grade III-IV/Glioblastoma
SCARB1::SUB1	Adenocarcinoma
SCARB2::AREG	Adenocarcinoma
SCARB2::NIPSNAP1	Adenocarcinoma
SCARB2::SGMS1	Adenocarcinoma
SCARB2::STAU2	Adenocarcinoma
SCCPDH::CNST	Transitional cell carcinoma | Adenocarcinoma
SCD5::ANTXR2	Adenocarcinoma
SCD5::HNRNPDL	Astrocytoma, grade III-IV/Glioblastoma
SCD5::PLAC8	Adenocarcinoma
SCD5::SEC31A	Adenocarcinoma
SCD5::STAP1	Adenocarcinoma
SCD::GPR19	Adenocarcinoma
SCD::SEC61A2	Astrocytoma, grade I-II
SCEL::LMO7	Adenocarcinoma
SCFD1::GPHN	Adenocarcinoma
SCFD1::ZNF592	Myelodysplastic syndrome, NOS
SCFD2::CLOCK	Astrocytoma, grade III-IV/Glioblastoma
SCFD2::FIP1L1	Astrocytoma, grade I-II
SCFD2::GSX2	Astrocytoma, grade III-IV/Glioblastoma
SCFD2::LNX1	Astrocytoma, grade I-II
SCFD2::NARS2	Adenocarcinoma
SCFD2::SPINK2	Astrocytoma, grade I-II
SCG2::PTGS1	Embryonal nervous system tumor, special type
SCG5::FRMD5	Astrocytoma, grade III-IV/Glioblastoma
SCGB1D2::ALDH3B1	Adenocarcinoma
SCGB1D2::FADS2	Adenocarcinoma
SCGB1D2::IQGAP1	Adenocarcinoma
SCGB2A2::MGP	Adenocarcinoma
SCGB2B2::ERCC1	Transitional cell carcinoma
SCGB2B2::ZNF599	Adenocarcinoma
SCGB3A1::CAST	Adenocarcinoma
SCLT1::NIPBL	Angiosarcoma
SCLY::RAMP1	Adenocarcinoma
SCLY::UBE2F	Squamous cell carcinoma
SCMH1::AGO3	Adenocarcinoma
SCMH1::CA6	Adenocarcinoma
SCMH1::CAP1	Transitional cell carcinoma
SCMH1::CASP9	Mesenchymal tumor, NOS
SCMH1::CUL3	Adenocarcinoma
SCMH1::EIF2B3	Adenocarcinoma
SCMH1::GPBP1L1	Adenocarcinoma
SCMH1::HOOK3	Mesenchymal tumor, NOS
SCMH1::MACF1	Adenocarcinoma
SCMH1::PPT1	Adenocarcinoma
SCMH1::SDCBP2	Squamous cell carcinoma
SCMH1::SHISA5	Squamous cell carcinoma
SCMH1::SQOR	Adenocarcinoma
SCMH1::TRAPPC3	Adenocarcinoma
SCML2::MAP7D2	Adenocarcinoma
SCML2::PPHLN1	Adenocarcinoma
SCML4::TUSC3	Adenocarcinoma
SCN4A::TRIM47	Adenocarcinoma
SCN8A::ANO2	Mesenchymal tumor, NOS
SCN8A::ATF1	Astrocytoma, grade I-II
SCN8A::KCNC2	Transitional cell carcinoma
SCN8A::PPFIA2	Mesenchymal tumor, NOS
SCN8A::SRGAP1	Adenocarcinoma
SCNM1::SSBP3	Malignant melanoma
SCNN1A::DCP1B	Squamous cell carcinoma
SCNN1A::LPAR5	Adenocarcinoma
SCNN1A::PKNOX1	Adenocarcinoma
SCNN1A::TNFRSF1A	Nonneoplastic epithelial disorder/lesion | Adenocarcinoma | Astrocytoma, grade III-IV/Glioblastoma
SCNN1G::COL27A1	Adenocarcinoma
SCO1::ARX	Astrocytoma, grade I-II
SCP2::ECHDC2	Adenocarcinoma
SCP2::FAF1	Adenocarcinoma
SCP2::NCAM1	Adenocarcinoma
SCP2::NTRK1	Adenocarcinoma
SCP2::STXBP3	Malignant melanoma
SCP2::TMPRSS2	Adenocarcinoma
SCRIB::BRAF	Adenocarcinoma
SCRIB::EEF1D	Adenocarcinoma
SCRIB::NRBP2	Astrocytoma, grade I-II
SCRN1::WDR53	Squamous cell carcinoma
SCRN1::WIPF3	Squamous cell carcinoma
SCRN2::CBX1	Adenocarcinoma
SCRN2::GIP	Malignant epithelial tumor, special type
SCRN2::SKAP1	Adenocarcinoma
SCRN2::SP6	Adenocarcinoma
SCUBE2::DENND5A	Adenocarcinoma
SCUBE2::LDHC	Transitional cell carcinoma
SCUBE3::ANKS1A	Adenocarcinoma
SCX::ZNF627	Adenocarcinoma
SCYL1::FRMD8	Adenocarcinoma
SCYL1::PACS1	Adenocarcinoma
SCYL1::TRPM8	Adenocarcinoma
SCYL2::ANKS1B	Malignant melanoma
SCYL2::DEPDC4	Mature B-cell neoplasm, NOS | Squamous cell carcinoma
SCYL2::GARIN6	Adenocarcinoma
SCYL2::UTP20	Transitional cell carcinoma
SCYL3::CLPTM1L	Malignant melanoma
SCYL3::KIFAP3	Adenocarcinoma | Squamous cell carcinoma
SCYL3::PDZRN4	Adenocarcinoma
SCYL3::TSPAN8	Mesenchymal tumor, NOS
SDAD1::CFAP299	Astrocytoma, grade I-II
SDAD1::CXCL9	Squamous cell carcinoma
SDAD1::PARM1	Squamous cell carcinoma
SDC1::IGK	Multiple myeloma
SDC1::PLAT	Squamous cell carcinoma
SDC1::PUM2	Adenocarcinoma
SDC2::C8ORF88	Malignant epithelial tumor, special type
SDC2::LIN7A	Mesenchymal tumor, NOS
SDC3::CHD1	Malignant melanoma
SDC3::SLC1A3	Astrocytoma, grade I-II
SDC3::ZNF827	Astrocytoma, grade I-II
SDC4::AP1G2	Adenocarcinoma
SDC4::EIF2AK2	Adenocarcinoma
SDC4::NRG1	Squamous cell carcinoma | Adenocarcinoma
SDC4::ROS1	Adenocarcinoma | Glioma, NOS | Squamous cell carcinoma
SDC4::SPCS1	Astrocytoma, grade III-IV/Glioblastoma
SDC4::TP53TG5	Adenocarcinoma
SDC4::TSHZ2	Adenocarcinoma
SDC4::YWHAB	Adenocarcinoma
SDCBP::BIRC6	Malignant melanoma
SDCBP::ESF1	Malignant melanoma
SDCBP::PLAG1	Spindle cell/pleomorphic lipoma
SDCCAG8::CATSPERE	Adenocarcinoma
SDCCAG8::CEP170	Squamous cell carcinoma
SDCCAG8::DCAF6	Adenocarcinoma
SDCCAG8::TFB2M	Malignant melanoma
SDE2::CCDC190	Astrocytoma, grade I-II
SDE2::SLC22A15	Adenocarcinoma
SDF2::ARHGAP44	Adenocarcinoma
SDF2::MAP2K6	Adenocarcinoma
SDF2::MSI2	Adenocarcinoma
SDF2::RPTOR	Adenocarcinoma
SDF2L1::DEPDC5	Astrocytoma, grade III-IV/Glioblastoma
SDF4::DVL1	Squamous cell carcinoma
SDF4::PPP1R2	Adenocarcinoma
SDHA::CTNND2	Adenocarcinoma
SDHA::MIF	Adenocarcinoma
SDHA::PLEKHG4B	Adenocarcinoma
SDHAF2::ACTN3	Adenocarcinoma
SDHAF2::CD5	Adenocarcinoma
SDHAF2::FNBP4	Squamous cell carcinoma
SDHAF2::MAJIN	Adenocarcinoma
SDHAF2::RIN1	Adenocarcinoma
SDHAF2::TPH1	Mesenchymal tumor, NOS
SDHAF4::SH3BGRL2	Malignant melanoma
SDHB::PLN	Adenocarcinoma
SDHC::KLHDC9	Adenocarcinoma
SDHC::UFC1	Adenocarcinoma
SDHD::CUL5	Adenocarcinoma
SDK1::AMACR	Adenocarcinoma
SDK1::BRAT1	Mesenchymal tumor, NOS
SDK1::CHST12	Adenocarcinoma
SDK1::NUPR2	Adenocarcinoma
SDK1::SLC29A4	Transitional cell carcinoma
SDK2::CDC42EP4	Squamous cell carcinoma
SDK2::TMTC2	Mesenchymal tumor, NOS
SDSL::DTX1	Adenocarcinoma
SEC11A::VPS33B	Malignant melanoma
SEC13::GOLPH3L	Transitional cell carcinoma
SEC14L1::CYP39A1	Synovial sarcoma
SEC14L1::GALK1	Adenocarcinoma
SEC14L1::MGAT5B	Adenocarcinoma
SEC14L1::SPOP	Squamous cell carcinoma
SEC14L1::TEX2	Adenocarcinoma
SEC14L2::CCDC157	Adenocarcinoma
SEC14L2::HORMAD2	Squamous cell carcinoma
SEC14L4::SIAH1	Transitional cell carcinoma
SEC16A::KMT2A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SEC16A::LHX3	Adenocarcinoma
SEC16A::MCRIP1	Squamous cell carcinoma
SEC16A::NOTCH1	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Adenoid cystic carcinoma | Adenocarcinoma | Acute myeloid leukemia, NOS | Skin
SEC16A::QSOX2	Adenocarcinoma
SEC16A::RXRA	Mesenchymal tumor, NOS
SEC16A::SLCO5A1	Mesenchymal tumor, NOS
SEC16A::ZNF133	Adenocarcinoma
SEC16B::EGF	Adenocarcinoma
SEC22A::TXNRD3	Squamous cell carcinoma
SEC22B::ACOT11	Adenocarcinoma
SEC22B::NOTCH2	Adenocarcinoma
SEC22B::WARS2	Malignant melanoma
SEC22C::MRPS28	Malignant melanoma
SEC23A::PSMC1	Adenocarcinoma
SEC23A::TRAPPC6B	Adenocarcinoma
SEC23B::CNGB3	Squamous cell carcinoma
SEC23B::DTD1	Adenocarcinoma
SEC23B::DZANK1	Malignant epithelial tumor, special type
SEC23B::KAT14	Adenocarcinoma
SEC23B::NAPB	Mesenchymal tumor, NOS
SEC23B::PLEKHM3	Squamous cell carcinoma
SEC23B::ZCCHC7	Squamous cell carcinoma
SEC23IP::CFAP46	Adenocarcinoma
SEC23IP::VGLL3	Myxoinflammatory fibroblastic sarcoma
SEC24A::CDH18	Mesenchymal tumor, NOS
SEC24A::DDX46	Adenocarcinoma
SEC24A::JADE2	Adenocarcinoma
SEC24A::KCNK7	Astrocytoma, grade I-II
SEC24A::LRMDA	Adenocarcinoma
SEC24A::PCBD2	Squamous cell carcinoma
SEC24B::MANBA	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SEC24B::NR4A3	Mesothelioma
SEC24C::ADK	Transitional cell carcinoma
SEC24C::CCT5	Squamous cell carcinoma
SEC24C::SEPTIN10	Adenocarcinoma
SEC24D::CFI	Adenocarcinoma
SEC24D::PLRG1	Adenocarcinoma
SEC31A::ABRAXAS1	Adenocarcinoma
SEC31A::AGMO	Squamous cell carcinoma
SEC31A::ALK	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma | Diffuse large B-cell lymphoma | Adenocarcinoma
SEC31A::ANAPC10	Adenocarcinoma
SEC31A::BRAF	Acinic cell carcinoma | Benign nevus
SEC31A::C6ORF62	Adenocarcinoma
SEC31A::EIF4G3	Adenocarcinoma
SEC31A::HNRNPDL	Astrocytoma, grade III-IV/Glioblastoma
SEC31A::JAK2	Hodgkin disease, nodular sclerosis
SEC31A::MUC7	Adenocarcinoma
SEC31A::SCD5	Squamous cell carcinoma | Adenocarcinoma
SEC31A::USP6	Aneurysmal bone cyst
SEC31B::GRID1	Adenocarcinoma
SEC61A1::EEFSEC	Adenocarcinoma
SEC61A1::EIF2AK2	Adenocarcinoma
SEC61A1::ELK3	Malignant epithelial tumor, special type
SEC61A1::INPP4B	Mesenchymal tumor, NOS
SEC61A1::KBTBD12	Adenocarcinoma
SEC61A1::SMR3B	Adenocarcinoma
SEC61A2::CAMK1D	Squamous cell carcinoma
SEC61B::SIT1	Adenocarcinoma
SEC61G::CHCHD2	Astrocytoma, grade III-IV/Glioblastoma
SEC61G::EGFR	Ependymoma | Astrocytoma, grade III-IV/Glioblastoma
SEC61G::GLUL	Astrocytoma, grade I-II
SEC61G::IKZF1	Astrocytoma, grade I-II
SEC61G::PHKG1	Astrocytoma, grade III-IV/Glioblastoma
SEC61G::SLC26A8	Astrocytoma, grade III-IV/Glioblastoma
SEC61G::VOPP1	Astrocytoma, grade III-IV/Glioblastoma
SEC62::ATG3	Squamous cell carcinoma
SEC62::MECOM	Squamous cell carcinoma
SEC62::PHC3	Adenocarcinoma
SEC62::RPL22L1	Squamous cell carcinoma
SEC63::FIG4	Acute myeloblastic leukemia without maturation (FAB type M1) | Skin | Acute myeloid leukemia, NOS
SEC63::PCBP2	Adenocarcinoma
SEC63::SCML4	Adenocarcinoma
SECISBP2::NEDD4L	Adenocarcinoma
SEH1L::IMPA2	Adenocarcinoma
SEL1L3::CCKAR	Adenocarcinoma
SEL1L3::HSD17B13	Adenocarcinoma
SEL1L::ANGEL1	Adenocarcinoma
SEL1L::FNTB	Mesenchymal tumor, NOS
SEL1L::MIOS	Adenocarcinoma
SEL1L::NTRK1	Adenocarcinoma
SEL1L::SERTAD2	Adenocarcinoma
SELENOF::COL24A1	Adenocarcinoma
SELENOI::GUCY1A1	Germ cell tumor, NOS
SELENON::TMEM59	Adenocarcinoma
SELENOP::BMERB1	Adenocarcinoma
SELENOP::C7	Adenocarcinoma
SELENOP::EIF2AK2	Adenocarcinoma
SELENOW::EHD2	Squamous cell carcinoma
SEM1::ADCY2	Adenocarcinoma
SEMA3A::MDFIC	Adenocarcinoma
SEMA3B::FLACC1	Adenocarcinoma
SEMA3B::GNAI2	Adenocarcinoma
SEMA3C::AUTS2	Adenocarcinoma
SEMA3C::CD36	Squamous cell carcinoma | Transitional cell carcinoma
SEMA3C::CNTNAP2	Adenocarcinoma
SEMA3C::PPP1R12C	Malignant melanoma
SEMA3D::ABCB1	Neuroblastoma
SEMA3D::KCNU1	Squamous cell carcinoma
SEMA3D::MET	Carcinoma, NOS
SEMA3D::RBM28	Adenocarcinoma
SEMA3E::CEP41	Malignant melanoma
SEMA3F::RBM6	Squamous cell carcinoma
SEMA3F::RNF123	Adenocarcinoma
SEMA3F::SLC9A9	Adenocarcinoma
SEMA4A::DAP3	Adenocarcinoma
SEMA4B::CERS3	Adenocarcinoma
SEMA4B::CIB2	Adenocarcinoma
SEMA4B::PIAS1	Adenocarcinoma
SEMA4B::WDR93	Adenocarcinoma
SEMA4B::ZNF710	Adenocarcinoma
SEMA4C::AFF3	Adenocarcinoma
SEMA4C::FAM178B	Squamous cell carcinoma
SEMA4C::IGFBP2	Adenocarcinoma
SEMA4C::PKM	Adenocarcinoma
SEMA4C::WNT5B	Adenocarcinoma
SEMA4D::RGS3	Adenocarcinoma
SEMA5A::BASP1	Malignant melanoma
SEMA5A::MARCHF6	Epithelioid sarcoma
SEMA5A::RBFOX2	Malignant melanoma
SEMA5A::RET	Adenocarcinoma
SEMA5A::ROPN1L	Squamous cell carcinoma
SEMA5A::SLC6A19	Mesenchymal tumor, NOS
SEMA5A::TMX4	Adenocarcinoma
SEMA5B::PLS1	Adenocarcinoma
SEMA6A::DTWD2	Adenocarcinoma
SEMA6A::LSM6	Adenocarcinoma
SEMA6C::CERS2	Squamous cell carcinoma
SEMA6C::VPS72	Adenocarcinoma
SEMA6D::EXD1	Astrocytoma, grade I-II
SENP2::ABR	Transitional cell carcinoma
SENP2::ANKRD27	Squamous cell carcinoma
SENP2::CLCN2	Adenocarcinoma
SENP2::LIPH	Astrocytoma, grade I-II
SENP2::MAP3K13	Malignant epithelial tumor, special type | Adenocarcinoma
SENP2::MSH5	Adenocarcinoma
SENP2::VPS8	Squamous cell carcinoma
SENP3::ABR	Adenocarcinoma
SENP3::ACADVL	Adenocarcinoma
SENP3::FXR2	Malignant melanoma
SENP3::GPS2	Astrocytoma, grade III-IV/Glioblastoma
SENP5::DYNLT2B	Adenocarcinoma
SENP5::KCNMB3	Squamous cell carcinoma
SENP5::PAK2	Squamous cell carcinoma | Adenocarcinoma
SENP5::PIGX	Adenocarcinoma
SENP5::PIGZ	Adenocarcinoma
SENP6::ACACB	Adenocarcinoma
SENP6::ADGRA2	Adenocarcinoma
SENP6::AKIRIN2	Mesenchymal tumor, NOS
SENP6::KATNA1	Adenocarcinoma
SENP6::NKAIN2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SENP6::OOEP	Adenocarcinoma
SENP6::PPIL6	Squamous cell carcinoma
SENP6::SLC35A1	Adenocarcinoma
SENP7::ABI3BP	Adenocarcinoma
SENP7::ETV6	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SENP7::RFC4	Adenocarcinoma
SENP7::ZBTB11	Mature B-cell neoplasm, NOS
SEPHS1::PTER	Adenocarcinoma
SEPHS2::MAPK3	Transitional cell carcinoma
SEPTIN10::PLCD4	Astrocytoma, grade I-II
SEPTIN11::GARNL3	Adenocarcinoma
SEPTIN11::GASK1B	Adenocarcinoma
SEPTIN11::WWC2	Adenocarcinoma
SEPTIN14::UPP1	Astrocytoma, grade I-II
SEPTIN1::SEC14L1	Adenocarcinoma
SEPTIN2::RHOH	Adenocarcinoma
SEPTIN3::BRAF	Malignant melanoma
SEPTIN6::CUL4B	Transitional cell carcinoma
SEPTIN6::RPL39	Malignant epithelial tumor, special type
SEPTIN6::UPF3B	Malignant epithelial tumor, special type
SEPTIN7::BRAF	Soft tissue tumor, special type
SEPTIN7::GLI3	Adenocarcinoma
SEPTIN8::AFF4	Adenocarcinoma
SEPTIN8::MEIKIN	Adenocarcinoma
SEPTIN9::ARSG	Adenocarcinoma
SEPTIN9::BAIAP2	Adenocarcinoma
SEPTIN9::BCAS3	Malignant melanoma
SEPTIN9::COL7A1	Mesothelioma
SEPTIN9::CRAT	Adenocarcinoma
SEPTIN9::DNAH17	Adenocarcinoma
SEPTIN9::JMJD6	Adenocarcinoma
SEPTIN9::KRT32	Adenocarcinoma
SEPTIN9::LPP	Adenocarcinoma
SEPTIN9::METTL2A	Adenocarcinoma
SEPTIN9::MGAT5B	Adenocarcinoma | Malignant epithelial tumor, special type
SEPTIN9::MPO	Adenocarcinoma
SEPTIN9::MRPL38	Adenocarcinoma
SEPTIN9::MYH13	Adenocarcinoma
SEPTIN9::NARF	Adenocarcinoma
SEPTIN9::RAB37	Malignant epithelial tumor, special type
SEPTIN9::SEC14L1	Adenocarcinoma
SEPTIN9::SMG6	Adenocarcinoma
SEPTIN9::TANC2	Adenocarcinoma
SEPTIN9::UBE2L5	Adenocarcinoma
SEPTIN9::VAV1	Adenocarcinoma
SEPTIN9::ZFTRAF1	Transitional cell carcinoma
SERF1A::SMN2	Adenocarcinoma
SERF1B::ANKRD55	Malignant melanoma
SERF1B::RNF111	Malignant melanoma
SERF2::GPN2	Adenocarcinoma
SERF2::IGK	Multiple myeloma
SERF2::PDIA3	Adenocarcinoma
SERGEF::ANKRD29	Adenocarcinoma
SERGEF::HBE1	Mesenchymal tumor, NOS
SERGEF::KCNC1	Malignant melanoma
SERINC1::NKAIN2	Squamous cell carcinoma
SERINC2::ARHGEF1	Adenocarcinoma
SERINC2::EIF2AK2	Transitional cell carcinoma
SERINC2::FN1	Adenocarcinoma
SERINC2::PFDN2	Transitional cell carcinoma
SERINC2::YY1	Transitional cell carcinoma
SERINC2::ZCCHC17	Squamous cell carcinoma | Undifferentiated carcinoma, small cell
SERINC2::ZNFX1	Adenocarcinoma
SERINC3::NCOA5	Malignant epithelial tumor, special type
SERINC3::TWSG1	Adenocarcinoma
SERINC3::WFDC11	Adenocarcinoma
SERINC3::ZCCHC7	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SERINC5::CDYL2	Adenocarcinoma
SERINC5::MYO10	Malignant melanoma
SERINC5::PLPP1	Adenocarcinoma
SERINC5::THBS4	Squamous cell carcinoma
SERINC5::TTC39A	Adenocarcinoma
SERINC5::ZFYVE16	Adenocarcinoma
SERPINA11::SERPINA12	Adenocarcinoma
SERPINA1::ABHD14A	Adenocarcinoma
SERPINA1::ANKS1A	Adenocarcinoma
SERPINA1::CCT5	Adenocarcinoma
SERPINA1::CD46	Adenocarcinoma
SERPINA1::CD63	Adenocarcinoma
SERPINA1::CPD	Adenocarcinoma
SERPINA1::FADS2	Adenocarcinoma
SERPINA1::FGG	Adenocarcinoma
SERPINA1::FOXP1	Adenocarcinoma
SERPINA1::GAPDH	Adenocarcinoma
SERPINA1::KIAA1217	Adenocarcinoma
SERPINA1::LGR4	Adenocarcinoma
SERPINA1::PEX1	Adenocarcinoma
SERPINA1::RPL35	Adenocarcinoma
SERPINA1::TF	Adenocarcinoma
SERPINA1::TMCO1	Adenocarcinoma
SERPINA1::TMT1A	Adenocarcinoma
SERPINA3::CPB1	Adenocarcinoma
SERPINA3::EIF2AK2	Adenocarcinoma
SERPINA3::LAP3	Adenocarcinoma
SERPINA3::RPL23	Adenocarcinoma
SERPINA5::CPB1	Adenocarcinoma
SERPINA6::GCH1	Adenocarcinoma
SERPINB13::SERPINB5	Squamous cell carcinoma
SERPINB1::SERPINB6	Diffuse large B-cell lymphoma
SERPINB5::CDH19	Adenocarcinoma
SERPINB7::SERPINB5	Squamous cell carcinoma
SERPINC1::HP	Adenocarcinoma
SERPINC1::STAT6	Adenocarcinoma
SERPIND1::MICALL1	Adenocarcinoma
SERPINE1::COL1A2	Adenocarcinoma
SERPINE1::FOSB	Pseudomyogenic hemangioendothelioma
SERPINE2::FARSB	Adenocarcinoma
SERPINE2::RABEP1	Malignant melanoma
SERPING1::CCT5	Adenocarcinoma
SERPING1::CHD1	Malignant melanoma
SERPINH1::MYO7A	Malignant melanoma
SERPINH1::ZBTB44	Adenocarcinoma
SERPINI1::NAALADL2	Adenocarcinoma
SERTAD2::BCL2L11	Malignant epithelial tumor, special type
SERTAD2::DEFB124	Mature B-cell neoplasm, NOS | Diffuse large B-cell lymphoma
SERTAD2::TGFA	Squamous cell carcinoma
SESN1::ARMC2	Mesenchymal tumor, NOS
SESN1::CENPW	Squamous cell carcinoma
SESN1::CRYBG1	Adenocarcinoma
SESN1::ECHDC1	Adenocarcinoma
SESN1::EYS	Squamous cell carcinoma
SESN1::METTL1	Mesenchymal tumor, NOS
SESN1::MGST2	Adenocarcinoma
SESN1::PPIL6	Adenocarcinoma
SESTD1::ACMSD	Adenocarcinoma
SESTD1::CCDC141	Adenocarcinoma
SESTD1::FGGY	Mesenchymal tumor, NOS
SESTD1::POU1F1	Mesenchymal tumor, NOS
SESTD1::ZNF385B	Adenocarcinoma
SET::GLE1	Adenocarcinoma
SET::NUP214	Heart | Acute undifferentiated leukemia | Chronic myeloid leukemia, t(9;22) | Skin | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Bilineage or biphenotypic leukemia | Acute myeloid leukemia, NOS | Acute myelomonocytic leukemia (FAB type M4) | Egypt | Algeria
SETBP1::BMAL1	Adenocarcinoma
SETBP1::NFYC	Transitional cell carcinoma
SETD1A::NLRC3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SETD1A::SRCAP	Skin | Acute myeloid leukemia, NOS | Adenocarcinoma
SETD1B::FOSB	Epithelioid hemangioendothelioma
SETD1B::KDM2B	Astrocytoma, grade III-IV/Glioblastoma
SETD1B::MLXIP	Squamous cell carcinoma
SETD1B::TFE3	Adenocarcinoma
SETD1B::TMEM120B	Adenocarcinoma
SETD2::ALK	Adenocarcinoma
SETD2::CCDC12	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SETD2::CCRL2	Mesenchymal tumor, NOS
SETD2::CD58	Mature B-cell neoplasm, NOS
SETD2::HIVEP3	Adenocarcinoma
SETD2::KIF9	Adenocarcinoma | Malignant epithelial tumor, special type
SETD2::MACROD2	Mesothelioma
SETD2::MRPL44	Adenocarcinoma
SETD2::NBEAL2	Mesothelioma
SETD2::NF1	Soft tissue tumor, special type
SETD2::NISCH	Mesothelioma
SETD2::PALMD	Malignant epithelial tumor, special type
SETD2::POGLUT1	Adenocarcinoma
SETD2::PRSS50	Adenocarcinoma
SETD2::QRICH1	Adenocarcinoma
SETD2::RBM6	Mesenchymal tumor, NOS
SETD2::SCAP	Adenocarcinoma
SETD2::SMARCC1	Adenocarcinoma
SETD2::SPATA12	Mesothelioma
SETD2::ULK4	Adenocarcinoma
SETD3::ALK	Adenocarcinoma
SETD3::ATG2B	Adenocarcinoma
SETD4::B4GALT6	Squamous cell carcinoma
SETD4::FTCD	Adenocarcinoma
SETD5::ATG7	Adenocarcinoma
SETD5::CIDEC	Adenocarcinoma
SETD5::GADL1	Adenocarcinoma
SETD5::GXYLT2	Adenocarcinoma
SETD5::IKZF1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SETD5::LMCD1	Adenocarcinoma
SETD5::MCM7	Adenocarcinoma
SETD5::NAALAD2	Undifferentiated carcinoma, small cell
SETD5::RAD18	Transitional cell carcinoma
SETD5::SAMD12	Adenocarcinoma
SETD5::SRGAP3	Adenocarcinoma
SETD7::ACAD11	Mesenchymal tumor, NOS
SETD7::CREM	Astrocytoma, grade I-II
SETD7::NPY5R	Malignant melanoma
SETDB1::CD46	Adenocarcinoma
SETDB1::GABPB2	Adenocarcinoma
SETDB1::PIP5K1A	Malignant melanoma
SETDB1::PKP4	Adenocarcinoma
SETDB1::PLEKHO1	Adenocarcinoma
SETDB2::AATF	Mesenchymal tumor, NOS
SETDB2::CAB39L	Transitional cell carcinoma
SETDB2::ERH	Adenocarcinoma
SETMAR::EYS	Squamous cell carcinoma
SETMAR::SUMF1	Transitional cell carcinoma
SETX::RAB14	Adenocarcinoma
SETX::TTF1	Squamous cell carcinoma
SEZ6::ERBB2	Carcinoma, NOS
SEZ6L::POMGNT1	Malignant epithelial tumor, special type
SF1::CST6	Adenocarcinoma
SF1::EHD1	Squamous cell carcinoma
SF1::ITPR1	Adenocarcinoma
SF1::MAJIN	Adenocarcinoma
SF1::PLAAT2	Squamous cell carcinoma
SF1::SF3B1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SF1::SYT7	Adenocarcinoma
SF1::ZSWIM5	Adenocarcinoma
SF3A1::PES1	Adenocarcinoma
SF3A2::AZU1	Adenocarcinoma
SF3A2::FNBP1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SF3A3::GNL2	Undifferentiated carcinoma, small cell
SF3A3::HPCAL4	Malignant epithelial tumor, special type
SF3B1::HSPD1	Transitional cell carcinoma
SF3B1::RFTN2	Squamous cell carcinoma
SF3B1::SATB2	Adenocarcinoma
SF3B2::SART1	Adenocarcinoma
SF3B2::TRMT112	Adenocarcinoma
SF3B3::ADAM12	Germ cell tumor, NOS
SF3B3::CDH1	Mature B-cell neoplasm, NOS
SF3B3::CDH15	Adenocarcinoma
SF3B3::CDH3	Adenocarcinoma
SF3B3::COG4	Adenocarcinoma
SF3B3::CTCF	Adenocarcinoma
SF3B3::DDX19B	Astrocytoma, grade III-IV/Glioblastoma
SF3B3::RXRA	Astrocytoma, grade III-IV/Glioblastoma
SFI1::CRACR2A	Germ cell tumor, NOS
SFI1::DEPDC5	Squamous cell carcinoma
SFI1::LIMK2	Astrocytoma, grade I-II
SFI1::OSBP2	Adenocarcinoma
SFI1::TPST2	Adenocarcinoma
SFI1::YPEL1	Adenocarcinoma
SFMBT1::ABHD5	Adenocarcinoma
SFMBT1::AP2A2	Undifferentiated carcinoma, small cell
SFMBT1::CAMK4	Adenocarcinoma
SFMBT1::EML1	Adenocarcinoma
SFMBT1::GNL3	Adenocarcinoma
SFMBT1::HPS3	Adenocarcinoma
SFMBT1::IGH	Chronic lymphocytic leukemia
SFMBT1::ITIH4	Adenocarcinoma
SFMBT1::PBRM1	Adenocarcinoma
SFMBT1::PTPRG	Malignant melanoma
SFMBT1::RFT1	Adenocarcinoma
SFMBT1::TKT	Adenocarcinoma
SFMBT1::WNT7A	Adenocarcinoma
SFMBT1::ZDHHC3	Mesothelioma
SFMBT2::AKR1C4	Squamous cell carcinoma
SFMBT2::CELF2	Adenocarcinoma
SFMBT2::PRKACB	Squamous cell carcinoma
SFMBT2::TGM2	Astrocytoma, grade I-II
SFN::CCT5	Squamous cell carcinoma
SFN::CLASP1	Squamous cell carcinoma
SFN::ELK3	Squamous cell carcinoma
SFN::HDLBP	Squamous cell carcinoma
SFN::PLAT	Squamous cell carcinoma
SFN::TYK2	Squamous cell carcinoma
SFPQ::ABL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SFPQ::PLEKHG4B	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SFPQ::TFE3	Soft tissue tumor, special type | Adenocarcinoma | PEComa
SFPQ::TFEB	Adenocarcinoma
SFPQ::ZFP36L1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SFPQ::ZFP36L2	Bilineage or biphenotypic leukemia | Egypt | Acute lymphoblastic leukemia/lymphoblastic lymphoma
SFRP1::ARMC5	Adenocarcinoma
SFSWAP::ITPK1	Multiple myeloma
SFSWAP::MYO1H	Astrocytoma, grade I-II
SFSWAP::UBC	Multiple myeloma
SFT2D1::TENT5A	Malignant melanoma
SFT2D2::GPR161	Mesenchymal tumor, NOS
SFT2D2::SUCO	Squamous cell carcinoma
SFTA3::SLC25A21	Squamous cell carcinoma
SFTA3::TRA	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SFTPA2::SFTPB	Adenocarcinoma
SFTPB::C3	Adenocarcinoma
SFTPB::DMTN	Adenocarcinoma
SFTPB::DPYSL2	Adenocarcinoma
SFTPB::MPC1	Adenocarcinoma
SFTPB::MUC1	Adenocarcinoma
SFTPB::RPLP0	Adenocarcinoma
SFTPB::SLC35C1	Adenocarcinoma
SFTPB::SRRM2	Adenocarcinoma
SFTPB::TPT1	Adenocarcinoma
SFTPB::USP39	Adenocarcinoma
SFTPB::WDR13	Adenocarcinoma
SFTPC::BMP1	Nonneoplastic epithelial disorder/lesion
SFTPC::CHD1	Adenocarcinoma
SFTPC::IGLL5	Adenocarcinoma
SFTPC::SUPT16H	Adenocarcinoma
SFTPC::ZNFX1	Adenocarcinoma
SFXN1::CPLX2	Adenocarcinoma
SFXN2::SUFU	Adenocarcinoma
SFXN5::DYNLL2	Adenocarcinoma
SFXN5::M1AP	Adenocarcinoma
SFXN5::RAB11FIP5	Malignant epithelial tumor, special type
SFXN5::SLC8A1	Adenocarcinoma
SFXN5::TMEM150A	Adenocarcinoma
SGCA::PPP1R9B	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SGCB::SPATA18	Squamous cell carcinoma
SGCB::TXLNA	Astrocytoma, grade I-II
SGCD::LCP2	Squamous cell carcinoma
SGCD::RARA	Adenocarcinoma
SGF29::CDR2	Adenocarcinoma
SGIP1::RET	Carcinoma, NOS
SGK2::SERINC2	Adenocarcinoma
SGK3::ANKS1A	Squamous cell carcinoma
SGK3::DNAJC5B	Adenocarcinoma
SGK3::KRT9	Adenocarcinoma
SGK3::NCK1	Malignant melanoma
SGK3::TRIM55	Adenocarcinoma
SGMS1::GAB2	Adenocarcinoma
SGMS1::GRID1	Squamous cell carcinoma
SGMS1::KCTD8	Squamous cell carcinoma
SGMS1::PARG	Adenocarcinoma
SGMS1::PSMB2	Adenocarcinoma
SGMS1::STK10	Adenocarcinoma
SGMS1::VSTM4	Adenocarcinoma
SGO1::EFHB	Squamous cell carcinoma
SGO2::FBXO8	Adenocarcinoma
SGPL1::ADAMTS14	Adenocarcinoma
SGPL1::BTBD9	Adenocarcinoma
SGPL1::COL13A1	Adenocarcinoma
SGPP1::NAA30	Astrocytoma, grade I-II
SGPP2::ABCA12	Adenocarcinoma
SGPP2::ALG14	Adenocarcinoma
SGPP2::TEN1	Adenocarcinoma
SGSH::TBC1D16	Adenocarcinoma
SGSM1::GAL3ST1	Mesenchymal tumor, NOS
SGSM2::EPN2	Transitional cell carcinoma
SGSM2::PTK6	Adenocarcinoma
SGSM2::SRR	Squamous cell carcinoma
SGSM3::DEFB126	Malignant melanoma
SGSM3::PLAUR	Adenocarcinoma
SGSM3::PPP6R2	Mesenchymal tumor, NOS
SGSM3::TNRC6B	Adenocarcinoma
SGTA::INSL3	Adenocarcinoma
SGTA::ZBTB7A	Multiple myeloma
SH2B2::CUX1	Mature B-cell neoplasm, NOS
SH2B3::ATXN2	Mesenchymal tumor, NOS
SH2B3::CUX2	Adenocarcinoma
SH2B3::FBXO21	Adenocarcinoma
SH2D3A::GPM6A	Squamous cell carcinoma
SH2D3A::RET	Carcinoma, NOS
SH2D4A::AP3M2	Adenocarcinoma
SH2D6::NCOA2	Transitional cell carcinoma
SH3BGR::IGSF5	Adenocarcinoma
SH3BGRL2::ADGRB3	Adenocarcinoma
SH3BGRL2::EYS	Adenocarcinoma
SH3BGRL2::HMGCLL1	Adenocarcinoma
SH3BGRL3::FAR1	Squamous cell carcinoma
SH3BGRL3::GRINA	Malignant melanoma
SH3BGRL::CBS	Mesenchymal tumor, NOS
SH3BP1::CACNA1I	Squamous cell carcinoma
SH3BP1::NTRK1	Soft tissue tumor, special type
SH3BP2::ATP8A1	Adenocarcinoma
SH3BP4::LANCL1	Adenocarcinoma
SH3BP4::MST1R	Squamous cell carcinoma
SH3BP4::PGK1	Adenocarcinoma
SH3BP4::SNED1	Adenocarcinoma
SH3BP5::HEATR6	Adenocarcinoma
SH3BP5::METTL6	Adenocarcinoma
SH3BP5::TXNDC11	Multiple myeloma
SH3D19::INPP4B	Malignant melanoma
SH3D19::LAMTOR3	Mesothelioma
SH3D19::ZNF721	Astrocytoma, grade III-IV/Glioblastoma
SH3D21::AGO3	Adenocarcinoma
SH3D21::PCGF3	Adenocarcinoma
SH3D21::THRAP3	Squamous cell carcinoma
SH3GL1::ANKRD24	Adenocarcinoma
SH3GL1::DOHH	Adenocarcinoma
SH3GL1::DPP9	Adenocarcinoma
SH3GL1::FN1	Adenocarcinoma
SH3GL1::IRF4	Adenocarcinoma
SH3GL1::MGAT5B	Adenocarcinoma
SH3GL1::MLLT1	Adenocarcinoma
SH3GL1::RUVBL2	Astrocytoma, grade I-II
SH3GL1::STAP2	Squamous cell carcinoma
SH3GL1::TAX1BP1	Adenocarcinoma
SH3GL2::FREM1	Malignant melanoma
SH3GLB1::CLCA1	Squamous cell carcinoma
SH3GLB2::CACNA1A	Adenocarcinoma
SH3GLB2::DYNC2I2	Adenocarcinoma
SH3GLB2::GTSE1	Adenocarcinoma
SH3KBP1::MAP7D2	Adenocarcinoma
SH3KBP1::TLR3	Skin | Acute myeloid leukemia, NOS
SH3KBP1::VSIG1	Malignant melanoma
SH3PXD2A::HNF4A	Adenocarcinoma
SH3PXD2A::HTRA1	Schwannoma
SH3PXD2A::ITPRIP	Transitional cell carcinoma
SH3PXD2A::MAP1S	Adenocarcinoma
SH3PXD2A::PDLIM1	Squamous cell carcinoma
SH3PXD2A::RB1	Adenocarcinoma
SH3PXD2A::STN1	Squamous cell carcinoma
SH3PXD2B::FER	Fibroblastic/myofibroblastic tumor, NOS
SH3RF1::NEK1	Adenocarcinoma
SH3RF1::SPOCK3	Adenocarcinoma
SH3RF1::TLL1	Adenocarcinoma
SH3RF2::MDM1	Mesenchymal tumor, NOS
SH3RF2::SLC23A1	Squamous cell carcinoma
SH3YL1::MTHFD1L	Mesenchymal tumor, NOS
SHANK1::MTHFD1L	Adenocarcinoma
SHANK2::ACER3	Adenocarcinoma
SHANK2::AHNAK	Adenocarcinoma
SHANK2::ANO1	Transitional cell carcinoma
SHANK2::ANXA13	Adenocarcinoma
SHANK2::ARHGEF17	Adenocarcinoma
SHANK2::BANF1	Adenocarcinoma
SHANK2::C7ORF57	Adenocarcinoma
SHANK2::CNTN6	Adenocarcinoma
SHANK2::COA4	Adenocarcinoma
SHANK2::COL8A2	Adenocarcinoma
SHANK2::CPT1A	Adenocarcinoma
SHANK2::CSTPP1	Squamous cell carcinoma
SHANK2::EFCAB6	Adenocarcinoma
SHANK2::ELP4	Adenocarcinoma
SHANK2::FCHSD2	Adenocarcinoma
SHANK2::HMGN3	Adenocarcinoma
SHANK2::IFT140	Transitional cell carcinoma
SHANK2::ITPK1	Adenocarcinoma
SHANK2::KDM2A	Adenocarcinoma
SHANK2::LILRB2	Adenocarcinoma
SHANK2::LRTOMT	Transitional cell carcinoma
SHANK2::MATN2	Transitional cell carcinoma
SHANK2::MS4A8	Squamous cell carcinoma
SHANK2::MYEOV	Adenocarcinoma
SHANK2::NEU3	Adenocarcinoma
SHANK2::NRXN2	Adenocarcinoma
SHANK2::NUMA1	Adenocarcinoma
SHANK2::OPCML	Adenocarcinoma
SHANK2::PATL1	Adenocarcinoma
SHANK2::PGA5	Adenocarcinoma
SHANK2::PIP5KL1	Adenocarcinoma
SHANK2::PRKCA	Adenocarcinoma
SHANK2::RBM4B	Adenocarcinoma
SHANK2::SPCS2	Adenocarcinoma
SHANK2::SPTBN2	Adenocarcinoma
SHANK2::SYT7	Adenocarcinoma
SHANK2::TACC1	Adenocarcinoma
SHANK2::TENM4	Adenocarcinoma
SHANK2::THRSP	Adenocarcinoma
SHANK2::UNC5D	Adenocarcinoma
SHANK2::WNT11	Adenocarcinoma
SHANK3::ACR	Nonneoplastic epithelial disorder/lesion
SHANK3::ADM2	Malignant melanoma
SHANK3::BAG4	Adenocarcinoma
SHANK3::LARGE1	Adenocarcinoma
SHANK3::MAPK1	Malignant melanoma
SHANK3::MIOX	Malignant melanoma
SHANK3::PLXNB2	Adenocarcinoma
SHB::CDKN2A	Mesothelioma
SHB::CPEB2	Adenocarcinoma
SHB::DDX6	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SHB::FAM219A	Transitional cell carcinoma
SHB::GRIN2A	Astrocytoma, grade I-II
SHB::LINGO2	Astrocytoma, grade III-IV/Glioblastoma
SHB::LYN	Adenocarcinoma
SHB::PAX5	Squamous cell carcinoma
SHB::SLC28A3	Adenocarcinoma
SHC1::ANAPC5	Malignant melanoma
SHC1::ASH1L	Adenocarcinoma
SHC1::EFNA3	Squamous cell carcinoma
SHC1::FOXP1	Adenocarcinoma
SHC1::IQGAP3	Malignant melanoma
SHC1::NUP210L	Adenocarcinoma
SHC1::RPRD2	Adenocarcinoma
SHC2::CREB3L3	Adenocarcinoma
SHC2::PTEN	Malignant melanoma
SHC2::R3HDM4	Astrocytoma, grade I-II
SHC2::RNF126	Malignant melanoma
SHC2::TJP3	Astrocytoma, grade I-II
SHC2::ZNF559	Mesenchymal tumor, NOS
SHC3::HACD4	Astrocytoma, grade I-II
SHH::KNG1	Adenocarcinoma
SHH::PLCB1	Squamous cell carcinoma
SHISA5::DNAAF11	Adenocarcinoma
SHISA5::IP6K2	Squamous cell carcinoma
SHISA5::UQCRC1	Transitional cell carcinoma
SHISA9::CCL19	Astrocytoma, grade I-II
SHISA9::CREB5	Malignant melanoma
SHISAL1::TTLL12	Malignant melanoma
SHKBP1::DDX21	Diffuse large B-cell lymphoma
SHLD1::CST4	Adenocarcinoma
SHLD1::LTO1	Adenocarcinoma
SHLD1::NCKAP1	Adenocarcinoma
SHLD2::BMPR1A	Adenocarcinoma
SHLD2::DOCK1	Adenocarcinoma
SHLD2::PAPSS2	Adenocarcinoma
SHLD2::PTEN	Adenocarcinoma
SHLD2::SEZ6L2	Adenocarcinoma
SHMT2::SLC16A7	Malignant melanoma
SHOC2::ADD3	Adenocarcinoma
SHOC2::EDRF1	Astrocytoma, grade I-II
SHOC2::RBM20	Adenocarcinoma
SHOC2::TMEM178A	Adenocarcinoma
SHPK::ATP2A3	Adenocarcinoma
SHPK::GUCY1A2	Transitional cell carcinoma
SHPRH::NDUFS5	Transitional cell carcinoma
SHPRH::PKIB	Adenocarcinoma
SHPRH::RCL1	Transitional cell carcinoma
SHQ1::PSMB7	Adenocarcinoma
SHROOM2::BHLHE41	Adenocarcinoma
SHROOM2::FRMPD4	Transitional cell carcinoma
SHROOM2::REPS2	Transitional cell carcinoma
SHROOM3::ART3	Germ cell tumor, NOS
SHROOM3::CCDC68	Adenocarcinoma
SHROOM3::COL8A1	Squamous cell carcinoma
SHROOM3::DCST2	Adenocarcinoma
SHROOM3::FABP5	Adenocarcinoma
SHROOM3::FAM47E	Adenocarcinoma
SHROOM3::FIP1L1	Adenocarcinoma
SHROOM3::GRSF1	Adenocarcinoma
SHROOM3::JCHAIN	Adenocarcinoma
SHROOM3::LUC7L	Adenocarcinoma
SHROOM3::MTHFD2L	Adenocarcinoma
SHROOM3::NNMT	Adenocarcinoma
SHROOM3::SCARB2	Adenocarcinoma
SHROOM3::STX18	Adenocarcinoma
SHROOM3::TRIM28	Adenocarcinoma
SHROOM4::AR	Adenocarcinoma
SHROOM4::ARID3A	Adenocarcinoma
SHROOM4::DIPK2B	Adenocarcinoma
SHROOM4::PAGE1	Adenocarcinoma
SHTN1::DZANK1	Adenocarcinoma
SHTN1::FAM24B	Adenocarcinoma
SHTN1::HSPA12A	Malignant melanoma
SHTN1::PDZD8	Adenocarcinoma
SHTN1::PRDX3	Transitional cell carcinoma
SHTN1::RET	Carcinoma, NOS
SHTN1::ROS1	Melanocytic neoplasm, special type
SHTN1::YTHDF1	Adenocarcinoma
SIAE::GRIK4	Adenocarcinoma
SIAE::HYLS1	Astrocytoma, grade III-IV/Glioblastoma
SIAH1::PRKN	Multiple myeloma
SIAH1::RIPOR1	Malignant melanoma
SIAH2::CFAP97	Adenocarcinoma
SIAH2::SERP1	Adenocarcinoma
SIDT1::HHLA2	Multiple myeloma
SIDT2::TAGLN	Adenocarcinoma | Nonneoplastic epithelial disorder/lesion | Nonneoplastic hematologic disorder/lesion | Schwannoma
SIGIRR::DEAF1	Adenocarcinoma
SIGMAR1::IGF2	Adenocarcinoma
SIK1::HUNK	Squamous cell carcinoma
SIK2::JAK2	Adenocarcinoma
SIK2::MEGF11	Astrocytoma, grade I-II
SIK2::PIR	Adenocarcinoma
SIK2::POU2AF2	Squamous cell carcinoma
SIK3::APOC3	Acute myeloid leukemia, NOS | Skin
SIK3::CD3D	Adenocarcinoma
SIK3::CFAP68	Skin | Acute myeloid leukemia, NOS | Acute monoblastic leukemia (FAB type M5)
SIK3::CNTN5	Squamous cell carcinoma
SIK3::CTNNBIP1	Adenocarcinoma
SIK3::KMT2A	Skin | Acute myeloid leukemia, NOS
SIK3::PCSK7	Malignant melanoma
SIK3::PPP1R1B	Adenocarcinoma
SIK3::SRSF9	Malignant epithelial tumor, special type
SIK3::TMPRSS2	Adenocarcinoma
SIKE1::FAF1	Adenocarcinoma
SIL1::CTNNA1	Adenocarcinoma
SIL1::DNAJC18	Squamous cell carcinoma | Adenocarcinoma
SIL1::ECSCR	Adenocarcinoma
SIL1::GFRA3	Acute myelomonocytic leukemia (FAB type M4)
SIL1::NRG2	Adenocarcinoma
SIL1::PAIP2	Mesenchymal tumor, NOS
SIL1::SLC23A1	Adenocarcinoma
SIL1::SMC1B	Squamous cell carcinoma
SIL1::STK10	Adenocarcinoma
SIM1::ASCC3	Adenocarcinoma
SIM2::GRIK1	Adenocarcinoma
SIM2::KCNJ6	Astrocytoma, grade I-II
SIM2::MORC3	Adenocarcinoma
SIN3A::ANKRD18B	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SIN3A::CSPG4	Adenocarcinoma
SIN3A::NEO1	Adenocarcinoma
SIN3A::OCA2	Transitional cell carcinoma
SIN3A::PTPN9	Astrocytoma, grade I-II
SIN3A::SEMA7A	Adenocarcinoma
SIN3A::SNUPN	Squamous cell carcinoma
SIN3B::BRME1	Mesenchymal tumor, NOS
SIN3B::TBC1D17	Mesenchymal tumor, NOS
SIN3B::ZNF285	Adenocarcinoma
SINHCAF::CD27	Adenocarcinoma
SINHCAF::COA1	Squamous cell carcinoma
SINHCAF::DENND5B	Multiple myeloma
SINHCAF::MADCAM1	Adenocarcinoma
SINHCAF::PLEKHA5	Adenocarcinoma
SINHCAF::SEPTIN9	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SINHCAF::TM7SF3	Adenocarcinoma
SIPA1::FRMD8	Squamous cell carcinoma | Malignant melanoma
SIPA1::RHOD	Squamous cell carcinoma
SIPA1L1::NF1	Adenocarcinoma
SIPA1L1::PAPOLA	Transitional cell carcinoma
SIPA1L2::NTPCR	Mesothelioma
SIPA1L2::TRIM11	Adenocarcinoma
SIPA1L3::C1QTNF3	Adenocarcinoma
SIPA1L3::CATSPERG	Adenocarcinoma
SIPA1L3::CD22	Squamous cell carcinoma
SIPA1L3::CEP89	Malignant melanoma
SIPA1L3::COLEC10	Adenocarcinoma
SIPA1L3::EIF3B	Adenocarcinoma
SIPA1L3::ERC1	Adenocarcinoma
SIPA1L3::ETHE1	Adenocarcinoma
SIPA1L3::GPI	Transitional cell carcinoma
SIPA1L3::GTF2F1	Adenocarcinoma
SIPA1L3::LIG1	Adenocarcinoma
SIPA1L3::LSM14A	Adenocarcinoma
SIPA1L3::MIX23	Adenocarcinoma
SIPA1L3::POLD1	Adenocarcinoma
SIPA1L3::PTOV1	Adenocarcinoma
SIPA1L3::RAB8A	Adenocarcinoma
SIPA1L3::RINL	Adenocarcinoma
SIPA1L3::SYMPK	Adenocarcinoma
SIPA1L3::WDR62	Adenocarcinoma
SIPA1L3::ZNF527	Adenocarcinoma
SIPA1L3::ZNF835	Adenocarcinoma
SIRPA::CWF19L2	Adenocarcinoma
SIRPB1::SIRPD	Nonneoplastic epithelial disorder/lesion
SIRT1::CELF2	Adenocarcinoma
SIRT1::DNAJC12	Squamous cell carcinoma
SIRT5::PHACTR1	Adenocarcinoma
SIRT6::CERS4	Adenocarcinoma
SIRT6::CREB3L3	Squamous cell carcinoma
SIRT7::CCDC57	Adenocarcinoma
SIX1::CYB5R2	Adenocarcinoma
SKA2::HEATR6	Mesenchymal tumor, NOS
SKA2::MYO19	Adenocarcinoma
SKAP1::ABCC11	Adenocarcinoma
SKAP1::BCAS3	Adenocarcinoma
SKAP1::CALCOCO2	Malignant melanoma
SKAP1::DNAH17	Adenocarcinoma
SKAP1::HLA-DPB1	Adenocarcinoma
SKAP1::HOXB3	Adenocarcinoma
SKAP1::HOXB6	Adenocarcinoma
SKAP1::HOXB9	Adenocarcinoma
SKAP1::IKZF3	Adenocarcinoma
SKAP1::NQO2	Adenocarcinoma
SKAP1::NR1D1	Adenocarcinoma
SKAP1::PSMD11	Adenocarcinoma
SKAP1::RBM6	Adenocarcinoma
SKAP1::SP2	Adenocarcinoma
SKAP1::TMEM100	Adenocarcinoma
SKAP1::YPEL2	Adenocarcinoma
SKAP1::ZNF74	Adenocarcinoma
SKAP2::NTRK2	Astrocytoma, grade III-IV/Glioblastoma
SKAP2::SCIN	Adenocarcinoma
SKAP2::SNX10	Adenoid cystic carcinoma
SKI::ATAD3A	Malignant epithelial tumor, special type
SKI::CA6	Malignant melanoma
SKI::CAPZB	Mesenchymal tumor, NOS
SKI::FAF1	Adenocarcinoma
SKI::KCNT2	Adenocarcinoma
SKI::PRKCZ	Adenocarcinoma
SKI::SSU72	Astrocytoma, grade III-IV/Glioblastoma
SKIC2::MSH5	Adenocarcinoma
SKIC8::MAPKAPK2	Adenocarcinoma
SKIL::FNDC3B	Squamous cell carcinoma
SKIL::GPR160	Adenocarcinoma
SKIL::PRKCI	Adenocarcinoma
SKIL::TNIK	Adenocarcinoma
SKP1::AFF4	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SKP1::CDKL3	Undifferentiated carcinoma, small cell
SKP1::PMPCA	Adenocarcinoma
SKP2::EXOSC10	Adenocarcinoma
SLA::GRIK1	Acute myeloblastic leukemia with maturation (FAB type M2)
SLAIN2::CWH43	Squamous cell carcinoma
SLAMF1::CD1A	Adenocarcinoma
SLAMF1::CD1C	Adenocarcinoma
SLBP::LETM1	Squamous cell carcinoma
SLBP::TMEM129	Adenocarcinoma
SLC10A7::EYS	Adenocarcinoma
SLC10A7::FKBP15	Adenocarcinoma
SLC10A7::TTC29	Adenocarcinoma
SLC11A2::ATP8B1	Squamous cell carcinoma
SLC11A2::CDC27	Adenocarcinoma
SLC11A2::PFKM	Astrocytoma, grade III-IV/Glioblastoma
SLC12A2::ALK	Benign epithelial tumor, special type
SLC12A2::C5ORF58	Adenocarcinoma
SLC12A2::CSNK1A1	Adenocarcinoma
SLC12A2::MEGF10	Adenocarcinoma
SLC12A2::PDHA1	Adenocarcinoma
SLC12A2::PPP2CA	Adenocarcinoma
SLC12A2::RET	Carcinoma, NOS
SLC12A2::ROS1	Adenocarcinoma | Inflammatory myofibroblastic tumor/myofibroblastic sarcoma
SLC12A4::DPEP2	Adenocarcinoma
SLC12A6::GOLGA8A	Transitional cell carcinoma
SLC12A6::NUTM1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SLC12A6::RPL13	Transitional cell carcinoma
SLC12A7::AAMDC	Malignant melanoma
SLC12A7::AFG1L	Malignant melanoma
SLC12A7::BRAF	Malignant melanoma
SLC12A7::CLPTM1L	Adenocarcinoma
SLC12A7::MTREX	Adenocarcinoma
SLC12A7::RASGEF1C	Adenocarcinoma
SLC12A7::TERT	Adenocarcinoma
SLC12A7::TMEM117	Adenocarcinoma
SLC12A7::TMEM232	Adenocarcinoma
SLC12A7::ZDHHC11B	Adenocarcinoma
SLC12A8::BCAS1	Squamous cell carcinoma
SLC12A8::BFSP2	Adenocarcinoma
SLC12A8::OSBPL11	Squamous cell carcinoma
SLC12A8::PARD6G	Malignant epithelial tumor, special type
SLC12A8::SLC41A3	Adenocarcinoma
SLC12A8::TMEM131	Adenocarcinoma
SLC12A9::MYB	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SLC14A2::ABHD3	Adenocarcinoma
SLC15A4::TMEM132D	Adenocarcinoma
SLC16A10::NME7	Squamous cell carcinoma
SLC16A10::PEX3	Adenocarcinoma
SLC16A14::SP110	Adenocarcinoma
SLC16A1::PTGR2	Adenocarcinoma
SLC16A1::SENP6	Adenocarcinoma
SLC16A3::AKAP10	Adenocarcinoma
SLC16A3::METRNL	Multiple myeloma
SLC16A3::MRPL4	Adenocarcinoma
SLC16A5::DCAF7	Squamous cell carcinoma
SLC16A5::KCTD2	Malignant melanoma
SLC16A5::MRPL58	Adenocarcinoma
SLC16A5::OTOP2	Adenocarcinoma
SLC16A5::UNK	Adenocarcinoma
SLC16A6::CA4	Transitional cell carcinoma
SLC16A6::PECAM1	Adenocarcinoma
SLC16A7::ACSS3	Mesenchymal tumor, NOS
SLC16A7::ATP23	Malignant epithelial tumor, special type
SLC16A7::BEST3	Mesenchymal tumor, NOS
SLC16A7::CALCOCO1	Adenoid cystic carcinoma
SLC16A7::GOLPH3	Malignant melanoma
SLC16A7::HOXC13	Transitional cell carcinoma
SLC16A7::MUCL1	Adenocarcinoma
SLC16A7::NUP107	Mesenchymal tumor, NOS
SLC16A7::OS9	Adenocarcinoma
SLC16A7::SARNP	Adenocarcinoma
SLC16A7::SYT1	Mesenchymal tumor, NOS
SLC16A7::TTC28	Squamous cell carcinoma
SLC16A9::ADK	Adenocarcinoma
SLC16A9::ANK3	Squamous cell carcinoma
SLC16A9::CCDC6	Adenocarcinoma
SLC18A2::IGF2	Malignant epithelial tumor, special type
SLC18B1::TRMT11	Malignant melanoma
SLC19A2::F5	Adenocarcinoma
SLC1A1::SMARCA2	Squamous cell carcinoma
SLC1A3::CDH12	Squamous cell carcinoma
SLC1A3::FYB1	Adenocarcinoma
SLC1A3::MAPKAP1	Squamous cell carcinoma
SLC1A3::METTL15	Adenocarcinoma
SLC1A3::RABEP1	Astrocytoma, grade I-II
SLC1A3::SHLD1	Adenocarcinoma
SLC1A5::AP2A1	Squamous cell carcinoma
SLC1A5::STAT6	Adenocarcinoma
SLC1A5::UBTF	Squamous cell carcinoma
SLC1A6::AKAP8L	Malignant epithelial tumor, special type
SLC20A1::ALK	Melanocytic neoplasm, special type
SLC20A1::ARRDC5	Mesenchymal tumor, NOS
SLC20A2::ADORA3	Adenocarcinoma
SLC20A2::ANKH	Squamous cell carcinoma
SLC20A2::CORO6	Malignant melanoma
SLC20A2::DOCK8	Adenocarcinoma
SLC20A2::FBXW7	Squamous cell carcinoma
SLC20A2::HIP1	Adenocarcinoma
SLC20A2::IDO1	Squamous cell carcinoma
SLC20A2::IKBKB	Adenocarcinoma
SLC20A2::TMIGD3	Adenocarcinoma
SLC20A2::TUSC3	Adenocarcinoma
SLC20A2::UNC5D	Adenocarcinoma
SLC20A2::ZMAT4	Adenocarcinoma | Squamous cell carcinoma
SLC22A15::ANO1	Adenocarcinoma
SLC22A17::BCAN	Astrocytoma, grade I-II
SLC22A23::CAMTA1	Adenocarcinoma
SLC22A23::ECHDC1	Transitional cell carcinoma
SLC22A23::GRIP1	Adenocarcinoma
SLC22A23::LRRC49	Malignant melanoma
SLC22A23::NAALADL2	Adenocarcinoma
SLC22A23::NRSN1	Adenocarcinoma
SLC22A23::PXDC1	Transitional cell carcinoma
SLC22A23::SERPINB6	Adenocarcinoma
SLC22A23::SMIM13	Adenocarcinoma
SLC22A23::TNFRSF21	Astrocytoma, grade III-IV/Glioblastoma
SLC22A23::TRAF3	Squamous cell carcinoma
SLC22A25::PACS1	Adenocarcinoma
SLC22A3::CYP20A1	Adenocarcinoma
SLC22A3::ZDHHC14	Astrocytoma, grade III-IV/Glioblastoma
SLC22A4::PDLIM4	Adenocarcinoma
SLC22A5::RAD50	Squamous cell carcinoma | Adenocarcinoma
SLC23A2::ATRN	Astrocytoma, grade III-IV/Glioblastoma
SLC23A2::CDS2	Adenocarcinoma
SLC23A2::PANK2	Malignant epithelial tumor, special type
SLC23A2::PHKB	Adenocarcinoma
SLC23A2::RASSF2	Adenocarcinoma
SLC23A2::TEAD4	Adenocarcinoma
SLC23A2::TMX4	Adenocarcinoma
SLC24A3::DSTN	Adenocarcinoma
SLC24A3::MACROD2	Squamous cell carcinoma
SLC24A3::PLCB4	Adenocarcinoma
SLC24A3::RIN2	Adenocarcinoma
SLC25A10::HGS	Adenocarcinoma
SLC25A10::USP32	Adenocarcinoma
SLC25A12::ERICH2	Adenocarcinoma
SLC25A12::NFASC	Astrocytoma, grade III-IV/Glioblastoma
SLC25A13::CD2AP	Adenocarcinoma
SLC25A13::CHAMP1	Adenocarcinoma
SLC25A13::FMC1	Adenocarcinoma
SLC25A13::GTPBP10	Mesenchymal tumor, NOS
SLC25A13::LUC7L2	Adenocarcinoma
SLC25A13::MAGI2	Squamous cell carcinoma
SLC25A13::SEM1	Adenocarcinoma
SLC25A13::SH2D3C	Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
SLC25A13::STK31	Adenocarcinoma
SLC25A14::BCORL1	Adenocarcinoma
SLC25A16::DRGX	Malignant melanoma
SLC25A16::NDUFA9	Squamous cell carcinoma
SLC25A17::DMC1	Squamous cell carcinoma
SLC25A17::EPN3	Adenocarcinoma
SLC25A17::RBFOX2	Transitional cell carcinoma
SLC25A17::RBX1	Squamous cell carcinoma
SLC25A17::ST13	Adenocarcinoma
SLC25A19::EXOC7	Astrocytoma, grade I-II
SLC25A1::SMTN	Malignant melanoma
SLC25A20::SLC26A6	Adenocarcinoma
SLC25A21::FOXA1	Adenocarcinoma
SLC25A21::MIPOL1	Adenocarcinoma
SLC25A22::CHID1	Adenocarcinoma
SLC25A22::POLR2L	Adenocarcinoma
SLC25A23::SLC2A9	Adenocarcinoma
SLC25A24::DHRS12	Adenocarcinoma
SLC25A24::NBPF6	Adenocarcinoma
SLC25A25::ADAMTSL3	Mesenchymal tumor, NOS
SLC25A25::CIZ1	Adenocarcinoma
SLC25A25::ELOA	Adenocarcinoma
SLC25A26::IMMT	Astrocytoma, grade III-IV/Glioblastoma
SLC25A26::LGMN	Adenocarcinoma
SLC25A26::TAFA1	Adenocarcinoma
SLC25A30::CCDC107	Adenocarcinoma
SLC25A32::LAPTM4B	Adenocarcinoma
SLC25A32::SMYD3	Adenocarcinoma
SLC25A33::APIP	Adenocarcinoma
SLC25A36::CLSTN2	Malignant melanoma
SLC25A36::PEX5L	Squamous cell carcinoma
SLC25A36::PLSCR1	Undifferentiated carcinoma, small cell
SLC25A39::EFCAB13	Adenocarcinoma
SLC25A3::DDX27	Malignant melanoma
SLC25A3::SIAE	Adenocarcinoma
SLC25A40::ADAM22	Adenocarcinoma
SLC25A41::THOP1	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
SLC25A42::GATAD2A	Adenocarcinoma
SLC25A42::SMARCA4	Malignant melanoma
SLC25A42::SUGP2	Adenocarcinoma
SLC25A44::RAB33A	Adenocarcinoma
SLC25A44::SEMA4A	Adenocarcinoma
SLC25A44::SYT11	Malignant epithelial tumor, special type
SLC25A51::DCN	Astrocytoma, grade I-II
SLC25A51::GLIPR2	Adenocarcinoma
SLC25A51::UBAP2	Mesenchymal tumor, NOS
SLC25A53::IL1RAPL2	Adenocarcinoma
SLC25A53::NXF3	Adenocarcinoma
SLC26A11::OAF	Squamous cell carcinoma
SLC26A11::RPTOR	Malignant melanoma
SLC26A2::ARHGEF37	Adenocarcinoma
SLC26A4::NNMT	Adenocarcinoma
SLC26A6::CYP2C8	Adenocarcinoma
SLC26A6::PRKAR2A	Adenocarcinoma
SLC26A6::UQCRC1	Adenocarcinoma
SLC27A1::KMT5C	Malignant melanoma
SLC27A1::PRORP	Malignant epithelial tumor, special type
SLC27A1::RASGRP4	Malignant melanoma
SLC29A1::DSP	Adenocarcinoma
SLC29A1::HSP90AB1	Chronic myeloid leukemia, t(9;22) | Nonneoplastic epithelial disorder/lesion | Heart
SLC29A1::RABEPK	Adenocarcinoma
SLC29A2::RAB6A	Adenocarcinoma
SLC29A3::UNC5B	Skin | Acute myeloid leukemia, NOS
SLC2A10::ACSS2	Squamous cell carcinoma
SLC2A11::LLPH	Squamous cell carcinoma
SLC2A12::SAMD3	Adenocarcinoma
SLC2A12::SGK1	Adenocarcinoma | Squamous cell carcinoma
SLC2A13::ANAPC7	Astrocytoma, grade III-IV/Glioblastoma
SLC2A13::ARHGDIB	Mesenchymal tumor, NOS
SLC2A13::FAM120A	Transitional cell carcinoma
SLC2A13::FAM186A	Malignant melanoma
SLC2A13::HSD17B6	Mesenchymal tumor, NOS
SLC2A13::RAB3IP	Adenocarcinoma
SLC2A13::TAFA2	Adenocarcinoma
SLC2A13::TERT	Adenocarcinoma
SLC2A13::ZNF329	Transitional cell carcinoma
SLC2A1::EBNA1BP2	Astrocytoma, grade III-IV/Glioblastoma
SLC2A1::ELOVL1	Adenocarcinoma
SLC2A1::FAF1	Adenocarcinoma
SLC2A1::GRHL3	Adenocarcinoma
SLC2A1::P3H1	Squamous cell carcinoma
SLC2A2::EIF5A2	Adenocarcinoma
SLC2A4::ERMAP	Chronic lymphocytic leukemia
SLC2A4RG::ZGPAT	Adenocarcinoma
SLC2A8::GARNL3	Adenocarcinoma
SLC2A9::CENATAC	Squamous cell carcinoma
SLC2A9::RAD51	Transitional cell carcinoma
SLC30A10::MEX3A	Adenocarcinoma
SLC30A4::CLRN2	Adenocarcinoma
SLC30A4::PDE2A	Adenocarcinoma
SLC30A4::VPS53	Adenocarcinoma
SLC30A5::KGD4	Adenocarcinoma
SLC30A6::ACTR2	Adenocarcinoma
SLC30A6::ALDH3A2	Malignant epithelial tumor, special type
SLC30A6::BABAM2	Adenocarcinoma
SLC30A6::GNA11	Adenocarcinoma
SLC30A6::SPAST	Adenocarcinoma
SLC30A7::CMTM8	Adenocarcinoma
SLC30A7::HHIPL2	Adenocarcinoma
SLC30A7::MACF1	Meningioma
SLC30A9::COX7B2	Adenocarcinoma
SLC30A9::NSUN7	Adenocarcinoma
SLC30A9::SLC2A9	Adenocarcinoma
SLC34A2::ACTB	Adenocarcinoma
SLC34A2::CLDN7	Adenocarcinoma
SLC34A2::EEA1	Adenocarcinoma
SLC34A2::EPHB1	Adenocarcinoma
SLC34A2::NDUFV1	Adenocarcinoma
SLC34A2::ROS1	Squamous cell carcinoma | Carcinoma, NOS | Adenocarcinoma
SLC35A1::LRRFIP1	Mesenchymal tumor, NOS
SLC35A3::CFAP276	Squamous cell carcinoma
SLC35A3::MFSD14A	Nonneoplastic epithelial disorder/lesion | Nonneoplastic hematologic disorder/lesion | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Mycosis fungoides/Sézary syndrome
SLC35A4::MTSS1	Mesothelioma
SLC35A4::PEX1	Adenocarcinoma
SLC35B1::CORO6	Adenocarcinoma
SLC35B1::IGFBP4	Adenocarcinoma
SLC35B3::GSTA5	Astrocytoma, grade I-II
SLC35C2::B4GALT5	Adenocarcinoma
SLC35C2::ELMO2	Malignant melanoma
SLC35D1::PRKAR2B	Adenocarcinoma
SLC35D2::LPPR1::MRPL50	Adenocarcinoma
SLC35E1::CYP4F22	Adenocarcinoma
SLC35E1::EPS15L1	Adenocarcinoma
SLC35E2B::PFKFB4	Transitional cell carcinoma
SLC35E3::L3MBTL3	Mesenchymal tumor, NOS
SLC35E3::OS9	Astrocytoma, grade III-IV/Glioblastoma
SLC35E4::HSCB	Adenocarcinoma
SLC35E4::SEC14L2	Adenocarcinoma
SLC35F2::AMPD3	Adenocarcinoma
SLC35F2::PIWIL4	Malignant melanoma
SLC35F3::KLHL1	Mesenchymal tumor, NOS
SLC35F5::WIPF1	Adenocarcinoma
SLC35G1::SLIT1	Astrocytoma, grade I-II
SLC35G2::IL20RB	Squamous cell carcinoma
SLC35G6::ALOX12	Adenocarcinoma
SLC35G6::FBN3	Acute myeloid leukemia, NOS | Skin
SLC35G6::SLC16A13	Adenocarcinoma
SLC36A1::SKIC3	Adenocarcinoma
SLC37A1::ABCG1	Adenocarcinoma
SLC37A1::MTA1	Adenocarcinoma
SLC37A1::NT5C3A	Adenocarcinoma
SLC37A1::PCNT	Adenocarcinoma
SLC37A1::PCP4	Adenocarcinoma
SLC37A3::FLYWCH2	Adenocarcinoma
SLC37A3::TPST1	Astrocytoma, grade III-IV/Glioblastoma
SLC37A4::HYOU1	Adenocarcinoma
SLC38A10::ARID5A	Multiple myeloma
SLC38A10::CYB5D2	Adenocarcinoma
SLC38A10::NPLOC4	Malignant melanoma | Adenocarcinoma
SLC38A10::OGFOD3	Adenocarcinoma
SLC38A10::P4HB	Adenocarcinoma
SLC38A10::RPTOR	Adenocarcinoma
SLC38A10::SEZ6	Squamous cell carcinoma
SLC38A10::TESPA1	Adenocarcinoma
SLC38A10::TMEM131	Adenocarcinoma
SLC38A10::TMEM207	Mesenchymal tumor, NOS
SLC38A10::TUT4	Adenocarcinoma
SLC38A11::RABGAP1L	Adenocarcinoma
SLC38A1::GTSE1	Adenocarcinoma
SLC38A1::HDAC7	Adenocarcinoma
SLC38A1::PCTP	Squamous cell carcinoma
SLC38A1::RHEBL1	Adenocarcinoma
SLC38A1::UNKL	Adenocarcinoma
SLC38A2::ABL2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SLC38A2::C12ORF4	Adenocarcinoma
SLC38A2::RAB3IP	Mesenchymal tumor, NOS
SLC38A9::KCNIP1	Adenocarcinoma
SLC39A11::ADSS2	Transitional cell carcinoma
SLC39A11::ATPAF2	Adenocarcinoma
SLC39A11::C17orf80	Adenocarcinoma
SLC39A11::CA11	Malignant epithelial tumor, special type
SLC39A11::CD69	Adenocarcinoma
SLC39A11::CDC42EP4	Adenocarcinoma
SLC39A11::CPSF4L	Adenocarcinoma
SLC39A11::ENPP7	Adenocarcinoma
SLC39A11::HTT	Malignant epithelial tumor, special type
SLC39A11::OPN3	Adenocarcinoma
SLC39A11::PITPNC1	Adenocarcinoma
SLC39A11::RPTOR	Adenocarcinoma
SLC39A11::SDK2	Adenocarcinoma
SLC39A11::SLC6A4	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
SLC39A11::VCF1	Malignant melanoma
SLC39A14::FAM110B	Adenocarcinoma
SLC39A14::FGF17	Adenocarcinoma
SLC39A14::IL4I1	Mesenchymal tumor, NOS
SLC39A14::PIWIL2	Adenocarcinoma
SLC39A14::PRKDC	Adenocarcinoma
SLC39A14::TSPAN15	Adenocarcinoma
SLC39A14::XPO7	Adenocarcinoma
SLC39A1::CRTC2	Nonneoplastic hematologic disorder/lesion | Nonneoplastic epithelial disorder/lesion
SLC39A1::PFDN2	Malignant melanoma
SLC39A1::RAB13	Squamous cell carcinoma
SLC39A3::DDX39A	Malignant melanoma
SLC39A3::PLPP2	Adenocarcinoma
SLC39A3::SGTA	Astrocytoma, grade III-IV/Glioblastoma
SLC39A5::KRT84	Adenocarcinoma
SLC39A5::NABP2	Adenocarcinoma
SLC39A6::LRIG1	Adenocarcinoma
SLC39A6::MAST2	Squamous cell carcinoma
SLC39A6::TBX15	Adenocarcinoma
SLC39A8::PPA1	Adenocarcinoma
SLC39A8::RET	Adenocarcinoma
SLC39A8::RHEB	Adenocarcinoma
SLC39A9::BCL2L13	Astrocytoma, grade III-IV/Glioblastoma
SLC39A9::MAP3K9	Adenocarcinoma
SLC39A9::PLEKHD1	Adenocarcinoma
SLC39A9::RAD51B	Adenocarcinoma
SLC39A9::SEC23IP	Adenocarcinoma
SLC39A9::USP15	Adenocarcinoma
SLC3A1::CAMKMT	Squamous cell carcinoma
SLC3A2::ASRGL1	Malignant epithelial tumor, special type
SLC3A2::DLGAP4	Adenocarcinoma
SLC3A2::GNG3	Squamous cell carcinoma
SLC3A2::GRAP2	Malignant melanoma
SLC3A2::NRG1	Adenocarcinoma
SLC3A2::NXF1	Adenocarcinoma
SLC3A2::POLR2G	Squamous cell carcinoma
SLC40A1::TYK2	Adenocarcinoma
SLC41A1::C1orf159	Adenocarcinoma
SLC41A2::ANAPC7	Adenocarcinoma
SLC41A2::DNM3	Mesenchymal tumor, NOS
SLC41A2::LIN7A	Mesenchymal tumor, NOS
SLC41A3::ALDH1L1	Adenocarcinoma
SLC41A3::B4GALT4	Astrocytoma, grade I-II
SLC43A1::COG7	Adenocarcinoma
SLC43A2::PRPF8	Adenocarcinoma
SLC43A2::SCARF1	Adenocarcinoma
SLC43A2::SMG6	Adenocarcinoma
SLC43A2::SMYD4	Adenocarcinoma
SLC44A1::BRAF	Astrocytoma, pilocytic/juvenile | Adenocarcinoma
SLC44A1::FSD1L	Squamous cell carcinoma
SLC44A1::NIPSNAP3A	Adenocarcinoma
SLC44A1::PRKCA	Neuroglial neoplasm, special type
SLC44A1::RAD23B	Adenocarcinoma
SLC44A2::LDLR	Adenocarcinoma
SLC44A2::PBX4	Adenocarcinoma
SLC44A2::PTPRQ	Mesenchymal tumor, NOS
SLC44A3::ABCD3	Squamous cell carcinoma
SLC44A4::OGT	Adenocarcinoma
SLC44A4::TNXB	Adenocarcinoma
SLC44A5::PTGFR	Adenocarcinoma
SLC45A1::NCOR2	Adenocarcinoma
SLC45A2::AMACR	Adenocarcinoma | Transitional cell carcinoma
SLC45A2::C1QTNF3	Adenocarcinoma
SLC45A2::CCDC125	Adenocarcinoma
SLC45A3::AP1G2	Adenocarcinoma
SLC45A3::BRAF	Adenocarcinoma
SLC45A3::CPNE4	Adenocarcinoma
SLC45A3::ELK4	Adenocarcinoma | Nonneoplastic epithelial disorder/lesion
SLC45A3::EPB41L4B	Adenocarcinoma
SLC45A3::ERG	Adenocarcinoma
SLC45A3::ETV1	Adenocarcinoma
SLC45A3::ETV4	Adenocarcinoma
SLC45A3::ETV5	Adenocarcinoma
SLC45A3::FAF1	Adenocarcinoma
SLC45A3::FGFR2	Adenocarcinoma
SLC45A3::FLI1	Adenocarcinoma
SLC45A3::FN1	Adenocarcinoma
SLC45A3::FOXP1	Adenocarcinoma
SLC45A3::PHYKPL	Adenocarcinoma
SLC45A3::SIAE	Adenocarcinoma
SLC45A3::SKIL	Adenocarcinoma
SLC45A3::STAT6	Adenocarcinoma
SLC45A3::TMPRSS2	Adenocarcinoma
SLC45A3::ZBTB7B	Adenocarcinoma
SLC45A3::ZNFX1	Adenocarcinoma
SLC47A2::ALDH3A1	Astrocytoma, grade I-II | Adenocarcinoma
SLC47A2::FADS2	Squamous cell carcinoma
SLC47A2::SPECC1	Mesenchymal tumor, NOS
SLC47A2::ULK2	Adenocarcinoma
SLC48A1::HECA	Adenocarcinoma
SLC49A4::DDT	Adenocarcinoma
SLC4A1AP::ALK	Adenocarcinoma
SLC4A1AP::GPN1	Astrocytoma, grade III-IV/Glioblastoma
SLC4A2::AOC1	Adenocarcinoma
SLC4A4::ARHGAP6	Adenocarcinoma
SLC4A4::AUNIP	Adenocarcinoma
SLC4A4::EPB41L1	Adenocarcinoma
SLC4A4::GOLGA4	Adenocarcinoma
SLC4A4::RASGRF1	Adenocarcinoma
SLC4A4::TMPRSS11E	Transitional cell carcinoma
SLC4A7::TYR	Astrocytoma, grade I-II
SLC4A8::BRF1	Adenocarcinoma
SLC4A8::MGAT4C	Mesenchymal tumor, NOS
SLC4A8::ZFP36L1	Adenocarcinoma
SLC52A2::HSF1	Adenocarcinoma
SLC5A1::DEPDC5	Adenocarcinoma
SLC5A1::YWHAH	Adenocarcinoma
SLC5A3::MYO3A	Squamous cell carcinoma
SLC66A1::SCMH1	Adenocarcinoma
SLC66A2::CTDP1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SLC66A2::HSBP1L1	Squamous cell carcinoma
SLC66A2::PARD6G	Adenocarcinoma
SLC6A11::CAV3	Astrocytoma, grade III-IV/Glioblastoma
SLC6A15::MYRFL	Mesenchymal tumor, NOS
SLC6A17::DPYD	Malignant melanoma
SLC6A17::IGF2	Malignant epithelial tumor, special type
SLC6A3::AGBL3	Meningioma
SLC6A6::FGD5	Adenocarcinoma
SLC6A6::TMEM43	Adenocarcinoma
SLC6A8::PREP	Mesenchymal tumor, NOS
SLC6A9::EIF2B3	Adenocarcinoma
SLC7A13::WDTC1	Squamous cell carcinoma
SLC7A1::AKNA	Mesenchymal tumor, NOS
SLC7A1::ARHGAP35	Squamous cell carcinoma
SLC7A1::B4GALT4	Adenocarcinoma
SLC7A1::CDX2	Transitional cell carcinoma
SLC7A1::RIDA	Adenocarcinoma
SLC7A1::RSPH9	Adenocarcinoma
SLC7A1::UBL3	Squamous cell carcinoma
SLC7A1::USPL1	Astrocytoma, grade I-II
SLC7A1::ZNF608	Mature B-cell neoplasm, NOS
SLC7A2::BAZ2B	Adenocarcinoma
SLC7A2::DHTKD1	Adenocarcinoma
SLC7A2::TERT	Adenocarcinoma
SLC7A5::WWP2	Adenocarcinoma
SLC7A6::GRXCR1	Adenocarcinoma
SLC7A6::NFATC3	Adenocarcinoma
SLC7A6::PHAF1	Malignant epithelial tumor, special type
SLC7A6::PLA2G15	Adenocarcinoma
SLC7A6::TANGO6	Adenocarcinoma
SLC7A7::ACIN1	Adenocarcinoma
SLC7A7::TMEM114	Adenocarcinoma
SLC8A1::ALK	Adenocarcinoma
SLC8A1::SRSF7	Mesenchymal tumor, NOS
SLC8B1::IQCD	Adenocarcinoma
SLC9A1::PEX10	Adenocarcinoma
SLC9A1::UBXN11	Adenocarcinoma
SLC9A1::WASF2	Malignant melanoma
SLC9A2::CRACDL	Malignant melanoma
SLC9A8::B4GALT5	Mesenchymal tumor, NOS
SLC9A8::BICDL2	Adenocarcinoma
SLC9A8::PREX1	Acute myeloblastic leukemia with maturation (FAB type M2)
SLC9A8::PTGIS	Adenocarcinoma
SLC9A8::RAE1	Adenocarcinoma
SLC9A8::TOM1L2	Transitional cell carcinoma
SLC9A9::KCNAB1	Squamous cell carcinoma
SLC9A9::PDLIM3	Adenocarcinoma
SLC9B1::LRRK1	Astrocytoma, grade I-II
SLC9B2::CENPE	Adenocarcinoma
SLCO1C1::ZPBP	Astrocytoma, grade III-IV/Glioblastoma
SLCO2A1::GUCA1C	Squamous cell carcinoma
SLCO2A1::RYK	Squamous cell carcinoma
SLCO2A1::SLC25A36	Squamous cell carcinoma
SLCO2B1::CEP128	Adenocarcinoma
SLCO2B1::HNF4A	Adenocarcinoma
SLCO3A1::BMPR2	Squamous cell carcinoma
SLCO3A1::DPH6	Adenocarcinoma
SLCO3A1::ELMO1	Hodgkin disease, NOS
SLCO3A1::EPHB1	Squamous cell carcinoma
SLCO3A1::GNB5	Adenocarcinoma
SLCO3A1::HDDC3	Astrocytoma, grade I-II
SLCO3A1::ITGA11	Mesenchymal tumor, NOS
SLCO4A1::ADRM1	Multiple myeloma
SLCO4A1::PFDN4	Squamous cell carcinoma
SLCO4C1::ARHGEF38	Adenocarcinoma
SLCO5A1::NR4A3	Leiomyosarcoma
SLFN11::CCL14	Transitional cell carcinoma
SLFN11::MIEN1	Adenocarcinoma | Transitional cell carcinoma
SLFN11::USP6	Nodular fasciitis
SLFN12::PSMD3	Adenocarcinoma
SLFN12L::ERBB2	Carcinoma, NOS
SLFN13::APBA3	Adenocarcinoma
SLFN13::ARHGAP44	Adenocarcinoma
SLFN5::CDK5RAP3	Squamous cell carcinoma
SLFN5::SYNRG	Adenocarcinoma
SLIT1::SFRP5	Astrocytoma, grade III-IV/Glioblastoma
SLIT2::PACRGL	Adenocarcinoma
SLIT3::HSD17B4	Adenocarcinoma
SLIT3::ITPR2	Mesenchymal tumor, NOS
SLIT3::SDCBP	Malignant epithelial tumor, special type
SLK::CFAP43	Adenocarcinoma
SLK::INA	Adenocarcinoma
SLK::ZFHX3	Adenocarcinoma
SLMAP::ALK	Adenocarcinoma
SLMAP::ARF4	Adenocarcinoma
SLMAP::CUL4B	Adenocarcinoma
SLMAP::CYP11A1	Malignant epithelial tumor, special type
SLMAP::ELN	Adenocarcinoma
SLMAP::FAF1	Adenocarcinoma
SLMAP::RAF1	Soft tissue tumor, special type
SLN::CADM2	Undifferentiated carcinoma, small cell
SLPI::DDX27	Mesothelioma
SLPI::MATN4	Adenocarcinoma
SLTM::ADGRL1	Adenocarcinoma
SLTM::ATE1	Adenocarcinoma
SLTM::EPB42	Adenocarcinoma
SLTM::UACA	Adenocarcinoma
SLU7::ATP10B	Mature B-cell neoplasm, NOS
SLX4::ADAM32	Adenocarcinoma
SLX4::LITAF	Adenocarcinoma
SLX4IP::CDS2	Squamous cell carcinoma
SLX4IP::CEP89	Adenocarcinoma
SLX4IP::DEFB126	Adenocarcinoma
SLX4IP::MKKS	Squamous cell carcinoma
SLX4IP::PLCB1	Mesenchymal tumor, NOS
SLX4IP::SLC24A3	Squamous cell carcinoma
SLX4IP::SUGT1	Adenocarcinoma
SLX9::FER	Mesenchymal tumor, NOS
SMAD2::C10ORF90	Adenocarcinoma
SMAD2::C10orf90	Adenocarcinoma
SMAD2::CABLES1	Adenocarcinoma
SMAD2::CD226	Squamous cell carcinoma
SMAD2::PARD6G	Mature B-cell neoplasm, NOS
SMAD2::TFF1	Acute myelomonocytic leukemia (FAB type M4)
SMAD2::ZBTB7C	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Adenocarcinoma
SMAD3::AAGAB	Transitional cell carcinoma
SMAD3::ATP8B4	Adenocarcinoma
SMAD3::DIS3L	Adenocarcinoma
SMAD3::DLGAP4	Adenocarcinoma
SMAD3::IL17RA	Adenocarcinoma
SMAD3::INTS14	Mesenchymal tumor, NOS
SMAD3::LRP5	Malignant melanoma
SMAD3::MAP2K1	Adenocarcinoma
SMAD3::MAP2K5	Adenocarcinoma
SMAD3::SENP8	Adenocarcinoma
SMAD3::SLC9A9	Adenocarcinoma
SMAD3::SMAD6	Adenocarcinoma
SMAD4::CPLX4	Astrocytoma, grade III-IV/Glioblastoma
SMAD4::NRG1	Squamous cell carcinoma
SMAD4::RAX	Astrocytoma, grade III-IV/Glioblastoma
SMAD4::SKAP1	Adenocarcinoma
SMAD5::COL5A1	Astrocytoma, grade I-II
SMAD6::CIAO2A	Adenocarcinoma
SMAD7::CTIF	Mesenchymal tumor, NOS
SMAD7::DYM	Adenocarcinoma
SMAD9::CCNA1	Adenocarcinoma
SMAGP::NELL2	Squamous cell carcinoma
SMAGP::TBC1D30	Adenocarcinoma
SMAP1::C14ORF132	Adenocarcinoma
SMAP1::C14orf132	Adenocarcinoma
SMAP1::CGA	Adenocarcinoma
SMAP1::FAR2	Malignant melanoma
SMAP1::KHDC1	Squamous cell carcinoma
SMAP2::CAP1	Adenocarcinoma
SMAP2::FBXO42	Adenocarcinoma
SMAP2::MYCL	Undifferentiated carcinoma, small cell
SMAP2::NLRX1	Malignant melanoma
SMARCA1::ALG13	Adenocarcinoma
SMARCA1::PGRMC1	Astrocytoma, grade III-IV/Glioblastoma
SMARCA2::BEND2	Adenocarcinoma
SMARCA2::CREM	Soft tissue tumor, special type | Neuroglial neoplasm, special type | Malignant epithelial tumor, special type
SMARCA2::DMRT1	Squamous cell carcinoma
SMARCA2::MEIOSIN	Malignant melanoma
SMARCA2::NR4A3	Chondrosarcoma, myxoid
SMARCA2::VLDLR	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SMARCA2::ZNF362	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SMARCA2::ZNF384	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SMARCA4::C19ORF38	Squamous cell carcinoma
SMARCA4::C19orf38	Squamous cell carcinoma
SMARCA4::CARM1	Squamous cell carcinoma | Astrocytoma, grade III-IV/Glioblastoma | Adenocarcinoma | Transitional cell carcinoma
SMARCA4::CREM	Soft tissue tumor, special type
SMARCA4::CTSB	Adenocarcinoma
SMARCA4::DHPS	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SMARCA4::DNM2	Adenocarcinoma
SMARCA4::DOCK6	Adenocarcinoma
SMARCA4::FOXO1	Adenocarcinoma
SMARCA4::ICAM1	Adenocarcinoma
SMARCA4::KDM4B	Squamous cell carcinoma
SMARCA4::RASAL3	Adenocarcinoma
SMARCA4::RNF216	Malignant epithelial tumor, special type
SMARCA4::SLC44A2	Adenocarcinoma
SMARCA4::SMIM7	Astrocytoma, grade I-II
SMARCA4::TGIF1	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
SMARCA4::TP73	Skin | Acute myeloid leukemia, NOS
SMARCA4::TYK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SMARCA4::ZNF700	Adenocarcinoma
SMARCA4::ZNF791	Squamous cell carcinoma
SMARCA5::LRBA	Transitional cell carcinoma
SMARCAD1::GRID2	Astrocytoma, grade I-II
SMARCB1::ACR	Squamous cell carcinoma
SMARCB1::IGF1R	Malignant soft tissue tumor, NOS
SMARCB1::MARK3	Adenocarcinoma
SMARCB1::PLAAT2	Adenocarcinoma
SMARCB1::SNW1	Transitional cell carcinoma
SMARCB1::WASF2	Epithelioid sarcoma
SMARCC1::CDC25A	Malignant melanoma
SMARCC1::CDK5RAP3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SMARCC1::CSPG5	Transitional cell carcinoma
SMARCC1::DAD1	Adenocarcinoma
SMARCC1::DHX30	Malignant epithelial tumor, special type
SMARCC1::DOCK3	Transitional cell carcinoma
SMARCC1::ITGB4	Astrocytoma, grade III-IV/Glioblastoma
SMARCC1::MAP4	Germ cell tumor, special type
SMARCC1::SHISA5	Transitional cell carcinoma
SMARCC1::SPINK8	Adenocarcinoma
SMARCC1::SYCP2L	Adenocarcinoma
SMARCC1::UQCRC1	Adenocarcinoma
SMARCC1::USP32	Mesenchymal tumor, NOS
SMARCC1::ZBTB8OS	Adenocarcinoma
SMARCC2::CS	Adenocarcinoma
SMARCC2::RHPN2	Adenocarcinoma
SMARCD2::HCK	Adenocarcinoma
SMARCD2::NUFIP2	Malignant melanoma
SMARCD2::STRADA	Adenocarcinoma
SMARCD3::PRKAG2	Adenocarcinoma
SMARCE1::CDK12	Carcinoma, NOS
SMARCE1::HELZ	Adenocarcinoma
SMARCE1::KRT222	Adenocarcinoma
SMARCE1::RARA	Adenocarcinoma
SMC1A::GTPBP6	Adenocarcinoma
SMC1A::HUWE1	Adenocarcinoma
SMC1A::UBQLN2	Squamous cell carcinoma
SMC2::AKNA	Malignant melanoma
SMC2::PGM5	Adenocarcinoma
SMC3::MXI1	Adenocarcinoma
SMC4::MECOM	Acute myeloid leukemia, NOS | Skin
SMC5::IMMP2L	Adenocarcinoma
SMC5::MAMDC2	Adenocarcinoma
SMC5::TJP2	Adenocarcinoma
SMCHD1::DLGAP1	Adenocarcinoma
SMCHD1::JAK2	T-prolymphocytic leukemia
SMCHD1::NDC80	Adenocarcinoma | Mature B-cell neoplasm, NOS
SMCO4::FDFT1	Adenocarcinoma
SMCO4::NIBAN2	Adenocarcinoma
SMCR8::ALKBH5	Adenocarcinoma
SMDT1::NFAM1	Adenocarcinoma
SMG1::ANO3	Adenocarcinoma
SMG1::DOC2A	Transitional cell carcinoma
SMG1::EMC8	Adenocarcinoma
SMG1::LRRK1	Adenocarcinoma
SMG1::MON2	Adenocarcinoma
SMG1::MYH11	Adenocarcinoma
SMG1::RPS15A	Adenocarcinoma
SMG1::SNF8	Adenocarcinoma
SMG1::SULT1A2	Transitional cell carcinoma
SMG5::CCT3	Adenocarcinoma
SMG5::MEF2D	Malignant epithelial tumor, special type
SMG5::PAQR6	Nonneoplastic epithelial disorder/lesion | Nonneoplastic hematologic disorder/lesion | Adenocarcinoma
SMG5::PMF1	Adenocarcinoma
SMG5::TMEM79	Adenocarcinoma
SMG6::ANKFY1	Adenocarcinoma
SMG6::DHX33	Adenocarcinoma
SMG6::LRMDA	Adenocarcinoma
SMG6::NXN	Adenocarcinoma
SMG6::RECK	Mesenchymal tumor, NOS
SMG6::SGSM2	Acute myelomonocytic leukemia (FAB type M4)
SMG6::SHPK	Adenocarcinoma
SMG6::VPS53	Adenocarcinoma | Undifferentiated round cell sarcoma
SMG6::WDR20	Adenocarcinoma
SMG7::COLGALT2	Transitional cell carcinoma
SMG7::LAMC2	Adenocarcinoma
SMG9::KCNN4	Transitional cell carcinoma
SMIM13::CYREN	Adenocarcinoma
SMIM13::ENPP3	Adenocarcinoma
SMIM13::MIB2	Adenocarcinoma
SMIM13::TM6SF1	Adenocarcinoma
SMIM13::TTLL5	Astrocytoma, grade III-IV/Glioblastoma
SMIM14::PDS5A	Transitional cell carcinoma
SMIM14::RFC1	Adenocarcinoma
SMIM15::ELOVL7	Squamous cell carcinoma
SMIM19::FGFR1	Adenocarcinoma
SMIM1::DLGAP3	Malignant melanoma
SMIM1::FAAP20	Adenocarcinoma
SMIM7::ARHGAP35	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
SMIM7::CACNA1A	Transitional cell carcinoma
SMLR1::PHF12	Adenocarcinoma
SMN1::FGFR2	Adenocarcinoma
SMO::STRIP2	Squamous cell carcinoma
SMO::TSPAN33	Squamous cell carcinoma
SMOC1::RAD51B	Germ cell tumor, NOS
SMOX::EIF3D	Astrocytoma, grade I-II
SMOX::PANK2	Adenocarcinoma
SMOX::SLC24A3	Adenocarcinoma
SMPD3::ALK	Adenocarcinoma
SMPD3::AP1G2	Adenocarcinoma
SMPD3::ATP6V0D1	Adenocarcinoma
SMPD3::MEIOB	Adenocarcinoma
SMPDL3A::FABP7	Adenocarcinoma
SMPX::MID1	Adenocarcinoma
SMPX::PDHA1	Mesenchymal tumor, NOS
SMS::CNKSR2	Adenocarcinoma
SMS::DYRK2	Adenocarcinoma
SMS::PHEX	Adenocarcinoma
SMS::PPARGC1A	Adenocarcinoma
SMTN::LIMK2	Adenocarcinoma
SMU1::AFAP1	Squamous cell carcinoma
SMU1::B4GALT1	Squamous cell carcinoma
SMU1::FAM219A	Adenocarcinoma
SMU1::JAK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SMUG1::PPP2R5A	Adenocarcinoma
SMURF1::AKAP9	Adenocarcinoma
SMURF1::AZGP1	Squamous cell carcinoma
SMURF1::CDK14	Adenocarcinoma
SMURF1::CDRT15L2	Adenocarcinoma
SMURF1::CFLAR	Adenocarcinoma
SMURF1::COL26A1	Astrocytoma, grade III-IV/Glioblastoma
SMURF1::DNAJC2	Adenocarcinoma
SMURF1::FAM200A	Adenocarcinoma
SMURF1::GJC3	Astrocytoma, grade I-II | Squamous cell carcinoma
SMURF1::H3-3A	Adenocarcinoma
SMURF1::KPNA7	Adenocarcinoma
SMURF1::PDAP1	Adenocarcinoma
SMURF1::PTCD1	Adenocarcinoma
SMURF1::SLC26A5	Adenocarcinoma
SMURF1::TMEM139	Angiosarcoma
SMURF1::TRIM4	Astrocytoma, grade I-II
SMURF2::DEDD2	Adenocarcinoma
SMURF2::DHX37	Adenocarcinoma
SMURF2::GNA13	Adenocarcinoma
SMURF2::IKZF3	Adenocarcinoma
SMURF2::LRRC37A3	Adenocarcinoma
SMURF2::NGFR	Adenocarcinoma
SMURF2::TEKT3	Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
SMURF2::UBAC2	Malignant melanoma
SMYD2::KCNK2	Adenocarcinoma
SMYD2::LPGAT1	Malignant melanoma
SMYD2::MGST2	Adenocarcinoma
SMYD2::PGBD2	Squamous cell carcinoma
SMYD2::PROX1	Adenocarcinoma
SMYD2::PTP4A1	Transitional cell carcinoma
SMYD3::AKT3	Astrocytoma, grade III-IV/Glioblastoma
SMYD3::COPA	Adenocarcinoma
SMYD3::EDARADD	Adenocarcinoma
SMYD3::EFCAB2	Refractory anemia with ringed sideroblasts | Mature B-cell neoplasm, NOS
SMYD3::ELOVL1	Squamous cell carcinoma
SMYD3::TFB2M	Adenocarcinoma
SMYD3::TRIM58	Adenocarcinoma
SMYD3::WLS	Adenocarcinoma
SMYD3::ZMYM4	Malignant melanoma
SMYD3::ZNF695	Squamous cell carcinoma | Adenocarcinoma
SMYD4::PELP1	Adenocarcinoma
SMYD4::SERPINF1	Adenocarcinoma
SMYD4::TRARG1	Adenocarcinoma
SNAI1::PFDN4	Adenocarcinoma
SNAI1::SLC9A8	Adenocarcinoma
SNAI2::PLAG1	Osteogenic/bone tumor, NOS
SNAP23::RTL9	Adenocarcinoma
SNAP29::CELSR1	Adenocarcinoma
SNAP29::IGLL1	Adenocarcinoma
SNAP29::MAPK1	Adenocarcinoma
SNAP29::SFI1	Adenocarcinoma
SNAP47::PRSS38	Adenocarcinoma
SNAP91::BCKDHB	Adenocarcinoma
SNAP91::SMPX	Adenocarcinoma
SNAPC1::PRKCH	Adenocarcinoma
SNAPC3::FOCAD	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
SNAPC3::LRRC19	Squamous cell carcinoma
SNAPC4::ABCA2	Adenocarcinoma
SNAPC5::BPIFB4	Adenocarcinoma
SNAPC5::RPL4	Adenocarcinoma
SNAPIN::FMNL1	Adenocarcinoma
SNAPIN::S100A1	Adenocarcinoma
SNCAIP::CSNK1G3	Adenocarcinoma
SNCAIP::KIF3A	Adenocarcinoma
SNCAIP::SRFBP1	Adenocarcinoma
SND1::AKAP9	Adenocarcinoma
SND1::ARF5	Adenocarcinoma
SND1::BRAF	Adenocarcinoma | Myxoinflammatory fibroblastic sarcoma | Squamous cell carcinoma | Malignant epithelial tumor, special type
SND1::CFTR	Adenocarcinoma
SND1::GRM8	Adenocarcinoma
SND1::IMMP2L	Mesenchymal tumor, NOS
SND1::LEP	Adenocarcinoma
SND1::SPAG16	Astrocytoma, grade III-IV/Glioblastoma
SNED1::HJURP	Adenocarcinoma
SNED1::PPP1R7	Adenocarcinoma
SNF8::PROCA1	Adenocarcinoma
SNIP1::KIF17	Astrocytoma, grade I-II
SNIP1::PUM1	Adenocarcinoma
SNN::LITAF	Adenocarcinoma
SNRK::SUCLG2	Malignant melanoma
SNRNP200::NAALADL2	Adenocarcinoma
SNRNP40::ADGRB2	Transitional cell carcinoma
SNRNP40::COL6A5	Squamous cell carcinoma
SNRNP40::EPB41	Squamous cell carcinoma
SNRNP40::MAP2K5	Adenocarcinoma
SNRNP40::PEF1	Adenocarcinoma
SNRNP40::SPOCD1	Adenocarcinoma
SNRNP48::NISCH	Adenocarcinoma
SNRNP48::STK3	Adenocarcinoma
SNRNP70::CDC42EP5	Transitional cell carcinoma
SNRNP70::MET	Adenocarcinoma
SNRNP70::NTRK3	Malignant peripheral nerve sheath tumor/Triton
SNRNP70::RABEP1	Adenocarcinoma
SNRNP70::RET	Adenocarcinoma | Carcinoma, NOS
SNRNP70::TIMM44	Adenocarcinoma
SNRNP70::ZNFX1	Malignant melanoma
SNRPA1::PCSK6	Adenocarcinoma
SNRPA1::PHRF1	Adenocarcinoma
SNRPA::ACTMAP	Adenocarcinoma
SNRPA::ANKRD24	Adenocarcinoma
SNRPA::GRIK5	Adenocarcinoma
SNRPB::RAB4A	Transitional cell carcinoma
SNRPD1::OSBPL1A	Adenocarcinoma
SNRPG::PCYOX1	Adenocarcinoma
SNRPN::CYFIP1	Astrocytoma, grade I-II
SNTA1::PXMP4	Squamous cell carcinoma
SNTA1::TPO	Adenocarcinoma
SNTB1::COL22A1	Adenocarcinoma
SNTB1::FGGY	Adenocarcinoma
SNTB1::ZNF250	Transitional cell carcinoma | Adenocarcinoma
SNTB2::CHST4	Adenocarcinoma
SNTB2::MCTP1	Adenocarcinoma
SNTB2::NUP93	Mesenchymal tumor, NOS
SNTB2::TANGO6	Squamous cell carcinoma
SNTB2::UTP4	Adenocarcinoma
SNTB2::VPS4A	Astrocytoma, grade III-IV/Glioblastoma | Nonneoplastic epithelial disorder/lesion
SNTG1::CHCHD7	Adenocarcinoma
SNTG2::RBKS	Malignant melanoma
SNTG2::TRAPPC12	Astrocytoma, grade III-IV/Glioblastoma
SNU13::ATXN10	Malignant melanoma
SNU13::FGF4	Malignant melanoma
SNUPN::KIF1C	Osteosarcoma, NOS
SNUPN::ZNF233	Squamous cell carcinoma
SNX11::MED24	Squamous cell carcinoma
SNX11::SNF8	Malignant epithelial tumor, special type
SNX13::AUTS2	Adenocarcinoma
SNX13::GLCCI1	Transitional cell carcinoma
SNX13::PHF14	Adenocarcinoma
SNX13::SDK1	Astrocytoma, grade III-IV/Glioblastoma
SNX13::STAP2	Adenocarcinoma
SNX14::COL21A1	Adenocarcinoma
SNX14::EYS	Adenocarcinoma
SNX14::NKAIN2	Adenocarcinoma
SNX14::OSTM1	Transitional cell carcinoma
SNX14::SYNCRIP	Squamous cell carcinoma
SNX15::MAJIN	Astrocytoma, grade I-II
SNX15::NAALADL1	Squamous cell carcinoma
SNX16::PCCA	Adenocarcinoma
SNX18::ANKRD55	Adenocarcinoma
SNX18::WDR93	Adenocarcinoma
SNX19::RRP12	Adenocarcinoma
SNX19::USP28	Adenocarcinoma
SNX1::ABL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SNX1::CIAO2A	Adenocarcinoma
SNX1::SCG5	Malignant melanoma
SNX24::SNCAIP	Adenocarcinoma
SNX27::ADAR	Adenocarcinoma
SNX27::CDKN3	Adenocarcinoma
SNX27::ILF2	Malignant melanoma
SNX27::PIP5K1A	Adenocarcinoma
SNX27::SCNM1	Adenocarcinoma
SNX27::TARS2	Adenocarcinoma
SNX27::THEM4	Transitional cell carcinoma
SNX27::TUFT1	Adenocarcinoma
SNX29::CIITA	Squamous cell carcinoma
SNX29::CLEC16A	Adenocarcinoma
SNX29::FLRT1	Astrocytoma, grade III-IV/Glioblastoma
SNX29::HS3ST4	Malignant melanoma
SNX29::JAK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SNX29::LITAF	Mature B-cell neoplasm, NOS | Diffuse large B-cell lymphoma
SNX29::NCAN	Transitional cell carcinoma
SNX29::NLRP1	Adenocarcinoma
SNX29::TNFRSF17	Adenocarcinoma
SNX2::ABL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SNX30::ADAMTS3	Squamous cell carcinoma
SNX30::ALDOB	Adenocarcinoma
SNX30::CNTLN	Squamous cell carcinoma
SNX30::DENND1A	Adenocarcinoma
SNX30::KIAA1958	Adenocarcinoma
SNX30::LPAR1	Astrocytoma, grade I-II
SNX30::PXT1	Transitional cell carcinoma
SNX30::SEC16A	Mesenchymal tumor, NOS
SNX30::SLC31A1	Adenocarcinoma
SNX31::PABPC1	Transitional cell carcinoma
SNX31::SPAG1	Transitional cell carcinoma
SNX32::PLCB3	Malignant melanoma
SNX4::OSBPL10	Astrocytoma, grade I-II
SNX4::PARD3B	Adenocarcinoma
SNX5::PCSK2	Malignant melanoma
SNX6::ADAMTS12	Adenocarcinoma
SNX6::BAZ1A	Adenocarcinoma
SNX6::MIPOL1	Adenocarcinoma
SNX6::RPS19	Multiple myeloma
SNX7::WNK1	Malignant melanoma
SNX8::BRAF	Soft tissue tumor, special type
SNX8::KDELR2	Squamous cell carcinoma
SNX9::CYP2C19::PDE6C	Adenocarcinoma
SNX9::DAP	Adenocarcinoma
SNX9::ZDHHC14	Adenocarcinoma
SOAT1::AGAP2	Mesenchymal tumor, NOS
SOBP::ABCA9	Adenocarcinoma
SOBP::CRYBG1	Astrocytoma, grade III-IV/Glioblastoma
SOBP::HDAC2	Multiple myeloma
SOBP::MET	Adenocarcinoma
SOBP::NHSL2	Malignant epithelial tumor, special type
SOCS1::MYC	Diffuse large B-cell lymphoma
SOCS5::ADCY2	Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
SOCS5::MSH2	Adenocarcinoma
SOCS5::PRADC1	Adenocarcinoma
SOCS5::SLC8A1	Adenocarcinoma
SOCS6::CTDP1	Adenocarcinoma
SOCS6::GLIS3	Adenocarcinoma
SOCS6::PMS1	Mesenchymal tumor, NOS
SOCS7::ERBB2	Carcinoma, NOS
SOCS7::FLOT2	Adenocarcinoma
SOCS7::MAPT	Transitional cell carcinoma
SOCS7::MIEN1	Adenocarcinoma
SOCS7::PHACTR1	Adenocarcinoma
SOCS7::PLXDC1	Adenocarcinoma
SOCS7::RSF1	Adenocarcinoma
SOCS7::SRCIN1	Adenocarcinoma
SOD1::TYK2	Adenocarcinoma
SON::IL10RB	Adenocarcinoma
SON::LRMDA	Adenocarcinoma
SORBS1::FAM135B	Mesenchymal tumor, NOS
SORBS1::TCTN3	Adenocarcinoma
SORBS2::AIF1	Adenocarcinoma
SORBS2::ARHGAP27	Adenocarcinoma
SORBS2::ELK4	Adenocarcinoma
SORBS2::FAM53B	Adenocarcinoma
SORBS2::MRPS35	Adenocarcinoma
SORBS2::OS9	Astrocytoma, grade III-IV/Glioblastoma
SORBS2::PDLIM3	Malignant epithelial tumor, special type
SORBS3::XPO7	Adenocarcinoma
SORCS2::SH3TC1	Transitional cell carcinoma
SORD::ADPGK	Adenocarcinoma
SORD::NT5DC1	Neuroblastoma
SORD::RAB27A	Adenocarcinoma
SORD::TRIM69	Adenocarcinoma
SORL1::CEP164	Adenocarcinoma
SORL1::CNTN5	Adenocarcinoma
SORL1::DDX6	Adenocarcinoma
SORL1::GLT8D1	Adenocarcinoma
SORL1::LMNA	Astrocytoma, grade I-II
SORL1::NEK4	Adenocarcinoma
SORL1::RHBG	Astrocytoma, grade I-II
SORL1::SC5D	Adenocarcinoma
SORL1::SYTL2	Adenocarcinoma
SORL1::TBCEL	Adenocarcinoma
SORL1::TECTA	Adenocarcinoma
SORT1::PSMA5	Adenocarcinoma
SOS1::ADCY3	Adenocarcinoma
SOS1::CDKL4	Adenocarcinoma
SOS1::DTL	Adenocarcinoma
SOS1::MAP4K3	Adenocarcinoma | Germ cell tumor, NOS
SOS2::NEMF	Adenocarcinoma
SOS2::NRXN3	Malignant melanoma
SOS2::POLN	Malignant epithelial tumor, special type
SOX10::FAM168A	Astrocytoma, grade I-II
SOX10::PLAG1	Soft tissue tumor, special type
SOX13::MERTK	Adenocarcinoma
SOX13::PPFIA4	Malignant epithelial tumor, special type
SOX13::PSD2	Adenocarcinoma
SOX2::TPRG1	Squamous cell carcinoma
SOX4::FOXP1	Germ cell tumor, NOS
SOX5::ALK	Astrocytoma, grade I-II
SOX5::DTD2	Adenocarcinoma
SOX5::FFAR2	Adenocarcinoma
SOX5::GUCY2C	Mesenchymal tumor, NOS
SOX5::LMNTD1	Adenocarcinoma
SOX5::MANSC1	Astrocytoma, grade I-II
SOX5::RASA4	Malignant melanoma
SOX5::SPSB2	Mesenchymal tumor, NOS
SOX6::ARV1	Adenocarcinoma
SOX6::BTBD10	Adenocarcinoma
SOX6::EYS	Squamous cell carcinoma
SOX6::GALNT18	Adenocarcinoma
SOX6::NTRK2	Glioma, NOS
SOX6::PTPRJ	Astrocytoma, grade I-II
SOX6::RAB5IF	Adenocarcinoma
SP100::ALK	Benign fibrous histiocytoma
SP100::GIGYF2	Mesenchymal tumor, NOS
SP110::FBXO36	Mature B-cell neoplasm, NOS
SP140L::PDE6D	Squamous cell carcinoma
SP1::ATF7	Mesenchymal tumor, NOS
SP1::COPZ1	Adenocarcinoma
SP1::IGFBP6	Malignant epithelial tumor, special type
SP1::MYG1	Adenocarcinoma
SP1::NPFF	Mesenchymal tumor, NOS
SP1::WNT9B	Malignant epithelial tumor, special type
SP2::KPNB1	Adenocarcinoma
SP3::CYBRD1	Mesenchymal tumor, NOS
SP3::GPR155	Adenocarcinoma
SP3::NDUFB3	Adenocarcinoma
SP3::OLA1	Adenocarcinoma
SP3::PRCP	Astrocytoma, grade III-IV/Glioblastoma
SP3::PTK2	Adenocarcinoma
SP3::SCRN3	Adenocarcinoma
SP3::SLC8A1	Adenocarcinoma
SP3::STK39	Squamous cell carcinoma
SP4::GPNMB	Astrocytoma, grade III-IV/Glioblastoma
SPAG16::CACHD1	Adenocarcinoma
SPAG16::CUL3	Squamous cell carcinoma
SPAG17::LRSAM1	Mesothelioma
SPAG17::PCF11	Adenocarcinoma
SPAG17::RABGAP1L	Adenocarcinoma
SPAG1::ANGPT1	Mesenchymal tumor, NOS
SPAG1::POLR2K	Adenocarcinoma
SPAG1::STK3	Squamous cell carcinoma
SPAG5::BLMH	Adenocarcinoma
SPAG5::FAM222B	Adenocarcinoma
SPAG5::SDF2	Mesenchymal tumor, NOS
SPAG5::SLC47A1	Adenocarcinoma
SPAG5::SYTL1	Adenocarcinoma
SPAG6::PLXDC2	Transitional cell carcinoma
SPAG7::CAMTA2	Squamous cell carcinoma
SPAG7::DNAH17	Squamous cell carcinoma
SPAG7::KIF1C	Mesothelioma
SPAG9::ARL17B	Adenocarcinoma
SPAG9::BRIP1	Adenocarcinoma
SPAG9::CA10	Adenocarcinoma
SPAG9::CLYBL	Astrocytoma, grade I-II
SPAG9::FAM117A	Adenocarcinoma
SPAG9::JAK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SPAG9::MBTD1	Adenocarcinoma
SPAG9::PCMT1	Transitional cell carcinoma
SPAG9::RDX	Malignant melanoma
SPAG9::SKAP1	Adenocarcinoma
SPAG9::TADA2A	Adenocarcinoma
SPAG9::TEKT1	Adenocarcinoma
SPAG9::TRIM37	Adenocarcinoma
SPARC::ATOX1	Adenocarcinoma
SPARC::COL3A1	Adenocarcinoma
SPARC::CTSD	Adenocarcinoma
SPARC::HSP90B1	Adenocarcinoma
SPARC::PDGFRB	Fibroblastic/myofibroblastic tumor, special type
SPARC::TRPS1	Adenocarcinoma
SPARC::USP6	Nodular fasciitis | Fibroma of tendon sheath | Aneurysmal bone cyst
SPARCL1::NCALD	Astrocytoma, grade I-II
SPARCL1::SEC63	Astrocytoma, grade I-II
SPART::SOHLH2	Adenocarcinoma
SPAST::LBH	Astrocytoma, grade I-II
SPAST::MEMO1	Adenocarcinoma
SPATA13::HSCB	Adenocarcinoma
SPATA13::IKBKB	Adenocarcinoma
SPATA13::MIPEP	Adenocarcinoma
SPATA13::PRRC2C	Adenocarcinoma
SPATA13::TNFRSF19	Adenocarcinoma
SPATA16::TTC28	Adenocarcinoma
SPATA18::EXOC1	Squamous cell carcinoma
SPATA20::EPN3	Adenocarcinoma
SPATA2::GSTA5	Adenocarcinoma
SPATA2::RTF2	Adenocarcinoma
SPATA2L::FANCA	Squamous cell carcinoma
SPATA33::DPEP1	Adenocarcinoma
SPATA6::BEND5	Adenocarcinoma
SPATA6::CRYZ	Malignant melanoma
SPATA6::MAD2L2	Adenocarcinoma
SPATA6::PIK3R3	Germ cell tumor, NOS
SPATA6L::GLIS3	Adenocarcinoma
SPATA7::GABRA3	Adenocarcinoma
SPATA7::KTN1	Mesenchymal tumor, NOS
SPATC1L::IGF1	Mesenchymal tumor, NOS
SPATS2::PPM1H	Adenocarcinoma
SPATS2::SENP1	Adenocarcinoma
SPATS2::TSPAN8	Adenocarcinoma
SPATS2L::COL3A1	Adenocarcinoma
SPATS2L::HAT1	Adenocarcinoma
SPATS2L::KCTD18	Malignant melanoma
SPATS2L::SGO2	Mesothelioma
SPC24::DOCK6	Transitional cell carcinoma
SPC25::NEK11	Squamous cell carcinoma
SPCS3::VEGFC	Adenocarcinoma
SPDEF::ILRUN	Adenocarcinoma
SPDEF::VSTM2B	Adenocarcinoma
SPDL1::SCGB3A2	Mesenchymal tumor, NOS
SPDYA::BABAM2	Squamous cell carcinoma
SPDYA::DRAM1	Squamous cell carcinoma
SPECC1::HM13	Adenocarcinoma
SPECC1::PDGFRB	Juvenile myelomonocytic leukemia
SPECC1::RET	Carcinoma, NOS
SPECC1::STAMBP	Adenocarcinoma
SPECC1::TMEM11	Adenocarcinoma
SPECC1L::ADORA2A	Nonneoplastic epithelial disorder/lesion
SPECC1L::ALK	Adenocarcinoma | Benign fibrous histiocytoma
SPECC1L::BCL2L13	Adenocarcinoma
SPECC1L::CABIN1	Malignant epithelial tumor, special type
SPECC1L::CDH4	Adenocarcinoma
SPECC1L::CPNE4	Adenocarcinoma
SPECC1L::HACD3	Adenocarcinoma
SPECC1L::MED15	Malignant melanoma
SPECC1L::MET	Adenocarcinoma
SPECC1L::MRTFA	Adenocarcinoma
SPECC1L::NELFCD	Adenocarcinoma
SPECC1L::NTRK2	Astrocytoma, grade III-IV/Glioblastoma | Soft tissue tumor, NOS | Soft tissue tumor, special type | Embryonal nervous system tumor, special type | Glioma, NOS
SPECC1L::NTRK3	Malignant soft tissue tumor, NOS | Fibroblastic/myofibroblastic tumor, special type | Osteogenic/bone tumor, special type | Mesenchymal tumor, special type
SPECC1L::PPP6R2	Astrocytoma, grade III-IV/Glioblastoma
SPECC1L::RAD51B	Adenocarcinoma
SPECC1L::RAF1	Ependymoma
SPECC1L::RET	Adenocarcinoma | Fibrosarcoma
SPECC1L::SMARCB1	Adenocarcinoma
SPECC1L::SNUPN	Astrocytoma, grade III-IV/Glioblastoma
SPECC1L::SQLE	Malignant melanoma
SPECC1L::TM6SF1	Mesenchymal tumor, NOS
SPECC1L::TMEM62	Adenocarcinoma
SPECC1L::UPB1	Transitional cell carcinoma
SPECC1L::XPNPEP3	Adenocarcinoma
SPEF2::CPLANE1	Adenocarcinoma
SPEF2::NADK2	Squamous cell carcinoma
SPEF2::SLC6A18	Adenocarcinoma
SPEN::CERS4	Adenocarcinoma
SPEN::CNIH3	Adenocarcinoma
SPEN::CTRC	Adenocarcinoma
SPEN::DNAJC16	Adenocarcinoma | Squamous cell carcinoma
SPEN::EFHD2	Transitional cell carcinoma
SPEN::FBLIM1	Transitional cell carcinoma
SPEN::FHAD1	Adenocarcinoma
SPEN::PLEKHM2	Squamous cell carcinoma
SPEN::SRARP	Squamous cell carcinoma
SPEN::TMEM51	Adenocarcinoma
SPEN::TNFRSF1B	Adenocarcinoma
SPEN::TTC34	Astrocytoma, grade I-II
SPG11::CAMK2G	Adenocarcinoma
SPG11::CD9	Squamous cell carcinoma
SPG11::JMJD7	Squamous cell carcinoma
SPG11::SORD	Undifferentiated carcinoma, small cell
SPG7::EFCAB12	Adenocarcinoma
SPG7::GSE1	Malignant melanoma
SPHK2::CGB7	Adenocarcinoma
SPICE1::MORC1	Adenocarcinoma
SPIDR::ANK1	Adenocarcinoma
SPIDR::BLK	Adenocarcinoma
SPIDR::CNBD1	Adenocarcinoma
SPIDR::COX6B1	Astrocytoma, grade I-II
SPIDR::CSMD3	Diffuse large B-cell lymphoma
SPIDR::DNAJC5B	Squamous cell carcinoma
SPIDR::DSCAM	Adenocarcinoma
SPIDR::FNTA	Adenocarcinoma
SPIDR::KCNB2	Astrocytoma, grade I-II
SPIDR::LAPTM4B	Adenocarcinoma
SPIDR::PIAS1	Malignant melanoma
SPIDR::POMGNT2	Adenocarcinoma
SPIDR::RGS20	Adenocarcinoma
SPIDR::RP1	Adenocarcinoma
SPIDR::SLA	Adenocarcinoma
SPIDR::SNX7	Squamous cell carcinoma
SPIDR::SYNC	Adenocarcinoma
SPIDR::TG	Adenocarcinoma
SPIDR::TGFB1	Adenocarcinoma
SPIDR::UBE2V2	Malignant melanoma | Transitional cell carcinoma | Adenocarcinoma
SPIN1::DAPK1	Adenocarcinoma
SPIN1::FUT9	Squamous cell carcinoma
SPIN3::HECTD2	Adenocarcinoma
SPINDOC::BUB1B	Squamous cell carcinoma
SPINDOC::MACROD1	Astrocytoma, grade III-IV/Glioblastoma
SPINDOC::RTN3	Adenocarcinoma
SPINDOC::TRPT1	Adenocarcinoma
SPINK1::C5ORF46	Transitional cell carcinoma
SPINK4::SQSTM1	Adenocarcinoma
SPINK5::DNAJC21	Malignant melanoma
SPINT1::ANXA1	Squamous cell carcinoma
SPINT1::SERP1	Adenocarcinoma
SPINT2::DPF1	Adenocarcinoma
SPINT2::GRIP1	Transitional cell carcinoma
SPINT2::MAP4K1	Adenocarcinoma
SPINT2::PAK1	Adenocarcinoma
SPINT2::PPP1R14A	Adenocarcinoma
SPINT2::TYROBP	Adenocarcinoma
SPINT2::VPS26B	Adenocarcinoma
SPINT2::ZNF260	Adenocarcinoma
SPINT2::ZNF607	Adenocarcinoma
SPIRE1::CUBN	Adenocarcinoma
SPIRE1::PSMG2	Malignant melanoma
SPIRE1::PTPN2	Embryonal nervous system tumor, special type
SPIRE2::CDK10	Adenocarcinoma
SPMAP1::CDK12	Adenocarcinoma
SPMIP4::FKBP9	Astrocytoma, grade III-IV/Glioblastoma
SPN::MPO	Acute myeloid leukemia, NOS | Skin
SPNS1::PRKCB	Adenocarcinoma
SPNS1::ZNF668	Astrocytoma, grade I-II
SPNS2::PSMD11	Adenocarcinoma
SPO11::GSTA1	Adenocarcinoma
SPOCD1::TEX46	Astrocytoma, grade III-IV/Glioblastoma
SPOCK1::ARHGAP26	Adenocarcinoma
SPOCK1::BRAF	Adenocarcinoma
SPOCK1::CDC23	Adenocarcinoma
SPOCK1::TBC1D9B	Adenocarcinoma
SPOCK2::ASCC1	Squamous cell carcinoma
SPON1::CD47	Adenocarcinoma
SPON1::PIK3R3	Adenocarcinoma
SPON1::SBF2	Mesenchymal tumor, NOS
SPON1::SIRT3	Astrocytoma, grade I-II
SPON1::STXBP6	Adenocarcinoma
SPON1::THAP2	Malignant epithelial tumor, special type
SPON1::TRIM29	Adenocarcinoma
SPON2::CTBP1	Adenocarcinoma
SPON2::EEF2	Adenocarcinoma
SPON2::HS1BP3	Adenocarcinoma
SPON2::PARP1	Adenocarcinoma
SPOP::AARSD1	Adenocarcinoma
SPOP::ARL5C	Adenocarcinoma
SPOP::CA10	Adenocarcinoma
SPOP::CDK12	Adenocarcinoma
SPOP::EFCAB13	Adenocarcinoma
SPOP::EPHX2	Malignant epithelial tumor, special type
SPOP::FAM117A	Adenocarcinoma
SPOP::GPATCH1	Adenocarcinoma
SPOP::LIMA1	Adenocarcinoma
SPOP::NBPF1	Astrocytoma, grade I-II
SPOP::NDUFS5	Adenocarcinoma
SPOP::PECAM1	Adenocarcinoma
SPOP::PRDM16	Astrocytoma, grade I-II
SPOP::RARA	Adenocarcinoma
SPOP::SLC35B1	Squamous cell carcinoma | Adenocarcinoma
SPOP::TAC4	Adenocarcinoma
SPOP::TAOK1	Adenocarcinoma
SPOP::TSPEAR	Adenocarcinoma
SPOP::VMP1	Adenocarcinoma
SPOP::XYLT2	Adenocarcinoma
SPOPL::ITPRID2	Adenocarcinoma
SPOUT1::KYAT1	Adenocarcinoma
SPP1::CLU	Adenocarcinoma
SPP1::STAT6	Adenocarcinoma
SPP1::THSD4	Squamous cell carcinoma
SPP1::TYK2	Adenocarcinoma
SPPL2A::TENM4	Malignant melanoma
SPPL2A::TNFAIP8L3	Squamous cell carcinoma
SPPL2A::TRPM7	Adenocarcinoma
SPPL2B::DOT1L	Adenocarcinoma
SPPL2B::GALK1	Adenocarcinoma
SPPL2B::POLR2E	Diffuse large B-cell lymphoma
SPPL3::ACADS	Squamous cell carcinoma
SPPL3::B3GALT4	Malignant epithelial tumor, special type
SPPL3::CD99L2	Adenocarcinoma
SPPL3::CPS1	Adenocarcinoma
SPPL3::IL31	Adenocarcinoma
SPPL3::KNTC1	Adenocarcinoma
SPPL3::OASL	Adenocarcinoma
SPPL3::UNC119B	Squamous cell carcinoma
SPRED1::AP3B2	Adenocarcinoma
SPRED1::GANC	Malignant melanoma
SPRED1::TMCO5A	Adenocarcinoma
SPRED2::G2E3	Astrocytoma, grade III-IV/Glioblastoma
SPRED2::NAPG	Astrocytoma, grade I-II
SPRED2::RAB1A	Transitional cell carcinoma | Adenocarcinoma
SPRED2::THADA	Skin | Acute myeloid leukemia, NOS
SPRED3::RASGRP4	Adenocarcinoma
SPRING1::HSPB8	Astrocytoma, grade III-IV/Glioblastoma
SPRING1::MDM2	Astrocytoma, grade III-IV/Glioblastoma
SPRING1::SLC35E3	Astrocytoma, grade III-IV/Glioblastoma
SPRING1::SRRM4	Astrocytoma, grade III-IV/Glioblastoma
SPRR1A::SPRR2E	Squamous cell carcinoma
SPRR2E::SPRR2G	Squamous cell carcinoma
SPRR2G::SPRR1B	Squamous cell carcinoma
SPRR2G::SPRR2D	Squamous cell carcinoma
SPRYD3::FCHSD2	Astrocytoma, grade I-II
SPRYD4::MDM1	Mesenchymal tumor, NOS
SPSB1::H6PD	Adenocarcinoma
SPSB1::RANBP1	Squamous cell carcinoma
SPSB1::TAF12	Mesenchymal tumor, NOS
SPSB2::DYRK4	Squamous cell carcinoma
SPSB3::ECI1	Adenocarcinoma
SPSB3::IFT140	Transitional cell carcinoma
SPSB3::MEIOB	Adenocarcinoma
SPSB4::PXYLP1	Undifferentiated carcinoma, small cell
SPTA1::GRIP1	Adenocarcinoma
SPTAN1::ABL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SPTAN1::AUH	Adenocarcinoma
SPTAN1::BBLN	Adenocarcinoma
SPTAN1::CADPS2	Adenocarcinoma
SPTAN1::FPGS	Adenocarcinoma
SPTAN1::GLE1	Adenocarcinoma
SPTAN1::MAPKAP1	Malignant melanoma
SPTAN1::SGTA	Malignant epithelial tumor, special type
SPTAN1::SLC27A4	Adenocarcinoma
SPTAN1::SLC34A3	Adenocarcinoma
SPTAN1::TBC1D13	Adenocarcinoma
SPTAN1::USP6	Nodular fasciitis
SPTAN1::ZER1	Transitional cell carcinoma
SPTB::RAB15	Adenocarcinoma
SPTBN1::ACYP2	Adenocarcinoma
SPTBN1::ALK	Adenocarcinoma
SPTBN1::ECI2	Adenocarcinoma
SPTBN1::FLT3	Atypical chronic myeloid leukemia | Lymph node
SPTBN1::MFN1	Malignant melanoma
SPTBN1::MUC2	Adenocarcinoma
SPTBN1::PDGFRB	Chronic myeloproliferative disorder, NOS
SPTBN1::SPAG5	Adenocarcinoma
SPTBN1::STX8	Malignant melanoma
SPTBN1::YWHAQ	Mesenchymal tumor, special type
SPTBN2::ARHGEF17	Malignant melanoma
SPTBN2::FGF19	Adenocarcinoma
SPTBN2::GDPD4	Adenocarcinoma
SPTBN2::PC	Adenocarcinoma
SPTBN4::AKT2	Astrocytoma, grade III-IV/Glioblastoma
SPTBN4::C19ORF47	Adenocarcinoma
SPTBN4::C19orf47	Adenocarcinoma
SPTBN4::RAD51B	Adenocarcinoma
SPTBN4::SIPA1L3	Adenocarcinoma
SPTBN4::TDP1	Adenocarcinoma
SPTBN5::MGA	Squamous cell carcinoma
SPTLC1::IARS1	Malignant epithelial tumor, special type
SPTLC2::DIAPH3	Adenocarcinoma
SPTLC2::DMAC2L	Adenocarcinoma
SPTLC2::PID1	Adenocarcinoma
SPTLC2::SNW1	Adenocarcinoma
SPTLC3::MAOA	Adenocarcinoma
SPTLC3::PLPP1	Adenocarcinoma
SPTY2D1::SERGEF	Malignant melanoma
SQLE::RBFOX3	Adenocarcinoma
SQOR::AFG2B	Adenocarcinoma
SQSTM1::ALK	Benign fibrous histiocytoma | Adenocarcinoma | Malignant soft tissue tumor, NOS | Diffuse large B-cell lymphoma | Soft tissue tumor, special type
SQSTM1::AP1G2	Adenocarcinoma
SQSTM1::CDX1	Soft tissue tumor, special type
SQSTM1::CPB1	Adenocarcinoma
SQSTM1::FGFR1	Acute myelomonocytic leukemia (FAB type M4)
SQSTM1::GRIA1	Adenocarcinoma
SQSTM1::IQCE	Adenocarcinoma
SQSTM1::NTRK1	Soft tissue tumor, special type | Adenocarcinoma | Fibrosarcoma | Carcinoma, NOS
SQSTM1::NTRK2	Glioma, NOS | Malignant epithelial tumor, special type | Melanocytic neoplasm, special type | Carcinoma in situ | Astrocytoma, grade I-II | Adenocarcinoma
SQSTM1::NTRK3	Adenocarcinoma | Malignant soft tissue tumor, NOS | Malignant epithelial tumor, special type
SQSTM1::NUP214	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Acute myeloid leukemia, NOS | Skin
SQSTM1::PDLIM7	Adenocarcinoma
SQSTM1::RET	Adenocarcinoma
SRBD1::ALK	Adenocarcinoma
SRBD1::ATL2	Malignant melanoma
SRBD1::CCDC88A	Adenocarcinoma
SRBD1::PLEKHA6	Adenocarcinoma
SRC::MANBAL	Adenocarcinoma
SRC::PTPRT	Adenocarcinoma
SRC::SPO11	Skin | Acute myeloid leukemia, NOS
SRC::VWC2	Acute erythroleukemia (FAB type M6)
SRCAP::GNB1L	Adenocarcinoma
SRCAP::IL11RA	Squamous cell carcinoma
SRCAP::RPS4Y1	Astrocytoma, grade III-IV/Glioblastoma
SRCIN1::CWC25	Transitional cell carcinoma
SRCIN1::FNDC8	Adenocarcinoma
SRCIN1::KRT39	Adenocarcinoma
SRCIN1::LASP1	Adenocarcinoma
SRCIN1::PCGF2	Adenocarcinoma
SRCIN1::PCYT2	Adenocarcinoma
SRCIN1::PSMB3	Transitional cell carcinoma
SRD5A1::ADAMTS16	Adenocarcinoma
SRD5A1::C1QTNF3	Adenocarcinoma
SRD5A1::MBTD1	Squamous cell carcinoma
SREBF1::DHRS4	Adenocarcinoma
SREBF1::DRC3	Adenocarcinoma
SREBF1::MED9	Transitional cell carcinoma
SREBF1::NACC1	Glioma, NOS
SREBF1::STAT3	Adenocarcinoma
SREBF1::TOM1L2	Adenocarcinoma
SREBF1::USP6	Nodular fasciitis
SREBF1::ZNF232	Adenocarcinoma
SREBF2::ACO2	Adenocarcinoma
SREBF2::ACTB	Multiple myeloma
SREBF2::C22ORF42	Adenocarcinoma
SREBF2::EFCAB6	Adenocarcinoma
SREBF2::FMNL2	Adenocarcinoma
SREBF2::MEI1	Adenocarcinoma
SREBF2::PLPP4	Adenocarcinoma
SREBF2::RNF214	Squamous cell carcinoma
SREK1::ST6GAL1	Squamous cell carcinoma
SREK1IP1::CCDC112	Malignant melanoma
SRF::CITED1	Vascular and perivascular tumor, NOS
SRF::F5	Adenocarcinoma
SRF::ICA1L	Vascular and perivascular tumor, NOS | Muscle tumor, special type
SRF::NCOA2	Spindle cell/sclerosing rhabdomyosarcoma | Vascular and perivascular tumor, special type | Vascular and perivascular tumor, NOS
SRF::NCOA3	Fibroblastic/myofibroblastic tumor, special type
SRF::NFKBIE	Fibroblastic/myofibroblastic tumor, special type | Vascular and perivascular tumor, NOS
SRF::RELA	Vascular and perivascular tumor, NOS | Fibroblastic/myofibroblastic tumor, special type | Fibroma
SRFBP1::PRM1	Adenocarcinoma
SRGAP1::AUTS2	Malignant epithelial tumor, special type
SRGAP1::BACE2	Squamous cell carcinoma
SRGAP1::GAB2	Adenocarcinoma
SRGAP1::KCNMB4	Transitional cell carcinoma
SRGAP1::KNTC1	Adenocarcinoma
SRGAP1::OS9	Adenocarcinoma
SRGAP1::PTPRR	Mesenchymal tumor, NOS
SRGAP1::PWP1	Adenocarcinoma
SRGAP1::RXYLT1	Adenocarcinoma
SRGAP1::TBC1D30	Adenocarcinoma
SRGAP1::USP15	Adenocarcinoma
SRGAP2::COL2A1	Adenocarcinoma
SRGAP2::ELF3	Adenocarcinoma
SRGAP2::KCNJ10	Squamous cell carcinoma
SRGAP2::MAPKAPK2	Adenocarcinoma
SRGAP2::PRPF3	Adenocarcinoma
SRGAP2::RALY	Malignant melanoma
SRGAP2::TBC1D22A	Malignant melanoma
SRGAP2::TCFL5	Adenocarcinoma
SRGAP2B::GORAB	Transitional cell carcinoma
SRGAP2B::SRGAP2	Schwannoma
SRGAP2C::NTNG1	Malignant melanoma
SRGAP3::ATP2B2	Squamous cell carcinoma | Adenocarcinoma
SRGAP3::CEPT1	Astrocytoma, grade III-IV/Glioblastoma
SRGAP3::FAM83H	Transitional cell carcinoma
SRGAP3::FGD5	Adenocarcinoma
SRGAP3::ITPR1	Squamous cell carcinoma
SRGAP3::LHFPL4	Adenocarcinoma
SRGAP3::OXTR	Adenocarcinoma
SRGAP3::PTTG1	Adenocarcinoma
SRGAP3::RAD18	Adenocarcinoma
SRGAP3::RAF1	Astrocytoma, pilocytic/juvenile
SRI::PIP4K2C	Mesenchymal tumor, NOS
SRM::C19ORF25	Malignant melanoma
SRM::PPP4R3A	Astrocytoma, grade III-IV/Glioblastoma
SRP54::THRSP	Adenocarcinoma
SRP68::AP1M2	Astrocytoma, grade III-IV/Glioblastoma
SRP68::CDK3	Transitional cell carcinoma
SRP68::EXOC7	Adenocarcinoma
SRP68::LPO	Adenocarcinoma
SRP68::MIEN1	Adenocarcinoma
SRP68::QRICH2	Adenocarcinoma
SRP68::RCAN1	Adenocarcinoma
SRP68::URM1	Astrocytoma, grade III-IV/Glioblastoma
SRP68::XIRP2	Transitional cell carcinoma
SRP9::PCNX1	Adenocarcinoma
SRPK1::ANKRD42	Adenocarcinoma
SRPK1::CCHCR1	Adenocarcinoma
SRPK1::CCL18	Germ cell tumor, NOS
SRPK1::CCND3	Adenocarcinoma
SRPK1::CEP57L1	Squamous cell carcinoma
SRPK1::CPNE5	Adenocarcinoma
SRPK1::DDAH1	Adenocarcinoma
SRPK1::EHMT2	Transitional cell carcinoma
SRPK1::PXT1	Adenocarcinoma
SRPK1::ROS1	Adenocarcinoma
SRPK2::ATXN7L1	Squamous cell carcinoma | Adenocarcinoma
SRPK2::DYNC1I1	Adenocarcinoma
SRPK2::EFCAB10	Adenocarcinoma
SRPK2::ELAPOR2	Squamous cell carcinoma
SRPK2::KIF12	Adenocarcinoma
SRPK2::LRP5	Squamous cell carcinoma
SRPK2::PRKAR2B	Adenocarcinoma
SRPK2::PUS7	Adenocarcinoma
SRPK2::ZC3HC1	Adenocarcinoma
SRRD::MST1	Adenocarcinoma
SRRD::SNX32	Squamous cell carcinoma
SRRM1::AUNIP	Adenocarcinoma
SRRM1::FAU	Adenocarcinoma
SRRM1::NFYC	Adenocarcinoma
SRRM2::KCTD5	Adenocarcinoma
SRRM2::PRSS27	Multiple myeloma
SRRM2::PRSS33	Squamous cell carcinoma
SRRM2::SNRPE	Adenocarcinoma
SRRT::PPP1R17	Astrocytoma, grade III-IV/Glioblastoma
SRRT::TRIP6	Adenocarcinoma
SRRT::ZAN	Astrocytoma, grade III-IV/Glioblastoma
SRSF11::LAP3	Adenocarcinoma
SRSF1::DDX5	Chronic lymphocytic leukemia
SRSF1::SKA2	Adenocarcinoma
SRSF3::BCL6	Follicular lymphoma
SRSF3::PLAG1	Lipoblastoma
SRSF3::PTCHD4	Adenocarcinoma
SRSF4::CREB5	Transitional cell carcinoma
SRSF4::MECR	Adenocarcinoma
SRSF4::SCRN3	Adenocarcinoma
SRSF4::SIAE	Adenocarcinoma
SRSF4::SNRNP40	Adenocarcinoma
SRSF5::CCT5	Squamous cell carcinoma
SRSF7::HNRNPLL	Squamous cell carcinoma
SRSF9::RFX4	Adenocarcinoma
SRSF9::UBC	Multiple myeloma
SS18::CHST9	Adenocarcinoma
SS18::DOCK2	Adenocarcinoma
SS18::KLF14	Synovial sarcoma
SS18::MEF2D	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SS18::NEDD4	Malignant soft tissue tumor, NOS | Synovial sarcoma
SS18::NPC1	Adenocarcinoma
SS18::POU5F1	Undifferentiated round cell sarcoma
SS18::PRKD2	Adenocarcinoma
SS18::SLC5A11	Undifferentiated carcinoma
SS18::SSX1	Synovial sarcoma | Epithelioid sarcoma
SS18::SSX2	Synovial sarcoma | Soft tissue tumor, special type | Soft tissue tumor, NOS
SS18::SSX4	Synovial sarcoma
SS18::SUPT3H	Adenocarcinoma
SS18::UBE2I	Adenocarcinoma
SS18::VGLL3	Schwannoma
SS18::ZBTB7A	Adenocarcinoma
SS18::ZNF521	Mesenchymal tumor, NOS
SS18L1::CDH4	Adenocarcinoma
SS18L1::GID8	Adenocarcinoma
SS18L1::JAM2	Malignant melanoma
SS18L1::SSX1	Synovial sarcoma
SSB::CASP8	Adenocarcinoma
SSBP1::PON1	Adenocarcinoma
SSBP1::PPP6R3	Squamous cell carcinoma
SSBP2::BSN	Skin | Acute myeloid leukemia, NOS
SSBP2::CPNE4	Adenocarcinoma
SSBP2::CSF1R	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SSBP2::FER	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SSBP2::JAK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SSBP2::LGALS2	Malignant melanoma
SSBP2::NTRK1	Adenocarcinoma
SSBP2::PDGFRB	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SSBP2::RPS23	Adenocarcinoma
SSBP2::SERINC5	Adenocarcinoma
SSBP3::ACOT11	Neuroblastoma
SSBP3::DHCR24	Adenocarcinoma
SSBP3::EDA	Transitional cell carcinoma
SSBP3::RHEX	Adenocarcinoma
SSBP3::TOX2	Adenocarcinoma
SSBP4::SLC5A5	Adenocarcinoma
SSH1::SART3	Malignant melanoma
SSH1::SVOP	Adenocarcinoma
SSH2::ANO1	Adenocarcinoma
SSH2::ASAP1	Adenocarcinoma
SSH2::BLMH	Squamous cell carcinoma
SSH2::CDK12	Adenocarcinoma
SSH2::DHX40	Adenocarcinoma
SSH2::DTD1	Adenocarcinoma
SSH2::KLHL28	Adenocarcinoma
SSH2::LBP	Adenocarcinoma
SSH2::NARS2	Adenocarcinoma
SSH2::NDUFS4	Adenocarcinoma
SSH2::NUFIP2	Adenocarcinoma
SSH2::PIPOX	Adenocarcinoma
SSH2::RUNDC3A	Squamous cell carcinoma
SSH2::SLC35B1	Adenocarcinoma
SSH2::SLC6A4	Adenocarcinoma
SSH2::TNFAIP1	Adenocarcinoma
SSH2::UST	Adenocarcinoma
SSH2::VSIR	Malignant melanoma
SSH3::CABP2	Adenocarcinoma
SSH3::KDM2A	Acute myeloid leukemia, NOS | Adenocarcinoma | Skin
SSPN::PKP2	Adenocarcinoma
SSPN::TEAD4	Astrocytoma, grade I-II
SSR1::CAGE1	Adenocarcinoma
SSR1::DMD	Astrocytoma, grade III-IV/Glioblastoma
SSR1::FARS2	Adenocarcinoma
SSR1::NTF3	Mesenchymal tumor, NOS
SSR2::ACOT11	Adenocarcinoma
SSR2::GON4L	Diffuse large B-cell lymphoma
SSR2::SUPT16H	Adenocarcinoma
SSR3::MAP2K3	Squamous cell carcinoma
SSR3::TRPC1	Adenocarcinoma
SSR3::VEPH1	Adenocarcinoma
SSRP1::MED19	Adenocarcinoma
SSU72::ASCC1	Adenocarcinoma
SSX2IP::LPAR3	Adenocarcinoma
SSX2IP::WDPCP	Malignant epithelial tumor, special type
ST13::MEI1	Malignant melanoma
ST13::ST8SIA3	Adenocarcinoma
ST14::APLP2	Adenocarcinoma
ST14::BARX2	Adenocarcinoma
ST14::ERBB2	Adenocarcinoma
ST14::ST7	Adenocarcinoma
ST3GAL1::AGO2	Multiple myeloma
ST3GAL1::COL22A1	Adenocarcinoma
ST3GAL1::EEA1	Adenocarcinoma
ST3GAL1::GPR39	Adenocarcinoma
ST3GAL1::TDRP	Adenocarcinoma
ST3GAL2::CATSPERB	Adenocarcinoma
ST3GAL2::COG4	Adenocarcinoma
ST3GAL2::VAC14	Adenocarcinoma
ST3GAL3::CSDE1	Multiple myeloma
ST3GAL3::EBNA1BP2	Adenocarcinoma
ST3GAL3::GLCCI1	Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
ST3GAL3::KDM4A	Adenocarcinoma
ST3GAL3::PTPRF	Adenocarcinoma
ST3GAL3::TAL1	Adenocarcinoma
ST3GAL3::TGFBR3	Adenocarcinoma
ST3GAL3::TIE1	Adenocarcinoma
ST3GAL3::ZMAT4	Transitional cell carcinoma
ST3GAL4::CFAP300	Adenocarcinoma
ST3GAL4::FAT3	Malignant melanoma
ST3GAL4::FGF19	Adenocarcinoma
ST3GAL4::HYLS1	Adenocarcinoma
ST3GAL4::ZW10	Mesenchymal tumor, NOS
ST3GAL5::IMMT	Astrocytoma, grade I-II
ST6GAL1::BCL6	Follicular lymphoma
ST6GAL1::HRG	Adenocarcinoma
ST6GAL1::IGK	Multiple myeloma
ST6GAL1::KNG1	Adenocarcinoma
ST6GAL1::LPP	Adenocarcinoma
ST6GAL1::NSD2	Astrocytoma, pilocytic/juvenile
ST6GAL1::PSMC3	Adenocarcinoma
ST6GAL1::TBCCD1	Squamous cell carcinoma
ST6GALNAC1::ZMAT5	Adenocarcinoma
ST6GALNAC2::BRIP1	Transitional cell carcinoma
ST6GALNAC2::JMJD6	Adenocarcinoma
ST6GALNAC3::AK5	Squamous cell carcinoma
ST7::ANKRD7	Adenocarcinoma
ST7::ASZ1	Adenocarcinoma
ST7::CAPZA2	Adenocarcinoma
ST7::CAV1	Astrocytoma, grade III-IV/Glioblastoma
ST7::CFTR	Astrocytoma, grade I-II
ST7::CNTNAP2	Mesenchymal tumor, NOS
ST7::COG5	Adenocarcinoma
ST7::EXOC4	Adenocarcinoma
ST7::FOXP2	Adenocarcinoma
ST7::MET	Astrocytoma, grade I-II | Adenocarcinoma | Carcinoma, NOS | Astrocytoma, grade III-IV/Glioblastoma
ST7::PRKAG2	Adenocarcinoma
ST7::PTPRZ1	Adenocarcinoma
ST7::TBXAS1	Mesenchymal tumor, NOS
ST7L::AP2A2	Adenocarcinoma
ST7L::CSMD2	Adenocarcinoma
ST7L::PRPF6	Adenocarcinoma
ST8SIA1::ABCC9	Adenocarcinoma
ST8SIA1::AEBP2	Malignant melanoma
ST8SIA1::FTO	Astrocytoma, grade I-II
ST8SIA1::LMNTD1	Adenocarcinoma
ST8SIA4::PAM	Astrocytoma, grade III-IV/Glioblastoma
STAG1::ANKS1B	Mesenchymal tumor, NOS
STAG1::ATF7	Alveolar rhabdomyosarcoma
STAG1::CCDC77	Adenocarcinoma
STAG1::FAM168A	Adenocarcinoma
STAG1::IL20RB	Squamous cell carcinoma
STAG1::ISY1	Adenocarcinoma
STAG1::MSL2	Adenocarcinoma | Squamous cell carcinoma
STAG1::NCK1	Adenocarcinoma | Squamous cell carcinoma
STAG1::P2RY13	Malignant melanoma
STAG1::SPSB4	Squamous cell carcinoma
STAG1::STXBP5L	Undifferentiated carcinoma, small cell
STAG1::USP6	Nodular fasciitis
STAG1::ZNF148	Adenocarcinoma
STAG2::AMMECR1	Transitional cell carcinoma
STAG2::ARHGEF6	Skin | Acute myeloid leukemia, NOS
STAG2::ATRX	Acute lymphoblastic leukemia/lymphoblastic lymphoma
STAG2::BMERB1	Adenocarcinoma
STAG2::BZW2	Acute megakaryoblastic leukemia (FAB type M7)
STAG2::CMC4	Adenocarcinoma
STAG2::CYRIB	Mesenchymal tumor, NOS
STAG2::GPR119	Acute megakaryoblastic leukemia (FAB type M7)
STAG2::GRIA3	Adenocarcinoma
STAG2::LMO2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
STAG2::PAK3	Astrocytoma, grade III-IV/Glioblastoma
STAG2::RTL9	Transitional cell carcinoma
STAG2::XIAP	Adenocarcinoma
STAM2::NOSTRIN	Transitional cell carcinoma
STAM2::THSD7B	Adenocarcinoma
STAM::EPYC	Mesenchymal tumor, NOS
STAM::HACD1	Adenocarcinoma
STAM::MRC1	Malignant melanoma
STAMBP::SPR	Adenocarcinoma
STAMBPL1::ATAD1	Astrocytoma, grade III-IV/Glioblastoma
STAMBPL1::CHUK	Mature B-cell neoplasm, NOS
STAMBPL1::PANK1	Adenocarcinoma
STARD10::CLTCL1	Malignant melanoma
STARD10::FAM168A	Multiple myeloma
STARD10::ZC3H12C	Adenocarcinoma
STARD13::CAB39L	Adenocarcinoma
STARD13::KLF5	Adenocarcinoma
STARD13::TNFRSF8	Adenocarcinoma
STARD3::ABR	Transitional cell carcinoma
STARD3::ACLY	Adenocarcinoma
STARD3::CACNA1C	Adenocarcinoma
STARD3::CASC3	Adenocarcinoma
STARD3::DOCK5	Adenocarcinoma
STARD3::DOK5	Adenocarcinoma
STARD3::ERBB2	Carcinoma, NOS
STARD3::FAM20A	Adenocarcinoma
STARD3::FBXL20	Adenocarcinoma
STARD3::GSDMB	Adenocarcinoma
STARD3::IKZF3	Adenocarcinoma
STARD3::JUP	Adenocarcinoma
STARD3::MIEN1	Adenocarcinoma
STARD3::NFIX	Adenocarcinoma
STARD3::OAZ1	Squamous cell carcinoma
STARD3::OMG	Adenocarcinoma
STARD3::PPP1R1B	Transitional cell carcinoma
STARD3::RAB5C	Adenocarcinoma
STARD3::SPMAP1	Adenocarcinoma
STARD3::STRADA	Adenocarcinoma
STARD3::STXBP4	Adenocarcinoma
STARD3::UVRAG	Adenocarcinoma
STARD3NL::BRAF	Adenocarcinoma
STARD4::ASTN2	Adenocarcinoma
STARD4::TCERG1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
STARD7::HS1BP3	Astrocytoma, grade III-IV/Glioblastoma
STARD7::LRRN1	Transitional cell carcinoma
STARD9::PDIA3	Squamous cell carcinoma
STAT1::SUMO1	Mesenchymal tumor, NOS
STAT2::ANKRD52	Adenocarcinoma
STAT3::C1ORF43	Adenocarcinoma
STAT3::CAVIN1	Squamous cell carcinoma | Adenocarcinoma | Mature B-cell neoplasm, NOS
STAT3::ETV4	Adenocarcinoma
STAT3::KAT2A	Squamous cell carcinoma
STAT3::NOS2	Adenocarcinoma
STAT3::RARA	Acute promyelocytic leukemia (FAB type M3)
STAT3::TPM3	Adenocarcinoma
STAT3::USP6	Aneurysmal bone cyst
STAT3::ZFPM2	Adenocarcinoma
STAT4::ACKR3	Adenocarcinoma
STAT5A::BMAL2	Adenocarcinoma
STAT5A::VAC14	Adenocarcinoma
STAT5B::ACSF2	Adenocarcinoma
STAT5B::NSRP1	Adenocarcinoma
STAT5B::PFAS	Adenocarcinoma
STAT5B::RARA	Acute promyelocytic leukemia (FAB type M3)
STAT5B::STAT3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
STAT5B::TENM4	Mesenchymal tumor, NOS
STAU1::ATF7IP2	Adenocarcinoma
STAU1::CTSA	Adenocarcinoma
STAU1::CYP26B1	Adenocarcinoma
STAU1::GPHB5	Adenocarcinoma
STAU1::MAP1LC3A	Adenocarcinoma
STAU1::MRPL4	Adenocarcinoma
STAU1::PABPC1L	Adenocarcinoma
STAU1::PLCE1	Squamous cell carcinoma
STAU1::PREX1	Adenocarcinoma
STAU2::C8ORF89	Adenocarcinoma
STAU2::DNAAF11	Astrocytoma, grade III-IV/Glioblastoma
STAU2::MSI2	Adenocarcinoma
STAU2::MTFR1	Adenocarcinoma
STAU2::OC90	Adenocarcinoma
STAU2::OSBPL2	Malignant melanoma
STAU2::PAWR	Adenocarcinoma
STAU2::PDE7A	Adenocarcinoma
STAU2::PLEKHF2	Adenocarcinoma
STAU2::RALYL	Adenocarcinoma
STC2::AP1G1	Adenocarcinoma
STC2::RNF11	Adenocarcinoma
STC2::TYK2	Adenocarcinoma
STEAP1B::POU6F2	Adenocarcinoma
STEAP2::GTPBP10	Adenocarcinoma
STEEP1::UBE2A	Adenocarcinoma
STIL::TAL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
STIM1::ANO9	Astrocytoma, grade I-II
STIM1::CLIP1	Adenocarcinoma
STIM1::FITM2	Adenocarcinoma
STIM1::GPR160	Adenocarcinoma
STIM1::HOMEZ	Adenocarcinoma
STIM1::MEF2D	Astrocytoma, grade III-IV/Glioblastoma
STIM1::NSD1	Acute myeloblastic leukemia without maturation (FAB type M1)
STIM1::NUP98	Adenocarcinoma
STIM1::PGAP2	Malignant melanoma
STIM1::PNPLA2	Malignant melanoma
STIM1::VHL	Squamous cell carcinoma
STIM2::GATAD2A	Squamous cell carcinoma
STIM2::IKZF1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
STIM2::SPIDR	Adenocarcinoma
STIM2::TBC1D19	Squamous cell carcinoma
STIMATE::RFT1	Adenocarcinoma
STIMATE::TP63	Diffuse large B-cell lymphoma
STIP1::CREB3L1	Squamous cell carcinoma
STIP1::MS4A18	Squamous cell carcinoma
STIP1::NSL1	Transitional cell carcinoma
STIP1::P2RY6	Adenocarcinoma
STIP1::PAK1	Squamous cell carcinoma
STIP1::PC	Squamous cell carcinoma
STIP1::RTN3	Adenocarcinoma
STIP1::UBE2G1	Squamous cell carcinoma
STK10::SH3PXD2B	Adenocarcinoma
STK10::SLIT3	Adenocarcinoma
STK10::SNX2	Acute myeloid leukemia, NOS | Skin | Adenocarcinoma
STK10::UBTD2	Adenocarcinoma
STK11::ARHGAP45	Adenocarcinoma
STK11::AZU1	Adenocarcinoma
STK11::BSG	Adenocarcinoma
STK11::CBARP	Transitional cell carcinoma
STK11::GPX4	Adenocarcinoma
STK11::KDM4B	Adenocarcinoma
STK11::MIDN	Adenocarcinoma
STK11::NOSIP	Mesothelioma
STK11::SMARCD2	Adenocarcinoma
STK11::SRFBP1	Adenocarcinoma
STK11::TYK2	Adenocarcinoma
STK11IP::INHA	Adenocarcinoma
STK11IP::S100A16	Adenocarcinoma
STK16::PLCD4	Adenocarcinoma
STK17B::HECW2	Adenocarcinoma
STK19::LY6G6D	Adenocarcinoma
STK19::LY6G6F	Adenocarcinoma
STK24::ATF7	Adenocarcinoma
STK24::DOCK9	Adenocarcinoma
STK24::MPC2	Malignant melanoma
STK24::PDE1A	Adenocarcinoma
STK24::PIP5K1B	Adenocarcinoma
STK24::RUNX1	Adenocarcinoma
STK24::SLC15A1	Transitional cell carcinoma | Mature B-cell neoplasm, NOS
STK24::TMTC4	Transitional cell carcinoma
STK24::TRIQK	Adenocarcinoma
STK26::ZC4H2	Adenocarcinoma
STK31::ASIC2	Adenocarcinoma
STK32A::PDXDC1	Malignant melanoma
STK32A::SPINK5	Malignant melanoma
STK32B::GINS1	Malignant melanoma
STK32B::SMIM14	Squamous cell carcinoma
STK32C::ADGRA1	Adenocarcinoma
STK32C::PWWP2B	Malignant melanoma
STK33::CHRNB4	Mesothelioma
STK35::BRAF	Mesothelioma
STK35::CHD6	Adenocarcinoma
STK35::GP5	Adenocarcinoma
STK38::GMDS	Adenocarcinoma
STK38::SRSF3	Adenocarcinoma
STK38::TDRD7	Adenocarcinoma
STK38::ZNF184	Transitional cell carcinoma
STK38L::CCDC91	Adenocarcinoma
STK38L::SMCO2	Squamous cell carcinoma
STK38L::TMPRSS12	Adenocarcinoma
STK39::B3GALT1	Adenocarcinoma
STK39::BRAF	Adenocarcinoma
STK39::CCDC150	Adenocarcinoma
STK39::ITGB6	Adenocarcinoma
STK39::MAT1A	Adenocarcinoma
STK39::NCKAP5	Squamous cell carcinoma
STK39::PARVA	Squamous cell carcinoma
STK39::SCN3A	Adenocarcinoma
STK39::SCN7A	Mesothelioma
STK39::TMEM245	Astrocytoma, grade I-II
STK3::COX6C	Adenocarcinoma
STK3::CPQ	Adenocarcinoma
STK3::LRRC69	Squamous cell carcinoma
STK3::MRPL48	Transitional cell carcinoma
STK3::NIPAL2	Adenocarcinoma
STK3::PAQR3	Adenocarcinoma
STK3::POLR2K	Adenocarcinoma
STK3::RREB1	Adenocarcinoma
STK3::SLC26A7	Squamous cell carcinoma
STK3::SPRR2E	Adenocarcinoma
STK3::SULT1A3	Squamous cell carcinoma
STK3::SULT1A4	Squamous cell carcinoma
STK3::ZHX2	Adenocarcinoma
STK40::GPHN	Adenocarcinoma
STK40::MDM4	Adenocarcinoma
STK40::OSCP1	Mesenchymal tumor, NOS
STK4::CPM	Adenocarcinoma
STK4::PKIG	Adenocarcinoma
STK4::TSHZ2	Adenocarcinoma
STKLD1::DBH	Squamous cell carcinoma
STMN1::SPI1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
STMN3::DGKG	Adenocarcinoma
STMN3::PTK6	Adenocarcinoma
STMP1::BRAF	Adenocarcinoma
STN1::COL17A1	Adenocarcinoma
STN1::PCGF3	Transitional cell carcinoma
STN1::SH3PXD2A	Squamous cell carcinoma
STN1::TM9SF3	Adenocarcinoma
STOM::DDX27	Adenocarcinoma
STOM::IDE	Adenocarcinoma
STOM::RC3H2	Malignant melanoma
STON2::RPGRIP1	Adenocarcinoma
STON2::SEL1L	Astrocytoma, grade III-IV/Glioblastoma
STON2::TJP2	Adenocarcinoma
STPG4::ALK	Adenocarcinoma
STRA6::NDUFAF1	Malignant epithelial tumor, special type
STRADA::GRB2	Adenocarcinoma
STRADA::LYZ	Squamous cell carcinoma
STRADB::NOP58	Adenocarcinoma
STRAP::MYO7A	Adenocarcinoma
STRBP::ASTN2	Adenocarcinoma
STRBP::ATG14	Adenocarcinoma
STRBP::DENND1A	Adenocarcinoma
STRBP::SLC35D2	Adenocarcinoma
STRIP1::AHCYL1	Adenocarcinoma
STRIP1::CSF1	Adenocarcinoma
STRIP1::LITAF	Adenocarcinoma
STRIP2::CTTNBP2	Astrocytoma, grade I-II
STRN3::BRAF	Benign nevus
STRN3::COCH	Squamous cell carcinoma
STRN3::EGLN3	Adenocarcinoma
STRN3::JAK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
STRN3::MAML3	Adenocarcinoma
STRN3::METTL3	Adenocarcinoma
STRN3::NTRK1	Adenocarcinoma
STRN3::NTRK3	Fibrosarcoma | Leiomyosarcoma | Endometrial stromal sarcoma
STRN3::PDGFRB	Skin | Acute myeloid leukemia, NOS
STRN3::PPP6R3	Adenocarcinoma
STRN3::PRKD1	Adenocarcinoma
STRN3::RARA	Acute promyelocytic leukemia (FAB type M3)
STRN3::RNASE10	Transitional cell carcinoma
STRN3::SNTG1	Adenocarcinoma
STRN4::AP2S1	Adenocarcinoma
STRN4::ERVV-2	Adenocarcinoma
STRN4::TECR	Adenocarcinoma
STRN4::UBE2S	Adenocarcinoma
STRN::ALK	Mesenchymal tumor, special type | Carcinoma, NOS | Benign epithelial tumor, special type | Inflammatory myofibroblastic tumor/myofibroblastic sarcoma | Adenocarcinoma | Mesothelioma
STRN::HEATR5B	Adenocarcinoma
STRN::NTRK2	Adenocarcinoma | Fibroblastic/myofibroblastic tumor, NOS | Astrocytoma, grade I-II
STRN::NTRK3	Fibrosarcoma
STRN::PDGFRA	Chronic eosinophilic leukemia/hypereosinophilic syndrome
STRN::SULT6B1	Adenocarcinoma
STT3B::EMC3	Astrocytoma, grade III-IV/Glioblastoma
STT3B::ZNF860	Transitional cell carcinoma
STUB1::MECP2	Adenocarcinoma
STUB1::RAB11FIP3	Adenocarcinoma
STUB1::RAB40C	Adenocarcinoma
STUB1::RHOT2	Adenocarcinoma
STUM::VTI1A	Adenocarcinoma
STX12::TMEM222	Squamous cell carcinoma
STX12::USP48	Malignant melanoma
STX12::WDTC1	Squamous cell carcinoma
STX16::GNAS	Squamous cell carcinoma
STX16::MYT1	Adenocarcinoma
STX16::NCOA5	Adenocarcinoma
STX16::RAE1	Adenocarcinoma
STX16::SIX4	Carcinoma, NOS
STX17::DAB2IP	Adenocarcinoma
STX17::NR4A3	Squamous cell carcinoma
STX18::LYAR	Adenocarcinoma
STX2::GRIN2B	Adenocarcinoma
STX3::MS4A15	Adenocarcinoma
STX3::OOSP1	Transitional cell carcinoma
STX3::PLEKHA7	Squamous cell carcinoma
STX5::ASIP	Adenocarcinoma
STX5::BSCL2	Adenocarcinoma
STX5::HMGA2	Embryonal rhabdomyosarcoma
STX5::PPP1R14B	Adenocarcinoma
STX5::SLC22A6	Adenocarcinoma
STX5::TAF6L	Mesenchymal tumor, NOS
STX5::WDR74	Squamous cell carcinoma
STX6::PRRC2C	Adenocarcinoma
STX6::SMYD3	Mesenchymal tumor, NOS
STX6::TNR	Squamous cell carcinoma
STX7::LMBRD1	Malignant melanoma
STX8::HSD17B4	Adenocarcinoma
STX8::MYOCD	Transitional cell carcinoma
STX8::RTN1	Adenocarcinoma
STX8::TMEM35A	Adenocarcinoma
STX8::TRIM16L	Astrocytoma, grade III-IV/Glioblastoma
STXBP1::CACNA2D2	Adenocarcinoma
STXBP1::LRSAM1	Adenocarcinoma
STXBP1::RALGPS1	Malignant epithelial tumor, special type
STXBP1::SOX13	Malignant epithelial tumor, special type
STXBP2::ARHGEF1	Adenocarcinoma
STXBP2::TRIM4	Adenocarcinoma
STXBP3::GPR61	Transitional cell carcinoma
STXBP4::GRN	Adenocarcinoma
STXBP4::MSI2	Adenocarcinoma
STXBP4::NIPA2	Adenocarcinoma
STXBP4::PPM1D	Adenocarcinoma
STXBP5::SAMD5	Malignant melanoma
STXBP5::SASH1	Mesenchymal tumor, NOS
STXBP5::TNFRSF19	Mesenchymal tumor, NOS
STXBP5L::EPHA3	Adenocarcinoma
STXBP5L::STAG1	Undifferentiated carcinoma, small cell
STXBP6::PLEKHA4	Adenocarcinoma
STXBP6::SLC44A4	Transitional cell carcinoma
STXBP6::ZNF410	Mesenchymal tumor, NOS
STYK1::GPR162	Adenocarcinoma
STYX::DAD1	Mesenchymal tumor, NOS
STYX::MDGA2	Adenocarcinoma
STYX::RTRAF	Adenocarcinoma
STYXL1::PRPF40B	Adenocarcinoma
SUB1::ECT2	Squamous cell carcinoma
SUB1::ELMO1	Malignant melanoma
SUB1::GHR	Malignant melanoma
SUCLA2::CASR	Adenocarcinoma
SUCLA2::CTTNBP2NL	Adenocarcinoma
SUCLA2::TINAG	Adenocarcinoma
SUCO::C12orf42	Mesenchymal tumor, NOS
SUCO::C1orf105	Adenocarcinoma
SUCO::CDH18	Mesenchymal tumor, NOS
SUCO::DARS2	Adenocarcinoma
SUCO::DENND1B	Mesenchymal tumor, NOS
SUCO::DNM3	Adenocarcinoma
SUCO::MYRFL	Mesenchymal tumor, NOS
SUCO::PRRC2C	Malignant epithelial tumor, special type
SUCO::RASAL2	Adenocarcinoma
SUCO::SND1	Adenocarcinoma
SUCO::TASL	Mesenchymal tumor, NOS
SUCO::ZCWPW2	Adenocarcinoma
SUDS3::CDK4	Astrocytoma, grade III-IV/Glioblastoma
SUFU::ADK	Mesothelioma | Squamous cell carcinoma
SUFU::ATP8A2	Malignant soft tissue tumor, NOS
SUFU::CYP17A1	Primitive neuroectodermal tumor/Medulloblastoma | Russia
SUFU::CYP26A1	Adenocarcinoma
SUFU::GBF1	Adenocarcinoma
SUFU::KCNH2	Adenocarcinoma
SUFU::WBP1L	Mesothelioma
SUFU::ZCCHC24	Astrocytoma, grade I-II
SUGCT::POU6F2	Adenocarcinoma
SUGCT::RALA	Germ cell tumor, NOS
SUGP1::CASP14	Adenocarcinoma
SUGP1::MEX3D	Adenocarcinoma
SUGP1::PEPD	Adenocarcinoma
SUGP1::TMEM221	Mesenchymal tumor, NOS
SUGP2::BORCS8	Adenocarcinoma
SUGP2::MEF2B	Adenocarcinoma
SULF1::ANKS1A	Adenocarcinoma
SULF1::C8orf34	Adenocarcinoma
SULF1::RPS29	Adenocarcinoma
SULF2::BCAS1	Adenocarcinoma
SULF2::DEXI	Adenocarcinoma
SULF2::GAB2	Adenocarcinoma
SULF2::PEX5L	Mesenchymal tumor, NOS
SULF2::PRICKLE2	Adenocarcinoma
SULF2::TSHZ2	Mesenchymal tumor, NOS
SULF2::WFDC3	Mesenchymal tumor, NOS
SULF2::ZNF217	Adenocarcinoma
SULT1B1::CSN2	Adenocarcinoma
SULT4A1::TFIP11	Malignant melanoma
SUMF1::CNTN4	Adenocarcinoma
SUMF2::EGFR	Adenocarcinoma
SUMF2::SEPTIN14	Astrocytoma, grade I-II
SUMO1::MBD5	Adenocarcinoma
SUMO2::ACOX1	Malignant epithelial tumor, special type
SUMO2::KCTD2	Squamous cell carcinoma
SUMO2::POLR2K	Adenocarcinoma
SUMO3::FAM83E	Adenocarcinoma
SUN1::ABHD16A	Malignant melanoma
SUN1::ICA1	Squamous cell carcinoma
SUN1::SI	Malignant melanoma
SUN2::GTPBP1	Astrocytoma, grade I-II
SUPT16H::CHD8	Squamous cell carcinoma
SUPT20H::ATP8A2	Mesenchymal tumor, NOS
SUPT4H1::CEP112	Adenocarcinoma
SUPT4H1::PSMD12	Adenocarcinoma
SUPT4H1::SEPTIN4	Adenocarcinoma
SUPT5H::ACVRL1	Squamous cell carcinoma
SUPT5H::ARHGEF19	Adenocarcinoma
SUPT5H::BRME1	Adenocarcinoma
SUPT5H::CALR3	Adenocarcinoma
SUPT5H::CATSPERG	Adenocarcinoma
SUPT5H::MED29	Adenocarcinoma
SUPT5H::NADSYN1	Adenocarcinoma
SUPT5H::PLEKHG2	Adenocarcinoma
SUPT5H::SAMD4B	Adenocarcinoma
SUPT5H::SIPA1L3	Adenocarcinoma
SUPT5H::ZSCAN5A	Adenocarcinoma
SUPT6H::MRO	Squamous cell carcinoma
SUPT6H::PRKCA	Adenocarcinoma
SUPT6H::SARM1	Transitional cell carcinoma
SUPT6H::TJP1	Adenocarcinoma
SUPT6H::UTP6	Adenocarcinoma
SUPT7L::RBKS	Adenocarcinoma | Squamous cell carcinoma
SUPV3L1::DDX21	Adenocarcinoma
SUPV3L1::VPS26A	Adenocarcinoma
SURF6::MED22	Mycosis fungoides/Sézary syndrome
SUSD1::UGCG	Adenocarcinoma
SUSD4::DEGS1	Adenocarcinoma
SUSD4::NVL	Adenocarcinoma
SUSD4::RYR2	Adenocarcinoma
SUSD6::PLEKHD1	Adenocarcinoma
SUSD6::RAD51B	Adenocarcinoma
SUSD6::RBM25	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SUSD6::SIVA1	Transitional cell carcinoma
SUSD6::SLC39A9	Adenocarcinoma
SUSD6::SMOC1	Adenocarcinoma
SUSD6::TXNDC16	Adenocarcinoma
SUZ12::ADAP2	Malignant epithelial tumor, special type
SUZ12::LRRC37B	Squamous cell carcinoma
SUZ12::NF1	Adenocarcinoma
SUZ12::STAP2	Adenocarcinoma
SUZ12::TAC4	Adenocarcinoma
SUZ12::VANGL1	Malignant melanoma
SV2B::ALK	Adenocarcinoma
SV2B::AQP9	Astrocytoma, grade III-IV/Glioblastoma
SV2C::NMU	Adenocarcinoma
SVBP::EBNA1BP2	Squamous cell carcinoma
SVEP1::TJP2	Mesenchymal tumor, NOS
SVIL::KIAA1217	Mesenchymal tumor, NOS
SVIL::RFC5	Adenocarcinoma
SVIL::STAM	Mesenchymal tumor, NOS
SVIL::TAF3	Adenocarcinoma
SVOPL::BRAF	Adenocarcinoma
SWAP70::WEE1	Adenocarcinoma | Squamous cell carcinoma
SWAP70::ZNF143	Adenocarcinoma | Astrocytoma, grade I-II | Mature B-cell neoplasm, NOS
SWI5::DNM1	Adenocarcinoma
SWI5::RINT1	Adenocarcinoma
SWT1::COLGALT2	Mesenchymal tumor, NOS
SWT1::DCAF8	Transitional cell carcinoma
SYAP1::REPS2	Adenocarcinoma
SYBU::NUDCD1	Adenocarcinoma
SYCP2::BCAS1	Adenocarcinoma
SYCP2::ZMYND8	Adenocarcinoma
SYDE2::TCTN1	Mesenchymal tumor, NOS
SYF2::RHD	Adenocarcinoma
SYF2::USP48	Adenocarcinoma
SYK::AUH	Adenocarcinoma
SYMPK::CRYL1	Adenocarcinoma
SYMPK::DYRK1B	Adenocarcinoma
SYMPK::ELSPBP1	Astrocytoma, grade I-II
SYMPK::LSM4	Astrocytoma, grade I-II
SYMPK::MAP3K13	Adenocarcinoma
SYMPK::RPRD2	Adenocarcinoma
SYMPK::ZNF573	Squamous cell carcinoma
SYN1::ATAD1	Astrocytoma, grade I-II
SYN2::PPARG	Undifferentiated carcinoma, small cell | Acinic cell carcinoma
SYNCRIP::CDK19	Adenocarcinoma
SYNCRIP::SEMA3A	Adenocarcinoma
SYNE1::CACNA1C	Adenocarcinoma
SYNE1::ESR1	Mesenchymal tumor, NOS
SYNE1::METTL24	Adenocarcinoma
SYNE1::RGS17	Adenocarcinoma
SYNE2::ACTN1	Adenocarcinoma
SYNE2::ATG2B	Transitional cell carcinoma
SYNE2::CATSPERB	Adenocarcinoma
SYNE2::DMRTA1	Adenocarcinoma
SYNE2::GEMIN2	Adenocarcinoma
SYNE2::ITPK1	Squamous cell carcinoma
SYNE2::MIPOL1	Adenocarcinoma
SYNE2::PRORP	Adenocarcinoma
SYNE2::RTN1	Adenocarcinoma
SYNE3::GSC	Adenocarcinoma
SYNE4::THAP8	Adenocarcinoma
SYNGAP1::COL11A2	Adenocarcinoma
SYNGAP1::HSP90AB1	Astrocytoma, grade III-IV/Glioblastoma
SYNGR1::TAB1	Astrocytoma, grade I-II
SYNGR2::MSI2	Squamous cell carcinoma
SYNGR2::TMC8	Squamous cell carcinoma
SYNJ1::C21orf62	Adenocarcinoma
SYNJ1::PDE9A	Astrocytoma, grade I-II
SYNJ2::CDK19	Adenocarcinoma
SYNJ2::COX4I1	Adenocarcinoma
SYNJ2::GTF2H5	Adenocarcinoma
SYNJ2::KIF25	Adenocarcinoma
SYNJ2::MTUS2	Adenocarcinoma
SYNJ2::SCN11A	Transitional cell carcinoma
SYNJ2::ZDHHC14	Adenocarcinoma
SYNPO2::METTL14	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
SYNPO2::TRIM24	Adenocarcinoma
SYNPO::NFYC	Adenocarcinoma
SYNRG::AATF	Mesothelioma
SYNRG::CCR7	Adenocarcinoma
SYNRG::CSH2	Adenocarcinoma
SYNRG::DDX52	Adenocarcinoma
SYNRG::FBXO47	Adenocarcinoma
SYNRG::IKZF3	Adenocarcinoma
SYNRG::KRT33A	Adenocarcinoma
SYNRG::MSI2	Adenocarcinoma
SYNRG::PIK3R5	Adenocarcinoma
SYNRG::PLXDC1	Adenocarcinoma
SYNRG::ROBO1	Squamous cell carcinoma
SYNRG::SHC2	Transitional cell carcinoma
SYNRG::TUBD1	Adenocarcinoma
SYNRG::ZNF384	Acute lymphoblastic leukemia/lymphoblastic lymphoma
SYPL1::AKR1D1	Adenocarcinoma
SYPL1::TMEM168	Squamous cell carcinoma
SYS1::IDO2	Transitional cell carcinoma
SYS1::TAF15	Astrocytoma, grade I-II
SYT12::TOP6BL	Adenocarcinoma
SYT14::HSD11B1	Malignant melanoma
SYT16::MNAT1	Transitional cell carcinoma
SYT16::PRELP	Astrocytoma, grade I-II
SYT1::ACSS3	Adenocarcinoma
SYT1::EPYC	Mesenchymal tumor, NOS
SYT1::FGD6	Atypical lipomatous tumor/atypical lipoma/well-differentiated liposarcoma
SYT1::METTL25	Atypical lipomatous tumor/atypical lipoma/well-differentiated liposarcoma
SYT1::PHKB	Mesenchymal tumor, NOS
SYT1::PPFIA2	Mesenchymal tumor, NOS
SYT1::RIC8B	Adenocarcinoma
SYT1::TBK1	Mesenchymal tumor, NOS
SYT2::KDM5B	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
SYT7::AHNAK	Adenocarcinoma
SYT7::FADS3	Adenocarcinoma
SYT7::KCNK4	Adenocarcinoma
SYT7::PACS1	Adenocarcinoma
SYT7::RNF214	Malignant epithelial tumor, special type
SYT7::SDHAF2	Squamous cell carcinoma
SYT8::TNNI2	Transitional cell carcinoma
SYTL2::CHRM1	Adenocarcinoma
SYTL2::DOK5	Adenocarcinoma
SYTL2::PICALM	Adenocarcinoma
SYTL2::TMEM135	Adenocarcinoma
SYTL3::AIG1	Adenocarcinoma
SYTL3::SNX9	Adenocarcinoma
SYVN1::IGK	Multiple myeloma
SZRD1::PRDM2	Adenocarcinoma
SZT2::EIF2B3	Adenocarcinoma
TAB1::C22orf42	Malignant epithelial tumor, special type
TAB1::PHF21B	Malignant melanoma
TAB1::PICK1	Astrocytoma, grade III-IV/Glioblastoma
TAB1::SMG9	Adenocarcinoma
TAB2::CCNG2	Adenocarcinoma
TAB2::KCNU1	Mesenchymal tumor, NOS
TAB2::PAX7	Mesenchymal tumor, NOS
TAB2::PCMT1	Adenocarcinoma
TAB2::PPP1R14C	Transitional cell carcinoma
TAB2::SMIM8	Adenocarcinoma
TAB2::UST	Transitional cell carcinoma
TAB3::DMD	Adenocarcinoma
TACC1::ANKS1A	Adenocarcinoma
TACC1::CDK4	Liposarcoma, dedifferentiated
TACC1::MYBPC1	Mesenchymal tumor, NOS
TACC2::ATE1	Adenocarcinoma
TACC2::HS1BP3	Adenocarcinoma
TACC2::MICU1	Adenocarcinoma
TACC2::PLPP4	Adenocarcinoma
TACC2::ZNF365	Adenocarcinoma
TACC3::TMEM129	Malignant melanoma
TACSTD2::OMA1	Adenocarcinoma
TADA1::CADM3	Adenocarcinoma
TADA2A::C17orf78	Malignant melanoma
TADA2A::ERBB2	Carcinoma, NOS
TADA2A::GDPD4	Adenocarcinoma
TADA2A::MED24	Adenocarcinoma
TADA2A::MEF2B	Adenocarcinoma
TADA2A::MYO1D	Adenocarcinoma
TADA2A::NLK	Adenocarcinoma
TADA2A::NT5C3B	Adenocarcinoma
TADA2A::PLXDC1	Transitional cell carcinoma
TADA2A::SPACA3	Adenocarcinoma
TADA2A::STARD3	Adenocarcinoma
TAF12::ATAD3C	Adenocarcinoma
TAF12::RAB6A	Adenocarcinoma
TAF12::TPRG1	Squamous cell carcinoma
TAF13::LYPLA1	Mesenchymal tumor, NOS
TAF13::SORT1	Adenocarcinoma
TAF15::AP2B1	Adenocarcinoma
TAF15::ETV4	Undifferentiated round cell sarcoma
TAF15::MAN1A2	Adenocarcinoma
TAF15::NR4A3	Chondrosarcoma, myxoid
TAF15::PDK3	Adenocarcinoma
TAF15::PTRH2	Adenocarcinoma
TAF15::ZNF384	Bilineage or biphenotypic leukemia | Acute monoblastic leukemia with differentiation (FAB type M5b) | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Acute myeloblastic leukemia without maturation (FAB type M1) | Egypt
TAF15::ZNHIT3	Adenocarcinoma
TAF1::ITGB1BP2	Squamous cell carcinoma
TAF1A::SLC12A7	Squamous cell carcinoma
TAF1B::FOSL2	Adenocarcinoma
TAF1B::NHEJ1	Astrocytoma, grade III-IV/Glioblastoma
TAF1B::SGCZ	Mesothelioma
TAF1D::PIK3CA	Undifferentiated carcinoma, small cell
TAF1D::TRIM49	Adenocarcinoma
TAF1D::TRIM49C	Adenocarcinoma
TAF2::ALDH16A1	Adenocarcinoma
TAF2::CLVS1	Mesenchymal tumor, NOS
TAF2::COL14A1	Osteosarcoma, NOS
TAF2::DEPTOR	Adenocarcinoma
TAF2::DSCC1	Adenocarcinoma
TAF2::SAMD12	Mature B-cell neoplasm, NOS
TAF3::APP	Transitional cell carcinoma
TAF3::DNAJC1	Adenocarcinoma
TAF3::KCNMA1	Adenocarcinoma
TAF3::SVIL	Malignant melanoma
TAF3::ZDHHC14	Adenocarcinoma
TAF3::ZNF365	Adenocarcinoma
TAF4::ALG10B	Squamous cell carcinoma
TAF4::B4GALT5	Adenocarcinoma
TAF4::BRIP1	Adenocarcinoma
TAF4::CDH22	Adenocarcinoma
TAF4::CDH4	Adenocarcinoma
TAF4::FAF1	Adenocarcinoma
TAF4::GATA5	Adenocarcinoma
TAF4::LAMA5	Transitional cell carcinoma
TAF4::LARGE1	Adenocarcinoma
TAF4::LSM14B	Adenocarcinoma
TAF4::MTG2	Adenocarcinoma
TAF4::NOL4L	Acute myeloblastic leukemia with maturation (FAB type M2)
TAF4::STX16	Squamous cell carcinoma
TAF4::TCFL5	Adenocarcinoma
TAF4::TSHZ2	Adenocarcinoma
TAF4B::AFG3L2	Acute myeloid leukemia, NOS | Skin
TAF4B::CHST9	Adenocarcinoma
TAF4B::NSG1	Mature B-cell neoplasm, NOS
TAF4B::WDR1	Adenocarcinoma
TAF6L::AKT3	Adenocarcinoma
TAF6L::GLYATL1	Adenocarcinoma
TAF6L::PCYT1A	Adenocarcinoma
TAF6L::SCGB1A1	Adenocarcinoma
TAF6L::TMEM109	Adenocarcinoma
TAF8::COL5A3	Astrocytoma, grade I-II
TAF8::CRISP1	Adenocarcinoma
TAF8::GRIP1	Malignant melanoma
TAF8::HFE	Transitional cell carcinoma
TAF8::SLC22A16	Squamous cell carcinoma
TAF9::ADAMTS6	Adenocarcinoma
TAFA2::IKZF4	Adenocarcinoma
TAFA2::KCNMB4	Adenocarcinoma
TAFA2::KRR1	Mesenchymal tumor, NOS
TAFA2::OOEP	Adenocarcinoma
TAFA2::PCBP2	Astrocytoma, grade III-IV/Glioblastoma
TAFA2::RAB3IP	Malignant melanoma
TAFA2::TMBIM4	Mesenchymal tumor, NOS
TAFA3::LPP	Adenocarcinoma
TAFA4::CACNA2D3	Adenocarcinoma
TAFA4::COL8A1	Mesothelioma
TAFA4::LMOD3	Adenocarcinoma
TAFA4::TMF1	Adenocarcinoma
TAFA4::UBA3	Malignant melanoma
TAFA5::MAPK8IP2	Transitional cell carcinoma
TAFA5::MCAT	Malignant melanoma
TAFA5::SYNE3	Malignant melanoma
TAFA5::TBC1D22A	Benign epithelial tumor, special type
TAFA5::ZFP2	Malignant melanoma
TAFA5::ZNF354B	Malignant melanoma
TAGLN2::PBX1	Adenocarcinoma
TAGLN::COP1	Mesenchymal tumor, NOS
TAL1::STIL	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TAL1::TRA	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TAL2::TRB	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TALDO1::CLCN3	Transitional cell carcinoma
TALDO1::EPS8L2	Squamous cell carcinoma
TALDO1::ZNFX1	Adenocarcinoma
TAMM41::ATG7	Squamous cell carcinoma
TAMM41::RAF1	Carcinoma, NOS
TANC1::MARCHF7	Transitional cell carcinoma | Squamous cell carcinoma | Adenocarcinoma
TANC1::MTMR4	Adenocarcinoma
TANC1::NR4A2	Adenocarcinoma
TANC1::PKP4	Adenocarcinoma
TANC1::RINL	Adenocarcinoma
TANC1::SLC4A1AP	Adenocarcinoma
TANC1::WDR75	Adenocarcinoma
TANC2::ACE	Adenocarcinoma
TANC2::ANKFN1	Adenocarcinoma
TANC2::ARHGEF12	Mesenchymal tumor, NOS
TANC2::CEP112	Squamous cell carcinoma
TANC2::CHD6	Adenocarcinoma
TANC2::CRB3	Adenocarcinoma
TANC2::CTDSP1	Adenocarcinoma
TANC2::EFCAB3	Adenocarcinoma
TANC2::FAM222B	Adenocarcinoma
TANC2::GOSR1	Adenocarcinoma
TANC2::KRT10	Adenocarcinoma
TANC2::LRRC37B	Adenocarcinoma
TANC2::MED13	Adenocarcinoma
TANC2::MRC2	Adenocarcinoma
TANC2::PHB1	Adenocarcinoma
TANC2::PRKCA	Squamous cell carcinoma | Adenocarcinoma
TANC2::RHOT1	Adenocarcinoma
TANC2::RNF2	Adenocarcinoma
TANC2::SPAG9	Adenocarcinoma
TANC2::SSH2	Adenocarcinoma
TANC2::STRADA	Adenocarcinoma
TANC2::TBC1D3G	Malignant melanoma
TANC2::TMEM104	Astrocytoma, grade I-II
TANC2::TSHZ2	Adenocarcinoma
TANC2::ZNF468	Mesenchymal tumor, NOS
TANC2::ZNF689	Adenocarcinoma
TANGO2::USP18	Malignant melanoma
TANGO6::CARMIL2	Malignant epithelial tumor, special type
TANGO6::CDH1	Adenocarcinoma | Malignant melanoma
TANGO6::CFDP1	Malignant melanoma
TANGO6::CLEC2L	Squamous cell carcinoma
TANGO6::FGF3	Transitional cell carcinoma
TANGO6::NAA15	Squamous cell carcinoma
TANGO6::PRMT7	Adenocarcinoma
TANGO6::WWP2	Adenocarcinoma
TANK::BRAF	Adenocarcinoma
TANK::CACNB4	Mesenchymal tumor, NOS
TANK::MARCHF7	Adenocarcinoma
TANK::MNAT1	Squamous cell carcinoma
TANK::SLC38A6	Squamous cell carcinoma
TAOK1::ABHD15	Adenocarcinoma
TAOK1::ACER3	Adenocarcinoma
TAOK1::ANKRD13B	Adenocarcinoma
TAOK1::ASGR2	Malignant melanoma
TAOK1::BCAS3	Adenocarcinoma
TAOK1::CCL2	Adenocarcinoma
TAOK1::CFAP97D1	Astrocytoma, grade I-II
TAOK1::CPD	Adenocarcinoma
TAOK1::EFCAB5	Adenocarcinoma
TAOK1::FAM222B	Adenocarcinoma
TAOK1::FLOT2	Adenocarcinoma
TAOK1::MAP2K4	Adenocarcinoma
TAOK1::NCOR1	Adenocarcinoma
TAOK1::NF1	Adenocarcinoma | Acute myelomonocytic leukemia (FAB type M4) | Squamous cell carcinoma
TAOK1::NLK	Mature B-cell neoplasm, NOS
TAOK1::PARD6G	Squamous cell carcinoma
TAOK1::PARP10	Adenocarcinoma
TAOK1::PCGF2	Adenocarcinoma
TAOK1::PIPOX	Adenocarcinoma
TAOK1::PROCA1	Adenocarcinoma
TAOK1::RAB8B	Malignant melanoma
TAOK1::RARA	Astrocytoma, grade III-IV/Glioblastoma
TAOK1::RB1CC1	Transitional cell carcinoma
TAOK1::RPL23A	Adenocarcinoma
TAOK1::SARM1	Adenocarcinoma
TAOK1::TMEM97	Astrocytoma, grade I-II
TAOK1::VMP1	Adenocarcinoma
TAOK1::ZNF207	Adenocarcinoma
TAOK1::ZNF385C	Adenocarcinoma
TAOK2::CPB1	Adenocarcinoma
TAOK3::AGTPBP1	Adenocarcinoma
TAOK3::ATP23	Astrocytoma, grade III-IV/Glioblastoma
TAOK3::SINHCAF	Adenocarcinoma
TAOK3::SUDS3	Squamous cell carcinoma
TAOK3::VSIG10	Transitional cell carcinoma | Squamous cell carcinoma
TAP2::DAXX	Adenocarcinoma
TAP2::VARS1	Astrocytoma, grade I-II
TAPBP::DAXX	Adenocarcinoma
TAPT1::LDB2	Transitional cell carcinoma
TARBP1::ARID4B	Adenocarcinoma
TARBP1::BTBD7	Adenocarcinoma
TARBP1::CACHD1	Adenocarcinoma
TARBP1::IRF2BP2	Adenocarcinoma
TARBP1::LYST	Adenocarcinoma
TARBP1::RBM34	Adenocarcinoma
TARBP1::TOMM20	Adenocarcinoma
TARDBP::ATAD3A	Adenocarcinoma
TARS2::MRPS21	Adenocarcinoma
TARS2::VPS45	Squamous cell carcinoma
TARS3::CERS3	Adenocarcinoma
TARS3::WFS1	Astrocytoma, grade III-IV/Glioblastoma
TASOR2::ABI1	Adenocarcinoma
TASOR2::AKR1E2	Transitional cell carcinoma
TASOR2::MACF1	Primitive neuroectodermal tumor/Medulloblastoma | Russia
TASOR2::NET1	Adenocarcinoma
TASOR2::ZMYND11	Astrocytoma, grade I-II
TASOR::ASB14	Adenocarcinoma
TASOR::TADA3	Adenocarcinoma
TASP1::AHCY	Squamous cell carcinoma
TASP1::DHCR7	Squamous cell carcinoma
TASP1::ESF1	Adenocarcinoma
TASP1::HLCS	Adenocarcinoma
TASP1::MACROD2	Adenocarcinoma
TASP1::RALGAPA2	Squamous cell carcinoma
TASP1::SEL1L2	Adenocarcinoma
TASP1::SLC24A3	Adenocarcinoma
TASP1::TRDN	Mesothelioma
TATDN1::CCT2	Adenocarcinoma
TATDN1::GSDMB	Adenocarcinoma
TATDN1::OC90	Adenocarcinoma
TATDN2::FANCD2	Adenocarcinoma
TATDN2::IRAK2	Malignant melanoma
TATDN2::SETD5	Adenocarcinoma
TATDN2::UNC13B	Mature B-cell neoplasm, NOS
TAX1BP1::AHCY	Adenocarcinoma
TAX1BP1::AMPH	Adenocarcinoma
TAX1BP1::BRAF	Malignant melanoma | Astrocytoma, grade I-II
TAX1BP1::CHN2	Adenocarcinoma
TAX1BP1::CLEC9A	Acute myeloblastic leukemia without maturation (FAB type M1)
TAX1BP1::GPX4	Adenocarcinoma
TAX1BP1::JAZF1	Adenocarcinoma
TAX1BP1::KCTD7	Mesothelioma
TAX1BP1::PRKD1	Adenocarcinoma
TAX1BP1::RABGEF1	Mesothelioma
TAX1BP3::NCBP3	Squamous cell carcinoma
TAX1BP3::PMP22	Adenocarcinoma
TBC1D10A::ANK1	Adenocarcinoma
TBC1D10A::OSBP2	Adenocarcinoma
TBC1D10A::POLR3H	Squamous cell carcinoma
TBC1D10A::RNF215	Adenocarcinoma
TBC1D10A::TFAP2B	Adenocarcinoma
TBC1D12::CYP2C18	Adenocarcinoma
TBC1D12::EXOC6	Squamous cell carcinoma
TBC1D12::HELLS	Squamous cell carcinoma
TBC1D12::MORN4	Adenocarcinoma
TBC1D12::SLC35G1	Adenocarcinoma
TBC1D13::ODF2	Adenocarcinoma
TBC1D14::BRSK2	Adenocarcinoma
TBC1D14::EVC	Adenocarcinoma
TBC1D14::EVC2	Adenocarcinoma
TBC1D14::GRPEL1	Transitional cell carcinoma
TBC1D14::HTRA3	Transitional cell carcinoma | Astrocytoma, grade III-IV/Glioblastoma
TBC1D14::KIAA0232	Adenocarcinoma
TBC1D14::MRFAP1	Adenocarcinoma
TBC1D15::ANTXR2	Adenocarcinoma
TBC1D15::BMPER	Astrocytoma, grade I-II
TBC1D15::CNOT2	Mesenchymal tumor, NOS
TBC1D15::CPSF6	Transitional cell carcinoma
TBC1D15::LGR5	Adenocarcinoma | Astrocytoma, grade III-IV/Glioblastoma
TBC1D15::MARS1	Adenocarcinoma
TBC1D15::METTL25	Atypical lipomatous tumor/atypical lipoma/well-differentiated liposarcoma
TBC1D15::MYF6	Malignant melanoma
TBC1D15::NPIPB2	Transitional cell carcinoma
TBC1D15::PTPRR	Adenocarcinoma
TBC1D15::RAB21	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TBC1D15::SEPHS1	Adenocarcinoma
TBC1D15::SLC16A7	Mesenchymal tumor, NOS
TBC1D15::TRHDE	Adenocarcinoma
TBC1D16::DNAI7	Adenocarcinoma
TBC1D16::EIF4A3	Adenocarcinoma
TBC1D16::GOSR2	Adenocarcinoma
TBC1D16::KIF3A	Malignant melanoma
TBC1D16::PARD3	Ependymoma
TBC1D16::RNF213	Acute myeloblastic leukemia without maturation (FAB type M1)
TBC1D16::ZNF106	Adenocarcinoma
TBC1D16::ZNF573	Adenocarcinoma
TBC1D17::PRR12	Squamous cell carcinoma
TBC1D19::ADGRA3	Astrocytoma, grade I-II
TBC1D19::ANAPC4	Squamous cell carcinoma
TBC1D1::LIMCH1	Malignant melanoma
TBC1D1::NMU	Adenocarcinoma
TBC1D1::PGM2	Adenocarcinoma
TBC1D1::RAB28	Squamous cell carcinoma
TBC1D20::C20ORF96	Adenocarcinoma | Transitional cell carcinoma
TBC1D22A::AP3D1	Malignant epithelial tumor, special type
TBC1D22A::ARFGAP3	Malignant melanoma
TBC1D22A::BACH2	Malignant melanoma
TBC1D22A::FBLN1	Squamous cell carcinoma
TBC1D22A::GCAT	Squamous cell carcinoma
TBC1D22A::GKN1	Adenocarcinoma
TBC1D22A::GRAMD4	Adenocarcinoma
TBC1D22A::GRAP2	Adenocarcinoma
TBC1D22A::GTSE1	Adenocarcinoma
TBC1D22A::OTUD7A	Malignant melanoma
TBC1D22A::POLDIP3	Adenocarcinoma
TBC1D22A::RIBC2	Adenocarcinoma
TBC1D22A::SMYD3	Malignant melanoma
TBC1D22A::SREBF2	Malignant melanoma
TBC1D22A::TRMU	Adenocarcinoma
TBC1D22A::TTC38	Adenocarcinoma
TBC1D22B::CCND3	Adenocarcinoma
TBC1D22B::FGD2	Adenocarcinoma
TBC1D22B::TSC22D1	Adenocarcinoma
TBC1D22B::YPEL1	Adenocarcinoma
TBC1D23::ABI3BP	Squamous cell carcinoma
TBC1D23::CMSS1	Adenocarcinoma
TBC1D23::TMEM45A	Adenocarcinoma
TBC1D25::ERLIN2	Adenocarcinoma
TBC1D25::HSPA9	Adenocarcinoma
TBC1D2::GABBR2	Squamous cell carcinoma
TBC1D2::NTRK2	Glioma, NOS
TBC1D2B::ACSBG1	Adenocarcinoma
TBC1D2B::CIB2	Adenocarcinoma
TBC1D2B::INTS4	Mesenchymal tumor, NOS
TBC1D2B::LUC7L2	Malignant melanoma
TBC1D30::EEF1AKMT3	Astrocytoma, grade III-IV/Glioblastoma
TBC1D30::PLP1	Mesenchymal tumor, NOS
TBC1D30::PPM1H	Astrocytoma, grade III-IV/Glioblastoma
TBC1D30::SYT1	Mesenchymal tumor, NOS
TBC1D31::ZNF704	Adenocarcinoma
TBC1D32::HBS1L	Adenocarcinoma
TBC1D32::RET	Adenocarcinoma
TBC1D32::RPF2	Mesenchymal tumor, NOS
TBC1D32::RSPO3	Transitional cell carcinoma
TBC1D3::NPEPPS	Adenocarcinoma
TBC1D4::COMMD6	Adenocarcinoma
TBC1D4::KLF12	Squamous cell carcinoma
TBC1D4::TRAPPC12	Transitional cell carcinoma
TBC1D5::AIG1	Adenocarcinoma
TBC1D5::HTT	Adenocarcinoma
TBC1D5::SETD5	Adenocarcinoma
TBC1D5::TOP2B	Adenocarcinoma
TBC1D8::CREG2	Transitional cell carcinoma
TBC1D8::EPB41L5	Squamous cell carcinoma
TBC1D8::LIPF	Transitional cell carcinoma
TBC1D8::RNF149	Transitional cell carcinoma
TBC1D8B::RNF128	Malignant epithelial tumor, special type | Adenocarcinoma | Transitional cell carcinoma
TBC1D9::CORO1C	Adenocarcinoma
TBC1D9::MAML3	Adenocarcinoma
TBC1D9::PAPSS1	Adenocarcinoma
TBC1D9::RNF150	Adenocarcinoma | Multiple myeloma
TBC1D9::SMARCA5	Adenocarcinoma
TBC1D9B::RNF130	Squamous cell carcinoma
TBC1D9B::TENM2	Adenocarcinoma
TBC1D9B::TYK2	Adenocarcinoma
TBCA::ARSB	Adenocarcinoma
TBCA::WDR41	Squamous cell carcinoma
TBCB::PRX	Transitional cell carcinoma
TBCCD1::PAFAH1B2	Undifferentiated carcinoma, small cell
TBCD::ASPSCR1	Squamous cell carcinoma
TBCD::CCDC57	Adenocarcinoma
TBCD::CPM	Adenocarcinoma
TBCD::CSNK1D	Malignant melanoma
TBCD::FN3K	Adenocarcinoma
TBCD::FN3KRP	Adenocarcinoma
TBCD::FOXK2	Adenocarcinoma
TBCD::GLIPR2	Adenocarcinoma
TBCD::HLCS	Mesenchymal tumor, NOS
TBCD::NFIX	Adenocarcinoma
TBCD::NHERF1	Adenocarcinoma
TBCD::RPTOR	Adenocarcinoma
TBCD::STXBP4	Adenocarcinoma
TBCE::AIM2	Adenocarcinoma
TBCE::GGPS1	Squamous cell carcinoma
TBCE::MAPRE2	Benign epithelial tumor, special type
TBCE::SIPA1L2	Mesothelioma
TBCE::TBC1D22A	Adenocarcinoma
TBCK::P4HA2	Angiofibroma
TBCK::PAPSS1	Squamous cell carcinoma
TBCK::SLC9B2	Squamous cell carcinoma
TBCK::USP10	Adenocarcinoma
TBCK::WDHD1	Adenocarcinoma
TBK1::ARHGAP5	Adenocarcinoma
TBK1::C12orf56	Adenocarcinoma
TBK1::CDK19	Mesenchymal tumor, NOS
TBK1::GRIP1	Malignant melanoma
TBK1::RBM48	Adenocarcinoma
TBK1::TMBIM4	Mesenchymal tumor, NOS
TBK1::TMPRSS12	Astrocytoma, grade III-IV/Glioblastoma
TBK1::TMTC2	Mesenchymal tumor, NOS
TBL1X::CASK	Adenocarcinoma
TBL1X::GPR143	Squamous cell carcinoma | Transitional cell carcinoma
TBL1X::WWC3	Adenocarcinoma | Squamous cell carcinoma
TBL1XR1::ADAM33	Adenocarcinoma
TBL1XR1::AKR1E2	Adenocarcinoma
TBL1XR1::ATG7	Adenocarcinoma
TBL1XR1::BOD1L1	Miscellaneous hematopoietic/lymphoid neoplasm, special type
TBL1XR1::CACNA1C	Adenocarcinoma
TBL1XR1::COPB2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TBL1XR1::CSF1R	Acute myeloid leukemia, NOS | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Skin
TBL1XR1::CTNNB1	Adenocarcinoma
TBL1XR1::DCUN1D1	Adenocarcinoma
TBL1XR1::DHX30	Adenocarcinoma
TBL1XR1::GRM1	Chondromyxoid fibroma
TBL1XR1::HMGA1	Hemangioma/lymphangioma
TBL1XR1::LXN	Adenocarcinoma
TBL1XR1::MAST3	Adenocarcinoma
TBL1XR1::MCF2L2	Adenocarcinoma
TBL1XR1::MIPEP	Adenocarcinoma
TBL1XR1::PDGFRB	Skin | Acute myeloid leukemia, NOS
TBL1XR1::PIK3CA	Adenocarcinoma
TBL1XR1::RAB5IF	Diffuse large B-cell lymphoma
TBL1XR1::RARA	Acute promyelocytic leukemia (FAB type M3)
TBL1XR1::RARB	Acute promyelocytic leukemia (FAB type M3)
TBL1XR1::RET	Adenocarcinoma
TBL1XR1::RGS17	Adenocarcinoma
TBL1XR1::ROCK1	Adenocarcinoma
TBL1XR1::SPMIP7	Adenocarcinoma
TBL1XR1::STAT3	Adenocarcinoma
TBL1XR1::TP63	Follicular lymphoma | Anaplastic large cell lymphoma, systemic type | Diffuse large B-cell lymphoma | Mature T- and NK-cell neoplasm, special type
TBL1XR1::TP73	Diffuse large B-cell lymphoma
TBL1XR1::TRMT9B	Squamous cell carcinoma
TBL1XR1::UEVLD	Undifferentiated carcinoma, small cell
TBL1XR1::USP13	Adenocarcinoma
TBP::FAM120B	Squamous cell carcinoma
TBPL1::KIAA0753	Acute myeloid leukemia, NOS | Skin
TBR1::PSMD14	Adenocarcinoma
TBRG1::IFT46	Adenocarcinoma
TBX15::AP4B1	Malignant melanoma
TBX15::FMN2	Mesenchymal tumor, NOS
TBX15::MAGI3	Mesenchymal tumor, NOS
TBX19::PCP4L1	Mesenchymal tumor, NOS
TBX1::SEPTIN5	Adenocarcinoma
TBX3::BIK	Adenocarcinoma
TBX3::RRM1	Adenocarcinoma
TBXAS1::TOMM7	Adenocarcinoma
TC2N::ATXN3	Adenocarcinoma
TC2N::FBLN5	Adenocarcinoma
TC2N::LPP	Squamous cell carcinoma
TC2N::TRIP11	Adenocarcinoma
TCAP::ERBB2	Carcinoma, NOS
TCEA1::ALKAL1	Astrocytoma, grade III-IV/Glioblastoma
TCEA1::EGFR	Squamous cell carcinoma
TCEA1::MTSS1	Squamous cell carcinoma
TCEA1::PLAG1	Adenoma
TCEA3::ASAP3	Squamous cell carcinoma
TCEA3::HMGCL	Adenocarcinoma
TCEA3::PRR16	Adenocarcinoma
TCEA3::WDHD1	Adenocarcinoma
TCEAL2::ALK	Adenocarcinoma
TCEANC2::MICU1	Adenocarcinoma
TCERG1L::CNTN1	Astrocytoma, grade I-II
TCF12::DSCAM	Adenocarcinoma
TCF12::ERG28	Adenocarcinoma
TCF12::FAM98B	Adenocarcinoma
TCF12::FOLR1	Astrocytoma, grade I-II
TCF12::LEO1	Skin | Acute myeloid leukemia, NOS
TCF12::MGST2	Adenocarcinoma
TCF12::NCOA3	Transitional cell carcinoma
TCF12::NIPA1	Adenocarcinoma
TCF12::NPAS1	Adenocarcinoma
TCF12::NR4A3	Chondrosarcoma, myxoid
TCF12::RGMA	Adenocarcinoma
TCF12::RNF111	Adenocarcinoma
TCF12::TEX9	Adenocarcinoma
TCF12::TMC3	Astrocytoma, grade I-II
TCF12::TMEM255B	Adenocarcinoma
TCF12::TPM1	Malignant melanoma
TCF12::TTC23	Adenocarcinoma
TCF12::VGLL3	Spindle cell/sclerosing rhabdomyosarcoma
TCF19::PSORS1C1	Adenocarcinoma
TCF20::CENPM	Malignant melanoma
TCF20::CYP2D6	Adenocarcinoma
TCF20::MRTFA	Adenocarcinoma
TCF20::NDUFA6	Adenocarcinoma
TCF20::NF2	Meningioma
TCF20::NFAM1	Adenocarcinoma
TCF20::RRAS	Adenocarcinoma
TCF20::SLC25A17	Malignant melanoma
TCF20::TTC28	Malignant melanoma
TCF25::SPIRE2	Adenocarcinoma
TCF25::ZC3H18	Adenocarcinoma
TCF3::ADAMTSL5	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TCF3::AP3D1	Adenocarcinoma
TCF3::APC2	Adenocarcinoma
TCF3::BEND2	Neuroglial neoplasm, special type
TCF3::C19ORF25	Adenocarcinoma
TCF3::DNAJC11	Adenocarcinoma
TCF3::FLI1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TCF3::HLF	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TCF3::OAZ1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TCF3::PBX1	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Skin | Nonneoplastic hematologic disorder/lesion | Acute myeloid leukemia, NOS | Burkitt lymphoma/leukemia | Adenocarcinoma | Acute myelomonocytic leukemia (FAB type M4)
TCF3::PIK3R1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TCF3::REXO1	Adenocarcinoma
TCF3::SYTL5	Adenocarcinoma
TCF3::TEF	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TCF3::TFPT	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TCF3::ZNF384	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TCF4::ERG	Soft tissue tumor, NOS
TCF4::HLF	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TCF4::MAML3	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
TCF4::ROCK1	Primitive neuroectodermal tumor/Medulloblastoma | Russia
TCF4::SOX5	Acute myeloblastic leukemia without maturation (FAB type M1)
TCF4::ZNF384	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TCF7::SPI1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TCF7L1::BRMS1L	Adenocarcinoma
TCF7L1::DNAH6	Adenocarcinoma
TCF7L1::GFPT1	Mesenchymal tumor, NOS
TCF7L1::KCMF1	Adenocarcinoma
TCF7L1::MEX3D	Adenocarcinoma
TCF7L1::NFASC	Adenocarcinoma
TCF7L1::ODF2	Adenocarcinoma
TCF7L1::TMEM182	Squamous cell carcinoma
TCF7L1::WIF1	Adenocarcinoma
TCF7L2::CHD7	Adenocarcinoma
TCF7L2::EIF3D	Adenocarcinoma
TCF7L2::MAML3	Malignant epithelial tumor, special type
TCF7L2::TACC2	Adenocarcinoma
TCF7L2::VTI1A	Adenocarcinoma
TCHP::IFT81	Adenocarcinoma
TCHP::MYO1H	Malignant melanoma
TCHP::PPTC7	Adenocarcinoma
TCIRG1::TMC5	Adenocarcinoma
TCN1::MS4A4A	Transitional cell carcinoma
TCN2::THOC5	Adenocarcinoma
TCOF1::GPX3	Adenocarcinoma
TCP11L1::SYT9	Adenocarcinoma
TCTA::ARIH2	Adenocarcinoma
TCTA::TAL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TCTA::VPS26C	Squamous cell carcinoma
TCTN1::CCDC63	Squamous cell carcinoma
TCTN1::CPM	Mesenchymal tumor, NOS
TCTN1::FGGY	Mesenchymal tumor, NOS
TCTN3::DHCR24	Adenocarcinoma
TDG::CDK17	Mesenchymal tumor, NOS
TDG::STAB2	Adenocarcinoma
TDP2::DCDC2	Adenocarcinoma
TDRD12::TEAD2	Adenocarcinoma
TDRD3::CUL4A	Malignant melanoma
TDRD3::DIAPH3	Adenocarcinoma
TDRD3::ESD	Astrocytoma, grade III-IV/Glioblastoma
TDRD3::GLI1	Astrocytoma, grade III-IV/Glioblastoma
TDRD3::LHFPL6	Adenocarcinoma
TDRD7::GNA14	Adenocarcinoma
TEAD1::ATP5MG	Undifferentiated carcinoma, small cell
TEAD1::BMAL1	Malignant melanoma | Adenocarcinoma
TEAD1::CAP2	Adenocarcinoma
TEAD1::CD47	Transitional cell carcinoma
TEAD1::CTR9	Adenocarcinoma
TEAD1::FAR1	Malignant melanoma
TEAD1::GDPD4	Adenocarcinoma
TEAD1::INSC	Mesenchymal tumor, NOS
TEAD1::MICAL2	Adenocarcinoma
TEAD1::MRTFB	Myxoinflammatory fibroblastic sarcoma
TEAD1::NCOA2	Spindle cell/sclerosing rhabdomyosarcoma | Ependymoma | Astrocytoma, grade III-IV/Glioblastoma
TEAD1::PARVA	Adenocarcinoma
TEAD1::UVRAG	Squamous cell carcinoma
TEAD1::ZCCHC8	Adenocarcinoma
TEAD2::NOSIP	Adenocarcinoma
TEAD3::ZFAND3	Mesenchymal tumor, NOS
TEAD4::C2CD5	Adenocarcinoma
TEAD4::CD82	Adenocarcinoma
TEAD4::CPM	Malignant melanoma
TEAD4::DCAF10	Adenocarcinoma
TEAD4::ERC1	Mesenchymal tumor, NOS
TEAD4::MAP3K12	Mesenchymal tumor, NOS
TEAD4::TSPAN9	Miscellaneous hematopoietic/lymphoid neoplasm, special type
TEAD4::TULP3	Adenocarcinoma
TEC::HMGCLL1	Squamous cell carcinoma
TEC::NCAM2	Adenocarcinoma
TEC::PASD1	Adenocarcinoma
TECPR1::ZFR	Squamous cell carcinoma
TECPR2::WDR20	Adenocarcinoma
TECR::GIPC1	Adenocarcinoma
TECR::ICAM3	Transitional cell carcinoma
TECR::ILVBL	Adenocarcinoma
TECR::NDUFB7	Adenocarcinoma
TECR::PKN1	Squamous cell carcinoma | Adenocarcinoma
TECR::TGFBR3L	Adenocarcinoma
TECTA::FOXN3	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
TECTB::ATRNL1	Adenocarcinoma
TECTB::TERT	Adenocarcinoma
TEDC2::CCNF	Adenocarcinoma | Squamous cell carcinoma
TEF::KIF26B	Squamous cell carcinoma
TEF::PLEKHO2	Malignant melanoma
TEFM::CADM2	Transitional cell carcinoma
TEFM::ERBB2	Carcinoma, NOS
TEKT5::RMI2	Adenocarcinoma
TEN1::CDK3	Adenocarcinoma
TEN1::TMEM94	Adenocarcinoma
TENM1::TMEM170A	Adenocarcinoma
TENM2::CATSPER3	Squamous cell carcinoma
TENM2::PCBD2	Squamous cell carcinoma
TENM2::RALGPS1	Mesothelioma
TENM3::ALK	Neuroblastoma
TENM3::NR3C2	Squamous cell carcinoma
TENM4::CADM1	Chronic lymphocytic leukemia
TENM4::DLEC1	Undifferentiated carcinoma, small cell
TENM4::DPP3	Transitional cell carcinoma
TENM4::GRIK4	Adenocarcinoma
TENM4::INTS4	Adenocarcinoma
TENM4::NARS2	Adenocarcinoma
TENM4::NOX4	Squamous cell carcinoma
TENM4::NRG1	Adenocarcinoma
TENM4::RBM4	Adenocarcinoma
TENM4::TMTC2	Adenocarcinoma
TENM4::ZDHHC18	Adenocarcinoma
TENT2::GPBP1	Adenocarcinoma
TENT4A::MTRR	Mesothelioma
TENT4A::PRIM1	Astrocytoma, grade III-IV/Glioblastoma
TENT4A::RAF1	Adenocarcinoma
TENT4A::SRD5A1	Adenocarcinoma
TENT4B::HEATR3	Adenocarcinoma | Squamous cell carcinoma
TENT4B::SHANK2	Adenocarcinoma
TEP1::HAUS4	Mature B-cell neoplasm, NOS
TEP1::RNASE1	Adenocarcinoma
TEPSIN::RHBDF2	Adenocarcinoma
TEPSIN::SLC38A10	Adenocarcinoma
TERF2::COG4	Adenocarcinoma
TERF2::JAK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TERF2::PDGFRB	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TERF2IP::AMY1C	Adenocarcinoma
TERF2IP::CKLF	Malignant melanoma
TERF2IP::CMTM1	Malignant melanoma
TERT::RPH3AL	Chordoma
TES::HNRNPU	Adenocarcinoma
TESC::ASAH1	Adenocarcinoma
TESC::ECHDC3	Adenocarcinoma
TESC::FBXO21	Adenocarcinoma
TESK1::LARGE1	Astrocytoma, grade III-IV/Glioblastoma
TESK2::C8A	Adenocarcinoma
TESK2::GNA12	Squamous cell carcinoma
TESK2::GPR37L1	Adenocarcinoma
TESK2::KNCN	Malignant melanoma
TESK2::PRDX1	Adenocarcinoma
TESK2::UTS2	Adenocarcinoma
TESMIN::COX18	Adenocarcinoma
TESMIN::CPT1A	Adenocarcinoma
TESMIN::HIPK3	Adenocarcinoma
TESMIN::KMT5B	Adenocarcinoma
TESMIN::PPFIA1	Adenocarcinoma
TESMIN::SART1	Adenocarcinoma
TET1::ASCC1	Adenocarcinoma
TET1::CCAR1	Astrocytoma, grade III-IV/Glioblastoma
TET1::DDX50	Malignant melanoma
TET1::EFHC2	Adenocarcinoma
TET1::RET	Carcinoma, NOS
TET1::TMEM222	Mesenchymal tumor, NOS
TET1::TTC12	Ependymoma
TET2::ADH6	Astrocytoma, grade I-II
TET2::ARHGEF38	Adenocarcinoma
TET2::KLK3	Adenocarcinoma
TET2::LANCL1	Adenocarcinoma
TET2::LARP7	Adenocarcinoma
TET2::OSTC	Adenocarcinoma
TET3::ACTG2	Adenocarcinoma
TET3::ANXA4	Adenocarcinoma
TET3::C2ORF78	Adenocarcinoma
TET3::C2orf78	Adenocarcinoma
TET3::DGUOK	Adenocarcinoma
TET3::KRT1	Adenocarcinoma
TET3::MNS1	Adenocarcinoma
TET3::PATL1	Adenocarcinoma
TET3::SPECC1	Adenocarcinoma
TEX10::HSDL2	Mesothelioma
TEX10::XPA	Diffuse large B-cell lymphoma
TEX14::SDK2	Adenocarcinoma
TEX14::TMEM98	Adenocarcinoma
TEX22::PACS2	Adenocarcinoma
TEX261::AAK1	Astrocytoma, grade I-II
TEX2::ACSF2	Adenocarcinoma
TEX2::ANKFN1	Adenocarcinoma
TEX2::BCAM	Squamous cell carcinoma
TEX2::BRAF	Adenocarcinoma
TEX2::CLASP2	Malignant melanoma
TEX2::CTDSP1	Adenocarcinoma
TEX2::GDPD1	Adenocarcinoma
TEX2::PDLIM3	Adenocarcinoma
TEX2::PECAM1	Angiosarcoma
TEX2::POLG2	Adenocarcinoma
TEX2::STARD3	Adenocarcinoma
TEX2::TANC2	Adenocarcinoma
TEX2::TOB1	Adenocarcinoma
TEX2::TTYH2	Adenocarcinoma
TEX9::CYFIP1	Adenocarcinoma
TF::ARFGEF2	Adenocarcinoma
TF::CCT5	Adenocarcinoma
TF::CLDN11	Adenocarcinoma
TF::HMGCS2	Adenocarcinoma
TF::HP	Adenocarcinoma
TF::TYK2	Adenocarcinoma
TF::UTRN	Adenocarcinoma
TFAM::ANK3	Adenocarcinoma
TFAP2A::CDK5RAP1	Adenocarcinoma
TFAP2A::MAK	Adenocarcinoma
TFB2M::SMYD3	Adenocarcinoma | Squamous cell carcinoma
TFB2M::ZNF124	Adenocarcinoma
TFCP2::BIN2	Adenocarcinoma
TFCP2::POU6F1	Adenocarcinoma
TFCP2::RNF41	Adenocarcinoma
TFCP2::SMAGP	Squamous cell carcinoma
TFCP2L1::CLASP1	Adenocarcinoma
TFDP1::ATP11A	Squamous cell carcinoma
TFDP1::ATP4B	Squamous cell carcinoma
TFDP1::CUL4A	Adenocarcinoma
TFDP1::GRK1	Adenocarcinoma
TFDP1::LAMP1	Squamous cell carcinoma
TFDP1::TMCO3	Adenocarcinoma
TFDP2::ATR	Adenocarcinoma
TFDP2::COG5	Squamous cell carcinoma
TFDP2::GK5	Astrocytoma, grade I-II
TFDP2::LANCL2	Adenocarcinoma
TFDP2::PLD1	Adenocarcinoma
TFE3::ASPSCR1	Adenocarcinoma
TFE3::CLTC	Adenocarcinoma
TFE3::DVL2	Adenocarcinoma
TFE3::EWSR1	Adenocarcinoma
TFE3::MED15	Adenocarcinoma
TFE3::NONO	Adenocarcinoma | Acute lymphoblastic leukemia/lymphoblastic lymphoma
TFE3::PRCC	Adenocarcinoma
TFE3::RAI2	Adenocarcinoma
TFE3::SFPQ	Adenocarcinoma
TFEB::CADM2	Adenocarcinoma
TFEB::CAPZA2	Adenocarcinoma
TFEB::COL21A1	Adenocarcinoma
TFEB::DIP2B	Astrocytoma, grade III-IV/Glioblastoma
TFEB::EPS15L1	Adenocarcinoma
TFEB::LASP1	Adenocarcinoma
TFEB::MDFI	Squamous cell carcinoma
TFEB::PGC	Adenocarcinoma
TFEB::SUPT3H	Adenocarcinoma
TFEB::TRERF1	Adenocarcinoma
TFF1::DDX21	Adenocarcinoma
TFF1::RABEP1	Adenocarcinoma
TFG::ADGRG7	Acute myeloblastic leukemia without maturation (FAB type M1) | Adenocarcinoma | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Multiple myeloma | Ependymoma | Acute myelomonocytic leukemia (FAB type M4) | Nonneoplastic hematologic disorder/lesion | Carcinoid tumor | Astrocytoma, grade III-IV/Glioblastoma | Acute myeloblastic leukemia with maturation (FAB type M2)
TFG::ALK	Carcinoma, NOS | Adenocarcinoma | Inflammatory myofibroblastic tumor/myofibroblastic sarcoma | Anaplastic large cell lymphoma, systemic type
TFG::CD46	Squamous cell carcinoma
TFG::FGFR1	Acute myeloblastic leukemia with maturation (FAB type M2)
TFG::MET	Fibrosarcoma | Adenocarcinoma | Soft tissue tumor, NOS | Soft tissue tumor, special type
TFG::NR4A3	Chondrosarcoma, myxoid
TFG::NTRK1	Adenocarcinoma
TFG::NTRK2	Melanocytic neoplasm, special type
TFG::NTRK3	Fibrosarcoma | Soft tissue tumor, NOS | Soft tissue tumor, special type
TFG::RET	Soft tissue tumor, special type
TFG::ROS1	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma | Meningioma
TFG::TFDP2	Squamous cell carcinoma
TFG::TMEM45A	Squamous cell carcinoma
TFG::ZBTB10	Soft tissue tumor, NOS
TFIP11::AMPD1	Squamous cell carcinoma
TFIP11::IL17RA	Transitional cell carcinoma
TFR2::NCOR2	Adenocarcinoma
TFRC::BCL6	Diffuse large B-cell lymphoma
TFRC::BLOC1S5	Adenocarcinoma
TFRC::CPA3	Squamous cell carcinoma
TFRC::DYNLT2B	Transitional cell carcinoma
TFRC::EBNA1BP2	Adenocarcinoma
TFRC::FBLN1	Transitional cell carcinoma
TFRC::JUP	Squamous cell carcinoma
TFRC::NSUN4	Squamous cell carcinoma
TG::FGFR1	Adenocarcinoma
TG::IGF1R	Adenocarcinoma
TG::THADA	Adenocarcinoma
TGDS::DAPK1	Adenocarcinoma
TGFA::FAM136A	Adenocarcinoma
TGFB1::CCDC97	Adenocarcinoma
TGFB1::FXYD5	Transitional cell carcinoma
TGFB1::HNRNPUL1	Adenocarcinoma
TGFB1::TMEM91	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TGFB1::TRPC6	Adenocarcinoma
TGFBI::ANXA1	Squamous cell carcinoma
TGFBI::MYH9	Adenocarcinoma
TGFBI::RABEP1	Malignant melanoma
TGFBI::TNNT1	Adenocarcinoma
TGFBR1::COL15A1	Adenocarcinoma
TGFBR2::NR2C2	Adenocarcinoma
TGFBR2::PREP	Adenocarcinoma
TGFBR2::XPC	Mesenchymal tumor, NOS
TGFBR2::ZBTB7A	Diffuse large B-cell lymphoma
TGFBR3::ANKS1A	Adenocarcinoma
TGFBR3::EDARADD	Adenocarcinoma
TGFBR3::LRTM1	Adenocarcinoma
TGFBR3::NRDC	Malignant melanoma
TGFBR3::PLAG1	Adenoma | Malignant epithelial tumor, special type
TGFBRAP1::ARHGAP15	Mesenchymal tumor, NOS
TGFBRAP1::CCDC146	Squamous cell carcinoma
TGFBRAP1::CNOT9	Adenocarcinoma
TGFBRAP1::DPP10	Mesenchymal tumor, NOS
TGIF1::DDX19B	Adenocarcinoma
TGIF2::DLGAP4	Adenocarcinoma
TGM2::ACVRL1	Malignant melanoma
TGM2::COL4A1	Adenocarcinoma
TGM2::TRPM5	Adenocarcinoma
TGM4::EEF2	Adenocarcinoma
TGOLN2::FOXP1	Adenocarcinoma
TGOLN2::IMMT	Adenocarcinoma
THADA::CFAP45	Adenocarcinoma
THADA::EML4	Squamous cell carcinoma
THADA::IGF2BP3	Adenoma | Adenocarcinoma
THADA::MAP4K3	Adenocarcinoma
THADA::MSH2	Diffuse large B-cell lymphoma
THADA::UBR2	Adenocarcinoma
THAP12::ADAM2	Adenocarcinoma
THAP12::ANO1	Adenocarcinoma
THAP12::FCHSD2	Adenocarcinoma
THAP12::MARK4	Adenocarcinoma
THAP12::POLD4	Adenocarcinoma
THAP12::TIMP3	Malignant epithelial tumor, special type
THAP1::SFRP1	Malignant melanoma
THAP2::GRIP1	Adenocarcinoma
THAP2::RAPGEF3	Mesenchymal tumor, NOS
THAP2::YEATS4	Mesenchymal tumor, NOS
THAP3::LCK	Adenocarcinoma
THAP3::TCEA3	Adenocarcinoma
THAP4::ANO7	Astrocytoma, grade III-IV/Glioblastoma
THAP4::BOK	Adenocarcinoma
THAP4::DOCK10	Astrocytoma, grade I-II
THAP7::A4GALT	Malignant melanoma
THAP7::NRG1	Squamous cell carcinoma
THAP7::PRODH	Squamous cell carcinoma
THAP8::WDR62	Adenocarcinoma
THBS1::ADGRF5	Soft tissue tumor, special type | Cartilage tumor, special type
THBS1::AGBL1	Squamous cell carcinoma
THBS1::ALK	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma
THBS1::IGF1R	Vascular and perivascular tumor, special type
THBS1::INSR	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma
THBS1::NFIB	Adenocarcinoma
THBS1::NRG1	Squamous cell carcinoma
THBS2::NME4	Adenocarcinoma
THBS2::USP6	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma
THBS3::HDGF	Adenocarcinoma
THBS4::COL3A1	Adenocarcinoma
THBS4::PHAX	Astrocytoma, grade I-II
THBS4::SCFD2	Squamous cell carcinoma
THEM4::ARHGEF11	Malignant melanoma
THEM4::DCST2	Adenocarcinoma
THEM4::S100A10	Adenocarcinoma
THEMIS2::IGH	Multiple myeloma
THEMIS2::IGK	Multiple myeloma
THOC1::GLI3	Mesenchymal tumor, NOS
THOC1::THADA	Malignant epithelial tumor, special type
THOC2::RHOXF2B	Adenocarcinoma
THOC5::ASCC2	Adenocarcinoma
THOC5::ISX	Malignant melanoma
THOC5::LYZ	Squamous cell carcinoma
THOC5::NIPSNAP1	Adenocarcinoma
THOC5::PIBF1	Transitional cell carcinoma
THOC5::SEC14L3	Adenocarcinoma
THOC5::SPATA16	Squamous cell carcinoma
THOC5::TTC28	Germ cell tumor, NOS
THOC7::LRIG1	Adenocarcinoma
THOP1::FTCD	Adenocarcinoma
THOP1::NOTCH3	Mesenchymal tumor, NOS
THRA::B4GALNT2	Adenocarcinoma
THRA::CACNB1	Adenocarcinoma
THRA::CDC6	Adenocarcinoma
THRA::CDK12	Adenocarcinoma
THRA::GOSR1	Adenocarcinoma
THRA::GSDMA	Adenocarcinoma | Astrocytoma, grade III-IV/Glioblastoma
THRA::KRT20	Malignant epithelial tumor, special type
THRA::PSMD3	Adenocarcinoma | Squamous cell carcinoma
THRA::TADA2A	Adenocarcinoma
THRA::USP32	Adenocarcinoma
THRAP3::AGO1	Adenocarcinoma
THRAP3::AGO3	Adenocarcinoma
THRAP3::ARHGEF10L	Adenocarcinoma
THRAP3::CAPZB	Adenocarcinoma
THRAP3::EPHB2	Adenocarcinoma
THRAP3::ERI3	Adenocarcinoma
THRAP3::INSL5	Adenocarcinoma
THRAP3::KEAP1	Adenocarcinoma
THRAP3::MAP7D1	Adenocarcinoma
THRAP3::MUTYH	Adenocarcinoma
THRAP3::NFIA	Mesenchymal tumor, NOS
THRAP3::RPN1	Adenocarcinoma
THRAP3::SH3BP2	Acute megakaryoblastic leukemia (FAB type M7)
THRAP3::STK11	Adenocarcinoma
THRAP3::TRAPPC3	Adenocarcinoma
THRAP3::USP6	Aneurysmal bone cyst
THRB::LMCD1	Adenocarcinoma
THRB::NECTIN3	Astrocytoma, grade I-II
THRSP::KCTD14	Adenocarcinoma
THSD4::ADAM10	Adenocarcinoma
THSD4::ALDH1A2	Adenocarcinoma
THSD4::LRRC49	Adenocarcinoma
THSD4::NR2E3	Adenocarcinoma
THSD4::PAQR5	Adenocarcinoma
THSD4::PTPA	Adenocarcinoma
THSD4::REC114	Squamous cell carcinoma
THSD4::THAP10	Adenocarcinoma
THSD4::WARS1	Squamous cell carcinoma
THSD4::ZNF710	Adenocarcinoma
THSD7A::PRKAR1B	Astrocytoma, grade I-II
THSD7B::DARS1	Adenocarcinoma
THTPA::MMP14	Adenocarcinoma
THUMPD2::ALK	Adenocarcinoma
THUMPD2::VSNL1	Adenocarcinoma
TIA1::ACTR2	Adenocarcinoma
TIA1::BCL11A	Adenocarcinoma
TIA1::FAM136A	Squamous cell carcinoma
TIA1::MRPL33	Astrocytoma, grade I-II
TIA1::SLC49A4	Adenocarcinoma
TIA1::SNRPG	Adenocarcinoma
TIA1::TGFA	Adenocarcinoma
TIAL1::CUZD1	Adenocarcinoma
TIAL1::MCMBP	Adenocarcinoma
TIAM1::FBLIM1	Adenocarcinoma
TIAM1::NCAM2	Mesenchymal tumor, NOS
TIAM1::NRIP1	Adenocarcinoma
TIAM1::NRP2	Squamous cell carcinoma
TIAM1::PCBP3	Squamous cell carcinoma
TIAM2::CDK12	Adenocarcinoma
TIAM2::PPIL4	Mesenchymal tumor, NOS
TICAM1::IL12RB1	Adenocarcinoma
TICAM1::NFIX	Squamous cell carcinoma
TICAM1::PTPRS	Adenocarcinoma
TICAM1::TLE2	Adenocarcinoma
TICAM1::VMP1	Adenocarcinoma
TICRR::ATXN7L1	Adenocarcinoma
TIGAR::CRP	Mesenchymal tumor, NOS
TIGAR::PRR4	Squamous cell carcinoma
TIGAR::PTPN6	Mesenchymal tumor, NOS
TIGAR::REC114	Adenocarcinoma
TIGAR::TSPAN9	Astrocytoma, grade III-IV/Glioblastoma
TIGAR::ZNF827	Mesenchymal tumor, NOS
TIMELESS::BAZ2A	Adenocarcinoma
TIMELESS::GLS2	Squamous cell carcinoma
TIMM17A::RASSF5	Adenocarcinoma
TIMM22::SGSM2	Adenocarcinoma
TIMM23::PRKG1	Astrocytoma, grade I-II
TIMM23B::RET	Adenocarcinoma
TIMM29::PDE4A	Adenocarcinoma
TIMM44::DAND5	Adenocarcinoma
TIMM44::MPND	Mesenchymal tumor, NOS
TIMM50::CTF1	Adenocarcinoma
TIMM50::IFNL1	Adenocarcinoma
TIMM8A::TRPC5	Squamous cell carcinoma
TIMM9::FCF1	Astrocytoma, grade I-II
TIMMDC1::RFESD	Adenocarcinoma
TIMP1::EIF2AK2	Malignant melanoma
TIMP2::ANXA1	Adenocarcinoma
TIMP2::CEP57	Adenocarcinoma
TIMP2::G6PC3	Malignant epithelial tumor, special type
TIMP2::MSI2	Adenocarcinoma
TIMP2::NOTCH1	Adenocarcinoma
TIMP2::RBFOX3	Adenocarcinoma
TIMP3::ALK	Mesenchymal tumor, special type | Inflammatory myofibroblastic tumor/myofibroblastic sarcoma | Rhabdomyosarcoma, NOS
TIMP3::FBXO7	Adenocarcinoma
TIMP3::RET	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma
TIMP3::ROS1	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma
TIMP3::SPCS3	Adenocarcinoma
TIMP3::SYN3	Transitional cell carcinoma
TIMP3::ZCCHC7	Soft tissue tumor, special type
TIMP3::ZNFX1	Malignant melanoma
TIPARP::LEKR1	Adenocarcinoma
TIPIN::ATP8B4	Mesenchymal tumor, NOS
TIPIN::NUTM1	Acute myelomonocytic leukemia (FAB type M4)
TIPRL::DCAF6	Mature B-cell neoplasm, NOS
TIRAP::FOXRED1	Adenocarcinoma
TJAP1::ABCC10	Squamous cell carcinoma
TJAP1::KLC4	Adenocarcinoma
TJP1::ROS1	Malignant peripheral nerve sheath tumor/Triton
TJP1::SLC20A1	Malignant melanoma
TJP1::TYK2	Adenocarcinoma
TJP2::FXN	Transitional cell carcinoma
TJP2::RPRD2	Malignant melanoma
TJP2::STX17	Squamous cell carcinoma
TJP2::TMEM38B	Adenocarcinoma
TJP3::LRRC8E	Squamous cell carcinoma
TJP3::ZNF554	Adenocarcinoma
TK1::AFMID	Adenocarcinoma
TK1::DNAH17	Transitional cell carcinoma
TK1::KMT2D	Adenocarcinoma
TK2::EXOC3L1	Adenocarcinoma
TKFC::TMEM109	Adenocarcinoma
TKT::CENPF	Adenocarcinoma
TKT::GPBP1	Adenocarcinoma
TLCD1::CRYBA1	Malignant epithelial tumor, special type
TLCD1::NEK8	Adenocarcinoma
TLCD2::LRP5	Adenocarcinoma
TLCD3B::GSG1L	Adenocarcinoma
TLCD4::ACADM	Mature B-cell neoplasm, NOS
TLCD4::FNBP1L	Adenocarcinoma
TLCD4::SNX7	Adenocarcinoma
TLCD5::POU2F3	Adenocarcinoma
TLDC2::DYNLRB1	Adenocarcinoma
TLE1::GRHL1	Soft tissue tumor, special type
TLE3::CT62	Adenocarcinoma
TLE3::IGK	Multiple myeloma
TLE3::JAK2	Bilineage or biphenotypic leukemia | Egypt
TLE3::THAP10	Squamous cell carcinoma
TLE3::TLE5	Carcinoma, NOS
TLE3::YWHAH	Adenocarcinoma
TLE4::NTRK2	Astrocytoma, pilocytic/juvenile
TLE5::ELK3	Squamous cell carcinoma
TLE5::FOXP1	Benign epithelial tumor, special type
TLE5::TNNT1	Squamous cell carcinoma
TLK1::ADK	Adenocarcinoma
TLK1::CAT	Adenocarcinoma
TLK1::CREG2	Squamous cell carcinoma
TLK1::KCNH7	Adenocarcinoma
TLK1::PRPF40A	Adenocarcinoma
TLK1::SSB	Adenocarcinoma
TLK1::XPO7	Adenocarcinoma
TLK2::BCAS3	Squamous cell carcinoma
TLK2::CEP112	Adenocarcinoma
TLK2::DCAF7	Adenocarcinoma
TLK2::FN3KRP	Malignant epithelial tumor, special type
TLK2::IRAK3	Transitional cell carcinoma
TLK2::KCNJ16	Adenocarcinoma
TLK2::PITPNC1	Adenocarcinoma
TLK2::SIGLEC9	Adenocarcinoma
TLK2::THRA	Transitional cell carcinoma
TLN1::EIF4G1	Adenocarcinoma
TLN1::RET	Carcinoma, NOS
TLN1::SFTPB	Adenocarcinoma
TLN2::FGF7	Adenocarcinoma
TLN2::FOXB1	Adenocarcinoma
TLN2::LACTB	Adenocarcinoma
TLN2::RAF1	Soft tissue tumor, NOS
TLN2::RBPMS2	Adenocarcinoma
TLN2::RPS27L	Adenocarcinoma
TLR1::BICD1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TLR4::SLC31A1	Mesenchymal tumor, NOS
TLX1::CTRB2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TLX1::RPP30	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TLX1::TRA	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TLX1::TRB	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TLX3::BCL11B	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TLX3::CDK6	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TLX3::RANBP17	Adenocarcinoma
TLX3::TRB	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TM2D1::STOX2	Adenocarcinoma
TM2D2::ADAM9	Adenocarcinoma
TM2D2::GOT1L1	Transitional cell carcinoma
TM2D2::IDO2	Adenocarcinoma
TM2D2::MSI2	Adenocarcinoma
TM2D3::CAVIN1	Adenocarcinoma
TM4SF18::WWTR1	Adenocarcinoma
TM4SF1::DDX27	Adenocarcinoma
TM7SF2::PRRG4	Undifferentiated carcinoma, small cell
TM7SF3::C12ORF42	Astrocytoma, grade III-IV/Glioblastoma
TM7SF3::C12orf42	Astrocytoma, grade III-IV/Glioblastoma
TM7SF3::INTS13	Squamous cell carcinoma
TM7SF3::KCNC2	Mesenchymal tumor, NOS
TM7SF3::SNX31	Adenocarcinoma
TM9SF1::NPAS3	Adenocarcinoma
TM9SF1::TSSK4	Adenocarcinoma
TM9SF2::CLYBL	Adenocarcinoma
TM9SF2::HSP90B1	Malignant melanoma
TM9SF2::IL17D	Adenocarcinoma
TM9SF2::MTUS2	Adenocarcinoma
TM9SF3::AVPI1	Adenocarcinoma
TM9SF3::PIK3AP1	Adenocarcinoma
TM9SF3::RPP30	Adenocarcinoma
TM9SF3::SLIT1	Adenocarcinoma
TM9SF3::TLL2	Adenocarcinoma
TM9SF4::COMMD7	Adenocarcinoma
TM9SF4::DEFB123	Malignant epithelial tumor, special type
TM9SF4::EYA2	Adenocarcinoma
TM9SF4::HM13	Squamous cell carcinoma
TM9SF4::PAK2	Soft tissue tumor, special type
TM9SF4::PLAGL2	Squamous cell carcinoma
TM9SF4::TPX2	Adenocarcinoma
TM9SF4::ZNF423	Adenocarcinoma
TMBIM4::GRIP1	Adenocarcinoma
TMBIM4::INO80	Adenocarcinoma
TMBIM4::MSRB3	Soft tissue tumor, special type
TMBIM4::PBX3	Mesenchymal tumor, NOS
TMBIM4::TMEM131	Squamous cell carcinoma
TMBIM6::CLCN3	Transitional cell carcinoma
TMBIM6::FKBP11	Malignant melanoma
TMBIM6::GLUL	Astrocytoma, grade III-IV/Glioblastoma
TMBIM6::TYK2	Adenocarcinoma
TMC2::PTPRA	Diffuse large B-cell lymphoma
TMC3::C15ORF40	Astrocytoma, grade I-II
TMC3::C15orf40	Astrocytoma, grade I-II
TMC4::MBOAT7	Adenocarcinoma
TMC5::GPRC5B	Adenocarcinoma
TMC5::JPT1	Adenocarcinoma
TMC5::SYT17	Adenocarcinoma
TMC5::VPS35L	Adenocarcinoma
TMC6::DNAH17	Adenocarcinoma
TMC6::TK1	Adenocarcinoma
TMC6::UACA	Adenocarcinoma
TMC6::VCF1	Adenocarcinoma
TMCC1::ACTR10	Adenocarcinoma
TMCC1::ALDH1L1	Adenocarcinoma
TMCC1::ARSG	Transitional cell carcinoma
TMCC1::CD96	Adenocarcinoma
TMCC1::LSAMP	Squamous cell carcinoma
TMCC1::QSOX2	Squamous cell carcinoma
TMCC2::HMCN1	Astrocytoma, grade I-II
TMCC2::MNAT1	Astrocytoma, grade I-II
TMCC2::NBEA	Embryonal nervous system tumor, special type
TMCC3::EEA1	Adenocarcinoma
TMCC3::TRHDE	Mesenchymal tumor, NOS
TMCO3::ATP11A	Mesenchymal tumor, NOS
TMCO3::KATNAL2	Adenocarcinoma
TMCO3::MCF2L	Adenocarcinoma
TMCO3::PRKCZ	Mesenchymal tumor, NOS
TMCO3::SPACA7	Squamous cell carcinoma
TMCO3::ST7	Adenocarcinoma
TMCO4::ERRFI1	Adenocarcinoma
TMCO4::KAZN	Adenocarcinoma
TMCO4::MAP7D1	Adenocarcinoma
TMCO4::PLA2G2A	Adenocarcinoma
TMCO6::ANKHD1	Mature B-cell neoplasm, NOS
TMCO6::CYSTM1	Adenocarcinoma
TMED10::MRPL48	Adenocarcinoma
TMED10::PSMD11	Adenocarcinoma
TMED10::TTLL5	Squamous cell carcinoma
TMED2::ALK	Adenocarcinoma
TMED2::RFLNA	Adenocarcinoma
TMED3::PCMTD2	Adenocarcinoma
TMED5::ADORA3	Adenocarcinoma
TMED5::HFM1	Adenocarcinoma
TMED5::TMIGD3	Adenocarcinoma
TMEFF2::CHMP1A	Adenocarcinoma
TMEFF2::RLIM	Adenocarcinoma
TMEFF2::SRPK2	Adenocarcinoma
TMEFF2::TMPRSS11B	Adenocarcinoma
TMEFF2::TMPRSS2	Adenocarcinoma
TMEFF2::UBE2E3	Adenocarcinoma
TMEM104::CDK12	Adenocarcinoma
TMEM104::DNAI2	Adenocarcinoma
TMEM104::LIN52	Adenocarcinoma
TMEM104::NHERF1	Adenocarcinoma
TMEM104::PCYT2	Squamous cell carcinoma
TMEM104::RAB37	Adenocarcinoma
TMEM106A::NMT1	Malignant melanoma
TMEM106A::TUBD1	Adenocarcinoma
TMEM106B::BRAF	Astrocytoma, grade I-II | Soft tissue tumor, special type
TMEM106B::ROS1	Adenocarcinoma
TMEM107::FXR2	Adenocarcinoma
TMEM107::WRAP53	Adenocarcinoma
TMEM108::GAP43	Adenocarcinoma
TMEM109::CD5	Adenocarcinoma
TMEM109::CTSD	Adenocarcinoma
TMEM116::RANGAP1	Adenocarcinoma
TMEM117::COL25A1	Malignant melanoma
TMEM117::DYNC1LI2	Malignant melanoma
TMEM117::KCNC2	Malignant melanoma
TMEM117::KIF16B	Squamous cell carcinoma
TMEM117::MCCC1	Adenocarcinoma
TMEM117::MCRS1	Malignant melanoma
TMEM117::PRIM1	Mesenchymal tumor, NOS
TMEM117::TTC33	Squamous cell carcinoma
TMEM117::UBC	Malignant melanoma
TMEM117::ZCRB1	Adenocarcinoma
TMEM119::ARIH2	Adenocarcinoma
TMEM11::UBAP1	Squamous cell carcinoma
TMEM120A::RCC1L	Transitional cell carcinoma
TMEM120B::AVIL	Astrocytoma, grade III-IV/Glioblastoma
TMEM120B::GRIP1	Mesenchymal tumor, NOS
TMEM120B::MORN3	Adenocarcinoma
TMEM120B::ORAI1	Malignant melanoma | Adenocarcinoma | Transitional cell carcinoma
TMEM120B::RNFT2	Astrocytoma, grade III-IV/Glioblastoma
TMEM120B::UBR4	Adenocarcinoma
TMEM120B::UBTF	Adenocarcinoma
TMEM123::CENPP	Transitional cell carcinoma
TMEM123::CNTN5	Adenocarcinoma
TMEM123::DYNC2H1	Squamous cell carcinoma
TMEM123::MMP10	Adenocarcinoma
TMEM123::MMP20	Adenocarcinoma
TMEM123::MMP27	Adenocarcinoma
TMEM123::MMP7	Adenocarcinoma
TMEM123::MMP8	Adenocarcinoma
TMEM126A::EED	Squamous cell carcinoma
TMEM127::STAM	Transitional cell carcinoma
TMEM127::ZAP70	Squamous cell carcinoma
TMEM130::KPNA7	Adenocarcinoma
TMEM131::FAM178B	Adenocarcinoma
TMEM131::PLA2G6	Malignant epithelial tumor, special type
TMEM131::RAPGEF4	Adenocarcinoma
TMEM131::SPATA16	Adenocarcinoma
TMEM131::TGFBRAP1	Adenocarcinoma
TMEM131L::ARFIP1	Adenocarcinoma
TMEM131L::LRAT	Adenocarcinoma
TMEM131L::MND1	Mature B-cell neoplasm, NOS | Adenocarcinoma
TMEM132B::PLPP4	Adenocarcinoma
TMEM132D::GALNT9	Astrocytoma, grade I-II
TMEM132D::PAH	Adenocarcinoma
TMEM132D::RALGAPA2	Adenocarcinoma
TMEM132D::STX2	Adenocarcinoma
TMEM132E::GPATCH8	Adenocarcinoma
TMEM134::SPTBN2	Adenocarcinoma
TMEM135::AAMDC	Adenocarcinoma
TMEM135::ALDH3B2	Adenocarcinoma
TMEM135::ARHGEF26	Germ cell tumor, NOS
TMEM135::CHEK1	Adenocarcinoma
TMEM135::CLMP	Adenocarcinoma
TMEM135::DEUP1	Astrocytoma, grade III-IV/Glioblastoma | Adenocarcinoma | Carcinoma, NOS
TMEM135::ELOVL1	Adenocarcinoma
TMEM135::FGD5	Transitional cell carcinoma
TMEM135::GPD1L	Astrocytoma, grade I-II
TMEM135::GRM5	Adenocarcinoma
TMEM135::HK1	Mesenchymal tumor, NOS
TMEM135::KCTD21	Adenocarcinoma
TMEM135::MIPEP	Adenocarcinoma
TMEM141::TRAF2	Adenocarcinoma
TMEM143::DBP	Adenocarcinoma
TMEM14B::BAG6	Adenocarcinoma
TMEM14B::TFAP2A	Adenocarcinoma
TMEM14C::PAK1IP1	Adenocarcinoma
TMEM150C::SCD5	Astrocytoma, grade I-II
TMEM154::RASGRF1	Acute monoblastic leukemia with differentiation (FAB type M5b) | Acute myeloid leukemia, NOS | Skin
TMEM160::ZC3H4	Adenocarcinoma
TMEM161A::TIMM44	Mesenchymal tumor, NOS
TMEM161B::CTNND2	Malignant melanoma
TMEM161B::FAM81B	Adenocarcinoma
TMEM164::NDUFV3	Adenocarcinoma
TMEM165::CRACD	Squamous cell carcinoma
TMEM165::DACH1	Adenocarcinoma
TMEM165::PDGFRA	Astrocytoma, grade I-II | Astrocytoma, grade III-IV/Glioblastoma
TMEM167A::ABLIM3	Malignant melanoma
TMEM167A::NUDT12	Malignant melanoma
TMEM167A::PAM	Malignant melanoma
TMEM167B::LYPLA1	Mesenchymal tumor, NOS
TMEM170A::ADAT1	Adenocarcinoma
TMEM170A::CHST6	Adenocarcinoma
TMEM170A::NUP93	Adenocarcinoma
TMEM170A::USP22	Adenocarcinoma
TMEM170B::ADTRP	Adenocarcinoma
TMEM170B::SMIM13	Adenocarcinoma
TMEM175::ATP9A	Adenocarcinoma
TMEM175::IDUA	Squamous cell carcinoma
TMEM176B::ARFGEF2	Adenocarcinoma
TMEM178B::BRAF	Adenocarcinoma
TMEM178B::DPP6	Malignant epithelial tumor, special type
TMEM178B::LHPP	Adenocarcinoma
TMEM178B::NDUFB2	Transitional cell carcinoma
TMEM178B::NR5A2	Malignant melanoma
TMEM178B::RBM28	Adenocarcinoma
TMEM179B::RSF1	Adenocarcinoma
TMEM179B::SCGB1D1	Adenocarcinoma
TMEM179B::SLC22A10	Adenocarcinoma
TMEM181::ARID1B	Multiple myeloma
TMEM181::HMGCLL1	Adenocarcinoma
TMEM182::ADAMTS12	Adenocarcinoma
TMEM182::ARHGAP15	Adenocarcinoma
TMEM182::IL18R1	Adenocarcinoma
TMEM182::SCN3A	Adenocarcinoma
TMEM182::SLC9A2	Adenocarcinoma
TMEM184B::BAIAP2L2	Adenocarcinoma
TMEM184B::CSNK1E	Squamous cell carcinoma
TMEM184B::DNAH14	Adenocarcinoma
TMEM184B::RNF25	Adenocarcinoma
TMEM184B::SUN2	Adenocarcinoma
TMEM185A::EOLA2	Malignant epithelial tumor, special type
TMEM18::ASXL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TMEM192::TMEM184C	Astrocytoma, grade III-IV/Glioblastoma
TMEM19::TSPAN8	Astrocytoma, grade III-IV/Glioblastoma
TMEM200A::FYN	Malignant melanoma
TMEM200B::KHDRBS1	Astrocytoma, grade III-IV/Glioblastoma
TMEM201::RBP7	Adenocarcinoma
TMEM201::SPSB1	Transitional cell carcinoma
TMEM203::TMEM87A	Adenocarcinoma
TMEM204::JPT2	Adenocarcinoma
TMEM209::COPG2	Adenocarcinoma
TMEM213::ARFGEF2	Adenocarcinoma
TMEM216::KCNG3	Adenocarcinoma
TMEM216::PGM3	Adenocarcinoma
TMEM216::TMEM138	Adenocarcinoma
TMEM219::CPB1	Adenocarcinoma
TMEM219::TAOK2	Adenocarcinoma
TMEM223::SLC22A6	Adenocarcinoma
TMEM223::SLC22A8	Adenocarcinoma
TMEM223::STX5	Adenocarcinoma
TMEM232::ANKRA2	Squamous cell carcinoma
TMEM234::CCDC28B	Adenocarcinoma
TMEM234::CSMD2	Astrocytoma, grade III-IV/Glioblastoma
TMEM234::RUSC1	Adenocarcinoma
TMEM241::HM13	Adenocarcinoma
TMEM241::NPC1	Squamous cell carcinoma
TMEM241::OSBPL1A	Adenocarcinoma
TMEM241::PACS1	Squamous cell carcinoma
TMEM241::RIOK3	Squamous cell carcinoma | Adenocarcinoma
TMEM241::SNX29	Adenocarcinoma
TMEM241::TAF4B	Adenocarcinoma
TMEM241::TTC39C	Mesothelioma
TMEM242::ARID1B	Adenocarcinoma
TMEM242::GTF2H5	Squamous cell carcinoma
TMEM242::PREP	Adenocarcinoma
TMEM242::TIAM2	Adenocarcinoma
TMEM245::ELP1	Adenocarcinoma
TMEM245::FRRS1L	Adenocarcinoma
TMEM245::NAA35	Adenocarcinoma
TMEM245::SLC44A1	Astrocytoma, grade I-II
TMEM248::ATOH8	Adenocarcinoma
TMEM248::RALY	Adenocarcinoma
TMEM248::SBDS	Malignant melanoma
TMEM248::TYW1	Transitional cell carcinoma
TMEM254::CREB3L3	Adenocarcinoma
TMEM255A::FPR2	Mesenchymal tumor, NOS
TMEM258::SCGB1D2	Transitional cell carcinoma
TMEM259::CCDC25	Adenocarcinoma
TMEM259::CNN2	Adenocarcinoma
TMEM259::KLF2	Multiple myeloma
TMEM259::PRSS57	Malignant melanoma
TMEM259::RNF126	Multiple myeloma
TMEM259::SBNO2	Squamous cell carcinoma
TMEM25::CD3G	Squamous cell carcinoma
TMEM25::CDH26	Adenocarcinoma
TMEM260::MLIP	Squamous cell carcinoma
TMEM263::RFX4	Adenocarcinoma
TMEM265::GABBR2	Adenocarcinoma
TMEM265::GNB1L	Adenocarcinoma
TMEM265::MVP	Adenocarcinoma
TMEM266::SMAD6	Adenocarcinoma
TMEM267::PAIP1	Adenocarcinoma
TMEM268::GADD45GIP1	Adenocarcinoma
TMEM272::KDM4B	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TMEM30A::FILIP1	Squamous cell carcinoma
TMEM35A::SLC25A43	Mesenchymal tumor, NOS
TMEM38A::CHERP	Malignant melanoma | Adenocarcinoma
TMEM38B::BCO2	Squamous cell carcinoma
TMEM39A::BBX	Adenocarcinoma
TMEM39A::CFAP91	Adenocarcinoma
TMEM39A::EPHA6	Adenocarcinoma
TMEM39B::C1ORF94	Adenocarcinoma
TMEM39B::C1orf94	Adenocarcinoma
TMEM39B::KHDRBS1	Adenocarcinoma
TMEM41A::EPHA2	Malignant epithelial tumor, special type
TMEM41A::LIPH	Transitional cell carcinoma
TMEM41B::TEKT1	Adenocarcinoma
TMEM45A::CMSS1	Squamous cell carcinoma | Adenocarcinoma
TMEM45A::LNP1	Squamous cell carcinoma
TMEM45B::BARX2	Adenocarcinoma
TMEM50B::GART	Adenocarcinoma
TMEM50B::RUNX1	Adenocarcinoma
TMEM50B::TLX2	Adenocarcinoma
TMEM50B::XXYLT1	Squamous cell carcinoma
TMEM51::KAZN	Squamous cell carcinoma
TMEM52B::RHNO1	Adenocarcinoma
TMEM52B::XIAP	Acute myeloblastic leukemia with maturation (FAB type M2)
TMEM53::CTPS1	Adenocarcinoma
TMEM53::EIF2B3	Adenocarcinoma
TMEM54::SUPT16H	Squamous cell carcinoma
TMEM54::TRIM62	Squamous cell carcinoma
TMEM59::ARFGEF2	Adenocarcinoma
TMEM59::MYBPC1	Adenocarcinoma
TMEM59::SSBP3	Adenocarcinoma
TMEM59::SUPT16H	Adenocarcinoma
TMEM59L::GGNBP2	Adenocarcinoma
TMEM60::HIP1	Adenocarcinoma
TMEM61::PHLDA3	Adenocarcinoma
TMEM63A::FCGR2A	Transitional cell carcinoma
TMEM63A::LEFTY1	Adenocarcinoma
TMEM63A::LPAR1	Adenocarcinoma
TMEM63A::NRDC	Adenocarcinoma
TMEM63A::SDE2	Adenocarcinoma
TMEM63B::ACTL10	Adenocarcinoma
TMEM63B::EFCAB14	Adenocarcinoma
TMEM63B::MRPL14	Adenocarcinoma
TMEM63B::POLR1C	Adenocarcinoma
TMEM63B::RSPH9	Adenocarcinoma
TMEM64::HHLA1	Adenocarcinoma
TMEM64::NECAB1	Adenocarcinoma
TMEM64::OC90	Adenocarcinoma
TMEM65::EXT1	Squamous cell carcinoma
TMEM67::STMN2	Adenocarcinoma
TMEM68::DPYS	Adenocarcinoma
TMEM68::PLAG1	Adenoma
TMEM68::ZNF821	Adenocarcinoma
TMEM69::MAST2	Adenocarcinoma
TMEM79::SMG5	Adenocarcinoma
TMEM87A::PTPRN2	Squamous cell carcinoma
TMEM87A::RASGRF1	Undifferentiated carcinoma
TMEM87B::IL1RN	Adenocarcinoma
TMEM87B::MERTK	Squamous cell carcinoma | Adenocarcinoma | Transitional cell carcinoma
TMEM8B::TLN1	Malignant melanoma
TMEM91::TGFB1	Astrocytoma, grade I-II
TMEM94::ELP5	Skin | Acute myeloid leukemia, NOS
TMEM94::GNAS	Adenocarcinoma
TMEM94::LRRC52	Mesenchymal tumor, NOS
TMEM94::MRPL58	Adenocarcinoma
TMEM94::NUP85	Squamous cell carcinoma
TMEM94::RHBDL3	Ependymoma
TMEM94::TMEM104	Adenocarcinoma
TMEM94::TTYH2	Adenocarcinoma
TMEM97::BLMH	Adenocarcinoma
TMEM97::SKAP1	Adenocarcinoma
TMEM98::GPATCH8	Squamous cell carcinoma
TMEM98::GRM5	Adenocarcinoma
TMEM9::MYO5B	Adenocarcinoma
TMEM9B::MGP	Adenocarcinoma
TMEM9B::PSIP1	Mesenchymal tumor, NOS
TMF1::FRMD4B	Adenocarcinoma
TMF1::RAF1	Soft tissue tumor, special type
TMF1::UBA3	Mature B-cell neoplasm, NOS
TMLHE::CDK12	Adenocarcinoma
TMLHE::NEDD9	Squamous cell carcinoma
TMLHE::VBP1	Adenocarcinoma
TMOD1::TDRD7	Adenocarcinoma
TMOD2::INSYN1	Astrocytoma, grade I-II
TMOD3::BCL2L10	Adenocarcinoma
TMOD3::EIF4E2	Adenocarcinoma
TMOD3::SPG11	Malignant epithelial tumor, special type
TMOD3::TACC3	Astrocytoma, grade I-II
TMPO::CS	Adenocarcinoma
TMPRSS11D::SPINK2	Squamous cell carcinoma
TMPRSS13::NIPAL2	Adenocarcinoma
TMPRSS15::INTS8	Adenocarcinoma
TMPRSS2::AMACR	Adenocarcinoma
TMPRSS2::ARFGEF2	Adenocarcinoma
TMPRSS2::ATF7IP	Adenocarcinoma
TMPRSS2::BRAF	Adenocarcinoma
TMPRSS2::CALB1	Adenocarcinoma
TMPRSS2::CFAP70	Adenocarcinoma
TMPRSS2::DGKG	Adenocarcinoma
TMPRSS2::DIAPH1	Adenocarcinoma
TMPRSS2::EML4	Adenocarcinoma
TMPRSS2::ERG	Adenocarcinoma | Malignant epithelial tumor, special type | Hyperplasia | Undifferentiated carcinoma, large cell | Nonneoplastic epithelial disorder/lesion | Adenosquamous carcinoma | Oligodendroglioma
TMPRSS2::ETV1	Adenocarcinoma | Squamous cell carcinoma
TMPRSS2::ETV4	Adenocarcinoma
TMPRSS2::ETV5	Adenocarcinoma
TMPRSS2::FGFR2	Adenocarcinoma
TMPRSS2::GRHL2	Adenocarcinoma
TMPRSS2::GUCA2A	Adenocarcinoma
TMPRSS2::HDLBP	Adenocarcinoma
TMPRSS2::HSF2BP	Squamous cell carcinoma
TMPRSS2::INPP4B	Adenocarcinoma
TMPRSS2::IRS2	Adenocarcinoma
TMPRSS2::KLF4	Adenocarcinoma
TMPRSS2::MLLT3	Adenocarcinoma
TMPRSS2::MORC3	Adenocarcinoma
TMPRSS2::MRPS6	Adenocarcinoma
TMPRSS2::MX1	Adenocarcinoma
TMPRSS2::PDE9A	Adenocarcinoma
TMPRSS2::PHF12	Adenocarcinoma
TMPRSS2::PPP3CA	Adenocarcinoma
TMPRSS2::RERE	Adenocarcinoma
TMPRSS2::SARS1	Adenocarcinoma
TMPRSS2::SETD4	Adenocarcinoma
TMPRSS2::SKIL	Adenocarcinoma
TMPRSS2::TBXAS1	Adenocarcinoma
TMPRSS2::TMEFF2	Adenocarcinoma
TMPRSS2::TMEM109	Adenocarcinoma
TMPRSS3::RSPH1	Adenocarcinoma
TMPRSS4::TMEM25	Adenocarcinoma
TMPRSS6::EME1	Adenocarcinoma
TMPRSS6::MPST	Adenocarcinoma
TMPRSS6::PPP6R3	Adenocarcinoma
TMPRSS9::PAX5	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TMSB10::CD63	Adenocarcinoma
TMSB10::CFB	Squamous cell carcinoma
TMSB10::CLCN3	Squamous cell carcinoma
TMSB10::COL6A2	Squamous cell carcinoma
TMSB10::RPS16	Adenocarcinoma
TMSB10::SCML2	Multiple myeloma
TMSB10::SNW1	Malignant melanoma
TMTC1::DNAI7	Astrocytoma, grade I-II
TMTC1::ERGIC2	Adenocarcinoma
TMTC1::PGD	Adenocarcinoma
TMTC1::SPPL3	Adenocarcinoma
TMTC1::YEATS4	Mesenchymal tumor, NOS
TMTC2::ABTB3	Mesenchymal tumor, NOS
TMTC2::GNA14	Mesenchymal tumor, NOS
TMTC2::HERC1	Mesenchymal tumor, NOS
TMTC2::LYZ	Mesenchymal tumor, NOS
TMTC2::METTL25	Adenocarcinoma
TMTC2::MYRFL	Mesenchymal tumor, NOS
TMTC2::NTRK3	Undifferentiated pleomorphic sarcoma
TMTC2::PPFIA2	Adenocarcinoma
TMTC2::PTPRR	Mesenchymal tumor, NOS
TMTC2::SOCS2	Malignant epithelial tumor, special type
TMTC3::ACSS3	Adenocarcinoma
TMTC3::CEP290	Mesenchymal tumor, NOS
TMTC3::CPNE4	Adenocarcinoma
TMTC3::EIF4B	Malignant melanoma
TMTC3::LIN7A	Adenocarcinoma
TMTC3::OSBPL8	Mesenchymal tumor, NOS
TMTC3::PRRC2C	Mesenchymal tumor, NOS
TMTC3::RILPL1	Mesenchymal tumor, NOS
TMTC3::RLIG1	Mesenchymal tumor, NOS
TMTC3::SLC35E3	Mesenchymal tumor, NOS
TMTC3::SLC6A15	Mesenchymal tumor, NOS
TMTC3::THAP2	Adenocarcinoma
TMTC3::TMEM19	Mesenchymal tumor, NOS
TMTC4::DOCK9	Mycosis fungoides/Sézary syndrome
TMTC4::FGF14	Adenocarcinoma
TMUB1::AGAP3	Squamous cell carcinoma
TMX1::RTRAF	Adenocarcinoma
TMX1::TRIM9	Malignant melanoma
TMX2::IFT46	Malignant epithelial tumor, special type
TMX2::MED19	Malignant epithelial tumor, special type
TMX2::TOP6BL	Adenocarcinoma
TMX3::METTL4	Squamous cell carcinoma
TMX4::PKIG	Adenocarcinoma
TNC::CDH3	Adenocarcinoma
TNC::COL17A1	Squamous cell carcinoma
TNC::GABBR2	Adenocarcinoma
TNC::NRG1	Adenocarcinoma
TNC::PDGFD	Dermatofibrosarcoma protuberans/Bednar tumor/giant cell fibroblastoma | Soft tissue tumor, special type
TNC::USP6	Aneurysmal bone cyst
TNFAIP1::AATF	Adenocarcinoma
TNFAIP2::ANKS1A	Transitional cell carcinoma
TNFAIP3::IL26	Mesenchymal tumor, NOS
TNFAIP6::ORC4	Mesenchymal tumor, NOS
TNFAIP8::CCNB1IP1	Adenocarcinoma
TNFAIP8::DMXL1	Transitional cell carcinoma
TNFAIP8L1::SPEF2	Adenocarcinoma
TNFRSF10A::BIN3	Adenocarcinoma
TNFRSF10A::DMTN	Transitional cell carcinoma
TNFRSF10B::LOXL2	Adenocarcinoma
TNFRSF10B::NRG1	Adenocarcinoma
TNFRSF10D::MAN1B1	Mature B-cell neoplasm, NOS
TNFRSF11A::RELCH	Adenocarcinoma
TNFRSF11B::COLEC10	Adenocarcinoma
TNFRSF13B::MPRIP	Mesenchymal tumor, NOS
TNFRSF13C::SREBF2	Adenocarcinoma
TNFRSF14::TXLNA	Adenocarcinoma
TNFRSF1A::CHD4	Malignant melanoma
TNFRSF1A::SCNN1A	Squamous cell carcinoma
TNFRSF1B::FBXO6	Malignant melanoma
TNFRSF6B::CD74	Adenocarcinoma
TNFRSF6B::IKZF3	Adenocarcinoma
TNFSF10::FNDC3B	Adenocarcinoma
TNFSF10::FXR1	Squamous cell carcinoma
TNFSF10::MGP	Adenocarcinoma
TNFSF10::NCEH1	Adenocarcinoma
TNFSF13B::MYLK	Squamous cell carcinoma
TNFSF13B::RAB20	Adenocarcinoma
TNFSF14::GRAMD1A	Squamous cell carcinoma
TNIK::DGCR8	Astrocytoma, grade I-II
TNIK::KCNMB2	Astrocytoma, grade I-II
TNIK::MTHFD1L	Adenocarcinoma
TNIK::SPATA16	Squamous cell carcinoma
TNIK::STXBP5L	Malignant melanoma
TNIP1::ANXA6	Adenocarcinoma
TNIP1::ARSI	Adenocarcinoma
TNIP1::CAMK2A	Adenocarcinoma
TNIP1::NIPAL4	Adenocarcinoma
TNIP1::PDGFRB	Egypt | Refractory anemia with excess blasts-1 | Myelodysplastic syndrome, NOS | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Bilineage or biphenotypic leukemia
TNIP1::RET	Carcinoma, NOS | Adenocarcinoma
TNIP1::RHPN1	Multiple myeloma
TNIP1::SGCD	Mesenchymal tumor, NOS
TNIP1::TCOF1	Adenocarcinoma
TNIP2::RET	Adenocarcinoma
TNK1::CHD3	Adenocarcinoma
TNK1::ZBTB7A	Acute megakaryoblastic leukemia (FAB type M7) | Skin | Acute myeloid leukemia, NOS
TNK2::MELTF	Germ cell tumor, NOS
TNK2::TRA2B	Adenocarcinoma
TNKS1BP1::PAX7	Adenocarcinoma
TNKS1BP1::PRSS1	Adenocarcinoma
TNKS1BP1::TYK2	Adenocarcinoma
TNKS2::FAM107B	Adenocarcinoma
TNKS2::HECTD2	Adenocarcinoma
TNKS::ASAH1	Adenocarcinoma
TNKS::FGF10	Adenocarcinoma
TNKS::KHDRBS3	Adenocarcinoma
TNKS::MSRA	Adenocarcinoma
TNKS::RHOT1	Adenocarcinoma
TNNI3::ZNF607	Transitional cell carcinoma
TNNT1::TNNI3	Diffuse large B-cell lymphoma
TNNT3::COL1A1	Squamous cell carcinoma
TNPO1::ENC1	Adenocarcinoma
TNPO1::GTF2H1	Adenocarcinoma
TNPO1::IKBKB	Adenocarcinoma
TNPO1::MEF2C	Adenocarcinoma
TNPO1::RUFY1	Adenocarcinoma
TNPO2::DAB1	Adenocarcinoma
TNPO2::DNASE2	Squamous cell carcinoma
TNPO2::ELK3	Malignant melanoma
TNPO2::GET3	Adenocarcinoma
TNPO2::HOOK2	Squamous cell carcinoma | Adenocarcinoma
TNPO2::NFIX	Malignant melanoma
TNPO2::PRDX2	Adenocarcinoma
TNPO2::RTBDN	Adenocarcinoma
TNPO3::AHCYL2	Adenocarcinoma
TNPO3::DYM	Adenocarcinoma
TNPO3::RCAN1	Adenocarcinoma
TNR::COP1	Astrocytoma, grade I-II
TNRC18::CYTH3	Adenocarcinoma
TNRC18::DGKB	Malignant melanoma
TNRC18::GRIN2B	Adenocarcinoma
TNRC18::HDAC9	Malignant melanoma
TNRC18::HOXA9	Acute myeloid leukemia, NOS | Skin
TNRC18::IKZF1	Acute myeloid leukemia, NOS | Skin
TNRC18::MKLN1	Astrocytoma, grade I-II
TNRC18::MYL4	Adenocarcinoma
TNRC18::NHERF1	Adenocarcinoma
TNRC18::RADIL	Adenocarcinoma
TNRC18::RARA	Acute promyelocytic leukemia (FAB type M3)
TNRC18::RNF216	Adenocarcinoma
TNRC18::RSPH10B	Adenocarcinoma
TNRC18::TGS1	Adenocarcinoma
TNRC18::TSGA13	Malignant melanoma
TNRC18::ZC3HAV1	Adenocarcinoma
TNRC6A::ANKS4B	Adenocarcinoma
TNRC6A::LCMT1	Adenocarcinoma
TNRC6A::LIX1L	Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
TNRC6A::METTL9	Squamous cell carcinoma
TNRC6A::PRKCB	Astrocytoma, grade III-IV/Glioblastoma
TNRC6B::ABL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TNRC6B::ATXN10	Malignant melanoma
TNRC6B::BASP1	Adenocarcinoma
TNRC6B::CBY1	Adenocarcinoma
TNRC6B::COL18A1	Adenocarcinoma
TNRC6B::EP300	Adenocarcinoma
TNRC6B::FAM83F	Transitional cell carcinoma
TNRC6B::LARGE1	Adenocarcinoma
TNRC6B::MRTFA	Adenocarcinoma
TNRC6B::PES1	Adenocarcinoma
TNRC6B::SEMA6D	Mesenchymal tumor, NOS
TNRC6B::SLC35F2	Astrocytoma, grade I-II
TNRC6B::STK11	Adenocarcinoma
TNRC6B::TAFA5	Adenocarcinoma
TNRC6B::TMEM184B	Astrocytoma, grade I-II
TNRC6B::TPST2	Transitional cell carcinoma
TNRC6B::ZC3H7B	Adenocarcinoma
TNRC6C::APPBP2	Adenocarcinoma
TNRC6C::PHACTR1	Squamous cell carcinoma
TNRC6C::PLCB4	Adenocarcinoma
TNRC6C::RPTOR	Malignant melanoma
TNRC6C::SCAPER	Adenocarcinoma
TNRC6C::TMC6	Adenocarcinoma
TNS1::ALK	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma
TNS1::FAP	Squamous cell carcinoma
TNS1::RNF25	Adenocarcinoma
TNS1::RPRM	Squamous cell carcinoma
TNS1::SNX1	Adenocarcinoma
TNS1::SPTBN1	Astrocytoma, grade I-II
TNS1::TMBIM1	Squamous cell carcinoma
TNS2::ACVR1B	Adenocarcinoma
TNS3::ALG13	Mesenchymal tumor, NOS
TNS3::ELMO1	Adenocarcinoma
TNS3::ESR1	Adenocarcinoma
TNS3::FGF10	Adenocarcinoma
TNS3::FOXI2	Adenocarcinoma
TNS3::HSPA1L	Adenocarcinoma
TNS3::HUS1	Mesenchymal tumor, NOS
TNS3::MAP3K3	Mesothelioma
TNS3::MET	Adenocarcinoma
TNS3::NUDCD3	Adenocarcinoma
TNS3::PKD1L1	Adenocarcinoma
TNS3::PSPH	Adenocarcinoma
TNS3::SPMIP7	Adenocarcinoma
TNS3::SUN3	Adenocarcinoma
TNS3::ZNRF2	Adenocarcinoma
TNS4::CCR7	Squamous cell carcinoma
TNS4::FBXL20	Adenocarcinoma
TNXB::DDR1	Mesothelioma
TOB1::SYNRG	Adenocarcinoma
TOB1::TTLL6	Adenocarcinoma
TOB1::UTRN	Adenocarcinoma
TOB2::ACO2	Adenocarcinoma
TOB2::MPPED1	Malignant melanoma
TOB2::MRPS18B	Adenocarcinoma
TOB2::MRTFA	Adenocarcinoma
TOGARAM1::FANCM	Adenocarcinoma
TOGARAM1::KCNK13	Transitional cell carcinoma
TOGARAM1::STYX	Transitional cell carcinoma
TOLLIP::AP2A2	Adenocarcinoma
TOLLIP::MUC5B	Adenocarcinoma
TOM1::ARFGEF2	Mesenchymal tumor, NOS
TOM1::GNA13	Adenocarcinoma
TOM1::HMGXB4	Adenocarcinoma
TOM1::PITPNB	Adenocarcinoma
TOM1L1::TMEM11	Adenocarcinoma
TOM1L2::ANK3	Adenocarcinoma
TOM1L2::ATPAF2	Squamous cell carcinoma
TOM1L2::BRAF	Myxoinflammatory fibroblastic sarcoma
TOM1L2::GALK1	Malignant epithelial tumor, special type
TOM1L2::NXN	Adenocarcinoma
TOM1L2::PECAM1	Adenocarcinoma
TOM1L2::PEMT	Adenocarcinoma
TOM1L2::SREBF1	Transitional cell carcinoma
TOM1L2::ULK2	Adenocarcinoma
TOMM20::DPT	Squamous cell carcinoma
TOMM20::EPHB2	Adenocarcinoma
TOMM34::ERC1	Adenocarcinoma
TOMM40::NECTIN2	Adenocarcinoma
TOMM40::PDZRN4	Transitional cell carcinoma
TOMM6::GCLC	Adenocarcinoma
TOMM70::IL17RD	Adenocarcinoma
TOMM70::KCTD8	Astrocytoma, grade I-II
TOMM7::KLK2	Adenocarcinoma
TOP1::ADGRL3	Adenocarcinoma
TOP1::CA10	Squamous cell carcinoma
TOP1::CDH4	Adenocarcinoma
TOP1::CHCT1	Adenocarcinoma
TOP1::CSE1L	Acute myeloid leukemia, NOS | Skin
TOP1::FAM193B	Adenocarcinoma
TOP1::LPIN3	Adenocarcinoma
TOP1::LYZ	Mesenchymal tumor, NOS
TOP1::PTPRT	Adenocarcinoma
TOP1::PZP	Adenocarcinoma
TOP1::SLC2A10	Squamous cell carcinoma
TOP2A::IKZF3	Adenocarcinoma
TOP2A::TLK2	Squamous cell carcinoma
TOP2B::AFF2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TOP2B::BRAF	Astrocytoma, pilocytic/juvenile
TOP2B::GADL1	Adenocarcinoma
TOP2B::NGLY1	Transitional cell carcinoma
TOP2B::UBA3	Undifferentiated round cell sarcoma
TOP3A::ANAPC16	Adenocarcinoma
TOP3A::EVI2A	Adenocarcinoma
TOP3A::HEATR6	Adenocarcinoma
TOP3A::MYO18A	Adenocarcinoma
TOP3A::TEKT1	Adenocarcinoma
TOP3A::ZCCHC8	Transitional cell carcinoma
TOP3B::GRAMD1B	Astrocytoma, grade I-II
TOP3B::MAPK1	Adenocarcinoma
TOP6BL::BBS1	Adenocarcinoma
TOP6BL::EFEMP2	Adenocarcinoma
TOP6BL::FADS1	Adenocarcinoma
TOP6BL::FAM161B	Adenocarcinoma
TOP6BL::FAM171A1	Adenocarcinoma
TOP6BL::KDM2A	Adenocarcinoma
TOP6BL::PPP6R3	Adenocarcinoma | Squamous cell carcinoma
TOP6BL::RBM14	Adenocarcinoma
TOP6BL::TSGA10IP	Squamous cell carcinoma
TOPBP1::NEK11	Adenocarcinoma
TOPBP1::SPDEF	Mesenchymal tumor, NOS
TOPORS::ADAMTSL1	Astrocytoma, grade I-II
TOR1A::ADD1	Astrocytoma, grade I-II
TOR1A::COG4	Adenocarcinoma
TOR1AIP1::EIF1	Malignant epithelial tumor, special type
TOR1AIP1::FAM20B	Astrocytoma, grade I-II
TOR1AIP2::ACBD6	Adenocarcinoma
TOR1AIP2::ETV6	Skin | Acute myeloid leukemia, NOS
TOR1AIP2::IFI16	Adenocarcinoma
TOR1B::ARHGAP27	Adenocarcinoma
TOR3A::LYPD8	Adenocarcinoma
TOR4A::UAP1L1	Malignant melanoma
TOX2::EIF5A	Adenocarcinoma
TOX3::CNTN5	Adenocarcinoma
TOX3::GNAO1	Adenocarcinoma
TOX3::HEYL	Adenocarcinoma
TOX3::ITFG1	Adenocarcinoma
TOX3::PHKB	Adenocarcinoma
TOX::CHD7	Adenocarcinoma
TOX::EYA1	Mature B-cell neoplasm, NOS
TOX::PAWR	Malignant epithelial tumor, special type
TOX::PGBD2	Adenocarcinoma
TOX::PPA2	Diffuse large B-cell lymphoma
TOX::RSPO2	Adenocarcinoma
TP53::ARID2	Osteosarcoma, NOS
TP53::BCL6B	Russia | Primitive neuroectodermal tumor/Medulloblastoma
TP53::CCNB1	Osteosarcoma, NOS
TP53::CD68	Adenocarcinoma
TP53::CDC16	Adenocarcinoma
TP53::CELSR1	Undifferentiated carcinoma
TP53::CHD3	Malignant melanoma
TP53::DHX33	Adenocarcinoma
TP53::ECSIT	Adenocarcinoma
TP53::FARP2	Adenocarcinoma
TP53::GID4	Astrocytoma, grade I-II
TP53::IGFL2	Adenocarcinoma
TP53::ITGB3	Osteosarcoma, NOS
TP53::KIAA0753	Adenocarcinoma
TP53::MYBBP1A	Adenocarcinoma
TP53::NKIRAS2	Adenocarcinoma
TP53::NTRK1	Melanocytic neoplasm, special type
TP53::SLC35G6	Adenocarcinoma
TP53::SLC6A4	Adenocarcinoma
TP53::SMYD4	Adenocarcinoma
TP53::ZNF565	Osteosarcoma, NOS
TP53BP1::ATP8B4	Mesenchymal tumor, NOS
TP53BP1::DAPK2	Astrocytoma, grade I-II
TP53BP1::DMXL2	Adenocarcinoma
TP53BP1::PDGFRB	Chronic myeloproliferative disorder, NOS
TP53BP1::STAU2	Adenocarcinoma
TP53BP2::GRHL2	Adenocarcinoma
TP53BP2::IGK	Multiple myeloma
TP53BP2::WDR26	Adenocarcinoma
TP53I13::CEP112	Adenocarcinoma
TP53I3::ALK	Adenocarcinoma
TP63::CYTH3	Squamous cell carcinoma
TP63::NTRK2	Squamous cell carcinoma
TP63::P3H2	Squamous cell carcinoma
TP63::TBL1XR1	Diffuse large B-cell lymphoma
TP63::TPRG1	Squamous cell carcinoma
TP73::CEP104	Astrocytoma, grade I-II
TPCN1::GNB1	Adenocarcinoma
TPCN2::MRPL21	Squamous cell carcinoma
TPCN2::MYO1D	Transitional cell carcinoma
TPCN2::RAB11FIP1	Adenocarcinoma
TPCN2::RARA	Adenocarcinoma
TPCN2::TMEM179B	Squamous cell carcinoma
TPCN2::YAP1	Leiomyoma
TPCN2::ZBTB1	Adenocarcinoma
TPD52::ANGPT1	Adenocarcinoma
TPD52::CCT5	Adenocarcinoma
TPD52::COPS5	Adenocarcinoma
TPD52::NECAB1	Adenocarcinoma
TPD52::PIERCE2	Adenocarcinoma
TPD52::RALYL	Squamous cell carcinoma
TPD52::STAU2	Adenocarcinoma
TPD52::ZNF704	Adenocarcinoma
TPD52L1::NKAIN2	Adenocarcinoma
TPD52L1::RNF217	Squamous cell carcinoma
TPD52L1::ROS1	Adenosquamous carcinoma
TPD52L1::SAMD3	Adenocarcinoma
TPD52L1::TRMT11	Adenocarcinoma
TPD52L2::PDZRN4	Adenocarcinoma
TPD52L2::ROS1	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma
TPGS1::PRKACA	Adenocarcinoma
TPGS2::DSG1	Adenocarcinoma
TPH1::ARL6IP5	Undifferentiated carcinoma, small cell
TPM1::ALK	Mesothelioma | Transitional cell carcinoma | Adenocarcinoma
TPM2::NDUFV1	Mesenchymal tumor, NOS
TPM3::ALK	Benign fibrous histiocytoma | Melanocytic neoplasm, special type | Vascular and perivascular tumor, special type | Anaplastic large cell lymphoma, systemic type | Inflammatory myofibroblastic tumor/myofibroblastic sarcoma | Adenocarcinoma
TPM3::ARHGEF11	Malignant melanoma
TPM3::CFAP141	Adenocarcinoma
TPM3::FAM193A	Adenocarcinoma
TPM3::GPR37L1	Adenocarcinoma
TPM3::JAK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TPM3::NTRK1	Undifferentiated round cell sarcoma | Schwannoma | Mesenchymal tumor, special type | Rhabdomyosarcoma, NOS | Malignant peripheral nerve sheath tumor/Triton | Carcinoma, NOS | Astrocytoma, grade III-IV/Glioblastoma | Fibrosarcoma | Melanocytic neoplasm, special type | Fibroblastic/myofibroblastic tumor, special type | Glioma, NOS | Miscellaneous hematopoietic/lymphoid neoplasm, special type | Mesoblastic nephroma | Soft tissue tumor, special type | Malignant soft tissue tumor, NOS | Transitional cell carcinoma | Adenocarcinoma | Squamous cell carcinoma | Soft tissue tumor, NOS | Astrocytoma, grade I-II
TPM3::PDGFRB	Chronic eosinophilic leukemia/hypereosinophilic syndrome
TPM3::ROS1	Glioma, NOS | Melanocytic neoplasm, special type | Adenocarcinoma
TPM3::TPR	Adenocarcinoma
TPM4::ACTB	Multiple myeloma
TPM4::ADRM1	Multiple myeloma
TPM4::ALK	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma | Anaplastic large cell lymphoma, systemic type
TPM4::ARID5A	Multiple myeloma
TPM4::BRD4	Multiple myeloma
TPM4::CCND1	Multiple myeloma
TPM4::CCNG2	Multiple myeloma
TPM4::CFL1	Multiple myeloma
TPM4::CIC	Multiple myeloma
TPM4::CSNK1G2	Multiple myeloma
TPM4::DUSP5	Multiple myeloma
TPM4::ELL	Multiple myeloma
TPM4::IGFL2	Mesenchymal tumor, NOS
TPM4::IGH	Multiple myeloma
TPM4::INTS2	Adenocarcinoma
TPM4::ISYNA1	Multiple myeloma
TPM4::KLF16	Multiple myeloma
TPM4::KLHL24	Multiple myeloma
TPM4::LMO4	Multiple myeloma
TPM4::LPAR2	Multiple myeloma
TPM4::LRRC25	Adenocarcinoma
TPM4::METRNL	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TPM4::NTRK2	Astrocytoma, grade I-II
TPM4::NTRK3	Soft tissue tumor, special type
TPM4::OAZ1	Multiple myeloma
TPM4::PDCD6	Multiple myeloma
TPM4::PNRC1	Multiple myeloma
TPM4::RBM38	Multiple myeloma
TPM4::RNF126	Multiple myeloma
TPM4::RNF166	Multiple myeloma
TPM4::RPL18A	Adenocarcinoma
TPM4::SOCS2	Multiple myeloma
TPM4::TCF3	Multiple myeloma
TPM4::TSC22D3	Multiple myeloma
TPM4::UBC	Multiple myeloma
TPM4::USP6	Aneurysmal bone cyst | Nodular fasciitis
TPM4::WNT11	Multiple myeloma
TPM4::ZBTB7A	Multiple myeloma
TPM4::ZNF580	Multiple myeloma
TPM4::ZNF787	Multiple myeloma
TPMT::BTBD9	Adenocarcinoma
TPO::COL9A3	Adenocarcinoma
TPPP::BRD9	Adenocarcinoma
TPPP::RETREG1	Adenocarcinoma
TPR::ALK	Adenocarcinoma
TPR::BRAF	Astrocytoma, NOS
TPR::FGFR1	Chronic myeloproliferative disorder, NOS
TPR::JAK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TPR::NTRK1	Adenocarcinoma | Fibrosarcoma | Soft tissue tumor, NOS | Mesenchymal tumor, special type | Dendritic cell neoplasm | Malignant soft tissue tumor, NOS | Soft tissue tumor, special type | Inflammatory myofibroblastic tumor/myofibroblastic sarcoma | Osteosarcoma, NOS | Neuroglial neoplasm, special type | Fibroblastic/myofibroblastic tumor, special type | Mesoblastic nephroma
TPR::PDGFRB	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TPR::RET	Adenocarcinoma | Carcinoma, NOS
TPR::ROS1	Astrocytoma, grade I-II | Fibroblastic/myofibroblastic tumor, special type
TPRA1::LPP	Adenocarcinoma
TPRG1::DGKG	Adenocarcinoma
TPRG1::SOX2	Squamous cell carcinoma
TPRN::CTDNEP1	Malignant epithelial tumor, special type
TPRN::TMEM87A	Adenocarcinoma
TPST2::CRYBB1	Adenocarcinoma
TPT1::ARFGEF2	Adenocarcinoma
TPT1::DDX27	Adenocarcinoma
TPT1::EIF2AK2	Adenocarcinoma
TPT1::ERBB3	Malignant epithelial tumor, special type
TPT1::IGK	Multiple myeloma
TPT1::LUC7L3	Adenocarcinoma
TPT1::MFN1	Adenocarcinoma
TPT1::MME	Adenocarcinoma
TPT1::MYH9	Adenocarcinoma
TPT1::NCALD	Adenocarcinoma
TPT1::PEX1	Mesenchymal tumor, NOS
TPT1::PLEKHB2	Adenocarcinoma
TPT1::SIAE	Adenocarcinoma
TPX2::ACLY	Adenocarcinoma
TPX2::COX4I2	Squamous cell carcinoma
TPX2::DEFB118	Malignant epithelial tumor, special type | Squamous cell carcinoma
TPX2::DEFB123	Malignant epithelial tumor, special type | Germ cell tumor, NOS | Adenocarcinoma
TPX2::DUSP15	Squamous cell carcinoma
TPX2::EYS	Squamous cell carcinoma
TPX2::HM13	Undifferentiated carcinoma, small cell | Adenocarcinoma | Transitional cell carcinoma
TPX2::ID1	Adenocarcinoma | Squamous cell carcinoma
TPX2::MECOM	Adenocarcinoma
TPX2::RALY	Squamous cell carcinoma
TPX2::REM1	Adenocarcinoma | Transitional cell carcinoma
TPX2::RIF1	Adenocarcinoma
TPX2::UNC5D	Squamous cell carcinoma
TRA2A::AQP1	Squamous cell carcinoma
TRA2A::EPDR1	Adenocarcinoma
TRA2A::HECW1	Adenocarcinoma
TRA2A::POU6F2	Adenocarcinoma
TRA2A::THADA	Adenocarcinoma
TRA2A::TYW1	Adenocarcinoma
TRA2B::DNAH5	Squamous cell carcinoma
TRA2B::FBXO21	Malignant epithelial tumor, special type
TRA2B::HRH4	Squamous cell carcinoma
TRA2B::P3H2	Malignant epithelial tumor, special type
TRA::CDKN2A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRA::CEP85L	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRA::IRF4	Peripheral T-cell lymphoma, unspecified
TRA::LMO2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRA::MDM4	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRA::MTCP1	Nonneoplastic hematologic disorder/lesion | T-prolymphocytic leukemia
TRA::MYC	T-prolymphocytic leukemia | Diffuse large B-cell lymphoma | Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRA::NECTIN2	Peripheral T-cell lymphoma, unspecified | Angioimmunoblastic T-cell lymphoma
TRA::NKX2-1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRA::NOTCH1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRA::OLIG2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRA::RHOH	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRA::SALL2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRA::TCL1A	Nonneoplastic hematologic disorder/lesion
TRA::TLX1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRA::TRB	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRABD2A::CHMP3	Squamous cell carcinoma
TRABD2B::BEND5	Adenocarcinoma
TRABD2B::OLFM3	Adenocarcinoma
TRABD2B::PKN2	Adenocarcinoma
TRABD2B::PSMD13	Malignant epithelial tumor, special type
TRABD::DDR2	Squamous cell carcinoma
TRADD::GFOD2	Adenocarcinoma
TRADD::SLC12A1	Adenocarcinoma
TRADD::SMOX	Squamous cell carcinoma
TRAF1::ALK	Anaplastic large cell lymphoma, cutaneous type | Anaplastic large cell lymphoma, systemic type
TRAF2::CACNA1B	Transitional cell carcinoma
TRAF2::CCDC183	Adenocarcinoma | Transitional cell carcinoma
TRAF2::MAMDC4	Adenocarcinoma
TRAF2::NTRK2	Malignant melanoma
TRAF2::RABL6	Adenocarcinoma
TRAF3::BMP3	Squamous cell carcinoma
TRAF3::CDC42BPB	Squamous cell carcinoma
TRAF3::CEP128	Multiple myeloma
TRAF3::ERN1	Adenocarcinoma
TRAF3::EXOC3L4	Multiple myeloma
TRAF3::IFNL1	Adenocarcinoma
TRAF3::ITPK1	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
TRAF3::KLC1	Adenocarcinoma
TRAF3::MARK3	Adenocarcinoma
TRAF3::MYO16	Adenocarcinoma
TRAF3::RCOR1	Adenocarcinoma
TRAF3::SFXN1	Squamous cell carcinoma
TRAF3::SIVA1	Adenocarcinoma
TRAF3::WDR20	Adenocarcinoma | Malignant epithelial tumor, special type
TRAF3::ZNF839	Adenocarcinoma
TRAF3IP1::GALNTL5	Adenocarcinoma
TRAF3IP1::ITSN2	Squamous cell carcinoma
TRAF3IP2::CD109	Mature B-cell neoplasm, NOS
TRAF3IP2::ELAPOR1	Adenocarcinoma
TRAF3IP2::FYN	Adenocarcinoma | Mature B-cell neoplasm, NOS
TRAF3IP2::REV3L	Squamous cell carcinoma
TRAF4::FASN	Astrocytoma, grade I-II
TRAF4::WSB1	Adenocarcinoma
TRAF7::LRRC1	Squamous cell carcinoma
TRAF7::MAPK8IP3	Transitional cell carcinoma
TRAF7::RAB26	Adenocarcinoma
TRAF7::WDR24	Skin | Acute myeloid leukemia, NOS
TRAIP::MST1	Adenocarcinoma
TRAIP::WASF2	Adenocarcinoma
TRAK1::CADM1	Astrocytoma, grade I-II
TRAK1::FRMD4B	Adenocarcinoma
TRAK1::PPIL2	Transitional cell carcinoma
TRAK1::RAF1	Malignant melanoma | Astrocytoma, grade I-II
TRAK1::TEX264	Mature B-cell neoplasm, NOS
TRAK1::TIMP4	Leiomyoma
TRAK2::CREB1	Acute erythroleukemia (FAB type M6)
TRAK2::KCTD18	Squamous cell carcinoma
TRAM1::CLVS1	Adenocarcinoma
TRAM1::ZFPM2	Adenocarcinoma
TRAM2::HCRTR2	Adenocarcinoma
TRAP1::ADCY9	Adenocarcinoma
TRAP1::CREBBP	Malignant epithelial tumor, special type | Squamous cell carcinoma
TRAPPC10::AGPAT3	Adenocarcinoma
TRAPPC10::BRWD1	Adenocarcinoma
TRAPPC10::GRID1	Adenocarcinoma
TRAPPC10::GRIK1	Adenocarcinoma
TRAPPC10::MTCL2	Adenocarcinoma
TRAPPC10::PKNOX1	Adenocarcinoma
TRAPPC10::RRP1	Adenocarcinoma
TRAPPC10::RTL4	Adenocarcinoma
TRAPPC10::UBASH3A	Adenocarcinoma
TRAPPC11::ING2	Squamous cell carcinoma
TRAPPC11::KCNN4	Adenocarcinoma
TRAPPC11::RBM46	Adenocarcinoma
TRAPPC11::WWC2	Adenocarcinoma
TRAPPC2::ATP2B3	Astrocytoma, grade I-II
TRAPPC2::GPM6B	Adenocarcinoma
TRAPPC2::RBM39	Adenocarcinoma
TRAPPC2B::ZNF550	Adenocarcinoma
TRAPPC3::MAP7D1	Adenocarcinoma
TRAPPC6B::MIA2	Adenocarcinoma
TRAPPC8::ANK3	Adenocarcinoma
TRAPPC8::DOK6	Adenocarcinoma
TRAPPC8::GAREM1	Adenocarcinoma
TRAPPC8::GREB1L	Adenocarcinoma
TRAPPC8::RNF125	Squamous cell carcinoma
TRAPPC8::SS18	Adenocarcinoma
TRAPPC9::AGO2	Transitional cell carcinoma
TRAPPC9::ASAP1	Adenocarcinoma
TRAPPC9::C2CD5	Adenocarcinoma
TRAPPC9::COL22A1	Adenocarcinoma
TRAPPC9::GFUS	Adenocarcinoma
TRAPPC9::JPH1	Adenocarcinoma
TRAPPC9::KCNK9	Adenocarcinoma
TRAPPC9::LIMA1	Adenocarcinoma
TRAPPC9::PLAT	Transitional cell carcinoma
TRAPPC9::PLEKHA2	Malignant melanoma
TRAPPC9::PSKH2	Adenocarcinoma
TRAPPC9::PTK2	Squamous cell carcinoma
TRAPPC9::SLC30A8	Squamous cell carcinoma
TRAPPC9::SLC45A4	Adenocarcinoma
TRAPPC9::SSBP3	Adenocarcinoma
TRAPPC9::TSNARE1	Adenocarcinoma
TRB::AHI1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRB::CCND2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRB::HOXA10	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRB::HOXA11	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRB::HOXA9	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRB::IL2RB	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRB::IRS4	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRB::LCK	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRB::LEF1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRB::LMO1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRB::LMO2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRB::LYL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRB::MECOM	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
TRB::MTCP1	T-prolymphocytic leukemia
TRB::MYB	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRB::MYC	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRB::NOTCH1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRB::PIM1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRB::TAL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRB::TAL2	Nonneoplastic hematologic disorder/lesion | Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRB::TLX1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRB::TRG	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRD::GNAQ	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRD::LMO1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRD::LMO2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRD::MYC	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRD::NKX2-1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRD::NKX2-5	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRD::RANBP17	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRD::TAL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRD::TLX1	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Mature T- and NK-cell neoplasm, NOS
TRD::TLX3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRERF1::ADGRF1	Mesenchymal tumor, NOS
TRERF1::AIF1	Adenocarcinoma
TRERF1::GNMT	Adenocarcinoma
TRERF1::MRPL14	Adenocarcinoma
TRERF1::OR2H1	Adenocarcinoma
TRERF1::PEX6	Adenocarcinoma
TRERF1::SUPT3H	Mesenchymal tumor, NOS
TRERF1::TMEM132C	Adenocarcinoma
TRERF1::VARS2	Adenocarcinoma
TRG::IGH	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRG::NTRK1	Adenocarcinoma
TRG::TCL1A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TRG::TRB	Nonneoplastic hematologic disorder/lesion
TRHDE::ANKS1B	Mesenchymal tumor, NOS
TRHDE::C12orf75	Mesenchymal tumor, NOS
TRHDE::DPY19L2	Mesenchymal tumor, NOS
TRHDE::LGR5	Adenocarcinoma
TRHDE::NUP107	Malignant melanoma
TRHDE::SFSWAP	Mesenchymal tumor, NOS
TRHDE::TBC1D15	Mesenchymal tumor, NOS
TRIB1::NSMCE2	Adenocarcinoma
TRIB1::SAE1	Transitional cell carcinoma
TRIB1::SLC25A32	Adenocarcinoma
TRIB3::DEFB125	Adenocarcinoma
TRIB3::DEFB129	Adenocarcinoma
TRIB3::SLC24A3	Adenocarcinoma
TRIM11::SLC2A5	Adenocarcinoma
TRIM13::PLAG1	Leiomyosarcoma
TRIM14::CORO2A	Adenocarcinoma
TRIM14::GAB2	Adenocarcinoma
TRIM16::TOP3A	Malignant epithelial tumor, special type
TRIM22::BRAF	Neuroglial neoplasm, special type
TRIM24::BRAF	Malignant melanoma | Astrocytoma, grade III-IV/Glioblastoma | Astrocytoma, grade I-II | Adenocarcinoma
TRIM24::ELAPOR2	Adenocarcinoma
TRIM24::FGFR1	Acute myelomonocytic leukemia (FAB type M4)
TRIM24::KLRG2	Multiple myeloma
TRIM24::MET	Astrocytoma, grade III-IV/Glioblastoma | Astrocytoma, grade I-II
TRIM24::NTRK2	Adenocarcinoma
TRIM24::RET	Carcinoma, NOS | Adenocarcinoma
TRIM24::SVOPL	Adenocarcinoma
TRIM24::ULK4	Adenocarcinoma
TRIM25::DLX3	Adenocarcinoma
TRIM25::MSI2	Adenocarcinoma
TRIM25::TBX4	Adenocarcinoma
TRIM25::TRIM37	Squamous cell carcinoma
TRIM26::DHX16	Adenocarcinoma
TRIM26::TJAP1	Malignant melanoma
TRIM27::PTPRR	Mesenchymal tumor, NOS
TRIM27::RET	Carcinoma, NOS | Adenocarcinoma
TRIM28::CHMP2A	Transitional cell carcinoma
TRIM28::ZBTB45	Transitional cell carcinoma | Squamous cell carcinoma
TRIM29::CBL	Adenocarcinoma
TRIM29::PAK1	Adenocarcinoma
TRIM29::TRIM65	Adenocarcinoma
TRIM2::ARFIP1	Adenocarcinoma | Malignant melanoma
TRIM2::CHD4	Adenocarcinoma
TRIM2::GALNTL6	Adenocarcinoma
TRIM2::GARIN1B	Adenocarcinoma
TRIM2::LRBA	Malignant melanoma
TRIM2::WDR37	Astrocytoma, grade I-II
TRIM31::ZFP57	Adenocarcinoma
TRIM32::MELK	Adenocarcinoma
TRIM33::ABCA4	Adenocarcinoma
TRIM33::ASB17	Malignant melanoma
TRIM33::BCAR3	Adenocarcinoma
TRIM33::COL24A1	Adenocarcinoma
TRIM33::CSDE1	Adenocarcinoma | Malignant melanoma
TRIM33::CSMD2	Squamous cell carcinoma
TRIM33::NTRK1	Adenocarcinoma
TRIM33::RAF1	Adenocarcinoma
TRIM33::RET	Carcinoma, NOS | Adenocarcinoma
TRIM33::SHC1	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
TRIM35::CCDC25	Adenocarcinoma
TRIM35::CCNB1IP1	Transitional cell carcinoma
TRIM35::GSR	Adenocarcinoma
TRIM35::PEBP4	Adenocarcinoma
TRIM36::HEXB	Adenocarcinoma
TRIM36::MCTP1	Adenocarcinoma
TRIM37::C17ORF67	Adenocarcinoma
TRIM37::C17orf67	Adenocarcinoma
TRIM37::DNAH17	Adenocarcinoma
TRIM37::MED13	Squamous cell carcinoma
TRIM37::MSI2	Adenocarcinoma
TRIM37::MYO19	Adenocarcinoma
TRIM37::PCTP	Adenocarcinoma
TRIM37::RNFT1	Adenocarcinoma
TRIM37::SKA2	Adenocarcinoma
TRIM37::TUBD1	Adenocarcinoma
TRIM37::VMP1	Adenocarcinoma
TRIM37::ZNF385D	Transitional cell carcinoma
TRIM41::ASB9	Adenocarcinoma
TRIM44::CCDC86	Adenocarcinoma
TRIM44::CD44	Adenocarcinoma | Malignant melanoma
TRIM44::SLC5A12	Adenocarcinoma
TRIM48::ADAMTS16	Malignant melanoma
TRIM4::BRAF	Adenocarcinoma
TRIM4::MET	Adenocarcinoma
TRIM4::TAF6	Adenocarcinoma
TRIM4::ZCWPW1	Adenocarcinoma
TRIM52::RACK1	Squamous cell carcinoma
TRIM59::IFT80	Adenocarcinoma
TRIM63::NTRK1	Malignant melanoma
TRIM65::GALK1	Astrocytoma, grade III-IV/Glioblastoma
TRIM65::SRP68	Squamous cell carcinoma
TRIM67::RET	Carcinoma, NOS
TRIM68::ARID1B	Adenocarcinoma
TRIM71::CNOT10	Germ cell tumor, NOS
TRIM73::POR	Squamous cell carcinoma
TRIM7::BICDL1	Adenocarcinoma
TRIO::ADAMTS12	Malignant melanoma
TRIO::ATAD1	Adenocarcinoma
TRIO::CDH18	Mesenchymal tumor, NOS
TRIO::CLIC5	Malignant melanoma
TRIO::CLNK	Malignant melanoma
TRIO::DAP	Mesenchymal tumor, NOS
TRIO::DNAH5	Adenocarcinoma
TRIO::FAM53B	Adenocarcinoma
TRIO::FBXL7	Squamous cell carcinoma | Undifferentiated pleomorphic sarcoma
TRIO::IFT52	Adenocarcinoma
TRIO::IQUB	Adenocarcinoma
TRIO::KDSR	Adenocarcinoma
TRIO::LIFR	Malignant melanoma
TRIO::LRFN5	Adenocarcinoma
TRIO::MARCHF11	Adenocarcinoma
TRIO::PPP2R5E	Squamous cell carcinoma
TRIO::SLC9A3	Malignant melanoma
TRIO::TERT	Myxofibrosarcoma | Liposarcoma, dedifferentiated | Undifferentiated pleomorphic sarcoma | Undifferentiated sarcoma | Liposarcoma, NOS | Pleomorphic rhabdomyosarcoma
TRIO::UHRF2	Adenocarcinoma
TRIO::ZNF131	Adenocarcinoma
TRIO::ZNF558	Myxofibrosarcoma
TRIOBP::CDC42EP1	Adenocarcinoma
TRIOBP::PES1	Malignant epithelial tumor, special type
TRIOBP::RAB6A	Malignant melanoma
TRIOBP::UNC13C	Adenocarcinoma
TRIP11::BRAF	Soft tissue tumor, special type
TRIP11::CYP46A1	Adenocarcinoma
TRIP11::FLT3	Egypt | Bilineage or biphenotypic leukemia | Peripheral T-cell lymphoma, unspecified
TRIP11::NUBPL	Adenocarcinoma
TRIP11::PDGFRB	Acute myeloblastic leukemia with maturation (FAB type M2) | Acute myeloid leukemia, NOS | Skin
TRIP12::AGFG1	Adenocarcinoma
TRIP12::BARD1	Adenocarcinoma
TRIP12::COL6A3	Adenocarcinoma
TRIP12::CPS1	Astrocytoma, grade III-IV/Glioblastoma
TRIP12::ITM2C	Mesenchymal tumor, NOS
TRIP12::KIF1A	Squamous cell carcinoma
TRIP12::MAFF	Malignant melanoma
TRIP12::NPM1	Acute myeloblastic leukemia with maturation (FAB type M2)
TRIP12::PID1	Adenocarcinoma | Squamous cell carcinoma
TRIP12::SLC16A14	Squamous cell carcinoma | Adenocarcinoma | Mature B-cell neoplasm, NOS | Malignant epithelial tumor, special type
TRIP12::SLC4A10	Adenocarcinoma
TRIP12::SP110	Adenocarcinoma
TRIP13::ANKRD33B	Adenocarcinoma
TRIP13::GPATCH2	Mesenchymal tumor, NOS
TRIQK::CXADR	Astrocytoma, grade III-IV/Glioblastoma
TRIQK::RAD54B	Adenocarcinoma
TRIQK::RUNX1	Acute myeloid leukemia, NOS | Skin
TRIR::GET3	Adenocarcinoma
TRIT1::ABCA10	Adenocarcinoma
TRIT1::ADH1B	Adenocarcinoma
TRIT1::ADH1C	Adenocarcinoma
TRIT1::CHI3L2	Adenocarcinoma
TRIT1::EP400	Undifferentiated carcinoma, small cell
TRIT1::MFSD2A	Adenocarcinoma
TRMT10B::AR	Adenocarcinoma
TRMT10C::CAMK4	Adenocarcinoma
TRMT11::CILK1	Adenocarcinoma
TRMT11::GRIK2	Carcinoma, NOS | Adenocarcinoma | Astrocytoma, grade III-IV/Glioblastoma
TRMT11::HINT3	Adenocarcinoma
TRMT11::NCOA7	Adenocarcinoma
TRMT11::RNF217	Adenocarcinoma
TRMT11::SLC16A10	Adenocarcinoma
TRMT11::TPD52L1	Adenocarcinoma
TRMT1::CPA4	Adenocarcinoma
TRMT1::GCDH	Adenocarcinoma
TRMT2B::ARL13A	Adenocarcinoma
TRMT61A::AMN	Transitional cell carcinoma
TRMT61A::NDUFA12	Mesenchymal tumor, NOS
TRMT9B::GATA4	Squamous cell carcinoma
TRMT9B::LEKR1	Adenocarcinoma
TRMU::ATXN10	Adenocarcinoma
TRMU::EMC1	Adenocarcinoma
TRMU::FBLN1	Transitional cell carcinoma
TRMU::GTSE1	Adenocarcinoma
TRMU::PPARA	Adenocarcinoma
TRMU::ST13	Malignant melanoma
TRMU::TMEM184B	Adenocarcinoma
TRMU::TTC38	Adenocarcinoma
TRNAU1AP::PHACTR4	Adenocarcinoma
TRNAU1AP::PTPRU	Adenocarcinoma
TRNAU1AP::RCC1	Adenocarcinoma
TRO::NTRK1	Adenocarcinoma
TRPC1::PTPRG	Adenocarcinoma
TRPC4AP::ADNP	Adenocarcinoma
TRPC4AP::ASIP	Transitional cell carcinoma
TRPC4AP::DYNLRB1	Adenocarcinoma
TRPC4AP::KCNB1	Astrocytoma, grade I-II
TRPC4AP::MRPL45	Adenocarcinoma
TRPC4AP::MTCL2	Squamous cell carcinoma
TRPC4AP::PLCG1	Adenocarcinoma
TRPC4AP::PPFIA1	Adenocarcinoma
TRPC4AP::RALY	Adenocarcinoma
TRPC4AP::RBM39	Adenocarcinoma
TRPC4AP::TMEM245	Adenocarcinoma
TRPC4AP::TOX2	Adenocarcinoma
TRPC4AP::ZNF430	Transitional cell carcinoma
TRPC6::NUDCD1	Chronic lymphocytic leukemia
TRPM1::PUM1::LCK	Melanocytic neoplasm, special type
TRPM3::KHDRBS2	Astrocytoma, grade III-IV/Glioblastoma
TRPM4::ELOF1	Adenocarcinoma
TRPM4::PPFIA3	Adenocarcinoma
TRPM7::EHD4	Transitional cell carcinoma
TRPM7::FAM227B	Adenocarcinoma
TRPM7::SPMIP8	Mesenchymal tumor, NOS
TRPM7::SRP14	Transitional cell carcinoma
TRPM7::TMEM104	Adenocarcinoma
TRPM7::TNFAIP8L3	Adenocarcinoma
TRPM8::RABEP1	Adenocarcinoma
TRPM8::RAP1GAP	Adenocarcinoma
TRPM8::SLC4A4	Adenocarcinoma
TRPM8::UGT1A6	Adenocarcinoma
TRPS1::CHRAC1	Adenocarcinoma
TRPS1::DEPTOR	Astrocytoma, grade I-II
TRPS1::LRATD2	Adenocarcinoma
TRPS1::LRP12	Adenocarcinoma
TRPS1::PAFAH1B1	Adenocarcinoma
TRPS1::PDE4DIP	Adenocarcinoma
TRPS1::PLAG1	Adenoma | Myoepithelioma/myoepithelial carcinoma/mixed tumor | Leiomyosarcoma | Benign epithelial tumor, special type
TRPS1::RAD21	Adenocarcinoma
TRPS1::SHFL	Adenocarcinoma
TRPS1::SPAG1	Adenocarcinoma
TRPS1::TBC1D9B	Adenocarcinoma
TRPS1::ZNRF2	Adenocarcinoma
TRPV3::UBE2G1	Adenocarcinoma
TRPV4::GIT2	Squamous cell carcinoma
TRPV4::KSR2	Mesenchymal tumor, NOS
TRPV6::KEL	Adenocarcinoma
TRRAP::ANKIB1	Adenocarcinoma
TRRAP::PRKAR2B	Adenocarcinoma
TRRAP::TMEM168	Adenocarcinoma
TRUB1::FHIP2A	Adenocarcinoma
TRUB2::KCNT1	Transitional cell carcinoma
TSC1::CEL	Adenocarcinoma
TSC1::DERL1	Adenocarcinoma
TSC1::DOLPP1	Squamous cell carcinoma
TSC1::PDGFRB	Thymus | Myelodysplastic/myeloproliferative disease, NOS | Chronic eosinophilic leukemia/hypereosinophilic syndrome
TSC1::RAPGEF1	Adenocarcinoma
TSC1::SARDH	Adenocarcinoma
TSC22D1::CCDC122	Adenocarcinoma
TSC22D1::DNAJC5B	Adenocarcinoma
TSC22D1::EIF2AK2	Adenocarcinoma
TSC22D1::LETM1	Squamous cell carcinoma
TSC22D1::NDUFS7	Adenocarcinoma
TSC22D1::NUFIP1	Adenocarcinoma
TSC22D1::PLEKHA5	Adenocarcinoma
TSC22D1::TPT1	Transitional cell carcinoma
TSC22D2::ADCY5	Squamous cell carcinoma
TSC22D2::FGF12	Transitional cell carcinoma
TSC22D2::SDCCAG8	Adenocarcinoma
TSC22D2::SELENOT	Adenocarcinoma
TSC22D3::AP3M1	Adenocarcinoma
TSC22D4::BCL2L15	Adenocarcinoma
TSC22D4::SPACDR	Astrocytoma, grade III-IV/Glioblastoma
TSC2::ATP6V0C	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TSC2::MAPK8IP3	Squamous cell carcinoma
TSC2::NPW	Adenocarcinoma
TSC2::TBL3	Adenocarcinoma
TSC2::TMEM204	Adenocarcinoma
TSEN15::ACBD6	Adenocarcinoma
TSEN2::ATG7	Mesenchymal tumor, NOS
TSEN2::PPARG	Transitional cell carcinoma
TSEN2::SYN2	Transitional cell carcinoma
TSEN54::NOTUM	Mesenchymal tumor, NOS
TSEN54::TMEM94	Adenocarcinoma
TSFM::CCDC59	Astrocytoma, grade III-IV/Glioblastoma
TSFM::CNOT2	Astrocytoma, grade III-IV/Glioblastoma
TSFM::CYP27B1	Astrocytoma, grade I-II
TSFM::DCTN2	Astrocytoma, grade I-II
TSFM::EEF1AKMT3	Astrocytoma, grade III-IV/Glioblastoma
TSFM::FRS2	Mesenchymal tumor, NOS
TSFM::GLI1	Astrocytoma, grade III-IV/Glioblastoma
TSFM::HMGA2	Malignant melanoma
TSFM::IFNG	Astrocytoma, grade III-IV/Glioblastoma
TSFM::INHBE	Astrocytoma, grade III-IV/Glioblastoma
TSFM::KIF5A	Astrocytoma, grade III-IV/Glioblastoma
TSFM::LRRIQ1	Mesenchymal tumor, NOS
TSFM::LYZ	Astrocytoma, grade III-IV/Glioblastoma
TSFM::MARCHF9	Adenocarcinoma
TSFM::NUP107	Astrocytoma, grade III-IV/Glioblastoma
TSFM::OS9	Squamous cell carcinoma | Astrocytoma, grade III-IV/Glioblastoma
TSFM::TJAP1	Astrocytoma, grade III-IV/Glioblastoma
TSGA10::LYG2	Adenocarcinoma
TSGA10::ZRANB3	Adenocarcinoma
TSHR::GTF2A1	Adenocarcinoma
TSHZ1::RNASEH2B	Mesenchymal tumor, NOS
TSHZ2::PIGU	Adenocarcinoma
TSHZ2::TOX2	Malignant epithelial tumor, special type
TSHZ3::CDH2	Adenocarcinoma
TSHZ3::CEACAM7	Astrocytoma, grade I-II
TSHZ3::IFNL1	Squamous cell carcinoma | Acute myeloid leukemia, NOS | Skin
TSKU::SFRP4	Adenocarcinoma
TSKU::SMTN	Adenocarcinoma
TSNARE1::COL22A1	Adenocarcinoma
TSNARE1::CYRIB	Adenocarcinoma
TSNARE1::GDF6	Transitional cell carcinoma
TSNARE1::LY6D	Adenocarcinoma
TSNARE1::LYNX1	Adenocarcinoma
TSNAX::DISC1	Adenocarcinoma
TSPAN10::PCYT2	Adenocarcinoma
TSPAN10::SQSTM1	Malignant melanoma
TSPAN13::BZW2	Transitional cell carcinoma
TSPAN14::ADARB2	Adenocarcinoma
TSPAN14::DYDC2	Adenocarcinoma
TSPAN14::HLA-E	Adenocarcinoma
TSPAN14::IFIT1	Adenocarcinoma
TSPAN14::PRXL2A	Adenocarcinoma
TSPAN14::SFTPD	Adenocarcinoma
TSPAN14::VDAC2	Adenocarcinoma
TSPAN15::HK1	Transitional cell carcinoma | Adenocarcinoma
TSPAN15::SAMD8	Adenocarcinoma
TSPAN15::VPS26A	Adenocarcinoma
TSPAN17::SFXN1	Adenocarcinoma
TSPAN18::PIK3R2	Adenocarcinoma
TSPAN18::TEX13B	Mesenchymal tumor, NOS
TSPAN1::CEP152	Adenocarcinoma
TSPAN1::EIF2AK2	Adenocarcinoma
TSPAN1::PHRF1	Adenocarcinoma
TSPAN1::TFF3	Adenocarcinoma
TSPAN1::USP20	Adenocarcinoma
TSPAN2::RESF1	Meningioma
TSPAN31::AVIL	Astrocytoma, grade III-IV/Glioblastoma
TSPAN31::LANCL2	Astrocytoma, grade I-II
TSPAN31::OS9	Astrocytoma, grade III-IV/Glioblastoma | Adenocarcinoma
TSPAN31::WIF1	Mesenchymal tumor, NOS
TSPAN3::CFB	Adenocarcinoma
TSPAN3::CHRNA3	Adenocarcinoma
TSPAN3::NRG4	Adenocarcinoma
TSPAN3::PLAT	Astrocytoma, grade I-II
TSPAN4::CD151	Ependymoma
TSPAN4::EPS8L2	Adenocarcinoma
TSPAN4::TALDO1	Adenocarcinoma
TSPAN4::VPREB3	Adenocarcinoma
TSPAN5::EMCN	Astrocytoma, grade I-II
TSPAN5::PKD2	Adenocarcinoma
TSPAN8::ASH2L	Mesenchymal tumor, NOS
TSPAN8::HSP90B1	Adenocarcinoma
TSPAN8::IL26	Mesenchymal tumor, NOS
TSPAN8::MGST1	Adenocarcinoma
TSPAN8::OSBPL8	Mesenchymal tumor, NOS
TSPAN8::UTRN	Adenocarcinoma
TSPAN9::CACNA1C	Adenocarcinoma
TSPAN9::DNM1L	Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
TSPAN9::FGD4	Malignant epithelial tumor, special type
TSPAN9::FOXJ2	Germ cell tumor, NOS
TSPAN9::GUCY2C	Germ cell tumor, NOS
TSPAN9::KLRG1	Malignant melanoma
TSPAN9::KRT7	Astrocytoma, grade I-II
TSPAN9::KRT86	Astrocytoma, grade I-II
TSPAN9::PRH1	Adenocarcinoma
TSPAN9::PRR4	Adenocarcinoma
TSPAN9::SLC2A13	Malignant melanoma
TSPAN9::TMEM200A	Mesenchymal tumor, NOS
TSPAN9::TTC38	Squamous cell carcinoma
TSPO::CDH18	Malignant melanoma
TSPO::LZTR1	Malignant melanoma
TSPO::PRR5	Transitional cell carcinoma
TSPOAP1::SNF8	Adenocarcinoma
TSSC4::LSP1	Adenocarcinoma
TSSK3::HDAC1	Adenocarcinoma
TSSK3::LAD1	Adenocarcinoma
TSTD1::ARHGAP30	Adenocarcinoma
TSTD1::F11R	Nonneoplastic epithelial disorder/lesion
TSTD1::LSM14A	Adenocarcinoma
TSTD3::TSHZ2	Adenocarcinoma
TTBK2::AFG2B	Adenocarcinoma
TTBK2::EMC7	Adenocarcinoma
TTBK2::TGM7	Adenocarcinoma
TTBK2::UBR1	Squamous cell carcinoma
TTBK2::WRAP53	Acute myeloblastic leukemia with maturation (FAB type M2)
TTBK2::ZNF106	Adenocarcinoma
TTC12::LUC7L2	Squamous cell carcinoma
TTC13::JAK2	Adenocarcinoma
TTC17::API5	Adenocarcinoma
TTC17::CNTN5	Adenocarcinoma
TTC17::TMPRSS4	Adenocarcinoma
TTC17::TTC28	Adenocarcinoma
TTC19::ATPAF2	Adenocarcinoma
TTC19::MMP28	Adenocarcinoma
TTC19::TMEM45A	Adenocarcinoma
TTC19::TOM1L2	Adenocarcinoma
TTC21B::COBLL1	Adenocarcinoma
TTC21B::SCN3A	Adenocarcinoma
TTC21B::SLC38A11	Adenocarcinoma
TTC23::TCF12	Adenocarcinoma
TTC23L::CACNA2D3	Transitional cell carcinoma
TTC27::ARHGEF33	Adenocarcinoma
TTC27::BIRC6	Adenocarcinoma | Chronic lymphocytic leukemia | Squamous cell carcinoma
TTC27::DHX57	Adenocarcinoma
TTC27::MORN2	Adenocarcinoma
TTC27::SPAST	Squamous cell carcinoma
TTC28::ARHGAP15	Transitional cell carcinoma
TTC28::ASCC2	Adenocarcinoma
TTC28::CD99L2	Adenocarcinoma
TTC28::EIF4ENIF1	Adenocarcinoma
TTC28::EP300	Squamous cell carcinoma
TTC28::EWSR1	Mesenchymal tumor, NOS
TTC28::HS6ST2	Adenocarcinoma
TTC28::KIAA1671	Adenocarcinoma
TTC28::NEFH	Mesenchymal tumor, NOS
TTC28::ODF1	Adenocarcinoma
TTC28::PDGFB	Osteosarcoma, NOS
TTC28::PITPNB	Adenocarcinoma
TTC28::ROS1	Adenocarcinoma
TTC28::TAFA5	Astrocytoma, grade I-II
TTC28::UBE2L3	Adenocarcinoma
TTC31::INO80B	Adenocarcinoma
TTC32::HDLBP	Adenocarcinoma
TTC32::WDR35	Adenocarcinoma
TTC33::ADAM19	Adenocarcinoma
TTC33::GRM5	Adenocarcinoma
TTC38::NACA4P	Squamous cell carcinoma
TTC39A::CDC42	Adenocarcinoma
TTC39A::CRISP1	Adenocarcinoma
TTC39A::FGGY	Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
TTC39A::MRPL37	Adenocarcinoma
TTC39A::PHGDH	Adenocarcinoma
TTC39B::LURAP1L	Squamous cell carcinoma
TTC39B::SPTSSA	Adenocarcinoma
TTC39C::CABLES1	Adenocarcinoma
TTC39C::LAMA3	Adenocarcinoma
TTC39C::MEP1B	Mycosis fungoides/Sézary syndrome
TTC39C::NPC1	Adenocarcinoma
TTC39C::SLC49A4	Squamous cell carcinoma
TTC3::BRWD1	Astrocytoma, grade I-II
TTC3::CBFB	Acute myelomonocytic leukemia (FAB type M4)
TTC3::CBS	Adenocarcinoma
TTC3::IL10RB	Adenocarcinoma
TTC3::ITM2B	Malignant melanoma
TTC3::KCNJ6	Astrocytoma, grade I-II
TTC3::ZNF83	Acute myelomonocytic leukemia (FAB type M4)
TTC4::SSBP3	Mesenchymal tumor, NOS
TTC6::ACTN4	Adenocarcinoma
TTC6::ADAMTS5	Adenocarcinoma
TTC6::ERCC6L2	Adenocarcinoma
TTC6::FAM131C	Adenocarcinoma
TTC6::FAM177A1	Adenocarcinoma
TTC6::HOXA1	Adenocarcinoma
TTC6::MIPOL1	Adenocarcinoma
TTC6::PAX9	Adenocarcinoma
TTC6::POLR3A	Adenocarcinoma
TTC6::PRORP	Adenocarcinoma
TTC6::SKAP2	Adenocarcinoma
TTC7A::ALK	Adenocarcinoma
TTC7B::CCDC88C	Squamous cell carcinoma
TTC7B::HTRA3	Malignant epithelial tumor, special type
TTC7B::PPP2R5C	Squamous cell carcinoma
TTC7B::RPS6KA5	Transitional cell carcinoma
TTC7B::RUNX1	Squamous cell carcinoma
TTC7B::SLC35F4	Mesenchymal tumor, NOS
TTC7B::SYNE2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
TTC9C::BSCL2	Transitional cell carcinoma
TTC9C::OSBPL2	Acute erythroleukemia (FAB type M6)
TTC9C::RHBDL3	Acute myeloid leukemia, NOS | Skin
TTF2::CD101	Mature B-cell neoplasm, NOS
TTI1::CFAP20DC	Adenocarcinoma
TTI1::EFCAB8	Adenocarcinoma
TTK::BCKDHB	Squamous cell carcinoma
TTK::TMEM63B	Mesenchymal tumor, NOS
TTLL10::CTAG2	Squamous cell carcinoma
TTLL11::NDUFA8	Squamous cell carcinoma
TTLL11::SNX30	Adenocarcinoma
TTLL11::VWCE	Adenocarcinoma
TTLL12::RAB17	Carcinoma, NOS
TTLL12::SCUBE1	Adenocarcinoma
TTLL12::USP39	Adenocarcinoma
TTLL1::KIF1B	Malignant melanoma
TTLL1::MCAT	Adenocarcinoma
TTLL1::TSPO	Undifferentiated carcinoma, small cell
TTLL3::MTMR14	Adenocarcinoma
TTLL4::CNOT9	Adenocarcinoma
TTLL4::MREG	Squamous cell carcinoma
TTLL5::BATF	Adenocarcinoma
TTLL5::EIF2B2	Adenocarcinoma
TTLL5::JDP2	Adenocarcinoma
TTLL5::RGS6	Squamous cell carcinoma
TTLL5::TCP11L2	Mesenchymal tumor, NOS
TTLL5::TMED10	Squamous cell carcinoma
TTLL5::TSHR	Adenocarcinoma
TTLL5::TTC6	Astrocytoma, grade III-IV/Glioblastoma
TTLL5::VRTN	Adenocarcinoma
TTLL6::NOS2	Adenocarcinoma
TTLL6::WRAP53	Adenocarcinoma
TTLL7::GNG5	Squamous cell carcinoma
TTLL7::MCOLN2	Adenocarcinoma
TTLL7::SAMD13	Adenocarcinoma
TTLL7::TERT	Adenocarcinoma
TTLL9::HM13	Adenocarcinoma
TTPA::SNX11	Adenocarcinoma
TTR::ARFGEF2	Adenocarcinoma
TTR::HRG	Adenocarcinoma
TTR::TYK2	Adenocarcinoma
TTYH2::APOO	Adenocarcinoma
TTYH3::ASPSCR1	Malignant melanoma
TTYH3::C7orf50	Malignant melanoma
TTYH3::DDX27	Malignant melanoma
TTYH3::EIF3B	Germ cell tumor, NOS
TTYH3::MAD1L1	Acute myeloid leukemia, NOS | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Skin
TTYH3::MAFK	Multiple myeloma
TTYH3::NOC4L	Malignant melanoma
TTYH3::SMAP1	Adenocarcinoma
TUBA1A::PTPN13	Adenocarcinoma
TUBA1C::IGFBP4	Adenocarcinoma
TUBA1C::PCGF2	Adenocarcinoma
TUBA1C::TMEM116	Mesenchymal tumor, NOS
TUBB2A::SLC22A23	Adenocarcinoma
TUBB2B::PAQR5	Adenocarcinoma
TUBB3::RSPRY1	Mesothelioma
TUBB3::TRPM5	Adenocarcinoma
TUBB4B::NELFB	Adenocarcinoma
TUBB6::OSBPL1A	Adenocarcinoma
TUBB6::ROBO1	Adenocarcinoma
TUBB::MDC1	Squamous cell carcinoma
TUBD1::CDK12	Adenocarcinoma
TUBD1::HEATR6	Adenocarcinoma
TUBD1::INPP5D	Squamous cell carcinoma
TUBD1::MYO18A	Adenocarcinoma
TUBD1::PTRH2	Squamous cell carcinoma | Adenocarcinoma
TUBD1::RPS6KB1	Adenocarcinoma
TUBD1::TOM1L1	Adenocarcinoma
TUBD1::USP32	Adenocarcinoma
TUBD1::VMP1	Adenocarcinoma
TUBG1::URGCP	Malignant melanoma
TUBGCP2::SORBS1	Mesenchymal tumor, NOS
TUBGCP2::UBE4A	Adenocarcinoma
TUBGCP3::ATP11A	Adenocarcinoma
TUBGCP3::FARP1	Adenocarcinoma
TUBGCP3::PDS5B	Adenocarcinoma
TUBGCP3::TFDP1	Squamous cell carcinoma
TUBGCP4::TMEM62	Adenocarcinoma | Transitional cell carcinoma
TUBGCP5::KCNU1	Adenocarcinoma
TUBGCP5::TUT4	Mesenchymal tumor, NOS
TUBGCP6::PLXNB2	Adenocarcinoma
TUFT1::ANXA9	Transitional cell carcinoma
TUFT1::CGN	Squamous cell carcinoma
TUFT1::KMT2E	Adenocarcinoma
TUFT1::PKN2	Mesenchymal tumor, NOS
TUFT1::PRKCA	Adenocarcinoma
TUFT1::SCNM1	Adenocarcinoma
TUFT1::ZBTB18	Adenocarcinoma
TULP3::C12orf57	Astrocytoma, grade I-II
TULP3::CCSER2	Mesenchymal tumor, NOS
TULP3::GGNBP2	Squamous cell carcinoma
TULP3::ITFG2	Adenocarcinoma
TULP3::PRMT8	Malignant melanoma
TULP3::UGCG	Mesenchymal tumor, NOS
TULP4::AHCYL1	Adenocarcinoma
TULP4::ESR1	Squamous cell carcinoma
TULP4::FNDC1	Squamous cell carcinoma
TULP4::RPS12	Adenocarcinoma
TULP4::SPSB4	Squamous cell carcinoma
TULP4::SYNJ2	Adenocarcinoma
TULP4::SYTL3	Adenocarcinoma
TULP4::WDR27	Adenocarcinoma
TULP4::ZDHHC14	Transitional cell carcinoma
TUSC2::RASSF1	Adenocarcinoma
TUSC3::ASAH1	Adenocarcinoma
TUSC3::HOOK3	Malignant epithelial tumor, special type
TUSC3::KCTD1	Adenocarcinoma
TUSC3::LOXL2	Adenocarcinoma
TUSC3::SORBS3	Adenocarcinoma
TUSC3::YEATS4	Diffuse large B-cell lymphoma
TUT1::BSCL2	Adenocarcinoma
TUT4::ELAVL4	Adenocarcinoma
TUT4::LRP8	Adenocarcinoma
TUT4::NFIA	Mesenchymal tumor, NOS
TUT7::ASPN	Mesenchymal tumor, NOS
TUT7::SHC3	Adenocarcinoma
TUT7::WIF1	Mesenchymal tumor, NOS
TWF2::ALAS1	Malignant epithelial tumor, special type
TWF2::FSTL4	Transitional cell carcinoma
TWF2::WDR82	Adenocarcinoma | Squamous cell carcinoma
TWSG1::MYL12A	Adenocarcinoma
TWSG1::PIK3C3	Undifferentiated carcinoma, small cell
TXLNB::CDC14A	Adenocarcinoma
TXLNB::PDLIM1	Mesenchymal tumor, NOS
TXLNG::SYAP1	Adenocarcinoma
TXN2::CABP2	Adenocarcinoma
TXN2::CTNNA1	Astrocytoma, grade I-II
TXN2::MYH9	Squamous cell carcinoma
TXN::GNB1	Adenocarcinoma
TXN::NDST3	Astrocytoma, grade III-IV/Glioblastoma
TXNDC11::ACSF3	Multiple myeloma
TXNDC11::BAMBI	Adenocarcinoma
TXNDC11::CIB4	Adenocarcinoma
TXNDC11::GSPT1	Adenocarcinoma
TXNDC11::RORA	Adenocarcinoma
TXNDC11::RUVBL1	Undifferentiated carcinoma, small cell
TXNDC11::TNFRSF17	Multiple myeloma
TXNDC11::ZC3H7A	Adenocarcinoma
TXNDC15::ARPC2	Astrocytoma, grade III-IV/Glioblastoma
TXNDC15::B2M	Multiple myeloma
TXNDC15::LEAP2	Adenocarcinoma
TXNDC15::TENM2	Squamous cell carcinoma
TXNDC16::ARG2	Adenocarcinoma
TXNDC16::GPR137C	Adenocarcinoma
TXNDC17::YBX2	Malignant melanoma
TXNDC5::RREB1	Adenocarcinoma
TXNIP::IGK	Multiple myeloma
TXNIP::NOTCH2NLA	Undifferentiated carcinoma, small cell
TXNL1::GRP	Adenocarcinoma
TXNL1::LRP1B	Transitional cell carcinoma
TXNRD1::ADGRD1	Adenocarcinoma
TXNRD1::GLT8D2	Squamous cell carcinoma
TXNRD1::GNAS	Squamous cell carcinoma
TXNRD1::HCFC2	Squamous cell carcinoma
TXNRD1::LAMTOR3	Squamous cell carcinoma
TXNRD1::SDS	Adenocarcinoma
TXNRD1::SLC41A2	Mesenchymal tumor, NOS
TXNRD1::USP30	Adenocarcinoma
TXNRD2::EVX1	Mesenchymal tumor, NOS
TXNRD2::HMOX1	Astrocytoma, grade III-IV/Glioblastoma
TXNRD2::RTN4R	Adenocarcinoma
TXNRD3::PODXL2	Undifferentiated carcinoma, small cell
TYK2::CDC37	Adenocarcinoma
TYK2::DOCK6	Adenocarcinoma
TYK2::KEAP1	Adenocarcinoma
TYK2::SHC2	Adenocarcinoma
TYK2::SYMPK	Malignant epithelial tumor, special type
TYK2::TMEM205	Adenocarcinoma
TYMP::ATP8B4	Squamous cell carcinoma
TYMP::PPP6R2	Adenocarcinoma
TYMP::SYCE3	Adenocarcinoma
TYMS::GNAS	Transitional cell carcinoma
TYMS::YES1	Squamous cell carcinoma
TYR::MMP20	Malignant melanoma
TYRO3::RTF1	Adenocarcinoma
TYW1::DMTF1	Adenocarcinoma
TYW1::GALNT17	Adenocarcinoma
TYW1::HGSNAT	Adenocarcinoma
TYW1::SIRPB2	Squamous cell carcinoma
TYW1::TMEM248	Adenocarcinoma
TYW1::TPST1	Adenocarcinoma
TYW1::TRA2A	Adenocarcinoma
TYW1::TSFM	Adenocarcinoma
TYW1B::BAZ1B	Adenocarcinoma
TYW1B::STX5	Adenocarcinoma
TYW1B::VWC2	Adenocarcinoma
U2AF2::KIR3DL2	Adenocarcinoma
U2AF2::NLRP9	Squamous cell carcinoma
U2AF2::RERE	Adenocarcinoma
U2AF2::TFE3	Soft tissue tumor, NOS | Adenocarcinoma
U2SURP::PARP9	Adenocarcinoma
UACA::ANKRD13D	Adenocarcinoma
UACA::LTK	Adenocarcinoma
UACA::PHF20	Malignant melanoma
UACA::PTPN6	Adenocarcinoma
UAP1::BCL9	Adenocarcinoma
UAP1::LIX1L	Adenocarcinoma
UAP1::LMX1A	Adenocarcinoma
UAP1::MDM2	Adenocarcinoma
UAP1::NOS1AP	Squamous cell carcinoma
UAP1::PTRH2	Adenocarcinoma
UAP1::TSHZ2	Adenocarcinoma
UBA1::ELK3	Squamous cell carcinoma
UBA1::KRBOX4	Adenocarcinoma
UBA2::CAPN12	Adenocarcinoma
UBA2::FUCA2	Adenocarcinoma
UBA2::GPI	Squamous cell carcinoma | Adenocarcinoma
UBA2::MIER2	Adenocarcinoma
UBA2::PDCD2L	Adenocarcinoma
UBA2::PEPD	Adenocarcinoma
UBA2::PPP1R36	Acute lymphoblastic leukemia/lymphoblastic lymphoma
UBA2::RAD51B	Adenocarcinoma
UBA2::WTIP	Skin | Acute monoblastic leukemia (FAB type M5) | Acute myeloid leukemia, NOS | Nonneoplastic epithelial disorder/lesion | Adenocarcinoma | Acute myelomonocytic leukemia (FAB type M4) | Acute myeloblastic leukemia with maturation (FAB type M2) | Nonneoplastic hematologic disorder/lesion
UBA2::ZNF146	Adenocarcinoma
UBA2::ZNF536	Adenocarcinoma
UBA3::FRMD4B	Adenocarcinoma
UBA3::LMOD3	Adenocarcinoma
UBA3::RBM6	Adenocarcinoma
UBA52::CACNA1C	Adenocarcinoma
UBA52::KXD1	Adenocarcinoma
UBA6::CCNA2	Adenocarcinoma
UBA6::PARM1	Mature B-cell neoplasm, NOS
UBA6::STAP1	Adenocarcinoma
UBA6::TMPRSS11D	Adenocarcinoma | Squamous cell carcinoma
UBAC1::QSOX2	Adenocarcinoma
UBAC1::SHANK2	Malignant melanoma
UBAC2::ASNS	Adenocarcinoma
UBAC2::CLYBL	Adenocarcinoma | Squamous cell carcinoma
UBAC2::DIP2A	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
UBAC2::SARM1	Malignant melanoma
UBAC2::SPTB	Adenocarcinoma
UBALD2::CEP295NL	Squamous cell carcinoma
UBALD2::FMN1	Malignant melanoma
UBALD2::IGH	Multiple myeloma
UBALD2::IGK	Multiple myeloma
UBALD2::TIMP2	Squamous cell carcinoma
UBALD2::ZNF710	Adenocarcinoma
UBAP1::ADAMTSL1	Astrocytoma, grade I-II
UBAP1::DCAF12	Acute lymphoblastic leukemia/lymphoblastic lymphoma
UBAP1::NFX1	Adenocarcinoma
UBAP1::PURG	Squamous cell carcinoma
UBAP1::UBAP2	Adenocarcinoma
UBAP1::UBE2R2	Adenocarcinoma
UBAP1::UNC13B	Squamous cell carcinoma
UBAP2::APTX	Adenocarcinoma
UBAP2::CDIN1	Adenocarcinoma
UBAP2::DCAF12	Adenocarcinoma | Mature B-cell neoplasm, NOS
UBAP2::FAM171A1	Adenocarcinoma
UBAP2::KIF24	Adenocarcinoma
UBAP2::LINGO2	Transitional cell carcinoma
UBAP2::NCF4	Astrocytoma, grade III-IV/Glioblastoma
UBAP2::SLC26A7	Squamous cell carcinoma
UBAP2::TEAD1	Adenocarcinoma
UBAP2::USP34	Adenocarcinoma
UBAP2L::AQP10	Mesothelioma
UBAP2L::EEFSEC	Squamous cell carcinoma
UBAP2L::TDRKH	Adenocarcinoma
UBASH3A::SFTA2	Malignant epithelial tumor, special type
UBASH3B::GRIK4	Malignant melanoma
UBASH3B::TRA2A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
UBB::STARD9	Mesenchymal tumor, NOS
UBC::DDX5	Multiple myeloma
UBC::IGH	Multiple myeloma
UBC::KLF2	Multiple myeloma
UBE2C::CDH26	Adenocarcinoma
UBE2C::DNTTIP1	Adenocarcinoma
UBE2D1::MFSD11	Mesenchymal tumor, NOS
UBE2D1::RET	Carcinoma, NOS
UBE2D2::AOPEP	Squamous cell carcinoma
UBE2D2::ARHGAP26	Squamous cell carcinoma
UBE2D2::CTNNA1	Adenocarcinoma
UBE2D2::MATR3	Adenocarcinoma
UBE2D2::NEBL	Adenocarcinoma
UBE2D2::OR7A5	Adenocarcinoma
UBE2D2::PAIP1	Adenocarcinoma
UBE2D2::PAIP2	Adenocarcinoma
UBE2D2::SND1	Adenocarcinoma
UBE2D2::SPINK5	Adenocarcinoma
UBE2D3::CA10	Adenocarcinoma
UBE2D3::GSTCD	Adenocarcinoma
UBE2D3::PRKD1	Adenocarcinoma
UBE2D3::SLC9B1	Squamous cell carcinoma
UBE2E1::ASCC3	Adenocarcinoma
UBE2E1::INTS10	Adenocarcinoma
UBE2E1::RAB14	Malignant melanoma
UBE2E1::ZNF385D	Astrocytoma, grade I-II
UBE2E2::SEMA3A	Astrocytoma, grade I-II
UBE2E2::TOGARAM1	Squamous cell carcinoma
UBE2E2::ZNF385D	Adenocarcinoma
UBE2E3::CDC42EP3	Adenocarcinoma
UBE2E3::TECPR2	Malignant melanoma
UBE2E3::WDR70	Adenocarcinoma
UBE2F::ALS2	Undifferentiated round cell sarcoma
UBE2F::LRRFIP1	Adenocarcinoma
UBE2F::RAMP1	Adenocarcinoma
UBE2G1::CXCL16	Adenocarcinoma
UBE2G1::PELP1	Transitional cell carcinoma | Adenocarcinoma
UBE2G1::PPIL2	Malignant epithelial tumor, special type
UBE2G1::SLC25A11	Adenocarcinoma
UBE2G1::SPNS2	Multiple myeloma
UBE2G1::SPNS3	Adenocarcinoma
UBE2G1::TULP2	Transitional cell carcinoma
UBE2G1::USP6	Soft tissue tumor, special type
UBE2G2::ABCG1	Adenocarcinoma
UBE2G2::GART	Adenocarcinoma
UBE2G2::RUNX1	Adenocarcinoma
UBE2G2::SON	Malignant melanoma
UBE2H::LMX1A	Mesenchymal tumor, NOS
UBE2H::ZC3HC1	Malignant epithelial tumor, special type | Malignant melanoma
UBE2I::CACNA1H	Adenocarcinoma
UBE2I::PDGFRB	Soft tissue tumor, special type
UBE2J1::CFAP206	Adenocarcinoma
UBE2J1::RRAGD	Adenocarcinoma
UBE2J2::ACAP3	Adenocarcinoma
UBE2J2::CFAP74	Adenocarcinoma
UBE2J2::GNB1	Adenocarcinoma
UBE2J2::INTS11	Adenocarcinoma
UBE2J2::MXRA8	Adenocarcinoma
UBE2J2::PKD1	Astrocytoma, pilocytic/juvenile
UBE2K::ENOPH1	Adenocarcinoma
UBE2K::FAM216B	Adenocarcinoma
UBE2K::G3BP2	Adenocarcinoma
UBE2K::KLB	Adenocarcinoma
UBE2K::LIAS	Squamous cell carcinoma | Adenocarcinoma
UBE2K::SLC9B2	Adenocarcinoma
UBE2K::UCHL1	Adenocarcinoma
UBE2K::WDR19	Adenocarcinoma
UBE2L3::APOL1	Malignant epithelial tumor, special type
UBE2L3::BID	Squamous cell carcinoma
UBE2L3::LLGL2	Adenocarcinoma
UBE2L3::YPEL1	Transitional cell carcinoma
UBE2N::APPL2	Adenocarcinoma
UBE2O::MXRA7	Squamous cell carcinoma
UBE2O::PRPSAP1	Adenocarcinoma | Squamous cell carcinoma
UBE2O::RHBDF2	Adenocarcinoma
UBE2O::RNF213	Adenocarcinoma
UBE2O::SRSF2	Adenocarcinoma
UBE2O::SSH2	Squamous cell carcinoma
UBE2Q1::HPS1	Adenocarcinoma
UBE2Q1::MAEL	Adenocarcinoma
UBE2Q1::MYO7A	Malignant melanoma
UBE2Q2::ABHD17C	Adenocarcinoma
UBE2Q2::CIMAP1C	Adenocarcinoma
UBE2Q2::FBXO22	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
UBE2Q2::METTL6	Adenocarcinoma
UBE2Q2::NRG4	Adenocarcinoma
UBE2Q2::TMEM266	Germ cell tumor, NOS
UBE2R2::ACO1	Adenocarcinoma
UBE2R2::FOCAD	Mesenchymal tumor, NOS
UBE2R2::ITLN1	Adenocarcinoma
UBE2R2::NFX1	Squamous cell carcinoma
UBE2R2::PRSS3	Squamous cell carcinoma
UBE2R2::TMEM8B	Adenocarcinoma
UBE2V1::PAAF1	Malignant melanoma
UBE2V1::SULF2	Adenocarcinoma
UBE2V2::MCM4	Squamous cell carcinoma
UBE2V2::NRIP1	Squamous cell carcinoma
UBE2Z::FKBP5	Adenocarcinoma
UBE2Z::MRPL45	Adenocarcinoma
UBE2Z::NPEPPS	Adenocarcinoma
UBE2Z::TRIM37	Adenocarcinoma
UBE2Z::UTP18	Adenocarcinoma
UBE2Z::ZNF652	Adenocarcinoma
UBE3A::CYP19A1	Adenocarcinoma
UBE3A::DTWD1	Squamous cell carcinoma
UBE3A::MYO5C	Astrocytoma, grade I-II
UBE3B::GNS	Adenocarcinoma
UBE3C::C1D	Squamous cell carcinoma
UBE3C::DNAJB6	Adenocarcinoma
UBE3C::DYNC2I1	Adenocarcinoma
UBE3C::FAF1	Transitional cell carcinoma
UBE3C::GBX1	Adenocarcinoma
UBE3C::KCNT2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
UBE3C::PTPRN2	Squamous cell carcinoma
UBE3D::SERPINB1	Adenocarcinoma
UBE4A::INSC	Adenocarcinoma
UBE4A::KMT2A	Undifferentiated sarcoma
UBE4B::CENPS	Transitional cell carcinoma
UBE4B::CORT	Transitional cell carcinoma
UBE4B::EIF2S2	Adenocarcinoma
UBE4B::KIF1B	Squamous cell carcinoma
UBE4B::MED18	Astrocytoma, grade III-IV/Glioblastoma
UBE4B::NMNAT1	Adenocarcinoma
UBE4B::PDPN	Squamous cell carcinoma
UBE4B::PEX14	Squamous cell carcinoma
UBE4B::PIK3CD	Adenocarcinoma
UBE4B::PLEKHG5	Squamous cell carcinoma
UBE4B::RBP7	Adenocarcinoma
UBE4B::SLC25A33	Adenocarcinoma
UBE4B::TBCB	Undifferentiated carcinoma, small cell
UBE4B::ZNF536	Transitional cell carcinoma
UBFD1::LDAF1	Astrocytoma, grade I-II
UBL3::CDK8	Transitional cell carcinoma
UBL3::CKAP2	Transitional cell carcinoma
UBL3::CRISPLD2	Adenocarcinoma
UBL3::MTIF3	Adenocarcinoma
UBL3::PAN3	Adenocarcinoma
UBL3::SUCLA2	Malignant melanoma
UBL3::ZNF211	Adenocarcinoma
UBL7::MAPK9	Adenocarcinoma
UBLCP1::CSNK1A1	Adenocarcinoma
UBN1::BLNK	Malignant melanoma
UBN1::LAMA5	Adenocarcinoma
UBN1::MGRN1	Adenocarcinoma
UBN1::SRRM2	Adenocarcinoma
UBN2::BRAF	Adenocarcinoma
UBN2::TPM1	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
UBOX5::LZTS3	Adenocarcinoma
UBP1::CMTM6	Astrocytoma, grade III-IV/Glioblastoma
UBP1::EIF3K	Adenocarcinoma
UBP1::MAP4	Astrocytoma, grade I-II
UBP1::SLC24A3	Mesenchymal tumor, NOS
UBQLN1::GKAP1	Adenocarcinoma
UBQLN1::KLC2	Adenocarcinoma
UBQLN1::NAV3	Mesenchymal tumor, NOS
UBQLN1::SLC28A3	Adenocarcinoma
UBQLN2::MAP2K4	Adenocarcinoma
UBQLN4::MEF2D	Squamous cell carcinoma
UBR1::STARD9	Astrocytoma, grade I-II
UBR1::SUPV3L1	Adenocarcinoma
UBR1::TGM5	Squamous cell carcinoma | Adenocarcinoma
UBR1::TTBK2	Astrocytoma, grade I-II
UBR2::ANHX	Adenocarcinoma
UBR2::BYSL	Mesenchymal tumor, NOS
UBR2::CDKAL1	Mesenchymal tumor, NOS
UBR2::KANK2	Adenocarcinoma
UBR2::MED20	Mesothelioma
UBR2::NDUFS2	Adenocarcinoma
UBR2::PXT1	Adenocarcinoma
UBR2::SRPK1	Adenocarcinoma
UBR2::XPO5	Adenocarcinoma
UBR3::CDK14	Meningioma
UBR3::SSB	Adenocarcinoma
UBR4::ALB	Adenocarcinoma
UBR4::ATP13A2	Adenocarcinoma
UBR4::C1QC	Mesenchymal tumor, NOS
UBR4::GLB1	Adenocarcinoma
UBR4::HSPG2	Adenocarcinoma
UBR4::KDM4B	Adenocarcinoma
UBR4::PAX7	Astrocytoma, grade I-II
UBR4::ZFP37	Acute myeloblastic leukemia with maturation (FAB type M2)
UBR5::CADM2	Adenocarcinoma
UBR5::CYBRD1	Adenocarcinoma
UBR5::DRD4	Adenocarcinoma
UBR5::ODF1	Transitional cell carcinoma
UBR5::PGR	Leiomyosarcoma
UBR5::RIMS4	Malignant melanoma
UBR5::SLC25A32	Adenocarcinoma
UBR5::SSTR5	Adenocarcinoma
UBR5::TRAF3	Squamous cell carcinoma
UBR5::ZNF423	Adenocarcinoma
UBR7::BTBD7	Adenocarcinoma
UBTD2::BOD1	Astrocytoma, grade I-II
UBTD2::C5ORF58	Malignant melanoma
UBTD2::C5orf58	Malignant melanoma
UBTD2::FBXW11	Adenocarcinoma
UBTD2::SH3PXD2B	Transitional cell carcinoma | Adenocarcinoma
UBTD2::STK10	Adenocarcinoma
UBTF::ATXN7L3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
UBTF::CA10	Adenocarcinoma
UBTF::CACNB1	Adenocarcinoma
UBTF::ETV4	Adenocarcinoma
UBTF::FOXP1	Mesenchymal tumor, NOS
UBTF::MAML3	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
UBTF::PYY	Adenocarcinoma
UBXN1::BSCL2	Adenocarcinoma
UBXN1::TOP6BL	Adenocarcinoma
UBXN1::WDR74	Malignant epithelial tumor, special type
UBXN2A::NIPSNAP2	Astrocytoma, grade III-IV/Glioblastoma
UBXN2A::TPO	Astrocytoma, grade I-II
UBXN2B::PHF3	Mesenchymal tumor, NOS
UBXN4::MSH2	Skin | Acute myeloid leukemia, NOS
UBXN4::R3HDM1	Adenocarcinoma
UBXN6::ABHD6	Adenocarcinoma
UBXN6::GRM4	Adenocarcinoma
UBXN6::STOX2	Adenocarcinoma
UBXN7::RPL39L	Astrocytoma, grade III-IV/Glioblastoma
UBXN8::NRG1	Adenocarcinoma
UCHL3::KLF5	Adenocarcinoma
UCHL5::FIRRM	Mesenchymal tumor, NOS
UCHL5::TARS2	Malignant melanoma
UCK2::CD37	Adenocarcinoma
UCK2::DARS2	Transitional cell carcinoma
UCK2::DHX9	Adenocarcinoma
UCK2::FAM78B	Adenocarcinoma
UCK2::MRPL9	Transitional cell carcinoma
UCK2::PBX1	Adenocarcinoma
UCK2::SNX27	Adenocarcinoma
UCK2::TBX19	Mesenchymal tumor, NOS
UCK2::TDRKH	Transitional cell carcinoma
UCKL1::SAMD10	Adenocarcinoma
UCKL1::TXN	Adenocarcinoma
UCKL1::ZBTB46	Adenocarcinoma
UCP2::AHNAK	Adenocarcinoma
UEVLD::PRMT3	Mesenchymal tumor, NOS
UEVLD::RET	Adenocarcinoma
UFC1::ANO1	Adenocarcinoma
UFD1::NTRK2	Osteosarcoma, NOS
UFD1::PLEKHG4B	Malignant melanoma
UFL1::HNRNPA1	Adenocarcinoma
UFM1::EEF1D	Adenocarcinoma
UFM1::PSPC1	Adenocarcinoma
UFSP2::CCDC110	Adenocarcinoma
UFSP2::EPHA4	Squamous cell carcinoma
UFSP2::ZNF621	Malignant melanoma
UGCG::DNAJC25	Adenocarcinoma
UGCG::UBXN11	Adenocarcinoma
UGDH::PDS5A	Adenocarcinoma
UGDH::SLC25A31	Adenocarcinoma
UGDH::TLR6	Adenocarcinoma
UGGT1::FAR1	Adenocarcinoma
UGGT1::FOXP1	Adenocarcinoma
UGGT1::TERT	Adenocarcinoma
UGGT2::ANKRD16	Adenocarcinoma
UGGT2::ARFGEF2	Meningioma
UGGT2::COL4A1	Adenocarcinoma
UGGT2::GPC5	Mesenchymal tumor, NOS
UGGT2::TRPC4	Adenocarcinoma
UGP2::MDH1	Adenocarcinoma
UGP2::PLEKHM3	Squamous cell carcinoma
UGT1A3::CCT5	Adenocarcinoma
UGT1A3::FGG	Adenocarcinoma
UGT1A6::GLUL	Adenocarcinoma
UGT1A6::JPH3	Adenocarcinoma
UGT2B4::MTHFD2L	Adenocarcinoma
UHMK1::DDR2	Atypical lipomatous tumor/atypical lipoma/well-differentiated liposarcoma
UHMK1::PPOX	Adenocarcinoma
UHRF1::ACTA2	Adenocarcinoma
UHRF1::KDM4B	Diffuse large B-cell lymphoma | Adenocarcinoma
UHRF2::ADAMTSL1	Adenocarcinoma
UHRF2::IL33	Transitional cell carcinoma
UHRF2::OLFM1	Adenocarcinoma
UHRF2::VLDLR	Adenocarcinoma
UHRF2::ZNG1A	Adenocarcinoma
UIMC1::DBN1	Adenocarcinoma
UIMC1::LILRB1	Adenocarcinoma
UIMC1::MXD3	Adenocarcinoma
UIMC1::PJA2	Adenocarcinoma
UIMC1::PMM2	Adenocarcinoma
UIMC1::PTPRO	Adenocarcinoma
ULK1::ANKLE2	Multiple myeloma
ULK1::ETHE1	Adenocarcinoma
ULK1::FBXW8	Squamous cell carcinoma
ULK1::PPP1R12C	Adenocarcinoma
ULK1::PRKAR1B	Adenocarcinoma
ULK1::SFSWAP	Adenocarcinoma | Squamous cell carcinoma
ULK1::TCTN1	Mesenchymal tumor, NOS
ULK2::ACADVL	Adenocarcinoma
ULK2::B9D1	Adenocarcinoma
ULK2::DOCK6	Adenocarcinoma
ULK2::MBD3	Adenocarcinoma
ULK2::NT5M	Adenocarcinoma
ULK4::ANO10	Adenocarcinoma
ULK4::FBXO44	Adenocarcinoma
ULK4::PRIMPOL	Adenocarcinoma
UMAD1::C1GALT1	Adenocarcinoma
UMAD1::GCK	Malignant melanoma
UMAD1::MRAP	Adenocarcinoma
UMODL1::GET1	Adenocarcinoma
UMPS::ERC2	Astrocytoma, grade I-II
UMPS::KALRN	Astrocytoma, grade I-II
UNC13A::NOSIP	Transitional cell carcinoma
UNC13A::ZNF492	Squamous cell carcinoma
UNC13B::DNAJB5	Squamous cell carcinoma
UNC13B::DNER	Adenocarcinoma
UNC13B::PRELID3A	Adenocarcinoma
UNC13B::PTPRD	Transitional cell carcinoma
UNC13B::TAF7L	Adenocarcinoma
UNC13B::UBE2R2	Squamous cell carcinoma
UNC13D::ACOX1	Transitional cell carcinoma
UNC13D::FBF1	Malignant epithelial tumor, special type
UNC13D::FYN	Astrocytoma, grade III-IV/Glioblastoma
UNC13D::SRP68	Adenocarcinoma
UNC45A::BLM	Adenocarcinoma
UNC45A::IQGAP1	Adenocarcinoma
UNC45A::MAN2A2	Transitional cell carcinoma
UNC45A::RALGAPB	Malignant melanoma
UNC45A::SV2B	Adenocarcinoma
UNC50::STARD7	Adenocarcinoma
UNC5A::ERGIC1	Adenocarcinoma
UNC5A::TTC38	Adenocarcinoma
UNC5B::ADAP2	Mesothelioma
UNC5B::IGF2	Malignant epithelial tumor, special type
UNC5D::EIF4EBP1	Adenocarcinoma
UNC5D::GSR	Astrocytoma, grade III-IV/Glioblastoma
UNC5D::NRG1	Adenocarcinoma
UNC79::BRF1	Astrocytoma, grade I-II
UNC79::LHFPL6	Adenocarcinoma
UNG::NEMP1	Adenocarcinoma
UNK::AVIL	Squamous cell carcinoma
UNK::B4GALNT2	Adenocarcinoma
UNK::C1QTNF1	Adenocarcinoma
UNK::DPYD	Squamous cell carcinoma
UNK::ICAM2	Adenocarcinoma
UNK::ITGB4	Adenocarcinoma
UNK::MYO15B	Adenocarcinoma
UNK::NAF1	Adenocarcinoma
UNK::PRKCA	Adenocarcinoma
UNK::RNF157	Adenocarcinoma
UNK::SPOP	Mesenchymal tumor, NOS
UNK::TMEM94	Adenocarcinoma
UNK::ZNF266	Adenocarcinoma
UNKL::ATP6V0C	Multiple myeloma
UNKL::DIP2B	Adenocarcinoma
UNKL::IFT140	Adenocarcinoma
UNKL::MARF1	Adenocarcinoma
UNKL::STX1B	Adenocarcinoma
UPF1::CRTC1	Transitional cell carcinoma
UPF1::EIF3M	Adenocarcinoma
UPF1::ELL	Multiple myeloma
UPF2::NUDT5	Adenocarcinoma
UPF2::PPP2R5C	Adenocarcinoma
UPF3A::CDC16	Adenocarcinoma
UPK2::SUPT16H	Transitional cell carcinoma
UPP1::NCALD	Malignant melanoma
UQCC1::ADAMTS12	Adenocarcinoma
UQCC1::CACNA2D4	Adenocarcinoma
UQCC1::CRLS1	Adenocarcinoma
UQCC1::GDF5	Squamous cell carcinoma
UQCC1::KIAA1755	Adenocarcinoma
UQCC1::LRBA	Adenocarcinoma
UQCC1::MMP24	Adenocarcinoma
UQCC1::MRPS35	Adenocarcinoma
UQCC1::RBM39	Malignant melanoma
UQCC1::SAMHD1	Adenocarcinoma
UQCC1::SHISA4	Malignant epithelial tumor, special type
UQCC5::NISCH	Adenocarcinoma
UQCC5::STAB1	Malignant epithelial tumor, special type
UQCC6::GLT8D2	Transitional cell carcinoma
UQCR10::CFAP276	Ependymoma
UQCR10::KALRN	Squamous cell carcinoma
UQCR11::CERS4	Adenocarcinoma
UQCRC1::ANO10	Acute lymphoblastic leukemia/lymphoblastic lymphoma
UQCRC1::FNIP2	Adenocarcinoma
UQCRC1::IP6K2	Squamous cell carcinoma
UQCRC1::PRKAR2A	Transitional cell carcinoma
UQCRC1::SMARCC1	Adenocarcinoma
UQCRC2::CYB5RL	Transitional cell carcinoma
UQCRH::SLC48A1	Adenocarcinoma
UQCRH::TSPAN1	Malignant melanoma
URB1::CRYZL1	Adenocarcinoma
URB1::TMEM50B	Adenocarcinoma
URGCP::ABCA13	Adenocarcinoma
URGCP::ITPRID1	Adenocarcinoma
URGCP::UPP1	Squamous cell carcinoma
URI1::ARHGAP33	Adenocarcinoma
URI1::C19ORF12	Adenocarcinoma
URI1::C19orf12	Adenocarcinoma
URI1::CCNE1	Squamous cell carcinoma
URI1::CHD4	Mesenchymal tumor, NOS
URI1::EIF3H	Adenocarcinoma
URI1::FAM156A	Adenocarcinoma
URI1::FOXA3	Adenocarcinoma
URI1::GPC6	Adenocarcinoma
URI1::IFNL1	Adenocarcinoma
URI1::KCNIP4	Germ cell tumor, NOS
URI1::PDCD5	Adenocarcinoma
URI1::PEPD	Adenocarcinoma
URI1::PLEKHF1	Adenocarcinoma
URI1::POP4	Adenocarcinoma
URI1::RHPN2	Mesenchymal tumor, NOS
URI1::RYR1	Adenocarcinoma
URI1::SLC35F1	Transitional cell carcinoma
URI1::TYW1B	Adenocarcinoma
URI1::VSTM2B	Adenocarcinoma
URI1::WDR88	Adenocarcinoma
URI1::XRCC1	Adenocarcinoma
URI1::ZNF33A	Transitional cell carcinoma
URI1::ZNF383	Malignant melanoma
URM1::AOPEP	Squamous cell carcinoma
URM1::TP53BP1	Adenocarcinoma
USB1::CX3CL1	Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
USB1::DRC7	Adenocarcinoma
USB1::MAPKAPK5	Adenocarcinoma
USF1::UCK2	Adenocarcinoma
USF2::CLASRP	Adenocarcinoma
USF2::IRX3	Adenocarcinoma
USF2::P3H2	Adenocarcinoma
USF2::ZNF30	Adenocarcinoma
USF3::NAA50	Adenocarcinoma
USP10::ATP2C2	Malignant melanoma | Diffuse large B-cell lymphoma
USP10::CDH13	Adenocarcinoma
USP10::KIFC3	Adenocarcinoma
USP10::ZDHHC7	Adenocarcinoma
USP12::DIAPH3	Adenocarcinoma
USP12::E2F3	Transitional cell carcinoma
USP12::LNX2	Adenocarcinoma
USP12::NXF3	Mesenchymal tumor, NOS
USP13::KCNMB2	Malignant melanoma
USP13::MAP3K21	Adenocarcinoma
USP13::PIK3CA	Adenocarcinoma
USP14::NOL4	Mesenchymal tumor, NOS
USP14::THOC1	Squamous cell carcinoma
USP15::CDH4	Adenocarcinoma
USP15::CNTN1	Soft tissue tumor, special type
USP15::CPSF6	Astrocytoma, grade I-II
USP15::DPY19L2	Mesenchymal tumor, NOS
USP15::PCBP2	Astrocytoma, grade III-IV/Glioblastoma
USP15::PKP4	Adenocarcinoma
USP15::PRRC2C	Mesenchymal tumor, NOS
USP15::SRGAP1	Mesenchymal tumor, NOS
USP15::SYT1	Adenocarcinoma
USP16::ACSS3	Mesenchymal tumor, NOS
USP16::CNBD2	Squamous cell carcinoma
USP16::RUNX1	Chronic myelomonocytic leukemia | Spleen
USP18::ADM2	Adenocarcinoma
USP18::BAG6	Adenocarcinoma
USP18::DAPK2	Adenocarcinoma
USP18::YWHAH	Malignant melanoma
USP19::VEPH1	Undifferentiated carcinoma, small cell
USP1::EFCAB7	Adenocarcinoma
USP1::SGIP1	Adenocarcinoma
USP21::IL19	Adenocarcinoma
USP21::NECTIN4	Adenocarcinoma
USP22::ATP2A3	Adenocarcinoma
USP22::CA7	Acute myelomonocytic leukemia (FAB type M4)
USP22::MMS22L	Adenocarcinoma
USP22::MYH10	Adenocarcinoma
USP22::MYO19	Adenocarcinoma
USP22::RNF167	Adenocarcinoma
USP22::SLC39A11	Adenocarcinoma
USP22::SPACA3	Adenocarcinoma
USP22::TMC3	Astrocytoma, grade III-IV/Glioblastoma
USP24::DHCR24	Astrocytoma, grade III-IV/Glioblastoma
USP25::CAPN3	Squamous cell carcinoma
USP25::CROCC2	Adenocarcinoma
USP25::CYYR1	Squamous cell carcinoma
USP25::DZIP3	Adenocarcinoma
USP25::JAK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
USP25::PCNT	Squamous cell carcinoma
USP25::PDGFRA	Chronic myeloproliferative disorder, NOS
USP25::SLC1A3	Astrocytoma, grade III-IV/Glioblastoma
USP25::SLITRK6	Malignant melanoma
USP25::TRAPPC10	Acute megakaryoblastic leukemia (FAB type M7)
USP28::DRD2	Malignant melanoma
USP28::TMEM25	Adenocarcinoma
USP28::TMPRSS2	Adenocarcinoma
USP2::YAP1	Astrocytoma, pilocytic/juvenile
USP30::STAB2	Mesenchymal tumor, NOS
USP31::CRYL1	Adenocarcinoma
USP31::ELAVL2	Transitional cell carcinoma
USP31::ERI2	Adenocarcinoma
USP31::GGA2	Adenocarcinoma
USP31::MRTFB	Adenocarcinoma
USP31::NPIPB5	Adenocarcinoma
USP31::PRKCB	Transitional cell carcinoma
USP31::RHD	Transitional cell carcinoma
USP31::SNRNP25	Squamous cell carcinoma
USP31::SRL	Adenocarcinoma
USP32::APPBP2	Adenocarcinoma
USP32::ARHGAP39	Adenocarcinoma
USP32::BCAS3	Adenocarcinoma
USP32::CFAP70	Mycosis fungoides/Sézary syndrome
USP32::CLTC	Adenocarcinoma
USP32::CRYBA4	Adenocarcinoma
USP32::CWC25	Adenocarcinoma
USP32::DHX40	Adenocarcinoma
USP32::ELOF1	Adenocarcinoma
USP32::EPHA1	Squamous cell carcinoma
USP32::EXOSC5	Adenocarcinoma
USP32::FAM222B	Adenocarcinoma
USP32::GPR137	Adenocarcinoma
USP32::HOXB9	Adenocarcinoma
USP32::LRRC37A2	Adenocarcinoma
USP32::MAP3K3	Adenocarcinoma
USP32::MED1	Adenocarcinoma
USP32::NPTN	Adenocarcinoma
USP32::PACSIN2	Adenocarcinoma
USP32::PCTP	Adenocarcinoma
USP32::PGS1	Adenocarcinoma
USP32::PSMD12	Adenocarcinoma
USP32::RAD51B	Mycosis fungoides/Sézary syndrome
USP32::RAD51C	Adenocarcinoma
USP32::RBFOX3	Adenocarcinoma
USP32::SCPEP1	Adenocarcinoma
USP32::SPANXN4	Astrocytoma, grade I-II
USP32::STXBP4	Adenocarcinoma
USP32::TANC2	Adenocarcinoma
USP32::TRPC4AP	Adenocarcinoma
USP32::UBE2O	Adenocarcinoma
USP33::CDK12	Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
USP33::FUBP1	Adenocarcinoma
USP33::TARS1	Adenocarcinoma
USP33::WASHC3	Malignant melanoma
USP34::C2orf74	Adenocarcinoma
USP34::CAPN13	Adenocarcinoma
USP34::CCDC117	Adenocarcinoma
USP34::CCT4	Adenocarcinoma
USP34::DNAAF10	Adenocarcinoma
USP34::FAM161A	Transitional cell carcinoma
USP34::FAM178B	Adenocarcinoma
USP34::GKN1	Adenocarcinoma
USP34::KDM4B	Adenocarcinoma
USP34::NAXD	Adenocarcinoma
USP34::PLEKHG1	Adenocarcinoma
USP34::SANBR	Diffuse large B-cell lymphoma
USP34::WDPCP	Adenocarcinoma
USP34::XPO1	Mature B-cell neoplasm, NOS | Adenocarcinoma
USP34::ZNF2	Squamous cell carcinoma
USP34::ZNF638	Adenocarcinoma
USP35::CHRDL2	Malignant melanoma
USP35::RNF169	Adenocarcinoma
USP35::TSHZ2	Adenocarcinoma
USP36::CEP295NL	Adenocarcinoma
USP36::DNAH17	Adenocarcinoma
USP37::NHEJ1	Malignant epithelial tumor, special type
USP37::OSMR	Squamous cell carcinoma
USP37::RNF25	Adenocarcinoma
USP37::SAMD12	Adenocarcinoma
USP37::TMBIM1	Adenocarcinoma
USP37::TNS1	Transitional cell carcinoma
USP38::IL17F	Transitional cell carcinoma
USP38::RIT2	Mesenchymal tumor, NOS
USP38::TMEM154	Malignant epithelial tumor, special type
USP39::CD8B	Squamous cell carcinoma
USP39::DNAH6	Adenocarcinoma
USP39::ELMOD3	Adenocarcinoma
USP39::GGCX	Squamous cell carcinoma
USP39::GNLY	Squamous cell carcinoma
USP39::REEP1	Malignant melanoma
USP39::VAMP8	Adenocarcinoma
USP3::HERC1	Squamous cell carcinoma
USP3::MYO1D	Adenocarcinoma
USP3::TLN2	Malignant epithelial tumor, special type
USP40::PMVK	Adenocarcinoma
USP42::ANKRD61	Adenocarcinoma
USP42::GLCCI1	Adenocarcinoma
USP42::SLC46A2	Adenocarcinoma
USP43::ENDOV	Adenocarcinoma
USP43::FYB2	Adenocarcinoma
USP43::TMEM116	Adenocarcinoma
USP45::ASCC3	Adenocarcinoma
USP45::RIOK1	Adenocarcinoma
USP46::PCDH7	Adenocarcinoma
USP46::PDGFRA	Astrocytoma, grade I-II
USP47::GALNT18	Mesenchymal tumor, NOS
USP47::RRAS2	Malignant melanoma
USP48::HSPG2	Adenocarcinoma
USP48::INA	Adenocarcinoma
USP48::KALRN	Mesenchymal tumor, NOS
USP48::MAN1C1	Squamous cell carcinoma
USP48::NPIPB3	Adenocarcinoma
USP48::PSMA8	Adenocarcinoma
USP48::SELENON	Squamous cell carcinoma
USP48::STPG1	Squamous cell carcinoma
USP48::WNT4	Adenocarcinoma
USP49::APOBEC2	Mesenchymal tumor, NOS
USP49::DAAM2	Astrocytoma, grade III-IV/Glioblastoma
USP49::GSTA1	Adenocarcinoma
USP49::KCTD20	Astrocytoma, grade III-IV/Glioblastoma
USP49::MED20	Adenocarcinoma
USP49::STRN	Adenocarcinoma
USP49::TAF8	Adenocarcinoma
USP4::AGO3	Adenocarcinoma
USP4::BBOX1	Astrocytoma, grade I-II
USP4::CCDC13	Transitional cell carcinoma
USP4::NICN1	Adenocarcinoma
USP4::RHOA	Transitional cell carcinoma
USP4::SCRIB	Adenocarcinoma
USP53::MYOZ2	Adenocarcinoma
USP53::NAA16	Mesenchymal tumor, NOS
USP53::SYNPO2	Adenocarcinoma
USP54::ADK	Mesenchymal tumor, NOS
USP54::AP3M1	Adenocarcinoma
USP54::DNAJB12	Adenocarcinoma
USP54::MYOZ1	Adenocarcinoma
USP54::PCDH15	Adenocarcinoma
USP54::PSMA6	Adenocarcinoma
USP54::TSPAN15	Adenocarcinoma
USP54::UBE2W	Adenocarcinoma
USP6::CDH11	Aneurysmal bone cyst
USP6::COL1A1	Adenocarcinoma
USP6::ELOF1	Adenocarcinoma
USP6::LUM	Aneurysmal bone cyst
USP6NL::AHCY	Adenocarcinoma
USP6NL::ANKRD16	Adenocarcinoma
USP6NL::ARMC3	Adenocarcinoma
USP6NL::CCDC3	Adenocarcinoma
USP6NL::FAM107B	Adenocarcinoma
USP6NL::FRMD4A	Adenocarcinoma
USP6NL::GDI2	Adenocarcinoma
USP6NL::ITIH5	Adenocarcinoma
USP6NL::LYZL1	Adenocarcinoma
USP6NL::PREP	Adenocarcinoma
USP6NL::RNF216	Adenocarcinoma
USP6NL::SVBP	Adenocarcinoma
USP6NL::UPF2	Adenocarcinoma
USP6NL::VPS26A	Adenocarcinoma
USP7::PRKCB	Adenocarcinoma
USP7::SMARCA2	Transitional cell carcinoma
USP7::TMEM186	Adenocarcinoma
USP7::TRA	Acute lymphoblastic leukemia/lymphoblastic lymphoma
USP8::ADAMTSL3	Mesenchymal tumor, NOS
USP8::AGBL1	Adenocarcinoma
USP8::BDP1	Malignant melanoma
USP8::CCDC171	Adenocarcinoma
USP8::CLPTM1L	Adenocarcinoma
USP8::INO80	Acute myeloid leukemia, NOS | Skin
USP8::MYEF2	Squamous cell carcinoma
USP8::PDGFRA	Cartilage tumor, special type
USP8::SLC27A2	Adenocarcinoma
USP8::TRPM7	Adenocarcinoma
USP8::TSPAN3	Mesenchymal tumor, NOS
USP9X::ATP6AP2	Adenocarcinoma
USP9X::BLVRB	Squamous cell carcinoma
USP9X::CD244	Adenocarcinoma
USP9X::DDX3X	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Adenocarcinoma
USP9X::ERAS	Adenocarcinoma
USP9X::GLOD5	Adenocarcinoma
USP9X::KDM6A	Adenocarcinoma
USP9X::MAGEB18	Adenocarcinoma
USP9X::MAPKAPK5	Adenocarcinoma
USP9X::MRPS31	Squamous cell carcinoma
USP9X::NXF2	Squamous cell carcinoma
USP9X::PRIM1	Adenocarcinoma
USP9X::RBBP7	Malignant melanoma
USP9X::USP6	Aneurysmal bone cyst
USP9X::ZNF692	Adenocarcinoma
USP9Y::ERC1	Mesenchymal tumor, NOS
USPL1::ANKRD7	Adenocarcinoma
USPL1::IGSF8	Adenocarcinoma
USPL1::RB1	Squamous cell carcinoma
UST::CCDC6	Adenocarcinoma
UST::MYB	Adenocarcinoma
UTP18::ITGB3	Adenocarcinoma
UTP18::KCTD17	Adenocarcinoma
UTP20::ANKS1B	Malignant melanoma
UTP20::SCYL2	Adenocarcinoma
UTP25::TRAF3IP3	Transitional cell carcinoma
UTP6::BCAS3	Squamous cell carcinoma
UTP6::PABPC1L	Astrocytoma, grade I-II
UTP6::SLC13A5	Mesenchymal tumor, NOS
UTRN::AIG1	Adenocarcinoma
UTRN::ARFGEF3	Mesenchymal tumor, NOS
UTRN::AXIN1	Adenocarcinoma
UTRN::ECT2L	Adenocarcinoma
UTRN::EIF4G3	Adenocarcinoma
UTRN::ENTPD5	Acute lymphoblastic leukemia/lymphoblastic lymphoma
UTRN::HEBP2	Mesenchymal tumor, NOS
UTRN::HMGA2	Mesenchymal tumor, NOS
UTRN::LAMB4	Mesenchymal tumor, NOS
UTRN::LYRM4	Adenocarcinoma
UTRN::MMADHC	Adenocarcinoma
UTRN::MSRA	Adenocarcinoma
UTRN::OS9	Adenocarcinoma
UTRN::OSTF1	Mesenchymal tumor, NOS
UTRN::PHACTR2	Adenocarcinoma
UTRN::PITPNA	Malignant melanoma
UTRN::PLAGL1	Adenocarcinoma
UTRN::POLE4	Acute lymphoblastic leukemia/lymphoblastic lymphoma
UTRN::PRKN	Adenocarcinoma
UTRN::SGK1	Adenocarcinoma
UTRN::SHPRH	Adenocarcinoma
UTRN::SLC22A23	Adenocarcinoma
UTRN::TBC1D31	Adenocarcinoma
UTRN::WIF1	Mesenchymal tumor, NOS
UTRN::ZC2HC1B	Adenocarcinoma
UVRAG::ACER3	Mesenchymal tumor, NOS
UVRAG::CMPK1	Adenocarcinoma
UVRAG::DGAT2	Adenocarcinoma
UVRAG::DPP3	Squamous cell carcinoma
UVRAG::EMSY	Adenocarcinoma
UVRAG::FAM168A	Adenocarcinoma
UVRAG::GDPD4	Adenocarcinoma
UVRAG::INTS4	Adenocarcinoma
UVRAG::KCNE3	Adenocarcinoma
UVRAG::KCTD14	Adenocarcinoma
UVRAG::KIRREL3	Adenocarcinoma
UVRAG::LRTOMT	Adenocarcinoma
UVRAG::MAP6	Adenocarcinoma
UVRAG::MOGAT2	Adenocarcinoma
UVRAG::MS4A8	Mesenchymal tumor, NOS
UVRAG::MYEOV	Adenocarcinoma
UVRAG::NOM1	Mesenchymal tumor, NOS
UVRAG::OTUB1	Adenocarcinoma
UVRAG::P4HA3	Malignant melanoma
UVRAG::PACRG	Adenocarcinoma
UVRAG::PAK1	Adenocarcinoma
UVRAG::PCBD1	Adenocarcinoma
UVRAG::RAD51B	Adenocarcinoma
UVRAG::RRAS2	Squamous cell carcinoma
UVRAG::SERPINH1	Adenocarcinoma
UVRAG::SHANK2	Adenocarcinoma
UVRAG::SLCO2B1	Adenocarcinoma
UVRAG::SOX6	Adenocarcinoma
UVRAG::SPCS2	Malignant epithelial tumor, special type
UVRAG::TRIM29	Adenocarcinoma
UVRAG::ZMAT4	Adenocarcinoma
UVSSA::MAEA	Acute myeloid leukemia, NOS | Skin
UXS1::ECRG4	Transitional cell carcinoma
UXS1::RET	Carcinoma, NOS
UXS1::TMEM241	Squamous cell carcinoma
UXT::TFE3	Clear cell sarcoma
VAC14::CDH8	Malignant melanoma
VAC14::HYDIN	Adenocarcinoma
VAC14::WWOX	Transitional cell carcinoma
VAMP1::CD27	Squamous cell carcinoma
VAMP1::CHD4	Adenocarcinoma
VAMP2::NRG1	Adenocarcinoma
VAMP3::SCAF4	Adenocarcinoma
VAMP4::MYRFL	Mesenchymal tumor, NOS
VAMP7::TGFB2	Adenocarcinoma
VAMP8::SCAF1	Adenocarcinoma
VAMP8::VAMP5	Nonneoplastic epithelial disorder/lesion
VANGL1::ATP1A1	Adenocarcinoma
VANGL1::HAO2	Adenocarcinoma
VANGL2::PDE4DIP	Adenocarcinoma
VANGL2::UFC1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
VAPA::CEP192	Acute myelomonocytic leukemia (FAB type M4)
VAPA::METTL4	Adenocarcinoma
VAPA::RAB31	Adenocarcinoma
VAPA::SLC28A3	Adenocarcinoma
VAPB::BCL2L1	Adenocarcinoma
VAPB::CASS4	Adenocarcinoma
VAPB::CDH12	Adenocarcinoma
VAPB::IKZF3	Adenocarcinoma
VAPB::PKIA	Malignant melanoma
VAPB::RBM38	Adenocarcinoma
VARS1::HSPA1L	Squamous cell carcinoma
VARS1::VMP1	Adenocarcinoma
VASN::RBFOX1	Astrocytoma, grade III-IV/Glioblastoma
VASP::C1ORF87	Miscellaneous hematopoietic/lymphoid neoplasm, special type
VASP::C1orf87	Benign epithelial tumor, special type
VASP::CYP2S1	Adenocarcinoma
VASP::EXOC3L2	Adenocarcinoma
VASP::NDUFA3	Adenocarcinoma
VASP::PPM1N	Adenocarcinoma
VAT1::BCAS3	Malignant melanoma
VAT1::COL5A1	Malignant melanoma
VAT1::CTNND1	Malignant melanoma
VAT1L::WWOX	Adenocarcinoma
VAV1::C1ORF198	Adenocarcinoma
VAV1::C1orf198	Adenocarcinoma
VAV1::CD28	Peripheral T-cell lymphoma, unspecified
VAV1::MYO1F	Peripheral T-cell lymphoma, unspecified
VAV1::S100A7	Angioimmunoblastic T-cell lymphoma
VAV1::STAP2	Peripheral T-cell lymphoma, unspecified
VAV1::THAP4	Peripheral T-cell lymphoma, unspecified
VAV2::ALG1	Adenocarcinoma
VAV2::BRD3	Embryonal nervous system tumor, special type
VAV2::CLNK	Malignant melanoma
VAV2::COL27A1	Adenocarcinoma
VAV2::DEUP1	Adenocarcinoma
VAV2::FNBP1	Diffuse large B-cell lymphoma
VAV2::MYMK	Adenocarcinoma
VAV2::NOTCH1	Astrocytoma, grade III-IV/Glioblastoma
VAV2::QSOX2	Adenoid cystic carcinoma
VAV2::RXRA	Malignant melanoma
VAV3::DAB1	Meningioma
VAV3::RAB9B	Adenocarcinoma
VAV3::RGL1	Adenocarcinoma
VAV3::ZHX2	Adenocarcinoma
VAX2::ALK	Spindle cell/sclerosing rhabdomyosarcoma
VAX2::PAIP2B	Adenocarcinoma
VAX2::UBE3D	Mesenchymal tumor, NOS
VBP1::BRCC3	Adenocarcinoma | Astrocytoma, grade III-IV/Glioblastoma
VBP1::GABRA3	Adenocarcinoma
VCAM1::CDC14A	Adenocarcinoma
VCAN::GABRA5	Mesothelioma
VCAN::NTRK2	Glioma, NOS
VCAN::PLAG1	Lipoblastoma
VCF1::ACLY	Malignant melanoma
VCF1::C17ORF80	Neuroblastoma
VCF1::CDC42EP4	Squamous cell carcinoma | Adenocarcinoma
VCF1::SLC39A11	Malignant melanoma | Adenocarcinoma
VCL::ABCC8	Adenocarcinoma
VCL::ALK	Mesenchymal tumor, special type | Soft tissue tumor, special type | Adenocarcinoma | Benign fibrous histiocytoma | Malignant epithelial tumor, special type | Astrocytoma, grade III-IV/Glioblastoma | Inflammatory myofibroblastic tumor/myofibroblastic sarcoma
VCL::ATF6	Adenocarcinoma
VCL::BRAF	Malignant epithelial tumor, special type
VCL::FGFR2	Adenocarcinoma
VCL::LRMDA	Mesenchymal tumor, NOS
VCL::NTRK2	Astrocytoma, grade III-IV/Glioblastoma
VCL::PLAU	Adenocarcinoma
VCL::RET	Fibroblastic/myofibroblastic tumor, special type
VCL::ROS1	Carcinoma, NOS
VCL::SAMD8	Adenocarcinoma
VCL::SEC24C	Squamous cell carcinoma
VCL::SFTPD	Squamous cell carcinoma
VCL::SFXN2	Squamous cell carcinoma
VCL::ZSWIM8	Adenocarcinoma
VCP::ATOSB	Adenocarcinoma
VCP::SPATA31G1	Astrocytoma, grade I-II
VCP::TFE3	Alveolar soft part sarcoma | Adenocarcinoma | PEComa
VCPIP1::CDH17	Adenocarcinoma
VDAC1::SKP1	Adenocarcinoma
VDAC2::NEO1	Adenocarcinoma
VDAC3::DKK4	Squamous cell carcinoma
VDR::USP6	Aneurysmal bone cyst
VEGFA::DDX27	Adenocarcinoma
VEGFA::NRDC	Mesenchymal tumor, NOS
VEGFA::RSPH9	Squamous cell carcinoma
VEGFA::STK38	Astrocytoma, grade I-II
VEZF1::ANKFN1	Adenocarcinoma
VEZF1::DDX42	Squamous cell carcinoma
VEZF1::KRT222	Adenocarcinoma
VEZT::FGD6	Germ cell tumor, NOS
VEZT::RLIG1	Mesenchymal tumor, NOS
VGF::CLCN3	Adenocarcinoma
VGF::SIAE	Malignant melanoma
VGLL1::CD40LG	Adenocarcinoma
VGLL2::CITED2	Undifferentiated round cell sarcoma | Spindle cell/sclerosing rhabdomyosarcoma
VGLL2::NCOA2	Spindle cell/sclerosing rhabdomyosarcoma | Fibrosarcoma | Rhabdomyosarcoma, NOS | Undifferentiated round cell sarcoma
VGLL3::RBMS3	Adenocarcinoma
VGLL4::CHL1	Squamous cell carcinoma
VGLL4::FOXP1	Adenocarcinoma
VGLL4::FXR1	Adenocarcinoma
VGLL4::IQSEC1	Adenocarcinoma
VGLL4::LIMD1	Transitional cell carcinoma
VGLL4::PRKG1	Adenocarcinoma
VGLL4::SH3BP5	Adenocarcinoma
VGLL4::SYNPR	Adenocarcinoma
VGLL4::TAMM41	Adenocarcinoma
VGLL4::TMEM40	Adenocarcinoma | Transitional cell carcinoma
VGLL4::UPF2	Transitional cell carcinoma
VHL::CFAP97	Adenocarcinoma
VHL::FANCD2OS	Astrocytoma, grade I-II
VHL::TATDN2	Adenocarcinoma
VILL::ABCA2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
VILL::CTDSPL	Adenocarcinoma
VILL::ITGA9	Adenocarcinoma
VIM::CLCN3	Adenocarcinoma
VIM::DNM1L	Adenocarcinoma
VIM::EEA1	Squamous cell carcinoma
VIM::IGK	Multiple myeloma
VIM::IQCE	Adenocarcinoma
VIM::KMT2A	Soft tissue tumor, special type | Undifferentiated sarcoma | Malignant soft tissue tumor, NOS
VIM::LAMA4	Malignant melanoma
VIM::NTRK3	Adenocarcinoma
VIM::PEX1	Malignant melanoma
VIM::PLEKHA5	Malignant melanoma
VIM::PTPRC	Transitional cell carcinoma
VIM::RET	Adenocarcinoma
VIM::SGK3	Malignant melanoma
VIM::SIAE	Adenocarcinoma
VIM::STAT6	Adenocarcinoma
VIPAS39::BBOF1	Adenocarcinoma
VIPAS39::ISM2	Adenocarcinoma
VIRMA::CAMK2A	Adenocarcinoma
VIRMA::CPA6	Transitional cell carcinoma
VIRMA::CYRIB	Squamous cell carcinoma
VIRMA::PNLIPRP1	Adenocarcinoma
VIRMA::SYBU	Astrocytoma, grade I-II
VIT::ALK	Adenocarcinoma
VKORC1::SGF29	Astrocytoma, grade I-II
VKORC1L1::ACHE	Adenocarcinoma
VKORC1L1::GUSB	Adenocarcinoma
VKORC1L1::RABGEF1	Adenocarcinoma
VKORC1L1::STEAP1B	Angiosarcoma
VLDLR::KANK1	Soft tissue tumor, NOS
VLDLR::SLC1A1	Mesothelioma
VMP1::AP1S2	Adenocarcinoma
VMP1::APPBP2	Adenocarcinoma
VMP1::BCAS3	Adenocarcinoma
VMP1::BRCA1	Mesenchymal tumor, NOS
VMP1::CDC42EP4	Adenocarcinoma
VMP1::CHCT1	Adenocarcinoma
VMP1::CLTC	Adenocarcinoma
VMP1::DHCR7	Adenocarcinoma
VMP1::FAM222B	Adenocarcinoma
VMP1::KDM2A	Adenocarcinoma
VMP1::KRTAP4-6	Adenocarcinoma
VMP1::MARCHF10	Adenocarcinoma
VMP1::PDK2	Adenocarcinoma
VMP1::PRR11	Malignant epithelial tumor, special type
VMP1::PSMA6	Adenocarcinoma
VMP1::PTRH2	Squamous cell carcinoma
VMP1::RNF24	Adenocarcinoma
VMP1::RNFT1	Adenocarcinoma
VMP1::SMARCD2	Adenocarcinoma
VMP1::TBX4	Adenocarcinoma
VMP1::TK1	Mesenchymal tumor, NOS
VMP1::TUBD1	Squamous cell carcinoma | Adenocarcinoma
VMP1::YPEL2	Adenocarcinoma
VNN1::SLC18B1	Adenocarcinoma
VOPP1::GRB10	Squamous cell carcinoma
VOPP1::IL22	Astrocytoma, grade III-IV/Glioblastoma
VOPP1::LANCL2	Astrocytoma, grade III-IV/Glioblastoma
VOPP1::RAPGEF5	Adenocarcinoma
VPS11::ATP5MG	Adenocarcinoma
VPS13A::KIF13A	Adenocarcinoma
VPS13A::SNRPF	Adenocarcinoma
VPS13B::AHI1	Adenocarcinoma
VPS13B::AKAP7	Adenocarcinoma
VPS13B::ANKRD46	Transitional cell carcinoma
VPS13B::CCDC6	Adenocarcinoma
VPS13B::CDADC1	Transitional cell carcinoma
VPS13B::CDH17	Malignant melanoma
VPS13B::DACH1	Adenocarcinoma
VPS13B::DPYS	Squamous cell carcinoma
VPS13B::EFR3A	Adenocarcinoma
VPS13B::ERICH5	Adenocarcinoma
VPS13B::GMDS	Adenocarcinoma
VPS13B::IL2RB	Germ cell tumor, NOS
VPS13B::MYO9B	Transitional cell carcinoma
VPS13B::NECAB1	Adenocarcinoma
VPS13B::OSR2	Adenocarcinoma
VPS13B::OXR1	Mature B-cell neoplasm, NOS
VPS13B::POLR2K	Adenocarcinoma
VPS13B::PPP1R16A	Adenocarcinoma
VPS13B::RASL11A	Adenocarcinoma
VPS13B::RGS22	Adenocarcinoma
VPS13B::SGCZ	Adenocarcinoma
VPS13B::SNX31	Adenocarcinoma
VPS13B::SPAG1	Adenocarcinoma
VPS13B::STAG2	Acute megakaryoblastic leukemia (FAB type M7)
VPS13B::STAU2	Mesenchymal tumor, NOS
VPS13B::TERF1	Adenocarcinoma
VPS13C::CENPN	Adenocarcinoma
VPS13C::ENKD1	Adenocarcinoma
VPS13C::HERC1	Adenocarcinoma
VPS13C::INSYN1	Adenocarcinoma
VPS13C::RB1CC1	Adenocarcinoma
VPS13C::SH2D4A	Adenocarcinoma
VPS13D::ARHGAP39	Adenocarcinoma
VPS13D::MFN2	Adenocarcinoma
VPS13D::RERE	Adenocarcinoma
VPS13D::TNFRSF1B	Malignant melanoma
VPS13D::TNFRSF8	Adenocarcinoma
VPS13D::VEGFC	Adenocarcinoma
VPS18::NTRK3	Osteosarcoma, NOS | Adenocarcinoma
VPS18::ZFYVE19	Squamous cell carcinoma
VPS26A::AGBL4	Adenocarcinoma
VPS26A::GDAP1L1	Adenocarcinoma
VPS26A::KIFBP	Adenocarcinoma
VPS26A::LRRTM3	Adenocarcinoma
VPS26B::CDIN1	Adenocarcinoma
VPS26C::BACH1	Adenocarcinoma
VPS26C::CTSH	Adenocarcinoma
VPS26C::IGSF5	Adenocarcinoma
VPS26C::MACROD2	Adenocarcinoma
VPS26C::NIPBL	Astrocytoma, grade I-II
VPS28::SF3A1	Adenocarcinoma
VPS29::HSPB8	Mesenchymal tumor, NOS
VPS29::MGME1	Squamous cell carcinoma
VPS29::SVOP	Adenocarcinoma
VPS29::TMEM91	Adenocarcinoma
VPS33A::ABCB9	Adenocarcinoma
VPS33A::ATXN2	Astrocytoma, grade I-II
VPS33A::MPHOSPH9	Diffuse large B-cell lymphoma
VPS35::DCN	Adenocarcinoma
VPS35::ITFG1	Adenocarcinoma
VPS35::PEDS1	Adenocarcinoma
VPS35::PHKB	Transitional cell carcinoma
VPS35::SLC6A2	Adenocarcinoma
VPS35L::C9	Adenocarcinoma
VPS35L::CDR2	Adenocarcinoma
VPS35L::IQCK	Adenocarcinoma
VPS35L::SYT17	Adenocarcinoma
VPS35L::TMC5	Adenocarcinoma
VPS36::LPAR6	Adenocarcinoma
VPS37A::DNAI4	Mesenchymal tumor, NOS
VPS37B::ABCB9	Adenocarcinoma
VPS37B::MPHOSPH9	Adenocarcinoma
VPS37B::PTPN11	Astrocytoma, grade I-II
VPS37B::SIRT4	Astrocytoma, grade III-IV/Glioblastoma
VPS37B::SPTBN1	Adenocarcinoma
VPS37B::UBC	Multiple myeloma
VPS37B::VPS33A	Adenocarcinoma
VPS37C::AHNAK	Adenocarcinoma
VPS37C::FADS3	Adenocarcinoma
VPS37C::SLC3A2	Adenocarcinoma
VPS39::LYSMD2	Astrocytoma, grade I-II
VPS39::TMEM87A	Squamous cell carcinoma
VPS41::ANKFN1	Adenocarcinoma
VPS41::CEP41	Adenocarcinoma
VPS41::ELMO1	Adenocarcinoma
VPS41::NPSR1	Transitional cell carcinoma
VPS41::SDK1	Astrocytoma, grade I-II
VPS41::SPMIP7	Adenocarcinoma
VPS41::TLE5	Squamous cell carcinoma
VPS41::VOPP1	Adenocarcinoma
VPS45::PLEKHO1	Nonneoplastic epithelial disorder/lesion
VPS4B::AEBP2	Acute myeloblastic leukemia with maturation (FAB type M2)
VPS4B::BCL2	Adenocarcinoma
VPS4B::SLC22A15	Adenocarcinoma
VPS50::CDH1	Adenocarcinoma
VPS50::PPP6R3	Adenocarcinoma
VPS52::TAPBP	Germ cell tumor, NOS
VPS52::ZNF358	Astrocytoma, grade I-II
VPS53::ABR	Squamous cell carcinoma
VPS53::ESR1	Adenocarcinoma
VPS53::F7	Adenocarcinoma
VPS53::GLOD4	Astrocytoma, grade I-II | Oligodendroglioma
VPS53::HS3ST5	Adenocarcinoma
VPS53::MYH2	Adenocarcinoma
VPS53::NXN	Russia | Primitive neuroectodermal tumor/Medulloblastoma
VPS53::RTN4RL1	Adenocarcinoma
VPS53::SMG6	Adenocarcinoma
VPS53::TXNDC17	Mesenchymal tumor, NOS
VPS53::ZZEF1	Adenocarcinoma
VPS54::PELI1	Transitional cell carcinoma
VPS72::GABPB2	Transitional cell carcinoma
VPS72::ROBO2	Adenocarcinoma
VPS72::RORC	Adenocarcinoma
VPS72::TSHZ2	Adenocarcinoma
VPS8::ACTL6A	Adenocarcinoma
VPS8::ARHGAP39	Astrocytoma, grade I-II
VPS8::EHHADH	Adenocarcinoma
VPS8::EIF2AK4	Adenocarcinoma
VPS8::EIF4G1	Adenocarcinoma
VPS8::EPHB3	Adenocarcinoma
VPS8::GLYR1	Adenocarcinoma
VPS8::HTR3C	Adenocarcinoma
VPS8::LRBA	Myelodysplastic syndrome, NOS
VPS8::NLGN1	Squamous cell carcinoma
VPS8::NPHP3	Squamous cell carcinoma
VPS9D1::ZNF827	Astrocytoma, grade I-II
VRK1::MMP14	Transitional cell carcinoma
VRK1::PAPOLA	Squamous cell carcinoma
VRK1::SAMD4A	Squamous cell carcinoma
VRK1::TDP1	Adenocarcinoma
VRK2::AGO3	Squamous cell carcinoma
VRK2::CHSY1	Adenocarcinoma
VRK3::PPP6R1	Squamous cell carcinoma
VRK3::PTOV1	Squamous cell carcinoma
VRK3::TGFB1	Squamous cell carcinoma
VSIG10::GLIPR1L2	Adenocarcinoma
VSIG1::MID2	Adenocarcinoma
VSTM2L::CTNNBL1	Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
VSTM2L::RPRD1B	Squamous cell carcinoma
VTA1::TIAM2	Malignant epithelial tumor, special type | Adenocarcinoma
VTCN1::AGBL4	Adenocarcinoma
VTCN1::DNM2	Adenocarcinoma
VTCN1::NRG1	Adenocarcinoma
VTCN1::NUP88	Adenocarcinoma
VTCN1::PTGFRN	Adenocarcinoma
VTI1A::ACSL5	Squamous cell carcinoma
VTI1A::C10ORF90	Adenocarcinoma
VTI1A::C10orf90	Adenocarcinoma
VTI1A::GTF2H5	Adenocarcinoma
VTI1A::HDAC1	Malignant epithelial tumor, special type
VTI1A::SUGP2	Adenocarcinoma
VTI1A::TCF7L2	Squamous cell carcinoma | Acute myeloid leukemia, NOS | Adenocarcinoma | Skin
VTI1B::PLEKHH1	Squamous cell carcinoma
VTI1B::RDH11	Acute myeloid leukemia, NOS | Acute monoblastic leukemia (FAB type M5) | Skin
VTN::SERPINC1	Adenocarcinoma
VWA2::AFAP1L2	Schwannoma
VWA2::IDE	Astrocytoma, grade I-II
VWA2::PRKCH	Adenocarcinoma
VWA8::COG5	Adenocarcinoma
VWA8::MYO5C	Squamous cell carcinoma
VWA8::PTPRG	Adenocarcinoma
VWA8::RB1	Adenocarcinoma
VWA8::RICTOR	Malignant melanoma
VWC2::EGFR	Malignant peripheral nerve sheath tumor/Triton
VWC2::RAB20	Astrocytoma, grade III-IV/Glioblastoma
VWCE::SH3D19	Mesenchymal tumor, NOS
VWF::ZC3H14	Adenocarcinoma
WAC::APBB1IP	Adenocarcinoma
WAC::GPR158	Undifferentiated carcinoma, small cell
WAC::RDX	Adenocarcinoma
WAC::RET	Adenocarcinoma | Carcinoma, NOS
WAC::UBAC2	Adenocarcinoma
WAPL::MMRN2	Adenocarcinoma
WAPL::NRP1	Adenocarcinoma
WAPL::PTPRT	Squamous cell carcinoma
WAPL::SIAE	Adenocarcinoma
WARS1::CCNY	Adenocarcinoma
WARS1::EPB41L4B	Adenocarcinoma
WARS1::KTN1	Adenocarcinoma
WARS1::MSH6	Adenocarcinoma
WARS1::PPP2R3C	Adenocarcinoma
WARS1::UTRN	Adenocarcinoma
WARS2::DLG2	Adenocarcinoma
WARS2::HMGCS2	Adenocarcinoma
WARS2::NTNG1	Malignant melanoma
WARS2::OXR1	Transitional cell carcinoma
WARS2::PHGDH	Squamous cell carcinoma
WARS2::REG4	Adenocarcinoma
WARS2::RPF1	Diffuse large B-cell lymphoma
WARS2::TMEM87B	Squamous cell carcinoma
WARS2::TPST1	Adenocarcinoma
WARS2::ZAR1	Squamous cell carcinoma
WASF1::SLC41A3	Mesenchymal tumor, NOS
WASF2::ACOT7	Squamous cell carcinoma
WASF2::AHDC1	Squamous cell carcinoma
WASF2::FGR	Adenocarcinoma | Squamous cell carcinoma | Malignant melanoma | Malignant epithelial tumor, special type
WASF2::IFI6	Adenocarcinoma
WASF2::RIPOR2	Squamous cell carcinoma
WASF2::SLC9A1	Adenocarcinoma
WASF2::TMEM222	Astrocytoma, grade I-II
WASF2::VANGL1	Adenocarcinoma
WASF3::ATP8A2	Adenocarcinoma
WASF3::CDK8	Adenocarcinoma
WASHC1::NPAS3	Adenocarcinoma
WASHC2A::ASAH2	Adenocarcinoma
WASHC2A::LURAP1L	Squamous cell carcinoma
WASHC4::AUTS2	Adenocarcinoma
WASHC4::HCAR1	Adenocarcinoma
WASHC4::LGR5	Astrocytoma, grade III-IV/Glioblastoma
WASHC4::NOPCHAP1	Astrocytoma, grade III-IV/Glioblastoma
WASHC4::PCDH9	Squamous cell carcinoma
WASHC4::PRDM4	Mesenchymal tumor, NOS
WASHC4::RFX4	Adenocarcinoma
WASL::FEZF1	Adenocarcinoma
WBP11::LGR5	Mesenchymal tumor, NOS
WBP11::MGP	Adenocarcinoma
WBP1L::ADAMTS2	Adenocarcinoma
WBP1L::ADTRP	Adenocarcinoma
WBP1L::ARL3	Astrocytoma, grade I-II | Adenocarcinoma
WBP1L::CELF2	Mycosis fungoides/Sézary syndrome
WBP1L::DLK1	Adenocarcinoma
WBP1L::HOXC8	Adenocarcinoma
WBP1L::PTEN	Adenocarcinoma
WBP1L::SFXN2	Adenocarcinoma
WBP1L::SUFU	Adenocarcinoma
WBP1L::TRIM8	Adenocarcinoma
WBP2::UNK	Squamous cell carcinoma
WBP2NL::MEI1	Adenocarcinoma
WBP2NL::SEPTIN3	Adenocarcinoma
WBP4::FANK1	Adenocarcinoma
WDCP::ALK	Adenocarcinoma
WDCP::SF3B6	Germ cell tumor, NOS
WDFY1::NYAP2	Mesenchymal tumor, NOS
WDFY1::PARD3B	Mesenchymal tumor, NOS
WDFY1::SERPINE2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
WDFY2::FOXO1	Adenocarcinoma
WDFY2::S1PR5	Adenocarcinoma
WDFY3::FOSL1	Adenocarcinoma
WDFY3::HNRNPD	Adenocarcinoma
WDFY3::KCNIP4	Adenocarcinoma
WDFY3::PLAGL1	Mesenchymal tumor, NOS
WDHD1::DLGAP5	Squamous cell carcinoma | Malignant melanoma | Adenocarcinoma
WDHD1::GCH1	Squamous cell carcinoma
WDHD1::LGALS3	Adenocarcinoma
WDPCP::ALK	Adenocarcinoma
WDPCP::SERTAD2	Squamous cell carcinoma
WDPCP::SOCS5	Adenocarcinoma
WDPCP::VPS54	Adenocarcinoma
WDR11::PDLIM1	Squamous cell carcinoma
WDR12::PARD3B	Adenocarcinoma
WDR17::LTA4H	Astrocytoma, grade I-II
WDR18::H2AX	Acute myeloid leukemia, NOS | Acute erythroleukemia (FAB type M6) | Skin
WDR18::JPT2	Squamous cell carcinoma
WDR18::TGM5	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
WDR20::DYNC1H1	Adenocarcinoma
WDR20::GET3	Astrocytoma, grade III-IV/Glioblastoma
WDR20::LGALS2	Astrocytoma, grade I-II
WDR20::LRP10	Adenocarcinoma
WDR20::PPP2R5C	Adenocarcinoma
WDR20::TECPR2	Astrocytoma, grade I-II
WDR25::MAST2	Adenocarcinoma
WDR27::HDDC2	Adenocarcinoma
WDR33::ATIC	Adenocarcinoma
WDR33::LRP1B	Malignant melanoma
WDR35::HS1BP3	Squamous cell carcinoma
WDR35::PUM2	Adenocarcinoma | Squamous cell carcinoma
WDR36::NREP	Squamous cell carcinoma
WDR37::AHNAK	Adenocarcinoma
WDR37::FAM107B	Transitional cell carcinoma
WDR37::PCDH12	Astrocytoma, grade I-II
WDR37::TUBAL3	Transitional cell carcinoma
WDR3::MYEOV	Adenocarcinoma
WDR43::PPP1CB	Mature B-cell neoplasm, NOS
WDR44::DOCK11	Adenocarcinoma
WDR45::TFE3	Adenocarcinoma
WDR45B::B3GNTL1	Squamous cell carcinoma
WDR45B::JDP2	Adenocarcinoma
WDR45B::OGFOD3	Astrocytoma, grade I-II
WDR45B::RAB40B	Adenocarcinoma
WDR45B::SEPTIN4	Adenocarcinoma
WDR47::CFAP276	Adenocarcinoma
WDR47::DECR2	Adenocarcinoma
WDR48::HERC2	Transitional cell carcinoma
WDR48::PDGFRB	Chronic myeloproliferative disorder, NOS
WDR48::PPARG	Transitional cell carcinoma
WDR49::VEPH1	Astrocytoma, grade I-II
WDR4::PDE9A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
WDR4::RUNX1	Transitional cell carcinoma
WDR55::ANKHD1	Adenocarcinoma
WDR55::DND1	Adenocarcinoma
WDR55::PAIP2	Adenocarcinoma
WDR59::AARSD1	Adenocarcinoma
WDR59::ASB9	Astrocytoma, grade III-IV/Glioblastoma
WDR59::CDH11	Malignant melanoma
WDR59::CFDP1	Adenocarcinoma
WDR59::CHST5	Transitional cell carcinoma
WDR59::CHST6	Adenocarcinoma
WDR59::KARS1	Adenocarcinoma
WDR59::KIFC3	Malignant melanoma
WDR59::PTGES3L	Adenocarcinoma
WDR5::PAX5	Acute lymphoblastic leukemia/lymphoblastic lymphoma
WDR62::FMNL2	Astrocytoma, grade III-IV/Glioblastoma
WDR62::HCST	Transitional cell carcinoma
WDR62::LRFN3	Mesenchymal tumor, NOS
WDR62::TRAPPC6A	Astrocytoma, grade I-II
WDR6::B2M	Multiple myeloma
WDR6::BCL2L11	Multiple myeloma
WDR6::CPNE8	Transitional cell carcinoma
WDR6::IGH	Multiple myeloma
WDR6::KLF2	Multiple myeloma
WDR70::ADAMTS12	Adenocarcinoma
WDR70::AGXT2	Malignant melanoma
WDR70::CACNA2D4	Transitional cell carcinoma
WDR70::GHR	Adenocarcinoma
WDR70::GRAMD4	Malignant melanoma
WDR70::NIPBL	Adenocarcinoma
WDR70::PGAP3	Adenocarcinoma
WDR70::PLCXD3	Adenocarcinoma
WDR70::RAI14	Adenocarcinoma
WDR72::AZIN1	Adenocarcinoma
WDR76::IDH3A	Malignant melanoma
WDR76::PDIA3	Adenocarcinoma
WDR76::SERF2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
WDR81::CYB5D1	Squamous cell carcinoma
WDR82::ARHGAP39	Adenocarcinoma
WDR82::GLT8D1	Malignant epithelial tumor, special type
WDR82::NT5DC2	Squamous cell carcinoma
WDR82::UBE4B	Adenocarcinoma
WDR90::ESYT3	Mesenchymal tumor, NOS
WDR90::RAB40C	Adenocarcinoma
WDSUB1::BAZ2B	Adenocarcinoma
WDSUB1::FYTTD1	Mesenchymal tumor, NOS
WDSUB1::GPD2	Transitional cell carcinoma
WDTC1::CD151	Adenocarcinoma
WDTC1::CRACR2B	Adenocarcinoma
WDTC1::FNBP1L	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
WDTC1::PRKRIP1	Adenocarcinoma
WDTC1::TMEM39B	Squamous cell carcinoma
WEE1::CHRNA3	Squamous cell carcinoma
WFDC2::COMMD7	Malignant epithelial tumor, special type
WFDC2::PI3	Adenocarcinoma
WFDC2::PIGT	Adenocarcinoma
WFDC3::NEURL2	Adenocarcinoma
WFDC3::OSBPL2	Adenocarcinoma
WFDC5::SDC4	Squamous cell carcinoma
WHRN::AMBP	Adenocarcinoma
WHRN::TNC	Squamous cell carcinoma
WIPF1::CHN1	Adenocarcinoma | Mature B-cell neoplasm, NOS
WIPF1::CIR1	Adenocarcinoma
WIPF2::CACNB1	Adenocarcinoma
WIPF2::CDC42EP4	Adenocarcinoma
WIPF2::CDK12	Adenocarcinoma
WIPF2::DBF4B	Squamous cell carcinoma
WIPF2::ERBB2	Adenocarcinoma
WIPF2::EZH1	Adenocarcinoma
WIPF2::GRB7	Adenocarcinoma
WIPF2::IKZF3	Adenocarcinoma
WIPF2::IL2RB	Adenocarcinoma
WIPF2::LASP1	Endometrial stromal sarcoma
WIPF2::LRRC3C	Adenocarcinoma
WIPF2::MED24	Transitional cell carcinoma
WIPF2::MRPL45	Mesenchymal tumor, NOS
WIPF2::MSL1	Transitional cell carcinoma
WIPF2::NFAM1	Adenocarcinoma
WIPF2::ORMDL3	Adenocarcinoma
WIPF2::PSMD11	Adenocarcinoma
WIPF2::PSMD3	Adenocarcinoma
WIPF2::RAMP2	Adenocarcinoma
WIPF2::RAPGEFL1	Adenocarcinoma
WIPF2::SEZ6	Adenocarcinoma
WIPF2::SP2	Adenocarcinoma
WIPF2::STARD3	Malignant epithelial tumor, special type
WIPF2::THRA	Adenocarcinoma
WIPF2::TUBD1	Adenocarcinoma
WIPF2::USP32	Adenocarcinoma
WIPF2::XYLT2	Malignant epithelial tumor, special type
WIPF2::ZPBP2	Adenocarcinoma
WIPI2::AIMP2	Malignant melanoma
WIPI2::ERP29	Diffuse large B-cell lymphoma
WIPI2::NXPH1	Astrocytoma, grade III-IV/Glioblastoma
WIZ::CYP4F3	Adenocarcinoma
WLS::TBX3	Adenocarcinoma
WNK1::B4GALNT3	Adenocarcinoma
WNK1::CCDC77	Adenocarcinoma
WNK1::DUSP16	Squamous cell carcinoma
WNK1::EIF3G	Adenocarcinoma
WNK1::ERC1	Adenocarcinoma
WNK1::GIPC1	Adenocarcinoma
WNK1::ID1	Acute erythroleukemia (FAB type M6)
WNK1::IQSEC3	Adenocarcinoma
WNK1::KDM4B	Squamous cell carcinoma
WNK1::KDM5A	Adenocarcinoma
WNK1::PDGFRB	Myelodysplastic/myeloproliferative disease, NOS | Thymus
WNK1::PIP4K2C	Adenocarcinoma
WNK1::PRMT8	Adenocarcinoma
WNK1::RAD52	Acute myeloid leukemia, NOS | Skin | Adenocarcinoma
WNK1::ROS1	Adenocarcinoma
WNK1::SH2B3	Adenocarcinoma
WNK1::STK38L	Astrocytoma, grade I-II
WNK1::WNT5B	Adenocarcinoma
WNK2::CARD19	Adenocarcinoma
WNK2::CENPP	Astrocytoma, grade I-II | Malignant epithelial tumor, special type | Transitional cell carcinoma
WNK2::FAM120A	Adenocarcinoma
WNK2::RECQL	Transitional cell carcinoma
WNK2::SECISBP2	Squamous cell carcinoma
WNK2::SH2B2	Adenocarcinoma
WNK2::SUSD3	Adenocarcinoma
WNK3::FGD1	Adenocarcinoma
WNK4::ZNF787	Neuroblastoma
WNT10B::CPS1	Adenocarcinoma
WNT11::TSPAN8	Adenocarcinoma
WNT2::ASZ1	Astrocytoma, grade I-II
WNT2::ST7	Astrocytoma, grade I-II
WNT5B::ERC1	Adenocarcinoma
WNT5B::NINJ2	Squamous cell carcinoma
WNT7A::PPFIA1	Transitional cell carcinoma
WNT7B::DGCR8	Adenocarcinoma
WNT7B::LRP6	Adenocarcinoma
WRAP53::AHCY	Adenocarcinoma
WRAP53::MPDU1	Squamous cell carcinoma
WRAP53::SLC44A2	Adenocarcinoma
WRN::ADAM9	Adenocarcinoma
WRN::FYTTD1	Squamous cell carcinoma
WRN::LETM2	Malignant epithelial tumor, special type
WRN::NRG1	Adenocarcinoma
WRNIP1::SERPINB6	Malignant melanoma
WSB1::FN3KRP	Adenocarcinoma
WSB1::HYPK	Acute lymphoblastic leukemia/lymphoblastic lymphoma
WSB1::MED1	Astrocytoma, grade III-IV/Glioblastoma
WSB1::NBR1	Skin | Acute myeloid leukemia, NOS | Acute myeloblastic leukemia with maturation (FAB type M2)
WSB1::SEZ6	Astrocytoma, grade III-IV/Glioblastoma
WSB1::XKR4	Adenocarcinoma
WSB2::RFC5	Adenocarcinoma
WSB2::VSIG10	Adenocarcinoma
WSCD1::DAPK1	Adenocarcinoma
WSCD1::NLRP1	Adenocarcinoma
WTAP::MAS1	Malignant melanoma
WTAP::SOCS2	Adenocarcinoma
WTIP::BIRC6	Endometrial stromal sarcoma
WTIP::GARRE1	Adenocarcinoma
WTIP::SCGB2B2	Adenocarcinoma
WWC1::FMN2	Adenocarcinoma
WWC1::GRK3	Adenocarcinoma
WWC1::RARS1	Adenocarcinoma
WWC1::SNTG2	Adenocarcinoma
WWC1::TENM2	Adenocarcinoma
WWC2::CCDC110	Squamous cell carcinoma
WWC3::SHROOM2	Adenocarcinoma
WWOX::CDH3	Adenocarcinoma
WWOX::CDIN1	Astrocytoma, grade III-IV/Glioblastoma
WWOX::NUDT7	Transitional cell carcinoma | Adenocarcinoma
WWOX::TGIF2	Adenocarcinoma
WWOX::VAT1L	Mature B-cell neoplasm, NOS | Adenocarcinoma
WWP1::ATP6V0D2	Adenocarcinoma
WWP1::C8ORF34	Adenocarcinoma
WWP1::CPB2	Adenocarcinoma
WWP1::ESRP1	Malignant melanoma
WWP1::LRRCC1	Adenocarcinoma
WWP1::NUBPL	Adenocarcinoma
WWP1::UTP23	Mesenchymal tumor, NOS
WWP1::ZNF704	Malignant melanoma
WWP2::CTSB	Adenocarcinoma
WWP2::CYB5B	Adenocarcinoma
WWP2::GSG1L	Adenocarcinoma
WWP2::NFAT5	Adenocarcinoma
WWP2::SNU13	Adenocarcinoma
WWP2::TANGO6	Squamous cell carcinoma | Adenocarcinoma
WWP2::TSEN54	Adenocarcinoma
WWP2::ZNF629	Malignant melanoma
WWTR1::ACTL6A	Epithelioid hemangioendothelioma
WWTR1::AFF2	Malignant soft tissue tumor, NOS
WWTR1::AGTR1	Squamous cell carcinoma
WWTR1::ANKUB1	Adenocarcinoma
WWTR1::ATR	Adenocarcinoma
WWTR1::CAMTA1	Epithelioid hemangioendothelioma
WWTR1::ESRRG	Malignant melanoma
WWTR1::FOSB	Epithelioid hemangioendothelioma | Vascular and perivascular tumor, special type
WWTR1::MAML2	Epithelioid hemangioendothelioma
WWTR1::NCOA2	Adenoma
WWTR1::NUTM1	Benign epithelial tumor, special type
WWTR1::PRKCE	Leiomyoma
WWTR1::RET	Carcinoma, NOS
WWTR1::TFE3	Epithelioid hemangioendothelioma
XAB2::UBE2F	Adenocarcinoma
XAF1::PIMREG	Adenocarcinoma
XBP1::CCT5	Adenocarcinoma
XBP1::KLK2	Adenocarcinoma
XBP1::TTC28	Germ cell tumor, NOS
XBP1::UTRN	Adenocarcinoma
XIAP::OLR1	Acute myeloblastic leukemia with maturation (FAB type M2)
XKR6::HOOK3	Adenocarcinoma
XPA::CORO2A	Squamous cell carcinoma
XPC::DAG1	Mesenchymal tumor, NOS
XPC::RCOR1	Adenocarcinoma
XPNPEP1::FAM13B	Mesenchymal tumor, NOS
XPNPEP3::EFCAB6	Adenocarcinoma
XPNPEP3::RTCB	Adenocarcinoma
XPNPEP3::SGSM3	Adenocarcinoma
XPO1::ALK	Anaplastic large cell lymphoma, systemic type
XPO1::BHLHE40	Diffuse large B-cell lymphoma
XPO1::C2ORF74	Transitional cell carcinoma
XPO1::C2orf74	Transitional cell carcinoma
XPO1::HORMAD1	Adenocarcinoma
XPO1::MLLT10	Acute megakaryoblastic leukemia (FAB type M7) | Acute lymphoblastic leukemia/lymphoblastic lymphoma
XPO1::PELI1	Diffuse large B-cell lymphoma
XPO1::TNRC18	Acute myeloid leukemia, NOS | Skin | Acute megakaryoblastic leukemia (FAB type M7) | Acute lymphoblastic leukemia/lymphoblastic lymphoma
XPO4::DMAC2	Mesenchymal tumor, NOS
XPO4::SSRP1	Adenocarcinoma
XPO4::ZDHHC20	Adenocarcinoma
XPO5::EYS	Adenocarcinoma
XPO5::KIF6	Adenocarcinoma
XPO5::MRPS10	Adenocarcinoma
XPO5::VARS1	Adenocarcinoma
XPO6::DRC3	Transitional cell carcinoma
XPO6::EYA4	Adenocarcinoma
XPO6::FBXO31	Transitional cell carcinoma
XPO6::HIRIP3	Squamous cell carcinoma
XPO6::PARN	Adenocarcinoma
XPO7::ETV4	Adenocarcinoma
XPO7::MACROH2A2	Adenocarcinoma
XPO7::NBN	Adenocarcinoma
XPOT::C12ORF56	Adenocarcinoma
XPOT::C12orf56	Adenocarcinoma
XPOT::EPYC	Transitional cell carcinoma
XPR1::AHNAK	Adenocarcinoma
XPR1::ARHGEF11	Transitional cell carcinoma
XPR1::BRINP3	Adenocarcinoma
XPR1::COP1	Adenocarcinoma
XPR1::DEDD	Transitional cell carcinoma
XPR1::DRC3	Adenocarcinoma
XPR1::FCGR3A	Squamous cell carcinoma
XPR1::KHDRBS1	Adenocarcinoma
XPR1::KIAA1614	Adenocarcinoma
XPR1::KIFAP3	Adenocarcinoma
XPR1::LHX4	Adenocarcinoma
XPR1::MR1	Squamous cell carcinoma
XPR1::MSMP	Adenocarcinoma
XPR1::NCF2	Malignant melanoma
XPR1::NME7	Adenocarcinoma
XPR1::QSOX1	Adenocarcinoma
XPR1::TNR	Mesenchymal tumor, NOS
XPR1::TOR3A	Squamous cell carcinoma
XPR1::TRMT1L	Undifferentiated carcinoma, small cell
XPR1::TYW3	Adenocarcinoma
XRCC1::MAL	Adenocarcinoma
XRCC2::ACTR3C	Adenocarcinoma
XRCC2::WASL	Malignant melanoma
XRCC4::CYFIP2	Myelodysplastic syndrome, NOS
XRCC5::ABCB1	Adenocarcinoma
XRCC5::ACADL	Adenocarcinoma
XRCC5::CCT5	Squamous cell carcinoma
XRCC5::FRMD4A	Alveolar rhabdomyosarcoma
XRCC5::MYL1	Adenocarcinoma
XRCC5::TMEM169	Adenocarcinoma
XRCC6::ACO2	Adenocarcinoma
XRCC6::ARSB	Malignant melanoma
XRCC6::GPX5	Adenocarcinoma
XRCC6::L3MBTL2	Adenocarcinoma
XRCC6::SREBF2	Adenocarcinoma
XRCC6::UBE2D2	Astrocytoma, grade I-II
XRN1::GK5	Squamous cell carcinoma
XRN1::NUP98	Acute erythroleukemia (FAB type M6)
XRN1::PIP4K2A	Adenocarcinoma
XRN1::PRKCE	Adenocarcinoma
XRN1::RUVBL1	Malignant melanoma
XRN1::SMYD3	Astrocytoma, grade III-IV/Glioblastoma
XRN2::RIN2	Mesenchymal tumor, NOS
XRN2::TMEM40	Squamous cell carcinoma
XRRA1::EMSY	Malignant melanoma
XRRA1::FAM168A	Adenocarcinoma
XRRA1::GUCY1A2	Adenocarcinoma
XRRA1::SHANK2	Adenocarcinoma
XXYLT1::ACAP2	Adenocarcinoma
XXYLT1::CEACAM7	Malignant melanoma
XXYLT1::ETV5	Mesenchymal tumor, NOS
XXYLT1::OPA1	Squamous cell carcinoma
XXYLT1::OSTN	Squamous cell carcinoma
XXYLT1::TPRG1	Squamous cell carcinoma
XYLB::DLEC1	Adenocarcinoma
XYLB::ITGA9	Adenocarcinoma
XYLB::OXSR1	Adenocarcinoma
XYLT1::ABR	Mesenchymal tumor, NOS
XYLT1::EEF2KMT	Mesenchymal tumor, NOS
XYLT1::GALNT6	Mesenchymal tumor, NOS
XYLT1::HS3ST4	Malignant melanoma
XYLT1::QPRT	Adenocarcinoma
XYLT1::SPN	Adenocarcinoma
XYLT2::ACSF2	Adenocarcinoma
YAE1::ALS2	Adenocarcinoma
YAE1::GJC3	Squamous cell carcinoma
YAF2::SYT1	Adenocarcinoma
YAF2::ZCRB1	Adenocarcinoma
YAP1::BEND2	Neuroglial neoplasm, special type
YAP1::CFAP300	Adenocarcinoma
YAP1::CNTN5	Transitional cell carcinoma
YAP1::FAM118B	Meningioma | Astrocytoma, pilocytic/juvenile
YAP1::FOXR1	Vascular and perivascular tumor, special type | Epithelioid hemangioendothelioma
YAP1::KDM2B	Neuroglial neoplasm, special type
YAP1::KMT2A	Sclerosing epithelioid fibrosarcoma | Malignant soft tissue tumor, NOS
YAP1::KMT2A::YAP1	Fibroblastic/myofibroblastic tumor, special type | Sclerosing epithelioid fibrosarcoma
YAP1::LEUTX	Malignant epithelial tumor, special type | Undifferentiated round cell sarcoma
YAP1::LMO1	Meningioma
YAP1::MAML2	Soft tissue tumor, special type | Adenocarcinoma | Myxoinflammatory fibroblastic sarcoma | Spindle cell/sclerosing rhabdomyosarcoma | Squamous cell carcinoma | Schwannoma | Ependymoma | Benign epithelial tumor, special type | Vascular and perivascular tumor, special type | Meningioma | Malignant melanoma | Malignant epithelial tumor, special type
YAP1::MAMLD1	Ependymoma
YAP1::MRPL48	Malignant melanoma
YAP1::MYEOV	Transitional cell carcinoma
YAP1::NUTM1	Benign epithelial tumor, special type | Malignant epithelial tumor, special type
YAP1::NUTM2B	Undifferentiated round cell sarcoma
YAP1::PYGO1	Meningioma
YAP1::RNF130	Mesenchymal tumor, NOS
YAP1::SHANK2	Squamous cell carcinoma
YAP1::SS18	Squamous cell carcinoma
YAP1::STIM1	Adenocarcinoma
YAP1::TFE3	Mesenchymal tumor, special type | Vascular and perivascular tumor, special type | Soft tissue tumor, special type | Epithelioid hemangioendothelioma | Fibroblastic/myofibroblastic tumor, special type
YAP1::TTC12	Malignant melanoma
YAP1::USP2	Adenocarcinoma
YARS1::ADM5	Adenocarcinoma
YARS1::ANKRD17	Mesenchymal tumor, NOS
YARS1::IMPA2	Adenocarcinoma
YARS1::RNF19B	Astrocytoma, grade III-IV/Glioblastoma
YARS1::ST3GAL3	Adenocarcinoma
YARS1::ZBTB8OS	Germ cell tumor, NOS
YBX3::APOLD1	Squamous cell carcinoma
YBX3::ATF7IP	Adenocarcinoma
YBX3::BORCS5	Adenocarcinoma
YBX3::DDX47	Squamous cell carcinoma
YBX3::MRPL42	Adenocarcinoma
YBX3::PGAP6	Adenocarcinoma
YDJC::CLEC16A	Squamous cell carcinoma
YEATS2::ABCC5	Squamous cell carcinoma
YEATS2::ATP11B	Squamous cell carcinoma
YEATS2::GNB4	Squamous cell carcinoma
YEATS2::HTR3C	Squamous cell carcinoma
YEATS2::HTR3E	Transitional cell carcinoma
YEATS2::LIPH	Squamous cell carcinoma
YEATS2::LRCH3	Adenocarcinoma
YEATS2::PRKCI	Adenocarcinoma
YEATS2::SEC62	Astrocytoma, grade III-IV/Glioblastoma
YEATS2::TPRG1	Squamous cell carcinoma
YEATS4::ATP23	Astrocytoma, grade III-IV/Glioblastoma
YEATS4::CPSF6	Adenocarcinoma
YEATS4::EP400	Astrocytoma, grade III-IV/Glioblastoma
YEATS4::LYZ	Transitional cell carcinoma
YEATS4::MARS1	Astrocytoma, grade III-IV/Glioblastoma
YEATS4::SLC35E3	Adenocarcinoma | Astrocytoma, grade III-IV/Glioblastoma
YEATS4::STK38L	Adenocarcinoma
YES1::ENOSF1	Diffuse large B-cell lymphoma
YES1::METTL4	Squamous cell carcinoma
YES1::SCFD2	Transitional cell carcinoma
YIF1A::CTSF	Squamous cell carcinoma
YIF1B::SAMD12	Squamous cell carcinoma
YIPF1::MRPL15	Transitional cell carcinoma
YIPF1::USP24	Adenocarcinoma
YIPF1::YTHDF2	Squamous cell carcinoma
YIPF2::ELP5	Adenocarcinoma
YIPF3::SERPING1	Adenocarcinoma
YIPF4::COMMD1	Adenocarcinoma
YIPF5::NR3C1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
YIPF6::NUGGC	Transitional cell carcinoma
YIPF7::ADRA1A	Adenocarcinoma
YJU2::ANKRD24	Squamous cell carcinoma
YJU2::EBI3	Astrocytoma, grade I-II
YJU2::KMT2A	Acute myelomonocytic leukemia (FAB type M4)
YJU2::MAP2K2	Astrocytoma, grade I-II
YJU2B::SAFB2	Adenocarcinoma
YKT6::EIF3B	Mesenchymal tumor, NOS
YLPM1::LIN52	Alveolar rhabdomyosarcoma
YLPM1::PRKD1	Adenocarcinoma
YME1L1::ANKRD26	Squamous cell carcinoma
YME1L1::SLC35D2	Adenocarcinoma
YME1L1::ZNF438	Adenocarcinoma
YPEL1::MAPK1	Adenocarcinoma
YPEL2::ATP5MC1	Adenocarcinoma
YPEL2::B4GALNT2	Adenocarcinoma
YPEL2::BPTF	Adenocarcinoma
YPEL2::HEATR6	Adenocarcinoma
YPEL2::HSPA12B	Adenocarcinoma
YPEL2::PAK1	Adenocarcinoma
YPEL2::SDF2	Adenocarcinoma
YPEL2::UBE2Z	Adenocarcinoma
YPEL3::EXD3	Adenocarcinoma
YPEL4::KMT2A	Acute lymphoblastic leukemia/lymphoblastic lymphoma
YPEL5::IGH	Multiple myeloma
YPEL5::PPP1CB	Chronic lymphocytic leukemia
YTHDC1::ADAMTS3	Squamous cell carcinoma
YTHDC1::GAK	Adenocarcinoma
YTHDC1::SULT1B1	Squamous cell carcinoma
YTHDC1::TMPRSS11F	Adenocarcinoma
YTHDF2::ARSB	Adenocarcinoma
YTHDF2::EYA3	Malignant epithelial tumor, special type
YTHDF2::RAB42	Squamous cell carcinoma
YTHDF2::SYTL1	Adenocarcinoma
YWHAB::ARHGAP32	Adenocarcinoma
YWHAB::BCL2L1	Adenocarcinoma
YWHAB::CRPPA	Transitional cell carcinoma
YWHAB::GLO1	Adenocarcinoma
YWHAB::STK4	Adenocarcinoma
YWHAE::CRK	Squamous cell carcinoma
YWHAE::ERCC8	Adenocarcinoma
YWHAE::GCGR	Malignant epithelial tumor, special type
YWHAE::INPP5K	Adenocarcinoma
YWHAE::MYH3	Squamous cell carcinoma
YWHAE::NUTM2A	Endometrial stromal sarcoma | Neuroglial neoplasm, special type
YWHAE::NUTM2B	Undifferentiated round cell sarcoma | Endometrial stromal sarcoma | Clear cell sarcoma | Malignant soft tissue tumor, NOS
YWHAE::NUTM2E	Undifferentiated round cell sarcoma | Clear cell sarcoma
YWHAE::PITPNA	Adenocarcinoma
YWHAE::ROS1	Inflammatory myofibroblastic tumor/myofibroblastic sarcoma
YWHAE::RPH3AL	Transitional cell carcinoma
YWHAE::RTN4RL1	Adenocarcinoma
YWHAE::SLC43A2	Adenocarcinoma
YWHAE::SMYD4	Malignant epithelial tumor, special type
YWHAE::SPNS3	Adenocarcinoma
YWHAE::TLCD2	Adenocarcinoma
YWHAE::TRARG1	Adenocarcinoma
YWHAE::TXLNB	Malignant melanoma
YWHAG::BRAF	Adenocarcinoma
YWHAG::CYB561	Adenocarcinoma
YWHAG::GPR37L1	Adenocarcinoma
YWHAG::OPA3	Malignant melanoma
YWHAG::PDIA3	Adenocarcinoma
YWHAG::RAB11FIP1	Adenocarcinoma
YWHAG::SSC4D	Adenocarcinoma
YWHAH::DEPDC5	Adenocarcinoma
YWHAQ::ADAM17	Squamous cell carcinoma
YWHAZ::GAL	Transitional cell carcinoma
YWHAZ::HHLA1	Adenocarcinoma
YWHAZ::KLF10	Multiple myeloma
YWHAZ::OXR1	Undifferentiated carcinoma, small cell
YWHAZ::PLAG1	Low-grade fibromyxoid sarcoma | Myxofibrosarcoma | Leiomyosarcoma | Lipoblastoma
YWHAZ::SCAF11	Adenocarcinoma
YWHAZ::UBA1	Squamous cell carcinoma
YWHAZ::ZBTB33	Adenocarcinoma
YY1::CCNK	Adenocarcinoma
YY1::EVL	Squamous cell carcinoma
YY1::TESPA1	Mesenchymal tumor, NOS
YY1AP1::ARHGEF2	Mesenchymal tumor, NOS | Adenocarcinoma
ZBED4::RANGAP1	Malignant melanoma
ZBED4::SPAG4	Adenocarcinoma
ZBED4::SUGCT	Adenocarcinoma
ZBED6::FIP1L1	Astrocytoma, grade I-II
ZBED6::TMCC2	Adenocarcinoma
ZBTB10::NTRK3	Astrocytoma, grade III-IV/Glioblastoma
ZBTB16::ABL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ZBTB16::RARA	Skin | Acute myeloid leukemia, NOS | Acute myeloblastic leukemia with maturation (FAB type M2) | Acute promyelocytic leukemia (FAB type M3)
ZBTB17::DLC1	Adenocarcinoma
ZBTB17::FAM131C	Adenocarcinoma
ZBTB17::FBXO42	Malignant epithelial tumor, special type
ZBTB17::MTOR	Adenocarcinoma
ZBTB1::MTHFD1	Adenocarcinoma
ZBTB20::CD200R1	Adenocarcinoma
ZBTB20::CD96	Adenocarcinoma
ZBTB20::CEP15	Astrocytoma, grade I-II
ZBTB20::CFAP44	Squamous cell carcinoma
ZBTB20::CLDN11	Adenocarcinoma
ZBTB20::CMSS1	Adenocarcinoma
ZBTB20::CPM	Mesenchymal tumor, NOS
ZBTB20::CPNE4	Adenocarcinoma
ZBTB20::DPYSL2	Adenocarcinoma
ZBTB20::EPHA6	Adenocarcinoma
ZBTB20::FOCAD	Malignant epithelial tumor, special type | Embryonal nervous system tumor, special type
ZBTB20::IFT57	Adenocarcinoma
ZBTB20::JAK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ZBTB20::KANSL2	Malignant melanoma
ZBTB20::LSAMP	Adenocarcinoma
ZBTB20::PGD	Squamous cell carcinoma
ZBTB20::PTPRD	Adenocarcinoma
ZBTB20::RERE	Adenocarcinoma
ZBTB20::SH3BGRL	Squamous cell carcinoma
ZBTB20::STON1	Adenocarcinoma
ZBTB20::TESMIN	Mesenchymal tumor, NOS
ZBTB20::TIGIT	Adenocarcinoma
ZBTB21::AIRE	Adenocarcinoma
ZBTB21::PFKL	Adenocarcinoma
ZBTB21::TFF1	Adenocarcinoma
ZBTB24::BEST3	Mesenchymal tumor, NOS
ZBTB24::SCML4	Adenocarcinoma
ZBTB24::STK32C	Mesenchymal tumor, NOS
ZBTB25::TPRG1	Squamous cell carcinoma
ZBTB2::AKAP12	Adenocarcinoma
ZBTB2::SYNE1	Adenocarcinoma
ZBTB38::CHCT1	Adenocarcinoma
ZBTB38::PXYLP1	Adenocarcinoma
ZBTB40::MACO1	Benign epithelial tumor, special type | Miscellaneous hematopoietic/lymphoid neoplasm, special type
ZBTB40::NBPF3	Adenocarcinoma
ZBTB40::PRCC	Astrocytoma, grade I-II
ZBTB40::TCEA3	Squamous cell carcinoma
ZBTB40::VPS13D	Adenocarcinoma
ZBTB41::RET	Adenocarcinoma
ZBTB43::PITPNC1	Adenocarcinoma
ZBTB44::BACE1	Astrocytoma, grade I-II
ZBTB44::FLT3	Chronic myeloproliferative disorder, NOS
ZBTB44::FRS2	Mesenchymal tumor, NOS
ZBTB44::JAK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ZBTB45::ZFR2	Adenocarcinoma
ZBTB48::ESPN	Astrocytoma, grade III-IV/Glioblastoma
ZBTB48::TAS1R1	Adenocarcinoma
ZBTB49::SLC23A2	Malignant melanoma
ZBTB4::ACADVL	Astrocytoma, grade III-IV/Glioblastoma
ZBTB4::RARA	Malignant epithelial tumor, special type
ZBTB4::SLC22A4	Adenocarcinoma
ZBTB5::SLC24A2	Adenocarcinoma
ZBTB5::SMARCA2	Transitional cell carcinoma
ZBTB7A::APBA3	Adenocarcinoma
ZBTB7A::COMP	Adenocarcinoma
ZBTB7A::CYP4F3	Astrocytoma, grade I-II
ZBTB7A::MAP2K2	Adenocarcinoma
ZBTB7A::MLLT1	Adenocarcinoma
ZBTB7A::TNK1	Acute myeloid leukemia, NOS | Acute megakaryoblastic leukemia (FAB type M7) | Skin
ZBTB7B::CKS1B	Adenocarcinoma
ZBTB7B::FCAMR	Adenocarcinoma
ZBTB7B::NTRK1	Transitional cell carcinoma | Adenocarcinoma
ZBTB7B::NUCKS1	Adenocarcinoma
ZBTB7B::ZMPSTE24	Adenocarcinoma
ZBTB7C::FBXO15	Astrocytoma, grade I-II
ZBTB7C::RAB12	Adenocarcinoma
ZBTB7C::SCFD2	Adenocarcinoma
ZBTB8A::TINAGL1	Adenocarcinoma
ZBTB8B::TRAF3IP1	Squamous cell carcinoma
ZBTB8OS::BSDC1	Transitional cell carcinoma
ZBTB8OS::ERI3	Adenocarcinoma
ZBTB8OS::IGF2BP1	Adenocarcinoma
ZBTB8OS::SYNC	Adenocarcinoma
ZBTB8OS::YARS1	Adenocarcinoma
ZC2HC1A::ANGPT1	Transitional cell carcinoma
ZC3H11A::ATP2B4	Mature B-cell neoplasm, NOS | Multiple myeloma
ZC3H11A::FIP1L1	Astrocytoma, grade I-II
ZC3H11A::TMCC2	Adenocarcinoma
ZC3H12C::SIDT2	Adenocarcinoma
ZC3H12C::VPS52	Adenocarcinoma
ZC3H13::LCP1	Chronic lymphocytic leukemia
ZC3H13::MRPS31	Adenocarcinoma
ZC3H13::NFE2L2	Squamous cell carcinoma
ZC3H15::CPS1	Adenocarcinoma
ZC3H15::FAM171B	Adenocarcinoma | Squamous cell carcinoma
ZC3H15::GULP1	Malignant melanoma
ZC3H15::SERINC1	Adenocarcinoma
ZC3H18::ADAD2	Mesenchymal tumor, NOS
ZC3H18::CHMP1A	Astrocytoma, grade III-IV/Glioblastoma
ZC3H18::ZFPM1	Adenocarcinoma
ZC3H3::KHDC4	Adenocarcinoma
ZC3H3::KLK3	Adenocarcinoma
ZC3H3::LY6H	Adenocarcinoma
ZC3H3::MROH6	Adenocarcinoma
ZC3H3::PYCR3	Squamous cell carcinoma
ZC3H3::SCRIB	Squamous cell carcinoma
ZC3H3::TOP1MT	Squamous cell carcinoma
ZC3H3::TRAPPC9	Mesenchymal tumor, NOS
ZC3H3::YY1	Adenocarcinoma
ZC3H4::APOBEC3A	Adenocarcinoma
ZC3H4::ARHGAP35	Adenocarcinoma
ZC3H4::KANK3	Mesenchymal tumor, NOS
ZC3H4::POLR2I	Adenocarcinoma
ZC3H4::SAE1	Squamous cell carcinoma
ZC3H4::TFE3	Soft tissue tumor, special type
ZC3H4::TTLL3	Astrocytoma, grade III-IV/Glioblastoma
ZC3H7A::BCOR	Endometrial stromal sarcoma
ZC3H7A::CD99	Transitional cell carcinoma
ZC3H7A::GSPT1	Adenocarcinoma
ZC3H7A::SKIL	Adenocarcinoma
ZC3H7A::SYT13	Adenocarcinoma
ZC3H7B::BCOR	Ewing sarcoma | Soft tissue tumor, special type | Endometrial stromal sarcoma | Desmoplastic small round cell tumor | Ossifying fibromyxoid tumor
ZC3H7B::GRAMD4	Malignant melanoma
ZC3H7B::L3MBTL2	Adenocarcinoma
ZC3H7B::MICALL1	Malignant melanoma
ZC3H7B::PRPF31	Adenocarcinoma
ZC3H7B::RBX1	Adenocarcinoma
ZC3H7B::SLC9A8	Adenocarcinoma
ZC3H7B::USP49	Adenocarcinoma
ZC3H8::PARD3B	Adenocarcinoma
ZC3HAV1::ABL2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ZC3HAV1::AKAP11	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ZC3HAV1::BRAF	Adenocarcinoma
ZC3HAV1::ITPKB	Adenocarcinoma
ZC3HAV1::SGCE	Astrocytoma, grade III-IV/Glioblastoma
ZC3HAV1L::CHMP1A	Adenocarcinoma | Nonneoplastic epithelial disorder/lesion
ZC3HC1::ADAM22	Adenocarcinoma
ZCCHC14::C16ORF95	Squamous cell carcinoma
ZCCHC14::IMPA2	Adenocarcinoma
ZCCHC14::SNX7	Adenocarcinoma
ZCCHC17::CCDC28B	Adenocarcinoma
ZCCHC17::FABP3	Astrocytoma, grade III-IV/Glioblastoma
ZCCHC17::NDP	Adenocarcinoma
ZCCHC17::PPP2R5C	Adenocarcinoma
ZCCHC7::ASTN2	Adenocarcinoma
ZCCHC7::GLIPR2	Adenocarcinoma
ZCCHC7::LRRC19	Squamous cell carcinoma
ZCCHC7::MLLT3	Adenocarcinoma
ZCCHC7::NRG1	Adenocarcinoma
ZCCHC7::PAX5	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ZCCHC7::PRSS3	Adenocarcinoma
ZCCHC7::SEC23B	Squamous cell carcinoma
ZCCHC7::SERINC3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ZCCHC7::TEK	Transitional cell carcinoma
ZCCHC7::UBAP1	Squamous cell carcinoma
ZCCHC7::UNC13B	Mesenchymal tumor, NOS
ZCCHC7::ZBTB7C	Squamous cell carcinoma
ZCCHC8::BRAF	Adenocarcinoma
ZCCHC8::DIABLO	Adenocarcinoma
ZCCHC8::PTPN12	Mesothelioma
ZCCHC8::ROS1	Melanocytic neoplasm, special type | Benign nevus | Astrocytoma, grade III-IV/Glioblastoma
ZCCHC8::RSRC2	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Astrocytoma, grade I-II | Adenocarcinoma | Oligodendroglioma
ZCCHC8::TOP3A	Transitional cell carcinoma
ZCRB1::ANHX	Astrocytoma, grade III-IV/Glioblastoma
ZCRB1::LIMA1	Malignant melanoma
ZCWPW2::OSBPL10	Malignant melanoma
ZCWPW2::PPP4R2	Undifferentiated carcinoma, small cell
ZDBF2::PSMD1	Mesenchymal tumor, NOS
ZDHHC11::RNF130	Adenocarcinoma
ZDHHC11::TPST2	Malignant melanoma
ZDHHC13::MGAT4C	Mesenchymal tumor, NOS
ZDHHC14::ARID1B	Mesenchymal tumor, NOS | Adenocarcinoma
ZDHHC14::FKBP5	Mesothelioma
ZDHHC14::NOX3	Astrocytoma, grade III-IV/Glioblastoma
ZDHHC14::PAWR	Atypical lipomatous tumor/atypical lipoma/well-differentiated liposarcoma
ZDHHC14::SYNJ2	Adenocarcinoma
ZDHHC14::TMEM242	Adenocarcinoma
ZDHHC14::TSPAN8	Mesenchymal tumor, NOS
ZDHHC16::PFKL	Adenocarcinoma
ZDHHC17::ANO4	Adenocarcinoma
ZDHHC17::ATP1A1	Malignant epithelial tumor, special type
ZDHHC17::CSRP2	Astrocytoma, grade III-IV/Glioblastoma | Mesenchymal tumor, NOS
ZDHHC17::GLIPR1L1	Malignant melanoma
ZDHHC17::MALRD1	Mesenchymal tumor, NOS
ZDHHC17::METTL25	Mesenchymal tumor, NOS
ZDHHC17::MMP27	Mesenchymal tumor, NOS
ZDHHC17::NAV3	Mesenchymal tumor, NOS
ZDHHC17::NCR2	Mesenchymal tumor, NOS
ZDHHC17::RAB3IP	Mesenchymal tumor, NOS
ZDHHC17::RNFT2	Adenocarcinoma
ZDHHC17::SYT1	Mesenchymal tumor, NOS
ZDHHC17::WIF1	Soft tissue tumor, NOS
ZDHHC18::ARID1A	Squamous cell carcinoma
ZDHHC19::PCYT1A	Adenocarcinoma
ZDHHC1::ATP6V0D1	Adenocarcinoma
ZDHHC1::KCTD19	Malignant epithelial tumor, special type
ZDHHC1::TPPP3	Nonneoplastic epithelial disorder/lesion
ZDHHC20::CCDC57	Adenocarcinoma
ZDHHC20::CPAMD8	Adenocarcinoma
ZDHHC20::GJB6	Adenocarcinoma
ZDHHC20::KCNK1	Transitional cell carcinoma
ZDHHC20::MICU2	Transitional cell carcinoma
ZDHHC20::MIPEP	Adenocarcinoma
ZDHHC20::SPATA13	Adenocarcinoma
ZDHHC20::UQCRC2	Adenocarcinoma
ZDHHC21::ELAVL2	Squamous cell carcinoma
ZDHHC21::PHGDH	Malignant melanoma
ZDHHC21::PSIP1	Adenocarcinoma
ZDHHC24::C2CD3	Adenocarcinoma
ZDHHC24::EEF2KMT	Adenocarcinoma
ZDHHC2::FGD6	Mesenchymal tumor, NOS
ZDHHC2::LTBP1	Adenocarcinoma
ZDHHC2::VPS37A	Adenocarcinoma
ZDHHC3::ATXN7	Malignant melanoma
ZDHHC3::CDCP1	Adenocarcinoma
ZDHHC3::KIF15	Adenocarcinoma
ZDHHC5::GPR137	Squamous cell carcinoma
ZDHHC5::LCT	Adenocarcinoma
ZDHHC5::SMTNL1	Adenocarcinoma
ZDHHC6::ACSL5	Adenocarcinoma
ZDHHC6::CTIF	Adenocarcinoma
ZDHHC6::TCF7L2	Adenocarcinoma
ZDHHC7::ABCB9	Adenocarcinoma
ZDHHC7::ACAD11	Malignant epithelial tumor, special type
ZDHHC7::C16ORF74	Adenocarcinoma
ZDHHC7::H3-3B	Adenocarcinoma
ZDHHC7::UNK	Adenocarcinoma
ZDHHC7::USP10	Malignant melanoma
ZDHHC9::SLCO1A2	Malignant melanoma
ZEB1::BMI1	Multiple myeloma | Acute lymphoblastic leukemia/lymphoblastic lymphoma
ZEB1::SYT1	Mesenchymal tumor, NOS
ZEB1::ZNF438	Mesothelioma
ZEB2::AKT3	Malignant melanoma
ZEB2::ALK	Malignant melanoma | Benign nevus
ZEB2::BCL11B	Skin | Acute myeloid leukemia, NOS
ZEB2::CXCR4	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ZEB2::PDGFRB	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ZEB2::PLAG1	Lipoblastoma
ZER1::TBC1D13	Adenocarcinoma
ZFAND1::PAG1	Adenocarcinoma
ZFAND1::STAU2	Adenocarcinoma
ZFAND1::ZC2HC1A	Adenocarcinoma
ZFAND2A::PHF14	Malignant melanoma
ZFAND2B::CYP27A1	Adenocarcinoma
ZFAND3::C6orf89	Adenocarcinoma
ZFAND3::CCNE1	Transitional cell carcinoma
ZFAND3::DNAH8	Astrocytoma, grade III-IV/Glioblastoma | Transitional cell carcinoma
ZFAND3::DSCAM	Adenocarcinoma
ZFAND3::EXD3	Adenocarcinoma
ZFAND3::KCTD20	Adenocarcinoma
ZFAND3::LYRM4	Adenocarcinoma
ZFAND3::MDGA1	Adenocarcinoma
ZFAND3::PDZD2	Adenocarcinoma
ZFAND3::POLR1C	Adenocarcinoma
ZFAND3::RNF8	Adenocarcinoma
ZFAND3::RPTOR	Malignant melanoma
ZFAND3::SPMAP2L	Adenocarcinoma
ZFAND3::SYNE1	Adenocarcinoma
ZFAND3::UBQLN1	Squamous cell carcinoma
ZFAND6::KCNRG	Malignant melanoma
ZFAND6::TRIM13	Malignant melanoma
ZFAT::TG	Adenocarcinoma
ZFC3H1::CDH4	Adenocarcinoma
ZFC3H1::MDM2	Osteosarcoma, NOS
ZFC3H1::MON2	Mesenchymal tumor, NOS
ZFC3H1::PPFIA2	Transitional cell carcinoma
ZFC3H1::PTPRR	Adenocarcinoma
ZFC3H1::SHISA9	Adenocarcinoma
ZFHX3::ARL15	Adenocarcinoma
ZFHX3::BCAR1	Adenocarcinoma
ZFHX3::C2CD6	Adenocarcinoma
ZFHX3::DLG2	Adenocarcinoma
ZFHX3::ENY2	Adenocarcinoma
ZFHX3::IL34	Squamous cell carcinoma
ZFHX3::LMF1	Adenocarcinoma
ZFHX3::PMFBP1	Adenocarcinoma | Squamous cell carcinoma
ZFHX3::WWP2	Squamous cell carcinoma
ZFHX3::ZFHX3	Adenocarcinoma
ZFHX3::ZMAT4	Adenocarcinoma
ZFHX3::ZNF821	Adenocarcinoma
ZFHX4::PLAG1	Soft tissue tumor, special type
ZFHX4::TRAM1	Mesenchymal tumor, NOS
ZFHX4::VRK1	Squamous cell carcinoma
ZFP1::TERF2IP	Mesothelioma
ZFP28::SLC35E1	Adenocarcinoma
ZFP28::SLC9A8	Adenocarcinoma
ZFP30::C19ORF33	Adenocarcinoma
ZFP30::C19orf33	Adenocarcinoma
ZFP30::CEACAM7	Transitional cell carcinoma
ZFP30::PRX	Adenocarcinoma
ZFP36::FOSB	Vascular and perivascular tumor, special type | Epithelioid hemangioendothelioma
ZFP36::IGL	Multiple myeloma
ZFP36::OAZ1	Squamous cell carcinoma
ZFP36::UBC	Multiple myeloma
ZFP36L1::EHD1	Diffuse large B-cell lymphoma
ZFP36L1::IGH	Diffuse large B-cell lymphoma
ZFP36L2::TRA	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ZFP36L2::ZFP36L2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ZFP3::ARRB2	Malignant epithelial tumor, special type
ZFP3::DGCR2	Mesenchymal tumor, NOS
ZFP3::PCCB	Adenocarcinoma
ZFP41::ANGPT1	Adenocarcinoma
ZFP41::LGR5	Mesenchymal tumor, NOS
ZFP64::CSE1L	Adenocarcinoma
ZFP64::NCOA2	Soft tissue tumor, NOS | Spindle cell/sclerosing rhabdomyosarcoma
ZFP64::NCOA3	Spindle cell/sclerosing rhabdomyosarcoma | Rhabdomyosarcoma, NOS
ZFP64::NDRG3	Adenocarcinoma
ZFP64::WBP1L	Mycosis fungoides/Sézary syndrome
ZFP90::CBFB	Malignant melanoma
ZFP90::NUTF2	Adenocarcinoma
ZFP90::PRMT7	Squamous cell carcinoma
ZFP91::LPXN	Adenocarcinoma
ZFP91::NOX4	Adenocarcinoma
ZFP91::RAB6A	Adenocarcinoma
ZFPL1::NUP98	Acute myeloid leukemia, NOS | Skin
ZFPL1::SART1	Adenocarcinoma
ZFPM2::ANXA13	Squamous cell carcinoma
ZFPM2::COL14A1	Adenocarcinoma
ZFPM2::ELF5	Mesothelioma
ZFPM2::OXR1	Malignant epithelial tumor, special type
ZFPM2::SLC27A2	Mesenchymal tumor, NOS
ZFR::DARS2	Squamous cell carcinoma
ZFR::PLEKHG4B	Squamous cell carcinoma
ZFR::RAI14	Adenocarcinoma
ZFR::RPL3	Malignant melanoma
ZFR::SND1	Adenocarcinoma
ZFR::TARS1	Adenocarcinoma
ZFTA::CRTC1	Adenocarcinoma
ZFTA::DUX4	Ependymoma
ZFTA::MAML2	Ependymoma
ZFTA::MRTFB	Chondroid lipoma
ZFTA::NCOA1	Chondroid lipoma | Neuroglial neoplasm, special type | Ependymoma
ZFTA::NCOA2	Neuroglial neoplasm, special type
ZFTA::RELA	Liposarcoma, NOS | Astrocytoma, grade I-II | Ependymoma | Neuroglial neoplasm, special type
ZFTA::YAP1	Ependymoma
ZFX::APOO	Adenocarcinoma
ZFX::GLYATL2	Adenocarcinoma
ZFX::KLHL15	Adenocarcinoma
ZFYVE16::BDP1	Adenocarcinoma
ZFYVE1::CEP128	Mesenchymal tumor, NOS
ZFYVE1::DENND4A	Astrocytoma, grade I-II
ZFYVE26::NR6A1	Squamous cell carcinoma
ZFYVE26::RAD51B	Adenocarcinoma
ZFYVE26::RBM25	Transitional cell carcinoma
ZFYVE28::CCDC149	Astrocytoma, grade I-II
ZFYVE28::CRMP1	Mesenchymal tumor, NOS
ZFYVE28::POLN	Adenocarcinoma
ZFYVE9::BTF3L4	Adenocarcinoma
ZFYVE9::CGA	Adenocarcinoma
ZFYVE9::ECHDC2	Mesenchymal tumor, NOS
ZGLP1::LDLR	Adenocarcinoma
ZGPAT::CNBD2	Adenocarcinoma
ZGPAT::HELZ2	Adenocarcinoma
ZHX1::ATAD2	Adenocarcinoma
ZHX1::RALYL	Adenocarcinoma
ZHX2::COL14A1	Adenocarcinoma
ZHX2::LELP1	Squamous cell carcinoma
ZHX2::PPM1B	Malignant epithelial tumor, special type
ZHX2::VAV3	Adenocarcinoma
ZHX3::CHD6	Adenocarcinoma
ZHX3::PDE4C	Astrocytoma, grade III-IV/Glioblastoma
ZHX3::SMG9	Mesothelioma
ZHX3::VSTM2L	Adenocarcinoma
ZIC1::BBX	Malignant melanoma
ZIM2::DENR	Adenocarcinoma
ZKSCAN1::BRAF	Malignant melanoma
ZKSCAN1::CCDC136	Adenocarcinoma
ZKSCAN1::NTRK1	Adenocarcinoma
ZKSCAN1::UEVLD	Adenocarcinoma
ZKSCAN4::SLC44A4	Adenocarcinoma
ZKSCAN5::SMO	Adenocarcinoma
ZMAT3::TP63	Malignant melanoma
ZMAT4::ELP3	Adenocarcinoma
ZMAT4::FGFR1	Squamous cell carcinoma
ZMAT4::SULF1	Adenocarcinoma
ZMAT5::ASCC2	Transitional cell carcinoma | Astrocytoma, grade III-IV/Glioblastoma
ZMAT5::HIRA	Squamous cell carcinoma
ZMAT5::KIAA1671	Adenocarcinoma
ZMAT5::NIPSNAP1	Squamous cell carcinoma
ZMIZ1::ABL1	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Spleen | Chronic myelomonocytic leukemia
ZMIZ1::ADK	Malignant epithelial tumor, special type
ZMIZ1::BTD	Malignant melanoma
ZMIZ1::CABCOCO1	Adenocarcinoma
ZMIZ1::CDPF1	Adenocarcinoma
ZMIZ1::CHST3	Mesenchymal tumor, NOS
ZMIZ1::CPEB3	Adenocarcinoma
ZMIZ1::DENND2A	Adenocarcinoma
ZMIZ1::LRMDA	Adenocarcinoma
ZMIZ1::NSMCE4A	Adenocarcinoma
ZMIZ1::PXYLP1	Adenocarcinoma
ZMIZ1::RET	Glioma, NOS | Carcinoma, NOS
ZMIZ1::XYLT2	Malignant melanoma
ZMIZ1::ZCCHC24	Adenocarcinoma
ZMIZ2::CHP2	Multiple myeloma
ZMPSTE24::CACNA1D	Astrocytoma, grade III-IV/Glioblastoma
ZMPSTE24::CAP1	Adenocarcinoma
ZMPSTE24::MFSD2A	Undifferentiated carcinoma, small cell
ZMPSTE24::RNF220	Adenocarcinoma
ZMPSTE24::SMAP2	Transitional cell carcinoma
ZMPSTE24::TMCO2	Adenocarcinoma
ZMPSTE24::YTHDF2	Adenocarcinoma
ZMYM1::ALK	Undifferentiated carcinoma, small cell
ZMYM2::DMRT2	Squamous cell carcinoma
ZMYM2::FGFR1	Acute myeloid leukemia, NOS | Skin | Acute lymphoblastic leukemia/lymphoblastic lymphoma | Chronic myeloproliferative disorder, special type | Mastocytosis | Egypt | Chronic myeloproliferative disorder, NOS | Bilineage or biphenotypic leukemia | Acute eosinophilic leukemia
ZMYM2::FLT3	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Chronic myeloproliferative disorder, NOS
ZMYM2::IFT88	Transitional cell carcinoma
ZMYM2::LATS2	Adenocarcinoma
ZMYM2::MPHOSPH8	Mesenchymal tumor, NOS
ZMYM2::MTMR6	Adenocarcinoma
ZMYM2::VWA8	Adenocarcinoma
ZMYM2::ZNF90	Adenocarcinoma
ZMYM4::AP2S1	Adenocarcinoma
ZMYM4::BSDC1	Adenocarcinoma
ZMYM4::PSMB2	Adenocarcinoma
ZMYM4::SMYD3	Malignant melanoma
ZMYM4::SSBP4	Adenocarcinoma
ZMYM4::UTP11	Adenocarcinoma
ZMYM5::IFT88	Adenocarcinoma
ZMYM5::PSPC1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ZMYM6::ACOX3	Transitional cell carcinoma
ZMYM6::SCMH1	Adenocarcinoma
ZMYND11::CDH18	Transitional cell carcinoma
ZMYND11::LYZL1	Adenocarcinoma
ZMYND11::MBTD1	Acute myeloblastic leukemia with minimal differentiation (FAB type M0) | Skin | Acute myeloid leukemia, NOS
ZMYND11::PCDH15	Adenocarcinoma
ZMYND11::SORBS2	Astrocytoma, grade I-II
ZMYND19::ARRDC1	Adenocarcinoma
ZMYND8::C20ORF203	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
ZMYND8::CELF5	Adenocarcinoma
ZMYND8::CEP250	Adenocarcinoma
ZMYND8::EPPIN	Adenocarcinoma
ZMYND8::EYA2	Adenocarcinoma
ZMYND8::GTPBP1	Adenocarcinoma
ZMYND8::MN1	Adenocarcinoma
ZMYND8::PDGFRB	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ZMYND8::PITPNB	Adenocarcinoma
ZMYND8::RELA	Acute erythroleukemia (FAB type M6)
ZMYND8::RNF43	Adenocarcinoma
ZMYND8::SULF2	Adenocarcinoma
ZMYND8::TFE3	Adenocarcinoma
ZMYND8::WFDC2	Malignant epithelial tumor, special type
ZMYND8::ZC4H2	Adenocarcinoma
ZNF100::GIPC1	Adenocarcinoma
ZNF101::NDUFA13	Malignant melanoma
ZNF106::ADGRF4	Adenocarcinoma
ZNF106::ADK	Adenocarcinoma
ZNF106::CNTLN	Malignant melanoma
ZNF106::PML	Acute promyelocytic leukemia (FAB type M3)
ZNF107::FAM83D	Adenocarcinoma
ZNF107::FOXP2	Adenocarcinoma
ZNF10::SPATA17	Adenocarcinoma
ZNF112::PLAUR	Adenocarcinoma
ZNF114::ETHE1	Malignant epithelial tumor, special type
ZNF121::NAGLU	Adenocarcinoma
ZNF121::OLFM2	Adenocarcinoma
ZNF124::AHCTF1	Adenocarcinoma
ZNF124::PUS3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ZNF131::DDX25	Acute erythroleukemia (FAB type M6)
ZNF131::GHR	Mesenchymal tumor, NOS
ZNF133::MS4A4A	Astrocytoma, grade I-II
ZNF134::RYR1	Malignant melanoma
ZNF135::FGFR2	Astrocytoma, grade III-IV/Glioblastoma
ZNF136::CALR	Adenocarcinoma
ZNF136::NFIX	Astrocytoma, grade I-II
ZNF136::RNASEH2A	Adenocarcinoma
ZNF136::XAB2	Malignant melanoma
ZNF140::ZNF268	Adenocarcinoma
ZNF142::POLR1B	Adenocarcinoma
ZNF143::CDIN1	Astrocytoma, grade III-IV/Glioblastoma
ZNF143::IPO7	Adenocarcinoma
ZNF143::TMEM41B	Adenocarcinoma
ZNF146::ABCA9	Mesenchymal tumor, NOS
ZNF146::KMT2B	Astrocytoma, grade I-II
ZNF146::NCAM2	Adenocarcinoma
ZNF146::PGPEP1	Adenocarcinoma
ZNF148::AGXT	Adenocarcinoma
ZNF148::FHAD1	Adenocarcinoma
ZNF148::LYPLA2	Adenocarcinoma
ZNF148::MYLK	Adenocarcinoma
ZNF148::OSBPL11	Adenocarcinoma | Squamous cell carcinoma
ZNF148::RPRD2	Transitional cell carcinoma
ZNF148::SLC41A3	Adenocarcinoma
ZNF148::SNX4	Squamous cell carcinoma
ZNF148::YPEL2	Adenocarcinoma
ZNF14::BST2	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
ZNF14::RGL3	Adenocarcinoma
ZNF14::STAT5A	Adenocarcinoma
ZNF154::KIR2DL1	Adenocarcinoma
ZNF160::ZNF415	Alveolar rhabdomyosarcoma
ZNF169::UBR7	Adenocarcinoma
ZNF16::PLEKHA4	Mesenchymal tumor, NOS
ZNF174::CLUAP1	Adenocarcinoma
ZNF175::CYP27B1	Astrocytoma, grade I-II
ZNF177::DAB1	Adenocarcinoma
ZNF177::RGL3	Mesenchymal tumor, NOS
ZNF177::TECR	Mesenchymal tumor, NOS
ZNF180::TOMM40	Adenocarcinoma
ZNF180::YWHAE	Squamous cell carcinoma
ZNF181::PEPD	Adenocarcinoma
ZNF184::CD2AP	Adenocarcinoma
ZNF185::FADS2	Squamous cell carcinoma
ZNF189::BAAT	Squamous cell carcinoma
ZNF18::TASP1	Adenocarcinoma
ZNF195::FHIP1B	Adenocarcinoma
ZNF197::OSBPL10	Mesothelioma
ZNF197::TAF3	Adenocarcinoma
ZNF19::PRKN	Astrocytoma, grade III-IV/Glioblastoma
ZNF200::COLEC12	Squamous cell carcinoma
ZNF205::UBE2I	Adenocarcinoma
ZNF207::C17orf75	Adenocarcinoma
ZNF207::ERBB2	Adenocarcinoma
ZNF207::ETV4	Adenocarcinoma
ZNF207::LRRC37B	Malignant melanoma
ZNF207::PPP6R3	Adenocarcinoma
ZNF207::RHOT1	Adenocarcinoma | Malignant epithelial tumor, special type
ZNF207::TANC2	Adenocarcinoma
ZNF208::MZF1	Adenocarcinoma
ZNF208::NRG2	Russia | Primitive neuroectodermal tumor/Medulloblastoma
ZNF208::ST3GAL4	Adenocarcinoma
ZNF20::DAND5	Adenocarcinoma
ZNF20::NFIX	Adenocarcinoma
ZNF20::TINCR	Malignant melanoma
ZNF212::PDE3B	Malignant melanoma
ZNF217::BCAS1	Adenocarcinoma
ZNF217::BCAS3	Adenocarcinoma
ZNF217::MAVS	Adenocarcinoma
ZNF217::PTGIS	Adenocarcinoma
ZNF217::ZNFX1	Adenocarcinoma
ZNF219::HNRNPC	Acute lymphoblastic leukemia/lymphoblastic lymphoma | Adenocarcinoma
ZNF222::PSG5	Adenocarcinoma
ZNF223::AP2A1	Mesenchymal tumor, NOS
ZNF224::CYP2S1	Mesenchymal tumor, NOS
ZNF226::AKT2	Squamous cell carcinoma
ZNF226::EIF3K	Mesenchymal tumor, NOS
ZNF227::HNRNPUL1	Squamous cell carcinoma
ZNF227::PDCD5	Adenocarcinoma
ZNF229::ERCC1	Adenocarcinoma
ZNF229::PPP1R13L	Adenocarcinoma
ZNF22::ETV1	Astrocytoma, grade I-II
ZNF234::CEACAM20	Adenocarcinoma
ZNF235::ACTN4	Adenocarcinoma
ZNF235::DBP	Adenocarcinoma
ZNF235::ZNF865	Astrocytoma, grade I-II
ZNF236::DTNA	Adenocarcinoma
ZNF236::QRSL1	Mesenchymal tumor, NOS
ZNF236::RFX3	Adenocarcinoma
ZNF236::ZNF627	Squamous cell carcinoma
ZNF239::RET	Carcinoma, NOS
ZNF239::SEC31B	Astrocytoma, grade I-II
ZNF248::FAM107B	Transitional cell carcinoma
ZNF24::ACAA2	Adenocarcinoma
ZNF251::ARHGAP39	Transitional cell carcinoma
ZNF251::CHMP4C	Mesenchymal tumor, NOS
ZNF251::COMMD5	Malignant epithelial tumor, special type
ZNF251::FAHD2B	Adenocarcinoma
ZNF253::BAZ1A	Adenocarcinoma
ZNF253::HSD17B14	Astrocytoma, grade I-II
ZNF253::SLC1A6	Malignant melanoma
ZNF254::ETFB	Astrocytoma, grade III-IV/Glioblastoma
ZNF254::NANOS3	Transitional cell carcinoma
ZNF254::TTBK1	Adenocarcinoma
ZNF257::ARIH2	Adenocarcinoma
ZNF257::TRHDE	Adenocarcinoma
ZNF260::DMWD	Skin | Acute myeloid leukemia, NOS
ZNF260::HECW1	Astrocytoma, grade III-IV/Glioblastoma
ZNF260::SCGB2B2	Adenocarcinoma
ZNF263::KCTD5	Adenocarcinoma
ZNF263::SUPT6H	Astrocytoma, grade III-IV/Glioblastoma
ZNF264::PIGG	Adenocarcinoma
ZNF266::MATK	Malignant melanoma
ZNF266::SMARCA4	Astrocytoma, grade I-II
ZNF267::AGBL4	Transitional cell carcinoma
ZNF267::GPR180	Squamous cell carcinoma
ZNF267::ZNF720	Carcinoma, NOS
ZNF268::ASB1	Adenocarcinoma
ZNF268::TRPM3	Malignant melanoma
ZNF273::DGKA	Acute myelomonocytic leukemia (FAB type M4)
ZNF274::CACNA2D4	Adenocarcinoma
ZNF274::JAK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ZNF276::JPH3	Adenocarcinoma
ZNF276::SPG7	Transitional cell carcinoma
ZNF276::VAC14	Transitional cell carcinoma
ZNF277::CEACAM19	Adenocarcinoma
ZNF277::CPT1A	Adenocarcinoma
ZNF277::IMMP2L	Adenocarcinoma
ZNF277::TERB2	Adenocarcinoma
ZNF277::TPD52L1	Adenocarcinoma
ZNF280B::BPIFC	Malignant melanoma
ZNF280D::RNF111	Adenocarcinoma
ZNF280D::STK3	Transitional cell carcinoma
ZNF282::CUL1	Adenocarcinoma
ZNF283::DPRX	Malignant melanoma
ZNF292::B3GAT2	Adenocarcinoma
ZNF292::CGA	Adenocarcinoma
ZNF292::DLGAP1	Adenocarcinoma
ZNF292::EYS	Adenocarcinoma
ZNF292::FIG4	Adenocarcinoma
ZNF292::GRM4	Astrocytoma, grade I-II
ZNF292::MAP3K4	Mesenchymal tumor, NOS
ZNF292::PRSS54	Adenocarcinoma
ZNF292::PTPRO	Adenocarcinoma
ZNF292::SLC35A1	Adenocarcinoma
ZNF292::SLIRP	Adenocarcinoma
ZNF292::TIAM2	Mature B-cell neoplasm, NOS
ZNF302::ANKRD27	Adenocarcinoma
ZNF302::CACNA1A	Adenocarcinoma
ZNF311::TTBK1	Adenocarcinoma
ZNF316::GNA12	Malignant melanoma
ZNF316::MAD1L1	Transitional cell carcinoma
ZNF317::AP3D1	Adenocarcinoma
ZNF318::CD2AP	Mesenchymal tumor, NOS
ZNF318::COL21A1	Adenocarcinoma
ZNF318::FOXP4	Adenocarcinoma
ZNF318::PDE3A	Adenocarcinoma
ZNF319::KCTD19	Mesothelioma
ZNF322::KIF6	Transitional cell carcinoma
ZNF322::PPIL6	Adenocarcinoma
ZNF326::CCDC18	Transitional cell carcinoma
ZNF326::NEGR1	Adenocarcinoma
ZNF329::EPG5	Astrocytoma, grade I-II
ZNF329::EPN1	Adenocarcinoma
ZNF331::NLRP11	Adenocarcinoma
ZNF331::NLRP4	Squamous cell carcinoma
ZNF333::CYP4F22	Adenocarcinoma
ZNF335::NCOA5	Squamous cell carcinoma
ZNF335::ZSWIM3	Transitional cell carcinoma
ZNF33A::PARD3	Astrocytoma, grade I-II
ZNF33B::CCPG1	Squamous cell carcinoma
ZNF33B::RET	Carcinoma, NOS
ZNF341::C20ORF144	Adenocarcinoma
ZNF341::CBFA2T2	Adenocarcinoma
ZNF341::DYNLRB1	Adenocarcinoma
ZNF343::CSNK2A1	Transitional cell carcinoma
ZNF343::PRPSAP2	Adenocarcinoma
ZNF343::SNRPB	Nonneoplastic epithelial disorder/lesion
ZNF345::DNAJB1	Adenocarcinoma
ZNF345::HSF2BP	Adenocarcinoma
ZNF345::LGALS13	Astrocytoma, grade I-II
ZNF345::PTPRH	Astrocytoma, grade I-II
ZNF345::TRIM21	Adenocarcinoma
ZNF346::NSD1	Adenocarcinoma
ZNF346::PAOX	Adenocarcinoma
ZNF350::SLC12A5	Adenocarcinoma
ZNF350::ZNF540	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
ZNF354A::SLC12A7	Adenocarcinoma
ZNF354C::PRSS3	Mesenchymal tumor, NOS
ZNF362::MAML3	Acute myeloid leukemia, NOS | Skin
ZNF362::SMARCA2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ZNF362::TCF4	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ZNF37A::EBF3	Adenocarcinoma
ZNF37A::MINDY3	Astrocytoma, grade I-II
ZNF37A::PIP5K1B	Adenocarcinoma
ZNF383::TEX14	Mesenchymal tumor, NOS
ZNF384::CDCA3	Squamous cell carcinoma
ZNF384::CREBBP	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ZNF384::RNF180	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ZNF384::TAF15	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ZNF384::TCF3	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ZNF385A::CBX5	Adenocarcinoma
ZNF385A::NAV3	Mesenchymal tumor, NOS
ZNF385B::CWC22	Adenocarcinoma
ZNF385B::FKBP7	Squamous cell carcinoma
ZNF385B::SCG5	Adenocarcinoma
ZNF385D::GLB1	Adenocarcinoma
ZNF395::PBK	Squamous cell carcinoma
ZNF395::SLC25A44	Adenocarcinoma
ZNF398::TPK1	Mesenchymal tumor, NOS
ZNF3::ACTL6B	Adenocarcinoma
ZNF3::MCM7	Adenocarcinoma
ZNF3::RUNDC3B	Adenocarcinoma
ZNF404::LYPD5	Malignant melanoma
ZNF407::C18ORF63	Adenocarcinoma
ZNF407::CYB5A	Mesenchymal tumor, NOS
ZNF407::EPSTI1	Mature B-cell neoplasm, NOS
ZNF410::ACOT4	Adenocarcinoma
ZNF410::ANKS3	Adenocarcinoma
ZNF410::LIN52	Squamous cell carcinoma
ZNF410::PTGR2	Adenocarcinoma
ZNF414::MYO1F	Adenocarcinoma
ZNF415::EIF3H	Adenocarcinoma
ZNF415::SMG9	Adenocarcinoma
ZNF416::C19orf18	Adenocarcinoma
ZNF416::DTD1	Adenocarcinoma
ZNF417::BAX	Adenocarcinoma
ZNF417::CNFN	Adenocarcinoma
ZNF417::KIR2DL3	Adenocarcinoma
ZNF418::USP25	Adenocarcinoma
ZNF420::DPF1	Adenocarcinoma
ZNF420::DROSHA	Astrocytoma, grade III-IV/Glioblastoma
ZNF420::SIPA1L3	Adenocarcinoma
ZNF420::SLC37A3	Malignant epithelial tumor, special type
ZNF420::SPINT2	Malignant melanoma
ZNF420::SULT2B1	Adenocarcinoma
ZNF423::CCAR1	Malignant epithelial tumor, special type
ZNF423::NCEH1	Malignant epithelial tumor, special type
ZNF423::NOD2	Adenocarcinoma
ZNF423::TNFSF10	Malignant epithelial tumor, special type
ZNF426::VWA3A	Adenocarcinoma
ZNF428::ETHE1	Adenocarcinoma
ZNF429::C2CD3	Malignant melanoma
ZNF429::LSM14A	Adenocarcinoma
ZNF430::BRD4	Malignant melanoma
ZNF430::CD19	Transitional cell carcinoma
ZNF430::GABRB1	Squamous cell carcinoma
ZNF430::JAK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ZNF430::KCNIP4	Transitional cell carcinoma
ZNF430::OR7E24	Malignant epithelial tumor, special type
ZNF430::TYK2	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ZNF431::EPS15L1	Mesenchymal tumor, NOS
ZNF431::SIGLEC6	Mesenchymal tumor, NOS
ZNF431::WIZ	Adenocarcinoma
ZNF432::COL6A1	Astrocytoma, grade III-IV/Glioblastoma
ZNF433::CACNA1A	Adenocarcinoma
ZNF433::DNAH17	Adenocarcinoma
ZNF433::RFX1	Astrocytoma, grade I-II
ZNF433::SLC1A6	Adenocarcinoma
ZNF438::RFTN1	Adenocarcinoma
ZNF43::EFHB	Adenocarcinoma
ZNF440::ECSIT	Malignant melanoma
ZNF442::NDUFB7	Adenocarcinoma
ZNF443::MYO9B	Adenocarcinoma
ZNF445::TCAIM	Adenocarcinoma
ZNF44::MYRFL	Mesenchymal tumor, NOS
ZNF451::NADSYN1	Adenocarcinoma
ZNF45::GARRE1	Malignant melanoma
ZNF460::C19ORF18	Adenocarcinoma
ZNF460::C19orf18	Adenocarcinoma
ZNF460::ELSPBP1	Adenocarcinoma
ZNF460::HSPD1	Astrocytoma, grade I-II
ZNF460::SYT4	Astrocytoma, grade I-II
ZNF461::AKT1	Adenocarcinoma
ZNF461::MATN2	Adenocarcinoma
ZNF462::DNAJC1	Adenocarcinoma
ZNF462::MUSK	Malignant soft tissue tumor, NOS
ZNF462::RAD23B	Squamous cell carcinoma
ZNF462::TBCA	Transitional cell carcinoma
ZNF462::VEGFA	Adenocarcinoma
ZNF462::ZBED2	Mesenchymal tumor, NOS
ZNF469::ZFPM1	Adenocarcinoma
ZNF470::ZNF835	Adenocarcinoma
ZNF473::AP2A1	Squamous cell carcinoma
ZNF473::NUP62	Adenocarcinoma
ZNF480::CKM	Squamous cell carcinoma
ZNF483::DNAJC25	Malignant epithelial tumor, special type
ZNF483::GAPVD1	Acute megakaryoblastic leukemia (FAB type M7)
ZNF485::TMX4	Transitional cell carcinoma
ZNF487::FXYD4	Adenocarcinoma
ZNF490::FARSA	Squamous cell carcinoma
ZNF490::ITSN1	Squamous cell carcinoma
ZNF490::PRDX2	Adenocarcinoma
ZNF492::FCHO1	Adenocarcinoma
ZNF492::NLRP5	Adenocarcinoma
ZNF493::RPL13A	Adenocarcinoma
ZNF493::TMBIM4	Mesenchymal tumor, NOS
ZNF496::WIF1	Mesenchymal tumor, NOS
ZNF496::ZC2HC1B	Adenocarcinoma
ZNF500::MMP25	Transitional cell carcinoma
ZNF507::ADGRL1	Adenocarcinoma
ZNF507::BCL2L13	Malignant melanoma
ZNF507::FXYD1	Mesenchymal tumor, NOS
ZNF507::TDRD12	Transitional cell carcinoma
ZNF511::PLPP4	Mesenchymal tumor, NOS
ZNF512::ANXA4	Adenocarcinoma
ZNF512::KCNK3	Adenocarcinoma
ZNF512B::SEPTIN1	Adenocarcinoma
ZNF516::MBP	Adenocarcinoma
ZNF518A::ATRNL1	Squamous cell carcinoma
ZNF519::PKP4	Adenocarcinoma
ZNF525::VAV1	Adenocarcinoma
ZNF526::CLASRP	Adenocarcinoma
ZNF526::DEDD2	Transitional cell carcinoma
ZNF527::HNRNPUL1	Squamous cell carcinoma
ZNF527::SMIM7	Astrocytoma, grade I-II
ZNF528::ZNF8	Adenocarcinoma
ZNF529::CLEC11A	Adenocarcinoma
ZNF529::FAM187B	Squamous cell carcinoma
ZNF529::FFAR2	Squamous cell carcinoma
ZNF529::IGSF23	Astrocytoma, grade I-II
ZNF529::RYR1	Malignant epithelial tumor, special type
ZNF532::DOK6	Squamous cell carcinoma
ZNF532::GMPR	Astrocytoma, grade III-IV/Glioblastoma
ZNF532::MALT1	Squamous cell carcinoma
ZNF532::NEDD4L	Adenocarcinoma
ZNF532::NUTM1	Muscle tumor, special type | Desmoplastic small round cell tumor | Embryonal nervous system tumor, NOS
ZNF536::FPR2	Adenocarcinoma
ZNF536::SPTBN1	Malignant epithelial tumor, special type
ZNF540::SIPA1L3	Astrocytoma, grade I-II
ZNF541::ZSWIM9	Adenocarcinoma
ZNF544::AP2A1	Astrocytoma, grade III-IV/Glioblastoma
ZNF544::CCDC61	Transitional cell carcinoma
ZNF544::GRIN2D	Malignant melanoma
ZNF544::SENP6	Adenocarcinoma
ZNF546::HNRNPD	Malignant epithelial tumor, special type
ZNF549::CTU1	Adenocarcinoma
ZNF550::CXCL17	Astrocytoma, grade III-IV/Glioblastoma
ZNF551::AATF	Mesenchymal tumor, NOS
ZNF551::ZNF776	Adenocarcinoma
ZNF552::UBL3	Adenocarcinoma
ZNF557::MBD3L2	Adenocarcinoma
ZNF557::SIGLECL1	Squamous cell carcinoma
ZNF557::ZNF714	Squamous cell carcinoma
ZNF558::MBD3L1	Adenocarcinoma
ZNF559::NIBAN3	Adenocarcinoma
ZNF561::MED16	Adenocarcinoma
ZNF562::DTX3	Mesenchymal tumor, NOS
ZNF562::RFX2	Squamous cell carcinoma
ZNF562::SARNP	Mesenchymal tumor, NOS
ZNF563::FDX2	Adenocarcinoma
ZNF564::AKAP8L	Adenocarcinoma
ZNF564::CACNA1A	Astrocytoma, grade I-II | Adenocarcinoma
ZNF564::COL5A3	Transitional cell carcinoma
ZNF564::POLN	Adenocarcinoma
ZNF564::WIZ	Adenocarcinoma
ZNF565::CATSPERD	Osteosarcoma, NOS
ZNF566::ZNF507	Malignant epithelial tumor, special type
ZNF567::GADD45GIP1	Adenocarcinoma
ZNF567::HCST	Malignant epithelial tumor, special type
ZNF567::ZNF761	Adenocarcinoma
ZNF569::A1BG	Mesenchymal tumor, NOS
ZNF569::IZUMO2	Adenocarcinoma
ZNF569::PRRC2C	Adenocarcinoma
ZNF570::ECH1	Transitional cell carcinoma
ZNF571::CATSPERG	Squamous cell carcinoma
ZNF571::TSHZ3	Squamous cell carcinoma
ZNF577::FGFR1	Adenocarcinoma
ZNF577::GRIK5	Astrocytoma, grade I-II
ZNF577::ZNF841	Adenocarcinoma
ZNF578::MYH14	Mesothelioma
ZNF578::NRDC	Malignant melanoma
ZNF57::MRE11	Squamous cell carcinoma
ZNF57::NANOS3	Malignant melanoma
ZNF583::CCDC106	Astrocytoma, grade I-II
ZNF584::LAIR1	Adenocarcinoma
ZNF585A::CACNA1G	Adenocarcinoma
ZNF585A::CCDC3	Adenocarcinoma
ZNF585A::FXYD1	Adenocarcinoma
ZNF585A::GRAMD1A	Adenocarcinoma
ZNF585B::C2CD2L	Acute myeloid leukemia, NOS | Skin | Acute erythroleukemia (FAB type M6)
ZNF585B::CACNA1G	Adenocarcinoma
ZNF585B::MYRIP	Adenocarcinoma
ZNF586::AATF	Mesenchymal tumor, NOS
ZNF586::HCST	Adenocarcinoma
ZNF586::SRC	Adenocarcinoma
ZNF586::ZSCAN4	Adenocarcinoma
ZNF587::APOM	Malignant melanoma
ZNF587::AURKC	Adenocarcinoma
ZNF587::BRSK1	Adenocarcinoma
ZNF587::SRC	Adenocarcinoma
ZNF587::TMEM150B	Adenocarcinoma
ZNF587::ZSCAN4	Adenocarcinoma
ZNF587B::LHFPL4	Adenocarcinoma
ZNF587B::SRC	Adenocarcinoma
ZNF587B::TMEM150B	Adenocarcinoma
ZNF587B::ZNF211	Carcinoma, NOS
ZNF587B::ZSCAN4	Adenocarcinoma
ZNF589::ALS2CL	Adenocarcinoma
ZNF589::CAMP	Adenocarcinoma
ZNF589::HMCES	Adenocarcinoma
ZNF589::LRRFIP2	Mesothelioma
ZNF592::NUTM1	Giant cell tumor of bone | Malignant epithelial tumor, special type
ZNF592::ZSCAN2	Adenocarcinoma
ZNF594::SCIMP	Adenocarcinoma
ZNF595::ATP11B	Squamous cell carcinoma
ZNF595::RAB28	Mesenchymal tumor, NOS
ZNF598::VPS35L	Transitional cell carcinoma
ZNF599::SCN1B	Squamous cell carcinoma
ZNF600::ERCC1	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
ZNF600::NFX1	Adenocarcinoma
ZNF606::GDAP1	Adenocarcinoma
ZNF606::RDH13	Transitional cell carcinoma
ZNF607::ARMC5	Adenocarcinoma
ZNF607::CAPN12	Adenocarcinoma
ZNF608::ARL14EPL	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ZNF609::KIAA0753	Adenocarcinoma
ZNF609::NPTXR	Malignant epithelial tumor, special type
ZNF609::PDCD7	Squamous cell carcinoma
ZNF609::SNX1	Adenocarcinoma
ZNF610::RALA	Astrocytoma, grade III-IV/Glioblastoma
ZNF610::UQCRFS1	Adenocarcinoma
ZNF613::CYP2A6	Adenocarcinoma
ZNF613::SIGLEC7	Transitional cell carcinoma
ZNF614::FXYD5	Adenocarcinoma
ZNF614::SLC7A9	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
ZNF615::FAM174B	Adenocarcinoma
ZNF615::SLC17A7	Malignant melanoma
ZNF615::ZNF614	Adenocarcinoma
ZNF616::TRAPPC8	Adenocarcinoma
ZNF618::MTAP	Adenocarcinoma
ZNF618::NUTM1	Acute lymphoblastic leukemia/lymphoblastic lymphoma
ZNF618::PARP4	Adenocarcinoma
ZNF618::SLC31A1	Astrocytoma, grade I-II
ZNF618::SUSD1	Adenocarcinoma
ZNF618::TMEM94	Adenocarcinoma
ZNF621::LARS2	Leiomyoma
ZNF621::PIK3R4	Undifferentiated carcinoma, small cell
ZNF622::RETREG1	Adenocarcinoma
ZNF625::SCAMP4	Squamous cell carcinoma
ZNF626::ADGRE5	Adenocarcinoma
ZNF626::RERG	Adenocarcinoma
ZNF627::METTL4	Mesenchymal tumor, NOS
ZNF627::MRI1	Adenocarcinoma
ZNF627::PRKCSH	Adenocarcinoma
ZNF638::ANTXR1	Adenocarcinoma
ZNF638::C2ORF74	Adenocarcinoma
ZNF638::C2ORF78	Transitional cell carcinoma
ZNF638::C2orf74	Adenocarcinoma
ZNF638::C2orf78	Transitional cell carcinoma
ZNF638::EXOC6B	Astrocytoma, grade I-II
ZNF638::KCNS3::PPM1G	Adenocarcinoma
ZNF638::MPHOSPH10	Squamous cell carcinoma
ZNF638::PHACTR1	Adenocarcinoma
ZNF638::SNRNP27	Adenocarcinoma
ZNF638::TRIM55	Malignant epithelial tumor, special type
ZNF641::MYRFL	Mesenchymal tumor, NOS
ZNF644::DPYD	Malignant melanoma
ZNF644::PTGER3	Adenocarcinoma
ZNF644::STARD3NL	Adenocarcinoma
ZNF646::VSTM1	Adenocarcinoma
ZNF649::ZNF577	Adenocarcinoma
ZNF652::CD300LD	Adenocarcinoma
ZNF652::MRPL1	Transitional cell carcinoma
ZNF652::PHB1	Squamous cell carcinoma | Adenocarcinoma
ZNF653::CNN1	Squamous cell carcinoma
ZNF653::ELOF1	Adenocarcinoma
ZNF653::NFIC	Squamous cell carcinoma
ZNF653::PDE4A	Squamous cell carcinoma
ZNF660::ARL6	Undifferentiated carcinoma, small cell
ZNF660::OSBPL10	Mesothelioma
ZNF660::TOPAZ1	Adenocarcinoma
ZNF664::AKR1C2	Adenocarcinoma
ZNF664::DDX55	Squamous cell carcinoma
ZNF664::EIF2S2	Adenocarcinoma
ZNF664::NAP1L1	Adenocarcinoma
ZNF664::SH3BP4	Mesenchymal tumor, NOS
ZNF665::NLRP12	Transitional cell carcinoma
ZNF665::RANBP3L	Mesenchymal tumor, NOS
ZNF667::ZNF837	Malignant melanoma
ZNF667::ZSCAN5B	Squamous cell carcinoma
ZNF669::ITPKB	Adenocarcinoma
ZNF669::ZNF136	Carcinoma, NOS
ZNF66::MLLT3	Adenocarcinoma
ZNF670::CNIH3	Adenocarcinoma
ZNF671::PRRG2	Adenocarcinoma
ZNF675::ARL5C	Adenocarcinoma
ZNF675::BRCA1	Adenocarcinoma
ZNF675::DNAH17	Adenocarcinoma
ZNF675::IGSF23	Adenocarcinoma
ZNF675::SLC27A1	Malignant epithelial tumor, special type
ZNF676::KANK3	Astrocytoma, grade I-II
ZNF677::WDR88	Squamous cell carcinoma
ZNF678::DNAH7	Adenocarcinoma
ZNF678::SMIM22	Astrocytoma, grade III-IV/Glioblastoma
ZNF679::VOPP1	Adenocarcinoma
ZNF681::IMMP2L	Adenocarcinoma
ZNF682::CRLF1	Malignant melanoma
ZNF684::CPA6	Adenocarcinoma
ZNF684::EIF2B3	Germ cell tumor, NOS
ZNF689::ZNF48	Astrocytoma, grade III-IV/Glioblastoma
ZNF691::MAST2	Malignant melanoma
ZNF695::SMYD3	Adenocarcinoma
ZNF695::TFB2M	Undifferentiated carcinoma, small cell
ZNF699::ELAVL1	Adenocarcinoma
ZNF699::NR1I2	Mesenchymal tumor, NOS
ZNF699::ZSWIM4	Adenocarcinoma
ZNF69::AP3D1	Astrocytoma, grade I-II
ZNF69::CFAP52	Adenocarcinoma
ZNF700::MAST1	Adenocarcinoma
ZNF700::TEX101	Squamous cell carcinoma
ZNF700::TOX	Transitional cell carcinoma
ZNF701::PSMA7	Adenocarcinoma
ZNF703::DDX27	Adenocarcinoma
ZNF703::EIF4EBP1	Adenocarcinoma
ZNF704::CYRIB	Astrocytoma, grade I-II
ZNF704::DLGAP1	Transitional cell carcinoma
ZNF704::ETNK2	Adenocarcinoma
ZNF704::GFER	Adenocarcinoma
ZNF704::IMPA1	Malignant melanoma
ZNF704::PAG1	Squamous cell carcinoma
ZNF704::TPD52	Adenocarcinoma
ZNF706::UBC	Multiple myeloma
ZNF709::CD177	Adenocarcinoma
ZNF709::ELL	Adenocarcinoma
ZNF709::MAN2B1	Squamous cell carcinoma
ZNF710::NTRK3	Astrocytoma, grade III-IV/Glioblastoma
ZNF710::PLIN1	Adenocarcinoma
ZNF713::LANCL2	Astrocytoma, grade III-IV/Glioblastoma
ZNF713::NELFB	Transitional cell carcinoma
ZNF713::SEPTIN14	Astrocytoma, grade III-IV/Glioblastoma
ZNF714::SIGLECL1	Squamous cell carcinoma
ZNF714::STAP2	Adenocarcinoma
ZNF716::SPMIP7	Adenocarcinoma
ZNF717::FOXP1	Adenocarcinoma
ZNF717::TMEM254	Adenocarcinoma
ZNF717::ZNF37A	Acute myelomonocytic leukemia (FAB type M4)
ZNF718::PLEKHG4B	Squamous cell carcinoma
ZNF718::SLC25A33	Malignant epithelial tumor, special type
ZNF71::HSPB8	Mesenchymal tumor, NOS
ZNF71::MYRFL	Mesenchymal tumor, NOS
ZNF721::CPLX1	Adenocarcinoma
ZNF721::FASN	Adenocarcinoma
ZNF721::YAP1	Adenocarcinoma
ZNF727::SND1	Adenocarcinoma
ZNF727::STRIP2	Adenocarcinoma
ZNF727::VPS50	Transitional cell carcinoma
ZNF730::CEP89	Mesenchymal tumor, NOS
ZNF732::DAB1	Adenocarcinoma
ZNF738::MAU2	Adenocarcinoma
ZNF74::ZNRF3	Miscellaneous hematopoietic/lymphoid neoplasm, special type
ZNF750::B3GNTL1	Adenocarcinoma
ZNF75D::UBR2	Squamous cell carcinoma
ZNF761::SARNP	Adenocarcinoma
ZNF763::CXORF58	Adenocarcinoma
ZNF763::CXorf58	Adenocarcinoma
ZNF763::RAD23A	Mesenchymal tumor, NOS
ZNF763::TEX101	Squamous cell carcinoma
ZNF768::LAT	Squamous cell carcinoma
ZNF76::ANKS1A	Squamous cell carcinoma
ZNF771::ZNF48	Adenocarcinoma
ZNF772::CYP4F2	Adenocarcinoma
ZNF772::ERCC2	Astrocytoma, grade III-IV/Glioblastoma
ZNF773::PPP2R1A	Adenocarcinoma
ZNF773::SNRPD2	Astrocytoma, grade III-IV/Glioblastoma
ZNF774::TTLL13	Adenocarcinoma
ZNF77::LPCAT2	Adenocarcinoma
ZNF780A::NADSYN1	Adenocarcinoma
ZNF780A::SAMD4B	Mesothelioma
ZNF784::NLRP9	Adenocarcinoma
ZNF786::ABCF2	Adenocarcinoma
ZNF786::DENND6B	Malignant melanoma
ZNF786::LANCL2	Adenocarcinoma
ZNF789::CYP3A43	Adenocarcinoma
ZNF789::RPL37A	Adenocarcinoma
ZNF789::ZNF394	Skin | Acute myeloid leukemia, NOS
ZNF790::ATP4A	Adenocarcinoma
ZNF790::RHPN2	Astrocytoma, grade I-II
ZNF790::SAXO5	Adenocarcinoma
ZNF791::ETHE1	Adenocarcinoma
ZNF791::FGFR1	Adenocarcinoma
ZNF791::HOOK2	Adenocarcinoma
ZNF791::KMT2E	Malignant melanoma
ZNF791::RNASEH2A	Adenocarcinoma
ZNF799::EPS15L1	Adenocarcinoma
ZNF799::SIGLECL1	Mesenchymal tumor, NOS
ZNF799::WDR83OS	Adenocarcinoma
ZNF79::NIBAN2	Adenocarcinoma
ZNF79::SLC2A8	Malignant melanoma | Adenocarcinoma
ZNF7::KALRN	Adenocarcinoma
ZNF7::PPIE	Adenocarcinoma
ZNF804A::IRF2	Astrocytoma, grade I-II
ZNF804A::PDE1A	Mature B-cell neoplasm, NOS
ZNF805::ETFB	Adenocarcinoma
ZNF808::LIG1	Adenocarcinoma
ZNF808::MISP	Transitional cell carcinoma
ZNF808::PIGX	Adenocarcinoma
ZNF813::FPR3	Malignant epithelial tumor, special type
ZNF813::TOP1	Adenocarcinoma
ZNF814::EIF3B	Malignant melanoma
ZNF814::IRF3	Adenocarcinoma
ZNF814::ZNF787	Squamous cell carcinoma
ZNF814::ZSCAN18	Squamous cell carcinoma
ZNF821::CHD9	Adenocarcinoma
ZNF821::RMI2	Malignant melanoma
ZNF823::SIPA1L3	Adenocarcinoma
ZNF823::VAV1	Adenocarcinoma
ZNF827::ABCE1	Adenocarcinoma
ZNF827::EEF2	Adenocarcinoma
ZNF836::IGSF23	Squamous cell carcinoma
ZNF839::LMX1B	Adenocarcinoma
ZNF839::MYH14	Adenocarcinoma
ZNF83::PCDH15	Adenocarcinoma
ZNF83::TARM1	Adenocarcinoma
ZNF83::ZNF444	Adenocarcinoma
ZNF841::NUDT19	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
ZNF841::ZNF432	Adenocarcinoma
ZNF841::ZNF615	Adenocarcinoma
ZNF844::CMSS1	Transitional cell carcinoma
ZNF844::SLC4A4	Adenocarcinoma
ZNF846::DNMT1	Adenocarcinoma
ZNF846::NFIX	Astrocytoma, grade I-II
ZNF84::BRAF	Astrocytoma, grade III-IV/Glioblastoma
ZNF850::COX6B1	Adenocarcinoma
ZNF850::WTIP	Squamous cell carcinoma
ZNF865::AXL	Adenocarcinoma
ZNF875::ATP1A3	Adenocarcinoma
ZNF875::BLVRB	Astrocytoma, grade I-II
ZNF875::CEACAM7	Adenocarcinoma
ZNF875::CHMP2A	Adenocarcinoma
ZNF875::FECH	Adenocarcinoma
ZNF875::PPP2R3A	Adenocarcinoma
ZNF880::ATOH8	Adenocarcinoma
ZNF880::DPRX	Acute myeloid leukemia, NOS | Skin
ZNF8::SSBP4	Squamous cell carcinoma
ZNF90::CMSS1	Germ cell tumor, NOS
ZNF90::RPS16	Multiple myeloma
ZNF91::ASF1B	Embryonal nervous system tumor, special type | Malignant epithelial tumor, special type
ZNF91::CCDC88A	Adenocarcinoma
ZNF91::GATAD2A	Acute myeloblastic leukemia with minimal differentiation (FAB type M0)
ZNF91::NANOS3	Astrocytoma, grade I-II
ZNF91::NR1H2	Adenocarcinoma
ZNF91::RNF38	Adenocarcinoma
ZNF93::CYP4F22	Adenocarcinoma
ZNF98::CPAMD8	Squamous cell carcinoma
ZNF98::NDUFA7	Adenocarcinoma
ZNFX1::CNBD2	Adenocarcinoma
ZNG1A::INSL6	Adenocarcinoma
ZNG1B::MAP4K4	Adenocarcinoma
ZNHIT1::PPP1R1B	Adenocarcinoma
ZNHIT3::DYNC2I1	Transitional cell carcinoma
ZNHIT6::ANKRD26	Adenocarcinoma
ZNRD2::FRMD8	Adenocarcinoma
ZNRF1::BCAS4	Adenocarcinoma
ZNRF1::ZFPM1	Acute myeloblastic leukemia without maturation (FAB type M1)
ZNRF2::ARMC10	Adenocarcinoma
ZNRF2::BBS9	Adenocarcinoma
ZNRF2::MTURN	Adenocarcinoma
ZNRF2::TMPRSS9	Acute myeloid leukemia, NOS | Skin
ZNRF2::VANGL1	Adenocarcinoma
ZNRF3::ASCC2	Adenocarcinoma
ZNRF3::CDC42EP1	Astrocytoma, grade III-IV/Glioblastoma
ZNRF3::CRYBB2	Astrocytoma, grade I-II
ZNRF3::DCAF11	Adenocarcinoma
ZNRF3::EMID1	Adenocarcinoma
ZNRF3::EWSR1	Adenocarcinoma | Squamous cell carcinoma
ZNRF3::FGFR1	Squamous cell carcinoma
ZNRF3::ITFG1	Adenocarcinoma
ZNRF3::MED15	Squamous cell carcinoma
ZNRF3::MYH9	Malignant melanoma
ZNRF3::MYO18B	Benign epithelial tumor, special type
ZNRF3::NF2	Squamous cell carcinoma
ZNRF3::PREPL	Adenocarcinoma
ZNRF3::SLC5A1	Adenocarcinoma
ZNRF3::TAFA5	Mesenchymal tumor, NOS
ZNRF3::XBP1	Malignant melanoma
ZNRF3::ZC3H7B	Squamous cell carcinoma
ZNRF4::AP3D1	Diffuse large B-cell lymphoma
ZP3::ST7	Adenocarcinoma
ZPBP::SUGCT	Squamous cell carcinoma
ZPLD1::NXPE3	Adenocarcinoma
ZRANB1::LHPP	Squamous cell carcinoma | Adenocarcinoma
ZRANB2::MTUS2	Adenocarcinoma
ZRANB2::ROS1	Adenocarcinoma
ZRANB3::LCT	Adenocarcinoma
ZRANB3::TMEM163	Adenocarcinoma
ZSCAN18::ATP9B	Astrocytoma, grade I-II
ZSCAN18::ZNF837	Astrocytoma, grade I-II
ZSCAN22::NOSIP	Adenocarcinoma
ZSCAN22::ZNF418	Adenocarcinoma
ZSCAN25::SPATS1	Squamous cell carcinoma
ZSCAN25::TPST1	Adenocarcinoma
ZSCAN29::MGMT	Adenocarcinoma
ZSCAN5A::DKKL1	Malignant melanoma
ZSCAN5A::GALP	Squamous cell carcinoma
ZSCAN9::MRPS18A	Adenocarcinoma
ZSWIM3::PTPRT	Malignant melanoma
ZSWIM4::C19ORF53	Adenocarcinoma
ZSWIM4::FAM98C	Adenocarcinoma
ZSWIM4::HSH2D	Adenocarcinoma
ZSWIM4::MRI1	Astrocytoma, grade III-IV/Glioblastoma
ZSWIM4::RFX1	Acute erythroleukemia (FAB type M6)
ZSWIM4::SLC1A6	Squamous cell carcinoma
ZSWIM4::UBQLN4	Astrocytoma, grade III-IV/Glioblastoma
ZSWIM4::YJU2B	Adenocarcinoma | Squamous cell carcinoma | Malignant epithelial tumor, special type
ZSWIM4::ZNF540	Adenocarcinoma
ZSWIM5::TP53BP2	Adenocarcinoma
ZSWIM6::CWC27	Adenocarcinoma
ZSWIM6::LYSMD3	Adenocarcinoma
ZSWIM6::NDUFAF2	Adenocarcinoma | Malignant melanoma
ZSWIM6::RET	Carcinoma, NOS
ZW10::UPK2	Transitional cell carcinoma
ZWILCH::ATG16L2	Adenocarcinoma
ZWILCH::IQCH	Adenocarcinoma
ZWILCH::MAP2K1	Adenocarcinoma
ZXDC::UROC1	Adenocarcinoma
ZYG11B::FGGY	Squamous cell carcinoma
ZYG11B::RPS13	Multiple myeloma
ZZEF1::ANKFY1	Adenocarcinoma
ZZEF1::CCDC144A	Adenocarcinoma
ZZEF1::NLRP1	Adenocarcinoma
ZZEF1::SMG6	Adenocarcinoma
ZZEF1::SPATA22	Adenocarcinoma
ZZZ3::AK5	Squamous cell carcinoma
ZZZ3::CDH1	Adenocarcinoma
ZZZ3::CXCL11	Adenocarcinoma
ZZZ3::NCK1	Adenocarcinoma
ZZZ3::NFIA	Adenocarcinoma
ZZZ3::USP33	Malignant epithelial tumor, special type
